-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 W1agnLiyAoH4yNlnGX8LKrva/0t3gq8vF5UzKcqF27KzVov5n7tJGQXQ192fsUMn
 BlJa/TY+GHOPgPatkGbZ8w==

<SEC-DOCUMENT>0001193125-10-083947.txt : 20100415
<SEC-HEADER>0001193125-10-083947.hdr.sgml : 20100415
<ACCEPTANCE-DATETIME>20100415091934
ACCESSION NUMBER:		0001193125-10-083947
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		9
FILED AS OF DATE:		20100415
DATE AS OF CHANGE:		20100415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dehaier Medical Systems Ltd
		CENTRAL INDEX KEY:			0001474627
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-163041
		FILM NUMBER:		10750818

	BUSINESS ADDRESS:	
		STREET 1:		1223 EPOCH CENTER
		STREET 2:		NO. 31 ZI ZHU YUAN ROAD
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100089
		BUSINESS PHONE:		(8610) 5166-0080

	MAIL ADDRESS:	
		STREET 1:		1223 EPOCH CENTER
		STREET 2:		NO. 31 ZI ZHU YUAN ROAD
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100089
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d424b3.htm
<DESCRIPTION>424 (B)(3)
<TEXT>
<HTML><HEAD>
<TITLE>424 (b)(3)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Filed Pursuant to Rule 424(b)(3)<BR>File No. 333-163041 </B></FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g53110424cov.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dehaier Medical Systems Limited </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Minimum Offering: 1,250,000 Common Shares </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum Offering: 1,500,000 Common Shares </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This is the initial public offering of Dehaier Medical Systems Limited, a British Virgin Islands limited company. We are offering a minimum of 1,250,000
and a maximum of 1,500,000 of our common shares. None of our officers, directors or affiliates may purchase shares in this offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
offering price will be $8.00 per common share. No public market currently exists for our common shares. We have applied for approval for quotation on the NASDAQ Capital Market under the symbol &#147;DHRM&#148; for the common shares we are offering.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Investing in these common shares involves significant risks. See &#147;Risk Factors&#148; beginning on page 14 of this prospectus. </B>
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Per&nbsp;Common&nbsp;Share</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Minimum&nbsp;Offering</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum&nbsp;Offering</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Public offering price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.00</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,000,000</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Placement discount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.56</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">700,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">840,000</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds to us, before expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.44</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,300,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,160,000</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect our total cash
expenses for this offering to be approximately $500,000, exclusive of the above commissions. In addition, we will pay our placement agent a non-accountable expense allowance of 1% of the amount of the offering, or up to $120,000 (maximum offering,
exclusive of any shares registered under Rule 462(b)) or $100,000 (minimum offering). The placement agent must sell the minimum number of securities offered (1,250,000 common shares) if any are sold. The placement agent is only required to use its
best efforts to sell the maximum number of securities offered (1,500,000 common shares). The offering will terminate upon the earlier of: (i)&nbsp;a date mutually acceptable to us and our placement agent after which the minimum offering is sold or
(ii)&nbsp;May&nbsp;31, 2010. Until we sell at least 1,250,000 shares, all investor funds will be held in an escrow account at SunTrust Bank, Richmond, Virginia. If we do not sell at least 1,250,000 shares by May&nbsp;31, 2010, all funds will be
promptly returned to investors (within one business day) without interest or deduction. If we complete this offering, net proceeds will be delivered to our company on the closing date. We will not be able to use such proceeds in China, however,
until we complete certain remittance procedures in China. If we complete this offering, then on the closing date, we will issue common shares to investors in the offering and placement agent warrants to our placement agent exercisable at a rate of
one warrant per share to purchase up to 10% of the aggregate number of Common Shares sold in this offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>These securities have not been
approved or disapproved by the Securities and Exchange Commission or any state securities commission nor has the Securities and Exchange Commission or any state securities commission passed upon the accuracy or adequacy of this prospectus. Any
representation to the contrary is a criminal offense. </B></FONT></P> <P STYLE="font-size:24px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Anderson&nbsp;&amp; Strudwick, Incorporated </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Prospectus dated April&nbsp;15, 2010 </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g53110424ifc.jpg" ALT="LOGO"> </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Except where the context otherwise requires and for purposes of this prospectus only: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the terms &#147;we,&#148; &#147;us,&#148; &#147;our company&#148; and &#147;our&#148; refer to (i)&nbsp;Dehaier Medical Systems Limited, a British
Virgin Islands company, (ii)&nbsp;Beijing Dehaier Medical Technology Company Limited, a PRC company, (iii)&nbsp;De-haier Medical Systems (Hong Kong) Limited, a Hong Kong company and (iv)&nbsp;Beijing Dehaier Technology Company Limited, a PRC
company. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;shares&#148; and &#147;common shares&#148; refer to our common shares, $0.002731 par value per share; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;our branded products&#148; refers to those products developed by our company; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;our distributed products&#148; refers to those products developed by third parties and distributed by our company; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;our products&#148; refers both to our branded products and our distributed products. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;China&#148; and &#147;PRC&#148; refer to the People&#146;s Republic of China, and for the purpose of this prospectus only, excluding Taiwan, Hong
Kong and Macau; and &#149; all references to &#147;RMB,&#148; &#147;Renminbi&#148; and &#147;&yen;&#148; are to the legal currency of China, and all references to &#147;$&#148; and &#147;U.S. dollars&#148; are to the legal currency of the United
States. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of clarity, where the context requires us to differentiate between the entities generally referred to
collectively as &#147;our company&#148;, and for purposes of this prospectus only: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Dehaier&#148; refers to Dehaier Medical Systems Limited, a British Virgin Islands business company with limited liability.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;DHK&#148; refers to De-haier Medical Systems (Hong Kong) Limited, our wholly-owned subsidiary in Hong Kong. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;BDL&#148; refers to Beijing Dehaier Medical Technology Company Limited, our PRC operating subsidiary, of which Dehaier owns 96.37% and BTL owns
the remaining 3.63% of equity. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;BTL&#148; refers to Beijing Dehaier Technology Company Limited, a PRC company controlled by our chief executive officer, Mr.&nbsp;Ping Chen. BTL
owns approximately 3.63% of BDL&#146;s equity. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This prospectus contains translations of certain Renminbi amounts into U.S.
dollars amounts at a specified rate solely for the convenience of the reader. Except as provided below or otherwise noted, all translations made in this prospectus are based upon a rate of &yen;6.8262 to $1.00, which was the exchange rate on
September&nbsp;30, 2009. Unless otherwise stated, we have translated balance sheet amounts with the exception of equity at December&nbsp;31, 2008 at &yen;6.8225 to $1.00 as compared to &yen;7.2946 to $1.00 at December&nbsp;31, 2007. We have stated
equity accounts at their historical rate. The average translation rates applied to income statement accounts for the year ended December&nbsp;31, 2008 and the year ended December&nbsp;31, 2007 were &yen;6.9483 and &yen;7.6040, respectively. The
translation rates of DHK were not significant for the years ended December&nbsp;31, 2008 and 2007. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We make no representation that the RMB or
U.S. dollar amounts referred to in this prospectus could have been or could be converted into U.S. dollars or RMB, as the case may be, at any particular rate or at all. See &#147;Risk Factors &#150; Fluctuation of the Renminbi could materially
affect our financial condition and results of operations&#148; for discussions of the effects of fluctuating exchange rates on the value of our common shares. Any discrepancies in any table between the amounts identified as total amounts and the sum
of the amounts listed therein are due to rounding. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This prospectus follows the English naming convention of first name followed by last name,
whether an individual&#146;s name is Chinese or English. For example, the name of the chief executive officer of Dehaier is presented as &#147;Ping Chen,&#148; even though, in Chinese, his name is presented as &#147;Chen Ping.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise indicated, all information in this prospectus assumes: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">no person will exercise any outstanding options; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the sale of 1,500,000 common shares, the maximum shares offered in this offering; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">an initial public offering price of $8.00 per common share. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have relied on statistics provided by a variety publicly-available sources regarding China&#146;s expectations of growth and market potential in our
industry, increased government spending on infrastructure and economic development. We did not, directly or indirectly, sponsor or participate in the publication of such materials. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">i </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_1"></A>PROSPECTUS SUMMARY </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This summary highlights information that we present more fully in the rest of this prospectus. This summary does not contain all of the information you
should consider before buying common shares in this offering. This summary contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In some
cases, you can identify forward-looking statements by terminology such as &#147;anticipate,&#148; &#147;estimate,&#148; &#147;plan,&#148; &#147;project,&#148; &#147;continuing,&#148; &#147;ongoing,&#148; &#147;expect,&#148; &#147;we believe,&#148;
&#147;we intend,&#148; &#147;may,&#148; &#147;should,&#148; &#147;could,&#148; and similar expressions. These statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to
differ materially from any future results, performances or achievements expressed or implied by the forward-looking statements. You should read the entire prospectus carefully, including the &#147;Risk Factors&#148; section and the financial
statements and the notes to those statements. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Company </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our business consists of the marketing and sale of home respiratory and oxygen homecare products and other medical devices in China. We develop and
assemble some of our branded products ourselves from components manufactured by third parties according to our specifications. We do not manufacture these components ourselves. In addition to our branded products, we also sell a variety of products
developed, manufactured and assembled by third parties, which we refer to in this prospectus as our distributed products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to 2009, our
branded products have accounted for approximately one-third of our revenues, and our distributed products have accounted for approximately two-thirds of our revenues. In the nine months ended September&nbsp;30, 2009, our branded products and
distributed products have each accounted for approximately half of our revenues. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We sell the majority of our branded and distributed products
to distributors, and a very small amount to other end users. Distributors, however, sell their products to the same end users. We estimate that approximately 90% of our sales are to distributors, 7% are to hospitals, 1% are to clinics, and 2% are to
individuals. Based on the expected use of products sold to distributors, we estimate that they sell approximately 60% of our products to hospitals, 20% to clinics and 10% to individuals. As a result, we estimate that approximately 67% of our
products (on a revenue basis, rather than unit basis) are sold to hospitals, approximately 21% to clinics and approximately 12% to individuals. We have contractual distribution relationships with over 2,000 independent distributors, and we employ 70
direct sales and sales support personnel. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Branded Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We develop, assemble and market home respiratory and oxygen homecare products and other medical devices in China. We offer a broad range of approximately
30 products that can be used in the surgery room, patient room and at home, and we also provide technical service products to manufacturers and distributors. In recent years, we have placed a significant emphasis on our respiratory and oxygen
homecare products. Through the integration of technology, customer input, and employee creativity, we seek to provide innovative, high quality and affordable products that improve the lives of people with sleep and respiratory disorders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our branded products include medical devices, technical service products and respiratory and oxygen homecare products: </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Devices </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Mobile Medical X-Ray Image Devices. </I></B>We provide four types of DHR Explorer Series mobile and C-armed X-ray machines. X-ray is used for
visualizing bone structures and other dense tissues such as tumors. These mobile and C-armed X-ray machines provide added convenience for use in hospitals and clinics. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Anesthesia Machines.</I></B> We provide two types of DHR ORSA Series anesthesia machines. These machines are used by anesthesiologists to support
the administration of anesthesia. These machines administer a precise and continuous supply of anesthetic gases and vapors to the patient at accurate and safe levels of pressure and flow. These machines maintain a continuous, closed-loop control
over the pressure of gas within a patient&#146;s mouth or respiratory according to the selected pressure input. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Patient Monitoring Devices.</I></B> We provide two types of DHR 930 patient monitoring devices which monitor patients&#146; physiological
parameters, such as heart rate, blood pressure, respiration and temperature. We also provide polysomnograph devices, which are used to monitor and record patients&#146; sleep data through multiple parameters. These machines are suitable for adult,
pediatric and neonatal care and principally used by hospitals in intensive care units, operating rooms and emergency rooms. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Technical Service Products </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Ventilator Air Compressor. </I></B>We provide two types of air compressors to support medical ventilators in surgery by supplying continuous
airflow for the ventilator. Where a facility lacks a central pressured air supply system, our C250 and C280 air compressors provide a portable source of such pressured air. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Trolleys for Ventilators. </I></B>We provide three types of trolleys to hold ventilators and their accessories for mobility. These trolleys can
be fit with a monitor to further enhance the portability and utility. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Sterilizers for Ventilators. </I></B>We provide one type of sterilizer to treat the air from patients in order to control cross-contamination and
infection in a facility in general and for subsequent ventilator patients in particular. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Respiratory
and Oxygen Homecare Products </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Oxygen Concentrating Products.</I></B> We provide two types of oxygen concentrator products, including, the DHR-3L/5L Oxi-Fairy and the DHR-3L/5L
Oxi-Pioneer. These products use our patented advanced Pressure Swing Absorbing (&#147;PSA&#148;) technology to produce highly-concentrated, therapeutic-level oxygen (approximately 90% oxygen concentration) from air at normal temperatures. These
products are used by patients with cardiovascular disease, respiratory diseases, such as chronic obstructive pulmonary disease, and geriatric patients. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Sleep Apnea Treatment Products. </I></B>We have designed and expect to provide several products designed for obstructive sleep apnea
(&#147;OSA&#148;) therapy. These products include our DHR CPAP C5, DHR Auto CPAP A8, and DHR Auto S-CPAP A9. Our DHR CPAP C5, Auto CPAP A8 and DHR S-CPAP A9 are in the process of obtaining PRC State Food and Drug Administration (SFDA) approval and
will not be available for sale until we receive such approval. The SFDA is the competent authority on regulating the safety of medical devices in the PRC. While we expect to receive this approval within the first half of 2010, we cannot guarantee
that we will obtain such SFDA approval in this timeframe or all. These products are all non-invasive therapy products that treat symptoms of sleep apnea. Our CPAP devices do not cure apnea but instead use air pressure to open customers&#146; airways
to reduce snoring and apnea disturbances during sleep. Our automatic CPAP products provide air pressure at a customized, adjustable level, while our traditional CPAP products provide a constant level of air pressure. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Diagnostic Products. </I></B>We have designed and expect to provide two types of screening and diagnosis products are portable sleep respiratory
recording devices that can be used in a healthcare facility or in a patient&#146;s home to assist physicians in determining whether the patient has obstructive sleep apnea requiring use of a CPAP device. We have applied to SFDA for approval of our
DHR 998 and DHR 999 diagnostic products, and they will not be available for sale until we receive such approval. While we expect to receive this approval within the first half of 2010, we cannot guarantee that we will obtain such SFDA approval in
this timeframe or all. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Thermotherapy Products</I></B>. We have designed and expect to provide our thermotherapy device for patients with rhinitis and delivers atomized
clean water at a therapeutic temperature to the affected site. We have not yet begun to market this device and cannot project when we will begin to market this device. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Distributed Products </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We serve as a
significant distributor in China for several foreign producers of medical devices and respiratory and oxygen homecare products, including IMD, Timesco, JMS and ResMed. We believe this extensive platform allows us to be responsive to local market
demand. We distribute medical devices and respiratory and oxygen homecare products for these companies. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Devices
</I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Mobile Medical X-Ray Image Devices. </I></B>We provide two types of X-ray machines developed by other companies: the IMD Radius Series mobile and
C-armed X-ray machine and the IMD Compact Series mobile-X-ray machine. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Ventilator. </I></B>We provide three types of ventilators developed by other companies: the ResMed VS Serena, Ultra and Integra
Ventilators. The VS Series of medical ventilators mechanically move breathable air to and from the lungs to support breathing support for patients who are physically unable to breathe or who are breathing insufficiently.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Laryngoscopes</I></B>. We provide four types of laryngoscopes developed by other companies: the Optima, Optima XL and Eclipse lines of
laryngoscopes from Timesco. Laryngoscopes are flexible lighted tubes that are used to look at the inside of the larynx. Anesthesiologists make use of laryngoscopes to assist with intubation in surgery. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Respiratory and Oxygen Homecare Products </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Sleep Apnea Treatment Products. </I></B>We provide two types of products developed by other companies designed for obstructive sleep apnea
(&#147;OSA&#148;) therapy. These products include the ResMed S6 and MAP MiniPAP. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Distribution Network
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To date, we have sold medical devices developed by our company and other producers to hospitals, clinics and other healthcare facilities
and have sold respiratory and oxygen homecare products to individual customers. We leverage our network of relationships with healthcare facilities and with distributors to drive sales of both our branded products and our distributed products. By
growing our distribution network and product offerings, we are able to offer both branded and distributed products for sale, depending on the needs and budget of the customer. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Assembly </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We assemble some of our
branded product components and final branded products at our assembly facility in Beijing. We employ 40 full-time employees at this facility. Every year we assemble under ten thousand of our branded products at this assembly facility. In some cases,
we assemble final branded products from components manufactured for us by our suppliers. For example, we assemble between approximately 40 and 50 C-arm X-ray machines each year from components supplied by our suppliers. We also allow Friend of
Health (Chuzhou) Medical Technology Co. Ltd. (&#147;Friend of Health&#148;) to assemble and distribute some of our branded products. Friend of Health assembles some of our oxygen concentrators and air compressors then distributes them in Chuzhou. No
other companies have this right to assemble and then directly distribute final products. In other cases, we assemble components that must be incorporated into final branded products. For example, we assemble the core component of our oxygen
concentrators, the oxi-chip, in our assembly facility and then provide that oxi-chip to another company for inclusion in the oxygen concentrator assembled by that company. Depending on the component or branded product, we assemble between
approximately 40 (C-arm X-ray machines) and more than 5,000 (oxi-chip) products or components annually. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Marketing </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We focus our marketing efforts on two annual exhibitions of medical devices in China and on our Customer Experience Centers (&#147;CECs&#148;). We use the
annual exhibitions to introduce our branded and distributed product offerings to distributors and end users. We have focused on meeting potential new distributors at these meetings and on showing our solutions to potential purchasers of those
branded and distributed products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have used our CEC model as another method to introduce our branded and distributed products to potential
purchasers. The CEC allows distributors, hospital and clinic representatives, individual purchasers and other interested parties to see how the products work in practice. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To date, we have not provided any market support to any distributors and have no current plans to do so. Distributors are responsible for meeting their
sales goals, and we understand that some distributors may purchase advertising. Nevertheless, Dehaier does not currently reimburse any such costs for growing such distributors&#146; client bases. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Industry </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In April
2009, the Chinese government implemented large-scale healthcare reform. The State Council allocated $123 billion as part of its New Medical Reform Plan. The plan, which is part of China&#146;s stimulus package aimed at correcting the recent global
economic down-turn, contemplates the development of a universal healthcare system that will cover 90% of China&#146;s population by the end of 2010 and will provide health coverage for all Chinese by 2020. In addition, the plan includes significant
improvements to health care facilities and expansion of China&#146;s health related infrastructure. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Specifically, within three years, the
Chinese government aims to improve the urban healthcare system by rebuilding and restructuring approximately 3,700 existing urban community health centers and 11,000 community health clinics. The plan will also accommodate the development of
approximately 2,400 new urban health centers. In effect, the plan de-emphasizes the prevalence of large, magnet facilities in favor of smaller, more accessible clinics. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, the plan is designed to dramatically improve medical services available for the 800&nbsp;million rural poor in China. Through the plan, the
Chinese government contemplates the development of clinics in every village and a hospital in every county in China by the end of 2011. If successfully implemented, the plan would result in at least 2,000 new county-level hospitals and 29,000
township hospitals and the upgrading of another 5,000 more. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Opportunity </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that we are well positioned to benefit from the rapid growth of expenditures on medical devices in China and the growing demand for domestic
medical devices in China. A recent article published by the Wharton School of the University of Pennsylvania suggests that the expected value of China&#146;s medical device market will reach $28 billion by 2014. As this market was valued at $12.14
billion in 2008, or roughly one-eighth of China&#146;s overall healthcare market, there may still be significant potential for growth. China&#146;s medical device market is projected to grow faster than the global medical device market. China is
already the third largest medical device market in the world behind the United States and Japan, and within the next five to seven years China is expected to surpass Japan and become the second largest medical device market in the world. The
respiratory and oxygen homecare market in China is also experiencing rapid growth. Market growth rates for 2009 are projected at 11.2%. Reasons for the rapid growth of China&#146;s medical device market include: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">fast growing economy; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increasing percentage of gross domestic product, or GDP, expected to be spent on healthcare by the Chinese government; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increasing desire for and utilization of more advanced technologies in Chinese hospitals and clinics; </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increasing availability of healthcare insurance; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">higher degree of operating autonomy at hospitals and clinics; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">growing desire for better quality of care. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Hospitals and clinics in China purchase almost all of their medical devices and supplies through distributors. These distributors tend to operate in
small territories in China, and many focus on eastern coastal cities. As a result, medical device companies need to develop relationships with several distributors in different regions to be able to reach a broad end user base. We believe the
ability to leverage local contacts and knowledge is vital in establishing an effective distribution network, constituting a significant barrier to entry for both smaller local companies and international competitors that lack a meaningful local
presence in China. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Competitive Strengths </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe we have the following principal competitive strengths, enabling us to attain a leading position in China&#146;s medical device and respiratory
and oxygen homecare industries: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our established brand and market position in China&#146;s medical device and respiratory and oxygen homecare industries; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our established distribution, sales and service network throughout China; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our research and development capabilities; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our established relationships with foreign medical device manufacturers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our established relationships with hospital customers; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">dedicated customer support and service. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Strategies </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our
objective is to strengthen our position as one of China&#146;s leaders in developing, assembling and marketing respiratory and oxygen homecare products and to develop a presence in certain select foreign markets, including, Europe and America. We
intend to achieve our objective by implementing the following strategies: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increasing our market share in China&#146;s respiratory and oxygen homecare market; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increasing our focus on research and development in order to develop more advanced products and new product lines; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">enhancing our market position and brand recognition in China as well as other certain select foreign markets; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">maintaining our disciplined cost focus; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">pursuing favorable opportunities to acquire complementary businesses; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">maintaining our distribution network through active management and regular reviews of distributor performance. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Challenges and Risks </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The successful execution of our strategies is subject to certain risks and uncertainties, including those related to: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">uncertainties in our development, introduction and marketing of new solution and services; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">recruitment, training and retention of skilled engineers and other personnel; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to respond to competitive pressures; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to build our brand recognition in our existing and any future markets; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to increase the market penetration of our products; </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to export our branded products to new markets in the future; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">uncertainties in the fluctuation of the RMB; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">uncertainties in the world economy, including potential continuance and recurrence of the current global economic slowdown;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to purchase products from our international suppliers at competitive prices; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">protection of our trade secrets and other valuable intellectual property; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to identify and negotiate favorable opportunities to acquire complementary businesses; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">complexities of the regulatory environment in China. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we face risks and uncertainties that may materially affect our business, financial condition, results of operations and prospects. Thus, you
should consider the risks discussed in &#147;Risk Factors&#148; and elsewhere in this prospectus before investing in our common shares. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Corporate Structure </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Historical Overview </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our founder,
Mr.&nbsp;Ping Chen, founded BTL on July&nbsp;5, 2001 to develop and distribute medical devices. He currently owns approximately 86% of BTL, and his wife and employees of Dehaier own the remaining 14% of BTL. BTL leases some of our property to us and
provides certain transportation and repair services to medical devices for which we are not obligated to perform warranty services, either because the warranty is expired or because the product was sold by another company. BTL served as the domestic
partner to our joint venture pursuant to which we, a British Virgin Islands company, own the majority BDL, a PRC company in the medical device business. At the time of the formation of the joint venture, foreign enterprises were not permitted to own
such companies without PRC partners. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2003, in order to continue to grow our business, BTL engaged in a corporate restructuring and Series
A venture capital financing. As a result of those actions, Dehaier, BDL and DHK were established and a venture capital investor, De-haier Investment Holdings, Ltd., a British Virgin Islands company, became a shareholder in Dehaier. At the same time,
Mr.&nbsp;Chen&#146;s wholly-owned company, Chen Ping Ltd., became a shareholder in Dehaier, and we created the holding company structure that is currently in place. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dehaier was incorporated as an international business company under the International Business Companies Act, 1984, in the British Virgin Islands on
July&nbsp;22, 2003 under the name &#147;De-Haier Medical Systems Limited.&#148; We changed this name to &#147;Dehaier Medical Systems Limited&#148; on June&nbsp;3, 2005. Dehaier is a holding company. Dehaier does not conduct business in China and
instead relies on BDL to conduct business in China. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On September&nbsp;24, 2003, we established BDL. BDL conducts substantially all of our
operations in China and is responsible for generating substantially all of our revenues. BDL was formed as a joint venture between a Chinese entity, BTL, and a foreign invested enterprise, Dehaier, in order to allow foreign investments to be used to
grow our business. Because BDL is engaged in an encouraged industry under the Foreign Investment Industrial Guidance Catalogue, it was allowed to have foreign investments and to be established as a Chinese-foreign equity joint-venture. This
structure allowed BDL access to foreign capital that would not have been available outside this structure. In addition to its engagement in an encouraged industry, the use of this joint venture structure allowed BDL to take advantage of favorable
tax rates available prior to January&nbsp;1, 2008. Before January&nbsp;1, 2008, equity joint-ventures such as BDL could enjoy a preferential enterprise income tax rate of 24%. In addition to the lower standard rate, such equity joint-ventures were
also allowed a two-year income tax exemption from the date they first became profitable and a 50% income tax reduction for the following three years after that time. After January&nbsp;1, 2008, the income tax rates were unified at 25% under the PRC
Enterprise Income Tax Law; however, BDL&#146;s ability to pay lower income taxes prior to this date left it with more net income with which to grow its business. See &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results
of Operations - Tax Matters Applicable to Our Company &#151; PRC Enterprise Income Taxes.&#148; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October&nbsp;15, 2003, we founded DHK and created a holding company structure by which we are the
parent company of BDL and DHK. DHK was formed in anticipation of opportunities to make use of its status as a Hong Kong company to grow our business; we have not yet made significant use of DHK for such purposes and have no present plans to do so.
BDL has been focused on the development and distribution of medical devices since its inception and began developing its respiratory and oxygen homecare business in 2006. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective as of January&nbsp;5, 2007, we completed a Series B venture capital financing with Crystal East Group Limited, a British Virgin Islands
company. Crystal East Group Limited subsequently completed the transfer of its shares to its individual shareholder, Yijen Chen. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Relationship among Dehaier, BTL, BDL and DHK </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BTL is a PRC company established on July&nbsp;5, 2001. Dehaier is a BVI company established on July&nbsp;22, 2003. DHK is a Hong Kong company established
on October&nbsp;15, 2003. Dehaier and BTL jointly established BDL on September&nbsp;24, 2003 as a Chinese-foreign equity joint-venture under the PRC laws. Dehaier has been and is BDL&#146;s foreign shareholder, and BTL has been and is BDL&#146;s
domestic shareholder since BDL was established. Currently, Dehaier owns 96.37% of BDL, and BTL owns 3.63% of BDL. Under PRC laws, the shareholders of the equity joint-venture share the profits, risks and losses in proportion to their respective
contributions of the equity joint-venture. DHK is the wholly owned subsidiary of Dehaier. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2009 Restructuring </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In preparation for the commencement of this initial public offering, our company completed a restructuring to accomplish two goals. First, we sought to
convert all Series A and Series B Preferred Shares into common shares. Second, we completed a shares split so that we would have, in the aggregate, 3,000,000 common shares outstanding prior to commencement of the offering. As to the first goal, our
Series A and Series B Preferred shareholders agreed to convert their respective Series A and Series B Preferred Shares into an equal number of our common shares. This 1:1 conversion was completed without consideration. As to the second goal, we
completed a 3.66140766-for-1 share split of common shares completed of October&nbsp;31, 2009. As a result of the conversions and share split, we have 3,000,000 common shares issued and outstanding prior to commencement of this offering and no issued
and outstanding preferred shares. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Structure </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of the above 2003 restructuring, rounds of financing completed in 2003 and 2007 and the 2009 conversion of outstanding preferred shares, the
following diagram illustrates our current corporate structure as of the date of this prospectus. </FONT></P>
 <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g53110424txpg8.jpg" ALT="LOGO"> </P>
 <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chen Ping Ltd. is a British Virgin Islands company beneficially owned by our Chief Executive Officer, Mr.&nbsp;Ping Chen. </FONT></P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">These shares were initially acquired by Crystal East Group Limited, a British Virgin Islands company, in our second round of venture capital financing.
Crystal East Group Limited transferred the Series B preferred shares to its shareholder, Ms.&nbsp;Chen, and such shares were converted into our common shares as of October&nbsp;31, 2009. Ms.&nbsp;Chen is not related to our chief executive officer,
Mr.&nbsp;Ping Chen. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">De-haier Investment Holdings Ltd, a British Virgin Islands company wholly owned by Milestone Capital Management Limited, obtained these shares in our
first round of venture capital financing. These Series A preferred shares were converted into our common shares as of October&nbsp;31, 2009. Ms. Yunli Lou and Mr.&nbsp;Liping Qiu, who are managers of Milestone Capital Management Limited, currently
serve on the board of directors of BDL, the majority owned subsidiary of Dehaier. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Such shareholders consist of employees and consultants to our company. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dehaier is our British Virgin Islands holding company that seeks to register its common shares in this initial public offering.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHK is a Hong Kong company owned by Dehaier, through which we may in the future conduct operations. We do not, however, have any present plans to do
so. We do not currently receive any significant revenues through DHK. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">BTL is a variable interest entity, and BDL is the primary beneficiary. BTL owns a building which is pledged as collateral for BDL&#146;s bank loans. In
exchange, BDL loans money to BTL to finance its operations. Dehaier, BDL and BTL are under common control, and BDL provides substantial financial support to BTL. This substantial financial support is primarily for working capital loans to finance
BTL&#146;s operations. At December&nbsp;31, 2006, 2007, 2008 and September&nbsp;30, 2009, BDL had advanced to BTL funds in the amount of $823,405, $786,816, $292,011 and $164,248, which represented 87%, 74%, 24% and 13% of BTL&#146;s equity,
respectively. Because BTL has insufficient equity to finance its </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
operations, BTL then is required to obtain additional financial support to fund its operations. Accordingly, BTL&#146;s sales are included in Dehaier&#146;s consolidated income from operations.
Mr.&nbsp;Chen owns 86% of BTL and his wife and employees of Dehaier own the remaining 14%. BTL performs certain out-of-warranty repair work for products we sell and provides transportation services related to such services. </FONT></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">BDL is our Chinese operating entity. We develop, assemble, market and distribute our branded products through BDL, and we market and distribute our
distributed products developed by other companies through BDL. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Offering </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="43%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares Offered:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Minimum:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,250,000 common shares</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Maximum:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,500,000 common shares</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares Outstanding Prior to Completion of Offering:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000 common shares</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares to be Outstanding after Offering:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Minimum:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,250,000 common shares</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Maximum:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,500,000 common shares</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Offering Price per Share:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$8.00</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gross Proceeds:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Minimum:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$10,000,000</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Maximum:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$12,000,000</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed NASDAQ Capital Market Symbol:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;DHRM&#148; (CUSIP No. G27010 100)</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Transfer Agent:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Computershare Trust Company, N.A.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">250 Royall Street, Canton, Massachusetts 02021</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Risk Factors:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Investing in these securities involves a high degree of risk. As an investor, you should be able to bear a complete loss of your investment. You should carefully
consider the information set forth in the &#147;Risk Factors&#148; section of this prospectus before deciding to invest in our common shares.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Closing of Offering:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">The offering contemplated by this prospectus will terminate upon the earlier of: (i)&nbsp;a date mutually acceptable to us and our placement agent after the minimum
offering is sold or (ii)&nbsp;May&nbsp;31, 2010. If we complete this offering, net proceeds will be delivered to our company on the closing date (such closing date being the above mutually acceptable date on or before May&nbsp;31, 2010, provided the
minimum offering has been sold). We will not complete this offering unless our application to list on the NASDAQ Capital Market is approved. We will not be able to use such proceeds in China, however, until we complete certain remittance procedures
in China. If we complete this offering, then on the closing date, we will issue shares to investors and placement agent warrants to our placement agent exercisable at a rate of one warrant per share to purchase up to 10% of the aggregate number of
common shares sold in this offering.</FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Placement </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have engaged Anderson&nbsp;&amp; Strudwick, Incorporated to conduct this offering on a &#147;best efforts, minimum/maximum&#148; basis. The offering
is being made without a firm commitment by the placement agent, which has no obligation or commitment to purchase any of our common shares. Our placement agent is required to use only its best efforts to sell the securities offered. The offering
will terminate upon the earlier of: (i)&nbsp;a date mutually acceptable to us and our placement agent after which at least 1,250,000 common shares are sold or (ii)&nbsp;May&nbsp;31, 2010. Until we sell at least 1,250,000 common shares, all investor
funds will be held in an escrow account at SunTrust Bank, Richmond, Virginia. If we do not sell at least 1,250,000 common shares by May&nbsp;31, 2010, all funds will be promptly returned to investors (within one business day) without interest or
deduction. If we complete this offering, net proceeds will be delivered to our company on the closing date. We will not be able to use such proceeds in China, however, until we complete certain remittance procedures in China. None of our officers,
directors or affiliates may purchase shares in this offering. If we complete this offering, then on the closing date, we will issue shares to investors and placement agent warrants to our placement agent exercisable at a rate of one warrant per
share to purchase up to 10% of the aggregate number of Common Shares Sold in this offering. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Make-Good Escrow </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have agreed with our placement agent to value our company on a forward-looking basis based on a multiple of approximately 6.6 times our targeted
after-tax earnings for the year ending December&nbsp;31, 2010, subject to the terms of a Make-Good Escrow Agreement, which has been executed, and our ability to redeem a sufficient number of Make-Good Shares to meet our target audited after-tax
earnings per share for the year ending December&nbsp;31, 2010, as more fully discussed below. We have 3,000,000 common shares outstanding prior to this offering and our valuation is based on targeted 2010 net income of $3,600,000. Based on the
valuation of our company at approximately $24,000,000 using this methodology, our earnings for the year ending December&nbsp;31, 2010 would be approximately $0.80 per share, assuming a maximum offering (4,500,000 ordinary shares outstanding upon
completion of the offering). This number excludes any shares issuable under the option pool or underlying the placement agent warrants. If we are unable to achieve these targeted after-tax earnings, then there is a risk that our company would be
considered overvalued based on this multiple. In order to mitigate some of this risk, Ping Chen, Zheng (Rita) Liu, Weibing Yang, Jian Sun and Yong Wang have collectively placed an aggregate of 600,000 common shares into escrow. This number is equal
to 40% of the maximum number of shares to be sold in this offering. Upon closing of this offering, the escrow agent will return any shares in excess of 40% of the actual number of shares sold in the offering. Such escrowed shares are referred to as
the &#147;Make-Good Shares.&#148; The Make-Good Shares will remain in escrow with SunTrust Bank or another bank acceptable to our placement agent pending the filing of our company&#146;s Form 10-K for the year ending December&nbsp;31, 2010.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the extent our audited after-tax earnings per share for the year ending December&nbsp;31, 2010 are less than the target of $0.80,
excluding any expenses associated with releasing the Make-Good Shares back to the original owners, our company will redeem and cancel, pro rata, the Make-Good Shares without any consideration to the extent necessary to cause our audited after-tax
earnings per share to be equal to the target of $0.80. We cannot guarantee that we will be able to redeem a sufficient number of Make-Good Shares to increase audited after-tax earnings per share to the target of $0.80 if our company either has low
net income or any net losses in 2010. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any remaining Make-Good Shares will be released from escrow to our initial shareholders upon the
earlier of (i)&nbsp;one (1)&nbsp;business day after the termination of this offering without closing or (ii)&nbsp;thirty (30)&nbsp;calendar days after the filing of the Form 10-K for the year ending December&nbsp;31, 2010 after redeeming any
Make-Good Shares. Additionally, notwithstanding any other terms of the Make-Good Escrow, if our shares trade at or above 2.5 times the price of this offering for a period of five trading days within a ten day trading period, the Make-Good Escrow
will terminate and the Make-Good Shares will be released to the initial shareholders. Any delay in redeeming the Make-Good Shares will delay the release of such remaining Make-Good Shares from escrow. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe the Make-Good Escrow arrangement benefits the shareholders of our company (other than those
who may forfeit shares without consideration) because it is designed to increase the likelihood that our company will achieve the after-tax earnings per share upon which our valuation is based. To the extent Make-Good Shares are redeemed without
cost, the after-tax per-share earnings will increase for all remaining outstanding shares. While we believe the Make-Good Escrow arrangement is a benefit to our shareholders, we may be unable to redeem enough Make-Good Shares to reach our targeted
2010 after-tax earnings per share. This could occur if we either have net losses or substantially lower than anticipated earnings. If this were to happen, our audited after-tax earnings after redemption of the Make-Good Shares could be less than the
target of $0.80 per share. See &#147;Risk Factors &#150; A redemption of Make-Good Shares may be insufficient to cause our company to achieve targeted earnings and may reduce our management&#146;s involvement and stake in our company.&#148;
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Placement Agent&#146;s Warrants </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with this offering, we will, for a nominal amount, sell our placement agent warrants exercisable at a rate of one warrant per share to
purchase up to ten percent of the shares sold in the offering. These warrants are exercisable for a period of five years from the date of issuance at a price equal to 125% of the price of the shares in this offering. If we complete the maximum
offering, then on the closing date we will issue 150,000 warrants to the placement agent to purchase one common share each. During the term of the warrants, the holders thereof will be given the opportunity to profit from a rise in the market price
of our common shares, with a resulting dilution in the interest of our other shareholders. The terms on which we could obtain additional capital during the life of these warrants may be adversely affected because the holders of these warrants might
be expected to exercise them when we are able to obtain any needed additional capital in a new offering of securities at a price greater than the exercise price of the warrants. If the placement agent exercises all of its warrants, we would have
between 2.94% (minimum offering) and 3.33% (maximum offering) more shares outstanding after the placement agent&#146;s warrant exercise than at the conclusion of the offering, assuming no other issuances (including any issuances under the share
incentive plan). See &#147;Placement.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Corporate Information </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our principal executive offices are located at 1223 Epoch Center, No.&nbsp;31 Zi Zhu Yuan Road, Haidian District, Beijing, People&#146;s Republic of China
(100089). Our website address is http://www.chinadhr.com. Information contained on our website or any other website is not a part of this prospectus. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Financial Information </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the table below, we provide you with summary financial data of our company. This information is derived from our consolidated financial statements
included elsewhere in this prospectus. Historical results are not necessarily indicative of the results that may be expected for any future period. When you read this historical selected financial data, it is important that you read it along with
the historical statements and notes and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; included elsewhere in this prospectus. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD ROWSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the nine<BR>months ended<BR>September&nbsp;30,&nbsp;2009</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the fiscal year ended<BR>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,422,460</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,414,430</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,599,512</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,586,824</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,496,086</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">970,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,110,278</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">980,351</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">848,421</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-controlling interest in income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(38,502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(62,331</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(53,214</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income attributable to Dehaier</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,071,776</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">918,020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">795,207</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic earnings per share (based on 1,891,930 shares outstanding on each of September&nbsp;30, 2009,&nbsp;December&nbsp;31, 2008
and 2007)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Diluted earnings per share (based on 3,000,000, 3,000,000 and 2,451,624 shares outstanding on September&nbsp;30,
2009,&nbsp;December&nbsp;31, 2008 and 2007,
respectively)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pro forma basic earnings per share (based on 1,291,930 shares outstanding on each of September&nbsp;30, 2009 and
December&nbsp;31,&nbsp;2008)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pro forma diluted earnings per share (based on 2,400,000 shares outstanding on each of September&nbsp;30, 2009 and
December&nbsp;31, 2008, respectively)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.86</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="8"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30, 2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,485,711</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,046,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,928,863</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,566,373</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,232,464</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,550,505</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Dehaier shareholders&#146; equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,676,245</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,608,704</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,310,499</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-controlling interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,243,093</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,205,232</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,067,859</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities and shareholders&#146; equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,485,711</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,046,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,928,863</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have presented these basic and diluted earnings per share in Dehaier after giving retroactive effect to the 3.66140766-for-1 share split of common
shares completed as of October&nbsp;31, 2009. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">We have presented
these pro forma earnings per share after (a)&nbsp;giving retroactive effect to the 3.66140766-for-1 share split of our common shares completed as of October&nbsp;31, 2009 and (b)&nbsp;assuming the redemption of all shares placed into escrow as
described in the section entitled &#147;Related Party Transactions &#150; Make-Good Shares Subject to Redemption.&#148; The number of escrowed shares is based on 600,000 common shares (40% of an assumed maximum of 1,500,000 common shares). Pro forma
basic EPS for the nine months ended September&nbsp;30, 2008 calculated on the foregoing assumptions and based on 1,291,930 Dehaier shares, is $0.40. Pro forma diluted EPS for the nine months ended September&nbsp;30, 2008 calculated on the foregoing
assumptions and based on 2,400,000 Dehaier shares, is $0.22. No pro forma numbers have been provided for the year ended December&nbsp;31, 2007. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</div></div>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_2"></A>RISK FACTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Investment in our securities involves a high degree of risk. You should carefully consider the risks described below together with all of the other
information included in this prospectus before making an investment decision. The risks and uncertainties described below represent our known material risks to our business. If any of the following risks actually occurs, our business, financial
condition or results of operations could suffer. In that case, you may lose all or part of your investment. You should not invest in this offering unless you can afford to lose your entire investment. </I></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Risks Related to Our Business and Industry </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We may be unable to pay our bank loan as it becomes due. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On May&nbsp;5, 2009, we borrowed RMB 10,000,000 from International and Commercial Bank of China (&#147;ICBC&#148;). We pay interest on this loan on a
monthly basis. As originally structured, the principal on this loan was to be repaid as follows: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RMB 2,000,000 on
November&nbsp;20, 2009 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RMB 3,000,000 on March&nbsp;20, 2010 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RMB 5,000,000 on May&nbsp;20, 2010. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On November&nbsp;17, 2009, we and ICBC agreed to modify the principal repayment terms of the loan as follows: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RMB 1,000,000 on January&nbsp;20, 2010 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RMB 4,000,000 on March&nbsp;20, 2010 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RMB 5,000,000 on May&nbsp;20, 2010 </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We made the RMB 1,000,000 payment on January&nbsp;20, 2010 as required. On March&nbsp;16, 2010, although we had sufficient cash to pay RMB 4,000,000, we
and ICBC agreed to modify the principal repayment terms of the loan. On March&nbsp;18, 2010, we and the bank executed an amendment that provides for principal repayment as follows: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RMB 3,000,000 on March&nbsp;20, 2010 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RMB 6,000,000 on May&nbsp;20, 2010 </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We made the RMB 3,000,000 principal payment on March&nbsp;18, 2010, two days before it was due under the loan, as modified. We do not currently have cash
and cash equivalents sufficient to repay the remaining RMB 6,000,000 in principal. Instead, we are relying on our projected cash flow to be able to repay the remaining principal on this loan. If we do not have sufficient cash to repay the loan as it
becomes due, we may need to seek to renegotiate the terms of the loan with ICBC. If we are unable to do so on terms that are acceptable to us or at all, or if we are otherwise unable to repay the loan when it matures, then ICBC will be able to seek
payment from our chief executive officer (through a personal guaranty offered by Mr.&nbsp;Ping Chen) and from BTL (through a mortgage on property of BTL). Because we have committed not to use proceeds from this offering for the repayment of the ICBC
loan, we must rely solely on existing capital resources for such repayment, and we have no guaranty that we will have sufficient capital for such repayment at such time as we require. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Repayment of the ICBC loan may significantly reduce our working capital and harm our liquidity. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have committed not to use any of the proceeds from this offering for the repayment of the ICBC loan. We have, however, allocated 25% of the proceeds
from this offering for working capital purposes. To the extent we have sufficient funds to repay the ICBC loan from our existing capital resources, we expect that such repayment will significantly deplete such resources. As a result, the funds
allocated to working capital in this offering may constitute a substantial percentage of our working capital after this offering is completed. Further, by using offering proceeds to replenish a portion of working capital after existing working
capital is used to repay the ICBC loan, we may not increase the total amount of working capital we need for ongoing operations. If we were to determine that this is the case, we may need to seek additional sources of capital, including equity or
debt financing. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>BTL may be unable to perform its contractual obligations to repay BDL&#146;s bank loan in the event BDL
defaults on the loan or to indemnify our chief executive officer if he is required to perform under his personal guarantee of the bank loan. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BTL has pledged its property at 45 Yong An Road, Science Park, Changping District, Beijing, 102200, as collateral for BDL&#146;s loan contract executed
on May&nbsp;5, 2009 with ICBC in Beijing. In addition, our chief executive officer, Mr.&nbsp;Chen, has personally guaranteed BDL&#146;s ICBC bank loan. BTL, in turn, has agreed to indemnify Mr.&nbsp;Chen and guarantee his performance should he ever
be called on to perform under BDL&#146;s bank loan. BTL and Mr.&nbsp;Chen entered into this agreement in order to effect the parties&#146; intentions that BTL, rather than Mr.&nbsp;Chen, would be the party responsible for guaranteeing BDL&#146;s
performance under the bank loan. If BDL is unable to perform the obligations of its bank loan, BTL would be contractually obligated to pay ICBC or Mr.&nbsp;Chen, if Mr.&nbsp;Chen has already paid the bank under his personal guarantee; however,
because BTL relies on funds from BDL to operate, it would likely have to sell the property interest it has pledged as collateral for BDL&#146;s bank loan in order to have sufficient funds to perform under these contractual obligations. If BTL were
unable to sell the property interest for the full amount outstanding on the loan, BTL would be unable to repay the loan. Additionally, to the extent Mr.&nbsp;Chen is forced to make any out of pocket payments to ICBC in accordance with his guarantee
of BDL&#146;s loan, BTL may not have sufficient funds to indemnify him as it has agreed to do, if BTL cannot sell the property interest for a sufficient amount. See &#147;Related Party Transactions.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our quarterly revenues and operating results are difficult to predict and could fall below investor expectations, which could cause the trading price
of our common shares to decline. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our quarterly revenues and operating results have fluctuated in the past and may continue to fluctuate
significantly depending upon numerous factors. In particular, during the period from April to May, we generally experience an increase in revenues associated with our attendance at the China International Medical Equipment Fair, the largest
exhibition of medical equipment, related products and services in Asia-Pacific region. This fair occurs in the spring each year. In addition, we generally experience an increase in revenues in the period from September through November. This
increase is associated with hospital purchasing designed to extinguish governmental budgets prior to the fiscal year end. We believe that our first quarter performance will generally decline as a result of the lack of business conducted during the
Chinese Lunar New Year Holiday. To the extent our financial performance fluctuates significantly, investors may lose confidence in our business and the price of our common shares could decrease. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We may fail to effectively develop and commercialize new products, which could materially and adversely affect our business, financial condition,
results of operations and prospects. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The respiratory and oxygen homecare market is developing rapidly and related technology trends are
constantly evolving. This results in the frequent introduction of new products, short product life cycles and significant price competition. Consequently, our future success depends on our ability to anticipate technology development trends and
identify, develop and commercialize in a timely and cost-effective manner the new and advanced products that our customers demand. New products contribute significantly to our revenues. In 2008, we developed three new products in the respiratory and
oxygen homecare market. We expect the respiratory and oxygen homecare market to continue to evolve toward newer and more advanced products. Moreover, it may take an extended period of time for our new products to gain market acceptance, if at all.
Furthermore, as the life cycle for a product matures, the average selling price generally decreases. In the future, we may be unable to offset the effect of declining average sales prices through increased sales volume and controlling product costs.
Lastly, during a product&#146;s life cycle, problems may arise regarding regulatory, intellectual property, product liability or other issues which may affect the product&#146;s continued commercial viability. Whether we are successful in developing
and commercializing new products will depend on our ability to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">accurately assess technology trends and customer needs and meet market demands; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">optimize our assembly and procurement processes to predict and control costs; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">assemble and deliver products in a timely manner; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increase customer awareness and acceptance of our products; </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">minimize the time and costs required to obtain required regulatory clearances or approvals; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">anticipate and compete effectively with other medical device developers, manufacturers and marketers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">price our products competitively; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">effectively integrate customer feedback into our research and development planning. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our revenues are highly dependent on a limited number of customers involved in China&#146;s healthcare device industry. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September 2009 and 2008, approximately 11%, 17%, 8% and 7%,
respectively, of our sales were from one customer, Poverty Aid Office. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We anticipate that our dependence on a limited number of customers
will continue for the foreseeable future. Consequently, any one of the following events may cause material fluctuations or declines in our revenues: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reduction, delay or cancellation of orders from one or more of our significant customers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">loss of one or more of our significant customers and our failure to identify additional or replacement customers; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">failure of any of our significant customers to make timely payment for our products. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To anticipate our client&#146;s future needs, we must maintain a close relationship with our key customers. Any failure to maintain this close
relationship, due to unsuccessful sales and marketing efforts, lack of suitable products, unsatisfactory performance or other reasons, could result in our losing a client and its business. If we lose a key customer or a portion of work we currently
receive from it, a key customer significantly reduces its purchasing levels or delays a major purchase or we fail to attract additional major customers, our revenues could decline, and our operating results could be materially and adversely
affected. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We sell our products primarily to distributors and our ability to add distributors will impact our revenue growth. Failure to
maintain or expand our distribution network would materially and adversely affect our business. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">With contractual relationships with over
2,000 independent distributors throughout China, we depend on sales to distributors for a significant majority of our revenues. Our distributors purchase all products ordered regardless of whether the products are ultimately sold. Products are not
purchased by distributors on consignment, and distributors have no right to return unsold products. As our existing distributor agreements expire, we may be unable to renew such agreements on favorable terms or at all, and we do not own, employ or
control these independent distributors. Furthermore, we actively manage our distribution network and regularly review the performance of each distributor. We may terminate agreements with distributors, without penalty, if we are not satisfied with
their performance for any reason. We periodically terminate relationships with underperforming exclusive distributors. Our distributors may also terminate their relationship with us without penalty. When an exclusive distributor in a particular
geographic area fails to meet our expectations, then we are economically incentivized to replace that distributor with a new distributor so that area can be served as well as possible. We occasionally terminate a relationship with a non-exclusive
distributor and are more likely to simply appoint another one; however, we have found that in some instances we are better served to replace an underperforming non-exclusive distributor with an exclusive distributor. Additionally, we have found that
even in cases where there may not be an economic incentive to terminate a non-exclusive distributor, having the ability to replace a distributor often motivates distributors to increase their efforts to meet our expectations. This policy may make us
less attractive to some distributors. In addition, we compete for distributors with other leading medical device companies who may enter into long-term distribution agreements, effectively preventing many distributors from selling our products. As a
result, a significant amount of time and resources must be devoted to maintaining and growing our distribution network. Any disruption in our distribution network could have negative effects on our ability to sell our products, which would in turn
materially and adversely affect our business, financial condition and results of operations. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We sell products for some of our competitors, some of which compete with our branded products.
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are the exclusive distributor in China for IMD, Timesco and JMS in the PRC. We are a non-exclusive regional distributor for ResMed.
Our agreement with IMD does not prohibit us from selling X-ray units from other companies, and we provide four types of branded mobile and C-armed X-ray machines. Our agreements with Timesco, JMS, and ResMed contain provisions that limit our ability
to sell products that compete with the products we sell for them. We do not currently sell any branded laryngoscopes, including any that would compete with those from Timesco. We also do not sell any infusion pumps or syringe pumps, including any
that would compete with those from JMS. We do not currently sell any products to treat obstructive sleep apnea that would compete with those from ResMed; however, we have developed and are currently seeking SFDA approval for our DHR CPAP C5, DHR
Auto CPAP A8 and DHR Auto S-CPAP A9. ResMed may claim that these products compete with the ResMed S6 and MAP MiniPAP and may seek to terminate our distribution agreement with them on that basis. The percentage of our total revenues attributable to
the distribution agreement for the ResMed S6 and MAP MiniPAP was 1.86% and 0.58% for the years ended December&nbsp;31, 2008 and 2007, respectively and 1.91% and 2.18% for the nine months ended September&nbsp;30, 2009 and 2008, respectively.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, our sales of X-ray machines that may compete with those from IMD and sleep apnea devices that may compete with those from ResMed
could result in claims from our suppliers that we have favored our branded products over distributed products in marketing. Further, where our agreements with suppliers limit our ability to sell competing branded products, we may have to forego
developing potentially profitable products. Any of these results could materially harm our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We rely on some of our competitors to
supply component parts for our branded products. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We obtain some components from companies that are competitors in our market, including
IMD and Spacelabs Medical Trading (Shanghai) Co., Ltd. None of these competitors supplies more than 4% of our components, and we are not reliant on them for such components. We do, however, provide detailed technical specifications to these
competitors for use in producing components for our branded products. If these companies were to reverse-engineer or otherwise misappropriate such information, our business could be materially harmed. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Although we do not own or control our distributors, the actions of these distributors may affect our business operations or our reputation in the
marketplace. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our distributors are independent from us, and as such, our ability to effectively manage their activities is limited.
Distributors could take any number of actions that could have material adverse effects on our business. If we fail to adequately manage our distribution network or if distributors do not comply with our distribution agreements, our corporate image
could be tarnished among end users, disrupting our sales. Furthermore, we could be liable for actions taken by our distributors, including any violations of applicable law in connection with the marketing or sale of our products, including
China&#146;s anti-corruption laws. Recently, the PRC government has increased its anti-bribery efforts in the healthcare sector to reduce improper payments received by hospital administrators and doctors in connection with the purchase of
pharmaceutical products and medical devices. Our distributors may violate these laws or otherwise engage in illegal practices with respect to their sales or marketing of our products. If our distributors violate these laws, we could be required to
pay damages or fines, which could materially and adversely affect our financial condition and results of operations. In addition, our brand and reputation, our sales activities or the price of our shares could be adversely affected if our company
becomes the target of any negative publicity as a result of actions taken by our distributors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We plan to expand our homecare and
technical service products internationally and become a leader in selected international markets. Such expansion can be difficult and time consuming, and if unsuccessful our future profits would be materially and adversely affected. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">While we currently operate exclusively in China, we envision competing in selected international markets with our homecare and technical service
products. We intend to enter into markets in which we have limited or no experience and in which our brand may be less recognized. To the extent we are able to </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
obtain approval to sell our branded products in the European Union, we currently plan to expand initially into Europe. We have not yet qualified or applied to do so, and we have no guarantee that
we will be successful with any such application for approval. We plan to devote significant resources to marketing and promoting our brand internationally and attracting distributors in foreign markets. Success in international markets will depend
on our ability to attract a sufficient number of distributors suitable for selling our branded products. Furthermore, in new markets we may fail to anticipate competitive conditions that are different from those in our existing markets. These
competitive conditions may make it difficult or impossible for us to operate effectively in these markets. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operation in international markets
will also expose us to many other risks, including but not limited to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">political instability; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">economic instability and recessions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">changes in tariffs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">difficulties of administering foreign operations generally; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">limited protection for intellectual property rights; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">obligations to comply with a wide variety of foreign laws and other regulatory requirements; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">financial condition, expertise and performance of international distributors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">export license requirements; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">unauthorized re-export of our branded products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">inability to purchase our distributed products from international suppliers at competitive prices; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">potentially adverse tax consequences; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">inability to effectively enforce contractual or legal rights. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We are highly dependent on our key personnel such as key executives and research and development personnel. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are highly dependent on the continued service of our key executives and other key personnel. In particular, we substantially rely on our chairman and
chief executive officer Mr.&nbsp;Ping Chen to manage our business and operations. We also rely on key research and development personnel for the development of new products. In addition, we rely on customer service personnel for the installation and
support of our products and on marketing and sales personnel, engineers and other personnel with technical and industry knowledge to market, sell, install and service our products. We have entered into standard one-year employment contracts with all
of our officers and managers and other key personnel and one-year employment contracts with our other employees. These contracts prohibit our employees from engaging in any conduct or activity that would be competitive with our business during the
course of their employment. Loss of any of our key personnel could severely disrupt our business. We may not be able to find suitable or qualified replacements, and will likely incur additional expenses in order to recruit and train any new
personnel. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Competition for qualified management and key personnel in the medical technology field is intense and the pool of qualified
candidates is limited. We not only compete with other medical device companies but also universities and other research institutions to attract and retain qualified personnel. This intense competition may force us to offer higher compensation and
benefit packages in order to attract and retain the most qualified personnel. Our future success depends on our ability to attract and retain these individuals and failure to do so could result in severe disruptions to our business and growth.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our business is subject to intense competition, which may reduce demand for our products and materially and adversely affect our business,
financial condition, results of operations and prospects. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The medical device market is highly competitive, and we expect competition to
intensify. Given the $585 billion stimulus initiative in China and its impact on healthcare, we expect the availability of healthcare to increase, as more hospitals and clinics are developed rurally. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We face direct competition from both domestic and international competitors across all product lines and price points. Our competitors also vary by
product. Currently, our competitors include publicly traded and privately held multinational companies, such as Respironics, Inc., ResMed Inc., and Covidien, as well as </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
domestic Chinese companies such as Beijing Aoji, Beijing Ya&#146;ao, Jiangsu Yuyue and Zhejiang Longfei. As we expand into international sales, we expect our competitors will primarily be
publicly traded and privately held multinational companies. We also expect to face competition in international sales from companies that have local operations in the markets in which we sell our products. Some of our larger competitors may have:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">greater financial and other resources; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">larger variety of products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">more products that have received regulatory approvals; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">greater pricing flexibility; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">more extensive research and development and technical capabilities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">patent portfolios that may present an obstacle to our conduct of business; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">greater knowledge of local market conditions where we seek to increase our international sales; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">stronger brand recognition; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">larger sales and distribution networks. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result, we may be unable to offer products similar to, or more desirable than, those offered by our competitors, market our products as effectively
as our competitors or otherwise respond successfully to competitive pressures. In addition, our competitors may be able to offer discounts on competing products as part of a &#147;bundle&#148; of non-competing products, systems and services that
they sell to our customers, and we may not be able to profitably match those discounts. Our competitors may develop technologies and products that are more effective than those we currently offer or that render our products obsolete or
uncompetitive. The timing of the introduction of competing products into the market could affect the market acceptance and market share of our products. As we expect demand for our products to increase along with the availability of healthcare, we
must continue to focus on competitive pricing and innovation by being at the forefront of market trends and improving our product and service offerings. Our failure to compete successfully could materially and adversely affect our business,
financial condition, results of operation and prospects. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Some of our internationally-based competitors may follow in the footsteps of
Covidien and establish production or research and development facilities in China, while others may enter into cooperative business arrangements with Chinese manufacturers. If we are unable to develop competitive branded products, obtain regulatory
approval or clearance and supply sufficient quantities to the market as quickly and effectively as our competitors, market acceptance of our branded products may be limited, which could result in decreased sales. In addition, we may not be able to
maintain our branded product cost advantages. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that corrupt practices in the medical device industry in China still occur. To
increase sales, certain manufacturers or distributors of medical devices may pay kickbacks or provide other benefits to hospital personnel who make procurement decisions. Our company policy prohibits these practices by our direct sales personnel and
our distribution agreements require our distributors to comply with applicable law. As a result, as competition intensifies in the medical device industry in China, we may lose sales, customers or contracts to competitors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If we fail to accurately project demand for our products, we may encounter problems of inadequate supply or oversupply, which would materially and
adversely affect our financial condition and results of operations, as well as damage our reputation and brand. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our distributors
typically order our products on a purchase order basis. We project demand for our products based on rolling projections from our distributors, our understanding of anticipated hospital procurement spending, and distributor inventory levels. Lack of
significant order backlog and the varying sales and purchasing cycles of our distributors and other customers, however, make it difficult for us to forecast future demand accurately. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we overestimate demand, we may purchase more distributed products or more unassembled parts or components for our branded products than we require. If
we underestimate demand, our third party suppliers may have inadequate supply of distributed products or unassembled parts or product component inventories, which could interrupt the assembly process and delay shipments of our branded
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
products, and could result in lost sales. In particular, we are seeking to reduce our procurement and inventory costs by matching our inventory closely with our projected product needs and by,
from time to time, deferring our purchase of components in anticipation of supplier price reductions. As we seek to balance reduced inventory costs and assembly flexibility, we may fail to accurately forecast demand and coordinate our procurement
and assembly to meet demand on a timely basis. Our inability to accurately predict our demand and to timely meet our demand could materially and adversely affect our financial conditions and results of operations as well as damage our reputation and
corporate brand. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Failure to manage our growth could strain our management, operational and other resources, which could materially and
adversely affect our business and prospects. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our growth strategy includes building our brand, increasing market penetration of our
existing products, developing new products, increasing our targeting of the home respiratory market in China, and increasing our exports. Pursuing these strategies has resulted in, and will continue to result in substantial demands on management
resources. In particular, the management of our growth will require, among other things: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">continued enhancement of our research and development capabilities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">information technology system enhancement; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">stringent cost controls and sufficient liquidity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">strengthening of financial and management controls and information technology systems; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increased marketing, sales and support activities; and hiring and training of new personnel. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we are not able to manage our growth successfully, our business and prospects would be materially and adversely affected. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A redemption of Make-Good Shares may be insufficient to cause our company to achieve targeted earnings and may reduce our management&#146;s
involvement and stake in our company. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As described in greater detail in the sections entitled &#147;Related Party Transactions &#150;
Make-Good Shares Subject to Redemption&#148; and &#147;Placement &#150; Market and Pricing Considerations,&#148; certain key members of our management have placed an aggregate of 600,000 common shares into escrow. This number being equal to 40% of
the maximum number of shares to be sold in this offering (such escrowed shares, the &#147;Make-Good Shares&#148;) pending determination of our audited net after-tax income for the year ending December&nbsp;31, 2010. The Make-Good Shares will consist
of a prorated allocation of shares beneficially owned by Ping Chen, Zheng (Rita) Liu, Weibing Yang, Jian Sun and Yong Wang, key members of our management team. Our company will redeem and cancel these Make-Good Shares pro rata without consideration
to the extent necessary to cause our earnings per share to be at least $0.80, excluding any expenses associated with releasing the Make-Good Shares back to the original owners. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We cannot guarantee that we will be able to redeem a sufficient number of Make-Good Shares to increase audited after-tax earnings per share to the target
of $0.80 if our company either has low net income or any net losses in 2010. To the extent there are an insufficient number of Make-Good Shares available for such redemption, our per-share after tax earnings may be less than the target of $0.80 for
2010. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As noted above, the holders of the Make-Good Shares are integral to our company&#146;s success. Prior to the commencement of this
offering, they collectively own 58.61% of our issued and outstanding shares. Assuming a maximum offering, they would collectively hold approximately 39.07% of our shares upon completion of the offering. In the event all of the Make-Good Shares are
redeemed, these members of management would collectively hold 23.44% of our shares, assuming a maximum offering. See &#147;Risk Factors &#150; We are substantially dependent upon our key personnel.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Unauthorized use of our brand name by third parties, and the expenses incurred in developing and preserving the value of our brand name, may adversely
affect our business. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We regard our brand name as critical to our success. Unauthorized use of our brand name by third parties may
adversely affect our business and reputation, including the perceived quality and reliability of </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
our branded products. We rely on trademark law, company brand name protection policies, and agreements with our employees, customers, business partners and others to protect the value of our
brand name. Despite our precautions, we may be unable to prevent third parties from using our brand name without authorization. Moreover, litigation may be necessary in the future to protect our brand name. However, because the validity,
enforceability and scope of protection of trademarks in the PRC are uncertain and still evolving, we may not be successful in prosecuting these cases. Future litigation could also result in substantial costs and diversion of our resources, and could
disrupt our business, as well as have a material adverse effect on our financial condition and results of operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If we fail to obtain
or maintain applicable regulatory clearances or approvals for our products, or if such clearances or approvals are delayed, we will be unable to commercially distribute and market our products at all or in a timely manner, which could significantly
disrupt our business and materially and adversely affect our sales and profitability. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The sale and marketing of our products are subject
to regulation in China. For a significant portion of our sales, we need to obtain and renew licenses and registrations with the SFDA. The processes for obtaining regulatory clearances or approvals can be lengthy and expensive, and the results are
unpredictable. In addition, the relevant regulatory authorities may introduce additional requirements or procedures that have the effect of delaying or prolonging the regulatory clearance or approval for our existing or new products. If we are
unable to obtain clearances or approvals needed to market existing or new branded products, or obtain such clearances or approvals in a timely fashion, our business would be significantly disrupted, and our sales and profitability could be
materially and adversely affected. Similarly, if the third parties from which we buy our distributed products fail to obtain such clearance, we would be unable to sell such distributed products, and our sales and profitability could be materially
and adversely affected. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We generate a significant portion of our revenues from a small number of products, and a reduction in demand for
any of these products could materially and adversely affect our financial condition and results of operations. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We derive a substantial
percentage of our revenues from a small number of products. Our three top selling product categories (mobile C arm X-ray system, general medical products and compressors) accounted, in the aggregate, for approximately 73%, 65%, 61% and 57% of our
total net revenues in the years ended December&nbsp;31, 2007 and 2008, and the nine months ended September&nbsp;30, 2008 and 2009, respectively. We expect a small number of our key products will continue to account for a significant portion of our
net revenues for the foreseeable future. As a result, continued market acceptance and popularity of these products is critical to our success, and a reduction in demand due to, among other factors, the introduction of competing products by our
competitors, the entry of new competitors, or end-users&#146; dissatisfaction with the quality of these products could materially and adversely affect our financial condition and results of operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If we fail to protect our intellectual property rights, it could harm our business and competitive position. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We rely on a combination of patent, copyright, trademark and trade secret laws and non-disclosure agreements and other methods to protect our
intellectual property rights. We own two patents in China covering our oxygen concentrators. We have applied for five additional patents related to our CPAP devices (2), portable sleep screening (2)&nbsp;and diagnostic services (1). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The process of seeking patent protection can be lengthy and expensive, our patent applications may fail to result in patents being issued, and our
existing and future patents may be insufficient to provide us with meaningful protection or commercial advantage. Our patents and patent applications may also be challenged, invalidated or circumvented. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also rely on trade secret rights to protect our business through non-disclosure provisions in employment agreements with employees. If our employees
breach their non-disclosure obligations, we may not have adequate remedies in China, and our trade secrets may become known to our competitors. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Implementation of PRC intellectual property-related laws has historically been lacking, primarily because of
ambiguities in the PRC laws and enforcement difficulties. Accordingly, intellectual property rights and confidentiality protections in China may not be as effective as in the United States or other western countries. Furthermore, policing
unauthorized use of proprietary technology is difficult and expensive, and we may need to resort to litigation to enforce or defend patents issued to us or to determine the enforceability, scope and validity of our proprietary rights or those of
others. Such litigation and an adverse determination in any such litigation, if any, could result in substantial costs and diversion of resources and management attention, which could harm our business and competitive position. See &#147;Risk
Factors &#150; Unauthorized use of our brand name by third parties, and the expenses incurred in developing and preserving the value of our brand name, may adversely affect our business.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We may be exposed to intellectual property infringement and other claims by third parties which, if successful, could disrupt our business and have a
material adverse effect on our financial condition and results of operations. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our success depends, in large part, on our ability to use
and develop our technology and know-how without infringing third party intellectual property rights. If we sell our branded products internationally, and as litigation becomes more common in China, we face a higher risk of being the subject of
claims for intellectual property infringement, invalidity or indemnification relating to other parties&#146; proprietary rights. Our current or potential competitors, many of which have substantial resources and have made substantial investments in
competing technologies, may have or may obtain patents that will prevent, limit or interfere with our ability to make, use or sell our branded products in either China or other countries, including the United States and other countries in Asia. The
validity and scope of claims relating to medical device technology patents involve complex scientific, legal and factual questions and analysis and, as a result, may be highly uncertain. In addition, the defense of intellectual property suits,
including patent infringement suits, and related legal and administrative proceedings can be both costly and time consuming and may significantly divert the efforts and resources of our technical and management personnel. Furthermore, an adverse
determination in any such litigation or proceedings to which we may become a party could cause us to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">pay damage awards; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">seek licenses from third parties; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">pay ongoing royalties; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">redesign our branded products; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">be restricted by injunctions, </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">each of which could effectively prevent us from pursuing some or all of our business and result in our customers or potential customers deferring or
limiting their purchase or use of our branded products, which could have a material adverse effect on our financial condition and results of operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We are subject to product liability exposure and have limited insurance coverage. Any product liability claims or potential safety-related regulatory
actions could damage our reputation and materially and adversely affect our business, financial condition and results of operations. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
medical devices we assemble and sell can expose us to potential product liability claims if the use of these products causes or is alleged to have caused personal injuries or other adverse effects. Any product liability claim or regulatory action
could be costly and time-consuming to defend. If successful, product liability claims may require us to pay substantial damages. We do not maintain product liability insurance to cover potential product liability arising from the use of our branded
products because product liability insurance available in China offers only limited coverage compared to coverage offered in many other countries. As we expand our sales internationally and increase our exposure to these risks in many countries, we
may be unable to obtain sufficient product liability insurance coverage on commercially reasonable terms, or at all. A product liability claim or potential safety-related regulatory action, with or without merit, could result in significant negative
publicity and could materially and adversely affect the marketability of our branded products and our reputation, as well as our business, financial condition and results of operations. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moreover, a material design, manufacturing or quality failure or defect in our branded products, other
safety issues or heightened regulatory scrutiny could each warrant a product recall by us and result in increased product liability claims. Also, if these products are deemed by the authorities in the countries where we sell our branded products to
fail to conform to product quality and safety requirements, we could be subject to regulatory action. In China, violation of PRC product quality and safety requirements may subject us to confiscation of related earnings, penalties, an order to cease
sales of the violating product or to cease operations pending rectification. Furthermore, if the violation is determined to be serious, our business license to assemble or sell violating and other products could be suspended or revoked. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We may undertake acquisitions, which may have a material adverse effect on our ability to manage our business, and may end up being unsuccessful. </B>
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our growth strategy may involve the acquisition of new technologies, businesses, products or services or the creation of strategic alliances
in areas in which we do not currently operate. We do not have any understanding, commitment or agreement in place with regard to any such acquisitions at this time. These acquisitions could require that our management develop expertise in new areas,
manage new business relationships and attract new types of customers. Furthermore, acquisitions may require significant attention from our management, and the diversion of our management&#146;s attention and resources could have a material adverse
effect on our ability to manage our business. We may also experience difficulties integrating acquisitions into our business and operations. Future acquisitions may also expose us to potential risks, including risks associated with: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the integration of new operations, services and personnel; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">unforeseen or hidden liabilities; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the diversion of resources from our existing businesses and technologies; our inability to generate sufficient revenue to offset the costs of
acquisitions; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">potential loss of, or harm to, relationships with employees or customers, any of which could significantly disrupt our ability to manage our business
and materially and adversely affect our business, financial condition and results of operations. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect to allocate a
portion of the net proceeds from this offering to such acquisitions, but we have not yet located any potential targets, and we may be unable to do so. Further, even if we find a target we believe to be suitable, we may be unable to negotiate
acquisition terms that are satisfactory to us. In the event we are unable to complete acquisitions, we have reserved the right to reallocate such funds to our working capital. If this happens, we would have broad discretion over the ultimate us of
such funds, and we could use such funds in ways with which investors might disagree. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We may need additional capital in the future, and we
may be unable to obtain such capital in a timely manner or on acceptable terms, or at all. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order for us to grow, remain competitive,
develop new products, and expand our distribution network, we may require additional capital in the future. Our ability to obtain additional capital in the future is subject to a variety of uncertainties, including: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our future financial condition, results of operations and cash flows; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">general market conditions for capital raising activities by medical device manufacturers and other related companies; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">economic, political and other conditions in China and elsewhere. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may be unable to obtain additional capital in a timely manner or on acceptable terms or at all. Furthermore, the terms and amount of any additional
capital raised through issuances of equity securities may result in significant shareholder dilution. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We rely on technology and know-how,
which we seek to protect, in part, by confidentiality provisions in contracts with our employees. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We rely on technology and know-how,
which we seek to protect by confidentially provisions in contracts with our employees. There can be no assurance that the confidentially provisions in such contracts will </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
not be breached, or that we will have adequate remedies for any breach, or that other parties may not obtain knowledge of our trade secrets and processes, technology and systems. Should these
events occur, our business and hence, our profitability, will be adversely affected. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We are heavily dependent upon the services of
experienced personnel who possess skills that are valuable in our industry, and we may have to actively compete for their services. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We
are heavily dependent upon our ability to attract, retain and motivate skilled personnel to serve our customers. Many of our personnel possess skills that would be valuable to all companies engaged in our industry. Consequently, we expect that we
will have to actively compete for these employees. Some of our competitors may be able to pay our employees more than we are able to pay to retain them. Our ability to profitably operate is substantially dependent upon our ability to locate, hire,
train and retain our personnel. Although we have not experienced difficulty locating, hiring, training or retaining our employees to date, there can be no assurance that we will be able to retain our current personnel, or that we will be able to
attract and assimilate other personnel in the future. If we are unable to effectively obtain and maintain skilled personnel, the development and quality of our services could be materially impaired. See &#147;Our Business &#150; Employees.&#148;
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If we experience a significant number of warranty claims, our costs could substantially increase and our reputation and brand could
suffer. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We typically sell our branded products with warranty terms covering 12 months after purchase. Our branded product warranty
requires us to repair all mechanical malfunctions and, if necessary, replace defective components. We accrue liability for potential warranty claims at the time of sale. If we experience an increase in warranty claims or if our repair and
replacement costs associated with warranty claims increase significantly, we may have to accrue a greater liability for potential warranty claims. Moreover, an increase in the frequency of warranty claims could substantially increase our costs and
harm our reputation and brand. Our business, financial condition, results of operations and prospects may suffer materially if we experience a significant increase in warranty claims on our branded products. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Foreign Operational Risks </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our operations could be adversely affected by changes in the political and economic conditions in the PRC. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We face risks related to conducting business in the PRC. Changes in the social, economic and political conditions of the PRC may adversely affect our
business. Unfavorable changes in government policies, political unrest and economic developments may also have a negative impact on our operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, all of our business operations are conducted in the PRC. Accordingly, any significant slowdown in the PRC economy may cause our customers to
reduce expenditures. This may in turn lead to a decline in the demand for our products and services. That would have a material adverse effect on our business, financial condition and results of operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">China&#146;s economy experienced overall growth of only 8.7% in 2009, its lowest growth rate in eight years, down from growth rates of 9.6% in 2008 and
13% in 2007. The global financial crisis has significantly decreased demand for Chinese exports, resulting in factory closures and losses of millions of jobs. This 8.7% growth rate is well above the 7.2% rate predicted by the World Bank and also
exceeds the 8% rate the Chinese government had predicted and said would be necessary to avoid significant further job losses. While China&#146;s growth rate has fallen, China&#146;s growth rate remains well above the World Bank&#146;s forecast for
decline of 1.5% for the world economy in 2009. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Since the adoption of the &#147;open door policy&#148; in 1978 and the &#147;socialist market
economy&#148; in 1993, the PRC government has been reforming and is expected to continue to reform its economic and political systems. Any changes in the political and economic policy of the PRC government may lead to changes in the laws and
regulations or the interpretation of the same, as well as changes in the foreign exchange regulations, taxation and import and export restrictions, which may in turn adversely affect our financial performance. While the current policy of the PRC
government seems to be one of imposing economic reform policies to encourage foreign investments and greater economic decentralization, there is no assurance that such a policy will continue to prevail in the future. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our failure to obtain the prior approval of the China Securities Regulatory Commission of the listing and
trading of our common shares on the NASDAQ Capital Market could have a material adverse effect on our business, operating results, reputation and trading price of our common shares, and may also create uncertainties for this offering.
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;8, 2006, six PRC regulatory agencies, including the China Securities Regulatory Commission (&#147;CSRC&#148;), promulgated
a regulation that became effective on September&nbsp;8, 2006. This regulation, among other things, has some provisions that purport to require that an offshore special purpose vehicle, or SPV, formed for listing purposes and controlled directly or
indirectly by PRC companies or individuals shall obtain the approval of the CSRC prior to the listing and trading of such SPV&#146;s securities on an overseas stock exchange. On September&nbsp;21, 2006, the CSRC published on its official website
procedures specifying documents and materials required to be submitted to it by SPVs seeking CSRC approval of their overseas listings. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We did
not seek CSRC approval in connection with our initial public offering or this offering. However, the application of this PRC regulation remains unclear with no consensus currently existing among the leading PRC law firms regarding the scope and
applicability of the CSRC approval requirement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our PRC counsel, Beijing Kang Da Law Firm, has advised us that because we completed our
restructuring before September&nbsp;8, 2006, the effective date of the new regulation, it was not and is not necessary for us to submit the application to the CSRC for its approval, and the listing and trading of our common shares on the NASDAQ
Capital Market does not require CSRC approval. A copy of Beijing Kang Da Law Firm&#146;s legal opinion regarding this PRC regulation is filed as an exhibit to our registration statement on Form S-1 in connection with this offering, which is
available at the SEC&#146;s website at www.sec.gov. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the CSRC or another PRC regulatory agency subsequently determines that CSRC approval
was required for our initial public offering or this offering, we may face regulatory actions or other sanctions from the CSRC or other PRC regulatory agencies. These regulatory agencies may impose fines and penalties on our operations in the PRC,
limit our operating privileges in the PRC, delay or restrict the repatriation of the proceeds from our initial public offering into the PRC, or take other actions that could have a material adverse effect on our business, financial condition,
results of operations, reputation and prospects, as well as the trading price of our common shares. The CSRC or other PRC regulatory agencies also may take actions requiring us, or making it advisable for us, to halt this offering before settlement
and delivery of the common shares offered hereby. Consequently, if you engage in market trading or other activities in anticipation of and prior to settlement and delivery, you do so at the risk that settlement and delivery may not occur.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Also, if later the CSRC requires that we obtain its approval, we may be unable to obtain a waiver of the CSRC approval requirements, if and
when procedures are established to obtain such a waiver. Any uncertainties and/or negative publicity regarding this CSRC approval requirement could have a material adverse effect on the trading price of our common shares. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We may become a passive foreign investment company, which could result in adverse U.S. tax consequences to U.S. investors. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based upon the nature of our business activities, we may be classified as a passive foreign investment company (&#147;PFIC&#148;), by the U.S. Internal
Revenue Service (&#147;IRS&#148;), for U.S. federal income tax purposes. Such characterization could result in adverse U.S. tax consequences to you if you are a U.S. investor. For example, if we are a PFIC, a U.S. investor will become subject to
burdensome reporting requirements. The determination of whether or not we are a PFIC is made on an annual basis and will depend on the composition of our income and assets from time to time. Specifically, we will be classified as a PFIC for U.S. tax
purposes if either: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">75% or more of our gross income in a taxable year is passive income; or </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the average percentage of our assets by value in a taxable year which produce or are held for the production of passive income (which includes cash) is
at least 50%. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The calculation of the value of our assets is based, in part, on the then market value of our common shares,
which is subject to change. In addition, the composition of our income and assets will be affected by how, and how quickly, we spend the cash we raise in this offering. We cannot assure you that we will not be a PFIC for any taxable year. See
&#147;Taxation &#150; United States Federal Income Taxation &#150; Passive Foreign Investment Company.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We may be subject to foreign
exchange controls in the PRC. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our PRC subsidiary and affiliates are subject to PRC rules and regulations on currency conversion. In the
PRC, the State Administration for Foreign Exchange (&#147;SAFE&#148;) regulates the conversion of the RMB into foreign currencies. Currently, foreign investment enterprises (&#147;FIEs&#148;) are required to apply to SAFE for &#147;Foreign Exchange
Registration Certificate for FIEs.&#148; BDL is a FIE. With such registration certifications (which need to be renewed annually), FIEs are allowed to open foreign currency accounts including the &#147;recurrent account&#148; and the &#147;capital
account.&#148; Currently, conversion within the scope of the &#147;recurrent account&#148; can be effected without requiring the approval of SAFE. However, conversion of currency in the &#147;capital account&#148; (e.g. for capital items such as
direct investments, loans, securities, etc.) still requires the approval of SAFE. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We do not have business interruption, litigation or
natural disaster insurance. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The insurance industry in China is still at an early state of development. In particular PRC insurance
companies offer limited business products. As a result, we do not have any business liability or disruption insurance coverage for our operations in China. Any business interruption, litigation or natural disaster may result in our business
incurring substantial costs and the diversion of resources. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The newly enacted Chinese enterprise income tax law will affect tax exemptions
on the dividends we receive and increase the enterprise income tax rate applicable to us. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are a holding company incorporated under the
laws of the British Virgin Islands. We conduct substantially all of our business through our wholly owned Chinese subsidiaries and we derive all of our income from these subsidiaries. Prior to January&nbsp;1, 2008, dividends derived by foreign legal
persons from business operations in China were not subject to the Chinese enterprise income tax. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March&nbsp;16, 2007, the National
People&#146;s Congress of the PRC passed the PRC Enterprise Income Tax Law (the &#147;EIT Law&#148;), which took effect on January&nbsp;1, 2008. Such tax exemptions ceased with the effectiveness of the EIT Law. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the EIT Law, if we are deemed to be a non-resident enterprise for Chinese tax purposes, a withholding tax at the rate of 10% would be applicable to
any dividends paid by our Chinese subsidiaries to us. However, if we are deemed to have a &#147;de facto management organization&#148; in China, we would be classified as a resident enterprise for Chinese tax purposes and thus would be subject to an
enterprise income tax rate of 25% on all of our income, including interest income on the proceeds from this offering on a worldwide basis. At present, the Chinese tax authority has not issued any guidance on the application of the EIT Law and its
implementing rules on non-Chinese enterprises or group enterprise controlled entities whose structures are like ours. As a result, it is unclear what factors will be used by the Chinese tax authorities to determine whether we are a &#147;de facto
management organization&#148; in China. However, as substantially all members of our management team are located in China, we may be deemed to be a resident enterprise and therefore subject to an enterprise income tax rate of 25% on our worldwide
income, with the possible exclusion of dividends received directly from another Chinese tax resident. As a result of such changes, our historical operating results will not be indicative of our operating results for future periods and the value of
our shares may be adversely affected. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We must remit the offering proceeds to China before they may be used to benefit our business in China,
and this process may take a number of months. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BDL is reported to PRC authorities as a special purpose vehicle for financing. The proceeds
of this offering must be sent back to the PRC, and the process for sending such proceeds back to the PRC may take several months after the closing of this offering. We may be unable to use these proceeds to grow our business until we receive such
proceeds in the PRC. In order to remit the offering proceeds to China, we will take the following actions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">First, we will open a special foreign exchange account for capital account transactions. To open this account, we must submit to SAFE certain
application forms, identity documents, transaction documents, form of foreign exchange registration of overseas investments of the domestic residents, and foreign exchange registration certificate of the invested company.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Second, we will remit the offering proceeds into this special foreign exchange account. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Third, we will apply for settlement of the foreign exchange. In order to do so, we must submit to SAFE certain application forms, identity documents,
payment order to a designated person, and a tax certificate. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The timing of the process is difficult to estimate because the
efficiencies of different SAFE branches can vary significantly. Ordinarily the process takes several months but is required to be accomplished within 180 days of application by law. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We rely on dividends paid by BDL for our cash needs. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We rely primarily on dividends paid by BDL for our cash needs, including the funds necessary to pay dividends and other cash distributions, if any, to
our shareholders, to service any debt we may incur and to pay our operating expenses. The payment of dividends by entities organized in China is subject to limitations. Regulations in the PRC currently permit payment of dividends only out of
accumulated profits as determined in accordance with accounting standards and regulations in China. Dividend policy is subject to the discretion of our Board of Directors and will depend on, among other things, our future earnings, financial
condition, capital requirements and other factors. Under British Virgin Islands law, we may only pay dividends from surplus (the excess, if any, at the time of the determination of the total assets of our company over the sum of our liabilities, as
shown in our books of account, plus our capital), and we must be solvent before and after the dividend payment in the sense that we will be able to satisfy our liabilities as they become due in the ordinary course of business; and the realizable
value of assets of our company will not be less than the sum of our total liabilities, other than deferred taxes as shown on our books of account, and our capital. If we determine to pay dividends on any of our common shares in the future, as a
holding company, we will be dependent on receipt of funds from our operating subsidiary, BDL. See &#147;Dividend Policy.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to
the new PRC enterprise income tax law effective on January&nbsp;1, 2008, dividends payable by a foreign investment entity to its foreign investors are subject to a withholding tax of up to 20%. At present, the Chinese tax authority has not issued
any guidance on the application of the EIT Law and its implementing rules on non-Chinese enterprises or group enterprise controlled entities whose structures are like ours. In practice, the tax authorities typically impose the withholding tax rate
of 10% rate, as prescribed in the implementation regulations; however, there can be no guarantee that this practice will continue as more guidance is provided by relevant government authorities. As a result, we are unable to predict whether payments
from BDL to Dehaier will be subject to withholding tax because it is unclear whether Dehaier will be deemed to be a resident enterprise for Chinese tax purposes. If so, Dehaier will be subject to an enterprise income tax rate of 25% on all of its
income, including interest income on the proceeds from this offering on a worldwide basis. However, if Dehaier is deemed to be a non-resident enterprise, then it will be subject to a withholding tax at the rate of 10% on any dividends paid by its
Chinese subsidiaries to Dehaier. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The payment of dividends by entities organized in China is subject to limitations, procedures and
formalities. Regulations in the PRC currently permit payment of dividends only out of accumulated profits as determined in accordance with accounting standards and regulations in China. BDL is also required to set aside at least 10% of its after-tax
profit based on PRC accounting standards each year to its compulsory reserves fund until the accumulative amount of such reserves reaches 50% of its registered capital. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;
</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The transfer to this reserve must be made before distribution of any dividend to shareholders. The surplus
reserve fund is non-distributable other than during liquidation and can be used to fund previous years&#146; losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in
proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital. For the years ended December&nbsp;31,
2008 and the years ended December&nbsp;31, 2007, respectively, the Company made no appropriations to surplus reserve. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>BDL is also required
to allocate a portion of its after-tax profits, as determined by its board of directors, to the general reserve, the staff welfare and bonus funds, and the enterprise expansion reserve, which may not be distributed to equity owners. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the Law of Chinese-Foreign Equity Joint Ventures, Chinese-foreign equity joint ventures are required to allocate a portion of their after-tax
profits in accordance with their Articles of Association, to the general reserve, the staff welfare and bonus funds, and the enterprise expansion reserve. According to the Articles of Association of BDL, the amount of each reserve is determined by
BDL&#146;s board of directors. The general reserve is used to offset future extraordinary losses. The subsidiaries may, upon a resolution passed by the shareholders, convert the general reserve into capital. The employee welfare and bonus reserve is
used for the collective welfare of the employees of the subsidiaries. The enterprise expansion reserve is used for the expansion of the subsidiaries&#146; operations and can be converted to capital subject to approval by the relevant authorities.
These reserves represent appropriations of retained earnings determined according to PRC law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of the date of this prospectus, the amounts
of these reserves have not yet been determined, and we have not committed to establishing such amounts at this time. Under current PRC laws, BDL is required to set aside reserve amounts, but has not yet done so. BDL has not done so because PRC
authorities grant companies flexibility in making a determination. Chinese law requires such a determination to be made in accordance with the companies&#146; organizational documents and BDL&#146;s organizational documents do not require the
determination to be made within a particular timeframe. Although we have not yet been required by PRC authorities to make such determinations or set aside such reserves, PRC authorities may require BDL to rectify its noncompliance and we may be
fined if we fail to do so after warning within the time period set in the warning. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PRC law requires allocation to the general reserve
before distribution of the after-tax profits of foreign invested companies, which could prevent us from receiving the dividends from BDL. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">PRC law requires that the after-tax profits of foreign invested companies be distributed after a portion of after-tax profits is allocated to the
reserve; therefore if for any reason, the dividends from BDL cannot be repatriated to us or not in time, then it may detrimentally affect our cash flow and even cause us to become insolvent. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Governmental control of currency conversion may affect the value of your investment. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The PRC government imposes controls on the convertibility of the Renminbi into foreign currencies and, in certain cases, the remittance of currency out
of China. We receive the majority of our revenues in Renminbi. Under our current corporate structure, our income is derived from payments from BDL. Shortages in the availability of foreign currency may restrict the ability of BDL to remit sufficient
foreign currency to pay dividends or other payments to us, or otherwise satisfy their foreign currency denominated obligations. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions,
interest payments and expenditures from trade-related transactions, can be made in foreign currencies without prior approval from SAFE by complying with certain procedural requirements. However, approval from appropriate government authorities is
required where Renminbi is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of bank loans denominated in foreign currencies. The PRC government may also at is discretion restrict access in
the future to foreign currencies for current account transactions. If the foreign </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
exchange control system prevents us from obtaining sufficient foreign currency to satisfy our currency demands, we may not be able to pay dividends in foreign currencies to our shareholders. See
&#147;Our Business &#150; Regulations on Foreign Exchange.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Fluctuation of the Renminbi could materially affect our financial
condition and results of operations. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The value of the Renminbi against the U.S. dollar and other currencies may fluctuate and is affected
by, among other things, changes in political and economic conditions. On July&nbsp;21, 2005, the PRC government changed its decade-old policy of pegging the value of the Renminbi to the U.S. dollar. Under the new policy, the Renminbi is permitted to
fluctuate within a narrow and managed band against a basket of certain foreign currencies. This change in policy has resulted in an appreciation of the Renminbi against the U.S. dollar. While the international reaction to the Renminbi revaluation
has generally been positive, there remains significant international pressure on the PRC government to adopt an even more flexible currency policy, which could result in a further and more significant appreciation of the Renminbi against the U.S.
dollar. Any significant revaluation of Renminbi may materially and adversely affect our cash flows, revenues, earnings and financial position, and the value of, and any dividends payable on, our common shares in U.S. dollars. For example, an
appreciation of Renminbi against the U.S. dollar would make any new Renminbi denominated investments or expenditures more costly to us, to the extent that we need to convert U.S. dollars into Renminbi for such purposes. See &#147;Exchange Rate
Information.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Changes in China&#146;s political and economic policies could harm our business. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">China&#146;s economy has historically been a planned economy subject to governmental plans and quotas and has, in certain aspects, been transitioning to
a more market-oriented economy. Although we believe that the economic reform and the macroeconomic measures adopted by the Chinese government have had a positive effect on the economic development of China, we cannot predict the future direction of
these economic reforms or the effects these measures may have on our business, financial position or results of operations. In addition, the Chinese economy differs from the economies of most countries belonging to the Organization for Economic
Cooperation and Development (&#147;OECD&#148;). These differences include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">economic structure; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">level of government involvement in the economy; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">level of development; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">level of capital reinvestment; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">control of foreign exchange; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">methods of allocating resources; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">balance of payments position. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of these differences, our business may not develop in the same way or at the same rate as might be expected if the Chinese economy were
similar to those of the OECD member countries. See &#147;Our Business &#150; Market Background.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If PRC law were to phase out the
preferential tax benefits currently being extended to certified high technology companies or if we were to fail to be certified to receive such a benefit, we would have to pay more taxes, which could have a material and adverse effect on our
financial condition and results of operations. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under PRC laws and regulations, a company may enjoy preferential tax benefits if it is
certified as a high technology enterprise. As a certified high technology enterprise, we are subject to an enterprise income tax rate of 15% tax rate so long as we continue to be so certified. If the PRC law were to phase out preferential tax
benefits currently granted to certified high technology enterprises or if we were to fail to be certified to receive such a benefit, we would be subject to the standard statutory tax rate, which currently is 25%. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If relations between the United States and China worsen, our share price may decrease and we may have
difficulty accessing U.S. capital markets. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At various times during recent years, the United States and China have had disagreements over
political and economic issues. Controversies may arise in the future between these two countries. Any political or trade controversies between the United States and China could adversely affect the market price of our common shares and our ability
to access U.S. capital markets. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Chinese government could change its policies toward private enterprise or even nationalize or expropriate
private enterprises, which could result in the total loss of our investment in that country. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our business is subject to significant political
and economic uncertainties and may be adversely affected by political, economic and social developments in China. Over the past several years, the Chinese government has pursued economic reform policies including the encouragement of private
economic activity and greater economic decentralization. The Chinese government may not continue to pursue these policies or may significantly alter them to our detriment from time to time with little, if any, prior notice. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Changes in policies, laws and regulations or in their interpretation or the imposition of confiscatory taxation, restrictions on currency conversion,
restrictions or prohibitions on dividend payments to shareholders, devaluations of currency or the nationalization or other expropriation of private enterprises could have a material adverse effect on our business. Nationalization or expropriation
could even result in the total loss of our investment in China and in the total loss of your investment in us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The PRC legal system
embodies uncertainties that could limit the legal protections available to you and us. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The PRC legal system is a civil law system based
on written statutes. Unlike common law systems, it is a system in which decided legal cases have limited precedential value. In 1979, the PRC government began to promulgate a comprehensive system of laws and regulations governing economic matters in
general. The overall effect of legislation over the past three decades has significantly increased the protections afforded to various forms of foreign investment in China. Our PRC operating subsidiary, BDL, is a foreign-invested enterprise and is
subject to laws and regulations applicable to foreign investment in China as well as laws and regulations applicable to foreign-invested enterprises. These laws and regulations change frequently, and their interpretation and enforcement involve
uncertainties. For example, we may have to resort to administrative and court proceedings to enforce the legal protections that we enjoy either by law or contract. However, since PRC administrative and court authorities have significant discretion
in interpreting and implementing statutory and contractual terms, it may be more difficult to evaluate the outcome of administrative and court proceedings and the level of legal protection we enjoy than in more developed legal systems. These
uncertainties may also impede our ability to enforce the contracts we have entered into. As a result, these uncertainties could materially and adversely affect our business and operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recent PRC regulations relating to offshore investment activities by PRC residents may increase the administrative burden we face and create
regulatory uncertainties that could restrict our overseas and cross-border investment activity, and a failure by our shareholders who are PRC residents to make any required applications and filings pursuant to such regulations may prevent us from
being able to distribute profits and could expose us and our PRC resident shareholders to liability under PRC law. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In October 2005, SAFE
promulgated regulations that require PRC residents and PRC corporate entities to register with and obtain approvals from relevant PRC government authorities in connection with their direct or indirect offshore investment activities. These
regulations apply to our shareholders who are PRC residents in connection with our prior and any future offshore acquisitions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The October
2005 SAFE regulation required registration by March&nbsp;31, 2006 of direct or indirect investments previously made by PRC residents in offshore companies prior to the implementation of the Notice on Issues Relating to the Administration of Foreign
Exchange in Fund-Raising and Reverse </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Investment Activities of Domestic Residents Conducted via Offshore Special Purpose Companies on November&nbsp;1, 2005. If a PRC shareholder with a direct or indirect stake in an offshore parent
company fails to make the required SAFE registration, the PRC subsidiaries of such offshore parent company may be prohibited from making distributions of profit to the offshore parent and from paying the offshore parent proceeds from any reduction
in capital, share transfer or liquidation in respect of the PRC subsidiaries. Furthermore, failure to comply with the various SAFE registration requirements described above could result in liability under PRC law for foreign exchange evasion.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We previously notified and urged our shareholders, and the shareholders of the offshore entities in our corporate group, who are PRC
residents to make the necessary applications and filings, as required under this regulation. However, as these regulations are relatively new and there is uncertainty concerning their reconciliation with other approval requirements, it is unclear
how they, and any future legislation concerning offshore or cross-border transactions, will be interpreted, amended and implemented by the relevant government authorities. While we believe that these shareholders submitted applications with local
SAFE offices, some of our shareholders may not comply with our request to make or obtain any applicable registrations or approvals required by the regulation or other related legislation. The failure or inability of our PRC resident shareholders to
obtain any required approvals or make any required registrations may subject us to fines and legal sanctions, prevent us from being able to make distributions or pay dividends, as a result of which our business operations and our ability to
distribute profits to you could be materially and adversely affected. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Because our operations are located in China, information about our
operations are not readily available from independent third-party sources. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because the BDL is based in China, our shareholders may have
greater difficulty in obtaining information about it on a timely basis than would shareholders of a U.S.-based company. BDL&#146;s operations will continue to be conducted in China and shareholders may have difficulty in obtaining information about
it from sources other than BDL itself. Information available from newspapers, trade journals, or local, regional or national regulatory agencies such as issuance of construction permits and contract awards for development projects will not be
readily available to shareholders and, where available, will likely be available only in Chinese. Shareholders will be dependent upon management for reports of their progress, development, activities and expenditure of proceeds. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Risks Associated with this Offering </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>There may not be an active, liquid trading market for our common shares. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to this offering, there has been no public market for our common shares. An active trading market for our common shares may not develop or be
sustained following this offering. You may not be able to sell your shares at the market price, if at all, if trading in our shares is not active. The initial public offering price was determined by negotiations between us and the placement agent
based upon a number of factors. The initial public offering price may not be indicative of prices that will prevail in the trading market. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Investors risk loss of use of funds allocated for purchases, with no right of return, during the offering period. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We cannot assure you that all or any shares will be sold. Anderson&nbsp;&amp; Strudwick, our placement agent, is offering our shares on a &#147;best
efforts, minimum-maximum basis.&#148; We have no firm commitment from anyone to purchase all or any of the shares offered. If offers to purchase a minimum of 1,250,000 shares are not received on or before May&nbsp;31, 2010, escrow provisions require
that all funds received be promptly refunded. If refunded, investors will receive no interest on their funds. During the offering period, investors will not have any use or right to return of the funds. None of our officers, directors or affiliates
may purchase shares in this offering. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The market price for our common shares may be volatile, which could result in substantial losses to
investors. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The market price for our common shares is likely to be volatile and subject to wide fluctuations in response to factors
including the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">actual or anticipated fluctuations in our quarterly operating results; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">changes in the Chinese economy; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">announcements by our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">additions or departures of key personnel; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">potential litigation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
addition, the securities markets have from time to time experienced significant price and volume fluctuations that are not related to the operating performance of particular companies. As a result, to the extent shareholders sell our shares in
negative market fluctuation, they may not receive a price per share that is based solely upon our business performance. We cannot guarantee that shareholders will not lose some of their entire investment in our common shares. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We have received approval to list our common shares on the NASDAQ Capital Market, provided we have 300 round-lot shareholders and pay the balance of
the listing application fee prior to our first day of trading. If we are unable to comply with these conditions, our common shares may not trade on the NASDAQ Capital Market. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have received approval to list our common shares on the NASDAQ Capital Market provided we pay the balance of our entry fee and show that we will have
300 round-lot shareholders prior to our first day of trading. If we are unable to meet these final conditions our shares may not trade on the NASDAQ Capital Market. Although we have received conditional approval to have our shares trade on the
NASDAQ Capital Market, investors should be aware that they will be required to commit their investment funds before we provide NASDAQ with confirmation that we have met the final conditions. However, investor funds will be held in escrow with
SunTrust Bank and we will not close this offering unless we have met these final conditions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we have relied on an exemption to
the blue sky registration requirements afforded to &#147;covered securities&#148;. Securities listed on the NASDAQ Capital Market are &#147;covered securities.&#148; If we were unable to meet the final conditions for listing, then we would be unable
to rely on the covered securities exemption to blue sky registration requirements and we would need to register the offering in each state in which we planned to sell shares. Consequently, we will not complete this offering until we have met the
final conditions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If we are listed on the NASDAQ Capital Market and our financial condition deteriorates, we may not meet continued
listing standards on the NASDAQ Capital Market. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The NASDAQ Capital Market also requires companies to fulfill specific requirements in
order for their shares to continue to be listed. In order to qualify for continued listing on the NASDAQ Capital Market, we must meet the following criteria: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our shareholders&#146; equity must be at least $2,500,000; or the market value of our listed securities must be at least $35,000,000; or our net income
from continuing operations in our last fiscal year (or two of the last three fiscal years) must have been at least $500,000; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The market value of our shares held by non-affiliates must be at least $500,000; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The market value of our shares must be at least $1,000,000; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The minimum bid price for our shares must be at least $1.00 per share; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We must have at least 300 shareholders; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We must have at least 2 market makers; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We must have adopted NASDAQ-mandated corporate governance measures, including a Board of Directors comprised of a majority of independent directors, an
Audit Committee comprised solely of independent directors and the adoption of a code of ethics among other items. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If our shares are listed on the NASDAQ Capital Market but are delisted from the NASDAQ Capital Market at
some later date, our shareholders could find it difficult to sell our shares. In addition, if our common shares are delisted from the NASDAQ Capital Market at some later date, we may apply to have our common shares quoted on the Bulletin Board or in
the &#147;pink sheets&#148; maintained by the National Quotation Bureau, Inc. The Bulletin Board and the &#147;pink sheets&#148; are generally considered to be less efficient markets than the NASDAQ Capital Market. In addition, if our common shares
are not so listed or is delisted at some later date, our common shares may be subject to the &#147;penny stock&#148; regulations. These rules impose additional sales practice requirements on broker-dealers that sell low-priced securities to persons
other than established customers and institutional accredited investors and require the delivery of a disclosure schedule explaining the nature and risks of the penny stock market. As a result, the ability or willingness of broker-dealers to sell or
make a market in our common shares might decline. If our common shares are not so listed or are delisted from the NASDAQ Capital Market at some later date or were to become subject to the penny stock regulations, it is likely that the price of our
shares would decline and that our shareholders would find it difficult to sell their shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We will incur increased costs as a result of
being a public company. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a
private company. In addition, the Sarbanes-Oxley Act, as well as new rules subsequently implemented by the SEC and NASDAQ, have required changes in corporate governance practices of public companies. We expect these new rules and regulations to
significantly increase our legal, accounting and financial compliance costs and to make certain corporate activities more time-consuming and costly. In addition, we will incur additional costs associated with our public company reporting
requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our classified board structure may prevent a change in our control. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our board of directors is divided into three classes of directors. The current terms of the directors expire in 2010, 2011 and 2012. Directors of each
class are chosen for three-year terms upon the expiration of their current terms, and each year one class of directors is elected by the shareholders. The staggered terms of our directors may reduce the possibility of a tender offer or an attempt at
a change in control, even though a tender offer or change in control might be in the best interest of our shareholders. See &#147;Management &#150; Board of Directors and Board Committees.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Shares eligible for future sale may adversely affect the market price of our common shares, as the future sale of a substantial amount of outstanding
common shares in the public marketplace could reduce the price of our common shares. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The market price of our shares could decline as a
result of sales of substantial amounts of our shares in the public market, or the perception that these sales could occur. In addition, these factors could make it more difficult for us to raise funds through future offerings of our common shares.
An aggregate of 3,000,000 shares will be outstanding before the consummation of this offering and 4,500,000 shares will be outstanding immediately after this offering, if the maximum offering is raised. All of the shares sold in the offering will be
freely transferable without restriction or further registration under the Securities Act. The remaining shares will be &#147;restricted securities&#148; as defined in Rule 144. These shares may be sold in the future without registration under the
Securities Act to the extent permitted by Rule 144 or other exemptions under the Securities Act. See &#147;Shares Eligible for Future Sale.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>You will experience immediate and substantial dilution. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The initial public offering price of our shares is expected to be substantially higher than the pro forma net tangible book value per share of our common
shares. Therefore, assuming the completion of the maximum offering, if you purchase shares in this offering, you will incur immediate dilution of approximately $3.46 or approximately 43.25% in the pro forma net tangible book value per share from the
price per share that you pay for the common shares. Assuming the completion of the minimum offering, if you purchase shares in this offering, you will incur immediate dilution of approximately $3.62 or approximately 45.25% in the pro forma net
tangible book value per share from the price per share that you pay for the shares. Accordingly, if you purchase shares in this offering, you will incur immediate and substantial dilution of your investment. See &#147;Dilution.&#148; </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We have not determined a specific use for a significant portion of the proceeds from this offering, and
we may use the proceeds in ways with which you may not agree. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our management and board of directors will have considerable discretion in
the application of the net proceeds received by us. In addition, in the event we are unable to locate favorable targets for acquisitions, we have reserved the right to re-allocate funds currently allocated to that purpose to our general working
capital. If that were to happen, then our management would have significant discretion over even more of the net proceeds to be received by our company in this offering. You will not have the opportunity, as part of your investment decision, to
assess whether the proceeds are being used appropriately. You must rely on the judgment of our management regarding the application of the net proceeds of this offering. The net proceeds may be used for corporate purposes that do not improve our
efforts to achieve profitability or increase our share price. The net proceeds from this offering may be placed in investments that do not produce income or that lose value. See &#147;Use of Proceeds.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Entities controlled by our employees, officers, management and/or directors will control a significant percentage of our common shares, decreasing
your influence on shareholder decisions. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Assuming the sale of the maximum offering, entities controlled by our employees, officers,
management and/or directors will, in the aggregate, beneficially own approximately 39.07% of our outstanding shares. Assuming the sale of the minimum offering, entities controlled by our employees, officers, management and/or directors will, in the
aggregate, beneficially own approximately 41.37% of our outstanding common shares. (Both numbers assume no redemption of shares under the Make-Good Share Escrow described under the sections entitled &#147;Related Party Transactions &#150; Make-Good
Shares Subject to Redemption&#148; and &#147;Placement &#150; Market and Pricing Considerations.&#148;) As a result, our employees, officers and directors will possess substantial ability to impact our management and affairs and the outcome of
matters submitted to shareholders for approval. These shareholders, acting individually or as a group, could exert control and substantial influence over matters such as electing directors and approving mergers or other business combination
transactions. This concentration of ownership and voting power may also discourage, delay or prevent a change in control of our company, which could deprive our shareholders of an opportunity to receive a premium for their shares as part of a sale
of our company and might reduce the price of our common shares. These actions may be taken even if they are opposed by our other shareholders, including those who purchase shares in this offering. See &#147;Principal Shareholders.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We will have an ongoing relationship with our placement agent that may impact our ability to obtain additional capital. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with this offering, we will, for a nominal amount, sell our placement agent warrants exercisable at a rate of one warrant per share to
purchase up to ten percent of the shares sold in the offering. These warrants are exercisable for a period of five years from the date of issuance at a price equal to 125% of the price of the shares in this offering. During the term of the warrants,
the holders thereof will be given the opportunity to profit from a rise in the market price of our common shares, with a resulting dilution in the interest of our other shareholders. The term on which we could obtain additional capital during the
life of these warrants may be adversely affected because the holders of these warrants might be expected to exercise them when we are able to obtain any needed additional capital in a new offering of securities at a price greater than the exercise
price of the warrants. See &#147;Placement.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We will have an ongoing relationship with our placement agent that may impact our
shareholders&#146; ability to impact decisions related to our operations. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with this offering, we have agreed to allow our
placement agent to designate two (2)&nbsp;non-voting observers to our Board of Directors until the earlier of the date that: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(i)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">the investors that purchase shares in this offering beneficially own less than ten percent (10%)&nbsp;of our outstanding shares; or </FONT></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(ii)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">the trading price per share is at least three (3)&nbsp;times the offering price for any consecutive 15 trading day period. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although our placement agent&#146;s observers will not be able to vote, they may nevertheless be in position to influence the outcome of matters
submitted to the Board of Directors for approval by virtue of their presence at such meetings and availability to provide opinions to the Board. We have agreed to reimburse the observers for their expenses for attending our Board meetings, subject
to a maximum reimbursement of $6,000 per meeting and $12,000 annually per observer, such amount being not more than the reimbursement to be received by any of our directors. We will also pay our observers the same amount of compensation as our
independent directors receive. As of the date of this prospectus, Mr.&nbsp;L. McCarthy Downs III and Mr.&nbsp;Ming Zhu are serving as our placement agent&#146;s observers to our Board of Directors. See &#147;Management &#150; Board of Directors
Observers.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>As the rights of shareholders under British Virgin Islands law differ from those under U.S. law, you may have fewer
protections as a shareholder. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our corporate affairs will be governed by our third amended and restated memorandum and articles of
association, the British Virgin Islands Business Companies Act, 2004 (the &#147;BVI Act&#148;), and the common law of the British Virgin Islands. The rights of shareholders to take legal action against our directors, actions by minority shareholders
and the fiduciary responsibilities of our directors under British Virgin Islands law are to a large extent governed by the common law of the British Virgin Islands and by the BVI Act. The common law of the British Virgin Islands is derived in part
from comparatively limited judicial precedent in the British Virgin Islands as well as from English common law, which has persuasive, but not binding, authority on a court in the British Virgin Islands. The rights of our shareholders and the
fiduciary responsibilities of our directors under British Virgin Islands law are not as clearly established as they would be under statutes or judicial precedents in some jurisdictions in the United States. In particular, the British Virgin Islands
has a less developed body of securities laws as compared to the United States, and some states (such as Delaware) have more fully developed and judicially interpreted bodies of corporate law. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of all of the above, holders of our shares may have more difficulty in protecting their interests through actions against our management,
directors or major shareholders than they would as shareholders of a U.S. company. For a discussion of significant differences between the provisions of the BVI Act and the laws applicable to companies incorporated in the United States and their
shareholders, see &#147;Description of Share Capital &#150; Differences in Corporate Law.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>British Virgin Islands companies may not
be able to initiate shareholder derivative actions, thereby depriving shareholders of the ability to protect their interests. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">British
Virgin Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States. The circumstances in which any such action may be brought, and the procedures and defenses that may be available in
respect to any such action, may result in the rights of shareholders of a British Virgin Islands company being more limited than those of shareholders of a company organized in the United States. Accordingly, shareholders may have fewer alternatives
available to them if they believe that corporate wrongdoing has occurred. The British Virgin Islands courts are also unlikely to recognize or enforce against us judgments of courts in the United States based on certain liability provisions of U.S.
securities law; and to impose liabilities against us, in original actions brought in the British Virgin Islands, based on certain liability provisions of U.S. securities laws that are penal in nature. There is no statutory recognition in the British
Virgin Islands of judgments obtained in the United States, although the courts of the British Virgin Islands will generally recognize and enforce the non-penal judgment of a foreign court of competent jurisdiction without retrial on the merits. This
means that even if shareholders were to sue us successfully, they may not be able to recover anything to make up for the losses suffered. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The laws of the British Virgin Islands provide little protection for minority shareholders, so minority
shareholders will have little or no recourse if the shareholders are dissatisfied with the conduct of our affairs. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the law of the
British Virgin Islands, there is little statutory law for the protection of minority shareholders other than the provisions of the BVI Act dealing with shareholder remedies. The principal protection under statutory law is that shareholders may bring
an action to enforce the constituent documents of the corporation, our third amended and restated memorandum and articles of association. Shareholders are entitled to have the affairs of the company conducted in accordance with the general law and
the articles and memorandum. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are common law rights for the protection of shareholders that may be invoked, largely dependent on English
company law, since the common law of the British Virgin Islands for business companies is limited. Under the general rule pursuant to English company law known as the rule in Foss v. Harbottle, a court will generally refuse to interfere with the
management of a company at the insistence of a minority of its shareholders who express dissatisfaction with the conduct of the company&#146;s affairs by the majority or the board of directors. However, every shareholder is entitled to have the
affairs of the company conducted properly according to law and the constituent documents of the corporation. As such, if those who control the company have persistently disregarded the requirements of company law or the provisions of the
company&#146;s memorandum and articles of association, then the courts will grant relief. Generally, the areas in which the courts will intervene are the following: (1)&nbsp;an act complained of which is outside the scope of the authorized business
or is illegal or not capable of ratification by the majority; (2)&nbsp;acts that constitute fraud on the minority where the wrongdoers control the company; (3)&nbsp;acts that infringe on the personal rights of the shareholders, such as the right to
vote; and (4)&nbsp;where the company has not complied with provisions requiring approval of a special or extraordinary majority of shareholders, which are more limited than the rights afforded minority shareholders under the laws of many states in
the United States. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_3"></A>FORWARD-LOOKING STATEMENTS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have made statements in this prospectus, including under &#147;Prospectus Summary,&#148; &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion
and Analysis of Financial Condition and Results of Operations,&#148; &#147;Our Business&#148; and elsewhere that constitute forward-looking statements. Forward-looking statements involve risks and uncertainties, such as statements about our plans,
objectives, expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as &#147;anticipate,&#148; &#147;estimate,&#148; &#147;plan,&#148; &#147;project,&#148; &#147;continuing,&#148;
&#147;ongoing,&#148; &#147;expect,&#148; &#147;we believe,&#148; &#147;we intend,&#148; &#147;may,&#148; &#147;should,&#148; &#147;could&#148; and similar expressions. These statements involve estimates, assumptions, known and unknown risks,
uncertainties and other factors that could cause actual results to differ materially from any future results, performances or achievements expressed or implied by the forward-looking statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Examples of forward-looking statements include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the timing of the development of future products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">projections of revenue, earnings, capital structure and other financial items; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">statements of our plans and objectives; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">statements regarding the capabilities of our business operations; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">statements of expected future economic performance </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">statements regarding competition in our market; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">assumptions underlying statements regarding us or our business. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The ultimate correctness of these forward-looking statements depends upon a number of known and unknown risks and events. We discuss our known material
risks under the heading &#147;Risk Factors&#148; above. Many factors could cause our actual results to differ materially from those expressed or implied in our forward-looking statements. Consequently, you should not place undue reliance on these
forward-looking statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The forward-looking statements speak only as of the date on which they are made, and, except as required by law,
we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. In addition, we cannot assess the impact of
each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_4"></A>OUR CORPORATE STRUCTURE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We were incorporated as an international business company under the International Business Companies Act, 1984, in the British Virgin Islands on
July&nbsp;22, 2003 under the name &#147;De-Haier Medical Systems Limited.&#148; We changed our name to &#147;Dehaier Medical Systems Limited&#148; on June&nbsp;3, 2005. On September&nbsp;24, 2003, we established BDL. On October&nbsp;15, 2003, we
founded DHK and created a holding company structure by which we are the parent company of BDL and DHK. BDL has been focused on the development and distribution of medical devices since its inception and began developing its respiratory and oxygen
homecare business in 2006. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following diagram illustrates our current corporate structure as of the date of this prospectus. Further
discussion of the history of our company from our chief executive officer&#146;s initial founding in 2001 of our affiliate, BTL, through our two rounds of private fundraising, may be found in the section titled &#147;Our Business &#150; Corporate
History.&#148; </FONT></P>
 <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g53110424txpg38.jpg" ALT="LOGO"> </P>
 <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chen Ping Ltd. is a British Virgin Islands company beneficially owned by our Chief Executive Officer, Mr.&nbsp;Ping Chen. </FONT></P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">These shares were
initially acquired by Crystal East Group Limited, a British Virgin Islands company, in our second round of venture capital financing. Crystal East Group Limited transferred the Series B preferred shares to its shareholder, Ms.&nbsp;Chen, and such
shares were converted into our common shares as of October&nbsp;31, 2009. Ms.&nbsp;Chen is not related to our chief executive officer, Mr.&nbsp;Ping Chen. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">De-haier Investment Holdings Ltd, a British Virgin Islands company wholly owned by Milestone Capital Management Limited, obtained these shares in our
first round of venture capital financing. These Series A preferred shares were converted into our common shares as of October&nbsp;31, 2009. Ms.&nbsp;Yunli Lou and Mr.&nbsp;Liping Qiu, who are managers of Milestone Capital Management Limited,
currently serve on the board of directors of BDL, the majority owned subsidiary of Dehaier. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Such shareholders
consist of employees and consultants to our company. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Dehaier is our
British Virgin Islands holding company that seeks to register its common shares in this initial public offering. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">)
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHK is a Hong Kong company owned by Dehaier, through which we may in the future conduct operations. We do not, however, have any present plans to do
so. We do not currently receive any significant revenues through DHK. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">)
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">BTL is a variable interest entity, and BDL is the primary beneficiary. BTL owns a building which is pledged as collateral for BDL&#146;s bank loans. In
exchange, BDL loans money to BTL to finance its operations. Dehaier, BDL and BTL are under common control, and BDL provides substantial financial support to BTL. This substantial financial support is primarily for working capital loans to finance
BTL&#146;s operations. At December&nbsp;31, 2006, 2007, 2008 and September&nbsp;30, 2009, BDL had advanced to BTL funds in the amount of $823,405, $786,816, $292,011 and $164,248, which represented 87%, 74%, 24% and 13% of BTL&#146;s equity,
respectively. Because BTL has insufficient equity to finance its operations, BTL then is required to obtain additional financial support to fund its operations. Accordingly, BTL&#146;s sales are included in Dehaier&#146;s consolidated income from
operations. Mr.&nbsp;Chen owns 86% of BTL and his wife and employees of Dehaier own the remaining 14%. BTL performs certain out-of-warranty repair work for products we sell and provides transportation services related to such services.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">BDL is our Chinese
operating entity. We develop, assemble, market and distribute our branded products through BDL, and we market and distribute products developed by other companies through BDL. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the opinion of our PRC legal counsel, (i)&nbsp;our ownership structure complies with, and immediately after this offering will comply with, current
PRC laws and regulations and the business and (ii)&nbsp;the operations of BDL comply with current PRC laws and regulations. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_5"></A>USE OF PROCEEDS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">After deducting the estimated placement discount and offering expenses payable by us, we expect to receive net proceeds of approximately $8,700,000 from
this offering if the minimum offering is sold and approximately $10,540,000 if the maximum offering is sold. The net proceeds from this offering must be remitted to China before we will be able to use the funds to grow our business. The procedure to
remit funds may take several months after completion of this offering, and we will be unable to use the funds in China until remittance is completed. See &#147;Risk Factors &#150; We must remit the offering proceeds to China before they may be used
to benefit our business in China, and this process may take a number of months.&#148; We intend to use the net proceeds of this offering as follows after we complete the remittance process, and we have ordered the specific uses of proceeds in order
of priority. We do not expect that our priorities for fund allocation would change if the amount we raise in this offering exceeds the size of the minimum offering but is less than the maximum offering. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="27%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:62pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description of Use</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage&nbsp;of&nbsp;Net&nbsp;Proceeds</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Product Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;25%</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;30%</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Potential Acquisitions</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;20%</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Working Capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;25%</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>100%</B></FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event we do not locate
any appropriate targets for acquisitions or are not able to negotiate such acquisitions on terms that are acceptable to us, we reserve the right to allocate such funds to our working capital purposes. There are no understandings, commitments or
agreements with respect to any such transaction at this time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will not use any portion of the net proceeds to repay our loan from ICBC and
will instead rely on our working capital (and, in particular, our cash and cash equivalents) to make such repayment. See &#147;Risk Factors&#151;We may be unable to repay our bank loan as it becomes due&#148; and &#147;&#151;Repayment of the ICBC
loan may significantly reduce our working capital and harm our liquidity.&#148; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will use a portion of our working capital to retain a consulting firm during our transition to operating
as a public company and an investor relations firm. Pending use of the net proceeds, we intend to invest our net proceeds in short-term, interest bearing, investment-grade obligations. These investments may have a material adverse effect on the U.S.
federal income tax consequences of an investment in our common shares. It is possible that we may become a passive foreign investment company for U.S. federal income taxpayers, which could result in negative tax consequences to you. These
consequences are discussed in more detail in &#147;Taxation.&#148; </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_6"></A>DIVIDEND POLICY
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have never declared or paid any cash dividends on our common shares. We anticipate that we will retain any earnings to support
operations and to finance the growth and development of our business. Therefore, we do not expect to pay cash dividends in the foreseeable future. Any future determination relating to our dividend policy will be made at the discretion of our Board
of Directors and will depend on a number of factors, including future earnings, capital requirements, financial conditions and future prospects and other factors the Board of Directors may deem relevant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under British Virgin Islands law, we may only pay dividends from surplus (the excess, if any, at the time of the determination of the total assets of our
company over the sum of our liabilities, as shown in our books of account, plus our capital), and we must be solvent before and after the dividend payment in the sense that we will be able to satisfy our liabilities as they become due in the
ordinary course of business; and the realizable value of assets of our company will not be less than the sum of our total liabilities, other than deferred taxes as shown on our books of account, and our capital. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we determine to pay dividends on any of our common shares in the future, as a holding company, we will be dependent on receipt of funds from our
majority-owned subsidiary, BDL. Payments of dividends by BDL to our company are subject to the requirement that foreign invested enterprises may only buy, sell and/or remit foreign currencies at those banks authorized to conduct foreign exchange
business. Further, such remittances would require BDL to provide an application for remittance that includes, in addition to the application form, a foreign registration certificate, board resolution, capital verification report, audit report on
profit and stock bonuses, and a tax certificate. There are no such similar foreign exchange restrictions in the British Virgin Islands. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_7"></A>CAPITALIZATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth our capitalization as of September&nbsp;30, 2009 on a pro forma as adjusted basis giving effect to the sale of the minimum
and maximum offering at a public offering price of $8.00 per share and to reflect the application of the proceeds after deducting the estimated placement fees. You should read this table in conjunction with our financial statements and related notes
appearing elsewhere in this prospectus and &#147;Use of Proceeds&#148; and &#147;Description of Share Capital.&#148; </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Minimum Offering (1,250,000 Common shares) </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>U.S. Dollars </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(unaudited) </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>September&nbsp;30, 2009 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>As&nbsp;Reported<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B>
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Pro
Forma<BR>Adjusted&nbsp;for&nbsp;IPO<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common shares</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,250,000</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,607</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional Paid-In
Capital</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,196,974</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,893,560</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Retained Earnings</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,696,547</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,696,547</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated Other Comprehensive Income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">774,531</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">774,531</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8,673,219</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>17,376,245</B></FONT></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum
Offering (1,500,000 Common shares) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>U.S. Dollars </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(unaudited) </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>September&nbsp;30, 2009 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>As&nbsp;Reported<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B>
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Pro
Forma<BR>Adjusted&nbsp;for&nbsp;IPO<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common shares</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,500,000</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,290</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional Paid-In
Capital</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,196,974</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,732,877</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Retained Earnings</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,696,547</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,696,547</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated Other Comprehensive Income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">774,531</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">774,531</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8,673,219</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>19,216,245</B></FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">This column gives
effect to the 3.66140766-for-1 share split of our common shares that was completed as of October&nbsp;31, 2009 but does not give effect to the conversion of outstanding preferred shares on such date as reported. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gives effect (i)&nbsp;to the conversion of outstanding preferred shares into common shares and simultaneous 3.66140766-for-1 share split of our common
shares that was completed as of October&nbsp;31, 2009, and (ii)&nbsp;to the sale of the minimum offering and the maximum offering, as applicable, at a public offering price of $8.00 per share and to reflect the application of the proceeds after
deducting the estimated underwriting discounts and our estimated offering expenses. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Pro forma adjusted
for IPO additional paid in capital reflects the net proceeds we expect to receive, after deducting a 7% underwriting discount, 1% non-accountable expense allowance and approximately $500,000 in expenses. In a maximum offering, we expect to receive
net proceeds of approximately $10,540,000 ($12,000,000 offering, less underwriting discount of $840,000, non- accountable expense allowance of $120,000 and offering expenses of $500,000). In a minimum offering, we expect to receive net proceeds of
approximately $8,700,000 ($10,000,000 offering, less underwriting discount of $700,000, non-accountable expense allowance of $100,000 and offering expenses of $500,000). </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_8"></A>EXCHANGE RATE INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our business is primarily conducted in China, and the financial records of our PRC subsidiary and BTL are maintained in RMB, their functional currency.
However, we use the U.S. dollar as our reporting and functional currency; therefore, periodic reports made to shareholders will include current period amounts translated into U.S. dollars using the then-current exchange rates, for the convenience of
the readers. Our financial statements have been translated into U.S. dollars in accordance with Accounting Standards Codification (&#147;ASC&#148;) 830-10, &#147;Foreign Currency Matters.&#148; We have translated our asset and liability accounts
using the exchange rate in effect at the balance sheet date. We translated our statements of operations using the average exchange rate for the period. We reported the resulting translation adjustments under other comprehensive income. Unless
otherwise noted, we have translated balance sheet amounts with the exception of equity at December&nbsp;31, 2008 at &yen;6.8225 to $1.00 as compared to &yen;7.2946 to $1.00 at December&nbsp;31, 2007. The average translation rates applied to income
statement accounts for the year ended December&nbsp;31, 2008 and the year ended December&nbsp;31, 2007 were &yen;6.9483 and &yen;7.6040, respectively. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We make no representation that any RMB or U.S. dollar amounts could have been, or could be, converted into U.S. dollars or RMB, as the case may be, at
any particular rate, or at all. The PRC government imposes control over its foreign currency reserves in part through direct regulation of the conversion of RMB into foreign exchange and through restrictions on foreign trade. On March&nbsp;15, 2010,
the noon buying rate was &yen;6.8259 to $1.00. The Company does not currently engage in currency hedging transactions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table
sets forth information concerning exchange rates between the RMB and the U.S. dollar for the periods indicated. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Noon Buying Rate</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:22pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Period</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Period-End</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Average<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Low</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>High</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(RMB per U.S. Dollar)</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2004</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.2765</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.2768</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.2764</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.2774</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2005</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.0702</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.1940</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.0702</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.2765</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2006</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.8041</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.9723</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.8041</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.0702</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2007</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.2946</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.6040</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.2946</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.8127</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2008</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8225</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.9483</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.7800</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.2946</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8259</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8307</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8176</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8470</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">July</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8319</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8317</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8300</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8342</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">August</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8299</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8323</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8299</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8358</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">September</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8262</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8277</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8247</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8303</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">October</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8264</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8267</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8248</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8292</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">November</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8265</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8271</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8255</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8300</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">December</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8259</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8275</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8244</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8299</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">January</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8268</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8269</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8258</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8295</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">February</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8258</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8285</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8258</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8330</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">March (through March 15, 2010)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8259</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8261</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8254</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8266</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Averages are
calculated using the daily rates during the relevant period. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_9"></A>DILUTION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you invest in our common shares, your interest will be diluted to the extent of the difference between the initial public offering price per common
share and the pro forma net tangible book value per common share after the offering. Dilution results from the fact that the per common share offering price is substantially in excess of the book value per common share attributable to the existing
shareholders for our presently outstanding common shares. Our unaudited net tangible book value attributable to shareholders at September&nbsp;30, 2009 was $9,910,207 or approximately $3.30 per common share. Unaudited net tangible book value per
common share as of September&nbsp;30, 2009 represents the amount of total assets less intangible assets and total liabilities, divided by the number of common shares outstanding. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the minimum offering is sold, we will have 4,250,000 common shares outstanding upon completion of the offering. Our post offering pro forma net
tangible book value, which gives effect to receipt of the net proceeds from the offering and issuance of additional shares in the offering, but does not take into consideration any other changes in our net tangible book value after
September&nbsp;30, 2009, will be approximately $18,610,207 or $4.38 per common share. This would result in dilution to investors in this offering of approximately $3.62 per common share or approximately 45.25% from the offering price of $8.00 per
common share. Net tangible book value per common share would increase to the benefit of present shareholders by $1.08 per share attributable to the purchase of the common shares by investors in this offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the maximum offering is sold, we will have 4,500,000 common shares outstanding upon completion of the offering. Our post offering pro forma net
tangible book value, which gives effect to receipt of the net proceeds from the offering and issuance of additional shares in the offering, but does not take into consideration any other changes in our net tangible book value after
September&nbsp;30, 2009, will be approximately $20,450,207 or $4.54 per common share. This would result in dilution to investors in this offering of approximately $3.46 per common share or approximately 43.25% from the offering price of $8.00 per
common share. Net tangible book value per common share would increase to the benefit of present shareholders by $1.24 per share attributable to the purchase of the common shares by investors in this offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth the estimated net tangible book value per common share after the offering and the dilution to persons purchasing common
shares based on the foregoing minimum and maximum offering assumptions. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Minimum<BR>Offering<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B>
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>Offering<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B>
</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Offering price per common share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.00</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.00</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net tangible book value per common share before the offering (unaudited)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.30</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.30</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increase per common share attributable to payments by new investors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.08</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.24</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pro forma net tangible book value per common share after the offering</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.38</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.54</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dilution per common share to new investors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.62</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.46</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Assumes gross proceeds from offering of 1,250,000 common shares. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Assumes gross
proceeds from offering of 1,500,000 common shares. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_10"></A>POST-OFFERING OWNERSHIP </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following charts illustrate our pro forma proportionate ownership, upon completion of the offering under alternative minimum and maximum offering
assumptions, by present shareholders and investors in this offering, compared to the relative amounts paid by each. The charts reflect payment by present shareholders as of the date the consideration was received and by investors in this offering at
the offering price without deduction of commissions or expenses. The charts further assume no changes in net tangible book value other than those resulting from the offering and provide alternative scenarios depending on whether the Make-Good Shares
are redeemed. See &#147;Risk Factors &#150; A redemption of Make-Good Shares may be insufficient to cause our company to achieve targeted earnings and may reduce our management&#146;s involvement and stake in our company,&#148; &#147;Related Party
Transactions &#150; Make-Good Shares Subject to Redemption&#148; and &#147;Placement &#150; Market and Pricing Considerations.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Scenario 1: Pro forma presentation assuming no redemption of any Make-Good Shares </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares Purchased</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total Consideration</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Average&nbsp;
Price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Per Share</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MINIMUM OFFERING</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Existing shareholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">70.6</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,910,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">49.8</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.30</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">New investors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,250,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">29.4</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">50.2</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.00</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,250,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,910,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.68</FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares Purchased</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total Consideration</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Average&nbsp;
Price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Per Share</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MAXIMUM OFFERING</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Existing shareholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">66.7</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,910,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">45.2</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.30</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">New investors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,500,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">33.3</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">54.8</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.00</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,500,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,910,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.87</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Scenario 2: Pro forma presentation
assuming redemption of all Make-Good Shares </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares Purchased</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total Consideration</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Average&nbsp;
Price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Per Share</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MINIMUM OFFERING</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Existing shareholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,400,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.8</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,910,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">49.8</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.13</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">New investors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,250,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">34.2</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">50.2</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.00</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,650,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,910,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.45</FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares Purchased</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total Consideration</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Average&nbsp;
Price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Per Share</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MAXIMUM OFFERING</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Existing shareholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,400,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">61.5</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,910,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">45.2</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.13</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">New investors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,500,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">38.5</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">54.8</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.00</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,900,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,910,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.62</FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_11"></A>SELECTED HISTORICAL CONDENSED </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED FINANCIAL AND OPERATING DATA </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">You should read the following selected financial data in conjunction with &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operations&#148; and the financial statements and related notes included elsewhere in this prospectus. The selected statements of operations data are for the fiscal years ended December&nbsp;31, 2008 and 2007. The selected balance sheet
data set forth below is as of December&nbsp;31, 2008 and 2007. This selected financial data is derived from our consolidated financial statements and should be read in conjunction with the consolidated financial statements and notes thereto which
are included elsewhere in this prospectus. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the nine<BR>months ended<BR>September&nbsp;30,&nbsp;2009</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the fiscal year ended<BR>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,422,460</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,414,430</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,599,512</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,586,824</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,496,086</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">970,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,110,278</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">980,351</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">848,421</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-controlling interest in income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(38,502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(62,331</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(53,214</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income attributable to Dehaier</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,071,776</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">918,020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">795,207</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic earnings per share (based on 1,891,930 shares outstanding on each of September&nbsp;30, 2009,&nbsp;December&nbsp;31, 2008
and 2007)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Diluted earnings per share (based on 3,000,000, 3,000,000 and 2,451,624 shares outstanding on September&nbsp;30,
2009,&nbsp;December&nbsp;31, 2008 and 2007,
respectively)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pro forma basic earnings per share (based on 1,291,930 shares outstanding on each of September&nbsp;30, 2009 and
December&nbsp;31, 2008)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pro forma diluted earnings per share (based on 2,400,000 shares outstanding on each of September&nbsp;30, 2009 and
December&nbsp;31, 2008, respectively)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.86</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="8"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B>
</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,485,711</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,046,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,928,863</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,566,373</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,232,464</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,550,505</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Dehaier shareholders&#146; equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,676,245</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,608,704</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,310,499</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-controlling interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,243,093</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,205,232</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,067,859</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities and shareholders&#146; equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,485,711</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,046,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,928,863</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">We have presented
these basic and diluted earnings per share in Dehaier after giving retroactive effect to the 3.66140766-for-1 share split of common shares completed as of October&nbsp;31, 2009. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">We have presented
these pro forma earnings per share after (a)&nbsp;giving retroactive effect to the 3.66140766-for-1 share split of our common shares completed as of October&nbsp;31, 2009 and (b)&nbsp;assuming the redemption of all shares placed into escrow as
described in the section entitled &#147;Related Party Transactions &#150; Make-Good Shares Subject to Redemption.&#148; The number of escrowed shares is based on 600,000 common shares (40% of an assumed maximum of 1,500,000 common shares). Pro forma
basic EPS for the nine months ended September&nbsp;30, 2008 calculated on the foregoing assumptions and based on 1,291,930 Dehaier shares, is $0.40. Pro forma diluted EPS for the nine months ended September&nbsp;30, 2008 calculated on the foregoing
assumptions and based on 2,400,000 Dehaier shares, is $0.22. No pro forma numbers have been provided for the year ended December&nbsp;31, 2007. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_12"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our audited historical
consolidated financial statements and the related notes included elsewhere in this prospectus. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results and the timing of selected events could
differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under &#147;Risk Factors&#148; and elsewhere in this prospectus. </I></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Overview </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have been
focused on the development and distribution of medical devices since our inception, and we began developing our respiratory and oxygen homecare business in 2006. We design, develop and market our branded products in China. We import the majority of
the products and medical components we sell to our customers. We design and develop some of the medical components that are part of the branded products to be distributed. Some of these medical components are manufactured by contractors in China
because we do not have a manufacturing facility. Most of our branded products we sell require light assembly. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to our branded
products, we also serve as a distributor of products designed and manufactured by other companies. We sell products from IMD (Italy), Timesco (UK), ResMed (Australia) and JMS (Japan). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We sell products primarily to distributors; however, we also sell products directly to hospitals, clinics and government health bureaus. We continually
seek to broaden our market reach by introducing new and more advanced products and new product lines that address different end-user populations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the past two fiscal year periods ended December&nbsp;31, 2007 and 2008, our total revenues amounted to approximately $6.60 million and $9.41 million,
respectively. For the nine month periods ended September&nbsp;30, 2008 and 2009, our total revenues amounted to approximately $6.53 million and $9.42 million, respectively. Our revenues are subject to value added tax (&#147;VAT&#148;), sales returns
and trade discounts .We deduct these amounts from our gross revenues to arrive at our total revenues. Our net income attributable to Dehaier for the periods ended December&nbsp;31, 2007 and 2008 was $0.79 million and $0.92 million, respectively, and
$0.52 million and $2.07 million for the nine month periods ended September&nbsp;30, 2008 and 2009, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Revenues </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our total revenues are derived from products we provide in our three product lines, (i)&nbsp;Medical Devices (ii)&nbsp;Respiratory and Oxygen Homecare
Products and (iii)&nbsp;Technical Service Products. We are currently operating in one business segment for all of our products we distribute. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Medical Devices &#150; Our Branded and Distributed Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We derive revenues in our medical devices product line from the sale of C-arm X-ray systems, anesthesia machines, patient monitors and general hospital
products. Our medical device line is our largest business line of products and has the most extensive market penetration of our three product lines. We anticipate that we will continue to experience revenue growth in our medical devices line as we
further penetrate the market through the development and introduction of new advanced product offerings. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Respiratory and Oxygen Homecare
Products &#150; Our Branded and Distributed Products </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We derive revenues in our respiratory and oxygen homecare line from sales of oxygen
concentrators, CPAP devices, portable sleep screening and diagnostic devices and thermotherapy devices. We anticipate that, on a percentage basis, net revenues in our respiratory and oxygen homecare product line will increase more rapidly than total
net revenues in the near term, as we introduce new and more advanced products in this product line. We expect to increase our market penetration in the respiratory and oxygen homecare market both in China and internationally through the use of
distributors as well as through our direct sales platform. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Technical Service Products &#150; Our Branded Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We derive revenues in our technical service products line from sales of our air compressors and ventilator trolleys. We anticipate continued growth in
revenues from our technical service products as we further penetrate this market by increasing the number of our distributors and maintaining a competitive pricing model. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our ability to increase our revenues depends in large part on our ability to (i)&nbsp;increase the market penetration of our existing products,
(ii)&nbsp;successfully identify, develop, introduce and commercialize, in a timely and cost-effective manner, new and upgraded products and (iii)&nbsp;enter into international markets in the future. Generally, we choose to devote our resources to
product development efforts that we believe are commercially feasible, can generate significant revenues and margins and can be introduced into the market quickly. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Factors Affecting Our Results of Operations &#150; Generally </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe the most significant factors that directly or indirectly affect our sales revenues and net income are: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">global economic conditions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the changes in China&#146;s macro-economic environment and healthcare-related government strategies and policies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the level of acceptance of our products among hospitals and other healthcare facilities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to attract and retain distributors, key customers and our direct sales force; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">new product introductions by us and our competitors; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to price our products at levels that provide favorable margins. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operating Costs and Expenses </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our
operating costs and expenses consist of cost of revenues, general and administrative expenses, selling expenses and other expenses. Our total operating costs and expenses decreased as a percentage of our total revenues for the year ended
December&nbsp;31, 2008 compared to the year ended December&nbsp;31, 2007 and for the nine months ended September&nbsp;30, 2009 compared to the same period in 2008. These decreases were primarily due to increased economies of scale and an increase in
revenue. The following table sets forth the components of our costs and expenses both in U.S. dollar amounts (in thousands) and as a percentage of total net revenues for the periods indicated. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the years ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the nine months ended September&nbsp;30,</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>%</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>%</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>%</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>%</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Revenues</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,414</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.00</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,600</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.00</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,422</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.00</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,532</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100.00</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Costs and expenses</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,931</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63.00</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,280</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">64.85</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,688</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60.37</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,111</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62.94</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,326</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14.09</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">758</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.48</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">788</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.36</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">918</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14.05</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Selling expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">974</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.35</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">881</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.35</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">544</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.77</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">785</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12.02</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total costs and expenses</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,231</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">87.44</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,919</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">89.68</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,020</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74.50</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,814</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">89.01</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Cost of revenues </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of revenues primarily includes wages, parts for assembly, handling charges, and other expenses associated with the assembly and distribution of
product. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General and Administrative Expenses </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative expenses consist primarily of salaries and benefits and related costs for our administrative personnel and management, fees and
expenses of our outside advisers, including legal, audit and valuation expenses, expenses associated with our administrative offices and the depreciation of equipment used for administrative purposes. We expect that our general and administrative
expenses will increase, both on an absolute basis and as a percentage of revenue, as we hire additional personnel and incur costs related to the anticipated growth of our business. In addition, we expect to incur additional general and
administrative expenses associated with becoming a public company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Selling Expenses </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Selling expenses consist primarily of compensation and benefits for our sales and marketing staff, expenses for promotional, advertising, travel and
entertainment activities, lease payments for our sales offices, and depreciation expenses related to equipment used for sales and marketing activities. Going forward, we expect our selling expenses to increase, both on an absolute basis and as a
percentage of revenue, as we increase our efforts to promote our products, especially our new respiratory and oxygen homecare products. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Tax Matters Applicable to Our Company </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Generally </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dehaier is a tax-exempt
company incorporated in the British Virgin Islands. BDL and BTL were incorporated in the PRC and are governed by PRC laws. DHK is subject to Hong Kong profits tax rate. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our company pays PRC enterprise income taxes, value added taxes and business taxes in China for revenues from BDL and is governed by British Virgin
Islands tax laws as to Dehaier. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>British Virgin Islands Tax </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are exempt from all provisions of the Income Tax Act of the British Virgin Islands, including with respect to all dividends, interests, rents,
royalties, compensation and other amounts payable by or to persons who are not resident in the British Virgin Islands. Capital gains realized with respect to any of our shares, debt obligations or other securities by persons who are not resident in
the British Virgin Islands are also exempt from all provisions of the Income Tax Act of the British Virgin Islands. No estate, inheritance tax succession or gift tax rate, duty, levy or other charge is payable by persons who are not resident in the
British Virgin Islands with respect to any of our shares, debt obligations, or other securities. No stamp duty is payable in the British Virgin Islands in relation to a transfer of shares in a British Virgin Islands Business Company. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PRC Enterprise Income Taxes </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">PRC
enterprise income tax is calculated based on taxable income determined under PRC accounting principles. According to the Foreign-invested Enterprises and Foreign Enterprises Income Tax Law (the &#147;FIE Income Tax Law&#148;) and the related
implementing rules, both of which issued in 1991, foreign-invested enterprises established in China are generally subject to an income tax rate of 33% (consisting of 30% enterprise income tax and 3% local income tax). The FIE Income Tax Law and the
related implementing rules provide certain favorable tax treatments to qualified foreign invested enterprises. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The FIE Income Tax Law was
replaced by the Enterprise Income Tax Law (the &#147;EIT Law&#148;) as of January&nbsp;1, 2008. Under the EIT Law, a unified enterprise income tax rate of 25% and unified tax deduction standards will be applied equally to both domestic-invested
enterprises and foreign-invested enterprises. Enterprises established prior to March&nbsp;16, 2007 eligible for preferential tax treatment in accordance with the currently prevailing tax laws and administrative regulations shall, under the
regulations of the State Council, gradually become subject to the EIT Law rate over a five-year transition period starting from the date of effectiveness of the EIT Law. The details of the transitional arrangement for the five-year period from
January&nbsp;1, 2008 to December&nbsp;31, 2012 applicable to enterprises approved for establishment prior to March&nbsp;16, 2007, such as our company, were adopted in January 2008. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Furthermore, under the EIT Law, an enterprise established outside of the PRC with &#147;de facto management
bodies&#148; within the PRC is considered a resident enterprise and will normally be subject to the enterprise income tax at the rate of 25% on its global income. If the PRC tax authorities subsequently determine that we or any of our non-PRC
subsidiaries should be classified as a PRC resident enterprise, then such entity&#146;s global income will be subject to PRC income tax at a tax rate of 25%. In addition, under the EIT Law, payments from BDL to us may be subject to a withholding
tax. The EIT Law currently provides for a withholding tax rate of 20%. If Dehaier is deemed to be a non-resident enterprise, then it will be subject to a withholding tax at the rate of 10% on any dividends paid by its Chinese subsidiaries to
Dehaier. In practice, the tax authorities typically impose the withholding tax rate of 10% rate, as prescribed in the implementation regulations; however, there can be no guarantee that this practice will continue as more guidance is provided by
relevant government authorities. We are actively monitoring the proposed withholding tax and are evaluating appropriate organizational changes to minimize the corresponding tax impact. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The State Council issued the &#147;Notice on Implementation of the Transition Period for Preferential Enterprise Income Tax,&#148; or the
&#147;Transition Implementation Notice,&#148; on December&nbsp;26, 2007, which provides detailed rules on how preferential tax rates under previous income tax laws or regulations would transition to the uniform 25% EIT rate. In addition, entities
that qualify as &#147;high and new technology enterprises&#148; will enjoy a 15% preferential tax rate under the EIT Law. The Ministry of Science and Technology, the Ministry of Finance and the State Administration of Taxation issued the
&#147;Measures on Qualification of High and New Technology Enterprises,&#148; or &#147;Circular 172,&#148; on April&nbsp;14, 2008, which provides detailed standards for &#147;high and new technology enterprises.&#148; In addition, according to the
Notice on Prepayment of Enterprise Income Tax issued by the State Administration of Taxation, enterprises that have been certified as &#147;high and new technology enterprises&#148; shall pre-pay EIT at the rate of 25% temporarily until re-certified
as &#147;high and new technology enterprises&#148; under Circular 172. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the current PRC laws, BDL and BTL are subject to EIT and VAT.
BDL was classified as a high and new technology company and operates in an approved economic-technological development area. Given this classification, it was entitled to an EIT rate of 15%, compared to the statutory rate of 30% for most companies
in China. This classification also exempted BDL from paying the EIT for the three calendar years ended December&nbsp;31, 2004, 2005 and 2006 and reduced BDL&#146;s EIT rate by 50% to 7.5% for the three calendar years ended December&nbsp;31, 2007,
2008 and 2009. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Due to the PRC&#146;s standardization of tax rates for all companies in China effective January&nbsp;1, 2008 and promulgation
of new standards for high technology companies, BDL paid the 25% tax rate in 2008. While the certification remained available in 2008, the standards were revised, requiring previously certified entities to apply for high technology certification
again. BDL subsequently applied for and obtained such high technology certification approval online and received the confirmation certificate. As a result, we have calculated our 2009 estimated income tax expenses at the preferential tax rate of
15%. While we believe that BDL will continue to qualify for this preferential tax rate so long as it continues to conduct business as it currently does and the requirements for qualification are not changed, we cannot guarantee that we will be
successful in remaining so certified. If we were to lose our preferential tax rate, we would need to calculate our estimated income tax expense at 25%, the standard enterprise tax rate in China. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PRC Value Added Tax </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the
Provisional Regulation of China on Value Added Tax and its implementing rules, issued in December 1993, all entities and individuals that are engaged in the businesses of sales of goods, provision of repair and placement services and importation of
goods into China are generally subject to a VAT at a rate of 17% (with the exception of certain goods which are subject to a rate of 13%) of the gross sales proceeds received, less any VAT already paid or borne by the taxpayer on the goods or
services purchased by it and utilized in the production of goods or provisions of services that have generated the gross sales proceeds. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PRC Business Tax </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies in China are generally subject to business tax and related surcharges by various local tax authorities at rates ranging from 3% to 20% on
revenue generated from providing services and revenue generated from the transfer of intangibles. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Critical Accounting
Policies </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Presentation in Accordance with US&nbsp;GAAP </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We prepare consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (&#147;US
GAAP&#148;). These accounting principles require us to make judgments, estimates and assumptions on the reported amounts of assets and liabilities at the end of each fiscal period, and the reported amounts of revenues and expenses during each fiscal
period. We continually evaluate these judgments and estimates based on our own historical experience, knowledge and assessment of current business and other conditions, our expectations regarding the future based on available information and
assumptions that we believe to be reasonable. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Basis of Consolidation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The consolidated financial statements include the accounts of Dehaier, BDL, its majority-owned subsidiary, and its wholly-owned subsidiary, DHK as well as
BTL. All significant inter-company transactions and balances are eliminated in consolidation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A group of shareholders, including the Chief
Executive Officer, holds more than 50% of the voting ownership interest of BDL and BTL. BTL is a variable interest entity, and Dehaier is the primary beneficiary. Dehaier, BDL and BTL are under common control, and Dehaier, through its 96.37%
subsidiary, BDL, provides substantial financial support to BTL. BTL owns a building which is pledged as collateral for BDL&#146;s bank loans. In exchange, BDL loans money to BTL to finance its operations. BTL&#146;s primary operation is to provide
repairs and transportation services to BDL&#146;s customers. Dehaier has included BTL in its consolidated financial statements since December&nbsp;31, 2006 and presented the non-controlling interest of BTL as a separate component in Dehaier&#146;s
equity section on the accompanying consolidated balance sheets. BTL&#146;s share of income (loss) is subtracted from (added to) consolidated income (loss) to arrive at Dehaier&#146;s net income (loss). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October&nbsp;31, 2009, BDL reconsidered whether it is the primary beneficiary of BTL when Dehaier&#146;s preferred stock was converted into common
shares. While such conversion dilutes Mr.&nbsp;Chen&#146;s interest in BDL such that BDL and BTL are not under common control after October&nbsp;30, 2009, BDL still has the obligation to absorb the expected losses of BTL. BTL is still a variable
interest entity because all of its activities either involve or are conducted on behalf of the reporting enterprise and its related parties. BDL is BTL&#146;s only customer referral source. On March&nbsp;3, 2010, BDL entered into a Loss Absorption
Agreement memorializing the understanding that BDL would continue to loan money to BTL as needed to fund its working capital such that BDL would absorb BTL&#146;s losses. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Carrying amount and classification of BTL&#146;s assets and liabilities included in the consolidated balance sheets are as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">392,431</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">770,598</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">268,407</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,573,073</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,988,906</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,380,680</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">367,842</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">921,047</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,587</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">367,842</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">921,047</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,587</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The accounts of BTL are
consolidated in the accompanying financial statements pursuant to Accounting Standards Codification (&#147;ASC&#148;) 810-10, &#147;Consolidation&#148;. As a VIE, BTL&#146;s revenues are included in the Company&#146;s total revenues, and its income
from operations is consolidated with the Company&#146;s. Because of the arrangements, the Company had a pecuniary interest in BTL that requires consolidation of the Company&#146;s and BTL&#146;s financial statements. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;1, 2009, the Company adopted the transition rules within ASC 810-10-65, regarding accounting
and reporting standards for the non-controlling interest in a subsidiary. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Use of Estimates </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The preparation of the consolidated financial statements in conformity with US&nbsp;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates are
adjusted to reflect actual experience when necessary. Significant accounting estimates reflected in the Company&#146;s consolidated financial statements include revenue recognition, allowance for doubtful accounts and impairment of long-lived
assets. Actual results could differ from those estimates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Cash and Cash Equivalents </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents consist of cash on hand and highly liquid investments which are unrestricted as to withdrawal or use, and which have maturities
of three months or less when purchased. Our company maintains uninsured cash and cash equivalents with various financial institutions mainly in the PRC and Hong Kong. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Accounts Receivable </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts receivable
are recorded at net realizable value. Accounts receivable terms typically are net 60-180 days from the end of the month in which services are provided or goods are delivered. Our typical trade receivable terms vary based on the type of customer. We
general require 100% prepayment before delivering our products to individual clients. Our contract terms general require 10%-30% prepayment for our hospital and healthcare center clients, and the trade receivable term in contracts for those clients
is generally between 60 and 90 days. Our contract terms general require 10% prepayment from our distributor clients, and the trade receivable term in contracts for those clients is generally between 60 and 180 days. With the exception of the
prepayments we require in some cases, our company generally does not require collateral or other security to support accounts receivable. An allowance, if required, is based on a combination of historical experience, aging analysis, and an
evaluation of the collectability of specific accounts. At September&nbsp;30, 2009, our accounts receivable aging was as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:90pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total&nbsp;Accounts&nbsp;Receivable</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:45pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1&nbsp;to&nbsp;3&nbsp;months</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:45pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>3&nbsp;to&nbsp;6&nbsp;months</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:63pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>6&nbsp;months&nbsp;to&nbsp;1&nbsp;year</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:38pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1&nbsp;to&nbsp;2&nbsp;years</B></FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,059,480</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,679,059</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,771,944</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,448,310</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">160,167</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Receivables are considered past due
after 3 years and written off. Management has determined this write-off policy by reviewing the decrease in likelihood of collection as a function of time and concluded that collectability of accounts receivable after three years was significantly
impaired, compared with collectability prior to such time. At December&nbsp;31, 2008 and 2007 and September&nbsp;30, 2009, an allowance for doubtful accounts has been provided based on management&#146;s analysis of both past bad debt allowances and
performance and current aging of accounts receivable. Based on this analysis, management believes that its historical bad debt rates and long-term accounts receivable (over one year) are relatively low and that, as a result, the allowance for
doubtful accounts is adequate. To the extent actual bad debts differ from management&#146;s estimates by 10%, consolidated net income would be an estimated $3,000, $11,000 and $2,000 higher or lower for the years ended December&nbsp;31, 2008 and
2007, and for the nine months ended September&nbsp;30, 2009, respectively, depending on whether the actual write-offs are greater or lower than estimated. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Fair Value of Financial Instruments </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
carrying amounts reported in the consolidated financial statements for current assets and current liabilities approximate fair value due to the short-term nature of these financial instruments. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2008, the Company adopted ASC 820-10, &#147;Fair Value Measurements and Disclosures,&#148; which establishes a single authoritative definition of fair
value and a framework for measuring fair value and expands disclosure of fair value measurements for both financial and nonfinancial assets and liabilities. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This standard defines fair value, provides guidance for measuring fair value and requires certain
disclosures. This standard does not require any new fair value measurements, but discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flows) and the cost
approach (cost to replace the service capacity of an asset or replacement cost). For purposes of ASC 820-10-15, nonfinancial assets and nonfinancial liabilities would include all assets and liabilities other than those meeting the definition of a
financial asset or financial liability as defined in ASC 820-10-15-15-1A. Management elected the deferral option available for one year for nonfinancial assets and liabilities as permitted by ASC 820-10. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company decided not to elect the fair value option prescribed by Financial Accounting Standards Board (&#147;FASB&#148;) ASC 825-10 for its financial
assets and liabilities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Inventory </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory is stated at the lower of cost or market and consists of assembled and unassembled parts relating to medical devices. The Company reviews its
inventory annually for possible obsolete goods and to determine if any reserves are necessary for potential obsolescence. At December&nbsp;31, 2008 and 2007 and September&nbsp;30, 2009, no reserve for obsolescence was considered necessary because
the Company&#146;s inventory consists of components that are assembled shortly prior to distribution. Because the Company orders components and ships products to order, it typically maintains very little inventory that could become obsolete.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Impairment of Long-Lived Assets </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no
longer be recoverable. When these events occur, the Company measures impairment by comparing the carrying value of the long-lived assets to the estimated undiscounted future cash flows expected to result from the use of the asset and eventual
disposition. If the sum of the expected future cash flows is less than the carrying amount of the asset, an impairment loss, equal to the excess of the carrying amount over the fair market value of the asset, is recognized. Management has determined
no impairment exists at the balance sheet dates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company reviews intangible assets for impairment. There was no impairment of intangible
assets for the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September&nbsp;30, 2009 and 2008. Although management believes the assumptions used in testing for impairment are reasonable, changes in any one of the
assumptions could produce a significantly different result. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Revenue Recognition </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company recognizes revenues when all the followings conditions have been satisfied: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Persuasive evidence an arrangement exists; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Delivery and/or installation has occurred (e.g., risks and rewards of ownership have passed); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The sales price is fixed or determinable; and, </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Collectibility is reasonably assured. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All revenues are based on firm customer orders with fixed terms and conditions. Because the products are assembled to the customers&#146; specification,
there is no right of return. The Company does not provide its customers with price protection or cash rebates. For products which include software, the software is an off-the-shelf package and an integral part of the products being delivered. The
Company does not provide any significant post-sale customer support services and does not provide customers with upgrades. The software is incidental to the product as a whole. For products that do not require installation, revenues are recognized
when the products are delivered. For products that require installation, revenues are recognized when the installation is completed. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the
PRC, a VAT rate of 17% of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such
VAT is paid to the authorities. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">52 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Service Income and Expense </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Service income and expense represents activities related to repairs and transportation services provided for the customers by BTL. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Warranty Costs </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company provides for
the estimated cost of product warranties at the time revenue is recognized. Warranty costs are included in general and administrative expenses. The Company&#146;s warranty obligation is affected by product failure rates and material usage and
service delivery costs incurred in correcting product failure. Should actual product failure rates, material usage or service delivery costs differ from the Company&#146;s estimates, the Company may be required to revise its estimated product
warranty liability. The term of the product warranty is generally twelve months. Provision for warranty costs was $158,065, $98,964 and $199,727 at December&nbsp;31, 2008 and 2007 and September&nbsp;30, 2009, respectively. The provision for warranty
costs is estimated based on historical cost. To the extent that actual warranty costs differ from management&#146;s estimates by 10%, consolidated net income would be an estimated $6,000, $1,000, $4,000 and $4,000 higher or lower for the years ended
December&nbsp;31, 2008 and 2007 and the nine months ended September&nbsp;30, 2009 and 2008, respectively, depending on whether the actual warranty costs are greater or less than estimated. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Value Added Tax </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company reports
revenues net of PRC&#146;s value added tax for all the periods presented in the consolidated statements of operations. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Income Taxes </B>
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2006, the FASB issued ASC 740-10, &#147;Accounting for Uncertainty in Income Taxes &#150; an Interpretation of Accounting for Income
Taxes.&#148; It prescribes a recognition threshold and measurement attribute for the financial statement recognition of a tax position taken or expected to be taken on a tax return. Under ASC 740-10, a tax benefit from an uncertain tax position
taken or expected to be taken may be recognized only if it is &#147;more likely than not&#148; that the position is sustainable upon examination, based on its technical merits. The tax benefit of a qualifying position under ASC 740-10 would equal
the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement with a taxing authority having full knowledge of all the relevant information. A liability (including interest and penalties, if applicable)
is established in the financial statements to the extent a current benefit has been recognized on a tax return for matters that are considered contingent upon the outcome of an uncertain tax position. Related interest and penalties, if any, are
included as components of income tax expense and income taxes payable. The Company is awaiting resolution of certain complex tax issues and has not yet filed its 2007 and 2008 Value Added Tax (&#147;VAT&#148;) tax returns for some of its customers.
However, all the potential VAT liabilities on these VAT returns were accrued and included in the accompanying consolidated financial statements. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Results of Operations </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our limited operating history makes it difficult to predict future operating results. We believe that period-to-period comparisons of operating results
should not be relied upon as indicative of future performance. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Nine Months Ended September&nbsp;30, 2009 Compared to Nine Months Ended
September&nbsp;30, 2008 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Revenues </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our total revenues increased by 44.25% from $6.53 million for the nine months ended September&nbsp;30, 2008 to $9.42 million for the nine months ended
September&nbsp;30, 2009. Our top three selling product categories (mobile C arm X-ray system, general medical products and compressors) accounted for 57% of our total revenues for the nine months ended September&nbsp;30, 2009. Our branded products
increased by $2.65 million during this period. The increase in revenues was due to the increased acceptance of our products among hospitals and other healthcare facilities as many of our end users such as hospitals became repeat customers when they
needed new medical equipment. In addition, in 2009, we developed our distribution network in China, which led to greater market penetration and more robust growth for the nine months ended September&nbsp;30, 2009. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">53 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Cost of Revenues </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our cost of revenues increased 38.38% from $4.11 million for the nine months ended September&nbsp;30, 2008 to $5.69 million for the nine months ended
September&nbsp;30, 2009. We had an increase in gross margin from 37.07% up to 39.63% for the nine months ended September&nbsp;30, 2008 and 2009, respectively. Our cost of revenues grew in U.S. dollars as our revenues grew, but our gross margin
increased largely because we were able to leverage a stronger relationship with an original equipment manufacturer, or OEM, supplier, and take advantage of economies of scale. We were able to purchase assembled products from this supplier for less
than it would cost us to assemble them ourselves. As our business with this supplier grew, our gross margin subsequently increased. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Expenses </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our operating expenses decreased by 25.52% from $1.82 million for the nine months ended September&nbsp;30, 2008 to $1.45 million for the nine months ended
September&nbsp;30, 2009. This decrease was due to decrease in general and administrative and selling expenses, for the reasons described below. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Expenses&#151;General and Administrative Expenses </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative expenses consist primarily of salaries and benefits and related costs for our administrative personnel and management, legal,
audit and valuation expenses and expenses associated with our administrative offices and the depreciation of equipment used for administrative purposes. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our general and administration expenses decreased by 14.18% from $0.92 million for the nine months ended September&nbsp;30, 2008 to $0.79 million for the
nine months ended September&nbsp;30, 2009. This decrease was largely because our professional expenses for the nine months ended September&nbsp;30, 2008 were $0.3 million consisting primarily of audit fees relating to our 2006 and 2007 financial
statements, compared with professional expenses for the same period in 2009 of $0.18 million. In addition, our meeting and entertainment expense decreased by about $0.01 million for the nine months ended September&nbsp;30, 2009 compared with the
nine months ended September&nbsp;30, 2008. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">However, we expect that our general and administration expenses will increase in the near term as
a result of Sarbanes-Oxley Section&nbsp;404 compliance and business expansion upon completion of this offering. Upon completion of this offering, we anticipate using a portion of the net proceeds to expand our marketing efforts in order to continue
to grow our revenues in China and internationally. Among other strategies to expand our business, we plan to open new CECs, in strengthen our market presence in China. These CECs give our potential customers an opportunity to experience our products
first-hand in an environment that is similar to the environment in which they will use the products, whether that is a home or healthcare facility. See &#147;Our Business &#150; Our Strategies.&#148; </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Expenses&#151;Selling Expense </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our selling expense decreased by 30.65% from $0.79 million for the nine months ended September&nbsp;30, 2008 to $0.54 million for the nine months ended
September&nbsp;30, 2009. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our selling expense primarily consists of salaries and related expenses for personnel engaged in sales, marketing
and customer support functions and costs associated with advertising and other marketing activities. Our selling expense decreased in both U.S. dollars and as a percentage of our total net revenues for the nine months ended September&nbsp;30, 2009,
mainly due to exhibition expenses to promote our products both inside and outside China for the nine months ended September&nbsp;30, 2008 that did not recur in 2009. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Income </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of the foregoing, we generated operating income of approximately $2.6 million for the nine months ended September&nbsp;30, 2009, compared to
approximately $0.90 million for the nine months ended September&nbsp;30, 2008. Operating income increased 188.9% largely due to the increase of revenues and gross profit margin as stated above. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">54 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Taxation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our income tax expenses were approximately $0.41 million for the nine months ended September&nbsp;30, 2009, compared to approximately $0.27 million for
the nine months ended September&nbsp;30, 2008. Our taxable income increased primarily due to increased revenues while our tax rate decreased. For the nine months ended September&nbsp;30, 2008, the income tax rate applicable for BDL is 25%. For the
nine months ended September&nbsp;30, 2009, BDL has obtained a high technology certification approval online and expects to receive the confirmation certificate in the near future. As a result, BDL uses a 15% income tax rate to calculate the income
tax expense for the nine months ended 2009. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Net Income </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of the foregoing, we had net income of approximately $2.11 million for the nine months ended September&nbsp;30, 2009, compared to
approximately $0.6 million for the nine months ended September&nbsp;30, 2008. After deduction of non-controlling interest in income, net income attributable to Dehaier was approximately $2.07 million and $0.52 million for the nine months ended
September&nbsp;30, 2009 and 2008, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Fiscal Year Ended December&nbsp;31, 2008 Compared to Fiscal Year Ended December&nbsp;31,
2007. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Revenues </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our total revenues increased by 42.64% from $6.6 million for the fiscal year ended December&nbsp;31, 2007 to $9.41 million for the fiscal year ended
December&nbsp;31, 2008. The increase in revenues was due to the increased acceptance of our products among hospitals and other healthcare facilities as many of our end users such as hospitals became repeat customers when they needed new medical
equipment. In addition, we developed our distribution network in China, which led to greater market penetration and more robust growth in 2008. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Cost of Revenues </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our cost of revenues increased 38.59% from $4.28 million for the fiscal year ended December&nbsp;31, 2007 to $5.93 million for the fiscal year ended
December&nbsp;31, 2008. Our cost of revenues grew in U.S. dollars as our revenues grew, but our gross margin increased largely because we were able to leverage a stronger relationship with an original equipment manufacturer, or OEM, supplier and
take advantage of economies of scale. We were able to purchase assembled products from this supplier for less than it would cost us to assemble them ourselves. As our business with this supplier grew, our gross margin subsequently increased. We had
an increase in gross margin of 1.85% from 35.15% up to 37.00% for the years ended December&nbsp;31, 2007 and 2008, respectively. This result is largely due to the fact that our sales in 2008 consisted of relatively higher margin medical devices.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Expenses </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our operating expenses increased by 40.12% from $1.72 million for the fiscal year ended December&nbsp;31, 2007 to $2.41 million for the fiscal year ended
December&nbsp;31, 2008. This increase was mainly due to an increase in administrative expense, and, to a lesser extent, an increase in our selling expense. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Expenses&#151;General and Administrative Expenses </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative expenses consist primarily of salaries and benefits and related costs for our administrative personnel and management and
expenses associated with our research and development and the registration of foreign exchange certificate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our general and administrative
expenses increased by 75.07% from $0.76 million for the fiscal year ended December&nbsp;31, 2007 to $1.3 million for the fiscal year ended December&nbsp;31, 2008. This increase was due primarily to increased headcount. During 2008, our headcount
increased by about 20 full-time employees. Most of these employees are in sales. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">However, we expect that our general and administration expenses will increase in the near term as a result
of Sarbanes-Oxley Section&nbsp;404 compliance and business expansion upon completion of this offering. Upon completion of this offering, we anticipate using a portion of the net proceeds to expand our marketing efforts in order to continue to grow
our revenues in China and internationally. Among other strategies to expand our business, we plan to open new Customer Experience Centers, or CECs, in strengthen our market presence in China. See &#147;Our Business &#150; Our Strategies.&#148;
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Expenses&#151;Selling Expense </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our selling expense increased by 10.56% from $0.88 million for the fiscal year ended December&nbsp;31, 2007 to $0.97 million for the fiscal year ended
December&nbsp;31, 2008. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our selling expense primarily consists of salaries and related expenses for personnel engaged in sales, marketing and
customer support functions and costs associated with advertising and other marketing activities. Our selling expense increased in both U.S. dollars and as a percentage of our total net revenues for the fiscal year ended December&nbsp;31, 2008,
mainly to promote our products. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Income </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of the foregoing, we generated an operating income of approximately $1.5 million in 2008, compared to approximately $0.97 million in 2007.
Operating income increased 54.64% largely due to the increase of revenues and gross profit margin. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Taxation </I></B>
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our income tax expense was approximately $0.42 million in 2008, compared to approximately $0.07 million in 2007. The increase in income tax in
2008 was primarily due to the change in applicable tax rate discussed above in &#147;PRC Enterprise Income Tax.&#148; As a result, our applicable tax rate in 2008 was 25%, compared to 7.5% in 2007. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Net Income </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a
result of the foregoing, we had net income of approximately $0.98 million in 2008, compared to approximately $0.85 million in 2007. After deduction of non-controlling interest in income, net income attributable to Dehaier was approximately $0.92
million and $0.79 million in 2008 and 2007, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Liquidity and Capital Resources </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Cash Flows and Working Capital </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To date, we have financed our operations primarily through cash flows from operations and short-term borrowings. As of December&nbsp;31, 2008, we had
approximately $0.28 million in cash and cash equivalents. As a result of the total cash activities, net cash increased from $282,603 on December&nbsp;31, 2008 to $937,970 on September&nbsp;30, 2009. We believe that our currently available working
capital of $5,819,136, including cash of $937,970, should be adequate to meet our anticipated cash needs and sustain our current operations for at least 12 months. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are in the process of repaying our loan from ICBC, and our final payment of RMB 6,000,000 in principal is due on May&nbsp;20, 2010. We are relying on
our projected cash flow for such repayment, and we believe that such projected cash flow will be sufficient to repay the ICBC loan as it becomes due. We do expect, however, that the repayment of the ICBC loan will significantly decrease our working
capital and materially decrease our liquidity generally. We believe, however, that the completion of this offering is likely to mitigate this decreased liquidity, as we have allocated 25% of the offering proceeds to our working capital needs. If we
are unable to complete this offering or if our cash flow is insufficient to repay the ICBC loan as it becomes due, we may seek to refinance the ICBC loan. If we are unable to do so on terms that are satisfactory to us or at all, then our liquidity
and capital resources may be significantly harmed. See &#147;Risk Factors &#150; We may be unable to pay our bank loan as it becomes due&#148; and &#147;&#150; Repayment of the ICBC loan may significantly reduce our working capital and harm our
liquidity.&#148; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">56 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently available working capital, especially cash, may not be sufficient to fund our anticipated
expansion or to repay our ICBC loan as it becomes due. In order to meet the working capital needs for our anticipated expansion, we may take the following actions: (i)&nbsp;continue to improve our collection of accounts receivable; (ii)&nbsp;if
necessary, raise additional capital through sale of equity; and (iii)&nbsp;enter into new, or refinance existing, short- and/or long-term commercial loans. We cannot assure you that financing will be available in the amounts we need or on terms
acceptable to us, if at all. The sale of additional equity securities, including convertible debt securities, would dilute our shareholders. The incurrence of debt would divert cash from working capital and capital expenditures to service debt
obligations and could result in operating and financial covenants that would restrict our operations and our ability to pay dividends to our shareholders. If we are unable to obtain additional equity or debt financing as required, our business,
operations and prospects may suffer. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Operating Activities </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net cash used in operating activities was $802,964 for the year ended December&nbsp;31, 2008 as compared to $1,656,945 net cash used in operating
activities for the same period in 2007. The decrease of net cash used in operating activities is a result of several factors, including </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(i) <U>Increase of $2,269,856 in accounts receivable</U>. This increase was associated with a growth in sales in 2008
compared with 2007 and the development of relationships with additional sales distributors. Our historical accounts receivable term, which differs from the typical contractual term, for distributors (ordinarily within one year) was longer than the
historical accounts receivable term for hospitals (usually three to six months). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(ii) <U>Increase of
$1,072,813 in prepayments and other current assets</U>. Our prepayment balance refers to amounts paid to suppliers for inventory purchases, and the increase in the amount corresponded with an increase in purchase agreements in 2008 compared with
2007. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(iii) <U>Increase of $1,267,130 in income tax payable</U>. The increase in taxes payable is attributable
to the growth in our income and the increase in our applicable tax rate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">These increases were mainly attributable to the growth of our
business during 2008. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net cash provided by operating activities was $1,573,390 for the nine months ended September&nbsp;30, 2009 as compared
to net cash used in operating activities of $978,152 for the same period in 2008. The cash generated from operating activities for the nine months ended September&nbsp;30, 2009 was approximately $2.5 million more than the same period ended in the
proceeding year primarily due to the following: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(i) <U>Increase of $1,544,278 in net income</U>. Our net
income increased because of a growth in both sales volume and gross margin in 2009. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(ii) <U>Increase of
$1,050,453 in inventory</U>. We have purchased more inventory in 2009 than we did in 2008 to meet management&#146;s expected demand for our products in the future. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(iii) <U>Increase of $642,788 in accounts receivable</U>. The increase in accounts receivable is attributable to the
growth in our income. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(iv) <U>Increase of $1,409,645 in tax payable</U>. The increase in taxes payable is
attributable to the growth in our income. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Investing Activities </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net cash used in investing activities for the year ended December&nbsp;31, 2008 was $637,811, compared to net cash used in investing activities of
$542,401 in the year ended December&nbsp;31, 2007. Net cash used in investing activities for the nine months ended September&nbsp;30, 2009 was $913,717, compared to $597,476 for the nine months ended September&nbsp;30, 2008. The cash used in
investing activities was mainly attributable to capital expenditures for the purchase of new equipment. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">57 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Financing Activities </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net cash provided by financing activities in the year ended December&nbsp;31, 2008 totaled $231,948, compared to net cash provided by financing activities
of $2,849,378 in the year ended December&nbsp;31, 2007. The cash provided by financing activities in the year ended December&nbsp;31, 2008 was mainly attributable to proceeds received from a bank loan provided by ICBC in Beijing. The cash provided
by financing activities for the year ended December&nbsp;31, 2007 was mainly attributable to the proceeds from issuance of Series B preferred shares and proceeds from bank loans. As of October&nbsp;31, 2009, the Series B preferred shares were
converted into common shares on a 1-for-1 basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net cash provided by financing activities for the nine months ended September&nbsp;30, 2009
was nil mainly because we did not incur any new bank loan or other financing activities. Net cash provided by financing activities for the nine months ended September&nbsp;30, 2008 totaled $238,984. The cash provided by financing activities for the
nine months ended September&nbsp;30, 2008 was mainly attributable to proceeds received from a bank loan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Contractual
Obligations and Commercial Commitments </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth our contractual obligations as of December&nbsp;31, 2008:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="12" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Payments due by period</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:80pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Contractual obligations</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Less&nbsp;than<BR>1 year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1-3&nbsp;years</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>3-5&nbsp;years</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>More&nbsp;than<BR>5 years</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating Lease Obligations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,855</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,328</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,527</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>19,855</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>18,328</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,527</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#151;&nbsp;&nbsp;</B></FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The leased
properties are principally located in the PRC, and we use such properties for administration and research and development purposes. The leases are renewable subject to negotiation. Rental expenses for the years ended December&nbsp;31, 2008 and 2007
and for the nine months ended September&nbsp;30, 2009 and 2008 were $32,011, $28,399, $36,174 and $25,507, respectively. Rent expense paid to the spouse of the chief executive officer for the years ended December&nbsp;31, 2008 and 2007 and for the
nine months ended September&nbsp;30, 2009 and 2008 was $0, $0, $17,418 and $0, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Capital Expenditures
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We made capital expenditures of approximately $0.71 million and $0.51 million in 2008 and 2007, and $0.92 million and $0.67 million
for the nine months ended September&nbsp;30, 2009 and 2008, respectively, representing 7.53%, 7.74% and 9.72%, 10.23%, of our total revenues, respectively. In the past, our capital expenditures were used to purchase machines for our assembly line.
Our capital expenditures may increase in the near term as our business continues to grow and as we expand and improve our financial and accounting systems and infrastructure. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Off-Balance Sheet Commitments and Arrangements </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have not entered into any financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into
any derivative contracts that are indexed to our shares and classified as shareholder&#146;s equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets
transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us
or engages in leasing, hedging or research and development services with us. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recent Accounting Pronouncements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2009, the FASB issued SFAS No.&nbsp;168, &#147;The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting
Principles &#150; a replacement of FASB Statement No.&nbsp;162.&#148; The objective of this Statement is to replace SFAS No.&nbsp;162 and to establish the FASB Accounting Standards Codification as the source of the authoritative accounting
principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">58 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rules and interpretive releases of the SEC under authority of federal securities laws are also sources of
authoritative GAAP for SEC registrants. This Statement shall be effective for financial statements issued for interim and annual periods ending after September&nbsp;15, 2009. On the effective date of this Statement, all then existing non-SEC
accounting and reporting standards are superseded. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2009, the FASB issued SFAS No.&nbsp;167, an amendment to FASB Interpretation 46(R)
&#147;Consolidation of Variable Interest Entities.&#148; The statement requires an entity to perform an analysis to determine whether the entity&#146;s variable interest give it a controlling financial interest in a variable interest entity by
rationalizing characteristics that would give it power to direct the activities of a variable interest entity and the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the variable
interest entity. The statement is effective for years beginning after November&nbsp;15, 2009 and is not expected to have a material effect on the Company&#146;s consolidated financial statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2009, the FASB issued SFAS No.&nbsp;166 &#147;Accounting for Transfers of Financial Assets&#148; an amendment to SFAS 140 &#147;Accounting for
Transfers and Servicing of Financial Assets and Extinguishment of Liabilities.&#148; The statement defines the term &#147;participating interest&#148; to establish specific conditions for reporting a transfer of financial assets as a sale and
improves financial reporting by eliminating (a)&nbsp;the exception for qualifying special-purpose entities from consolidation guidance and (b)&nbsp;the exception that permitted sale accounting for certain mortgage securitizations when a transferor
has not surrendered control over the transferred financial assets. The statement is effective for annual reports for years beginning after November&nbsp;15, 2009 and is not expected to have a material effect on the Company&#146;s consolidated
financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October&nbsp;7, 2009, the FASB issued ASU No.&nbsp;2009-13, Revenue Recognition (Topic 605): Multiple-Deliverable
Revenue Arrangements&#151;a consensus of the FASB Emerging Issues Task Force. The amendments to FASB ASC 605-25, Revenue Recognition: Multiple-Element Arrangements, permit vendors to account for products and services separately rather than as a
combined unit. Any vendor who enters into multiple-deliverable arrangements with customers that are covered by Subtopic 605-25 will be affected, the FASB said. As a result of the changes, multiple-deliverable arrangements will be separated in more
circumstances than under existing guidance. With the changes to Subtopic 605-25, the FASB is eliminating the residual method of allocation and instead requiring entities to allocate the arrangement consolidation at the inception of the arrangement
to all deliverables using the relative selling price method. Vendors will be required to determine their best estimate of the selling price consistently with the method they use to determine the selling price when the good or service is sold
separately. The changes in ASU No.&nbsp;2009-13 will be effective for revenue arrangements that begin or are changed in fiscal years that start June&nbsp;15, 2010, or later. Entities that adopt the changes before then will have to apply them to
their results from the beginning of their fiscal years. The adoption of this accounting standard is not expected to have a material effect on the Company&#146;s consolidated financial statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;26, 2009, the FASB issued ASU 2009-05, Measuring Liabilities at Fair Value, to clarify how entities should estimate the fair value of
liabilities under the FASB ASC Topic 820, Fair Value Measurements and Disclosures. The amendments in ASU 2009-05 reduce potential ambiguity in financial reporting when measuring the fair value of liabilities. Therefore, preparers, investors, and
other users of financial statements will have a better understanding of how the fair value of liabilities was measured, helping to improve consistency in the application of Topic 820. The FASB issued ASU 2009-05 as a result of expressed concern that
there may be a lack of observable market information to measure the fair value of a liability. For example, in the hypothetical transfer of an asset subject to a restriction there will be no observable data available to measure the liability because
it is restricted from being transferred. This guidance is effective for the first reporting period (including interim periods) beginning after issuance. The adoption of this accounting standard is not expected to have a material effect on the
Company&#146;s consolidated financial statements. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">59 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Quantitative and Qualitative Disclosure about Market Risk </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Interest Rate Risk </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our risk exposure from changes in interest rates relates primarily to the interest expenses associated with our historical bank borrowings, as well as the
interest income generated by excess cash invested in demand and time deposits. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have not historically used, and do not expect to use in the
future, any derivative financial instruments to manage our interest risk exposure. Such interest-earning instruments and borrowings carry a degree of interest rate risk. We have not been exposed nor do we anticipate being exposed to material risks
due to changes in interest rates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Foreign Exchange Risk </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated translation adjustments amounted to $778,766, $398,581 and $774,531 as of December&nbsp;31, 2008, 2007 and September&nbsp;30, 2009,
respectively. Asset and liability accounts at December&nbsp;31, 2008, 2007 and September&nbsp;30 2009 were translated at &yen;6.8225 to $1.00, at &yen;7.2946 to $1.00 and at &yen;6.8263 to $1.00, respectively. The average translation rates applied
to the statements of income for the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September&nbsp;30, 2009 and 2008 were &yen;6.9483, &yen;7.6038, &yen;6.8323 and &yen;6.9848 to $1.00, respectively. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Inflation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although China has experienced an increasing inflation rate, inflation has not had a material impact on our results of operations in recent years.
According to the National Bureau of Statistics of China, the change in the consumer price index in China was 0.46%, (0.77%), and 1.16% in 2001, 2002 and 2003, respectively. However in connection with a 3.9% increase in 2004, the Chinese government
announced measures to restrict lending and investment in China in order to reduce inflationary pressures in China&#146;s economy. Following the government&#146;s actions, the consumer price index decreased to 1.8% in 2005 and to 1.5% in 2006. In
2007, the consumer price index increased to 4.8%. In response, China&#146;s central bank, the People&#146;s Bank of China, announced that the bank reserve ratio would rise half a percentage point to 15.5% in an effort to reduce inflation pressures.
China&#146;s consumer price index growth rate reached 8.7% year over year in 2008. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Taxation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the EIT Law and the supplementary regulations, only high-tech companies that have been re-certified as such under the new criteria are granted
the preferential enterprise income tax rate of 15%. Due to the PRC&#146;s standardization of tax rates for all companies in China effective January&nbsp;1, 2008 and promulgation of new standards for high technology companies, BDL paid the 25% tax
rate in 2008. While the certification remained available in 2008, the standards were revised, requiring previously certified entities to apply for high technology certification again. BDL subsequently applied for and obtained such high technology
certification approval online and received the confirmation certificate. As a result, we have calculated our 2009 estimated income tax expenses at the preferential tax rate of 15%. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">60 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_13"></A>OUR BUSINESS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Corporate History </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our
founder, Mr.&nbsp;Ping Chen, founded BTL on July&nbsp;5, 2001 to develop and distribute medical devices. He currently owns approximately 86% of BTL, and his wife and employees of Dehaier own the remaining 14% of BTL. BTL leases some of our property
to us and provides certain transportation and repair services to medical devices for which we are not obligated to perform warranty services, either because the warranty is expired or because the product was sold by another company. BTL served as
the domestic partner to our joint venture pursuant to which we, a British Virgin Islands company, own the majority BDL, a PRC company in the medical device business. At the time of the formation of the joint venture, foreign enterprises were not
permitted to own such companies without PRC partners. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2003, in order to continue to grow our business, BTL engaged in a corporate
restructuring and Series A venture capital financing. As a result of those actions, Dehaier, BDL and DHK were established and a venture capital investor, De-haier Investment Holdings, Ltd., a British Virgin Islands company wholly owned by Milestone
Capital Management Limited, became a Series A preferred shareholder in Dehaier. At the same time, Mr.&nbsp;Chen&#146;s wholly-owned company, Chen Ping Ltd., became a shareholder in Dehaier, and we created the holding company structure that remains
in place. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dehaier was incorporated as an international business company in the British Virgin Islands in 2003 under the name &#147;De-Haier
Medical Systems Limited.&#148; We changed this name to &#147;Dehaier Medical Systems Limited&#148; in 2005. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2003, we also established BDL
in the PRC as a joint venture between a Chinese entity, BTL, and a foreign invested enterprise, Dehaier, in order to allow foreign investments to be used to grow our business. Because BDL is engaged in an encouraged industry under the Foreign
Investment Industrial Guidance Catalogue, it was allowed to have foreign investments and to be established as a Chinese-foreign equity joint-venture. This structure allowed BDL access to foreign capital that would not have been available outside
this structure. In addition to its engagement in an encouraged industry, the use of this joint venture structure allowed BDL to take advantage of favorable tax rates available prior to January&nbsp;1, 2008. Before January&nbsp;1, 2008, equity
joint-ventures such as BDL could enjoy a preferential enterprise income tax rate of 24%. In addition to the lower standard rate, such equity joint-ventures were also allowed a two-year income tax exemption from the date they first became profitable
and a 50% income tax reduction for the following three years after that time. After January&nbsp;1, 2008, the income tax rates were unified at 25% under the PRC Enterprise Income Tax Law; however, BDL&#146;s ability to pay lower income taxes prior
to this date left it with more net income with which to grow its business. See &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Tax Matters Applicable to Our Company &#151; PRC Enterprise Income
Taxes.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2003, we also founded DHK and created a holding company structure by which we are the parent company of BDL and DHK.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BDL has been focused on the development and distribution of medical devices since its inception and began developing its respiratory and
oxygen homecare business in 2006. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective as of January&nbsp;5, 2007, we completed a Series B venture capital financing with Crystal East
Group Limited, a British Virgin Islands company. Crystal East Group Limited subsequently completed the transfer of its Series B preferred shares to its individual shareholder, Yijen Chen. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective as of October&nbsp;31, 2009, we converted all of the Series A and Series B preferred shares into common shares on a 1-for-1 basis and completed
a 3.66140766-for-1 share split of all common shares. At the conclusion of these actions, we have 3,000,000 common shares issued and outstanding prior to commencement of this initial public offering and no preferred shares issued and outstanding.
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">61 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Relationship among Dehaier, BTL, BDL and DHK </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BTL is a PRC company established on July&nbsp;5, 2001. Dehaier is a BVI company established on July&nbsp;22, 2003. DHK is a Hong Kong company established
on October&nbsp;15, 2003. Dehaier and BTL jointly established BDL on September&nbsp;24, 2003 as a Chinese-foreign equity joint-venture under the PRC laws. Dehaier has been and is BDL&#146;s foreign shareholder, and BTL has been and is BDL&#146;s
domestic shareholder since BDL was established. Currently, Dehaier owns 96.37% of BDL, and BTL owns 3.63% of BDL. Under PRC laws, the shareholders of the equity joint-venture share the profits, risks and losses in proportion to their respective
contributions of the equity joint-venture. DHK is the wholly owned subsidiary of Dehaier. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financings and Restructurings </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>2003 Series A Financing </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October&nbsp;23, 2003, Dehaier issued 120,000 Series A Preferred Shares for $1,200,000 and an option to purchase an additional $1,200,000 worth of
Series A Preferred Shares to De-haier Investment Holdings Ltd., a British Virgin Islands company wholly owned by Milestone Capital Management Limited. The investor did not exercise the option to acquire the additional $1,200,000 in Series A
Preferred Shares. At the time of the Series A venture capital financing, BTL&#146;s founder Mr.&nbsp;Ping Chen, sought capital to grow the business, and a foreign (non-Chinese) investor wanted to invest in BTL. Chinese law at the time required such
foreign investments in companies like BTL to be in the form of a joint venture between a foreign company and a Chinese company. For this reason, our company was restructured to create a joint venture, with BTL as the Chinese party to the joint
venture and Dehaier as the foreign party to the joint venture. The parties entered into a Shareholder Agreement that granted certain rights to the Series A Preferred shareholders that terminated upon conversion of the Series A Preferred Shares to
common shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Series A financing was exempt from registration under U.S. Securities laws by virtue of exemptions provided by Regulation
S, Section&nbsp;4(2) of the Securities Act of 1933 and by falling outside an offering covered by Section&nbsp;5 of the Securities Act of 1933. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>2007 Series B Financing </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective January&nbsp;5, 2007, Dehaier agreed to issue $2,000,000 (182,635 shares) in Series B Preferred Shares to Crystal East Group Limited, a British
Virgin Islands company. In connection with the Series B Financing, the parties entered into a Shareholder Agreement that granted certain rights to the Series B preferred shareholders that terminated upon conversion of the Series B Preferred Shares
to common shares. Crystal East Group Limited subsequently transferred its Series B preferred shares to Yijen Chen on October&nbsp;31, 2009. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Series B financing was exempt from registration under U.S. Securities laws by virtue of exemptions provided by Regulation S, Section&nbsp;4(2) of the
Securities Act of 1933 and by falling outside the an offering covered by Section&nbsp;5 of the Securities Act of 1933. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>2009 Restructuring </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In preparation for the commencement of this initial public offering, our company completed a restructuring to accomplish two goals. First, we sought to
convert all Series A and Series B Preferred Shares into common shares. Second, we completed a shares split so that we would have, in the aggregate, 3,000,000 common shares outstanding prior to commencement of the offering. As to the first goal, our
Series A and Series B Preferred shareholders agreed to convert their respective Series A and Series B Preferred Shares into an equal number of our common shares. This 1:1 conversion was completed without consideration. As to the second goal, we
completed a 3.66140766-for-1 share split of common shares completed of October&nbsp;31, 2009. As a result of the conversions and share split, we have 3,000,000 common shares issued and outstanding prior to commencement of this offering and no issued
and outstanding preferred shares. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">62 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recent Corporate Developments </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe our business has developed significantly in the last three years. In 2006, we took a major step toward becoming the company we are today by
beginning to offer respiratory and oxygen homecare products to supplement the medical devices we sold at that time. As part of this development, we developed our patented &#147;Oxi-chip&#148; technology, which produces highly-concentrated,
therapeutic-level oxygen from air at normal temperatures. We also launched our sales of our DHR family of oxygen concentrators. In the course of developing our branded products, we also received our EN ISO 13485 certification, which is a
certification by the International Organization for Standardization that recognizes a comprehensive management system for the design and manufacture of medical devices. ISO 13485 certification requires an organization to demonstrate the
implementation and maintenance of systems to ensure product safety and quality, and compliance with ISO 13485 is often seen as a first step in achieving compliance with European regulatory requirements. Finally, we negotiated for our second round of
venture capital financing in order to continue to develop our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This Series B financing closed in early 2007. Upon closing this round
of fundraising, we were able to begin a new round of research and development into developing our next generation of oxygen concentrators. Our ventilator product offerings continued to grow, as we began to distribute homecare MAP and S6 ventilators
made by ResMed. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2008, we focused on growing our sales and support offerings. To that end, we opened an online sales platform for our
respiratory and oxygen homecare products to make those products more easily available throughout China. We also established our first Customer Experience Center, or CEC, in Beijing. We have used this CEC to increase our marketing efforts, with the
goal of increasing our market penetration in China&#146;s large cities. These CECs are complementary to our current marketing and distribution model because the CECs give our potential customers an opportunity to experience our products first-hand
in an environment that is similar to the environment in which they will use the products, whether that is a home or healthcare facility. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
2009, we developed several CPAP, sleep diagnostic and screening products. We have begun the registration process for these products. We have also developed several technical service products, which are not themselves medical devices but which are
used in connection with medical devices. For example, our ventilator trolleys and air compressors are not medical devices but enhance the utility of our ventilators. Finally, in preparation to enter the international market with our branded
products, we have established an international business department within our company and have applied for and received CE certificates for our branded oxygen concentrators and air compressors. CE certificates are European conformance marks that
designate a product as meeting certain safety, health or environmental requirements in European Union member countries. These CE marks are required before a product may be marketed in European Union member countries. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Since September&nbsp;30, 2009 we have not developed any new products, received any new patents or entered into any new contracts with new providers. We
have not had any material corporate developments since September&nbsp;30, 2009. During this time, we have continued to market and sell our branded and distributed products. We have recently benefitted from additional spending in our industry, as
government initiatives and public interest in health care have grown. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under our Agency Agreement with Timesco, effective September&nbsp;8,
2009, we are required to place a minimum order for $50,000 every three months. We made the minimum $50,000 order for the three month period from September&nbsp;8, 2009 through December&nbsp;8, 2009 and for the three month period from
December&nbsp;9, 2009 through March&nbsp;8, 2010. We also expect to meet the minimum order requirement for the current period. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to
our loan agreement with ICBC, we were originally required to pay interest monthly and to make principal payments of RMB 2,000,000 on November&nbsp;20, 2009, RMB 3,000,000 on March&nbsp;20, 2010 and RMB 5,000,000 on May&nbsp;20, 2010. On
November&nbsp;17, 2009, we agreed with ICBC to make principal payments of RMB 1,000,000 on January&nbsp;20, 2010, RMB 4,000,000 on March&nbsp;20, 2010 and RMB 5,000,000 on May&nbsp;20, 2010. We made the RMB 1,000,000 principal payment on
January&nbsp;20, 2010 as required. On March&nbsp;16, 2010, although we had sufficient cash to pay RMB 4,000,000, we and ICBC </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;
</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">63 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
agreed to modify the principal repayment terms of the loan. On March&nbsp;18, 2010, we and the bank executed an amendment that provides for principal repayment of RMB 3,000,000 on March&nbsp;20,
2010 and RMB 6,000,000 on May&nbsp;20, 2010. We made the RMB 3,000,000 principal payment on March&nbsp;18, 2010, two days before it was due under the loan, as modified. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March&nbsp;3, 2010, BDL entered into an agreement with BTL, whereby BDL provides a guarantee to fund BTL&#146;s expenses and losses in connection with
BTL&#146;s operations. This written agreement memorialized the oral agreement which had existed between BDL and BTL since inception. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">China is
trending toward greater investment in our industry. The Chinese government implemented large-scale healthcare reform in April 2009. As part of China&#146;s stimulus package, the State Council allocated $123 billion as part of its New Medical Reform
Plan. Allocation of this stimulus money has resulted in increased spending in our industry. Additionally, the 2003 outbreak of SARS, the 2006 avian flu and the 2009 swine flu pandemic have heightened public awareness of safe filtering, resulting in
increased spending in our industry and increased interest in our products, including, in particular, our products related to ventilators and respiratory care. See &#147;Our Industry,&#148; &#147;Risk Factors&#148; and &#147;Our Market.&#148;
</FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Market </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>China&#146;s Economic Development </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">China&#146;s population of approximately 1.3 billion people is expected to grow by roughly 9&nbsp;million people per year. The country&#146;s gross
national product has grown at a rate of approximately 9% for more than 25 years, the fastest growth rate for a major economy. In the same 25 year period, China has moved more than 300&nbsp;million people out of poverty and quadrupled the average
Chinese person&#146;s income. The potential of this market is noted by the fact that 400 of the world&#146;s largest 500 companies have invested in China. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2010, the Chinese government is posed with the difficult task of maintaining China&#146;s economy in the midst of the global economic financial
crisis. China&#146;s economy experienced overall growth of only 8.7% in 2009, its lowest growth rate in eight years, down from growth rates of 9.6% in 2008 and 13% in 2007. The global financial crisis has significantly decreased demand for Chinese
exports, resulting in factory closures and losses of millions of jobs. This 8.7% growth rate is well above the 7.2% rate predicted by the World Bank and also exceeds the 8% rate the Chinese government had predicted and said would be necessary to
avoid significant further job losses. While China&#146;s growth rate has fallen, China&#146;s growth rate remains well above the World Bank&#146;s forecast for decline of 1.5% for the world economy in 2009. See &#147;Risk Factors &#150; Our
operations could be adversely affected by changes in the political and economic conditions in the PRC.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>China&#146;s Healthcare
Industry &#150; Generally </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">From 1940 through the 1950s, China&#146;s government developed a healthcare system that would address the main
health considerations of the day &#150; improved sanitation, improved diet and disease prevention. The healthcare system provided universal access to all Chinese citizens. In China&#146;s rural areas local governments generally financed the
healthcare system. The results of the government&#146;s focus upon healthcare resulted in a dramatic long-term improvement of the health of China&#146;s citizens. For example, in 1949, the life expectancy of a Chinese citizen was 35 years; by 2009,
the life expectancy of a Chinese citizen had risen to over 73 years, more than six years greater than the worldwide average life expectancy. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the 1980s, the Chinese government, led by Deng Xiaoping, introduced socialist market reforms designed to increase China&#146;s presence in the
international community while increasing the standard of living in China. However, these reforms also pushed an ever-increasing portion of healthcare costs upon individual citizens. Consequently, an ever-widening gap arose between the provision of
healthcare services to citizens in wealthy, urban areas and those in poor, rural areas. In 1975, over 85% of the rural population was covered by government-provided healthcare; in 1997, that proportion had decreased to 10% of the rural population.
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">64 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In April 2009, the Chinese government implemented large-scale healthcare reform. The State Council allocated
$123 billion as part of its New Medical Reform Plan. The plan, which is part of China&#146;s stimulus package aimed at correcting the recent global economic down-turn, contemplates the development of a universal healthcare system that will cover 90%
of China&#146;s population by the end of 2010 and will provide healthcare coverage to all Chinese by 2020. In addition, the plan includes significant improvements to health care facilities and expansion of China&#146;s health related infrastructure.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Specifically, within three years, the Chinese government aims to improve the urban healthcare system by rebuilding and restructuring
approximately 3,700 existing urban community health centers and 11,000 community health clinics. The plan will also accommodate the development of approximately 2,400 new urban health centers. In effect, the plan de-emphasizes the prevalence of
large, magnet facilities in favor of smaller, more accessible clinics. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, the plan is designed to dramatically improve medical
services available for the 800&nbsp;million rural poor in China. Through the plan, the Chinese government contemplates the development of clinics in every village and a hospital in every county in China by the end of 2011. If successfully
implemented, the plan would result in at least 2,000 new county hospitals and 29,000 village clinics. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>China&#146;s Healthcare Industry
&#150; Medical Device Market Background </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">China&#146;s medical device market is projected to grow faster than the global medical device
market. Reasons for this faster growth in China include: <B><I> </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>A fast growing domestic economy. </I></B>China&#146;s gross
domestic product grew by 8.7% in 2009 while many leading world economies contracted. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Increasing desire for and utilization of more
advanced technologies in Chinese hospitals and clinics. </I></B>The market penetration of common medical equipment in Chinese hospitals is low compared to hospitals in more developed countries. However, we believe hospitals in China are purchasing
more advanced technology as they attempt to compete for patients and generate additional profits. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Increasing availability of healthcare
insurance. </I></B>The increasing availability of healthcare insurance generally provides coverage for more advanced and extensive healthcare services than were previously available. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Increasing autonomy at the hospital level. </I></B>Although governmental entities own and control substantially all of the hospitals in China,
recent healthcare system reforms have resulted in a trend of greater operating autonomy at local levels. For example, hospitals in China today rely less and less on governmental funding and are generally expected to earn enough revenues on their own
to cover 70% to 90% of their operating expenses. This has led to a greater focus on achieving efficiencies and improving services by regional hospital administrators, who now typically have the authority to make decisions regarding equipment
purchases. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Increasing government focus on improving quality of care. </I></B>The outbreaks of SARS in 2003, avian flu in 2006 and swine
flu in the last two years have heightened the government&#146;s awareness of the need to improve the country&#146;s healthcare infrastructure, and healthcare has become a priority for the PRC government. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Chinese Healthcare Institutions. </I></B>According to the PRC Ministry of Health, there were approximately 19,847 hospitals and 270,000 healthcare
clinics in China in 2007. The hospitals, which on average had approximately 135 beds, can be further divided into approximately 1,182 large-sized hospitals, 6,608 medium-sized hospitals and 12,057 small-sized hospitals, commonly referred to as Tier
III, Tier II and Tier I and other hospitals, respectively, in China. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Chinese Medical Device Manufacturers. </I></B>According to China
Medical Device Manufacturer magazine, as of 2008 there were approximately 13,000 medical device manufacturers in China, but most are small- and medium-sized companies producing basic medical supplies, such as bandages, patient aids and medical or
surgical instruments. However, only 60 companies in China accounted for RMB100 million in </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">65 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
sales per year as of 2008. However, more advanced medical products are expected to be produced in China in the next few years. Those China-based companies that are able to develop and manufacture
more advanced products at lower costs than their international competitors should be able to capitalize on the growing desire for better quality of care in China and emerge as leaders in domestic medical device manufacturing. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Device Marketing and Distribution in China. </I></B>Hospitals in China purchase a majority of their medical devices and supplies through
distributors. Medical device distribution is highly specialized and localized in China. Most medical device distributors operate within relatively small territories. Few distributors are willing or able to cover the entire country. Most distributors
focus on China&#146;s eastern coastal cities, where purchasing power is concentrated, while western China tends to have very limited coverage. In addition, different provinces in China often have their own medical and insurance practices, purchasing
policies and regulatory requirements which further increases the complexity of medical device distribution. As a result, most manufacturers need to appoint multiple distributors to effectively cover all of the geographic areas in China. The ability
to leverage local contacts and knowledge is vital in creating an effective distribution network in China, creating a significant barrier to entry for both smaller local companies and larger international competitors that lack a meaningful local
presence. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Strengths </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe we have the following principal competitive strengths, enabling us to attain a leading position in China&#146;s medical device and respiratory
and oxygen homecare industries: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our Brand and Leading Market Position. </I></B>We believe that we have established ourselves as one of the most recognized brands in the medical
device and respiratory and oxygen homecare markets in China. We believe we have one of the most experienced management teams in China&#146;s medical device and respiratory and oxygen homecare industries. Each of our executive officers has over 10
years of experience in the medical device and respiratory and oxygen homecare industries. Over time they have been able to develop a comprehensive understanding of local markets and customer needs within those markets. Through our experienced
leadership, strong brand and market position we have developed a broad customer base throughout China, allowing for more rapid acceptance of our branded products. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Distribution, Sales and Service Network. </I></B>Through our extensive distribution, sales and service network for medical devices and
respiratory and oxygen homecare products in China, we have established a strong platform of business contacts and local knowledge which enables us to develop products and provide services tailored to our customers&#146; local needs. We have
contractual distribution relationships with over 2,000 independent distributors, and we employ 70 direct sales and sales support personnel. We do not own, employ or control these independent distributors. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Research and Development Capabilities. </I></B>Our research and development team has 20 engineers. We increased our annual investment in research
and development activities in each of the last several years. We developed eight new home respiratory therapy products in the last four years, including three new products in 2008. In addition to developing new products, our research and development
efforts have helped us to improve our assembly processes, reduce our costs, and make the development process quicker and more efficient. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Vertically Integrated Operating Model.</I></B> We employ a vertically integrated operating model that enables us to efficiently develop, assemble
and market quality products at competitive prices. We believe this integrated model allows us to lower our costs for materials and components, reduce our capital expenditures, create a more efficient workflow, and improve our quality control. This
model also provides for a more effective upstream and downstream channel of business cooperation. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Relationships with Foreign Medical Device Manufacturers. </I></B>We distribute a wide range of medical devices in China for several foreign
medical device manufacturers, including IMD, Timesco, JMS and ResMed. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Customer Support and Service Team. </I></B>We have customer support teams located in our Beijing headquarters and each of our 26 offices
throughout China. This extensive customer support network allows us to provide domestic training, technical support, and warranty, maintenance </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">66 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:0%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
and repair services to end-users of our products, as well as support and service to our distributors. We also maintain a 24-hour customer service center in Beijing, staffed with senior technical
support engineers prepared to provide preliminary support and on-site guidance and repair if necessary. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Products &#150; Overview </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">When we began to sell our products in China, substantially all of the products we sold were distributed products from foreign suppliers. When we
completed our Series A financing in 2003, we used some of the proceeds from that financing to establish a research and development department in order to develop products of our own to address market needs. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At that time, our management concluded that it could develop its own products for sale through its existing network of independent distributors, who were
already selling medical devices for our company to our desired customer base. We made this decision based in large part on our conclusion that we would be able to meet the needs of different markets with our branded products than we already met with
our distributed products. Because our distribution team was already in place, we only needed to form research and development and assembly teams to be able to offer its branded products. As noted above, the Series A financing proceeds allowed us to
form these teams. Based on feedback from our distribution team, our management has been able to provide guidance to our research and development team about what needs to address with new products and what improvements to make to existing products.
This feedback has grown sales of our branded products. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our branded and distributed products fall into three general categories: (i)&nbsp;medical devices; (ii)&nbsp;technical service products and
(iii)&nbsp;respiratory and oxygen homecare products. Our medical devices and technical service branded and distributed products are mainly used in hospitals and clinics, while our respiratory and oxygen homecare branded and distributed products are
mainly for at-home use by individual customers. Our technical service branded products consist of components for use in ventilators. Prior to 2009, our branded products have accounted for approximately one-third of our revenues, and our distributed
products have accounted for approximately two-thirds of our revenues. In the nine months ended September&nbsp;30, 2009, our branded products and distributed products have each accounted for approximately half of our revenues. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the years
ended</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the nine months ended<BR>September&nbsp;30,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Branded products</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,462,559</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">35.70</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,193,764</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">33.24</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,731,057</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">50.21</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,084,210</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">32.91</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Distributed products</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,235,501</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">64.30</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,405,748</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">66.767</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,691,403</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">49.79</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,447,644</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">68.09</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,698,060</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,599,512</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,422,460</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,531,854</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Branded Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our management believes that our branded products, which are generally less expensive than products from foreign companies, tend to be more attractive to
smaller city and rural hospitals and healthcare facilities and other end-users for whom price is a significant factor in deciding whether to purchase our products. Our branded products include medical devices, technical service products and
respiratory and oxygen homecare products. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">67 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Devices </I></B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Mobile Medical X-Ray Image Devices. </I></B>We provide four types of DHR Explorer Series mobile and C-armed X-ray machines. X-ray is used for
visualizing bone structures and other dense tissues such as tumors. These mobile and C-armed X-ray machines provide added convenience for use in hospitals and clinics. Our C-arm series of X-ray systems are suitable for ortho reduction and fixation
procedures, intervertebral disc imaging and treatment, spinal operation, uterine and oviduct imaging, bladder and ureter imaging and gastric imaging. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Anesthesia Machines</I></B>. We provide two types of DHR ORSA Series anesthesia machines. These machines are used by anesthesiologists to support
the administration of anesthesia. These machines administer a precise and continuous supply of anesthetic gases and vapors to the patient at accurate and safe levels of pressure and flow. These machines maintain a continuous, closed-loop control
over the pressure of gas within a patient&#146;s mouth or respiratory according to the selected pressure input. In addition, these machines feature a modular design for mobility and ease of maintenance, cleaning and disinfection.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Patient Monitoring Devices</I></B>. We provide two types of DHR 930 patient monitoring devices which monitor patients&#146; physiological
parameters, such as heart rate, blood pressure, respiration and temperature. We also provide polysomnograph devices, which are used to monitor and record patients&#146; sleep data through multiple parameters. These machines are suitable for adult,
pediatric and neonatal care and principally used by hospitals in intensive care units, operating rooms and emergency rooms. Our monitors have a number of optional features, such as local area network connections, optional printer features, different
screen sizes, and the ability to use in monitoring up to 32 patients at a time. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Technical Service
Products </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Ventilator Air Compressor. </I></B>We provide two types of air compressors to support medical ventilators in surgery by supplying continuous
airflow for the ventilator. Where a facility lacks a central pressured air supply system, our C250 and C280 air compressors provide a portable source of such pressured air. Our air compressors feature oil-less motors, large locking castors, high
flow capacity, and spill-proof switches. We have designed our air compressors to be adaptable for use with any ventilator. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Trolleys for Ventilators. </I></B>We provide three types of trolleys to hold ventilators and their accessories for mobility. These trolleys can
be fit with a monitor to further enhance the portability and utility. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Sterilizers for Ventilators. </I></B>We provide one type of sterilizer to treat the air from patients in order to control cross-contamination and
infection in a facility in general and for subsequent ventilator patients in particular. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Respiratory
and Oxygen Homecare Products </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Oxygen Concentrating Products</I></B>. We provide two types of oxygen concentrator products, including, the DHR-3L/5L Oxi-Fairy and the DHR-3L/5L
Oxi-Pioneer. These products use our patented advanced Pressure Swing Absorbing (&#147;PSA&#148;) technology to produce highly-concentrated, therapeutic-level oxygen (approximately 90% oxygen concentration) from air at normal temperatures. These
products are used by patients with cardiovascular disease, respiratory diseases, such as chronic obstructive pulmonary disease, and geriatric patients. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Sleep Apnea Treatment Products. </I></B>We have designed and expect to provide several products designed for obstructive sleep apnea
(&#147;OSA&#148;) therapy. These products include our DHR CPAP C5, DHR Auto CPAP A8, and DHR Auto S-CPAP A9. Our DHR CPAP C5, Auto CPAP A8 and DHR S-CPAP A9 are in the process of obtaining SFDA approval and will not be available for sale until we
receive such approval. While we expect to receive this approval within the first half of 2010, we cannot guarantee that we will obtain such SFDA approval in this timeframe or all. These products are all non-invasive therapy products that treat
symptoms of sleep apnea. Our CPAP devices do not cure apnea but instead use air pressure to open customers&#146; airways to </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">68 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:0%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
reduce snoring and apnea disturbances during sleep. Our automatic CPAP products provide air pressure at a customized, adjustable level, while our traditional CPAP products provide a constant
level of air pressure. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Diagnostic Products. </I></B>We have designed and expect to provide two types of screening and diagnosis products are portable sleep respiratory
recording devices that can be used in a healthcare facility or in a patient&#146;s home to assist physicians in determining whether the patient has obstructive sleep apnea requiring use of a CPAP device. We have applied to SFDA for approval of our
DHR 998 and DHR 999 diagnostic products, and they will not be available for sale until we receive such approval. While we expect to receive this approval within the first half of 2010, we cannot guarantee that we will obtain such SFDA approval in
this timeframe or all. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Thermotherapy Products</I></B>. We have designed and expect to provide our thermotherapy device for patients with rhinitis and delivers atomized
clean water at a therapeutic temperature to the affected site. We have not yet begun to market this device and cannot project when we will begin to market this device. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Research and Development of Our Branded Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our success to date has in part resulted from our strong research and development capabilities, which allow us to regularly introduce new and more
advanced products at more competitive prices within a shorter period of time. We increased our annual investment in research and development activities as a percentage of net revenues every year since 2003. Research and development costs were
$87,660, $47,228, $50,671 and $36,989 for the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September 2009 and 2008, respectively. Our research and development team consists of 20 engineers, representing more than
one-tenth of our employees nationwide. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our project selection goals focus on projects that we believe are commercially feasible, can generate
significant revenue and can be introduced into the market in the near-term. While our research and development department may conduct research into areas that are likely to lead to short-, medium- and long-range business opportunities for our
company, we focus our development of products on those solutions we believe are most likely to generate significant near-term revenues. Thus, we would generally devote more resources to a solution expected to have an immediate financial return (for
example, a ventilator) than to a project with a potentially greater overall payoff that is more distant and tenuous (for example, an artificial lung). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our management seeks feedback from our distribution network to learn about needs for future products and improvements to existing products that our
research and development department can seek to address. Once we identify a product opportunity, our sales and service, research and development, and assembly teams work closely together to determine potential market demand for a product and how it
fits with our current design and assembly capabilities. We organize regular meetings in which our sales and service, research and development and assembly teams review progress and, if necessary, adjust the emphasis of our research and development
projects. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we deem a new product to be commercially feasible, our research and development team will work closely with our assembly team to
move assembly forward. This integrated approach allows us to identify potential difficulties in commercializing our branded product or product improvement. Furthermore, it enables us to make adjustments as necessary and develop cost-efficient
assembly processes prior to distribution. We believe these abilities can significantly shorten the time it takes to launch a commercialized product. In the last three years, we have developed and brought to market 5 new products, which appeal to a
wide range of end-users. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We maintain a 5,400 square foot research and development center in our facility in Beijing, which allows us to
compete for skilled research and development technicians and managers. In addition, we are enhancing our research and development ability by cooperating with the research institutes of two top ranking Universities in China: Beijing University of
Aeronautics&nbsp;&amp; Astronautics and Beijing University of Technology and Science. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">69 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Principal Suppliers &#150; Our Branded Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We use the following principal suppliers to manufacture the components in the products we develop and assemble: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Friend of Health (Chuzhou) Medical Technology Co., Ltd. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">IMI Morgren Trading (Shanghai) Co., Ltd </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yuyao Best Medical Device Parts Factory </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Contec Medical Systems Co., Ltd. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tianjin HSD Metal Product Co., Ltd. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe the components provided by our suppliers are widely available and do not anticipate that we will be unable to obtain these components from
other suppliers in the event our principal suppliers are unable or unwilling to supply us. Notwithstanding this fact, we currently purchase approximately 13.5% of our supplies from Friend of Health (Chuzhou) Medical Technology Co., Ltd., and this
company may be considered a major supplier or our company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We provide the technical specifications and files needed for our suppliers to
manufacture components. We purchase the same components from a wide variety of suppliers; for example, we purchase a component of our oxygen concentrator, the oxi-chip, from several suppliers, including Yueqing Dingji Pneumatic Machinery Factory,
Shanghai Showpeak Molecular Sieves Co., Ltd., Yuyao Best Medical Device Parts Factory and Beijing Xishenglong Electric Equipment Co., Ltd. We only provide separately outsourced core parts to Friend of Health to incorporate into components.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We outsource the production of some of our oxygen concentrators and air compressors to Friend of Health under production agreements. We
provide the technical specifications and files needed for Friend of Health to manufacture these branded products. We provide separately outsourced core parts to Friend of Health to incorporate into the components they assemble and distribute for us.
We test and approve each part produced by Friend of Health before they begin mass production. We require Friend of Health to maintain minimum supplies of our branded products and components for use in our branded products, and we permit them to sell
our branded products only in Chuzhou. Friend of Health delivers products to us on credit, and we are required to make payment within 45 days after the date of delivery. Friend of Health is the only supplier that also assembles and distributes
finished branded products for us. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Assembly of Our Branded Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">After our research and development team designs the technical specifications and computer models for our branded products, we typically work with an
independent contractor to fabricate working prototypes before we commence with the production run of a product. We test prototypes to confirm that they operate as expected and with the quality we require. During the prototyping process, we apply for
SFDA approval as necessary. Once both of these processes are completed, we commission a production run of components for assembly into our branded products. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We depend on component and product manufacturing and logistical services provided by third parties. All of our branded products are manufactured in whole
or in part by a variety of third-party manufacturers. While these arrangements may lower operating costs, they also reduce our direct control over production. It is uncertain what effect such diminished control will have on the quality or quantity
of products or services, or on our flexibility to respond to changing conditions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We maintain a 32,000 square foot product center in
Changping Science Park in Beijing. This product center contains our research and development area and our assembly facilities. Final assembly of our products is currently performed in this facility by our 40 employees in assembly and by some of our
external vendors, such as Friend of Health. Currently, the supply and manufacture of many critical components is performed by sole-sourced third-party vendors in China. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Proprietary Rights for Our Branded Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are developing a portfolio of intellectual property rights in China to protect the technologies, inventions and improvements that we believe are
significant to our business in China. We have two </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">70 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
patents issued in China for an oxygen concentrator. We have applied for five additional patents related to our CPAP devices (2), portable sleep screening (2)&nbsp;and diagnostic services (1).
Moreover, we possess proprietary technology and know-how in assembly processes, design and engineering. We have not filed for any patent protection outside of China. To protect our brand name recognition, we have registered the brand name
&#147;Dehaier&#148; for trademark protection in China. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our success in the medical equipment industry depends in substantial part on effective
management of both intellectual property assets and infringement risks. In particular, we must be able to protect our own intellectual property as well as minimize the risk that any of our branded products may infringe upon the intellectual property
rights of others. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We enter into agreements with all our employees involved in research and development, under which all intellectual property
generated during their employment belongs to us, and they waive all relevant rights or claims to such intellectual property. All our employees involved in research and development are also bound by a confidentiality obligation and have agreed to
disclose and assign to us all inventions conceived by them during their term of employment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that we have successfully established
our brand in China. We have registered trademarks in China for the Dehaier name and logo used on our own-brand products. As part of our overall strategy to protect and enhance the value of our brand, we actively enforce our registered trademarks
against any unauthorized use by a third party. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Distributed Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our management believes that our distributed products, which are generally more expensive than products from Chinese companies, tend to be more attractive
to larger city hospitals and more affluent healthcare facilities and other end-users for whom perceived quality is a significant factor in deciding which products to purchase. While we believe that the quality of our branded products is also strong,
we understand that some consumers in China associate more well-known international brands with higher quality than they associate with domestically produced brands. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We serve as a significant distributor in China for several foreign producers of medical devices and respiratory and oxygen homecare products, including
IMD, Timesco, JMS and ResMed. We believe this extensive platform allows us to be responsive to local market demand. We distribute medical devices and respiratory and oxygen homecare products for these companies. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Devices </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Mobile Medical X-Ray Image Devices. </I></B>We provide two types of X-ray machines developed by other companies: the IMD Radius Series mobile and
C-armed X-ray machine and the IMD </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Compact Series mobile-X-ray machine. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Ventilator. </I></B>We provide three types of ventilators developed by other companies: the ResMed VS Serena, Ultra and Integra
Ventilators. The VS Series of medical ventilators mechanically move breathable air to and from the lungs to support breathing support for patients who are physically unable to breathe or who are breathing insufficiently.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Laryngoscopes</I></B>. We provide four types of laryngoscopes developed by other companies: the Optima, Optima XL and Eclipse lines of
laryngoscopes from Timesco. Laryngoscopes are flexible lighted tubes that are used to look at the inside of the larynx. Anesthesiologists make use of laryngoscopes to assist with intubation in surgery. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Respiratory and Oxygen Homecare Products </I></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Sleep Apnea Treatment Products. </I></B>We provide two types of products developed by other companies designed for obstructive sleep apnea
(&#147;OSA&#148;) therapy. These products include the ResMed S6 and MAP MiniPAP. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">71 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Relationships with Suppliers of Our Distributed Products </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">While we develop, assemble, market and sell our branded products, we also serve as the distributor for a number of international companies looking to
sell their brands of products in China. We are a distribution agent for some or all products marketed in China by IMD (Italy), Timesco (UK), ResMed (Australia) and JMS (Japan). In this capacity, we are responsible for sales, marketing and after-sale
services of these products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We sign agency agreements with these international suppliers annually with the aim of settling marketing
promotion modes, costs, product training and resolution of customer service issues. The agency agreements cover purchasing price, purchasing intervals, order quantity, transportation and type of payment, spare part supply and after-sale service
terms. We negotiate renewal of these agency agreements as they expire to confirm ongoing distributor expectations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We seek to enlarge the
scope of products we are able to sell as agent for these companies and constantly try to identify competitive suppliers and products on the international market to assist them with marketing and selling their products in China. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Agreements with Current Suppliers of Our Distributed Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We currently have supply agreements with suppliers of our distributed products. The key terms of those agreements are set forth in this section.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>IMD China Co., Ltd.</I> Our current Sales Agency Agreement with IMD is dated December&nbsp;21, 2009. Under this agreement, we have been
appointed to act as IMD&#146;s exclusive agent in the PRC to sell the IMD Radius S9 and Radius R9 Mobile C-arm X-Ray Unit; provided, however, that third parties may also deal directly with IMD if they choose. We have undertaken to sell not less than
$2 million of these units between January&nbsp;1, 2010 and January&nbsp;1, 2011. This agreement may be extended with mutual consent and may be terminated if either party fails to perform under the agreement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Timesco of London Ltd.</I> Our Agency Agreement with Timesco is effective September&nbsp;8, 2009 for a period of one year but subject to review on
performance every six months. We have been appointed to act as Timesco&#146;s exclusive agent in the PRC, excluding Hong Kong, Taiwan and Macao, to sell its Optima, Optima XL and Eclipse laryngoscopes. Timesco may fulfill any contracts, orders or
quotations prior to the effective date of the agreement but has agreed to refer all inquiries after such date to our company. We are not permitted to sell any competitors&#146; laryngoscopes that compete with Timesco&#146;s Optima, Optima XL and
Eclipse lines of laryngoscopes. Our annual sales target under this agreement is $200,000, and we are expected to place a minimum order for $50,000 every three months. We must pay half of the cost for such orders before shipment and the remainder
within 90 days. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Dalian Wande Electronics Co., Ltd. (JMS)</I>. Our Sales Agency Agreement with JMS is effective November&nbsp;1, 2009 for a
period of one year. Under this agreement, we have been appointed by JMS&#146; General Agent, Dalian Wande, to serve as JMS&#146; product distributor in the PRC. We distribute JMS syringe pumps and infusion pumps under this agreement. Payment must be
made prior to delivery of such pumps. We may not sell competing pumps during the term of the agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>ResMed Asia Pacific Limited.</I>
Our Distribution Agreement with ResMed is effective July&nbsp;1, 2009 for a period of twelve months. This agreement is subject to extension for a subsequent twelve month period if we are in compliance and provide notice to ResMed of our intention to
renew sixty days prior to July&nbsp;1, 2010. The agreement may be further renewed upon agreement with ResMed. This Distribution Agreement appoints us as the non-exclusive distributor of ResMed products in Sichuan, Hubei, Chongqing, Guizhou, Guangxi,
Yunnan, Anhui, Shanxi (except for homecare), Henan, Guangdong (except for homecare), Hunan and Hebei provinces. In our first year under this agreement, we must purchase at least $600,000 of ResMed products; if the agreement is renewed, we must
purchase at least $800,000 of ResMed products during the second year. ResMed has the ability to discontinue products or increase prices of products with 60 days&#146; prior notice. ResMed may terminate the agreement in the event we provide
non-ResMed equipment for the diagnosis or treatment of sleep disordered breathing. We are required to provide monthly forecasts of our requirements for ResMed Products for the next three months,
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">72 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
and the first month&#146;s projection is considered a firm commitment to purchase such products from ResMed, subject to its acceptance of such offer. In addition, we must keep sufficient ResMed
stock to meet one month&#146;s projected requirement. We are required to provide the original purchaser of ResMed Products a warranty which is to be fulfilled by ResMed. We are obligated to meet certain minimum levels of sales and marketing activity
with respect to ResMed products and training. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Principal Suppliers &#150; Our Distributed Products </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the products we design, we distribute products designed and manufactured by the following companies: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">IMD (Italy) </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Timesco (UK) </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">ResMed (Australia) </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">JMS (Japan) and </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The exact
products from these suppliers are available only from such suppliers; however, we do not anticipate that we will be unable to obtain similar products from other suppliers in the event our principal suppliers are unable or unwilling to supply us. In
addition, we have designed similar products to those supplied by IMD and ResMed. See &#147;We sell products for some of our competitors, some of which compete with our branded products.&#148; </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Service </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We maintain a
24-hour customer service center in Beijing for technical support and repair. We staff our customer service center with senior technical support engineers who provide preliminary support. Our engineers attempt to quickly diagnose and assist in
repairing problems over the phone, or determine whether a service visit to the customer&#146;s premises is necessary. In some instances, our engineers will provide on-site operating guidance and repair service. We periodically review customer calls
to ensure that any issues raised by our customers are resolved to their satisfaction. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Strategies </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our objective is to strengthen our position as one of China&#146;s leaders in developing, distributing and marketing medical devices and home respiratory
therapy products and to become an industry leader in certain select foreign markets. We intend to achieve our objective by implementing the following strategies: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Increase Market Share. </I></B>We have plans to develop and introduce more technologically advanced home respiratory products while maintaining
steady rates of growth in the sales of our existing medical devices. We plan to establish 32 new Customer Experience Centers (&#147;CEC&#148;) over the next three years after completion of this offering, add more direct sales personnel, and increase
our marketing activities to further penetrate China&#146;s market. These CECs are complementary to our current marketing and distribution model because the CECs give our potential customers an opportunity to experience our products first-hand in an
environment that is similar to the environment in which they will use the products, whether that is a home or healthcare facility. We plan to target distributors, hospitals, clinics and individuals with the CECs. CECs can provide marketing, training
and after-sales support to distributors, hospitals and clinics and can provide a experience to individuals, whether they come in on their own or referred by a hospital doctor. We plan to establish CECs in each of China&#146;s 32 provincial capital
cities. We expect to open these CECs in order based on considerations of existing sales of the products we sell, estimated potential market size and other strategic considerations, such as geographic diversity and expected profitability. We have not
yet determined the order in which we plan to establish these CECs or the cost of such CECs, as the order and exact timing will depend substantially on whether and when this offering is completed and the expense of establishing a CEC will depend on
market research that we will conduct prior to beginning to establish a given CEC. We expect that the order may change over time as the foregoing variables change (for example, if a potential market grows dramatically or if one of the products we
sell becomes more popular in one province than another). At present, we expect to place our highest priority on building CECs </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">73 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:0%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
in Beijing, Shanghai and Guangzhou. The cost of building and maintaining a CEC in a large city like Beijing is approximately RMB 422,000 (approximately $61,820) in the first year. We also plan to
capitalize on the anticipated market growth by leveraging our significant local industry expertise, strong brand recognition, broad customer base and established distribution network. Additionally we plan to increase our exposure through increased
participation at industry exhibitions and technology forums. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Expand into Select Foreign Markets. </I></B>Assuming successful completion of this offering and the receipt of approval to sell our branded
products in the European Union, we currently plan to expand initially into Europe. We have not yet qualified or applied to sell our branded products in the European Union, and we have no guarantee that we will be successful with any such application
for approval. We have received CE certificates for two of our branded products (our oxygen concentrators and air compressors). We are applying for CE certificates for other branded products. CE certificates are European conformance marks that
designate a product as meeting certain safety, health or environmental requirements in European Union member countries. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Increase Research and Development. </I></B>We intend to broaden our market reach by introducing more advanced branded products and new branded
product lines that address different end-user segments. Some of the segments we intend to direct future focus to include: oxygen therapy and health care, sleep and respiratory diagnosis and therapy, and homecare data collection and transportation.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Enhance Market Position and Brand Recognition. </I></B>We plan to enhance our position in the market and bolster our brand recognition through
the above mentioned 32 CECs which will be established in each of China&#146;s 32 capital cities. The CECs will provide purchasers of our branded products with extensive pre-sale education in the use of the branded product as well as post-sale
service of the branded product. We also plan to grow our international business though the establishment of a more extensive distribution network and technical service products relationships with international manufacturers and distributors.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Maintaining Our Disciplined Cost Focus. </I></B>We plan to maintain our disciplined cost focus while further improving our cost structure. Our
research and development team will work with our assembly team to optimize our design in order to improve our margins and competitive cost advantages. As our sales volume increases, so too will the size of our purchases of components. We intend to
take advantage of this situation by leveraging our purchasing power to reduce our purchasing costs. As we build economies of scale, we anticipate further increases in our operational efficiencies. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Maintain Distribution Network. </I></B>We plan to maintain our existing distribution network through active management of our distributors. We
will periodically review the performance of our distributors and assess areas that need improvement; agreements with distributors who fail to perform to our standards will be terminated. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Pursue Strategic Acquisitions and Alliances. </I></B>We expect to evaluate potential acquisitions of assets and companies as a part of our
efforts to expand our presence in the medical device market. We expect to focus on acquisitions that enhance our ability to serve our existing customer base, enter new market segments in China or grow into new international markets. We have not yet
identified any potential targets, and we do not have any understandings, commitments or agreements in place with regard to such acquisitions. We cannot guarantee that we will identify favorable opportunities or that we will be able to negotiate
acceptable acquisition terms if we do locate such opportunities. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Customers </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have three categories of customers: distributors, hospitals and government agencies and individual consumers to whom we sell directly. Our customer
base is widely dispersed on both a geographic and revenues basis. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">74 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our distributors. </I></B>Sales to our distributors make up the substantial majority of our revenues
as over 90% of our sales are to distributors. Based on the expected use of products sold to distributors, we estimate that they sell approximately 60% of our products to hospitals, 20% to clinics and 10% to individuals. As a result, we estimate that
approximately 67% of our products (on a revenue basis, rather than unit basis) are sold to hospitals, approximately 21% to clinics and approximately 12% to individuals. We have contractual distribution relationships with over 2,000 independent
distributors. We do not own, employ or control these independent distributors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Hospital and governmental agency customers. </I></B>Our
hospital and governmental agency customers account for approximately 7% of our direct sales. Our hospital and governmental agency customers primarily include hospitals as well as provincial level public health bureaus and population and family
planning bureaus. These customers typically place large volume orders that are awarded based on bids submitted by competing medical equipment companies through a state-owned bidding agent. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Individual consumers. </I></B>We sell our home respiratory therapy products directly to consumers through our CEC centers and through the
E-commerce website: www.cpap-oxygen.com. The information on this website is not incorporated in this prospectus. Such sales account for approximately 2% of our direct sales. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Dependence on Major Customers. </I></B>For the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September 2009 and 2008,
approximately 11%, 17%, 8% and 7%, respectively, of our sales were from one customer, Poverty Aid Office. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our business would be harmed if we
lost or reduced our relationships with Poverty Aid Office. See &#147;Risk Factors &#150; Our revenues are highly dependent on a limited number of customers involved in China&#146;s healthcare device industry.&#148; <B><I> </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Concentration of Receivables</I></B><I></I><B><I>.</I></B><I></I><B><I> </I></B>At December&nbsp;31, 2008 and 2007, receivables from four customers
were approximately 17%, 13%, 11%, 10% and 20%, 12%, 11%, 10%, respectively. At September 2009 and 2008, receivables from four customers were approximately 9%, 9%, 8%, 7% and 16%, 14%, 9%, 8%, respectively. With the exception of Poverty Aid Office,
no other customer accounted for more than ten percent of our revenues, notwithstanding having receivables at various balance sheet dates in excess of ten percent of total receivables. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The table below shows the four highest receivable percentages as of December&nbsp;31, 2007 and 2008 and September&nbsp;30, 2008 and 2009. The four
customers vary at each period and only our major customer, Poverty Aid Office, has been identified. The loss of any other customer would not materially affect our business. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,
2007</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31, 2008</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30, 2008</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30, 2009</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">A</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">B&nbsp;(Poverty&nbsp;Aid&nbsp;Office)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">17</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">B&nbsp;(Poverty&nbsp;Aid&nbsp;Office)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">B&nbsp;(Poverty&nbsp;Aid&nbsp;Office)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">12</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">13</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">A</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">I</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">C</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">11</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">11</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">G</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">K</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Competition
&#150; Generally </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The medical device industry is characterized by rapid product development, technological advances, intense competition
and a strong emphasis on proprietary information. Across all product lines and product tiers, we face direct competition from both domestic and international competitors. We compete based on factors such as price, value, customer support, brand
recognition, reputation, and product functionality, reliability and compatibility. Each of our branded products competes against functionally similar products from domestic and international companies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our competitors include publicly traded and privately held multinational companies, such as Respironics, Inc., ResMed Inc., and Covidien, as well as
domestic Chinese companies such as Beijing Aoji, Beijing Ya&#146;ao, Jiangsu Yuyue and Zhejiang Longfei. We believe that we can continue to compete successfully in China because our established domestic distribution network and customer support and
service network </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">75 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
allows us significantly better access to China&#146;s small and medium-sized hospitals. In addition, our strong investment in research and development, coupled with our low-cost operating model,
allows us to compete effectively for sales to large hospitals. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe our competitive position in China varies depending on the product
in question. While we are a much smaller company overall than, for example, General Electric, Siemens or Philips and are unable to offer the range or depth of products each of those companies offers, we believe our market position is favorable in
several segments. The following charts provide our marketing department&#146;s estimations of our primary competitors by product, both as to our branded products and as to our distributed products: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:59pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Branded Product</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:105pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Primary Competitors in China</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:146pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Dehaier&#146;s Estimated Competitive Position*</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR Explorer Series C-armed</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">X-ray machine</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Nanjing Pulang, Beijing Wantong, Beijing Smart, Shenzhen Nanyun</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR ORSA Series anesthesia machines</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Drugg, GE, Spacelab</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR 930 patient monitoring devices</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shenzhen Mindray, Shenzhen Jinkewei, Zhuhai Baolaite</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">C250 and C280 air compressors</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beijing Yi&#146;an, Guangdong Puling</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Greater than average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Trolleys</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">An OEM business model, N/A</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sterilizers</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">An OEM business model, N/A</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR oxygen concentrator</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beijing Aoji, Beijing Ya&#146;ao, Jiangsu</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yuyue and Zhejiang Longfei</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Smaller than average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR CPAP C5,* DHR Auto</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">CPAP
A8,* DHR Auto S-CPAP A9</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Foreign companies such as</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Respironics, ResMed, and Covidien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Not in market yet</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR 998* and DHR 999*</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">screening and diagnosis products</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Foreign companies such as</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Respironics, ResMed, and Covidien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Not in market yet</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR thermotherapy device</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">none</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Not in market yet</FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:68pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Distributed Product</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:105pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Primary Competitors in China</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:142pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Dehaier&#146;s Estimated Competitive Position</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">IMD C-armed X-ray machine</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philips, GE, Siemens</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Smaller than average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">ResMed Ventilators</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Drugg (GER), GE, TYCO (USA), Newport (USA)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Smaller than average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">ResMed S6 and MAP MiniPAP</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Respironics (USA), Covidien (USA), GE</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Smaller than average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">JMS pump</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">B Braun (GER), Atom (JPN), Smiths (UK)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Smaller than average</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Timesco laryngoscope</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kirchner &amp; Wilhelm (GER), WelchAllyn (USA)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Greater than average</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A &#147;greater than average&#148; position indicates Dehaier estimates its competitive position in the top third of all competitors. &#147;Average&#148; indicates
Dehaier estimates its competitive position in the middle third of all competitors and &#147;Smaller than average&#148; indicates Dehaier estimates its competitive position in the bottom third of all competitors. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As we expand into international markets, our competitors will include publicly traded and privately held multinational companies such as Respironics,
Inc., ResMed Inc. and Covidien. These companies typically </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">76 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
focus on the premium segments of the market. We believe we can successfully penetrate certain international markets by offering products of comparable quality at lower prices. We will also face
competition in international sales from companies that have local operations in the markets in which we sell our branded products. We believe that we can compete successfully with these companies by offering high quality branded products at
comparable prices. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Methods of Competition </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">China&#146;s medical device market currently features a significant number of small distributors. We seek to distinguish our company from our competitors
by being able to offer branded and distributed products that address the device needs of customers that may have very different needs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For
example, China is currently investing heavily in health care nationwide; however, money for healthcare is currently unevenly distributed. There are a number of large hospitals that have significant resources and a number of rural clinics that have
extremely limited budgets. We are able to provide distributed products that reach the more affluent customers, as these customers frequently tend to ascribe more perceived value to products made by well-known foreign companies, such as Timesco and
ResMed. We are also able to supply our branded products to less wealthy customers, who tend to care less about perceived value and more about functionality. One of our strategies in competing in this market is to make our products as mobile as
possible. For this reason, our air compressors, mobile X-ray devices, trolleys and the like are all portable. This portability addresses the budgetary limitations of, for instance, a rural clinic that can only afford to purchase a single air
compressor. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We currently compete on three levels. First, we have a network of contractual distribution relationships with over 2,000
independent distributors, and we employ 70 direct sales and sales support personnel. Second, in 2008 we opened an online sales platform for our respiratory and oxygen homecare products to make those products more easily available throughout China.
Third, we established our first Customer Experience Center, or CEC, in Beijing. We have used this CEC to increase our marketing efforts, with the goal of increasing our market penetration in China&#146;s large cities. These CECs are complementary to
our current marketing and distribution model because the CECs give our potential customers an opportunity to experience our products first-hand in an environment that is similar to the environment in which they will use the products, whether that is
a home or healthcare facility. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Employees </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of March&nbsp;22, 2010, we had 155 employees, including 148 full-time employees and 7 part-time employees. Out of that total, 40 were employed in
assembly, 20 were in research and development, 15 were in general administration, 70 were in marketing, sales, and customer support and service, and 10 were in procurement and supply management. As required by PRC regulations, we participate in
various employee benefit plans that are organized by municipal and provincial governments, including pension, work-related injury benefits, maternity insurance, and medical and unemployment benefit plans. We are required under PRC law to make
contributions to the employee benefit plans at specified percentages of the salaries, bonuses, housing funds and certain allowances of our employees, up to a maximum amount specified by the local government from time to time. We make contributions
to the employee benefit 10% of employee salaries. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Generally, we enter into a three-year standard employment contract with all of our
officers, managers and other key employees and a one-year standard employment contract with all other employees. According to these employment contracts, all of our employees are prohibited from engaging in any activities that compete with our
business during the period of their employment with us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under Chinese law, we may only terminate employment agreements without cause and
without penalty by providing notice of non-renewal one month prior to the date on which the employment agreement is scheduled to expire. If we fail to provide this notice or if we wish to terminate an employment agreement in the absence of cause,
then we are obligated to pay the employee one month&#146;s salary for each year we have employed the employee. We are, however, permitted to terminate an employee for cause without penalty to our company, where the employee has committed a crime or
the employee&#146;s actions or inactions have resulted in a material adverse effect to us. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">77 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_14"></A>DESCRIPTION OF PROPERTY </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are headquartered and our principal executive offices are located at the Epoch Center in Beijing. We assemble and test all our branded products at our
32,000 square foot product facility at the Changping Science Park in Beijing. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Office</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Address</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Rental Term Expiration</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Space</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Principal Executive&nbsp;Office</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">1223 Epoch Center, 31 Zi Zhu Yuan Road, Haidian District, Beijing, 100089</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">December 31, 2011</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,800 square feet</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Product Center</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 Yong An Road, Science Park, Changping District, Beijing, 102200</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">September 24, 2010</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,000 square feet</FONT></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_15">
</A>REGULATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our products are medical devices and are subject to regulatory controls governing medical devices. As a distributor of
medical equipment and supplies we are subject to regulation and oversight by different levels of the food and drug administration in China, in particular the SFDA. We are also subject to other PRC government laws and regulations. SFDA requirements
include obtaining certifications, permits, compliance with clinical testing standards, assembly practices, quality standards, applicable industry standards and adverse event reporting, and advertising and packaging standards. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>China&#146;s Regulation of Medical Devices </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Classification of Medical Devices </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
China, medical devices are classified by the SFDA into three different categories, Class I, Class II and Class III, depending on the degree of risk associated with each medical device and the extent of control needed to ensure safety and
effectiveness. Classification of a medical device is important because the class to which a medical device is assigned determines, among other things, whether a company needs to obtain a permit and the level of regulatory authority involved in
obtaining such permit. Classification of a device also determines the types of registration required and the level of regulatory authority involved in effecting the product registration. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Class I devices require product certification and are those with low risk to the human body and are subject to &#147;general controls.&#148; Class I
devices are regulated by the city level food and drug administration where the company is located. Class II devices are those with medium risk to the human body and are subject to &#147;special controls.&#148; Class II devices require product
certification, usually through a quality system assessment, and are regulated by the provincial level food and drug administration where the company is located. Class III devices are those with high risk to the human body, such as life-sustaining,
life-supporting or implantable devices. Class III devices also require product certification and are regulated by the SFDA under the strictest regulatory control. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The majority of our products are classified as Class II or Class III devices. Our anesthesia machines and ventilators are classified as Class III medical
devices, while the remainder of our products are either classified as Class II or, in the case of our ventilator trolleys and sterilizers, not categorized devices. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Assembly Permit </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A company must obtain a
permit from the provincial level food and drug administration before commencing the assembly of Class II and Class III medical devices. No assembly permit is required for Class I devices, but the company must notify the provincial level food and
drug administration where the company is located and file for record with it. An assembly permit, once obtained, is valid for five years and is renewable upon expiration. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have a single assembly permit, which covers all products we assemble and is scheduled to expire on September&nbsp;15, 2013. To renew an assembly
permit, a company needs to submit to the provincial level food and drug administration an application to renew the permit, along with required information nine months before the expiration date of the permit. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">78 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Distribution License </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A manufacturer or distributor must obtain a distribution license in order to engage in sales and distribution of Class II and Class III medical devices in
China. A distribution license is valid for five years and is renewable upon expiration. Our distribution license will expire on May&nbsp;16, 2010. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registration Requirement </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Before a
medical device can be manufactured for commercial distribution, a company must effect medical device registration by proving the safety and effectiveness of the medical device to the satisfaction of respective levels of the food and drug
administration. In order to conduct a clinical trial on a Class II or Class III medical device, the SFDA requires companies to apply for and obtain in advance a favorable inspection result for the device from an inspection center jointly recognized
by the SFDA and the Administration of Quality Supervision, Inspection and Quarantine. The application to the inspection center must be supported by appropriate data, such as animal and laboratory testing results. If the inspection center approves
the application for clinical trial, and the respective levels of the food and drug administration approve the institutions which will conduct the clinical trials, the company may begin the clinical trial. A registration application for a Class II or
Class III device must provide required pre-clinical and clinical trial data and information about the device and its components regarding, among other things, device design, production and labeling. The provincial level food and drug administration,
within 60 days of receiving an application for the registration of a Class II device, and the SFDA, within 90 days of receiving an application for the registration of a Class III device, will notify the applicant whether the application for
registration is approved. If approved, a registration certificate will be issued within ten days of written approval. If the food and drug administration requires supplemental information, the approval process may take much longer. The registration
is valid for four years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The SFDA may change its policies, adopt additional regulations, revise existing regulations or tighten enforcement,
each of which could block or delay the approval process for a medical device. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table discloses the current registration
expiration dates for the products we sell. It is the obligation of that produces the product to seek registration and any renewals. We are responsible for registering our branded products but must rely on the suppliers of other products to seek
registration for those products. We will either cease to sell such product or seek comparable products from other suppliers in the event the registration is not renewed on expiration. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Devices </I></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:46pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Product Type</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Product Model</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Registration&nbsp;Expiration</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Mobile Medical X-Ray Image Devices.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Explorer Series mobile and C-armed X-ray machine</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">November 2010</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">IMD Compact Series mobile-X-ray machine</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">December 2012</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Anesthesia Machines.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR ORSA Series anesthesia machine</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">September 2013</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Patient Monitoring Devices.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR 930 patient monitor</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">December 2011</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Medical Ventilator.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Resmed Ventilator</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">November 2013</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Technical
Service Products </I></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Product</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Registration Expiration</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Ventilator Air Compressor.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">November 2011</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Trolleys for Ventilators.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Not a medical device</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Sterilizers for Ventilators.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Not a medical device</FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">79 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Respiratory and Oxygen Homecare Products </I></B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="53%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:46pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Product Type</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Product Model</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Registration Expiration</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Oxygen Concentrating Products.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Oxygen concentrator</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">November 2010</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Sleep Apnea Treatment Products.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">CPAP C5</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Application stage</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Auto CPAP A8</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Application stage</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Auto S-CPAP A9</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Application stage</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Diagnostic Products.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR 998</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Application stage</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHR 999</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Application stage</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Thermotherapy Products.</I></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thermotherapy device</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Application stage</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Continuing SFDA
Regulation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are subject to continuing regulation by the SFDA. In the event of significant modification to an approved medical device,
its labeling or its assembly process, a new premarket approval or premarket approval supplement may be required. Our products are subject to, among others, the following regulations: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">SFDA&#146;s quality system regulations which require companies to create, implement and follow certain design, testing, control, documentation and
other quality assurance procedures; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">medical device reporting regulations, which require that companies report to the SFDA certain types of adverse reaction and other events involving
their products; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">SFDA&#146;s general prohibition against promoting products for unapproved uses. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Class II and III devices may also be subject to special controls applicable to them, such as supply purchase information, performance standards, quality
inspection procedures and product testing devices which may not be required for Class I devices. We believe we are in compliance with the applicable SFDA guidelines, but we could be required to change our compliance activities or be subject to other
special controls if the SFDA changes or modifies its existing regulations or adopts new requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are also subject to inspection and
market surveillance by the SFDA to determine compliance with regulatory requirements. If the SFDA decides to enforce its regulations and rules, the agency can institute a wide variety of enforcement actions such as: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">fines, injunctions and civil penalties; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">recall or seizure of our products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the imposition of operating restrictions, partial suspension or complete shutdown of assembly; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">criminal prosecution. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>China Compulsory Certification Requirements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">China Compulsory Certification, or CCC, inclusive of a certificate and a mark, serves as evidence that the covered products can be imported, marketed or
used in China. The CCC mark is administered by the China National Certification and Accreditation Administration, which designates the China Quality Certification Center to process CCC mark applications. Some medical devices are required to have a
CCC mark. We have received a certificate and a mark for each of our branded products for which a CCC mark is required. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other National and
Provincial Level Laws and Regulations in China </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beyond those laws and regulations we consider material to our business, we are subject to
evolving regulations under many other laws and regulations administered by governmental authorities at the national, provincial and city levels, some of which are, or may be, applicable to our business. Our hospital customers are also subject to a
wide variety of laws and regulations that could affect the nature and scope of their relationships with us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Laws regulating the conduct of
business in our industry cover a broad array of subjects. We must comply with numerous additional state and local laws relating to matters such as safe working conditions, environmental protection and fire hazard control, which affect all companies
doing business in China. We </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">80 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
believe we are currently in compliance with these laws and regulations in all material respects. We may be required to incur significant costs to comply with these laws and regulations in the
future. Unanticipated changes in existing regulatory requirements or adoption of new requirements could have a material adverse effect on our business, financial condition and results of operations. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Restriction on Foreign Ownership </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The principal regulation governing foreign ownership of medical device businesses in the PRC is the Foreign Investment Industrial Guidance Catalogue,
effective as of December&nbsp;11, 2007 (the &#147;Catalogue&#148;). The Catalogue classifies the various industries into four categories: encouraged, permitted, restricted and prohibited. As confirmed by the government authorities, BDL is engaged in
an encouraged industry. Such a designation offers businesses distinct advantages. For example, businesses engaged in encouraged industries: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">are not subject to restrictions on foreign investment, and, as such, foreign can own a majority in Sino-foreign joint ventures or establish
wholly-owned foreign enterprises in the PRC; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">provided such company has total investment of less than $100 million, the company is subject to regional (not central) government examination and
approval which are generally more efficient and less time-consuming; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">may import certain equipment while enjoying a tariff and import-stage value-added tax exemption. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The National Development and Reform Commission and the Ministry of Commerce periodically jointly revise the Foreign Investment Industrial Guidance
Catalogue. As such, there is a possibility that our company&#146;s business may fall outside the scope of the definition of an encouraged industry in the future. Should this occur, we would no longer benefit from such designation. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Regulation of Foreign Currency Exchange </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The principal regulations governing foreign currency exchange in China are the Foreign Exchange Administration Regulations (1996), as amended, and the
Administration Rules of the Settlement, Sale and Payment of Foreign Exchange (1996). Under these regulations, Renminbi are freely convertible for current account items, including the distribution of dividends, interest payments, trade and
service-related foreign exchange transactions, but not for most capital account items, such as direct investment, loan, repatriation of investment and investment in securities outside China, unless the prior approval of SAFE or its local
counterparts is obtained. In addition, any loans to an operating subsidiary in China that is a foreign invested enterprise, cannot, in the aggregate, exceed the difference between its respective approved total investment amount and its respective
approved registered capital amount. Furthermore, any foreign loan must be registered with SAFE or its local counterparts for the loan to be effective. Any increase in the amount of the total investment and registered capital must be approved by the
PRC Ministry of Commerce or its local counterpart. We may not be able to obtain these government approvals or registrations on a timely basis, if at all, which could result in a delay in the process of making these loans. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The dividends paid by the subsidiary to its shareholder are deemed shareholder income and are taxable in China. Pursuant to the Administration Rules of
the Settlement, Sale and Payment of Foreign Exchange (1996), foreign-invested enterprises in China may purchase or remit foreign exchange, subject to a cap approved by SAFE, for settlement of current account transactions without the approval of
SAFE. Foreign exchange transactions under the capital account are still subject to limitations and require approvals from, or registration with, SAFE and other relevant PRC governmental authorities. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Regulation of Dividend Distribution </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The principal regulations governing the distribution of dividends by foreign holding companies include the Foreign Investment Enterprise Law (1986), as
amended, and the Administrative Rules under the Foreign Investment Enterprise Law (2001). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under these regulations, foreign investment
enterprises in China may pay dividends only out of their retained profits, if any, determined in accordance with PRC accounting standards and regulations. In </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">81 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
addition, foreign investment enterprises in China are required to allocate at least 10% of their respective retained profits each year, if any, to fund certain reserve funds unless these reserves
have reached 50% of the registered capital of the enterprises. These reserves are not distributable as cash dividends. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Notice 75 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On
October&nbsp;21, 2005, SAFE issued Notice 75, which became effective as of November&nbsp;1, 2005. According to Notice 75, prior registration with the local SAFE branch is required for PRC residents to establish or to control an offshore company for
the purposes of financing that offshore company with assets or equity interests in an onshore enterprise located in the PRC. An amendment to registration or filing with the local SAFE branch by such PRC resident is also required for the injection of
equity interests or assets of an onshore enterprise in the offshore company or overseas funds raised by such offshore company, or any other material change involving a change in the capital of the offshore company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moreover, Notice 75 applies retroactively. As a result, PRC residents who have established or acquired control of offshore companies that have made
onshore investments in the PRC in the past are required to complete the relevant registration procedures with the local SAFE branch. Under the relevant rules, failure to comply with the registration procedures set forth in Notice 75 may result in
restrictions being imposed on the foreign exchange activities of the relevant onshore company, including the increase of its registered capital, the payment of dividends and other distributions to its offshore parent or affiliate and capital inflow
from the offshore entity, and may also subject relevant PRC residents to penalties under PRC foreign exchange administration regulations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">PRC
residents who control our company are required to register with SAFE in connection with their investments in us. Such individuals completed this registration in 2007, and 2008, as amended. If we use our equity interest to purchase the assets or
equity interest of a PRC company owned by PRC residents in the future, such PRC residents will be subject to the registration procedures described in Notice 75. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Trademark Rights </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
PRC Trademark Law, adopted in 1982 and revised in 2001, with its implementation rules adopted in 2002, protects registered trademarks. The Trademark Office of the State Administration of Industry and Commerce (&#147;SAIC&#148;), handles trademark
registrations and grants trademark registrations for a term of ten years. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Regulations on Offshore Parent Holding
Companies&#146; </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Direct Investment in and Loans to Their PRC Subsidiaries </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">An offshore company may invest equity in a PRC company, which will become the PRC subsidiary of the offshore holding company after investment. Such
equity investment is subject to a series of laws and regulations generally applicable to any foreign-invested enterprise in China, which include the Wholly Foreign Owned Enterprise Law, the Sino-foreign Equity Joint Venture Enterprise Law, the
Sino-foreign Contractual Joint Venture Enterprise Law, all as amended from time to time, and their respective implementing rules; the Tentative Provisions on the Foreign Exchange Registration Administration of Foreign-Invested Enterprise; and the
Notice on Certain Matters Relating to the Change of Registered Capital of Foreign-Invested Enterprises. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the aforesaid laws and
regulations, the increase of the registered capital of a foreign-invested enterprise is subject to the prior approval by the original approval authority of its establishment. In addition, the increase of registered capital and total investment
amount shall both be registered with SAIC and SAFE. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shareholder loans made by offshore parent holding companies to their PRC subsidiaries are
regarded as foreign debts in China for regulatory purpose, which is subject to a number of PRC laws and regulations, including the PRC Foreign Exchange Administration Regulations, the Interim Measures on Administration on Foreign Debts, the
Tentative Provisions on the Statistics Monitoring of Foreign Debts and its implementation rules, and the Administration Rules on the Settlement, Sale and Payment of Foreign Exchange. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">82 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under these regulations, the shareholder loans made by offshore parent holding companies to their PRC
subsidiaries shall be registered with SAFE. Furthermore, the total amount of foreign debts that can be borrowed by such PRC subsidiaries, including any shareholder loans, shall not exceed the difference between the total investment amount and the
registered capital amount of the PRC subsidiaries, both of which are subject to the governmental approval. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_16">
</A>MANAGEMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Officers and Directors </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth our executive officers and directors, their ages and the positions held by them: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:13pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:27pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:36pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Appointed</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ping
Chen</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer and Chairman and Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2003</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Zheng (Rita)
Liu</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer and Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2003</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weibing
Yang</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President of Sales and Marketing</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2003</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yong
Wang</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President of Research and Development</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2003</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yunxiang (Phil)
Fan</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(3)(4)(5)(6)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Independent Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jimin (Peter)
Zhuo</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(4)(5)(6)(7)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Independent Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bin
Qiu</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(4)(5)(6)(7)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Independent Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">The
individual&#146;s business address is c/o BDL, 1223 Epoch Center, No.&nbsp;31 Zi Zhu Yuan Road, Haidian District, Beijing 100089 People&#146;s Republic of China. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Class III director
whose term expires in 2012. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Class II director
whose term expires in 2011. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Member of audit
committee. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Member of
compensation committee. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Member of
nominating committee. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Class I director
whose term expires in 2010. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Ping Chen. </I>Mr.&nbsp;Chen is our Chief Executive Officer. Prior to his service as our
Chief Executive Officer, from 1993-2000, Mr.&nbsp;Chen served as the CEO of Beijing Chengcheng Medical Electronic Equipment Co. Prior to 1993, Mr.&nbsp;Chen served as an engineer at the No.&nbsp;2 Academy, Ministry of Aeronautics and Astronautics
from 1987 to 1991 and moved up to the Head of the Civilian Products Division there from 1991-1993. Mr.&nbsp;Chen founded BTL in 2001 and has served as CEO since that time. Mr.&nbsp;Chen received his bachelor&#146;s degree in 1984 from the National
University of Defense Technology and his master&#146;s degree in 1987 from the Ministry of Aeronautics and Astronautics. Mr.&nbsp;Chen has been chosen as a director because he is our CEO, the leader of our Company and a key experienced member of
management. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Zheng (Rita) Liu. </I>Ms.&nbsp;Liu is our Chief Financial Officer. She has served in this role since 2003. She is a
Professional National Accountant of National Institute Accountants, Member of Chartered Institute of Management Accountant and Institute Financial Accountants. In the past, Ms.&nbsp;Liu served as the Finance Manager for Lehman Brown Investment
Consulting (China) Co. and Bro-rad Laboratory Instruments (China) Co., Ltd. Ms Liu received her bachelor&#146;s degree from the Renmin University of China in 1992 and her Master&#146;s degree in Business Administration from Peking University in
2001. Ms.&nbsp;Liu was chosen as a director because of her financial expertise and awareness of our financial capabilities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Weibing Yang.
</I>Dr.&nbsp;Yang is our Vice President of Sales and Marketing. Prior to becoming our VP of Sales and Marketing in 2003, Dr.&nbsp;Yang served us as a Sales Director in 2003. Prior to joining our company as a Sales Director, Dr.&nbsp;Yang served as a
Product Manager for AMTRONIX Inc. from 1996-1997. From 1993-1996, Dr.&nbsp;Yang served as a sales manager for Planmeca Medical Equipment Co. Dr.&nbsp;Yang also served as a doctor in the Beijing Ship Hospital from 1989-1992. Dr.&nbsp;Yang graduated
from the Medical School at SooChow University in 1989. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">83 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Yong Wang. </I>Mr.&nbsp;Wang is our Vice President of Research and Development. Mr.&nbsp;Wang served as a
Control Engineer at the Engineering Institution of Beijing from 1994-1997. Mr.&nbsp;Wang then served as the Vice General Manager and Chief Engineer for the Beijing Sinoeverlife Medical Technology Co., Ltd., from 1997-2003. From 2003 through present,
Mr.&nbsp;Wang has been our Vice President of Research and Development. Mr.&nbsp;Wang received his bachelor&#146;s degree in 1994 from Tianjin University. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Yunxiang (Phil) Fan.</I> Mr.&nbsp;Fan is a director of our company. In 2003, Mr.&nbsp;Fan co-founded Tri-Tech Holding Inc., a company operating in the
water pollution remediation, software and engineering industry in China (&#147;Tri-Tech&#148;). He currently serves as the President and a director of Tri-Tech. Prior to founding Tri-Tech, Mr.&nbsp;Fan provided technical, engineering and management
services in several U.S. engineering firms, including Black and Beatch, Parsons Brinckerhoff, Inc., and Chastain-Skillman, Inc. From 2003 through 2005, Mr.&nbsp;Fan was the Asia Regional Sales Manager for Met-Pro Corporation. Mr.&nbsp;Fan earned his
bachelor&#146;s and master&#146;s degrees in environmental engineering from Hunan University and a master&#146;s degree in civil engineering from Louisiana State University. Mr.&nbsp;Fan has been a registered professional engineer in the United
States since 2001. Mr.&nbsp;Fan was chosen as a director because we believe we can benefit from the guidance of the president of a Chinese company publicly traded in the U.S. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Ji Min (Peter) Zhuo.</I> Mr.&nbsp;Zhuo has over 15 years of financial and accounting work experience. From June 2007 through present, Mr.&nbsp;Zhuo
has served as vice president and chief accounting officer of Vanceinfo Technology Limited, a China-based IT outsourcing company listed on the New York Stock Exchange (NYSE Arca: VIT). From 2005 to 2006, he was chief financial officer of Ebis Company
Limited, a China based IT service company. From 2004 to 2005, Mr.&nbsp;Zhuo worked as a controller at Morgan Stanley Properties (China) Co. Ltd. From 1994 to 2004, Mr.&nbsp;Zhuo was an auditor with Arthur Andersen Beijing and Sydney office, and
PriceWaterhouseCoopers Beijing office. He is a China Certified Public Accountant and also passed China Bar examination and U.S CPA examination. He obtained bachelor degree with major in international accounting from Central University of
Finance&nbsp;&amp; Economic in China, and Master of Law (L.L.M) from University of Southern California, Gould School of Law. Mr.&nbsp;Zhuo was chosen as a director because of his accounting background and financial experience. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Bin Qiu.</I> Mr.&nbsp;Qiu has more than 17 years of experience in medicine and homecare medical devices. From May 2002 through present, he has served
as a director and CEO of Beijing Dawn Aerospace Bio-Tech Co., Ltd., a Bio-Pharmacy and healthcare food R&amp;D, manufacturing and distribution company. Before this, he was CEO of Shandong Fushan Dongsheng Industry Co., Ltd from May 2001 to April
2002. From 1998 to 2001, he was VP of Shanxi Fushan Medicine Co., Ltd. From 1995 to 1998, he was a department manager of Shandong SanZhu Industry Co., Ltd, a healthcare medicine and food company in China. Mr.&nbsp;Qiu earned his bachelor&#146;s
degree from Shandong Chinese Medicine University. Mr.&nbsp;Qiu was chosen as a director because we believe we can learn from his experience in the medical device industry. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Compensation </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Compensation Table </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
following table shows the annual compensation paid by us for the years ended December&nbsp;31, 2008 and 2009 to Ping Chen, our principal executive officer. His current employment agreement commenced on January&nbsp;1, 2009 and is scheduled to run
through December&nbsp;31, 2012. No officer had a salary during either of the previous two years of more than $100,000. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and principal position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total&nbsp;Paid</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ping Chen<BR>Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009<BR>2008</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$<BR>$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,400<BR>27,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$<BR>$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0<BR>0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$<BR>$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0<BR>0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$<BR>$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,400<BR>27,000</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Employment Agreements
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under Chinese law, we may only terminate employment agreements without cause and without penalty by providing notice of non-renewal one
month prior to the date on which the employment agreement is scheduled to expire. If we fail to provide this notice or if we wish to terminate an employment agreement in the absence of cause, then we are obligated to pay the employee one
month&#146;s salary for each year we </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">84 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
have employed the employee. We are, however, permitted to terminate an employee for cause without penalty to our company, where the employee has committed a crime or the employee&#146;s actions
or inactions have resulted in a material adverse effect to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our employment agreements with our executive officers generally provide for a
term of three (3)&nbsp;years and a salary to be paid monthly. The agreements also provide that executive officers are to work an average of forty hours per week and are entitled to all legal holidays as well as other paid leave in accordance with
PRC laws and regulations and our internal work policies. Under such agreements, our executive officers can be terminated for cause without further compensation. The employment agreements also provide that we will pay for all mandatory social
security programs for our executive officers in accordance with PRC regulations. During the agreement and for one (1)&nbsp;year afterward, our executive officers are subject to keep trade secrets confidential. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Share Option Pool </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We intend to
establish a pool for share options for our employees following the completion of this offering. This pool will contain options to purchase our common shares equal to ten percent (10%)&nbsp;of the number of common shares outstanding at the conclusion
of this offering, not including any shares underlying placement agent&#146;s warrants. This pool will contain options to purchase up to 450,000 of our common shares subject to outstanding share options or reserved for issuance under our share
incentive plan, assuming a maximum offering. The options will vest at a rate of 20%&nbsp;per year for five years and have a per share exercise price equal to the fair market value of one of our common shares on the date of grant. Other than those
granted under this pool, we will not grant any shares or options to our employees prior to the second anniversary of the closing of this offering. We expect to grant options under this pool to certain employees as of the closing of this offering.
Any options granted as of the closing of this offering will have an exercise price per common share equal to the offering price. We have not yet determined the recipients of any such grants. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board of Directors and Board Committees </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Composition of Board </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our board of
directors currently consists of 5 directors. We expect that all current directors will continue to serve after this offering. There are no family relationships between any of our executive officers and directors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The directors will be divided into three classes, as nearly equal in number as the then total number of directors permits. Class I directors shall face
re-election at our annual general meeting of shareholders in 2010 and every three years thereafter. Class II directors shall face re-election at our annual general meeting of shareholders in 2011 and every three years thereafter. Class III directors
shall face re-election at our annual general meeting of shareholders in 2012 and every three years thereafter. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the number of directors
changes, any increase or decrease will be apportioned among the classes so as to maintain the number of directors in each class as nearly as possible. Any additional directors of a class elected to fill a vacancy resulting from an increase in such
class will hold office for a term that coincides with the remaining term of that class. Decreases in the number of directors will not shorten the term of any incumbent director. These board provisions could make it more difficult for third parties
to gain control of our company by making it difficult to replace members of the Board of Directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A director may vote in respect of any
contract or transaction in which he is interested, provided, however that the nature of the interest of any director in any such contract or transaction shall be disclosed by him at or prior to its consideration and any vote on that matter. A
general notice or disclosure to the directors or otherwise contained in the minutes of a meeting or a written resolution of the directors or any committee thereof of the nature of a director&#146;s interest shall be sufficient disclosure and after
such general notice it shall not be necessary to give special notice relating to any particular transaction. A director may be counted for a quorum upon a motion in respect of any contract or arrangement which he shall make with our company, or in
which he is so interested and may vote on such motion. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">85 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no membership qualifications for directors. Further, there are no share ownership qualifications
for directors unless so fixed by us in a general meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors maintains a majority of independent directors who are deemed
to be independent under the definition of independence provided by NASDAQ Stock Market Rule 4200(a)(15). Messers. Fan, Zhuo and Qiu are our independent directors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no other arrangements or understandings pursuant to which our directors are selected or nominated. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Ping Chen currently holds both the positions of Chief Executive Officer and Chairman of the Board. These two positions have not been
consolidated into one position; Mr.&nbsp;Chen simply holds both positions at this time. We do not have a lead independent director because of the foregoing reason and also because we believe our independent directors are encouraged to freely voice
their opinions on a relatively small company board. We believe this leadership structure is appropriate because we are a smaller reporting company in the process of listing on a public exchange; as such we deem it appropriate to be able to benefit
from the guidance of Mr.&nbsp;Chen as both our principal executive officer and Chairman of the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors plays a
significant role in our risk oversight. The Board of Directors makes all relevant Company decisions. As such, it is important for us to have both our Chief Executive Officer and Chief Financial Officer serve on the Board as they play key roles in
the risk oversight or the Company. As a smaller reporting company with a small board of directors, we believe it is appropriate to have the involvement and input of all of our directors in risk oversight matters. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Committees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, three
committees have been established under the board: the audit committee, the compensation committee and the nominating committee. The audit committee is responsible for overseeing the accounting and financial reporting processes of our company and
audits of the financial statements of our company, including the appointment, compensation and oversight of the work of our independent auditors. The compensation committee of the board of directors reviews and makes recommendations to the board
regarding our compensation policies for our officers and all forms of compensation, and also administers our incentive compensation plans and equity-based plans (but our board retains the authority to interpret those plans). The nominating committee
of the board of directors is responsible for the assessment of the performance of the board, considering and making recommendations to the board with respect to the nominations or elections of directors and other governance issues. The nominating
committee considers diversity of opinion and experience when nominating directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Observers </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with this offering, we have agreed to allow our placement agent to designate two non-voting observers to our Board of Directors until the
earlier of the date that: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the investors that purchase common shares in this offering beneficially own less than ten percent (10%)&nbsp;of our outstanding common shares; or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the average closing price per common share equals or exceeds three (3)&nbsp;times the offering price for a period of 15 consecutive trading days.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although our placement agent&#146;s observers will not be able to vote, they may nevertheless significantly influence the
outcome of matters submitted to the Board of Directors for approval. We have agreed to reimburse the observers for their expenses for attending our Board meetings, subject to a maximum reimbursement of $6,000 per meeting and $12,000 annually, which
amount is not more than the reimbursement payable to our directors. The observers will be required to certify that such travel expenses are not reimbursed by any other party. We will also pay observers the same amount as our independent directors
receive. As of the date of this prospectus, Mr.&nbsp;L. McCarthy Downs III and Mr.&nbsp;Ming Zhu are serving as our placement agent&#146;s observers to our Board of Directors. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">86 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Duties of Directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under British Virgin Islands law, our directors have a duty to act honestly, in good faith and with a view to our best interests. Our directors also have
a duty to exercise the care, diligence and skills that a reasonably prudent person would exercise in comparable circumstances. See &#147;Description of Share Capital&#151;Differences in Corporate Law&#148; for additional information on our
directors&#146; fiduciary duties under British Virgin Islands law. In fulfilling their duty of care to us, our directors must ensure compliance with our third amended and restated memorandum and articles of association. We have the right to seek
damages if a duty owed by our directors is breached. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The functions and powers of our board of directors include, among others: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">appointing officers and determining the term of office of the officers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">authorizing the payment of donations to religious, charitable, public or other bodies, clubs, funds or associations as deemed advisable;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">exercising the borrowing powers of the company and mortgaging the property of the company; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">executing cheques, promissory notes and other negotiable instruments on behalf of the company; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">maintaining or registering a register of mortgages, charges or other encumbrances of the company. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Interested Transactions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A director may
vote, attend a board meeting or sign a document on our behalf with respect to any contract or transaction in which he or she is interested. A director must promptly disclose the interest to all other directors after becoming aware of the fact that
he or she is interested in a transaction we have entered into or are to enter into. A general notice or disclosure to the board or otherwise contained in the minutes of a meeting or a written resolution of the board or any committee of the board
that a director is a shareholder, director, officer or trustee of any specified firm or company and is to be regarded as interested in any transaction with such firm or company will be sufficient disclosure, and, after such general notice, it will
not be necessary to give special notice relating to any particular transaction. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Remuneration and Borrowing </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The directors may receive such remuneration as our board of directors may determine from time to time. Each director is entitled to be repaid or prepaid
all traveling, hotel and incidental expenses reasonably incurred or expected to be incurred in attending meetings of our board of directors or committees of our board of directors or shareholder meetings or otherwise in connection with the discharge
of his or her duties as a director. The compensation committee will assist the directors in reviewing and approving the compensation structure for the directors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our board of directors may exercise all the powers of the company to borrow money and to mortgage or charge our undertakings and property or any part
thereof, to issue debentures, debenture stock and other securities whenever money is borrowed or as security for any debt, liability or obligation of the company or of any third party. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Qualification </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A director is not
required to hold shares as a qualification to office. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Limitation on Liability and Other Indemnification Matters </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">British Virgin Islands law does not limit the extent to which a company&#146;s memorandum and articles of association may provide for indemnification of
officers and directors, except to the extent any such provision may be held by the British Virgin Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under our third amended and restated memorandum and articles of association, we may indemnify our directors, officers and liquidators against
all expenses, including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with civil, criminal, </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">87 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
administrative or investigative proceedings to which they are party or are threatened to be made a party by reason of their acting as our director, officer or liquidator. To be entitled to
indemnification, these persons must have acted honestly and in good faith with a view to the best interest of the company and, in the case of criminal proceedings, they must have had no reasonable cause to believe their conduct was unlawful.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Insofar as indemnification for liabilities arising under the Securities Act may be permitted for our directors or officers under the
foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable as a matter of United States law. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All directors
hold office until the next annual meeting of shareholders at which their respective class of directors is re-elected and until their successors have been duly elected and qualified. There are no family relationships among our directors or executive
officers. Officers are elected by and serve at the discretion of the Board of Directors. Employee directors do not receive any compensation for their services. Non-employee directors are entitled to receive $2,000 per meeting for serving as
directors and may receive option grants from our company. In addition, non-employee directors are entitled to receive compensation for their actual travel expenses for each Board of Directors meeting attended, up to a maximum of $6,000 per meeting
and $12,000 per year. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Director Compensation Table FY 2009 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Director&nbsp;fees&nbsp;earned&nbsp;or&nbsp;paid&nbsp;in&nbsp;cash</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD></TR>

<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ping
Chen</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Zheng (Rita)
Liu</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yunxiang (Phil)
Fan</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jimin (Peter)
Zhuo</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bin
Qiu</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">None of the
directors received any common share awards, option awards, nonqualified deferred compensation earnings or non-equity incentive plan compensation in fiscal year 2009. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Chen and Ms.&nbsp;Liu received payment in their capacity as officers of our company and/or subsidiaries/affiliates but did not receive any
compensation for serving as directors of our company. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Messers. Fan, Zhuo and Qiu did not become directors until 2009 and received no payment in 2009. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Limitation of Director and Officer Liability </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under British Virgin Islands law, each of our directors and officers, in performing his or her functions, is required to act honestly and in good faith
with a view to our best interests and exercise the care, diligence and skill that a reasonably prudent person would exercise in comparable circumstances. Our third amended and restated memorandum and articles of association provide that, to the
fullest extent permitted by British Virgin Islands law or any other applicable laws, our directors will not be personally liable to us or our shareholders for any acts or omissions in the performance of their duties. Such limitation of liability
does not affect the availability of equitable remedies such as injunctive relief or rescission. These provisions will not limit the liability of directors under United States federal securities laws. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may indemnify any of our directors or anyone serving at our request as a director of another entity against all expenses, including legal fees, and
against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings. We may only indemnify a director if he or she acted honestly and in good faith with the view
to our best interests and, in the case of criminal proceedings, the director had no reasonable cause to believe that his or her conduct was unlawful. The decision of our board of directors as to whether the director acted honestly and in good faith
with a view to our best interests and as to whether the director had no reasonable cause to believe that his or her conduct was unlawful, is in the absence of fraud sufficient for the purposes of indemnification, unless a question of law is
involved. The termination of any proceedings </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">88 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
by any judgment, order, settlement, conviction or the entry of no plea does not, by itself, create a presumption that a director did not act honestly and in good faith and with a view to our best
interests or that the director had reasonable cause to believe that his or her conduct was unlawful. If a director to be indemnified has been successful in defense of any proceedings referred to above, the director is entitled to be indemnified
against all expenses, including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred by the director or officer in connection with the proceedings. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may purchase and maintain insurance in relation to any of our directors or officers against any liability asserted against the directors or officers
and incurred by the directors or officers in that capacity, whether or not we have or would have had the power to indemnify the directors or officers against the liability as provided in our third amended and restated memorandum and articles of
association. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Insofar as indemnification for liabilities arising under the Securities Act may be permitted for our directors or officers under
the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable as a matter of United States law. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_17"></A>RELATED PARTY TRANSACTIONS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Related Parties </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
following shareholders of Dehaier are related parties based on their positions as executive officers: Ping Chen, Chief Executive Officer; Weibing Yang, Vice President of Sales and Marketing; Yong Wang, Vice President of Research and Development; and
Zheng Liu, Chief Financial Officer. Additionally the following 5% shareholders are also considered related persons: Jian Sun; Yijen Chen; and Dehaier Investment Holdings, LLC. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Prior Related Party Transactions </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our chief executive officer and his spouse rent our principal executive office, located at 1223 Epoch Center, 31 Zi Zhu Yuan Road, Haidian District,
Beijing, 100089, to our company. Mr.&nbsp;Chen and his wife, who hold the property pursuant to a 70 year lease entered on January&nbsp;4, 2009, have entered an agreement to rent the office to BDL until December&nbsp;31, 2011 for a monthly rental
rate of approximately $2,500 (&yen;17,000). We believe this rental rate is the market price based on our experience in the area; however, these terms cannot be considered negotiated at arms-length as we did not have independent directors at the time
we entered into this relationship. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BTL, which holds the product center property located at 45 Yong An Road, Science Park, Chanping District,
Beijing, 102200, pursuant to a 50 year lease entered on September&nbsp;10, 2003, rents our product center to our company without charge. The current rental term will expire on September&nbsp;24, 2010. BTL&#146;s building is also pledged as
collateral for BDL&#146;s bank loans. In exchange, BDL loans money to BTL to finance BTL&#146;s operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BDL will pay all utility fees for
the above two properties. As noted above, both properties are held pursuant to long-term leases. Under Chinese law, land belongs to the PRC and use of such property is granted to individuals and entities pursuant to long-term leases. These leases
are typically between 50 and 70 years, as is the case for these properties, and may be renewed upon expiration on terms to be negotiated at the time of renewal. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BTL has pledged its property at 45 Yong An Road, Science Park, Changping District, Beijing, 102200, as collateral for BDL&#146;s loan contract, executed
on May&nbsp;5, 2009 with ICBC in Beijing. The term of BDL&#146;s loan from ICBC is until May&nbsp;20, 2010. The principal amount of the loan is RMB 10,000,000 and the loan carries an interest rate equal to the benchmark interest rate of the
People&#146;s Bank plus 5%. In exchange, BDL advances money to BTL to finance its operations. The advances from BDL to BTL are non-interest bearing. On March&nbsp;3, 2010 BDL and BTL memorialized their agreement by entering into a Loss Absorption
Agreement whereby BDL will guarantee the performance of all contracts, agreements or transactions in connection with BTL&#146;s operations. The term of the Loss Absorption Agreement is for a </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">89 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
period of twenty-five years. The Loss Absorption Agreement also provides that BTL must seek the consent of BDL before entering into any transactions that would materially affect its assets,
obligations, rights or operations. These are advances made to BTL as needed with no repayment schedule. Repayments are made when BTL has the available funds. At December&nbsp;31, 2006, 2007, 2008 and September&nbsp;30, 2009, BDL had advanced to BTL
funds in the amount of $823,405, $786,816, $292,011 and $164,248, respectively. Additionally, Mr.&nbsp;Chen has personally guaranteed BDL&#146;s bank loan. BTL, in turn, has agreed to indemnify Mr.&nbsp;Chen and guarantee his performance should he
ever be called on to perform under BDL&#146;s bank loan. Thus, BTL will ultimately be legally obligated to make payment on the loan if BDL cannot do so. Because BTL relies on funds from BDL to operate, it may not have the actual capacity to do so.
However, BTL&#146;s performance is secured by the property it has pledged as collateral. In the event BTL does not have the ability to make payment, BTL will attempt to renegotiate the loan with ICBC rather than lose its property. If BTL is
unsuccessful at renegotiating the loan, ICBC will have the option of seeking ultimate recourse from the property that BTL has pledged as collateral for the loan. Additionally, no shareholders of BTL have agreed to contribute funds to BTL in the
event it has insufficient funds to repay BDL&#146;s bank loan. See &#147;Risk Factors &#150; BTL may be unable to perform on its obligation to repay BDL&#146;s bank loan in the event of BDL&#146;s default.&#148; The amount of the advances
attributable to related parties based on percentage ownership in BTL are as follows. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="11" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount of Related Person&#146;s Interest in Loan from BDL to BTL</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:51pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Related Person</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage<BR>Ownership&nbsp;of&nbsp;BTL</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2006</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ping Chen (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">96</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">790,496</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">755,343</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">280,331</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">157,678</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weibing Yang</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,234</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,868</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,920</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,642</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jian Sun</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,234</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,868</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,920</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,642</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Zheng Liu</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,234</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,868</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,920</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,642</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yong Wang</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,234</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,868</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,920</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,642</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ping Chen and his wife collectively own 96% of BTL. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As described in the section &#147;Financings and Restructurings,&#148; in preparation for the commencement of this initial public offering, our company
completed a restructuring to accomplish two goals. First, we sought to convert all Series A and Series B Preferred Shares into common shares. Second, we completed a shares split so that we would have, in the aggregate, 3,000,000 common shares
outstanding prior to commencement of the offering. As to the first goal, our Series A and Series B Preferred shareholders agreed to convert their respective Series A and Series B Preferred Shares into an equal number of our common shares. This 1:1
conversion was completed without consideration. As to the second goal, we completed a 3.66140766-for-1 share split of common shares completed of October&nbsp;31, 2009. As a result of the conversions and share split, we have 3,000,000 common shares
issued and outstanding prior to commencement of this offering and no issued and outstanding preferred shares. No parties received any compensation of any sort in exchange for converting their shares. We completed both of these steps because we
agreed with out placement agent that, prior to commencement of this offering, we would have issued and outstanding 3,000,000 common shares and no preferred shares. We did not enter into any written agreements related to the restructuring and
conversion. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Make-Good Shares Subject to Redemption </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As described in more detail in the section entitled &#147;Placement &#150; Market and Pricing Consideration&#148; our company had been valued on a
forward-looking basis for purposes of this offering. We and our placement agent agreed to value our company at a multiple of approximately 6.6 times our targeted 2010 audited net after-tax income. We have 3,000,000 common shares outstanding prior to
this offering and our valuation is based on targeted net income of $3,600,000 for 2010. Based on the valuation of our company at approximately $24,000,000 using this methodology, our earnings per share would be approximately $0.80. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Valuing a company on a forward-looking basis is subject to a number of risks, including the possibility that the company will not achieve the targeted
income levels and that world markets may not maintain the same valuation for companies in general in the future. In order to mitigate some of this risk, certain key members of the management of our company placed an aggregate of 600,000 common
shares into </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">90 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
escrow. This number is equal to 40% of the maximum number of shares to be sold in this offering. Upon closing of this offering, the escrow agent will return any shares in excess of 40% of the
actual number of shares sold in the offering. Such escrowed shares are referred to as the &#147;Make-Good Shares&#148;). The Make-Good Shares will remain in escrow with SunTrust Bank or another bank acceptable to our placement agent pending the
filing of our company&#146;s Form 10-K for the year ending December&nbsp;31, 2010. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the extent our audited after-tax earnings per share for
the year ending December&nbsp;31, 2010 are less than the target of $0.80, excluding any expenses associated with releasing the Make-Good Shares back to the original owners, our company will redeem and cancel, pro rata, the Make-Good Shares without
any consideration to the extent necessary to cause our audited after-tax earnings to be equal to the target of $0.80. We cannot guarantee that we will be able to redeem a sufficient number of Make-Good Shares to increase audited after-tax earnings
per share to the target of $0.80 if our company either has low net income or any net losses in 2010. Any remaining Make-Good Shares will be released from escrow to Ping Chen, Zheng (Rita) Liu, Weibing Yang, Jian Sun and Yong Wang upon the earlier of
(i)&nbsp;one (1)&nbsp;business day after the termination of this offering without closing or (ii)&nbsp;thirty (30)&nbsp;calendar days after the filing of the Form 10-K for the year ending December&nbsp;31, 2010 after redeeming any Make-Good Shares.
Additionally, notwithstanding any other terms of the Make-Good Escrow, if our shares trade at or above 2.5 times the price of this offering for a period of five trading days within a ten day trading period, the Make-Good Escrow will terminate and
the Make-Good Shares will be released to the initial shareholders. Any delay in redeeming the Make-Good Shares will delay the release of such remaining Make-Good Shares from escrow. See &#147;Risk Factors &#150; A redemption of Make-Good Shares may
be insufficient to cause our company to achieve targeted earnings and may reduce our management&#146;s involvement and stake in our company.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because the Make-Good Shares have been escrowed as a condition of completing the initial public offering and will be released to the holders thereof
without regard to such holders&#146; continued employment if Dehaier meets the foregoing criteria, we have determined that no compensatory arrangement exists. Accordingly, we account for the Make-Good Shares as an element of the overall transaction
and we do not recognize any compensation expense upon the return of such Make-Good Shares to the holders. If our company does not meet the criteria for releasing the Make-Good Shares, then we will redeem the Make-Good Shares without payment,
resulting in the reduction of Dehaier common shares outstanding. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_18"></A>PRINCIPAL SHAREHOLDERS </B>
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth information with respect to beneficial ownership of our common shares as of March&nbsp;22, 2010 by:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each person who is known by us to beneficially own more than 5% of our outstanding common shares; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of our directors and named executive officers; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">All directors and named executive officers as a group. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we have included the share ownership of each of the individuals subject to the Make-Good Share Escrow described above. See &#147;Related
Party Transactions &#150; Make-Good Shares Subject to Redemption.&#148; The below table assumes no redemption of any shares subject to such Make-Good Share Escrow. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The number and percentage of common shares beneficially owned before the offering are based on 3,000,000 common shares outstanding as of March&nbsp;22,
2010. Information with respect to beneficial ownership has been furnished by each director, officer or beneficial owner of more than 5% of our common shares. Beneficial ownership is determined in accordance with the rules of the SEC and generally
requires that such person have voting or investment power with respect to securities. In computing the number of common shares beneficially owned by a person listed below and the percentage ownership of such person, common shares underlying options,
warrants or convertible securities held by each such person that are exercisable or convertible within 60 days of March&nbsp;22, 2010 are deemed outstanding, but are not deemed outstanding for computing the percentage ownership of any
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">91 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
other person. Except as otherwise indicated in the footnotes to this table, or as required by applicable community property laws, all persons listed have sole voting and investment power for all
common shares shown as beneficially owned by them. Unless otherwise indicated in the footnotes, the address for each principal shareholder is in the care of BDL, 1223 Epoch Center, No.&nbsp;31 Zi Zhu Yuan Road, Haidian District, Beijing 100089,
People&#146;s Republic of China. As of the date of the Prospectus, we had nine (9)&nbsp;shareholders of record. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:138pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive Officers and Directors</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount&nbsp;of&nbsp;
Beneficial</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Ownership<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Pre-Offering</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1">
<B>Ownership<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Post-<BR>Minimum</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Offering</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1">
<B>Percentage</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Ownership</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Post-<BR>Maximum</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Offering</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1">
<B>Percentage</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Ownership</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ping Chen, Chief Executive Officer, Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,104,742</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">36.82</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">25.99</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">24.55</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Zheng (Rita) Liu, Chief Financial Officer, Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">96,452</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.22</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.27</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.14</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yunxiang (Phil) Fan, Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jimin (Peter) Zhuo, Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bin Qiu, Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weibing Yang, Vice President of Sales and Marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">263,471</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.78</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.20</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.85</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yong Wang, Vice President of Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,455</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.35</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>All officers and directors as a group (7 persons)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,505,120</B></FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>50.17</B></FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>35.41</B></FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>33.45</B></FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>%&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jian Sun</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">253,076</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.44</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.95</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.62</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chen Ping Ltd.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,104,742</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">36.82</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">25.99</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">24.55</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">De-haier Investment Holdings Ltd.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">527,693</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">17.59</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">12.42</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.73</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yijen Chen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">624,113</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">20.80</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">14.69</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.87</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less than 1%. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Beneficial
ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the common shares. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">The number of our
common shares outstanding used in calculating the percentage for each listed person excludes the common shares underlying options held by such person. In addition, the percentage ownership assumes the return to the shareholder of all shares subject
to the Make-Good Escrow. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Ping Chen has the
sole power to direct the voting and disposition of the 1,104,742 shares held by Chen Ping Ltd. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">These shares are
subject to the Make-Good Escrow. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Milestone Capital
Management Limited, the sole shareholder of De-haier Investment Holdings Ltd., has discretionary authority to vote and dispose of the 527,693 shares held by De-haier Investment Holdings Ltd. Ms.&nbsp;Yunli Lou and Mr.&nbsp;Liping Qiu in their
capacities as managers of Milestone Capital Management Limited, may also be deemed to have investment discretion and voting power over the shares held by De-haier Investment Holdings Ltd. Ms.&nbsp;Lou and Mr.&nbsp;Qiu disclaim any such beneficial
ownership of the shares. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">92 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_19"></A>DESCRIPTION OF SHARE CAPITAL </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We were incorporated as an international business company under the International Business Companies Act, 1984, in the British Virgin Islands on
July&nbsp;22, 2003 under the name &#147;De-Haier Medical Systems Limited.&#148; We changed our name to &#147;Dehaier Medical Systems Limited&#148; on June&nbsp;3, 2005. As of the date of this prospectus, we have authorized 18,307,038 common shares,
of $0.002731 par value. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following are summaries of the material provisions of our third amended and restated memorandum and articles of
association that will be in force at the time of the closing of this offering and the BVI Act, insofar as they relate to the material terms of our common shares. Our third amended and restated memorandum and articles of association are filed as
exhibits to the registration statement of which this prospectus is a part. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common Shares </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All of our issued common shares
are fully paid and non-assessable. Certificates representing the common shares are issued in registered form. Our shareholders who are non-residents of the British Virgin Islands may freely hold and vote their common shares. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Distributions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The holders of our common
shares are entitled to such dividends as may be declared by our board of directors subject to the BVI Act. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting rights </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any action required or permitted to be taken by the shareholders must be effected at a duly called annual or special meeting of the shareholders entitled
to vote on such action and may not be effected by a resolution in writing. At each general meeting, each shareholder who is present in person or by proxy (or, in the case of a shareholder being a corporation, by its duly authorized representative)
will have one vote for each common share which such shareholder holds. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Election of directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Delaware law permits cumulative voting for the election of directors only if expressly authorized in the certificate of incorporation. The laws of the
British Virgin Islands, however, do not specifically prohibit or restrict the creation of cumulative voting rights for the election of our directors. Cumulative voting is not a concept that is accepted as a common practice in the British Virgin
Islands, and we have made no provisions in our third amended and restated memorandum and articles of association to allow cumulative voting for elections of directors. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Meetings </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We must provide written notice
of all meetings of shareholders, stating the time, place and, in the case of a special meeting of shareholders, the purpose or purposes thereof, at least 10 days before the date of the proposed meeting to those persons whose names appear as
shareholders in the register of members on the date of the notice and are entitled to vote at the meeting. Our board of directors shall call a special meeting upon the written request of shareholders holding at least 30% of our outstanding voting
shares. In addition, our board of directors may call a special meeting of shareholders on its own motion. A meeting of shareholders may be called on short notice: (a)&nbsp;if it is so agreed by shareholders holding not less than 90% of the common
shares entitled to vote on the matters to be considered at the meeting, or 90% of the common shares of each class or series entitled to vote together as a class or series, together with not less than 90% of the remaining votes; or (b)&nbsp;if all
shareholders holding common shares entitled to vote on the matters to be considered at the meeting have waived notice of the meeting, and presence at the meeting shall be deemed to constitute waiver for this purpose. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">93 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At any meeting of shareholders, a quorum will be present if there are shareholders present in person or by
proxy representing not less than 50% of the issued common shares entitled to vote on the resolutions to be considered at the meeting. Such quorum may be represented by only a single shareholder or proxy. If no quorum is present within two hours of
the start time of the meeting, the meeting shall be dissolved if it was requested by shareholders. In any other case, the meeting shall be adjourned to the next business day, and if shareholders representing not less than one-third of the votes of
the common shares or each class of shares entitled to vote on the matters to be considered at the meeting are present within one hour of the start time of the adjourned meeting, a quorum will be present. If not, the meeting will be dissolved. No
business may be transacted at any general meeting unless a quorum is present at the commencement of business. If present, the chairman of our board of directors shall be the chairman presiding at any meeting of the shareholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A corporation that is a shareholder shall be deemed for the purpose of our third amended and restated memorandum and articles of association to be
present in person if represented by its duly authorized representative. This duly authorized representative shall be entitled to exercise the same powers on behalf of the corporation which he represents as that corporation could exercise if it were
our individual shareholder. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Protection of minority shareholders </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We would normally expect British Virgin Islands courts to follow English case law precedents, which permit a minority shareholder to commence a
representative action, or derivative actions in our name, to challenge (1)&nbsp;an act which is ultra vires or illegal, (2)&nbsp;an act which constitutes a fraud against the minority by parties in control of us, (3)&nbsp;the act complained of
constitutes an infringement of individual rights of shareholders, such as the right to vote and pre-emptive rights and (4)&nbsp;an irregularity in the passing of a resolution which requires a special or extraordinary majority of the shareholders.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Pre-emptive rights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There
are no pre-emptive rights applicable to the issue by us of new common shares under either British Virgin Islands law or our third amended and restated memorandum and articles of association. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Transfer of common shares </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to
the restrictions in our third amended and restated memorandum and articles of association, the lock-up agreements with our placement agent described in &#147;Shares Eligible for Future Sale&#151; Lock-Up Agreements&#148; and applicable securities
laws, any of our shareholders may transfer all or any of his or her common shares by written instrument of transfer signed by the transferor and containing the name and address of the transferee. Our board of directors may resolve by resolution to
refuse or delay the registration of the transfer of any common share. If our board of directors resolves to refuse or delay any transfer, it shall specify the reasons for such refusal in the resolution. Our directors may not resolve or refuse or
delay the transfer of a common share unless: (a)&nbsp;the person transferring the shares has failed to pay any amount due in respect of any of those shares; or (b)&nbsp;such refusal or delay is deemed necessary or advisable in our view or that of
our legal counsel in order to avoid violation of, or in order to ensure compliance with, any applicable, corporate, securities and other laws and regulations. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Liquidation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we are wound up and the
assets available for distribution among our shareholders are more than sufficient to repay all amounts paid to us on account of the issue of shares immediately prior to the winding up, the excess shall be distributable pari passu among those
shareholders in proportion to the amount paid up immediately prior to the winding up on the shares held by them, respectively. If we are wound up and the assets available for distribution among the shareholders as such are insufficient to repay the
whole of the amounts paid to us on account of the issue of shares, those assets shall be distributed so that, to the greatest extent possible, the losses shall be borne by the shareholders in proportion to the amounts paid up immediately prior to
the winding up on the shares held by them, respectively. If we are wound up, the liquidator appointed by us may, in accordance with the BVI Act, divide among our shareholders in specie or kind the whole or any part of our assets (whether they shall
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">94 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
consist of property of the same kind or not) and may, for such purpose, set such value as the liquidator deems fair upon any property to be divided and may determine how such division shall be
carried out as between the shareholders or different classes of shareholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Calls on common shares and forfeiture of common shares </B>
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our board of directors may from time to time make calls upon shareholders for any amounts unpaid on their common shares in a notice served to
such shareholders at least 14 days prior to the specified time of payment. The common shares that have been called upon and remain unpaid are subject to forfeiture. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Redemption of common shares </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to
the provisions of the BVI Act, we may issue shares on terms that are subject to redemption, at our option or at the option of the holders, on such terms and in such manner as may be determined by our third amended and restated memorandum and
articles of association and subject to any applicable requirements imposed from time to time by, the BVI Act, the SEC, the NASDAQ Capital Market, or by any recognized stock exchange on which our securities are listed. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Modifications of rights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All or any of
the special rights attached to any class of shares may, subject to the provisions of the BVI Act, be amended only pursuant to a resolution passed at a meeting by a majority of the votes cast by those entitled to vote at a meeting of the holders of
the shares of that class. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Changes in the number of shares we are authorized to issue and those in issue</B> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may from time to time by resolution of our board of directors: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">amend our memorandum of association to increase or decrease the maximum number of shares we are authorized to issue; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">subject to our memorandum, divide our authorized and issued shares into a larger number of shares; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">subject to our memorandum, combine our authorized and issued shares into a smaller number of shares. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Untraceable shareholders </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are
entitled to sell any shares of a shareholder who is untraceable, provided that: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">all checks or warrants in respect of dividends of these shares, not being less than three in number, for any sums payable in cash to the holder of such
shares have remained uncashed for a period of twelve years prior to the publication of the notice and during the three months referred to in the third bullet point below; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">we have not during that time received any indication of the whereabouts or existence of the shareholder or person entitled to these shares by death,
bankruptcy or operation of law; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">we have caused a notice to be published in newspapers in the manner stipulated by our third amended and restated memorandum and articles of
association, giving notice of our intention to sell these shares, and a period of three months has elapsed since such notice. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The net proceeds of any such sale shall belong to us, and when we receive these net proceeds we shall become indebted to the former shareholder for an
amount equal to the net proceeds. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Inspection of books and records </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under British Virgin Islands Law, holders of our common shares are entitled, upon giving written notice to us, to inspect (i)&nbsp;our third amended and
restated memorandum and articles of association, (ii)&nbsp;the register of members, (iii)&nbsp;the register of directors and (iv)&nbsp;minutes of meetings and resolutions of members, and to make copies and take extracts from the documents and
records. However, our directors can refuse access if they are satisfied that to allow such access would be contrary to our interests. See &#147;Where You Can Find Additional Information.&#148; </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">95 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Rights of non-resident or foreign shareholders </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no limitations imposed by our third amended and restated memorandum and articles of association on the rights of non-resident or foreign
shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our third amended and restated memorandum and articles of association governing the ownership threshold above which shareholder ownership must be
disclosed. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Issuance of additional common shares </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our third amended and restated memorandum and articles of association authorizes our board of directors to issue additional common shares from authorized
but unissued shares, to the extent available, from time to time as our board of directors shall determine. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Differences in
Corporate Law </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The BVI Act and the laws of the British Virgin Islands affecting British Virgin Islands companies like us and our
shareholders differ from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of the significant differences between the provisions of the laws of the British Virgin Islands applicable to us and the laws
applicable to companies incorporated in the United States and their shareholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Mergers and similar arrangements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the laws of the British Virgin Islands, two or more companies may merge or consolidate in accordance with Section&nbsp;170 of the BVI Act. A merger
means the merging of two or more constituent companies into one of the constituent companies and a consolidation means the uniting of two or more constituent companies into a new company. In order to merge or consolidate, the directors of each
constituent company must approve a written plan of merger or consolidation, which must be authorized by a resolution of shareholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">While a
director may vote on the plan of merger or consolidation even if he has a financial interest in the plan, the interested director must disclose the interest to all other directors of the company promptly upon becoming aware of the fact that he is
interested in a transaction entered into or to be entered into by the company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A transaction entered into by our company in respect of which
a director is interested (including a merger or consolidation) is voidable by us unless the director&#146;s interest was (a)&nbsp;disclosed to the board prior to the transaction or (b)&nbsp;the transaction is (i)&nbsp;between the director and the
company and (ii)&nbsp;the transaction is in the ordinary course of the company&#146;s business and on usual terms and conditions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding the above, a transaction entered into by the company is not voidable if the material facts of the interest are known to the shareholders
and they approve or ratify it or the company received fair value for the transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shareholders not otherwise entitled to vote on the
merger or consolidation may still acquire the right to vote if the plan of merger or consolidation contains any provision which, if proposed as an amendment to the memorandum or articles of association, would entitle them to vote as a class or
series on the proposed amendment. In any event, all shareholders must be given a copy of the plan of merger or consolidation irrespective of whether they are entitled to vote at the meeting to approve the plan of merger or consolidation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The shareholders of the constituent companies are not required to receive shares of the surviving or consolidated company but may receive debt
obligations or other securities of the surviving or consolidated company, other assets, or a combination thereof. Further, some or all of the shares of a class or series may be converted into a kind of asset while the other shares of the same class
or series may receive a different kind of asset. As such, not all the shares of a class or series must receive the same kind of consideration. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">96 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">After the plan of merger or consolidation has been approved by the directors and authorized by a resolution
of the shareholders, articles of merger or consolidation are executed by each company and filed with the Registrar of Corporate Affairs in the British Virgin Islands. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A shareholder may dissent from a mandatory redemption of his shares, an arrangement (if permitted by the court), a merger (unless the shareholder was a
shareholder of the surviving company prior to the merger and continues to hold the same or similar shares after the merger) or a consolidation. A shareholder properly exercising his dissent rights is entitled to a cash payment equal to the fair
value of his shares. A shareholder dissenting from a merger or consolidation must object in writing to the merger or consolidation before the vote by the shareholders on the merger or consolidation, unless notice of the meeting was not given to the
shareholder. If the merger or consolidation is approved by the shareholders, the company must give notice of this fact to each shareholder within 20 days who gave written objection. These shareholders then have 20 days to give to the company their
written election in the form specified by the BVI Act to dissent from the merger or consolidation, provided that in the case of a merger, the 20 days starts when the plan of merger is delivered to the shareholder. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon giving notice of his election to dissent, a shareholder ceases to have any shareholder rights except the right to be paid the fair value of his
shares. As such, the merger or consolidation may proceed in the ordinary course notwithstanding his dissent. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Within seven days of the later
of the delivery of the notice of election to dissent and the effective date of the merger or consolidation, the company must make a written offer to each dissenting shareholder to purchase his shares at a specified price per share that the company
determines to be the fair value of the shares. The company and the shareholder then have 30 days to agree upon the price. If the company and a shareholder fail to agree on the price within the 30 days, then the company and the shareholder shall,
within 20 days immediately following the expiration of the 30-day period, each designate an appraiser and these two appraisers shall designate a third appraiser. These three appraisers shall fix the fair value of the shares as of the close of
business on the day prior to the shareholders&#146; approval of the transaction without taking into account any change in value as a result of the transaction. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Shareholders&#146; suits </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are both
statutory and common law remedies available to our shareholders as a matter of British Virgin Islands law. These are summarized below: </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Prejudiced members </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A shareholder who
considers that the affairs of the company have been, are being, or are likely to be, conducted in a manner that is, or any act or acts of the company have been, or are, likely to be oppressive, unfairly discriminatory or unfairly prejudicial to him
in that capacity, can apply to the court under Section&nbsp;184I of the BVI Act, inter alia, for an order that his shares be acquired, that he be provided compensation, that the Court regulate the future conduct of the company, or that any decision
of the company which contravenes the BVI Act or our third amended and restated memorandum and articles of association be set aside. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Derivative actions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;184C of
the BVI Act provides that a shareholder of a company may, with the leave of the Court, bring an action in the name of the company to redress any wrong done to it. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Just and equitable winding up </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
addition to the statutory remedies outlined above, shareholders can also petition for the winding up of a company on the grounds that it is just and equitable for the court to so order. Save in exceptional circumstances, this remedy is only
available where the company has been operated as a quasi partnership and trust and confidence between the partners has broken down. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">97 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Indemnification of directors and executive officers and limitation of liability </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">British Virgin Islands law does not limit the extent to which a company&#146;s articles of association may provide for indemnification of officers and
directors, except to the extent any provision providing indemnification may be held by the British Virgin Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a
crime. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under our third amended and restated memorandum and articles of association, we indemnify against all expenses, including legal fees,
and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings for any person who: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">is or was a party or is threatened to be made a party to any threatened, pending or completed proceedings, whether civil, criminal, administrative or
investigative, by reason of the fact that the person is or was our director; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">is or was, at our request, serving as a director or officer of, or in any other capacity is or was acting for, another body corporate or a partnership,
joint venture, trust or other enterprise. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">These indemnities only apply if the person acted honestly and in good faith with
a view to our best interests and, in the case of criminal proceedings, the person had no reasonable cause to believe that his conduct was unlawful. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under
the foregoing provisions, we have been advised that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Anti-takeover provisions in our third amended and restated memorandum and articles of association </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Some provisions of our third amended and restated memorandum and articles of association may discourage, delay or prevent a change in control of our
company or management that shareholders may consider favorable, including provisions that provide for a staggered board of directors and prevent shareholders from taking an action by written consent in lieu of a meeting. However, under British
Virgin Islands law, our directors may only exercise the rights and powers granted to them under our third amended and restated memorandum and articles of association, as amended and restated from time to time, as they believe in good faith to be in
the best interests of our company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Directors&#146; fiduciary duties </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two
components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform
himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in a manner he reasonably believes to be in the best interests of the
corporation. He must not use his corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest
possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action
taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must prove the
procedural fairness of the transaction and that the transaction was of fair value to the corporation. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">98 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under British Virgin Islands law, our directors owe the company certain statutory and fiduciary duties
including, among others, a duty to act honestly, in good faith, for a proper purpose and with a view to what the directors believe to be in the best interests of the company. Our directors are also required, when exercising powers or performing
duties as a director, to exercise the care, diligence and skill that a reasonable director would exercise in comparable circumstances, taking into account without limitation, the nature of the company, the nature of the decision and the position of
the director and the nature of the responsibilities undertaken. In the exercise of their powers, our directors must ensure neither they nor the company acts in a manner which contravenes the BVI Act or our third amended and restated memorandum and
articles of association, as amended and re-stated from time to time. A shareholder has the right to seek damages for breaches of duties owed to us by our directors. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Shareholder action by written consent </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written consent by amendment to its
certificate of incorporation. British Virgin Islands law provides that shareholders may approve corporate matters by way of a written resolution without a meeting signed by or on behalf of shareholders sufficient to constitute the requisite majority
of shareholders who would have been entitled to vote on such matter at a general meeting; provided that if the consent is less than unanimous, notice must be given to all non-consenting shareholders. However, our third amended and restated
memorandum and articles of association do not permit shareholders to act by written consent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Shareholder proposals </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders, provided it
complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special
meetings. British Virgin Islands law and our third amended and restated memorandum and articles of association allow our shareholders holding not less than 30% of the votes of the outstanding voting shares to requisition a shareholders&#146;
meeting. We are not obliged by law to call shareholders&#146; annual general meetings, but our third amended and restated memorandum and articles of association do permit the directors to call such a meeting. The location of any shareholders&#146;
meeting can be determined by the board of directors and can be held anywhere in the world. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Cumulative voting </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation&#146;s certificate of
incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is
entitled on a single director, which increases the shareholder&#146;s voting power with respect to electing such director. As permitted under British Virgin Islands law, our third amended and restated memorandum and articles of association do not
provide for cumulative voting. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Removal of directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Delaware
General Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under
our third amended and restated memorandum and articles of association, directors can be removed from office, with cause, by a resolution of shareholders or by a resolution of directors passed at a meeting of directors called for the purpose of
removing the director or for purposes including the removal of the director. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Transactions with interested shareholders </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Delaware General Corporation Law contains a business combination statute applicable to Delaware public corporations whereby, unless the corporation
has specifically elected not to be governed by such </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">99 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an &#147;interested shareholder&#148; for three years following the
date that such person becomes an interested shareholder. An interested shareholder generally is a person or group who or which owns or owned 15% or more of the target&#146;s outstanding voting shares within the past three years. This has the effect
of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an
interested shareholder, the board of directors approves either the business combination or the transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware public corporation to
negotiate the terms of any acquisition transaction with the target&#146;s board of directors. British Virgin Islands law has no comparable statute. However, our third amended and restated memorandum and articles of association expressly provide for
the same protection afforded by the Delaware business combination statute. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dissolution; Winding Up </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders
holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation&#146;s outstanding shares. Delaware law allows a Delaware
corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board. Under the BVI Act and our third amended and restated memorandum and articles of association, we may
appoint a voluntary liquidator by a resolution of the shareholders or by resolution of directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Variation of rights of shares
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the
outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our third amended and restated memorandum and articles of association, if at any time our shares are divided into different classes of shares, the
rights attached to any class may only be varied, whether or not our company is in liquidation, by a resolution passed at a meeting by a majority of the votes cast by those entitled to vote at a meeting of the holders of the issued shares in that
class. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Amendment of governing documents </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Delaware General Corporation Law, a corporation&#146;s governing documents may be amended with the approval of a majority of the outstanding
shares entitled to vote, unless the certificate of incorporation provides otherwise. As permitted by British Virgin Islands law, our third amended and restated memorandum and articles of association may be amended by a resolution of shareholders
and, subject to certain exceptions, by a resolution of directors. Any amendment is effective from the date it is registered at the Registry of Corporate Affairs in the British Virgin Islands. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_20"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to this offering, there has been no market for our common shares, and a liquid trading market for our common shares may not develop or be sustained
after this offering. Future sales of substantial amounts of common shares, including common shares issued upon exercise of outstanding options and exercise of the warrants offered in this prospectus in the public market after this offering or the
anticipation of those sales could adversely affect market prices prevailing from time to time and could impair our ability to raise capital through sales of our equity securities. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon the completion of the offering, we will have outstanding 4,500,000 common shares, assuming no exercise of outstanding options and the closing of the
maximum offering. Of these common shares, the common shares sold in this offering will be freely tradable without restriction under the Securities Act. The remaining approximately 3,000,000 common shares outstanding will be restricted shares held by
existing </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">100 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
shareholders that could be sold pursuant to Rule 144. We have not agreed to register these restricted shares. We have not issued any warrants to purchase our common shares or other securities
convertible into our common shares. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Rule 144 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In general, under Rule 144 as currently in effect, beginning 90 days after the effective date of the registration statement of which this prospectus is a
part, a person (or persons whose shares are aggregated) who is deemed to be an affiliate of our company at the time of sale, or at any time during the preceding three months, and who has beneficially owned restricted shares for at least six months,
would be entitled to sell within any three-month period a number of our common shares that does not exceed the greater of 1% of the then outstanding common shares or the average weekly trading volume of common shares during the four calendar weeks
preceding such sale. Sales under Rule 144 are subject to certain manner of sale provisions, notice requirements and the availability of current public information about our company. In addition, sales by our affiliates may be subject to the terms of
lock-up agreements and Make-Good Escrow agreements. See &#147;Shares Eligible for Future Sale &#150; Lock-Up Agreements&#148; and &#147;Related Party Transactions &#150; Make-Good Shares Subject to Redemption.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A person who has not been our affiliate at any time during the three months preceding a sale, and who has beneficially owned his or her common shares for
at least six months, would be entitled under Rule 144 to sell such shares without regard to any manner of sale, notice provisions or volume limitations described above. Any such sales must comply with the public information provision of Rule 144
until our common shares have been held for one year. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Rule 701 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Securities issued in reliance on Rule 701 are also restricted and may be sold by shareholders other than affiliates of our company subject only to manner
of sale provisions of Rule 144 and by affiliates under Rule 144 without compliance with its six-month holding period requirement. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registration on Form S-8 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We intend to file a registration statement on Form S-8 under the Securities Act as soon as practicable after the closing of this offering to register up
to 450,000 of our common shares subject to outstanding share options or reserved for issuance under our share incentive plan, such amount being equal to ten percent (10%)&nbsp;of the number of common shares issued and outstanding immediately after
the closing of the offering, assuming a maximum offering. This registration will permit the resale of these common shares by nonaffiliates in the public market without restriction under the Securities Act, upon the completion of the lock-up period
described below. Common shares registered pursuant to the Form S-8 held by affiliates will be subject to Rule 144 volume limitations. As of the date of this Prospectus, we have not issued any options to purchase our common shares. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lock-Up Agreements </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each
of our executive officers, directors and individuals who on the effective date of the registration statement of which this prospectus is a part are the beneficial owners of more than 5% of our common shares, has agreed not to register, offer, sell,
contract to sell or grant any of our common shares or any securities convertible into or exercisable or exchangeable for our common shares or any warrants to purchase our common shares (including, without limitation, securities of our company which
may be deemed to be beneficially owned by such individuals in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon the exercise of a stock option or warrant) for a period of
(a)&nbsp;as to one-half (1/2)&nbsp;of the common shares now or in the future beneficially owned by such individual, ninety (90)&nbsp;days after the date of effectiveness or commencement of sales of this public offering and (b)&nbsp;as to the other
one-half of such common shares now or in the future beneficially owned by such individual, one hundred ninety (190)&nbsp;days after the date of effectiveness or commencement of sales of this public offering. Upon the expiration of these lock-up
agreements, additional common shares will be available for sale in the public market. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">101 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary of Shares Available for Future Sale </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table summarizes the total shares potentially available for future sale. To the extent we sell a number of common shares between the
minimum and maximum offering, the below tables will be adjusted proportionately as to numbers of shares available for sale (as to option pool and placement agent shares) and dates on which such shares may be sold (as to currently outstanding
shares). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Minimum Offering </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date Available for Sale</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Currently Outstanding Common Shares: 3,000,000</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="text-indent:4.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,205,001</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">After 90 days from the date of effectiveness or commencement of sales of the public offering</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="text-indent:4.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,294,999</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">After 190 days from the date of effectiveness or commencement of sales of the public offering</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="text-indent:4.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">500,000</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">After 30 days after filing of Form 10-K for the year ending December 31, 2010, assuming no redemption of Make-Good Shares; any delay in redemption will also delay the release of
these shares</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common Shares in Option Pool: 425,000</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">From vesting dates through expiration of grants</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common Shares Underlying Placement Agent&#146;s Warrants: 125,000</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">After 180 days from the date of effectiveness or commencement of sales of the public offering</FONT></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum Offering</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date Available for Sale</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Currently Outstanding Common Shares: 3,000,000</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="text-indent:4.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,155,001</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">After 90 days from the date of effectiveness or commencement of sales of the public offering</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="text-indent:4.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,244,999</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">After 190 days from the date of effectiveness or commencement of sales of the public offering</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="text-indent:4.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">600,000</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">After 30 days after filing of Form 10-K for the year ending December 31, 2010, assuming no redemption of Make-Good Shares; any delay in redemption will also delay the release of
these shares</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common Shares in Option Pool: 450,000</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">From vesting dates through expiration of grants</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common Shares Underlying Placement Agent&#146;s Warrants: 150,000</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">After 180 days from the date of effectiveness or commencement of sales of the public offering</FONT></TD></TR></TABLE>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">102 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_21"></A>TAX MATTERS APPLICABLE TO U.S. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>HOLDERS OF OUR COMMON SHARES </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following sets forth the material British Virgin Islands, Chinese and U.S. federal income tax consequences of an investment in our common shares. It
is directed to U.S. Holders (as defined below) of our common shares and is based upon laws and relevant interpretations thereof in effect as of the date of this prospectus, all of which are subject to change. This discussion does not deal with all
possible tax consequences relating to an investment in our common shares, such as the tax consequences under state, local and other tax laws. To the extent that the discussion relates to matters of British Virgin Islands tax law, it represents the
opinion of Kaufman&nbsp;&amp; Canoles, P.C., our British Virgin Islands counsel. To the extent that the discussion relates to matters of United States tax law, it represents the opinion of Kaufman&nbsp;&amp; Canoles, P.C., our United States counsel.
To the extent that the discussion relates to matters of Chinese tax law, it represents the opinion of Beijing Kang Da Law Firm, our Chinese counsel. All such tax opinions of the above counsel are set forth in full in this section. All such tax
opinions rely on the factual statements made in this registration statement and are limited to the matters discussed herein. Any variance in facts from those stated in the registration statement may affect the conclusions stated below. All such
opinions are as of the date of this registration statement, and each respective counsel undertakes no obligation to update its respective opinion. Each opinion is based on statutes, regulations and agency and judicial interpretations thereof, all of
which may be subject to change either prospectively or retrospectively. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>People&#146;s Republic of China Enterprise Taxation
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2007, the PRC National People&#146;s Congress enacted the PRC Enterprise Income Tax Law and related implementation rules, or the EIT
Law, which became effective on January&nbsp;1, 2008. The EIT Law imposes a single uniform income tax rate of 25% on all Chinese enterprises, including foreign-invested enterprises, and levies a withholding tax rate of 10% on dividends payable by
Chinese subsidiaries to their foreign shareholders unless any such foreign shareholders&#146; jurisdiction of incorporation has a tax treaty with China that provides for a different withholding agreement. Under the EIT Law, enterprises established
outside China but deemed to have a &#147;de facto management body&#148; within the country may be considered &#147;resident enterprises&#148; for Chinese tax purposes and, therefore, may be subject to an enterprise income tax rate of 25% on their
worldwide income. Pursuant to the implementation rules of the EIT Law, &#147;de facto management bodies&#148; have material and overall management control over the business, personnel, accounts and properties of the enterprise. At present, the
Chinese tax authority has not issued any guidance on the application of the EIT Law and its implementing rules on non-Chinese enterprise or group enterprise controlled entities whose structures are like ours. As a result, it is unclear what factors
will be used by the Chinese tax authorities to determine whether we are a &#147;de facto management organization&#148; in China. However, as substantially all members of our management team are located in China, and may remain there in the future,
we may be deemed a resident enterprise subject to an enterprise income tax rate of 25% on our worldwide income, with the possible exclusion of dividends received directly from another Chinese tax resident. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>British Virgin Islands Taxation </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the BVI Act as currently in effect, a holder of common shares who is not a resident of the British Virgin Islands is exempt from British Virgin
Islands income tax on dividends paid with respect to the common shares and all holders of common shares are not liable to the British Virgin Islands for income tax on gains realized during that year on sale or disposal of such shares. The British
Virgin Islands does not impose a withholding tax on dividends paid by a company incorporated or re-registered under the BVI Act. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no
capital gains, gift or inheritance taxes levied by the British Virgin Islands on companies incorporated or re-registered under the BVI Act. In addition, shares of companies incorporated or reregistered under the BVI Act are not subject to transfer
taxes, stamp duties or similar charges. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">103 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There is no income tax treaty or convention currently in effect between the United States and the British
Virgin Islands or between China and the British Virgin Islands. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>United States Federal Income Taxation </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a discussion the material U.S. federal income tax consequences to U.S. Holders (as defined below) under present law of an investment in
our common shares. This discussion applies only to U.S. Holders that hold common shares as capital assets and that have the U.S. dollar as their functional currency. This discussion is based on the tax laws of the United States in effect as of the
date of this prospectus and on U.S. Treasury regulations in effect or, in some cases, proposed, as of the date of this prospectus, as well as judicial and administrative interpretations thereof available on or before such date. All of the foregoing
authorities are subject to change, which change could apply retroactively and could affect the tax consequences discussed below. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>WE URGE POTENTIAL PURCHASERS OF OUR SHARES TO CONSULT THEIR OWN TAX </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADVISORS CONCERNING THE U.S. FEDERAL, STATE, LOCAL AND NON-U.S. TAX </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSEQUENCES OF PURCHASING, OWNING AND DISPOSING OF OUR SHARES. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following does not address the tax consequences to any particular investor or to persons in special tax situations such as: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">banks; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">financial institutions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">insurance companies; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">regulated investment companies; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">real estate investment trusts; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">broker-dealers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">traders that elect to mark-to-market; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">U.S. expatriates; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">tax-exempt entities; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">persons liable for alternative minimum tax; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">persons holding our common shares as part of a straddle, hedging, conversion or integrated transaction; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">persons that actually or constructively own 10% or more of our voting shares; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">persons who acquired our common shares pursuant to the exercise of any employee share option or otherwise as consideration; or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">persons holding our common shares through partnerships or other pass-through entities. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prospective purchasers are urged to consult their tax advisors about the application of the U.S. Federal tax rules to their particular circumstances as
well as the state, local, foreign and other tax consequences to them of the purchase, ownership and disposition of our common shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
discussion below of the U.S. federal income tax consequences to &#147;U.S. Holders&#148; will apply to you if you are a beneficial owner of shares and you are, for U.S. federal income tax purposes, </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">an individual who is a citizen or resident of the United States; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized under the laws of the United States, any state
thereof or the District of Columbia; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">an estate whose income is subject to U.S. federal income taxation regardless of its source; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a trust that (1)&nbsp;is subject to the primary supervision of a court within the United States and the control of one or more U.S. persons for all
substantial decisions or (2)&nbsp;has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Taxation of dividends and other distributions on our common shares </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to the passive foreign investment company rules discussed below, the gross amount of distributions made by us to you with respect to the common
shares (including the amount of any taxes withheld therefrom) will generally be includable in your gross income as dividend income on the date of receipt by you, but only to the extent that the distribution is paid out of our current or accumulated
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">104 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
earnings and profits (as determined under U.S. federal income tax principles). The dividends will not be eligible for the dividends-received deduction allowed to corporations in respect of
dividends received from other U.S. corporations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">With respect to non-corporate U.S. Holders, including individual U.S. Holders, for taxable
years beginning before January&nbsp;1, 2011, dividends will be taxed at the lower capital gains rate applicable to qualified dividend income, provided that (1)&nbsp;the common shares are readily tradable on an established securities market in the
United States, or we are eligible for the benefits of an approved qualifying income tax treaty with the United States that includes an exchange of information program, (2)&nbsp;we are not a passive foreign investment company (as discussed below) for
either our taxable year in which the dividend is paid or the preceding taxable year, and (3)&nbsp;certain holding period requirements are met. Under U.S. Internal Revenue Service authority, common shares are considered for purpose of clause
(1)&nbsp;above to be readily tradable on an established securities market in the United States if they are listed on the NASDAQ Capital Market. You are urged to consult your tax advisors regarding the availability of the lower rate for dividends
paid with respect to our common shares, including the effects of any change in law after the date of this prospectus. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dividends will
constitute foreign source income for foreign tax credit limitation purposes. If the dividends are taxed as qualified dividend income (as discussed above), the amount of the dividend taken into account for purposes of calculating the foreign tax
credit limitation will be limited to the gross amount of the dividend, multiplied by the reduced rate divided by the highest rate of tax normally applicable to dividends. The limitation on foreign taxes eligible for credit is calculated separately
with respect to specific classes of income. For this purpose, dividends distributed by us with respect to our common shares will constitute &#147;passive category income&#148; but could, in the case of certain U.S. Holders, constitute &#147;general
category income.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the extent that the amount of the distribution exceeds our current and accumulated earnings and profits (as
determined under U.S. federal income tax principles), it will be treated first as a tax-free return of your tax basis in your common shares, and to the extent the amount of the distribution exceeds your tax basis, the excess will be taxed as capital
gain. We do not intend to calculate our earnings and profits under U.S. federal income tax principles. Therefore, a U.S. Holder should expect that a distribution will be treated as a dividend even if that distribution would otherwise be treated as a
non-taxable return of capital or as capital gain under the rules discussed above. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Taxation of Dispositions of Common Shares
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to the passive foreign investment company rules discussed below, you will recognize taxable gain or loss on any sale, exchange or
other taxable disposition of a share equal to the difference between the amount realized (in U.S. dollars) for the share and your tax basis (in U.S. dollars) in the common shares. The gain or loss will be capital gain or loss. If you are a
non-corporate U.S. Holder, including an individual U.S. Holder, who has held the common shares for more than one year, you will be eligible for reduced tax rates of 0% (for individuals in the 10% or 15% tax brackets) or 15% for all other
individuals, assuming the renewal of current capital gains rates prior to their scheduled expiration at the end of 2010. If capital gains preferential rates are not renewed, such gains would be taxable at the personal income rates then in place. The
deductibility of capital losses is subject to limitations. Any such gain or loss that you recognize will generally be treated as United States source income or loss for foreign tax credit limitation purposes. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Passive Foreign Investment Company </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on our current and anticipated operations and the composition of our assets, we do not expect to be a passive foreign investment company, or PFIC,
for U.S. federal income tax purposes for our current taxable year ending December&nbsp;31, 2008. Our actual PFIC status for the current taxable year ending December&nbsp;31, 2008 will not be determinable until the close of such taxable year and,
accordingly, there is no guarantee that we will not be a PFIC for the current taxable year. Because PFIC status is a factual determination for each taxable year which cannot be made until the close of the taxable year. A non-U.S. corporation is
considered a PFIC for any taxable year if either: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">at least 75% of its gross income is passive income; or </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;
</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">105 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">at least 50% of the value of its assets (based on an average of the quarterly values of the assets during a taxable year) is attributable to assets
that produce or are held for the production of passive income (the &#147;asset test&#148;). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will be treated as owning
our proportionate share of the assets and earning our proportionate share of the income of any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We must make a separate determination each year as to whether we are a PFIC. As a result, our PFIC status may change. In particular, because the value of
our assets for purposes of the asset test will generally be determined based on the market price of our common shares, our PFIC status will depend in large part on the market price of our common shares. Accordingly, fluctuations in the market price
of the common shares may cause us to become a PFIC. In addition, the application of the PFIC rules is subject to uncertainty in several respects and the composition of our income and assets will be affected by how, and how quickly, we spend the cash
we raise in this offering. If we are a PFIC for any year during which you hold common shares, we will continue to be treated as a PFIC for all succeeding years during which you hold common shares. However, if we cease to be a PFIC, you may avoid
some of the adverse effects of the PFIC regime by making a &#147;deemed sale&#148; election with respect to the common shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we are a
PFIC for any taxable year during which you hold common shares, you will be subject to special tax rules with respect to any &#147;excess distribution&#148; that you receive and any gain you realize from a sale or other disposition (including a
pledge) of the common shares, unless you make a &#147;mark-to-market&#148; election as discussed below. Distributions you receive in a taxable year that are greater than 125% of the average annual distributions you received during the shorter of the
three preceding taxable years or your holding period for the common shares will be treated as an excess distribution. Under these special tax rules: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the excess distribution or gain will be allocated ratably over your holding period for the common shares; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we were a PFIC, will be treated as
ordinary income, and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the amount allocated to each other year will be subject to the highest tax rate in effect for that year and the interest charge generally applicable to
underpayments of tax will be imposed on the resulting tax attributable to each such year. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The tax liability for amounts
allocated to years prior to the year of disposition or &#147;excess distribution&#148; cannot be offset by any net operating losses for such years, and gains (but not losses) realized on the sale of the common shares cannot be treated as capital,
even if you hold the common shares as capital assets. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A U.S. Holder of &#147;marketable stock&#148; (as defined below) in a PFIC may make a
mark-to-market election for such stock to elect out of the tax treatment discussed above. If you make a mark-to-market election for the common shares, you will include in income each year an amount equal to the excess, if any, of the fair market
value of the common shares as of the close of your taxable year over your adjusted basis in such common shares. You are allowed a deduction for the excess, if any, of the adjusted basis of the common shares over their fair market value as of the
close of the taxable year. However, deductions are allowable only to the extent of any net mark-to-market gains on the common shares included in your income for prior taxable years. Amounts included in your income under a mark-to-market election, as
well as gain on the actual sale or other disposition of the common shares, are treated as ordinary income. Ordinary loss treatment also applies to the deductible portion of any mark-to-market loss on the common shares, as well as to any loss
realized on the actual sale or disposition of the common shares, to the extent that the amount of such loss does not exceed the net mark-to-market gains previously included for such common shares. Your basis in the common shares will be adjusted to
reflect any such income or loss amounts. If you make a valid mark-to-market election, the tax rules that apply to distributions by corporations which are not PFICs would apply to distributions by us, except that the lower applicable capital gains
rate for qualified dividend income discussed above under &#147;&#151;Taxation of Dividends and Other Distributions on our Common shares&#148; generally would not apply. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;
</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">106 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The mark-to-market election is available only for &#147;marketable stock&#148;, which is stock that is
traded in other than de minimis quantities on at least 15 days during each calendar quarter (&#147;regularly traded&#148;) on a qualified exchange or other market (as defined in applicable U.S. Treasury regulations), including the NASDAQ Capital
Market. If the common shares are regularly traded on the NASDAQ Capital Market and if you are a holder of common shares, the mark-to-market election would be available to you were we to be or become a PFIC. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alternatively, a U.S. Holder of stock in a PFIC may make a &#147;qualified electing fund&#148; election with respect to such PFIC to elect out of the tax
treatment discussed above. A U.S. Holder who makes a valid qualified electing fund election with respect to a PFIC will generally include in gross income for a taxable year such holder&#146;s pro rata share of the corporation&#146;s earnings and
profits for the taxable year. However, the qualified electing fund election is available only if such PFIC provides such U.S. Holder with certain information regarding its earnings and profits as required under applicable U.S. Treasury regulations.
We do not currently intend to prepare or provide the information that would enable you to make a qualified electing fund election. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you
hold common shares in any year in which we are a PFIC, you will be required to file U.S. Internal Revenue Service Form 8621 regarding distributions received on the common shares and any gain realized on the disposition of the common shares.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">You are urged to consult your tax advisors regarding the application of the PFIC rules to your investment in our common shares and the
elections discussed above. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Information Reporting and Backup Withholding </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dividend payments with respect to our common shares and proceeds from the sale, exchange or redemption of our common shares may be subject to information
reporting to the U.S. Internal Revenue Service and possible U.S. backup withholding at a current rate of 28%. Backup withholding will not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number and makes any other
required certification on U.S. Internal Revenue Service Form W-9 or who is otherwise exempt from backup withholding. U.S. Holders who are required to establish their exempt status generally must provide such certification on U.S. Internal Revenue
Service Form W-9. U.S. Holders are urged to consult their tax advisors regarding the application of the U.S. information reporting and backup withholding rules. Backup withholding is not an additional tax. Amounts withheld as backup withholding may
be credited against your U.S. federal income tax liability, and you may obtain a refund of any excess amounts withheld under the backup withholding rules by filing the appropriate claim for refund with the U.S. Internal Revenue Service and
furnishing any required information. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">107 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_22"></A>ENFORCEABILITY OF CIVIL LIABILITIES </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are incorporated under the laws of the British Virgin Islands with limited liability. We are incorporated in the British Virgin Islands because of
certain benefits associated with being a British Virgin Islands corporation, such as political and economic stability, an effective judicial system, a favorable tax system, the absence of exchange control or currency restrictions and the
availability of professional and support services. However, the British Virgin Islands has a less developed body of securities laws as compared to the United States and provides protections for investors to a significantly lesser extent. In
addition, British Virgin Islands companies may not have standing to sue before the federal courts of the United States. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Substantially all of
our assets are located outside the United States. In addition, a majority of our directors and officers are nationals and/or residents of countries other than the United States, and all or a substantial portion of such persons&#146; assets are
located outside the United States. As a result, it may be difficult for investors to effect service of process within the United States upon us or such persons or to enforce against them or against us, judgments obtained in United States courts,
including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state thereof. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have
appointed CT Corporation System as our agent to receive service of process with respect to any action brought against us in the United States District Court for the Southern District of New York under the federal securities laws of the United States
or of any State of the United States or any action brought against us in the Supreme Court of the State of New York in the County of New York under the securities laws of the State of New York. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beijing Kang Da Law Firm, our counsel as to Chinese law, has advised us that there is uncertainty as to whether the courts of China would
(1)&nbsp;recognize or enforce judgments of United States courts obtained against us or such persons predicated upon the civil liability provisions of the securities laws of the United States or any state thereof, or (2)&nbsp;be competent to hear
original actions brought in each respective jurisdiction, against us or such persons predicated upon the securities laws of the United States or any state thereof. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beijing Kang Da Law Firm has advised us that the recognition and enforcement of foreign judgments are provided for under the Chinese Civil Procedure Law.
Chinese courts may recognize and enforce foreign judgments in accordance with the requirements of the Chinese Civil Procedure Law based either on treaties between China and the country where the judgment is made or in reciprocity between
jurisdictions. China does not have any treaties or other agreements with the British Virgin Islands or the United States that provide for the reciprocal recognition and enforcement of foreign judgments. As a result, it is uncertain whether a Chinese
court would enforce a judgment rendered by a court in either of these two jurisdictions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have been advised by Kaufman&nbsp;&amp; Canoles,
our counsel as to British Virgin Islands law, that the United States and the British Virgin Islands do not have a treaty providing for reciprocal recognition and enforcement of judgments of courts of the United States in civil and commercial matters
and that a final judgment for the payment of money rendered by any general or state court in the United States based on civil liability, whether or not predicated solely upon the U.S. federal securities laws, is unlikely to be enforceable in the
British Virgin Islands. We have also been advised by Kaufman&nbsp;&amp; Canoles that a final and conclusive judgment obtained in U.S. federal or state courts under which a sum of money is payable as compensatory damages (i.e., not being a sum
claimed by a revenue authority for taxes or other charges of a similar nature by a governmental authority, or in respect of a fine or penalty or multiple or punitive damages) may be the subject of an action on a debt in the court of the British
Virgin Islands under the common law doctrine of obligation. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">108 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_23"></A>PLACEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have engaged Anderson&nbsp;&amp; Strudwick, Incorporated to conduct this offering on a &#147;best efforts, minimum/maximum&#148; basis. The offering
is being made without a firm commitment by the placement agent, which has no obligation or commitment to purchase any of our shares. None of our officers, directors or affiliates may purchase shares in this offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless sooner withdrawn or canceled by either us or the placement agent, the offering will continue until the earlier of (i)&nbsp;a date mutually
acceptable to us and our placement agent after which the minimum offering is sold or (ii)&nbsp;May&nbsp;31, 2010 (the &#147;Offering Termination Date&#148;). The Placement Agent has agreed in accordance with the provisions of SEC Rule 15c2-4 to
cause all funds received by the Placement Agent for the sale of the common shares to be promptly deposited in an escrow account maintained by SunTrust Bank, N.A. (the &#147;Escrow Agent&#148;) as escrow agent for the investors in the offering. The
Escrow Agent will exercise signature control on the escrow account and will act based on joint instructions from our company and the placement agent. On the closing date for the offering, net proceeds in the escrow account maintained by the Escrow
Agent will be delivered to our company. We will not be able to use such proceeds in China, however, until we complete certain remittance procedures in China. If we do not complete this offering before the Offering Termination Date, all amounts will
be promptly returned as described below. If we complete this offering, then on the closing date, we will issue shares to investors and placement agent warrants to our placement agent exercisable at a rate of one warrant per share to purchase up to
10% of the aggregate number of common shares sold in This offering. In the event of any dispute between our company and the placement, including about whether the minimum offering has been sold and whether and how funds are to be reimbursed, the
escrow agent is entitled to petition a court of competent jurisdiction to resolve any such dispute. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Investors must pay in full for all common
shares at the time of investment. Payment for the common shares may be made (i)&nbsp;by check, bank draft or money order made payable to &#147;SunTrust Bank&#148; and delivered to the Placement Agent no less than four business days before the date
of closing, or (ii)&nbsp;by authorization of withdrawal from securities accounts maintained with the Placement Agent. If payment is made by authorization of withdrawal from securities accounts, the funds authorized to be withdrawn from a securities
account will continue to accrue interest, if any interest is to accrue on such amounts, at the contractual rates until closing or termination of the offering, but a hold will be placed on such funds, thereby making them unavailable to the purchaser
until closing or termination of the offering. If a purchaser authorizes the Placement Agent to withdraw the amount of the purchase price from a securities account, such Placement Agent will do so as of the date of closing. The Placement Agents will
inform prospective purchasers of the anticipated date of closing. If payment is made by check, investors should make all checks payable to the Escrow Agent. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds deposited in escrow with the Escrow Agent may not be withdrawn by investors prior to the earlier of the closing of the offering or the Offering
Termination Date. If the offering is withdrawn or canceled or if the 1,250,000 share minimum offering is not reached and proceeds therefrom are not received by us on or prior to the Offering Termination Date, all proceeds will be promptly returned
by the Escrow Agent without interest or deduction to the persons from which they are received (within one business day) in accordance with applicable securities laws. All such proceeds will be placed in a non-interest bearing account pending such
time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to that certain placement agreement by and between the placement agent and us, the obligations of the placement agent to
solicit offers to purchase the shares and of investors solicited by the placement agent to purchase our common shares are subject to approval of certain legal matters by counsel to the placement agent. The placement agent&#146;s ability to complete
this &#147;best efforts minimum/maximum&#148; transaction is dependent upon the existence of stable U.S. trading markets. As such, the placement agent&#146;s obligations under the placement agreement are also subject to various conditions which are
customary in transactions of this type, including that, as of the closing of the offering, there shall not have occurred (i)&nbsp;a suspension or material limitation in trading in securities or the publication of quotations on the NASDAQ Stock
Market (National Market System or Capital Market); (ii)&nbsp;a general moratorium on commercial banking activities in the State of New York or China; (iii)&nbsp;the engagement by </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">109 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the United States or China in hostilities which have resulted in the declaration of a national emergency or war if any such event would have a material adverse effect, in the placement
agent&#146;s reasonable judgment, as to make it impracticable or inadvisable to proceed with the solicitation of offers to consummate the offering with respect to investors solicited by the placement agent on the terms and conditions contemplated
herein. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have agreed to indemnify the placement agent against certain liabilities, including liabilities under the Securities Act of 1933,
or to contribute to payments the placement agent may be required to make in respect of those liabilities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The placement agent is offering the
common shares, subject to prior sale, when, as and if issued to and accepted by it, subject to conditions contained in the placement agreement, such as the receipt by the placement agent of officers&#146; certificates and legal opinions. The
placement agent reserves the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part in the event (i)&nbsp;our representations or warranties are incorrect or misleading or we fail to fulfill our agreements
with the placement agent; (ii)&nbsp;a material adverse change occurs affecting our business, management, property, assets, results of operations, condition or prospects; (iii)&nbsp;trading is suspended on any national securities exchange;
(iv)&nbsp;war is declared; (v)&nbsp;a banking moratorium is declared in Virginia, New York or the U.S.; or (vi)&nbsp;any laws, regulations, court or administrative order or other governmental or agency act causes the placement agent to believe that
our business or the U.S. securities markets will be materially adversely affected. The placement agent&#146;s discretion in this regard is broad. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The placement agent intends to offer our common shares to its retail customers only in states in which we are permitted to offer our common shares. We
have relied on an exemption to the blue sky registration requirements afforded to &#147;covered securities&#148;. Securities listed on the NASDAQ Capital Market are &#147;covered securities.&#148; If we were unable to meet the NASDAQ Capital
Market&#146;s listing standards, then we would be unable to rely on the covered securities exemption to blue sky registration requirements and we would need to register the offering in each state in which we planned to sell shares. Consequently, we
will not complete this offering unless we meet the NASDAQ Capital Market&#146;s listing requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with this offering, the
placement agent or certain of the securities dealers may distribute prospectuses electronically. No forms of prospectus other than printed prospectuses and electronically distributed prospectuses that are printable in Adobe PDF format will be used
in connection with this offering. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Foreign Regulatory Restrictions on Purchase of our Shares </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have not taken any action to permit a public offering of our shares outside the United States or to permit the possession or distribution of this
prospectus outside the United States. People outside the United States who come into possession of this prospectus must inform themselves about and observe any restrictions relating to this offering of our shares and the distribution of this
prospectus outside the United States. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Commissions and Discounts </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The placement agent has advised us that it proposes to offer the common shares to the public at the initial public offering price on the cover page of
this prospectus. The following table shows the public offering price, placement agent fee to be paid by us to the placement agent and the proceeds, before expenses, to us. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Per&nbsp;Common&nbsp;share</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Minimum&nbsp;Offering</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum&nbsp;Offering</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Public offering price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.00</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,000,000</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Placement discount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.56</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">700,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">840,000</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds to us, before expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.44</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,300,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,160,000</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect our total cash
expenses for this offering to be approximately $500,000, exclusive of the above commissions. In addition, we will pay the placement agent a non-accountable expense allowance of 1% of the amount of the offering, or up to $120,000 (maximum offering,
exclusive of shares registered under </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">110 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Rule 462(b)) or $100,000 (minimum offering). The placement agent must sell the minimum number of securities offered (1,250,000 common shares) if any are sold. The placement agent is required to
use only its best efforts to sell the securities offered. The offering will terminate upon the earlier of: (i)&nbsp;a date mutually acceptable to us and our placement agent after which the minimum offering is sold or (ii)&nbsp;May&nbsp;31, 2010.
Until we sell at least 1,250,000 shares, all investor funds will be held in an escrow account at SunTrust Bank, Richmond, Virginia. If we do not sell at least 1,250,000 shares by May&nbsp;31, 2010, all funds will be promptly returned to investors
(within one business day) without interest or deduction. If we complete this offering, then on the closing date, we will issue shares to investors and placement agent warrants to our placement agent. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Placement Agent&#146;s Warrants </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have agreed to sell to the placement agent, on the closing date of this offering, at a price of $0.001 per warrant, placement agent&#146;s warrants
exercisable at a rate of one warrant per share to purchase 10% of the number of common shares issued by us in connection with the offering. We will issue between 125,000 and 150,000 placement agent&#146;s warrants in connection with this offering,
depending on the number of common shares sold in this offering. Each placement agent&#146;s warrant will be exercisable to purchase one common share. The placement agent&#146;s warrants will be exercisable at 125% the offering price per common share
for a period of five years after issuance on the closing date of this offering. The placement agent&#146;s warrants may not be exercised, sold, transferred, pledged, assigned or hypothecated for a period of 180 days after the date of effectiveness
or commencement of sales of the public offering, except to officers or partners and shareholders of the placement agent. This restriction is imposed pursuant to the requirements of FINRA Rule 5110(g)(1). If we do not complete this offering by
selling at least the minimum number of common shares, we will not issue any placement agent&#146;s warrants to our placement agent exercisable at a rate of one warrant per share to purchase up to 10% of the aggregate number of common shares sold in
this offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the life of the placement agent&#146;s warrants, the holders thereof are given, at nominal costs, the opportunity to
profit from a rise in the market price of our common shares with a resulting dilution in the interest of other shareholders. Further, the holders may be expected to exercise the placement agent&#146;s warrant at a time when we would, in all
likelihood, be able to obtain equity capital on terms more favorable than those provided in the placement agent&#146;s warrants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are
required for the life of the placement agent&#146;s warrants to reserve sufficient common shares to deliver upon exercise of the warrants and to take all necessary actions to ensure that we may validly and legally issue fully paid and non-assessable
shares on exercise of the warrants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The placement agent has a right to demand registration of the common shares in the event registered
common shares are not available at the time of exercise and an exemption from such registration is not otherwise available. If this happens, we will be required to file the registration statement within ninety (90)&nbsp;days after demand and to pay
the costs associated with the registration other than the placement agent&#146;s counsel fees and any underwriting or selling commissions. We are required to seek the listing of the shares on the same exchange on which our common shares trade, if
any. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the extent we are unable to register the shares, the placement agent may exercise the warrant with a cashless exercise, which is
designed to give the placement agent the economic benefit of exercising the placement agent&#146;s warrants. A cashless exercise, however, would not result in the payment of any exercise price to us. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The placement agent&#146;s warrants also contain anti-dilution provisions, consistent with applicable FINRA rules, to adjust the terms of the placement
agent&#146;s warrants as necessary to protect against dilution in the event we reorganize, consolidate, merge or subdivide our shares. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Market and Pricing Considerations </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There is not an established market for our common shares. We negotiated with our placement agent to determine the offering price of our common shares in
this offering using a multiple of approximately 6.6 times our targeted after-tax net income for the fiscal year ending December&nbsp;31, 2010. Noting past </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">111 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
offerings completed by our placement agent, we believe that this multiple approximates the valuation multiples utilized in similar offerings for similarly-sized companies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to prevailing market conditions, the factors considered in determining the applicable multiples were: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The history of, and the prospects for, our company and the industry in which we compete; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An assessment of our management, its past and present operation, and the prospects for, and timing of, our future revenues;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The present state of our development; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The factors listed above in relation to market values and various valuation measures of other companies engaged in activities similar to ours.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Using the above valuation methodology, we calculated an approximate enterprise value of $24,000,000. This resulted in a per
share price of $8.00, based on 3,000,000 shares issued and outstanding prior to this offering. We have used this price in connection with this offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the valuation of our company at approximately $24,000,000 using this methodology, our earnings for the year ending December&nbsp;31, 2010 would
be approximately $0.80 assuming a maximum offering (4,500,000 ordinary shares outstanding upon completion of the offering). This number excludes any shares issuable under the option pool or underlying the placement agent warrants. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we are unable to achieve the targeted after-tax earnings upon which our valuation is based, then there is a risk that our company would be considered
overvalued based on this multiple. In order to mitigate some of this risk, Ping Chen, Zheng (Rita) Liu, Weibing Yang, Jian Sun and Yong Wang placed an aggregate of 600,000 common shares into escrow. This number being equal to 40% of the maximum
number of shares to be sold in this offering. See &#147;Related Party Transactions-Make-Good Shares Subject to Redemption.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">An active
trading market for our common shares may not develop. It is possible that after this offering the common shares will not trade in the public market at or above the initial offering price. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The exercise price for the placement agent&#146;s warrants issued to our placement agent in connection with, and conditional on the closing of, this
offering has been negotiated between our company and the placement agent. The exercise price (125% of the offering price of common shares in this offering), along with the length of time the placement agent must wait before exercise (at least 180
days after the closing of this offering) are influenced by the valuation attributed by FINRA in its calculation of the acceptability of aggregate placement consideration. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Discretionary Shares </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The placement agent will not sell any shares in this offering to accounts over which it exercises discretionary authority, without first receiving
written consent from those accounts. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Application for Listing on the NASDAQ Capital Market </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have applied to list our common shares on the NASDAQ Capital Market under the symbol &#147;DHRM.&#148; As this offering is a best-efforts offering,
the NASDAQ Capital Market has indicated that it is unable to admit our common shares for listing until the completion of the offering and, consequently, the satisfaction of NASDAQ Capital Market listing standards. If so admitted, we expect our
common shares to begin trading on the NASDAQ Capital Market on the day following the closing of this offering. If our common shares are eventually listed on the NASDAQ Capital Market, we will be subject to continued listing requirements and
corporate governance standards. We expect these new rules and regulations to significantly increase our legal, accounting and financial compliance costs. We and our placement agent agree that we will not close this offering unless we satisfy the
NASDAQ Capital Market&#146;s listing standards and will be able to trade on the NASDAQ Capital Market; however, we have not yet received such admission and have no assurance that we will receive such admission. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">112 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Price Stabilization, Short Positions and Penalty Bids </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to facilitate the offering of the common shares, the placement agent may engage in transactions that stabilize, maintain or otherwise affect the
price of the common shares. In order to facilitate the offering, the placement agent may, but is not required to, bid for, and purchase, common shares in the open market to stabilize the price of the common shares. These activities may raise or
maintain the market price of the common shares above independent market levels or prevent or retard a decline in the market price of the common shares. The placement agent is not required to engage in these activities, and may end any of these
activities at any time. We and the placement agent have agreed to indemnify each other against certain liabilities, including liabilities under the Securities Act. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_24"></A>LEGAL MATTERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certain matters as to Virginia law and U.S. federal law in connection with this offering will be passed upon for us and for the placement agent by
Kaufman&nbsp;&amp; Canoles, P.C. The validity of the shares and certain legal matters relating to the offering as to British Virgin Islands law will be passed upon for us by Kaufman&nbsp;&amp; Canoles, P.C. Certain legal matters relating to the
offering as to Chinese law will be passed upon for us by Beijing Kang Da Law Firm, People&#146;s Republic of China. Kaufman&nbsp;&amp; Canoles, P.C. may rely upon Beijing Kang Da Law Firm with respect to matters governed by PRC law. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_25"></A>EXPERTS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Financial statements as of December&nbsp;31, 2008 and 2007, and for the years then ended appearing in this prospectus, have been included herein and in
the registration statement in reliance upon the report of Friedman LLP, an independent registered public accounting firm, appearing elsewhere herein, and upon the authority of that firm as experts in accounting and auditing. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_26"></A>INTERESTS OF EXPERTS AND COUNSEL </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Attorneys with Kaufman&nbsp;&amp; Canoles, P.C., representing our company with respect to this offering beneficially own 44,999 common shares of our
company as of the date of this prospectus. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_27"></A>WHERE YOU CAN FIND MORE INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have filed with the SEC a registration statement on Form S-1 under the Securities Act of 1933 with respect to our common shares offered by this
prospectus. This prospectus does not contain all of the information set forth in the registration statement and the exhibits to the registration statement. For further information regarding us and our common shares offered hereby, please refer to
the registration statement and the exhibits filed as part of the registration statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This registration statement, including exhibits
thereto, and any periodic reports we may in the future be required to file may be inspected without charge at the Public Reference Room maintained by the SEC at 100 F Street, NE, Washington, D.C. 20549. You may obtain copies of the registration
statement, including the exhibits thereto, and all of our periodic reports after payment of the fees prescribed by the SEC. For additional information regarding the operation of the Public Reference Room, you may call the SEC at 1-800-SEC-0330. The
SEC also maintains a website which provides on-line access to reports and other information regarding registrants that file electronically with the SEC at the address: http://www.sec.gov. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">113 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="424bc53110_28"></A>EXPENSES RELATED TO THIS OFFERING </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The estimated expenses payable by us in connection with this offering (other than the placement discounts and commissions) will be as follows. With the
exception of the filing fees for the U.S. Securities Exchange Commission, FINRA and NASDAQ, all amounts are estimates. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">U.S. Securities Exchange Commission registration fee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> 845</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">FINRA filing fee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,013</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">NASDAQ listing fee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Legal fees and expenses for Chinese counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">95,000</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Legal fees and expenses for British Virgin Islands counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,000</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Legal fees and expenses for U.S. counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">160,000</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounting fees and expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Printing fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Miscellaneous</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,142</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">500,000</FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">114 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="index"></A>D<A NAME="424bc53110_29"></A>EHAIER MEDICAL SYSTEMS LIMITED AND
AFFILIATE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INDEX TO FINANCIAL STATEMENTS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>PAGE</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CONSOLIDATED FINANCIAL STATEMENTS</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#fin53110_1">Report of Independent Registered Public Accounting Firm</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-2</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#fin53110_2">Consolidated Balance Sheets as of December&nbsp;31, 2008 and 2007 and September&nbsp;30,2009
(unaudited)</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-3</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#fin53110_3">Consolidated Statements of Operations for the Years Ended December&nbsp;
31, 2008 and 2007, and for the Nine Months Ended September&nbsp;30, 2009 (unaudited) and 2008 (unaudited)</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-4</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#fin53110_4">Consolidated Statements of Shareholders&#146; Equity for the Years Ended December&nbsp;
31, 2008, 2007, and for the Nine Months Ended September&nbsp;30, 2009 (unaudited)</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-5</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#fin53110_5">Consolidated Statements of Cash Flows for the Years Ended December&nbsp;
31, 2008 and 2007, and for the Nine Months Ended September&nbsp;30, 2009 (unaudited) and 2008 (unaudited)</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-6</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#fin53110_6">Notes to the Consolidated Financial Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-7</FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px">

<IMG SRC="g53110424fin_pg002a.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="fin53110_1"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>To the Board of Directors and Shareholders </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dehaier Medical Systems Limited </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have
audited the accompanying consolidated balance sheets of Dehaier Medical Systems Limited and Affiliate as of December&nbsp;31, 2008 and 2007, and the consolidated related statements of operations, cash flows and shareholders&#146; equity for the
years then ended. Dehaier Medical Systems Limited and Affiliate management is responsible for these consolidated financial statements. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control
over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the company&#146;s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of
Dehaier Medical Systems Limited and Affiliate as of December&nbsp;31, 2008 and 2007, and the consolidated results of their operations and their cash flows for the years then ended in conformity with accounting principles generally accepted in the
United States of America. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Friedman LLP</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">New York, New York</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;22, 2010</FONT></TD></TR></TABLE>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g53110424fin_pg002b.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="fin53110_2"></A>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED BALANCE SHEETS </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>ASSETS</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CURRENT ASSETS:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">282,603</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,143,352</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">937,970</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts receivable, less allowance for doubtful accounts of $141,926, $101,830 and $148,570</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,416,702</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,170,103</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,059,480</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other receivables</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,187,360</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">538,886</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,461,635</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prepaid expenses and other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,798,887</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">726,073</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,300,742</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,575,228</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,277,110</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,625,682</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Due from shareholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,280</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Due from officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,418</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total current assets</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,260,780</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,892,222</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,385,509</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,196,127</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,609,521</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,927,592</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intangible assets, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">36,525</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,049</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,131</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax receivable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">552,968</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">354,071</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,163,479</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total assets</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,046,400</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,928,863</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,485,711</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>LIABILITIES AND SHAREHOLDERS&#146; EQUITY</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CURRENT LIABILITIES:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Short-term borrowings</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,465,740</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,233,792</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,464,920</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,320</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,894</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79,855</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Advances from customers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">230,394</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">159,540</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,695</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250,839</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,308</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">297,448</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Taxes payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,052,137</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,785,007</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,461,781</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warranty obligation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">158,065</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">98,964</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">199,727</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Due to officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">969</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,947</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total current liabilities</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,232,464</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,550,505</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,566,373</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Commitments and contingency</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Shareholders&#146; equity</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preferred Stock Series A, $0.01 par value, 120,000 shares authorized, 120,000 shares issued and outstanding (liquidation value of
$1,200,000)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,200</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,200</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,200</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preferred Stock Series B, $0.01 par value, 380,000 shares authorized, 182,635 shares issued and outstanding (liquidation value of
$2,000,000)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,826</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,826</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,826</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Common stock, $0.002731 par value, 16,476,300 shares authorized, 1,891,930 shares issued and outstanding *</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,196,974</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,196,974</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,196,974</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Retained earnings</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,624,771</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,706,751</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,696,547</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated other comprehensive income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">778,766</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">398,581</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">774,531</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total Dehaier Medical Systems Limited shareholders&#146; equity</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,608,704</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,310,499</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,676,245</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-controlling interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,205,232</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,067,859</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,243,093</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total shareholders&#146; equity</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,813,936</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,378,358</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,919,338</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total liabilities and shareholders&#146; equity</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,046,400</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,928,863</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,485,711</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The change in par value of common shares pursuant to the stock split was retroactively adjusted. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">The accompanying notes are an integral part of these consolidated financial statements. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="fin53110_3"></A>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED STATEMENTS OF OPERATIONS </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the years ended<BR>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the nine months ended<BR>September&nbsp;30,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,414,430</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,599,512</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,422,460</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,531,854</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5,931,087</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,279,571</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5,688,352</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,110,704</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gross profit</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,483,343</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,319,941</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,734,108</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,421,150</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Service income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">418,483</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">369,001</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">298,036</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,622</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Service expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(105,436</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(79,815</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(113,066</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(115,674</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,326,406</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(757,642</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(787,784</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(917,943</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Selling expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(973,898</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(880,863</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(544,470</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(785,132</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operating income</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,496,086</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">970,622</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,586,824</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">904,023</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Financial expense (including interest expense of $97,122 and $45,221, $67,704 and $65,022)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(104,474</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(43,953</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(66,384</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(71,029</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other income (expense)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,071</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,600</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,306</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Income before provision for income taxes and non-controlling interest</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,395,683</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">922,069</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,520,440</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">836,300</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Provision for income taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(415,332</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(73,648</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(410,162</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(270,300</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net income</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">980,351</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">848,421</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,110,278</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">566,000</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-controlling interest in income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(62,331</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(53,214</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(38,502</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(44,437</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net income attributable to Dehaier Medical Systems Limited</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">918,020</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">795,207</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,071,776</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">521,563</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Earnings per share</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">-Basic</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.48</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.42</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.10</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.27</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">-Diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.31</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.32</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.69</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.17</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Weighted average number of common shares used in computation</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">-Basic</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">-Diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,451,624</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
accompanying notes are an integral part of these consolidated financial statements. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="fin53110_4"></A>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#146; EQUITY </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="28%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="20" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Dehaier Medical Systems Limited</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Common&nbsp;stock<BR>Shares US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Preferred&nbsp;A<BR>Shares US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Preferred&nbsp;B<BR>Shares US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Additional<BR>paid-in<BR>capital</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Retained<BR>earnings<BR>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accumulated<BR>other<BR>Comprehensive<BR>income</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B>
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Comprehensive<BR>income</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-<BR>controlling<BR>interest<BR>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Balance as of January 1, 2007</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,200</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,198,800</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">911,544</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">102,714</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">946,293</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,165,718</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares issued</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,635</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,826</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,998,174</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,000,000</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Foreign currency translation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">295,867</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">295,867</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">68,352</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">364,219</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">795,207</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">795,207</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,214</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">848,421</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Comprehensive income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,091,074</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Balance as of December 31, 2007</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,200</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,635</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,826</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,196,974</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,706,751</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">398,581</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,067,859</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,378,358</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Foreign currency translation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">380,185</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">380,185</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,042</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">455,227</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">918,020</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">918,020</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">62,331</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">980,351</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Comprehensive income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,298,205</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Balance as of December 31, 2008</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,200</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,635</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,826</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,196,974</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,624,771</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">778,766</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,205,232</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,813,936</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Foreign currency translation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,235</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,235</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(641</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,876</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,071,776</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,071,776</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">38,502</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,110,278</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Comprehensive income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,067,541</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Balance as of September 30, 2009 (unaudited)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,167</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,200</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,635</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,826</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,196,974</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,696,547</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">774,531</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,243,093</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,919,338</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">The accompanying notes are an integral part of these consolidated financial statements. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="fin53110_5"></A>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED STATEMENTS OF CASH FLOWS </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the years ended<BR>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the nine months ended<BR>September&nbsp;30,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Unaudited)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operating Activities</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">980,351</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">848,421</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,110,278</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">566,000</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjustments to reconcile net income to net cash provided by (used in) operating activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Depreciation and amortization</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">235,867</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">147,801</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">210,231</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">155,423</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Provision for (recovery of) doubtful accounts</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,297</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">112,358</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18,765</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Provision for (recovery of) warranty</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,102</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,111</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">41,662</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3,907</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gain on sale of equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3,324</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3,306</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Changes in assets and liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increase in accounts receivable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,269,896</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(344,628</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(642,778</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,371,519</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Decrease (increase) in prepayments and other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,072,813</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(496,610</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">498,145</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(117,116</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increase in other receivables</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(648,474</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(119,052</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(274,275</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(691,451</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Decrease (increase) in inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">701,882</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,280,919</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,050,453</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(304,441</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increase in tax receivable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(198,896</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(352,981</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(610,511</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(205,295</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Decrease) increase in accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,425</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(308,326</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,536</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">101,926</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Decrease) increase in advances from customers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">70,854</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(484,448</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(170,699</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">55,054</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Decrease) increase in accrued expenses and other current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,531</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">81,730</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">46,609</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18,830</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increase in tax payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,267,130</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,598</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,409,645</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">878,075</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net cash provided by (used in) operating activities</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(802,964</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,656,945</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,573,390</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(978,152</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Investing Activities</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds from sale of equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,102</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,929</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Capital expenditures and other additions</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(708,580</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(510,871</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(915,693</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(668,027</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds from (advances to) related parties</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,667</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(31,530</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,976</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,622</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net cash used in investing activities</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(637,811</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(542,401</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(913,717</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(597,476</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Financing Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds from bank loans</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">231,948</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">849,378</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">238,984</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds from issuance of Series B preferred shares</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,000,000</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net cash provided by financing activities</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">231,948</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,849,378</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">238,984</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effect of exchange rate fluctuations on cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">348,078</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">288,549</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,306</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">394,095</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Net increase (decrease) in cash and cash equivalents</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(860,749</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">938,581</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">655,367</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(942,549</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents at beginning of period</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,143,352</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">204,771</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">282,603</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,143,352</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents at end of period</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">282,603</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,143,352</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">937,970</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,803</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Supplemental cash flow information</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Income tax paid</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,765</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">130</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,824</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,745</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest paid</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">97,122</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,221</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,704</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,022</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
accompanying notes are an integral part of these consolidated financial statements. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="fin53110_6"></A>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1. ORGANIZATION AND PRINCIPAL ACTIVITIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dehaier Medical Systems Limited (&#147;Dehaier&#148;) was incorporated in the British Virgin Islands in 2003 as a limited liability company. Dehaier
distributes and provides after-sale services for medical equipment in China mainly through its majority-owned subsidiary Beijing Dehaier Medical Technology Co. Limited (&#147;BDL&#148;) and its affiliate Beijing Dehaier Technology Limited
(&#147;BTL&#148;). On October&nbsp;23, 2003, Dehaier established a wholly-owned subsidiary in Hong Kong, De-haier Medical System (Hong Kong) Limited (&#147;DHK&#148;), (collectively, the &#147;Company&#148;). Both BDL and BTL were incorporated in
the People&#146;s Republic of China (&#147;PRC&#148;). The Company distributes branded, proprietary medical equipment, such as sleep apnea machines, patient monitors, air compressors, and oxygen generators; moreover, standard product registration,
product certification and quality management system have been established in the Company. ISO13485 industry standard has also already been passed. It also has the distribution rights for a number of international medical equipment suppliers for
products including anesthesia equipment, patient monitors, mobile C-arm X-ray machines and other medical equipment accessories. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Basis of Presentation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The accompanying consolidated financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United
States of America (&#147;US GAAP&#148;). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The accompanying consolidated interim financial statements include all adjustments that in the
opinion of management, are necessary in order to make the consolidated interim financial statements not misleading. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Basis of Consolidation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The consolidated financial statements include the accounts of Dehaier, BDL, its majority-owned subsidiary, and its wholly-owned subsidiary, DHK as well as
BTL. All significant inter-company transactions and balances are eliminated in consolidation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A group of shareholders, including the Chief
Executive officer, holds more than 50% of the voting ownership interest of Dehaier, BDL and BTL. BTL is a variable interest entity, and BDL is the primary beneficiary. BTL owns a building which is pledged as collateral for BDL&#146;s bank loans. In
exchange, BDL loans money to BTL to finance its operations. BTL&#146;s primary operation is to provide repairs and transportation services to BDL&#146;s customers. Because of these arrangements, BDL is the primary beneficiary of BTL, which is the
entity that is most closely associated with BTL. Dehaier has included BTL in its consolidated financial statements through the consolidation with BDL since December&nbsp;31, 2006. Dehaier, BDL and BTL were under common control until October&nbsp;31,
2009, when each share of preferred stock was converted into a common share (see note 13). Because the chief executive officer held more than 50% of the voting ownership interest of each of Dehaier, BDL, BTL and DHK at December&nbsp;31, 2006, the
Company initially measured the assets, liabilities and noncontrolling interest of the variable interest entity at the amounts at which they were carried in the accounts of the reporting entity that controls the variables interest entity pursuant to
FASB ASC 810-10. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October&nbsp;31, 2009, BDL reconsidered whether it is the primary beneficiary of BTL when Dehaier&#146;s preferred stock
was converted into common shares. While such conversion dilutes Mr.&nbsp;Chen&#146;s interest in BDL such that BDL and BTL are not under common control after October&nbsp;30, 2009, BDL still has the obligation to absorb the expected losses of BTL.
BTL is still a variable interest entity because all of its activities either involve or are conducted on behalf of the reporting enterprise and its related parties. BDL is BTL&#146;s only customer referral source. On March&nbsp;3, 2010, BDL entered
into a Loss Absorption Agreement memorializing the understanding that BDL would continue to loan money to BTL as needed to fund its working capital such that BDL would absorb BTL&#146;s losses. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES-continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The carrying amount and classification of BTL&#146;s assets and liabilities included in the consolidated
balance sheets are as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">392,431</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">770,598</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">268,407</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,573,073</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,988,906</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,380,680</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">367,842</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">921,407</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,587</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">367,842</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">921,407</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,587</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The accounts of BTL are
consolidated in the accompanying financial statements pursuant to Accounting Standards Codification (&#147;ASC&#148;) 810-10, &#147;Consolidation&#148;. As a VIE, BTL&#146;s revenues are included in the Company&#146;s service income, and its income
from operations is consolidated with the Company&#146;s. Because of the arrangements, the Company had a pecuniary interest in BTL that requires consolidation of the Company&#146;s and BTL&#146;s financial statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;1, 2009, the Company adopted the transition rules within ASC 810-10-65, regarding accounting and reporting standards for the
non-controlling interest in a subsidiary. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Use of Estimates </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The preparation of the consolidated financial statements in conformity with US&nbsp;GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates are
adjusted to reflect actual experience when necessary. Significant accounting estimates reflected in the Company&#146;s consolidated financial statements include revenue recognition, allowance for doubtful accounts, useful lives of property and
equipment and intangible assets. Actual results could differ from those estimates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Cash and Cash Equivalents </I></B>
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents consist of cash on hand and highly liquid investments which are unrestricted as to withdrawal or use, and which have
maturities of three months or less when purchased. The Company maintains uninsured cash and cash equivalents with various financial institutions mainly in the PRC and Hong Kong. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Accounts Receivable </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts receivable are recorded at net realizable value. Accounts receivable terms typically are net 60-180 days from the end of the month in which the
services were provided. The company generally does not require collateral or other security to support accounts receivable. An allowance, if required, is based on a combination of historical experience, aging analysis, and an evaluation of the
collectibility of specific accounts. Receivables are considered past due after 3 years and written off. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES-continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Advances to Suppliers and Advances from Customers </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company, as is the common practice in the PRC, will often pay advance payments to suppliers for unassembled parts, or receive advance payments from
customers. Advances to suppliers were $1,798,887, $675,108 and $1,300,742 as of December&nbsp;31, 2008 and 2007 and September&nbsp;30, 2009, respectively. Advances from customers were $230,394, $159,540 and $59,695 as of December&nbsp;31, 2008 and
2007 and September&nbsp;30, 2009, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Fair Value of Financial Instruments </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The carrying amounts reported in the consolidated financial statements for current assets and current liabilities approximate fair value due to the
short-term nature of these financial instruments. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2008, the Company adopted ASC 820-10, &#147;Fair Value Measurements and
Disclosures&#148;, which establishes a single authoritative definition of fair value and a framework for measuring fair value and expands disclosure of fair value measurements for both financial and nonfinancial assets and liabilities. This standard
defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but discusses valuation techniques, such as the market approach (comparable market
prices), the income approach (present value of future income or cash flows) and the cost approach (cost to replace the service capacity of an asset or replacement cost). For purposes of ASC 820-10-15, nonfinancial assets and nonfinancial liabilities
would include all assets and liabilities other than those meeting the definition of a financial asset or financial liability as defined in ASC 820-10-15-15-1A. Management elected the deferral option available for one year for nonfinancial assets and
liabilities as permitted by ASC-820-10. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company decided not to elect the fair value option prescribed by Financial Accounting Standards
Board (&#147;FASB&#148;) ASC-825-10 for its financial assets and liabilities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Inventory </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory is stated at the lower of cost or market and consists of assembled and unassembled parts relating to medical devices. The Company reviews its
inventory annually for possible obsolete goods and to determine if any reserves are necessary for potential obsolescence. At December&nbsp;31, 2008 and 2007 and September&nbsp;30, 2009, no reserve for obsolescence is considered necessary.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Property and Equipment </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property and equipment are recorded at cost less accumulated depreciation and amortization. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Depreciation and amortization are calculated on a straight-line basis over the following estimated useful lives: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">Leasehold improvements</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">Shorter of the useful lives or the lease term</FONT></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">Building and land use rights</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">20-40 years</FONT></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">Machinery and equipment</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">10-15 years</FONT></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">Furniture and office equipment</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">5 years</FONT></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">Motor vehicles</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">5 years</FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES-continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Intangible Assets </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intangible assets consist primarily of purchased technology rights with finite lives and are stated at cost less accumulated amortization. Amortization is
calculated on a straight-line basis over the estimated useful lives of these assets of 6 to 10 years and recognized in cost of revenues. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Company reviews intangible assets for impairment in accordance with the provisions of ASC 360-10, &#147;Impairment or Disposal of Long-Lived Assets.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There was no impairment of intangible assets for the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September&nbsp;30, 2009
and 2008. Although management believes the assumptions used in testing for impairment are reasonable, changes in any one of the assumptions could produce a significantly different result. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Impairment of Long-Lived Assets </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no
longer be recoverable. When these events occur, the Company measures impairment by comparing the carrying value of the long-lived assets to the estimated undiscounted future cash flows expected to result from the use of the asset and eventual
disposition. If the sum of the expected future cash flows is less than the carrying amount of the asset, an impairment loss, equal to the excess of the carrying amount over the fair market value of the asset, is recognized. Management has determined
no impairment exists at the balance sheet dates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Revenue Recognition </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company recognizes revenues when all the followings conditions have been satisfied: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Persuasive evidence of an arrangement exists; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Delivery and/or installation has occurred (e.g., risks and rewards of ownership has passed); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The sales price is fixed or determinable; and, </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Collectibility is reasonably assured. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All revenues are based on firm customer orders with fixed terms and conditions. Because the products are assembled to the customers&#146; specification,
there is no right of return. The Company does not provide its customers with price protection or cash rebates. For products which include software, the software is an off-the-shelf package and an integral part of the products being delivered. The
Company does not provide any significant post-sale customer support services and does not provide customers with upgrades. The software is incidental to the product as a whole. For products that do not require installation, revenues are recognized
when the products are delivered. For products that require installation, revenues are recognized when the installation is completed. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For all
service income, the Company recognizes the revenue upon the completion of the repairs when the equipment has been returned to and accepted by the customers. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the PRC, value added tax (VAT) of 17% of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT
collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Cost of Revenues </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of revenues primarily includes wages to assemble parts and the costs of unassembled parts, handling charges, and other expenses associated with the
assembly and distribution of product. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-10 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES-continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Service income and expense </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Service income and expense represents activities related to repair and transportation service provided for the customers by BTL. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Foreign Currency Translation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The accounts of Dehaier, BDL, BTL and DHK are measured using the currency of the primary economic environment in which the entity operates (the
&#147;functional currency&#148;). Dehaier&#146;s functional currency is US dollars (&#147;$&#148;) while BDL and BTL maintain their accounts in Renminbi (&#147;RMB&#148;) and DHK maintains its currency in Hong Kong dollars (&#147;HKD&#148;). The
accompanying consolidated financial statements are presented in US dollars. Foreign currency transactions are translated into US dollars using fixed exchange rates in effect at the time of the transaction. Generally foreign exchange gains and losses
resulting from the settlement of such transactions are recognized in the consolidated statements of operations. The foreign currency accounts of DHK, BDL and BTL are translated in accordance with ASC 830-10, &#147;Foreign Currency Matters&#148;.
Assets and liabilities are translated at current exchange rates quoted by the People&#146;s Bank of China at the balance sheet dates and revenues and expenses are translated at average exchange rates in effect during the periods. Resulting
translation adjustments are recorded as other comprehensive income (loss) and accumulated as a separate component of equity in non-controlling interest. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Warranty Costs </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company provides for the estimated cost of product warranties at the time revenue is recognized. Warranty costs are included in general and
administrative expenses. The Company&#146;s warranty obligation is affected by product failure rates and material usage and service delivery costs incurred in correcting product failure. Should actual product failure rates, material usage or service
delivery costs differ from the Company&#146;s estimates, the Company may be required to revise its estimated product warranty liability. The term of the product warranty is generally twelve months. Provision for warranty costs was $158,065, $98,964
and $199,727 at December&nbsp;31, 2008 and 2007 and September&nbsp;30, 2009, respectively. Warranty expense for the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September&nbsp;30, 2009 and 2008 was $150,382, $60,298,
$83,588 and $72,801, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Research and Development Costs </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development costs relating to the development of new products and processes, including significant improvements and refinements to existing
products, are expensed as incurred. Research and development costs were $87,660, $47,228, $50,671 and $36,989 for the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September&nbsp;30, 2009 and 2008, respectively.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Shipping and Handling Expenses </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shipping and handling expenses of $68,135, $67,308, $49,591 and $36,711 for the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended
September&nbsp;30, 2009 and 2008 were included in operating expenses in the consolidated statements of operations, respectively. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Advertising Costs </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Advertising costs are expensed as incurred. Advertising costs were $52,677, $18,591, $42,758 and $51,130 for the years ended December&nbsp;31, 2008 and
2007, and for the nine months ended September&nbsp;30, 2009 and 2008, respectively. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-11 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES-continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Earnings Per Share </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company follows the provisions of ASC 260-10, &#147;Earnings Per Share&#148;. Basic earnings per share is computed by dividing net income attributable
to holders of common shares by the weighted average number of common shares outstanding during the years. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common shares were
exercised or converted into common shares. Convertible preferred shares are included in the computation of diluted earnings per share on an &#147;if converted&#148; basis, when the impact is dilutive. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth computation of basic and diluted weighted average share information: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year
Ended</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nine Months Ended<BR>September&nbsp;30,</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted average number of common shares outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,891,930</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dilutive effect of convertible preferred shares</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,108,070</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">559,694</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,108,070</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,108,070</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted average number of common shares outstanding, assuming dilution</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,451,624</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000,000</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Value Added Tax </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company reports revenues net of PRC&#146;s value added tax for all the periods presented in the consolidated statements of operations. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stock-Based Compensation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company follows the provisions of ASC 718-10, &#147;Share-Based Payment Arrangement.&#148; On </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">December&nbsp;7, 2009, the Company&#146;s Board of Directors and shareholders have approved the creation of a share incentive plan to be implemented after
the Company has completed its public offering. This plan will authorize the issuance of up to 10% of the number of shares outstanding after the Company has completed its public offering. Pursuant to the anticipated plan, the Company may issue
options to purchase its common shares to employees and directors of the Company and its affiliates. The Company will fair value share-based awards to be granted under the new plan. Accordingly, compensation will be measured on the grant date using
appropriate valuation models. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Income Taxes </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740-10, &#147;Accounting for Income Taxes.&#148;
Under this method, income tax expense is recognized for the amount of: (i)&nbsp;taxes payable or refundable for the current year; and, (ii)&nbsp;deferred tax consequences of temporary differences resulting from matters that have been recognized in
an entity&#146;s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or
settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets
reported if, based on the weight of available positive and negative evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of December&nbsp;31, 2008 and 2007, and as of September&nbsp;30,
2009, the Company did not record any deferred tax assets or liabilities. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-12 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES-continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Income Taxes - Continued </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">ASC 740-10 prescribes a recognition threshold and measurement attribute for the financial statement recognition of a tax position taken or expected to be
taken on a tax return. Under ASC 740-10, a tax benefit from an uncertain tax position taken or expected to be taken may be recognized only if it is &#147;more likely than not&#148; that the position is sustainable upon examination, based on its
technical merits. The tax benefit of a qualifying position under ASC 740-10 would equal the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement with a taxing authority having full knowledge of all
the relevant information. A liability (including interest and penalties, if applicable) is established in the financial statements to the extent a current benefit has been recognized on a tax return for matters that are considered contingent upon
the outcome of an uncertain tax position. Related interest and penalties, if any, are included as components of income tax expense and income taxes payable. The Company is awaiting resolution of certain complex tax issues and has not yet filed its
2007 and 2008 Value Added Tax (&#147;VAT&#148;) tax returns for some of its customers. However, all the potential VAT liabilities on these VAT returns were accrued and included in the accompanying consolidated financial statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The implementation of ASC 740-10 resulted in no material liability for unrecognized tax benefits and no material change to the beginning retained
earnings of the Company. As of December&nbsp;31, 2008 and 2007, and September&nbsp;30, 2009 the Company did not have a liability for any unrecognized tax benefits. The Company recognizes interest and penalties, if any, related to unrecognized tax
benefits as income tax expense in the statement of operations. During the years ended December&nbsp;31, 2008 and 2007, and the nine months ended September&nbsp;30, 2009 and 2008, the Company did not incur any interest or penalties. Income tax
returns for the years prior to 2004 are no longer subject to examination by tax authorities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Recently Issued Accounting
Standards </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2009, the FASB issued SFAS No.&nbsp;168, &#147;The FASB Accounting Standards Codification and the Hierarchy of
Generally Accepted Accounting Principles &#150; a Replacement of FASB Statement No.&nbsp;162&#148;. The objective of this statement is to replace SFAS No.&nbsp;162 and to establish the FASB Accounting Standards Codification as the source of the
authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP. Rules and interpretive releases of the SEC under authority of federal securities
laws are also sources of authoritative GAAP for SEC registrants. This statement shall be effective for financial statements issued for interim and annual periods ending after September&nbsp;15, 2009. On the effective date of this statement, all then
existing non-SEC accounting and reporting standards are superseded. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2009, the FASB issued SFAS No.&nbsp;167, an amendment to FASB
Interpretation 46(R), &#147;Consolidation of Variable Interest Entities.&#148; The statement requires an entity to perform an analysis to determine whether the entity&#146;s variable interest give it a controlling financial interest in a variable
interest entity by rationalizing characteristics that would give it power to direct the activities of a variable interest entity and the obligation to absorb losses or the right to receive benefits from the entity that could potentially be
significant to the variable interest entity. The statement is effective for years beginning after November&nbsp;15, 2009 and is not expected to have a material effect on the Company&#146;s consolidated financial statements. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-13 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES-continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Recently Issued Accounting Standards-continued </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2009, the FASB issued SFAS No.&nbsp;166, &#147;Accounting for Transfers of Financial Assets&#148;, an amendment to SFAS NO. 140, &#147;Accounting
for Transfers and Servicing of Financial Assets and Extinguishment of Liabilities.&#148; The statement defines the term &#147;participating interest&#148; to establish specific conditions for reporting a transfer of financial assets as a sale and
improves financial reporting by eliminating (a)&nbsp;the exception for qualifying special-purpose entities from consolidation guidance and (b)&nbsp;the exception that permitted sale accounting for certain mortgage securitizations when a transferor
has not surrendered control over the transferred financial assets. The statement is effective for annual reports for years beginning after November&nbsp;15, 2009 and is not expected to have a material effect on the Company&#146;s consolidated
financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October&nbsp;7, 2009, the FASB issued Accounting Standards Update (ASU) No.&nbsp;2009-13, Revenue Recognition (Topic
605): Multiple-Deliverable Revenue Arrangements&#151;a Consensus of the FASB Emerging Issues Task Force. The amendments to FASB ASC 605-25, Revenue Recognition: Multiple-Element Arrangements, permit vendors to account for products and services
separately rather than as a combined unit. Any vendor who enters into multiple-deliverable arrangements with customers that are covered by Subtopic 605-25 will be affected, the FASB said. As a result of the changes, multiple-deliverable arrangements
will be separated in more circumstances than under existing guidance. With the changes to Subtopic 605-25, the FASB is eliminating the residual method of allocation and instead requiring entities to allocate the arrangement consolidation at the
inception of the arrangement to all deliverables using the relative selling price method. Vendors will be required to determine their best estimate of the selling price consistently with the method they use to determine the selling price when the
good or service is sold separately. The changes in ASU No.&nbsp;2009-13 will be effective for revenue arrangements that begin or are changed in fiscal years that start June&nbsp;15, 2010, or later. Entities that adopt the changes before then will
have to apply them to their results from the beginning of their fiscal years. The adoption of this accounting standard is not expected to have a material effect on the Company&#146;s consolidated financial statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;26, 2009, the FASB issued Accounting Standard Update (ASU) 2009-05, Measuring Liabilities at Fair Value, to clarify how entities should
estimate the fair value of liabilities under the FASB ASC Topic 820, Fair Value Measurements and Disclosures. The amendments in ASU 2009-05 reduce potential ambiguity in financial reporting when measuring the fair value of liabilities. Therefore,
preparers, investors, and other users of financial statements will have a better understanding of how the fair value of liabilities was measured, helping to improve consistency in the application of Topic 820. The FASB issued ASU 2009-05 as a result
of expressed concern that there may be a lack of observable market information to measure the fair value of a liability. For example, in the hypothetical transfer of an asset subject to a restriction there will be no observable data available to
measure the liability because it is restricted from being transferred. This guidance is effective for the first reporting period (including interim periods) beginning after issuance. The adoption of this accounting standard is not expected to have a
material effect on the Company&#146;s consolidated financial statements. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-14 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3. OTHER RECEIVABLES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other receivables consist of the following: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Due from suppliers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">251,697</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">220,547</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">351,581</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deposits for ongoing contracts</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">874,260</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">215,694</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,029,114</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Staff advance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61,403</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">102,645</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,940</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,187,360</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">538,886</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,461,635</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4. PREPAID EXPENSES AND OTHER CURRENT ASSETS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prepaid expenses and other current assets consist of the following: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Advances to suppliers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">505,140</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">285,918</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,815</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prepayment for equipment purchase</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,293,747</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">389,190</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,160,927</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prepaid expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,965</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,798,887</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">726,073</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,300,742</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5. PROPERTY AND EQUIPMENT, NET </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property and equipment consist of the following: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Building</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,227,641</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,144,019</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,215,473</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Land use rights</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">284,940</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">266,500</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">284,780</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Machinery and equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,040,771</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">365,642</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,947,659</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Automobiles</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">56,428</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,805</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">56,148</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Office and computer equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">267,125</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">201,228</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">277,396</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,876,905</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,068,194</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,781,456</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less: Accumulated depreciation and amortization</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(680,778</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(458,673</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(853,864</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,196,127</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,609,521</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,927,592</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31, 2008 and 2007 and September&nbsp;30, 2009, BTL&#146;s building was pledged to a bank as collateral for
short-term borrowings of RMB10,000,000 (US$1,465,740), RMB9,000,000((US$1,233,792) and RMB 10,000,000 (US$1,464,920), respectively (see Note 8). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Depreciation and amortization expense was $235,867, $147,801, $210,231 and $182,816, for the years ended December&nbsp;31, 2008 and 2007, and for the
nine months ended September 2009 and 2008, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Land Use Rights </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There is no private ownership of land in China. Land is owned by the government and the government grants land use rights for specified terms. The
Company&#146;s land use rights are reported at the purchase price (RMB1,944,000 in 2002). </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-15 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6. INTANGIBLE ASSETS, NET </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intangible assets consist of the following: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Technology rights</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,623</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,623</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,623</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less: accumulated amortization</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(146,098</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(109,574</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(173,492</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intangible assets, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">36,525</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,049</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,131</FONT></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intangible assets represent technology rights relating to the anesthesia machines under the brand of Kontron. Amortization
expense for each of the years ended December&nbsp;31, 2008 and 2007 was $36,525, and for each of the nine months ended September 2009 and 2008 was $27,394. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7. TAX RECEIVABLE </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax receivable
consists of the following: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value added tax receivable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">552,968</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">354,071</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,163,479</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enterprises or individuals who sell commodities, engage in repair and
maintenance or import and export goods in the PRC are subject to a value added tax in accordance with Chinese laws. The value added tax standard rate is 17% of the gross sales price. A credit is available whereby VAT paid on the purchases of
unassembled medical components of the Company&#146;s product used in contract and production can be used to offset the VAT due on sales of the product. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The tax receivable as of December&nbsp;31, 2008 and 2007, and September&nbsp;30, 2009 was $552,968, $354,071 and $1,163,479, respectively, which
represents VAT credit on the purchased products. These amounts can be used to offset the VAT due on sales of the finished product. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.
SHORT-TERM BORROWINGS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has a line of credit for RMB10,000,000 with a commercial bank in China to finance its working capital.
The credit line bears interest at a variable rate and is renewed annually on May&nbsp;18th. Average interest rates for the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September&nbsp;30, 2009 were 7.84%, 6.86% and
7.66%, respectively. Pursuant to the terms of the agreement, the line of credit is secured by BTL&#146;s building (see note 5) and guaranteed by BDL and an officer of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On June&nbsp;2, 2009, the bank renewed the Company&#146;s credit line with payments due on November&nbsp;20, 2009,&nbsp;March&nbsp;20, 2010 and
May&nbsp;20, 2010 for RMB2,000,000, RMB3,000,000 and RMB5,000,000, respectively. On November&nbsp;17, 2009, the bank and the Company agreed to a new payment schedule whereby on January&nbsp;20, 2010,&nbsp;March&nbsp;20, 2010 and May&nbsp;20, 2010,
RMB 1,000,000, RMB 4,000,000 and RMB 5,000,000 are due, respectively. On January&nbsp;20, 2010, RMB 1,000,000 was paid. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March&nbsp;16,
2010, the bank and the Company negotiated (and on March&nbsp;18, 2010 the bank and the Company executed) an amendment to the repayment schedule whereby on March&nbsp;20, 2010 and May&nbsp;20, 2010, RMB3,000,000 and RMB6,000,000 are due,
respectively. On March&nbsp;18, 2010, RMB3,000,000 was paid. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-16 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other payables consist of the following: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued salaries and social welfare</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">153,952</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113,972</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">172,325</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,054</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,822</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,044</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other payables, non-trade vendors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77,833</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,514</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">106,079</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250,839</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,308</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">297,448</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10. TAXES PAYABLE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Taxes payable consists of the following: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value added tax</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,542,227</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,699,153</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,555,625</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enterprise income tax</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">504,445</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79,767</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">901,853</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Employee withholding taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,777</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,112</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,221</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Business tax</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,174</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">487</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">673</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">City construction tax</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">514</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,488</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">409</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,052,137</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,785,007</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,461,781</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11. NON-CONTROLLING INTEREST </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-controlling interest consists of the following: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">384,211</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">384,211</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">384,211</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Retained earnings</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">642,940</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">580,609</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">681,442</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated other comprehensive income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">178,081</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">103,039</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">177,440</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,205,232</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,067,859</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,243,093</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-17 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12. COMMITMENTS AND CONTINGENCY </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Leases </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The lease
commitments are for office premises and a warehouse facility, all of which are classified as operating leases. These non-cancelable leases have lease terms between one and two years. Future minimum lease payments under these leases at
December&nbsp;31, 2008, are as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="89%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:92pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ending December&nbsp;31,</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,328</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,527</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total minimum lease payments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,855</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rent expense for the year ended December&nbsp;31, 2008 and 2007, and
for the nine months ended September&nbsp;30, 2009 and 2008 was $32,011, $28,399, $36,174, and $25,507 respectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rent expense paid to the
spouse of the chief executive officer for the years ended December&nbsp;31, 2008 and 2007 and for the nine months ended September&nbsp;30, 2009 and 2008 was $0, $0, $17,418 and $0, respectively. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On December&nbsp;15, 2009, BTL agreed to lease its building to BDL free of any charges through September&nbsp;24, 2010. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Employment Contracts </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the PRC labor law, all employees have signed employment contracts with the Company. Management employees have employment contracts with terms up to
three years and non-management employees have a one year employment contract renewable on an annual basis. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Contingency
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Labor Contract Law of the People&#146;s Republic of China, effective as of January&nbsp;1, 2008, requires employers to assure the
liability of the severance payments if employees are terminated and have been working for the employers for at least two years prior to January&nbsp;1, 2008. The Company has estimated its possible severance payments of approximately $88,000 and
$154,000 as of December&nbsp;31, 2008 and September&nbsp;30, 2009, respectively, which have not been reflected in its consolidated financial statements. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-18 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13. SHAREHOLDERS&#146; EQUITY </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Common Shares </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At
December&nbsp;31, 2008 and 2007, and September&nbsp;30, 2009, the Company&#146;s Memorandum and Articles of Association authorized share capital of US $50,000 was comprised of 4,500,000 common shares and 500,000 Preferred Shares (120,000 shares of
Series A Preferred Shares and 380,000 shares of Series B Preferred Shares) of US$0.01 par value. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October&nbsp;31, 2009, the board of
directors approved a 3.6614-for-1 stock split of the Company&#146;s common shares. Accordingly, all common share and per share information in the accompanying consolidated financial statements give retroactive effect to the stock split. Prior to the
stock split, there were 516,722 common shares issued and outstanding at September&nbsp;30, 2009,&nbsp;December&nbsp;31, 2008 and 2007. The par value of the common stock was $.01 per share prior to the stock split. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March&nbsp;22, 2010, the founders of the Company placed an aggregate of 600,000 common shares of the Company into escrow. That number being equal to
40% of the maximum number of shares to be sold in an initial public offering (&#147;IPO&#148;) until such time as the Company files its Form 10-K with the Securities and Exchange Commission for the year ending December&nbsp;31, 2010, or the
termination of the IPO without closing, if earlier. The shares in escrow (Make-Good Shares) will be accounted for as an element in the IPO and the Company will not recognize any compensation expense upon the return of such Make-Good Shares to the
holders. To the extent the Company&#146;s earnings per share for the year ending December&nbsp;31, 2010 are less than $.80, the Company shall redeem, pro rata, such shares. Alternatively, if the closing price of the common shares is equal to at
least 2.5 times of the IPO offering price for five trading days in any ten trading day period, then the Make-Good Shares will be returned to the founders. These shares are included as part of the calculation of the basic and diluted earning per
share for all the periods presented in the accompanying consolidated financial statements. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Convertible Preferred Shares
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In October 2003, the Company issued 120,000 Series A convertible preferred shares (&#147;Series A Preferred Shares&#148;) for total
proceeds of $1,200,000. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2007, the Company issued in aggregate 182,635 Series B convertible preferred shares (&#147;Series B Preferred
Shares&#148;) for total proceeds of $2,000,000. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Series A Preferred Shares and Series B Preferred Shares are collectively referred to as the
&#147;Preferred Shares&#148;. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preferred Shares have priority over the common stock &#147;Ordinary Shares&#148;. Certain rights, preferences
and privileges of the Preferred Shares are listed below: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The holders of Preferred Shares are entitled to receive noncumulative dividends,
when and if declared by the board of directors. Dividends are not mandatory and shall not accrue. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preferred Shares Series A and B have a
liquidation preference of $10 and $10.95074 per share, respectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The holders of Preferred Shares are entitled to one vote for each share
of common stock the Preferred Shares could be converted to. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preferred Shares are non-redeemable. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On October&nbsp;31, 2009, each share of preferred stock was converted into common shares on a 1-to-1 basis. In addition, all preferred shares in
authorized capital on October&nbsp;31, 2009, were re-designated as common shares. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-19 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13. SHAREHOLDERS&#146; EQUITY-continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following is a pro-forma earnings per share calculation for the year ended December&nbsp;31, 2008 and
the nine months ended September&nbsp;30, 2009 giving effect to the conversion of all the outstanding preferred shares and the effect of the stock split: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,<BR>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30,<BR>2009</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic earnings per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.31</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.69</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>14. INCOME TAXES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>British Virgin Islands </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dehaier is a tax-exempt company incorporated in the British Virgin Islands. BDL and BTL were incorporated in the PRC and are governed by the PRC laws.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Hong Kong </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">DHK is subject to Hong Kong profits tax at a rate of 17.5% on its assessable profits. No Hong Kong profits tax has been provided as the Company did not
have any taxable profit that was earned in or derived from Hong Kong during the years presented. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>PRC
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BDL is entitled to a preferential tax rate of 15% as a &#147;high technology&#148; company, and is entitled to a three-year exemption
from income taxes commencing in 2004, followed by a 50% reduction in tax rates for the succeeding three years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In May 2008, PRC issued new
standards for &#147;high technology&#148; companies and required the Company to update their certification. Dehaier did not get the updated certification in 2008. On May&nbsp;18, 2009, the State Tax of the Beijing Changping District issued &#147;the
Notice to Tax Affairs&#148; (Tax Notice [2009]7013) to cancel &#147;Approved to relief the Enterprise Income Tax&#148; act. The tax rate for BDL is 25% in 2008. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">PRC government grants a preferential income tax rate of 15% to government-certified high technology companies, and under the new standard the period of
validity for the certification of high technology companies is three years. In 2009, BDL is engaged in updating its certification for &#147;high technology&#148; company and should get the government approval online at the end of November 2009 and
certification later. Therefore, BDL used a 15% income tax rate to calculate the income tax expense for nine months ended September&nbsp;30, 2009. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BTL is entitled to a preferential tax rate of 15% as a &#147;high technology&#148; company, and is entitled to a three-year exemption from income taxes
commencing in 2002, followed by a 50% reduction in tax rates for the succeeding three years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A reconciliation of income tax expense and the
amount computed by applying the statutory income tax rate to the income before income tax provision is as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended<BR>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nine Months Ended<BR>September&nbsp;30,</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax computed at statutory rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">415,332</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,648</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">410,162</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">270,300</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increase in income taxes resulting from temporary differences</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Permanent differences</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">415,332</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,648</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">410,162</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">270,300</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-20 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS&#151;Continued </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>15. RELATED PARTY TRANSACTIONS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31, 2007, amounts due from shareholders and an officer were $9,280 and $27,418, respectively, for temporary advances. These amounts were
repaid in 2008. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31 2008, the amount due to an officer was $969 representing expenses paid by an officer of the Company. This
amount was repaid in the first six months of 2009. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At September&nbsp;30, 2009, the amount due to an officer was $2,947 representing expenses
paid by an officer of the Company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>16. CONCENTRATIONS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Major Customers </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September 2009 and 2008, approximately 11%, 17%, 8% and 7%,
respectively, of the Company&#146;s revenues were to one customer. At December&nbsp;31, 2008 and 2007, receivables from four customers were approximately 17%, 13%, 11%, 10% and 20%, 12%, 11%, 10%, respectively. At September 2009 and 2008,
receivables from four customers were approximately 9%, 9%, 8%, 7% and 16%, 14%, 9%, 8%, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Revenues </I></B>
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the years ended December&nbsp;31, 2008 and 2007, and for the nine months ended September 2009 and 2008, the Company&#146;s three top
selling products accounted, in the aggregate, for approximately 73%, 65%, 61% and 57%, respectively, of its total net revenues. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following
represents the revenues by products, all derived from China: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For the years ended<BR>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>For&nbsp;the&nbsp;nine&nbsp;months&nbsp;ended<BR>September&nbsp;30,</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:30pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Products</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2007</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2008</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>US$</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medical Devices</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,814,682</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,281,865</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,292,406</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,057,131</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Technical Service</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">484,799</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">264,414</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,231,993</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">381,093</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Respiratory and Oxygen Homecare</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">114,949</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,233</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">898,061</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">93,630</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:1px solid #000000">&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,414,430</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,599,512</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,422,460</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,531,854</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-top:3px double #000000">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-21 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g53110424ibc_pg022.jpg" ALT="LOGO"> </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<DIV STYLE="position:relative;float:left; margin-right:1%; width:48%;padding-right:9px;padding-bottom:8px;overflow:hidden">
 <P STYLE="line-height:2px;margin-top:0px;margin-bottom:0px;border-bottom:2pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:right; width:48%;padding-right:9px;padding-bottom:8px;overflow:hidden">
 <P STYLE="line-height:2px;margin-top:0px;margin-bottom:0px;border-bottom:2pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P></DIV><br clear="All">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><DIV STYLE="position:relative;float:left; margin-right:1%; width:48%;padding-right:9px;padding-bottom:8px;overflow:hidden">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>No dealer, salesperson or other person is authorized to give any information or to
represent anything not contained in this prospectus. You must not rely on any unauthorized information or representations. This prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it
is lawful to do so. The information contained in this prospectus is current only as of its date. </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;
</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="88%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Page</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_1">Prospectus Summary</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_2">Risk Factors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_3">Forward-Looking Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_4">Our Corporate Structure</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_5">Use of Proceeds</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_6">Dividend Policy</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_7">Capitalization</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_8">Exchange Rate Information</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_9">Dilution</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_10">Post-Offering Ownership</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_11">Selected Historical Condensed Consolidated Financial and Operating Data</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_12">Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_13">Our Business</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_14">Description of Property</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_15">Regulation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_16">Management</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">83</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_17">Related Party Transactions</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">89</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_18">Principal Shareholders</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_19">Description of Share Capital</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">93</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_20">Shares Eligible for Future Sale</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_21">Tax Matters Applicable to U.S. Holders of Our Common Shares</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">103</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_22">Enforceability of Civil Liabilities</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">108</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_23">Placement</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">109</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_24">Legal Matters</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_25">Experts</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_26">Interests of Experts and Counsel</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_27">Where You Can Find More Information</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_28">Expenses Related to This Offering</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">114</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#424bc53110_29">Index to Financial Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">F-1</FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Until
July&nbsp;14, 2010 (90 days after the commencement of this offering), all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the
dealer&#146;s obligation to deliver a prospectus when acting as an underwriter and with respect to unsold allotments or subscriptions. </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P></DIV><DIV STYLE="position:relative;float:right; width:48%;padding-right:9px;padding-bottom:8px;overflow:hidden">

 <P STYLE="margin-top:96px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g53110424bc_pg023.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>DEHAIER MEDICAL </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SYSTEMS LIMITED </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>Common Shares </B></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>1,250,000 Share Minimum </B></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>1,500,000 Share Maximum </B></FONT></P> <P STYLE="font-size:96px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>Prospectus
</B></FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:96px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>Anderson &amp; Strudwick, </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>Incorporated </B></FONT></P>
<P STYLE="font-size:96px;margin-top:0px;margin-bottom:0px">&nbsp;</P></DIV><br clear="All">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><DIV STYLE="position:relative;float:left; margin-right:1%; width:48%;padding-right:9px;padding-bottom:8px;overflow:hidden">
 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:2pt solid #000000">&nbsp;
</P></DIV><DIV STYLE="position:relative;float:right; width:48%;padding-right:9px;padding-bottom:8px;overflow:hidden">
 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:2pt solid #000000">&nbsp;</P></DIV><br clear="All">

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g53110424bc_pg023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g53110424bc_pg023.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`0`#>`P$1``(1`0,1`?_$`*4```(#`0$!`0``````
M```````)!P@*!@0%`@$!``$%`0$```````````````$"`P4&!P0($```!P`!
M!`$#`P,"`PD````!`@,$!08'"``1$@D3(10*,2(5(Q8701A183*AL4)2LB0F
M=SD1``(!`P,!!@0$!`0&`P````$"`P`1!"$2!3%!46$B$P9Q,D(4@:%B(Y%2
M<@>Q,U,5T>&"LD-C@Y-T_]H`#`,!``(1`Q$`/P#?QTI1TI7D>OV4<B5P_=(,
MT#+MVP+.%"I)?.Z6(W;)"H80*4RRZA2%[_J80#JM(WE.V,$M8G3N&I_*J6=4
M%V(`_P".@JG>C[S&/$%D3J*1U+2BTGMU%T)$9)OG\O)36>WBR?;?$JHTDL;O
MK=F,H0%0*BS47.8IO`O6W<;P,J,"!NS2]H[=#*H66)+Z77(B+;--6`&EZP67
MR:,.Z"UWOU"$E':W?$]MW<+FI2P?3U;E%SM'M#U$=7R9\TJVBL`$"J/17;?=
M5>],B#V%Q7=!@"IR#1P0`3%0RR/8JB"A"XOGN,&'+'G8H/\`M64I>(]@L;/$
M>YXFNC#K;:>C`GV\;EG(1L>8C[V`A9!W_P`KCP=?,#TZCJ#4^]8*LE1TI1TI
M1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI
M1TI1TI58N4S9=K1`M#HTFM2X5"5CM/:10.%WS//Y]N@G(W2,9H%4,XELWF6#
M"<#]IC"R9.DP#^J/6S>UV5L[[5=HS7*F`M:QE0Z1L3T692T7]3*>RL/S*D8W
MK-?[=01(!UV,-7`[XR`_P!';2I-1V26K#YY,FD*O'V^'ML6TLQI5<JV?PNKW
MB$;1$3-6980$CGB1S@I:2#=27(`-X6U`BJ<2K@J'75.+X:/*180LK8CPL4VC
M]UH(V+,L?=G\;)=A&=9(-P'EM6EYO(/$QD)03JXW7^196%@6/;C9:6&[HDEB
M=;U5:M<AKQ6;;0+AD(S!+W24K3%8A7+6[,$Y?JC4%/Y;:?6_NJZ95"JZUFQP
M6E\TEC`9:1CA2!$Q@44`^TY/M[!R<3(PN7V?8S[&R70>6*23RXW,8H_T)M(\
MQ.B/>]K"V$BY7(BR(I\'=]U'N$*L?,ZKK-@3?^V/5L=NK+:W4UH^P#=,_P"2
M>14G:<QE`DZE=XE.0:E5\22,0_3,9O+UV;:@83,)V`DDE6KM`WU(LD/ZE$!'
MYTY_@^0]M\O-PO)KMRX'L>YAU5E/:K+9E/:#76.,Y+%Y?!CY##;=!(MQW@]J
MGN*FX([ZF/O_`-OZ?]_6'KWT=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4
M=*4=*4=*4=*4=*4=*4=*4=*4=*552\<@K%4S/&R,9AQ';59VV^:V<BH:J1Q7
M#<W[4G/_`,-EYI%0J8A\J961U2'_`&@4P=C=;3A<!C98#%L[80#Y,1G-CW?N
M*OP.ZQ'=6%R>4E@!`&-N%_FG"BX[_(3^5_"E?[)S)Y+61_(Q])V)-@T9B8CF
M!X>\6+YODL9H)A`WR[=KR]$RR)DFZP_&8_VQ4NWU[!W'KIO#>SO;6,BR9N&6
M=NC<AG18JW__`#0"6=A;7YKUIV?SW,3.5QI[`=5Q<9YC_P#=+LC!'PI5&R;;
MJ4@+]CHFZ\G7Y'K5XFZ)KW.[CEQU0(FH00<L75.R>'7.U1,F44?@.]$P_()3
M"8WUZZKP_"\7'M?CL'C%L1;[?C,S+/@1).POWW"]EZTKD.1S6N,O)RR+&_JY
ML$'X;8A^'6JY9?R!0=/VF0&=42[2D#6;#"8S46&G?Y5C=&QF7(@OHO#32;LH
MFU/+DL106F*-)&\EX>P-RH-CD*JGX['R?M\K&>6`G@BDD1LB0P^@8<A=(N1A
MCUV[#:/)3I)$2S`V-8K$Y4%A@7BE9480J)/5$D1MOQ)'TONU>%OID%@=17FF
M+HP;KN$1NDJ:D6J*HTY%Z@Y.Z;6=&MQ,FK'\?^2KP$1%TCK7&BWH'I=X.GV7
M>1)/D6*8X'$U4.%(R@B%?O8GE5H18H79;Y6&+Z>AF1G[C&'17-E(%JHDR54V
M,C''=482'Y@H-H,C3_RX[#T9NTKUUO3!?7[[`H7C#K%B9:>1:%RKD!)V(E^J
M<`S6DR99S/IZ2+6T1U1B&!5/DK?(Y`[65B$4`(W,_?%*F8"%4,'/_P"X'L&;
MW-Q,;\80_*\>J>E(Q"^OQTERA=C]>&=T<A.NU3?6U;3[7]T)P^<ZYMUPLIFW
MJNOIY2#S!0/IGT9+:;CII3G6.V7*7LCNP3*LLWM2$Y'U.3K59.E,C7;)+D0D
M67'3,F:PDB9O26<.9)W?+.Y(9O7R?(DF*2:8_%QF3A<.+&$$.PXI0NKO==Z+
MY3ES'YEA+77%A!O+H3<G7H"\C/)-ZLA(FW!2JZ[6.H@C'0R`6,TAT3IH!I<_
M/=@BK:A'MY-6.9RDD\=QL>M'.A<P%@EH_P"4\VQIKYR*,A:HZM>)4'4JDU2C
MU5^X)&_\(:;R'$2899HMS1*`3<69%;Y3(!<(7ZJA8N!U%9_%STG`#V#DD"W1
MB.H4]6"]"U@I/2IGZP]9"L_OMC]XT7Z[-=H.%9WET%MND3==&TWN/D+<K7FM
M(CY5T#*H1[D[1F\-_+SYD5G'@J)"IM2D./8#@/4VJH+<7KM[9[C[AC\*I_EO
M@WMTK*UNEQ5MO5MR"UY);,H:D>5QO9Y$];L,G?HN9E8^&9.?C7.HS35^=)0I
M2#V#O%-H[Z7EQY_):U#>-;<5.!X+35JIL>C,34J7.KS&R6@LZNBX^TB'XQEI
M7K%<.NJY=-DW(?>]B"H82`<`Z5.RW4T[WB'[!7_*W09JA.N*/(##B1%77LI;
M5IW^/'%<>F0D&3'^&26IUSL;QO*+`\^5(%4B)G(D?L;N7L*J2+4O67_(%IV7
M\ZAX8<B./:6211-!)15MVC]PK][I+9O-'%*F6MTQ94N'^W@IQ59N1YYO`6B3
M*G!<H_"IV55LTN*\7(3WO7FJ<LY_B]Q4X/:=RL4K\B>N!;ZT\FHA"S6>*27<
MVM"I-2U"182L'7TD#E!^+TB#DZ2@E$$P`PS3;I<U:^8]M<K54HK^\O7%[#*H
MXEU`:,2S^<8[!H24F1`%G#&(5FMQ8#(KIE[F`B8"J)`\A*`=^HJFWB*8'Q]W
MAQN>8JZ=/X[K?'QLC(RK4U5WF*K58M98R)107/9E6M>M-JBT*\[(H<45E'93
M&*B<QBE+V$516:^Y?DPV*7Y.6?%^.7%%7:Z%&7AU7*Y<H.4M,U:[36(1TFUL
M=WC*36X%\[<QK=)%RZ;)IG-\K4A#&.7Y/I-JKV=]-1#W,XD5,IE>,G/D!`I?
M,Y>(VB`D)A`.XD$X`/@(_IW^O2U4V\14(R/Y&GK^A[<I0)>$Y)Q5Y1FF]<7I
M\EBDBRLC>P.W"31O"N8=Q+)OV\HJY7(0$#D*H!C``AWZ6J=AJ_O.KGUGW`?C
MM$<C=/HM]L%?EK%5*T-6KK>'1M<=(6MLNY03DF\K)M&*"D<+<R;DA5CB50!`
MOEV[]14`7-J7#3/R`J;H>9_YHI7!;EY/Y&-B<T\-(1:Y:QIXVMF4AW5<+,RU
M]CVYYA`AP$4`[G[=Q`!`![3:JMG9?6I;JGN&O-\@VMFH_K'YU6^MO5'"3.?K
M<+E4Q#NU&BRC=T1O(L=#6:K&;.$C)G`IA\3E$!^H=*;1VFK"X+[!-*V?4JWG
M=A]>G-#%X:?,]2=:;I%3IB=&K:S=FNZ;!87<';Y1\R0D%4/A34!$Q04,'?L'
MUZBH(%NM6=OO+OCCF6PU7C]=M7K,'MEYA'5@IF:.EEPL]FBVB,@NHO%-P0%L
MKY%BUP*!E2=Q3$.E18VO2AH3\D'A+:K!*U>F9)R]O,[#.'Z$A&4C$D[:_03C
MGRD>Y>G8P%I?O2,`<I]@5,F4OU`!["/;I:IV&N`IWY$'\GHDW"WCUO<UJCF#
M8TJ%?O\`#Y[;;=9)<C9<"1!Y'/AH=?3A?Y1OW.H!9AU]J;L7^I]3!-J;?$58
M!K[Z./+E&15_VK>P9`8]B1Z"*_%*VE5>^4C'QXMF12OC`HY)_(?,)3"4/A24
M-W[@`#%-IJ]6X(/6$U,%9O(^/%5<KMFZ4O\`@U248JG:IK*J&2OF1VA\Q3,8
M1[*G.\6./8?H`_3=N$:.2%"X9K"Q'I94E]>G[4Z`_`;0*USD0R2':0.T>>%;
M:?KB8C\Z2UR3CD]'D/LY2Y(:0_CA6,%9C[#R*YNRK0PB!'36/SO&D,BX_P!9
M=)]P$`>E*B8Q^PIB!>NS>VI#QT>^*$XR-;SE,3C5/<3-D?<93C^G7QKGW+H,
MM[.XE8?2&GS".^T<7I0*?ZM/"ERW^J,Z(LIW8SU%5*5-T4KF1X-\-%6QBB8P
M)MZQ"O933UW1B@8157^X=_(?NH81+W'HN!EOG"VY)QTT')\A?XNP6$#P%ETT
MK4\J!<;J'C_'#Q+?]()D/YGOI?VT6F#=$!*#F7<C9XB00FZV[8<A[1J<G#R+
M!11RG)(-X_+8J$4?HNS%$JA'Y"E-V'N(&[AO_"XLZ&\Z*N,Z[7!Q$@#`Z6),
M[-:W4%?\*U;D9XF%HF+3*=RVG:4@]]A&%O?]7^->6Q[<QLM;_D5D6322DUY6
MT&B#$,U8PU^E6B$+M-0*S`1^UI^T1((3228E*FVFDC&3'Y4SB:O&X63&R?3!
M)C4*F[J6B4EL:2_;)CM>,GJ8SKH15,W(QRQ;]`S$M;H`["TR6[$E%G'8'&FM
MZL3PLA[<>;KVR24BS8W%\B9CAJ=L554KC%_F\;(1TMRSTIHL<R"U/XRTUXY!
MF\<`(24R5!JB(@DJ`:[[SFPQ!)PT:DX2F^3Z8\Y$Q#+@0D:^IFR`;E'R1[G/
M45E?;T4YD3/<@3D6AW?*/3!!R9/T8ZDV)^9[*.AINV9[C"$:)%44M<?EM6I+
M1-H4I%QT9''+A-F2AVI5`!-^?E'[(-+5,\<G`0?1=1-Y`)"*%4ZY'R7"3%KV
MB;E99S?_`$3D1K=CW?9<1#90#Y7GTU((K?,/DD"@$N,-(_\`Y/28Z#O^XSY-
M3VK%W7O3;L#@9_4+5/11W+2%_M0L3`;[/4Y5)*)AIEK'H.X7B'D,@S.!:[3,
MKC%VY;2[8_&K(/U?A$Q55%_AY/S\^/Q6+'+8OZNYL59!YF4DAL_(!^>2<W]!
M6N$47L0%OO'&1RYL[(2%,=EG*=`;7&-$?I6,$>H1JS&W4FS-&C1LP:MF+-!-
MLS9MT6C5LB4")-VS=,J*""1`^A4TDB`4H?Z`'7-&=I&+N278DD]Y/4UMZJ%4
M*NB@6%8.?RCJ[*U'FA@E[G%:Y8*W9LFD)"(IS2!2A3E;4RS1B4TG;9]J8S^R
MN;2L]*C\I_$6C)N1%,`[B(Q5Y#I55KO3(RP^R"^;;OO%#2]'XWV^NI2W]DYG
M5IU[`%?SN.02%-1K@,Y*($\+6IU1'Q_]P'9)']P&^H"\*D#32HHRC)\R@Z=P
MU8Z3PGWN>MM"Y#7ZT<MY*/I=C(CI^#R4HQ6I%,A%49]D5Q(Q$:DLFH1--D<I
MC=Q6.(]P5-J=3^.?@VA5CFGS#UHF5VS,L5?55Y!T.-NA#1<JRCIS059FK0B4
M,_>NI57^.KK'P57_`'I%.3P%4QQZ&J'T`I?NT:'6\D_(>M%AJ+&N8U3X#D">
M)TI<(%6]UF2JBL&+S59Z2I[EFX-XVJ((Y7<-F9#"V=#]PV`%"E*"I'R4NBY;
MPWMW-_;9V1V75VV(V/;]YGH!Y1]"GJ,NYJ\K9;A)4).*?N^Q:U#OA78@<%6Q
M109F,42%-V#I4@"PJ*->46F,?AK3:]OE[G>4=+4B(6A+:G;=-1BZTG60=O[H
M64E6#:)BG)Y50K`B:*PNC%*)SE*00Z5/;6Z'TE#EO*;T_P!*PN?M$Q9FK>+T
M'*]ECHJQ62"LT8-@M,[,+0*MB;+LIA`DK5IE`/F:.!(=NL=(#]P.4L5:;1J1
M;RHY+8MZEN=+O$O4G@F8NM60@HO--4N6B-[SL,RYNUHE(]>-S+._N;RQ/".F
MYE6R4I\/=1T[4(@;L"(^4U7\PUI:61\ZO9+0^8LY<*GI5[NVSTVQ:]99C([1
M:;I:\U,]A(>T2-\B`H0VEND_CZY')/%&3--83IG;I@3R$H`+PJ;"U-D]$+KA
M-S7Y1W.R\CL7JS?FE6+LKR%S*X,+9HIX#0%A>*2$^\>5BTW6RM)&UT^?6+(E
M\S'3.@J4Q4R`V^HU#WMX4V;\G7_\X6?_`-\YI_Z)SH*H3K25^`^"\1]J]8.-
MI\N:!S2U.LQ_)GD2%0JG%JO66X5J)FTVE%._G;M"5F->G:3#ADX!!B[<_04@
M5(D(#Y=U5F]].ZEO\LWF#&]B%?H_$_,-CS[C_!3N15YY@[F!O%8O)W<&RAS:
M9'/<]6F%)D\_.J(.UEB&$BSHZAC"!!-]%2+VUZUMLX%:-PEA]4E:)QIX@\EL
M`LM\@EEIFTZ9@6J4>I2+&K)K2"$8[MER?R<:Q=G^Y4,W1`4A<J?0!,8"ATJV
M;]M41]H&%<@*][6>(?-2L81J&O87G&9S4!=I'(81M;[)`R":-L35([KGWS!T
M1,K>;27*J8Q4#IE.'R`<OCTJ5^4CMI)OX_5!EMAY>\M\^@=$OV-R]VPB[-8S
M1,^D/X6^4E\IIL1(M)&*<@8Z:;YHLB5-9$XBFH03IB/8>_2I?I3`O;8?:?61
MF=3<-O:GSWT?;=46D4,SI3N?CF%:*Q@%HX+'9+7,MA%1M'1R<BDFBW0\G#EP
MJ4``I"G,"H47[-*F_*J)[CJ]Z<N4>LZ#O.NV7DAH$-F>F8#40E_DU_-*!7+Y
M3;)?7QK4822B<S<,S:R2@0@&.9)N7X0_KN#IE=M3Y=UJTTWK-F]X7;.%)U]$
M';(&1*"$-49HI3>0G3=-@M-=G1CWJ)C#XJM_C/\`\>_8.LA@\DV$I41JX)OJ
MTB_@=CI<>!O7@R<09!!W%;>"G_N4V/B*RU^UMWHB^XZ3B]2VS;9VJ9WD.4P3
MFJ/-"DH^(E^0/(:^I5S/636%K)(.,30BJJH#TS0$A24+Y&,7L4.OJ'^U2<>O
M!X_,Y>%A)EY&7.PD$0++BXD6^4EGW&[/Y=U[UQGWL<L\C-QT&1D-!%CQKM+D
M`SSOMCT7:+!=;6L:13.X="JS5WEJXW_EX>!9VQY7SMTA\["#:WP^*9DLJT4_
M>NYT._.BR!BE-W%%=02]_B-V[GC\Y.(88<D[9G,8>_T7C;)G%^P11`I\0.^N
M;2\;'ZDDD0W1H&*V^KSB&/\`&23S?`GNIF'IIVKAEQ<Y,;/7^0S]FQF[&VC<
MWSC2;3#L9'.F"<2^,>RMI9XNBY5J\I99ALCX.5"`U!-'XCJE']>:_P!X^%]Y
M>Z/;6'D>WU+01DS30HQ$QW#R%0"`ZHI-U!W7-P*V[V!R'M[A.8R(N5($KVC2
M1@#&+'S7/TEB!KTTL34`>S6[<2MTY[62V8`FO)YTG%5Z#MZ%-CF43$:;IT,#
MJ..SSY)`&2+6&F&Z+9!]+JD31*9)RZ(*ODGYY_\`MIA>[.#]A1XG/V3D"[M&
M9"6:&%K&\I-R67S%8Q<ZJIMK;&>\,G@^2]RM/QEVQ-JA@@`$D@N+):VATW.=
M.I%]*^%"VU2>43JT.SB;/*6<C**GVC0!AJ)<DJ+XNXG(X)X;^E6.)>(E0"0M
M[]10I+-(H#\@G[EZOS8GH#[J9GBBBNR$^:6/U-&R''UYV3?9CJ!^RATM5N/(
M,I]",*\CV!`T1]FHB4_3BPVW2MIZC#MJ\&$J7>X6;-87*%%KOJU_L\Y,<>G4
MTQ.3^]]+>('@=/Y_ZC#F`IZ[DV(0*2D9E\4Y(3L9`BB!3"!NM)YP86%BY,W*
M_L<5CQ*N6%/^7"#N@XN!OKGR7(?-<'M(8UL?&G(R)88\+]W-E=C`2/GD.DF=
M(OTQ0KY<=3W7%:U^/&&U7CEC]-R*HJ.GK*LQYAE9^2.*TW;[3)+*2-JN=A=G
M,=5[/6F><KO'2IS',*BHAW$`#KY-]P<YE>X^7FY?+LLDC>51HL:*-J1H.Q44
M!5'<*[AQ?&P<5@1X,%RJ#4GJS'5G8]K,Q))\:FKK#5D*PV?EED!7D)Q"2'N'
MR8CJ9!$"B<2E-=JX4QO$.X]@`>I%7$Z4FK8]_P!*3O\`GNR[/PFS""SR=;YU
M"D:Z7@:2+C487-ZU4X6PHM]*G82)EI5]9(5J10[ML8RC<'8?$<W@!NIJY7XY
M#Q''?CAN.BZ?@"O%SDC@&LDE5L6HMJDUKG9<ECK0TA[0@2W9V8D6M"3E`=N%
MH5`72[E!<B8]P.(^7452"3UK5W^.A(<:7F;V>RPTIQSC.56FQ2DW<<TPFJJU
MF1HN30$P+*M1U[39_+&N)=W*NSO0\U!,B5T5-,1$%0*-4.3^%)5MR:3K\F/[
M<Z!7:0\VH0KM`R(.43-Q8(?.5TEXJ$%`4N_F!P\1*/U^G?I50^2N.L7#CEHP
M]IO(*X0W`+4MRSFS;+R+C8^HNH)UGM%ME3N86N*:R,;?I6">UF#;L&D@5\P<
M?$9+Y44_`/J'2@(M:^M4_P"8.<Z'QKX[U/C=<<.?93%H[[9+VT4M?(+(=FND
M?:$Z>SK$_4%8;.ZW!3]9:@5FDNN$EY`9V3Q*0I_+I4@@F]:QN'-HY5\0?2#@
M+G">)EXU;D/;ZS:VD14X9E$0L[5'%TF[G+4O2KI$2ZC"1EX2-9.FBYF_D#HR
M:J1!\"&$2NVK?5M:6-Z?_5IM><<E+3SY]E55<XS1\64E[_&R.VS,&Q=V?6IY
M^)SWZPJ+2KI./A*PL_6=@[=J)_+)'1`A3%(80C6JF/TBJ,^JJ*=Z+[T(B>JD
M:O<ZHGM?(FQS,S"M%)J`2J,O%W]`DS*2#8BS!&$E"2*:9%%3`FN*Y2%$PG`!
MFJCHM6/YD>J;G'P&Y_M.3G`K(K?H67-='0U++7.=HMYAW3'$BZ,\LF6VRO(N
M49)*NJ_<NF*1P35:NHM8"&,4X&*$'6J;@C6F:^^'6+EM7IMR_5-'R6RX+<;C
MKV8R,YE=S=-G%BJ+X%;&U.RD56Q4R%,N+?YDBF*50$5">90-W#J:A?FTI<GK
M;]I%.X>>IFWY!E]ZS9KRUL&TZHYK$)H<O-5R$I4#;(R&2C=)=22-9F8B=-%K
ML1%&+*NFNLL)1/XIE/W5)6[>%4IXZ\=^`=VQ[D/;^9?/JL0?+S2':LED=DK9
MM5MS"C6<KI68D+E>K##T\I[0ZNTDN+9TDB<PM&0F.4#+"0"JJ-QH.E:'_2Y[
M,IJ4)6>&?(_D%E&YW%H`U_#="H;[1K)H%RCV1DP:UZ[,)"BM&Y$(.&;K+A-O
M7B!RMR)HN"F.7Y1&J&6VHZ5'/MXEM=Y">ROB3@;1]?\`'N.&0M)&VZOI-ALJ
M^29Y;5W)65EL"<%99&=KT?>$8^NQS./%NB9SV?.CI>`=C]!0:*32\OQE$7$C
M[$N2,LS;*N8Y#*KBHZ?-4C+1[;^1TIL9B"CE(HMT@>`4WP]Q#Y`*(E[AT[*E
MOEJ;ORR5D37OA4!%$SF"OZX02D.4YP.,M2``GB41,!A'Z`';Z].RI3Y?QK6A
M\:G^T[XO$_R_[>/C\/$WR?)_C;Q\?#MY^?E].WZ]^H\:M_5?QJP_2HK'OOC]
M2Q:CKFR.E!=!8^2G,O;VC@Y_C.6K\-,J;XSD<>\5`1**<3JUX5=-P\OJJ@4"
M!Y%-U]><"@Q^+Q.'06]/C>.QB/U\A.<C(('C!$`?`]U<(Y-C+FS\@W1\O*FO
M^G%B$40/@)7N/$55]CG*5"C4E)A,5(ZA65<DR(D,0R-5X4<=C:%8T':G_6W2
M=;YK#@I0-^Y1=@AW["4`ZV=^2.?):$VDGB&W^ODLOTD([[8L`.G0,U85</[5
M+R?)&^O]&)!O8'XSRD?$"E>XS%C(2[PUD8S8STL"TPN]A8UA9Y59!ZJ+IX\F
M<LGQ:L],J2SDQS+)QKE)^BH8!24`X`4>H<S)Z<*C&:/T$LMF8HMQH`LZ7,,@
M%K%P4(T(M6F\=&7D/JAO6.I(`8V.I)B:PD6_7:=P[*L?(<8*9=XQQ;ZI*-Z`
MT1.LS?:;FZ5FT;`D':Y#)*L[G7(]@KN''QX!?(CEO*14@S0_3LFE_5-KD?N?
M,P91B9:G(<ZB&;9#E$#6\;D_;98_E*2(Q\3I67;A<?(7[B`^DO;)'ND@OW.H
M'K0>(96`\!J?U5N-.\9S6WEI?98^V7(7#9`SZVX=/,M)I6CMVSQ(U9SVPVVE
M.GKBBYVL]+][--5D6KMTFB8AP*;L)*<GW)P7(Y*XL>4N'RX)M'DJ89(21YY4
MCD`$LMO+$P+*M[C3JAXCD\2'UVA.1A$:M"?4237RQLR7V1WU<&Q-JV+>LKB1
M$8MFYMON=JK.I<@]LA(5Q=[[5UF3NIU2LQK<A*UCF:@R.HRAZ+06H%:$0;_&
M11=$1$H`4A0^/_[E^[9>9Y+_`&3#BDQ?;^$["*)[B1W)\^1-?5I93YKF]@>N
MIKO7L_@X^.Q/]PG=)N4R%!=UL551\L4=M`B#2P[130^N8UN5'2E+UYC\JN`7
M':^YC$\MAI2FDW*'G3Y:TEL>E=4M[R&CWC/^<1KQ(*G6J69M@>F1,HDGX`H<
MH&\1\>X4/*D9`8ZFO7C863E`M`MU7J;@`7^)%=[GMUX3>R+$D9RK,LJY)XRP
ML+F#-'62GM)B.K5LKZ*!7,4[K=KAT7U8L$6T>)?TS((+D06+V_8<.\JZN-RF
MXJW/CSXLGISJ5?K_`,_&OBM_7!Z[W!U"->'W&9=0G?Y2(9;2E3E#OV'Y"IQQ
MA#]WT^O^O55ZM%F[:\V&&]?N(<A-"XU<?*QBV6\@6U-@;GI%'SVE,:K-FJ"R
MY0KSR=DHV(9L'2`K2H&00,X,H'RB8"?J(4;T+;+^85=,$_HC(*GT2;`]EZM!
M&XWC%7N,[IT1EN9U^_V%<[RRZ#'TJKQ=NFG*I2I*.IJU-XU"8D%U"%*43KKG
M,(``"/5=61?H*D8'S,S55Z1T@JT1(JHJX14*LD0B)1.J(F2$X#X%#N(!]>E+
M'I2\\GP3UN\H+)-\K<_P3';[;G%[ETYO3+#DRT?..;Y7S,ADY-=K=H&.77D6
MRHHG!\#82J*?O(H8WD;JE7#"ZG2KDL4L#>G*+-8&W70_"F&MG;-T4?LW+9P1
M/Q*;[99)8J?</VE'XC&`O<`^@=55:KA[K%YCI=0M5$OB-/N%*L39>I7"M3JT
M9)0LDWE"BW6@9EDNJ=$QW@#X@BH`',/Z!W#I<55M8=AO7'XAQHX_<:X>0@<#
MQS/<DBY9P5U+(4>LQL&K*KI@()'DWC5$KV0!N41!(%E#E2`1`@``CTJ"2>M1
M5L'L`X?8'ME+XZ:]N55HVRZ$2L*5&D2R<M]_+$N<Z[K=9,5TVCG$:U"5FF2J
M!/F63["7N;L40$;;2HK;&/F->F+"RIHC-$A,2WN?AJ:Y78^2G`*][I!\%=QL
M>/Z)L\^ZB)>(PB_5!M>_ED%XUY,0SU2.F(&7KS.1"+0572,J<BJ:8]_IY!WG
MU$#[+^:BX>4<<Y2H?0';5GZ+DV+9+#DIF:YMF.;0*KUQ*)U6DU"K5"*5D9`2
M$=R)(6#CX]H=X]%N4%%@3$ZGQ@`B/B':NXZ5YM3KV5U\BUJT2T6?R;."8LVZ
M2JRSATU8H)$302.NJ83J)E`?!%,QA#]>P#TN!UH`2;#K52JWSLX;3_']?E=4
M-+@YK#&=E7II]"K51L\FG_<:4JE!.(MO%Q5<7L+@Z<HL5$YDVQDRCW$Q@*`B
M%L2H5W@^6O4<+)688[+:8B]KCI_&I%W3CGQEY?42KL.0.6TS6J0R79V^K(W>
M.63+%N9-@4J$@S544CY*,5>,7)2JI"9/S_:"A!,0`"Y>O+8JUNT5]/".,G''
MBS6I"`P#(\^R"O2BZ;^7"HPS.,/++%`2H.)B7/\`)(R@(%4$$ON%U"I@80)V
M`1[KTU)\:AN[<..!D1:K;RJT##<DDK+6$+!H5FT>U1/]UH0A8MF::G[&E'2R
M\M#1[IJVC_N#';-"*@8GD7]_ZP2`+GI50#NP0?,385V2?-[BLKQ87YGDUJ!'
MB\WB0EU=6%A,EKY8@UC1IX.P:&BPE3MO[A7*T^C<0\Q_\H"(4^HFSU+^3OJ]
M]ID?<?:;3]Q>VW3NO\.E6F?OF\8Q>R+LX)-(]HY>NE!_1-NT1.NL<?\`D1-,
M1ZNQHTDBQIJ[$`?$Z"O(S!%+GH!>LZ,IQM+8Z)$UDR8.5;=D5+9.VQBBJ*<C
MS%YJ*ZK8CL'!"%5,Y<YW1G1U?J)O@\!,'B?KZ(B]R'&SGRN@BRY"#X<?QWH)
M<=+":46[+W[JY4W$>KC+#VO`H/QRLOU&_$HAOX?&H7UCCC9K_G^CQ-2$HV+5
M<WV5Y`%DTS*,D+9S(YP&K5767=E`RJS%S1J)\9S`01!HIY%*(=N^9XGW%C8'
M(8TV5?[;%R<<-MZE./XW>]AWB26_7YA6/SN)FRL2:.#_`#IX92+]`V5F;5U\
M43^%+=O7$*_\7G"%0Y$9^RR`I954(.1T$+!>>']W?$)\*3^C[;4_/3N.MQ>B
MF!TCKG.@GX@=?^D(IAT?!]W8'N=3F>W<ALSR#<(MD7(1CNEQI/V<N,="`+GL
MUUK4LK@LGAR,?EHA!YO*9-SXKGL*3)^Y`Y[+FPZG2NYK].?TF9K]LFWTAF$\
MZ:))5&UZ3=5<_?3;,X@9!+(N=^1,)W*])A$VX@9)K>XM0`3$"'.@/<0\.1F)
MFPR8L"KE0`_N)#&)0I[?N.+R"L\+7ZMBN-;D!J]$4#X\B3RDPS6\KR/Z9(_]
M69$#'(/"93\13.<.ITS7IR/NELKHURV39BDB]*FFK#CCJUH5>E'[<*YR6P"4
MFN,&W*JIE3^W9V-FR7?$4[*I*"8_;F?.9L.1`V%B2>IB(/-"I.7`EOY\/*5<
MW&[;M"S!;:$6%;EQN/)%(N1.NR=^DAM!(U_Y<B`G'F[+!P"PZ@ZTVOCK`OT+
M>[D$`DX]R1/QMX'A8V@65TX.S,>/:[#G$6(T>4G%DU/EC;95P3:R0)JE,'@/
MCUR;W'/&V&(SL9+_`+?F,J`7U./,W[JI?1X)KLEQVZUO'%1L)RVH<?-H$;IH
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M`TB>N$K"-V#1C<)/3K[9W^S7MU89=94\A&M&C4&\810R2(&(4*8(R'!UL!W6
MJOD\N)L22(&-F:0%;,&('A8#:-/SJ-N8'$;:-BUSWE<FYCBYM-MM[2"QC)^'
M2<92;\E89^592%?ITY?<E0AA9.[4UC8YG]ZH[:@Y0;H@H?\`Z3&#JEXV9I'*
MF]@!5S%RHHH\/'$B!+L7N1;M-CW7Z?PJ[O..K<IJ=PE]:&91O&6[<DEX2/SQ
M'?I>;@]6U7_'3EA1(2,<R&@8CF]OIUGU6125E'@IH2#L6C)XR\U`^42"%R3<
M(U&V]>/".-)EY#M(L8-]NH6^O8Q!`_#K48>J'+^4>,<=?;3HENR+;J6ZMTY<
M$\"R21SO1*<XE#1=#LY(>7RO+K'+6&=B6<N^G&21&[5T\,0S<$@75%'N$0JZ
MJ[$'PJ[R4F-+/C1HR&P&YK@]HZD6!Z5&]@XW\XJM^.1G.4T>G;]_N,O-W:V3
M;*+&L+6KM+*D3VCV5>PQAX151*YG.6+81*ZS-'LY,W.8@!\8F'J"L@Q0JWWG
MK5:Y&(W.M*QC]!1Y3IMO8?AWU8WU`<3="SOE3I_(,T9N=%SU3CU5J`M2+9AM
MWX\T";N3!>+34-%4'1K_`':X6&RHMH,SY_+=DVR[UX<2=A/X!,*$.6U`MTM:
MK/*9,;XRXX*,_J$W#!B!XD`"W<*COU,>L-AM4SO/+3FUF6]U75Y#FE<M0R6G
MWNQZCFC2*A(V<;6:O3CJAK/(5";;.)EV<J2CM)=`[5NFF4H`!P,AAW7=[AMU
M5\GR)B"8V(R%/1`8BQ[+$7[-*U6=>RM;K'MSV]9/(KV.>T/EQ8:[!V[)V>,X
M[QX/QKV.]UNSPV67"[UY]!R-HA8^RH,5$95)DM)21S&8BJHDJB41\?(PAX9(
MFEF:VE@+&MHP^0@P./B5MK%F;>H.H!O;X=E>_B3Z[.4N;^[_`#?:.0T/:=+F
MC9-H.Q;=R!AJC8VV*/\`8KI%SD-7Z51[%(L"1B*5/A7#%JDU\R+B"0B)0'ZC
M*1L,@%A<VN3XTR<[&?B&B@LHW!54D;MHL22/&J02O#CF7NFB\HC;52.5M6W.
M_P#,5K.9]8(K`]9L\ZPI[&S"G$#0^1!;U"8[1<M9QCH5W2:K9P3X6A!25$0(
MF%O8[$WW7W=U_P`Z]BY>+"L?HM&85BL?,H!/BEKD]U,`]B&2;W*<^-FF=7XX
M\G^26'UG@'+9_P`3`SVGW#2<_<<BGE)3*2TV>/J[Q*.@YI&VF=&6</TEEQ\"
M'(FH`I%ZKE5C(=P8KML.O6O%@RPC"41R1QRF>[W(!V@]`>ITJ*[7Q/Y25STD
M>N7BQ2L9W!CHNH\HJ58-UKM:J-QC[5FE9F[G;Y^PRF@MXQLA(U:,:J/&8NCO
MB$1!,P^?T#IL<0*@!N3KUJM,G&;EY\EW38L9VDD6)``%K]:OG[3,TTFQ<[N"
M#G0\.Y';YP4SK,M.=:33,+K5OO3"=UP\6\8TEG<JW4)".=$34<-V/BY>'*T!
M(Q_(P=CAU<F!]1;@E`.RO'QTB+A3"-XTS&86+$"P[;$_CTKQ>P&FZY1>(_`W
M,<(X5:G=,R"ZQ\EH5`NSC6=]DN/U>>M0>,H[2,SS&_Q4]KXUPDZZ3;,G4NK'
M,%VA"@83$3$$EPBJ%-OXV_A3":)\J:2:51)MT(VKN/Z6866]NZYJBG$3$^8E
M!X%>ZV?<X=NT+/:T\-5^/^(N,QT>J+3+%1E-PSN4RS)K`_LL_$QDI&6I$%46
M[Q\5,C3XQ54^$1ZM('$4AL03T&M>S+FQ7S,10Z%5%V:X/<?,PMKIX59ZM-7M
MG]"^D\(T.+W,")TK,N*=8K#^K6'C5?X5>UZ7:KJS=MXO/F[MF5S<PB+P\!U)
M*-$C"QC$U'BA0(40ZN`7QS'9KA>ZO,UEYA<OU(C&TA-PPT`';W7'3OZ5IHO-
M<<6^ISE6;R:D.%@9&B7DBW(8SMO%OCD0E_LA*=/XGRT8=8B"@]RI*F*<2F`!
M*.5P<E<3+3*9=_IMN`["P^6_@&M<=H%JU?)B,\#0AMNX6)[;'K;QM>U5RLF!
M60R[N2K;^*;2(34K9(9-N0K5C#RL?4V>:Y0U2;+(G`T7FU;7<2GB42BYDDQ*
M!0!81#8L;GL4*L60K&/8J-?4L#(9IS<=LS@)X(;DZ6K%2\9-<O$5#[BP[@0H
MCBT[HUNWBW9K7PZKQY=Q]SJ9#QH1],JU@K#QFT5=@\,2HXE41J./0!E#`987
M;FS2*]D<"!S`FJT2`P^2Q@"_D^X4DPI2&W9LJ."0+?N9,GJ9#?`(!".\,>P5
M;AXLK.FEL='4@7OY8EVQ+\=Q+GNL.^K?3L!!6F(?0%FA8FQ0,J@9K)PLY',Y
M:)D6Q^PF;OHY^BX9NT#"`=RJ$,4?^'6HX^1/BRKD8KO'.INK*2K`]X(L0?A6
M=EBCFC,4RJ\3"Q!`(([B#H:7-/\`K!R&!<S,IQINEWXONY]<SN>J%--&7;#;
M0Z,<RI_[JPC16U@H+]!RL?R7!HDP55^@?(```!T3'_N;S$ZI%[DA@Y-(Q99)
M-T>2@_1E0E)01V;BP'=6J2^S\&(L_$2289?YE6SPM_5#)N0COL%/C7*0W&NV
MX4C)F<U.O0L/(IBE.Z!QKAY)I3)I)T()2+G7.(%F=6"EO89=(QSNUJZX6<)I
MG4.FFW\2B7US>Y,3G&7;+(\RZK%F,ID4CY1CYZ!)`P^D3`"]@2US5F+B)^-!
MO&BH?F?'!"'O]7%8LMN\QDGK:U7UP^M-H&F,U6R$2@V?%,O&(5Z6<SM50C5S
MBX25ICN4*:9BJQ*"H#E*+6543CU3G32_8`&-H?-Y+3YA5BY==&WJ%<L-#Z@'
ME9U^4N!=P`3K6R<="L6.-H4`]-I)6WZ"=0IZA3\IN!4S=8>LA1TI1TI1TI1T
HI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI7__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g53110424cov.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g53110424cov.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`5@$@`P$1``(1`0,1`?_$`+4```("`@(#`0``````
M```````(!PD&"@4+`0($`P$!``$%`0$```````````````$"`P0%!@<($```
M!@("`0,#!``#!`@'```!`@,$!08'"``1$B$3"3$4%4$B%@I1(Q=A<208T3)"
M4C.U&3G3-*56-W<X$0`"`0,#`@0$`@<%!@<!```!`@,`$00A$@4Q05%A$P9Q
M(C(4@4*14F(C,Q4'H;'!0V/A<H)3)#31\9)SDT149/_:``P#`0`"$0,1`#\`
MW^.*4<4HXI1Q2HYR#DRO8[AY69EUTE48"/1L$^V3<$3=QE12?-VDS9A1,4QW
M+*%27%50I`[-X^("`B'-AQ_&9/(3)#$#>1MBFVADL2J>1:UA^FL7*RXL2-I)
M/I47/B%O8M\!UK@*!D5S+WO).-+"=(+%3WD=88-<I$DB6/'-O0.\KL\R(B`)
MJ-V$F@^AU#!V8RT:90W_`(@".1G\>L.!C<EC_P#;S*48:_)-'HZ&_<J5D'DX
M`Z5:QLLR9,N))_%C(8?M(VJL/(&Z_%;]ZF0![_Z/UYI@3WK/KSR:4<4HXI1Q
M2CBE'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'%*.*
M4<4HXI1Q2CBE'%*.*4<4J"LN9@)C]O.IQS1=[,U&OPF0):..W("$G2%K`YAK
M*LP='73'[BM1[5:0=B0BAD4$R?M'W0ZWO$<0<]D,A`@FD:)6O],NP,EQ;\Y(
M1;VN2?"M;G9_VH8(+RHH<CQ3=9K?[HN3X"D8MU]1ITU.2<M[EKA\5,W<U9&B
MC=28=9*TNR^=!P]L<,545',\[QE/N47[_P!EN8PD;HM@_P#&#KM\/`.9#'##
M:*?+8*AN%$/(X][(W91,H*)<]26[5SN1D_;NSR7DC@!+"U_4Q9>K#]8QG4V'
M8#O41S-XME2E*]7,<2S2U;":Y5;^=X(6*_(O$;?:8SWLN'].BI(RX)6"[U6%
M8)I`<#J+)2L>FY3`$I`_-M#A8F5%)D<BAA]O<C+Z64+?-@<@F@D86^2-V-[6
ML4<J=8Q6#)DS8[K%B,'Y/$CWPZZ96(VI0'NZ@?'<H/1ZM'UUV$QOL]BFN9>Q
M?*F?UZ>(NW=L79/MYJM3S!4S6:J]BCS=+1DY"/B&171.`&`P=AZ"`\\P]Q>W
M^2]L<M)Q'*)MR$L01JKJ=5=#T*L+$'_&NQXKE,3F,),[#:\3=1W5AU5AV8'0
MBIQYI*V-'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'
M%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'(O^BE)YMF0L=7(?+E5>0LA=\,G
MF)I:H/)>+:AD''4PS10R1CU5)\Y32.K.1#%%RU`0$QWC!%(/14P#V/M,F3(?
MB<I77"S-JB0*Q]*923#,+#\K$J?!6)[5HN;`2(9T14Y./<[20-Z$?O$-_$"X
M\P!WJI6:R0F<,=0>)++&2,K(-IS)?QYY,FGA5:]DB'?).G&4])LM/SJ'32D3
M(G=1[1!T83&[3$H`=L0>>KP<:;9,_+1L(5*P\M`HL\3"P@Y&`>'TNQ7IK?1C
M7#R99/HQ8#J9#>3!D8_+(#?U,24^-KJ+^7<4CI,AL;:RHU/IM@G,3UV2R!)6
M/3>[3HBPL6EFX<>85;]J/?'JPE<-,77V25%M%)K"#([==#T$//KMSQ\F(\^9
MEQQY>2F.J<A$FJ<CQ[:19\0Z&>(#<Y'S`@^5<Y]TLZ10X[-!"9BV*Y'S8F6+
M[\5SU$;G1>UB*E#!&Y!]<LMLMK?PJ]'Q9EF^H82^0W`[$IOL\#[)LSFCXK,E
M>@R=&:U:]%0%8RP%!-85!33'LY>:SG?9X]Q\2?:N\3\KB0')XG)/7*PSJ<=V
M[R1$VMU%KGI69QG/GBLX<V%,>#/+Z6=".D&0-!*H_4?J3^BMK./D&,JP92D8
M[;R$;(M&[^/?-%B+M7K)VB1PU=-ETQ,FL@X04*<ABB(&*("'/E62.2&1HI01
M(I((.A!!L0?,=*]J1ED4.A!0BX([@]#7HYE(UFZ9,73YJ@]D3'(Q9JKIE=.Q
M3+YJ?;H";W52I%]3&`!`OIV(=ARI8I70NJDHO4VT'Q-"Z*P4D;CT'C7W\MWJ
MJCDTHXI1Q2CBE'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q
M2CBE'%*.*4<4HXI406^UY<AGSU&L8LA[8Q`41BG@7TD.HX3'P!S^3;.JXM^/
M53$P^V"1W13@'J8H^G-OB8O$3(#E93Q/^8>ENMX;2'%_.^VWG6#/-G1DB&%7
M';Y[7^-UT_MI&MA=C]H*/#OE9.T:5ZL1Q$A4"SY:S%-7^S%9F`06594%I6*"
MFK*H%_<DBB^?@<P>I1^@=O[?]N>U\V8".+FN4DO]$&.L27[7E+RV![DJEA7-
M\IRW,8Z'?)Q^$@_-)*7;_P!`5-?(,UZIRO6:IW*SUVP>;H?(EMN=UY?9MM*-
M?'6%Z$P2'HSEJ:X+(_D0;>HD3=G*L(F$/J`ASV'`X6#BXPZ\-[>XD#J>2RQD
M2D]CZ=[7[E1:N"R<^;-8J>0Y7/)Z?:0&%!Y;R+_CK2=7G$D')*/FDCI3G&V*
M)MS&_,[4[]XR@I)5%BH)06?0$\6J'16<F`HG3%P/N==)@'7ESL,'EIXPK1\U
M@Q"_TX/%S,MSV#KZF@\=NG>M#E82-?=QV3)IUR<V-2;>*G;8^.OPJ**CD%C0
M'TG@_*\=1,1:W9>GX-Q58K&F4XO)TQK!FR.056J><JO*1=BG91B="313+-)M
MGA47C0YR=>0EZVN7Q[Y\:\WQ33Y?N3$C8.TT#0KFXQ/SXSJR*I^6_IEENK6-
M84&4N*QXW-$4'$9#+M$<@D.-,/IF5@Q(L?K`;45(&5;.\L2%]L66VS5A/_D*
M_AK>^OP7C]B\LJ8J'P1O+35(\!1(L_$Y#2$BQ3`BB?W"H`'Y%#K`XK%CQ6@Q
M^)):#:^1Q;-U"6_ZGC)+];?E1NGRC_+:LG-F:42SYPVRW6+,5>A;_)S4MTO^
M9AUU_6%8R.1V[.3G;;F=,D\55I':P[X5^..@J:_429*V0PUL]$E1%1HI.1O;
M$3O2G*?\K]N7]%.9/\M9XX\7B#L(9LWC'/\`E2K<Y&$W?:WS?+TV;O*K/W=G
M:?/^:X&-F*/SH=(<D=KC3YOUK>=7(?'-\B*&#\7Y%U!S9).;YES7V1B:SKTE
M%G.>4V$I%O5)_I4QJQCHJ"9$6+]FL#DX>#:"<HK&*((J=^._U%_IXW-\IC^[
M^%40<1R"E\O=:V))'_'+ZZ&X86ZM*"H.HKO?:?NL<=AR\#R),N=BD+!;K.CG
M]WM_`@W/1"#V-/(TO3]&4O<Y;KJ6-M]-;ME=DLXQ#8LQ'XQ=OA25::UX`CG*
M,FF>UD!4C9XL@V<K>[^YS[[HZ21>';`1HH(<2'?B3$_9XS':9@.N9E$;?DZL
MH)`MHNU02>E7)<22232;9X[?<3`7$=^F/"#?YNQ(!/C<V%.1CC,;IZ^CZQ8J
M^[@I9[&-)6-I":YINST*@I-3DC+-EZ?>/R1L))S*:11^R]U=T4WD)3.0*JHG
MQ_(\,D:-E02*\08JTEMJ2RW^9(%`W,%U^:P7IHN@.^Q.0+,(94*N5N$ZLB=F
ME8FP)\-3\=2&+82#"59MI&+>LY*/>)%7:/V#E%XS=(F_ZJS9TW.H@ND;KT,4
MP@/.==)(G,<JLLBFQ!%B#X$'45M5974.A!4]"-0?QK[.4U56KK\F/]A&<T_V
MIFM;<#XGI^7E*0RCHR[SDM-R2)D;_)'(92I1B$87]SR(!0J#DA^S@Y-XAZ<F
MU5A+B]-<X^8#,.((.C06P'QZ[<3^4+#1J]>II?7S$EAR'C=@UMB"DE%1#6Q(
M^ZH,W&QQDDY!LL5-5L[\R"7H`$8IM'C58NR?]HZU4G(R]4Q'JA,0;&!:"PMD
M-G\LI3+_`!%J26,#R.>5ID<ZD6DU2Z`2./%?R]1*7Z<FU3L\Z<_"/SV9%G<:
MUR;RU\;^[KJX3#<9-5UB/`-YGZ`ZB'H_<0KV`G))JFXEVSR-.18%RE*DI[@>
M'9>C"J-H\:MZU&V^6V]Q3;<BP>!\UX8FJU,R5?;4+8.F2V,)^8DFT6C(QSIJ
M$FR6,:!D3N")"\237*D;R[*)BB7D5218VJC%W_93=8RV>_Y<-G-*I?!BM?R*
MC0LE6HV926DU);JO2-1M9((<8P*DW!`V63>E,1PDHHR.!R%$W1!FU5;-+BFS
M^5'YR\8?'S*8\H>/*O`YYR?=8AM<).%;W!.'A:M1I%N5>#F'LJR8R_O/+"4P
M*-4/$G;82K=B4Q>**M]34(ZS_P!@FRY$JSZU9H^//<IA'29V+B@2NOF$[=F.
MK62'.5R1_)K69^E3V903<ID(D#4KI,X>?9P$O0Q4%1V(IEP^<[%YDA6+H3\I
MAT@\P$Y--IHY?),1*<H"6V"'F0P"`A]0'TXIM/E5N^(,D-\P8RI63VM2N]#:
MW:":SS>GY)@TZS>X!%V)_;86B`3>R)8B5*0H&.A[R@D`P`(@/8`JFM5G=+^S
M/,X6V4R9B/7W#]&RCCS'<R:J)WZ:L$HB:R6**`&MC6BTHTOVIH9M,D50:K%.
MH#E-,%0$`-XA-5A+B]-_KS_8LU9L&)*K-[&-[A2LM2B#AU8ZE1,:V^=K\#Y+
MG*S8(3#P"'D7`-B`<ZA2E((G`"AZ<6J"AJ:5/[#'QQI$.JK9,NI))E$ZBJN)
M+"FFF0/J<ZASE(0H!^HB`<6IM)Z5R%$_L"_'3DNZ53'M'M>3+#<;M/Q=7K$&
MPQO)+/):<F7:3&.8MTRNQ$5'#E8I?]G?KQ:A4@7-6!;L[?471K7VS;$Y&@+-
M9:M5WT0P>1%228K3:RLRX,V0,@G(NV342)F+V?M0.@Y%0!<VJFJA?V5M?LJR
M+Z(Q9J1N+DV6BV19*3B\>8Y8W:2C8TZY&I)%^PK,K*.V;$[E0J8+*$*F*A@+
MWV(!R:JV>)K/D_G_`*DLY!FC\??R$*O#*"D5HE@.84=&5#L#)`W(85A4+T/9
M>N^+4V>>E<Q_Z[S+OK_TW?DAZ_Q_Y;[-_P#!XM38/&F0U0^5B+VCS)$X>5TY
MW/PDO-1$O(LKOF3"-BJ=%(YB44W/XM_/N$?MH]T^;^X*`JB4ASD\._(P!Q:H
M*V%[U8%E78/!V#!A"YCRS0<9&LBJJ$`%VLT77AF%D?'W4HX)%P@+HZ?F'8$[
M$.^14`$]*KBVQ^;O2337+B^%\MNLF.[6E7(&U$=TRI1L_`.H:RLP?1+AI)JV
M2/%<'#8P&[!/QZ$.A'ODVJ0I-(MEO^TEHQ6*/*RN(J5E3)U^;JM$HFF6%G#X
M]BG_`+JX$=*/+25_;#QQ&B/9N@8+&.(==!]>138:P[`_]J;4RX14VOL!B&_8
M7F6CYNE!1U/FHG++.9CU$1.L[<R*S2@'C'*"P>/L^PL!BCWY]^G%3L-._KS_
M`&`?C^V:S7CK`F.9/*2-[RE84*M4PL5-BXV(<33E)55LT</6]H?K(BN")@*(
M)&]>3:HVFUZ>_8NO4,9]L^M#7"*1YR&59+N,H6"W0T@^0;'%,Z+0D$<&IV*9
M%NC&'HX";G8>W<G/$!3%.;9'N!"D;`$^.[6]<_RL6/Z@>48_S+8F1F!-O"W:
MJRKO9<>TTSMA5[IH;2)IN8Z[-U1*%?=BLG$$HG*LI$TFQQCYJLZ(8I_`0$>S
M^G?Z<]*P<?D,P"3*AYV:$Z$2RQ8D/_%(C`V\:Y#)FQ,>ZPR<;%(-1L1YY/P1
M@=:1G(M=SUDM"04DX+?C,E2,"RWWV1IFJZ-8+68K^(IHP[>!6A;1&11Q,4?(
MY/,I3!^H!SN>/GX'C&41/P.'F::1*_)Y(([L7W(6_&N:RXN3S%.]>4R(.MY&
M7#AMY6LP'^%5XWK&].K[M1"QFT-H\FU=^*\':=B9#;6=8@`G2(2603DG3MZ"
M#9,%C%4`!4.</^T/7/0L+D\S(3=C?SV>(BX:/$&"I[_+\H`N=*Y;)PX(CMG_
M`)9')?HTYR6_$7UM_;2L7^O8D6CIB-:Y7UX!<S9TLFYQ[JOE>#646'I9%K%6
M$D:=FT]TY`*101]M(##Y#USJ./R>6$B2MB<CMN!:7.@8>!+)>YMX=S6DRHL#
M8T8GQ+Z_P\:46\@UK#_"LPQOFQK)5!K:;$4UJG,35Q7#^78M9NJH?+FJ=D<)
M1[)^JQ<`11:S8AE"H"U5<`"A$RQ20#TBIS%Y+A6CS#BXW[J#+D^X@:__`&^<
M@N1<=$R%O<#0DRGN*OXG((^.)Y+N\"^E*/\`FXS=#KU:(VVW[;!V-1E;[JSQ
M]9`K[U]_+HV)A7N-G\F10BY<H8"LC<7M2<@^4$&YYNG)+@W:."^9TG)5%@'M
M(!#98F$_(X_KHOHR.XF5=1Z.4FD@MU"R6NP[K8=ZPY\@8LOI,?415,9/:6!A
M=#?]9>Q\;GM3\:/PV0ZLWQYFU!FPM.QEU:26NNB#.4CDP<140DXE2Y`V2MON
M^3I>NXGJ\FX:QCU4OB!$3HE_8T]."][S<=EMD\,2T7MV!ER^4*GZFLIBPT[;
MYW`9U'<ACJ]=+[<3*@$7)65^6D!@P[CH+GU)V\5B4D*Q^`^FK9L=Y>C_`#I=
M<Q"Q)D&K4:^.\.:JQ<TX,J;9?;!851S!M9D!=0/)[CW&;P7*B:[CR**XE5`?
M(I.O)^0XB2TV3R[?;Y4\`R,YE%OL\'_Z^#$.TLPV@@=M.EZ[K%ST)CAP0)88
MY#%C`_Y^3_FY+^,<9N;GXTXT-9:C_%[,]<V6PVW"U%NHUN[V1HJ!;QO#M295
MNDZK,$Y*J5RM0:]/!]D@T;'!D*Z1T>P;QZIN<A-C98RHT2*.'F9X-\2'^%QN
M#8V=QT]5T^8L?FL0?JD`K?QS0>B[%V?CXY-KM^?+R>ZK^PK:6&EP1T4U9/AB
MOY#:0R=CR6];1L]-,4`;8ZKHD2IN/HOR]]E`,"$33&3EV21@3=/3=`H<!*0/
M;`HCYOS61QSS?;<8I;'1C>9_XDK="Q\%/55[=]:ZWCXLI4]7+($C#2-?I0=@
M/$CN?T:5-G-+6PKJ]_ECJ\-4_DBS)&S.)W^`*@ZM5?GSP)!=.[-)U&64*]<9
M(?%477>%LMU:)JO/:$_DDKXAZ=<FKRZK4U;^9RM7_.O2:+@S-F9J!@>?H>LL
M34F:5VL$0]CJK/8_I34\U(LPDP03G':#H[MV8P]&<G.(CZ\5`4=Q6727QUX$
MM7RL9(U(GMBK58,9,,+6/+ALV2\U`O[)/VZ.H+.V_CY&6=/UHQX+B2742.(K
M&6,"?7U[XJ;G;>VM115XJ\#\<^6-GF^XN;XG).+L^1N&:ABIEDA\UA7U'38L
M/9F4F"<L212*T35$B8()?;E*0`#BEAX:&MJG^N!<KEECX_[8[R9;;/>GKS+U
M[A59.SSDG,2(Q:C5HW.R2D'KA5RDB0JI@`"'#P$>PZ'D5;?K6HQL,3&>*?E6
MN$96H$FUN-ZWGXU8''>;&CU8EM9KS!H*4QQ,N)A5-5<D(X75:1<B*AB$(DW6
M[$2"')JX+[?.U-%\R>7+9KCOA=L.89@ZUC#&52Q/@0*WCPE8@Y0E21D\3UV2
M=P9'CY%ZNH1DY<'(``H8A>NB^G7%!J*Q.Q?(Y\C^'JYB2&1W[?-$;AC2OV^'
MIE,J3M^G1(21>R,/"U>5&+@3Q[6921B!4%LD(BFBHD(A^\..E1M4"E#R=LSO
M?A;9>]?RK93,<)F#^9ME[W(1=PL$2*L\^4:*/"JPJZX,X]8I%?$Z)4$RE'L/
M$.*DJ*[)BQTG(F>=-(VCU;*DMC*^Y/PE4HM?*K:/;SE@A5K)5HHMAFF:#PZ:
M)IUTU=./:<"(&1<*`J'[BAR*M#0ZUJ`["_&MH_\`#!D3!F?]FLGY1VS7>W%S
M(5;7V"@*-7G-BDH5,'J=MM+J6DT4EZM!2(D.H@8P"\<B4I>_`_4_"KF[=H*A
M+=O^P%D[*E[JTOI;5U]=:%&UQ6/L=:NM#Q787LS8?O?=)*M'48VDTT6R3(03
M\#*>7?KT`"`<4""VM8M=_F?@,_Z%N-5MC*YE`,N6BQNULBYOQ/3<)L_Y-1$Y
MIU)1M,CXZ:/&N8X!(#0CAR0"*^37Q*82G,'%2%`-^U7<_#C\-.L6/K/AWY!:
M#GN?SY`2E*7F\:0E@JL%"H5BQS34[!V^E`8++G//5@3K(D((%]IT0%BCZ%'@
MU2S=J<K^Q'_[768._P#[FHO_`)JKR*H7ZA6L!_7VIF9LB9$W@HF`LEP&',DV
MS5:(@XS)E@:O'B-.8R.4X!M+RL8BS[,2>)&*JE9+&_:W<&*H'J4.35QNQIX\
MC_#)DG177783;>?WVR#8\NX:J*-PP^IC6Y6.+386`[\(R7>SHS<LY4?F792O
MMI)D3,7HQS#Z@7B]4[KFUM*5?X>\T[?;[[/RV&LT;\[2UFJL\=R]K1D*YDO\
M8^/),5")I-S.'2()B@8INQ`.Q'BJFTZ"MU[5;`G_`"^UNQ5MSL/EW85[-S!)
MC\WF"[(V^6A6Q&:#0D9$@B!",H\5$S*&].SG/ZCZ!R*MDWK65_M9D2^XTJ67
M(3V4[5:/)55,!33\?LSF_>8/$!`@"(^OH`=_3DBJDJDWYR7["3W#J[R+?LY%
MFIJ_KZ*3J/=(.VIP''T>(>*[911,!`I@[#OL/U#BJEZ5LV_Z6_)N?$VM$EI-
MC+3JRX@EM<\6N7@93I%);VV,MZ=?;)397+V0026E6T@ITNFH`#XAV!A$PCQ5
M!T-5V;L[M_*/\?["IK;#4'X_8^:NSM=&O4^L47']DMKEDT3$[J;7A&!3NV<(
MBIXI"Y4*5,RQ@(`B/%2HOXU;%\&NT^>=X:'?<H9]UHQ+3*Y5YUFWQ9E^GT&(
MJ86R43\DYIC%,/L"*&+`G+T+]L?P]PPIB/D'(HP`Z5=MEIW)QM=4D64_(0;9
M,#MGYFU3;W%E]NX+T9Q)1`(GDUFJ)0$#`W$3"4PAX&'KK:<2L<F2$>-7?J+R
M&,W'8->P/QK`S2ZQ;E8JO?Y=P_$=?T57ADS)-U;0#]NVSWL.G&0\6_?/6.N.
MM]'A5!AH]DFY=`SD\M0#Y*.(W;D4$YTUT5.P-X&*``//0N,XW#;(5GP./,KL
M%!R\R5AN)L+K`XO<V&H(Z7KE<O+R/3(7*RM@4FT$"#0#L95-M/,'PK6PS!LU
MA*_SM-GZ]K7DO8=W=;=9*S0LC;EY^R#9FCR;KKEHUL3@<;4J:@8&'C(5211*
MH4%EVI/<`0```!Y](\1[:YOC\>:#(Y+&X](84>6'C\6)"%<$H/6D5G8M8VT#
M&U>1\AS'&Y4T<L.)-EM+(RI)E3NVJZ-^[0A0!<=R!21/-OLQ2YP0I.+-<,9P
MSB,E)4"U;77$[Y5E#QYUH]TX&VVBJ3MK29)NFP("8[X0,J8OD(F'OG:)[0XB
M&YS<KD<J<.J_/ES@%FLP`1)%2Y!O]/05SK<[GR&V+!B0QE2?E@C)L-/K92P&
MENM2+J#2]D=_MDZ!@)YE6UU>!M#)Y8+5,0298>.@J1&,'#Q^Z3AX<D=&G6<H
MM!0:)*%]DS@Q0'Z\U_N_,]N>P?;>1S\>+%)/$0B*WS%Y"0`-S;FL";L>MKUE
M<!C\S[HY>+C&G=(7!9F70*@!OH+#M87[FG@^07X=9K0O$*VR^.,OSF4H^,G&
MU?OT3/UQHV=-H:W)O8]U..7:#ERW=L#+JIHJ%53`R:ZJ:A3"8`\>(_I__6"'
MWYRX]M<EAQXLC)OB9')!:.Q"@6%CWT-B`1TKH_='L*3VQ@?S?$R&E0,`X9=;
M-<$GK<=C<=2*ISP[1H:YJKW3*TF\C<-8S(W),';K$&P65RHJ*D!BFEF7(LL\
MG9]<WLHB8ITF"!SJB`%`0'V#F,Z;"`PN*16YG)^G3Y$'YYY.@"J-3W8V%<#Q
M^-'.QR<YB.-AZV^IO")/VFZ#2RBYJTHURFHES:FD[*LL9Y6O>-F4;DV6C3J(
MUW1+3-B5#[+#E73.0?'+N2XP4$%4C"=T<S@GO]KKR)R>7?9P3)$V.K9/$P9)
M,*FV[D^1-[Y#_P"A";D'Z=#MT6,'M?N9(RXE80YLD-I"/IPL0=(E_P!606%N
MIN+ZES4_XS<W"5DJ/#8X:?Z;9<S=C17'.O\`"/G'L(Z7Z&Q*`FNV;+<Z.5,\
M+?LG0Z2B_P!VJ*3A1)8QA\S%)WHN37"BCGFY(_<\3A90FRF`N>1Y-C^[QHQ^
M:*%K#:+@$=KFMGB'(D:),0>CGY$6R`=/M,(?7,Q[/(+FYU(/>KA/COK3#/%G
MB,N5R$6A]1M9(MYAC36`DD/%:YS4892+R/L;)E.F4KF6M#DBK1@X]!(DNZ$"
ME.JH)O(/ZA93\%BOQ&0X?W=R;#(Y%P?X:GYH<-?!4!#,/$)V`KO/:T*\G.N?
M$NW@L-3%BJ?SD:29!\VZ*?`MW)JZC]1]`_W_`*C_`+_3].>+VKT&O/)I77"_
MV2P$?E.RM]/_`,.84Z_4>_XBZY(JZOTURNT]4PRSE\'2=O:Z.R<U9=6M?9I=
M;,N4-I*Q?D$BX]BX<C>3B\6.U:>5!/\`%"9(R)4U!*(`H3L!$TU7:U*AL-2H
MG6N$Q';;CIMJO::)G6EK7W%M^QUE;:2P5.T5]!ZHR6]E](9/@WK.4163$3M%
MVZ:Y"]"8`^G%+U*)\#T5E"U&:L&+_C3JAKK4H:[1,/.[+[7!-H0<Z10[,)9K
M$7&50C9`AT3IK-SJ^\F=,0'T$HC%1>MY;XD,>V+&FCV+:[9,;8>QFLX4F9Z'
MC<&OK#)T.>JT\^-)5FU(R-N#^4O9>;B%TE'BC\3+F6[$1Z$`"#5IM6TKK\L^
M)E5^5')"2@G\%-T9-(PIF.F<`4RB)1$BB8E43.`#Z&*("`_X<FK@.EZD#YGL
M$V/7;>*YTNV9AO&=YMU1Z%8EL@9&7(ZM3EC(5=DK&0CQT03`Y:P##P:MS#U_
MDIE`0#BH0W%J^FW8"VEP/9]:DVQ,N3^',KX]Q=E&+R!C[%;ZV/Z]6+'(J-)]
MHU>1\#(I'LE449JJ)$55*(E,CZ_7I4W!&E+-O30YO'.Z>=J%/Y$L^4YJ`R@[
MC'F2[@11*UVI<SMOX3DTDMTHC)J`H!CE-T)3!T(>G%2.EZ[++4*'=:X:0XL'
M,&8I*_1E!Q#&6V=R==P09/V=3)6T+(<DPZ*H8JS>N1RAT2+''S%ND0!_ZO(J
MSU-==;\@VVV1ODZW<EKM!L))ZQLEE88KP%1^CK*Q52&7_%UII[*`*B1[-.W`
MR$@8OD4JZZIPZ(`=35T#:*G7Y@M-ZUHNZT[P3#MT1LK'7XUCR=-E*`+6'),[
M,M5K&_54`Z@>TU52(T1`@@G[;<#`4!.;M4*2:YJU:!*9&^&K!>\>-X<Z]OQ+
M<<I53,+1@U\UYG'3G(DJ,'9E4VZ8JK.ZO).CH+J'\CF:KHE#HJ0\7[4O\UJ?
M7^M1\AQ<4Y3D]'LFS8HT/,,BI.8<>/W`@TK^3A3,+ZM)F44*1!O=VY"@D``8
MQWZ:1`\0,(\@G6U0XJ^+^Q'_`.UUF#_99J*/_P!55Y(JA?J%:WW]:K$M*SOG
M#=;#V163J2I&0M3F==L31A(O8A^=B[R=!`*K"6CEF\A'/FZ@%.DNBH11-0H"
M40$.*N-I8^=?G\Y^*]!]-7L'K5K3$7F1SH_3;6'*$Y.YAO\`:(/'U551*M$U
MYQ#2MA=QKZRV(#`Y.1=,2LVA4S=&,M_EJ*23>U5W8%H]-U!O.'9GY`-8<B.\
M0;!P$/<*Q=(*YW*@VN+QW(&.T=3==;UV6BD)1XS<&(LZCY`"K'0$/;$OD!^*
MDWM85OH:"Z*Z-X>/"[/:?35NL,/DFBF81=B<Y:NMXK4U6I=PQ?F`T38)E^R0
MDVCN/(4WFD1TT4*HD;P$3EY%6B;FH9^=;.&L&"-3J[9-E->:KLL27R/%05`Q
M[8Y=:LNBS"[=9S/3,+:6#9>6AG,;7D%3J_;F3%=,/`P^(]<5*WOITK0XWU;8
M]6R72;9C'!['72IY%P[5+VRQ-'6*4M:%>2F'$RFS=#8)D/OI%2;C6R#WL2D!
M,'`)E`0+V,U<'2NS,T8__CG6;_\`2]!_\@9\'K5H]:T!OD^14RK\VN2Z9?WT
MI9JW)['8CQVK'2$F^.5K2Y/^#L'=>BU2KE5BHXS>3<B4C<4P346.<.CCV*KH
MT%=CCCNC5#&=%J=!H-=BJG3:E!1L)7*Y",T6,7$Q;%LFBV:-&R!2)D(0A>Q'
MKLQA$PB(B(\BK-9GR*4AOR;YD/@K178Z]-%1+-'Q]*5:NMR`85Y":MQ0KZ#%
MJ!0$1<JMGRQB`'KV3T]>N=W_`$SX;^>^^..P7'[@9`=R>RQ_,2?*X%<U[PY#
M^6^V\O*7^)Z15?,M\MAYZFM0;)M&;8GB)6HI$2.IJWIU4,=*E/WY/\][32+.
M(L[E%,`[3G(VL6UG(>0B"B8QPF$?(H!SZZXW.;EITRR3;D^8DF\EQ<$%D'^Z
MSHR^>[SKPG,QEP4,7_XN/5/C-DFS?!@K`_\`#47O</),V&2*NT*G'2<O?\2Z
M203DA?>CR2,0A'O=DIQL8GDFH@A+)Q\K[B8G\B+*&[`HAWM(^7+28^5)\T:8
M^1R3>-F)&&I\]NY+>0%8;8"JDT*6#M+%AKX7%CD-YV.UKCQ-1GB/;3+NK^W=
MIRGKU+0D')H3+NC+0,R#(:E;JQ7UT(<\(^.Y.@FW82SF&^\0%%5`Y55`$!,/
M91V7+>T^(]S^T8N,]PH\D902[EOZD;M\VX6ZE0VTW!T'XU@X/.YW#<\^9Q3*
MK[MFUK;64:$'R-K]>]/]\CGS-9=VAQ/':[,\42>`X:P,(T^;FDP(2$Y8'2+M
M-^E!0!7J#<&]5(*"#H%%2D=+K`4H@0A`,?@?Z=?T;XCVQRC>XGRUSYHV/VQ7
M15%K%FL3=S<K8?*!XDV'4>[/Z@9_+X0XI8&Q4=1ZU]6)O>POT7H;G4FJP*)E
M].N-*K*M"0ZTQ3%7K7#%2=H-7%7H4F],49O+EW!4ABS-F1$/<;%<`8I3@`@4
M$BB4WIV?Q#9#RQ/O$,]CD2`G?*H^G'CM]*'HUO[SIQ^-G^F$==F^,D0KH5C)
M^J5_%NXOW\J8"C2T6[CV$S.M'^3*\]O99"FTPR,FXO&YNPCIT";*P6AHX2++
M$Q1491P7Q0<D3,Y`XHE#WEG)6V@SH721H8"N-.L&V22ZB+C\0#54(.WUY%[B
M]OJZ!2VTQ75HQ+*IFA]6Z)J7RY[BS,.OI(>QM>]NI-K&L"81R;L3E"WZK4ZT
MFELGY5<Q%D^1O9&&.@XB,>T!HY159ZMXEDFKE1N1@R`",GJ2!RIJJD]H!(D4
MY^>=<]S?&^WN,A]TY<6SC,4,G$8;:-+*1KFSJ1>Y^I2;D#74D"NKXSC\SE<R
M3A<=]V;.0V?.+6C3MC1&_;HP'7IH+UM]X[Q_4<4T6IXVH4*UKU-I$#'5NN0S
M(A4T&$5%MR-FZ8>(![BIP)YJJ#^Y50QCF$3&$>?(G(9^9RN?+R6>YDS)Y"[L
M>I9B2?\`8.PT'2O=L7%@PL9,3%4)CQJ%4#L!69\Q*R*.*5HR?.-\<N[>T'R3
M9#R!@G7>]Y`HTAC#$$8QMS!FDUK;R1B:\NRDV2$P^408G<,7)@(L7S[3[_=T
M')%7%8``&E2RG_73^1*FX+<YE<FK63;9$,:VJ7"]6FIRR9,:P+B/.K*,V:;Q
MI^-?O*P[.FW)'Q[A<RI14,B42D`17J=XK`\>(9O?:B5;4+:7XT]K,TUW$^1K
M=D##-KJ:=\QG9Z.O<6/LSE9=N@HMC_)5]63`RWL"!0(!Q*7KKODV-20;W'6D
MDQIJ+LE6\LTRY7W1;8R]X[KUNC9Z9QPM0+NB:Q5Z,DBOR4]U/&@17*R>I)E;
M+K@D4QTS',!`$W014^5=C[\?F?<L[(X!CLD93UM>ZM`K*.H.F8RF'KE2=2JL
M&1./;24C$NH>%5@4G#A$Y6J`ICY-BD/V`&`.15DBQM6E%:?B]W[R]\F&2+M4
MM8<EM*,7:Z8N2=VN,0:CU1[5F^033!IR+GK0,9'RC)6.3]U(4#G%8.@)V(AR
M;U<#"VM7=_*+\#&9M^MIY/8.G9OQK0X>1HU*JY:]9V%F=2:+JL036+<KG5BH
MEZS%!RL@)B]'$?'ZAR*H#6%J4;8/X1X+3+7ZKY(R9M?O5D8L<^A:M/U?6EA+
MV-G67$HD[$DA$P<A?8)=I4TGB";8!(B0Q57!!%,`$1";U4&/D*IJP/\`%7M3
MN;L_)0V*L=9MB\,FO/W[G.6Q\!)5B11I+:73,:5LSY^XDDYB[+LDA[8,W+Q8
M5C!ZB0!,"]26'?K6[A\@/QMWG<S`F+L"4C:*[X+K=+@&E1NB$)%I243E&L,X
M2.BT8ZS10/6AN@=1:2W15A()3'3,!BF'@50IM28_'?\`UY<1Z2YRB]A;SER5
MSM<Z6BX/C>$=51A6*[69EPV%L>R.2DD9!66EDFZJB38IBI)M_(5.S&'HM-@"
M2.]&:_2J)?E\'9;Y,=VJW6</:<;`0-EQJRGL1N(Z>K`K,9AY&V-8XV9">CSN
M(1G6%FB8./NEUDR)H'`YQ``'E55BRBMK/XO-$['J]\>%6U0V*;5FS3$ZTORF
M1:[&+!*P"+'(<K)O7-9.^,0J3]PRC9`$5UD>TON`,*)S%`IQBJ&.MQ5+F3_Z
ML3=GD]:Y:T;6R>-ZXWF?S]2B++7W3NQ4-ZW=@ZC&L/9XAT+B03BSE`4'"A&Z
MQ`*4.AZ\AFJO4\JL/^5;6G/#KX>%-?*^&1=H<V0$=C*+FY2`@)*T7.]S,2OW
M/SZ4/%-%7ZC<SDQC@'M]II>/EZ\BJ0?FO6N[\0V`?EEU1RWFJQXE^/N[3\I?
M</IT><2SV]>Z\0;&&4M#"0^\J]JNC6,93%C*NET#1`QEDTA%;Q\2=\G2JV*D
M:FIA8_$!N^.4D,P6_P",-+*UQ"Q-[3*FRO\`(S0;C%VB7;N4W136EF>'8KRS
M0RJ10,B*Q">V4"!T7TXO0,MK58GM/C;Y5=S<;Q>+,_\`P_:S6>M5TZ2M0<L-
MN*##SU*51;E9D4JDLV?'-%]L2`@)!(HB*?0>'8`(*@%1K>I?^)_7+?K4J_'Q
MK)Z2477S7JW+C+7BT2NVT?FQ]#&AT)!2-BZ+3(0AB1SV9D90YES`FBW,'FHJ
MIY@0IFE0Q4ZCK6!?V`=)<X;$-:=FNR7MT\U/P0,?*3>,\941[:,NQBTNHG'7
M&YI,UGC:*GVJ4>;P('NH&:(&.8W9?(W(HI`T-:U6Y]1MWR#[8U",THUVSF^J
ML9B3%.'Z=`6BD+Q4NU9T"MMJPG)SR[0SB(B8PJ#4JBSM9<B1`\CG$.A'DU4#
M8?-UO78-X_?16GVG^/1S"]<-8[#&*:I&7F1KT/,V<&*D/$LV<DX080;%_)NV
MC5P`@91-$P`4/+Z>O(/6K?4Z5HSY'P;FC>;YD+7FC6+%&1,B8ED-F,77?_4,
M].G:[5HZK5U>D.9>4F92PLHYO$%02B5_%-<2*+"0"D`1,'<U=N`/.U=B(@04
MT$4S=>1$DR#U].RD`H]?[.PY%6:_7BE5!?+A'?ZDQFF.N953(AFS<+&9G_2@
ME(X@,>G6M$\P<D`H@JS>,#"54!$``H=_IZ>N?TFD_ETO,^X3J<+AYMODTMD4
MCS!Z5POOA/NTX_BA_P#8SX[^:I\S#X$518[3CL@VYA=9QL56&S7\B>7LLV=N
M).G$AB33NE3$`=F!3`<J4,+,R9RG\NA,W*<0].^>Y(9./Q&P8#^^PO;V/`FN
M@R.0E5K^;7O?XD5YN53*G&1)]&3RTLK?M18J%;>0M_=4156"?5R@X4LUC,+I
MQCO6'9[>N[OSD$S92X9BL\CB&GG>'$O:LD\K#B,<)=B8`.B4P="4.MME9"9&
M?FXV/HF1R>%QD0[^GCH)Y+?LAPX/D?.L"&%X<7&EEL6AP\C,<]B\K&)/Q*[3
M^%5,XL;2,?)-F4S"U>R)V(J0_P`1R"#F,CKJ)OVG1K]R;*H.H>QN#*"4B[-R
MW7*)A`RI0$>>L<JT;QF2&22(QW_>168Q>!:,Z,@[A@1X*:X?!5U?9*J/O`^2
M30-?]5_RMY@@^)%/_6(**LS5KC&%2C+P4A%$VVJ&TCPE7O\`#D444,NYUXSL
MR/%MY!@9X8ZB+-JZ:H+>("Z6=#WWP63/+C.>4G+0$]<["&^)M-!EXIW$&U@6
M96(_*%KJ(8EF484=I?\`^;(.V0=[P3"P(\@1^T36`672F@V*="OT/(KO!.3E
MG0MPP'MRT/1G[IP4H*"A3LRLF)*'=6JPE$$@(BF/@8/)<P]CS.Q?>N?CP>OG
M8XSN+M?[K`/J@#QDQR?5C([ZGR45BS>W<667T<:8XN5?^!E#9<_L3#Y''AI^
M-9ZPUZW`PI88PEFQ38L?Y%R"[;XUIF=99LE+8AP[C*1*2,?SU+L=7/,1;%62
M:KKHJR?DDJW:E4*0Q#NE3&P7]P>T>:@8XV7'D\?C*9I,93MR,B878)(C[6(!
M`(34%K7!"J*REXOGN.F7UH7BRY2(TF(O%%&="49=P%]1NTL+VU)K=(T0U2Q#
MJ/K_`%:@XF>QMI)*-D9^WY+:.64F[R3:7:?<E9'4RR,HF^:G<"<C4A3F312#
MQ+ZB;OXQ]\^ZN7]V\_+R'+!HBI*QPD%1"@Z(%/0V^K2Y-?07MOA<'@^+3%P2
M'!&YI-"9&/5B1U\O`4YW..K?T<4HXI58VSWRZ::ZCYL-KQEB=R$XRR6`BK+_
M`!:AXWL%Z>'BIEN=VQ531@2.'2BAVZ8G,4J8B4H=CZ<LO/&C;#?=6PQN,RLJ
M+UHPHCO:Y-O[ZG33W?+67>RMVNR:YWI2T!1)5I"W>!E(A_7[/5)"13=*1R,Y
M"R*9'#/[\L>X!+L1[,W4*/0E$.5I(D@NIZ59RL+(PF"Y"VOT[@_"FZ6=,&YP
M(X<M$#B`&`BRR*1Q*(B`&`IS%$0$0^O*KBL6QKXIV:B*U!S%DFW*+"$@(J0F
MY=^J4129Q<6T6?/G9_`IC"FW:H&./0"/0>G!(`N>E2H+,%'4FEPU5W-U[W0I
MDS?M>[H-PJ\#9WM/?/UHUY$#^=CD4UW;9J@_324=IHI*!V=,#%`0$/J`\I21
M7%U.E7\C%GQ6"3KM8B]-*8Q2%,<Y@(0A1,8YA`I2E*`B8QC"/12E`/41^G*Z
MQZ_!!XT="8K9TV<"0`$P(+I*B4!]`$P)F,(`(_X\4L:6S,6W&%<'Y/Q'AS(+
M^S)7;-\NUA**SA:19K)%KOGDS&038)R9B(UW%UYN>1E4@]UVHD0I`,<1`I!$
M*&=58*>IK(BQ9IHWEC`V(+G4#_SIE5%6S1/R540:I>0!Y*'313\S?0.S"4OD
M/7^_E=ZQZ]D5T'!/<;K)+I]B7S14(J3R+]2^1!,7L/U#BE<>G.P:SAZT1F8I
M5W&E,>1:IR+0[A@0AO`YWJ)5A4:E(;T$5`*`#R+BIVMUL;&OI9KL'R*;^/69
MO&[@!,D]9J(N$5R@82&,FX1$Y%0`Q1`1`1]0ZY-001H>M?6(@4!,80*4H")C
M"(````=B(B/H``'%*K3P?\NNANQ.>6VM>*\R)3F77DG;89G75X23CDG<E22R
M)Y]HWD':)&BBJ!8M;VP`W^<)0`G8B'+2SQLVU3K6?+QF9##]Q(EH@!W\:YW)
M'RHZ18IV49:DW#+R+?.KZ>K%9)4&$/)28(3UP29KP<8ZD&B)V:+I=%^D90HF
M'V?/H_0@(!)EC#;"?FJ(^.S)<?[E$O#8F_D*L*7<-VQ0.Y71;D,8"`==4B11
M.("8"@90Q0$PE*(]?7H.7*P;$]*]DE4ETRJHJ)K)'[\5$CE43-T(E'Q.01*/
M0@(>GZ\4I?-FMI\(Z@XGG<UYYN"%1Q[6Y&!BI>5(W5D7#9]995I#1"(1[/S=
MJ"X?O4RCT7]I1\A]`$>4NZHNYNE7L?'FRI1#"+N?\*PC(6\FO6,M=Z'M)99Z
MR+8>R46L'I\Q7J59K/+2:5OB7LY`K_QZ#CWTN@V=QL>HH*IT@3)^T#"`F+W!
MD4+O/TU<3#G?(.,H'JB]]0!IH=:9VL6.)N=8A+5$_<'A;)$,IF/_`"+-=@Y-
M'R+8CIN+M@\(FX:*BBH'FFH4#%'T$`'E5Q:_:L=E*L5/4&N4:!''`5F(,C@`
MB0RK0$#``]`(D$Z/?0]"'IWR:IKRX>1Z0B@[=,TS'*`BBX71()B&[`.TU#`)
MBF$!_3H>*FQJ&]@<^XCU4P[<,[9DGD*AC*CHQ3BR3B3,[H6Y)F:CJ_'>TS:%
M%P[.M)RJ)>B`(@4PF^@"/*68(-S=*N0PR9$HAB%Y&Z5SV%,R4#8/%=(S/BV6
M5G<>Y$@FEDJ<RJS<,#24.^`3-7@-71$UTR+%#LO8>H>H<E6#*&'0U$T3P2M#
M)I(IL?C4I<FK=5E;CUXMEVMTZEQ5,FVPG3-I\UR*QT_<:,EXNBU:"KKA</(`
M!4[E\Z]L1#T*F?GI?L_(.-[5YB"UWS9L'&`[D&5V<#\`+_$5R'/1>MS>!)VQ
MX\F4^`LBJI_23_;5,<WAR0K&$J%(KMG$=,XX^-?<O)SM=D4Q@7O6QE\+48]P
MJU,4Z8.7$1.HG3$0\A1$P]>("`^R0\Q%D\U/&I#0Y/N3CX1<_P"5AQ>H0"/!
ME-_.N`EP'AXZ-R"'BXC*DT'YYWVC^P_HKB]J<%V^I8ZV[HT%#A,S5.UKT,U+
MIT5'G,=Q+3;J!1M%FKZ#8BR0+R$FK]FJ"8``J@;S$HF'RY<]K<YB97(\1G3O
MLAEY+E,^1CT50VQ')L;!?F'ETJWS7&S8^)GXL*AI4Q,+%0#J3;<R_$Z'SZU4
MWCG%Z:TC*XLCB1E7R(T639V?3[;=HM6VEDD4@%`Z>,\F2)8`D3,KKB*Z2#U2
M!3]SVRA]_P"@&]8Y+DRL:<I)OEP"+IR&`=^Q>MYH5WEE`T)42]_X?;B<3##.
MV"NU,L&S8N2+!C_IR';8_'9K;ZJF%*F0@32N(G<>TI]F222(MJ1O&9U$ID.F
M)$V9\#['`G$(-FA/$/QP2BL1&%]/92="/D;3MFS&`<NC&;&N;9_&V;KU^YQ/
MF)/Z^P2/XE>E9P@C$AP&41R?_ES+C_X,C2W[.XJO@#34Q,A:L=,8W&&1YR4Q
MQ".2-F;?!/R-8^=9=P,^;NQ`$&F*=LZA'/)EJ@Z#]K90Y(]BV(8``QP#LW+2
MIB\C(W*<;&F3,-?NN(E&/E`CJ9L"0A3;\P^=F\!6Z1IL51@Y3M%#T$.>GJPF
M_P#R\I03KV/R@>=68X4KL;BRO)/(Z.R7IW7+`T$[5:%N,?MW\?=K8G,HR5*X
M$DA)R]2@7)2G\E'KN"9MA5'R.KZ`;S3FLF3E<G9(V-S&3&UCNC.!RJ$:Z:*L
MC#3Z5E8VT`KL./A3"BN@FP(F'4,,G"8=/$E5Z]2@%^IJPC"$')5*Z0K>,8QV
M+'5D!!^X@*3)&M>M>7X,6XNEK-B]=)--6@6-!H(*`Q*FT:F((@F@Y+_Q(>?\
MY/'EX3F5FRDC^4/(OIYF.U[!)Q_FH3INNS7ZLI^6NJXZ-H9UV`0L^I"'=!*O
MZT?ZC6[:#R/6K!?7]>>?B_>NFKSR:4<4K3@99'I+S^R'LUG&_7.K4^L:XX(L
ML">4MTS&P49^:A:&I78=LE(2ZL8B#U-V8XI)D]PZIS>)#&_7"O?)):VT#O75
M-$_\ACA16+.X-AKU-[Z5.O\`65C5'>.=_P#9YS&O"1N7MA'+UJLDR.BG(-JJ
ME;;8LE&^ZH0BYD2Y``H$`"E(8P%$P]_MJQ>C,!H?]M6?<)_>08RD'8EK>%[#
M_"J'<5VW.>Y5,WLR]?LE5Z0R&]NLTQKV3<H[LS6"7F&48PBTT>2HN&&*B;>[
ML0C0!OX-S(I`H'L)IF5#L<8!VW/<;OC_`'5NI5@Q7@B1&V!0;",-?MJW:MHW
M$=SR!AW^O7-7;*N1I/(EU+J-EQ5I>)56PB\=DN9+;"8^5*ZM$=%V9TBW83$>
M9)1X@FL<O0=B3Q..6"5QOFZVKG)5CEYS;$H6/U1IIVM?RZ@UJWO<3L,`_$5I
MQG^HVS)E%V9V%VBFVL!8:OE"YUU@-596<4FK9E5(R690ZXN8P45UE02%0RBA
MA,8Q1ZYA[0N.K7LS-IUKH1*9^3FBD`;&CBUT!UMUUUM6RY\SFT=.UWT[U.IV
M81S7<+9D"1HBCVH8UR7_`*-,,FOJG58LUDA\J9028/I*OU*0E)$BKE-D";AP
MIUV<B15!#+G=50;KZ^!M6@XG&;(R9&BVA0#J1NM>]MHOJ?C5/6EEKNSCYRL$
MX_QB5UARGQM14FK[BO'>V%KV<QK)19J4$I()NK=**&B'SM47[<7;4A%!9NB&
M*"I3`(<L1DG(`&B^`-ZVF6B#AW>6SR;B`2FQKW\/[JL1VBO][RG_`&1=2,%U
MN\W"/H^.<8QEOLM<A;5-,JT[E(N&OEZD23L)%OVT:[$[2%9)].RJ>0J`7QZ$
M`-=<ELI5!T%8..B1\!+*ZC>S6![VN!_XTKOR\Y6S!DCYD\4Z[.K`5]AK'5!K
M=D;XHG=@I+67'UZ4EX`DW-A9\CLE"%0>+/I`J:8^"RIDFX)I@4?(W*)W8SA+
M_*/.U9/%Q11\4TUOWK$_,$WD6-A84Z_P%XQS=0<P;PNKAF6"N>,4)^O-(C'%
M3S'.YTJ^/I^5=R4Y%Q<7?9;WXZ34A*T4[-11BN;W>RF<$*IX@%>,&4L"?EOX
MWK$YJ2%XH0J%9+&Y*A21XD?&JQM#-3)#Y7=[ODKN5ZV#V#QIBV(RG/NH5'$N
M0)&MJ31K1>[8>-@'#UN[6:(1%<A6")@;I)F*O[Y>S?M[&U&AFD8W(`-;'-RA
MQN%CJJ(TI4?4.E@/[S6Z3K]A:O:ZX7QSA"J2UBGJ[C6MM:U%35MD`E;+)MVR
MBRHO)F1!)#[Q\LJN83J>("/^WZ\SU&U0M<E/*T\K3-8,QOITKD<X6DE'POER
MYJ+$;EJF,[U8@64.1,I#PU8E)!,?-42I@85&X`'8^HB`<,;*3Y5$*[YE3Q8#
M^VNN$THU0W!D(/!?R?ZG8YLV8+)7=K;L$S1J_P"`._*N.V]L!1^8P$%*#F2/
ME&+L2^[V=4"]%^@ZN-7L)D!)W&N[R\G$!?C\DA5,8-_CI^FF,UXUGRVW^;[4
M-CL2=VZSKDZRFV<SW!NE$G/\,G+-'W"_1-?]L'!CMAC(U>*350,8/MESF*0!
M(0.ZU7_J0'ZG6K,^1#_*9?0(]%1M73KT%_[Z<O?3*69=D?FWM>"PDE[MB;"]
M$^Q88,LNRDOJ]09232JSQRZG#W%@4%GDG^4?(N3)$1<J.2H>V4Z)!,8*Y26F
M*DW`[$VK$PXXH.'$Q&V1F^H+O/7I:IJT2G-E=0/CC^53)<MG7_4%3'KZ5AL:
M$K&09G,T?B^YILRQDXVA;G*IG;RKZ)3L\>=0[115JFHV!42@83E&J+>D3F^G
M;6_]M6\X8^5GX\>P*S:M<;;CJ+C\#5)6=6V+I?XJ-:+_`#V79[+6V6Q6QT@V
MR0-AS58;K88.K(?<O&K>7H+BV+,X-C]\BD5)=:-.?WUBE3.3LOCCN/W(8F\A
M/G6UB]3^92(J!,9(Q:PL#^-M:O7^=.8N6(=9?BGT\H=IM5'FKE8J!0WA:=9)
MNKRPLZ16,=4%*.=GAGT5)F:N'-K,4$U%4RF43'O]Q>RY&1<(B`FYMY5I^'"2
MY&3E.%;:"=1<:W/^%3;_`&+LTY7PSJQI_ARA9$M6-T,P9;K5$R1:82;>UUXY
MK$!5T5W3-U:FCHDM'F-(D(NN8BP>XF0WN&,'8#7DL0BK>US5K@HHY<B69U5]
MJD@$7%SY4]FCF)])L"Y-SW.:M[,9(RN?'&)Z;&YMH1\HV#+V/HU^RC)&>B[M
M'R<H>3BBW.P,&+H5T8Z1.41$Q3IDZ(4E:"-22IO8:UA9DF7/$@R(U0,QVG:%
M)OI;QL*U*]C=L:%F;!.V>7L?TW)SJP1^5%X1CL/F/>N8@L[?FY^465:(5#6V
MGMXR$7JD(T)[)$FHBBW;@`G6\P-S$=PREE!M?K?7]%=-!C/'-%$Y7Z;[%C^6
MP'=S?4U8KOMD>^UG^M'J/&9+M4];KMEJ;H5?D9VQ/5'T[*1BTSD:]P(2#IPH
MY<OB1U?@&+<JISB<Q$TQ.;R'H;DI/VH!ZFM?AHC\]*T:@(MS8=.@'^-;+?QT
MV7#\9J=KEAG'^4,;W&=QM@G',9+5ZH7:NV.7AD&=?CVIS2,9%R3N08)).A%(
M163(`*!X_7TYEQ%=@52-!6@SEE^Y>616`9S8D$`Z]J?/E=8=5YYD0D;;/9ML
M,<P47=6R#K6IN.4E"*JH3AIA])R63)AE^W_@5&",[),%E/0HGAR^OJ7GH7#,
MF)!A8\ALL+OGS>*[0%A4^-]J,!_J5R^>&GER)5'S.JXT=_S7),A'PNP/^[42
M3N/XZV6"6IL:P%2MWB[84UPJY7Q""1SB#7]$MTR])H/$P\1B+)!L5&R)@'Q,
M^:%+WWZ#M8,^3%@7-D;_`*F&#(S'M?\`[C*/IXZD?K(Q!/[+&L&3%2:4XZC]
MS))%`M_^7!\\IOX,!8>8K]H6JCDS)='?G9&]S+VV%MV->K*I$6:.,::\U5IB
M#'KH50`?!K;XLD3(L##T"A2'\>^C<39?\MXR9+@C$XJ/#':TV7(<B7\8SO1O
M`VO2.#[O+C:Q!R,UISYQPJ(D^&X;&'PIQMD=.M<MLZT:M9SQC`VXI"*!%V`J
M`1MOKZR@E$SNOVAB",O$NOV`'DFH'8>@@/..]M^\/<7M/)^YX/*DB)^I.L;C
MP=#\K#XBM]R_`<3SD/H<E"L@[-T9?-6&H/PJFC)'Q:;-X=A#U?$-CQ_NQKHT
M4%=MK-M<S;K3]?3,8WF&.LG"0SNM+1S;_P"7%(Y%EEB@)Q'OT]DX[^J/MKEY
MONN7CR.%]Q$6.9@D[7_]V'HX8_4""`.E<#E^S.8P(_0P7BY'B@=,?)&JC_3D
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M[I*E783+@\%&5/\`(O1>O("GO32.+):3<#[P7O'A7)UEX-M8FYQ,Z:%,405$
M!4`3`!A\^]P9HR9$42-+M6P:06G4#_*EM]10_2WATTKJ.+QS"K,5"$FY"F\9
M)_/'?H&[CQZTR/.<K;4<4HXI22WCXV]!,F7"SY!R#I_K]<KQ=99Q.VZUV'&E
M;E)VRS+PX'=24U(.61W$@[7.4!,=03"(ARV8HF-RHO66F?FQJ$25PJ]`"=*:
M7'V.*#B>HQ%`QG3:W0Z3`(&;0M5JD0RA(*,0.<QSI,XYBBBV2*<YA$>B]CWZ
M\K``%ATK&>1Y'+R$ESW/6E5GOC3^/VT6I[>+%IOKK,V^2DOS$A8G^+*JO*/)
M3W07^_<N31_FLY]X/+R-V/?KRCTH[WVBLD9^:J[1+)M^)IG+QB7&.2\=R6(K
M_0JK<,7R\6RA)2@S\*RD:F^AXY1JJPC',*ND9BHQ9J,D132$GB04R]!Z!RL@
M$6[58262.3U48B2_7O413^D^HMJIF+L=637##DY1,)/R2F(JC)T2!=U_&\D0
MJ)2/J?&+-#-8-T4J!`\T"E-T4/\`#E.Q+6L+"KJY>4CM(LCAW'S&YN?C4E9>
MP7AK8"JC1\W8OH^5JA]PF["N7NMQEDB"NDBB5-<C.3;KI)JE*80[*`#UR656
MT87JW%-+`V^%BK^(-JB?$VBVFV"+NUR3AG63"V,,@,H5Q76=RI5`@("Q-H)T
M@BV<Q*,JP9I.DV*[=N0ATP-T8I0`>0(T4W4`&KDN;ESIZ<TCLE[V)N+UG3;6
M/7EGFISL>TPQCEOGMXP/%NLOI5:*)D%>.58?BU&2MF!O^3,V/'?Y`D%3Q%+]
MOTY.Q=VZWS51]Q/Z7H;V]&_TWT_16-YNTRU.V4F(NP9^UVQ#F"=A&9H^(F,@
M4:"LLE',CG%0S5H]D6BSA)`3B(^(&ZY#(C&["YJN'+RL<%8)'13X&U2=B[#F
M*<(U)&B8@QW3\:TQLHHJC6:7`Q]?AB*JE*157[&.001,H<A``3"`B(!UR551
MHHL*M2RRS-ZDK%G\2;FL1PGJ]KKK<6R$P%A7&^'RW%ZG)6H,?52*K(6&01`X
M)/)?\8W0^^<)@H;HY^Q#L>%55^D6JJ;)GR+>N[/;I<WM4\<JJS7!6>L5ZZ5Z
M:J5MAHZQ5BQQKN'GH&7:I/HN7BGZ)F[V/D&:Y3(N6CI`XD.0P"4Q1Z'D$`BQ
MZ54K,C!E-F'0U@^&\&X<UXI2&.,%XSI>):$VD'LLWJ%"@(^MU]&3DQ2&0?IQ
MD:B@V*Z>BB3W#^/D?Q#OZ<*H4646%52S2SOZDS%G\3J:X%3637I;-0;'JX8Q
MRIGLL>G$ER^>JQ1L@!&I,48Q-B6S"W_)@V)'MR(@7W.@3(!?H'(V+NWV&ZJA
MDS^C]OO;T;_3?3]%8/F'1G3G8*W)W[-VL^&,I79*/1B26NZT*!G9\L:W$XHL
MORCQH=V+=+S'Q*)N@`>040FY`)JN+,RH%V0R.J^`-JE6CX+PUC3'!L/8_P`7
MT:GXL4:R#%3']?K<7&U-9I+%.2307A6[<C)<C\J@@MYD,*@#Z]\D*H&T`;35
MMYYI)/5=F,H[WU\M:6@/C`^.T#IJAI7K<"B4TE8DCABFI@9.=1$!2E4Q"._8
M^3$/10.A#E/HQ?JC]%7_`.89W_-D_2:GS*6L^OF;[10;KE_#6.LE6[%<FG-8
MWL5RJT7/2](EDGS*33D:T]?MUEHIV20C4%@.D)3`HB0WU*'*BBMJ1>K,61/"
MK)$[*K=0#:_QKF\P8+PWL%5#43.&,*1E>G'=)O1K5\KL;98<'B/HDY*RDT'"
M*:Y`'T,4`'KAD5Q\PO413S0-OA9E;Q!M7KB+!&&,`U=6E83Q=1L65)=T=ZO7
MJ-6XRNQ;AVHD1`[APUCFZ*:ZHHIE+V?OHH=?3DJJKHHL*B6:6=M\S,S^)-Z7
M.Q?&7\>UME9^<LVF.N,Y+VEU]]8Y&2Q54W+J:>>^9S]S(*GCA%RO[YA/Y&]?
M(>^4>C$>JBL@<AG*`%ED`'34Z5+.0]1-7\M8XIF'\FX#Q7>\68Z_'_P3']HI
ML-+U.I?B8X\1&?@(1VV48QOV,6H9NE[9"^"1A*'H/!C0C;86JTF5D1R&5'82
M-U(.IKXL'Z9ZHZT3DW9M?M><2X<L-DBT(.?F<>TN&K,C+P[9W]^WC7[J-;(J
MN6:+S_-*F81*!_7DJBKJ``:F;*R<@!9G9E'2YO:F8Y56/7'*_B??9^]^.^Y]
M]S]A[OVWO_=>OWGV?E_F>_\`7W/#]W_>Y='KV-MVVPOUZ=K^7A>J#Z=Q>U[Z
M?'RJ(%R8740039+,&YST>XEB5ZX$D9RE4AE2!;E($(I)8!=%ENA4^W(9YY>7
MB`E\^;8'F029`Q'KQ[@]K>IM_=[MW;;TO\OCVK";[`V"V!]-K;;_`$W^;;;O
M?K;6OHHB.(B6AHK27<:M+K8MI8UYLQ*<(]IBHCB6)50KA@;),CQ"SP'1A]M1
M14!$ON>)/:#D9QY<XI&<&$0RI-Y/4SV7U-^M]UK=0!X:WJ<<8/K`XY'J>BNV
MW01Z[=O:U[^?CVJ:.:4=-:SZ.32N&L/\?_"R7\K_``W\<^U4_,?R'[+\+]EZ
M>[^2_)?\#]K_`-[W?V?X\O0?<>LOVN_[B_R[+[K^5M;_``JW+Z7IGUMOI6UW
M6M;SOI2&U."P3)3MAE-.[Q$UQQ"E?N+E6ZY"S\MJ]<VAQ.,I&2;AM&CC2'>^
MTFN4'==?H*-U5!4=(.RE!$>ZRY^<CQXXO>$#R*Y`C=V5<V,_E(!/K,.GRS(0
M0+(R7O7-0Q\:\KOP4@1EOO4!CCL.X.GI@]=486ZD-TIS,9&J!Z=%GHJ48A6S
M@H9HA!+.G-?06,;MXE7W+A%NBXA4W(F*W.V33:F(':90`>@X[DQF#-89Y8Y/
M<L`'MVW@7LUNNX[K]:Z##]#[=?MK"'M:]OPOV\+:>%9_S`K)HXI1Q2CBE'%*
M.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1
$Q2O_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g53110424fin_pg002a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g53110424fin_pg002a.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`3@%1`P$1``(1`0,1`?_$`,,``0`!`P4!`0``````
M```````'!@@)`0(#!0H$"P$!```'`0$```````````````$"`P0%!@@'"1``
M``8!`P,"`@0+!@4%`````0(#!`4&!P`1""$2"3$30111(A4*87&!D:'14A8V
M=K>QP3)B%QA"(S,T&?"B)Y=8$0`!`P($`P8$`@4)`PT````!``(#$00A$@4&
M,4$'46%Q(A,(@9&A%+$RP4)2(Q7PT>%B<K(S4Q:2-AA#<Z.STR0T1#5U)A<)
M_]H`#`,!``(1`Q$`/P#W\:(FB)HB:(FB)HB:(J$R1.25=JQI.)521>_O%28T
M%%D2N$P:SEUK\'(%%(_U1,>/D52E'U*80,'4-$5=`&P;?A'\VX[?HT1:Z(FB
M)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:
M(FB)HB:(FB)HB:(M@'`?0!$=O3XAJD93F`#30CXCQ'%1(`-*XIWC^P;UV]/A
M]/KH9:.RY7'"M:8<*T2G>G>/[!Q_('Z]!+4T`/$<NWG\*8J-.\+7N]?JF_-J
M(?7`!U>\44JT[Q_8-^,=@^/74#*0TG*[-CAX"HQX8\E,`.U;@$!`!#T'KJ=K
MFO:'M(+2%*M=3(HNS'_`X_SCC'^IE0T12CHB:(FB)HB:(FB)HB:(FB)HB:(F
MB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(O.KY=
M\:>7K(/)_C7-\&,<UG+7&K&]*G)W)&,;/E]IB6L7W+4^YM%=;H7MQ$7_`!]>
M;!"U:KKL'T:@W>D8I2!CJ*`<X`!>M?;AKOM^T/9NM1]4KV;3][WMVR&WNF61
MN7PVHR.<Z-DEO<1ASG%[3Y<S@!0X"FJZ_!JS[MLEFPNA'ZH/$]^(PX<\%A\X
MZ\YN57):DVR'A<"\5L8YPH?(S,^(K8TN&0.7TY1&T/A#$J%XLS-NI6\\R,BX
MLSBQ"JV0<D6,Q403W$OH<>I-R]*-D['UR!][JVL7FT;G2+&YC,-II`G,E]>?
M;,>1)8M:&`$.<"<U.5<%JL<DTN!9$'5</^6P+1F-?WOX<^Y2'A?/ODZY58SQ
MID_B3X\..F8:M.XJH%BO\Y.<C\[4<\1D6UMY:5DX*+B)SD]"NS0[6((R42$"
MK]IE3`94P_5)J&Z=N]']C[BOMO;]WEJ6E74.H31Q1C2;&8_;L$>4ET6EO&9[
MGDMJ1P=4#"M6"'4;J+UK:W8Y@[Y?^W"96RKYL<#5B4R#D?PUXLL-(K+9>7LY
M\9<C<_W*9;0C!%5U(.THVI\F[9.@BT;HF.HJG&.P2*'<8@E`=I]O:5[:]RW[
M=%T3J?<6^JSD^D+O1;**-YK^422V$;"_^J'"IP:*T"R(?J,,/J2V+\C0*_O'
M^'#,</B?%=UA#GG#\^<9QM_XMX3B*93FU(R[1N4$!(9IY%O\^<5,NLL*9+O6
M',MUJ=:Y+1J=QPC?+-44F#>27B&[B,DT3M79!%5,VJ&[.F.J]+=SG0>H.J?<
M3?=VD^E.;ING1VNJ6SKZV@N;60BU$L=U#$\O?'F<U[/,QQ`(5NZ>&[:+N"'!
MH.9HD?F&09B1W'E7GQY+V85-R=Y5:T[44]Y1U7X9R=41$PJG7CFRIE!,.XF%
M0Q]]QZCOKYR7[8V7T[(FAL8F>``*`#,:``4H!X+T&&GHLH*#*,./+MY^*J#5
MHJJB[,?\#C_..,?ZF5#1%*.B)HBV&.!-]P$=@WZ=?R;!U^.H5QH?AWH,7!O:
MK%+[Y/\`QW8LNEFQSDGFGQNHM]I<PZK]MI]HRQ4X>PUV;8B`.XJ7BWDBDZ8O
MFXF#O3.4#%WZAKU#0>B?5_<^FPZQH.V=9N]-N&AT<L5M)(Q[3B"U[`6NJ.P^
M*QTNK:=`\QS3,;(.(/%4TS\N7C!D7C./8<]N*KQ](.VS%BT;9FI:SAV\>+$;
MM6J"1)03JKN%U"D(4`$3&$`#5[-T!ZWV\#KJ?:>O,MV-+G.=:2M#6MXDDM%`
M%!FL:6]V1D["[LQ_F5X>5\TXJP30IK*>9[]5<78WK@L`GKQ>)MA7JS$?:K]M
M%QOVA+2"R+5K\](O$44N\P=RBA2AU'7G&@Z#KFZ=79H.V[.YOM:EKDAAC<][
M\M2[*`*F@!)IR"O)+B""#[BX<(XZTQ5FG_E]\6__`._N*'_W321]/Q2OKKTX
M>WCKN6>I_I#<&6M/_!S''LP:K3^+:9A^_CQ':KJ<+<F>//)"&=6'C]FW%F:H
M9@*)9%_C&]UJYI1AG/?\N63+`R3U:-,X]LWM@N5,3]H]N^PZT'=&S-W[)O1I
M^\-+O],NG8@7,$D.8=K2\`$<L*XJXBN[:=N:![7CN-:>*^[.'(7!W&BE$R/R
M!RM1<-T(\PQKY;?D2QQM7KPS<F1RI'Q02DHN@U^?>ILU3)I=W<<$S"`=!U:[
M=VSN7=^H?PG:MA=:AJ8C=(8H&%[Q&S\SZ#]5M02JDD\,+,\S@UO:>WL4HQTQ
M'2\:QF8MV@_BI)BUDV$BU5(LT>1KUN5VT?-ER"*:S5RV.50ARB(&(8!#H.L+
M.R:WF=;R1R"9CBUS2T@AS:@BAQ)J*4'`\54:X/:'`X%8_P!WY<O&"P=NF#[G
MKQ69O6+EPS>-'&9:8BNV=-%U&SENLDI)E,FL@ND8ABCU`P"&O8X/;QUUN8&7
M5OM+7GV\@JUS;.8@CM!#5C3K.EM`+IF"O>JTQCY+/']FF]U[%^(^8W'C)&1K
M:Y<,ZO2*9E&K3]FGW;1BZDW+:*B8^06=O%D(]DLL8I"B()IF,/0!UB=P]%>K
MFTM(EU_<^V]8L-%@IZDTUM+'&VIH*N<T#$X!5K?4K"Z?Z<$K'/[`5-^=>2N`
M>,58B[IR(S#CS"M1FII&MQ-DR3:8JJ0TA8'#-W((PS1_*N&[=>158L%E2I%-
MW"FD8?0!UJNU=G;LWQ?.TS9VFWFIW[8\YCMXG2O#:@9BUH+@*D"I%*D!5Y[B
M"V&:=[6M/`G@5;+%>6?QCS<BUBHOGMQ1=2#U4$6K<,VT1$55!`1`H*.)E)$@
M[!_Q&`-;[<^WOKG9PNGN=I:^R)K:DFSFX#B?R<E9NUC3&$!T[!4T^*OMK]GK
M]LB8VP5::B;+7YEJ5]$3U?DV$S"RK,_5-W'2D:X<L7K90/\`"HFH8IO@.O(;
MF&YLKV33[Z*2"]BIF9(TL?\`[#J.%.\!9!K@]OJ1T='2M0:CP4%9\YB<6>+!
MJN7DCG[%.#C7890M0#)USA:B-E&$^1"8"&"7=-_G_LT9)O[WM[^W[Q=_4-;3
MM386]]]>N[9NDWVIQVT;7RFVB=+Z;7YBTO#`2T$-)J13!4YKB"W#3.]K"[A4
MJX-A),I1@RE(UP@^C9%JV?L7S1=)=H\8O$B.&KQJX2,9)=LX;J%.0Y1$IRB`
M@.PZU*4N@DDBN&NC=&2'!X+2"TT<"#0@@\<%7-.1J.U6YM>:'$Y[GA;BZRY#
MXB><C6[EPR6PDVO$$MDE)XT@AL[MHI54W9I0CAI7BB\5()`,1N'>8`#6XR]/
M=^0;3;ON?1]19LY^7+>.A>VW=G=D;24@-\SO*W'$\%0-S`)?0#VF;]FN/R5S
M'>&WH/IO\/S>O4=:6Y]!4#]:G9C\57`J*JVW+G,?BM@.]TO&&:^06)<5Y#R,
M#(:'2[U>(&MV.VED98L"P4@XJ2>(.GJ3N;-\HF<I>TRX"0!W`=;=H.P]\;IT
MRYUK;6DWU_HUE7UYX8R^.+*,SL[A@,K?,>[Q"MY+JVBD]*9[6R88$\:\*?%7
M(@H`_`0ZB'7;?</RZU`2M):`#Y@3X`<:JXRFI'(!0-GOE-QSXM0D%9.1V:L;
MX2K]GEU("NS62[7$U*,FIM%HH_6BXYY+N&R+EZDQ2,L*91[@3*(^@:V7;&S]
MX;VNIK/9NEWNJ7-NP/D;;LSEC2XMJ0,12E?#ABJ$]S;6S`^X>UC7<*J:(F:B
MIZ(C9^#?LYF$F6+24AY:+=MW\;*Q<@W3=L)*.?-556KQB]:K$4253,8BA#`8
MHB`@.L'/#/:SOMKECH[B-Q:YC@6N:X&CFN::$%I!!%*JLTM>&EA!:[F%%3;D
M=@AYF]]QI;99H:W(&,JZ=VD<-IV2,/D1E3U0;&2LSFL%7&32A5"O41!P).P0
M5+UZAK,.VQN1FWV;L?8W+=KON#`VZ+"(72@$F,/X9L#AQP4GJQ>H8@X&0<N=
M.WP4U:P:G0>@"/T:@3051091^3/'_)>4LBX1Q]F#'URR]B+VO]4,;5VS1DI<
MJ![ZY&J7[V0+9<[Z%[W*I2![Q2_6,`?'6P:KM+=>B:%9[HU;3+VWVY?FEO<O
MB<V&8Y<U&/(H33'#DJ$-U;SR/AB>#*P^8<PISU@%74<95R]C'!E!L&5,Q7FL
MXTQO5$6KBRWBY2S2"K,$W>O6L:S6E)5ZHFU:)N9!ZB@03F#N55*4.HAK):+H
MNM;EU:+0MNVDU[J\SG!D43<SW%K2\T'$X#E^"@7!H<Z0AK6\230+M*#D.DY3
MIE9R+CBT0EVHETAF5BJ5NK4BVEJ_8X*23]YA+0\FT.HU?,'B/UDU"&$I@'5O
MJ5AJ.CWTVEZM!);ZG;S/BDB>*/8]AH6N'(U'`X@\5!CVR1ME8:L=PHJSU:J9
M6CYPY[\+.-%O:X_Y"<HL(X7N[V$:V5G5,DY"KM2G75??.WK%E,H1\N];+JQK
MIY'+ID5`!(8Z)PWW*.MZVGTPZC;ZL)-4V=H>J:E81/+7O@MY)&M<.3BT&A5K
M+>VD#Q'-(UKSR*B^&\LGC*L$DSAX?GIQ1>R3]8J#-J7-U#2,NL?H5,JB\RDB
M!C#Z;F#?6Q7/0/K;9VC[ZYVGN!EJP5<[[&XH`./ZF/P5`:OI9=E]>.OBK]HV
M7CIE@QE8AZSE(J39MY".DXUVW?1[]B[2(LU>,GC515L[:.45`.FJF8Q#E$!`
M1#7DDS)+9[X;ECX[B-Q#V/:6O802"'-=0M(H:@BHX'$+(!S'-#V$.:3@1B/&
MO8OM]W_(;_V_KU"K/V@JOI]X6H%,&WI\.@B(_I[0'5$L<W&,`FO,GA]<5(*#
MF5^?AXV>W_57E?W%*(?^0#R+_P"(W8&X8+6VZ_W?'7V0ZS5_A.BR<AMC;OC_
M`.J1KS"WC+IS_P`[-_<6>;[M6(!P+@S#Z%K.'DQWVWV+CED<.OJ(`577$WO/
M8T]9+^*V``^[E)Q=S$5<:DU-/!;3M9GI61Q<XN<#X5Y?!2KS-\J&2<1\Y7_!
M_"5'J1K!0.(.1^8.3,@9(BYJ>B'L'4&3AU7<<U*(K-BKSI@_FQCERO9=ZJHB
MT,N@5)LL('$<5TNZ":+N/IS:]2=USW'V>I[GBT6UAMI!$Z)\@:);F:22.3,&
MYF^G'&`YU'DN&!+4-9N[:\?:VX:Z../U'YNRE:"GPXK`!RYBL8^*SSI9?+#2
M$AC;`/D/X599"9IM.KDY8$!R3F2M72MP]<KE/J$6_?.G$SGRHLG3)%NV[6II
ME4@>VCOKKW8#]>ZY>U32I9VQ7NZ]C;IM#'++(QDCK:SGMIO5EEE>,K&6TOI.
MH3F$0<_$DK!7(9I.L2,;^2YC<".(#I`>[AFX5Y8!>Y_&3=ZTQMCYI)(.&LBU
MH]3;R#9V0Z3IL]0@6"3M!RFIL=-PBN4Q3E-U`P"`Z^6NJR-FU2YE86ECKB0@
MM(+:%Y.!&!'81A1;[""(6`X'*/P5<:L%5479C_@<?YQQC_4RH:(I1T1-$7"8
M![Q]-C=OX]]PW_1JG*TN#2.\'P(Y=ZG#AE_K#]*_.5-EC@+B7S/^7"0Y[\1+
MGRVJTMF.99X]@Z9BAOE5Q3;`UM[M6:EWK%Q.P)(1&4CU$D2K]YQ4,F)``.N_
MV0AVMU8W/[7>G=OTPW%;[?NHK1IDEGNG6HE:V%U&-,4<CG.'8Z@)IS7FOW=K
M::S<_>P&<%QX!IICV.(PIV8K*YQ)R?X!.47(G%6"\;>(S(%$OM]L*Z-6MF0^
M+C*KTV!E8"(D;4B^G+"C=9%2,2*2#,"1O9.!G!DR#_BWUSEU'VG[H=C[(N]V
MZWU`M[[2H8V"6"WU.>25S9"UA`B=&P.H3YL>&(J0LO97NE7%VV&.Q<QY.#BU
MM!W\</@%DP^\HD`GAKY9[!T*?#7:'P`2YLQ_L(?A$VVV_IMKRKV0!L7N6V^Y
ME?7;%?G-4BKOL;EP%:_FS4(KAWT5]NMN;1Z"E/4:3X+`'Q3Y:_=<*WQDX^5[
MD#@;'<MG.%P[CJ)S#+R'&7(\ZZD,EL:M&-KJ]>SC*+68R[ES84W!SN45#I+"
M;N)]40`.I-_]+O?-J6_]<N]J:AJ)V\_5+AUM&W58&D1&9V0-C=-5M!09<N'>
ML'IMYH$5FP74#C(&^9Q:*$^)/Z%)'B?K>%,M^=V:Y"^*[#^0<4^/2`P!-P&8
M)=S5[12\7V>ZR,"^:-X^O1<^NX*F21MHQ;QG'&$BJ!XYTZ*B@D8`-A>OTFXM
MO>U*UV/USOK*[ZOOU8/@A]2.:\BMP\.)F>SA1N<$U).8`DFI-QI`CEUMTVFL
M>VQR8UX$]P_!9&/O;@"'BC:`/K_N>Q$`?1_#^1/@`Z\7]A+7-Z].8SRL.@Z@
M!Q-?+'V$=BO]UD?8M..,K?P*]#N%.F",2^@!_I#0OCU$`I43^(.@ZY,UH$[K
MOZG#^(RBF/\`F5PQ_#XU6P%N2V;3DS'X-*_-Y\7>=_%IB6N<F8CGGP(R)RQR
M!)<C[;(TRX4O!;3*3"MTX$$6IJVZF7%HA#1KK[:0<.0;`F?=-8#]W4`#[/\`
M7O9/6W<M[H=]TWW;:Z!I8T:,202WEQ;N?)F=^]:UD<K7,+0`#5IJ#5N-5YAH
MUU96OJ.NX'3YPW+@TY:5K^8CC4?)>GKQ56KPU<F.1[IUQ#\:UMXYYFPK4W63
M(3)F1L`-,:DBT7+UO2W2=9L#>TS8_;ZZ%E.3VA3)WM3+"`CVF#7"'7O1^OVQ
M=I1P;[WG%K6AZE/Z)MH;Z>8.+&^H#(R2)@RBF%"2'4PX+;-,N-,OKD-M[1T4
MK<0X!H_NG\5%?WNY-)SP0XUMG"1545^9='172.&Y3I*8XR614@B(#N4Y#B4>
MO4!UG_8!<3VW4K6[B`NCFBVW<.#@[*X$/C(+26FI!`P5/=KF^E;,=3*9B,>Y
MI63MSX+/$A=*7',)7@GA%B$E`LA<2%983U3FDUG<<F"KAM-5R<C))%<IE.\I
MO<$0/]8=QUX;:^Z+KUI.J&ZL=TZF^4/=Y9)&RL_-6F25KV<>-!6G#L69&B:5
M/;MC=$T.(&(%#P[>*Q!>*2%LWC>\V?+3Q-4"^6VY\3+!B)//F)JM;YE6<=XO
MFE(NE6-)LT=*%'V3J15G=QKPQ"H`_*T9N%2BN!C'Z+Z\7-AUC]M>W.OVL6L$
M'4./4OX?=2QMR"Y#1*TN<VM*DM:YM!Y:O`P6$TLSV>KS:5;O)M`PD!W(U'#\
M"N#[S)QT+RXY9^)#C4,J>#<YHLG)6D1DNGV=L?.2<)C4]><..\IRBP).HM_F
M0VW%`3["`["%3V5;\FZ7;$Z@[\BC;/;Z8S2GOB=FH^,R7,;VC*0<6N=@2`32
MJFW';"^N[6!I(?("!\*%7+>)CRC15*\.V6;CR6>*L<N>+^'MV$<U5J:<J)V!
MZZQR@YBL/QCD')O?4DK4FBUK:9]S&7DV*P`(COK1O<#T0&H^X2RT_9$;7[4W
MP^"]LGQBL8CN*/N7`?LP^>1X%?*0<05=:3JHBTJ47%?7MAE-:8GE3Q/;18!O
M%9B/*<-YB?&3RNSM)R3[+WD!K'*SEA86;X!!./A+;#YDBZ:JU35(#A)&<B(T
M\@B0QC%(R=-B$V`NP]8^X;<NB7/MNW9L':,?_P`7V=>:7I<1;6DDC7V\DI'G
M+3D+LA)&;,T\%K^@,G;KC)KBN>6-SAX$.&*_1)M=F@*769^XVJ69U^L5*#E;
M-9)V16*WCX6!@F2TI,2KY8^Y46<?'M5%E##T`A!'7R&L+&[U*XBTVRC,NH7$
MC(V-:,Q=*\AK0T8$DN(`7H,LC6,()-`*X=@Q7A,J?">X^?N'\HODELI9F,D)
M,%L1^,V.=.W,:I"(8+?(6=D]9II*H>V-J(Q;PZJ@E$B<K.2J@#[B11+]2+KJ
M?#[1I]E]$K#*ZR\MWN3+'G#_`+^,PO8<""86R.D#:T+8XS4XK0FVG\<9<ZE,
M[*\?X=3PRFORIAX_!>EKPC\\5>>W`_&]TM[PXYYQ(=7!W(F(>`#>889,H2"+
M`TY*L5#F<ME;K!`UE#"8H`5RNND'5$P!Q;[E^F+.EG52_P!*TQH_TQ?.-[8/
M%2QUM.<X8UU.+"2P^`/-;1H6H.U#3VYO\6/RGO[*>/Z"L3/WMNNQ]PP/P&J<
MJJX0C+3S,CZU(N&9DBO$(^=ILE%O5FIUTUD2.DT'1A()R&(!@`1`0W#72O\`
M^>-_-I&X-X:Q;_XUOH`F:/VG-D<YH/,8C&G*H6$W>ULT5NQE0XO<.[E_0J5X
M7<GLU^"?DS#>,+R!VA[9.$V1)B34X/<NYLSDD%5H]Z]*HWQ_<I%056T1`M73
MY)N]:J'(6N2"H+$WB'::J%MU-V3M7W3[-?UOZ50L@ZH6C`-:TF)OGE>`2Z[M
MVM)Q+14$#]X!0TD:0:FFW-SHDK=-U(AUL\>1X.`KAB30C]'S4Q4%=!U][1RL
MY;+).&[CQVQ+A!=%0BR*R*K'%ADET5DS&(J11,P"4Q1$#%$!`1`=:7J;WL]B
M6F6TPD;,S>L@+'?JD13@@UH<PY_-7D1;_J:4@U'VPI\V_2B]5NN+5L:T'T'\
M0ZE>:,)I7`H.*\E_B8``^\)><+TZ?8HA]``:WP8CT^D3!UU]!/<,X'V>=,8Z
MN<<V8#S$4-K0^4FE00?@5INBL)W#>.!YO'_25^E%ZT-?/RO9Q6Y56$S[Q,&W
MALYICT``JV.=@]=O_F;'77X:Z5]G'J_\2FVG.-'-FN*D8_\`E9CS_LD?)8C<
M#B=)FKQ_I"N`\.&__BJX!;!N/^UG$H!Z`'2LM_3\@:TCW#DMZ\[L,@=_O'>D
MG"@_>O[#P5UH]!IL`>03D"R8]X`'X@UY$"'?EQ5V7M!Q-%X6/-I=N'V._O!_
M%*W<\*[%6GBY&<0&`9*A)JI2EXC7QG;WD&RJGS-:A4EY*2^7M[EBH7L(8$C%
M]P0[2CKZ;>U_2>IVN^U#<^E=)+B>VWK+KD7IF.<6QR-;;F4>J]S0"65`%<>!
M(J%I>O3VT6M0OO6!]LUAP`J<:\L!Q^BZ+D+RU^ZA6C"&4J_C/C=!O\DRU%M#
M''[3'?'G)M,MYKNZA7J%5/#61PC"LHIPC.JH&%1=<4``/KD4#ZAKG:G37WZ[
M>W587^M:O)#H\5U&9S=ZE:W$!BSCU`Z,R2U);48,)QXC\PHW%[MJ2W>R*%WJ
MN::$-H0>6->';]%G9^[9T7D!CKQ289K_`"&BK?`3*MLR'+8ZKU[2?M;%"8CE
M9E)S3FJD=*E)(Q,4Y<_.NH]LH4@$8.41(4J8D`.7_>?JNT-3]P6J7FRW6\NG
MFWB^Z?!E,;[H-_>N:6>4FM&NIAG#^/$[!MELW\*:V:M0XTK^SR6>;ZO^;\VN
M6_79V#^7P6=];N*^C5507Y]'C=+W92Y7;`F.WD#\BP?\PO<'7!BP=-NH#K[#
M]9I6C1='X_[L;=X?^Z1KS2V>&SN)_P`V;_JU=WXM/)3Q^X%<,,'4R_\`(_C%
M2K?DW#&,K^>EY9<9[86:NMVL1)T]@=X?'&(+Y77T;,$KY7J)TWI%R)+"FHF4
MQ`$WA?7'H?OWJSU2US6-M:-J5]IUKJ,T;I;=]EE-([=YRMEN8I*MJX&K:$@9
M2?,!EK#4XM-MXXBYK9'L8[S9J"I(.(!QY^'%319<C8US?ECD=S7Q)+TGEM+<
MF.(V7L!9'SQA*5`N'.'-$Q;B>Q7"MXD-6)Y<<NJ9!S=:X=-ZO.V&-B(I1NW!
MJQ)WF,F;&;9TC<.U++;_`$MW+%/H,>A[EL=1@L;L%UQJUU<7D,+KG.RMN(+.
M%V01PRR/#B3)6@(MKR:.87=\TMD>ZU<"65(!#6X8T/'G3$+U2RF(\66VRU#(
MEHQCCVRW^GM&Q:E>+!3:[+W&JD*8[DA:Y99&,<S4(!'*YU`!LLEL<YC>HB.N
M%&ZUKNGVMQH^GWEW!I,\A]2%DSVQ25(J9(VG*_@!B#4<UN?V\,PCEEC8Z4-&
M)&(PY8*3BAVE`.@;!MT]-8AC&QL#&@!H'`"@^`Y*[X8+74R*+LQ_P./\XXQ_
MJ94-$4HZ(FB+88.H#\-P_N_5J5[J#$&@Q41S[UYM?&!Q"Y*X7\POEYY!92Q#
M9*7AO/UF;/,.WV64AC0][;IWV3E/>B4V4FZD2$^SW)%?^>BC]4?IZ:Z_ZU=1
M=F;B]O'3_:6AWT5QN328<MU`QI#XSD(&9Y:`X5-*9C3'`+!6&FSP:K<W,X:8
M)#Y<:UJ:\.5*8UICVKTD=@#M]4H_H_-\0'7'CV&0975H:!PJ?I3#Q[5F\K6G
MRM"Q!>=[`>8>3GB^Y'82P+0IC)N5+@;%YJW2X%6/2DY8L'E>F3LJ+<\H]CV0
M?)Q$:NN8#*E$2ICMN.P:Z&]JN[ML[!Z\:-N7==RRTT&%MT)))"\L8)+2:)N#
M&N-2][1P^(`6#W%!<W.F^E;L<Z0R`X=@XJK>.O`_%^1/&%@?BERAP=7&SV2X
MG8RQ;F"MOH.OM;9"65GC^%BYHZ$_&HN%&5J@9QL*Z#Y!<YTWJ)%2G,(=<5OC
MJGJ^G];=7Z@;(U&=UNW7)[JT<)'F.2)T[GM!8XBK'-P+32H)"N+33HG:7':W
M+*$LQPQKX_R^2QZ^&7#?D&\=N8<M^.K.>,+EE7A17IZPV;BARNCE:^YK]>C9
M!0\\I3+.S+-$GHR/L"#DQP2%H<L9/D<HD$S5TD=/U7W)[JZ1=9M&TWK!M*\M
M[#J;+&QFIZ83+621OE,T9(+*C@149VT=@[`V6DP:AI%PZTE&>R=BUXQI7"A[
M^WX4YJ7/O)/%OD%S!\=C;$/&C%MARYDA//\`C6U'JE<5BD)`M>AX6[-I.5]R
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MV7G0>6O"O'BLU/&SR&>73*V><6X[SKX=IK`N(K99TXJ^YA6SA!V5''\&=D\6
M//*P;6,05DB)ND4DA3`P"/N;_#7+V^>DW0O0]IWFK[9ZBPZGN"!@=!:ML)HC
M*^O#/(\M&'<>/Q6QVE]J1N69[3TXL:NJ#0>`4??>7N)7)?E[P\P92.+N'K'F
MB[U#D]5[[,UBM.85L[9UB*H=^CUY-<\W*12`MOM*2;(CV&.?N6`>W8!VV#V:
M;ZV5L7?FJZCOS4X=,TVZT66W;)(U\E722QCR,C:_S90YU304!Q)H%:[BL[J\
MCA?;Q^H]DN8BO*A[?D5&+GR7^?)>!:URE^#A.`L)FK.'BYZWYXA):O,52-R-
M4WTG'-GE8.HV3.4#F`9!`H%`0$X^NLS#T3]JGW)N-5ZI,=8YR]T;-/FCD=S#
M8Y#G&8@4_P`.G<I)-4W`UH;'9T'#CF^@X#QP4V>(_P`9/*/$W(KD#Y)?(O;Z
ME:N:_)2)2K"%0I"R#^L8<H0+19W,&VDFON1IY-PUKL6Q1;L5'#6/CV/9\RZ5
M75.&N=?^MFS=:V;I71OHY;W#.F.CS-F,L[0)[JYHYID-279*22.QREQ(.5H:
M`:FD:3=PW#]1OB/N9*X=@./SY4Y!5?Y.N,6?LS>2;PSY@Q?C&?N>,N/&:,E6
M'-=QBU8HD7CZ%FPQ\$9(3)'TBT>J(.OLAQM\NDN;_E#N`;AK#]']];8VWT7Z
MB;7UF\CAUK6K*PBMHB"3*Z%\[Y!@*`4>VA.%<#15]0LYG7UI=M`,4;B'4XBH
MX^&'%8AO*!X6>6^7O)O+L.-<398_@SY![1A.[<U9.O/H9I6:C8L86ATYM3ZP
MLG+QO**NGK<IYN-%JFJ"TM)J@I_A#MZ1Z&^YS86V^AP=OE\7_P!E[4MKR#11
M(TN>^*ZC#6M::%HRDB/S$48T=JPNJZ-=2:J?0:?LIG-+Z=W&OXK*9G_AMF$?
M-]XO\W8IPW,?[6..?&C(6+[-=HHT0A5<>'_=G*$%4:VNV6D49386TI'H(^RW
M5(`*EW$-C;<_[8ZE:!_PR;TVEK5^W_6FK[EMKN.)V8OGRF%TT@(&7+@XXD$F
MN'!9-UG.-=BNF,+;1L.6O9QP(^2D_P`]5;YJYJXALN*/"7$UMN]GY.W**Q_E
MJ]P[F(80.+\-)N6BUJ<6%[(R;)RFE:G"S=HJ5J1908HC_<.X2`;$>U?4>G&V
M^HCM_P#4N\BMK/1K62>UMI`XNN+RA]*@97!GY@2?S9>^EWJT%U>6GVUG7U'N
M`)KE`;SJ3R/#"I5JU*^ZL<!ZW5:]#N,R\R2OHZ*9)2BM:S@SK\$ZF_ETQF9*
M*@T*6JG$LY&4]QP1$#G%,#``F,(=P^@WOOMZL7>HS:D[3=ORNEG>6F:S]60-
M<ZC6YS(,P:S"N'#`<%9P;6LF1,8]\I<!YJ.H":8\`.?Q[50O!?QS<@_$1Y89
MNI\;Z)EO+OC=Y58KAD+Y>IVPP%AE,1Y7@22[B)F;HL=:NNY)5M,MG*0N6T>H
M8T98@$_>9H(ZR_57K/L[W!=!(-1WK=:=IO6?0K]S888XY&-O+5^4&.(AKZ$`
MU#7O:*PFE,P"MK.QN-*U@QVK7NTZ3B>.4T)Q^/T4Z?>).)/)'EM0.#45QQQ'
M9<LR.-.7E?O][:UU6&24K=.9PRS9Q.O_`+8E(PAF::Z@%$$Q44WW^KK7_9QU
M0V3TWOMUC>5\RQ=?:";>#."?4ES/\HR@\0X4)I\U7UK3KK4/M_0;@R4EU32@
M)&/T\>Y9=></"+`_D"X^7'CYGVM)2U;L#55S7;$U1;A:\=W!!LJG"WBF2*I#
MC'3T0JMOM_T7B`G;N"J(*G(/-_2[JANGI'NFVWGLJ<17\$E',J?2GBK^\AE'
M!S)!@:C#B,0LSJ%A!?P.AF%:M./,'D1_+'Y+S"^'GQD^1KA]Y@K%;N5$;8<G
MX8QMQ>MV`L8<F32L1(5FTTJ*D:".*H!LFI)'M3%RRK3%1M\H^0.HP,U,W]Y1
M)))0W:WN,ZV]%.HG0+3M.Z>OAL]S76NB_O=/#',?%/)%*+AXH#&6ND=4%KZN
MK6@J::[H6GWEIJ,KKD$QAF5K^1H<!\E[0M?/);<M##L4P[;[`([!ZCL&^P?C
MU)(XLC<X<0"5`X"IQ"\6L55/*UP2\M_DEY48"\:-RY1XZY.6E.)J<RID2K42
M*/`1K^,F6UAC5CNI1^]3?+H&2%)9NW,4"]V_P'Z1ZOK?0CJU[?MD[`W'O:WT
M+6=$@:Z6/[::9P?Z.1P.0-'YCQSG`<,5I5O%JEAJT][!;N?#(YW=^9V;M_E5
M7TLO*+YQ5WK-!UX(Y]HU6=MD7+K_`'%UU3Y9NJL0B[CL"+#O]E(PFVW#?;7D
MTW1+VU,A>^+JI`^4-):W^%W`J0#05SX5.%>2S`U36JXV1I_;:K^_-9A3+O)7
MQ:<HL,X6H<OD'+-^K%"0K%&A58\LI*OF.3*-.R;1JI)O&#$#,(Z.<*F$ZI`$
MJ0[;CL`^5>VG=^W=A]=M#W)NNY9::';22F29U2T!T$T8X`D^9[>7#%7>K027
MFF21P"LCA@.W@5ARXC<R/-]Q.XPX(XTQGA"M=T88.QC5<:MK8^SS5H9W8D:O
M&I1Y)=>*0;2",<J]!/N%$JRI2".P&$/3H/J+T\]M._-^:QO,=38+<:IJ,]SZ
M?\.N'Y1*XN`)JVIJ2#AP[5B[.\UBVM8X'V9+F"A(</HLQGCWY?\`D'Y(7O(-
M>YD>.N4X6U&N5&/F:=<'N48R_)W.Q.)@C%[6BL&#)J=B=E&'%W[HB8#`42_C
MYVZM[#Z6[/MK-_3C>,&YY9W4E#;1]OZ0H3CG>[-B`.7%933;W4+QSA>VWI`<
M*\\>\*PKD]PGSUD[[Q/PVY2!@M]<^*U&XT25-R!D>3:UJ4I,19E(//Z32&DX
MN4>J/G#HK^SQGMB5FH4BCE,P&`0$2^G;+ZC;6T+VD[BV+_$_0WQ<Z]#-#"'2
M-E?"/MPXM<UN6@R.J"\8#G7'&7]I-/N&*8L)MFBA-*BN.!^:]"<=AS$<2Y1D
M(K%>-XU^@)3H/8^CUABZ1.78Q3I.6T4FLF8I@W`2B`@.N6)-;UN5IBEN[IT1
MY&60_3-19[[2U97)%'7^RT?@%(A4MA$1*4#;CU#UV_".W7H&L2(V->7-'Y@*
MUQ)HKEN5HHT4'/Q6_M'Z?[/U:CF=^R/G_0HU;V+?J92K\^7QOIK*91Y7%17(
MW.'D$\BQQ4.@HN`D3P:L8R8$351,`J`&P#OL'T:^P_5Z%L^DZ-&^M';7T`BG
M:-38<>Y>6Q.I*2/\V7ZL65WP,\/^*W);@C7GW(+CIA;,\DWHF(:XUE\DXYJU
MNF65>-0&[L(=A,3$:ZDX^/*_>+K`D@JF4JJISA]8V^N6O='U'ZB[+ZNW\>R]
M<U/3(S=S2`03OC9G+8VN)8T@&H:`:U)H%LNCVEG>VH-W&)*-C:*\J.<<%C45
MXXT?QN^93R#\9\%2)*5QXSGXT\QY(C\>O)I<\9#_`#]1;3D-66SJ;>JK/%H"
M]0DA]D>XHLX28/Q;E,8#'W]ZMMZZEUDZ!;$WGNUKKC>.E;]M;;[HLS%S(YF/
M?,_(VN4L>SU`:-,GF[`,'=QLTV\O+2W+1%)#2A/`OH0/A7Y8E>]]G_VC7U_[
M=#UZ#_TB^H?`=?*>4`2N`X!Q_%>D`4%%].J:BFB*+LQ_P./\XXQ_J94-$4HZ
M(FB+;U$1]-O[?U:IC.7.JT`84->/;44P4<*=ZT[>OH'380_7H`YO"E*\.P)A
M1;@WZ[_3J9N>GGI6O+L_G0TY+:<@FVV';\/QU*]I=0"HQQ(P.')2FIPKY5H4
MG:`ATV$>H````[^OY]2M8\.S9CDI^7O\>Q35)'F-2M/;+^R7\'0/_0:E]&E7
M4;4FM!A\SQ*C4)V"(B(E#^W</Q?#4?2<[$D#'@!A\:\3W\E*<.&*=IA_!](>
MNIQG`+J>8G@34#P4I#B:@TIV<T!/;J`@`CZB'Q]?7;;TWU/3MJ?I^"FQ.#S7
MZ()#=.H&#X]V_P"3;J/QT+6%I!%5$!G.M?FM1)W>H_VC_>&VI&AQ.9X`PY<?
MFAH<.7R6@I[AL(@8/H,&X?F'<-3%M>!(/S_%0X?DJ#XK4"B40V`-@Z?`-OPA
MT_!J$A<,N1H<*XXTIWH`:DN<3W().[U*4=^H@/4!Z=>FI2TF2M/*,*UQISJA
MI3M6WV2_LE#\`>GX/P=-^FH>F<P-21C45H#XA*DXG!U,"@)C_P`12CMZ#^`/
M3X:!I$OE8`SMK^CM4&9Z?O#4U3V]Q'ZI=A]1W'ZWXP#;XZ/9+09'"M36HKAR
M`4]6T[UOV'H&P?D'T^G4U'%GF'FYBN''M\,5##M6PR?=Z@'Y]OA^??4IB+B2
MXU'('$>/BC7$'@/%:@EMMMUV'<-Q'ITV'\?KJ,GJ$UB#03Q/<IR^JU[1`-B@
M`]?01Z=?7?U$='"2E*!P+AAPHWG\5(3AA^9;/:`!*($3W`P#OMU`.F_PZFV#
MUU%P?F&2G'$D<NP?SJ!-`,HQYKGU41-0-:8<47%V#]`!^'I_<`#JF8W.XO/P
M`%/C2JGS=Y6O:;]H?SC^O4:/[OJI*-[_`)K02"8O7U_'_?Z_#42W-0N#2]O`
MD<_#DIJ@&GZJW=@_MC^G]>IZ#O\`FI:-[_FMHD$>FX;?1L'ZM4P'MQ::^-,/
M"B@<QPS4\$]LHB`B4.FW3X=/0?3;IJ&1V:H+LHY5P/>0G'S$#/VKD#H`!]`:
MJJ.)Q/%:Z(FB+B]XF_;];?<`Z%'U'8?S;#JF^5L8!?A4T':>/+OH:*+FEM*\
MU^?QXU$C&RORQ(!5CF#G_P"1PPD0`QE"@3!:W<<X$17$"%WZ]/RAK[)=5P#I
MFA^9N8[6V_A7$9]4:!4<N!)[!0KRAI+97"A.662OQ;0?59WONU91_P!A4#T'
M8U7P\(;`(AN&/6N_7;UV`/R;#Z"&N(O>.YK.KMZ#3-Z\^`H30EE.%>/*JW';
M32ZRS"E,S>?9Q_%7QY[\/7"?D[S)H_.3.%*LM[R[C^(JD3!UZ5LYC8M=ITAS
M)OZLYGJ0#`"3*\3)2AG0$6<BV5723]U(Y2B4WF^U?<3U9V3TWO.EVU+JVL]L
MWKI7N<(JW(?,(VOI*7$,!$8IE;F%31U:$9*;1M.N;EMY.PFX%*XX'+PKV_S+
M*20!`I0,.X@4`$>GKMU].FO%EE"034"@6[1031%%V8_X''^<<8_U,J&B*4=$
M31%QJJD1246543222(95554Q2)III@)E%%#G,4I"$(`B(B(``==$6+7!7/-[
MDOD&A"3*JK?"&;Y*[5[CE**XNR36"MY?&1U"Q[J8R/9()A1KFRY%U]E+6*JE
MCW(&1CXE-(OS!W8"0BJYWG'(]BF^1UF=\B,5X`@^/F29.D-Z'?*O`/HY>"AX
M2ORL=<\KS<K9HRTM(W)2LN=:'&&/&E2C3H=@NW/N%T12)DG)F0I?D%%8-@,K
MUW",.&%6^6DK6^K\#8+)D*8>VN7KSZNT]*Y+IP*,#C^.B$7LX(,W#X0FF':=
MJ0#F5(NANG("W-,6\?U*]F+$+ESF/*@XMG.1T-$&?8KA6K*+OCY.:KT6\L3R
M("S7*6IR$#&$>23B))-ONT!<@"#98BXH/-.6H1;EMCXEO@LUSN#,.1F1*3D"
M&K+)D\"XV6`R.Y;XKOL'5W:E>D;=".Z8RD"$CR,U5HN9;%6;D4[%G!%W4#R7
ME;0KP1)7;!3IS_<5'2,[D-&&6:22W[OQ_'^QWIW,UXC*175CXQAD1.+9K+C[
MZ2?S9&YS`=4@Z(K?\I\U,NX0CN6-ROJ52-A^GV7)%&Q+DU"+7:HXKR;5J!69
M*FTS,[91ZJWDZIDNPS0)Q=A3%FBTECEC'Q2E=,G)B*XGE<_SO`U&F7K%V<"8
MP2>6[#%&F:^MBRJWQM(KY.RO2Z/)397D^Z9OHYU%Q5G5,W0(84#+(D$X"`GT
M14/R9SODS`E(Q5AZN9#0N')#);N9,SR%(X=L]NBH6ITI%2<M5_MV,<01DL^9
M0;EPXC*NV.D"*`2<T@L)Q%(Y!(OKL'**Z95XL8AR]Q^>05(OV5,D8HHBT7DR
MM34DUI%LE+XWJF1<>W.O*'K]@CI.%FXY_"NS"1!ZR.`N"HF,4B9B+?A#E1<<
M[9[RUA-6--BFR8VX_8\F[M19IBSEKGBO,]LO.6ZY(&<2!5OL:Y4I_`U2+E:Z
M]13*RF(Y4C@#%%55!$BY>.#OD9,9PSU6\C\C4[]4<%9!KM%3KR.'J-47-J3M
M&$L>9%3DI6;A7BSU@[C)JZJE33;$2(J@W3`X")S#HBB:&Y09FALHQ#O)5O:M
M<?V+D*\P]$/<>PN%\HX9?HS%XD*?1:L2;KV5([D#5LD.`%DE+JR,"[9Q,N9R
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M%DG#NVR\49C#Q4=$`*A6@D4,*PF,J38FY%-?%_*\SFK!5(R98DH7[3GALK56
M2K*3U&K6AK7+?/U:-O-30D7#U\A5+]&PR,U&$577,1B_2#WE0`%3D5GW*WG/
M-89S&WK%&:/)RG82A(#(/)@D9BO).0G3VN6Z0)'H4:N6*E0LC`4NZ4VB%D+R
M^"25[U6+6.;>V1*2%PF13'F[(UUF<K8.I&,L_5?#]1OF+,K9/<W)>L4VZIV]
M.JS>'6%88PKJU2;6+1B7<9?W;LZS;W5EB`D)1*0!-HBHF,Y*9;?\;WF=896H
M7YIB#-5QA<CRM-@WQX/,6",:7F;I=[O^,FAI614C9QA7FZDZBB@[E&CQ[".6
M+995%TBL0BVS'*+($UQOY@<I,?R54=8PHU,O+[C%*BP"487=MBVI2RL_E:1D
M&\@1"<I]QOS=PVA4VYDT'$-%)/B*G)(%$A%W7)3*V;H#(%$K&-9U!O"2..I.
MVV"(H+K!DCF4)1&8C6+:9/4,\WVBPCS%S-@JX%PZBE%GY7Q`(H9)/L%0BZ:8
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M(FB)HB\[WEXQ'YA<F<C>.<QP/JU'R'QRQQ2YF?R'C6Z9<_TJKM]R[,NK+`HI
MWS]W;[CF_6.`K-678O8MLVDD&24D)U%"J'*`%Z\]N6L>W+0-GZ\WJI=7=AOB
M_N6LM;B&V?=.@MV>D[-%6WN(6ND<)`\.&:@';5:WK3=6N;F(Z>`;9AJ<6MJ>
M^I!_%8KV'"KS.Q,*]KL7X?O%9&1$I<IC(<HWC\D7!DYD;Q8(@("?M#Z6;<I$
MYEU)SD,'R[P3N13<I_\`4*8W77N\_43V\7=^R^GZE[S=.(8X`YUBTM;%!)ZT
M/D&GT\LF+<,S?#!8<VVH8@V$!-:US#CXYU)-!XI><UDI7,?P7CL\;N`:4Z;P
MM,6L-$S'E^N0=#K3<KB/;SPU?'/*-)U,*UAD^552*DS<O5NTJ>XAV]N"U??7
MML,-UJC][[KU35PZ6X;%+IT'_>)CE(C$DE@/3$A8`2XM8W^KBJ[+'4)GMC-I
M!!#S.?ZT:\DGX+UY8UJ\C1\<T"E2\^ZM4M4*35:O)VA][WSMDD:_!,(E[/O/
MF7+QQ\U,.6AG"GN+*G[U![CF'<P_/S6]0CU;6;O588A!#<W4LK8Q0B,22.>&
M#*&BC`<N#0,,`!@MQB8(XFQ@U#6@?(45;:QBJ)HB:(HNS'_`X_SCC'^IE0T1
M2CHB:(N%PW0=H+-72*3ELY240<-UTRJHKHJE$BJ*R1P,11)0AA`Q1`0,`[#T
MT1=6>N5Y1E$QJD%#GCH!6.7@H\T:S,QA5X@A4XE>(:"B+>-6BB$`&QT2D,@`
M;$$NB*D;%AS$5OM$3>+9BS'-GND#\M]AV^PTFM35GAODEC.6?V7/248YE8\&
M;@YE$O:5)[9Q$Q=A'?1%]MYQ=C/*#%G%Y+QY1\AQL<[&0CX^\U2"MC)@^$@I
M&>,VL\Q?H-7)TA$ACD*4QB")1'8=M$79R%(I<O634J5J-9DZ8I&HPRE0?P46
M\JZD.W*D1O%*5YPU4B%(UN1`@)H&1%(@$``*&P:(ME-H='QU"(UG'].JU&KC
M=95RA`U"`BJU#).5^SWW)(R&:,F97"_ME[S]G<?M#<1VT1=+5L08GHTW*V6E
M8QQ]3[%.E5)-3U7IM=@)F6(NX*[7)(R<5'-'KTB[LH+'*H<P'5#O'<W71%5#
MJKUI]'R\2^KT(]BK`=RI/1CN*8N8^<4>)II/#S#-9`[>3.Z21(545RG%0I"@
M;<`#8B[%Y'1\B@1M(,6;YLDNU=)MWC9%R@FZ8.$G;%R1)8ATRN&3M`BJ1P#N
M34(4Q1`P`.B+B^R(K[3^VOLUB$S\B,9]K@U0"4^S!7!T,=]H`0'?R`NB@J*/
M?[?N!W;=W71%\J=:KB1%$TH"%3(K-#9%2$BV)"JV(RQ'(SZ@%0`%)L7"95!=
MCNOW@!N_<-]$7T(PD,WEGD^WB8Q&=D63*-D)I)@U3EW\=&JNUHY@]DBI`\=,
MH]9^N=!(YS)I&64$@`)S;D7(A%1C5P^=M8YDU=RCA-W)N6S5%!>2=)-$&"3F
M062(11ZX28M4D2G4$QBI)E(`@4H`!%0:6%\/-[R?)R&*,;(Y)44464R"E1JP
MG=CKJH"U67-:2183@KK-1]HY_?[C)_5$1+TT15Y(Q<;+Q[J)EH]E)Q3YNJT?
M1L@U1>,'K1PF9)=J\9N"*-W39=(XE.FH4Q#E$0$!#1%L<PT2\5C5WD8P=KPS
MH7T,LY:H.%8AZ9FXCC.XM14ASQ[DT>[60$Z(D,**IR;]IS`)%\3BJ5=W'OHE
MU7()U%2CI9])Q;F)8+QTB]</2R3AZ_8JH':O'CB1*#A150AE#K@!Q$3``Z(J
M<M^),59!=L']]QGCZ\/HI)1O%O;A3:Y9G<:@JJ595"/<S4:]69HJK$`YBIF*
M4QP`1#?KHBKQ%NW;H(M6Z"*#9NDF@@W13(D@@BB4I$444B`5-))(A0`I2@`%
M```-$7Q-X6'9FE#M(J.:FG'1GTV9NR;(C,/CLVT<=[*^VF7[0=GCV2*`JK=Y
MQ11(01[2%`"*C+)A_$MRCX2(N&+\=VR)K2!VM<B[-2JW/1U?;*(MVZC>#92L
M:[;1*!V[1),2-RIE%-(A=MB%`"*MF43%QL<UAXZ-8,(ADR2CF44R:(-8QI'H
M(@W18-6"":;1NS1;@!"I$(!"D#8`VT1?&A6*VVKR=1;5^$0JB,66#1K",6Q3
MKR4*1L#(D.E"D0"-3B2,P]H&Q4@1!+ZH%[>FB*F;UB3%>4&\>TR7C6@Y#:Q"
MIEHIM>:A7[8A&*J%(152/2GH]^1F=8B8%.*8%[RAL;<.FB+MYBAT>PU=6CS]
M.JTY2EF32-5I\Q7XJ3JRD<P!$&+`]>>M%X@S)E\NG[27L^VGV%[0#8-$7#!8
M[H%7JHT6LT>HUVDF;O&AJ?!UN'B:L=K(@<)!L>OL&:$2=!^"AO?**(E5[A[]
M]QT1=\,+#F?MI48J.&49,'$4SDA9-_M!I%NU6B[N,:O/;^8;QSI=@@=1`A@2
M.=%,3%$2%$"*AV6%\/1MT<Y(CL4XWC\B/#N5'=]8TBM,[HY5>)&0>*KVEO&)
MSBJKQ`XD6,*XF5)]4PB'31%)>B)HB:(FB)HBX]O0.PO0-@]/34F:7L^JC1J=
MO^7]`?KTR,Y@_/\`I4N'[(^BUV'Z/TZI^B[DXJ;RK>'IJL!044$U%$T1-$47
M9C_@<?YQQC_4RH:(I1T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$
MT1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%'F4F
MS5W4!1>22,4A^]./UOG%V[MTG[[:_P!9<M6GLLDEE_<D721&Y#]O8F=4#G$I
M"F,!%(0;[==_4?7;Z>GIT]-$6NB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(
DFB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g53110424fin_pg002b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g53110424fin_pg002b.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`&P+&`P$1``(1`0,1`?_$`*L```$%`0$!`0$`````
M``````<#!`4&"`(!``D*`0$!`0$!`0```````````````0(#!`40```&`0,"
M!`0#!@,%!@<```$"`P0%!@<1$A,`""$Q,A1!(C,50B,646%20S0)<6(7@:%R
M4T2QP:+")!CPD6-S@R4*$0`"`0(#"``$!00#`0$``````1$"`R$Q$T%187&1
MX1($\-$B%(&A,@45L<%"8O%R(U)#_]H`#`,!``(1`Q$`/P#^Z#+N3&6*Z>O;
MY*#G9Z-;S57AGS:NIL%))B2T6*,K*$N9*2?1R2L?&O)9-1?C.=7B`PD(<P;1
MN3/%[MU+UO)?CU*/G#-!\'5R0N+O']TM]<AH>1DYMY5WU4:^P.T!!)HQ396*
MP0[N8EK`NJ5)B@VY5%ES%3#0YRE&N3M=]QV;5M)3]&<[F4^Y=S\+3'4D5:AY
M(FF-)IU=OV6GD1'QA$L2U^SM'SUJ%@9*S2+V?E8UI$N7+^-B"/G3!DB=80,!
MD@/<4<G[U=SZ&L_CJ2-A[DH"N6N1BE*K<Y&G56S5>FWG*<6SCU:;5;=<$H-Q
M$12[=1^E./&0HV:/,_D&[==K'E=I&5,`<@IPR$/-F6J]A/',YDVSH+.X6%6A
M6;E%L^A(ETJYL-CC*U&D^XV22AH2/02D)5,#JN7*12:B.X!#3HVSO]Y79M^*
M6"^/^0$,N]?%SVJ9KM"K.3;DP-1DK]<T(JQT"VL31#MG,.V2:%HJ%PFJLA.F
M3A%3*,W[MFX22,FJ?1%0%.NEG]3/+1^XW/*J5L):C=XN-[7*W.%FH^4I+ZBX
MYD<JSYGU@HEQB6E*B7`MI*0>RV-[7;VT>_;:<I6C@R2SA#4[<%BD4V=_%\_P
M.O\`(W$\5$<27JW<@WDK#3(VUXJROC6'R@\*PQK9KFTKH1D_)?9G<JV@Y*/@
MI^9F*+-S,1'KN6;:301%<B1B&,FN'#UY,1_)5O*GE\;"XU?/-0M65;9B*-86
M1I-U1D"J4W)QIT:7;'K([/\`54#5+$4YT9BP4(95E]W13VBS.\3`!/M6%..3
MI3[CO2ZH3!\Q[KH)40D7>,,N1F/W-_<XU;9.>QE>>5-.>);QH;9_(-&EJ=VZ
M+K<C:S%9H2"D>*0'.4RA4R#NZD%UZ7R'DAW;8IA[57*A+FM,7,6"SYOJQDU8
M-R+""E<%Q9IRUKV>4,86L/&RU>!%Q#N%1!.1*X3!,=QREZ0'?I6#>(ZNG<U0
M:'7,66*=C+NJAE`D/*-FK2#4=2M+JCIE&N)V[9`9@Z1&MTVEJRS!.:=FY"LU
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M%<E>V6KPUL3<L:W/W^'NLPT90DVF904(Y4RADU`2Y-@@`Q7[MYMI4M-89CU_
MW?8IA[E"4V8+;(J7G;OF>CE]S771&$&^P=!*6BSS-AD2**(0U?GH$S=Q%.E?
ME?DD&P)@`F\+@3[F[7]-2P;_`*!SB[^SGL;QF2X:#LCQA.TYK=(>O^R3;V9X
MR>1B4S&1?VIRX2!"9DT%2IE0.H7\X=@F`>J:RQ!)5NZS#]UT&M2TN^1B:/,7
M^]R7VIXBTQ1'1@*"\@\D"L1-Q5KRLHU=%)!JIFD@*R64,D1,"'/EG6F]2E&$
MH9UGN2;6.;H4;,8TREC^'R<N1MCFTV^-A$HB?>.XA[9&47/L8VP2D]2I6;A8
MY=:.2DD4N;9PG,BY$K<>MG!MO*`_:=MI4*:FX^11:-WR8UN]BK%?9UFT,6UU
MO<YCVNR2\YC:674GH&1L48Y5E:G`7J2O,%%F=5AQ^<YC0,@0R9W!40,(E[M.
M)VP<_P"2N-XK\9+]']U^)K%>6^+ZI+/;?D52:M$3,TR"4BW<Q4HNE3'V.TVZ
MW-57@%@*Q&RIDD2*+:.W)G"?"@?4=/(8Q-/I+)KI&63,)R!XE'8(?(``4=`^
M.A@'7R\0T\PZ-X0>_P!>KQMXY2S,BW='C6*R!D[&\HC;(:=Q=&*S"ZDA!&0A
MKS]KIJ=XL,=CJ3*HH%FG*W7GR2[]D)4'WYA3)IJ(@90,K'(XWO9\&VL:EO'5
MG[GL3THD`M<I&8I<):Z"ID*IV.P1CMO"61$619-]4XIV@"YG&16L<NFNA":`
M]?`IHT(X$BH)W$XK]SKQ<1A\+(.U4G5['68>Q'B)B#^\Q+.3-!S[8C2P10O&
MQ%_M\RP256*TE6P*`5='>(IJ`)!'4!ZC/517YTJO>I!NPS%#2#[,\?)1=BK#
M?"T@DPGI*:;,_M[^.=4UG<26:%,Q>.G;N%"+>#\JP)N>9,Q>/0`UJ,7?8J]=
M*JE2VP7,^ZRMI,9N5NE(R)CEG%4)?*<(>S,HI56Y8_;NHU@J]BF<#*RRK.PM
MG\Y')*1#T$'I1D&X``@904J>?^2K:_27^BYA&Y2%CK4M1;G0KI!Q$;835.R*
M0+J0E(.<]VC#OX9S#S<C$D<E?L%6KENHJFHS=DV*_()5#$87M7Y\8?D593N5
MKA,98IR$WKMB</<TRC&#I]-</*W%2OZ@DFDN]-#V"7DY1O6H<(YI$."'.#HX
MF5(4B1%#F`.B-4W*KB55?ZOC,*&&\JUG,%;7LU77+QQUBL=3GXW[A%RCBO6^
MKOSQ=FK;Y]"/9.(<N(F03V"9NN<NOGH("`&=;7ZD^9(9.N,U1*X[L<+2+!D`
M[`BKAW!5M_`,)$K-LW6=.'8'LLG%QJA$TD#?+O`XCH`=9/206',GOLL4R.O#
MG'EFH$;.QT-/03*TNJX]?OX>>CT))JX22K<M*H-%P1<E!=)0_P`BFH:CIKU3
MS^MC77_V?]2F9'S_`/Z=6IA&2V/+N:H/+-3:>O?D7=291Y+!<Y6/BHIK!5R8
MG&ENN+=J_DT4WZT:T7%L45!`JG"KMIP__6K\/[["\IY*(&67&+%H*:073H"6
M1F5I,:+"N2K0UE3KC^);B5TK)HR<6NZ1.IR))I&25*)3&\0`:6#E["BM.X-(
MV5(#&5AQW=*N6VR5I84F<G7U16_4:E18NI.3D@J\587MKA8!RW8JG9OGK0B2
MVTI!%(ZJ9#YQ.SOT[!'N`[CJQV_LX)W96Z3DUG=SQ&;Q]9ZC2(9BG6H<L[-J
M.K5>I>%K:+HD<!A9LA5%P^,DIQZ%24$OIM4OQG9\?'`Q5[U5OZ*<5SCX_N*V
M3N6I-7QI6LG(P]OL:%LK\';H>LP4)]PN#BLRJ4<^6G%6?N4V;**A(F0!T\54
M6!,B11`@G.8I36ZOIX+H1>_77]%:A"F4\]J8J>@:6QO=I.I-7,"VF[NT?U..
MC63JRR_VALRAHZ;L#*>ML@S<K)*.6L<V.JDFH!4^8X"0/+#.CO)9AJLTS)0L
M#(2<!"2-OEVS8#,X"/D8R.?22A5$R<#-Q++LH\BA0,)QY%"`(%$-=1`.@UU,
M+,SK'=RA9&K/YPV++S'S/^J;O$=2J?W.H.5KO<(U)RY?O*_/M9]U5V]7:EC'
MP.I!=9%-(&3@``ZA2D-WLIXF:O<=K].,CW_W(,'3:&BX3'UYF,F3EBME6/BT
MCJ"C9B&E:*DU=7%U,V!Q*EK#2"A4)-EPR*;M1%Z,@T*D`BM\O2I/Q>67QU_(
MS_(5U/Q=.;CYB9NY*,?1M?4I./[_`'>QS,)89^3I:"U=@)RH1-+L`5&U(6)6
MR34;%(3<39RK1R;!%==9XZ;*\9N,@J=>2#>O2:#I=JB+K68"UP7.,+8X>/FH
M@SIJJS<J1LDT3>,U'#18A%6JYD5@W)F#4H_M#01TCG54JZI60"\Z=RM7PA9*
M-59N-(\D;_&VV7CE)"[X_H$0T94PD3]S!U-Y"LM<C55W"DVW*FB@H=0`$3"!
M2AKT9`U4RR.K148.PN8L\*K,,DWH1JLI"S7MD5_F;\<O77\I!R2*B`E.59LY
M63,!O`WPZ$8%S9Y51RE"8UG<>VVK)6Z2L4;3+5(S%3<)6!:KQSJ7EY0]5CII
MW:8:L+LF!Q:R+QL1LJ<4TU>$RR0*`7>L9*0GY3*D(2O6"/<XNL"4$X$ZT?(N
M;`1_58>ZQSVNMF+QPH5)_&394VZ+@$E>4FT=`$HBV#85'%.?V^0KK9,<S=(L
M6/KM6ZW7K>[@)^6K4\Z1KMLDI=C`C,N:C,3*58L2J\(L=6*>B1=-$Q#E$Y!$
M2C=#BM/BBDYS[Q,>8&N3>IVI,1?%K3.WOS.K72*LJ%;D[$M5V:E8AKC.Q$MD
M264FD!1<,XE)9RB=5`@@)W")3PZW[Z286KIFBNTJ<J%;6C;!,2MOG(6)]K!1
MXR*559V0SEG'6*XN!730K\"O)-P9D`YE%C.#:$3,0JAR>FW3-,G@J]ZJW]-*
MP*H_SX$/DBM4";H=XB8NXV:5J=7NCEW6$6\S,1T4ZFW;QO623)K<6I),F"Y4
MY4S/VQE$AU*0AB'-+B2IXX&Z?:N7FJ&OI>WXQ_$*MWM<I5XTDC#59Y;5"KMR
M/F[68@H`\?%`BNHZG7[^Q.F#%)BRXP%0!/O`NIP`"%,8.!U@!<7W*JV*IX]F
MZOB>_35HR5%3UD@L>+O*I$3#"GP$@1F[N<W+R,X6N-8"4%RT-%G*Y$S\)!!,
MH%.)MK$TOW"XL%2YC?N^,#M?N7CGT7!OJ'1;_?7TQ49._2<)%#$PDO4ZO7YD
MU=FPED+!,M(TUE;SS9VQ2BVB[A=VZ9+;#<8$4/#%7N7KF--.$?D7P^9X0[S"
M*\/$3L]7,W.A0A+.S%HU807N*9(7:(+8F4@Y;20!)1,<NFDF@DH=%PD8JH`/
M04>S>=Q4-8-A\1/R(E-L.34H_*H78?3QT$2ZCIKU#W&9,Q=S=%PHK:4+=$7%
M<]8BL?S8H5V`<STA8(^_VI[4FR];9L3G</AJ[J.</)<N@`PC$%':@<)1-U?Z
MGCO>S=MUNFE?2LAM+]S>/HD9D9%E8S14*ZRPP).-(P'3*:D<05:/LEJC*\"*
MR[N4>/6+QRG')E*91^:.=;`T3*(L##]F^L\L<>*(V'[J:%.5AC;(J-LPU\(7
M#4[*NG<9[-6J-,V3@0L(VM#!XX0<1SNLJ'%S,$$-C5J&\3#L,7H9^[OQ,,>X
M\[IJ#D:SH5:!B[@A*K9%RQCT$)V"7B5!4Q`W8JV*Z$.Y5VJTJ85F6)(AR'R2
M)'J2R`&3U$+@5>W>C!$3FKNPK>(+_&8X>P;*8L$E2U;PB26R=BO'#$(L;*-6
M:%:JY#M5?5E7ZLHD;P;$4(D00WB!CD*,+]U?6-2>16\F]Y5>Q?:V=,G*PS2F
MPQQ7\GS+::R]A^EI14;9'TK%MHQFXN-WB4;8[([@W)#*1W(T*<J>U3\T@C2?
M=WMS"07N)ISR)BI))K84D9K"-BSPP3D(WV+UK38-*),Z;RK:272(TGE"S!-B
M2P\"8I[A/M\1G-C[J_E&R0<8][P8?(&-K[DQ&E+-ZE1,;&R2[7KF4<1Y&DWK
M=2`>V!G7$VE$MDP6&GW\6TW-RR!T$3K&T`=H"8"F.!M?N-RG!TXI;_C$NT+G
MJ3]C+/+UA_)%&40H<YDZ,:R<G4+4UGX:L,8YV_B6,K4IZ1:1UG2._;E^W.>,
M')U!%)10$U-MYBKWKE>"IAQO(BO=U]-M!NV=)C5+XBZ[GVTK)Q,*YAD6LAC5
M&OUIU99A/*+4SXJD"HE+QPP@E("W_P"V4XO0!C`P,?=WLXQ816F<:X_RU)8D
M1B9TCR-9`1.YK)QX5"0N:$2TL4CCB-<F?"_7N4?3WS:5<-RH@F#-43%.)TUB
MIL3?\E<R5/YE$0[M*&#S,<;)P%LKLMB:4L[5E'R;-@@KD^%J1(LE@L^-'(.W
M!)J-A'LH5N\3$R3IJ8"G41*BLBJI&=*?;U4ZJ\&@XU[(D+8+/=JFS]XE(TAK
M4WDJX=H"FR.2X13^5CRLS!J"BB23`_N`#P*?X^.G1%JNTU4M)H6@+S&V"QY`
MK35H\1=T65A(J265)JF[=S5<86)/VFP3"<C9K()IG'0``_AU6<69(R1WQ5/&
MN0KU1)2I*.&&.INO0]DFD<I8@C[`Y6L-9AK<V6JN+)*Y-<D6KB:3C9$B"#$K
MEXORD:IJ[/F27#QXA]R)EQ>DR==J]7I=@R7>[3&3$U$U**>PE?;M*_71BTY2
M>LUCL;UA$5Z.;KS39NCRB=5R]7323*/S'+'D=K%7C4WP*]/YPF8V(IZ;+$V0
MI7)M[">&&Q0NZJT',Q:5221<6AY8;8]GEJ=&5UJD[:@B\*[6!VH]0*B03',"
M</7JK+#$I-K[N(FFU`]@M&-,C(3\-E&E8JNE"C4(R?L5-DKBQ;3B-S5?0\BX
M@YNCQ58<C)KOF2IP!L@N&P%$3IAH^=LD*]6SE!6;.=]PK&0MA.YH-,JELDKJ
M9)%6CR"]B</$U*I#2!5^1U8X1K[5V^`"&320?MP$VX3%+&>BRHI?,T$`:``:
MZZ``:^'CX>?AX>/4.I[T!]T!R<-0_P`/'H"K35NK%<7C&]@G8R$5FI!"(ABR
MKQ!@$O+.B*J-HF-.Z43(\DW)$3BFW((JJ;1VE'0>@'2=BB3OUXTJRXO$$RG<
M)^S=B1#DX^,BJP(BBFLJ"@"4@F`Q@U$`T`=+!PUZ=^('+YW+XDQ/<ZA3LG3C
MZ@'R%(D@Z-:+1#OF%`LMF6XRMJDA>")KUZ(MC]58B;*.DUF+N25'8S(N8#`$
M&O3$O(5[C^Y/$?:MAZWYYS98G%5QG0RQ?ZDG&\/*3KAH::F8ZOQZ2$1"-7TJ
M^56EI5!$2HI'V"?4V@`(A8WY'#VO95NPZULC^IC;%G]XG^WGF"V1%'K7<)%1
M-EL#YO&0;2]5NV4-G+23LI3,X]K-VB%CH(CYX)@*BBJY345.(%*`F\.KAL//
M8_<ZW"2;YJ/F6KN1_NG]E7:=E$,+9RRD^J^1QJ<)=_T^RI-PL0?IBQ.WC&)D
MAD(*(?1Y2NG+!4NP5`.&P?#J+/$Z^U^Y4>E2KM7ZJL8!:A_>N_MW.,;9.RVE
MF"<&BX>G:%7,A2H8QR'SP<KDQQ)-:8B$<:O@_?I2KB)<%!1!-0B8ICN$.N]N
M:FTG)FQ^\UWEY>+\-\=PLYQ_NB]DO;GCC#>4\MY;-`5C/]?:VG$Z#.I6R>LM
MK@'L?'R3220JT+$/IUHW<(RK9-,5T4^1PL5$NY34H='35#C8>C^3JB*DTFOC
M<;1#(L";&QLG@SL@UTE0_69F?Z<E?U26)&)+,>V&I@W^^A.>R,'_`*`4/=<H
M\>S?X=>3@:5ZE^JZMB7]R(S)BACFB@R=`D+?=*,TDW<*\5L./WL&PLS<T',L
M)YHBU=6*OV>-(BJ]CD^0#M#B8FH`)1T$#?47_5]>JUIU.KQX/E\AQ:<45J\+
M4)2S.YN4;X^L+2ULH\[Y)&,L%BC6*J$-*6IB@S(C+G@Y%4LFS3+PH(R:22X$
M$4DRE/`M'@Z%2\J<$4+(7;-4<B66<L+FW9&K*-T@HVM9*K51GV457<E044+]
M%HSLJ;F%D)1BX&+E74>L[B'<6[<1ZXH*J'(1'CDN3?C;8A/]KM+L-RD[(ZM6
M0F=<LMBKEQN6*XV>8M\;W&VU,D.G"3TVP-#*V%-4J=<C2NFK63;,)`D>B5R@
MH4505LLGA1Q+]EO$,#F2@2V/+#+SL)&2KF%>EDJZI#A,1K^O3<?8(AXQ+88:
MPP*JK:1C$C['3!RB(`.I-=!"&FK?CXO(#S;LUQNO$97BK;:+YD,^9Z6WQY>)
M&U+4AHY=U!H,NHC%-XZET:HUO>#B=<*'<KL'#M3>!#JF2*5,-4U.ERLS"M6D
MVUFR],^V3$$98,CS<35F4*QR_3VM+R=3X1K'1%*NK!DR=0S64F8&/8-RFL25
M:>J1(O$E$CJ1NQ)0#BBB9/2N5FO"W,P5BK]K,%!R]3D)O*.9L@LL<G6<8V@;
M[9JY)0U,DCQ;^"93K;[358:5L\["PLFJV9.Y]S+*H@/*(F<B98V885%M.8*U
M1>PSMNQO+4"SU"LS<5>L=66:M\3?CVVP/;9,V.W`]#($G:W#Q^M%SZN2"R+@
M9SD:%]X=0%"\:B2)TYB9JM6FT\FOCD2L+V@52,?"E(92S1:J*E=Y#(3'$T_:
M*T7'C"R/;@>^-C@E`TN#M\I&0UJ.#MFSD)AXW34(03%.*9!*,?;V]]37,;9`
M[(L)9+F,S3UE"[!)9V)B,EX4BKI*1:*'^C,LG+UPU9;-_P#T]<-8%D$T;!P%
MTG&J947(&(4`Z8[@_7M-MMU3S);(W9?V]9?O$[?\HTQ6[S,[CDN(_9RD[.LH
M2%QRLN[=3-3@8R!D8=)C&VAX[!63WBJ=T=%$!$I$REZAU\+>XNC?`%':(8:(
MNM89=?!17I:&_F98)"5`[^G.J(JI+RBC+WKMQ^FW9T07(=%7=H<YC#KJQ,U6
MK=43.#"'4J[(PD8Y:R]GD+6NXFYZ40?RA&B:[..E91P]80"?LTTDU6-?:K%:
M(G,`J'33`3B)A'H;I5-*PD`F1.SC#V3J)(4*Q*6]LW>Y!F\F,;17K(X@KO7K
M!9;@G<[*SKUD8HE785FQNRBR?QIB*M'D8<6ZQ3E`@EI/&W$0-Y;M)@W>4[7E
MN(RMDVI35SM-;N,_$03#$#B$/+5FM1-1;^P=6;%5AMD8VD(.%22=`E*E4$QE
M#)'1%0W4-KPIR2&>0NR+"N3)G,UAL2U]0E,ZP^)H:ZN(*[2D,1HVP].GGJ\Y
MJ:#0`1K#^?/QM)]=N&^<CFR+9T)TDB@`C5-2B#624<T(FB@FD"2#9%-!!!(>
M)%)%("%22(D30A")`D4"@4```#3JR1VJ'O!A'X1Q_&LLH1A(@'D1F*SSEKR!
M%O1;JL9R0L=6AZ?-(J(HMD1!H_A(-$J@CN7,H)SBH(F\$D^VLN6W5Y/B#2F=
MJL+5YJDOI?*68\BU_&3I*1QO2L@6.OR5:JDFTAG%=B9(58>K05CM;^`@WBS=
MDM.OI-1(R@KF,=R!%B5554II;2JS9MI>,M\6+USL_P`'T^0QM-U6`&O6O%TQ
M;Y>"MT26,86B73R`]DY"\PEOE6D8@>SU^UOY,%WC9P4=SALW6*8BJ0''6K4\
M]I/"UE&)T3M'P]'I)N(./F*W9$,NS^;F=WKLBA%W5K?;;)^]M;C[XFP$9"%L
M<>8T<^CGB;EJ[CMJ*A#&20.EB69T[:WAUKL*]BW5C5<SKF6;S$T,E'LET6R2
M%;8FB8ID:!C_`&X`HLS*]9K.]ZWYO*[.`_*!>IF;2ICQ4P!/(O:CBG*-6RW4
MK2%F%IF*;4LTS+Q-A7A[/5K)^D6%*;3V/K"R13DJG*L8:.("2J1U!`QU"FW)
M*'3%B<]*VZO)S)=Y_"%%LU<QY5IUJ[DHG&%FHMMK!7CE)TN$[CI#@J[N06=-
MEO=*MAT4,<H)K"L!3D.0P`(,3IX490%1LU!!-=/>82J',;<)Q$P"/GJ;77_'
MH:34<`-0N"(&,M>9;/)6FZVYGF_[62R4VT/X)U3X-I%UPM6(PJ3.+KL1+L&K
MR)+M7%V]?*G/H8#AM*`,25>-2QR*3$]I5!18ST3;+7DC)L/+X]5Q8QC<@69G
M)$JU%</&\@O%5YS#PL"^(\7=Q[$YY%XJ\DC#&M1%QJF(F8F?"V76C8/CJ2YL
M,PID#(UQMUDA&%;6O-VEH"2LT;7HDS]:*B(08RO0\%'MF;V36<B8&)E'+@0.
MX,L)2Z:AG2:=R*DS[6*>WP='X&=7:]6&MQIFPIV&V)8ZM=H=H-9`\DBRE$Y_
M'LA395D1RL?:1Q#J<>[<02G*0Y9BL#G53;J>/Y!3Q9B:GX<K"54I3(S.."2E
M)MZJJ#4CF4G9QR=Y,S+U*-:1T:1Y).3[CE;MD&Y`*4J:9"%`H26%333CB7>4
MB6LQ'248[`_MI6/>1CLR)Q27]J^;*-5P06`-R*O$L.TP>)1\>AOR1%5&H1E)
MJM=IT&=V6%JT#$UR)!VX%V\)&0K!".9E7=J$`ZRXMVY>130!.;4?#7I+,T4T
MVVW3..($I7ME@)7+SC,RN2<GHSRBU?,T@57M%F*K!LX-)-!S$U=O9*%-3M4C
M+.8HGEBQL@U5>*GW<A!*GL)G-6K7DZL99=%<-LU<P,LQA>;VB]8TIS1$Z.D^
M@"X\4BG<HUF%GR\0:N'FSS0/F21BKA)%*4I`+LTUUN)K3MP\\2CX^[8H/'5\
MG+^PREE:PR=B?S;Z78W!_1)M!R29?'?MH@)PM!9WE&NUM4^V*CB2Y63-,-H)
MF\=4G/[>U_\`574EKYVY5B_H58TC<K[&S=0&S(QEGCI"MOYE>/N"16\[$R;6
MUU>S5QXR<H(HIIF^WD<H)H$*FJ4!4WZIN54Y9&Z;=JE1GS!_<>P_MFO=/)3;
M)3'ZK9/&C#$2<]&6ZV0%L3H4=('EVL,6=@YJ.6``E%55A/LUU54*&B9A)TJN
M5U*&\!5:M5*/Z%FL?:U6[%E".RL3).4H68AXV`B86O1\C3)6H03*#54.X&OQ
M-QH]I>5Y_9D5C(RSQBZ;O7J0AJJ4Q$S$P8=BTW,U=0R2%%)(-[8V4M%M;IVI
M@#`AVDJ@@M5B?:%(<[JH+^Q,M$/E2JBX,J<RXB[`%/#3;U9978M[ZNI2Y?`=
M&?T*HX]BG4[3HS'SJ#D*#+U*22C[#4):O,'47'2D8^?-9-D]>*1S]RBZ*_;/
M$'I'*O.FH)Q'JJMTO"#5-JU3QY\"J%[6J8V@X)E#W7)D#;H"?LMJ;93BK'&#
MD1_/73:6WO)ES(P,C5)1I84DD4U62D0+!`C5O[9%`4$A)K5JRP@KHM-<3QWV
MKT@D/68RL6W)=!>UN*L,$K:*E:FY+19H>X2Q9^W,[7)V&'L*4JO8K#O?JO"H
MHOV[M90[5=OO$.L*3G]O:WU+\0Z5.IPE'KL#5:^W%E`UF'C8"':"JLN+6+B6
M:3!@@=PX.JX<'2;($**BAC'/IJ(B/4F#2M6Z%M(&=QA3[)<:_>9N.+(SE9A+
M+7HHKH$'3!)C;5XA>7,=FY;K`+M081`J:A3%$A`,700'JIMLUXVYVEU0CFB2
M9$TRF(F0$RIIE'0@$23*0A"E```"@0GD'AT<H:5M[P!4+MP@\=W>=O,9D3)D
MO)6:2GI"::VA_3IM-^6:>+OF\2M.GI2%U+7JR9<2Q,>66!HQ3``(F(ZB*6/"
MWQ+##83C826S#+M[]DATZS,\2?R:;B<B00I;MO5&=/;+8],TK[9U`&;1D>@J
M3G5>:.DBJ>/B49(\+:PQ(/%G;E"8DKTK6H"_Y'DVDO&H,W$A.NZ8,^623;BW
M<6M6?@J1`RTO;I$H%,Y?2*KU14Z93:`(#K985NA;R(R3VHT+*$O(R\W9[U'*
M6*G15"NC*&?5D65VJ\.]DWS5C.!/56>>1[E0\V\(JZB%HQTH1QXJ;TT3)I.=
M=BS7@V^HUN?9AVZ7VS?K&PTI8;8I<L>7Y[/1%JM\"_E;+BENW941U*EB)]HU
M?-H5DT30%`Z7$ND`E5`^X^[I37<I6&07K>NJ?%9$O7NVR!KF2IW*#7(F2WLQ
M8IF2E9&.FWU+E(TL>_332:U"/DW%'_6<12('8!V$8TED4$%1$X[SB)AKKKJP
MJ6'`U38LTN5)?+-BF#N%1F:19+#:I*#L$FX>3(#-$;/GT6ZF4Y9S4CO6C1%9
M.J+(D,P.U3VG/'*'1,H(F$_6>29OPM<2.R!A:"O;BMR32T73'=@J:3]A"V;'
M,I%PLJA`RA6A).L+HR<).PSNONPCVYBHJ-#&:K()K-CHK%!3K,5;"^-LHLGV
MG8^<0]?AZY9\CX]+!U5_1G4I1[41C,VRI2\@YF)J)MKZ:C9X)-U*3;YR^/)(
MD;2R3MTLJBZ2,H;7):?"C*"W3N!:[*N,,?:[1=:=#8.E6TM5JQ4Y&&;04Q[&
MMNZFP86D)BOSDM(1[*$?K)D!L[9JF,J8RBAQ$1Z&IIW(-Y0T`VS;J<=3".HB
M81#37S`-?#H3R3`]>,#X\R+?,?Y(M<>\?V7&C&[1U8%.1<(1?M+_``J4!/$E
M8HHBSEA(P3'V@K%-[550YR>)QZ":7F@=#V<X84P_BC!RC6U*T3#-MI%VIV^W
MS7ZB//T&=/8(I2?L95PDIUG)OE54Y)!8W&_;*G05`4A$O032]B@GV':YB.-I
M>:\?HL)@]<S]8+[9L@MWL_)2#HTAD=HDSG4:X\>*K+5F)9E1`\8S:[&T:J)C
M($()C:AY4;D(5/M7Q;1IMQ8ZFK:X><5PM4<#-)!"S/5E(JE4H7YH60B4'@.6
M;2XG,]`7<KQ&<//;-P5W`B0`#RHV0$(,14PUT+D"09?>+5^AX7'QY2;*UDE5
M*_!2\I/-O!=K^7(.I6656<JI[`6.5,1*`IEZ":=R*K=.VK#V1W]\D+S4(BU_
MZD4*#QK9VTRR9OFRU1KCZRR<0SCN9L=>+=M9.U.'(.$5"J@X304*)3H)B%+]
M.Y="1?X+J$FX;/Y20LTA*H8FGL,+3;^=6<2KZH64T:K,.7S@R0)N;&[<Q22I
MGPDW<NIA*.O4$T[D4>K]K%>K=*MF/762\KVRHV['3K&+R-LLI2BGCX!S"GKO
MOHN0KE#KLB2?;PYQ13=.%G/@&XQ#'U,+%F'3;;F!_`=L=3C$90+#=LJ9&?25
M%E,;)2=\N";U:'ITT6-"3CX2-@8FNUYD]>*0S0YY`62D@8[9/5<0`0%B$J$\
MAY6.V+%U/N<O?X1"P)62:LM8M+Q=U8I!XS)(U2FR](CF[&/<&.TCHMVPGWKM
MXV0*FFZDW)W)PWZ``U-.Y%8BNRKMWAY&,GV-).6VQ&2Y#,#&[JS,JXMX9)F)
M)X_F;6YFU71U7TC+MY!=@N*Q5"FC%3-``J.A08F/"WNQ)>Z]I>&;]49ZEV")
MF/ME@O[_`"<J]C+#+Q$_%W63?L9!_+0$_%N6DK#D>F8%1<-TE`0<M5%45B*)
MJG*+$Q59MU9S'`?V+MW935ZF,@1&5,Q4.6L,=58Z;C:/9H*.K\B2GIR:,2X/
M&3%5GC-W!V\JHFN*2I"JD*34H"746)%8H3E.KJ<RW;LS>W>>O41EG-%->VAW
M67T_"U.UPC.N23FK1+:#9**1\E5)9=#WS!F0KL$ETP7,&OR^&EEG3PI64A$A
M\6TR#G;58V$4T":N=A:VF<>N6S5VX4F6,#"UEJX9K+HF68I(P]?;)%33,!"B
M!C`&IAZ21T6RGW?`L+=6=44&]Y.J-LI*,DVKN1ZA:D(^ZI-)HJ!)EC*KR45+
MUVR1TF1JD*C>2CG:!%44EDR$7335+!X4+'%$/(]LE*?5^IQC6TY,BK-2'$P^
MJ^46=X?OLF,G]C,8]E</9RQ(SL;8&5@,)?=1LBQ=Q`\2.QH0$4MEEC3HXDO`
M=NV/(*/39JA8+(\6NI,B3\];)UU/3MPMQ*^K52R-I=N2E0?LR5\X-4F"2*$>
MW13(1%%,I0#I+'A1Q%<7=O>,\.(PR-(8R[;[)`S%;:N)FQ3%C?.HJ<LIK6^3
ME9&<=/I"7<A)B4B2[A515)HDFW*8$B%*$-4NFA0@YZAT-RC[4/V]!*/M0_;_
M`/`^7_SZ"4<'-H'A\=0'JG.Y6Z5-)GWN"Q2AEBCRD`LW93*:[-RT7IUC*U<T
M:XM7"!@5AK>S=QLCM9G`!,B[;"U?,U@*=!PD;41J2.3NUM;#)&/8]7&$.ZJR
MZ>2Z58J>VD?T^[RG:)^[U2.C'Z+W[?6(7*`)/9*.H4&\+Q,T9C[HT9-2`!E#
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MQ?V^>V^9C9/-.(GESS9:Y^;/9`9UX\\^O-/CR1D?!1A7!TW)=2+JG4,8=V@>
MJAS2FXEH^1^]6:KG@[:FK=GCR(7N0Q!G7%']MCOQ>9G_`+>.(>Q:/DLF=GLI
M3I#$^/&5*=95E(^_38S[2<!ID6^$FOTXW=%,AN!MPE<'T,?=H&*[]RS>MTT1
MXUU0S[GITM^G31<I2JIX07JS2+;!'?O_`&K.XWNG@$\B]KU[[7^TN2Q&]G@5
M=U['Q:OC)A3K,S;,2("R,[QM?)=C<5&JA#%<A*<@`)DAV;O>S<H]C24:;X8G
M.]4K;Q2\8_(_NY*^8_:5)3WK8(L6027W3F2!L+'81U]S]UN]N+0&_P"=R[O1
MX^76\9-)V?M7^J>?XS.?'D`/-1L@LYV@+1">2%\?(_J8U_2Q85FYN`R7M6"E
M/*=-P/WEQ!*NS.P6^W:F35X`6#VW)I#M<MW:UGAS_N">M5+NGLEDHZL[;)&L
MT]A1&*TRU>2$/&V!_95LC6%8B4VK58A_%O;"&,TXTCT$...*\$^PH`8^B=YP
MM^O[%*ANGJQ\QH?<:@&:K,ZNDJY=>YRZ&)::UL:!6H(J,E28U*K'+Q2$$V,B
MH3D*=9P.Q<2J*"8`,7H;TO8B)4<^PL<N7"Y1>J617.)D@N%)"GJ40M1/BP^/
M#5RNGM"5P]Z5PH#W]1'E"R`K"22,F+<T<)B@802AI7^'79T!E3![FG-6S`PL
M4YF.&R'Q95)1Y0:C$2T'%).<CSIZ.O7V4DK7JM9))K0EV`-$_N"0J`"H*'*L
M4`Z$T?8X=>QH+MS?Y$6CK6UOT1<6K%A(1)JK+7)^=-_/L%8=-:<41KSYBWGJ
M\WCI),X"G(K/E'!SB=-RJ3:!4E5F]MCKV!0LAWA1I4KXP7>6!U7<4S02&'7@
MTY@SR-:5+A:5VBT/83(MU:SD*+K;6++'&66&%>).3(O"IG,#A-(T?8_UZ]@[
M24%EJRX@J<:RM4C1<E/(>DJS]D:,J[)/(2R)MHM[8D'\0^;K0K]B]D2F:ODD
M`W>W4.#55!02+)^M7;&;GIW)H7^'7L93L\CW<3Z<6XF("\TAJQS%D6-G8ZA.
MH:S.W]`B\?Q;>G6.M.H8P39:S9+F@[<-2."H2;45BI.0^0HFX7:Z*FO"8CD-
M&_,X=2Q9.6[O(6=C%L4L+5;*I$U.KW=)I)!2F,I:IQVQ#',IB&9=659J_CWS
M%Q*)WM:4,`Z&B#L-QA<:=<Y&C['#KV-(Y`K65D\7D)0K.$ADNLQD?*LY&0;L
M$HK(,[`QPF?URS,&QDS-(NZNTA26.T.BJQ57!5$_Y(%.E?B-"_PGGV`=:X3-
M<*^HS&XV'+]IK2M*F7D]*85:59M9T\L2TQ[J,A)E@NU,JUI$+#.A:0YBBL@9
M=-1276.GHITYET;KSW;]O3<5&6K_`'HOCP$L$N\8F;0&#&LVPB;)!HNF,JXF
MWJN5YQ*KH5R1B;6_CHX6Y'#9:78,UTQ7!KXIE`Z2:/L/=U?R"77S=T3?+KAQ
M:4&LAB!7(=Y@*[%UL8]"VQ\`"A'--M]_>R29$9&G$1!RR1:Q9$I!%3@=/'#P
M3F0026JS>\FZ8\9PQ?R)7,AL@A:H5Q'_`.L0T,:=**)+8.;5Q[87.0323<63
M>T-IM,R_VW[7\\8<A48TCGG^X&!/A`4KB-&]PRW]AK?ZIG2R4[)25=M>1*O.
M(7"H.<<+5R1IC237K[N&HA+,U>'=PTS&KH-'P2ZP@JFD<S@3B0PI"F84C1OP
M\IY]BRY`H><PF**QQMDQXA7)(2U/(SNR,HR6L4%`M_=S"%\J;]!M'I!<E%DB
MQ2I'"*[$Z;@CD$@5;`"J<(-T6KM-Q-QX<^@6KV_F(-E3_M*[LYW>0:-#OE!*
M5PJXAY&619RJ3C>D?8F+4-ZB@:")M1U+KU#U%$S3#9=FIC%H8MMAZRG%VBP2
MUK0%A%OJW9XN/J<K]DJ5S%XW<2T;`2UE,W*=W$G0D$%BD$AM-Y37`YM7-C69
MCXTWW=3*F,9RS0F7:%%/XS*:ETJ=9:0,[-1<LWS8+*BMI*7JK*9(\*ABE`09
M*E!)NZ;F367T7%0@3`Y5T7ZE]+4\X+I;$>\4,IR["G*S)L9LK!'0$3)*)TCW
M,A7LPFB%GU]7,Z0;R#57M>"L.B),2DWSZ,X4BA5%FW*%.6A?V1U[&F<XV._0
M],D(_'%<M,C;YY+[=7)6!81;UE7I4[N/*B\L!I!ZE[&,]NNJ8S@$5TDRHGW:
M&V`8%8OXY=>QGUY_KZI8,V-HQQD9&5^UY2_TCXXL@T#G4:(?H)R>16CE8A<4
ME2"=`AC&6W&$5-Q0*0$C1]A/_'KV&,;!]U,)5,H1]@G[:#^$-BI>BOZZ^A<H
M2$\P;@1]D95L[E8['\U[R6=F6C7[`"++LF[1)S'*KK./;E2-'V-ZZ]BM2DEW
M./8^B<K#+=<@&\OEM";7CD/U7:9Y@FS@5L92T@R1K3&Q5UJHX7DDD$7;8RY3
MH$]P940!3I(T;_#KV-#2];S;*7JC%K-O<QV,YUFDYNKF0B&072K.*ZR9/6S.
M'<G;)MDG.05%CLY472"ZC`$CBU$HJZ$2%8OIYJ.89+&YF(^QXU9LUES,9*PR
MS*9*4@J@HQ1IUB>-`7,"8%(4DL@V'=\H:E`/CU90T;\;.O8I^0+)<*G>*2]C
MZ]=K)2U(&WL[+&TR&93:C:9$L0YK3F0;*.&STA#D2=D3.B)B`H8`.``.H$\5
MN*K-Z<8B-X`<AGSLYL]O7JR684)==.K+X,1BPKS3&#!%:)C?U&URFDJ998SE
MO.'=GE"RW*;V"*81!@<',4/2KMG"4^.'<:-[9'7L2SB-[G:]?(04EY.YTRZY
MMGW<R+]>ELR8=QM'0]E^R-FIT6K&2G:597;".+MT<SC)XL8QCF;G$J/"Y535
M5].4$T/8_P!>O83PH[SFE>*G$W*NY*.T?XZF7V3K!;K)$_IJ*R.RD(MM%Q59
MA(]DI%JP,RV,Y58+PCH$T&R10?(E<&#K!='V-K75_(L.6FV:W#VU+UZ2M#>L
MI6R@K1+6J0J<F]?U/]./F]TCP<1MEKEJCT/U&JFL9VQ.O(I'(`$;+):AT#LW
MGNZ]=A$5*XYEA'=*6O./LHR,,YQS-M91K#C%6]VPMK2])IPSN??).(22(^D*
M2<CA(01,*1%#$7,=P0W1,*S>AS$QOX\MP]=ONY=;.C653IJ1\'-9IK2311[M
M`H2DG7G<&=^^R^E7BP'W)&;C;HNFQ3:_=RIF@TUUS(^X%(H))HWYV1S[%1BX
MCN[K*51K3]_)WIG,163++/7=[(4AG.4R<7J<^K5J!,1#)E',YZ*);'C+[!)L
MBD402;&0D2*%`%E$[!H^QD_'J_D7+!33+`S+=682RXE4!Q[#!/AF>1J[J<4R
M(95F=VI7!A#*2;:/9L4G1'W,'M%G*J(M--BIC)*[-_9'7L(L5^YE[FF5?2M,
M"(PT9.7IM>:)W2O2#L&D-$ED(?);VMA$ED6$E-67WC,Y?N[H`C@9&]NFL98_
M22:-]/9U?R*(K']W->K[NK/7%DNJK3M[O<FRR'"O*6PM,GE%R%))7:E+1X)1
M;$+I&*(2Q8^3:()13MNH'N.%<`,HG`:/L1LZ]@Z8E9Y"^^7(\L6_HX]42KXU
M!')SN$D;=]\.C(FM3MN6)45=(U<Q%&0()/U%7`O"N#$T0X@%)79]B<U'/L#B
MOG[IWN0[Z\L-25B<<VF.N\54D&^0JU(NJ&I5BK,\=SJ$$C7V3MI)W]`[AU)"
M:6D",77M$RIE("IDTDT?8G9'/L6'$K'N!A+K&5G)'NK!3HC%3193*"S^M(O;
M9<7,U!$+'VRNQQ$"M+C78IF^*XD6"!(N117*=,$SE,0$ET;^V.O8YME=[BYJ
MY'6JUE6K<3$93>3L&==.O/*_,T-#%$2W856VLC(#-K04KD91\?>Q40DFIRIJ
MBH8A.(Z2:-][NO8'"BG<+8F57?V^NYMJ;R1@,S.5:GCJPT&05@;.IDHQ,;1M
M@G%%D81\Q:T4@"R4.`(\8"#D1<#MZ%5F_MB/^VWI\;R5KR/<&ADQ`]V"V*1I
MX'&K8"U-L1S3U[%^CW:EU>*.6DR1LWC?UDJ<%RKM#;@3**1M@[>DDT;\[.K^
M1!OJ!W6Q^(Y^95N\@O?UL<,8@:K7IP]E=JW`;1#23RQQTN\:5_[2[9P"+YE[
M"/43261<$,"A54@,/2U5337->0T;\;.O8N@5C.<W_IR[JMHM5<5KTK?IJWLK
M>V2-$75V@$&WJU4L#2?=6.Q1M3DD%GHD=Q#I-PT>(I+@)D@.@KVU;,[8Y(NA
M>C9,[RE*_P#N)FXZ(DK37<WP-C>XRL*[>OT.TX]X:_DI:[3IX]A;7Z$@%>DQ
M;U92.!NNH5>.7;)J\A"N0V#YFU.&0T;^V,M[SZ%KKT?G)+-#U.Y%O#FM%+2!
MB!@O<)T%10F.(\MJ6>N6EI:,$FY[^5SRHN(TYSI'`2`)-NV29T/8X=6.J7"=
MRT39,>T^X/YJV4N8;7R9NN1SS50B[%77;N+<)Q-'G&<0W8_=2H2STAX64BD0
M%-NRXGQ#'(591)='V.'7L%[#],MU5A)XELGKI/R:]IM2D>-OM;>PF0KZ,W(C
M5EF2S)JUX$E85=$#$.`G+L$#:B`"(:-_AU[`*<PG=D-H4A6D]+C6G.;U,CM[
M8J>@+%1Q*C?8N(4P1[(&HR)HUW5%5I@DGM%\5NB9J9P18Q2]>BBY:5$5)^7Q
M`T?8VQU[#1:O]P<Y2\N0\-:,CT_(LTD#2FV0[=JZCJDH%N24-*U]I;I28@)+
MABQ-L3.T;$7;`9,"`/%UJJ[9_P`4XY9A6;ZQPGGV&4NQ[K)1&^6E=6T5]M)N
M<8Q]9H$2>K/5ZHVIF0'S#(<U'O()XC+RCW*5;4&343,\*9HP%!L0I%B*@?*N
MVEL8T?8_U7XOY$"_9=TJ<;#&4"]?9BYCR*LZ/#@*UJ-BM>G'3QV1RQ;VI.<3
M!"TK'.9)5VLH!Q#>F5,$]F]:SG#Z#0OQLZEIMM5[I7=I/-T.1E$:B6%P=$1K
M*>M*\7.M!5>6!/+5A)6CDE(J6GF#1:.4,TDW)>82*`FN&PH&X7*U7$9X]@[%
M[9'7L'S,%8R?.MZ"RQY+#!&_7K!S<WY7[F.Y*DG`V91=B"C%PTDA37L2D?O*
MB('$"CXF+X=<VT5V;^SQZ@ZM%.S\FB6LU:RRZD>U>X1`T\ZL+9-=VW;6N9<Y
MA(,TLW?64A75?!L4AQ`RNW:FB4HB<XI)H7^'7L4!2([MH>"J4L@]F9J<I.2L
MG6.PT6/EJV[ALD8[C8=>.HF/B6NS^TDDDI\[@DBTDUP:O&<H3@<E%N0-XJM7
MTMDSO>.7`*]"@L\1>(;RTLT^2S9<-/91E:=*S!(9I#M?N[N0DJ'#(MH8OM25
M>K"[18MR."JNE&[4BCD3+',8UG`:-]+9//L`Z0KW<G*5.[Q^+ULNUN<E,/.V
MJ,EF.QP#UZQS4[L<']N?5Q:+EWJJ+!K"J2GW,L<LTA>-1J2.*134"22*S?6[
MKV-BTFH6FK5N192UA>6.></)5XW?*2D](-T2JMQ;Q:+8EED9-TU(@FF0RB15
MA1%;<8H`!A#I(T+ZW=7\C&3>O=SBU%FH^I.<Q15O>84LT7-R.2[-67;'_61V
MK%DKTG0SM9!W+QR<6O\`<55U$3H,A8J)%+N<E(*:1H^QLB>;^07++0>Y.$J5
M9A<99`K:UHD[A*GM5TO:=HL49"UI:B6%M&*1,%*V5]+.GK.W)QQBH^^(U*)C
MJG34("B"J8&A?X=>P0$V>4'N$UD&",U6<IM*P8&*,Q,Q-CDAM\(<Z[1L^E(]
M)I!2D+8730J8+"BV`S1U\Z2&FA;*@NC?X=>P&:"R[N-EB3N8/FICKU.P08N9
MNC.TS(7ZUM[E>:$(QK!L**6!X,JU7:R*IM\\@H1V7\P@ZR2:%_AU?R+?9L<Y
M=B7G<)-8_M5S7F)?'T6WP['VBYOINGQ]U<L[.M)NFE:6>H)LTF\B+`3F45U,
MGN!(2>?3`UHWO&)Y8]2_TF.SDPO%N/D.P5"9IBE2HQ*FM5H!_`^TLA9*WC<%
M)!&8M-M<O"*,EHL$S`8/(=`#3I.)G1OSLZ]@2*PF74LC+.3IY63EB934.C-%
MN,.IADN&5G0.%&CVJ#+[57I8<@M1$L62<"5,02NC-BF/TDNC?X9[V04+BSN6
M0Q!<TY+(*LCEFR0PM(]/[]<B&@G;BX"_6.==6_/HEDLC7U2)`>(;Q9@!,2IF
M3#:4HFC?VQ//L7Z1H.;ZO7QB*A;W$]-J5'+2KJ:=2\JX31N,G%Q*>-A:#?Y^
MYRC=JR<H.``BCIRS!?:90@%$=J1H^QPZ]@86FN9D<XUMT;BR%SO7IAS-XJ=H
MGR)DAM9YQ5HE9&;O(!*RI%Y.9V"+(2`2.@Z(A8(Z.6-N(P2*4IE%F`T;^R.O
M8C;E4\^?IS&2E:#+*S^(@;$K/Q+:;DF9Y>>0?>Z@RR$N&>%;3'N)(ABI,ADY
M*T0J*/+[IH578`I&C?V1U-&99@<NV'']:1H,XYJ%U?.X:(FU8IQ!29JPVMK=
M2NV.RQXV!HE&33W'#N3&7:`=(/>ECS)%3$RQ"@E?B5V;Z6#3?/KLZ`7&#SU)
M5RD2&487)[@'4S=?UG6,/9'9PMHBW+!=M$8Z>*V",F:>>3K<O%P9Y!PDS>-M
MDA)IE=(*D(J*:2*S?F7'5_(IMAQSW@3B,++Q-ED(UQ%8H@&J<5)W*43F%KF]
MR5/OI@[I[4K)6J?8;9#8R+'I+#*,UX=[(I$*4W$*PF3N#L^QPGF_D::B)W);
M2SWBKRU'N<I&/I1L2H7A-[0P@&\<K28A-9PNV):4;`P*G:D7!#%+'J""YP,4
M.`0."1H7YV1S[`(H%0S^RJVUDUS!%S,?B,SF:;Y<R7"6LUPS-&K0,A%,ZX+6
MV6@]?@Y,\=(-7Y07CF!FSM$`0W`<Y4\P[-_9'7L3N/H;NK'WOZO5DTSQ\O0)
M9D[4L]4E$I9M>[HTO63*V!635HHE&X8BCGJL8Y6#W$JQ3,I\Q]I^DC1]A[IY
M]B'K=2SXD_>N6S3-,9.KL\R&M<G<\E5VQ4.9"0;64N.6U&K*5MG#5V0;3)HM
M9H=LRATV[1-4B^\3;>D]2Z-_>NI>^T:K98KU.<-<O(WQ*W':UQ=V_N,W(RZ+
MM0D2FA(-XXDEF[-)F[M"2244=B@K%M5#K`*3<2@(@DM-F[_E'4UZX1741`J)
MB[]==3B(`(AY:@`#J&O5DV[5>R#\<.X3OP[T>W/)*,5;_P"W!EK+6'EU+$@3
M(7;?9V&6VCAD@50\1*OX%)I#VZ&F9A8R+<8AQ'<2&JJY7B@%*F/;4M\9..G[
MO^G5_(R3C3,/<SWQW%53#G:)D##&/[)<)VM/<U7N"3HE-I];B$`9R$3E+M[R
MXF>,R\8)=F9`GZ<;,SNT2'*=:/5!-<.'M?\`M;5%&:>TXU^I[5RKSK\9C?V-
MTE_MW5FX]D=^[/,PPMNCJ=D>9@XJUPV+<TW*1AXQA&6V&G#W/%4UD@MBM..H
MV;DHTDL[@5EI)-HH!VZ*AB&`PY]B;M-*IV'KILU4T>.$P?GQ2/[%W:'4(&`R
MM9>V;/\`D.;@6;&?+A+,7<FO;HC]3M+^SB&\;/5VC1C*"MT.2%,-C.1RLX05
MXRMU4/F.`>96*N!59JX2;-R;V+4+*G>YV_\`>E;\"9F:9,P#>)G%U`D*-F:"
MK>-X;%N/*K:):AWRQXO^W$1DXNWS\HXB$8Y%RFX:*+(G4,5,FT/2E%*6U(N@
MJG->:R#QW0=L$1_<2[;%L(=SN,KU2J!<F6-;S-5VDY'2K62(6]0$DZEU:L]F
MH^+EHQ2/BWC)(#K-U77NDUQ(($V@(\KM%5=VW73$45-OH;HH=$K_`!V&5,V=
MA.-NX+M"Q#VCY+[:<Y.\8]O5=P4KAVR4[,$)"9CCW::JV/[+#L[?((1S]N\I
M%+,+F?4=M2H33(P%0*99,NEO4.Y["NT_H_,XW;%=S#".?4VXCVV5I3LD=]IP
MS?<8%&0K)<&!9%KNJ3/AJ::U-:S]Q:Y&^T\BS8(%3Q?@TWA$@</,-P=C?VMK
M[?1^,YS-QN-NXGGLV'TY>7AUY@__`#\W^/AU#T"S73<IMX]NA]/5M\O#?R?F
M:Z>K7X^?0'9M>,^OEM_#LT\A]6SY^33S_P`NOQZ`9CM]X73?NVCIIR;]OP]O
MN_)W:>K7YMO[^@%1V[PTV:[?#?R[=-Q->?=X;]?3KXZ?NZ`X;:?)MXMNSPTW
M;MW(/U>3\S?_`(_+T!T?3C4W;?J'W<^[FVZDUW</CR?P;?FV[.@'(_#_`.Z.
MN[S\TM-WQW_X?CTUZ`:!LW#Y?U)=>7F].I-G!KX;_P!NGS:Z;N@/4M-X_P!-
MIJOZ=^[7G2UVZ_-IKZOAOTT\.@'RGD73=Y&TV:\GD.GK_F_X_BTUZ`AE]-HZ
M^Q]7AZ_::<J.[EV^//Y>KQW;=OQZ`>AM^7SUV+>?+Q;-WAI^#D_CU^??KT`@
M73\CT;=RGGNVZ\RGU/YFW]OPW;>@%G&W1ONW[MQMWU-=NP=>'C_+Y?X-OSZ^
M7QZ`Y-LX3:\>NS\//IM_S;?#_P`WET!(DUW)Z;--/P[?+0WIU^;;_%\=W0"3
MSZK;Z>N[\?GZTM>/7Y>7^#7\70#)YY)Z<>FX=?+;IRAKMW?F<W[-/'=MZ`;A
MI[,F_33<7U;^/78IY>W\=NGHT\-VOQTZ`Z2X]R7'II[<=-?<:[>0=.#W/S>K
M7S^;?Y_+MZ`74^JU_I--RGUM>;70^O'^+?IZOANU_=T!XRT^;T[=C?3CW^6Q
M'3=_-TU\M?'377X=`=GTX@T]KIP^'KX_J+Z:;OGW?Q:_'7H"-)MT)KP[>1KM
MW\G+N_,^KM_,Y?\`B^73H"82\TM=GTPTV:^6I==FGAQ?MU\=>@%5?K-M-?6K
MY:?\O^7N_F?^3=T`F\V\0Z_PGU]SR^VTW!NYMOA_PZ>.[RZ`CG&S:AN]KK^=
MLW<^WT+:\W%\F[3_`)G^;3QUZ`D3Z;%OJ>D?/=KKM^/_`-77UZ>&S]W0""&S
MF5V[=VTGGS^G0-.;D_+T_9^+33H#MUIQFW[M.0NFG)QZ\GR\GM_FX]WGKX:^
MKPZ`1#9S&TY=?RM_N>?3=O)KP:_+K_R^/Y===/CT`X+I[@=---Q?XM==4_5O
M^;E_\.WH#X^S@3W>GB4UX>?BVZCKLXOSN?\`X?FUUTZ`3#7E\>?3B)KMV\WJ
M\/<;/GV_LT_?KT`X^3Y--WX-=_/R>@=./?X^7EI^+37H!FKI[HWT_4?7;R>Y
M\CZ;/\WGIM_V_#H!VR\A]'F']/IP>7P^.NOG^_7H!-7UCKN\S^?T]>0FF[;_
M`-1_#\-?/H!<=/SMW\2>FF[3=\.3C\=O_%\FGG\>@&[CT*>C7B#7G]7X?7^'
M_CT_=T`E^7S*Z[MNTNO]5R:[3:^G\S@_AT^7U:=`+CLW_'=M4]'/QZ:&]6GY
M/N?\?'77H#YQM]JKZOI*?U')P?2-_6:>.S_F?NZ`2+LW)^O=HG_2^XX-?:FU
M]K_*]ML\OAKY?-T!\.W0OU-=H;->7?\`2'7W7X>73T<GQUT\=>@/2[.,=O#]
M;_J>;;IM_P"HY?YVO^W33X=`*#IJGKIKL+Z=>33PU]'R<?\`OV^70#XVG(77
M^$WGOW:;@]&WX_[].@&*OK6]']2W_;RZ>'E\/VZ?'S_=T`FKMWGW<>FY+;LY
MN?R'3WG'\_\`AN_#KK\>@$R::CZM>%SLV[^'3<GKY_)QZ^6_Q\]/CT!ZC]<O
MI])=V_\`I==Y-/;Z^&OGKM\.337X=`*#IQFV\.F_X\FNFX_U.7Y]VO\`MTUZ
M`=CMXS:\GJ#U\VW7_/L\-?V_#=T!Z;;X:<WXO7RZ:[@TUW>'_=IY]`1Z^WPT
MX]VO\[DV:\B6N_=^7M_9\-WE\>@%$].`-.#;R+:;]^W3>7U;_P`W=_'KX[N@
M/`VZDU\N0NWZVSZ)?I;?GW:^>_\`E_NTZ`DU?I_@\R^KT>8?L\=.@(_Y=Q==
MFNSQXN733QT]MQ_)KKZ]/']OAT`Y+IL+]3TCZ-_#Z`_9X;?^_7H!O^7PJ?7V
M\'CL]UKMXR:\7\SC_9M^;]GQZ`4+LW^&W78GZ^;73:?3FW?)OU\_CM_=T!P.
MS0_G],?J\_+]0FNNOAM_@_?IIT`Z^74-?X2Z[>73TJ>G3\'[-/AK^[H")#^K
M)_3_`-.73=]?ZP:;]?QZ?3U_[>@'YMO$ENW^9]-W+O\`0IZN+^9M].[_`+=.
M@%#:<*VFGI-KR[]FNTOJW^.W]NGA_OZ`9-?-79RZ;_EV:[O6?7Z_S;_/=N_?
M^[H#UUIR)^7U$/K;]-NT_P"WQTU]'X^3]W0"Y]G*CKOW;3;=G/IIO+ZM/R]W
M_%X[^@$4]NJ6FS9HAIMYOX5-/J?G\OEKK^'77X]`=_`^F[ZJGGKMUY#_`$MW
M\S_=Y]`>&V:AZM><=.3FT^M\W+\-W\&OPTV]`>J^27]-]0GU=>3UCI[?_/\`
MP_[^@.S::G\_Q^K?Y<GX-/#;Y^7CI_LZ`]4V[1_;Q'^ER\NN\/I_AX]?V^'0
M"A=.53R\S:_4T\D]--?Q:>K3X^?CT`Z#38/GIH.NW=KIXZZ:?-K_`(>/0$`K
MM]T&G#_3GTV\WOMNWY=-?#C_`(M?GV^?0#CPY@TUTXS;>;?OW?-NV;OFV_LW
M?+M\N@')].8OIU]NGZ-V[;R%UT_!M_\`%IY=`-CZ:I[>#Z27U-^[;RF]?+X;
M-?I_BUZ`Z1V?/LW>1--.?3ZP[=.?PYOX]?Q:Z]`*_+M4UX->1+77DVZ^'KT^
M3E_9IX;N@&`;.4F[CUXC^CGX_0IKMXOEY-//_-OT\>@'1-NU73=KS!NW<NGK
22TXM_P`G+M]6S^9IKX]`?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g53110424ibc_pg022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g53110424ibc_pg022.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@#*@)R`P$1``(1`0,1`?_$`/`````&`P$!`0``````
M```````$!08'"`(#"0$*"P$``00#`0$```````````````,$!08!`@<("1``
M`0,"!`,%`P@&!@<%!`$5`0(#!!$%`"$2!C$3!T%1(A0(83)2<9&AT4(C%0F!
MP9(S-#6QX6)3)!;P<J+28S87@K)#5`KQPD1D)1CBDW15-W-6=297H\.41865
MM68H.!$``0,"`P4$!P8#!@('!@$-`0`"`Q$$(1(%,4%1$P9A<3(4@9&AL<$B
M!]%"4B,S%?#A-/%B<B06"))3@J*R0W,U-L+28T14%^*S)54)@R:3H]-DE#<8
M_]H`#`,!``(1`Q$`/P"PG2SH[8K;MYIFYL0E(05)?98;>YNEVJ!I<">7D5`G
M/@,>M;R\`%`N"V=F[-0;%=+9NR-B;9VVM%LA*Y[(0XPNCGA6H+4<B,R",5&]
MF;*X4VBJLL4)A;0[U-'2O?T';*GA)#/G9JQHU.`*<`7H22*DH(2``%4KA@[P
MGN2S?$.]7WV-*N6Z##T.>427VU^9(X<M04$:1XO'6G#%+O-BN=IM5M]N,;AM
MMW:0^OSEO<CD.2M3:.0KW0WRU*#JM0SJ!BLS^-2L_P!WN4E`4(`"30Y!5=)S
M^T..D]N&[W%K"X;0"4G"`96@[,P]ZY7>OCT&WKU(QK;<-D7&W67<+`=+MR2R
MXORVI+OW?*-%*2M2@:@$"GMQ;.D^L7:6\.?A10W5G346J1N#-ZHUT;_)N>N#
MC%MZV[DE7BWHE1U3&K?RX[4KR2TOM/%"UAWF.+416E*`8OFM_4;SI:YF-(Z>
M_P"U<\TCZ>>7<2[>\GV!=Y>EO1K8_2#;=FVQLZT18-OM,+RS:UZURAY=M++&
MI6:2\I*!4BHKCEFHZY/>R.:\D-<:4&Q=*L-"BLX\X.+!4>A2!,<0I*4`U4%5
M(H>%".)%..(Q/DB37`IH,N:DMUU!00HBI]H!X4QAOZ@6-Z@J[[-VL;N]<'+1
M!:=&I;4A`<#RG#J!4.Y:JFM>_%@:W/"6<0$C/^D>Y,J[0K0RV_6&JB`>50U)
M)]X95I]&$?)]BC<5`6\7F2PKEH+*0HA+9!\-":FM*9\<25G9GY:52QN`R`,=
M3!4WZES&(ZWW"ZD:4"I-:9FF9X8N^CV;A<LXT/N5??=122Y9#2/^*+F3U9GQ
M+G(E)#I*V4O_`/AN`44H%7B*0D\.PXZ+969`PVJFZZZTJ?F'\;%SIZC72VPN
M87)C*$A:THJJJLAP*`"H$J[QBWV.DOD:UPJ:KCO45_I=N'CF-Y^\5V%5/W-?
M8<O6A+^JIR^[<`)&KMT^W%UTK3WVLO-=LRD>M><^J]89>0NMF$$<P'U*+C[[
MA[%*J#WBF)Y4/<BRFUE2B!D23Q'?\N!9!"\Y:_A^D?7@6:A#EK^'Z1]>!%0A
MRU_#](^O`BH0Y:_A^D?7@14(<M?P_2/KP(J$.6OX?I'UX$5"'+7\/TCZ\"*A
M#EK^'Z1]>!%0ARU_#](^O`BH0Y:_A^D?7@14(<M?P_2/KP(J$.6OX?I'UX$5
M"W-I*4D$4-:_0.[`M3BM2FUE2B!D23Q'?\N!9!"\Y:_A^D?7@6:A#EK^'Z1]
M>!%0ARU_#](^O`BH0Y:_A^D?7@14(P@$)`/'/^DX%J=J+\M?P_2/KP+:H0Y:
M_A^D?7@14+>@$(`/&A^DG`M=]5HY:_A^D?7@6U0MS:2D&HIG[/U8%J35:U-K
M*B0,B>\?7@60119-H4E1)%!2G$=X[C@02"MV,K5%E-K*E$#(DGB._P"7&%L"
M%FVA22:BF7>/U8%@FJ\<0I2J@5%!VCZ\"R"*+Q"%A0)&0/>/KP()",8RM4,"
M$,"$,"%L#:S0@9'AF/KP#:L@T(*>U@4&VT)6=)[J$\*5X5X897NTJX:->MS"
MI4JV=:%+2E)J:#L([1[*8@7^!W?\%T&"42R-(W!3;M=))0@#Q$(33+CX12O#
MCBNWNQ=)T;PM]"L[L_[E#0<\/`<0<\CV5Q6;[PJ_V&U6CV0I)<94"*:J=V>7
M8<^W$'_W95GM-JN[TZDL);:;4X`M24I2FBC51`H*@$8K-UXRK1!^F5<+:C3;
M\,-N*`2I"/;Q/<,\5F^VE3%BG]%V+&N-%1U%Q1[/=X>U>D8@'7`B<6*7-*XI
M7F6-JT)#;R@VC3114<LDFE:$C&!<B0Y!O24OZ94&7V<EN:ZD+26T+5I*2DTJ
M>VE2!\V)VRVA,DTG;_H=4A"ZI!`!'M`KV#@3C%Y;\RX<_C3W!+MN1&W(=H3H
MAWTQ&@^%IJE:0*Y#QD)X_IPPN+,\H@#'!+P7;>:*\"IDVSO<M)\3B`%M@"@U
MU5I.7AK2N(_R3T^\XQ&8>XUR;@4R"$)$A-#2OAU`UHFO$8E@PQV;6'<U-WNS
MN+AL*G2TSXCJ04/!54T'A6.[O2,5JZ^*4M_U?04^[+(6T^E2?W>H$GYAP.?#
M#)/U-5EN:74-I"J@)0%FAR%!7B/Z,,'^,]Z?Q^`=R=25)6`I)J#P/^F>&EUX
M!WK=988H6T,.D`A.1S'B3V_IP(7OEWO@_P!I/^]@0AY=[X/]I/\`O8$+50_3
M3].!"^/[H/NE.YK>GS,ML1W(HDK#H"5UU$)0`2*T53/V8]37ED`RG,->[^:X
M;H6LVM_5U,@]?V*TD2ZV>'H2_<6&VQ2C94FC@!SS*LJ?)VXKDEJYKOD)=Z-B
ML$E[;R'*T@9?;_%$\MMW?:-UOL1E+$!3C>G[T`.*4K4%`UJG,9#!Y1Y::U&!
MW)N+IF<`4(J-ZZ@]'+K951XC(6VETOMD)!!)TD$\*'ABB:G$Z$$[<%?[3+FH
M2KJQVVG"'6E4`2@9"M:I!KQ[L5%TAD>212BDYZ?+3@CKCS3(JZXAL?$X=*`.
M-5J^RD=ISRQ@"IIM3<UI@:%:(=XB2'7D15N/(0VI*I450$7F53]REZA*EGC2
MF8&$KJW#!\HH:++'RM\;BY"*RE(6M86IQ3A4E;BM2M.E-`#I%4UK3"-F"(SG
MQ^9+.F)V"B-J40">X$_+2IP]S,I0-"1+I"<78)`>?25.J4-/+1J&==1U<.&7
M'&B%!G4GJBWMDQ(2?"J4L)][-L*R"P='BU=V5,2MCI8NV";F934BE*[/2$UG
MN.2=E<.*IWU'ZWW.&RF1&FH!6HI""[H&2P*ZM)H2/9BVVFC5<WYZC_#V=ZAY
M]9VQ\L?\7\E&2NO:Q"4].N+*="%+4E+@<4JB:E/NCY\2G[*W\9_X?YII^YC\
M(]?\E4#JOZR8"&GXEGM]RF3V5E#C;:2AC(42I+_*5JJ*$Y9'$Q9=/MY39>8=
MI^[V]ZC;S4VX@BGI5&.L'J$NEGV;)OUVDE32V`Z6.>4:5<Q/*3S>6:_>$=F+
M=H6BNEU!D#"<Q#MW851.H->@L+&6[F?DC8*UKZANVG!<O+UZE[_?G;ZU&#\M
MPONL0FVM12VREM*EN+=#1)*BH94[,=2LNG(&`>8GR'_#_P#B"\PZK]6-0O+B
M6.QM>;&RM'<T_-C2N##3UJI5^N=VO<R3(GOR5N.O%Q22XL!*^[1E0"G#%TL=
M,BAA;RY`]E-N48^TKC.JZWJ>I:E->S<R,R.J69B0W`"F[A78D-SFANC@)-1X
MR37Y*9\<3!B8Z/(*`\5&U>[%Q**X2\J/Q>Q"&#RH_%[$(8/*C\7L0A@\J/Q>
MQ"&#RH_%[$(8/*C\7L0A@\J/Q>Q"&#RH_%[$(8/*C\7L0A@\J/Q>Q"&#RH_%
M[$(8/*C\7L0A@\J/Q>Q"&#RH_%[$(8/*C\7L0A@\J/Q>Q"&#RH_%[$(8/*C\
M7L0A@\J/Q>Q"&#RH_%[$(8/*C\7L0A@\J/Q>Q"&#RH_%[$(8/*C\7L0A@\J/
MQ>Q"&#RH_%[$(8/*C\7L0A@\J/Q>Q"&#RH_%[$(8/*C\7L0A@\J/Q>Q"&#RH
M_%[$(8/*C\7L0A@\J/Q>Q"&#RH_%[$(8/*C\7L0MK;?,KG2E.RO'](P>5'XO
M8DI).73"M4;2G2`*UI^C!Y8<?8DC<5&SVIRVDT"/K^3#&^ML,V;V*<T4N+QC
MN4HV12$+0M2J'*B>\5';\N($VH+'#-M-=BZGI9`/SG&JFG;5P;"P1D1IH:\#
MX:=F*[>VU21FV=BZKI#@UC2#P5@-N71-&]3F@5%#D:G(4SQ6+VV<6X%7:QNF
M@XC'O5@=M;B$5UK2Y44!I73W9C(C$&;8AA%?8K##?B-P^4$=ZMWTWW4T\ME3
MKX9*5-434+U9"F?A(KBLWMNYF9Q.Q6BSOQ+1F6F;M_DKU[$O:GT10EZK:M'B
MK7M&7#%1O@[:!@K/8EN&.-5<?:7**6CS0*BONGMH>_%0O8G\PR5([%,.I5;M
M^;<N%SJZTV!$#?WVA6M1&13W$$JIAA:2O-ZR-WA)^!24H_+/%4IW=;Y=N=N`
M2VM`!-5J)5PU4R(RIB]61:=^*AI[IT/W:^G^2@87U;3RVGWPG0HT6:'4:U`H
M>%`:<<6!MNV1H>3B4SYKIOS3\M=VWL4DV.<;FD,.J)0O,I"N)3122%4KD17"
M%W;LC@+MIP]Z6@S<T8\5*EHM4R,@N,+<2A120%`G@"!0D]QQ$T'!/Z'BG=##
M[+J'%N$K*T*4DBF84,JUPSGEK6.BD8OTQW*;[#<%I90I60R'&N9/R8A+BUJW
M-FVG@EHW\MV:E<**4K-<5K"=/8H5S[<LLQAGY4?B]B7\V?P^U2_8YI;;15SW
MTI)J*4*J"F5:TQ&OMQG=CO4E'<_(/EW<5)=MF52D:N944IPIGQX8:W-M5HQW
M\$O'+S#2E,$Z&F.:@+U::GA2O=VU&&?E1^+V?S2J/@4`'<`/FRPT(H:(6IUW
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M%LW@X]'LK\A@)\TWK+/,%4%24**$K200ILJ`KEPPE``9F#<7CWA+$&BKKT;O
M&^C?[U'W`J)+@OS7'H\=@%M+0UI":)2$("0%$5XYXG+VT93=1:JV?,4X5%3*
M6-)TI0DDC2`"%5)/$G%?,8CP::@XK(1)UY0Y@U@4UC[/97V8PLI`F*;#2M0"
ME.52#F:&E:Y=U,"%6OJKLZ+<X\B<\Z4O1V6EQ:))Y+E#XTTXDGL-0,2>FW!9
M,(MU?>HR^%3Z%R0ZX23;T2;>PX_.F.!8BL%*TH4[S0I6I:`DIH`3QQV;2((9
M(`YQ;6G$*GZ@XL8Y]#@J5&3O9$N:](:=9B,-:FVBHJ2K5JU`ZP:Z0D8FA:PG
M80H+S9'%59W?U2NL*^JCR[4RS9XSI_%;DLAIU`6D+2&DG3K(21P!Q8+&R8;5
MIIA4^]535]5?'<.C!V`>Y5SZUS[MU+V6U;]I(7*8?E.HY"P!S&X_W[;*L@X$
M*4CC4'VXLW3PAL=6CN9*90UXQ[6D+E77#+SJ#0)]+MBX2R%A!%?NO#C[E&G3
M7IY)V;8W[EN:WQFKC<TNF9!H'>0M"2TVI*E$K&M!J:4X8EM;NC<U%N:'L5;Z
M$Z!&FV,MQJ'S.`P#MN%>Y1?N3:NWT27I`2AEUUY;BT!2P*DZ@G-9`!&)O1[F
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MKP514<5L0E*:T%*\>/Z\8*:W!J119T/<?FQA-TX+8=*0>%`<SW_IPQOO`K+H
MA',&.Y/:T/*<>2A:ZI!RX``?H'?B!K0%=!@G,<C`-E%+UIE1XZ:I2!I2-7B)
MK0#VG$!,W-/0["[XKHFE7OY8!(JI'LVX"LMMH44`$*R`)'`<36M2<-;ZT`!*
MMUE>$D"JF"W;A<CEJKA*M(->X$'+,>S$$^U88R.U3K+Q_,![%.&P]]W-%R2E
M>41I#2JA2,@`*J&7O$8K5_9MR.%,:*S:?=NSM(V571'I3U:CK;98<)*F6VE"
MNGM6$U'#%(O;$@'Y33N5XLKW&E157JV5U2;DJ:90[16GXF_T4'LQ5KNR`J",
M.[^2MMK,V2$.)%:G>K967<EME0UH<;2\%M@*!<*A4@9FB\56YM^1)S`#4=B>
MQ-$CPT4H5$V^.GJ+]$GO1&4ME:5D$:JG4#0`%1X$8?V=TZH&*:7UFQU2-JYV
M=0NGTRPW1#+NNA75PT4`O)*Q7+*@(X8OUA*)+-CG$5Q]Y4"YA8[*`<$Z-D1%
M)#;ZC73[I^5-.P4."^</+&A&T>]*VX/-'I5I+"__`(34]I<0WI&DA/`IKV`'
MCB#3\`HVKE/R"ZTV`A:P0D5.D9"G:<J8CY03*>]/XOTQW*0K6*I0W2J*I.GV
MU'Z>W#2X!Y>/%;J3;,2TD!'AJJM*=M!GG7#)84EVN0I/+)4*"A(R["GN%<1<
MGZCN]2D7Z;>Y2E8YR*C+[`[%?%\YXX:S^$=Z=6_C/<I'CR%J;&@E([@/IH17
MAAJG:5%KHT5!0U:*]G&G=B*=XCWH1=G[XJ#GC"0*5[*\>%,:H1Q*0D42*#NP
M(0J.\?/B4J/8A?E(_P!9^85Q]0U\35(G3O:3^X;HP\]S8\!EQ!+A21S%G44:
M4G-03IS/97#"_N1!%0F@<#[%?NA]!M-9FF?<EM82RG_2S5]P73_I%)DV9<.V
MKN)1RVPEH5J"C6I69X#(XX[K]L;E[GC$8KUYT@^+2H!%"?EHNQ'IZW;-:;A(
M8=9T!6HZG0G@!WG,Y8XSK5F<AH-RZ_HMZ,XQWKM5TNZ@LR;7";?E)#C*6D`5
MRS0%'/@348Y=J-D\S`MV4*Z/;W@$=%,EVO+5P9"W'6G&VT%12'`24`:B*=ZA
ME3#..S>V1KCL#A[TL;NHIN*2MHL,^;D.LQVF@Z%%*TN))*-2,BGB,_Z,/+_P
M>E)!2>O[I*-?PCAGV'N^3$*S9Z5D)!=\1<I]HKI^FM,;K*1WW4-A25'.G8">
MW`A,.^M-S8:F55H%$]W;^G#VTVI*3PJH'47I/MVXJ>*HC:'UI6I"Q3)95J)K
M[3BUV+A&6R'<569F&1Y8-I7._JGT^D6P3&8D?F-+<+*"VH*.I62-0`)2#WXM
M]E>`=R@[VS=OVKF%U,Z>SY-Z=7>&(CEJCN%`COQ^<XTH)`<((]X%RI'LQTS1
MM68+)EN#Q]IJN9:UI+S>OGIP]RBJWQMN[<BNPXLA4UU==,M#9(0`=2DA0RS&
M6)\QF=A(Q4/:NY5R&]A]Q4.[XN[%1RG1FEP*U"E"2FG$_+B3L;)QQ*K'4>M1
MVA)<<>]5'WM<%/.N:%H40YPJ,L@<72VLG^793@O-_6NN1W<L@!KF/V*,93KS
M[1;-*:DFF0]VOM/?B0LK9\4V<[*%<]B%8>8>*25H4@@*'$5XUQ++;:L,"$,"
M$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"
M$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"$,"%O\`+N=P^<8%BH0\NYW#YQ@1
M4(VA)2V$GB`1^G/MQE:[3@E2W0W'DI0I-:JKQ[B.WV8C[[P>I6+1[-[GU4C6
MBRK*-80`E-`:J`/`'AEBK7'B'<NBVMF[#`U3T@V^2-6EOP"M/$/=ID3A%NU6
MNQM',HX\04]K&TM$A*%"BOHS*.W$?>?!6ZPVJ;X4/6TVE50LBHH12E._A6N*
MU**O5HMMOI4@62,BW-EQL'()6NB236E>`XD>S&N]6>#](]RG':=]D,HUQGUL
M+T)S*%)J*@@'/OQ$W]:*7LMRLOTLZA3HUV#-Q?J$^+F<<E&H''.@Q4;ZW,I+
MAP"L,-R(G!BZ1]-M]-NQPKS".74$D&JJ4XZ:UXXJ%Y9.%:JT6=X`X44]O]08
MJ8*&VY8J4J"BJJ4IR!&I5?#7/CB+\H>"D_.#^"JW]0;>]N^49S-Q8>:9*`^V
MP^EQ::I2BC:$FK@IQ[CAS&SEM#>"1<_F.S\4M;<V/:F(D2)#U*>;0JJ=-!DD
MDT5P.6,2R")A?P2D'Z@3XA[/DI;=*U.1D(4`B@KK30U.5/=IAKYYJ?+>QM^3
M$=4ZS*>5J54C01495`X9J`P>>8L)^V5AU"TJ4D@:?Z:8;75R)8L@XH4C0@4Z
M%G(`4]O8>&(Y"=D-Y*#6IJNFC+M)&FO=B+D_4=WE2<7Z;>X*0[#*?0XBI2*C
M+Q5/O5[#[,-;CPCO3JW\1[E,MNE!9;4LYZ`,@3V'+Y:G#5.T>5FI1[R?Z<13
MO$>]"WQW$ME6HTJ!3*O#&J$9\PUWG]DX$(C4?[=?T8$+\K-#"$*"CXP`H:54
MH:I(K^BM<?5A?$HFJ=MHW5=[0VRS&?&AE1*!3217,CPTKAAJ&GLOH\SGN:6`
MT`IC7C7A12NF:W<Z*'R6P!S%M021LKP[U9+I3U,NUZN+4)<1:)$`:')@>HV^
M%**]7C5EI0H#]&.>ZE9NA):T%P7H7Z;==2:L>5?1QQM&\.<?>NJ_17J:;6B,
MRY*`()JHN*!H.-<^&.6ZSI?R&E:=R]/].W-O<,YH>0>`75'IMUEB)C10W="7
M#RR4<P@5TI[C7MQS2\T7.^M7"G8%=8-5)JS"@-%:FP]84.)4'9:5U30@NJI0
M@@@9X@9K%\3LN/J4U%.QS>;FV"M.Y3KL'JC`7*;076CS&B@?>*J*K;X9CA3$
M;>VI+<":)Y;WQE\0`5IF;I'EQ67$NZTK0E6KC0TII'LH<5]T9B.4J1%*8+42
M`"1F`"1[1Q&,-%7`+*:T]TZUY#W?UG#CD#BM:IDW&:E#:TJ`';Q).?LPO;MR
M/H$TGF+79*"B@[>UR0E:CE4).53V$5_T[<66V;F9EXJ,=&&.YV\;E37J%,;D
MI>"&VP4O<U2J:B2BA2#J[#4XL%A;5(JX^Q1%_<G9E'M5!.K<>U+CR!(2A+RW
M75K6$I"OO"5!/"E`#3%QTV(L>T!QI55B[Y=PTAP`*Y5]1KA'VDMUJUQDNH)"
M="E+U$N*"333GX:UQU+3G4B`IN7%>HM5.D79DB:'XTQJ-N&Y5DW,JY7.,]+J
M^PK2HMM$>!85F:$T51)Q:M/-1L"Y?U-YO5(#<1BA.X$JOLZ)-0\Z]-6Y52B2
M@\`:`9'C2@Q=+9H=;,ILI\2N!:K;/$KVS$\QI24H>&O>?Z<.!@:*)AG(8;>@
MI6M=^"+.-!P@DD4%,J8V2H-%K\LGXE?1@HLYBAY9/Q*^C!1&8H>63\2OHP41
MF*'ED_$KZ,%$9BAY9/Q*^C!1&8H>63\2OHP41F*'ED_$KZ,%$9BAY9/Q*^C!
M1&8H>63\2OHP41F*'ED_$KZ,%$9BAY9/Q*^C!1&8H>63\2OHP41F*'ED_$KZ
M,%$9BAY9/Q*^C!1&8H>63\2OHP(!QQV+-,1"E4*U#]`QJ30524TKH]@JLU0F
M0<GEGY4IQJ&W+S5@9D[2:^Y:LDN)&YFL^5:_*)'VS]&-WLD9&7U87`;`37W)
M5D@+LL@()7GE$_$KYAALV=U/G:0MW$#PD%>^4'Q+_0!3^G&U;I_S0,:Z+B2:
M^Q8:YI'S/8#PQ^Q#RB?B7^R/KQ@F\9\TK&B,;:$U6U8_^8SV_8AY1/Q*^88U
M\R.!16/\;/;]B]\FGXU?,,'F''8W!-GSY7%HH1Q7GE`/M*^C&['S2G)$T9^V
MH"4AE:]V5^`IN7GE4?$KYAAR(96_K.C:>\_8EG-D/Z+2X+PQ4@^\KZ,!`!H#
M4+2KA@X4=O0\LGXE?1C%$9BAY9/Q*^C!1&8H>63\2OHP41F*'ED_$KZ,%$9B
MAY9/Q*^C!1&8H>63\2OHP41F*'ED_$KZ,%$9BAY9/Q*^C!1&8HS@6JV-HYAT
MBI6?=`[<*L8UP)<:42;WN:X!HK5+D*P29%%+"TG(T`!!H:TS[*88RW+8W4;2
MG:IRRTMURW.XN'<`I`L-B=2ZC[FHTJRIEV>SB,1M]=@MHK[HNEG.-M>X*5K=
M8W5I"`SI!()HG,\,^S%7GNOF%*;%TBUTHT%*U4C6[:S_`)4GDY!DJUZ0#[O'
MAV4PW\UB,`K+;:43'7&E/@LXVW'_`##10%%7,3V#AVTHD'#"\N=]`I2RTP!P
MH7>H*>;#M:6XTRI:%]M/#[*]WMQ6I[L-?0#<K3;Z8`W-F.W@%)-KVRX-(*"?
M$*I*117$4(SRP@Z^H"0,:*9MH'.>V$^$FE4Z%6=N*@*2M;2QQ0E*=/#Y^(Q'
M3W+I]H`4BYHL_#\U.*+Q[C/BOEQDEM%`D.A2M51D?9A$0-?'0E-S?2.DYA`P
MPI4[E8+ISU7FVQ33$F2`A:M"E*<<!`TE((!(%=6(^XT:&1I)>ZO<%)6FKS"1
ML>1M.\JP-HZB/3+@[`ES'C'E):\OR5*47/?Y@-304!%*=^(2YTZ*#PN)[P%9
MX+E\M*@`E2U:;==A=+=^"&0U$4@KE.2:Z/$2<C[JC0]N(J6SBIS,Q!X*5AE(
M/+H*#>K6[,VY<;C'`BNEE9(6)!`J$HH5)&KPG6,L5_4LH@<RN\>]3=I`U[@X
MD[%-#41;+#4*0P\\_H("RT`%4H"4Z001BO4;Q4CY5O$ISP]JK<B,.^5H%-A=
M%)`4!4UJ*9'+#9\Q:XM&-.U'EF\2DV195Q7]8:H`0--*)SH>X=V-X92]]",*
M)*6$1MS`[UL.JB0M`00*"G:._P"?#M-T91**0E.D`)H-52"`.WNKALZV:YQ=
M4XE.&W+FM#:#`)V6NXAM31YBCXN!)I2O81QX8;7-LT,&)VIU;7+B\X#9\5,U
MDNP*FVU:#4`ZBLU[!3NH,,_+MXE//,.X!/\`:Y3K2EA9U!-0D4()H#Q_3B!>
MR3.:#"I]Z<@BBUT.-<DG!9P0H<&23@C!##ORHXE"_*^H>X_-CZF5"^)&9O$+
MT`CV83D=A0;TE(:BC<4?M\V;;'_.0Y;T994E9++I;5X"GN5VTX89R:=',"2*
MX)[INKW>ERCRY+37MXJ_71?J:B=#:,F4EV2"?$Z\CF)%,P1J"ACG^L:7$6&H
M&Q>M/I]U<)FADLS`\[BX`^HE=`MB=2FXRXVB6G[!U)?35-`*_:H,<YN-)C)-
M!O796:I*UV:N!Q[^Y6IV[U7>*:B<XJJ,J/@UR]AS.*K>Z4P%QIN*LEIJKRP`
MGL5F.G'4M]Z5$")#O,!"B0[XM(6BN5<A6G'%-O;!]*Y7>HJPV5X0X&H74GI3
MOYJ>TW%FOI>1R$E'/>24A6D"@JH#5EPQ1]3MI(YP&L=3+P/$]BN=A,)8:DBN
M;BIU5)"VRI#J:*1J2$J'!0J`*>S$:QK@\5!VI_0TK0T35F.+JKQ'W?\`WCAX
MM%&=_E\EM=02NGO=M"#0<.S&\0=S-B8W#29*@&E`JZ;SN9YBJUII-:FGZJ98
MLUHQX`J#ZDRE<T1D$A4YZC7]5O;?DMLK?"2\E3325.J54)TU2@$Y'/%GT]CJ
MX@^I5R_>WB%S_P"HTB?=E/K<??9"SK"724:04`A-%Z:`#+%LT]KN:W`[>"I-
M]<OCGD`P904.[8%S*ZCM7/\`%FT2G$.-Z]2GTK"]"4FN:A4`$#/'3=.8\L`#
M233@N#]4.?=ZCR@"6$U]6/P4#[OW1Y92V$N!]M""EE2%I6VWPU)2I.7B/]&+
M9IT<H&+7>HKG74W4PT>TY4='2;*#$[.`4"W>[KEN+4JJPM5:).I*:@#B`<L7
M.T_IF5J#3?@=I7'+N_.H!UW+1LLF)'`[/@D4^X!V]W;VX6'B4)%A)4[%A0]Q
M^;&U0G69O$(4/<?FP5",S>(0H>X_-@J$9F\0A0]Q^;!4(S-XA"A[C\V"H1F;
MQ"%#W'YL%0C,WB$*'N/S8*A&9O$(4/<?FP5",S>(0H>X_-@J$9F\0A0]Q^;!
M4(S-XA"A[C\V"H1F;Q"%#W'YCC(!=X02L9VC:0O*'&QCD`S%IH.PK((.(V(?
MK-![3W?+A-CFR?ID.[L?<@$'8LPVX24A"RI*=:@$J)"/C(I4)]O#"CF/9XP1
MWBB"0W;@M)<;2*J<0D=ZEI`^<D81,L0-"YH/>%L&N><L8+G[@!4UX4"=^VMC
M;TW;(;C;6V9N?=$AX#D,V2Q7:Y:RI24)5K@M<M*"I0%5*TU.&LNIZ;`[+/<0
M,=P=(QI]1(4]8=,:]?@&.QO'M.]L$KAZPTJVNQ_RY_6IU`,=-N]/N[;,U*)$
M:9N=R#MB*ZFB2DI>N,A9H0KM1BM:O]1.CM$>;._F8^YRAU6.#A0UIB,V.!5]
MT?Z-=>ZW")=-AD@MBXMI*PL.84J2UQ8:;,=A5L=H?D>>M#<VA$U?2_:SJU!*
M1-W+-NY:414I>3!MP"EH&1"54)X&F.>S?6OI&UNVRP-D):ZHVT])RT70;+_:
MKUM=-%S?75NV#:X9X\U.P<ROL*M!M/\`].QUKN2$.;HZS[>M[I2@NMV.QO36
M4DGQ!"IFA=`.!I7$-JW^XC2XQ^1`7=P)]P5UTG_:1<S@<ZZB]+V?^\ISM'_I
MNN8T@WCU`;F;%"5+M>TK?HK7+2'G4O5';44KPQ6!_N*=(,T4+FLX$.!]H"LO
M_P#R%HS?EN[LFX&W*6T[..[M3L1_Z:S;]04^H3?*3V*?LVVW&N'VF^74U[.X
MX!_N(+#FFA<Z,;10G^,5C_\`Y%Z;_P#JW^S[$DS_`/TUC:FW#;O4;?6WD^XF
M=MJUJ0ONT>3"10=NK]';@/\`N0L0?Z1Y_P"@[#V+8_[0^G#_`/-O]8^Q15>O
M_38]74*4;!U[L$FBJH-TLJV%*%/_`!0U5*144\).6?'$W:_[C-,=;M+K<@TX
M'CPI7UJ&O_\`:+$'.%A=@Q;JD5]XWJ$MV?\`IX?6E:@ZK;>Y.E&ZM.E2$M7V
MZ6OF"OB"?-PU)"@.`(SP[A_W$:"Z0>9A>V+>0'5[/NGW*EW/^T[J5KC'IUPS
MG#9F+*4WXEP]ZJKO?\FG\PK8K3TA[H7+W'#8"U./[4O-GO"EE*J`--N!F2"M
M.8`0:_+BV:;]8>@M5<!/*8R16CC3WM"J.H_[=/J?I5>4ULM-A8:^YYJJ0]0/
M37ZA.ECSK>_^BW4O:?*<6VZ;YM&?R4%L'F:)<2(MM24C/633MQT.SZFZ9NH6
M26=]:&%P!:#-%FIVC-4'L("YAJ/0O6FG7,EO>Z9?F6-Q#GBVG+"1M(?D+2.T
M.(.Y0>\%1WC&D)4Q(2"I4=]*F7PD4JHM.!+@`KQIB9AN;:X-+>2-YI7Y7!V'
MH)5;N+&^L\;N&6(5I\['-QX?,!CV+Q/CJ4^*G'3G3Y:5IAP&N.P%-"YHP)`7
MM#2M#3OIE\^-,S:TJ*A&85I457F-@"=@)6Q!`J1@O0E1X))^0'!0\%IG9Q'K
M1M+(=&E*?$12H!-#^CAC):X"I!HMV@O-&8GLQ7CD"0TD*Y3JDGB0VX0*=YS`
MQIF;Q"W=#,P5>QP!X@CX(K0CB"/T8,S>(269M:5%5N98<=<2@(5GVZ3W$X`Y
MIV$(#FN-&D$IV0+/XFU\JJA3/0:YY\1AM<S\MM`10CBIS2]/-PXF1KA0BF!4
MJ66QNNH;5J/B2"4T-0*TX<<5>ZO#7;C5=5TG1V\L`-/J4N6+:@=;1H`#E1XP
MGQ4XJ%0.!Q$WM\*>(>M7S1]&#7#,TCT%3;M_8@6IH+;"Z@5U(R^6G?BK7-^,
M^#A3O71;;2&&A`P'!2FG9Y:C%IM@C[E38*6CVHH,@FN$!?8TS#UA6%FEQ-@=
MLJ&GUT1"!LE_SL9/+<J7D@IY2JTJ*U%*TPQOKX;`YOK"2LK$@CY37N5O=M]+
M7)-L9>;94@C)5&%U%$H-309#Q8J\]\,^!&SB%9X+%V2N4[>"<#73PP7$E20O
M4JON5-:'LIC2.\#Y`TN&)XIPVS,;@^A%%$>\HWDI!9:3H*5*2=":$@#M`Q)-
M^8?+BH^](WJ-5.7,HTM-A;`42"L9:J^+N&1PYC^5M#@5$!I.(!I5*]JC/NN-
M)2VYFH>((40DA5>(%!2F,2N;RSB$YM6N\PW`[?@K<;0LDQYNTRH[,ER0PH%:
MVF7''`DZ/>T)4J@`.*]J+F\0KM9,=A@?4N@NS8Z[C!B,.FE&TAQ*Z#,$^]6A
MJ*8IM_<Y'.:TA34,4G-J&NIW%7%V'MESRZ`PE7(U`DMH46P0,B5)!`-?IQ2M
M2NW<MP!QJ/>K-9,D;1SFN`IP*LA9-J,R4M/R$,O&,`E/,2E11K&H@<*5IB!\
MU+Q*D:IR3[3&88\#;+0"31*4I2"-)R`KAVQQ>T./B6%"]_;0EU20A(36M`!2
MH&1PZMOU/0D+G]/TJ-Y;B^9[Q[:?/A^F"2')SB5+1H40"4USS'S8S1W`K%4L
MP[BE*45HD@]II2E>_#:Z:[(,#M3FV(#S7#!2!:MQ(:*27$Y5HO6D@4&0K4=H
MPRRNX%/,[.(]:>S>^>6D)0Y04`.ERE<@*Y=^$#9DFJD6N;E&(V+<C?AUH"G<
MB1D710^S.E<8\F5G,WB$Y(F\XKA&OE$4&9<10]^=?9C/DRLYF\0E/_,MK_OW
M._B./=_J_1AIE/:C,WB%^79R5=Z?G/U8^GU%\.LP6M:"G3VDDTIGW?)C5S21
M7@G5O(T-<W[QI3VI1C6V6\PJ2B&\XT@@**$$J-32H[*8B)M5\N\,KM('K-$J
MW3-1G^:%CG#:G/M";>;9/?%NCNA(>`+920L`FA50?9`XYX=ZU8663:%:NFIK
MRUU%CB,:CWJ_?32;>9;UM1IYO-+274HU*Y:E:??JG(`8Y3JT4,$H;#L(/O7K
M_0;Z2^LV.EVLH/BK];=@/V]45F6ME+BFT.)(62E8X@))0DE1X#(9XHUY^H5?
M+3PCT*SFT43K88LMLI'.2`""JH02E1"O"`#4#%8O-A5IL]H5TMC[WN,,L(9<
M`=T@YD4&0`X&M<L5.]MW3$NQX*UV5P(0&;JU5\NFVZI5UBM^?<U%+3>8-:'0
MFHS(RQ4[NT+27C8,5:H+L/CR$[0I`N<@<LK:6D4R54CAF<N/;B-6RA;<UP4H
M+(6,@!Q'$5[JX?6N[O6LGZ959MY70NES2L5"5`DZ>Q5,J8MMJ?E"J]WM=W*H
M6^)R_P#$_>)]Y?:!7W3GEEBT66U5B]W]RH_U8G.-V];S:TETJ57,=E0.'L&+
M5I_ZH[E4=5_0*Y9]3;_>'/,H$9I%6E^)%=0IG\(R(XXZII&UOI]R\\=:WMQI
M]E+=6M><TBGI=0^PJF\J=.DH6EQ:??=!3GVJS'`=V+OIY.P[%YCU#5[F\O"Z
MZ)K5)`94!D4_HK]6)=,IGM,KB-E5[R5=Z?G/U8Q1)9@AR5=Z?G/U8*(S!#DJ
M[T_.?JP41F"')5WI^<_5@HC,$.2KO3\Y^K!1&8(<E7>GYS]6"B,P0Y*N]/SG
MZL%$9@AR5=Z?G/U8*(S!#DJ[T_.?JP41F"')5WI^<_5@HC,$.2KO3\Y^K!1&
M8(<E7>GYS]6"B,P0Y*Z5K1/`J`6<^P40DFIPF^UOIW!]J[+&WQ=Z5CGBCJU[
M<SSL6Z%;YEPE-PX42;-F..H:;@PH<J7/>*U)2E34%AIR4M))XZ*85?=1VMO)
MYN<`!CJ@GLQ]BE[6PU.]>V&QMRZ20AK:;,SC0#O)-%=_HW^7-ZK^M:6I>W.F
ML_;=FE*Y3-[WD%6EHA2D@/,P2U(GN(":D?=#ACE=[]0])TIF:WD;7LHNI].?
M0CK;6+@-U6!]I%7&H(/N74?I?^1;9F&XK_5WJINF?<V5(<N%AV18U6.&X="%
M*CKNT]*7'F]507`@"G9ECGVK?6_.\1POJ<O'M7H;I[_;/TS9LS:]>&6Y+JM&
M.#:##;QJNCO3+\N7T<=(TQ'8W23;LNYM",M=RZ@N'=\MV8QI49C"+F$PQ(6Z
M-0"$<O5P%,<^OOJAKUU(1$7",_>&%!Q]"[AHGT<^G^G0M?;V,,]TP`L+@/$-
MG'?17,M,/8NQK4EC:]MLEFB-%#:8NW[+;;4@H4H"@1"BH1RTJH2`H$4KBJ7T
M.O:_)YEMS(?6K,Z3I_18_*W<<-F>R@^Q2%LO==GN=S>Y[L::Y">:8:AJD*DJ
M0XY31)6RXMR0F.LGB$TR-!B$NM#U7F?FETC\H^8[>Y+Z9JW3;+8BVN!-&7DY
MJUQ-*C;N5FK#(FW%:5M,-LL-.<M9C0D1HQ"*BBY,@,%",O>IB,FL)(?DN2`#
MNVD^@8J6@U+0YI`W,VE<>SVJ1F+A;[?I$BXP^8J@##3W.>)R\(2T%`G].&$D
M!8"6L>&<2*#VX^Q/C=Z<#_E7-)[$]V"'6D.(4"E204G,9'AD148B7BCB$\B>
M96!YWK+&B40QFI0AC"$*GOP(7NHUH4A236I)S'L`H:_/C%`BI&Q(]ULMIO;2
MHMVMEIND4A2%1[I`8G-\M8TK;T/MN(HM-010C&T3[ZW=GMWEN-10D>Y)3P1S
MQ%MV`Z`[BJE=4O0#Z/>LC<MK?/0+IU<7IH(?G0+,Q9[D*I4C4W+MZ8ZT$:ZY
M95H>S%OTOZ@=9:,_/:W,GAIB<V'#97=Q51O.A^@M6!CO;"&9QQH6UH>.W"E=
MO:N6W6;_`-.UZ5=WQY,CI5O7?72VYIU.6Z$M^/N';K3I*U!$F$^AB2ZU5023
MKKI`QT'3O]QVO:6!'J+1(-YK3TTH?55<EZE_VQ]#:_(9K*MFX_@&SVBBXX]>
M?R"O69TQ,Z[=-W-I]9=OMB4HQ]LNLV>^:6RLI6;5,*0I;B1[B7"0K+'9]`_W
M&=):LUD<D628M;F)``S4Q-:\5YXZG_VJ]0Z.'RV$QG@:XEAJXNR5^6HIO%-Y
M7'3J3T@ZG]';O-L/5786Z^G]V@/\AZ+N>QW*VA9*M`7&D/1Q%E-D\"VM51GP
MQV#3NK=&UB$26$S<17`C9LW%<"UCIGJ'I>7)J5NYT;G%C:C"H!=O'`%,<,/M
M@H#+[A%%K4VPZ4-MJS0\MQ2$HY:QPS)PXEM[^\QM):@JLF%UQB^/EI?M<)!(
M.DYG,TSS'949UQ(W-VYL88XXM`![P*%3FD6)Y@"D6!;&7FBTM"BE24C)(]M<
M0)O:N-%T2/1H[R(-FW;/2B]PV&A:=<=OPD5`\05_:!HD\3C!O*[2F\G0-O<U
M<S`IL1MO2XCB4OQUDDD$I23V&F9`RSP"\H*`JL672$MO)F>"352A8;#KTZVR
M2O1I`!RR-=510'#6YO109CQ5]TS1GDY:'"BFO;6TB5)JR2#0#)1J"?D]N*K>
M7PS8+J>D:,1&#16(VKL=!+0Y!IF.!]F7NXJ]Y>8'%76RLG%U2,%9W:G3I%&2
MN.5$T(TA1RH./A&=1BKW%\T/HKGI]BXQ._Q?!28>GI%0F,0![I(4*#LKX<J8
M;B^;7M4AY!U,4[]H]*(\ZZQR]&)6:&M%$5*T<3H]N&-]>-`KA52%C8FM3L5]
M]M](HD&V);5&2><P"F@5Q*4CQ50.[%7N+VLGH5G@LB6;]J;6X^E346+)4W'`
M>#2RV0%:0L#(DZ>`QBWO1SV=X6+BQ/(?_A*IIO'IY!3/>,T-H45$`U50D9D>
MY7ABZ6-X!B#@J9?614;KZ?-/IY,)D+:"B0[F&BHGQ"NDFH/'+#NYOFB6E=P3
M2WL7&+"HQ*6;'L)<9(YD)XI"LUH3J2,Z#CIRKAI+>MY9QP3V"T,4K7G=]BM1
MTR@OV:?"UPBJ'(HA94DU3H]WLIGJ[\5J]O!3%6G3ZJ_G3_:ENG*;=3$6V7:D
MHT`)&I1`/$YFE<4C4;X&1VY6BS-**\>T-KQ;1;"PI(2#2H'`T.7$)Q5);D22
M9!O5A_\`E_4G0M+,!I2V5H2@^)8*J*)&0(`J,@>\833=,2_7Q;@(;=2$(-2"
M:$I`\0%*YY=N'L?@'<M2H;OM[2ZX5(40,N.@&NDGO.'=M^KZ$WN?T_2HUF7<
MAVFKL_L]_P`HP_4>D5V\$*62O($GBGL_3B0C\`[ED+2+VE7_`(E/EI^HXQ)"
M9AE&XK*V#<@8'+UU^UE2F?\`[,)>0<L4X+2=ZN@D!U=`:#W>S].#]O=_%4N+
MYC1EPP6I>]7=2"7C1*JG44^SAG@\@[^*H\^SL2FCJ,VVA*5O*3I'$Z*'MR.O
M!Y%R//,[$H?]47/C<X4_\/AW?O>&$OV5_:L>>9V+\]/'T37Q86^.&U.M)4VZ
MZXIU"4);I2A/BU#237A3#>YF?%'\@!KQ2UM%--=1QQ4Q<*\=HV*^O2CIRFZ;
M:"EP!H<9*DEQ*2YXEN"JR4]AX9<,<CUW4[B.X!&7!PW'CWKUMT?T^]NG!SHF
MNS,QJ..&":<OIT+1?I#0=;:`>25*3I!T`U4/=[4XEY]:??6YD<<:;DRDZ1TJ
MPNVEKI-N\C_W5;WI=+VY8RAQQ+#CC;`*RD)(*TI%%+&7C%,<^EO[^69S6-:Y
M@-*D&OO74M&@C;&([8CE@5).VH_DI4L_4VT/;EAL(=1<%3)3\9MBI4(FE6ED
M`)((T*(K7LP2V6>W?/)7.UCB*;*@$J;T'5O-ZD^PN<H8W93;OXUX*[]EW)`;
M@V],G0E:F@!HH/%EWDXHDG-F\071XLD7A*G+9MTB.2&E<U>?`@BE*"@S!Q&S
MQ&-I`!QQQ4C!*)#4G&M,%>[I;?8[2&F]9*%):2HU&H)T@&AR%?T8JU\QY:X$
M8$*TV3F$-H<*J7)^XHRT+:0XHBE34YT-1Q!`Q`>5[U,YF<5#VYKH@!?+75-$
MFI^+.O`CMPO!$YK@`#2J:7-R(P6BAP59MXW!MDN'6K205&I%14]G#M.+3:,?
M088*K3W.=Y%10JH.^;NVKS/+62:K)KG\/"E,6BR8_;N4%>O9LWJD_4F>E33A
M4HD%9\-?#P'`98N6FV[B`\US*H:H<T9:",JH)U'4"X^.2W13:TGPG@H4)][C
MGCHFCOE$K6.`RT/N7$NJ((8[:667%@W'9B52.Z1T1I\A""HHUJ-%$&E36@H!
MB_6&SM7DSJ-T+M1<80!CN26>/^G=B7&Q1#?"%Y@64,"$,"$,"$,"$,"$,"$,
M"$,"%Z*9U/R>W",QF%!"`2>*V:Q[WAK-^_@LAI)IFGLSH:>TX1R:J15HCIW'
M_P!Y+W%I/;M!JU]?PX^XE2+TYZ1=2>KUV;L?33:-WW?<5.<DBT0I<B*TOB53
MY?(3'@-I&9)4O$+K/4EIH;#)=R1E@X&I5JZ9Z#ZDZIE#-.MY,IWD4`]N/L7<
MSTR?D)]6M_?A%ZZZW1S:MCD*BS7[!95H==6T4:U(7<R`M9'`A*$4)QQWJ+ZZ
MPVP\OHABR$'/G#B<V[+0MW5VU7J#HC_;A:-8Z;J?S/FLS2P,+`*4^:H+7;Z;
MU]`GI^_+/]+'IV;BFQ[,M,N\I::CN7BX0S<+T\Z@THY.EI?>8#BB`K0I-!F*
M8\]]1?4S6=4F+739<^'RUWX<2O4_2WTOZ4T:)KX8G&1A!!<6D@C$'!HQJ%?^
MW;8LUH98C0[+:X\:,CE16TQ&G%,'+3RWG0I[*G:HXILLL\XI)+)Z_P"2Z.^*
MW?\`J5<.VGV)%W?(N$>.S;F]H.[A:NM(;SD'E(5;F'%%)ER%.T*&F\S5*O\`
MLXULM-M'R<ZXFD!!IN/PJJYKMU;Z?$R"QMHY+N0UJ031NS<1O"X\]<=K^L`]
M?T]-^D6S-NVSI]+81,3U#W$N6_;HD<NTG26KK*EF*9<5DE:(Z(U04TSQZ8Z/
M9]-(^F7WVK/N7WS(3^6TMJYY'RLRACCB<-M*8U"\8_5;6_\`<';]6#0^D6Z?
M;].S_*ZX?'(70M<:.DS<]C?D!S>'=L*;EO\`2:WNK<JK=OSKYUBOFYG;;=+B
M-R=/8:K#T<0XM)BVVV2;\Z'53IK<MP<UEMLA24E0TTQ*0]5W&C6?G-/T[2V:
M8#^G<9C<D5QHUL@&RI%=N^BJG_VBUWJ6(MU_J6_FUG<^!S1;UW5S1N=3C\RE
MKIYZ<O5/T`Z:Q[9L3<W3C<V\=R7V,;QNI4"Z)O-BV[*D@.2XCL]N:S<YENBH
MU!M32.8HG%8U#K/H_JV9US<VDENZ,9<@.6)Y;OH:N-:X5-/4IS2_IU]3OIWH
M\6G6U[:Z@R2Z<_F@.)#7Y`&FCP,S:&O>,%;*V=!-R3&K9<]R]4^H>\YC$IMR
M>F\,IM%J6D@EXI8BN1W&65K)4D`&@H*8I$_4MFP/M;.U@B!;1A&)](#0/:N\
M'HR[@M+.^O+F9TTE#+1PH!0URU!(QIMJK8;9L^T=N(CL069*51X[>I]T*F%U
MTBBDE:D*7X2*@U''%&U&;4;O,Z0,H3@!A0>M=2T+2M%L;83,GG=,/Q.:1[&A
M23#=3)CI>9=><;6MRBG$A"LED:=.A%`FE!EPQ69(S&\M?@X*[V,D<]N'M.%2
M/4:(]5)X+03W<?Z#7"1IL'B3ES'TJW:AG\2?F.,4>D\LW]W^/2O<&._:L@.`
M^;:A@64,"%B4^TCY/_9A#D'F%_,DQ.RHH.[#8MP\@4H%YHSKJ4?V:?\`=POC
M2E2M'4.+0&NXC:O5)"N-?T4^K&"UAVM!6H:W[PS=ZUI92G@I=,SIU434YG(`
M8U9%#$[-&QK7'@M#%4G,YY;P)P`X##8%'747I!TRZKVAVP]1MA[6WM:I"%M.
MQ=R6:#<RE"TE)+$F0RJ5'6*Y*;6DC$A;ZWJFE.;+82O8ZM#0FE.[9[$QO-!T
M+5&&/4[:&5NT9AC79M[EQ#]37_I^?3-U*7<=P="[U?NAVZI3JY;<.*_(O^T)
M,Q55+;EVV4LR8D1:J?NW"$C@,=CZ6^M^N:/&UESRY`/O8U[,,PKVTIW+@'6W
M^W?I#J*9TL!NX,VZ)S`/16-U.Q<`?47^5IZM?2N[*G;KV`_O?9K<K3&WSL!#
MMZMAC4)#URM[+:YMK%*$E0(!RIVX[=I/U:T'J!S8HG!LQ`K6HQ.W;VKSYJ/T
M0ZGZ:S2%A?;M)R["2T'`DC::4KLQ5/K1":4X&446ZRZIF0G2ZVMEQ%4J9=9=
M:;6VXVJM:UQ=WC/$)[=[7`]H-/:JW;6]PV8P:C&^/+L(!%3OV@[,%+EDLK:U
MI:6WJ``/B`KGF>RG$XAY]0E@-'4_CTKH6DZ5!,P$%].\?8GX>EK5P27&HIKV
M4"*>S/0>W#/]YFXMIZ?M4Q=](636DQ<TFF\C[$3A]+KO#E5,6C(4"DE(K0?(
M*=N$Y-7>X4>6^U-+#IPQ/(:'Y2>S[%.>S]G2%E+:F$DM@"H2*Y&N?SXC9IX7
M@DG<=BONGV`CC`(-2K2;-V(ZZEE08\9-:4%*9=FDG%1O+JHP.%%8;+369J?,
MKC;$Z>*6$I=CTTMAQ-$I!J$]M4G++%7N;IN>A.Y6RTL1'&0W-0E2@GIXZL!8
MBIHK,$([^T>&F&YNPT5%,$Z\KWJ1=C=.WA=&#Y44%"?`#EK;K0Z<0M]J4AJ3
MEI3^-Z?V=K\VS!7DA[+:,.)]P<H[8-`*5S_L8J\^H3&3Y:4HK1!;,R4=4&J:
MV^=HLQ[0M\1QXDK0NH&20FA*?"#J%,;6E_,;F,.IES!:7D#&VDCAM#2N?.\N
MG3=SNTMPC2@$J3K*:9D@Z1I!J$XOUE=8[0J7+`R84=AW*)+YL)^V0BB`XX'`
MM2J(*>5XCQ`"-53VYXDI'QR.S$XIF83">6RI;VIQ=.[4[/>=BRHDEQ#5/LHJ
M2!]HE!RJ,-;E\<<#G@XC[0E((732B-P-"K*0;#'\HVTY"7&;;=8(<HE+F2E>
MZHI(`[\L5^4LF-7.IW*;AM1!X:GO5QNG:(#0BJ2GW6F@*Z:'10$Y=N6>*?J4
M;?-/C!.7#W!6.RA;R6R&N8U]ZLQ(O48,JTT0,CX".(/^L<0C[1D9YK2XO''9
MCZ%)<QV3)A11_?MQ%2-#:TZ0E840"2#7+[5.S&OS\%KBHFNU[0$.`NJU4.5:
M>+3VBO;B8M[<NA:X@XA,I)WM>6X4!447.^+JKW>(^R3G3_7SQ)6-FU\]'9J9
M3\$VN+EYCV#:F#,O:TE2ZIJ#2F=.%?BQ,?MT/%WL^Q,>>_L3>7?5+*B2GQ5K
M1)[>[QX1,3V'(WPC8MN>_@$2?O"4-ZBX4T.5#IS[N)KA>W$C7$T&Q(S7<D;0
M6ANW^-Z;\C<:=)<#IU`E/O"E$GVFM:'#S\S@FW[C-P;[?M3>E;L#"A5T%)J5
M$]G;E16'S;4D`X[$V-W4U-*IM3^H+#:5%QX)0W4@IK4TR-:J.0QGRCJT%2E8
MKF$UYIIP43;VZXP+)9)-P$I#G)J$LH*^;4$I)718J.[AEB3M]'$K:NS;/XW)
ME/J<,1HTA55_^K=@?WTSW^7[R_F]_%A_TK<<';*JF_Z[B_\`A^.G\8KYMP"K
M@*TXTQZI%Q`XT:]I/>OEV_\`+.5^![4<MYY4R))67"TQ,CEUMDD.+25U-*$$
M@!/TX0O7#E4J*D%/M)NH[;4H7OIE+MN[:%TTVKU.VU8=K,NYP6W8B.2AYP,K
M44I*5]H))<KCD&N6=U-.`R-[JD;!VKVGTSU-I4.E`/GB#LAH,PX8*HN_>JAF
M7:8;5Y@/+>0IMU3BRVIM*JN`&I!U)Q>](Z7C;!DN?E/;@N#=5]::A!."&N"1
M[7UFO4'[MUMP%12/N7%IU"E#KTD:_P!.,.Z5MK9SC'1V8UV)II'U5U*QP>"(
M'"A).PJ<NA_4./=MZHC)8?CR7Y")S\B22$(4IQ*GA'6H^!"AW4&*_J6C7++:
M4QPO+!&[$#L*O_T[ZPCU373-)*T5>-_:NLT*X+#$%3@60B.VYXCEX@DH5F30
M*3F,<GDCMXCEE(:[M7J2.YDF&:(YF\1BI2VMO=;4A'WA0A!TE6M034`9$@CQ
M9X97<,+O"0112%E/,1F%31RN;L#JHPRTSIDM%2$,Y!X544I&1SS/RXK-W8EU
M:-)%."M-G=N!:`:.)V*0]R=39B5Q95M<!2]]VX&W"6P`G50A)TZJXAG6C6>,
M4[PI<W+V[31)$K=MZNL$/HY942I!0GWJHIG3VUP16T9>'#PIA=7$KZTQ%%!&
MXIUS>2^AQ4@.KYFE4A2RA)U=NHGPCLQ8[2.W)#*BO!5Z=UT'9\C@P';15`WX
M_?HWGW4K"P`KO(H*^W%JL;5C@#N4%>W#Q7:N=75CJ!N6+)7$2R2IQ0Y"0E57
MCH!5RQVT56N+MIMNTL:T;?YKE'4>M:K;W,D5O%*Z$`4(!(Q%2J:;GW[*FMNH
MN'-1/50-Z5J"`-7C"@#3W:XO%C8RM(>UA.'!<"ZJZOG?!)9SDL>XC`X'`J$I
M*EO.NO$J45J)S)4>T#B<6>RCE8?G:0N&W$DD\[I'`XE$#4<<C[<2BW(`P&Q>
M@$F@%3@6%ERU_"<"$"A8S*308$+$`JR`J<"$""G(BAP(7F!"S2A:ZZ$E5,S0
M5IC(!()&P#'L6KGM9XB`O"A0-"D@]U,\-FWEJYV1LC"_A7%`>PBH(HO%!2%K
M;4E06TX&7$:25(=4*AM0`/C(/#&\5Q!."87M<!MH:I5\;XS20%II7'#!2'TU
MZ5]1NKNY(VT.F&SKUO/=$M]AINW6B,M]##;JREU^<X&76V&F@*DDI*0#B`U[
MJ?2-!C'GKF&&5X=E#WAI);MIW5'K5JZ5Z0ZCZOE?9Z%:7%PP9.8^-CGB,.KE
M+R/"'8TJ16AIL7T6^D7\A:?=!:=U>IF^*;#[S,MC8VWU)=@1V2GQM7^Z,A+[
MZB172V0E!.DY@X\_=2?6ZYL7.BTPF5AJ`6FNW"NS9O7K[H#_`&M26+6:CKTS
M99'`$QT-1CO:2=VU?1UT9]+W1/H'MR-8NF6S+'9(L0T66K8([\@GPA:ZMA#R
MDUXJJ1V8X'>]4:U?C)?3/D9WE>OM.Z7Z?Z8;R-'M64.\-!]P4^A$N0G1R3'B
MMIT+4$<IU0/#E*2`=(`[#BLW#><[\K,TFM5-'3HG4FD<TN.[AV%;D(C6]M`:
M)6V!1`>.MT?ZVJIK7#<:5G<)''$$'U)-\D-NPMS`&A6M=Z:2VXZTN,KDJHX'
M0E02<_!I-5!PTRRQ(B*1^`#CW*$9?9_`:I..ZF3S%2XWD(P:JF;,4!]XG514
M>*[X5(3V*I6N6',>FS7,9#0[F`TH![:H_>+&S<\7[`9!$7,)IB:T`';O4&]0
MU;7W=:;A:-Z1KMNZPW"),BR&(;TN"PFW36ELR@HV]UIT)<CK(4I!"B#EBRZ!
MIE_ISO-P2MCN&$.:'"M2W$#*<'8[C4+E6NZVW7M-=:W<=&SN,3@?E/+?\I.R
MH%#M3,LMQB[1L-MVKT]LUCMNT[4P(]ILT*#Y<V^.GQ!(8>0'5OA69=/B)KGG
MBSOTN#6)?.ZC-(V^.W$AI]`(`'9156UO[OIVW_;=,M+:2RI2N!=Z\A/M3?F;
MIO4IY_\`#K_.MDY:QSV"75-%UKW7%^.A6*Y5X4Q+PV=A#&+>>*.5PK1S0#@=
MVS;Q2+M7OA:FUB88H\Y?0_B-*D8=@2._NN_%YM%\?N4>22$M2FWY#*7#0CG*
M4E8R7Q_3AY!I.G2D.C@&W\(H%%2Z[JUQ/&VXE/*C.RNT)3B]1]T[?"8;5W=<
MANJ06)*%.2W22H:T.+4I2DZ4G"5WTW8W-'\H%W=\%FVZIU2*[Y8SB"NW<I:M
M/6>XIO$*UKG,/I1&:?=4XH-DH6A*EJ6W6E$DTJ>[%=O.AX76KKEL9;4D8#T#
MU\%>;'ZA&"Y\DV5KBP`G'945Q]:D*V=4-NW%Z>J%)+,IIQMEM<A^D9IXK3K0
M03I2IQ)('M.*/<=)7L$P=RGD@&M&G@K]I_U$TVX@+_,PT;0'YA@30"OI('>4
MZ?\`/JH"D"ZMLM,N%(:D*.ALE7#QY@ZJY8C_`-JSNR-KGX?R4S)U9%$P22/8
MV-VPDX'N3]MU[@3FVJK#:W$ZT56`E::FA00K,4Q$75I-!*YA:ZC3MIV*9L]9
ML;R%DO.CYCALJ.)2L"#P(/R88\R/-EJ,W!2@<UPS-(+5X5)'%0'RXPZ6)OB<
M`L9V\0L@0149@\#C<$.&9IJTK8$$5&Q#&4(8$(8$+!9H!1)5GV=F$Y02V@60
MQLAHXT`7A!5GITTK3O\`K&&C]/$F)>04J,C!A0K3(APY$=^/*BLR(\I*D26'
M64O-R$+3H4AYHI4'4J2:&H.7LPZAGDMG#R[7M>TX.V8\:IM/&RY9R[@!\?`X
MX+E]ZG?RFO33U_9G7G;UE;Z2=0)#RYC>X=FQFX]I?EK*257"P(0W!=#JDU6M
M"4K-36N.@:#]2>HM&>63/?-"\`8DFE-]3WKGO4OTXT+7F1F*)L,L9<:T\50,
M,.%/:OG[Z[?E^]>?3)/G/[OV[,O^T7)CC-OW]MQD2K`S&33E/W"*VTN7!=6@
MC6%G3KJ4Y4QV/1>O-'U&,.U*Z@A>1L>\-/M7+K_H;5=+=DT^UGE8#]UA*:^Q
M]MJ=;:R4ZG50FA4E7',$U2:<<3+KPMQ)%$XM+:&4TD('&JM-9.D,.^164!MC
MG*2GPI905^(?ZM<15[J9!;RW5&.PJRV^EZ;D)#F%V'!.=OT]/VM7,98?KDHA
MMD\!0T-!PIB,.M`'*]X!/$IM+IC\](&$MKN"E_9G3L0^27DEM8RT+;TJ%2.R
MF&EW>%[<K#53-I9&,_,TCM5L]K[0#/E]""=:!4I1V?#7NQ5[JZ?&\!]0:*QV
M\$64XC;Q4LQ]E)<Y="1FFJ`@^',5!'``89OO0&G'<4XY$1P&-5*&S]F)CS4N
M%'AY="=(H/&V3Q'93%?N[[.VC'`J0M+1K?&*`<<%85%H;0VTEHH4`VFNG@%9
MU3^C$?#)5OSFAKO4C*UH<`S$447]0;>O\+<05'PK<*D$DT14FI3PTT[\.H'C
MG-R8NK@$QO6N=:2-:*N+"JCWS;29KJQR])!*@=`&JM12HS(Q:K.::,U<"%4/
M+7'X'>I-)OI_!<<)FMNUK[JDJY>D$T-/=KB3-XXFM4M'`T-_-%']J=%@VG8[
M7(0F(TD.J4<PA`"LE5"\LP!WX:7EX[RK\=W'M"=VD,`N&DTI7X*8D;?MLB,P
M)$="J:BD-M(SS'O>&AIE3$!YT\?:I[);<0GIMN`W;%CDLJ*$@A+:DC4D5K2G
M9F<1T\@?*7$XG[$HU\31E:10)TR[NIEI16"#D**)[2!P*CPQB$,>^CJ463-$
MT5+A3O4:WS<(!RHD4<K15*T(]OMP[Y479ZECS-O^-OK4/WK<1+CN?VE"M>!(
M&9/LQ8K6WB-LP_W4PEEC,A(<*5XJ/)=T6MQ1"U*33B"3PI[2,.XX&M=5@^9-
M)Y(^7XAM3.G7%90O-6:N\]@([\+\M_X2F7-C_$$W)5V#?*.O132I?BI_K`YX
M<-MFD`G:L<^#>]M>](4R^^^4N<U-.&K4D$$FH&8PM#%;Q.K(0`1O2,\D<C0&
M.!-=R9TZ\J4TM>HM#4H4!TIR/&E1V'#UL5N_PD%,72QL\;@.],:[[I0P@EQQ
M`"4JR4H"M`/EXG$M%:"0`1C,:;E"232-+G4.2IQW450NK/7&/9%BT><9C.3G
M'T+6)`:<82VA*DK)2H*0E9508F]/T*ZE<XF%]*#=VJJZOU+9V[6L9/'S*FHS
M"NS"JISNSK`[-M,Z&B2MY1JEM8?6M3HX@I5J)7BVVFB/8T!T;@>Y4RZZF#C\
MLH/I58_\PO=ROWFOMX]WO<<6JO\`</AIL7+?.#_F_P#>5VJMU\VN_;7ZI6SR
M$CQ+2%4!.0'#M)Q:+05D'%><>IM-=92YB$U5-.L(64T4KFM:2!7,$\*_+BRQ
M10/9^?NI3XJM1.#IH_3\$\KS<;^+;#2Y(+<0(0&D!#BETKF*)!H2HG$-<V]E
MG%"-OQ5UEOM6A@:+<.R=B;#[J'%'G!3<H`T;6"%4^UE3$J3C1534[K5)[FMW
M7*$2*"5I4#PKEWGC@(J*+%W(UL#(QO%2G/MJ^S[%=HLV`]R7R^PVM8J`&2\G
M6,L\TUPWN&9K22+C&X>L$*P]$:N-+U6%FP/G8/6X!==]H=78,W;D%V3)<#IA
MQD$J4@_N6]*J^+@JN6.`ZSH9\WLWKW7HFM-%H35+<+J9%"E.,3TH;UD%)6G4
M54!)R-.!PVGT1Q+<#X1[RG5OU&V)KFU'B^Q/*P==41I;$5J[AE3KZ&&U+=2$
MN.E6D-I(54$G#=^ANR':GMOU2T3L-=C@K=;5ZJN/1K=YB<TL/O!(6:O)!""3
M5**D9#CBN7NAG&@5QL]=%V:5Q4\0-\P9C"5L36?"I3:DI^Z\:*:CH715"3QQ
M$LTTQ#)VJ3\V&@)D[HW#'0%N%])`!)HM)-"1V`U-:UPH+21IK&/G&Q)RW\;8
MBZ0@,IBJM;VO<:0U++<A#B4A1?!/++:"10D+(U5SX<*8F;*.^PJ#M57O]3L!
MO"HMU1\M,AHDV]EB0\RIP,.G22DZE:Z\3DJN.BZ&)!&P3?J5^*Y]K,L<SI)(
MC5A`]@7.+>KTGSO*=80E)XK2DBA!KQ-.)QUC3?`WN7CKKK_S0]Y^*8^)=4A:
M%,E2B:C,X$+U#10JI(.1P(6[`A>*%01W@CYQ@0M3;90220<J?2/JP(0<;*R"
M"!E3Z3]>!"PY!^(?,<"%N9:4%'/C0=W].-73&)I:/O8(,L,32Z9N;@LI$90<
MCI2KFKD+Y(0T%.+2\?W39:0%.K4Z,QI!PUBETC3G^8NZ`GBEM+M[C5YS!:PE
MU"*``XC^2[)>B#\H;J_ZC7;9NGJLF\=+>EJGF9+5N4%1-Z;A6D<U83"6VJ1:
MF9"$@!UVA"#5.=,<<ZP^I>DZ%`^/3I`9378O3GTB_P!MVL]77HU#7_RK9CJT
M=A5HV"AJOK9]-GHUZ*>F;:\3;?3;9%LL<)+#A=G-H`OTV6XA`,BZW$MK=N;R
ME:BIQ:DJ.KACRMK?6FH]37!DNC2.,_+4;G'YO<%[WT3HCIKI6U&G:#"&3,`$
MKA]^GA]7S>M6L#"DMMAI#$=Q"4H(9"@U1`TU`H#J4D5/>3BFW5X`^@-356!E
MSY?Y:T*.(*`H%8*DCB!VX=*00N5R89CC3J;.D^$\5D?:3IK0#"MNPEQ<Y-[F
MXY#0.*93EW<DJHP'$*;553ITCEE-#K&HT.@9X>@9CEXJL3WHYH!XCU53:O5]
M##@7`=#<U2=+MS<2%/\`,5]IIE%62LG,:LL35GI^89'@%NRFY1VK7<$%3:$$
MJ,YTRZ+4X[=T.7%A2B5S)BM#J@1EX(YY:4TX`=^+!%`RW9RV``<!N5(FNKB[
M#GW/B&`[MJ3V$LI!=M$I'-=!6W"EZUM.+7FF,S34`A1\(KV86;XA7955RZ\8
M23*?C\_E7!"K7<%'2R^`/*I=H/"M*/O*$5Q(;JMQ"12!=D*;25RF$KCB@7+A
MITJ=7]I8U450BG'#ZUW=Z8W6T]R:<^J65-K4MZ.ZCBLUD):-%)#9)TA033%K
MMQ\@55E_6*3K5%;<F<U1<\K&2I:T/$$Y@A`32HK49UPK(X@4;XCL61VK.W/*
M9:OM^?!!2P_$@I_\3PJ*$D'W=(IA*><NRV_W0X$^]1LL?D[EU]L$H#?4*?!(
M*KM<H&V0IIXMS[I=TU(U!2F:I/-3VT(!`]N%+>SCEN0Z<?ET-3NQ!"C;VYDT
MVR?#%A+*YA'H<TGV!3EM7?PDKL.R;VOGHD*TQ7'2#+#B@DKYZU',5IIIBC=1
M]-\A[]0LP=^.[!7^RZD$S;:RNSP^"D]&_MIVC<D>QS8LY$V+J;65J4HC3XDJ
MJVHH-4$$4[#BL.Z?O;[3_.'+605'H-/@NIVVL:;:77E:CY:>T`_%35:^HFUW
M&@MN1-KF*.-J4,S0Y"M>&*-/TW=1W&>C:^E=!M^HM.9;@APW)VQ-SV2X`EJ4
M*`@?>H6WFH5'O#,>W$3=Z-,/$*$<"I:UU*QN_"X)>:<:>0%-.(6D)!\)[*94
M[QEALV,Q-$1^Z**2&7[OA6>-D(8$(8$(8$(8$(8$(8$(C/M=KNT=R'=;;!N4
M1Y)2]&GQ69C+@(I0M2$+;I3V8$+FAUQ_+DV)?GWMV]&PG9M\;!==VF"3MBY$
MJ'-3%9`4JV/!LJ4G1X5+`!H#B_Z3UC<M>V/4'59LS?:/B%2]3Z2@:POLQCP5
M1MO]-+]LN^FQ;JLTBQSXCR6U)FH+;;VDD<QAVFAUM7>#E7%RNM7M;J)CK8@X
M8_!56UTJZMY'-N`<3AW!7$VKLZ#.9;9?B1G/NPE2BG65!61HL`@DI.7MQ5KJ
M]RNK7&JM=K8D,QVI8F](+<%AV#&0C2H426U:J5-3X4G"7[X.*7\@4X[)L9YA
MYM"VPE*>!*%#(?*D'#&ZU5LSP>`3VVLB&&O%2S"VO'90D*;JHI`U)&6HB@5W
MTPS??-<PMX@A.1:93FIL3KM5I9CKII%0DU-#0BJ,NS$<ETZ2$"@0*`#.O?G4
MX$*/=U0%STO(3[IJE0(J3D1E2N%K9V2X8[@Y)S?I.[E#DW;"4+4I38I3X>XF
MO&E,6'SA455(#]C1[Z(RW.S2A*2<O:<'G"M#:&8Y]RVV[9LAY]I:6"UXBJKB
M54'A/'2GORPE/<F2)S,,4"T,1SG<GH(*8J64.-*^ZU5(K0UIW]V(U;(C/NB(
MRU%BJ#1/'V`5X&G'#V*U,D8?3:LICWO<2N4L<X5U"A'R@=N7;AQ!9$R@;J%)
MS#\LJ(KU?G%ZJ/@!.NM3^GLP^_;TS4<72[%0)*ZDA1J.T@9'CPIB7@9RX6LX
M!:IK&[&AJ1P_T[<.X/'Z$WN?T_2FI/O&D%-%*S/=E4$]^?##U,4TY5Q4]3B$
MBFJO<,S2AQE,G^,]Z3GY[#3+BU$T2DGLSQI)#S@&]JU$W)!<=X4.;FWM%82M
M*5+:2!P4MOC4@G)5#7$Q96)#5!WMZ*JN&\>HZ8K4AQ#Q=T-.*`0M'<:#-0[Q
MBWZ38GF`[5!W6M@6K@3L"Y<[WW+,O>Y;C<')4A;JWEITOKU-)0E1IR@A1H>_
MV8Z990&"/'>%P#5]5$VH/%=B9[]V<#894"I8J2L>Z0JO`$UR&'JC?.@[TF>8
M'<>->S&JB*^]0'*NT^8@MR'RM*J5%*5H0H=I[1B[QV<$1S,K7O7#-4UN_P!7
M_K<A_P`+:+9#D02E0N(6>6I"F.6HMYC45:R`=7`8UNV.?E#32E?@HFV9:12A
MTP<<<*'U_!27MC>=H%SCQ)UM:F1%A*4J=0%I%,@I->`%,1<NG9_F)=4"NU=7
MT;6](<QD5P!D!'#BD;JD]MUZ^1';"IJH;<1-0FA^\4F@**#[M->SMPKIUU?W
M!`N<NW<VBAOJ'<:+)?9-$'Y7:<V_BD#;NS[UN.6W'AM#D+4$KD%/A:)X)5[:
M9XF;ZYM;'()*YG-KM4)H_2.IZZUKXP<K<#Z<5(3G1_<%FOEMARF93\&2['=%
MT1$(B`J<12-S!X2I7#5BK7G44+&N$;AGH:=ZL[/IEK-EJ=K<!IY#9XW.V[`\
M$X]RMI8ML/QX$>&X@!+=$)2G(Z`#Q(/;BD7-]YM_,F`S]@HO4NGZ>V*T.2OK
M46[UN3FU9+[DEU;<1L5"4J(/%>9-<^&)BPLVZC"9?O!V7AL`^U437M1N-(<9
MR:6H&.&_O]2CVX=18-SLT9VV/NMOPI29+3J5'F"0E6I)4:U4`KLPZ.@2.W')
MO[E3#U[)<6\LFG/:)XVDC,*XC9@K6=+>I>X6&[>TJYNE"HR5C4"5<PT!\1/"
MAQ6-7TKDM.0%=IZ$UVXOM.%S=O9YFFX`#U54BS^O\K;-T;3<;K(TNN57513X
M%>[IH0!BMQ:+YEG->TYJD>I2UYUZZPNS!?OC%`-P&&Y:MT^H%=SM*EQ+K*:6
M^AQ(<:<4EQ('WB2A53I/A^;#ZRZ>C%TS.UV6N./8MKKK[1KNPD:UXH6\>T?%
M42OW7C>L6Y2%-WJ;-C/ON-O-R%%U*6VC5-!5-"K4:]^+W9=/V0(JTU[_`.2\
MU=2_4_5(-3-M8R1^4!WM!-*\:HC_`-;Y4AM//2Z:UJE*2$5)S(3G2O;B4'33
M1)S86N`[UHWZN3PPBVD#74&)R\<?BF/N+<-IOCBEJ0JA`-4*T>(9C@#VXF[2
MTO+=X$@')'9\5S[7M<TK60Z5D<@OR10U^7;CA3A6F*C]P)UJT5T5.BN>7R]N
M)-5588$(8$(8$(8$(8$(8$+8E!.>DK%.":FGRTP]MHK>9AJ2'#M36:Y`-&#)
M3CC7W)]=.NF6]NK.[;9L?I[M^Y[FW-=G4M1;?;(_-#`6H($RXR5'DV^WLJ-5
MNN$)RIQQ4]5U1FE\R6]E9'"QM6U`Q/?7@K1TGT[JW5M[^WZ=#G<,I<2"0&DT
MPPV]J^L3\O7\GS8'1[\,ZH=98T7?/5J.B!,@0I4.(_9=O)<0%R/PD2U&-)E,
MUHF04K02*IJ,>3.O_JEJ6HW+K33',<QI/A;\0OHE]+_H=HO2.GLU+5X'<]P!
M-3AQ.!"[@V7=VP(=P:VCMN=`N6X8:E>:MMG;:N,F`@H74W>ZQ=45E*4"@"5>
M]04&.-WNDZI=?YK4#(6[<:MK7'9M]:]`1ZCI%TX,M`8R*"D;LHPPQH%+3+*4
M,H?YZG%R,ULK5JY&C@*=FK5]&&>8%O(``#-X[?[%.-<YL8;04XTQ/>=ZS''Y
M<-GV4$AJ[-7O3&6S@F.9]:]A1.1.8C+Y;GO&M!6G#Y<2HA:158Y\G8O6)<:2
MIQ1B&2VTVHJIGI5Q`.7`C!RRTY&.RU2$_*E9FGKF`PHHVO\`.ES]2$(;MD5"
ME!I2&PVX^V,BWK&:BL"@^7$Y:6<1&9V8N':N?ZD9A)EB\"9]`P"M,5U)(*=4
ME1=0`KN!`HO+(XEVR/9X33%1K8Y&G8?2B"VWG20EAZ4V3XDZR6@?AT$=V'T<
MSI&YGT!&'!:S1"1I,@QINP2#<(BFU)4AUB,4D*Y3;80\T0:A"5@U#B.`/?AS
M"&ND:'>&H58NX&9C2M1L2>ZMI;*F9,;SJ71H+J_$\S]KF\T@D$4I7VXF'10F
MF4D)ARY/X"(%CD:?*/(N#*4I`A+'-*5CB"3V\,:->62968-_C>F\\(RDOKFH
MF==FFUJ+B$%"4E7-0:G02:%`%*#2HTQ8K>XEY>[`*M3P1B2HKM1&X1'(%H,9
M/AN5U4E#:OL<IO[P`)R%:+XXV\S*YP=4?+7=O*UY+.U)-U:<1#MMB11+R4ZW
MQ2A47CS"23Q'BPXBB$I\P_QGAV8)CJ#&S0M@?X&&HIMJ<<2DN5&$^\PHP!\M
M9V=,="3I)2RDNE3O]XL%&9-#3"\SY66SHXS\SG-/M&ST!5Z8MN[R-UQB(@:4
MPW';QVI/L[CUUWZU<R0&(KK*FU-#EJ;<CZ@"D@F@(/B[Z#$M>-ACT$M`K)E.
MW':F6G"34-=9YFO)8[#+AO&U2-?I!5O=%R+[^A^W^90>8*<U%&%&I2:I^[X5
MQ3-/E>=.9;O#0UN84I_>*OVH&%FKR%CG;6_>_N-3^M.X]"0A,ES3QH5`G+/C
M3#*ZTR*:IIBIN"\!C$<CCD[Z;%(UMW1RRV.:ERN?WB=1%!P%",L5F\T:(DEP
M->]6S2]6,`I&_P!9JG];-]<M24<Q`Y92,D>$4.8I7%7NNG(,SI0'U).]7JSZ
MJNLC8\S*`4\*D*W;QC2E`/+0`H#24I`JHD4''VXK=WIPMVYJ';16>PUMLSZ7
M+FY<NX4Q3O9EL2"$M*\2AJ%<QI/Z?9B.,1:,Q'RJ9%PR7]%P6\FGZ.VA^O#,
MF5KC458G7+>6BA%>Y>!0)(U#YN'TXV#C(*,P<%IRYFXN(IW($T^TG](_KPLU
MI`^;:M3'<U^4CU++&J4QW[4,"$,"$/\`3MQMF*VS%,O>'3_;.^8HC[@MC$QQ
ME"Q%F*2!*C+44D:'@-6@J2"1VTP\LKZ>RKRC\KB*@XC^13:XM8;MP,PQ;LI@
MH`>V1<=B2"T^PA^WK72/<V4\N+&17[MEUJIU+/"I/'$[%-;W<9<XDNH<-A]2
M&VT40.4&B?\`:VVW6N<MM.OAPH*$9Y?+B(Y;>WUIM1*ICL*S+2`>%0*&GRXS
MD`P"=08-/>M[:4@H2$B@*0,NP$#!0)8XBA1^B1P`QLDN2Q>T'=_3@1R6).?:
M#RE)TC4"0GLX$\>_&02#4;5AT$;@6FM"D>3MGS^020I)JK2JE013M`QOS7\4
MAY"WX'UKR'LE$1.MQM2FRH^\H',FI%:8.:_CBM3$R(Y&5RI5D0(L1M09:2GP
M\3XB.TT.7;@YDFX_,M',#FEIV**-P2DMAY*PF@U:-*:9^TXD+:.2;Q!1-W^3
MX%`&X[XU&+B0K,'.M#Q`.7SXFX.='2%H^0+>+ENM6R._4-?>H0W!O&*T5A3B
M@CC2IU<<A4>W$_:VI<0XC&BB;N[#06M(VJ(9V]HSY?TN*(0HCYP3GF*\,2`M
M#VJ/\[VA-I[="7D$:P1I5I\.>?>:YYX/*=ZQYWM"TQKBAY`U'Q*HG(4S/R#&
M6P<LYEJZXYHRX+7<8CK2$ENE'!S/%4D\4GY!A1:IM.N,-,NID5YBFUI3I)'B
M*2`.'?A6"%\CJ'8FLYB8"[[W>H2W=O!%L:D,(6$J2%#,:CP5VDXGK738W.K0
M[.*K]U>8921M5(.H_4AWD2/ODIH36B*4`).7B[1BU6.FLI6AIWJK7EWC4G>H
M`O.X)R[4)*WJI?1XZC+EK%1IJ<CGB:LHVQ2T;Q7/;Z\O:/8V@:7'=NJ56N[,
M`R7W"5:5K4I)U&NHGQ5[2,7:RD9(<D],@I2F'>N;ZA9LB<ZZ(=F.W'#^2-[#
MV%NWJ?NZR;(V7:WKG?[]=8UMMS#22[SUR2&UJD?^5A0`>:\]V)RPSU[4K/3(
M\T)H[M-4RTW2=7ZAE,.B-^<<1F4O_P#U+W47_P`W:/\`[]G_`$)_<SO^:/\`
MSW[O^#_V<17[SVC]'-Z?L5H_T=J?X7>/+LWKGC0_Z$8[#5>1.;'Q7HRXBOS'
M"D;8G5YA`2<ACDI\U*=ZR!TD%-4D9`I5I('Z"*84Y=OO</:D,SV>%WJJL'TI
M5FGQ*J"5'-1H>\YYXPV.VC%6$568Y7Y\\A)/:I7Z<;EOUJE<RVQ8DA*'F]2)
M!54J"*`!(R*=([<5[7K?SCF%M?E81[5U?H7J74;5[H;:+.PO!)PPP[2%;#;W
M4V\R;@A6ZK)!;@(;`:;MSA6MT@>%#K;IY3;J^!(X8H%[IKQF+*EU#0<3N7?Q
MU%=RMC%Q#EC)%3A@*BIV[@I^V;?;)NU;OX?&$..RE0=#@!4VY5*0V32I-%'A
M498K3[74H_'$X>D?:NCZ5<:==6W*@E:]YW8_$!0QUCV`!%NCO+4ZU(8*FEE(
M6"2IS)(-2,36BZC=VI\OE.+JTPWBG'L5&ZVT7GV,EI<M+"YN8'LXX5X+G?<(
M:K;,,!P.,@**5IHI/@22*^$4KEQQUO3'W,UOF?&>3O.&`X[5X\U6QNM&O)(;
M5Q<'5`QV^M2!L??5[VS<%)8G-OPY$<1BVYJ68P#@7S:K!T^[3+//#/5=.CN`
M>4*]RM/2_6>KZ8\1W`<V+B:?!&=Y71<\.SESO,OO.=BW*)2#5-`JE*`]F&NF
MZ/'%:99FTDS.-$OUOU5%J=);:>MT6M!`K4#TBB83=ZN;32H'G%.0T)YB%:UZ
MBI5"6PHG5E^K#LZ;"UA(`SC8J3IVMW44+FRR.%1L/?V>M)S\@O%-1PJ23F34
M4S)^3#RUMV-IGH$SNO+SGFF0%Y[_`+%H`]H'L_T&),W38ODC;F:-Z:LGCC;D
M+<Q&]>%(`R*3[`!]0QI)=F5I9EI5*"YC=AEIVKRA_P!#AO59YL?%"A_T(P51
MS8^*%#_H1@JCFQ\4*'_0C!5'-CXH4/\`H1@JCFQ\4*'_`$(QJYS6BKMBR)6'
M84$@K6EM`*EJKI2D$DT^3(#Y<*1-=.:1`DK+GL8TN>0&A6I]+/I/ZK>JW?+6
MR.G;+<.UP@F5O'>,R"Y+M-@CEQ)#,156F9MY+!.B.E1*E#%,ZPZITWI6S+KZ
M9D,YK0&IQ]`*ZI]-OI%K/U3U5HCADBLFT&<$`.;@*[2<>Y?8)Z9?1_Z</0)T
MN>W+-9AQ9C<2/+N^YKU$YU[W#+=2!(HW][(GN2'R4L0FARVS12LL>..JNJ^H
M^N;UEM9EXT^-Y<7C`$$4[_6`OHMTE]-^EOIII[(G",:B&@$D$EQ&-%(UEF]8
M_5=-*[>J5T5Z$07GFEM,-*B;WW[`9.@1)LK-5GMKX.26M!;2:`G$?+'IW3,(
MN(J75\<2.!ICMIM5KEU?5M='DVPN;:#8<*$;./P5X-B;%V9TUL:-O[+L\&T,
M@)+OE=4B1.5D5%^:\@2'%5&HE2C4XK%WK%WJ$G,N6NPV#``>@'%3%EH5C8_-
M'("[AC]BDAIXNMI!2$E/&E,Z\.'<!B-RC,7[RIUL@>,HV!;,9&U9*;DJ.9,A
M+)_\0D*/PHH=1KW`8>\V/BH]S7,\6"T7'S$5I$&'(0S&:0L*='O.%1K4T&M6
MGAC,;F/<'C^Q0]](]SFB&I%#5(2([BV4!:@X`D4>4*I&=>9I6-0"3GPKEB:A
MN(6,I7'@HXVI?B\),=M45UTFCD^0E)5S&E%+0`I56A90"`:=E<.Q.T@$_*.!
MVI+D,X)'EA>E0E2&PRW5`C-)+;A0,ZE2$@5'RX>V\L0!&\G;N4/J36QN&X9?
MBFJHEUWE,-T2M>AE3@2I20HZ4%154DBN'@GC`P(JJC*,UP&\7`+<K;+:P7)S
M_-"C0-M%2-*CGJ---4T&,><=6E4]\D[@D"Z;<$4+?MC3FAM"5.:5@%)SJHU4
M#0Y8?6EPQV+W"M5"ZE;R,>6AN&5,9R"[+>0%)(8*_OW*@!-"%$JSJ?$,6:&:
M,1$UW*HSPR&38B4IE4RYOSI8+,>V1T.-J4:H+L>I90`"2"\K+AGVX580:-C^
M8D_VIN\&/&3!-ME];GGKW*1H?6HNQ6UY\Q9KJ;1[P2$'+L&)6%I9$V(@[Z]G
M!15U-$2X!PJD5Q2;-9G)X5JD78:$`DE847`5!)S*<O:,.HPQ\H:[8/L*JE_G
MB8Z;'+ACWD!*NU+0L,LR"A2''=;[M$U*&TD$J)%<O%AMJ%V&-Y)/Y:L>@Z5=
M/8+MD9(.-</M3@W!M^\JF1ID>W2G8@:3H?;2%(*%)"L@E16$E1S%..(!MW:-
M&7.!3=C]BWOK?4'ZC)((W%A(QPX`(E$E2(N4EEQ@U-.8VL`=E-5-.9]N'5M<
M6TLP8'"M#Q3O+J#H@V-CC)AP]*7XT]T.(75)3WI<213]"LOTXQ=6[)*A@JEX
M+NYM12X#FGM_DG+#O*6W,U^,J`2D:E%2LJ`4!)*E98:OTW-"*M^[BK)8ZA-(
MT.8:MIMJG<SO1BSQ57"=*APHS;2EK>F2&8['*0XA+QYKZT(26P37,'%?N-!9
M=/,):3CN&S`TV<?4I1_4MM:MR33-;(.W%4TZL^LC=-KZAS-GV);]ELMD\JY!
MGQ%(D2+LT^T'TSX3B%K;DPW0O2DA1&I)&+9H/T_TV:`.NP#(\#-4'U4IN5(U
MCZH:CIY/D79VC@1\5+6QO6A=[C%CM7"6TH*:#9=EMEJ2_P`I(;><4@HR>)S4
M!]KABNZUT%H\,DA@H"UYP%:8%6;1/JMK=PR,R--7-%=F\=ZN'$ZOB-;MO!3*
M9+D^$'WZ*2E;8/CUJ4L@E.@^W%"'2#I)9<F8-:!2GH^*Z3%U_=R,9Y@!H)]?
M9@I<L&Z;=N!IGRZT\Q]M;B&Q746VRD+572$T!/?7%7U72KO32YK@<#1=`T;7
M1?QM<*'!.@%-*@U'"N(D!Q':K`X$8E>*6A--2@*\/;C;([@LM8YXJT8+T$$5
M&8QJ<,"M7?)XL%[@0O?]..$9#('#(,$+0^RW);4T^VAYI8(4VXE*TFH(KI6"
M*BN7=ATQY&.QRS7`A1_*VFJVR%2+7K7#>"U/QBK46U@#2I)4KW1AXRX81\Y`
M*9<I_!):5`E21Q0HI4*'(T&6%6O:_%IJ$O$TM!JLL;)5>U/>?G.!",LFJ37X
MC_0,"$IA*:`Z16@SH*X$([$H"O@,AW#M.!"W37VFXPUN)2*GB?E[L:MQ>1O3
M>5CB<P&"C'<NX8L8DJ?:04@T&=,Q3/(CMP^MK>5TH);\B:&6,'*2*JKV[]\Q
MVURPF0V=6H#-1.7RIH,SBVV5J,`!BH?4)(Z5JJE[UWPI7,"7!J!S`*A0$#MX
MXGH-,F+N8&$LXX?:H274X(F<D/`>-W>JT;HWLLZQKKP[5<*_-GBQ6EF:@$4*
MK]S=E]0PU4/3M]A#JB74I`KJ\1';VT&>6)5FF32?ILJHY][R\7FBUQ^HL5C2
MI^4TV'2E+15J4%J4=*0*)-*J-,\)OL71N+'MHX;DF-1C(P<%*^V-TP[@A*DR
M6%N!0;*`H$A2N`(`[^W#.\M'B&K&U=4;$^T^\9-<9`X'Y3\$^YMU2N(XA*TJ
M4TGQA-:H%"<S2F(ORT_X3[%-YF\54CJSO21::+C7R6V?$I++:!I014I;!H"0
M#EGBQV5@_(TN:0"T8JL7]WE>\`['$*KUXW9=;NRZMRYONE0)3Y@)"=5*#245
M459]N5,6BTMF$Y>`52N;P$U!Q4%7*')GJ=9E@N+4I1"@FH*>P4I3OQ9+5MNP
M?.0%7;IT\A+F@E;G=K*_#W7%,*=89CA2TZD9)2E(R2I67S89PO8)SC\N8^](
M7EBYL(?(VE0#[%!]V59DS'6Y4,AIM+K2&!3F27GP&VP@"M"TH5KD,\34TDK8
MC-%BQ@JX\`J7=0VMU,RS<X9Y'4ICC[%W6]`WILLW1_;,7JUN"VN2NH6[[4PW
M;0ZTAJ1M[:4@:1'BLJR;N-SC4756E8K0TX8X5UKU!-J#S;:6XRS@D4;M]M%Z
M%^G/2$'3,0U&2,4<`:G'M21_D./WS/\`_M[_`#![C_'^[]W][_:]WVXE?/77
M`_TN7_I<%(\FW_`/ZG-LW<5\JV/7"^2*R2A2JZ033C3VX%@D#:O""DT(H1Q&
M!"\P+*7;%=IUKDI7&<0VTI0+FI.HZAP[1EIQJ^`3-KO"GM!U8Z;=!OW7."F-
MO=2GF&`E87(?0A*E!82$.N#3KI2M$DUI7%>N;&K]F]=D/5`<R-E=I`4C;2W3
M=[`H+B3$,I=R>576%E12HG2"*>[B)O;+@,5>=$ZD\F\&N"F^3U/A/V-U=]D1
MUM(!`<4I%7%!*3R@@@FHXUKVXKHTF[?<B:`'(!17:_ZPTJZTI_FW-\SB!4[J
M#XU5`=\[@A7^^3Y5K2AN.'Y391RZ'0'E@450`Y>S'0]+\[#$(W5##@:\%X]Z
MMOHIM6SPXQAU4S8[P8*E:2HJ30=E,P>XXF5`^<*R7)?=&EQ94GX3E@*93OYL
MF<[:+1C"30P(0P(0P(0P(0P(0P(0P(0P(0`*BE"05.+.EM/V5*H5$*7P;2$@
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M:DFMNM=U&2>XJ;<`%O?6GN5]8JUMQHMMAL1XMOBI2WRV64-J6T,D-@MA(`0!
M3@<5:Z(N'N?4ESCQKZN"MME#Y5H;LHG-#8;;06U)U.*]QSAHIG2F9/ARXXB#
MM4@E!IO1JSK6G93A7VGOQ@I>#?Z%MP)PL$MMI14IJYG1?RC/LKPP)K>;"D"2
MVVI[FEM2WFZAM6NB$@D$A2*'54C#FWV'@H#>43?4HFJ@E2U^^E`TA%:#AG04
MPZ9XAWA8.P]R3W@F.D+;312E!LD99*K7@/9B63%(EQB)64`)J5HU%1H!4E0(
MH<.H/`>],+VWYV/`)NK89CO-!21^\0"J@\'B][Y![,+[%5I++EW#7<'!'G3'
M4@_XA(IXO=/R=I'?C*D$T;S-0AB0VT\%%UOEZ4FA!%?%05U5P\M=W>H'5/U3
M_@'Q3"4E3#19"JK>&3@%-)-#6G;BU0_HJG3?K%-VZ+664QD9%Q5'W.Q20*@:
M<C2M>W$M8;05$:@FM=1SU^3CJ#*&T-`*]X:B@%1`24_:Q,-K3YMM569_U#Z$
M65%_S#=&+;`27&HZAH1H.BH359)K04`.$IIC;PF5VT?V+>TL/W2X;8#'/7_J
M@N^"DJ?*C;5A)M@6T+C,BN,,-:14GP:W.)TALJ&1XU]F(49M1?G'Z8."L8NO
MV=ODJT.Q-]>Z-P6Q8+=PEK4$-)T(;2J(*(0FB`2:)RS]M<*?L;9<:5]2;OUS
M58WEMN&&$;"3C[^*.CJ!,!T7BWV^9"5DXH(30+X-G2$D^][<)S:))"SFPYA(
M#N*4MM?ON;_GQ&+:AK3;7=OXI58G[*N*"E#:+:X[[ZVR5)U$9J*?#PPW\KJ;
M:D`N[*44CYK3;RE:464G:,AQA<JS7%JYQ>6I[E(2IAU+(25Z$DNJ4I92,J4-
M<-K;4+J"X,=Y\K,U*''T)W;Z+;7,;A;S@/(V5&'M55>HW3N[/;DF;IV]N?<%
MC7?T*A=0]I[D=<O>PMR606F?":,*PW8N1+'>HTQYA:7HI0I3:7`02JHO>E>3
MF>(YLK@!5M*APV8$C<=YP&Y<FZKZ5U.&<RLG(874VX8X\53NU^BS=ZMH09L?
M>DQO?0BS;LBVSUJC;;=;9<=<;L4%9DK?96Q'0DT2O31>21GBQ?NUA8ORD?*'
M`88G'>1PKA[53/\`1&IWAJ9SLX_S0A[1ZB;<M?2W>4>*B79MR7&=MC<$)QY4
MF38KY"E>4?1'--3C<F0VHM$@:12I/'$>]^FW]P^,$9\'>AU:$<=ZD=-M-;TB
M3+/FY+#E!-<0W`'TJPN]?49`C;V@VJ/<)L%FPVR-:5)#*G&9,EQI/,>+B2E,
M=#>8-0K/&+7I^&)KW-H7OKLX5J!Z%?/]5AT3(J_F--3ZE8KIGZE#83"_QGGT
M%R%';\JZE]`0Z27@70*!;M15%*I]N*7KO1GGBYKFX'^*^A7O1.OQ9L'S8A=.
MMD[_`-N;\MPF6.<TZM*4B0Q4<QE=`%I5PKI57'GW7M!U+0YN3,V@K@=Q"]'=
M.=5V&N6X=&X9PT5Q[$X8UVA2WI$=;C;;D62N/3F)7K4D#Q``#37N.(M\,\$;
M'RX9Q@IB/6+5TSX6$5;M2T*`"AJ.PX;G$IYF$XJ-B&!"&!"&!"%`00H5!%",
M"$U;M9$E*I,6B=(\3(34K45$ZM0.5`0.&'=L\#Y#O13>FB0I)(6DI4,E)/%)
M'$'VC#Q"&!"-,>X?]8_T#`A'@^``-)X=^!"\7)4A)**BG'/B/T8$)@;IW`XP
MP<U<!X=8KPKW=N'MK:\XA^ZJC[RZ$56;Z>]5'W[NR<RXI)DFB@375[HKD#\^
M+7:V)P`"K,M]27$X*HVY]XOAV3JDE==5/'PKQ["36N+18V1V#:H:]O=]<%`]
MXW$[.6M'-H:^^5A5<A[!BQQQ\I@8-RK4LG-D+^/]BA3>4Q]J-)=25*4A)(2#
M2M#7CGAS!^H/2F\LG)87G=\<%3^^7VZON/.,3-"E*<"6,RH$&GO5%?FQ:-/P
M%%6KV]3<-YOB8R#)=<&ALE(-:U%3QKV=F-I['F2N?Q*C!?`C$XI]=*>H2K7-
MD/S)DA?*UJ4RMPC*J:J!5J%1\F&=SI](_2G^GZD(9\]?NE36_P!=1*ENP[*X
M\\J2U1P*&D-/$E.DJTT5X0.[##R04W^^?Q513O54VX-\R>]SUR$E2FDI(TEP
M$EL**CPK2M,243<K`W@`D+A_-CYOXL?6D&R;9:<9J&G4%Q-`"E3OB)!I0::&
M@XXTGN_)CF<33XJ+L+3SEPZ/@VOM"?NW.DLRX2_,.1B65'3XXRZY&O:O^UAM
M^^#C[5+_`+'V>Q/B]>GR?.B.OV>$^]&;;"I5&UMB@*=8H5'*N&=OK8,IQWGW
MIW=:!YJ(,`W#W(AT!]',/J-U5;WK?K%R=C;%E^:?@SZI9W!>8)YC,7FG2CR$
M=Q`6\G2KFC2`13#W5.J1:61CKC*"/4H6T^GAFO6SAN,9KLXKL7&B/2%Q`AI*
M$R``WY=JK+;:*(;2-`2DE*$@9`#+'$)+T0WSKFOB*[/##RK)MKP%$J_]&FO_
M`)S_`)O_`,[<$_S#Y_>_M?1B;_?>W=Q3?]D/`<=B^#/EH^'Z3]>/>2^+]2MK
M9Y5=%!JI6HKPK3C7OP+!Q6"DI6HJ4*D\3F/9P%!@0"0L>6CX?I/UX%FI6Q+"
MUI*6\DU\0I7.G?Q&6-FO<W!JP,'!_P!X+>PX^PH-MN*2JJ49^*AX5%:T.>$G
MQL>:N&*DF:I?9V_/L<*8#CW):%WNUO3K,M>@T;HI"5"IS!\0.?APD^T@D\;:
M^E3XZAU=NR7_`*K?L1"=>9US2A+\IU;3:JI;!Y:-8[2E`2%9'MQM!;0VS<D3
M0&UKQ]]5'WW4&K3/_,E)&7@!O/`(B\X7]/,2V-(`'+;0W6@IXN6E.HGMKQPZ
MYCLI;A0]@4%)+)*[/(:N6CEH^$?3A.B3J4.6CX?I/UX*+-2O.6CX?I/UX$5*
M'+1\/TGZ\"*E#EH^'Z3]>!%2ART?#])^O`BI0Y:/A^D_7@14H<M'P_2?KP(J
M4.6CX?I/UX$5*'+1\/TGZ\"*E9AI`^P"J@*4J4H!7L)!K0X4LK2X=(Z6X-;>
MI(&S#=B$I(]E6/C'Y;0`_M._NJKB>CWT<;Y]5O4"+8+%%EV_:EMN,9O<^[7&
M_N66EE"G;79D?NY=S>:41I4#I:"U<0#BE]=]6:?TS8F2-P$CW9`,#B037'N7
M8_I3]-M0ZWU87K(3^RM94BKJY@X#:,:;=Z^O>TIZ&_E\=%K)8[-`CKW`_&1;
M-J[-M#'-O6X+N6VX[3@;=4XIYB5-*3(DJJZ0"G5I2`/&]_;ZKUAJ[C>/<^S+
MM^`_ZM"OI?HHZ:Z`T!C-)A;'J+6[:EYK2FQQ(]BW]!>@.Z-T;K=Z_P#J/0S<
M>I5]4B9M7:)"9-OVA:`KS#*&(Q`BQDQVUI2HA&HD9G#[5=<CTJU_:NGZ198\
MCR*$U`RFA=4U)!-110&FZ?>:K=.O^H'.ECD>7M^[@XYAX:;BN@S`=DO'W*T;
MJ0A`HV@!"6T4`"&P."108YG<6LT=+J<DR/PK[?X*Z+ILMJQSK>T;E:UO?OXF
MJ=<2,AAM-4C7F2JM>/Z:82;+(W`'!2):';4M):0D@@9CVGN^7"54\$3*;%LP
M+=K6M\*.LLMJ;2I2:DUJ:J'!1'8:<,"V6PQVJ'P=A^TKN^7`M'L;)XTWW&5%
MQ?+H!J-:@*^3WCC=CW-\*8RVD#3\HV]I24[%=2Z\X"*JJI5=.=!G09@84;-(
M'#'>D76\64T&[B44DLM*BH64^+GM9U5VZNRM,2/F)>/L"B>4S@B4E"1(CMT\
M"F`HC,YZCV\</+>:0L))QJF\[0T$#91-&\PU!3ZQD@%:@!\(*B!6O&F'D4KW
MRM8X_*7`*J7CG!Q(VA-72PD'FIE*2<O\-5:P?[0)-$T^G$T;>/</>H[S$O'W
M)-EQ;($EU?XJTY3@6]60/&BJ@5PY@@(Q:UN6O$J/NG<U_P`^)HD>X1+<E"5B
M?RO#4+4E)4@$`@J2:C50YBG'$I%*\4:?#P_FHXVEF'<V5I+1MQ*;CT2T+2HJ
MOB:D<2VWG\E$]^'\5XZ+P8>H_!1M]!IDGZ;#6G%WVI/MNU(UXE+;A7'6O+[T
MI&=,J`$:?#7"\FO,BCRNQE&T^Y03>G([N3S'.Y<)P#:5V8;3CCWIX)MVT-@P
M4R)-Z;E75ZO!"4J6HG2:!`HC2">%.&(6/5+W5[MMC0"-Q-*TQH"=P[%.0Z=I
M6@L_<X)>9>1[&\<WRG#N)447>58KG<S<WI*G70%!E1<<'+2NFH)0%!(*J#L[
M,72UMA;L``&<=ZINKZA87$YGEMW&2NW,X>P&B:=Q38T)4$SIJ4U%$";+"1J4
M":5<*14GY,2\3GEHK15NZBMYZW#`]F;<'NPW<>Q$$-HH50IBEH_NG9D.4#EF
MKEA`<.D=M<L*!SO3W*#>TA]`Y^6N]Q/Q68D+CBCQ2HJ-4E(2F@%!]D8VSN[/
M4$YAN[B`4B=0>M'X^XYL*BHDQ^.I%%H*'5:4J30I)004J`(X'(XCIM/LYW%T
MK*N<:G$A2%KJ,]M(;B*1PF=B<:BO<<$Y8_4;S3:H>Z;>Q<K>\A30E/L,TY[B
M2A*@$H317*4NA'#B,1=YI$L+1)HSGQ7`<*T)(+=I%#7?1/9>H8)"/WQIN+8G
M``Y2';G5:0<!7UHVBR6V[-/-;:O$-;U')<>'<'E/EB4\3S%L(?4L-H4D`4&5
M!3"0DY1!U9CY*[2,/^S0I_/#:WMMFT!_EY.TE_\`V\RJ[LR_=3+%U@ZF]..M
M\6Q6WI[N9@-='I$*#!BO&Z"UZIEPB.16&GES&YB^;J4HFN)[46Z:;2"ZT+,Q
MS<A><SC6E,[7`DTW\%1],O.J&:Q/H_5-PR:'*>4!'&PT^Z:L:TG`C:35<9NJ
M&Y>HO1;JA=-G=2U./W23=)TRVOG0EF^[;<D+5:[]"6A(U1939"5#[*\L=/TJ
M'3[[2V3V3:7%:..8G"FRE2!CP7!K[K&_T37;BWU&3Y,U&C*!38>`JGULOKVP
MAY+?,D0VT2`^EEEU3:`XBFAT:2*E7;WX9W=G.TT`X[E;M*ZHN-0:'02BE.`7
M33TO^KUVR;DMEC?7;946Z%F%<GU3FK?IDOR$J$A4AT!A@MQZUX!1'><<ZZJZ
M6CUN!QG%)V^%P'`;"!M'M7>^E.LY-*RLMI,H(&88'A4XUIBKQ;=Z]V=[<MX5
M$W#RBY>I3;,:8N-(BR6FGU(;DQ);+8#I7P4*T``.*5>=$V-Q9QPW,571LP(<
MX?,0,V%=F&PG!=-L>L)!,Z>.4<Q^W`'#=N]RN#M3JJS<&VFYCK2ZI!"F`DMT
M/`A8&=1Q[CCF.K]*&T?2V:[+7>2NE:/U?.YHSR`CN:IFBW"'-2%1I"5UH0!3
M]/'%*DM+F$_FUIW+HUMJ%M<>$XHX*YU[\:$44@\`4HO<:K1#`A"N"JS5-F]6
M1*TKEQ1H6-;T@54K70%:R`HD)K[*879-)4-KA4+":332G5%(R(&KZ0.TCOQ(
M(2BS'"$$+%3J)K6F5!W*(P(6I0HI0'`%5/T5P+5Y(:2-J\`"DKU"M$^WOQFB
M;<U_%1%OJ(I:5*;J$Z4Y"IX)H:YGCB:TV5C&`';F*BKYDDCBX[P%1?J8J4R7
M5NK/+2DZAI":C4`,P*\<7"SE;4!NU56:)S)*G8J9[CDAYV711&DFOB/:3[?9
MBUV1(P4)?`&JB9R6EMU2%&I2K,DFO?W]QQ)O\2BAL1:Y6YN[,N`(U)<J@@*5
MF%T!X&M,^.-<_+^>M$A=L=)`6-\1(51MR;)EV#<<AY\U@%:A'9S.E2U#BH^-
M6??B:L;T@`5"I]]9SUKBEN%T\N^XQ'3'BA6E3:BX/"%#4"%:`0FE.RF'\^IB
M)I^8!P2=IICY`,X-2.Y20KTX/11%EB*Z')2T\\Q=:EK*JFO+42A*<LZ#$'+K
MTKCD+QE[A]BL=IT_"XU+"33B?M4NL>FEU=F#MIAKBST4?=>D-@.%O0FNE-=.
MFH.=*UPE^]._&WU#[$^_T[!_RW>L_:M=K]+>\]QSV$OLEV&AMMT*S0='$+*D
MZ21IQ'2=76L4AC>X9FFA[PGG^FM0?&`S"&F`X#<*T4W;,])=W@W$&6RER.AL
M:&R5*`6'6\^\^&O;VXB]3ZEM[R)L<3A4/K["I'1.G)K&Y?-.*AS*>T%6MM?I
MTD:64LQ6D)#:4Z4@IJH`U/?B%&J-KXE9O(,_"IML?0)3L!VW/QT-F8R(REI"
MD!*5H"5GPD5JFN?&IKBJNZ@O8Y79'@`.-,!LKW*39IK&@$-W!318N@VW]N6:
M)MR$Q'CPHL8@-!"E*67R>:MUU9+KSJ^U2B54[<-;[7;^]:ULLE0TU&`'N"DK
M*+D9@``"!N2ROIW;;:U&;8BQJQ$AMA:&PE*4C@-`\)([2:DTQ%27$THH\U'<
ME3;0$U(Q[RE3\);_`+M'NT]U/'O][Z,.\[^.Y+5/9ZE^:ECZ7+X8H8$(8$(8
M$(]%]Q7^M^H8$(VDE)"AQ201\H-<"RT@.!.RJW.2''4Z5<*@]G97Z\"?^8BX
M^PI-?:6XL%(%-(&9`SJ?KP)K.]KWU;LHB9!!(/$$@_*,L"162$*<)"14@5XT
MP(04VM)H1GQXC!4!:ES0:%8Z3W?T8Q4(#VDT&U>8RMD,"$,"$,"$,"$,;-:7
MFC=J*57ND@5ID<)E[0[)C7N*U#FDT&U6#]./IZWOZCNI5AV-M6#<"V7&I6X]
MP*9+\2TV?S"$,1XSJ3RQ.>:)Y+-2Z33PXKO5_6=GTYI?Y\F1Y80*`N/J:#3T
MKK7TE^G^H]?:V;*TA$FGL<!*:AH'XC\Q&8[?#5?6O96>C_Y</0RQ;4V]8XM\
MZC7"$4;5VJAU0F7.X2&=$^ZWCRX<?8F(>5J?>-$.KT-@FIQY'N+G6.MM8<;C
M-^T1UD#B0,00*4..()W;.U?1_1;'I3Z9Z'^UV#AYAS0V@:[QG&E0*<<=B>_I
M3]/VZ]\[F3ZF/4=+D;JWG<FO.;3L,MIJ(G:T%Q5(@:B!18BHC-$T;3F?>XJ.
M&O5&LVVDVOD^GR7W@;CAE%=E*F@KVIKTSI=]K&JFZU\9-*+L#4.P_P`(J?8N
MCH"%OT2:H6X0DT/N$U3[0"GLQSZQ:^-IN+[Y9G?,1MH3B1A5="OC'(\6VGBL
M#3E!V?*,!MIN3Q@QT,M!2?M``]GMQ&3WEQ<SN8\?Y=OA/;W=RF+2T@MX0]A_
M/=@1V=Z6&?<_2<))REC&$_&Q#&CY&L\6]"4H_P"Y1_VO^\K"?F(N/L*$800"
M2>XCZ,8=/$1@4(BJ$I]:U$"FHTS'`X4;*QVPI&5CG$947=B.(2XD)%$I5VCX
M3A5I%0=R0?$\,.&X^Y(<G*,A)K7FM]A[$J!^G#OFQUVJ#2!>4*4_!(!HA+:U
M>Q(4K/VXD;1S7QDMXII<D;-]$A7=>;[B*FI6I)I3M50FH%!\N'T%!*S-L!%5
M6KFTG>2YH%*'>$T7GWU)`'+&?VG6T#@>VN9Q/B:`;"HOR<_!O_$/M2=+,I31
M(@09AX:ED/.Y?9\%?"/UX6CN+<8F1P/`;$TGL[G/@T$4XA$HEON\\Z8NWXFH
MG3J,=P4/;1*@"K+&9[ZVCB<_F'`?QN2;-+NKIPMPS%^&T#WI?.T;5$8\]?K?
M%4ML%1;9:4VXA0%5$H(JY4=@&(]NH.GPMSZ2"G3="MK/_P`P(;Z0?=5$G[E$
M>LTX[4M"Y"D`I#);,9P*2=*O#(#:B"1EWX5@#)9Z73Z.WX$#LQI1+R&Q-IR-
M,MC/2OS;*G>,:;#@H1<NJI<I?,VLZW)CZM;;M&SF"DE',(U<>S%ZL](MX&MN
MF.#7#80N.:KJM_9:F(I;![&XX[1L/!(SD^<'%\C;Q9X:M3C(U\=-*K'N@XEN
M9$W![R?0HFZU2^G_`$K4_P!J3ITJXJ:*E67Q*'#F,$UR`&2L/K>2(M#FN):H
M^9TKXLTS,DN]O!-)Y7VKA9GV2,J\LD`]VIL*&9KATV1KC0'%5Z3]5)[YC$I\
MLPI@9ZDJ2I.HY4(U`$Y8W6%KRIGW?Z=F%!;RN&8#`]JCI'R"0@;*HL\Z@AM`
M))6XE"10T*B%4KE0<,*QMFMW9R-HHMXII(P^1S0]K6$T)I39B*[^Q*6W;=)O
M=X1`M[A8D1-<F0\"$\EIO2#FH@*4NO@2*E9!I6F(G4V6^3G7-?1CW;*T]*QT
MT-4UV=S[2K;<'$DAH'_$0N3'K7];&R]A>KO9=N@IO.X871A%OA;JNJ74N0X^
MYYB6')[T:V.#RZH\&U`MRM-75E)`&K+%VZ;Z6GDZ8E=>199)JNC%14,-2VN.
MT@@XTILHN;?47K^WA^IUB=/GKIEI%'!<.RN_4C#&24%*NHYKA4`AVT&BA+UZ
M=*NM5VN[_5:UWJ?U4Z.;H;A[SZ:7?\-C(E[;L-[MZ91V[9'&5>9>LVO4[Y8H
MYH6D+I08L?0MSI-E9R:;=NR:C&\A[,IPV8U`H:X;]E%SSZH=.WW4-RW7=`:)
M=-+JEV9K#X3]QQ#]O8N<EFW_`'!A;0E@L.M,H;4PX-,E&@$!+D<CFMK'PD`C
M%S?:07CJVPS>SWKE.G=0ZGI<OE&5;(#3YOE&']XT"L3LOJ-,6\A<,*DKC-JD
MO%A*G$QV6M*'7I"D@I9::4ZD*4JE%$#CB$O=%<`26@>D+M>@]523%N5]74%>
M_?CO]"NCL'K=/C^32F:EA22WKH%+KW#P@\#BH76DUP#5V?0M;GE+CF!H!O[2
MN@72_P!2%VC<AM5V1*82DZ8I0M&DE1*O$I(!J37%5O=`MY*\QJZCI?4C8&@2
M2$'L!72GIIU^L5^CVXM3E0KJV5I1`>E(<9<JVH+!=22T3HJ4BM2J@XXXOJ_3
M;W-<(V`@^M=GZ=ZH@$C>?(0.XJZ>V-SQ;Y$"BZ`^WRTK0I*D*JM)(J%`<0G(
MXY9JFEW%C*`]M`:TQ!V=R[-8:U87T=89*D4K@1MV;0G;V`]AX4S_`*,1%"I=
MOS"HV(8PA#`A>E*J$T[*]G=C(VH2%<8((,A`^\K10%!X*$D_H(P[CG:/E=L6
M2F]SF\Q4Y&A\*N/S8<,>U_A*3=(UIH=J3Y#S0UI*P"HJ`'?6I'R8="VF+<]/
ME2;Y6%I`.)22N:VR:)<25'(CCE^D4QID=P3:J39[XE-T<(#7#4:<17LXXV9S
M6/J/"E/RG1Y7>)5HZJ;%M]]:?\N^.:6_`0DA04%)4<C3L&+)I=W_`)J-CB?X
M!4#?6AY3GM&P?%<M>KNR[KMQ]Z0$.2&>8]XDD$H*"C35())"J_1CHUE/$[$'
MWJEWL$HK@JM3+W*2/++;6AY"J+2I)R!5J3Q33-)Q.B*25O,8*M*@7R,C<6/-
M'!3%T]B?B!9:`U)4:GOH@:CD>/##/4(9H[8NIL(WCBG-A)#-<B,G`@[NQ/S=
M72*/?'6)2T`,#WE+6A!I5*B0E2DDYC#2UN^7^H:)Y=Z='+X!7V)6L73N#:G0
MJ$2XRT4%M?`:44).?94'"%Y+=RETD>,9.&(%5O9Z;&R@<,5;[86RX]\MC966
MR:A9.I`X?*<LE8J5U/=6WYDU0RM-H*MUEIC7$!H!P4WV;I!$DE(%%N`@!"%)
M42,B<@HX9_NO]\J2_9S^!OK"G2P])X\.*AM;82ODI0A)*:E6@!(-#X:GOQ3[
MN[A==2.+S4O/'BIB*#EQ-9D&``VI[V_IY&8">:E*>^FE7;7L)PW-XUF,3B2A
M\&<4R^Y.V+MNVPE!2(P?4![U0GL]WQ4X8Q^XR<2DO)G@G/$@M(!!H@JS2D"M
M*_9KP%!EA@;B0DFF]/1#&&T/!&'X;26EJ)R`S\/S<,*P3/<^A"T?"*?)M4<W
MUGF(*6**%5`?9S('Q4[1A\D^4_@H[YDKX/MZ>*,2?)?V;.*9>8BXG;P*_-A\
MH/C/S#Z\?2Q?#A#R@^,_,/KP(0\H/C/S#Z\"$/*#XS\P^O`A;FF^4"`:U->%
M,"%MP(0P(0P(1548*45:SF2>'>:]^!"V-,AHDA1-13A3`A;?*<[Q\PI[*4[O
MTXP0MVVYD&8(N8N9',[^S^O!@@VQ8,YW+'R@^,_,/KQE:(>4'QGYA]>!"'E!
M\9^8?7@0AY0?&?F'UX$(>4'QGYA]>!"'E!\9^;^O&"YS2,NTD):$M!<7;,A]
MR=>S]F7S?^Y[-LC:<)ZZ;EOTR%!MENCM*6Z\[,?Y'.5I!#<:,`5N*)\*1AOK
M>M:=T]:&[O2-E<5)]']+ZAU9JHLK)I-3N7U8=&NG_33\M_TW;>O%Z3:;[U.W
M,B1*L=GUA3^Z=U/0>4Y?+@&^;):L-H>55+/NA":@UQY)O;_4>M^H+LAQ_;#<
M.<P[LA=4`;L1OW+ZC="](:%]+^B8;DM:W5WVK3(:8\S+\U=^TI4]*W1+<G7?
M>TWU$=<9TZ_KD3VI%LAR7EMMKDL/!V$VRRXFC<!ABJ4E``H`""342.JWFFZ+
M8'3[+*V\W]@IC7TD8;U`6+;KJ*X-]+4VW,PWXX_"J[6V)2%1YI;1RD<H!+85
M5#:4MI0E#8`2$H2A(R`QPVYG\S>&IJ5V>T@\I8M&P41NVM:$+4I7,)U%-0!I
MKF!VUI7&+D4CIV+>UQDJGQ$1K92":4`Q7QXBK&S8E5E@:/>/$]@QLMT?QA/Q
ML6YEH.ZJDC33LKQK]6&EU]WT_!"/MHT(":UI7/Y23^O#-"VI3J-*TR)^88$+
M.,O5S12FA=./'+#B#85D+!S-:AWFF'K?"L&F_8B;\9A:4AU:6T\Q!U!(.>>5
M,N(P'L&*;9[#^[[$5N5IC.>7<1(:(.EGQ)2#FHD'CQSPO;7CH06%I&-5&WMM
M!<2!\5*`4P2'=MOP6A23)TM$440TGQ(-:T.O@1AU'?OEHT"CW8#'>F$NG1F-
MS7FC*&IX#>4VW[1L1AH+F3TTK0(<`0-5"<E)4HDT'=A>FI9L6_+WJ'_:-*I_
M4>W^:2E7+9-M256]Q!()^];U.IJ:5316D:@..)"WL]0F9GH<M:)A<R:=I\GE
MVOSB@->_T]B;EUW/>'VW!:KA;(]4D-K8>//`--)`+8"7"GCGEA[;:;-YAGF6
MU@K\U>"87>K6T=L]]N?SP/E[U'<U&XWR7EW'GNFI47I1<3PK4(.0SQ=+.#38
MZ#+Z@J3>7E_>@XFJ0F)&\8<Q$J'<HC*@?O4>!2'DI%$@BHTD#Y:XDI[32IHL
MI8:]Q4=#?=2:6<\+V"VW5VUW[N*<EQMURW3&9ND2[0XMQBI67F&VF5..%22B
MFDK03Q[L0K)W6$HMV`^6)QVD>M2=VS4M7T]]R'Q&X`%-E=HKNX*(Y<6]-/+:
MG7E"9#:E!;(8;3RQ7(DAT$ZZ?HIBT65+D5VA<_OVZW9_?B!]'V).EP;DY'"A
M<GE`A6:8K2D'B#XN<"1WXEF!K/RQN]:@)WS21\RX(,QVD;/1Z$U!$NK(46_(
MR2*T6&UM*_02\\FE/9AS%XQW*NR_JI(E+FK72:TVTM!*6^6H*"D]I-`*$'#M
M81%3M"4Z?96OLXTIB5A_2;W*/D_4/>M3$*?<'A%A0GI3KFD,\D:E!:EH1K(-
M-*$ZC4XTN;N*SA,LQ`:<!7B?[%HW3KS5)&6UG7-G!=3\`V^BI"K;Z_/4]!])
MG1:Y[:VK=8C76OJ"RBS;:6TEMR7:QHI.N,P-J<+`C,/+#)50<RIKEAAT?HLV
MO:HRXNJNL`XTK6A.[U)G]2.K]/Z)T;]HTDAFIEM79:5&(!*^4A^Y3'[XN\W:
MY7"Y.3ILB9?YDU]<RX7"7-4I+]Q>DNI<6Y*:2X5"J2%*XTQZ%TUD%HYT$M!;
ML):.X&@]@7C-VHRWMR^XO1FNI'EU2=Y))]))VU5[''O42QLK;W6[IIO7>_4'
MI=:[/'LDJ1/MTB(SME_9S;EM<MFX+`J3(@R"W$<!1-B)Y:VE4(U8BKBWT.]O
MGL8]C)6"NT`G=V5XJ<&H=3VL4<MLV5UGFV"KFTV\*#AC7'>GSLOI+;O5@K;<
MQFV,=(=\7MEN<_O&\P'&]HWR"A]R.]<H?,3%6^6W&UDM(277![J3B&OM=N='
M!99,=*&@TIM/<KMIW2^E?4*,0:@YFGW.QSC0`]],H*@'=UV?Z*6/=71^VVI3
M.X+KO.4_N'J#(#[#&[=J69218[?M:.XRH1;=/Y@DRB7`XM24I4GPXF67KKMK
M2[`O:"1VTJ50=:L[SI6<PQ%Q8PEK7#>`:`]QI7TI+V5U$=COH2],-:-Y%PBA
MJ?93&ESIXY8?Q5LZ7ZPN;=A?,XT>&@5/#^U6NVOU5D,K1R)93X110=4,\JT%
M*#/%7O;+$X+M6C=0^;C#JXJ\O3/KHICRK<Z9%CO+>:3_`(<5`22`I8>\);6A
M.8H.(Q1+S0P0<,5U#1^JB'C$KJST3]0[?GX]H?N0DPBB.N/->E*,A0T*YB7#
MI/.&HBA)RQ0-=Z1%Z!(&U<QIW<5UO0>M'0.R5P<0NENR-[0MPL(<;E1W6G$!
M32D/!:Z)-*J2`-.8..)ZYHLE@\T::@XX8+T!T[K@OH&YB,>U22`E2=:5!0["
M.W.F*JK8O,"%C15:ZC2O"@X=U:5P(61`(4E0J%)*3^G`A1ANY*[0XW*_^$=T
MI6X1I#:]2BH95U433#VU.%-]4TG_`%/0HDNNXV`7"W-)(4O1].GM[<6N!N>/
M)Q":S/Y<3G\`F#(W6MM_6J42$T*AJH*5/;4\#A7R9X**_<"MW^?8$NC:I26-
M-`0'->?:<].9QGR9X+/[@5']^W$IS6IJ3I6`HHX*&=1P)`X87M;8QSM?39]B
M3EO>;&8^*J%U+FS+DS*BNLMN<U2]#I2"1IIJ\-*9XN6G[E7-0V*G]YV%+NC[
MKX:Y*U4JI#(570D(!H2FF2<66*\Y3!'78JY+9B60R<5*'2O94Z%*B%S6I!44
M*):"??3IRS/?ACJM_6R<.T>]/=*T\>>;W.]RNRK8UMN5I5'=U)>:;0D+2VG5
M5:"553J&8IEGBJ></%6OR(2'M?I+=;A=%VIEATQ4`AJ1R]2G6\^*-6E()53B
M<(SZT8X^778$K;V/YE:;U>3IIT:BV:W($]KE*2C30`$E1I3+4,LL5#4]6,\>
M3-]ZJM%I;<H9SP4SPMOVJS*2J-&0I_WDO*^R,AITT(.8[\0ANZ[\$^2D7%%S
MFJH5%>LT%`36IH.P5Q'.H7&FRJ$8\V?@'SGZL:H1V+_B"`?#4D99\/FP(2TE
MD)(.HFF!"US#1A8I[P/Z*9X7MQ\]4)@3(^H$J44(*B==*BM<QQ';B00HQ_&K
M#_YUC^._#_W[/\5_=?O/>]F);]OO^W97T*#\]8]GBHOS=.2GX/H./I4OB=R8
MN"')3\'T'`CDQ<$.2GX/H.!')BX(<E/P?0<".3%P0Y*?@^@X$<F+@AR4_!]!
MP(Y,7!#DI^#Z#@1R8N"')3\'T'`CDQ<$.2GX/H.!')BX(<E/P?0<".3%P601
MI%`D@?(<"W:T-%&X!8\I/P?0<""`X4.Q#DI^#Z#@6G)BX(<E/P?0<".3%P0Y
M*?@^@X$<F+@AR4_!]!P(Y,7!#DI^#Z#@1R8N""&&EJ:UE2$*<"4J0"0XNNA#
M-<_?=4$FF=3C!<UGYCR`UIJ?1N2;X'.RQ6["Z61P:*=N"^@C\NGTU[9Z!=.[
M]ZJ>N\5Z&ZW!BOPK>VV@2&H;KJD1=NV4/A+[%]W`\$I2HYI37ACS9]4=<FZG
MU(:1ISB+<8$#9Z=_J(7T#^@WTWTOHC0?]5Z];QON'#,"ZM=W`T]BF?8>S=X^
MN3KTYNJ^L/-V1EIB=<K3!(3:]F[=@R`BT;?A)(#8N+S82F1RS52JZJC#%L^G
M]&Z5'`UK6R\L-XFM/2K1=ZAJ/7.JW$<,COVQTSBUF`:&DX`85I3M7<:P62VV
M^#%LMA;BP;38($>W0X@82S)8,5`;?U*2`A:7%BIU557ACDEZZ2[O'ZH]U>8"
M/6:_!=$TNPBTBR9ID3,M"'>G'[5(>TEK<,MIQ6I&E2:&E%$`<"`"<L5BXC9"
M\OC%'<5;[>1\S0R4U:!L3@AM*)4TD%))*4BA[Z"E03ANZ1[Q\QJIF.V@:`6M
M`-.U/*&TMEL<Q7$``&@S''*@.&<K&M`+10U3D)12IP"B:T^0']6$%LCX!-``
M2>X9XPGXV([%!',J"/=X@CXL,[K[OI^"$9Y+JSJ2X`DTHFH[,CV5S(PT0C#0
M.O,&E#V'`A;@VA%2E(3J-54[3WX<0;"LA%E^^JG9Q]GRX>M\(6KQ5I'84ESR
M%,TK6BTD9]H!H<L.(F`NHX8*O7C&1LK&*%(,F,9JXC1U5+Z4I5J4`!QID1C:
M>-C8RX`52.G2/<[*XU%46WH51W(D<K*H[49*'0#5*BA("@5<0?TX>Z'!%,TR
M/;5X-0>':FVOS2QM,+'$1.!!'$':HDDOV]IU2E1D*2H:?'J6,R3D"I5#EBS5
M*H_E+?\`#[3]J2I;ED6WJ*4L$UJVVDA/'WJ=A.)&TEE9'1IHVJ2ELK4M+BP5
M]/VI#>CVA4=UKS2V6G4D+4D)!"20:@BB@<.^8^4Y'FK3NV*$=!&Z7EUR-)V\
M$ANV>SZ?\-=W_P#B:WB!IIE2JN_#B,%F#13TIK=6KH,8[LM]7V)'EV2W-HU)
MNQ3GQ$D5^E>)>VGI&,\/,VXX_:H&]L!>1_YFY+SW@>X!(MMCQ[7<VKI&NBG9
M27`%($@$/)75M22V%%*JH6:4%:X6FI?1&U;"(R[[U#A0UXG;2FQ0+(OVU^:"
M4RP@XQU-"#A7<?E\6W<ES=6V;'?FG=Q6J<4O*4VW-:8<4LJ=34:$I"U^(:55
M`S%,-M/U.337NLI6#FC8X;1\$ZUK3]+NK07EE25H%7C,?EPQWCM]2J'U%Z\]
M$.GF[=L;!O\`NZ3+W5NNXIM-LV_MI,F]7&WRM"%&7?(UN4XY#AJ*QX5Z2*U.
M6+Q9Z1U!<6HU5\1?:.Q#G"@=3`TQ%0*4K2E<-H7*=5ZSZ*LJ:7I]US-39@^)
MM3E)QILX$':I5=M;D=>F#*NB1F!S'&7(Y/`YI223W4.!]P_(!R&,-1B-M.[,
M=O<I+3HK+4;3S)D<RZW-.&!V[MW>D68R['75]X.5K52E)\!KP)X`D]F'[[BU
MY'RL_-HD;VV-B.:]U8U5SU4]9-U=%NG*;SL7:\;=.[[]>XNW-O,3'D-0;7+E
M1%/2+S?&G'&U2;5#H%`(ID*$YXG.FM/=J#PVXS&/*#39@>!&Q<I^IFOSZ3I<
M5YI$Y@E<VKBVA.[<X%<R[A^9SUSZ.VF=MM,W9V]^H<QAQ,Z]FS-"W;47,',"
M;:S`D($]<%20$MJ)J#4G+%KU'I/0M2ECBN8W<N-P=E:YP#B!AF&_;V+FW3GU
M=ZAL;1\MO>2-OW-+>91E:5Q`JVFT#<N6_4KJKOGK)NBX;PZA[CG;GW-<QIDW
M":VF.TTV'776X\""G[N#':4Z=(3XL\R<3EG:6VG`1V3!&T<*_&JY7U!KFK:Y
MJ9U/59WSS@X.=2O''*`#ZDV=HQ]O_P"8K*O>:;DYM-FZPU[D:L[C;-V?LK<A
M"I[=N=>(:1+<C@A!5E4XE8&<V-W-^8FNW^2C#>MBG;,]@E)-<IV'W+Z`W/6=
MT/Z46+86UW.ENX-K=,=R;46YMC<5OA6*3M&=*,1#D:TWN!:6RQ*FS%10A]PA
M:PK]YVG%#?TY<7FH/;;O`G'S.I4`"M*"I)WKM>B?4>Q9I0LQI[;9K!XJ'YN(
MQ)':N6_J&];6[NLTBV0K7M2P]/;?M23)9LS^VGW&+K!;2XI),?RJFK>E*T@*
M1I;);)-"#7%EL-(DTYN5Y)/::J@=1Z[/J,Y=`XL:<0!@#WTQH4A[4ZL;9ZL6
M='33J\^$77FH<L&]M"`ZW/+(;87-?<""E)93RU@$)455()SQAMA=6;C*]Q+:
MU]:L&F:G9]0VXBUM@FN&M`:784I@/"1[5"G4+IYN'I9N$,71A+]ODDO6N^6]
M1<M<^+DI"6RDKT/MMK!74T.H4Q)6M^VXSQS"N4"E>W^Q4S6;"]T^0B$TMLQ+
M0-WI1NR;S?T(0R^N.L`^.J145["L$"H.(^[@YSJQC!372_5=]92<FYD)`W8?
M8K`[-ZFH8+3:BXIE2M*FZD^-0HA>K-0"%T/'LQ7+RU=EI3<NU].Z^Q\HS/J*
MJ[G3GKB_9G(1\V\H14I9*T+04_XBA0=="/"$]^(!]J<CP14+K4&KQ!\3HG`&
MF-/0NP/I%Z[NIE7J=<)SDB%;K6%NI>=264/KU+"E$`:%:%#++'*>J.GX;]CH
MPT->2,>S>/2NY]+=3W4,;<LI`'=]BZ<=/NM%LW*PT^;A!7'4`GRT7-X+<H6U
M%-2L)R_3CD6J])>59_EV'-Q)79=*ZJ?._P#/DS#T?8I]CR6IC2'XSNIM8KV?
M-P[,<YO[>]@N1&TEHIB/2K]:7EO<QYFD$K?50I7]-?ZL\+Q`Y/GQ<GI:P@D)
MMS%[CB[@B.13#F;<?94W=(SNL7&VRR6U,28CB-*'(2FD*"TJ!5K4",L92*/7
MVS1+];9-OFIHR\"&'4$\QM10-#Z>%'$*)R.66-HIN7,&IO.QSFU;P7/7J.Y<
MMDW:5:;@E21`2_RI8!K<&7EJ,22LGP$MM4UTR!XXZ!I+H9FL`H7FE-NU5>^E
MNHV/S..0`U4%R]^*,E#:WU:7*ZTJ4@`ITD@FH!`-<6+RQX*O><'%1/?>I"H*
MWQ&>6AU+AHI"@HZ:^'L(H!AY#8,?'F<W&I36:_<'T:Z@HL;%UA3=5MQY+BEN
MN*T!3E$D4%3E1(X`XVEL&,C+FM^98BOW\P5>:(S?+FQ*G)]Q;)35*0I)`*J:
MC4&IK\N$&"YC_3-$X?<1R?J4*4+;9X-Q&EIAD$#,C,UKV^(\</'33MA#G..=
M-!D=-1H^3@I4VIMB&REM2DH;;%25-@DA0%4F@)X*Q7KZ[N7M,;GDLKLP^Q6*
MRAA9()&-`?0X]ZFBU6Z/SFDM/\T.:>:%T%=(%*#B<L16=W%2V8JQW3JU-Q9)
M>Y:%>`)11-2A*LBG]-<1%\YU2*[5-6L$1B9(6C.1M4UI;0BFD4R["?KQ69G$
MR4)P3W=3<@IM"S5202,NW"64(6/(:^`?3]>,H6MQE`T:4<5@&E3E0_17`A+T
M9AIM"2EL)/&N=<\"$:J.%17`A%9@JRKV`_2,9:]S7C*=I6=Q59.N'4J3L7;L
MIBV1C)O,V#)7!4!404()#DXJH4)>:)\(74&G#%MTVSAN:/DQ`VCCAO[.Y1%S
M<3,/RN(7#[\;WO\`_=:?_P`Z_P"8OXU[AW>_Q_L\/9CKW(L?^6WP=OVKCG/O
MOQN_5_C<OE7ICV'YF+M7RUY+^Q"F#S,7:CDO[$*8/,Q=J.2_L0I@\S%VHY+^
MQ"F#S,7:CDO[$*8/,Q=J.2_L0I@\S%VHY+^Q>'+"K'MD&9NRJ.0\\$..-G'*
M"X[`CD/[%[3"'F8NU')?V(4P>9B[4<E_8A3!YF+M1R7]B%,'F8NU')?V(4P>
M9B[4<E_8A2F-F3L>[*VM4<E_8O*C"RSR).Q>@T((I44(KD*C/,]G#",EQ'%(
MV)V8O=LH*^O@M.60USJBC=N.*OA^7WZ55^H;JXS/GA;NT-FW%BX+#O\`*Y-P
M44R%I=*D\IZ!$Y:G'U$@(*$DXY_]3.HFZ'HYMHG']PDD8`&XX&M:D;-R[_\`
M0;Z=3=2]2,U74F1_L$<,AJ2,W,&4L^4CL.-<%U%Z^[]F==^HECZ/=,DOKZ:;
M(NT+:^WK?"*D?YOW-)D&#>=SR5C7^()8>;4B".#105Y5QR31;2&PLI-5U2GF
M7XBGS?V+TMUEU6W]PAZ0L<_E11M`W#>NO/0KI=:.A&S+/MJQ);7=(B52[W?&
M/WMVG.-)YD=212K3;U0%=IQS+4M3DU2]F-X3Y;F.R;\*X5"N6A:2=';&VS`S
M!H#MW]JL46?*QHU3_B[DZF:Z`=2`A25!04K@%ZE#+$$WG-E,3:>3`PQQKW>M
M=)NQ:36+#'7S^<9L,,M#7'?C1/&RH3&?:10U4GF95(\67']&(F\WI:QMY"*X
M*0@RTTD20/$D!P'/C2O?[<,!L4X,!1;=;L@-J-"D*"AV=W94]F$Y6%X`&Y;!
M+;#B0V!G\V$>2_L6:A*4?]ZC_M?]TX14@-B4L-YXW24R[D+T<1\HPW\O)V(1
M_+OQKRGH7A(PK$PMK5:N>&;4G^XY)4K@H*I3_4(P[:"0.\+1TS*';L*1'$E2
M33Y?HQ(C:H&Z>)6T9M6ZTI2]*5S!]U%1SZYU#M2!\HH,-[MX#,C?U"?8D;%I
M@)=)X1C[$U]QR6Y2%4&K7*6^M"A1*FU+*B.XU`Q*Z/&Z`?/A44'I49K5Q%=&
MD5=N\430E0HM$(=A,^(!Q-""*4IGEQSQ-L.:I!J!AL4`87]B29<*WAK^":^8
M=X[<.8I"S`GY>Y)2L(;E^\FP]9H:D.:@0DU)`ID":T';EA['<1AXI6J@IM.E
ME)SD"([2#C1(TK;UM<:H*GCQ3WBF'PN`?$%7K[1K?$\Q_P#'I3,F;8@+"D!(
MK7@0*?T=N+!8:C-%;AL306`G:>U0<FEVN3(9'YOX[4D#:EF"TGPITJ2K4II9
M"2E0-1R5)<!!&1!R.'CM6O2VD;&AW?NW[N"C(["/3;@7S27AM6T/]\%E=^S-
M55`Z_P"]^N_0F2-Y]-[5MB_='DVIJV;SL:X4YV^[=7)>?3,W<R^E:G'&F&I)
M6ZL9H"<6GI[3NF-7(9J;I6:AG!!`H#0U`J#B-Q!&S%>?_JW?]<?3LF?ID,GT
M6\!YM7_.T.VY64-31QIB%SIV5;K3Z<=^WCU,[CV'OOJCLO=\5V)LC<EAM34^
M$U<K\X7[I=IESG*<D,-P0%",XMOQ^Z*`8ZY?V5OJFG1=.:-?PQ7L-,\;GAM&
MEQ=0#-OJ-W%>;](BDZ1U63ZCWMG>S:5>?/&]\3\IH`QVT$8/8[?N7E[_`#%[
MK?.I>U+1TEZ51UV>5<6K+^&[HO*TWV[WRX_X:TAR5:'4HMJ6I2@7&RVH*`H2
M!AA_H:32].>_59R^:E:LHX>LDJ2F^N6J=0ZW'^U6SX+/-EK0M!J:#$-I0]_H
M7779^S^HMYVG%F7Z1#M-T78I;=Z\PPY,@V>^<AQZ:W$=E):7<&($E24I<`\0
M&.53:OHL%^Z$,D>X/:`!3Y@2*&M=XV`KUO9Z-U%J72S-1N3#RW,K^ICZJ+YK
M_5CU<ZEVG=5SV'N"\7*Z7^WNO"5NZ:ER/$NML4^XB--VG%6/+1K,Z*)+@3K6
M<LCCNF@-L>6/+BC",*BB\2=>:UJ,NL76DW&;R\,[F#;3`[!\"N>LMQ:G7W);
MAD*D++KCRA59>-3P[0:G/#F2WG=>G)2E,<>Y4B(`L;RAE<-W8B#+94HK330%
M$<<\@#P_3AT;68MIA7O3U_S1T^^O5K4D@K4CDZR,@LA02K-NI0!J-*'L]N'5
MA&_*YII4$C:G0MC921/ERO+FAU*@X8''@N\!Z5[>]5?H;V0U^!?].)^U=K7G
M<>VXUJ;08]NNFUXSS+TDJ4IE*&-RH"EO+ID3GBHRWEQIVIO,)JZ0AM:TVG`8
M#<=BZU=Q0ZKT[#*(8V1PN+B0/$,I;0B@KMKM7`5G51(6D)J2`A*@M":*((;6
MDE*D%0)KWG%QMY:P\Z^\/9BN7W4<>,D!):-M<#[5JEOH>5FDKT>&GN&J12J5
M9T*5"H/LQJ.;+A+^GNQW;O8E[&":T>)(S2N/KQ5D.E75Z%/M".EG50IG[*F$
M-6^[24Z[G99+FI'-=N1(4B*KP#N&G#/4;6"(,=9^,DYJX;A3OWJ]:?=:=?,?
M:ZG7G.`$>%14UK4[AL3.ZI]/;QTPN<9+RA/VS=R7MOW^.KG0WHC@"V&I#R1I
M9=2@T36I6!7*N&\5_:6[<MQF]#:J#U?I2727&[.0P.Q&0YCQV!-S;^Z94-P)
M<<RTN`4->+:DC(=]<;76GO<*?+4]JC],UI^F39IR_("-@K[%/NT.H+B8;\)+
MAU)@/O+33(*;*5H437W:95^*@Q`W&G/MX7/D#0.^JZ_HG5=O=.8UCGDX4&7^
M:ZJ=.^HDCIQT%M$^>\W'W-O>X1Y,N"%!3[MH*`$R=/A/+9:;3S,O!48YW=VH
MNYZ1`$5QKA@O0^A7TD-F)9796D>GU*SO0/KP_:+I`+%];=\T\MUHK44*>:6!
M1IS530F)]COKB)U;2(9FD,:"KWHNOG.*.<NS'0?K.YN6.Q!F3HZEZGGAI<2I
M')"J$:JC[S5]G'$.KNGA!<![&#,Z.N'>0NR=.]0M+<KGN\7P5PHMPC3VV'H[
MFI+NLIKDHALU7EGV?/CEMU#);..<8#;1=DL+R*Y@JT_,0CX6#W_I!PWC<)15
MB=\MW8AF2"#E\QKAK/;SFY$C*9`T;^]9P:,KMJ@+U"=,SOW94Q^VM?\`T]9(
M[\F$4*TN38J4%R3`4H`DI=ID.TC%LZ?OF6VH1"<_E%XKV'^:@-;MC+83&,#/
MRS1<,+QN>0J?-3("D.LR'[?RE#[UE<9:DJ;=1Q;(*<AVX[?;0-NX^;#0L[<"
MN/RW+XI.4^N?V)J/JF2W'GT!*@VA!5XL]-/LBF>%V-BC;D?XNY(SLG=)F!&P
M;TTT1;PR\'VPVVI*]25H6"M(4:&@I6I2<8?R7-+1M[EB".XYHI3UJ5K%!N$Y
M#(5)>YJ4E2A0T[S0YUIAORF\%)\JY[/6G7:I%Z8O#+%O>F*BHJF<M;90DJ[.
M6?\`Q!3Y*88W<#R"6THGUM#*`'/HK$;'W=%1+_#Y3JTK0%A8"*I71)IH54:A
M48JMS;2O=1M*]ZL5M/&'!N-:*REE-K?+$I@NN*`34I;X&E0#F:5Q&21OB\:E
MXVF7P*6=O;J1:Y2T)6M)4M*"--*5/`Y^W$3<Q/F-64HIV!S8HFQN\0"FNU;A
M@3J(+_W^@J.H:4T%*^+5QQ"3:==!V>C<O?BEV2-><HVIQ:D$`A:5`]J34?0,
M,I(WQ^()2G<MN@Z=54TI7B*TI7AWX1S=A21E8"0=H7K2"XJB:99FIIE48V;5
MV`JLL>UYH$K%Y"*`G.@X?-^K"@B><0E*(NE:0X#7*I.7Z<)$TPQ6%F^XEQI;
M:312TG3J\(RS.9]F-:_,-NU9&PJJW6J'8Y>W[FN4IPR?)R(RPA&H*6HGE:34
M:P$\3V'%[T8GET.S"B@KP4*Y(?@C']P__P`SZ/W/V>_CQQT#/)_U>*YYRQP^
M^OD>Y`^(_1CV1@OE*AR!\1^C!@A#D#XC]&#!"'('Q'Z,&"$.0/B/T8,$(<@?
M$?HP8(0Y`^(_1@P0L%,"OO'A[,/[2G+/^+X!;#8O`P*CQ'Z,+2TY3NY!V+9R
M!\1^C$5@M4.0/B/T8,$(<@?$?HP8(0Y`^(_1@P0AR!\1^C!@A>%@4/B/T=^%
MK>G.'I]R!M6OD#XC]&)/!;I<V[MBY;JO-KVY96')=WODQJ!;FDI*V@\XZAM:
MY`2-8::#FI5,](.&DVH6NFPS7EULC&'J2NC:)<]1:TS3;;[SP"OH4N,>V>CW
MTZ;<Z(;(=1!ZG[^BN/[NFLZ$7+;^V[E$0B7(4_&".6N]RE%+6K-,<5XYX\Q3
M:A+U9UD^_GJ[2HXY`.&;#+Z<"OH+I&DP]!]#MTN`9=5)8[#;E`.;WA3_`.@7
MHO)L-ID]8-R06UKCPY=DV+'6D<QN2[ICS[TA)JI54U2R[Q`&JNHDXC>K[N1]
ML;.S.%%%='6,>L:H=7O,7,._L75&WE*W65NZ%AM;2EE&:%A)0I7RA7;CET37
ML8&2?J`4/>NRQO9)<&2/]-QJ.Y.YE7F9*2X2&A^Z(J=)J-*!7@FE<*!3P\(4
MI6N.Q&;$N6HH&@(8X4<<&82H_I[,\05YO4Y8>!+L&2NY)6TI"4:@4#EU[,OM
M$]V&(V*01DK5%4EIQ-$&B4JKF3_1P&,H2NR4EL%!)![^_M[NW`A+4?\`>H_[
M7_=.(X[5)#8E+`A>CB/E&,'8A'<(+*U.K**"@-:_JQNQN9-I]H20_)4%N#2F
MF8[>T86:*$!-G>$]Q22Y(4E)(2.[.O;A_0*(1ZV++<*X2*"FE0KV@AL&GTX9
MW-#*T+))$9HF!<G*1$NI\5(^L5[?`3G\N)^R\+>\*N7'B1%]7.0PXH4/EP:#
MA]GO^7$E&,M1_>2";T]\I;4-(\)/?V$8536;Q^A)KAJRH]Z`?GIA6+]1O>F\
MGZ;NY(TEPMMU`!J.WV#$DJQ>[QV)MK5K45$4Q-V'],.\^]5J3QE(3I*4K4.(
M/Z\2$5.8,VS'W+3*U^#_``_9BF7>I4%J!='[JY";MK<)Y-P\^XVF"+<M-)CD
MY,@*BN0@R"EP+!R5EGA6PM[N:]!MZ^+"FVNZG:J9KC-,OX7W&L`.M(J[=F']
MBJU>?6OTJ@6U[I#TYBVKJ(MJ,Z]"38K8TG8]A1'0KE1'9R64QY+Z'?#X/"E`
MS%1BUVGT]U1NJNZDN9Y(I)2*M+JNP`;M%:`ANRM=^"Y=J?UWZ8L-//2W2NG0
MZE);@M,<K1RFU)=\IJTGQ5V[25R2ZW;DVBGJ%#ZO=0C9+?NF)"MLVR=/=A+A
MML0[I#=0N1=5/Q6&E*=6NA25&O=CO>AVDTFF"RD<Y\08<7$N/K.)_@+R!U;U
M+I%QJSM7N86V.LM-1;Q`"+$XDG&A&[YET)]'OJBWMZB^GV[O\\R9;%SV1NQ]
MB*A/^'2[;YD9$FW1W0V0'T",!S2K-2^..0=0=,6VEWKKN!@8"=PIL7I+Z2?4
M"YZTZ;ET^%Q)B90?QZ57K\SOIA8;WT%C]0T6J.G=>SMP6F*Q=HT=IAYG;UYF
MN1Y<!U+8"7(QDI24!7N*X8G>CM7<^XY-:MILX$?:J?\`5?I_3=-T*&_<T?N$
ML8<\[RXKYY9H4MSD)%2GQ'OR%#])QU)GS3E^ZB\W6;26\W<M;"%--O*=^Z;9
MT*4O0MTN./'ELLM-M^)3BE)X8<UIM3YK2X@#$E=&>G'H*W1UBZ4=(KUMZTW?
M;VX-Y7F^/;UW%NN6NVPMO[?A2$)LK5NM+R0N4[?6$N*:*@10)]N*/JNMG397
MBN&8]^TU]&Q6S2.CM7U"=LS@#;N`(WBA&!!IM74SU"6>3T+]*>^;#MF9"M+^
MQ^G4>RPG;C%,@7>.MMN)<Y.F#H0VJ>)"@%)H`JE<JXAK&\\_=MGQ-7>@=E/X
MQ79-8TMNE]*&"E'@8KY?]"&W&FFFPRRUI;:;"4I4$(R!<T>`N*-22,L\='D%
M+`@;`%P`N+[>1[B2XFI/K20ZH(+BE9`+57]HX<L\`[A[E*L\#>X>Y%%.M.T"
M?$016M2-!]])0?"H*';Q%,L;\CG-/$)9@=E<YOC&Q65Z6=6K1,MS_2[JAJNV
MT+J41[1=)!4M[:<Q55,R=3A*3&:"J#B`,L5^ZLC4UI4%6GIW4X^:(M8J8:?>
MQKN45]3]A7KI9N-RTS7!/M<PF98+]$.N!<;4L'E++J?`9A/O!)T@=F&EAJGF
MGY:ICU!H`LYLP'RG[4]/3YMRY=0NHUEM++W(M<1]J;N"6H_<)LT10D2([REU
M2/,%H#Y*X>:T,MNUNYP*D>C=.DEUJW=_W#`<WK%%8#JQUR3NGJ6];;`Z6;;M
M8.6"TEI2_)"`P4>94TDJ*%>8*=*CP\.7;BN:3I++C._>&D^Q=+U+K+SNL#2-
M/J&QD5]&)]BFC9?4V5%799?FT.!HA7)TAI!J`*ZVM*Q3NK3$%>60(70]&UP\
MP8[UU`Z%]?W+0F.MF2VCRY:?>)?>KRW5@+U$+R2GLIBB:UH(O")"-C:>U=1T
MOJ-T4C6@X%=MNCW6FU7^UVB6B6E3,<LE*DN*/-:?"`M3E5',!1X8XYU#TN&1
MRO`V,<?4"5WCIKJDEK!FKB%<Z'+8N$=N3&4'&74:T+2>((%,<D?'Y4577+&_
M%V*A&4<#\OZAC1L@E&8)_+XO0LE`%*@>!!!RKD>-1W8R7\L<P[&XI%T8E:8S
ML<*+A9ZY>CKO3?J9&W7:D(C;1WX9+R%H:7RK=N)A.J2U*Y20EN/)"@I!.9J<
M\=RZ%U4W]F8W&LC,#W4P/I7'.I].;9WN9OAVA5CV_):C19+LA*I!2R$OJ:0H
M,<X#QI;U^,I3V$XLUTW+,1V!10=F`/8BS-T8<?0@MMT4OAXL@*GZ*80&U+6_
MZS?XW*6K3?K/:HJ9+G+U!!"DJ/A%<\J4(-#C92B5+!OFQRY"FH[K:5:E#PTK
M59)I4Y\3A"?],IY%^F/XWJ09Z+5Y9,^(D1)41)*2R<GM62N8357`]F(&&/FW
M63B#[ELZ3E#/P2WM7J;<HJ$LI+"4K4!74X2=`TCBKC0X0OK$"I"E+"^-*%2?
M"W^7'5NNN(YJE)4KQ+]X9_%[,1@L`1529OR#@I,L6^RZ&E^9Y9J,T*5W]NHG
M"4]@!'5+07Y,E#LHK`V+?B'(R$..(50BJM:JD:0#]JF*Q>V0]*>^=[4ZD[V:
M&D)4VHC2$I4I=%'*@-#P.&`LZ"E$N#F&;B*IZ(N@+3+@"4EUH+.DJR)ID,P:
M9XP;?EXD)>#Q'N6*Y^LUYA&5*`_6?;C%*;$Z6YN7RE)===/*1XEGLTTP&T!%
M0,2A-F\[PCHU):6D*8UE`"B->M(20HY9"G9C'DOF;4;TUNYN2P$;2J!]?]VW
M2+(:=1.6U%=4DJ92?NB:`J&>>9.+[H]B.6%5;R](/:J<_P"8KI_Y17\?Y_W5
M>_W<?<^G%HH%5J^]?);R1_=?[']6/8Z^7/*B_"/4O#$YG`<NGLTUK^C.E,".
M5%^$>I>^6T>'1KI]K36M<^-,91RHOPCU(<D?W7^Q_5C".5%^$>I#DC^Z_P!C
M^K`CE1?A'J7GDJG76GVM'#VTI3&<$<J+\(]2],7F9!/+IG73IKV4K3VXPCE1
M?A'J7@BA&12'*YUTZJ=E*T]F-@YS11I(".5'^$+WD#^Y'[']6,E[R*$FG>CE
M1_A'J0Y(_NO]C^K&B.5%^$>I#DC^Z_V/ZL".5%^$>I#DC^Z_V/ZL".5%^$>I
M#DC^Z_V/ZL".5%^$>I#DC^Z_V/ZL".5%^$>I>"#I-2=8'V>-:Y<*=F,@EN+<
M"DIV1LC+@T`KTP@X4I2D(43I2*4*R>P"E2<L;<R3\1]::-MY)_TZU73[\O#H
M]98LS=WJ(W^QIV7TTC+$9A]H-JE3_P#XI^*M](07'GBVRE:<Z$C'&/JEK\UT
M8=#T][HY00V3*2,QJ3\U-N%-J]-_0'I!NG27'6^JQMDM80:!X!%:``X]KO8K
M#66U[G]276=RZ7!"7)N\+TJ&^N.M2F;'M>&M#=P3+8%?*,6*S?=L:M*5R5@)
MSQ'0Z3'H6@"6@:]P%:85)"OO4_4%QK>KBVMGN,EP<[2#BR-OB8.#2'`$;,`N
MZNU;1:K%:[3M^PV\6ZU6"W,6>WPTN)>T1(;89$@*1X0)@`<4.Q:B#CCVH7%U
M-?%K'O`KQ76="M+:TT;)%&QDSAB0`">\I[0E!%6VR$H!*$(0:!(J``$@Y#&)
M[>41U,6-,74Q/;5+V,TA>((GCF-PI7@I8VO!1,Y:W@GDQJ/K6Y3E#31)"U*\
M(]_MQ6+QD[?"YP-=RO-C;7T`\Q>BMN105V5_L!3L?D&:HMH2HQV7"&&DU+?A
MI1UM*1I\7>.[$889'>)SBI5MVUF#,!V)5M$XQWPDMJ2MHZUITD**?B4"*@'C
MAN6T^4I<32$5S%/=3D&:VT5F,IQ:L@LMZT&G$`FJ3C79AN6>;)^(K4Y'5$/*
M2HE-`L$'P^+.@(RRQD',*A',D_$?6ER$5-1''7DJYB0DI+@(7FJAIJ%>!Q'F
MM?2I</?3:=B,1Y:7M0)"2FE-1`K6M:9"M*8RLYW\2C8/MP41G?Q*V:U?&O\`
MT_3C7*.`3CS+.Q8+7PU*_:(!^G&6MX!1][.7.;D-!0[$@2UGFO44:9TH<O=[
M*8>QL;E%0*J.=+)0_,?6D<K50ZE&@S-3D/::Y853#._B4J^8\MMZ:HBG-?4$
MJ.04GDHJ`:>('#<,:^_8'8BFSTE/`2=.D<?$';?0%'\A:EQV4JKI+83H/`)*
M/<H>P5X8LA8R-P#``,XV=ZK3"7QO+\2&GW(J%T2H*50)1I34Y`5X"OR8=T%<
M%'YW\2D*605JU4*#W^[Q/Z,/K=C',Q`)JF-S))S,"=@2*IQ9*DA1*:D`5RIG
M0`<*8=1QQAXP'J32263EGYCL2'(6LK4DJ.D<03D/E[L/\C.`4:[Y_%BFW+=T
M/+TN411--*O#6@KP-..'D,L<489L4#>2L%R;=K!6@Q`XBJS;M5SN8_P,4H6K
MW2\VI+%.*RX5)"<D`T]N":]BC875&9;VNAON)FR3RN9;8UQIN[^*UW#9NT!;
M;C%WFF+>X=T@OV^X674R\W+BOIH_&<;)4.4X:5!%#3"#-9OX7!]DYT4K34.Q
M%#Q&S<D-3Z5T&>%UO<2L?;O%"TT((/$;UP]]=T&3T*G;2A=%X$78NQMR1WG&
M&V(33@B7ZW..+5;4/1T)0A$U@UT5J0>&6/0'TSU634K9SM</F97`T,E7<`*`
MUHOG#_NCTYGT^U6SGZ6CY&EF09A!2-K@0XG-EP(KB>Y4=ZO6RU]5M@6#J]M]
MLC<%GB-V7?L)#:5."7&(#$N.AL:_+1W!J4NE$C,G'2+)TVGZ@&.<X6KS@VOR
MT[MBY%K4<?6'3\>OV#&QR1-:V1K12I(%2[97U*S/Y;F_=O[8V7UMG;KEVRTP
MK'-L&YKO?K[)*(D>URF3:5<]C4EU_4[125#*H`XXKW7]I)<WL,5L#DD!^5NP
MFE<3Z#Z2NM?07J33>FK.:&C(YMA(H#2JK]ZY?6O&ZN0972GIH_IZ<&<E-[W(
MMJ0B1NYZW2R_&3;XDG3+@P&Y`UME8JL\,-NGM$@TV4R3PL$NRE!AQ%1@>])?
M4KZD.ZGNGZ-:P,>V!Y:'4VT.!V*+O2;Z([KUPN3^\.H?XWMGIWMJ;&"H;<9R
MU7K>:5A+IC0WYB&5&`E.;SR-030)KXL2&N=10V0$45&2UPIPIOI_+L47T1TA
M?ZM(1<1%MJ8BXEPPS5&`KV$KKC;?2?Z<K%<(UT9Z2[1:?MWEW84R3$D3"M,-
M05&N#D)3K,`R6UFA<()*Q6O#$".H+R?].1^S<5UBWZ'T>U^6ZBA=WM"=?5+K
MQTPZ,08\K?\`NNUV%M;+K5FM+QF*N\GRJ75LLL6^&M19AE:B$!0Y:=69IAE'
MILEW(7SC.UQS8XXG>G<_45CHC.3%E#(_E`%!0-P`'9AL5#^O'YB?2>3TME6/
M;%M>WG?=][/=2;-?X2)UGLRKNAR(_9=U$!QM+D9%)#:&<D*2DJHK%HTK1863
M!SV@-90@#"I!!&S9P<",1@J7KW7T.MVALXQEH:D[*BE*8TKQ7"ER2TF.B*EM
M(>8U(+J$ITA16MPB.L>)49!71!5XJ<<6P-&3ED?+PW+E;HY#.Z7,>2['+7#A
MB./%(4LI*J!04DI\5""">)*@,JG"H&%-RFF[!3@DMY033ED)-3JT$`^RM,-Y
MY9(P.6XMKMHG4)=CMHBREK5[RE'P%O,_8422GY"3ABYSG^,D]Z7P)J<:&JM%
MTOWE9.HFVO\`HQU,<*BTR\WL&_RGTF3!N<A"A"A,S'SJ;2F0$U:2JJDDBF>(
MV:"V@=6W8UA[!17.+4!KCQ'*`YQPQQ_@<$[;@H>FOIS,VPP[%F]4=Y\TS+A$
M*&O*64%3*7"VV0[$2TA?B)H"589MGDF);<.<\`X`FM/Y*0NI'=)P4:/GN!4.
M&[+A0'MKLWJK5LNKK$AQ]2U`44L*UD`J5XG2E5<^8LGY:XL=@R..$F%H:XM(
MJ,*JBV$\AU!UY$>7<G$N&#NVIVXC`J<MN;ZJBUI0X<DZ2E+G!1H$I(K[QQ7+
MVT=38NCZ+K9+\'NQ[5<K8O45<+720I-8K#;C0=H5GFZBA2=0).DUIW8INH02
M-.5F`I7X+LG3VJ131YI3F>'X5QW+JET!Z]/P6"RS=DL1F[6KR<53)\NIYEBJ
M&F\]#JDJH,JXH]_8"8.CE:'!P(-1MK]J[-HNJQQAKFFC00NXW0?K5!W!:HR)
M-RYT0PHHB)*"TXA9#:9)>43Q2X:)![#CC75?2\<?SVT;68XX8>@;%V_ICJ*(
MD![JCO5PHRFGF4/,*4MIT!Q*B2JNH#@>ZF.6/AY#S'0`@[`NJ,N6731*RF78
MMQ&1!'800?D[<)O:'M+3L*'.+6EPVA0SUXZ76[JSTVW'M1Z/&-R?A.2['+?:
M2M$:\0FE.P2XM25%##K@T+X`I.)/I[5+G3KUN21[69J$`D8'WTVJ*U?3K>^M
M'.>QCI:5!(!/K7S^WJYNVCS6W)C0B7:TRWK/=&BD,O?B,)9:D-K;4$K!UCPI
M(KI(QWR%[[Z)MPPU:1[0N/7`%E,;=XH1CZU'HE)AJ"]0>)4=*@K74YU2DCB1
M]&%F0R-=F=X4@ZY%/DP?Q&U-S=.Y;BU$93$*DZPX%I65)"J!&F@KG2IQ.6D$
M+_$QI]"B+Z]O&#Y)7CN)3,V-N&]HW&V5NI:8U5<0ITH;'M4"0!7VX0U&S;G=
MD:`PTV#L2]AJEQRVMDD>3VD\5<1K?#2HJD/+64*TI.A9434@#(&M*_1BKNM7
M1S9F8.QQ&U65MT'1T>:CM1JVW^&TXE3*B4K.JCIIH)%:(!-0#VXU=;/=XJGO
M2C;L-\+B/2G9%W)J><(42"<J*]GZ\1TEM(V0M;X:J0CO?RQ4FM$_[!N5X.-C
M4Z!IS&LTR*17#6X@EY>_:G5O>@R8G<IRL^]/+I;1S55-%>_\@IQXY8CW66?Q
MBO>GOF6\5+>Q+P=Q7YN("76XJ47!X@EQ!;:*7%M.$5&D@4(.(6[8(LS6X$$A
M3EE(][14DMH%8X7)N@2A*:)%$I2<DIH,@`,ABO%[W.HXDA3COEB#FX$E&$7%
MI+84XE`!40"L@5/<*\<"1SOXE,C>F^&[<Y^#17TJ6EE+TAYEU*E(;6$JTNJ2
M3I2DFF?##NUAE>[::)N;L"H+C7O4,7K>S$>,M]3S:U(U%Q1>02`!6JB"*?IQ
M+3V,CPS)@<R2EO(LA,E'<*XT5&^O76+9K5O=N%SG-N.V[3SH:)+2D%.D:*-!
M9J2GCEBZZ-I]P&"I.Q4#5]2@C?\`+08[E1?_`.K,M7_XKCWN5^_3^X^+ACHG
M^FQV>&OI7-_]<1_A'CI_-?/GCT@O`*&!"&!"&!"&!"&!"&!"&!"&!"&!"&!"
M&!"&!"&!"]''&S&&1V44K0^Q-[ECI(2UNW;ZL4JV+;\[=M_L6U[8E2KA?KI#
MM\,H"R6WGGD@K7H2M26M%02`37LPVOIF:?82:A-C#&*D#Q&G#=[5+=$ANN:H
M-)@:X3DTS.\.VFT5/L7<7JQ$A]*.F&Q?3QMR.828%JM]_P!]J:"!(FSRA3D2
MV3B%`K7)<>+RDJRT(!K7+'!K4P=5=0/UJ!KF6KWY@)*!U`*;`2-W%>S8)8NE
M=`CZ8E&8M@(F<SP%]2X4)H=F7<%:+T/[#:@;6F=0Y<1:)>XM%MV_(*2$O[?C
M.*7)N9U`'7=IZ26R*ZF6ZFARPEUMJY=<BQBJ(6M]HHJQ],],=J.HW6JW=.5"
MYT<0-:Y7$XCLHT;UT/A.F.VMY!\9:+:0"*U.=?DSQS*"$LN3/,01V+NUOEB.
M4_I\`N($KU)>I3IUZX^J5LVU<C=H=RW;"M<[9NY$"?MR5M2V1EBPN1VZAVSM
M-6X<PK:05/.@:JC/'I2[Z:Z>ONB[!\<=+N6T8[,TT(>YM7$FN!J37;O7SCUK
MZK_4#IKZWZII-L]\^GNU:<1L:!\D7-(:#4;FT)QW':NGMV_,KZ7;9GVO8MSV
MY?VIS$%B=O"7MN/#G6]BZK"$&V18RI[<FBDNJ74I%`CACD!^D>OWLLEW#-;"
MU:PD9R_-2HPP815>E;C_`'B=+Z)>P=%Z[;:A<:ID$A=`R%T8-`*$OE8ZOS?A
MHN@6R=UP=W;:L&[K+YD6;<%M9N=M3,97&EIBO%82'F5$\MRJ3D"1[<<PN[3R
M=\ZPE`,K'4)&ROO]B].Z#JK>HNFQU/9![;(MS97T$E*5V`EO_64D"5$D--NO
MA;<](2D&/IY3C20`A+M5)5J(&>7'%>EM'B5PJ*9C[U8X-2A?`Q^5XJQIW;P.
MU;F'TZM20K4FA'R_/A,VKQO"<,O8GF@#O9]J<ULNTI<EF.MEMUMPT"S4E%,J
MN$C).?97#"<B,T=6O8G\3'2MS-I3M3L4XU*!CH=0E;F04LD(!3XC4@$THGNP
MR+P!7%2H.Y)KEOF)<1Y<H>TUU<I1H*TTYD#CG@SC>BJS<?E-++;C2TJ32H*1
ME4`\?D.,AX.Q8)P*R,Q5/"ZVH_"DFI^C"P@?V*O^;?\`A?\`QZ47=?><TFH%
M*CWB.[N&%XF%@(-$K'*914@BG%%5O#Q!5=5""<J5IWD@X56YV%)4IY#;#IS5
M5)31-*Y]O'AEC*9?D?\`-C]9^Q*,]6K:S"0#XGPH$TR&A(SS]F$HA_G@_<`/
MBES,QMFZ%GSESMK=@P&VM$S9`^[%30-IJHGA1*<R/DQ8V_FD%OX@?:JPZ?R[
M7L>UQ):1AW=Z19$AD(%%ZO%P2"2,CA^V)Q.)`49YD?A=ZDE274.-E(#E3V\I
MQ2?G2D]V%6R-@^4U/<DGMEG.>-CLNS<L$6*\/MJ4Q#<"RD%K64HUZJ$$:C0`
MI/;3&1J5M&[,^M`>S[5KY*YE_+REM=YV#O123866$I-WE,QEDG4VAX*<)&:@
MH)X4]IP]9?\`/_IV$]^`3>33G0^.2.O>?L2;YS;=L\,2.N<Z,RN0EI3!*L\B
M%J5D<CEA=MG>W`,CBU@.X$U]RA;N;3K=Y$C7NN!M(I2FZF(.SL3(OF\+E*"F
MXP1`)H$B/5**:@36@!X8D-,TMXO&-N"UT6-=I.PTVCBH"XUIMR#:,SM:[NW8
M\>Q,QZ0I2'%O../.KH5J50@'^S4]N+5^WVM<6"BK-\6'$.D_CTJMGJ)Z56/K
M+TROVT[K&YMP1'<N6U):!_B(-^9;6454`5-MOA`2"C425<,6;IS4&:-JEOE!
M\N31P'#$UQPV^Q<?^JW1NF=6],.M[]ADDY9,9WMH3MQ!X[*K@!TTO]RZ?;ON
MFRMW07X=MW+)?VMNVSSFBR[:I2T%GG,,OELI<0X?&L@)(X$X[]KI;J$EO<:?
M\L=`<:;,#A2J^=72FHOZ;UB[T*_#G6#<\>44)+SF:QQJ0*`[<:T&Q1!U2LUZ
MZ:WO=6Q8-RGV[;E_+#K0;4H(W':8LKS,.,[0A+K#+RA4'*O?C:%T5_>Q!P\%
M`:[2:;EM<0:CH-R9F/!9,21E)P!Q!.`Q'94)C],M\V3IKO.W;HW#L.P]0K5$
M=CNR]OWUE:BEQE]#RIEM?:)+,]H)JU5*DA8%1ASK-KRW3OC(;G<<I`Q'K%%,
MZ!J(L]19/>#F!SJD\0=E:TQXXKZ6HW4K:=PZ=1NJAN;%NV%+L;6X9,V1&+#-
MOMGDF0F.CEQVD:(BFU-F@JM0J<<2=HE_<:MRG.8Z*AH"XU)P.8UV85.U>P[+
M5H&=,QZC;NA8PN:VFQV(/`4IAQ7(/U9>N?>6WNJUOM'1O=UEOO3J/L]HSHJX
MD>YV:_W*[EZ0Q(#Z7DRV!;F.4"A00KF)(H003>-,T>*V8#.WY@-FW'W+D'4W
M4FHEY$,M1F&(.P;\*8]F*YD]5>KN]NL^Z5;MZA7,W>[)@-VZ-R4>3@P&(J`T
MPW"@H4IIM!0D:LZ_+BQV]E#%0M:`S;AZ]BH\MU=7(+IGDDXX[^]1LV\`EQ+@
M)!11%`,E5%2>&5,2,@BR@0BCJX]R9O@J0Z/;7&O!)2T%*SPXURKVXUKA12QE
MA=`&4/,I_&](Z_M?]K]>-T[;X1W)*5^\7\H_I.&5UN]*?Q"K*K()JVZXHAM#
M0%%+J`Y45.BE2=/;PPSK19)HX-%23P5@^D.SK-:+3_UEW^%Q+':FD*VQ$>5R
MEWJ_MJT,RH23I"HH<6DA14E51PPC/"9!\M*JY6.GG2Y>95I`-<-O<G?$D1_4
M]LZZ6]R,Q:.J.TFY%SA--.J,F^6MIQYWD-JHIQ;:6DI"DD`:CB'>SRDF67'/
MB*=G%6G_`"G4C!!+A<1BC,PPQV[.!HJE/NR(:W6)*5-.0W%QYS"TJ2Y#=;)2
MM#Z2/"2H4%*\1BQV<\99E`-`%S66PDL;^2T/RRX@$['=R/VV_+94DQM:`FJF
M]=!I<'NDT4K('&LQCE;0!:V3+BTDS%PIV?V*R.P-ZB1I:D/:)*0%NK<*`VXH
M)``;(5J)H.T#%6U.UHX'"N7XKIO3>M!C7,=FQ?V<!VJY_3#J7)MQAA<JC+"W
M5"B@-+3PHBM5?8'$8IUS;@2!SA\H*[;I%_));U:[<NNOIX]1"+7%BM&YMD.-
M):;2KQA:R\R0`$%2M5$XI^OZ<V[;2,`'M_E5=)Z<U:2)X+BNVG2SK?$N[MAM
MT^<D*EPF"A+:%%L!0*1S"0"%Y8X3U)T=?6[G7\9BY`&(J:D[20*4IZ5W_I;K
M&R#1ID[93<.=4&C<M#0`>*NX[E:\*#B=2#J2M.I*AP(4*@_,<<U;<-YW*+75
M!_C>NF/;S(3D(Q&"P4E>I)24E(2L*0JM%D@::Y'($9X&QO;/S13)Z:I5F40\
MMXJ5\^7YI>S;AT;ZDV'J=MZW(;VSU+:DQ;J8Z%Z6-T0F6DE+8T):1,GI5S15
M7B2A7:*8]#?3.[CUBQ_:JTO(G$DNV$'92E36F&(VKA/U-KH,_P"\O!=9R`-#
M68N!:,:@T%#NQ7//9N[RY:8S]V?)T.N$D$$YZD_:4GM.+O/:G.^V``D&_<J3
M9ZI'<6S;X!PAX&F;AQI[4L[AW?;$Q&>04O+<Y@3K"3I*0CN)][]6%;>W?#XB
M$E=:C#-X0[TT^U-O;=P,MXR``V\X25K``9(22E.D\<DI'9QPO.Z-PRD',DX9
M#@\>%28_N-Z+'+7,^\U(H4D%.2A7,J!X>S$.^SS/J*44S%?@@1_-5+]EW.^X
MI"5K))H$FHIPSKG4XU\CVA+>9[U*MJO(H-:ZJ`230]Q/M[L1TUK20C#:IF![
MW0M-<"%(5MW"&PA22L*R%24TS/=JPQO86QPYB!3,-B>6V<R4S#84]XNZTM%+
MCKO*;2!J<730DUR"B"?>.0Q'".-R=%SQO*O7T'A&-M1B_P`C3Y[<+\LQ%)!J
MW;4`J`D:@-*GVO<I4&N*#J4C3<S1"M1(X=FU7_3(GMM8GFE"QI]BG$.E63=0
M>)J:"G#BFIXXKTD;H_F.()4\TB5O+;@1CBDG<>ZFMI6"=<Y'+>EU;9MD)9"E
MRY+AII922*Z#343PKEA:*VDF%64IVIK+(V$XX]RI_=[K=GY$RYO//&;*2XIU
MM)JT@+7S"SWT;*J4IV8L]M;B(#-38%6'EY>X@X5/O4`]1-Q7<6R2TRX\RJCH
M44?:\`R)KPKBT:7;QWKRUHH6`''M*A=8NW6L3'&M7$[.P+G)O#SMQN!;GJ5%
M;F.%,BYODO!U"#H2@,K!0"TG+]&.DZ7:PQ,HZA7,-4NY97$M)VI,_P`J6?\`
M\_"X4_A&N'Q>YQ]F)/STG9P3#]IL>!V5]*XG.6]3:"M15I%*YI[2!W=YQW=>
M$46Y".]7SCZL90AR$=ZOG'U8$(<A'>KYQ]6!"'(1WJ^<?5@0AR$=ZOG'U8$(
M<A'>KYQ]6!"'(1WJ^<?5@0AR$=ZOG'U8$(<A'>KYQ]6!"'(1WJ^<?5@0AR$=
MZOG'U8$(<A'>KYQ]6!"'(1WJ^<?5@0O4Q]2DH03K6I*$!1%"M1HD<.TXRU^0
M@]M/7@BF9I']T^XKH)Z`.G42=O+<?6/<-O<.UNFEHF.)\QI*7;T0ODOMZFSX
M&'&N''/CCG?U!U=UC`+#8V4>\+N7T+Z2CO(I];RU?%4^HG[%/%Y<O_5#J+:[
M<KS\Z_\`4C=<*UH<:725%8DGG39KJE)<I&M.W6>8WE1`4":C%:TNQ&DZ/%<M
M%"YA/M*MW6.J/?;FP!_SE\\.C._*"`:?\!7;3:5M@;;V];+#:F$QK?9XL.WV
MV(D)Y<>##92RTA(2$YT25*/:M:CVT'-]:N3=79E/$KHO3%LRPTVW$6#XX\LG
M^(@4KZ05(D/4H,N+J0ZIQE"4\&BTWSW)#HSJTAKCPQ#8*T>=-<#BN2?JBOO2
MCI]U&ZC]9]N36;[NG<]MLEDC)Y2FT"_6*&NVRWK2JJ-4>,25/>)6LC(C'?NA
MX[N[TVWAN#^2R,4Q^[M'LW;EX/\`KUU+H?0W6C]<TQC9-1GC<']DQJ'5PW.*
MI'T^L3[I>W?>77576XO2[A'?>=7JURVUZ)DP5"G4L%>A`J$I"NW'3[B2".S=
M:1X2TQ[OX*\P=*VCWMN.KM<)_=KBZJT.VB(@GOI4-7TA>BKJ+9=Z=$=K6A#K
MKMYV<6-KWAJ5.2F1(EO!4J+)8#@44QWTN$)[#I(&/(/7&EOL=7DN!^G)\P--
MA%`03OKM'\E]9_\`;]UQ;:MT4-,.(:VFWL"MJA12\#0IHO))5JTT/NDB@53O
MQSEQS.)XE=K````\-,$KL2BE5%!-5T">/'Y\:.V)Q!XD][0XB!"GR9(3SGD!
M,2N:0M(-<JUX^W%?OJ\P*T60_+15E!+B5<YT$U)HKM*23V<,/O)1Y:TPHF)O
MWU([4N,3I$<I+3I!3WBH5_K"HK3&ILHG"AV+'GWHTK<"DK4N5%Y@-/&V@A*L
M@.U2N'#"?[<,M(G$46?W!U?F1J-<+3,1I<B+C@_^*D!)32A`J0?>X8;.CN6'
M,QV;L*D_W.PWHT&+.Y^[DN)IQUK1G\G@QH9+MOB:#W)&6>WN2#"<!M1*7$M2
M4DB=HUA0*BI)TU%-0``)TC"C))SXFIN]K"TM<?D(H>[>D%RWV%"?O-P%Q*SH
M"4L*K57`YD]V,B68_P#=T_Z047^W:+_S?:$K/L6Y5L;C+N*'(C:M:5Z.2[6@
M%"5:@H4'<,9C=+S<V2CR.-0I.S=IME`Z*)P<TFOIPP]B:CDG:X6I'FY3JTK*
M2T&ZH<4#[@7HII7PKB9B%^]N5C692-M<0HB]OK&KA3'%)SEVL<92^7;5J.FB
M0X`L5KVT2GAA<6%Z1M"AO/6G!(4C=+K22IB/'BI!R:+&5*^^:J).K]6)2STH
MR,//KGJ=ZB+[6;Z&;)8,#H,HW';O^"9URW+=W24><4E#@-0@*2*$@T%#D!7$
MB-,C:,&@)@[6-9N`8'LHQV!-#@F;,65'F+)6MTD+4M3BR0,Q34L@8EK*S&X*
M$OFWH!()JD1^K2-39(S.5?#QKPQ+%@C.4;**#D$@8>;XTCO)#I*E5J!V9#Z:
MX7M#2X:?XV*"9_5CT^XI!E/K3K0`F@TC,&O#Y<6#<FM]L36FRX\*WSKE,<6T
MF(AQ\N((^Y;9:4ZMT)()*FTH*A[1C,0S7T#<,<,?2JIJNKVNEV[WWM#%RW4K
MZ5\O77'="]\]1MY;F1=KCN+\;W+<O)7XLI@RW;4VH+MY+26DIYJ-(\82"<>F
M],MV/\M;1@-8VWI0;`&M%`.S@OE1K^H1WW76H75O06XE>YHX_,['U!.S<SW_
M`%DZ/0=P-B+_`)PZ9E*)H=1F_:F&P@*6DJ+B]5*J.JA7G08CVN\K?X;BK3"U
MVL:<^X?MC;[%22:K0HU*A51\0-%I*L\E94()R.)V<F\C[U$Q/YK6!@Q:T>Q*
M5QZE[\F;83L9_>6XE[.89=:9VX+G)3;4,KSY)CZ]*F4DJHDU'C.(*XTYUM^=
M@"</7C\%9K74-4=:-LHWN,37!U-V%1L]*AU:4)7I:2$I31-`E*<DC2G@!6B0
M!A$`@8J6M^=F!GK3M1!?O*_UC_2<2K/`.X)P:`X;%J<44@$4XTS^0XV0!5%E
M**C4T_1C"WV)&7]K_M?KPHI5OA'<DLBJW/T?TG#&ZVCTIXQV4-4N=)^F?^;9
M4[=&Y7UVCI_ME`DW:Z25I:9E@`:X-M"T*3(E*6"#2M#E3#79M5LT[2Q=,S$5
MJD7JYU./4"X0H%G81;]DV*.(MDL:$*;BMI"J(DEL+HN0%#5JRH>S&.];W=X:
M4&"C_:NZ+OLB^0-RV&6]'O-N=0^'$*5KE00I*),20$E/-C.H-"G+Y<-9X1+^
M:=C$SLKZ>VO&W+32,.IV5VCUT5B^M%FM.]=N1.MNRHC"+==D,V7=]HBI"1;K
M@EM*E3I+8S;<=>'$G@1AA)<<DA@V$A7#7;&/6+"/5[-M)6FIIV*J2"6TA*2:
M`UKV_P#LQ-;,%1SCBG!;)\M+C:T.E'*<"AH)&HBA`5GFGV8;7$'.%=X2D%\Z
MTG:T&@)5DMC;T4ZVZTZXGG!LH4E-0GF::4IJ.5>RN*M>60J0NT].ZP]\31Q(
M"OUT:W^;8S;W2\AIY@I4"$D\%)X@J.*Q>V+:576]$O*."ZO=">O<\7^"E-X?
M46TMOHDRM+C#2U/,,\@4"*-H2JM*U!.*3J^F-NV.MS^%=$LM3-I.VX!V47T)
M]-]X,;GL<>8ET)2`U"2TX/\`$O2&DI;7)J#FR^4E2<N!XX\T]3Z2-+U#(?$7
M5KWG`>A>C^D=8.J668G8!VJ2L0:MRJ!ZY>BW_77TY=0-KPHB).Z+';%[LV=K
M0A2D[@LC;DME#)*5+_QL4.L$`@J4H9BF=GZ*UYVC]21M8:!Y:UW<X_;3T552
MZUT&/7=#DB>*E@+AZ`OD:LM]2PENWS"6W&75MK9)H4O(*DNMN"N9;6DCLS&/
M76J6(MX8KD#&4`^]>2[&\,=W)IE?E8XCU*36-$EEE[DM+:1J)!2?M4%/>]F(
M532<4"4P5A$9*6UIR*$Y(&=20!AI)^H5(P_I!/-VTNSFB\@N:0H<#[>ZE<:!
M.H?U`MT)F1;WV@HFI!TZJG(9=M#C*>J0;;+"B%+<<"Z5(2:)J"<J=@H,1$_Z
MSN].V761H;P"D"W7,+2`5G))(SH:@X0?`+AO+]/J2T-\6/!JG]M&-)W;N.V;
M9B)#SUREPDNM*!4/*1I`>>*`#DX4U%<\NS%6U*7R>`5QTR/S;:KKU#$&W1HT
M.`VAB/#CL1HS*:!#:6&TMH\(IFH)\7?CG5P\R7#WG:7$^U=%MV\NW8S<&`>Q
M.!B4TVR7I+J(Z=)4I]>333;?C=6L$_W:33/(X3;%S3E.Y*/EY+:\56'=.[F=
MZ[D+D4.?@]J=?BVL*)TOT\+EP3]E9<4?`0,M.+!963<HIM5=O;TU)KBM*(UO
M"%-.+60H%+CKJDJ(-!J4309DC/+"Y%#EX)($D`G>%!O4N!;TP'_*.)?6KG`I
M!!H-`H30#$OH\W)E>>('O41K$/.B8*;"?<J!;IVS*GL2G'FP6X;BUL-@41J4
M:JUBAU"OR8O=G?$`*A7EB`<$P/P&[_\`EHON?W2O=_\`LF)>I^*CJ?8N,LVU
M**]`2H_V:9'M&0X\,>@/-C@O&-U8,#:!K0>P!(4J#R"@);*BK5J&FI!%./=6
MN$I)S)3+A15BYM7A]&HD4`&A;`/=05&$PY]=I]:;>6E7I:4D54B@[R,2*PL*
M#N'S#`A"@[A\PP(0H.X?,,"$*#N'S#`A"@[A\PP(0H.X?,,"$*#N'S#`A8K2
M"E0`%:998$+6T@C5J3W4K^G`A;J#N'S#`A>*0K0M;('F&$*D1LAG(9&M@4[:
MN`9=N&MX_EVY?N:0?4:I*9\K&4A&:1Y#`/\`&<M?16J[;["V@CHUZ9=A;-D(
M6G<74-M6[-TI(T/3+:^T+BB,A(HI2`E6:5&A&//VK7+K_K!]U,YS[4C*&N)+
M0<!@"2!L7LSHNQ=TOT#%IE,MS<4<YPP=1U3B=OWE*'HLV2-Q]4-]]17SS(73
MVSO[3VL\XGF1W-X[E92YN=:%*!"G;%MM+42HS96O2#3$KU/>&ST6QL2XB5K*
M.Q(K\SCCQVC:H/H[0AU5UKJMO(<UOIDV6(G&C>6QWR\!5YV=JZ0002EH@&K:
MT+70>ZV"`5+R]P%0K7+/%`EE$-^R7*'-,9%#B*D#&FRJZWI<[7NEMXV,^0Y3
M\HQVBIPQ.&TJJWJ1Z_W/;5W3T9L$"[6Z[;VVHK<2]_0+A'CQ-JV2/<TLR`W'
MISG9MRCQ'`"E0'*..B](=+-U.X%Q,QO+!V%H(7G/ZQ_5V]Z<>>E[.-K9I<.8
MT!KAOP<!7VKC)O;=C/53?<5BV(E#9>WR\Q;4R"M2UR4.*0N6H*)"?.*3J</V
MP36N.[65K;Z2SEM8P,:*"@`V;%\Z.MM7O>I.I&Z?,^22XCERN))=4@T<234D
MFFTXJ=6I4*R65#\IV/Y*%;ENRDKTA3K+".:B&R%?:>>0D!(XXB&Q&?51*"<C
ML*;E?IA#HFF"2>CG11`T=0X8<:\5U#_+8W7L_=_3_=VY+O:XMKNVQ[SR6[N_
M)>BMN6FZ-,O13<([4AB-*>LRD/%+C@4MI*R$D#'&_J_;7,6JQ-MV5AD%``T4
MJ*X[-_;P7LG_`&G]7]#7NGR:KK-RVWY!^9F;*,!O:'`>Q=7-M7ZR[AMD6^6.
MZPKQ9KDJ0;;=(+G-A341GUQWE15GWD-O(*?81VXX;=,8UI:6@2-VB@J#VKV=
MHUW%?7$ES;.+[*1Q?&:U&1Q)93LRD)X08WG9D6-P$AVB7!]G2-1(/$8KSGY,
MSCL`5ETX!US*#LR#_M)R7V8TE^)`04<N,0AQ::4%..J@S)IA*")KFF20`EQK
MCN6UW+(PT8YP`X$A$V9*0ZDEXA(U9E1I[IIAW0;$Q#G;:FJ442P:\LE[OTG5
MI[JU(I7&I:"I"RE#,V?'9M]*]5/(\*TJH/LJI0=O#5C3(W:-J?&XBIL;ZEX+
MB="2$JY;E2GP^!=/TTRPS\J>WUJ+Y\'`+8B>W0ZDI&>54C^O"L=O0&JT?,"?
MRC0=B3)[@=.I!J*UH,@!1/9V8=,C8"`0-J1?)(6GYG;.)2*MY"0L%P!0032N
M8I3/V<<2'*B_"WU!1=`G!='4';L196"HN)!634D4&14<R*XBBP"\=@*8*0&&
MFO<,'9O@$PWGP.:$.TIJ"0E1%.-`*'+%CM6,Y>P>I5B%SG,D+B3\IV]R2U/+
M&:G5_*5J/Z\.P`-BCJGB40F.I6FA7J53M-33LX]F'EOX/2F<\LC7T:YP%-Q*
M;+Y.A9J:@&F9RS'#NP[BQD`.RJ;233<L_.[9Q*1GUJ(352CF>)/=\N)$?+X<
M%'F:5WB<X^DI'FJ64:4J54$5`4?KP[B%65=B5!WLDG/<,QI0;SP20MTMU"UD
M&G`J(P[MV!TS0-O\DC;RMAEYKP"`UVWM:1\4UYSP#E2Z$IU:2M3FE.I5-"5*
M40@%5,JXDP#</,#?$."KVGQB.2>_O9#R`20"20-IV'!<[/63ZIWNFFKI7M"!
M#G[DW#8;HY=+TN85#:R7VFVV72PFJ'9DAE1"&SD`=0QTKH[IMDLD5Q<C,&GY
M00*&E=M17?V;,<%Y&^NOUPTZR9/TQI[6/DP;F`&89L<#M&U<09[K@2#S%_=`
M)0=1J*T%0:UJ0,=B($-P&,P.4[-V'N7A7E26\Y=6IF^8G?OVG;OQ2KTGWL-H
M[T1'G!M>W=PM/6J_L/T4R[%E`MM@-K"FU.!U5:D8BKL-J74&;VKH/3=]Y9N1
MY/+.T5P/>-BCCJYM&5L?>EYL3G+=@*0+G8UI2-4F),7S$!"Z>/R[2\\\@,;V
M[GB)IJ:90I>2U#[AUQ""T/>3A@,NZ@&`]"@]ZO.=SRT*_HQB[<XQ@$G;]JE[
M1Q:?EP-$WW/?5\N(]/\`,[B4G.?^)_V_UX,[^)]:>,\([@D]U=`-2CQ[2>XX
M<VKB7&I)P3VV`+C4;EHYJ?C^DX?@8I[D;P")/O(2VI2=*J5H*I&JG'C3@,1!
M>_,?F.WBL0PR/?E-0I)Z<]+%[L0]N;<TT[<V!;N6_=[U(263-;0I9,"TJ73G
M2EZ**T\`1GGC!).TDJ?@@R-^<`^A%.J?55K<[+.T=KQQ9]@V10:M%KBGD_BS
MZ0--PNQ:T`:U$J74$E1).,%/XY98_P!-[FCL-%!E32G`#@`<A\G9@21QVXK4
MZHBB@2%:5)"@:*TFE4UXT)[,.(6@M=@L!H/RT^6M:?%3+T/ZBL[5W`[M?<B1
M)V%O%LP+_'=HMEB0L<IJ9RW-32'"5`)734"..(>]8S.<!AV*ZZ9J#&V_E2?E
M<,H'?AL]*:O6+8L_IEO%^T+#ALDX(NFW9JQ5$RUS"2PTA[,.N1TTUX:6DC\H
M)+CZ:J.O='-CVFGN3"%Q#24@+`.D$Z<L_;3MQ)3/.%"1@HAC.94R-;4'#`)T
M;8O*H[KZU.K1J)4@ZU)UU-000>W#5S`\$4%2$_MKB6&9A:]S6APV$C8>PJWW
M3/>;SK(8*E$M,\P**R22%H`&HD'[6(*]LS39N79NF-9#GBKB>\J_OIZZ@B/?
M5.SWDMI`Y;;4AT\MPITJ"@A14G,CC3LQ5;RRHQS@!6FW>NP6=\R5S3M:OH(]
M)_6*=?+G"L:Y+TR)'\D^Q=Y,AR.ZMTA!_#FF`K2ZVU[J3]H"N.0=4:7'-!,Y
M[&F0-.):"1VU(J*=BZYTSJ3K>:+(]S8\XJ`2`?0#1=>V'TRFD/-+"T$@52JH
M]T5&61SQYTO89()@#4=F*]#6%RRYMQ(W@MBV@5*UI"DJT`A0"@4IU`@@U!'B
MPG<L+^7)%\LK7`U&![JC%9BC/-DS8QN:!0XC?7!?'MZV/3ZKH_ZK^H-AM:?(
M;8W)/&\-I-N-AJ.B'?U.S+G%C"B4%NWW,+:&D`(X#+'L?HO5W:UT>V.9QDN6
M,`)<<Q!#AL)J1]B\==8:(_2.L3<!N6%[R<!0$93M&Q12^XJSVR*V_*95J#@!
M00*:-%=5/];$CY1Z1\TW<$1L-]MJI*]2EK76I6VHZ"<NXCY,.C9?Y8'*,WMW
MK5FIL9+D.P*=+!N)IQA2%K;"2"2=2:9"H[<\\0<MJ\R4%:\%8K>_AD:`T#-3
ML6B7>6')K>AQ"Z:Q0&M*J&7LQKY6;M3CS+>Q.VW/(*4.E0&M(4`3Q[AP[\)&
M,-.5P!/<G\<\)C!<!6G!*,B]"*V5I5ITE(4*T`2I037(]JB!^G"<D6=M&"A!
MKAP6SKF!H^4"IPV!7&]'%E7>-P[CWU*"DLV"-^!077`2VNXS0E<IMA2JTE1(
M[B5DC-*5<<<_ZNFCDA,,8`DXC`^Q7CI"%\<XEE),9X[/4NB;5P02VV74I]U/
M,42:=FLFE3PKCG-W9R.MXFL)YF05[<%U""ZB89'.`RU-*^G9\%63U&]=(FSK
M/#VM!E!J^79A,V\I5)(7#MQ6IML:`JK'F4T53*J0:XN'3/3TTC"][<PR[^\*
MC:KU+;PW#V$T%/4J<6;U)[:CW!<)F\.)Y)TH:CJ+R`*)S;)R2E2B<AD#BW#I
MZ4>%M"JE9=56K[HB0@CMQ]Z?LKK\B6C1%>;=2M-*I7XB"`05C*BJ9GN.$#HS
M@<6BO\=B</UMI>2'4!)WIM7+J/'G1E&4K]\%!.AS22=(U5S%<CC(TE[?"T!-
MKB_;=@-SD937:4Q&+E;I7F=;[;41FBY"WW`4-A=55=4:I(-<L*#3[EOA)'I*
M:%L)\3J^E$?QW9O_`)V)QI^]1P[_`),27D+S\4FSB?M3//9\6[:+BU>-L&,O
M]T">RB2!W'C[,=PBU`RG"H7E&\TQQ8?YJ.+E9G$*U<HD)KP!K3+$U:DD$N(.
MQ5:YT]X->'8F\];:)YQ;IJ%0FGB%,L_FP[!%0HF9AB!!:4D.LN.(*=)%2,Z'
ML/R8DZ-XA5[DO1)<9Q!`()J*Y`_KPC)*(R!M[DD\&,T*P##A(&DBI`K3A7MQ
MH+@$TH5IG["LG(ZFTA14#4TR![B?U87JC/V(-QU.)*@H"AIF#W`_KP51G[%J
M4C25#X21P[C3!5`=7<L,96Z&!"&!"&!"R`K_`*>W"5S(+9C'N%<YIAN6[8RY
MCGUH&CUJ:/3WT^=ZE=9NG>TDL&3&G[C8?NB0DJ1'MMLE!R0[)`S4PZEKL[..
M(CK"]CT/0I+R?YPYH;08$%YR@U.&!-2KA]);*/J?K""UEB/EV"1YKC7EL+QL
M[0NQ77&[05WB^7%)#EMVS;O(1HS%$-P[=8HSPC"/7P`2I#*&R!Q"L<-TFQ.H
MACA*T2B7,203A4X8+U?UI>Q:+T^^^:QTK71Y&1L(#FD"E23@1AN5M?27MF9L
M3I=LB/-:BMS]R09FX]WRG$^7;9O&YF_/HD2"]0A,:(\AM1/:G++#/KB8ZEK)
MM[7!L3P..X;**G?3=]QH/3L.JWS^7>7$9=.X@_,<SA_V0T>A5]Z_^OKI?TNA
M[HMVRG1O#?-GO-UVH;"^F3;F(,Z-!4XQ?7"H$7&V)E*1RTCP/4/LQ;-`Z#O-
M0='J$\C&VS6;"#4DTPX#8J+]2/KUT[TU8R0Z&'RZL^4-(:0*`YLSC4;`1LVK
MG+U7ZS;]W=L)C=W4"?`_ZG]1X$2VAFSQOPYFR6&&=+#4*,36.AU(5JT^\HU.
M.QZ-IS((A86@Y<@PS'$5V]Z\?===2ZCJU@[7;Z0/N'8MXM_@*-NFMN`;70Z%
MNM"BEU46UJ334X1344JS-,2.I\V2)MF,)XAE<[<XC`D#:`=U5RKI"**ZU']V
MNW!TI.8GB3C[5NZF7U%QNC-DBR73`MS;*9+L=P!N9(T$**0,PA%2"%=N$+"T
MD?+'%6CFNS$\1B*#UJ$Z[ZAN+C4GQ0$MMRS+0X\/L4E^GO9NZNJN_K)TDVU?
M;K8(6^'F6;U(ARI@CIMEL/F)#\J''4E#@0RI22HYDJ'8,/\`K2[T#2H1J.HV
MSIF1-K0.:*]F/:E/HCH.M=8]:1='Z7=>6%W)1SG!Q:W-7$AN)V;E]5O3G:]L
MV!L[:&Q[2I2K3M>QPK/!<4/$L1])7)4.-9`34]M3CPOK,K;F\N+EK1&)9GNR
MC[N9Q(;Z*T7W6Z3TU_36FV^C3/$TEI;QP%[:@.,3&QEP!Q`<6U%<<<5.6VI+
M"6G[FZTHH@(*D)JD*6M7@.A1\(R/;BGO8Z5_);@7&E>&]7BSG;!(^=PJUS0`
M/35(KDCG.O/..`EYYQY/"J4+55"%'M4D8?"W(%*A:SS-E-1@C++H>%0"*=AP
M.C:W[P6@9N!JB=[O\3:]CN]_GN+;AVN"]->"$U4\615$="O=2Z[4Z2<LL*V=
MG)>W#;>$C,YP'<#7'N'Q3#5[^#1M.EU&Z<`R,5RUH7=@W>M5^C>K/84B(Q*5
M:-QZWD:U-!AE91F0`7!1)R''%N=T)?,:'F>+*>QRY,/K5H[HW/%K-1IIXV);
MVOUYG;[WM;+'9K,XQMI,)YZ4MY;#CY<6PKRI0INB0EMVA77B,1U_TX_3&F1[
MVN?O(!^*7Z<^I=MU)J/[=#9W$3Z^)SF$>H8JQ*QI=<:X\O1XTBB5:DUR']GA
MBMM=SR0!3+Q74V%T!+'@UP1=;H&I-#7,=G=A5L!J#4+<S@BE$WY)`==)J`6U
M"I&693]6)!MNYPJ"$U2[='DC;4-(!/WHS^0#$6Z!SKQXK2@"=OE$>FO&VKO@
M$Q'%#4I785']&>+#;6Y#-H55MI@YD@I]T^XHJ^X@(%54\0_H.'/EW<0FJ2)#
MR`Y055X1F/TX6C:YC<M*J&O[KDSY,A=\H-00D5Q]"]:*$5U"IX"A_JPXAS&5
MM13%,Q=F7\ML;@78;0D62^A*M`JHI.=",3`B;3%X!36:26'Q1D_])OVI'>>!
M</A5P':.X87BR?IY@HLR6US.6R2MBGPJPXD<,1AB,4WILIE9*E*#>GCK/"@S
M)('`?)B8L[5PE;(UP.W`;=BB+^Y9:NY1^9I^]L`'%49]4/J'Z1[7VAN3:,V]
M"][JNUOEP[5;;'<9#8MMR2E&F9=)L2B(28R%%2-9!5I(&+;TWT[=R:JV[E>U
ML&:M"#4C@O,?UL^KV@=.Z++H.E7(GUJ5I`;&<6DBF-1Q(WKDCN3HMU"9Z20N
MN%\<F2+'=K[$MQ%VFNS+_+L\DNL1[RVMZJV;?SF-*4N>-3=%#(C';-+U"QAU
M.330USIV"N%*4HW9Z]FU>'M1^GO4+NFO_N!KLS*3`N$65PD!S%H+B?E)(&[!
M5AN;J"XMM(5X30G(I)KQ'L.)V:-QN!<5&4M.&_%4^TA>;9DTKJO?X>P#;7OJ
MF/,<+?-=;JEY"DJ:7\"T+"TJ[\J8CY[1\M<K@"58K.,DMQ^7>IEWKRNJW1F!
MNEA//W=L>>J%>&D$&7*M3*!RG0I/NM)2*G5Q'#";&&-HB)J6BE>U=*TVXBEL
MX[3(1+'&`784)X\53EY?A6[I/`H4FHJA1'`^W+#>Y/RT[40C)<.8>!3>*M:E
M&E/%^H89)\11$7?_`!/^W^O&J>L\([@DJ0G4E.=**_4<*PRB(DD5J$\@>&.)
M/!)RU(1D5*+A]QM"%+6L]R0D'#KS;>!4C$TR[,%/6Q.CUN%M_P"HW5$"S[30
M.9;[7,4MJ;>7&ADRQ'!2LZR0K,4H,,C0DGM4G"\0X4P[$QNI_52?O%UFT693
MEGV-;"XQ;+&PR(Z2=*$./NK0$H>YJ&T\<QC%:J1Y[)0&M!!&.T';W*%76]:R
MI-$B@`%.```[,L90B:CI!/=]=,861BBSB@NE,J5_5A:.4,:01M2K&515R0VG
M6E06D`&JT$`I\.:T]RD\1\F&$\#IWX$"N"6CBD:]KFG$.'O5LXTI/6CHT]9Y
M*$O;YZ<0&G8+KRDNRIM@"%E*DA)YBG`@)X\,1UPTZ7)R7_F8[1A[U=8V.OHC
M-.X4&[>J:Q]2F64N:@[]ZETJ!20M#JD*24FA!213#M\K9FM<T4P5>O!$V0B)
MI:!MKOKC@E>,EYI0`=`U&@-"`FM`">^AQAIRN!.XIA(X!I<`<`5+&V[\NV(8
M0]*4E)4E)6T2*U-=/?2@P3ADPP%%.]-:B8I`755Q.EN]X\9YDQI*W"5ZE+4L
M5U%**C,UH*?3BJZIE@/*(J<M:A=PT/6V$!I#JUVU"[#>F[K%(M]G2J%=Q%N<
M5U#R'E$E*J9(:2$G5K!(SX8YUJ%H)W$'`GBNT:->@QAX/`KZ0^AN][E==G[&
M:GK<?E3[,V;@X"#HEZ@L/NI/C2AQK(5[<>;NLM,=%J#RS83N&ZGVKT!T?U!$
M8&V\K7$\:A65)K4]@H!EW5SS.8.*<*PM^;$+HC)&24#-M:KA?^=1TZ,79W3'
MKI;X];AMB\R-F[@?80O4;-?$%ZVRWECP!N%.:*#7,ET4[<=Q^C.JC]P=H,M:
M7)^5VYI`+C4;2/D%*;RN%_6JT;%IAUZ)O],`7-^\^K@T4.P>.N.X+Y_3NURY
M,J8=>*D)0"P\5@H67`0M*4^\"F@K\N/0]S:LMW4\0XA>:H-;9.W,&D'A48)(
M1=GH2BAM[QBH*QD#JS%.W('"L36R6X#108^\IE+>N=>.+=A(]P2_:-QSX+(4
MF5(*QD"ISPT5D016I)&&;],<Y^?,/45/V^IFV`F>"YHW#MP3VL6Z9,N>RI3B
MJ(-%@JJ5$GB.[#2>WY!H:%2L.MMFV,</2%/D?<3:6&_$H$(!H5)R-*]^(B6P
M=+(9`X`$[**8CU$9`*.V<4BSMQ./!T`KY80E2U`@BB7&RE-!4DN.Z4CVG&K;
M3RS72O(<,I%.U+17)N96QL!!S`XKMCZ>=JIV-TAVM$F)#=[NL95_OK824+1*
MN9#T5MT*SYK<#EA1X$\,<'U^Y(U%V8$MJO0>@6M=-:00'41GK#UBL?1WIWN+
MJ/>Y+;,.TQY";:T7&TO7"^A2V;=:66UFADR9H30$4Y9U^[A]T[I[^HKH6\(Y
M64TJX5!]29Z[KD&B6CG7)QIN(%>ZJ^>#J'U^W%U&W-=]U2+J_P#BM\F/S;BT
MXX51VN>KPQX24G[J,T@)`3V&N/0^F]*C1[1ID>QY(I\H([=Z\O:QUJ+W496Q
M1R-BH?F)%#CL3-L>[GH4[\1FS0VP<E.%1'B&:OT9X?\`DXN"K]OK,D$W-+JA
M20WURM,0AI-W2XXO)&A6G,=AJ<\L1+M$+G$APQ/!6IO65L&C,'5IQ"U3_4O"
MALI:#1N"R5)!<>1H:*0/&D#/Q5QO'T^^0D->W#L*BM5Z]CM61F)KR7.(-'#@
MFG)]0.XKU%F18+S$&W4!<;;*N8X"*D!51P/?A7_34OXV^HIE%U[),*AL@](3
M1_ZE2O\`S\G_`/>$<?VL.OV%W]WU%0_^L+O^]MXJ3-Q[5&NO+)X#N[?T]^(B
MSO""!O5UO-&C#"***+IM?B-'Q?J]HKBTVU\\--*[E5;K16<!O4>7/;;B04A.
M0-.T4!XURSPZ%[)6BJ][HT=3@*)J.[?<2]RTCPZ2>_@%=OZ,2?G%`_L\79ZD
MWIEN=9=TN`?:TT'8#[*87BEYH)&Y0FJZ9'%(P"F+3V;T35#.DT&=#3P^SY<+
MM\0[U%^18DU<!;@HJM`:\`,\Q^O$@M?(M6KRXC^`Y5\6?MR_]W&%GR+-ZT*C
M-JU:??56G'B?9\N#%)RV;&1N<-H"U"&49N9@\.(S^?&RC$#"*C5NH3[03G\M
M<"%EY9H9$&HXYG`A#R[7<?VC@0LA':&=#E_:/#B<-)Z33Q0G8"G/@LWOXBBZ
M4?EQ[%?.Y^IG59:=3&V=LFTVQSB(\ZZ/A0<*/=6HQU*%3\N.:_5BXEG?%HD9
M-'@'_A.;X+TK_MTZ>@BBEU]X!<R.0;/QQEOQ5@^K\^Q66%8&]S2S`VW?-RVN
M->YC0"Y9M$5Q=[O2*GQKY\:/I!XIKEBO]+:!<T&VJFOJQJK-"Z>&HW/]-S#A
MZU#'6_\`,BNUXB[@V1TOVK!A[8E`VK_,,]V=&O*X4=L1HS<>WMCD-+?;``4F
MGA(Q?;'Z=.N+UU_,*ASLQP[%Y5ZD_P!QUY-%^Q6-HTV#!E8[#%NVOAXD[U72
M3M>'UCN/37?<93.B1'-MW<E:4F45V9*%.1GW@`I3]&Z!>:A3%I==P6!&E1@"
M0$=^&U<CFTL]2EVK2PN82<U<:<>RJB+JCN]&\-[7&?"06;/9I`M=C:!HEIB`
MV([G^O5Y)S/;BUVMLV"#S0\5%S/J+4I'DZ9]P8(]M;>URM$5QJ.RF2X8RVVG
M="3Y=900AQS^\Y:C4@\:8U,'._.Q.;'UJG,U*73,T;*-W;?<M$+F*0XMU:EN
M*6X^M2R25+=6E2\^(3J.0[!A>TM\L[2JW<3/OK]F?$N=3V+K?^5-MMB?U<WA
MN>4T'$;=V2AN,NN<>1<KDS&4I'M6V:'')_K;J+K?36Q`TS.H>X#-\%Z]_P!E
M/3,=_P#42]U)PJ;)F88;"`Y=_P!AZ/RUE\>-O)022@`CPD)`R`![,>4+A_,A
MS_B%?7BOK';/YDAD_$2?6:I\!Y-JL#<5T'5-6HU[2T4:DY]E"<0MNVL[B=H4
ME=R\F%I&]WP350LJ`J309)S(\(.7;W8?XJ/\Z>/M13<F^=O[#V[+OVXKEY*!
M&94ZQ(D1RF5<W`H)3'APV_?65J`J,@*J.0PK8:%/=3")@S.KCP;7''X)KU=K
MQZ8M#<OP;EJJ&=7/4E*ZEV__`"[9X,C;>W)3;;LADR0[<[DH*/*=>DL_=,1Q
M0E*$$DA1U=F.I]-]'>2FYUQ1TAV&E*"M2*>I>0/J#]9Y>I;-VGV3LO*+@X`_
MBP'N*@6$HE9*PE9TI0%+U9A*0$Y!0%:`?+BU:W$+:)K1Q"YW9MO#HPN23BZO
MM5C>A&[8VW]]VDS946&Q*;?@OKD:4,%*V%(90"<DN*6:`\:XJ_5>GY[9S16M
M*BG9_&Q=H^EO4-O_`*H!H-H^*Z01;DB2QSP6%,J==##C#W-#C:5``J/81CD9
MAY;R#XMZ]9/OH[Z5SHQ0-H/8M$R8VVDJ0:+(-*@G.GS4KC=HQ`/%)O-&$\`4
MUY,Q2VW5OJ%-!/A&GQ=G#LQ*-:&B@V*"\[(G`\^']ILN)ST2]`X_W;9_7B+D
M:6WQX%@/M*E8973:3(YVT24]@3#?GC[UNOBJI/#[52,6"U`+.X*OPN+()G[P
MPGV%([L@!!+I)`X4)][Z>S"Z@O.R)HW3=]CLZF6;C>K=;Y,ISEL,S'0AVF02
MYH)S0K.GR8D;6#FQEQ&PJ)O-8C@FY<OCR@^A:IU\MT.$W<KA<K5!B/%24.+E
M5YM`2'4DGPASB!W'#J.Q,C^4P.SGL4?/U)I\$+I[IXCMFBKG8?*..[X*-SU3
MZ?HH)&[K*R\M]QI)5+!2K3G0"N1%<//V&Z[55+[K_H__`.OKZ1_[R:&Y.O72
MS;EQ9@7#>,54B6&_+&)"DRXIU(!_Q4MD*0R![#\N).QZ9NY6M?3`D[3[E2+S
MZH]`65V_\\27@`QJ.&&\[!14DZX>KR755OZ8/"$D/RX$K<$MEM3\IAR,ZEQ-
MOC.@H;<TDC6!4#/%]T;I1XNHC<"K*U(W5W>U<!^HWU^A@MYHM.=M``(.XFAV
M=BYR=/+8SOSK'M#;%YF*?C;CW5'>NTRYD2E3^6^)3L.6M8"GF)#2%I"#D$U&
M.IZIH[-)THW[,'AF'J7CSIRQT_J_ZF0:E?S%_,G:XM)K0YQV[^[L5P_S#-_6
M^T63;/1G;K+-M5)4UN"Z"*T&VH%@@K,3;\!"$^%#4UQ!"`!DE-.S%6Z*F=-<
M><F>7.?ACQ!JX]Y/N7J3_<KU%8:+:6'2EC&UL;X6D@4Q&.P4W;2N/US44%2D
M\33/Y_GQU:XK4=R\CAE),C?TV?'^Q,R4HJ0]7L5^K#<*=M12E."?_1S<;-FW
M$_9+D=5FWK&=L<V.*(4ZZM)8B*:<'B:<YC@U*3FKMPQ?^H>]7;1<7$*#.H6W
MI&T-PWRQ/"BV;DIRBLR&'>8N.*G.H;.??AC<;/2GP^:\).YI`]A*CD"E?::X
M:)Y5$7S1+I'9K_7C4I_$*AH[`M-MMEUODQFW6B!)N4Y]8#4>*V5JS-"IPBI0
MV*\<:8G`)V`QN+C0>WT*?X=BV7T5BL[AWF[#W/O7EA^T[1B+YB8KRQJ0B[``
M@(-*9X4V*3L@7.!V#BH"WMU%W'OZX.72\SG%A)5Y6VM?<VVV)U>%N%#11EE;
M2#HU`5(&#:GQ!:<IXJ/W'77:<QQ:P/=23X4UXD)X`G`G5M0$@(DXXI*R!2@I
MV>P'`G2*.>XK]'](P+(VHKC"=1;"DU[]XOMSX'@<N!]F,$Y?FX)RS=WI[=,-
MZ2.GN]+3NEIU:H[#R(]SC.?>LSK>X4M.Q'65>!2=!\/PTPC+"V]@-P=JE[.[
M>V<0;B:*0_4!L.)MK=L+<>V&A)VKU`;%WLCS)/)A29!+DR'2@!+;M33LQ"V,
MQDSC<U]/8GVOV++22+=GASTX_,0H)C/J6HZU`I23F!3))S/T8D`:A5J9M&EH
MVT2Y&G);4`FBJ`D!0UT-1GXL8#@FL,DML<P"EWIY?U,S4%U6AL.&J4#1V)SR
MX'$3J,`F=G_NT5UT#69*@.)\7P"ZL>E?<LC<=_VU98<8:Y-S:$M:V]27(S4M
M*4JH>%6TYGMQ1M8@$%K+*-K6$KT+TSJSY#$P_>("[SV#K]<!N&=9-M7-VVO6
M[=&V=K'E`<MB*\$)E)T<.8JF2N(QS2_Z?CU"W\RX8T78]+U=]H:@[%U\V/?-
M2(=E7(G7!3]O5-9NSH$AMU;12F6TIT@C4TXH`)(RX8XAKNGB+-)0-+792WW'
MTKMG2>K&^B:XFM:^PJ(_6UTI:ZT^ESK)L@1TR+A+VA-NMFU**2U>;!R[S;UI
M(!H5.P0DI^T%$'CAST#JITOJ:SNJT:),II_?:6CVD+/U!TEFI],7=NX5!BK_
M`,+@[W!?"M9)B$.<M3KRGD270\E3BBB.[4)5$"#D%LJ223VA0Q[JM[476D>;
M/BI7V+YZ:)<F;6;NT^[$XCU%WV)ZR'.8]K!.DEOO[$I'ZL0]M^D/3[RI2VD,
MS^8=Y/L-/@G8$K=C%;!HC4@=YS4.W#C<K#)_2^D)T6"!*"^:RKQ)4DFHJ-5"
M1D33$/J&WT)S98>I2Q!;G/-4><\0000E.D5H>[AEA@-BLL9^0*5>BNT7-]=3
MMD[,*2ZW<;]!>N#6HI4[;+:\FY3VM0S25,1CF,QB)UR8P:>YXVY@/85/=/0B
M?4@P_@)]1"[S7);;:4^3$5+,@/,-!V06C$9MC0;5(*1DMAMAL)`X52<<&NF"
MZOR7<5Z!M)/*V.5FRB^>;UZ>HQ'5/?QV#MJ;YG8>P+ERI4]JBF+KNEL*@W"Y
M*C@Z'F(*T*C(</NC,9X]$=!]*10VT5YE&9\;7;.(JO)OU,ZQN=8OKC2[1Q!M
MYGQFA_":?!4=\[;H4<R5/(=*AH`:&BAIJJ=(S`ICI#V-EF-N=C17X+D=[J?E
M].CB<?\`,<S$[Z4*94G<0G.*##JO"=`0:EOPG,E'`FASP>1C4+^]/I6J)+DN
M+(*@SJ3P*6TI/].,>2CX)$W%ZXY@<#VHO72I2_"HKXZ@%`4S\(/`X=6UDVIR
M#<F=U<W#,G-)H2=Z,LS9$<.!I24I=`"P$BF0[!]G]&'?DRI&SO'4J%IYCG]X
MKC\>#R;DW\\_MVKKK>-M(4VY1-304%!P!!XD8XE9W3:U%*%>NKVS?EJ`HJN^
MV$H-"FA)-*!)[N[%@%Y\H(*@39DYJA1O<]KDU4&Z@^P<,OUC&1>&N)5>N[(U
MRD;TS9NU%*45I;.FE*T3[:=M<2?G(^*@;S2)`PT&Y,JX;9"0X%HS\0K0$\>S
MCAW;7@RG(<*JN3:<^.N8;4QKE:D('*"<TU0!2F?##R.\+I&MKM(]ZKES9G/@
M,"FK*MP:2`00K4.T]Q[CQQ.5*B[RT<00-J3BTELT`K7/.I]G$U/9@)/%5Y['
M1.RFJ**:65*(3D22,T\*Y=N,5*TJ5CR5_#]*?KP5*Q0+!22DT(H:>S]6'L!^
M3THH%C0856:!"@P(H%Z0DI43V`]GL/ZL)RW#8XRW#,$AS0;>[MOO/RT_X=R[
M@^BW9R]M^F&QW<MJ:E=1=P29\IM6D+,"VK$6.\:']VX."3G[,>;NL[HS:IDJ
M<U<,>]>V_HWI-UI'0T+8Q_F)"'#M`RD^P%-CK]L"Z;_8W/'V\AZX2NG6VD;A
MB6F)'6_)N,RZ3V(T=IMH)\:U1$.Y=@%#Q&+?T9>BV:TO*Y)]9K+J#JV^N;6V
M;5D<1P%*;`-FQ<7-WV^ZV:\W.RWNWR[+>X<];4ZUSVE1ID&0X$/(;D-+HII7
M+=2JAX`C'?H)N;I\4[3\KF;N\KYP2Z?>:1J)@O1^?$2UW?C]JM7T+$6Q]-;A
M==T37HMJWC<?\NK2T>4XHIU,A;%2"A"UBJW$4J.W%6UBS==1!C?U,X=7?0=J
MZ#TR?VG2[B.<N$=X]H;4UH#FQ'#Q;E"V_=DS=@WN59IY;,(D2[/<60I;,^#)
M)6TI;P"FU/HKI5G6HKB:T^[;#;"V.VF*Y?U%I%UHFK$,)DC>*UVX'@FQ&*J(
MTDBE-5"4\"*UX5RQ.QBC`!LHJM=AIS'`BI3Q@U+:,SQJ?HPYB-&2<<GQ"@8G
M".]:[@[X%=H?RG9H;OO5V`:!3NW]N245'B+:9[C+B@>P)<4D4[SCA_UTH=&L
MJ[>9\%[D_P!B-TUNO:T7;XC[GKN:TSSYR(J15;CH.GO0I=0HGA2F/-]QE$0.
M%`T+Z;Z&<VJ1<"T>X)V[DE,MSHT9;B1RHK"$)S)+CB@@)2D5*CGV#+MQ`VTI
MC><K:E]?1B5,:FV$ZQ(V8@1B,>\JO76+K?L_I3:ENRI$.Z[@4M3,';T*8T_(
MF3T_NUW%#"E^68BUIXBG5[<6WIWHR?4YS,\.;$<2X@@=S:[3V[`N,_43Z@:5
MT@S-;2-?)P!J5S"WEU5WQU/N<>X[LNK;\..XX85F:UHBVG4%C5%I[ZE).DUK
MD<=9L=#CTX4C8UHWX;>TG>O#?5WU*O>J;P#._EYMF9U-O>B<=25<E2#DFIRR
M`!X4&666)HNJT`;DM#<Q>5B;1N;&OLVIY6R5'HE)<&H',9FF9RX=N$WC,#FH
M<-ZL=G>`M#*_+LIN]2>3$X\YE6A`Y;B7`3H%.6=8()X&HQ5I[-SK-V;$T4[<
M&/3(XY+=V.88@T.T;]JZ6],]U+W7L3;]\DI2PZ\R]#T(H`I$!:6$KH@4JL9U
M[<<CDA$5U*VGWJ^NJ]=]%ZG)J6@0/?M8P#^WBGJJ:15(`4*$`\:U'MQ@,:3V
MU5ID<>6['[I]R;DJ2\%NCEBA;4E(J,U>&GVL2(:T"@59J=Z<*)*5[.N(4H)4
MT6DD9C2JH/SYXBW,`U>/@6_:IRV)_99O_$^`4?NO)^\"%CF'4$9?;[.([\6&
M9@K&VE*N"HT$KV3%X)-,57+JMU5F[;F+V]M\(BSW6"X]=G2'&X]4D$%JI7[Q
MXA)Q.V5CG(S`%O:N8=<];.M7&V'RD\*A5,3'O^]+W'B-/KF7&6\43IX27$(;
M)-'P'/W*#4TX8LLL(BTXMH`<Q^"X5?7'4>OW4-IIV<Q<P&M37$BN->Q2EU:V
MOOB7M2UIN#%D%OV)#\G*=CW5_P`Q/4ZEL,36FE-H:><;;("D:C0D]V$]%=&T
MEIKG>:C#93#T>E7CZD:?J]KTS`ZY^5L,8+Z&A.&_CM5(+L\AEQQ.E)6DJU)*
M1ED<]5*5/LQ?K1K33`>I>8KZ\:-^'>HLOEQ<UK%<AHH-1I[M3E7$GY8ON*M%
M!0;%2II,^HOFW$#V`*$MSWA+27'*H\"%Z04\%.?=U%14$ZL6O2K9T<['.V"O
MN*YCUGJ\<,<C6@%_=VJ%T7!^V2H=UCN*1+C23(;4VI27&GFE)?8>"TD*&EQL
M#(UH:8LQ?G.5^+.!Q"Y5HVIS66J>;;4$$&OIQ`]_H2=U!WSN/J#=Y6Y]USQ<
M=P2$Q4O26]0;=0Q&989:0E0`0B*TVE-,AJ22.-<:0V]O;QB.W8UD8V``#::G
MVE6[4]4FUG5GW\[W/,F7Q$FE&AM!4FFS<H=GJHXJIRHK&UP3RZ]R>P8L[:A-
M&?4)5V`U[>.6&0)HINTVA-!^0_'<9D1UJ1(CN(?CK!(*'VEA;:@:Y$+2,"M%
MJ:/&X*6.LR(^[MF[1ZFPDT=<CLV7<03F?/,-K")*P:*(5RB*T/'#>ZPCKVJR
MQMJ`!XBJR/-N(*"1DI"5#2I*\E5()"%$BH[\1Y2S*4H=JDW:'2*\;D:7=K[,
MB[5VPTT)";G,2MF1*2$\PB$VX`X\\M!\)"2DDY&F,4/H3YKFAH(KF[=B.;AZ
MD;:V0R]8.E$5N"XMLQ)^\EAQ=P<?2"7"PEQ&I.I8KD*8R*;`I*P:XR%TN-6X
M5X55:IDN7-E/2YTCS<Q]:EORRI9<DK))+KA7X@M=<QPQE2QI]W8D=1"=1K05
M-?G]F!2;0,H[D6=<"@-*CQ]HQE;4`V(OC"%@Y[BOT?TC`LC:B2EH134:5K3C
MC"=1;"DYXA2ED&H-:']&-7;#W)RS:.])K#FEU`4?NW#RW"<PA"QXETXU3[,\
M,:FE-RE1QWJWFR)+75?HEN/9#C9&X^G$=R][?>"];TRVC-Z*R@G627-1/<,,
MIZ"8`8`M[MZL5H[S.AS6/BF=,'"N)`#0*<0.S8JB(=HIQ[0II+;A;4TJM6W0
M:*:-.)2H4)X8DX*<HCL5:EC=$6VS\9`:U]2,&7KR5X1QJ*\>%,J]^$5M0'<$
MY]MW)V+)BK8(5HD*6O4K2`D)34U64I(PG/\`HGBD[>3DZ@#]US0/>NN7I2W$
MUL;9&Z^JMR=HB0!9MJ,.I6W6?(:HN6T2FI2R\2>RO9CG&I-,DQC_`!&B[QT0
MTZ7:S/F_[YA`KV\%<#T_;XNCV]=K-SYS;KEYF2)$UY;VD2+B@F3"D%:U``+I
MRP5>Z>)`Q6[VT=2FY=6T2]945*^H/TR;S=W/LZ%+5<(RBIV3;YUN4I`DQ)T4
MA(<B+(TN:FQJ<`)J<\\<(ZWT\QZDZ8-<`6--=W:"O0O1NI1C3FP85SNX`XE6
MMDLHD1'F':*:?:5'<U`*"DNIY:M2:4-0K,<,<ZYXM9&RG#*X'TU72XV<^W<S
M;5CA["O@!]2^QG>DOJ-ZU;!$=;#-@ZD;C3&"PD5ARYAF1'4Z"4Z'&'P13@.[
MACZ$=+WPO>C;5[3BZ)I];05\LNL[-VA]?WX=5HDE?2F'WG<.]1[:E.RG`M&I
M50*C4:9&GVC[,3`8&VX!`KW*.TW.Q[6DGQ$[3OJ?BI9B.M\A20KW@4@4.:C4
M)'#C4XKEQ@"NCPDFV%>Q3!T]MCZPA;S12E*%))64TU+!*>)-<NWLQ6;TFBN6
MA@917@?>GX^XW"<6RLZ5M*("=)()XI%4@@U/MPQ@MGW.#:U"LUO<,MHKDO`V
MGW!7;]#%D$O=F]]Z.-BFU[1:]MQ'BA)!F7Q7FY*6U4*@XVPTBJQD`JE>(Q4^
MJKYL5BZP=XR\?'[5:OIQ;5G=J.U@#O:5-'K7Z[CI?TU5MVT3I$7?F^#*LEF:
MAI29=KMDA"FKO>E-E.H.AILHC'W2O4>%#B"Z#Z<FEU3S+P2VN_%6#ZD]6VT.
MF&W:0'@4PP]R^=:\R7(R"MUKE\T+55VA=<*U%2N;0E7,6HZE5^T<>FXK+)&&
MBHH!LP]R\9ZC?B2624'YG.)KWG>4S)<YMYK0=*16H\)SH#EP]N%XH.4XNWD*
MEZA.)`&[ZU]B0>65%2D)%"HT(H.W]!PX474HX.`^08%G,[B47D<$_*?Z,9!(
MV)2*81DE^P\45\7>?G.-LQXE+B]C&Q'>:CXNRG;QP_Q]BC/.%=V;I:@=7A'9
MV&O9[<>8X9G0GB%]`[L`-J!N4<7.UM_;;"C]G*E/],L2T-\Z8&@(IV_R5:DE
MY9(#:U[?Y)G2;*R^FG*"?T`]M?9APV=U0%%31.E-:42(-M,JJ-"5^$^'2.[V
M*/#$WE(^\B>$3"E*)B;CVNA`*TL``(74:>/CX@U[L+12NC^6NW%5K4M,`<T`
MTP.[M4+7?;]%.+Y`%"M0H.%,_P!.):V:[,V4NP:0:4X8JF76FT?6HP[%'%PM
M!4I1H,AJ]TFM!GP(IBTP7K9S3+3TJ!O;;`@IJR(82[IY?`=A]I[ZG#Q5"]L'
M/?G!I1O!-QQASF+\)">8L5XT&HYX%"2,=&[*5K6WH`-:U-.%/UG`M$56UK57
M53*E*5_6,+1S9&Y:565AY?\`M_[/_P!=A5D^9P;3;VH0Y']O_9_KPNA9M07)
M+C;#!UO/NICLM@9N/N4TM#,T*DFN(_4X`RRDO2_8WPTX=M?@D[6R=/J;&-=^
MJYN%-E,..*^F78^TFMJ=-.G6VFVTML6/9UG:6T&]`_$78XDRB$U.@N*%>W'E
MR^N?W34W7(&7)(&TK6N8TK7#96J^B&BSNL.F+2&W;E?%$17C5M":)+V!Y>SI
MZG[LE,@QDWVX-.35(5H3M_;5M>N#P+J7$%`)!"0#[V+;RY-+O;>SB/-YU,1A
MEK3=C7;V+D.F7,\%WK&K7LX=''&\AI%*]E2?;1?-OU&W+)ZI=5-S[F:0]*>W
MCNR4[%#A<YSS$B2B-'KSBXX%-0DH.9)H.S'I"!CM/T>"T<<Y8RF;97$G9C3U
MKYH:[J@ZIZAFE;'R7SW!=MSY10#@*^'LX;E*/72XQK6-D=/8JRB+MBS!4B-%
M<Y87,?2FK[JD@CFI4*US.'%M&W^I=B""*=^^O9W)YUC>-B@MM+M_D,$8K)7Q
M.`;3Y=VP[S1.K8F\MN]1=M1.E?464AFXPV%KVK?W&PMQQZI$:WOU*#4.#WRY
MP[,,8]/<RYYQDJW\-/YIII^IV&LV!TV^:/,[&S$@Y3W4J?\`B"BS=.S;]L.[
MFT;AB+BO.K7Y20I)\I-:U`-.QGQJ2L.I`*1VUQ/1S0Y0W,,VRG:N=Z_T_?Z,
M]S9VN=:U.22F#VC8X#<",=IHMD5SDM)JFI)TTK3C0UX>S#IV:*!\I%6EM/:%
M21:OFD;(#2,OI7MH5V`_*G+R]_=3I":AC_)^WHI1_:7>]97JR%`$<*8XI];(
M^=HUD*T/,K[%[._V.1.CU[6?FPY/P>N^VU'DR;LY(<3X6VU.I22<DI&JE:5R
M3CS'KDQL86L`S%S1V;O2OJ)TU)S-3B-,`QM?0`JT^IKK]*Z,[:CW^V0(UTW'
M>KNY9;"9;X0W"1*86%73E%EWS28PSY?AK\0Q;NAND6=1S/EN'Y(FQM=3+6OS
M4I6H_C!<E_W!?4T=`B(VT'F)[I[HL),F2C2[-X79J[*8=ZXS*W3/O=VN-[O+
MZ)UWN\N1*N=P^\2N2MQU5%1D+<<3%0D9`"N/0<.C1V]L+>!V7**5I_-?/K5=
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MY+IFC]/0,YK<Y8"=@K[4I6S=-HO,94RTRF9\5,QZ&7V'`ILJ934K2H).I*E"
MF-9K>YMW,#V&KB/14T4S:ZM:7['"-P&!WUW+1/F%Q`6E);.H?:KQK[!B6\KN
MS>S^:AYIN3NJERSJ5+VQN*.HT+7*D\PYU`"1R]/$9IK6N(BZAY.I025K44]Y
M4SI5R+K29HR,OYG&OW1W)B.20BKJ<U)JX$^T9TK2F+%R.?E=6@::^I4RZD&G
M.?,T<TM!.7PYJ;JXTKW%4Y]05A:B/-[NAAQUQ]UN%-.HAMEI:5.%7$@D.('9
MBTV%P`T-RUIVK@GU,TAYC;KA.4.QY=-FW[W\E%_27J39=C7ZYF\-O+CW2,]'
M7+1'YZ6VHZ`L%NA\*U<P\.&)Z>T=J-J`SY2'5'"O;V*J=)]<6>BWK9'0AS<H
MPS`8_P#"4C=9.LK.\VK=;ML^?AV&$E9DLNI-9;Y)T27WO!1L#[!!^7"NG:6^
MU):YU2[?3=ZU7_JG]2)]<ADBCHVW+:9,U:[,*X>Y5)OUT%2JI*E%=3JXT`[*
M8N%A;9J#-2G8O.DMUYC;\JB"_P!TT%3FJN8HG709"E>W%B@;D<&TJJUJFJ1Z
M>'-IS#3C3=Z5!6Z9R9DL)0X6V-)*Z>*I2"1W<58L43S$P2!E3]N'!<&U_59+
M^^-(R1^&M:^STID18DZ^3XMFM$27<+I.E-1(,*(PX\[)<>6$Y:!1"4#,DFE,
M2,\HBM^>1Z*_%8L-*NM0N8[6R@<9W\,34[!2E<3ZDO[PZ*=6=GN2VMQ["O\`
M`1"MT^\R)0CA^(W9[?RE/S52&R6@=+J"$5)S.>6(_3]5AO261TP.%'`U_FK_
M`'GT^ZET>%]Q>0/:R.E:M(\0!]7S#%5XN+J"MRAX>[_:%3G[,AA]<R$.$--N
M_A1-H;:XCC8^1I:'BH]B9\Z4%(5X/=K]JM>SNPW4Y9VSJ[4S94AK(+UCAFV@
MND&M<PDBF&K[D,=2FPJSV]N00X$5]2FWIM;+K?=J;IVI=;7<T6:]L!=FN3L4
MF+!E-K130A:D%U;J%*.130#MPE)-S6Y:4Q4GYD190!4]_P#)(KDGIWTB"_+0
MT;SW6$<CEOM:[;#=2-.A]A1>U/I4*E-1D1AN*!/XLUSM-%"6]NHNZ-W.-(O,
MY\06G=<>UQU>6BP4:O!%C-(%&V8Z?`A)KI2`,8(JI.".I(PJ,%%LS0``T%(:
M*]>E2M:M1%-1505RP-;EV;%-P0EHYCC5U*;*8)*6YI-*5_33]6,IR!5$G?=7
M^G^G`I1OA'<DY:]%,JUP)5C,]<5ASA\)^?&*I3D'BL5.!22*4K3M]M<%4"&A
MVHD\WK*<Z4KV5XT]N"E4]MK?,#C[$E.O:'%-::T.G56G$<:4]N,.;@>Y.A;$
M&M?8DYU7+5IIJ]M:?7A@G8%5)'2+?B^G6^;/NHJ4F"E[\)NS15J:D0+G_AU-
M.-:2%#4Y6IK3#"X-)FOW!M/:IK0;@0ZBV-PS,<#V>U.3KULYO8V_I42*RE%H
MW`P=QV0LT+"H=P_Q2&@\DE*EL(<S/;W#"K+W*0W+MPV^W8CJ'3?+7KKEC\S'
MFNS8*[.U0DE84:<,J\:X<U4&:@;%(73;:=QWYN^Q;,MT=;\B^W%@)6DD-1XL
M1:7+@Z^O@A"6%=I%<,;^?E0D4J?4G=AI4VH74<S/E8PD$D5!W]FSXJ[O6CJ1
M#@7&S]*=JR&FMG]-VH\>[N17``[?%!#2)&E`^^0TXDU\1KWC$+;:*=0!O#(&
M%GS9<M:]E:CW+J-_U!:6D-O9L`SQD;_%0;-BL%T!WX57QEEYU@RXR(T:$IUS
MFLN(<6DR%)=&D1WELB@XTQ!ZI:"`'?Z%>>EM59>.``RFO%?2%Z5.H4:ZQ_P\
M*GP+B])MKJTQ$+5'-R:4D)FV]84@,J=83I<316HYU[,<JZFM!,QTI_#3T`+N
M.@ZCY:9MN/F%:UK3:NR^WWI\BP1EOT,A(4I2RO4I[3J*:BGA5JIVX\UZ_`YT
M[HV?**C=P-?@O16B7+9+0/(W<>*^1+\YOIX-F>L.=N"/&#-OZ@[1LNXD.I:T
M(?N#?,AW`Z@2'5)4VFJLN./:GT7O1K723+5YRR6X(K6M<I-,,*8`#>O`7^YS
MITZ#U/'JT3\[;A]2T-I2I%<:FNW@N9.V7M*TIT^RM:<5]U#WXZB).9;YZ4V^
MPD?!<KLGA\S'@8$#W*=[;;B^VV&FJI+J"5#V*!X8JU[)RXW/I7%='LV<R)K-
ME0%.PEQ[)9F'4M!"N25+.K34II0^Z<1`M/.CQ9?17[%:(YOVFWYQ&>F[9]J@
MJ_=2)2ILH!Q#+/.(0I2PJJ=(%=12*`$\<2NGZ7)8L=*[YXR#C2GVJN:WUG'!
MI[YHXLTCW@%F?$$D#;E[>"[*^DB3;^F?ICB;]W?*9LL>\1-P=0]RW"71'(V[
MS'(EICD+(,B2H,!IJFDJ4ZD@=_$>H[!VK=1B"!]`23LK2A':O1'0-Y;:;T.-
M1U`B,2,SBIV&A.6O$UV]FQ<5^NGJ4W3ULWU>=ZS7`RB0ZN%M56HN.VG;48K8
MAQ/<;2)F@$NG2"EQ1&=*X]!=+]*QZ'IC;PR"5]-F7+[:GW+RIUQU[^]WLT=L
MRC&.(\=:^S!5SE3)$D)0X\ZZE%`%/*UN+`[5JH*K5VG%OC<R5C9,M,P!IPJN
M;?N+I81\M'$<?Y(BM&L4K2AKPKV?*,8DC:\4;@:IB:EV8E>H3H32M<_DPCY?
MM]B%E@\OV^S^:%K<1K`SI3V5P>7[?8DI8S(``:46KD?VA\W]>#RYXI'RSOQ?
MQZT.2?B''X?Z\.,H]BC_`"C_`,>_A_-?0Q<X*J*S'90?,>['E]?1>\_33#EV
MSF+(710]M1]6'EG][T*#B@YA=4;"D1W;I*EE":)/`#,#+VU/'#VH!VA+>3:B
M#&W'$K)''2KL)[/:,+>>>MO*#@FKN#;KBFG*YD!6=.'B]@P-O7%X&]0^IV8)
M:*;E"EXVVK2ZDI'NN"N?#21_1BP6UX[ET*IEY9"I!&-%"MVL2V'UBGAT$`4/
M'L)Q+6-VX.!W%5>]LVD;,5'=SMQ0I2D@`TXC/.JJ9&N+?92F6(N.W-\`JM=6
M8.%,:)ES8*P<B`5^]EQ)S)]F?=AVJG?VH:UQIB`2D:3$Y24E=%552E3D:>RF
M!5^A&U$^4CX?I5]>!"P6TD(40G,#+,_7A2+]0(16A[CA\BH4A](K#_F;JAT\
ML"$%3EQWWM])'B(4A3@0\E5",BTC/N&>('J&Y,6ESM.S+\%8^B[87O4L,)Q`
M</@OIQNR0AITJ2`U#85(*0`!IA17$4!32@#22*<,>4-%F?<:C,P_CKZL5[\O
MK5MI810BG].\^ICBN>/JFZ@S-E>G>%MNV3)%ON/4%5R?N<F.K2\;++DJ3*<.
MH%2"NJ453I)22*TQVWI2R;K.H1RRC],C;V+QK]6.H9NF^B[N]@/YD[G-H-OW
MMRX_]%K,F]=2+?)?;"X.UF95\EH45(2M+;*FFE%:2DUT-`TKCNNI`"%K1N"\
M3=&V7FC->.J<@)KPW^\ID[NO;E]W/?[P^LO&7<W415J"=3<-A9#30I042DC,
MU)[\9MJFR[:A5_5)9=3U!]3X0>["H1%J0I0:<2=+S#J7&G4@(=;4D5"D+2`I
M-#C1H<#CL5>A9)!=#ED@]Y5L>GO5C;VXK0QL7K!&%QM3C3<:V;J00NX674D,
MLK=?4-2/*5"B34#3A%]F^V)NR:M)S4[UT>RZHT[6XFZ'U"SY(6\MAXAHI7=M
M1O?G1"][2CF^V(HWCLM]GS=ON^WYK$YYEM0U(;N+015LA%2HC@<L;6^O"_$E
MB13)&75.%:$#XJE]3=)3:2Z/4+*C]+DF#6@?,02UQ!H*D"@.)PQ71?\`*AN,
M=.X>J<-21YU6W;(^E0)U--^;>*&UI]W4VZW4U'RXYI]8QGT:R((-'U]@"]'_
M`.R8<OJ#66.!:>3OPK@_95=W=LO*8MU_F5^]C)2TVO(4:4R0XD#W59?IQYAU
MV/GRQ,.R@^"^F?2A/F#(:@M;[J+C1^8'U&2YO_8?3Z*M;R=JV55\DW)8".?,
MNCI0PP6PD(/EXJCG3Y<\=_\`IOIQM+%\]#\^`[@1[Z5]*^>O^YSJB2_ZI;I[
MW59#*7;>+2%3NW3(_EVE`>)(4D$*)(2"33VYJQTNAX%>?[*[.6H.*?5NGHY=
M.&7`D]M/DPSO*<HIW:8FJ>,*X("6TFM"!6BOF]HXX@&[2K)%-RF=Z=C,J/RT
M#2>W[2_B/MQD[$KYVF]*,>>$*`;*T4.H*0I2%I4GW5(<31;:TG@001B#?&+C
M`[^*D[+4#%,+FOS"BD=GJ%NF="$&9N*[/Q&$I9:8<F/*2&@GW%>*JTFF=2:]
MN(UVD6\4X<YH+B."OS/J%J%S$RW:]P8S#:KK>G*:R=BR5"E5WA]1`-`"4`BB
M`=*`:=E!BH=4R00W#,K:#9Z20O0WTVGNM0@#W.)WJ>%S65MT-"./$]E>T'/$
M/O74KW:>.*6]J3U2&;_"2JC;L!2BGPYE-=)!H%94Q#W[0;B)^]KA[:A;:9.Z
M*SD8VM2_X#<HTYS_`-IPE8KJ-$YD$U-*4Q8+<'EFO!5BXNB=0C:_P<P5[JBJ
M:6[]NV[<NW9]@G4:CW);:$RM2M4.4ZH(:DIHK,A2N!\.?#$K:84=C@#AQ47K
MEA#U-#+9``-8#3^/2N:6_P"T2MC;DN6VY4I<B1:7'&$2\D"4RZD?XC0`&_O$
M"AH.S'2-#B;<:>)6["X_!>(NM]+N>G[^6)KJ4V;MYV*)+C="E!"75A.F@0'%
M:>&0*0:$8EWVN5A=P"YHQT]\UTDKL6]OH487V]);KS"5`E=,P*42./`]N'6G
M@UV%535[SRP.4TH%"NYMPMIU!).0!`]I2*]YQ;["W$C0]W'XKE>L:W)).YE=
MP]RBF8^X5FJS3Y!P.9[*XL<ELT6Q+:5P]X5,:7NN>8S]05IZBK2>BK:-YW#U
MJC[E@!3>WMC0'KGN"4JBVTKF-.1;>T6%A;;BG%:R"02FF6*AU->^6T\QRD5?
M4`;*X;J=B]`_0'0+W4>I!J+FAT,)!-<<:_R70CU@+N<?TY]1E0Y#T-XV2,RM
MQ"RI?EGKQ&0ZTVXLJ4AN0RLZD)(!KF,4#I?4C+J0-/F#C[J5]6]>K?K9(\='
M3W\4;6F0MK@`:-RM^"^=J8YJ>6TRS(ENK6EIMJ.D*=*E*IDD5\(KGCK\F=^6
M0TV+Q7I\-W<B)TU3"&FGJ"==KZ([VO31G7)Z!M&Q`AY^?>UZ'U,4U*5';%$E
ML#(U%:XUQ5QL;2-K<=O:M4ZY=(>FJG6+-JZ@[B%7//J+B;`U(;J13QI*P'1P
MH4G$7*?S7=Z>.C(<6F@`-/XXJ.)?6G=MRW#:KA(<9AV:W36)#EGMI\O'2RE7
M+65-M!`6`EPC/OP@7FHX)7RT9C.+C+NPPXT]*1.M-E:A[J5=[>O1;=Q1(^X(
MJ&JMI;5**VEH"QFXL*CU.9.>-J=JD+)Y#`VF-%!4IU:TJ4I14H5()H36M:D]
MI^7&*[5-0L`=LVI#6ZM>2U5`X9`?T`8WW*;9^GZ42=(U\1P&,+<`T2:IQ9J"
M<JD<!]6!23?".Y%7N"?E.`IS!M*T8PG"3^>[\7^RGZL8JM\O8M:WW13Q?[*?
MJQLU/+44!24ZI1=6HGQ5K6@XCV<,#O">Y.T14M2S51J>^@']`&(U;THO4U`U
M"E4J!&JA349@E*@4DI.8RJ,,;G]0=RVCD,4K7C:%:JXK7U2].T2[M$N[HZ2S
MD6^Z+=\;\K;C@TM+UJSTMQI"#49^'CQPDP?.WO"N381JEJZ67[K"<>P?R53^
M:IM*M""HKTM\RI)9*U`(6$UHHK71-,_>Q*=Z@Q91G8KH[7<9].W3"7NVY!+G
M5#J#'_#]M6^E7;+99*$)DSVZZDH6ILK-2*Y8@[MW,U-MM]TQ@]FTJR6L\&G:
M&\$`3<QQ[:$!5Y8N+HGN3WGW)#LI>J4\XK4J6E1*M;P)HM1)K4YC$P(Q;2QP
M-\#R`5RVZN+FZN'7)K2,U]2L9T.W%,AR3$0XVJVRY3DJ0V^XL2$O-C4AR+(!
M$A*\J:->BG9B)UNS90KJ'1.L2![0XT*^D/T2]6(-UD[8MUWNDP(7(A,PY<=M
MEBZ19+-$-QK@RTVVRN'(IX'-)64\3CE>O6;3;.H,:+T;H&H.EG8\G;1?2'T]
MFR7;0H*>4XAL`M&H4!FFM"`=1*:\:X\Q]26K6W+C2AJO3G3EVXV[:=GP7`G\
M^[:+!:]/F^6&0'O,;LVD^^.85*86(TF&TK42BC3J"H&FHUIPQVSZ!:DYC[FS
M!HPD&G>TU[=H7`/]V>FL?IMI>$?,/_P%?/U:$1XZRE4OE.MJ*%IH#XVUZ54)
M!]XIKCTHUN6WR]I]Z\F:4X$1FO#W*RNR+O&?:2V4`I.I6:NU(K6OZ,534@>2
M[O'O74].<PA@!%:#>G1NJ2Y.MRXC"])2VM9I0_=)/B3D.WY\-[`@!3VJ%OD-
MHKWJI,ZW3=R[BA;4M\-U3U]O5OM,!32W.:I-RF1X(0T-55.+4\:<37%S;>P2
M=/7,=`)(F$57')[*6?4VL)K&^X!IV5"Z,^OSK2Q9[)MKTM[*D<VV;-M=CB]0
MYL0I1&:DP;-#1:-IH6!S'05A<R1550\0.P#'/.A>DQJ0EUR?$M>6X]I.SU+J
M?U3ZHFLM%M.E=.<&N-N'FAV96MP-/\6Q<K2A*B:I/R`E*:G,D`$#4HYJ/:<S
MGCK>+8O*_="\UZ9!/%937-P[,^I[UD!3(`T_3C+0&-#>`HG$#\\#'\6@^Q"F
M-DLC#;:%)J14U/:?U'`A%SQ/RG`A#`A#`A8_7C*9?:OH8NK*\^'V>WY,>75]
M%4B"-K]\<.%,^.!-+K[OI^"48\%#B4I2"5#B.';\F`X"J:MQ(':G=!VL78ZG
MU-JYE*4J"<\N.&GG!MJIOR+T@7/9@>8D*4VJJ5$#A3//&6WC<X%4TNK)P%>Q
M0#NO9[C2U_=T25*T^)-:<14<:XL=G>`TKMJJC?61RNH-Q4!W[;&EYXJ0?=(K
M4?\`M.0Q:+*]&94:^LB6XA0A>K)RG'$I0<_%[*U(_5BSP7M&4;LJJQ=69Q'8
MHZG69SFI5HRU5S4GO)R[</(+HOF8VN!<%5+NR=4@UK1-.Y6KQ^Z>/L[CB<58
MO;,D8C%)*H:VCH2F@X_/QX#&4P@C,3,AXE%G$E25)'$Y?3@*)_T7(KY=WN'[
M0QJHI6G]%5C%T]2O3=A221%FW&\+/8EV+:94=)/9I`<3GBI]>_\`IX>GXKJG
MT;MC)U87#>1\%W_O3J6[%?'>4EX&U3V@@G2"MYA;2<R:>%2JXX+T[_5'O/N7
ML/K.,VMASW;`&^TT7%+U:W^XW;EMW%9+-DM8M-N1[P;A(TJ9&7`J56H[*8]`
M=+;`O"7UL'G+%],<#[E3C8Z'=M='^HF\'`&WY]R&W;6=04I]3B`'QI3XD(#;
MI\1R/#%^A&69W:?L7GOIMCM(Z/OIY<&S"@_ZH]X5=HX.NO8E)3^H?0,3#J>6
MIVA<HG=2W#?Q&O\`'K2HRXE"2%',FO`GL&&P*CG-)V);AJ2@!:P5(4G5I2=*
ME`D'2#]E1';V8D(_`#V*-E_4IVJ<NF76#=_39Q(M$Y-RL+SE9^V+R@R84EI1
M!6EE0\+4BF06<J$CMPSO]+9JK&0R;&R!WL(^*FNGNJM0Z2OGZAIV#Y(S$_M8
M2''?Q:/L76[\OO>?27>G6>\-;?B/[#WAN3:=R>N5IYQ39YS5J+<TI2:!LK7J
M7VY@`#'(/JU92Z?I58&EU*#`5VD"J]9?[:M;T?J?ZA0F+\O4G/&)PJ<=Y`]Z
M[:WF=!VAM&5(OC\*-#1(7,DN<Y"HKC#R52M#+J"4.GE9Z4FH.7''G/2VW>L7
ML<;FG,V@]6'J7T>UB<=(]/ZAKFJ2M\S&Z3(*BI`<ZE,:[`-B^6_JMU2D;_ZN
M;UW/-G3;S`GWZZ,6!,][FO6^R19ZF8++5:%J(MM-17W3D<>U>G].AT[0H&1T
MYAVT[OM7Q$ZZ^I=OU#UY?ZCK4+N4:-CJ#B0XDTJ."SMUU;0E)060*#[N.XE\
M@]M0W4U)XC$J,2DK+7[&X:'6@RM]7V)_0+PA]A9:54Y5!!2?>%1X@#48ICK,
M%Q/:5.V=ZTOH4]+9<2-.HTK3MK6E>&6&=S9.^7*.*M-M>``T[$\VKPTE*$J7
MXAQHD]IKW'L.&ALI*;$Z\ZEQ-UU&@**_ZPQ%^2':L^<[4<CW)1JD%%21]H9Y
M?)3#VSCY#BT?>3B.X!@=(=C2/<5=/TO[QM;4:_;<F3&V;JN;$N$2.Z"EM^/&
MCN!01((#165D`(K4UQS[K72I)WYV@D;?:O37T2ZTAM@+4.`>\AHQWG`>]3Y!
MW+-N&]+UMB/;74VW;]EM:Y,E*?NV[A.==?Y*%$_>I*%5*A4"E,5^TTYL-F.:
M:9L!7>NI7.O7UIU9);&05KQ[>]2SLE87??+U3I\K+*ZD`@\HB@[":=V*_J%N
MZUM'-.^4'W!7GIV\E_=W.G<'/+:CN4>SY*X\B6V!X`\ZA'>0%J":Y&E:8M;6
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MT%308<00V+9P\EN%=XX%2>E:7=W<[8[6!\CW5H`":T!)W;ABNG'Y=>V-Y,73
MJ5^(VZ=9(5RM6W51'+JT8"Y>B7,0LMMR`A2BUSDZAV!5<<OZZO(HB.2,S@XD
M4QH0#P7M+_;'T?JYU"5QD\ICM=AO/$A+WKS<L5O5M^R[YW]<+/LE$ER0O:U@
MNK'XON:ZN$OMSI,%A;DD;>;:6&^8H!L/`BM<-NB).=$)9&_FD&IINS&C:\=]
M.Y7GZV6=E;:I<V&OWPN+>-S<K6D'$L:=E7;RN6]YZU;6VNE</I=L&T6]2$"M
MUW.CSE\FJX:PY2K12,R#PQ?2&B[`:*"A7G&UO]+@#H],MRVW/_>G'9L&P;56
MW=O4#=N[I"Y.X+S/><="Q^'QG^7;8Z-5>66=7WE3P(X#+"Y!*S+2Y.9M#COV
M^C@HMG.MJHA-`I!(4E*2$@UX#LIB-D%'D=JDH@1&`:UIO2<%A"DE1(224J([
M`4*[L^-,)E.H?'Z%-ER2=[]%$7)RB[CT]EB(TRGWQ#D\M06D?^(FKIK2M,8.
MSM3R,_.!6C3@>Y5<?>;^]0":U4G@:5!(XXR%8XL8VG^Z/<DA_P!T?ZWZCC*>
MVOC/<DI[W_T#&$]15:TE*A7/AP/U8%L`47QA.(MZ3W_WI^0?T#&"G#=B3N:C
MO^@_5A12]5H>6E6FAX5XY=W?@0D]P^)1[,:.V'N2K=RT\UOO^@_5B.3I:W74
MD42:U^48UI4U0&%[JBJL7Z9MT,0=YRMEW90>L'42`NSO\[P!$AELL%D!7V05
MT2K@KLQL79`7\,?4K/;O_P`HZUPJ]A;_`,0HE?I]TCA;8W)?MX=1&W6ML;%O
M,AB'`G(+2;_/@NO/166$J\3B&6CDL52:G$7,\73<K#4K%G$[3W9I``?X]^U0
MOU$ZB7;J)NRY[BN0#<:2X6;9#!U)MMJ84M,2`V?M(;!)J/BPO8PF"(L.]Q/N
M3+6[QE]="9IV1AOJ)^U-E$@G0WGHH$UK]FE!E2O##U0<E3&>Y3!T^OLF!<X*
M4T"-38S-."ZB@/R8C-0\*0T.Z%IJ`KLJNZ'H_P!YPW[Q9@\XY&FQ7RF/*;8=
M=*W7E)+:#RTF@`[3PQS[5+8R7CW@?<;[EZFZ1U)D[8Y`<*T]2^L'TU[@E2]N
M1+;-(H&A(@N)4'&GTZ?&4N)J@K%35-:C'G7KNR,=T9J?-@#W+U=TK/YB-D#=
MK@?=54%_.^VVW=?3!M&_J25KVSU+L[H*1[C=Q2(RE$=HYB$`^PUQ*_07_P!>
M/']P_%<Q_P!RED__`$$S;X_L7R@H86H*4@#2IQU0S`]YU9.7=4X]D;SWGWE>
M!2PQT8=H`]P3JL]\N%L1H;2D9$9K`RH.WOPC<6S;N(P/\)(]F*?:7?.TZ];=
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MQY5YQX+Z*U1:(R4%27&P=5"*YTI4&GSX.>>"9W1^9H[_`()Y6>ULOO:=13XD
MT`2FA.1%:^T8P9S0X;BEK>S;)1Y<00>"L!8=M%3.D1M1-013OS^<8K4T_);M
MJ59X'OF/A`"5;AL-*(CJE-'[WQ4Y8R]@J<:VESYBKG4!!HG,U@V05<2*=@57
M=_[3Y3DC2V3H4Z0-('NU4!E7++%KLW-RCYMZJU_IS&L>X$^$[NQ5;W'95%;G
M^&'!5/ES_7BT61:#@[$+G5[:C+10#N"R*!<7Y;,5&FASH5&O8>W%@CER?*'*
ML75K7#L41W2V*25*Y0U"I":"FJI.FN>0Q-V30)F3%Y(#@:*IWUOE:YV\!,^5
M9'7JJ*--,\@#])`Q9?.-[*JL36YFVBA3:EVA:07%).H9::#@,J\<(OU$B3(U
MH+>]0MSI^0YLQV<$V)L+D!0Y8%14JI0IJ>RF1Q(L=G;F4--&36/<=Z2>4.\X
MVHFODQ^+V*\WY?,%+OJ":F<H."W;%W"[S#Q:>D2&(J71EDI#;U1\F*!]3+YU
MIH,;&M#LQ.^E,2NU?0VT:_J9[2?!0]^Q=I=RQ2-O7-E"U$N,Z-=!6BE`$TK2
MM,<9T0"&\8W:'U/=@O3_`-0+AUUH,S0T-+3'LQ^^%Q6]6,-3=ON"M/B4W(0E
M5!53D9LJ1\G,/'NQW_I4L(;BO"OU7%+!Y;\SP#AZ%3KJ0H;:Z,],MJUI-O+\
MV_79M7@6G0`ME1`/C"PX!4]@Q?;3\Z\?%L`.WT+S]U)<>5Z&L+=K0'W$>9W8
M<[L.WP[U75"^6E:J5)6!Q^7$S(VD@MMV6M>Y<BR^8<V,X`-/P6UETNJ"2FG'
M,&O#!Y8<4VFBY5:&J<[0TMMIXT0D?0,+M&5H;P4&\U>3VI5BR,RV4#A4&IJ/
M=&-J$D.#LM#7O[$UN&ET>!I0JS_I0ZKVGH]UWV3OC<4Q$+;UN<G0[_/<:UHA
M0;I$7"96\4U4J.7%E2\JC3W'%7ZKA9KU@^SRM$E,#V[J\*[%TGZ.Z[%TQU5%
MJS93!(TX'=A6N]=;O55ZK+_N.1T4V3T<N$2Z;(WG?+4P9BX_FO\`,3D]^DMJ
M,E8YC3.@*"*9:#CB_3W1[;"UN==G!;-'(\9:84:YV%?1N7KCZT?5W4=3Z@TC
M0M+E=<VEW##S!6F+F1EQH*UQ)VJ+?57`Z,=/^I+&T=[;$8C6F?9K?<]NWFQ1
M1&\JXZ@Q[FT^MO0A:&I2"<R3J/#'1^FM5N+O16747YMQS7,<TX``8AP(X[%S
M+ZLV_P!.^FM0@TG6[!L3W1AXE:*N<]U06N:2!0`5K4FNY0-`Z/=-=T:YO2WJ
MS:43WDCRM@O;R!+0ZG)P+>4M-&RH^``9#$[^X:G_`/3-_P"(_8N96_0'3?4H
MYFAWYMXSL!:W[2E*9T*ZK6127$V$71E`"G#:9<>4%U%-0TJ[5&M.[#+]ZTO>
M3FWX?S6\GT]ZEL<6B*4#91QJ?^JD-</<5G66[K9Y\);=:-EAY:JCW@LI0I(I
M4=O;A*34K*XIR"<-M?X[$U%AU!9DB>U<&\14UIMVT6]J^!S)QV-$4,M,UX1E
M@CL*'$!8)ID.T8T\U#LJM3>QP_+=MG8[L:#[RE&/?$%7\8V7<Z-("ZD#B:J'
M9A'RDOX6^O\`DL><BXO]0^U*+5\*%:E/$&HH*\:82=I]W).PQM;E`-<3Q[E)
M6]Y;.TZ9CWELA<*5%-Q5E>@&V-Q;EOC&]T.M0MJ;/N#EPNMRD/*:2\VPUSY,
M:AHA2(Q:`3F=5<\5GJKS$<L=J&1F20AH^8U-30T%-U:KI_TNZ?UEV?50\,MK
M<&7-4[(QGX=BCK=G5G<-TWINF_PMP76U_B]Z*$(M]Q>:85;X3I1#=#8H%EUM
M==/`8DX.G#;P\@%I%.&Q4_JGZ@ZW)U7^YVD^;,ZN6IIB0=H%5TD],O4)_>.U
M]JWU]YTR8\N=:I)=KJD",\6.8I9&I96GQ$]^79CFO673\ML_*T@LR!WO'P7K
MKZ.=3:CJU@_4+YH-P)<@`).&1IVD`[25*&[PJ-?;PRVE)9:?#R'%%204ON%7
MB"0:)0#V<<1VFF2[LHVS@,BC#34&IHW;@>Y="U@V]O</O;A[FU!)%!0;SC5-
M,34UHI;1_P#P8?6?T_=Y#$FX6`%6RDCN'VJ';?,?%SH62/BX@#[5SY]8MSO=
MXW5M+;]AMMYE*MMIESWY4&URI,9*YZ74L-*=2@!*R6<QQ%<7KI>338;$NDD=
MG,AW#8`.U>1?KQJ6H:WKL6DZ=:W1;%#&\.#10N<35I^;"F48]JII&Z)]9MRM
M`1]LK@-N-IYDJZRT0DM@@%3J@NI0GY145IBZ0ZM8`B.W)?*3@#O]55YPN/I9
M]2.H;[Y;;E6<@RE[W.`:*#$_*>'M6P>F15O2[*WSU)VG8FPD%Z*B2U)D*TFK
MJ*ET)4I(]F)B'6+B'9"T^D_8E?\`[)'3!7J#4>2!MY;0^G_%E2$];?2IL9.N
MY7R[;[G(4H/0;;$DN1*DU26TQSRZTXT5QPRN9;^_NS.QF2-P`H"3L%"EQIW0
M'3[!;"X=>W+,<SVM837&AHXCY=@3<NWJ0VW9(BH'3OI=8MNGEKY=RO*8<R[(
M6!5M;02VH@FE"-5:'#UFBW,[<CYGQU&T`&GHJM+7K[3;>;EZ-IT$<X#LLP+B
M6X&N!;EQ%1B=ZG_TC=:KWU)WG,LNXMY+A;T7+G;CL]F3_AK;>;*("8URM:D(
M2&$KM3C;+K"207"XJHH*XJVKZ1Y9ADE>^4`XU;VTW5]*ZO\`1WJN\O;JZDNY
M<F05%,,WB.ZE$^MS=2.F7^.'J?VAL6R[NWI>).P($>T0W+Q<8&U$OK=BS[[-
M65-P5N.*!2IFCB"0"*"N-]+LY[6-DML<HQ)!V$U(#>[>:X8X)[KVN:%J5[+<
MZE`V:Y?.&&LCL/E'S=II1<P/5;TIVCT4W7"VK9(N[(R;B7MP6J]WRY,WFSWB
MQ7)L"&;<_!#CA?BODI>2[I+8SQ8679G>)V[6U!&.W81B*[=G8J'U#I$5GK4M
MCI[_`/\`-K6!P:&M&-21B#7=3WJH$E*F0MQ3B'59G4VK4TH'M0KB1^O"PNW;
M"T*'MI`R7EAN';M37<7S%+<I342JE:T[>.$7NS/+N)4_R@[&M$GO/'1[H]X=
MOL.-"E[>W!?2NY2]T1OT5.X;MM2YA*K=NRR2H*4NJ/*:N`0ORCB$D:5NJ<(%
M#2@`P)\;5I;MQ4`;BM$FP7:]VJ>DHFVN>[&6W2@7I><0I?>`--1@!QHI6%U0
MQ@\-*>I-I;FL`4I0UXXRI:&(,^:NU)[WO_H&!+I./$_*<83H1`BM47?>+(20
MFNHD9FG#]&,A.K:W#R15)ZWBM15I`K3*O=@HG8M0/O))QE.T7?!.FBB./ZL(
MRR%A`"6A`-:HDIPI)32M,J]^$?,$BE$J(@7>E%=6$:*1\F/Q>Q:W'='96OMI
MAM-,8G```U"W:!`,@QKBIEZ-]/[ONN[#<\N4Y9MM;0=9NTN[.T96$Q7$RE1K
M<5*0E\OI:*5&M16N>$))W2QNCI3,"*]ZD;6,B5DQV-<#3<:&M#P4F^IV]3[[
M(V?,MUSE/;/ND67,BA+A#+\Q!;845Z2`XI#84*G//#2%OE\:YL-^"F.IBV.T
M9<1TJ_=N&WUJICS_`"EI;":I"0$FO94Y8E8I#*S-2E,%3VVQ=&)"<3BE)EZH
M0:#@.W"E35,I*@%NY.^VSW&'8K[8HIEY!`!(U5/`GNPWGMA/M<0HL099N<#\
MRZP^D[>[]MN-G?+X0LW"(>035(X$'4?$=6*CK$'DWN<WYAE&W!=Z^GMVYUG&
M7;>8X>U?8/Z*-SM7[;<5:'P_%M;2FHK3ITK96XE6M:>U9)410Y4./.'79,['
M/IE+G#9V<5['Z)O>5+"^E:&E*\13XI!_-=M"+WZ)NI,EYJOX.[:;O'50*H_$
MFM*0/%32%5XC$)]'M1=IG6XG8T/+OEH21M.W#@G?^X'2([[H"Z)>6FU;G%`#
MFP)H>'A]J^.0(#:&4`UTQV`3PU*+*"I1`R!*B<>XWMRNIQ`/KQ^*^9CY3,[F
M.%"=W=A\$`@N>$**#4*J!7W36GZ:8PV/FGEU+:[TE(Z1K:QM#G5&'97'U)UV
M=4^7(C6BUPG)MPN4B+!M\>*V7I4B?)>0S'8#8231_5I01]NE<L\1VL.&EP<X
M2%QX$`>Y631B+O48M.@C#GOI4[PN@'J9Z?0/3WZ>>E729Y#'^<]_[E7U!ZD/
M!*$29T^RP'A9X+RD:B]`L<B:&@V3IYJ*TJ,43HR[N=;Z@O+F6K(F2'+3$$4'
M&E%U_P"H.GVG2/2=O91@275PUKGU^4L.;8*5K@-]-JYP2REQ9>2D-CAH2:CY
MS0XZ62][R\FK&FE/C[%P^];%-%!<@!LC69:#>"!C7T>U$\"CUX<@3W8$(ZU!
M?E)3Y8)4LGQ)6=("*<01Q.HC+"D;^6:]BW8R20TC%2%ODVB5$_?`#PA54YBA
MK].6%?,'@M_+7/X4F$`$C/(XQY@\$D:@T.U#+_3_`-F#S!X+"&7^G_LP>8/!
M"P^O#JON3/[5](-RV^4$K`!II]T:CG0=@]N/)V9O$+Z*T/`INR+9ITD#.A[*
M4X=^,U!V%,[EKL[,#O\`@E[;K3GFD"BE?>-C4`2,R,Z@4RQAV#3W'W*4LZ8`
MX8J_^Q=K-/6I3[C;;C@I1TYG/LJ#3'.KR\-*DBJNUG9XT`-*\%GN6U+8B.9\
M$J"33W17L[!GA/2[LU>0:_,/<G6H0&)K0`<6_%4\W[;U.+D>/5J4Z"10TJ"F
MM>`I7%UL[IU`1Q5,O6.(+:'$*L5ZVZXMU=:J04JI4>&ORC+/%HL;IP<#N51O
M;,%M*8]RA7=NV-`5I2$I+85D#2I4O/A[,3;;IQ>,#55:[M!LH57Z[[=6%.TR
MHI9%!VU-*99XLEG=.`;7BJEJ%F"QPH<U"FTY95-H45'544H4\.VM``<2OG`J
MR;%PVM(3(NEJ-%4;)%.(23]`&',$C92'$[U'7=H,:C<HXNUM64J!J!F"-/8%
M?/QQ:82W(,1L51OK8,#G`'!-*1#2QIJ`=5<J9BE/;[<*YF\1ZU"$@;<%T"_+
MHMP5U-WI=M%6X&T&&2*$@IE7'[YNO_%#:<N.6.9?5=S?V2'$;3[RNT?0@%W4
MT[VXM`;4[A@W:5V`O:"Y;)*`::^6/T:QX?TC+''[24,FB<"*T/N7I7JF/G:5
M<,`J3EH.-'`X<?0N/WJOM*G7_(%I2A.NS<%H:%$,K?4G4YD*C4V"*G*AQVGI
M:XD%"0:47B3KFW-U>.MI0[+7@1[USP]2C^C>VW;*#H;M&UHT5+0("6U%"0H!
M'%)<T`YYG'5]')==<PCY7;]VSBO-/U',<++?3H2T\@`4!J1B3C39M5<"ZY4C
M5E6OT_UXL4A!N0ZOW3\%SH0M8UKQMR_!*-O=TJ&M&OQ<2.`IPQOG;7:%%WC2
M6U">"%I4A)!`!2#2HRRQMMQ5<<QP<10[5L#O+.H>(\*#YZ_1ACJ$KHH0YH))
M=3#N*RQKL13:$I1YH>2IMQ(T'2%(4E-%J^SJ"JA6?`'"%K!SC5QI7BF,MG)$
M1)'7,-_!=0^G>\]K;$ZR>E.=O-%N;LMOVZC_`!EW2I-MLDN3;XJK==W&F]*&
MS#==(2L)\*C[,56]K<]*W]E"U_.YT@`:#F-'/V"FP\=X*]&Z1U!I6D]:]/W&
MJL!B9!;9G/P`K''M)H/XQ4H_F4;VV#N%_II:+#?[;?=PPOQJZ2Y-FN;5TAQ+
M'/76-"D/,A2#+5+<+GO&B<J8BOI78W5C:S&\8]C#0!KVEIJ-KL=VP##<59O]
MY'4?3VM:[8S]-FWE<&?,6/:\`4=3PN^*YB0KD8):=846WV5*4V\U]VX@DUR6
MUH56HQUS-;\%XB-QJ(/RW#XAP:?LJI2VWU8W]M!O39MX7R"%J"P$RW9J*DU(
M4R^IS4""12HIB"&@:*\FK/F)X%26E]?=7:;.'VMR]]#L></@K!6'U;]3(3##
M$\6:^-*`"G;I:XB'%@"A)4E*E+*@<ZTIAC?].61R&S&4BM?93XKKVA?77JRV
MC<W7([>2.C<E"#QS5^??@G>OU862Y4C;IZ6;8GZ*:I48LL!U1\54M(CE2"D$
M#-1J1B-/3E!M-58V?[A=%\-[IS'NWT:3[B4J-=>>A-Q07+GTQFQ%_P!W&>;`
M%3Q&EP*RQ`?Z=U_\?M"V_P#O)T)_]&[_`('_`/NK<.J/I>=9>?78MR1I#19T
MQ7Q*=9(?=2S4*86`E*%J'O'&9=,Z@L;.1X>2ZOP1_P#<?Z<:V6LN(7Q3!X:T
M!KA4&I.&7%=+INVNGVV_36FR;=C7=F'+MHW%N%$9QQ"[C`FM&5)96"I4AQ88
M%=*2%9#'*P-<OM9:ZZD8*.#65(!K7':=Z]K26'2>C_3!NJZ=S6QO@>7@--2W
M+C]WA5<Z_P#._I>\*E1MSNT2TAH^7N:N7F0PI=%^%.I!`)RJ,=5'3G4#JEKR
M1V+QK_K'Z30/$[A(YXW4)/JR55E.A'J_Z![6E)V4(-PM4".B2_:KG)2\(K5P
M#K)4RL/**O\`%./@\:*)(&>*[U!T;KUS:\YL@^4T<#3$;>.%%V?Z6?[@NA;+
M5V:/I[,EM(^OSU:2^E*#,&UP`W+I5N7<^VH<Z.Z[9$2I$ZWQ;L9SJPB.6%-(
MD,.N-+4"W&"36BN"<<BTK1]3N'NCCF!CSEA:""X8T(IM/908KV'U9U3TL+.*
MZU%@BM7-#G%WRC)0%QJX#"F]<_.L'YC>S^G]SN.V-A[!MN]K_&4N.J[F8FUV
M6#+TJ!C/:6W3+4VJATY`@5KCHVG?3"^NY&F662./>W#'_I'9Z.Y>5>O/]W>C
M]%N=I/1MK%.-F>A</^J0"N=F\_6SUKWG/E7";,VY9)3P0P?P>SAQ,5AA2U,1
MD.J<1S"SS#XJ9UXG'7]#Z*TK2+#RMR"Z3,7;2[;3?CC@O(?6?^X_KOJG53?N
M,=L71-:&M!V"M'>)U":[*[E`%^ZT]5K[S573=]ZTG4-$:Y".VZE2JUY<=2%M
MA0^S6HX8FHM"TADK7Q@-D!PP/V+F5Q]0^K]3S07&J7!@D%'-`(%.&Q1+<[S+
MENE^8](?>=)YCSSSCSCG^NM:U%=3WUQ*MTRWX@^E17G=5D-#=2R=]1[PF[)G
MAI%&-39_X9*#4FOV:4Q)0LM;2VH0TN%4YAMHY`)KLETQV[]FSCN37FRGG%52
M1V$J'+4OO-#0J&(N75(W.Y#&D5WT/OHI6!ELP?EM<']M:+;MS>.X-D;HLN[]
MNSTP+Q9)9EQWC7F/.!M30B**<O+/(<(<!R.6&;[:.<4>10_%6C0=4N-&SBU#
MOG`K3AC7WJ^W3+8O4WJ_TB>ZQW6X37;W8M_;SW_!VS*LL&[6_?UZB6^.W:)\
M&0M.N.S$N+8B.,K4&N6A2BG[6*_<<FUO/+-`I0"H(PX"E=^-#3$X*]VVAG4M
M#DUELH,SIVNRU&<4`!JW;N]6]23T5O\`LJ1TIW/U%ZSOVJ98MPW%BXWC:LVS
M/76S[(_%YGX._!BO3&5W"WF9<V5NK88>,=@JJ%:<:S!SJ!AH[&F)!^RG&OH4
MKITD=WYZ:Y<T2-,;14TK5SZTKM7%;?;$6V[MW+;[5R$6IB^W5-M3$5JBJMYG
MR50E-#6O0#%*,JU%!A2E#@HV&!C[NIH<=O9]G!,%:U:E`*-*D4]F,J2E`$A`
MV511Y2=-*BM1E45[<82MJ"9,`=BT1;R[9[E;9[:U`6V=$G)"*:JI>\="/$:I
M0*C`31238W.--Y'N4B=>X++][M^\8B&T1=YVJ+<DJ:S;,@,(=E56"4%U3BSJ
M%:@X"!4<4I:EV;+]T&OKP5>GB0!I)!KV?(<9W*P,!(P2:ZM>OB>`QA*@8;$C
MF0I*B2NH!-1EC&*D&QN(%`43ERN8$:54H55X=H&-@4[MHW,)S(CS5?'](QE.
MZ%$M:_B.-<PXI3+V+PJ)]X_)7#:X()%$M$*`HDY[ZOEPV2S?$.]$7RM*0$U"
MRH``#,\<J<3C.=G$>M2X(.PU4E]-.F,_?;\BZ7.0JS;/L@,J^WM]"DCR[2>8
M8L'4E*7'W>!(K0'#*ZH7@@X42\<;'&KZ5[4X>HW55JXVR'L78;+EKV#84'0V
MP0B=?9#XY*WI;Z0>=$8'B2FN8PUKA53HMVMMGD4Y@8[OK0TP3E9'^:?3DP20
M]-Z:[B?67#XWDVB:^VV&4Z:J$2K^K4<O#6N6`[$PU'FW.F1-+7%_"A[56=\G
M7H-2MK6DK/!P%UQ;:J]HY2T@$9$##ZV($="1M2QM&,MFC9\@1YI0`;H0,D]U
M>`J,+YFG817O5;O+=C:EJ<L!TA3)4:H"DJ4.PTIW>W&PV*!?0./!7I].U[<=
MG,N)4XE3-PB(:H?<T9>$=PQ":S%&^(EQ%2%T[H:Y+(6-:<,[O>OKE]`N^BQ$
MM,!Z0=<IJ-5*EI27%J=2A1T"E5*;)'R''G7K:S)LIW,!+@`<!7>%ZWZ4OG-$
M+JT^=OO"NU^8E;T7OT<]=;:4!;2=M"0RV02&O+OL.!8`S`!-:G+'+OIC\O6,
M6;`F3?WU^"ZM]7/\QT#J9DV<G;_T7+XJTM`I1X*E*$()H<RA(17]-,>^Y@<P
M-,,K?^R%\N[J,,N',9BT<,=W8LT--ZTA1Y6HZ4K(--9!*4D\`%$4J<AC0![1
MGH<HWTP3*:Z\FPRD5.RG?@NH/Y=_I[5>;LSZA-PVM]5GV^Y+9Z=1)RVWE7*\
MIULW3<;S1HE5MLK(HTD@E3B@I/#'(_J)KS8K9T,#VND`\(()]0Q7ISZ$]`,U
M!AZBO&EN7$9A3?NKW*(?S"=\'=GJ!G61,DRHG3;;ULLC82L+9,ZX.JN]V<:`
MK]_*5)0'4DE25)I0<,3_`-,[7)TQ%J;P1//%F-<#4DC?CN5`^N>N.N^J9K",
M_EPS90!N`IM&Y4<T$C24D@>SMQ?+05T]\CL).8,-^_=P7'W7#C<-B^YDKV;E
MCR1_=_0<:I:HXH<E/]W]!P(J.*-1W3')-%)33*@.1R[AW8R"G5I<MMGEYQJ*
M(V[<_,(\NYJ4..M0.G/LJ13LQD53_P#=F?A2464U-$5%30TXYXPHEQS.+AO)
M*')3\'T'&%K4#:AR1_=_0<"Q4<5ARD_!V]QQ)?8FGVKZ?%1F%I*$`:CPJF@R
MSX_HQXX7TC30N,%"-=0,\P!PRIQP]M-CO0D)SL]*UV!:(TA"3DD+2!0=A<''
M])PY?BPC^Z?<D6>,=X]ZZ']-9L'\%4R[(:37/-0^S^G'+KRR<1A78NEV5\TO
MH>*-[J\D]`D);<;42",J&M:UX8UTB$PYP=[@GM[-SLI&P-5,MW6B2X])T!OE
MK6YI\1]TZNRG<<7:U.5M>"I]YXRH>NME4U'*5)3Q'#AP57LSQ.65Z"ZBK%YO
M4,;OLKBXRU);J`*$&M?M$94S&)T7OY@X*O2VYF:7#:H:>V@ZI!5(;3J4FK.D
MDYJS1K\(TT&+#;WK>77<J[/9.$F(WIFW':2FRLJ0@`U'&IK^R,+"^:HF^LG&
MI&*C>\[?6P%$)'+[JFN?LIA]9WK33O56N[)PJ178H;O-J4VI25)J5:J4[*GO
MIEBU6ET'@,X_VJHZC9$QNIL4<W&UA+E5(R!5P%>SY,\/U1[ZR.-5?W\NMCE[
MHZFJ2*-FRVB@.1J)9"LNS/'-?JICHT'^(^\KM7^WZ,QZCJ$?`-]S5UG\NF6S
MI5FWK0H]_A4%``?*,<89)RN4\\5Z9U!ADCB8-X=_V5SH]3^W"=]6R`49/7*.
M^0*D5*`MH\.`2#7N..\],7K?V]HKC1>2_J'9N_<7"AI4KB;ZBYBY?5O<JB:J
MB284&-V@(A,)2\">S->7?CLFCOYFEP/&PL^)7AGK-HCZKOV\)O\`V&J$?]/I
M&)15<?!+5O05-J-0*+[3_9^3&BB+LTHE9J0VISRXU<Q"*G+PT`SH:XD(R,H&
M^B8.C<&<T^$E'FE!"B3\-/I'U8TN/`._[4DMZ'$EU"!6JWHJQEV(?2E7Z:K&
M&>]!!RD_QL5K?49+2J;TWM;JE:[?T[MB)7+-/"I22GDN5\1R[A3#?1#_`)F4
M?WC[U:/J%MT]Q_\`I(O_`,DS:H$C2T.NJ<*I&M+2&?O7BXG0@^'2#2BN_$L\
M%UTX[Z?%<TU2.N5K0..Q*C<E&GB>)X?^W&X;10CH'$I:$E=`0I/9]K^K&N*C
M3;CM2@W<RA`349<<QC>J;&R=7#8C"+@M>FBD"IH*JIVTQFJ/)2;D9;EO!P`$
MK/-=9.BGA4TG4I2BHI`01P/;C%3P6"+FA()K2J.-S1S`7@'6D+8=4@YI?,=]
M#X86>!;<*,SA&9O.'EAXGA;V^>.5E[*?S8G5:#[2NW7IB]24/K[8MQ[9G6>'
MMN_;7M\6VJMK`,R#.LSL9%O\X2H(#"UMDY!)TG'$>J>FI-+O([@9G`2AV.W!
MV:B^B_T@^I$7772[NEKYP'^7>RE?Q,+5R@ZM[:D]*^H6\-GR&[A&-ON+A@>9
M:4A,ZT39+\N*XPLJTO,L%RB2FM*YTQV'IK5#=Q5!_++5X4Z_Z1U#I'KF:T+"
M-/;*:'&E!39WCW**F[E&1(AON,F9'1(;?EPPX8RW/+R&7VB'DZB#J;X4RQ.L
MT^"^AFMY?$:D>I5C2HS!JD>J.PY-RUP/8*+HQZM/47OS>G2_I-+VU='=K[2N
M]B;B76W0#_\`3$D18#3:$O7U)#J0I`HIO@,<EZ;Z+ATK7YKDFK@\NQ':2,%[
M"^L/U6O.HNB[)L7S6[X!">YS6M*YE&Y+4MQ:5%M+BRMQ#KYD.ONFM93SZJ%3
MB@:$>W'4:G>O(-&C!J*/7$Z\Z*-!F,^_&*FN"2=;&4YD1=EJ2A;E4T`U9*SS
M([*>W&N-<4YMK6LS&BM:I$FW0J2W121FKB:=@QO138L'#Q53??N2@ZK@<AF*
M&N0[<"?0V8$8P*2WIR&:^(:NPC,>+]/<<(RX1E/8K5SG#@FO/G*2M*B4>/5V
M]Q'LPSVJQ6-D[MJN@'HEWWMZ-$WA`OF]K]'W79++=9FT-IW&>H;%799:6D7:
M2JUN/Q&;C<E.%7W?-15)/'$1<DNN"UM*`X\=F%/2ND]*7>FV#9FW,=7T\6&)
MPP[Z*1-[]:.EG4>VO]*]C1KM+N?5B+=-D7EYMB]M[1V%=HQ$3;@M5N\JN):8
MEYGI6I2O$$*(PDW,26N-6C`'?LQJFAFL-1$EM:,#;C.UXK38#7`;3]BY);YV
MMN/8&Z;OLS>$(V_<5BD%B>P5AQ3@7_#RRM-`I$MI`6DY5!PH-E%LVV\L<U*-
M.SAV@=R8SCJ`I7'B>S`2MS5QKQ2+,=2#S,])53AGF#V?HQ@'YE)V`+7T.VGQ
M2))?0I8(K[@'#VJ]N-E*T)4ZR%)W7T,6X279^P+FTUR^WR%S&L+8`KS`E'O\
M-)[\%:IK&TMN=N!/Q^U5N?=10<>/8.!IP/MP;E9;;X).<4%*J.%!C"=IO/<'
M/E/].-E,,\([DE/<$_*<!6[=JT8PMUXHA()/`?\`LQ&ITBSJTKTTKE7Z:8$+
M0%H)4E*TZT9J34@I`&HJ-1F$C,TKC5Q%"-]%ORW$`D?*5+O3OI8]NJ,YNC=#
MR[!LB%54V[/'E2)R,E-Q[2RX$K?<DZ2`JJ:9XBN]3%G9.#J+3U)ZFR-PPF]H
M;.CJL&QK0H,6V$R?+R;BEHZ52KBX@JYI?(\223C.U24]D>:PTK\JB=NNA&I#
M;:@D`MLIT-)-/=;2*`(!X8P>S8IBUM',;F.T8E3_`-`WFYAWWLB6JD#<>RY#
M;#8SYMQB).E"A443][D17Y,"=JO4J.YYAQO3I5&5Y1Q*O#1<0".10U)2`V*>
MS`DI;<S,+NQ:4,.)4DD)HDC@?;A2+]5O>JO?6CHPYQW!.6$\CPISJ"*Y9=W?
MB3K14^[82"=RM%T5W&W:9:0%J0OSC+_#+0W0JSJ/%B'U.VYK2_B%8ND=2;:%
ML#J5#R?65]*7Y?W5FS7K=NW+/^)MMW2.802U)260\7'PD)86HD.*H:GA08Y'
MK]J602N(-`TKU=TEJC;CDPBF,C?>"NYWK87S_2;US75(4YLF9$J30<VL2A_U
M#7CC@/0S?_WY@`W2-]Y7H;ZN?_ZVU3_P/_9>OBM""G2V:%2=*"4FH)%!0'A2
MN/H&S\^7DC[K&_\`9'VKY6W=WY.V#V?J$GWE3)T+Z+W?KMO^V;)MJW8EN4I<
M[<]W;0IS\#L4%[3+DN)TT#\MU'(CI)!<<4`"!GBI=2]2,TBV?;N<!AQ]BM/T
MUZ7ONL.J;>VO6GR#@]Q)V5:TN'MHOHW@1]L=+^GDCR4:+9ML]/-KOW%EF-'1
M'BM1+'&+SZ'J%*>9>2RD$=JU$8\XQ1_Z@U[,P5J_XKZ`W<-IT/TDUL9`RL^!
M7R^;OW'.WMNW<>\9Z]<O<]\N-\>43P_$)3DAM-.YME24CV#'IK2+,Z?I<%D[
M;%&![U\\NK]0_=NJ+[4_^?.7>P#X)&Q(JN(8$(8$+PIU%%::0KQ?)0\/;C!2
MT'B/<C<A$-37+:"ZTJ2I(`U'C3Q'*@P)RM"4^ZD>P#]`P(7JT*0!6F>`)"?8
M%KQE-UYB1^Q97TU/NF,X-`"J?%7M3[*=^/&Z^DJ;MS65IU$4K7A^C#VT^]Z$
MWGVA-Z.ZIE6I(!-3QK\5:Y8=D5%$B-H[U+5@WJY#9#)EJ03V!2LJ>P&G#$5)
MI%O)@YSZ>C[%-1:@Z+PTKVI_M;T5(2EHOAQ*P=1JJO9WFF=,1,VDV]F\"-SB
M"*XT^Q2L&JRS-.#:#O\`M16<\B<@U2D(HK2I/O*!!H2<P33"\;BT9!L.";S$
MR`N.VBC:\VY;FNB!RA6BJ>*NDTKV<,.88Q#3*22H.6V,N#JJ-[C8T.I65A2J
M94H*'(\13/CB4@<7_.=R0\FR*(MQJ35,"XV=ILJ/+\**\$C("O'+N&):WN9,
M[8L,I-%7KZ(,!D;BX!1KN"W1U(`2DA6HZ:`9G2JH.7#$MRQO*K\O-FKF``*A
M^\V-YU*QRZ`^SQ4J:',8?VN5I`)WJ&O+2@-:[%!FY+&ZTI:]&2:UKPH#2M:8
MM%K,(@)&XN;LKZE4-0M*L=2M**);K"750Y8XJ[#^C$_;W+Y:9@,5SS5V/A!R
M@55S?0`I4?>?4B-I316V;=))H:A:)ZD@#.FD@?+BA_544T:#O/O*Z=]#9'1Z
MI<NH,TP`/92@%/5OJNL\!(6UI-:4*LO[(K])&.*%@DCB:<,5Z@B'F)*.PY0-
M*;Z@C%57Z_6`W+<MAW`ENJDJ=:D(`')266*-*2*%>HIK7/CCK'3$KC`(3X0/
M2O/OU$TFW;.Z8%V8GL^Q?-UUN+RNJ.YG74CEN7F=H4*U("@.))'%/S8]#Z(P
M,TF!@W,W]Y7SS^HMI'#U)?7+"<[IMF[PM44.JT#+/Q`9_I/ZL2@Q5'MHQ*W,
M[:E*.M2$9'C0T]I!Q@A1UY"UK@,4:9=+<@/954`A5>&DY$_+3"K97-I2F`HF
M;V!T?+.RM4J&6FG@H3[>[]'MP/E+Q0A(^69Q*-0W2Y(8)`%%(&7_`-MQN^O?
MA+>LFW:&D5*LOZBEJ&[MJYU`V%:<O^T,--%/^:D_Q.]ZL7U`:,MB.%K%_P#D
MFJ!XSP.K62CNTD"OSXF7?U3O\/Q7.+MI+@0`31*;4Y+2-`.H`DU417/Y",*)
MF8GG</:CBYJ4H*@LU`K2HI^K&5MY"'B:^C[%K9GAS551RIP([:^T]V!(S6C(
MZ9235*K$YL(0"ZH9D',5'B/`UXX$W,+1Q5K/2%LW:?47JV[M7?2K>[8;YMZY
MMPXTV28CJ[FTEQJWN,NE:4^9+U"$T\2LJ=F*WKFJWVGP&6U8US@:X@G`''"O
M#T\%T;Z:]/=+]5ZT-+ZCDEMXS0`Q%H-2/[[7#:K#=?/1/%Z;['OF]=D;IG7=
MC;SSDJX[8G,MOSX]M2YID&`[#C1P>2XH$%P+R&*[H?6%U=ZHT:A'&R@^3+6C
M@:;:N)KPIAQ71OJU_M_L^F](;KG3$EU<6S<'<PQD4()K\C&G"GJ40>B7==UM
M/J"VI&@79$")>X5PAW6(X&RS<XK$93S$9T@!2E)4:`UJ#BP]>L=J5IGA:#&!
M4TK4"N-.Y4#Z%7L>E]8MBNGNCA<0"1QH>-=JZF]?^B-CZX;83#G.,6S<UH6I
M_;^XRRA4B(TLJ#]KDJ""Y)M\DJ%0?O$E`TJ`K7G^@:W^SW7*A.:)V!!QKP.Z
MA[J`[PO8O7W06B_4?2IH7M?%<,!+'LH'NP/B+@1CAL"X6=1-D;DZ6[NN^S=W
MQ_)WNV2CS$-.)=COPW@'(4MA8SY<B,0JA)()(QURSOXKAK=2M'5!93L.WTU7
MS^U+IR;1-1N=$O,!&RK3A4T._=[`IMN5S&X?2M#(5S)FS-WN,N*!)*+?,=TM
MA>HD@);X4H,1@>YMX)AXY'`'TG<KI+''>?2N%OBN8KFE!N:**I?GV_C/T?7B
M;7*O*G@BC]Q0%TU).0][CV]QQD)W!:G)Z4DO7`K2X@'-50*'VU[_`&8V8`YX
M:ZH;5/H;;ERM>[8"B#P7RM:G0DIS"215?L1WD#"5P]D1HT^M/8YB^4,H2"=V
M[O3SZ>]*-^]56=SN[.L,R9_E>PR[].DR&ULPEMQ"4BVQI*D!$J\2@*LQD'4L
M=HQ%.U,LFY;@W*:`;=I]*M=GHM]/1T3*VV\XU[>RF[X*$)CSZ2[YEF1$=0=*
MX<@:)4904$J$E!`T^++@,\/GS,?%_>2LEH(+@P@8@[3O[DC*;>N4J)$BZG)+
MZRS'9'OR'W*!J,T!6KSZP$H':3AL#52UBTC!PPJNC>PU>F#TT6T6SJO;+MN_
MK0[M6UNWIM,)=SLEFD[L!+VT(4/6EEN\6MG2MYQX+#:E<*C$1,)'7)<"!'7'
M#$[*4.P`\*5WU5PTQFF1ASS5UQ)M!I0;MP!K2F)WX*^_2'I3TPZ7;:9O&PK,
MW88>Y8[5_G2+S(95<&H-VCF>VY=)<P%$=BW+4>6I`0L#M)SQJ&@"G;7#BI"+
M3F63SJ(%<,M3N!%`.X+E?^8I:X\7K+8+FT8%;SL6V2'_`";T:1)5(CO.-*=G
M/,C6X'F5-K9+A*^6KC3&:FF&VJBKZ=\CZ``"JYU/OJ2MT`)H-5./8/EP;14I
M2*!I8TDFM$C/OJ<0$D)`U`Y5[`>\^W`W:I&")K'U%=B3'O>'^J/Z3C8I\W8I
MKZ%7.)+OM\V5<E'R&[;'-BM::<[\22RMN'R@K4T3S:#-)/=C#11.?)QN+9:F
MH'HXJ!+O&?MLZ;;)"0F1&FR$2A2A;DLN+:<:1PHVD4R-37MP*3A`W84%$@NO
M*;5I`!%`<Z_7@3D"J0'7U$+R3V]_?\N-\%+L\('8$GJ65TK3+N_]N,)Q&P&M
M5CC"5Y3>U%%.J4"D@4/=7L->_$:5NM6E]Q;3,6.[*D.N!"&FDE2E5[``*ZL-
MYI71TR@&J<01-EKF-**PNV.G=CVM:V-]]6Y+,*V(;2NQ;=U-FY2P"2T)D=">
M=4OC.M!I(P@;A^\#8IRWTR![`0YX.W:,?8H\W_U*NF_YB&FQ^$[:ME&K;9X0
M<C1G4?9<?9UJ2I;8X$4`KA#<I>*,Q&H%>]1\>``%`G(`5H.WY>W&$^8U\_SN
M%",%YVC^O`GO-FCB<T-&P^Y/WIA>E6#J!M6XDI#`NB(LI*ZZ'&)B%1BE0!23
MXW$GY<";D2"VYY&*PZG69-@Z@[KM:`H--79UYK6`%<N4A$A/NA(H.9EEC*WT
MFYDNK)[Y``X2.&'8!]J8G97V84B_5;WJ)U(!T;P=X*WQW2A8H`:D<:^SVXD2
M%1KN!H%*E2KM*<6941(6IOG*6A>DY@`BA%?9A22%K[4N-:XJ'L'/BU$!OAJ%
MW,]#-P>?W-M2>Y+Y%P;>MRVG@EMM)#$QM0"U)2%T6E)2:$<<<FZLB9'IT[V[
M0![PO4/0=Q(+RU.'ZC5].GK8W&B-Z->L<M0(4-I*2XI5>2M;C[#"2V:ZB:-U
M-3QQY\Z*L8V];,E!-<X]A[EZQ^K5P[_[:ZI@/T?_`&7KX_8UJD2@RPT'7YTU
MYEJW0([#LJ5<GY24J1$CM,>,/*Y@IW#/'MB]U&/1XW7[2'3%C<';!1H&ZAW<
M5\KWV<^KW%O:::"^[<\A[=PQ-*;-U-M=J^A7TE=!V>A?3QN+<F&7M];G;AW/
M>D]*&]3*O+4MNV@L)"ELV5OWU)-%O"I)./+O6?4]YK>HN9(V-L)KBRM>S:2O
M?G0715OT[TW'</:X:CE!QIO`KNWJ./S!NI+>RNB0VA"E+1>.IU[CVD165$.&
MQ6=!NEY=6$D*$5Q*4,D\-2J8FOIEIQ9J;9W5(KO4-]=>HG:;TA"VV<UU[*:.
M:ZN`H=E*=F]<*U14H.DA*#1*M#7[MO6D+#:-53I;"M.9/#'I&Z(-P\C95>+'
M1-<XFI-5CY='>KZ/JPWJM>0WB4/+H[U?1]6"J.0WB4/+H[U?1]6"J.0WB5Z&
M$#M5]'U8%NR,,-0O>0CO5\X^K`MUL:CH+B!57'V=WR8$+!Q`6XI!J`C@1QS-
M,\O9@V+5[`_:L/+H[U?1]6"J3Y#>)7GET_$KN[/JPOSW<!L2'VKZ6)M>2NM>
M9X--??\`>36GVO=^C'D)?21-F5K\`5JH=62JT/#OP]M/O>CXI"9I)%`4CNBB
ME!(IW`"F9`[![<.ZA(%KJ;"L64.)9U+!#FH9J%%\*9$YX,%'\Z7\+D[K4ISG
M-U4K33O.FM>W.E:8C+^.1[FN8TD`?%3VD35B?S?E.84KW*7+0V9@0BAT(`!-
M#121]!!^;$:`6.&;#'>IMC<^S%JW7.U$H4$M**.Y*?#72<\AAUSX?QM]83CR
MS>(49W2WA(73PI!SS(%>WLXX?VDT3F?*YIQXJ+U"$M-&"HR[E$]W%%.IIJ`*
M@.T*IJ'Z:XD[<'G-=]T."J-U&YQH0:)A2["[(67U(7R^(0H$IK[$TIPQ/\R+
M\0]:8^58FS>+:VM@GE-H<&13H`50<#2E<-C<%EQ1AJV@V)E=6@V@5%%!>ZK`
MV&W%*"%#224J`((*AV$=AQ8K&X<X@?=*J.H6=&N--RKAN>W!',+92CWZZ/#V
M"G#%QLI(S2A"YIKEG@?E4\^AF:J%U:OEM4X5)NNU9?-)5DI,5TN#7\26?>_L
M\<5#ZH,?<:1"V`%[FDU#<:;=M%:_H^^*VUJ6.1S6NPH":<%V`MRDT0@*&HGW
M:BI%,\NT4QQ9C74C%,0<>Q>G[9S87R.E(:TC`G"JA[J$P93MQB+3J(:=<CH4
M*ELAA:2XR#FD@D"HQTKIBZMFT89&!^.%1Q7%_J%%+)5\;7.9Q`J%\R_7^VOV
MO?\`>(TR.['?1=9E1(:+3JM3FL*(6`HZ@H']./1^CS1.TR`-<TG)Q[2OG-]3
M6/9KMVQP(>9<`=I^5J@"74/4X)J,NROB[.%<37*E`S%IR\:*@6C'PQALP+7'
M''##TI3:4G0/$G@GM'<<:EC^!]2C[WYW@MQ'8O*JU5J=.JM:FE*\>ZE,)T-4
MWR'+LQIP1EI:=8HL>VBAP]N?#&4D6N&)!"6D.(+T<,K34%L'EJ%=2I;!2#I[
M2E)I[!@6IV5.RBLWZBB1N39[Y)Y4CI_:>2\?<>*2G5RU\%D'C0X8Z,]GF9,1
MXG>]6'K^*2MC5IH;6+=_\)JKF'%!/O$G4>VN5./R8F"]ANW_`##P\>U446[W
M/H6D8<%M1(;":..("J\%*H:=F%L[.(]:R;)QW>Q'FU$J&I1*36NHY<#2M<L8
MSLXCUJ/.!HC;>C/3I[*TI[>[&"]AWA(3`FE$=;E--I2DA!4GM.FO&HXGVXR)
M&;R$U=$\FM,$KVJ\OPKC$FPY$B#/A.HD6^XQ)"XDF#+CN!^+):D-*2XCDR$!
M=`17"=];VMRVI<TGO6T/F],D9?V;R)VN#J"M<*<-Y&"[C^D/U&_]?=H7[:>^
M515[SVU:XS.XV2TV(V[MO<TM.W$MN5UZ6@$R%&H4M0*L<HZET06-Y!>6M1``
M>UK7$[*[J[ANW+W+],/J1#UKH;NDM;+`7L`J\BM0*`8[\55KU&=`(7IZW)MS
MU"=,7KK$V78-X6V9N.Q-OQ/,61F6^7'%0`*/JL]P51OE9(2%<,6;0^H(;VV?
M83/9),8W#Y<10BGK&TBO:%R/K;Z:R=#SLUVS:\.\TQ]*4JUKVD[-U*BNSC@N
MK%AW$C<&W+#N:'&D16KQ98EZ9:?2I#J3<F"\E-%9E"$DCNIBA76C,BO"T.!R
MOIAV4VKU1T_KDFL6=A?6D$D>G2QCF2Y3RVU#?$ZE!OVG<5PN]<$V]'U$;S?N
M<-4>((ED5;7`RIN,Y`3;(^MYI1`;6@2"L*4#2N.G=-F)FEN8UX=1W&I&`P*\
M(?5.RGM.N;P2G,)75C.YS"!0LXC,'##>"$U>C-R5?MA]7]B+)=,^S(OT=E9U
MJCKMC#B@XRT:E!<<2!J%*G#H-<9VFAH)!CV52?2C"_2+[3;KY81:R/9FP#GY
M74`KM<<*`8JL3DDIYM1IY,A<8&G[S1JU+X@J(*:$XFQ+&20",.U4MMH'/$;1
MFD(K08GU)-?D:E%97I2$BN>D`"IJ<SE@,D8%2X`=Z>16F49'?*^NPX%&;-!O
M.Y+M"V_MNV+NM^NCR8EM@1PGG27W@=("B%)1X*JU'++"$EY;1M)YC`X#\04A
M9:5)?74=I""^21U``*DG@!O]"NITI]$'4ZZ[BLD_JO:(MMV9#=1^(PC?^1>9
M2!1Q#D5FW(4^Z%DT65E((X'%>O+^%[LH>'$#CAZ_@N@Z']/M0-Y_F+>2.)SL
M26$#NQV!=9=O[8V[LRUQK!M6S6_;]F92MB-!MZ`VV^`GG.NOK*W%R)3P/,=*
MU$ZB2:8A63R&8G%PK6M/=W;`NYV>BZ3I-B+2X=&QH!^9Q`&..TKEGZYM@^G#
M;P=OUKNPVSU/NJ&U*VQ9),:X1+PL/M<]5ZBQ5G_+H9C:W4*6$\Q:4IXG$]9O
ME<*S>"NVA;A2H&.![UQWJK3+!DK[G39HI7--<K7-=B30D4.VFWL7,;;VYWMK
M;AVWN2/#MUT7MJ],7N+;Y26BW,EPE!<3S:U`ZFF7:+"34%0![,/@]A&)%.'%
M0%J,A<TU#G`5)V#C3O1'=&[[UN[=%[W=>Y@>OFX+U+OMPE*65`SID@R25:C5
M:65$)]H3AB]K6O.2F7<!LV*0CB^<3@X>W^"KMW/UUM;MZ.[KZ<;UVHXY=Y^R
M!M6'N6U3U153)<5"&X4I;#:DJCLIIFD9%&7#"5:;*X'UJ:N-2N9[46;!B7-/
M<`=^"Y[7F_WF_2Q+OM[E7B<TQ'@B3,D.2'4Q(##<>$PF0\M:GFF6$!*<Z)`H
M,9:3][:F\<37T):0TBN/\8=R;#SK=7!K37Q9:AW8V3\1.;@T$M"1GUIT>%8K
MJ'NJ%>![CC45JGD+'E^P[.")*6*^)8K_`&E9T_2<93KEOX'U(SMR]JV[N.SW
MQETMN6NYQ906VYH6$-2$J6G4D@A)%:]F,X!2+&/+0VAV!/3K_:VK9OZ5.B:$
MP]P18EZ8<C@)CO*ELH5(<:6BB'"ITU616JN.,'L3NV8\U%#AV*!G7#KS</`<
M5?UXU(/:GS8W4Q:?4DMQ22E7B!/RCOPHI%K'4&!2>\2`FA(S/`D?T8U)`VD!
M.8P16JT!2R4I"EDJ]T5-5?(.W&O,9Q'K2NZNY.+;&T[]N^XM6VPV]R8ZZO0X
M^0M$.(D)*EO2Y0'*80V@$U41PIB/6S6DFE#53>Y(V)T7+C4%,3?/4-AG0\75
M,2MO6IQ:?WC+QYC#\ALFN7B!3AI=?=[BGEO%(*YFD8\%`FX-Q7G=EQ?O%_N#
MMTG/NESF.I6VVT"D)#4:,LE,9IM*0D!(`-*]N&BM=DQV48&E0D:I-,B:"@]@
M]F6,JRMA@<:-()7GRUQ@N:-I`3Z"U8&FM!CO7M1[?GQC.SB%O);LY;L1X3[E
MFA;B"E3)4'D.-NM.-U#B'&'$/H<0H9I6DMT!&,9V<1ZU@P1>1(%-BF[KI':?
MW%:=S<U&C<>U[)/2YJ&F3):C&-+(7P=?0MH<S,D$YXV!!&!JH'3>6R!\+2,_
M,.%<=@4'D$`@@@C(@Y$$',$=A&%8OU6]ZC-28]C79P1@=JR;]]/RC]6)(JDW
MA!K3@I+VIRQ<(*W=`;0M96I=-":TH5%60PX(/E>S%05M\M\'.P948[EVB]"<
M63N;JSL+:4)QYR)>]TV6W6\Q"M<II"GT.RC*#=5",VPVM1KX0!7'(^LW-CTF
MY>\T:&C;_B"]-_3UC[J^M([8&1YD&#<3AB<!P`7TJ?F-WP67T@]2;)4<MR-:
M]OC/2EYP7#D/.T^VI7*"E'/WJGCCAG0S7S=3MNHVN,.8$NI@!7&IW4WKU3]7
MKB"'Z>ZC:2O8VYDBHQA(#G'*[PC:=H]:Y.>@;T[.7&>YUUW=:U"W663Y3IU!
M=66ERK[#*K=<-T+8=`$JWQF8W(:`!274*(SQV'ZD]2V[8G6UC,R20-;@QP)'
MRBHPWU7F?Z!?3RU,O^I-:;RVR9BWF#+7*[+AFV[%UZU)U-N.>+D)"64_$%.@
MB.D=J''55*>!..#VTLMW$7.!-T7MHW[U*BN&W`;5Z@OYXY,(Q2U8YHKNR@XG
MN`VE<!/7!U37U+ZWW2!;70[MSIXT]L^R%M[F\R0TL?CTPZ%*3JES$!)4/?#9
M!X8]0]":.;73FW<K"W`8D47A?ZR=0R:GUF=*MG\W2XV^)IS,!HW"HPWE4\Y;
MAS*%U.9\*LR<R>'$XOI>)#S&D%IWKE[35M4.6Y_=K_95]6!90Y;G]VO]E7U8
M$(<MS^[7^RKZL"$.6Y_=K_95]6!"'+<_NU_LJ^K`A'B@!JJ4`+"!0I315:=E
M!6N!"(<MRI/+74\3H-3\II@0O>6Y_=K_`&5?5@0O.4Y_=KX_"?JP)ID=P.U?
M2K<65!=0:\,A\@QY)7TB22N.5TU()I6GZ:?5AY:_>]'Q0DUZ$CF*/*-<C_LC
M#LX"J*5P0CVU]^A*#IU`4(S^@'$;Y\+3R#E(-LVZ_P#=G2FBJ$9+R%.W*E<'
MG@6G%/+2Q(.(WJ;]K69E#+27&R"&T@J(R)IQ'`TQ7;N]#WY1OP5HM[,B(G<`
M?8G>[9[?RUA930I53(Y&F6&B;J%MX62*TLI86T$J;U_:XZE@_9XT&)O2_`?\
M7V)G=;^Y5VO,!I*GDE;:#J<`4HJI4*(KPKPQ;[?P>A5*\\3DV$3(J"8KE7"!
MDM!3HK4YU)!X'"JBTA76UH=)6DHH4@YE79Q[,\;Q?J+27]-0KNVV(+3Z?#70
M1V_$G%FLQL55U#]-RJWNFW(4I]*0/"55X]H'L[QBT6&WT+FNN[*=@3@],+JK
M%URVFYJ"471<^U/A)()CS(Z6M)K3(.)J?9B-ZJ_H#W%8^GO_`*F/H^"[),E2
M'D%!`*%_HH,B/T@8XDSQ'TKU==,YC&,[`D3<UO1,<?F(2.884EM(4#JU%&HD
MD5R.G$CH%/.C_%\52^K;$^1=7@N$7JOV#$W>U==[[=AJE;AVJX^S=+6D`O/L
M\Q27I"FTU2I332=69&0QZ4Z?NLD$3,,&_%>$/K'TE%?PF^L?ZV,U?3;6OV47
M,"8H+6E2-122BNH4*3V!5:&IKCI\5USK8-WU"\QL,[FD7%>8P4_CU(RW[B?D
MQLFIVK>74Z"FAKIT]E*TIWX9/\9[ULL65!*B37W2,OE&-"D9Q5E!Q1YE1));
M4$+#C+@U5X,J*R,JYGLQ@8[$U/RBCME"K.>H%U^3&Z33$K26E[!AL!6?[QM#
M3R_9P73Y1B#TC^HE_P#%=_VBKS]0`TML*[K&'_\`)QA5W8>6@J+GBJ`!I[/E
MJ<2K?ZE_^'XJAN\?H6E^0@N$T5P'=W?+A=92@U-5K2%>[VY>PX`W''8HM]F"
M#3:C9F_"H#OK]'#&2!N2(L3O6]M\*2E16FIX_H)';\F#!!L7;MB,+FH0DJ!S
M%.T=IIV'&<%CR#E(/27JW>ND^_;!OJR7!49RS2T.W"WZE!F\VPJ`E6^2FNEQ
MI0.JBLJC#/4K/SMA)"-X5CZ3OKC0=;ANHP<F85*^BBX#;'5+9"F;[$A7C9N\
M;);KO.CN^*+.1.8;?3"C%O44J:6LH/"E,L\<KLXCHMTZN#C@/3@O9=[>V76V
MEQMN"#E;BH.DL[I]+\5ZYDWSJ!T!<,8-6V0E=WWATQBRDJ8<;M<AM7FKQMJ+
MKUJ2\$KC-H`0%5Q-.E%Z<@-)]],`>VG\$<509[OJ/Z:.\[\UQTN_9&*$`>S=
M7>N;OK3ZO],NM%_V%?MA7V5<I5KM5RVK>([\(P71%AOOR(-P=2HCGL/H>U)5
MFH)\)`4",6;0K8V\#VG?(3MXM"XG]3-7M.I=9@U6Q`$)LV@BF+7"5YIOQH57
M_H#N14+J9;F%N?X3<<&Y624$$`/MS65,1&TA1&292PHU^SPSQ./D#6%^X`E5
MK3),DS+5V&9[6GTE),3IWO+>_4"\[`V79GKIN&+,O;Z;<A:6E*;A%<A='72E
MI!=CU4V%$:N`SQ%&_:UY<?#OV)M!HUS+JDC+9I,@.%.&/N3VZ0^FK?6_NI>V
M-L;UV[O38]CO$:;+?OKMDDICQVK:I:74N2G4^3YCRDD(&KLSH",#[[\MSMKP
M#AAZ%:=+Z2O)Y,ET,"\[1W;%V%V#Z?NC?3)]N=M79D-F[MLMM/;DD/.2+G*+
M38;,D-KJQ'=?(UJ*#D5$#%?GNS)(6FGS<%VC0^B-.TUK-5']1;_,WOV8>M3`
M9)+20\=;B5*"2G,!H`!"<Z&HPA@K5Y\*"O4C<;_%Z&=3Y>TWGXVX8FV)KD1Q
MLJ$EF*TUSKC.@EO40^B,="2:>(=V>)"UP`]*K/5+Q-8!^XE?-C.N;]S4FXRI
M\VX2I:4^8<E279;H(SJZ[(45@D]U<\6,N'ER1_&Q<9Y;FR.C<`,IP--OVI/Y
MJ>X_1]>&E5MD**.NIU*%%?,.[Y<8)3N-I#`DY_\`=_I&`)W!^HDY;H;H"":]
MU,!-$_:W,D=YY)<<R5F3W?7C*?QM(8.Y$5J"!4UXTR_T&!/;?Q^A$'GDZADK
MW1V#O/MP)X!5$CH45%5=)U$TI7@2/96N,)ZS!H]"F?J"L[EZ0=.]U?OI]HY]
MBO"SFL!(<5&*:5&@)2*ZJ'V8RW$=M$^M@&RO`V#[56UQ6IQ>1&E6CY:=H]AK
MC*?)/S)-`2<\A@3X;`M`(E/M18P<DON*T(;CLNO+4LT`2$-H4HFN&MP1@.U*
M<M^7-2@[5-VW.D)@QHFY.I=Y&U+"X'%6^"5M*NL\(4I*^1'KJ;U+!R<TX:[Z
MK!+<N4`5XI*W!U6+,![:NP8"MJ[;=24J=;0R;O)T*"Z2)*%J`2Z4@*TJ)H3C
M;#T*9L[,EV8XDJ&6TN!'WCJUJ4M:E)4HN!*E&I*75_>+UG,UX=F&=UM:IX61
MJT]BV?U5RPS4]:V564W(?Z#+VX%*V5D:]N"\-:Y9_HPUG\0[E.>2H`4!J)`[
MR!P[SA#!:26?Y;NXHPAM2%)55/B4&P<Z!3I#8*JC@"K`@V/^0(WT4R]1TFZ=
M..FET.?EH=SL^HY_>,2$J-*5&C(^W/AAY!^F>]42UAY.HY/3[U#+B"O4[7)=
M5T/&BCJI\N>',/Z@[UMKC<Y#>*U(-%I^45R^3$IM5'O;)PJ1MHI$VJE3EQ8:
M4-2'O"*<-0%23GA.XNN3`6*MNC#;H0_>J/:OI4_*CZ<-P=X;>ZB7J&6X]M0^
MC;BU)TN2G(5O<F/2DA82"\VES037'&NN;ELVBW40Q):/^TTKUE]++*6RY&H0
M_J,/O%/BNS_JOV!=.O'3?9^P.:Y#L^Y]V0+ANBY>,+:LT-]Z7/ALZ`O_`!-S
MC*Y22:`"IJ"!CC_1%XRTDF=O`(]_V+T?UEHK^H-.@%R-H&WT(]9[19-OVFW6
M+;EO:M&W[+"CVRT6YI*4HAV^$TEAAHD5YC@0W5:S4K42HYG"%Y<>>OY'@U+C
M\*+?I[1+#3[)FE"GY(.'^(EW_M*'/4?U4'2'I)N+=49QL7R<P;%M-MPHI)O-
MU:Y"9`22%EFVQ7U2%D`J`3D"<6OI;IUUWJT0`Q(<?4*JG?47J2SZ;T6XRN&<
M`#UFB^<U:W''Y3K[K\J4_(<>DRY!"G93SAJIY:JDJ6LC4HG[2CCT[:,\OI@L
MSM`HO`DE\-3O+F\::M+B?:AC-NSEP-9P"86[L\#7#80AA9+(8$(8$(8$(8$(
M8$(8$(8$(8$+Z;9EH"70H!51P"B#Q3\E.&/'_.?V+Z4>5B[40=A!K3J`\5:<
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MQY1L)=4^M5^WQN!MI+X9TE1!`U)*N*T\0".S%DT^&1[VLW$KGFL7S(V/$9%:
M855>KA-\SYQ8"2HCQ>$TH:TH.RM,6:*&6'%BYKJE[SA\U*T"1^G]X19.I6R[
MRHA(A;DM4=T_9#<V06UT`^UH`H>PXS>:>-2L91<U^5II3!-NG]1=I6L1W%L6
MF1[L:BH]&Q=O&\W`:'.IX=X^K'GB0RPS3-PRL=0+V=`^*2SANG_J%OH]2-&&
MN7X6\UT=1[**:76H[\2&E2.AD$K/'51?4L#)[$G;@N)77XW+IOO.^71$9U^T
MW.9)9NK#22YK;+E%@H&1JBM1VC+'H3I][)=*M[LG_,.94\*U(V;EXLZP@.B:
MC>W$U3:W#ZT=C3Y6C#AL5#.K_2V+<8CW4GIRIJX;8EPC)GV]HA$RW7!FA>!C
M`!2([6=1]G+/%RL=3O&R!KLO*H=V_=O7F[7NFK*6UDU+2VREQE%16HH:U(`"
MK@"C0T4<%-(4I)-2A93522?EQ:;6Z$H^>BY@V`27!MQ\DE:?-_`7AQB2F<TV
M56DT1AE="2"6DBO<@#3&A%4BYH<*%>ZU`ZAQ`R[NW&`T56AC;2AV*TO5M9D]
M*^C=X&>NVF`5'XDQ%E2<\Z:F!3$!:N-O<N$?WI#M[RN@:]9PZITI8:Q=5\X#
MR?E-&Y&?(W#'YJ,%37$U-,57)3JAII3-->'M^7$TP`N,GWBN:/:*D[PZGHVK
M2I14:FE?9A5)K2F8LJTKTZ*FM`0<N%#7OQE/>0RF];>:E7N$Y<:J)^3NP41R
M&=JS2^XD``Y#Y>^O?@6#`RF]!V6G0:D]G:>\8Q4)LUCW&BT)ELE"TK`5J0XB
MJJFB7$%"J<,Z&H[CA6&<,=RG;')5K)HW`M`7=_\`+]ZLM;]Z*L;1EEAR\]-K
MN;3(1*DCG2[,^CF66<TVHU"(E"ASL6JG#'/^K+`>9#VYLAIL[#C4]J]!?3FX
M@DLW"X<X293@#OIA[5?"1RB%/R&FW60AX3$.H4ZP[!4RXF2Q*9*]*XBVSXDI
M25$T`Q'VK0:MJ:[N->SM75'211Z+(R9K9LS?#)\P&!V#"B^9;U`S>F#W5+<:
MNCCLY>S2]K;>G1G(3[=W=<=<OD6&T\$/-VMFX%:64K3J"!2I%#B\Z;FY!S4#
MLV[^/7VKQSJ]@RTU&5H!R.>7`'8-V`]RC"PWQ^SWJR71MP,&U7*--0MM)JD-
MR$.JR!JH#3D,/G,#VY#X34>M1\$8CG$K<9,S3CCBTU'\UUW]*,UI'7#JMI_#
M[?)WAL_:-\M=P4\R[->12*F;':8*>;$2Z%%94D@ZD@5[,0UY9Q0T+`30\>SV
MKH/1MR+?5A,\,+W$UJ,,5T-?NJ7%Z4NNNQV4.1V$O.N*24+&EUP)!2G4XJM2
M`*TQ'B-M#48G;3>NS:H;;S37P@`&-IPXXU2.9R2"RB@%-":#(`9`#V4&$/(P
M9L_S9@>*9FX)88\WRD419;[C8!2H&IIXJG]>%/+1]J0_+34W??+#;-K[FG[J
M>:CV6%99KEV<<H$+L[S')FM`JJ`%)KV&AP_MX(VL!QVJ#UNYC=`;5Y&4>O%<
M%]W=)=J=0>HFW8'IRF/;EL?4`W%-KLD]UJ->=L2;"YS+L;ZIU+"$V^1&;6]'
M>*4)(`3F2,/XY"YPC=3ED8T[%S)T;&RY*D4-<<:@C"A[-O<>Q3&G\O3>4BPV
MJ;`ZD;.DWZ703;(EIYQB.\IYYM+#5V8DN15K`:HJH\)&''EXZ[#0;_XQ2V1G
M:H>5Z)NOPW0Y8%[8MYB1WE-S=R)OD`V1E.2DN)<0XIZB6E"H4D'4#V8P+8$U
M'@[_`()(SQMS,!/,!``IV5)+JT4&=<MO[#V/NW_*?3^_7+=;5BAQ[?N:_P`A
MJ.+;)W2V-5S3:2RHG\,CJ/*0JJ@I8XXTEA8P5;52]C`Z0<R6@PJ.--F'\\:*
M"WY+A(KIX=WM^7#8A2C86;JHBM9)4J@J:GMX_/C-%(QP,R#;L2<\\LH'#WAV
M>P^W`G,$#,^_8B:E%1J:<*8PG8B:.*3W'U`K!II!4#EG0$CC\F,52[68`#:I
MMZ=/IOW2_J9LY8YDF(P_N.$/M,JALBM#G1LH)J,J]^$GO<QM6[:I?.Z*1A;X
M7`5^*KBVZM2J".N2MY"4Q66?"M3@0G45&BM0*J]V$A<2$5P4O'&Q[LAJ"-OK
MP4A[;Z3;IOC#T^YB+M2QLH#CM]O3H8;+9H'!&CKTF0X`J@`/$UQCGS'\(6YE
MR$9:N.\4IL[?Y)S+WUL;I;&7;^F\=O<6X4#0=S79E`Y#Y%'S$86E%$$DT-3P
M&-'R%WR[PE8A<3OS38,.^GN4)7V_7?<L]=SODQR=+=(<\;ZGF6%%(U".@*Y;
M0'<!EC6G%3-O8AX(^;'AAZTC(2$)*0:@\2<SQKQRPQ-S)V*XQ6(B-6@^E&&D
M)4#7L/R82?(Z2A=N4O:6K903+44I2F"V!E&0\7$=O]6$R:`GL4O&T,P;L0Y*
M/;V=OM.&G/?V*<LH(\Z\+**GWOGQHYY?B5*S-$9`;P0#*`0:JR(/'^K&M4W<
M:M(--B]>4=*?:X@_(4'6FGZ4XP$[Y#/)';L4R/GS71&UARBFK#O>1%<7]L1+
MM&8<2%*SJOGZJ&F0RIA5LCF#*VE%R:X)9KHB;X<@]Y4/E`H4&H"1IXYT%!GA
M2.>0/;2FU3FH:;;R1B4YN8!48X>Y:%MI0ILCM(&?LH>&)`7,G8J!JS)(6G*/
M6K)^GWIW=.I&];/9K>TKR<=\R[]-3PM]J2H<UY1H="E`Y*-0,,;V1\C#LK15
MO0M'N]<ZARAIY3&M+J88+Z<_13,8W5U:MFV=E-O3-K].MLWF/$,!6F-/N]R<
MAVJ4IPI20]Y>,2L`4*2"<<:ZWN8[?1KD@_YC*V@W8O;7#NJO9_TP\I<7<6GZ
M>";6,D2U-3@TD4.%/FIN7;;J%:_\NV?;5A7*+LJ(DRUNL*TH*DM(2RTL443H
M#RM6>=1CB>E3OMR[E_?VU^"]`ZG</FB;"X-#&#"@H5#S;%4I"T@+IIH!X,LD
MU&==0`KWX<6_F&7W*M@#\V\5VXGWJ)CL6@/U0.<,*R5.``P%.&`"X?\`KJZP
M,[]ZE1MC6247MO\`35,BUREMZA'F[EDJYT^6UXBG3";K&`I5(RKCU)T+I;((
M6:A*#YH-(_NT<*'#^:\1_6CJ:VUO4WZ;IKR;&OYF-34'"AW8]BHTIM*N(^;V
MXZ`1F-3M7#[2WCLHGPPUROVU-3Z#@O.2CV_/C9;QQMBC$;:Y0-Z')1[?GP+=
M#DH]OSX$(<E'M^?`A#DH]OSX$(<E'M^?`A#DH]OSX$(<E'M^?`A#DH]OSX$(
M<E'M^?`A?4M]RXH(4I%3VY$Y9Y''CC,U?3%)]Q@QM"'UN(2EK4,U``E930&O
M;X<)2"9Y`@!<>Q:/>R,5>0`E3:]D:O<SD)TE:5H!0FATA6FA^'AG^G#*XN'V
MG]35G?\`P4O:QR79_P`L,_<K66[8`M$9/,1DK-"E!)U4/9GB,NM0C>/E>"5:
M[6S$9JX46NYUA15G0!RZ@)-,Z=M.[#.V+YB7`$T(3N[?!$P#,!4*MF]=W.17
M%H:%>8LMK"33EZB4FM#E0'%KLXGNC`(-%4[ZYA`(#AFHJJ;WW`^B4*E:0I8)
M5K(JW0U42%9)Q8[*S%1A@J9>W9WG%,#<-Y3!M*99<2I#^25E=0I5!]V"3PS[
M<6BUMF5#7>+@J_<7S(X'9G`=ZJQN'<:3-<Y3R2^AQ;Q80NBJZRHBB:#(Y<<6
MRWL7<GF93D`K7L7,]3UBVYQ:V5O,)P';ZEA%W=+;0A10H)RXJ)_][&>3#Z5O
M9:G*=A1V]=2)+%L##*%.4*E9$G-7'B1W80\BZ2?-&TEM!BI&\UG+"6.>`^FQ
M0#>]UOSDN\X+;)U4U%0.:JFE"<633]/>Q[7.:0P+G&IZHYSG$NPXJ/';FZ"_
MFL!?#QJ`5Q[*XGO+1\54KR]S^!P)2,AY9=2Z%*#B'$/#2I25H6TK4AP$$%*D
MTJ",QA<-MVV<T9<!(6X#BFEE=&._@<_!@?B=VU=WMAWLW[:^W+UJ*A<K)9Y!
M56HY:H"J.U.9YC@S/$GCCS3J]FZWDG8]M)'.%.W'&B]KV%R^^T**XL_S(6AM
M2-@Q"D&'1QQ2`X4A3:QJ"B"%$4`J,P3AG94C_4P4O(^.:RY;S^938N8OK#V"
M^[^+3&`Z2TIV4NGN-GE)+:E@&A"E@=_''9>E;^*2UAMF/!<UM*>DKRM]5-(F
MO7SQRL++=KOE=N.`."Y%QMTW_IY=[G=+;$CS[)*988OUFF$EF8J0/\48+)U-
M)<&FI%`%=N.I.8#;`0?-<5&`VTWE>86ZV_I>0MN(3)8$Y"2!2KC0'WI7W/TG
MM'4:S-[WZ02FG)Q8,O<>S98;:E0'$DK<$%E(25JY1%`FJ<;0W+H!28Y#V_R4
M-K?2EKU!'^YZ$0^Z..1AH55RX1GX3[S$F/)AO(>6P8\MLM2FW4J*"AUH^)*D
MJR)]T=^)ZWGCGC:YC@XD+D\]G=V5R^SO6EMW$XM>#N<W:$FJ0Z@T4%`TKQKD
M.VH)&'GEYJ5RFBQ#%)<.+8!F<."R9<04GQ@^(CM[`,`AE_"426\[#\[2%:2^
M.HO'IBVA(*PIW;&YYD!9K52!,D$(2HG,:>8$CL%:8K)(M[[E3_+*YQ(!VG%=
M`N(WW/0UI#;@OEBN'.>!M:TN>03V45:U+]WQ<$`',\:G$Z&/9\KA1RYB6..8
MTPS?!:RZD&A70_*<9Q6O+=P6@N(J?$..-T\$,E-A625`UTFM.-#\V!:O:8_&
M*519Q]U"U)"5$"F=1W`G&"<:+9C&N`-46YS?Q_[1QE/>3&L4KJ\@IS0`=1K4
M`DY5_1AC<"8W4;HP3&`:GABA\+.4[+XU;STB==+%T*ZL1;MN%A<G:NY(J+#?
M)2'"W^`JF+&B]!JH:D1XSH27BL$MM@E.$-8M774%8Q5]%,],ZE<6%TQLGRQ%
M[=^ZHK5?0?&OK,EB)<(CS<N+*C1;A;YD=8?AR(\U)7!F<U)4DQ)"*E)XT[,5
M&V@?&2)FEK<1C[5WJ6]\Q"1:D/AXC8N9GJY],<'>_478.XK!<=F]/;=N"2_8
MMQ2`N6RU<]RS5RGK<[)3#B*8C-W`+2REQ>D:TFI&+3IMQ&('?,2&NKLQ.&SM
M/\ER+JO3VNO!+;,#X^50NW-=F)W[Z+D7O;8VZ-B[VO\`T]O$&2-Q6*X3;>Y$
MC!]]4E,5;@;EPA0NOQ)+2`XTO[:"#QQ*"6(@4<,5460%SL[6_*#C@KK]#M^/
M[:W?T#W^S:X]UE2)3O2>^,RWUPU1#>5F'YB8M:FR[)@BG+2Z2$$^'.F&%Z1*
MWY,<=W\=BSITC[>_RM.PU';]FU=H77([:@A(+3:'G(32'%`+4J,LLG0FO,*5
M::@D>*M<1K8I*8`KI\EY(_*7FARA)BG6@M7B2%!1''.M37&_+DX%:"=SCE!)
M)6B0YK"`A1)*P@4415:\D)[/$H\!Q.,<N3@L27)B_4=1<N/S`NMZ8]OL_2';
M=XB!ZXK=>WNEEXKDMM!05;[4_P`OQM'4KF.MDT4@T(P[CCE$0`:<2J?J%U)<
M:A)DS.A:QI!&RM!4$G^*J"_2GT[WW=NF?7G<.U[2B+>+KM!W:FSMTR"IB;)G
M1KDJ3=8ED6"EPR9$!*FBH%(`6/%EAS;Q2AX<6D&I%?7[$QE&1[9'_H"CB-PS
M``COW*L&Q^GW6S=+H:V+:=WK:B3)$>=?&IMQMUGL\J"4HNC\ZX+6B&V&'M14
M2L$$&E:G#P9MC?X^U;OO+"-Q-R]K:BH;2M0<1B/#@<=]-R2M_P!ZWSL*]7#;
MJ>L$O=;;D02;K<-M;AN<ZW&Y(:0)%O\`.)=:\VJ,TM*%D`HU`@$TQ@9Z[26]
MRE;2QCOHFW,,%,Q%#4T+3OQX'>H.>>*0H@KU+TU`2K4Z'55""2!3FG.I/'/&
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M=\-NI"VW"A0'A<2JH/=AO('1_J`A6C3Y8=4MO.:<]L]K^)IJ$DI!?4ZTV@R7
M4!',CMA;CM'?<JVV%/:5UX@4QK@1@GD5O.ZCV-=3BK&=(]F;HM-Y-WOUMB6:
MVW>W.V?RDUY4:7*9FI"0IJ,LA;REM_&*'",K7$`X).=H9+':MS<U[R&UWFA-
M`.ZI3?OM]Z<]*;C*A;7VT[?MS19+\65=+XK[BWK2JO*AQE!;3BV2JA-,^_"+
M8GDEK6DD;5,VV=SBUY^9M:]E,#[13T*$MV;[W5O1:%7V\2'(["U*8MS389A`
M$G2GDME+2=(/&G9C4TXJ6;Y7B*T3)*4J.I2`HTXD`GYR*XU<YK,7&B>VT46[
MPX+8ALT'+11.?N@`<<\A[<:<V+B%9[.*++F-#1'M"1Q;^7AB(Y\?X@K?;,@N
M[4WMLX/M1M<*T0\(X#3^O&1*P_>"6@C#VYH/F:>"`(K@=(S*<=R<-AEJ/E.U
M#^K^DX8J<M&N8ZKQ0('B<&Y/IW-<X937!#`FYV+R@RK3C7/`GO,9Y4LK\]-G
MK4NV`><Z.=0XKE0W;[WMNY5.8"074+5[`"!F._&5R:]CDCZB:)`0>6#Z*N42
MA#B_$$FJL_GH<;Q`F1H&VJN#XW3<N)HJYV%.*-L6N?/E1+=&96N3/DL1F(Z$
M!R0\\ZL)9Y(34@-K.I7#PX=RR,A'YI#>]5/6=/>YW*:P\SAO71W;,F)T(V@W
MT]LP2_U"WG$\WN:[1Z%RV1G=*D6M2VOOFW9H-&VTDU.5*X2!_+=?R8:;2G,^
M[4;1QPWX*/TV^BZ;)M6T_?)_E,7W\I\!X4-<,5]2WY3OIF>Z0=,Y_4+=\`1M
M^;\C6Y$.$MY?.V_9BPX\MAZ,5*:1=KFYI7)(\2,@#F<>6?J3KEM/J/(LYFOM
MJ_,1L[/:O:'T:Z/=H>A37^H,,=_="K&NVG$5IZ`5>GJW/$K="(H(U0H$=+J1
M]EQ9.K5V:CHS.*M;V\T$39Y6EL+MA.PJ\74T4CG-8X%S1C3<J7^ISK$ST4Z4
M7F_-.LN;DW$PYMO9L,JH^F]S@4?C`32JHEH:JMXU\(4#CH71&C2ZEJ^81ET9
M(QW;`N5?4WK&;I[I;+IISNF!#\OW<3MKW+Y[70_+==F2E.+E.N+=?6ZM3CLA
MYTZGGW7%E2W7'%&JE*)).9./4D-M!I\;;0$"2FS?@O!<SXI99+ADHDDE=5V)
MP/!8<I7P?0,+INAR5?!]`PF9(P:$BJ$.2KX/H&,MD8XT:02A#E*^#Z!C="')
M5\'T#"9EC!H2*H0Y*O@_HQCFQ\0A#DJ^#^C!S8^(0AR5?!_1@YL?$(0Y*O@_
MHP<V/B$(<E7P?T8.;'Q"$.4KX/H&%$+Z2]NWUF40EU04HA9"B:THA:NW.AQY
M(_;ROHYY],?>^XTI3R><XE(<HGEN:!Q&:LC48?V-@1(0H^_O_D![U,O0^Z,.
MJ4\X[3D\M)6XH$K)SU5RIIKBO]6V.`[PK#TE?BI[BK=W7>D5+#3*9B5*9`22
M%4"JY5`[.&*IY)W!6GSE-ZB?=>[V6XJR90.M*U#QTH*TXG$OIEBXAV'W@HG4
M[X5:*XT^*J1O?<*70IQ*R0X5J#FH4(-:*KG4#CBZ6=E6E10*EWE[0G'%5VW?
M?V9K?+0O[]#7+U:@0:?:`%#2HQ:+&Q.:M,%6+Z^%*5QHH_0Z;W9I\2Z+7Y.&
MTM:4I519<"??0KL!%,2+XN5=M:?P_:H"XEYUJYPXGW*HM_88BW*1+9D.E-7$
ML(4Y4I`6=!6:T50<>_%YLV9[-S.+:+CNJNR7H?P>CUHN2G$D.NZP&P>/;6E?
M;EAM^WGL4I97HK4;EG=9K2VBRGWZ"N8X*[?;3"D,1AER%(ZK?#F4WY0HRN@U
M'3VFN?Z<6&W_`$RJ7>78>"P;TW)#*@$T\69]E/GPJHM%&V'$NE9%0H`4J.[3
MWTPUEVN_C<L2@,$<G]Y=>O2Y?_Q?I'88[JR[-L\RX663X@2VS$7J@U'%*5,`
MT&.']4_UX]/Q7KCZ<ZH)NG#:UQ(;["#\%9N"X$/`$$U/ZL5E790EZA]F_CNU
MKC*::#BYD0MJ3H*E)*$DE2B#G4#%PZ/N^7?9.!7-_J)I//TXS4\0K[5P)ZA[
M7<85=6U12VA3KZ0DISU1ZC5P^U7+'<K34<L[:FGRGX+QOU#TUYJW="1_W@/J
MJH,L\F^[;Y-[LLJ1;9]OD@ID15*0Z^TFBC$>03REQ5G,@@FN)(Q^<[:J@3MU
M/1#EM`0!P4MN;EZ:]9W6F-_,,[,WJF*&6=Q6\M,PIREHY8:FZ4I2GGK]\5U4
M)SPHVVO;9N9@.3=W*8AO.F^LK5NGWK6VVJ1-RO><"YX'S.J1O(JH.WOTBW9L
M-,J283U\VVX5/0[]:T*DQ^00K2A80IQ8)1G6O9B1L;^YYABDKD`KCQP7-]9Z
M4OM.O#^WNYL>S,W&H]"AAMZAIH(0Y]XE1(J`HD46FFI"@4Y@YC$J+PC:H.2&
M>`_YBH=OJ"K1[#D"^]`>I%DTE3]CN;=X9!(5K(4S(2$(%"E6ENE3WXK&KFNN
M0.X@>X*^Z6:].2D<#\57/G)4EI9\(=;*\S[JDK*"V>\CCBW7!K+_`-$+ESVE
MH+=I#RB;[Z0N@&H4&8.&Y-"LLC);5%1)254*2D9YDCV_)C9/QL6M^7R].@UK
MJK0CLI3A7OP%!A$NW<B:ICBE5U'.G?\`)W8UHMVVK0*46/-3\8^<XWH$]\@]
M'8KJ`E=5`YCM'=[2,83>>`P$`[T=\*TT(2M"Q0I4-2%I4*%*AP4E0-".T8*9
MOEXI"I;\S?$-G>NH?H_]8B+*JP](>IJDBQC_`.C=I[L+I0Y"=>*$Q;3?62"V
M]$3[L9Q.GE`4-:XB[RQ([#L_C@K;TWU+);N%M=$T.VO>NAW527:CT]Z@IOC:
M5Q6=H7Z4MIULI?8<CP'9MLG-/5\"DK:#C"T4(*JUPQM8>4TTV9Z^RBL^ON@D
MM\]MB',Q[ZK@_P!+?55NKISO6?OZ]6#;O4>_W"U6>U"[;MB"7-A1+,4-QW(*
MR"A#IAH"-2@23F<.'`2-+230[P:'UA4.UB',,8J,QI3;3^:=G3+?MNOC&]]S
M;HVQ"W3+LNZ9O4B#M5-PF6>$[.;EMW"(EM5NHZ$PB*A)\!.?9C;$[5&W+/):
M@TLJT;"3V[?1\%<[IG^8ELO<UVN3'4S;\3I_$\E)N$.[Q9$S<$B3-:9;7Y%M
M+B42&G%Y)22=`(QBM``*>NBL9O'/H020``I6Z6>LWHYU2NDJPMSY6U-P>:Y=
MJMFYRW%_'HBRH(G09H2F/J60/NE$+SQFH+LM<4&\?`WS!\`.W:*\#P/8IMZI
M;BN.VNGV\[K:?++O]IVE>K_:X"Y+:0N5:X7F8\QM:M*BY;U+2M'ATJ*^)QDC
M>M#J`O2,<*_P5\X=E-RZH;_M#=^O+ANN^=Q0H^X-POJ4J0U(O$D-N7(ZU!(9
MCJ5FE-/=R(P]MA6$'CM6\T`8US_NM\(-"-N_C5?03L;:VW.B6P+-LBV7%3MM
MLD;RJ9EVD1TR[A/>5)9="%(`2Z[-DM@]I#9IQPZ`H*;E5KO4&,>1-0-)QW#$
M^ZJI)ZY%=1-I=-MMG8MTD;>Z8/$0]Z[?M*50F6;S<GO.,W.1*AJ:=>:E+;6D
MH545XY'&KV_>P[]]%(:7%IUV\`BKSBW803P(/%<VG^IEKWKO&QW[JQMQ-WM-
MFL$2P?@^UO(;7?F,6YG3;I#LEB,65R"HZGEJ05.=M37&N0N=F/A`V*P?M-Y;
MV5-/DRL<:AQI@,00!W[]J:6X[GL*;;S'VUM#<EMN?XDMWSCU[:N,1N$XH%$-
M]MNV1\@D46O72G`82+!,[E`.KMVX+%A!J,<^:\NHC;EA%"*$X8$8[:^M31#V
MMOKKQM.Q1.FO2-K;<&TM.6^]WZPW*X0K;N"3'35ER6R\]Y)Y]M8JM82>-,)B
MT<X@QL%.-:#V;5!7&H:7TO?/N-1F,LQI1N7.17;4GPFFP`]JB;<^R>JW0:]V
MJ];@M9VW<FY"W+5/2B-.LMQ;04E;"FGDJ9?H?>U>!P&E,;NM?+@3O^4GTA6R
MTU;IWJJV<+-SWR2MSEM"TMW88'TC&BZ@]"-W=<^LFR++-VWTHMNY+DAI^-.O
M\?<=KM-C93J2AHF"E2DV^04JU<A*0%`$CAAU%U$S3`)9VAP(RT[3B#[%QN[^
MDLW4'4%S!HLSFO$3G5D%`&U:#B<HJ"0-N/!,CU:^DJY1-T[7WQN_=,)V1O0,
M6R;M+;YD7.[6.XPHR=8?F'ELF$Z5`(4EO2D@YG$)>ZE=ZE,Z:TMY"T@`"AIW
MC^-JZ%TIIVC_`$QZ;+.JM0B>(W.<0P@O-:8&F;9W;*<%IZ:=%MB[,M]P3+V>
ME%U<M3\2T7-];3\Z#,DLZ?Q)]]2"[)D-/'6EJH;!RI3$_!T+=S6[+A\N1TC`
MXMX%PK3T;%S?JC_<=8Q2B/I]F>`&C3CBW<3LQ(58NH/IJZQHW#;]PPMUKWRF
M`[&E`>:3#DACSS:Q&Y*EZ6FFFCIJ1Q]F&U_T;?Z;&)6/YI)H17=M[5<>DO\`
M<5TS=20.U*,QSA^!(+@#E(-=FT[.%5"GJMZ1;WZ6;_Y^[+"_:8&X+/;KY;YR
M4JD0)+TAML/L^::'+YR%*&L]F*C?B\LWYM@V>G91=[AU#3-9N&7-H]K3=?/2
MN-'8DTWTJJI:RZ5E*F2&U*"OODZLC3PH/B5APP?*"=I"E(+(NDR_='M7K;97
MJSI2GMK6N&]UL;Z59;:R)*-H3H32M:5^O#-6>SLJMQ&"=\39]PNMEEWFQ285
M\5;;?^(76SV]U2[Y;V0H)*7+<I(<="-55*05!"`5'(83\@:J+A^I,-AK#=*N
M;8P:4\T!+2&G<<=@W;DUM"%D\MP*%$JKI(!2M(4GMR4#4%/%)&$9K<P$`[UT
M:!L#JW-K_2RT+5Z&#4>(<>XX03@;1WKWD'XA\QQA/T.0?B'S'`A#D'XA\QP(
M0Y!^(?,<"%*^RT%WI]U5A%7A5!LDBOV?NI+A*:<:JIQP+G^N?^IH_P#P&_\`
M:>HV84.:A200":I&DJ.8\"0E/$DT&-)3(V,F+]0##O5AF<]C&/C\8&'>K#;%
MAVSI#MUKJ'N%IM>^YH4C;-BET=#+[VHHER2K4VVTPQ]X3I%!C%J72'_.;%1=
M;UISR;>`_P"<]M5U3_+"])=WZE;E/J<ZQP!<-OHN!N>Q;5<BL_YGW$MTL)NI
MAN&OX':<UQ4D46\D*KIRQ6NMNI(=-TYVE0N^0#-Z7"I71/HW].+W6=8_U)U,
MPBT/RL+AMR'M7U^=)K6Q:=F6Q13R@8\B;4@)II2L!!I0!6KM&6/*>HL%ZY\P
M_$/>%[9L()K>-P;^A&WY.ZE/B5!.Y;@B;<[C>9;[;#(>=$EYY:0B-$B!QV1,
M?74!$:,R@J6H\.';BXM9YMEO9MV8#W*"=>:?I=E<WEX0,"?>OGP]5W6:3UIZ
MG.NPICIV/M-QVU;8B)<U-RF$+T7&ZI*0E!3?7$JSH3R-`!K4X]&]'=.NT=C+
M@BE6KY]?5'KB\UW7;JQTYQ.FAX#:;/"*_P#6JJV5[O\`3/A^C%[G'.NVS\`?
M<N>VEMR;)Q?7F5"]PHM4,1DWZI[T(84MOU/0A##]"&(N7]1W>4(8T0A@0A@0
MA@0A@0C7E3\8X5X'Z\2OV(JNT^W][Q[4T9%P6I:$)4%4\!\:2A)&D\-2L>:;
M>!\ARO%35>X1JDC35YP[@H[WEOMBY.MF`LIJ]F%'54J*2FE?DQ:]/TRV#'N<
MT\P4IB>U0VKZW()(F6[AD.;-@#PI\5._2+=_DHDEN6Y4@-@:0$GQ44,Q0GCB
MJ:[IANI*.!+`>Y7GIK5((8"\GYZ)]R^J$5F?+8FS%-H:U:%5``(KI0>_413$
M3^PQ_A/K*>#J(_B'J"B7=G64.JY"&'%,)0L!873F>+)0(X8?6>D1QDMRG$\2
MHO4>IHF.;S7`G*>"AC>/6&.U;HS*8BD58Y14I52-22G5XJ\*_1BVVFFQX4;4
MU[52KWJB"CLA^:AIOQI@H5<WD)#OF$.>\FGB((SIV$TKEB<9:-C\`HJJ_J":
M7QN!]`2S#W3S;5<D+6G2XVMM82$I)3H3D"G@<\#[9DLPDD'S@4VTP2S-6!LW
M-J!\Q]P5=YJ$3I+B%U4V7EI;`4H$(*R$U4""2!VXLD'Y5L<GX5SS47F>[%<6
MER-FT.6V,F2"0V]5M`))H0-?:<\AA+S$M-JDS;Q06IEC!$@[:I"6XM3RG2HE
M8\'LTIR'AX5PM$T2#FN\?V*J/NIK@ETI!.S938DB6PZIY!6:HJ210#(@TS'#
M#YLKV"C3@FA@C<:FM>]8B(P4.***E(J/$K+C[?9@YTG%8\O%P284BI``R]GM
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M8N^GWA`&4A<WO].BD)#F54+WZRH96'.2WS4`I*2D%DK37[SDGP%VOVN.+7#J
M3YF-CD+2P`;A[UQKJ30(I+B20-<UP>:%A+=^_+19[6ZI[YV*KRL&>S=K1S>:
MYM^_*<E0I8.2HT5*M9:<4@F@]T"N6-=1BACMVS6XI*7@'&M10E0MGU1JNA-\
MM)^995IBUKB.TN(+J)ZRY71#JDZ57)J7TKW:^D%RA2]8Y3N9Y;24'D,N*6HU
MR"@*5[,0]9B*&JMC?]-:_`+B89;C_$0*]U4_^E_2Z^[47O.`]-@;@V?NNTN,
MQ+Q9EA__`!OEBF('4"O+<0``I/`G$??WL3;F.:4?FL``/=3=OV)Q:Z%/!9O@
MCE:^T=6@&VF-,=N]4LN,:;;WWK=/C2K=)M\J5%>8E-!!=<#ZU(DH60%!*VJ#
M3P[<6Z._MKNW;(RO.WG=3N[US;4=/=!.8XH7<=Y[*)#=?6E1`[!VTS^3&V=G
M%-XK/-X_E/;@BKCRPE1J/F'?A;<EQ:$8T1!<S137G6M,Z<*5[^_``GD%NS',
M."Q$E2QJ2:)/`<>&1S^48RG'EXN"(<]SXL92R-1IFA6A:O>-0/DRXUKC4[>Q
M,[N$R`/&X)UQ)C2DE.=$I.G/,&A(KGGGC&8@X;0H&9D\;@6G&O!>+EK2TZ5*
M4EL(U..(.A;("DE+Z5I(4E3;@201VXVF<Z4?F;/4MA&^6<2@?G5PX$\*+H+T
M4]4]RWI8I/1+JWNJUVFPW/9MPVNWNV[1G7MP71;[7+M3+-Q`\HSY=N3IYDFJ
MEI&D'(8:B"*M"#7O4J^]U+DY8W`P<*`EN.PG;N]2(7K\N7>"8Y:VWU!VW>)R
MY!2Q%N469:HS]H5FS,1,&27W&"%:?=J<(SV^2!SX\'AI(JD(+R1DP>6AN-:C
M<>)S5%*[<-B@KIST[ZE[&ZFW"R7W8VYFHDQFY[9DW!JQW-ZU/JD1ELMS8<Q,
M=YB2RH(HF@KG6N-;:(&W,LX^:G<EKB.*^HXD2SD[C0\,0`.]1+OWHOU)V-;Y
M5\W!M&^V^Q.7B=;8EX<M[Z`X]%4VH*6EQII=O9+;J:.K2$*SH<L)6C63Q&1V
M-'D8=E/4G+8WP2-BF:6.#:EKL!3_`-JNX;5$=NNDNWW.W7``/.6R0T_'0L)=
M2%L.)>;37W5IYR`H]BJ=V',EO`&9@/F`XJ1;#:OC=$X'Y^!(_LPP4H[Q]0?5
M[>U[O=^W!NJXNS+_`&5&W)Q3RV(QLS?*I!AQ&4HCPDE+*0HMI"E#(FF&M*+6
M+3[2!H;&W8>)/M*AIEYUAUAYAUQAV-RE-.,K4TXA3#I>:4%I(.I+AK7CA_`*
M0@!/975A`P)).T+I]UPWQ*V;Z2^C?BOLC<6X+[:]U-/W=]Z=<(S;2U3G4.W9
M*B5M2G`H)0X2`%4&%B11H-2*C?PQVJCPZ1^XZL8)\OERQX.X>$@$;Z@D'B*$
M[E*3O5_8/J5Z.;TV*TW>GG[/T\3NO<LU<<-QK?=K<A+C$9!;IS2'&E9G@,NT
MX='RK@00=F.)WJMWT.K=,ZM;M@-+1TE,<2:$;SCOVKBE(4%/K%7'$)7X=:=+
MBDY::I1P*AP`[*8BIYSG(BPCW+MH=6!C68`#96HKO]JN'T`WQ>-G[6W-9U]%
M&-Y/W]2&K/<K['$:WPVU!3;BY3CJ1+#:4FNH*`21GA&&[NHL6#'=6E/2JGKN
MA&]>'13.;(<M2W,2*;0`*-->\!.2T[YWOTZZ?-;(N'4'8_3NVL7&Z3WI-N=>
MN=]6S<I/F'8,.*W5N(A@^!!312^.%(KV\9'D<6UQV`?QV+1W1=IK%T9[J.5[
M"&BCG&I+6@5-#C6E3WT2+(]3>Q(NT[OLN_6B^]5K7+1%D6"^7R1'%QLFXHAY
MC4B,E\*FLVV?*2D*0H^%!-!C+[ZX='RWFK>X*P:9TO8:5<%UC$R*1O?3#;0&
MHV;1O32V%ZX^K/3?;VZ=N[,9M-CA[LN$>3%=ML.`P];A##C;\53XC<QPO!=-
M1\0.>&(%J]^>\;5F['?_`!53M_I]SJ5N;)EP+7#YW,:(WEI!P#FT-#@3CM"=
M\/UV?B<T/;WVC=ER6.4SYMBY)F3FTM)"E`*GK6X5./J6NHRHJ@X8M&G=5,TL
M9+1D8`XM8[_M`K@/4/\`M\O=3S.MM6DD:^I+9#(\'_B<0%:+IUU9VAU5M+UV
MVG<'W93:UFXVFZ*2U=K24YZE--D-/-/'@KLQ;;/4([X"8N.9^)%:4)Q-&C8.
M`&'!>>^M/IIJG0=W''J48=8TIF:/E>,,0>[ALV%/IPZ6E$`)?<<;;YB?"M:'
M5!*TJ(-5"G#N.8Q)R1,C+,N(>:&N.%"=^S8J,#$;YOEJBV!J`36A&RGI4X=;
M;'M[J=T@Z777<EM8O$*,B19+DB2FM7E-*+1:4*%A6MA-2FA-*8YU<V44VO.L
MI@#;/EK39A@-NU>F.JM:U"T^G&D]3:',^+5(79'/!)%!R\,M<NRHV+G=NSTD
M](-RA8MD&Y;9N:FZ1I%L7(G1VY3E$H6ZAYPHT%:LQ3('$X_IK1Q"YX8\.'!S
MBD="_P!Q?7&ER1RZS/;W5@*8"&*,T`V5:`20!QJ5S1WSLBX]/-U7K:5RD1)L
MFT37(WG8BZID)'B0'&_=:=2DY@=N.6ZY)%I-XR.XC<^%[B!0G"FWWA?0GHG7
M]/ZGZ2MNI[89K>Y&)K^E0-.8TP(-:8\$VTM(*$E8*:U-22#2IS]H`Q'7TO.B
M#M+B<']I+O?57[2!IET[+#JEO)+_`,NC01Z02583I/LV9;;5#ZQ7_<\C:NV+
M1<F[1!?0P7_\S,+<1&G,H;0`>2J,^H+&8*:URQ9]$TB]%H9-;<#(-E!E[:4%
M%PCZP]<V^I=31?3/IFQ@N>JCMN(W48VNQQ:&Y<"/2<%"U^>M,J^7N786Y";+
M(O5V7;%NI90VY$$^0EKD-M_>(2E(SUYFHQ5=1G9)=/CB\##0+T#TC8ZGIW3=
MII&NQANKV\0$C@20\N`((!`#:4W)*IADK)RF#<AC"46]I"5`U%37O/"GLP)_
M:Q0/B<^48@\:;EMY3?=])^O`F4SHFOHS`%#E-_#]*OKP+52AL9MO_*'544R3
MMR$]2I'C;EA*37N`6<L"YMU)>0VW4L?-'_R[3_UGHYM;:=KVS;T;UWD%(AMO
M)7MFU`J\[?)8HM@K8!`$-"Z`GM&9QAQD`K#02C97$5[D[EU2XGEC99TVC:`5
M;WT?>E3=/JZZB2M][\0]&Z.;6N:DWR5$<6VYN6XL)0XQLW;O(*"RPUH#<E]N
MCFFM3GBOZ]U'9P69A!'[E3`C97NV*<Z3^E>I:MK3=7U!CG6^:II4`^K<OJ?Z
M=V>VQCM[;E@M=MM$*(BV6K;\*ULMM0[=`2REI#$5"``$(2@`&E0K4>)QY[UN
M]U.\D=^Z/S2G@`WY?N[.Q>Q(8X(-.AT2V:UFGQ?,`!1V9U,U7CYB"1L)H%TL
MG._Y<V,$-LEU4.%R&V@H@E*E(2Y55:FE2JO'+%,?SA^1;G%Q[]_:K!/=WYTI
MT%HX-D:T93E!WBM:[<*[5QB]<G71O:5B>Z/V"Z%O<FZF/.;EG,)2';1MF8IM
M1MY734D74!2%*%%:6R.W'?.ANE[2^CCO;]KG3,I2CB!7N&"\I_6KKUEA:'1;
M20"X>"'TH=N![MZY!+C,U(#/*0BB&4!2J)81X6`G/)'*`H.['=!/*R,0B@8T
M4&`7DB`"V_2QQ)J<3B:G$UXK'RS7PG]H_7C`GD&PI5\\D@HXBG<AY=KX3^T?
MKQGS$O%(H>7:[C^T<(N<7',=I0AY=KN/[1QECW,-6[4(>7:^$_M'Z\*^8EXH
M0\NUW']HX1)+C4[2A#R[7<?VCC"$/+M=Q_:.!"'EVNX_M'`A#R[7<?VC@0AY
M=KN/[1P(6SDR?B'[(X=V)7[$4"Z.7K>#$"W-Q@ZDK1^\`0I5*D::G20<\<:M
MM*FB\3*>D+U%JFI#(1"ZI]*A%[=$D7$R5IHV%E31K5*A4$G2.'S8FF6<Q%(F
M]^(5-9J$HE<ZY-.&^O'9Z$];=U)N31"TU""!I4%4KI(SH#6M1C8Z2Y_ZC/:%
M.V_4L<#<HDIAP/V+.3O9ZYS>9)4I*"A9*JJ]ZF7><SA#]N9P6?WY^S-[TEO7
MY)2ZR7%:'5:M1*C09C+B<)NTF1[PZ%E0-N("U?J4-RVLTE'#9M^Q,F^32XV$
M-J+B`DI%?AI2OBSKGB7MK!T5,[:44!>F-S'OC=4AI(V\$TF7E,J*DU/A*>/>
M0>_V8D^6S@JMYNXX>W^:56[JKRRHRZI2I9434\%)">RO=B.NK61\X=$WY,O9
MMQ2\=_.UF4U`)2*JA4<_#J)K[*U![#AZUCA`6$?-E2[;B(OS/._@4]5K8EV5
MAV2L(E)660U11^Y#9*5U35-21WUPVY$NX*7FU&S=:&)K_G(V4/V)BT;8*T!6
M6M2AD3Q^?NP[A:YL>5V!JJFP$#'B40E^-6M.:0G,\.WN-#A5$DC(F&1YHP;4
M54E2`DJ!`<KIIG6E*\*TI7MP)-EQ#)X'5]!^Q'[;;C+D*2E-7#IJDT%*C+-1
M"<P<(RR,`+"?F1'!)-=97"L6%%9WHO$<VIOC;LIR:@MKE&&I/81-;4P$J(KX
M=;E:<!2N*7U#:SSZ=(V(5=5N\;G+L70KV66KPND.6#*^I[2T@8#M73J(4MO"
M.*%+;SY00!17,T*-"*Y`\,<GFGB@DY4II)PQ^"[Y'^;'S8\6)[6UE9>1J02C
MF-Z@",T5%0*'M&6&5Y=0$#ENJ\''`_8IJSM@^"KQ\K@J:^NGI3'E6)[?UN0I
M+CS"(5RAA&@1D`J\LZ5*`2HD)/NDGOQ=^DM8CDE%F'5?D)I0[MOJ7(/J'TW,
MRR=>LC_+YK16HWUW5JN+&X8C$$E]!X,M?9(4"$`$*21J36G;2O''7+"28BK=
MB\\ZG;LAKS10_P`<%!VY6$/`R1F72IWAQJ-0H#BSV<LM0#M"YWK%K;N#G84=
M4J%]R,+Y(4$9\VH-4@CP+SXUQ:+9SI11_AI[5R;5HK2!KBY@<2:#[?8HU>!;
M"BI(51155>=#W\:UIAQR6EU<:*G0V[I9:2NY49W[:>JJDSHOO.Y[<WWMID3;
MDU8I4X1;E$+Z51WDRWBD(2C6HI2X5`UIEB(UK2+65C70FKZ5/8=ZN.@:B^VN
MQ;<W.YSJ,;C0[AM`I7M4P]0^J\;;N[K_`+1ZB;#V_N^T0YZ1#70M7=-ODLAQ
M#C,D49+J0JE2K#*SMGL;RK?YI`*D<!Z:*R:MJUW87SK&\M6LN*5-2#AN-02F
M,B%Z<-VK4;9?-S[-N:!S6(5X6'X#.O,,MEAMSPI.7'#PVEZ[:T^L?:H,VFE:
MC5]U/R,VWY2?<UR1)GIYOTQ*W=G[WVQN!)JM$:).C,2W:FNAIN6ZPI2P@U/R
M'$T)XP`"[&G!*#290*``MW8C[5'%TZ1=2K&I9N6S;Z6\],QJ&9+#^@^(H<C*
M>11-1\M<9Y\7'WII<V4MOES#;7>"H]N$&?;G%"?`GP:$#_%PY$=-:#(*=;2F
MN#S$7'WIKR7\/<DQ3[:`2K6"*>'EN%>?]@)U'YL8\Q%Q]A61#(32GM"V)6"D
MK`64CB0VLD95%12HP&>+C[UNV$%I#]M4=9N!2E(U$`9"HH:=M014?IQJ9XMQ
MP3"2P<Y]0*CO6Y^Y!32DI6"3E3+,=QR&-^?%Q]Z6\I_=2,F6\V[S""2*4376
MD@&HX5`(/#NQKSHJUJE3:C+E`5@=@>KSKETV:\K9-UOS;/';3'CV'<#7XO#:
M;92$-ALOTY,9*4T"=62<:F>(UJ<.XH=I=O<,\L\Y0\4+MP!P.&TD=BO5TB_,
MFLR9=H7U4L4VUJARXTB=?MNJ8D15\MYNC3EH<4I2&"HZB6PI>5*4QK?2P/LC
M!`:DMI_&Q1^DZ/-H>K-GMSSK<.V';3N("O7U:]1/0;?<^!(8WAM]^%U$VPY/
M5;MP6UMJ&IE(3%?7<(\],>&$!:T``*"U9Y4&(?I^-UAI_E;D97MD=3&M6X4-
M<?:IKKO7+*_U-M]$TL:+>-A`:XT<,W`'$_!<M>N/IXW7.V-/W7LCIMT^N,&'
M<GFF]Q=*+CN*Y2;C9DK4:2+(LN6UI;7A!2R5J*O=!%,2TTK2TAM*GOV*IZ/=
M2W=VQT?--L*DDMPS;CCC3T55!(>Q=[W!YQB-M/<BW&`KS/,M$^.B&I!(4W-=
MD,--0W@1[CA2KV89@UV55TY;C44K0T_LXCMV)Z0NA?4J2T)#UBCV=I2&G!+N
M\R%$4XT^YRFEI0]*2MQM2\@4@@#CAW%*QK,KC0]Q*799W$C1\I,?^)K?>:^Q
M/"X;%G_A<>#OCK=9&K1;4'D6MJZR+RNW-"H7RXR4+C.D#(`*\/$<,$]U$V,D
M.->X_8D'6_EGB2&-AN@=@->^F-!05[T<VMO_`*9=)XU[M.U-\;VO;&X;4(-\
MBP$0X$"ZQW0YRPX5J"BRG4L%*J*HK(88'48QOQ[BD->T:/5G0SEI#V[<#@12
MNY1W(ZW6FS/+.SNGFV[3(2$H$J8TZ\ZL)2$I=<2X#]XH^(]YX8V;*V1N=@^4
M^A35M9<H-8]U8P-NT^U1]N+J[U`OZ%B9N)V.%D!4>U`L1"FN=4K"%5IC>NY3
M4<%K3Y*%_#^,%&,A]+SA=?D2GWG/$ZY+4'%*5WH(U4&#%*UF9A&T4_CM2<M?
MC44JJ*Y*S!/M[\%$IESC,_Q':L.:49UH/UG/AA&>*-[*/-!5+V\$#Y/SJY:;
MD5>>2I8U."I`S*5$\3VTPU\M;#8[V%/*6T8I'&XCM(4D=']^W/ISO^QWR%,1
M'BR7FXEY:4HDFW.R$(6X&TU4YK9630!2O9B5T/5F-N0QKO`[*<#L!IP[%4?J
M/TWI_672TUE*P^:8P\N@I1P:0,3A[:+M@M\.HYH4E3#IY\5Q)U!UF<AJ6VL4
MJ15/8:$8[%S(Y;>/E&I:\D[1@0<<>U?,^6S_`&W439SX2QDAPX?*0,1MVC8I
MRL3C%[Z%[LM.O4=MWV+>64A*J@25(6X14<$Z,4*[K!KPO)L+<';MW\!BN]]+
MV[^H/HMJ>FQ?F:A82&5S*@98P''-4T!P8<`2<-B@-Q<A8,YH+82DI5S$@@BE
M,])H<_D[<7O2X*0.$W@=4@X;":A>?VLCA@-C,!(QV([#3X*MO6SIWTIW-;9U
MYW`FR;3W6IER;9MPN/.-OR[A;4![DNM4/F%N*6F@2":G/%*ZJM=-@;S96C-4
MY33>*+T3]'NJ?J!!<0=,]/Y[G1G.:V6/,!1KL!2I%-ZIGM7KC+LC0@[PV3M'
M?)M[KS=LNDRU-?B`!=64IEN+6R'K<0<TTUCL%,<_T[J)D5P6-@8X#82/YKV1
MU+]$)]2TZ.?3-1NM(U*6CGAA<\G#^XUXKWII]0NK6[>H;<:UW!BVVO;ML)-J
MLUG;Y,2.5&JBM"@DE67$=V&FI=2WUPSEPM^7U?%7GZ=?0[ISH6`ZO<-N+WJ<
M_?<]F8[-I(`VU.U1>TDH!!%,Z@9=M>P8K$#9,SWRBCG&J[I`]LL8D="^&X/C
MS.:ZM-GA)&"W`5(`XDT'Z<.$LMOEWO@_VD_[V!"]\N]\'^TGZ\"WS2",Y=B4
MFV5I:25(&2`3[IH!Q[<\84!+<.\RUKJ^,>\(K)%4H2E)4M3B4I2A!4I2B%`)
M2E()43W#&5-3/;!$9I32,;_Y;5/FP;$_M+;.XKSN6$I4*[0$O-VHK:6](CVQ
M27D.EMM:UMEY;VD)4`HTX86CMII6ET8J!VA<LZADTW6+\7EJ_,6M#-C@:@DG
M`@'?MV*2?3UT`WWZO>H"),AZ18>GUH+,?<6X41U:=NQ.8"UMBRK-$_YDE0DA
M.0*6ZDK*1BK:[U!8:5#)!))34"TAC:.-7;A4"@])7:_IQT*=1CCO9(R8&$.)
M)`P[CC[%],/3K9>V^GVVK#LO9=@B;;VQMZ!'@6BVP"`"E`3YB;/57[VY3'ZK
M6O,452N.*:@^:^NO-N/S5V+TG9NATFU\HQHR4VJY/0FQ>=W4S-<306A*'\R-
M*4J\0-`:']&(/6I7T\U<#+'E`]0IL%2F<,\,EV(8W5D=L%#O[:44K>J?K;8^
MC'3([AGNQIDY#KD*T61QW[R]720D\F*6TU6Y;TI5JD.#P!M)3740"ETKHE[K
M.L0.MHB^VS',<`!\IXTWJ)^HG5EGT5T[</NY!'J1C'+;0N+B7`'%H(&%=I"^
M9[<NXKWO'<U[W5N:6;E?+[*7-G7%1_><QQ9CP6T*S1&MC*@RT*?NTCMKCUIT
M_8PZ=9B*2C7TV;=G<OG7J6HR]0ZO-J&J/+6EQ+=]<2=U>S:D?$A*0Z0ENQ1C
MJ5PV(836J&!"&!"&!"&!"&!"&!"&!"&!"&!"&!"\Q*_8LJQC\^1)24O**ZT%
M2>%"".SV=^*$5V^\OLK$BS/_``_D5_[N'EI][T?%0'.YSB>"+I=<2``H@#@,
ML.SL6:TQ6Y$EQ"M6JO'+A^K$1BL>?*]=E..$$*":"E./](P]M?">]'[@B;P6
M]IJ[0#CX:U&51Q''#I8=?9FEO$41=;6@5U5SIPIV'VGNQA1ZU8$(8$+87GBC
MEAPA'8*"@/?@0DQ2"@D%6H\:TIQ[*5/#`A8+3J24UI7*OZ?T8$C.S/$YG$)6
MM\52E-(<9U`^XHFE3V]GR8S1;V-AL)W)_P`:SQXH3*4X&%+2*@(K2@H,]7:,
M1UQ^L1W>Y6.*QR1B2F'V(O!F2VYC+K5Q6AQEP/-+#>:%L^-*@=?%)&&=RSF0
M.9V*0L=3-I=,QI0KJ?TTOS.X-M66Z*D<R08C3,E%=1YS:0DNE=<R\<Z4RICB
M>L67_P"<":;UZ2Z8O/.6`[E.<.>PR$N<RBC103EX%`U&=<Z'$5-94D(HK3'<
M<I@CX++=LVS[PL4NP;C@LW6USHBX4N(HAI;Z'AH"FG]*S'>;)U)4`:4]N'>F
MN.FW0N@:$`CUJ,UF#]WL39TK5P=ZJ_:N$_J'Z/.=,]X77;CB''K7)TS-L7`L
MDFX6]U:^:T^OF*'-MNG1JJ=8%:#'=>E;OSC0XKS)UOH_E'EM*&JY];EG1F'%
M(<"T\EU:5(""4@()!2%=HH.[%Y@`$SANS+A^KBC"%!^[)[%.;&4ITJ7I+!24
M!(*%$KU^*I%*4IVXL]EL7(->\(_Q_`J));SDDJ!')'#3777CGP3QKA\JT*`U
MVK"')DP)#,MA94[#=:DM@>$E;#B5#Q#44\.-,-+O".O8GD#O+20WP%*2>XJ?
M/46TBY2=C;NAHYD;<.U(BY<@</Q%@)2XT5_;4EL5KEAGI@'.>=^4>]7;JRMS
M?LU/=+$UOI!)57GREWPZ6B/C+?WE>!!<"Q4`\,3*K`=396JUL3G(=/).R(JD
MD$+9E/(6E0/$*0M"@?D.(8DUV)P+BZ_&:)\VWJ_U'LR6T0-X7Q+3=`F,[.=D
M1J#L4R\7`1\A&,@D[5NU\C_U"31.Y/J.ZA/-I9NT;:M]:2"`FZV!B034DDJ4
M%I43G@Q2AR[JHN.MUGF^&^=+-COH/O/P8TB"^*9I"%)4[I"E9'V8*K.7@M8Z
MA=()BM,OI*&E+KJ=MMW>",^)<;<2SX^ZF5,8J%D,<!4FBW(OWI^6H^9V1O..
MLD:DQ9\=4<$_99UN:M`]I.,U&RB,KB,U1ZUO=N/IW6FB=J;\0:@U\W$.6>7[
MT8%J">**+NG0!DA+>W-\I!S.M^(LUX9$OC!L6:%V-0L1>^@N6G:6]7%=G-D1
M$M+/9S/O#1M7;[,%5G(1B"*]ZU+WYT>MY+<7IE.E`G2LS;BT6U)%%#2AIAXA
M86`:\*8Q4!9$;W8@BO::>]2#+Z@6BZ].E[NMVS+%,_R[<OPANR7B,92XEND+
M96ISS8Y9#+BJ43H`!2<\\%<*T239[;S0T^>,.<1FS;=M:>Y*73[U[==.DR),
M/IN]M[;UG=#G_P!"N6QNXVUAQ8*>='COZ`A8*JCC0X1GM[>Y:&3M#A7"M?AB
MK#:316K.1;1-9*\4!(&';L4E[*_,AZG,-SK+U#LNU[_M*\.ORMS+M.WK?:[O
M-DR/<E2)I+A<<UBF0&0P<O\`,$I;\P!%03@/\.STJ&U>/J%\)\A(P2UP!&![
MG#8DKJ1ZD-B>HAVQ[8N-@L>PD6YVWLVS?-^F3`W;[/"7S%0XT>SQB2Y(--;B
MTKTG@#B:MGVQM@)*-?4XGA7[%3KVWZOL[07EQGEE<'#+'7;B!6HV#?3$]FU,
MSJ#9>C6P6[8;[TPC[CVCN1E+]HW_`+*WBZ^F<65A;K<>+-YSD=;A1I7SF@=*
MC05I3-Q^WM:2&9F$;05&:+'USJENZ2&YY=^QU.6]A`IO-0*5'`XA5UNUVZ!L
MB6NV[%WG/2^7S%1.O3$4V\Y>6Y2HMO=\TE!)U:@BM!3MPS!TW\(]-%?-,L.N
MFD"]EAV4P!QXUPVJ"Y#R7WG7D!X-K4HMID"CR6T^%M#GM0@`5[0,-WY,Q,?@
MW*UB.6(".>G.`%:;*HDMZB?=[NW^K&K3BG,+*2`HHM>L@TI3VU_4,*)ZBRG:
M$C36A[_ZL860*K6IS6*4IG7C7]0[\(7'@]*5B%'>A%UM:U`ZJ94X5[3[1WX9
MIPI_Z'V[H\S<%W_JM>HGG`M,:U;?:$CSE6U!,>6\HM<I#9`![O;B3THV4$_,
MEIFJJ/\`4BUZZFTH6O2=&A[*D[S5NRE#[ZE=).FW6#874A4ZR;,<N3KVW=#3
M\6?#4T\Y%;1RDR6TH4Z>2C)(/;CI^F:G;WT3X;>N9C:^VE>Y>'>NOI?UETI;
MMU_J3)DN'``M-:...4\#0;%;WHFZF4O>FWY0*6+WMJ6J&RZ0P'WF(CSS3J3)
MY3)(**#Q8K6M5S'O5P^D<%Z;75=$&:M[9$4XU9(/_:7*6Z>KN9:=U7V`_LJ"
MJU6R<]:W7(MPD&0#%<6VX\R"RXTIW[DDC,'.AQ#W/6ILY6VY(I0#;CL7;+?_
M`&D7EYHHU%DK^9DS$4P%1AC7M4Q;_L5@Z]]'F[M8XCLF6Y"5<MN2)D?R[T:[
MMH2J3'9"7:N"B$5)]X`98GKVW_>=+9<@$X$U.[`+C'1=]J?T?^IL=M+(WR;Y
MFLFK2F5KCE.\"A)7,.3$DP)9MDZ/*C7)JC,AN0VI.N6@:9)2M5/"70:#L&./
MR1>5O'-[2OJ]TQKMQK-U!KVER0W-@8VU:""`:#<*C<5EY3_B?[/_`-=AHK24
M/*?\3_8_^NP(628M%)/,X*'V?;_K8$)2Y']O_9_KP(7O(_M#C\/9^U@47?"Z
MYS>37E9<>^J.M1G'J16FWWI3K8\O'C-%UQW4*(H`H4*B0,!3B.:R@B,US3.P
M9CZ,5*D7;T#8UOCWK<K+4F^!E,JS6%M252&Y!*=,N>05<AAEO4#5)\2AC-2%
M6KBYNM9N0VUKY3>I^],_1+=_JLD=0+<')5LVPF19HE^WD6E-VZQVY3WFGH=O
M<4ME/XA)2V6P4G[0/LQ&:GK/[5`<:854GHW0DU_U9`^%M=+Y3,V&&>KJ^FE%
MWYZ6]/\`:_2_:%FV5L6"U9MLVAC2U%90E4B9(<0GS%RF2Z!<JXW%P$R77`I2
MP:)T`8XGJ]_^\7GF-N5U5[&L]/LM"M8[.S`!<`#3N4WVI',>:372`A2RKC3E
MI"@*?VCEA@$C?[%=_I#!9L&TINY+JXW;TR65:5ND`EL&C9U'34$9XJVHVUUJ
M&JBS94P96^W:M+.2TAM77#Z<^.I]&[W+B1ZQ>M\_KGU?NBFI#:=I[$*['M.&
MRDAKR[]%7&<XH%"7WI$A`IX:H34`G'I/H7IZTTK2>90>8I7TX#W+PS]8.NKO
MJ/J#R0<3;QFAQW`'XJJ7(_M_[/\`7BZ+DB'(_M_[/]>!"'(_M_[/]>!"'(_M
M_P"S_7@0AR/[?^S_`%X$(<C^W_L_UX$(<C^W_L_UX$(<C^W_`+/]>!"'(_M_
M[/\`7@0AR/[?^S_7@0AR/[?^S_7@0AR/[?\`L_UX$(<C^W_L_P!>!"\Y']O_
M`&?Z\2OV+*GC%3Y$7!=$?/-)XW5]2P6VA=-2:TK3,]O'@1C=K&L\(I5)M<6$
MEN%4GNHTN*"4Y`Y95[._&RWYLG%:J82Y,7!)4"%,;M:UF#11%`O*8W10($!6
M1%1C"RL>6CX1@0L5H0$J(2*@$_1@6DA(82-M$4P)ASI>*Q*$J-2`3@1SY>*]
M0RVI:4E`()X9_+WXREK>9QF:)#5E<4Z69#,+R7,0"%*(2.Z@16I%#VX*J;9<
M1Q^#!*%]NJ%L)#2@$D`!*:&AH*]YXXT='&XU<,4X.J2%G++ODX8)`A.!I_6L
MC2$.US&=6U"F$WP1EI#1CZ4VYT;Y`_[]5=7T\[X;7%E;?2NCACB3%!4*-%DE
M*@FN9U:^!KCGVMZ7")#*(_S*[:G[5W#H;7J1MM@_8K=&[:E)T'2DAOPYY'2D
M*XYYJKBH20L#R'#%=/?*\O))Q2BS-"U%L*HMQ*D-JS\+BLDJ\0IEA":WA?&0
MYM0,=^T+`N9H3F8ZAV>M5+]4]I=OEDV_&4D.S[5^-!N4I`4YRG(B5+;2O3X@
MK4<LZ'ABP]*ZA>P70BAD+8^%!\0N2_4*TDG@,K,9#O\`XP7&CJ'LHQ;E*0VV
MEN.^AY32"DGEJ6DE/B551(5WUQVZRN0ZCY#60BI[2O/.HZ:TVX<]I+\N/>JO
M[CL3H+D(Z0^JH;50)T+H?%P`]T=N6+%YDLB')-'5]GI7)==TEDC:,9\P?7?V
MJ$+DPN)*5'=5J<:\"UT`"U`J)(H`.'=B1M)'R,J\U*HEW;M@-*4*(ZPTEQ9&
M>D@`#,U\/#].']Y%'RAAN"2NR7MCMX\(J`T[:5)X[:JR##"=\^GF=$:*5W7I
MM=O,(E*-74VP-ZID=L>ZXAUM5*D$CL(Q7Y7.MGU@.4G;_!70Y^3J&@PA@!N8
MR23C6E*#VJJ!2WHU(1I"B5#C0A5%"A)S%#B1LY99&_F&JH^:0297G9@D4\3\
MIPV.U2H."\P(JAC"`DU]:VE^`T&8X`CL[P<"D>3'78M!D.GB4'Y6FC\Q*,L%
M`LB)@V#VE:E**Z:J&G"B4I`_0D#!0%;!C6[%Y4^SYA]6,4",C5X0%<0#^@8,
MH60`-B]"B*#*@RI0$4^0C/!E;P6,C=N]>E1(IDGM\"4H/Z2@))&#*$96]_?C
M[U.?1=Y-X.Z-@2/OD;IL<V3#;6HZ6IMJ94ZVX""%ZP34"N?=C(H#0;4-A8V0
M7+6@2#"OK/\`&"@5X/Q9#\=Q1YL9UUARH`.MI:FU5!&55)Q@[*)W(]UP\<W'
MV>ZBTJ=*RDK*5Z:T"DH4G/C5)!2KAVC&*!;MB:SP@BO:?M1!;BV75%A:F:T)
MY1+>9XTT4I^C&I:*4W)X^:26V;:2D.@:20"`=O;2I])6,B9*D-M(>D.NMQT<
MMAM:R6FD$U(0W70*GMI7!RV$9"/E19@0O+8@`'DDX;2B@<6GW5J37CI.FORZ
M:5QKY:#\/M/VJ0<UKO$BKK[O,559/#C0_9';3"K6-8W*T8!:<F+A[UJ"BK)1
MRI7L'#]&-@&C'L62T-Q8/F2E9;%=]QW:W62PP7KM=;G(,2+;HH*I+BP@NEQ`
M'$`"AQ#,?>S7G);(0TG``#[$YNY]'TZQ=>ZC.8HV4+C2H%<!N.WUJ0(/0GJA
M<[ZQMT[3EVJ\R[?+NC46[.-Q4&'#DICOJCN:E&4XA-5`"E:8FFVMQGY9SY@-
MX&.ZNQ5%_7O1;+"6_AOA+;0ORN<T?>IFH104X%1QN"P7':EYEV&]L&//B`I(
M(4GF$%/B36@*<Z5&&=]!=1Q![:X/I2G>K-H=W;]0Z0S7=)D8^T=(UM*X_,''
MU?*D2@J4DD+2K3HIXJ@`D$<00DUIQIB+-V(S\XP5F+/\]';,MV.!I45.-:[\
MRW)C-*TK*%*4I()65N*412M-154(]G##;-5Q>VN)JIV*Q`G<W*&T)%-PH=GH
M3MVQN7<6U[D_==MW6?;+D[&=9<5#=4TJ8TI&DL/*S^Z0#JIEF,.8-4U.Q>'6
M,KHW/^5U*8MVTQ!2FM=&Z!U19MM.H[2*YTV(NDROK3,&&AP(.VF]6%M?4GJ#
M8]Y[`MLO?-]N=HF6B"J9%DNZ`'K^EYMR,ESEI>6U'2"FH53Q8D=1O]4-J).:
MXN(VX?9[URCH+I#I*[CO-5TNSABOXK@Q!S2X48"13+F+=G8H.W5:C`W!N&U(
M!0XQN*ZN*)*BHLY%E)4NJB`ETT/$]N*?/&RY>)K@9I1OQV^A>F^G;V[-@;![
MZVQ;E+:#$;-M*^U35TJZ];DZ>H@6V6V[>]MV_1R[7I9;,%2=1#D52&T..+=K
M16I2AX1BVZ1U5=V66RNY2ZQ=0!M!NVXT!]J\\_5+_;7T]UZR2[Z>B99ZRW,9
M)`]Y,@=X11SG-&4@GY0W;O676;?/3_J+'C[@M%LW':=W.7-`E0GH\-N!'A*3
M1<YMQI&I:U4J0:YG&G5-UH@AY^GQTG=OJ?M6?H1]/.N_II-^VZK<\S1VD@#:
M7"N%217#9A10,VFJP"*C/,CCD<\5A>K49Y2#P0#^C`A9):3J'@[1V'OP(1XM
M-Y>$9_+QK\N!:9Q'XTO6':]SW!*#-I@N2G`=#ZGM2;?%9/B5(?6"'`XCNK2@
MP=J87>L00CE1>,BOP4AK>LG3EY#%N=B7S=#D<M/7!6I5LA:DE*V&T@E9=;4?
M"1VCC@(+A08$X*I7=CJ>H.+P]QM3XFX8MWC`5Q&&"<?1CH+O'U*;W9LMJF/1
M+:B0&MV;W>*S!M<)U]E<AAG4#K>Y!*6DC+72HQ&ZM>?MEF9GN&<#:NG=$=.-
MF`AABRQ'=C\35?1BUTNMWI/Z<[+V)`M<:SV^^L1IEKAZ4?B3H9;Y*KEN6I6W
M,N=P9:YU%:FVT.(TA)KCBU[U%<ZV7.<\F$'+2@W>BN]=ST_0AH=(H6AN;Y^.
M)PVFO!/?;<YFX,H6RD);TH-.S3I!`!S[\1UM%%'(`T?*3CV^U6;/$8\\F,P&
M!X%3/M6TF[7"';V?`9+S"''14Z&.8"]EG0%`S/9A2ZA?3\BH/\<4PDO(:?GT
M*->ISK.SMW:5PVY9'5LVFU6UVTPY#"TUNMW"*!I1.I24P7/""DBM<ZXG>D=(
M\S>":[;G<33U=U%RWKSJAFE6\C=.DY<CF"M*'"A_%5<9W%*D.%Y\!3RJE:J`
M$E9UJ"M--1U'MSQW]MK!;0AL;<IIVKQ%J;C<ZC)>.-7N.)X_!8<M'PC&B9H<
MM'PC`A#EH^$8$(<I!X(K^C`A#EH^$8$(<M'PC`A#E)/!'T'`A#EH^$8$(<M'
MPC`A#E)/!'T'`A#EH^$8$(<M'PC`A#EH^$8$(<I/P?0<2OV+*F+%85_0P)-\
MC8Z9MZ\/`_(?Z,"T\Q'VI(P(\Q'VH8$>8C[4,"/,1]J&!'F(^U#`CS$?:M*W
M$T4FIK0CAV\,"U?/&YA`VD(K@3%#+&5HZ1K30[5DA?+4%@YIX<>ZF!8$[0:B
MM5FZ^IZFJF5?II]6!;>;/$K34=P^G`CS9XE8K&I-!2M1_2,+6[090';*'W)2
M.\^;$G8?<I+Z:WYZP[C@S&"`0\VVY7L2HT)![<L0FKV9FKRP#[%8^B=6EM]7
M#IW$09MV)V\%TYMT]F=#A3&W`M$EE#H/:*Y$*'%)J.!QR;4"(KZ2$X.:ZG9L
M&]>L;.[AOHVR6YJTBN."7$.(*A0GC7@>PYX;.J6FG!)7-Q'F\N/U=OH&W%-?
MJ)8F]Q[=<$6B[I`^^A-K(:0JN3NIU7A31!/RX=:-(RRNN;/@SLQ43K%J+^VY
M<8!?3?@N6/6O9J(RWUAET&(IYQ54GWV=2U%L_;S3E3CCJ5AJ<4Q:8B2TXC`C
M`KS_`*]9<B:6W(H]CW-XX@\51C=FU0MU4A3?C>05CV(.?BH`0JO9BYV\I#`7
MGY3[US.?33+(\`;E5K?M@5!1'D):->=0Z?%2A[@,ABQV4L>6E<5R+J>SDAE-
M!@F$Y"DN)>>0A)1%:\P]50!#03F4CBHYC+CB<F>V2,!NV@57\M,&!SQN&]3#
MT`O,:/?[ELN<!^$[OL]PMRUJ%.5)4TIUDT[-:\JX@+FUG<ZK0,@QVJY]%74,
MM[)873CSKA@9$-HSCYL3L:,H.)4$7ZS/V&=/L;ZE*7;I<F*WJXAEMU09`RS2
M$$4.-K">-YY+:\P=GQ43JUC)9ZS-:.`$D;B#0U&!W'>F<HA-:\!7&3M6P19U
M:5::=E?U8PE8XW.K1%BZA)H:U%.S]."B5$$BTN.)4@@5J:=GM!P)XB^!"&!"
MT.+2I-!QJ.S`M@""M.,)0,+A4+27VP2"34$@Y=HRP+?E/7GF&^\_-@1R7IT;
M-W(_MC=>VKY$514>XC4HCW6U*2U(-/\`[66JG><8K0A;"`N8ZIH0G=UPL*+%
MON<_%`_"=QPFK[:GE'29##J$..E2#FV[K7[ASP'Q4W%*P0N<T?B#O?\`V*&-
M0QFA3KR\O!8*?;2:$FOR8*%'EY>"TNO(6A24DU-*5%.!!_H&,M::I:"WDYHK
M0#':0!L*+I;4I)4"D!/&J@#\QX\,8>\1^*OJ2[GACLIKZ!4>M:5$@E"6W75<
MKFZ6&EO'05%%:-A1KJ[.-,:\UN7-1U.XI=K*LYA<QK`?O.#?>O7H<NWR?+7&
M'*@/J8Y[3,^,]%4^RL>%UCG-I#J!QJ,-[BX:R+-1PQ`V'>L1!MY;&ZM'QR0M
M(!+7`T/"@*LMZ>.DV]=T7:-NNS7ES:5IB.OQEW^*LINCO,8!+%JT%+J.804+
M<&2:T.+'TWHEU=O%X`WD?BJ*^A<E^KOU%Z;Z?TEVDW%NVZU$M!Y;O#4?CPW#
M8.Y=`9?3<2-WPMYKWCN@7.T-1HUKA%R.NWL("6VYM:U<+,Q`4%IKJ(4<7B73
M6OFY@;2FS$+R2_ZB6[]"DT*'3+:."<?.\'YB:4&`:,0<1V[4X=R;&VANZ0JX
MWG;UGEWUJ(N)$NJX:%O-!S2E:VFW06BX6P0G6"!Q&8&-AI-O-5MP&A@%:[<5
M7^GNMNI^F839Z1=R1Z:'9RS.0,*[*$<=PJJF^H;:?378>Q8FW(EEM+5VF2"Y
MM7RL<LWR/<$$/7*YW2Y.)YDJ+)0`A*%FIT:4Y4Q0==TW2H2<M<N[Y<:[ZE>H
M_H;K/U"Z_P"H678N7&WC<1(7ORL+:5`8TX5!QJ,.[%43#+K@2X.6=:0NK:2V
MDZA7PLFBFDYY)[!EBB70;;&KL(SL[MWL7O&*RDMH>=<T+0[*2""2X8$]M2#B
MG?L/:4[=^[K%MR,2TJX3XQ<<!^[,1AQ+TMMUWW&TN,I*<^/##_2[.2^F')`/
M?A[U&?4O5&='=$7>M74C(X^2<N(S5=\K:-VUJ17LQ5J?5#:K?MN\=.Y]FMS<
M:-!$6T1914$J:$.2RYR0DY\IKQ>+AGBR:]8RZ5I^>^:&LW93FP[@O(/^U[J3
M4M1L=3LIW.?>NE,YVTRDO<37833=M4"=68G*Z@3Y:/$W<XENNK;E<EQY,>FO
MV*+M<N-,\<\>TM^;[IQ'<<0O<O2\K96$-KFHF(`>ZO#AGV8B;PMF+<A^9I*L
M]M:,?-(9I'1D`%M!6IQVTV+8&E*`.6??D>/=AU;NMG#+=N.7NJAS;L'*T!S.
M)*/%K+QCP]M,S[,A[<.DYYK%L:B%P$L`4!&K5X<SPI7CC"R)&E'1%>2@)&A2
MJ4*4J"B"?B`S`P+!GA8"]SA0"I]'8G[8M@K>BBY[@6+5:`VIQ<EPCF2$C,,1
M4$A9<>^RH<,958O]=LKQM+,OKVM(2A=]X.BWMV+9K2K39Q5B0J.RI=YN30R<
M7)=%"EI:?"%'+&H<"_E_>(3;3;7GQON+NF9KZ-WX4K[TZ^A'0#=G6[="[7MU
M!M.VK.[S=Y;LGM%\6*%)72#;F99\"[DM)*4H;*E-KIJIB(UC5K;3(7MD<1<%
MART%1FIA4[L:8KI?3.B7VH3Q"!C39\QN<D@')49J#?A7!=[]G=*+5T*Z5PVM
ME;:EP=C6;RS#NZ51EO?BM\F^%Z5=;H`&W"ITJ*:^XFM<<KUCJ$7=H8;IQS$;
M,2O0VD=/6]D:V+14<<%,?KPN+<_8WIZW1"6B1^*V%R*7T4+;C?X9$D)4A?!0
MT-KS[QBAZ4^"WC=&":ND)V<0/L4SJ$G)(;>"DV44I\PRXTQ';7!)G2Y27]NP
MBA7O"*D`Y$K6VVA*0.U2ED`>TXLUI:3W<K&0`%[C05-%4I+MLMPV"(T+G4QP
M'I)V!2Y9]Y(9%WC;=DA=SAS%;>ES6\F;;/2JERA^8%6U2HJ#I=2"=!R.+!#8
MO@E$5R!G[,51]8U/-(^"!U7LV\/7L*I-UTW@B\WEO;L!6N%992FY;E"@.R1G
M)>03DYS'#Q&6.G]-6$=NP3N%&9C[UY:^H'4$USJDEO$XFC&CV&JKVJ,Y4T`I
M4TS[*G]6+9<R-D>.7X/4N<1/`@<V3]4_:%YY=WN'[0PW2*'EW>X?M#`A#R[O
M</VA@0C+#:FPK4*5(IG7A@0M+K#BG%*`%"<LQW#`A8>7=[A^T,"$:8;4VE05
MD2:\:]F!"+N,.*6I0`H5$C,=N!"Q\N[W#]H8$(VPA2$:5<:D]_=@0BJH[I4H
M@"A)(S':<"%YY=WN'[0P(0\N[W#]H8$)0I_13#_S$?:L8^Q21BO+H*&!,[K[
MOI^"*.2"E2D:0:95KWCY,":(E@0A@0A@0A@0A@0M"VAXE5/VE4^<X$(M@0L3
MQQE-9O'Z%YC*20P(0P(7H-#A:W_5'<?<E86YI,O8?<C\"06)33FHH"'$N:AE
MFD\/D.&EYO25A?\`E+Z@XJ^?1C>:+G:7;<MX.2?"XP"LDH0WQ2D'[)I]..>:
MKI0=(^ZIXC7^/4O3/16N&>VB94UR_$JPD&<MXZBVE-02*$D9T.*>_P"6;EJ]
M2`.NN9OH4L-.:TN!204K06R#P\0X_*,;)15LZZ;,CS;9%E1X(4ELI3*+:`5N
M-C]ZNE,U*3].+/H]X6.8S@%0NING06/NZ8O)=Z\5S(WSM5RWW*5!?924NA<J
M*X@:@AH'2EAWL2YXZT]F.C17QY+1NJN'S6I9=O9V>O8JL[VVR\N'<2Y"0K2P
M2W4'PFJ_&G(YG$]97N`H52=8Z=;>.)IM*K\+2Y$A3U%G6\_!4RAI0HDJTI`X
M"N=,6!M^:#N7-+[3Q$YT0'A)'J3"C.3+!=X5VCU:E0Y;$I#8)2A0CN)=<:*A
MX@AU`()XTPXBN.>U]=S57X)7:1J$%\S[LGOPK[5(?7^S15W:R[\LQ*K+O&V0
MG\D@,L7)+:4NL,J34N)4D%1*LZC#+2_ZM7GJRQ<V2'6J?U;,Q](!^*K*L5*A
MV$G^G#IVT]ZJH11U`1IH2:U^BGUXPGEL:YO1\454T%**JD5I]`I@3I%,"$,"
M%I4[11!'A!H2.-.VG96F"JV#:KQU4#2TEAV0J0X\VWRW$(2@(5JU*U#Q5%![
M,:DA*M8X@DC`"JQN3#MM>0RXIIWF-AU"FUZJ)*E)HNG!54\.[&3@E8?F;Z4C
M*.I15WDGYS7&$NO,"RL@M2:4-"FI2?A)IF/;E@6*8J?MW3#O+HQM6].-B5=]
MFNOVJYRJDN(B.+_P_-/$:4:0!PQD8TXI2(Y9P&URDJM_//PCYSC=2:U+5K-2
M*8$+U&JI*`DK2AQ20H*(44H40FB025*X#VX3E<&1EQP`I[UH\-+:/-&U'O4H
M;"Z1;QZAWJ)`M,%<6.J(U/EOSVW(Y;BEYMN2XD$!*@V%U2>WMQ*6%J;VC8Q4
MT!QX?:J[U;]2^F.D]%<7D/F:2WY<KB7Y20-IPP72_87I]V!T^CL.(@MWF[+B
M+BSI]Q:;<+JA(<5S4QQJ9:*442G2:4`/'%RM-(M(X\D@&<8$G>O$?4GU<ZFZ
MON+B".0V^F@U8&FE!1M<=IJ:[]Z;WJ-Z./=4[#:U;?2VK<UB"(UO+[B6FGK2
MXX@2&70A"25PXX):XE1XXC]7TF&:S,4(&</;CQH58OHQ]6+WIG49+'6WF31I
M(9,Q)J6O#?ERD\3MKZ%+FR=MV_9VSK'MJ&PAA-KML5MQ#:11,YUI*YZTK%"O
MF2*FIS'R8M>FVGD[)L;!1@"Y;UIKUUU/U+-J#G%T3Y#2IW8)>2"``34T&9XG
MVY87!J*JMS,Y<KF<"M4N2B'`N$MW]W&ANR'%)<:;>2EFCM6.=X%NDI`">XGN
MPWNWY(:UH*IQIMHV^U&"V>:,=(`>T'#'U^M<C>JFZ[SU%WA.W1=8LZ+$3-5"
MLB5K#K,1B,2D-ZDT0E;I45*'$:N['(>I[X.<2%];?I#TUT/H73<6FZ=(UNKO
M8*TVU(':F4DEMZJD).ASQ(J=.2J$?)BAW5WYAS&=@^"[,+$"T99'$MDIWFNU
M72]*&UF4Q-Q;J?CN+5%N"K1;W)324DEQ`D+F1E4JIM*1HKPSQU'I>R`CYFPT
M7@W_`'9]87M_K,'0]O+EC;^8X`[0`?E-.VA4M]5>F<CJ3<+2B;=(\&S66R7=
MP-*&J0[='DJ,9Q231(:4HBJAFD#%HUBR&L6PMB00!3T[%QWZ9?4J#Z?Z9))9
ML+KZX?RS2E,N(.W_`!8*H'4Z&F2SLZ<=(+MD1;W'FSJ"UV5UR+X5'-272DDU
MQQ6^9RY#'^$D>HT7TYZ%F\Q:1W&/YD3'_P#$T.^*C1$0H]P<RH%=65*?)WXK
M9_4*OS/U7=P^*WI@NK`5ITU[!2@H:?JQE+HRW&>"P2@$9Y$Y<"!].)A1Z=-G
MVU=KL\&HT%]EDE*7I\H!J"P59H+B\E$*`)R[L8*AM6U$619'7YG@D>C^U2+$
MA[9V2]Y<KC;MW(M!<>9B#_Z*BN)&L:Y"O&HH3I)';PQJ[!I/8JQ);ZO?R!\)
M=RZX]V],>^S[KN*5YJ^35R&4.MJB06U>5B1DE80F-'CM)H^I:EB@(U=V(?SY
M[%9;/0VUV8*</3OZ<=W>H'=]RLUHAR(>V;;RVMQ7>,3YQ28\@%5GVY&4$.W&
MZND_>,@:FT'5PPROM2,$1N-[0KWH725QJ,H;$/RP<>]=Q[5TKC]`(O3_`*;S
M-ER=AV:^2(B;'YI;(=N#ER6S&G2IK[7AE7>4APE?,)&L]F.5ZUU`Z_9(^O@8
M3Z@2O1_3N@VFBV[;>0`2OP'><%>;U929RO3UZAMG66`U$V[L/:-A9V^(0:1#
MN$F)`BW*]/K#51YIF0VM"EIS2!3MQS]FH^;VE6ET?D_F&U4MZR2/\Q>BSTL7
MUL%Q=J4NR2*J*PGEVV5"D%3BJKULKBDTX5)PO;BEVV,;#1,[^YMG6#[B:F=M
M1Z!3[56^[]=9]BAV'I#TK7'O/5K>*&(;%5+7'V;;9*A&EWJ>60I/XFQ"<YK#
M!-6LG'*((QV_0M*`MA=TQ8`5YDZOZQ_.DTO3C2^EJV/CF.Q6E6W;^C/26'9H
M[SLF=9XCMOC.7%TB9>+I*6?Q.[W!])+LJ<_)=+BG352B`#EA];V@O+\`C&JJ
MFLZM<=-Z(9=1/^<E;O[<%3!^0]+?>D2'%.ON.+4ZXHU4MPG4HD]ISQT9MKY-
MH@X`'UKSA=W$MW<.N)35[C7T'$+5C*;(8$(8$(8$(8$(8$(8$(8$(8$(8$(8
M$(8$(8$(8$(8$*1\1JMO.DXE#`M7/<_Q&JP+;:C4H22>)I@6JTO-)#9*$"M1
MP&?'V8$(EH7\*OV3]6!"&A?PJ_9/U8$+PI4.((^4$8$+S`A>'/(\#@0L>6CX
M1@0L2VBONC&4UF\?H0#:*^Z,*1@%X!V)$K%UL4&A&=<Z`G#K(S@%K5:.6KX%
M?LGZL&1G`(JARU?`K]D_5C(:UIJ!0K9KG--6FA7NA?#2K]D_5C5T<;_&`4B8
MHR_F%HS\5*_3/="MO7F(ZATMZ&]+M%T\.HDMJ']M.5,5W5;:K'-8`&<%T3HC
M6'V=V&RR'E@T`K@K]6J]";"B7&*06IB`M26%!:6.WEKT:N62*Y&AQRV_MN5*
M9"*&J]#Q7K;I@DB.%-R>,2XI+=2FIKGG[/8,,$IS).)64QD7:,XPII"P$*Y3
M3PJVIPI(3DJG%7SX7T^5T5Q5Q-*HU?/-8-9M^3X+GUUFZ82H3"I4`%3BGI-P
M2I:#SI24\P.1WP17F(*ZMHR)0"0*#'3=,O+>X'+?0T%?X]:XG?Z7DG,A;2N"
MJ#.VV[<8SZ9,=&EZ*"%!NK0\:T\O7[FM)!JFM1B;;/%'X#3N57O+9[7&@HJP
M;DVJBW7-YA3:5)Y:BTC0?"KL*0.T=F++%/$8VFH\(]RY]J&EPESG<MI.8U-.
MU0S?-J$N/OK32J5:`I)&DJ!2H@9$$I-,.HI@:B,X$8T5-U+1;:6TEI$PR``C
M#8:C$)W6FRJWQT9N^RGDK7=MBRU7_;+FDK=7#%>="3D5>4922C*H`.>-F%T9
MS1G*[BK((G:ET0V"X'-U"(48YWB:*;&\-@]2I^^TV0X$-)#B5%"P@$E+@KJ0
M1V*!'##YI=2I7(&.G8_*\NIVI&D-.)T:D*%=7%*A\.-JJ5CF!'R8'>BA%*BA
M![NW`E!(_B4GE*AF4J`[R","?K'`A%%Y+41V'!O2C=R+2":!?VPH$*[0<^!Q
MJ>*>-:T8`8(@XZ2K4XNJCF2I69[.W!M2T<1(^08+#F)[T_M8S1;\EZP<60!3
MC7LJ>P^S!0[EL(7`_,,%H+RP:9_IJ/JPTF+VOH"1@M^4."G3HE<VKI*W#L"Y
M\K\.WE:)*V69BTIC"ZL)*(BD!PI!F%2`6T@ZCV#"7F#"#(^I:,2/8MVVI,C#
MFH`:?&OP4*S[8[:YLJU2DN"3:I4F#*4I"@XXXT\K[Q8(!J`=/Z,9;?\`-'Y3
M<5(NMKISB8(\P[/L2<M;0JE*VZ(%5$J&M-<_&*U2/EPV_=7LN3:.8>8*>W%;
M6UG<.N"RY8]A`K2A`5M/2[TFL.\KW+W'N;S"[18U!ZW1G6%+CW5;H+!0\%)"
M70SS>8*'(H&+;H6GF_O6NNV9K2IJT[#@2*^FBX'];>NKO0='DTG2G,COIF@%
M[31[/G;X<=[00>PE=((%KCP6(B7`R_)C6]5L$W0TA]R$J0IT1UJ:":M!"6Q0
M]B1CHMOIMG;`"*-H<!2M,5XNU+6KW4I7/F>[EN<'9:X`@4J/;ZT;6LI40E5`
M*4IPX##MT;'&K@"5%B1X9RP3D.Y:B234G/+/@<N'#&O(AI3**++99&1.A:2(
MG$5&XTV(=E.P5^GC\^%\[\F2IR<%JQ[HW9F&CEI*T@D:@*=FH?7C```HI)C&
M2-#W@%Y&)6IUQ&GQ:'$DT4A02M)20004FH((.-9(XY&%KP".U9Y>4AT'RR@X
M$;5#W4?I)M[?>W7K/:XR-NSD/.3X4JWM-IBO35!(TRHZ$E1U%`JKM&6.?:UH
M5M+7-&TX\%UWZ;?4_4.B=8;J6LS2W,3=C7DFG<J07GI)<(F[K=T\MCKD[=\A
M,9ZX/+:6+:RR[I#TA"M(0TV-1(J:`8IFH]-M,D;K6,-H!6@[MJ]W:%]>]-NN
MDKCKFX-+09FLC)P#AFQ`I6N'M71;:FWHFTML6?;L17\GB-PYJ]*4ID32`ZZZ
MV10.M@Y!6>.K:=9V]KI40:P"XK0G>138OG1UKU1?=6=83:]>3/F?,XECG&I:
MRA;E[!V(_=&Y<JWS3`Y2YJ8DQM"GBD)2UY)U91J-!34*_+A>/\M_Y>!4'IC8
MQJ\<#Q_E@\.`W5#MO>N?NX(ZIW3O:DAQ`Y]MW#?[0XNE:AUTO-K!_NPO4$G@
M:X\_7;G.N9,Y)/,=_P!HK[`=,NGM)[2.)SFVKK:(Y1L(,;2*IA,VQU*5N*U!
M`":K(*4)K6E5$`89\J/;E%5U>&2"2ZF:2!D:TT[R4O6C;MYO+BH=GC*D2&@%
M.%33BFD!8UI*B$D`%*JYXSRHOPA,KO5[>U=EH"I";VEMK;0\UNNZ)NDYVCC%
MEMB0A&I`U44L%00$4J0?>`IC?%0+;RXO#EA+F$\$4N^ZYMS::C1N1;[6I"T1
M8<-HQUH;24I/GO[QPY:2>RN-'OI\OWBMH=)<_4(G:G^>RAH'X@"HJ!PJG-T=
MZ([]ZZ[WB]-.FENAWK<EQC2+D&)<U$*!&A1"DRY\YU)#BV8"%!;J@?"GCQ&*
M[J6J?MC'.G<:4.U6S0]/EOM5-E95;"<,HV8KH'Z)O35+VQZV-Y]/^HVP+%U/
M8Z81KC`L[<R7Y>Q2MYL0[;=HFXX2+DUY6YV*T(DJ*GU)=*4THDGA1-<ZOMF:
M,V:T`9.?O#;LXKJ'371_[=K3HM5C$UN/NN%1M737H-T^FV#UP;\L5VME@B6W
M:B]T[XL\';\%,*QFZR9%G82VRE/WCRFWYQ(<625)'A"44`IFH]07]YIH>R:0
M-+<<=IKO74-,;IK;QS=,@9!&UU"&BE308^I0)ZOO46YUOG[%V7$M]QC;UZ:[
MFO#^[]WQI5;="O$.Y2K?$M+$5`*B^M3(=4Z/"'T@]E,5C3I"Z*7F',W(:@[Q
M0U"F]1#I)8J'Y\XH>!J*'T+H3OS:,FV]*>HNQ9$IR38IG0)-P5N::X5,3=S7
M2'?Y%\DS[@L^6-SFJ5'0H%04H:`!F*PL,M;L,MF`-KN4G/E@LR^]?G<-YVK@
M[U*]8<R!Z?NGGIZVZS;9&XK*[>+@)+[;CR+3)N,J6\;S>7VM3K+,%J04-1TB
MKSBCJHE..Q],=+.O;QFHS,'EV@-((P)&/Q7G'ZC?4BVTRT?HEDZEX]N<.:<:
M.PI_U2I/]!W1!ZVPY/5W?#RW+U>A*CVR;*;T3EQY?WESNBBOQ-AU0\*P=)00
M`=-,=&U6Z;;.9IM@WEMDHTAN`Q7&.EV"X<_6=3',NXCG8]^+FN&P@[B%,W6'
M>+F\]Q%EHARS6L&)&;2L+09"'`772E!(JO34GM.)/1K1\+Q(_P`0WJD==ZW=
M:Q<B*ZE?+$#@'&H"B4,`5(:]XE1\)S)XD^TXM\\AD?F)J:!4]D;2P9@":>S<
MO>3_`,(_LGZL(K;E1_A"')_X1_9/U8$<J/\`"$.3_P`(_LGZL".5'^$(<G_A
M']D_5@1RH_PA#D_\(_LGZL".5'^$(<G_`(1_9/U8$<J/\(0Y/_"/[)^K`CE1
M_A"')_X1_9/U8$<J/\(0Y/\`PC^R?JP(Y4?X0AR?^$?V3]6!'*C_``A#D_\`
M"/[)^K`CE1_A"')_X1_9/U8$<J/\(0Y/_"/[)^K`CE1_A"')_P"$?V3]6!'*
MC_"%[R!_='C\)QA1WVI[5Q'T5AYS.U"N"B.<SM0K@HCG,[4*X*(YS.U"N"B.
M<SM0K@HCG,[5I?07$!*:5"@<^ZA'M[\%$<YG:BOEG/[/SGZL%%GG,[4/+.?V
M?G/U8*(YS.U#RSG]GYS]6"B.<SM0\JX>U'SG_=QE(2.#G5"Q5'6@%1*:#C0F
MO=\(QLPAK@3L2:U5&''.9VK%%[QPHUP<*C8L(8V0A@0LF%^7>#K?OE22JOL(
M.6&MURY(^7]Y;0FX9.U\)``/$JY'2'=G.C-VU]X):<0H@$@#F)TA!.?MQSGJ
M/398;4W!RY<[1AMQKV+OG2/4MFZ)MA+S/,EM:T&7#MK\%8IB0VPHL*JI2CJ"
MD44BA`'&HSRQ36PO=LHNE8<KG5&7VI>8GL@LH`<U5;3P%-513/5PP.AD!H*5
M6YD;+"!C2B:N\]LL7^!(24I5)KKBE=4I2Z4K0HJ("B/N5J%:'$IHTLUO<N=,
M?RRP@4Q-:A06H:,Z]BRP91(#7'##'L*Y^;HVBY9+E.MRF0F(E];C(`.2%G,Y
MI`!U@XN$<SIA\AP7--9LS8DB4`D<,??151Z@;47^(B>ADAIU99;)"@I*M1&I
M8H0E/MJ3BRV\I<UK:X@!4F[T][AG%,IQ]:BJ^;1#T,%ML%T%16<Z4*>PZ2>.
M)>V?Y4E\QJ'"@ICB/4JX_2WNSM.4@C^-R8>U7#L7<T2>^L*AW)1M$^*:D"'*
M(YBZ$)'+-?%F,2T<C915M:)MIT7[;,6W8K:UV-Q/J-%"W6WIH]LG>,XPXO*L
MUW6+K;5)U4++J<PJB`D+JNN1(IAW'=Q2'**U_CM7+>I-"NM*<7R9"'$D923@
M:D#$!0+/8<=TA"""SJ*]65=6FFGC6FD]V'="!4TH55K5_(J9:_/2GH_M3>6P
MX5DT[N_L`'=C53<+!**M<WUHFMM:DD!)J:<0>\>S"7/9VJ3B89796[>U%%LN
M(H"DY]P)_5@Y[.U/FZ9<N%06^L_8BBV7:J5H53,\#PP<]G:E/VRY:*G+0=I^
MQ$G4J<1I2#6M<_9\E<8,S.U+6]I+.:,IZ47$,*%7$5/9D#E^GVX3?>11'*[-
M_'I4_::1,QAYF4DG=7[$#"10Z6QJIED!GV?3C3]Q@X.]7\TZ_:W=GM6E<=U`
M!*0:FF6?ZL'[C!P?ZA]J/VM_9[49A6R1<7F8L6&_*F27VXT6.R@K=D..&FEI
M.6KEU\7=C,+O/S\N'!V&W#[4TOHH-,MO-7CV,AJ=_!6)Z;^GOJNYNBPW:58W
M-L0;=>H+\JY7E%1'AHD)$B0W%;UEX\@G0"I-5$9C$R[IJ_<!')R\C^W^2Y;U
M1]5NB^F8O\Q)+-,1\K86!Q)X?,YHJKV^I#T/[*<ZB0-\V*[B#M;=UFMLXP85
MN6E*KC'BM(F.F5YI26I$X_>*2`H!9[</NG=*M9[IULX4='@:[#W'^2KW7?U5
MU;HC3K>_M&"6&[9FC<,<H.Y^%`>ZJB9KTD=+E7.).DS]SJ@PTHI942F.2^X`
M.<J1*`2XH.+!(20K36F+7+TSI4TIN&M/,V;!]W!<8U+_`'.==W-B;&""U#W5
M_-)^<`\*,&SM*LG;+;:[#;6;+9(,2%:8PI%C-16F7&.\J>;JIXJ&1K3CB1M[
M$6[VN;0,&X=RX+JFK7VO7#M1U>:5]^3QJP^BHIZ`4:Q(J*7E1C-$NVWD>T.%
M*%#4,%"MO*R]BU./H;("M6>>0'UC!1'E9>Q)CB@M:E#@HDBO'/"1G8TY36H3
M^-I:P-.T!8C";[AA%!5;AQ;B-JWI>#1"FJZJ#,C^O"/^7D%)P2$@8N>[_,GY
M.S$_!%%0X@F+NY9B?BBVN4N>F(UYM4;@(RGO?T`4&$8Y;"20PB)^085H/MV*
M8CU:Y@LW:);22_LSMK3^+&II4[R=ZR==0[734<*ZJ`5H.&9P^%E+*VC"UL8Q
MQ)'P*8PM;#$'/!,N<_\`#3WU2=.;;E0),#S2HSSS<A*%M5U@NQELHU4IX-:O
MFPRFCY#Z/<VO8?Y)_82"+46WSOT0?C7^W%547L3<"=H2MN/VQYJX(NIFVH2Q
MR&9[?,*5R&'7*`MZ234@8X#JMI+8SO=-2A>XBF.!)[`OK/TEUAI?4UG;ZKI<
M5P((K>)I#F-!JV-H-`'$$5&&(P2(UM+:>W5)5N>1(N4Y"`X;7#?"V4N)J="R
M5MI6":#MI3$896@`BI#N"L5W=ZG>W(N-/!CBD-#G^4FG=FX\4)^\+A/C-PK6
MTSMNTU6@PHS2$3D-I44A2I:3S'B]370FB:TX8PZ0-QH59[/29C$'Z@YIKP-?
M@$T4PT+4AQR4Y)2IQ#?.ED)6E3JN6DG-8*:J%<Z]PKATZ$L%26J;OK:UT\9H
M&DGL1I5O:0TI]T(;:3(,=2E*;*PO/0LL)*I`2Z11'@U*KD*8B+NYCM[B-[C5
M@:2:8[PHZUOI)I:RLD%,&U`W^E=]ORW_`$'[UZ=73ICZJ^HFY+3MVW;CV[NA
MC:_365&:C[AOUEOT!8C+DW!Y^,Y`ENK@EWRX0Z%M4\6=!Q#KGJRSUB[=8:6)
M6RL'S%X#1A4FA!.[L7H'Z:=%:CILPU[43`ZSD(RAKB7BN`J"T#;VE2?:;M_E
MW\U>=#C16(UMW#"2N-'3DUR;_L-MMQ1&02OS%N(%*C,?HJ$D;+CI]DAKDI\%
MU>1UN=??%*#6IV`<5*NT=S/;?_,:WSM1U*%P]U[=N4F`\\:*94_MBWW-#*:\
M$KD0212OB^?&9'0OTIH@!H&T-0!CZU&,CBL-3=&P.(D=FP'93%5^]5=AV_TT
MZ*[GD#;+5EW'NWU07R1`NJV$IN5\ML9%PNOXM%=2>>Y$C0WN4XQ307"55)PR
MT3\V7RY::R$-]>&/K4IJ+LI9(#3*0?510'ZC?5G?NK-DVSTRLT1JS3;?L>WQ
M=W6^VW9]VW(?88;+-XO262.;(=2VCEQ^%3J41I`/4-!Z$K="5_+R5XFON7%?
MJ'U^VQMW6S'O,M-U*>NJYY^GCH5/ZJ=497GGE2F!=A=K_?9"W"!&MRD`193Z
M&=*DS4MZ$@)`(R/>>LWGE]"A;;QM.7+F.4#:<.S@O*L)N-<U\7U\2^.@;QP!
M)^*[(;YOUNV/MB!M>PQ68,F2SRK?!HE+D*UE"4N%]*22TE:`.6!JJGNPVTN*
MVU*=MVX&K'5Q'\U>M9O;+3M-?#;$M)8<*#[560L'6M8T@O.%USLJM7$C+%L<
MR(?IA<2O!-<W/.J,G:AR%=Z?G/U8P*TQVI;#=P0Y"^]/SGZL90AR%]Z?G/U8
M$(<A?>GYS]6!"'(7WI^<_5@0AR%]Z?G/U8$(<A?>GYS]6!"'(7WI^<_5@0AR
M%]Z?G/U8$(<A?>GYS]6!"'(7WI^<_5@0AR%]Z?G/U8$(<A?>GYS]6!"'(7WI
M^<_5@0AR%]Z?G/U8$+WD+[T\>\_5C"BOM2[A@IA#`A#`A#`A#`A#`A#`A#`A
M#`A#`A#`A8J2%I*36A[N/Z\"%H\JWWK^=/\`NX$+,16Z<5_.G_=P\B_3"U.U
M>^5;[U_.G_=PHL(>5;[U_.G_`'<"%X8K>?B7W<4Y?[.&,OZA4;YHQW1;N!^"
M<>WKH]:)L5:'EH;;=2K,\2""`:4R.(W4K47EL83B,P/J5ITW5S9S-F::'9ZU
M=O:NZF;S#:>!;+[>AI0`44UT)5F"HJKGWXYYJ5J+2H&Q=]TC6'7NG@G'!2$Q
M,35DFG,!0:4\.L$9>]6E<1`-156ZV.:W8>+0EMJ:ZM8U(:(3XJ:54)&5#59R
MSQJ^7E`.[4OFR^E1CO\`Z?Q-SH7<FE^7>#:F9"&RA*`I6HQ5I2I"E#6ZHA52
M:@94Q-6-\0*$XJGZKIHNS4BM54KJ#TWGMV\P;A;G8<AIE9CK0D/B0ZTV2%ZT
MIHTAW37/@#BT6=X:@55(O+!HJW@:>I5<MME,YAU7*!3H6AP@"@=;>4@A-:T&
MD?/B8GO?RVXXU5=-D,Q!X**M^[-845),8:OPZ60X``XE14:+2:4U([.[$E97
MQRT*@;RQ:#@DB=85=5.E$I*RM[<FR6E1T<W1SGXS6A57R4:UJ#:3PTB@QFTO
MOGKVJ%O-)&M1%[L2/@J3W+;!+3:D(5S5M^,9%(=22%`>$'2*=^+;9SF=I[/B
MN6:STQ*Z01PX9"?;3[%'D^UR()4VZVD.IR6FE:%0!&7'W2,.]RK;].O+5],:
M`I$\DY_=CC\*N\>W$<K19?JCO123!62FJ`./V3WX%=]+@YT;CP(]R*J@*H?"
MG@?LGNP*5%B''+3:B'D5?`COK2M<"VDTMMH@("O@2?\`LX8W1^<=RDM+B$\3
MG':'4]@05$;2E7A&L`Y4%-0'"E*TKAM527DD27&4L4+;?&N2#[?KP+/DPK)>
MF#:,2Z;WD7V;+:CG:T02(4-Z.IP2I$K4D.QJ4!<CE`*^[+%KZ7@$MT''<5YL
M_P!R&MVVE=+_`+;'(6:@_$4.T&@'=O70TK#KI4[K=YG[Q2UNT45C-6@KT@$J
MJ!P&.KSV30QLKMR^=DLMQ,.;)(3)7"M"?6I_M;PWYT>G[;#KCU^V;,\_`"2-
M?X?$^\6AXK"U*2I":'3IRQ5-2C.BWC9!@)3[2:+TU973>KOI7_INX&;7(!F9
M7;E`:2/4TJO.HKJZ1I+Q+Q2."2Z=12G^R"<L7&V)=`UQWBOK7F22)T$AMW^*
M,Y#WMPQ[<$,+I-#`A:U95/RXV"E8/T6HAYISN1\RO][&4JM3CBG""H`4RRK^
MLG`A:\1DOZCN]"&$T(8$+?"8D7!X,0X$^Y.+<Y/+B1W`-9.G275)4A(K]HY8
M6=?6MJT5`S`8J6M='UO4:,LXB00*;ZC=P4D6[I9>"P)=]?A;<CG[QQ,M]M4D
M1\O=;"JEP#/NQ7M3U\W3&Q6KOF:ZIIPHK]H7TOO+E[Y>I9?(V+8ZL<^@SOJ/
ME&W[M3Z%O5-Z6[7<Y5J\SO.ZMA*W5R&4QXI4KBPE:FT?NB#G7MPVCAO;D5J<
M5+FXZ,Z2=R9(Q>TVD;Z>C>HGZP75G=_3;=-VN$2);I.UFX4F"BV)=9";1+>Y
M+D9S2XX^X1(*4IT%-5=]<4OKJU-O$UPVT'N7??\`;GU[JFJ:P[0XXQR'/.4?
MW:X#;N&"K=T4]./5GKQU(V[TBV5ML1]Y7ZP/[RCIWK)?VJQ&VRPMM,NZ+D76
M/SGVD(<26^4EPJ[:5&./7&O0Z?:233G!HP_@+Z(Z?TC?:MJ45F^/*(R#_P`6
M!]RL1Z[/0G,]#W1SIMOK</4)._MW;VZBS-GWMBQVMV/MC;\'\">N4$,.KYMU
MN$Q$F*M#CVA#2PGPIIXL5S0NO+;4KQT#L`#\>'\>A7;K3H"YT72VR,%#0'V+
M;^7WZ.V_58QN?J)OF_3MF=%MB/B-?+C"3Y>[[BG<AY]VWVBXO-2(]OB0XL9<
MB7(4VOE-*2@460<8USJY]K'@>*2^G?1TNN1F2\%6A7$]8_HAZ*^E^5TXZP;`
MMD^;8;S>HVU)MDO-[<W):X=\_"'KW:-SPICK;+\HOQ6%)/,*FDK6!IX8I&G]
M92:I.\$UR8>M735^@[*-S?+M`R'%=7]ZWG\>Z6>CS>:RVZE&^^D!2DLM(:1"
MW)8+C8G8:DM(0>5YQS(5R6!QX8H4+^?K=P[^X_\`[)73F0#3]!MXA7QL'_6"
MH;UBYFU?S*NBM]<HVQ>['L)"W%?;<,NXVR7F*5^[6`*U]N)>#_TNSA0>Y1T_
M_J9_>?>MGJMW!<.DWKIV1U!M3*)3Z-M[;GFWO-N!%P9$"=;)B#(;6REE"TU3
M51(!`KB3T.Q%YI3JXT?3V+%]>0V=WGE\5*A43]>GJEO_`%BWM;&+#'$/\"C/
MQX%JC.B=;-G.RE:'9JG6EJ:G[@DI\"W4T:3VHICH73'2#'-\P17+CZL5QSKW
MZDPV;'V\1`>6$#O(H%7_`*2;3NC&V+],9A/S;_O&4W!MSJ"MZX7%Z2"A\J<7
MK4L,K\9":!*$F@&+]!'Y6A&Q>7KR_P!0Z@O`UQ))*ZB=*MB6?H1TX$*2B*[?
M%1FY%\D-I27+C<U!+QBA20%&`R"D!/OZ]7BX`$Q_<[UL1Q^4>\JY#3X>G]))
MN!_F22X=Q`'P*B^^W![<MVEWR>I2I4U:%(I4)B1T_NX<=*M10RE!`H23EQQ-
MQ60TYS8Z4S+DFHW]WJ-UG:3R6G'N27Y5OO7\Z?\`=Q()NAY5OO7\Z?\`=P(0
M\JWWK^=/^[@0AY5OO7\Z?]W`A#RK?>OYT_[N!"'E6^]?SI_W<"$/*M]Z_G3_
M`+N!")N)"%J2*T![>/#]&!"PP(0P(0P(0P(0P(0P(0P(0P(7OUXPHK[4K<M?
MPG#!3"'+7\)P(0Y:_A.!"'+7\)P(0Y:_A.!"'+7\)P(0Y:_A.!"'+7\)P(7H
M;77W3C9GC'>L+/EK^$X>96\`M5@6UU]TX:R@!^"V"`;77W3C$>+Q5!V+/EK^
M$X=Y6\`M5B6UU]TX;2$M?1I("V"\T.?"<:9W\3ZT(:'/A.#._B?6A#0Y\)QJ
M<<3M6ABB)S%K<QWT"`96L@&J:*"JDTX=@]N'%KEYAS[,I3:];2$9,#F&Q2WL
M#=#EKN+492EAHK2I55$-D@)3F":'ABMZSIPN"2UHIW!7SIK59((PUTKJ<,QI
M[U;JWS6)[;,AEQI:EH;=4&R*HK11K0Y4Q2;NP=$TL:*%N"[A8:K'-:1M:<<@
M]R7V9(0HD*U5210&O:,Z5[,00B<)"9,1P*D0^0_-4T[T;4X'F%U`.I:=22!X
MN6"IO4,ZZ%&HKP.%P:;,$;=J2S#:N#$N#.85)8*75NO%/,=<2[74RAQ6I95X
MJ`>S#[3IWQS5D<2WOP3/RT,['U8PNQ^Z%46Z=,MKV'>LFV-R95N-P9,N+#?:
MI&>#KII1LCEM)U'-8&9Q=O-17,36-`JW%<[FLWVU[(7_`*;A@#W\-RC3J5T?
MO,!EV2W#9+:P0T64B4V6UU/[W2H>/M1V'&0][?"2/2HB[T]TYJSV*HFQ'SMJ
M_3IBW6#:9DM,6]PEBCR6Y+WD@IYI0`T!QT5J/=KB7;/;MH12J@&V\L56QU:.
MS!-#JKTP;VON"8XVEC\)N;JY=I6TTA+/+6$+6AI2`$:4\P9#+$A:WU'$-<=V
M]0>KZ>]X:Y@RNQJ1A7A7BJU[IV0I:UNEM25N:23IS/@%#PKP&6+/:W;7-Q-5
M1+[2Y2XX&JB.X;=>@+T%MW3VK4DT&?>>%:8T[U%6MC-`:OK3TI"?@:E#355*
M@T/`_HKC([%:]/N6PQD$TJ1L**+@T"@<B`<B3W?)C5U<I[E)-U!K2'9CACM1
M#R`('B^7/]6(OF2?B*E[;7H97?FL:[O`*P5!`XK`[<U4PUGD?F&)V*VZ?-;W
M,1?#&QC<U/E`%<!C@$27;35:Z^&JE:JFE*UK6G"F$,[^)]:>/C:6D`"M%H\H
MW_?-_M_U8,[N)]J9^6DXE63].%WB6[<TBU/W%$9^;'<-M2IE"UON:2'TQ'"`
MI:DBFM(X95QT+HR[BC`C?3F<PXD8[N*\<_[KNE+N33;?J.)AD@:0Q^VE&$;=
MU!F.U7C1J(4*U*!J)(TDD&AU#OKV=F.GWKR\L()RGU+P[?V@CDCEA#2V=H%`
M-A[.!P.Q2)TNW`C;&Z8DB8HBSWI+MGNZ$G25IN">2RI?8K[Q1K6N([66QSVA
M,K0Y[6U!(K3NKL5[^FW4PM>JVPW!I#*PQX]H</BDG?6VGMI[GN-H<1]P2J5;
MEZ:-NP74AUHM&E%!E"]*B.!&&V@:B/VUD4I+I`]^)-33,:#T!-_JATR=`Z@D
M,=.5*6R"@I7FC/\`%,CG-T)YB>RGB]N=,3KRYT><$T51NXXSR7L8T-IC0`;C
MM120[71H</VJZ5'^S2M#AOG?Q/K2/+C_``CU+%'F'!1(6L`&I`)-,^)QKG?7
M!SJ]Y2PCLF,#Y),K_P`/\%:DMDD^$TH<J4/RYTQLR0N=E+CZUL+B)AI``7_W
M@"/;7%>A"220I(TFA"OD_2<*DM`Q>[^/2D2Z:5U2RO\`A%/<$L6[;]^O*M-H
MM$RX5(`5'BNK9S-`5N!-$MCM/8,,'ZEI4;S'*\\T&AQW^M3NF=+:OJI;R(96
M,?L)!I3C5/V/TGO28HEWFXV;;J`0'O,R6G'=-"5-H8<((6H"H-.SVX87NLPQ
M1!VECFW.85;M^7&IICOHNB6/T?N&M\SKNH06EB6X.>1XSL;B6XD5W[MBW-Q.
ME%CH53KAN6YH-%QT)TVY1R&DO`Z$KJ#EW$89M.N7HJ&%E>%1[@GS;3Z1=..Y
M6MNN-0>-IA<0/8]$[AU5FQD+B[3MD#;324EGELLLO+D)2-`"WTH"D*4D>]QK
MAS#T[=N.>=[S7$@DG$^E1^H_4JV>#:=/6C;>QC^6)P:!)RQ@PN<&AQ?E`J:D
MDXU*CBZWN[79[S=TGRY$E?A(<D/+:2G,T;2MQ213^C$D-)@M1G+&9SAL"H&I
M:WU'JORZC<74MH'5:U[WN:'4I4-)H#3>,4E$N+3106I%>!)(]O'*N%6MR#Y,
M.[!0Q9*=N:OI7;W\L'ISTLW7T@ZA;HW'LC:UZWC8]Y*M*KC<[6F[J3;7K,U)
MM@1%N+4AB$WSP2VH`)YE2,\>,_\`<KJ>LZ;U);V]M=7$5LZ.I:R1[14`;@1Q
MX+[$_P#ZNK0NG=5Z'U[4;ZQM)]3AO8VQRR0QOE8#&PD-D<TN:*UJ`1M1[J!L
MR5!_-#].?4YEI]$3<GI:ZX[`E---E$5F9LU^TW2$AY*`EH250;T"@'/E-BF0
M&.-Q:@]^F21O>7-#:T).TDDGTG$\5]"-0TODZ^R6!H8!<.!RBF`I08;AN"KW
M^=/TYN/4STF[0EV>"P9%BZX;#F-71;^@)B7BW[E@+?0XD^!@!:02#0ZAWX;=
M%3PG4'&C:U.X<4X^I$3[[2F1MJ:#X*?_`,MSHWMNW?E[S-@-3G9"]RR]_63<
MU_;<CQ5PIMUB0%OS8[4@>4$3E-\Q2G!RPE.I7#!U#*]VO\ISB8?PUJ-^[8D^
MEX8K;IPOMFMC?3:T!IW;Q10?ZY^H5@ZA^GFV;7Z<6^^;[V[TWW;L1-UZO-Q(
M<#8+WDTN6-VVP+O.!7N*Z/T^\<@:V4E`2*5`QMH^G1S:F\Q48T4J`*5[P*56
M]]J3++2_S&ATDF-2`3A7?M5H^GEKN?4OT7]"DV:2PO<-@<Z:W9M4Q3L&'$C;
M)WF7+FXW(DH9=5*BQ%**E*`4">[$;)$^VUR2*-OB!&SB"$H]IO\`1XI'/</F
M:=I_$%0WUP;QMJ?5#TIW?M.X6F[W/IKMH3[PS%G,N1[-=8-_<D08NX%,J*&.
M6RO7RG.*1PQ8-'T.[<T0OS&$?=))'J."A->UFTTAYN'D.EXFE?7M5#_4-U_W
M/U?W)(NT:^RKK=I"51+YN_EN-,-V\NK4W8MM6Q*N5%B1>8?&R$A52<=:T#1&
MVD)C+&AN:M,HIL7`^MOJ*V\&:W<6EK",#3&I.Y5ZM%A6E*8C0<5J=0TI;25!
M;CLU0:"PE`U%Z2I?'BHG'5+!UM:VC@UC&G(=@`W+@DFLOU:9S9JR/=@"[YB"
M=]36A76[I5TLMG3ZP[:N5_2R;S&MZ)T-M#;:!:&7T)5SRG36)-6E5-8HLI4H
M5H3BO73FS-_+V]BN>DQ6^G6W-E8SF`;:"OK25O&^IW%.?1%<>8AQ25-U<4E$
MA84M2@D!5'-1/=GC?3H>5&7._5S&AWTPW[52.I-8FU&^S,E>80P-IF-,"=U:
M;TQM"SGI(KG3A2O93LQ).>]YJ\DD<355H?+7+A7;VK<T@@G6GLRJ*X,[^)]:
MPC`B<T:@=(.5!EGPX#"S+@,;1V)2<-\VUNRV5H='0;0#W[5D+:M6223VT!).
M7'/`^[C+3FP''`)2[DEEE%S`P")NT`8&N&P#B5Z+8Z4E02[I'%6AW2!WUTZ:
M8;^8@_'[4KY;4#'YCE?)W?R6`@$BH6:'MS[..9H>.'$=TS*`VA'%:MM)YHQ=
M$%N;=L`IAL]"\,*@)*Z>TJ4,9?<![<K:56GA.4[5B(5>#@/R*)PAG=Q0O"PV
MGPE"%$9%12"2?E(J<8S.XE"UN-(T^%M%:C@A-?Z,&9W$HP1?D'^['[(QG,[B
M44"'(/\`=C]D8QF=Q**!#D'^['[(P9G<2B@0Y!_NQ^R,&9W$HH$.0?[L?LC!
MF=Q**!#D'^['[(P9G<2B@0Y!_NQ^R,&9W$HH%LY'_"''X1]6'OV*(P]J4N0?
MB'S'#%3"'(/Q#YC@0AR#\0^8X$(<@_$/F.!"'(/Q#YC@0AR#\0^8X$(<@_$/
MF.!"'(/Q#YC@0O>0?B'TXRTT<"L+WE'O&''/'`K%%X62?M#Z<(O=G=59"`8/
MQ#YCC#'97`H7O*/>,+\\<"L47A8)^T/IP@]V9U5D+SD'XA\QQJLH<@_$/F.!
M"'(/Q#YC@0AR%?$/IQLQV4U24K.8W+VHS&*XSJ7@?$GA3#ALL'WVDI2%TD(H
MTJ<^GN[UL.!J:Z2V5(;2`H"B20/M$9#%2U&`/E>Y@P+B0NA]/]0-S1P/#LS0
M!7"F"L9"FL24<YI04"*4!!(K2IRJ.S%0N[0UPH,5U]FHP^5:X`D&G#@4KL/#
M0?">->SA09X9^4?Q"<Q3,F%6X(\EQ#:FW$I(;%%.H!S6",P.S,G"#B6G*W:$
MO94MG.,OS`D[.U17U>VB-P6V#?[75B[VI#4=Q5%<QYI;@`Y9;"CI:)U'53+$
MKHL[F32&4U&44]:K/4=N'ADD0I5YKZDV"J]M;?0&Y2WW(B`EQAQE+J%J`%7&
M]8*J+/?BP^;B[5%6KXH1^9&YQ[*?%51W"]9_\T3H^YMM,/HG-Z3*B1VV7X^D
M%P.):2$H6H*2/Z<.HF/E-&N`51N96V\N5S2:E:%;6VQO"U/;:M4H7&6S5R&B
M<R\F;%0Y4N@K4G2I("!0))X8=&.2THYS@[-P[%FXMFOB9(:4=7X*!]U>GK<'
M**[.85T:!*0VV\6I*"WX'4N)>2FA2XD@>P8DH-6;&*.#CW44#/HQE.8%OM5<
M-W=%]X,AQ:]ORBR*%3S0Y@20H4!2FJS7V8L/[E'^%WL5>N=`NY12.,M/H4#W
M#9%RA*?4[;9J$,JHZHPI)"#V5HWG7&O[E'^%WL5<O=&O[![6RCQBHIV)FO6Y
MO4L%%`:A.M*FUJ/"G*6`XE1/8<\!U"-PH&NQ[DR\O<-&9S20,?4DM=LTBGEW
M`KX7&RS04S.M:M-?9A+%3>E&&X<*1/'?3[4GR(C>H:M"#3,!07G7M*-0&&DX
M^8=RZ)8!EK'RZ$9C5$G(:Z+R"D45P!S3G_2,(*=AB,A!:=Z(^2;_`+H_,<%%
M(>6?^$^Q*VWGUV;<-INK#H8<MDI$C,+JJ.HUD-H(%`MT)H*T'?B1T.],&LMA
M-:4:?>J?]1.GK;J'H74=*N8LTO(>6$TH'%IQ._:!L73*-.BSX4"?&6L,3HK#
MR5+11(2XTE:BM==(2A1H3WX[?%J#7AL!:XO.PX47QIY4NF:E/97S7/-M,^@;
MV$C8<<:U7J9Z&GVZ.4Y9YC:D$.`/(\3"Z()(#;F?]&%KQLUU;F")A#R*5)'P
M*;VT`&2>W+H[IL@=4AU*`@[AMP4\;I;=WUL7;^Z;>A<VZVN0BVWL!)#S<=NK
M17F,T/!(4GMH<\5*QL'V]\;*:XBCE;B0<VPX[AO!7<>K[:;J_HF'J.&IF@C#
M'`M>7.,3<E104I5M17&BA)O;-]DN*\K:;C(;"J!QJ&^H$DY`)T:SQ[L726^L
MK.VY+Y6OD/"N'K'8N6Z;TYU#JUM$RQLIY)GDAHI2M!4XN(`P!VE.>)TFW[*#
M2U6)V(P]FV_+<;:00*5*P5:F@*CW@,,!J5G^,*Q0?2_K27]:T=#_`(W,^#BG
M*CI$_$;0-P[DLEM;":E$:87'D&M:*6A);4:9Y$X:R:M`V0Y8WO:-XI0]V*FX
M/I$Z%HNM4U*RBE(^:(YR]NZA(:6XBAP)VK'_`"[TPM8/XEN.;?@BI,>($("U
M#W554IM0".)PWN+N?4(76UE&YL],U74I1N)V'AL4G'H'TXTD9]6DDE8,/R#\
MQ)P%,PI2NWLV(JK?>Q+&D.6/9<-*FU(0W<[VXD`.*64!*$ZU(4F@U&N&#[76
M&VS;ALT9+C3**U!Q]&Y1W^K>E-+F,'3>GW+W"M.9E<2`*UHT[SABD.?U=W/=
ME+8C3HMF2C4A"+4PTVI"!5*0E02D*\(J#VXFF=.VAB;)>YC>D?.`?O;UM?\`
MU'ZFNK3):LMVVH;X6L(>P<"3A4;Z)CSI5VN#@D3YMPFJ4?XDO4>437]XVI7*
M#5!G3/#FQTJVLYC-8Q/?-E(I48#"IVC@/6N:W&LWNIYA<W&<BKLCB<N&&%/O
M8X;J51)Z.MI:4ZTJ"@"55I3C[_`E7R5P]FFUB)F:(,C/`[?8H^!T<[2]['BF
MX4]F9.';NQ]W[T>,?8^U]P[TD-GER6MKVF==E0Y*P\8\:268^AMZ1R2$U50'
MB<1FN]8V&AMCBU2:..5\;34[*D`GMP)Q5UZ5^GW7'5CIW].Z?/+%;Y"XT;@U
MX+FDX[P#NW*8[IZ3^MVW=D];=[[VVL_LBU]#-D63>VY6K\4F5<&+_I=@6FU(
MAJD)%S1!)?>YQ0VR!H40L@8Y;=_6OIJWOX;5CG7;;AY:TQ%M`16I.8C#"F"]
M$Z=_M/\`JG=V%_>:RZVL;33[9LU9FR?FESF@1LY;7?/1V;YLK:`XUH%4;:VX
M6;X%O1)`D1D@N((SYC9)TJ1[#3'4[/4(KT-Y;2,XPK3>O..KZ7)HMVVUOJ-J
MZF;&@[>-%W__`"B9=-J>HFS:FGWH-SVC>A##B%*3'>M#S07IKF0M.>/(W^[,
M-;J]I>-%6<HB@V@@-PX8T-%]4_\`]6K?-CZ-UVV(<[S%Z'M.P49E9L..-,/:
MKML[1M>^MWV#?EP4Y'N_3.\=2]O,-,(1J>1>;>U8;FT\HYH9=5'C/)`\7+K7
M.@QYEL[I[[5K,1Y@91V$8FO9CA1?3Q\L=Z)=0$;F-8\NHZE:.X4X45)O6FPQ
MNG\NR7=V&&R[:XFQ-P'DE;B52+5N:-:WGD+-5:BI]RM<A4XD>FHI-,U0PRNS
M%WX=GM43J[FW>G^:(^084W[TN_EL*8W'Z5-\;5<<2L.[CW#;G8QT%;<:\[7#
M25G6I*6PXHE"55JE>8X8E]98^;5/W!@_*`V;TCTY;9M'-EG:)..[=Z56CU0+
MG=*_0#TNZ0;[0NS=1;O=+!8XNW'4M"3&C[=OLZZ.2WN0.6^VW:VT*6M)6LE:
M:X2TIUU)J1NH/EA%*@[37A3N*C.H8HH+-MI)\\N-'-V"G&N.*BW:W6_?-D]*
M:^F,RZ0+#M-J0^J3?5J=B7E^TS5F6U9X"B$N*86^4K"T=JJ$XZ7HVB0RWIO)
MVYLV`["<%0-2ZICM;#R4;BU[<<=F&*YD7N?+W!-ND:T&9`LQD%V?->D.2;A?
M9+I.IR=(45J*4$G0`:=^.D6&@LM""\M([*_%<0ZHZPDNXB'AY'H^U$8EC;;#
M4*.GQ<&TZ25N*)S]U/O$XL?+A:RK<*!<F-['=,?&6NS%VW"GO5V/3UT3B0'8
MV_\`>$(!Z$6Y%DMTI*O+/%1#C;\UM8HI""*I`J13$5/>5K;L!J_Y:[A7"O%2
M>DV-O:@SR8@8^K%3ONW<<I]QR(TXDJ>0YYEQ/[@44`RU&%=264-D@@@84MK.
M2$UD<T]U5G6=<MY;4P6['M<1MP^U1NZT?NPE)R;2%GL*ZJ)(]A!&)81!S,[2
M``N;68G:'-F^9[GDU'`@8+<W;9;C:G0TK2E.K@<Q[*##4S-$@CXJ89:2/:78
M4`3@M.U9\Y2:!*>;I"0I+F1/?1)QK-<,A\52I&UT&YNS2-[!WU^"E.#T,O-P
MBQW+:MEZZR'%I7J<*(K+:5`-%:%#F`D<<L0%]K3('%P:X@#L5C@^GUS=,:PR
MPB6NTAWHW*P'2'TN6B5&\QOIMR5-;?2I$9EQQ$9X!SQ!50E9`&8[*XI&J]<L
M="^T@BE;,[[Q+:"AKN/8NN]+_2QAC;;74L#G.WT=NQX=BM1O':.SMN6C\'M^
MV[<]",;0PEZ*P7HJD(',4'`G4OFZAQ[L0,.MZE/X7T[UT34M!Z9TO3/)26[G
MSY:9FTIL[:%4!Z@=-[7,=?>M[0A/+6"I`!2R*)`"4!`KX@/GQ?M&U:;R4<4H
M<Z7&I%*'$^G!<'UG1;<!_E@&0UP!VCOW*`)U@N-OE-Q),=:ENK2VV$`G4ZHZ
M6T!)&HJ6K+%EANL@YTII&`N476F3MNOD(.)P%:E;KGM6^V-<1-[M,VRMS5A$
M:1,CN%AQ2A5-7&TD-ZNRM,;VNLV5U/R&G*>)I3V+-UH^IVEOYE\#W1=B1>1I
M)2XT0M)*544E::A1%0M)*5`@5RQ-R0Y#1K@X<1L*B(972M#BQS"=QVK/RS?P
MX0-0:4*>\C"H<*\$7>AZR"V4I`%#6O&OL&"JQR'<0M7D'/C1_M?5@JCD.XA8
M+AN(`.I)J:95_6,:229!6A/<D9FOB:'`%Q)V#^:U^67WI^?^K"/F?[CO8FW.
MD_Y3_9]J'EU?$GZ?JPZ#9"*Y2L">4_\`=/\`9]J'(5\0QDM</$"$NQSG>)I;
MWT7G(/Q#YCC"W6SDJ[QW]N'WV)AY9W$;4H<E'M^?#%/T.2CV_/@0AR4>WY\"
M$.2CV_/@0AR4>WY\"$.2CV_/@0AR4>WY\"$.2CV_/@0AR4>WY\"$.2CV_/@0
MAR4>WY\"$.2CV_/@0AR4>WY\"$.2CV_/@0AR4>WY\"$.2CV_/@0AR4>WY\"$
M.2CV_/@0AR4>WY\"$8CCD.(6VM:?&E1HH]XR-,:W%H'1!W$+%I>NM[@D8$%6
M`V3NIIAM,5;FI101XO%]I(_1BG:K`(F!W]ZGL*Z/HFO274GEZFC6U]1`^*FZ
M'*4\P%HI11KP/<,09I57^SO2!7L6^7=XT*#YQY1=C+6J.I],.>E$9U'A65J2
MT4+2VH9D&AQ$/!+S3B59VO!8'$BI`3>9ZD[:0MV.[/C+TM+0I+C#[22ET<M7
M\2E"5*3V4J0<\*0R.A)(!Q"'6K+SY#0Y<47M]_V85+#4U"FEH2VI*GDK%$U%
M>'O8<>;?VK7]FCX8]ZK[U1M%A-VLM\A2TH$IYY,I6L%.@,NA`;!%$552O'$Y
M9W;@X'&BHO5&EQVKQL%$P[0W"CW)$M,QIDH=;2A]D!I[0LG6E;@]X$#$Z^5T
MP&W!1EK$VXBRX4:G1U&V$W(2-R[>N+W+DH:7,C1WUIY;B&6V2I(30-EPMZCQ
MJ3C0`U3EUBW*2-M%52_R=Y6591"N3RD)(U"7222#D:ZJ`U&+'15/S&M_\M,"
M[;RW-':"G+=:KFG2KGM*898<<6.'?KKW]F!,+R:8N;^XMH^GR]V]1M.W9MV8
MI:[WTMM)=<)+SS;B6G25#2IPE/%0%,9`^8=Z8NDM,IP&Q,6=,Z4*?4IS8\MD
M%*DZH#I6]F!EHD.<L(/:>.)$IM!>6=K\P``39>1T=;<)38=RQ.9XRVXM!U$F
MA6GDH6G3E3C7+#2XQ<.Y/#JS;F0/B\(%$ASH72=PE44;@;UDJ<;4ZHZ`K-2`
M.2*:<(J=M[R<Q$6]3,1\O^+=[4E*@=+&TJ4M5^X95<6!7_[$.S!3@L<WJC>U
MWJ*2GI73*,RKEVV^RZ*-'_-QF@/[!2^$K\`[>&>&,TK[2\$X!P`3RQM.I+X2
MMNVDV3V%IK6FPU[-ZNWT?ZF]&Y^R;2T-B39$W;;3]MN#[LMEQHEY96VN0$/K
MJHC@:?HQUWI^Z?J5D!S.6\B@=P/9B%X+^J=OT9T9U8XSV[+B]D>7&.C:/-*T
M.!P[QM4OQNINPF23:NGUM=*J"CKB&B`/<JHUYF9X8GOVR['_`,^[UG_WESB;
MZD=)6NS081Z&_P#])/':/5")<[XBQG;\>QPYZVD,M10#%?N2D#RO-6/"\WI]
MY'?B"OM'MH+@WES/GG-*NKC@,-YW*T=)?5"?7KV+IW1;>SMK"<D-B<&D@U^8
M[&^(DG9ZTT]U]2M^6*^W*RO7*-;Y<%5`+=;VHRDH40*A84O35)H<L3%AHVG7
M,?FGOJQHQ)/'#CVJO=;?4?Z@]-:Q)H5N^W@BB.#HQ1PKO#@12NP]G>HVF;VW
M1.+GFK]=WT.UYK:IJTMKK7BVE(%/DQ(?M&B'_O!ZA]JYU<==];ZJ?\UJCVC_
M`,0C_P!I-EY:Y"CS`XMLFJ6W''7$IRSH"JN9J?EP[C;I]NP0QY7,;OP[U7+O
M4KN5Y%U=/EGK\S\Q.;TU-<*#;N4S>F[8VS^H_7/IGL'?29+.T]U[D;M%[D0I
MC-MDL0W8<MXO"=(0MN.TA;`UJ(KIJ!QQ4.O]8O="Z2O-4Z?:#JD<9RBA=@00
M[`8G#@NA?1/I?0^LOJ=I>@=1S%NC3W#>8:@8!S<*DTQKOPXKKUU+Z3?E6]#-
MN;IB7C<_2-G<\C:VXH5H1N3?*=Z;@_&C;%M6PV>R6F1+2[/>GNMFJ6DI;K0D
M''B.SZ\^L,E_!*1.+8W`.`<,*FH(<#AMKL*^SEU]%_\`:;IEK>Z7HSK:3J:&
MPS4_*)S968BF-:D=GH7S*=(K]?MTS8L00)<Z:Y(CPHL2,VIY^9+?D\B-'CLM
M*=+CDEY:4H0DDDJ"1GCVQI/4=XZS-_J-1<N87R5W.I4]R^1W5_2#V:DW2=!H
M;K4'`,:W^^:`#^Q?0/TA_*;WANVR6^]=9NHSW3^3+AL7#_)6U;?!N]V8AR4Z
MX[5UN4U:(T2<ML$EEH*4FGBX8X5U%_N-FT^^DM>F&\R9A(+ZT!`-'4PJ16GS
M;.!*]C?2W_\`5UW=[HUMK77$YMY9LKZ4H,K@2`:N`V4[<-BK9Z[/R\[YZ7^G
M$[K?TTWW-ZD;"V[)MS6_=O7N"U$W/M6VSI#K1W"R[:0ZU.@1UJ;2M"DI4DDG
MA3&_0_UWU+J;5A9:R"USJD&IH:;1LVC;0^C>IOZW_P"QK3>D-('4?3EVTVK&
MX[*;=OB[5:?\DS>J;_8.O5MAR5**%;'GATA:U-!UN?&66-12H-J;3721F<SB
MB?[H=3AU.\L3ILI;*R,5H=A+&<"K+_L"ADL7=5Z)JCVR5,`B+L<`+AHI4[-E
M%<3\P;?G2KIWZ6>M\/J7NG;NST=4.GNX]K[;BJ>5(W!OW=KEI4S;&HD%I*Y$
MM*9\-M2TFJ4("J4KCCG2.G75QJUH&O<^=KP75V`4[_4O;_U@U'3=,Z:U?2-3
M+.8(6F.E`2X\O#U57S(^D'TX[_WQ;8DV2A>W[`J*I4Z]RV'D%@(=<2XF#;WP
MA<D-J)(ID:T'#'ML=5CITP,N<2UH^"^/<_T2UCZD:S&Z1ICTM\F!`QI4;\!L
M7TA?E^=.-L]+;AU`LE@C+E7"Z[2M,FZW5Y:G')!AS93##SB5!/+2MHDE)X$T
M[,><_K5KK^I)&%Q-`=GH*^EG^USZ/_\`VKL7V)!R/J:G"M36JGKI?>$2.I?J
M4V82.?MWJ3;9T5`'[N#OG9]EF("S]LJN-O?4GAI!IGQQQAL7(\F#3*"_W-7L
M6YN('V$\$(`<QH)]-1\%3&_1%;R_+-WDQ'"GS$Z;[V0HJJHB9M;J?/?6HFGN
M-^42*=U<2]K_`.>-[OL58NZ_L!/;]JI5Z)>MF\>D.U-P1[!9;??XVX`T]<X=
MU6MF$I;#3Z4/,RD'5#+0?*B`#S-(2:8O<>FMNR*\50K#7I+6W=EW**O4EON]
M[XWR-_\`5^]"^;@C55MG9%N6TFS6N(MM++3L-#:WC&+C02E]2C5[+A3%@L.G
MF0/P`^8A5#4>N0.8R<XDX>U57W)>;UO)^(]>%GRD1M+,&RM.DVJ#'`HTTVR@
MA#G+3F"2:*QU#2-&:V+-P%5Y_P"J-:N[FX=)"3DK5)T:RZ%!+#1*M*@W&0J@
MD.&@0V!3-Q1X'$JJ-<:FZZ%"<%;'I1T1+7D-U;N83'C$)EQ+4LA,E+H`*.8N
MAYC1(]V@KB-O;ET,K8P:5;7VT3W2K02P/E(V/^"G/<VX$.(5$C:6$!M4<L-I
MT-,IT\O2T@9-Z1P[L*06PEI+O&/J6+N\=;Q/:-@:5':60LA"BI9)H%%1*B>S
M.F>'R@8)/-8.V>M.RU;54^D.2`HLDJKI5I/NCMH:4PWGN3$TM&&%5/6.D-D&
M>F]2%#L;8C.--M"@:Y:-1S(``%33,D#%??>'S#0-N960Z.QEH]U-C4Z-NPW8
MTIMMYMGE>`(HD!0545S[<L(WUX[8-JD=$LVU!(Q5GK);E/VT*B6\.//@MN24
M`A=$9)2@@^$IQ2=0O2Z<Q]@73["S:V$2]JE7I_N.%$EN6FY2&X<LE*8R9[HJ
M5)-5:W%4(\`.*S?6OY+IJ8C^Q6S2+[DWL;1V[^PIZ[RAQ)2G'O/PY*2U4-1'
MPXI0(&50?!7L[\)Z<*J0U7_.5S?Q_8JY7#IO?]RRWG;+;G!`9(+P75QRH2/$
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M5J,%2+<FS-P[4N;EKW!`1;I0JJ*&I'FX\UE/OOLO@"J4U^G'3-/UR'4Z1,\5
M*^K^U<&U/19=,N'%WA!HD#R+WL^G$HHQ#R+WL^G`A;F+/,F*+3$1Z:M*>86H
M[<AQ:4@A/,*8Z%K":JI4BE3AO<W3+-@DDV$T^*V997M^>58"LK<3OPV>\A*+
M&R=PRU:(VW+RL][<204U'$??-H77]%,,OWNU[$I_I[J/\)]11R\],]V6$-.W
M2U28<1QM+SLA394J.RM`7J4@@5(J`1WG$LW7K?*/EW!2-[TMU%!;B0,.P'?P
M36_!ISD9,]FWW1RWJ=<9\TF&=`4V`5GMR`QM^X17WRQC%N/K54%OJ=K(1J.#
M#X>_?[$1Y+'_`(:W'$C(J<1RE!7VDE'9I.6,)2H6?)1[?GP^^Q:I9"030)!/
MR##%;K+E*^#Z!@0ARE?!]`P(6%!W#YA@0L@WJX)!_0,"%[RE?!]`P(7A;*<R
MF@^08$(!LJS":CY!@0O2T1F49#V#`A84'</F&!"R#9(J$5'R#`A>EH@5**`>
MP8$+P(U<$@TXY#`A>\I7P?0,"%B$@F@2"?D&!"RY2O@^@8$+'10TTBO=08$+
M+E*^#Z!@0ARE?!]`P(0Y1&>BE,SD.SMQFIV;EB@VT%5LCNNLNH<:"BI*@3I-
M/",^\95PA-`)F9:`XU3BUDY,H>"1W8>Y39M'=CCNB*^K311]]1X:4YGCW8K=
MY94V``KK/3FM0V[!S:$]N*Z]^A]-LOFT]Z6^=!@72/&O,-U'G8S$I/WL>KC(
M$AMPI149@"AQYK^J7F;/5XC&][&D#8X@;N"];_26YLM2TJ4NCC>0XXEK3O/$
M*Y\OIKT[GII-V'LZ9F5!,G;EG?2@D$%0#L04)X99XH,E_>/.5TTI(_ON^U=4
MBLK(,S"&'$_@;]B:LOH/T9ED^:Z7]/U.GBL[7MP)'V:EE#9-.''&GF[O_FR_
M\;OM2GD[/_DQ?\#?L3$O7I3].-\B.,3>C>S'67:)H+6Y&&2PHEI^#+2^R:IK
M5%.XY'#V#7]1@H3-,!QS5]BJUWH'3UT#GM`:G\-?BH;O7Y<GI9O2'7(^S[SM
MR6L*\K+L.XKHA,-Q5/&U&EN.L'20*!:5#$D>L]2#VD3$@=KAZZ%13?IUTWJ#
M'?D\DMW[*U[/0J@=9_R\>H/3VQ73</1W>MPZA6:,VIZ?LC="(D6^NM(0FHM5
MSB(:BOJ14D)4E!IEF<\731OJ/)'2.X!S5VUJ/;0U5.U7Z+Z-(7212OP!WD>X
MKD_%1;-S(D1Y#"X4YE^3'>8E-J8E,2(4CR\IAZ,\E#[:VI`T&J1G[,\=HL-?
M9<N`:X^M<*UOIBXM6$THF'>]A-MN.MA&I))*W"A/@.=`"K/,=V+A:W;,E7'$
MKEE_8RME`=B>W%1!N78K$>5%#90OG,+3Q10J6%!--1`*Z\!Q.'3;J,D`'YB5
M'NLWY3@*TX*&[UMUJ*XY"<1I<34E"VR'@0"!]V4\WB>-*##WDWGXA7T*.-G/
MOE9_PC_W5'-TV\$`DU1495)02.`(22%'YL/[9@$!;<N',+L-FRBC;RSNFS-<
MPYAE^Z*#;V`)J.6I2$J`"J!)&JA->-"33Z<,9M.87<YKJAN.T[L5*:??36T\
M><&@>WWJ7/39M;;M_P#4+T2V_O&W,WK:5_ZF[5LNX[/-U&%<+/<K@B)*9F*0
M0XF.GG))T'4308B>KW.CZ>>^,EKPTXC`[#P73.CKYEYK[&$YFEVPXCU+ZX'_
M`,M[T&6J:X87I8Z2O/L$LH<NEHN5P*DM*4@5<?NA*D:@:98\?Q:QKSXI(H)9
MG`DNQ<=I[ZFG97#<O;^G=,:)-)%>WC8V?*UM`T`8;Z4H:UQ)"XA?G6;%Z/\`
MIONGI@9Z5;#VATGM6Y+;U%M5\C[6ML3;5KDK@R-N2X3ES0SJ5++B%++2W5%9
M!("NS'H'Z"]5:C:B>'5GN=;EV)<:T%1L)V+P=_O&^CFEWUY'U!I%LR62%E<C
M&8O/92AKCNHN<EHZB66)M\79]V5+@LP6)#TBVP)4R.E#BBAM;LYF,Y&:UJ31
M(*P:X]/GJ;174?S`/2OEK<?1#K;7]5(T[3KB*$N^]7#VE&-N=;-GWF47X,^;
M;'82@N*XXXRH*=%:*2MM:DH<![#10.6'D?4&E7D8AC<PT/85)ZM]"?J=T9<6
MVKV%J77;2*T&(I0C<%/6X-Y7/JY<=KQ>EVRKUO'?5\E-6N1"V_#<G2[E(6I$
M9(TM)UQV675`O.KHVTD$K-,L5K6NMM/Z9C=>.<W\O&FXU.79LWKMQ^@FO?6&
M2R;J_P#E=7>,I(:!L!<:T::FE:$@J[^Q?RLO57?XJ+EO[?'27I5&=(8587/Q
M7=6Y[<XM`4ZW,1;(K5H<DH!34)<2E)-"K'(]:_W)PPDB"(%@V$-;0]V.*[AI
M7_ZMO2KCR_[MK#H\V6NWL_\`AJ/^NWY47JLV3M6\[FZ0=7]I]7'[5!<N,S8,
MC;!VGN&ZAK4M;.UYDJ=-M\FY);1J"%NH2I%`#J-,4UW^Y#5KYXB@A`C)P.5J
M[7+_`/JY_ICI,'SSR3O8T?F`NH["M:?+LK38-BYM>CSJ\C<W7#I%8NH%HB7;
M;URZG;:VWNBQ7-A27$,7"](L\UB;%4J/+;4PXXI*D^$U!&+[==?:GJO1]T^8
M9083B*5!RFGJ/\UR2U_VF]`]-]>V,^FNE;.R[C`.9P%.8T'?P7VK6/H5T2V0
M):-D=)M@;9=2J9!:E6W9UABK0E(CVAW2^Y&>EH6PAI97XQJ4FM"<>.V=3WC[
MZ%DDDAK,/O';4G<1[E]&I>A;'1K&[;I5M;OG%F!F,;"[PLPS.:7>LE?*S^49
MM*U[C_,"D[;O;:+BGIM<NK6XD52A<=%UVQ<I%K@)>9<'+<6U)<6M%`K2MK4*
M$`X]6];:\YWTLE?&XBX<6-)!(/S%H-3W5J%\Z_HOT@VX_P!P['ZE%&2'O.4M
M:0UWSGY6D4;0TV`4W+Z#?S%H'7BX=&]EM>G9C=\S>K'7OH_<KW;MDN%B[W'9
M$+<7F=V-/.@!"+:F$@.R"I2`I"--372?,W2,\,6IR3W&5S39R-&;'$N9QWT!
M7T`Z^TS7CI$D/3SGNN8]0C):'&@C#9*T&P"N7"BG'U);8:WUT!Z[[)E!+3FZ
M^E.^HKS(4W(E-/N;6N-P0)26M6B0B:TTE.H)H5"F-=!F-IKXN&^'F"E#2@.!
M(X8'=N3WJV+4M7Z/N].U-C>8W3G&E`<0'&M*4K4+AE^0&+\O=G6,7*VSX-HO
M73ZPGSLEEV.RJY6JZ%!9;2YH6MP)='B"2**XXZO]6[VWU32[3E-',;$S$`5K
MD`V^U>//]K'25STSK^KW%P"&RLJ*\"7$>_#O4X_FX;`L]SZM>FRZ[AM,>[,0
MK)O&'%B3G5B/!N2;Q9I2)D=E)+)F&$]353)"R*YD8J/1EP(87#8\-V[]O':O
M2/U-Z<DUN[MI78M=%4UQKBX8\?35;=@0(XL$!,5):CQXZ4\L`(#*`E)HD(`&
MBIRQ>7W[Y#5[W.[S7WE0&C](06;0UK6-IP`%/4%<OTDA3'5JY1$J6I,W;%RJ
MD:SS6D38:B2E-=26455VZ14\*XJ?7%^=2TAKHV@%CVBH`&RHV[5UCHR.+2M6
M#9W$@C834;N*A;J+ZC=J]`/6%UUG+A7'>4;?/2[INW;H^S9L"2@;XVX_*AO0
M+C.:?<8B>6B2=4@T4O0F@Q7+6WEO-'M&.;1['NQ(Q((:._<I36]4M[35KE[7
M?)(T#LP+MWI5`[9-ZM[HV&KIS+W1(L'2]%QW'<Y6U8:#"9D'<M\GWVY0;J\I
M:3<(B9<U02.8A*D@5&+UH^BN+<^49Z;:8^M<RU?J5E2T/.7A7#U5457+J!:-
MAQ9&W>G"&GY+[2VY=U>"C:DC31?X8A:0XMPI!`U)`KB\:5ICX'U<,`N5=0=0
M-FB+8G%NW8:>Y5^=;G71]^XW=XR9DEQ2ER'Z>:6`<DN)S2A"!D@)-*8N1#"U
MN4"H'`+D<^H.+W9G.)/:3[RES;^U)%_D*C0&77G$$!(;1I`43X<U:$4!.,A[
MF"H)`':H*>*2=X(<:5XE7"Z;=%K'MAMB_7YA=PNX^^2R2A3<67D6GW$+)1RV
ME`U`KAE<W!N/`2#WJ2MK=MN:O:*#L"?.X=PN2%/LMI2XXO\`?.-I"6RM(T)Y
M2:)#:0@<!05PZTB$LB?S?F.?"N.[M6]],UY'*P`;C3#?V*/2:E16FJS4JJ-1
MU9US-<_TXF-F`5/NBY\F4DXIR6RS(E!I_+4%!5*#Y:=V(^^)#<"IW1;,EP!"
ME&WQUI+:.70)0!2@`)H:&E*5.(MMQD@(=B:]ZO`M7->W**"@3UM]J*P2$*JL
MU``';F`!^G$#=W;&G,-JL$%G(Z+(<:A21MG;"9<EL.MZ$MA*@2A.9U4([3BL
MWU]05J?6K;HFCNJ#04'8K5;4V]'CMM!*@$"IJ`0G43GX:4Q5;R\&+JXE=(LM
M/,;0P@>H)\L=.ML3AIEQ.85N-+4YI3S0IMU+J5!P@K"0M()SS&6*\;X\\!SB
M0>TT]2M,&GM$>8,;FXT%?<G!:>GUCC*FOR(#,^XR92AYEQQ3<=F*T"(VAM-!
MGJ-:#LPY%XT'`T"4\B=X'J"<[%E$)OE--LMA(*E"+DT4U*Z!5$J5D>WMQ%7,
MIEG<ZI(-/<MH[1T;LWW44N-VMLJRSH*FY`6ZPL(:*W`HD451*3PPE#!SI0U@
MH^M<-N&*?W-Y%%:%K@#L&P*`GNGFXU7=-_V<56>:E$<F?(2D-/1T)/F&N.M1
MKEF,7>/4H&6GE7AI=2F(K[USZ72I7W9NX@6@FM1AAZ%KW=NG<<2#<HEQ:MUR
M+:$J>0WS$K984G07E-Z0UI"JD`5S[,,[+3H77'/%&M<:@#`)'6-=O([<V8:7
M!@I4XU5-NHUMN_4.1%B6FV";<H[09CL(:)4F,:)<?(;2%-I02GC2M<=`M-7M
M]!8+H&KJ9:=_]BX=K6FW_4<ODF1D.,@=4`#`=H[TL6#T?[IF694^]715K6U&
M+[3$5E)36A(0[S:++M>[*F'?_P!Q8:;!7N4Y'](9[FQ!E!:ZG<D)OTV6XPWF
MYV^@Q=$+5(3;OP]N-->4DE7(8F+<Y275D:4KH0#G3&+SK[59;<"!C>73#`;-
MW:FS_ICI5H(VS/.=H`.)VBBL[TPV!M>W[3E(V5:8DR[2G!$OBYWWMVC7)M/A
M0[+!#98<2C7I1X20#Q&.=ZGU#J]ZX"]S-B#JBAIC2F[L73]&Z,TNWLP;!K77
M&_`5R^KC1+<NRR=N15*O<5OSKC\4-*BD<L-I6=3.9"@XW7Q=AJ,+V5^2`XN)
M/>?M3Z32&VQRN8VG:!]B3=RWC;>\_+;<;B3_`#K"O!S(K1:<404E*EZ276QG
M1(J?9AW:Q/TEKIGRO=G)<`7$^(UWE:74K-8RP-C:&L`;@T#PBGP4@Q.GNT8^
MQ_\`+5S;@Z'>;(-/*,/LJ<0*D@Z'5:AE05.(P=17\-UFASY'&FT[O2I/]AT?
M]N?'<,AYA;A5C2:^D+FOUJZ=VNR713]A:5Y1I:4A`3I/N@J4K4$DA2LQQRQU
MOIS5'W,8=-FK3>5YDZLZ?;8WSY(6MR9CL`]U**!_+/?W"^/P?U8Z#YH>Q<N\
MI)PWKU#6E05JK2N5*<01WX02*W8$(',$=^!"+\C^W_L_UX$+:A&@$5K4]U/U
MG`A9X$+!:-8I6F=>%>P^T=^!"];1H!%:YUX4[!\O=C"49'G%:K(IJ".\$?.,
M%5OR#Q6CR_\`;_V?Z\%4<@\5N0C0G36OZ*?KP)"0%CLNU9\OF>#4$ZJBISIE
M7&#GI^6TN?N'%:M<VOYGRLWG@M:6%,EPN*;0@4HXXM+:32M>/B/Z`<(&:=GZ
ML9;WD)9K8I/TGYNX%9HHX`IM?.230+89F/-D@T(2M,4!12<CW'"?G[9N#W`.
MX)Y'I.HS,$D,3G1G8:+<]9[E!<;5,AR8;2P2VJ:PY%=<&DYH9<!41GWXWCO;
M-[PTR`#BMSHNJM%3"ZBU.:&4ZG5D).04EM2DZCP2I6023AT#&_\`1<'%1]Q#
M<6WZK"*(N65%6I1""2#IX^T9Y=F`@@T.U-F2.?B&G*MV!+#9VH8$(%-01W@C
MYQC%4L(20#58-M<M1.JM12E*=WM/=A6.1K"<PJ"$&`\4<CR'HSH=:64$4X99
M]]<-9XVS;,/:G43Y8MCL5U\_+5W"NXJZFVQ:R5QTV2;RRK40'$*94:=Y*:_I
MQYM^M.GAEU!<YA0C+2G!H/MHO9G^W6[=?Z9.PG+E)&.-:.(75I)\1%."1G^D
MXX6QCBXSDX.%*<%Z=$?+B`K7%:'*%T`\/#7Y.W"JU7".?^9)UQV-ZT]Z]"MT
MV/9=[Z>6+J`K;5KE1K4Y:+];;1<Y$5B,X)H>>C/NPW'@IU2VSS4`@:201>K/
MI>'4K7S$,F3Y:X@NKAWA<LU+KC4=&UH:1(QLN=WB&%*]F-?6NZ+3GF&T2132
M\V@H`]TI("TN#V.(6"/9BBRVS(IG,=B0![*KID;Y+F%CIB*4J*"FT8XXK:E*
M4Z]*4E3IJYS!K054"4G344R`PAR0#5IH$J(H!6K<%\P?KKVI;NFGKEW+'MD9
MJ+:>H&WK!N]0T%MMFXRB[&NI@I!"$-2IK&M0IVT.>>.Q]%WTLS6O<2:=O!<8
MZ^T^"!CF@#$)].=*K7N6PMOP8IE3EQFBRRPC4X^ZZ4I0V@))*E*4>S@,=FM]
M9A,),OR9*;2,5YXO.F)[VZ;R'"CJ_=)I[5+.Q?RO]X[TAHN/4'=L7IGMZ2TA
M;=JMD1F^W^<I\?=..O/!IFW.$$>#2HI[\4?5_JA969?;V<3Y9P",P>`UIW&I
M;C0[@KQHWT1O]1C%U<W3&0#YBTQ.JYHQ(!SX5%0"1Z#L4QN?D]^G"6VPS=]U
M]5[I+98H\]&W!;;0V\L!(+W+1;9`24G@FIX\<4IGU'ZH?'S!,*;O%]JZ`[Z'
M]%,L6WKFN&8>'Y??E4*=0?R4>BUWCR#L#JUU)VC>$Q^5`&Y8MJWI87IVMQ2?
M.H\M;IC*"%)%4NA`&?&N)#2?JKJ[`77[,[0^GC+7`4&(J""-N&U-+KZ#:+-D
M;I=PV!KXZD.CSU-2-H+>"X<^JCTA]=?1WNJ+9>I]M@WK:.XI,B)M?J/MIO7M
M*\N-I6HVUURJOP:_(:3J7"65:4YH6L8ZETY]1K;5VA@:YI)`H78X]E!MW+AG
M7OTTO>FIO+QCG-?AS&L+0VOWJ5-:5J14*/.C=NEP^I?3'<+"`TFU]1-CW$.I
M(-&XFY[6^^G4*:0ME!%>RM<7C5Y6ZUH,T3/DRM.W&ON7/>EXY.FNI8&3DS%[
MQL&6E>^J^Y.Z(4X^Y-KI1(I(2U2JD(=\:1JX*J%5&7;CQ/'->P22RPR`0AQ9
MEH<2W#-6N^NRF%-J^C[8()-*MG.'YCP#7@#3!49]6'0#TH=2;UTBZH^K>?MU
MW;G12];C&S++ORY1H>PKGN?>C%K8BMWIN31R\FU*@A<:.M>A*W#498G]`N]=
MAMIV6DPYDXH:`X#;7Q#'"B8=56^D61M;R>%LDT9!!=0MK0[13$8\0K.P-J[,
MM]I39K5LW9D6T>7@I;M5OVK8V-I28980]$#%O9MXBSX3L1U)!)*@#6N(-FMZ
MY->20.G<)&5^:KZ[]GS8=G#<I%FG:3):,N)+6`B2GA:!3UUJOE$_.U],/3;T
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M;3DHCO2[?:2XM3C=RNR%J!>45!);!TGAB`Z<TZTUNU=<TSEF[CMW^A=&ZIUO
M5=.NH+>\LXL",0*<-U2NFZDA+B9D?E)1]W-CMM@+;#:DIDL(KP-$%(/S8KTK
MG17Y@8SE97`4X88[*;3CV55H=J,USIW,`8&EOAIL[-J^'KKG8FNC_P":1UCM
M%OB-P[?9_4Q:MRVW0CR[C5LO-WLN['&UA/W>E$F20@I``#@RRS]!=-\^XZ=D
MBGE#H'0.&6AKX#0UJ=B\TZ\8/]3P2W#`&,N&.)&&+7@T].Q?=&_+0[)BH?:6
MY$ES8\ES0YH4IF:\9#K@50^$\X'VXX#'I\3[]W+(#H7DBHVD5I[UWRZU*:VB
M==VK2Z.Y@#0VN+<&XUW[.`7R<?ED2&MG?FS=4=LQ(KC%.I?7O;CT<NZRW"DW
M.\R(Q>6AM02KF$*T*TD]^.W:SJ`U+H*6$#(7@.VUIBW#<O#/3G36L]*_[@&Z
ME,#+#/*[$-+0*YL:DFNU?3/ZJNJE_P"AG0_J#U5V]:++>[KM.VPY$6U[A>D1
M[1)5+N<.!68Y%0M\M,&2'"E.DJ2DBHK7'$.GY.=<.A%6EC'"O&A]%-G:O9FH
MG4M--S=6\H,DQ&!:?E!%:;<:*%MF]*.OG7?8]MWGU3]11VS9-Z;51NAC8'1;
M:D#;-M$2X6=UQF%<-R75^ZWF7%<2K0X@*1J2`12N-V7IM;HAC2YP.VO\8I:T
MAO=1TZYU#4)&O9+;F/)E.%0<:DD?>V45,_RO;HW;NKEVV]$==,"1M_>-J+$E
M;3SC2K1-3+8>+C;;7.4AJ/HS%2?%[,7+7+F2?3HG/J:-9\,%RSHC2XV:C<VU
MM%RZLY6;<<E6YJ4&!VTKAQ3K_-V@2VXGIXW$[&*4M[OW;;TR`H+5(1(M=J>"
M-(`+:6Q;R36M=7LQ'=-73GWLMNUI:UL=:UK][@NK=3:6[R-K5X#V#*33;XC7
M;VT4;=*@).U6G0O4%Q015)%*)3X:5[,="AM)):$/`]!^U<YN;:6+`2"M>'\U
M(T=^XP4OKM=SE6J5*8F0WIT*2["E"%,#58S,IA2762I;=%$'Q)44]N'UM%;F
MS=830YR7>+"FW@056M8O+RPOF7><AH`%-F[O58-UVWIYTVF2-R[I,.-=%.O/
MHAL,AZXS'E$*YKD=*U.+4Z5`EPU)Q-V&@1W5NV&.D?*QJ16M:#LI2B@-7U\G
M_-&3.7@BE?#3MQK6JJ?U#ZL[EWJI5OC);L6VPJK5MA.(YTMI0J')\EM+6LN'
MQ!`2"@'222*XMEEIC+1H:2'>BBY+K?4SFO-&$X_B_DHPM5O>FJ3RFG9+I.E%
M&U#C6N9KD!B6<(R/E;0JH2W\LHQJI@VWTFFW!YB1=&%,L*TEM`!65(.:JZ5`
M)*:#CA%SS'MQJFC+!]\[.U^0-[*UKZ0K1;:V?:-L1V4LQ64!+825J;2%G,J)
M434DUKC1TF8%H%"13UJ8@M1;M+GD.ICP1R[W3)4>+X4&GC"M0H"<J`#/].&U
MO9.@/S.#O1_--;B\;.*,:6^FJ9W(.I:B"X5JU5%!0]WMQ,LG:P4:U0\DCXS0
MC-5:1;PMS)O-:O834GZ<\;NO*"N4X=J8,MG7%TP>$%X'=4A29MZQJ4TC4C2`
MG*J:BOA^;$1?ZD,O@/K_`)+I.FZ2+<X/#O13XJ5;79$@I!:YG$U`T]@HGMX$
M8K<UYG:74H>%59X[<YA0;E*=@V^EU3:S'R24%0I6HR[:=N*S>7.)JK5IUF72
ML;3`N"G';^U6O`Z&@V"$Y%'$:NP@CABKWUT*'BNDZ79MA(PK[%,UHLZ6TH2E
M&0[@.WMXCC3%9N)RXD#:K=%"TD2`4%-B?C$3D-E`:)-,E>$?II\F(LPO,@?F
MP[E*0R-PCIB=Z.QDJ1KU)I733AV:J_TX5R.XIWE"3=P2'X<1#T=!6LDDI!`X
M&@)R-1EC+<79#M4=>WS8`8\A)&^M.W@HNG.S;Y+;,IY4=3BTM\V)1HIUFARS
M%">/>,3-JT6#Q>O^=H!&79XA2M<=BJQ$FJW`LF?EYC6IQIEQI3#;2BF&!:V[
M-;&HP<D3E*8(4Z^L>%2AEH30Z1GGGB'F,DEUSVNRLKL_G_)6^&Q9%;"!QS/`
MI5-)_:EJN/EQ*C-I<#RE25.I"T3&23RF"D:2$I5QJ348?C4)VM#8R11,QIVG
M/_)EB#I1@7<>VE/BG-:-I;<L,VXW.U66VPKC=FX[4V4Q&3JY<9.E"(R5Z@RA
M8/B[R!AN^ZN9OEE>3'78GEGH6E64PN^4":4I@-N^M.Q&;E&YT=^,=;JI#:DA
MU>FC5:C2E`"?"#G3&F;O]:<:G$+R'E6E(<._W44+7CI]8K/HO5PM<:_*(HXT
M^VM#K*N*G&%A2TI*3FFH-,3MKJ%T&-B#P&``#^*JIZGTW:FV89"'S!HS&E*F
MF)WTJ:HMT]ND*R76ZBW65,2TS9"9:.1&4ZZF6FC?(=5DE0*"3JH.&%M2BFNK
M=I?(WY75V''#O2&A7UKIDSH?+N=5E*Y@-X-=B<G41-O<LTF\7*S3)B%U2PY&
MTMJ:4C.G(TK4I2=7&HK7#+26/N9>2#E[3BE]?N(F1\^-OHK_`"4&[5E;>N;T
M!DH=;<L4LW!F8T1'E(<(6.6[K0HKT!="#EBRZYIT\#8W<T2-H,`"-W>56]%N
M[9['UBR/J=I''N46=:+I-=E2'&TO^7:0I5NN,9+A>,E(',:=6EQ`\::4(!H>
MS$[H[M,\N!/;YG@88C[%SOK*75/,Q&SGI$)'5%":B@IL*C.ZQ6;MMF'-?F.7
M18C(5<@*RIMN4!0HFMZ6E)2D>Z:"J<2AOXX<+:,M'?\`R4%<-%_$([C!]-I4
M0_AML_N5>_\``KW>_P#JQ:?W23\!\/%<V_9I>(\?#=ZU$'*;^'Z5?7BWKGZ'
M*;^'Z5?7@0ARF_A^E7UX$(<IOX?I5]>!"'*;^'Z5?7@0ARF_A^E7UX$(<IOX
M?I5]>!"R#3?P_2KZ\8*<P^#TKWE-_#]*OKQA+(<IOX?I5]>!"\+*/A^DXREX
M[=DC<QVJ0NF?3J?U%W3;[-`3HMZ9C";K<=2B(\8G4O*M/%ITU&8U=^(?7M3?
MI&D3ZC"1SHVU;VDD"GJ)5@Z;T"WUG7;;3)Q^3,\@]V4GX+IE9?3UTGL$A2F]
MIPY\B(IIM$FY29ES1SD("G%LM3'W6FBHG/2,Q0=F.&:GUIU)J%>2:5_C@O1>
ME_3/I;3Z&=H+1W_:I`<V]8&2&F++:(S2$I2AIBWQ6FT`)'NH0T`*G/VG#6RU
M'5W6[3=O=YBIKCVFGL5JCT3IZV;R;>-O)&S#CB4R=S;1LMV\NJY6BVS%0M0C
MJ=ALE:`L:556$@KR)XUIA['?7[GAH>:]ZQ+H^C2QEC8VYCV*"=_=,;%>K2];
M&;7!@ZR5HDQF4,*;<3[BB6J%5*\#BWZ9U++I^$Q)-%S;J+H"VU"O):!7@J7;
MLZ<7S:;CBG__`*0AA>EB6D!'-;H/'I12FD9?HQTW3[]NI6<=\VE)!7VT7'-9
MZ9;I4C[6GS1&GQ^*9'*;^'C[5=_RX>*@25;<&/O7G)1\/TJ^O&5FA67*;^'Z
M5?7C">L\([@ARD?#]*OKQA;(<IOX?I/UX$+IC^64ZB+U&ZDQTZ@9VU+2^XDD
ME*G&9JD)4`31-&^P4QP'ZULSP1'\+@?91>J?]LMVX6]TS_XC_P#M.79MQ9`"
MDFA.1X'O[\>=XZB(!>O8Y>9'Z5H*B5!1-3E]'R8RME\F?K#BHV_^8IU;2E/+
M2_N/;%[003JY<VUQ9#Q"B:U5."5C/*E!ECL73'_E/_[,>X+SOUC_`.M8O\0^
M*^J[:SJI&U-KR5*U*D[=LKRSE52UVV,2K+OK\F.37PI?S#=S'?\`:*]`6G]+
M'_@'N2HIQ8<TI-,TTR':!WCOPV3A?.A^;W%%M]2?0V]Z=)N_3V7;"L&FMRV;
MB6]4^T!Q7Z#\F.F]"?H]M3[ER7ZB[^Y6J]#UKB;HWK9E7%KS,7;]A-Y2VI2M
M`DHTQV7'$I(#P25>ZJJ:YTQ.=7SSV]@70DBN'K5.Z'@M[C4.7.`?F!]`"ZVN
M//M+4/,.I`*M(#AT!"R5)\'ND`*&6.*V9EN^;)*:-:#[EZ0NO*V%M'%&!^91
MOK-%S;_,UZ\]6>@72#9VY^D]TBV"]77J'^"SKM,@6ZY-/6QJV3)0B"-<XTIA
MM2W&?>"0HZ>.+7TU"VZC+''[@P[R<?2J%US?.TNSBACJ&U^`5R>D&ZI>]NDO
M3[=\Y3"IVYMGV6YW!<=0+,J;(A(,UXM)`:;YLD*.A("4C(`##35M/I))%$2"
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MO?HLV:^I"7(;/7+:-UE,J3X%!VV7M+5*$%("H`-!0:A6E<6_HF)MQ?QPG[SJ
M'U%5'ZJ:F^UT+S(/@C!'K`74/TR[BE[J],_IYW!-D.2G[WT<V#=77ED56_(V
MY;VGET%$I"BP/"*`4RQ`:A8-M=6N,N&)^*Z'TU(;WI*"Z=XLH^"X[?\`J#[`
MF?Z;.AEYY84Y9NNJDEQ55:(]TV=<X:FP"=(2X\TDGOIA_P!#1SNN^;$XY2]W
ML=14;ZD1<_3/,R8@`>P451O0;Z]NJG03H7;?3MTKZ%1.J.];ONW<.YK$](OL
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M]>'LHK/'&QK3;L\`'P"^2C\PCT]]2MU_F<]3[SMRWP8UOO\`;.F&XA/N#JF8
MR9KNW;.U.>U)/[Y]VUHT)'A!2:#,U[+TEJCW6#X`:#DO]C2N+]8:#YF\9RL'
MF=AK_P!-?8%`M27K'ME]QT/OO;7L/F"V2&D/?@]OYP:4*%06_J54YBM!ECD-
MM>']SN.&<^]=A?;LT_3+83BM&-]RX)=+[-MSI%^9KU-DVVRVVUL7OK<^Y/DQ
M8C2+C*?W<B/K6_<2E4PA^9,4I0UT(-.&+S;ZHZ7IV2W)^41T]BKC]/TF_P"J
M8=0;&WFL9MH*UQ7;3U+=,YG6+HIU0Z9VV;$M<G>NV9%F@SYK#K\6'-5)CR(T
MEX,D.);9=8!K6F*!H[\ADGQS9C[:A6$6+=0BN)7#Y6NI[_L45]0=_P!K])_I
M7A,;HOK%[W+L[IW:=E6&)`C*95NW<WX*U:HC5IY]75M1WRIUVGATI^7$CI<;
MKN\[SBM'VXMNG90*5H?@N2'H;D7_`*3;B9ZA(MS-ZN9MMZBO6]YUX0_.WUM0
M,UQ;)#IC.!>82<APIB]SVPN8?+.J&B@PW9>_N7/=`O;>PD=/09ZFJE;U`2>J
M?J#OEC;WS-A-;5V[<9-PV_8XEH3%CV^7,0&)"T7);8F3"N.FFE:U4&>%]/TY
MMI.9@*9A3OWK.I]4_NDGE6?<^;X?%.:RV&)M+;ZU.2H#$"&R!<)MQ>7%A0&0
M``Z5MJ25F@J>.+G94H"J=>WAS4KBJU;O]1]L1(N=GZ>1FKF[$BR/,[CG(2N)
M"T)4!(M49Q*H\]94*)#J5``ZN(&+W9:.PT<1\Q`*XMUIUAYH\F+`M-/5@J1R
M9%_W3=/QB<_)O%QE(YJI$MQ3JFE..*!#25$H;;4``$I`2`,L6`6;;1HR_>7.
M9=4NX8FNF<<KZT]"=EKV(74)=O"TV]"RI6H#MJ3PX"N!14DKK@U*FG:FU&WD
MH59[>TQ$%0NXJ27>3EVH>UIJ[[O#*M<%%,>28IFC1K?9(R5)<\PX0#(4M14$
MJ0#I#:%$I14$Y)H,(3;0FER39D!FQWP25,NSUT.EE24LIH$I2E((13Q`*H%5
MR/;A(;4V-Y(13%)1C!:=#>1[R2K(?*K#Q-UNBP7>9I.:3F<A]=<"59!S17@C
MQA+;=JD4T+!'#+2:C(UQAWA/<MQ;\H\W>W'U8J3]GSX$B,&KA)3'=\P&F7-"
M0'%&I#.D"GB&=>.6*_?[%>.G)#=O`=B%9';FV.862IL%M8UH)U#6D@`*K4$5
M&*A?7!B-!P76+32&/:'44T[>VJ$DT:`%0$UKP%*9DXJ-W>OJ2=JMMCI,;2UP
M&(4L6^QK80T"@:20$CNRKQ[3BL7MX1M.*N%E9QCO3VB6Y;:$J;H#[0#PX9$X
M80OYC,_:5)21B-V4<$O@#M`K3N'=A59A_5"U/)'+4JF:1D>ZI'Z,"DDA3'FG
M(R$/H"U>(&N7%660X98UC_6HF-U;-D:7'>FH;6VU+C`H^[Y[9(JH&H4-)K6O
M'$U<4\F>\>]1-C;-BU$.'!WN*E%P_P#AFFA*4``@9#3WG/LQ#JR)LKNENF7=
M-A@->8N3%')`2M0#(:/,<]TT.E&>,&@Q.Q,&_P!2[O3E/^GT8%,._0'>/BL:
M`\0,939)-S@+G-!EH)*-04M)2E0*JU/O5RKQ&$8;K)*6[@2F\C><,AV(O$LL
M2%;S;F6$M&0^IU9;*DN%U3:Q4.`ZP,^`-*XE)[IQ;'4G$T]E5'2Z2V-KIP!L
M4'*LMX9WDF%+N$U^WNN)(BNRGELZ%*50!!60":<>.+%#"VUMQ<LVJF23NNK@
MV[ZT&'J46=58*]E;F,FULI?MDM)UM-40I+BPI2]2QXS11[^S$MI<YUBK7X@8
M>K!5K7YCHS:1[U[L!JW;RC"#<F6)JV73,AQWFD<R&^BI4[S4A+C@6`!11(RX
M8WNI#92"-NPE,NGK8:^)W2BO+8"/22%77JM<!;+Q<3:J0YC4DI?6R$H1(*13
M3+:'W<EI(%$I6"$C(8LVEVXNFASA7!47J@_MDQ:S"A4/?YGN']Y9.%?<:]_O
M]WC[.&+KY,\-RH/^HH>&_L478L*HJ&!"&!"&!"&!"&!"&!"&!"\)`%3P^?\`
MHP%@>,CO"5AS0X93L*W!A]2W6TM+6M@H"T(25J*G/<2V$UYBCW)J1AG+Y.V%
M2X>M;PV%V_\`I6EQ5I^DOIL&\;6]>]YKNUH;=D,(M5N&EHO0S3S4OE$ZVM0-
M1J`*J95Q0>HNKVV5P;.`U8&`^M=2Z,Z`M=3MVZGJS'-N^86T/X6D4W*]>T=@
M[7V'%,':5J@6F(H)0^$-J,B2$)`+FNA"7'%#4:GB<<LU'6YKYQC=4M=W]Z]*
M:%H>A:;;M\M3S31\O?ZD\4I4NM!6G',=ORGV8B5/KPI*30BA_1^K$C!^D/2B
M@36G,**J+20D\2!K/!/8FIXC&[_`4UO?Z9W>/>F1>888C//$$$`E(4-)509D
M`^T8E+!4G4-JABX"!=%.1Y$4..9H63D%%0T\54`J#2N+18/,4@?7!5>^C%X#
M;24R[%63J-TW8L//O5K*4M'2J;%UHHUJ)!6DU"5Z*<$U)QT33+Z*[I;.(I2O
MJ7+>K^DX='TTZQ!C-S6MIAL=7[%#-024Y5&FN5/>`4G,Y9@XF/+6W$>M<TY]
MS^$K>RPTM06/>0H*5X334"":&E#GW89/:&O(;L!4C&2Z,%VTA&GTJ<0`@5.H
M'NRH>TT&%K;QGN25SX!WHBM"D&BA0TKQ!RX=A/=A\F*OA^7;)5'ZYS8ZC1N?
ML^ZML]I6Y%=;><30$E(0DC,TK7+''_KE_P"FHO\`Q!\5Z"_VR'_]Z+GAE=[P
MNXCGN_\`;/\`W1CRR[]4?X/BO;EML=_B^`6C&4Z7RE_F8EBR_F$7M]1+;E\V
M=L.[+3I41S&;<J&@!0!3FID]N.Z?3FATR0?W2O.7U/NVC6X@#B'!?35T<F)N
M/2GIM/"M1E[#VHZ30Y@6>,@&I[R#CD>NMR:K<#_XSCZS5=ZT&;G:!:'A'\`G
M\]36JO#*OR:17$,=A[E*#:N`?YT<0L[J]-5]*=(\CO"T!5/L(GVYYD=X4IL5
MQT7Z;.P<.[W?R7+/JD*`=H/O4T_EQ74JW?!C@U$G:SZ4_P!I;02ZH<.Q`KW8
MN77E#H;J_C:N??37_P!1L[S\%U[<R>516GQ@A5*Z>!"J=M.['%7T\BS_`!#W
MA>B=2)\\..7[5$W5OHETSZ];>M^T^K>UF-Z6&V7'\>8@2)<V"TJ[U=;2^7(+
MC3X\NRLT"B&U:\^&'/-EMR70#^`F9AAGPN#ZTYK#9MK;%VQ:MKV%JU;=VW8X
MHAVBWF6B.Q!A-:@&5/W"4I3A2HGQ5S&$7,U*^>93;ND=LK3=N&"48_2M/;RA
M<-C!QI4=WP3<NW4#IK;6W8]^ZB;"M2'FGF%B?N[;\9>EQM;:PE#DX+6:*X`$
MG!Y'48SG?:/:P8DT.`XGN25S?Z9);R,CNV.>6$`5&)IL]*^2GIELYN!U&Z@F
MV)$R.YNO=4>(]&*7F),=JZ780WXSB"4/1W$K-%I)2,L\QCT/IU?)V_\`X7P*
M\G=7@<YW_C#WKZX=L%V7L#8SP;6`O9FV-&M!0I2?PF.`2E>E0K[<<&U2=L.L
M3Q__`!GGUN7J_IK'3+0__P!K'[ERQ_.9V_\`YA]">XGBVI1V_P!2^G]R1EFE
ML75QIQ9!S"`F6/GIBS=-W[(M5MY<*!]3ZBJ;]4&N?T_>M8*O,.'_`!-5DO0!
M+7>/1)Z9Y*2E;K?2VTVYU*5#4V;7*G0TH(.8\`![L-.I+H3ZC*X???7_`*K1
M[PI+IRYNK7IJVS--`T*GGYUG2_<G43T8PH-AM@GS[#ULV%=>4J7$BA$>9&N]
MG><+LIYENB7+@R*`U\5>`-'G1=^S3-=+WTV-^";]<VTFM:&TT^8BGLHF=^2M
MZ8YG37:O4_?&[F]OR-V2!8MOV1,)HRY-AL*V5R;BRU<7"=*KA-0E2M!)H".!
MQ*_4+66W<HE:3E[_`../L4+]/=(-BSEO'S&N[L5R/S*[>ZCT<=4VBX&K=<[A
MM*Q[@29DB*F=M^[7IMBXVY:HX4=$E(!*E42-/MQ1+*\8XCN5]OK23'AV*U_1
MEJW-=%^D\BWEM,4]-=E(B-(6M]#,9C;MO9CL)>6D%Q+#3837V8C=8<'2%PV$
MJ2T=O+B##N7&CU^VY=M]9NW[@`"J?TRV[=`$*2O6B`NXP5D)025%$P::<>WA
MGB=TU[X]-K'XL%`ZBQC]1ROP;0KN7L^3YOI[L&YO%##3NQMO/OR)*TQX[>FV
MLI/,>?+;2%52<B:XA[NXG87!HQS$GTXJ8LK>V(!+@1WK@7U]B+:]=74*\[:?
M;N4*Z2MI3G;G:7FI[,:<Y9X"1]Y%4ZA+L=Z*HJS\.FIIEBSZ?;22V44AJ"Y@
M*J]_<Q17TL;:4:\A7_'7+KM;-K0(EJNEA/EX7E(TJ9:6KI<15(TNMM22B*IQ
M.G(K4!AP[31M(Q)&S#W)J+T#PE5#W'TUWEU0W(SN;JKN:[;TE-+!AMWAQAN#
M:@EQQYM#%N96IMAEM;JB$-:DBIH<3]A8Y1@`*]BA+Z]`--_>IGLFUX>WXO*A
MBI#0;5RV5M-$H10J;2M*2E@4R)R"<6"*2XD'*8TT:*>I0-[/:Q1YWN`-*E0O
MU*]0.R=@\Z"RL;JW$T5);LUM=66$.Z%4\W=&DJ9CZ59:4*+E>(IB:L.G+C5)
M*3@AC17X*CW_`%A;:6TN@<"YWRGLWJAN^=]=0NKDY'XS)G0[:TH.Q+0WHCV6
M.@E12PI*U)<DOI!HXZH?>98Z#I?2\5LP`T7(.HNM7W#R65]JU6O;:(<1QN3(
M#L520)#020DBJ3H"J4H%]W=B5IE^4;L/5@J$79W%YVDU]>*<L&$7G&8=G@O(
M43I7(#2DH;!R0K60`16N!.+?$E2M:>GK3)1+W#+$Y:QJ4V""$@9('A)3X4`8
MRG2>#]P8@I+-NBZ72*(((``^U6M$@A-<8JG/G8T@+\P\M3CJ**4:^\D_+P.!
M,;R9LQ:1N!1EA)5I0!FFFK+AGG[#C!P%4RI7!+T:`E9"@*I(I72>-<@037CA
M#SBD[*S<3CX4J_@CI07-`"0?B2#V9A)(-,\-+F]:'`.X*3N(9XG-;$"11:FH
M3X>;3RE\L.(!5HJG0%"IU<*`80%U%([ED@!V'K3:EXWYLKL$X-OP(J]VV`.N
M(0DW-D!2B`FM%4U=B13M.6'.H-CAL7&`AQHI70W/EOV\\$"N]7SFW"S;8A-S
M%.QY[KS_`"68K#B7T+6&V\BXT5-M'/[1%,<=FLKB^E=-(#4&GH']J]#VEU!8
M6S1&X$4JDQCK1'M[RFI.WVFRT=2D_BKZPEL'/[L#D&@^S73V8;2Z),8G9`2Z
MF"&]96EK,#,X<L''NWJ:]O\`6/IC>7V+>WN:!`DJC)=5%FH?A-B14!QMN3*:
M:CNK2.Q*C7%7O=%OZ'Y'>I6[3.K>D=1H)W@`]O\`)2\RA#K##\527XDAHO,2
M&U)4RXWQU)<!TFO9WXCX;>2V9R9?U`37TJW1/TZ2,/TLAUGN/;][VK/DK-1I
M[#VI^O"J<P_JA)KL:YR`^RM0CQTHUI4%(7K+>HC))*DT]N,!-KS>HDNG4%=O
MGOQ]QQN?;F5);8=@#3-*4H2-3RN"@E7#MIB9M=&9=6[;@NH75]AHJ?=:Q+:S
MN@;X6TX[\?BM(WE;KFM+-GDF4%>,:FG6*A'B.3R$4\(P7>B-@@,K35P(]I1:
MZU)/,(GX-(/L"VW2ZO/QDLO7-J`V4$+CNJT)D'+Q!P^!(1PS.%+"R<:52=[>
M`[2E38UZVY:^?$5#:=F2'`I,EMY+J'$U%7DO(*D*`^7LPTU'27O>]X!H2I#3
MIK5\3'/<`XC%3#%F1IK2G8CJ9*$+#:DM`J="C6AY0',TY<:4&("*P=;7!D-:
M4(5JBF@8P.C(+EO5J0I*5LO(*AJ&ME:016GO%-..'J4\X.*)K;65J(3D5$C-
M/"ORXC9/U#WI(NS'-Q7J4J;/,6*(;"E*-0:#21P!).9QM%XCW+4J(Y\J`W<Y
M$N0SK6PXIR*LU25K-?"0:*2$TXG+%IL:Y>Q0-\`';%`'5%:+](1-34O.D-2$
M44D--'PBA-$JH0!E7%KZ=\3AW^]<MZFVCO3<VJY'V6I:WU<JX-,J=2V*NIY;
MVI*3S&PILD]U:C#B_MS/<-I]TU]:2TN\;9V\A=AG;3U*LW4-YVXW6X3M))D.
M<SL%:A.>=.['0>GIA;1!IH"N3=6RBYF+AQ40_A8^FO`<?GQ;_.Q+GODY.";G
ME!\9^8?7AUFB_$H#)/\`A_CU+4ZR$%"0ZV%+K0.$IK2G#2%=IPC+/''2AK5&
M64>)J]\NL$)4V^I60U-,K6V:\-*R$U&?SX2\VW@LAKB:41\66>LZ6XDIU>=$
M(9JH@<3[W`#!YH_A]J?3V0A^]7T?S6].VKPL5\FZS3*DE/+4KVI`)J,+0R\T
M$TI0J/WD<%M&UKI052V#VC6,CV\3A5960VM<?M\M([]0.?=D<"$>M^RY\Z2F
M.'4(20#K`"B#4Y!)*:Y>W"-U,+:V,^TC<G5G!'=3B!S\KCV5^*=*^E$N),81
M.NT-J&\&U)D)3S%)*Z'0XC4`DIK0YFAQ4)>J7OBD:V)H<&G',?L5F9T?<3W$
M<#9'<N1P:79?"#OI7&G>%87I+LZU;8%RD7%-NOC\UU#K8?8&N.VVI.E35=>D
MD@>+%"UC6KN88$M]*[;T7T19Z<\&XD,U/Q,`^)5F86ZU!"%"(%H0GDMI+Y`0
MVC)*$D-9)1V8HLTCGRE\IS/*[2+32XV".*!@;3<?Y)51O%:U`&WMYU_^(7V`
MG^Z]F-3(S)E#<>-4B+6!L@D8VA&Q*$;=2E%8\@@9)_\`B%>W_AX23A&_QU3M
M%^52FO8'2>!IQ+>'$=QRVY:50DN?<'W&U+CMA#H*=/BU9%0U<4CLPH+C.<I%
M`4QU%SF6;G-%348>E,B]?B,X-)D.:4I2X```0=136N8S%,3E@6@"A5!OYY=[
M*>G^28DC9TU]2W6)L!E).H<QW2[_`-M`!`-1PJ<61CF<L4-,%$2PN='SA\KB
M*I$F].Y-YBR8,Z3#E(DLJ00TX5.)-11820`0GY1QPO;7#K:;FL>:T(]:K>HV
M$^I1FSD>71Y@:4KLV8)CW3H.\II1@VAAPZ4)*E/%!)0D(K32KB!B1_>9_P`1
M4-_HX</^JHMN/13><9U/E=O3%H2Y12FW(9;T!0S35\/%%!VI"CW8LMMJ=LZW
M89'_`)A:*]Z@)^C-7,[S$S\K,:8'9NW)OW#IMO&*/O-N7`)!R4TT7%%5#0%-
M<D^W#N/5;.,US`X**U#I+6((0]T9(+J85X'L30D[.W('*.V*]-*":!(MDEX%
M-316MI)2*GLXX6_>[3\0]:A_].ZI_P`IWJ/V*W'H7MEXL_J"L+LRUW:*R[8M
MRPEJD6R8PREUUEOE!QUQH)2%I%16F.;?5Q\>J=,`M(:(W`\:[>Y=K^@UCJ/3
M_5)YL)<R<$5-1EJ0>!K[%W-=.>G_`+7MSRI]&/+3#S&B;9]VG=BO;<;!$\Q@
MU)Q^"TXV2R^53\Y*V2K+ZTMEW=N-*<3>>EEAF!V,PISQ6^YS+<XR"GW@WS4J
MKD?9VX[5].+IHTV4/P(!'N7F?ZNZ=+!K,4L3BX%S=U.*^B7TF755Y]-?1F<Z
MA:'E;&M$=8=KS#Y-HQ`I0(!!6&J^RN.6Z^[-K$_`O)_CU+N/1TKW]/VXD%'!
M@]P4\OFBEGC05IWT2,0QQ%%9QM7$7\[&QOR>GO0._-M+/D.H=WB/.-,N/J99
MG[=3)0QI:2I92J2P.RF=3B\]#W0L9C'3-6FW#B%S+ZA6UU>0!X90"O:D;\N)
MZ?'W]LZ0[%E)CS+-=(I6N+)8;0KR)4@E3[:"I1">S+%[ZRE;<Z,YK>`=ZESW
MZ>PS6NLFYF;0L>`!QKC5=PWH[H<62G@0<JD9)';0=V.*N=GA-N,`W&O=C\%Z
M'F'/F;<G"M,.\\?2N?OYF3&ZE^C_`*@2]FW:\6:^VZ[[1EL3K'<9=JG)9=OL
M>W2$"9#<:?2R6YU5)K11`KB:Z=NHVSM?.P/;383W=A5:ZJCE9$X0/+#V*G?H
ME]%>RNN/2.;NGK??NI=\OK.XIT2&VUU#NZXHM:(<*0&7T/\`/)<\V^X3F,B,
ML637^IKBRGBCTEK((3%5P`!J[,<=@W4'H5<Z7T"#5;6:?5BZ6=L^5I)(HW*T
MTV\25=6S_EN^CVWEI;_3.9?7@II:7MQ[HO-V+3B5)4%M-N/(:;(5G0#3[,5Z
M7JS6)XG02O:8W@M.`V'`JRGI'1X1SHV.$C<1B=HQ"Y*[)Z16+_ZH?JOM.V37
MK)M^S]0-UVNR08C"5BV06;FZVU&:<4^A3C2-9(!IGB^6/5LC;&-P@;6-E/&<
M?^JN3ZYT)%J-T6&Z<RKP?`#Z/$%]%6S8#,#8.TX"7')*;?M^V0$OOFJW1"CH
MC!RF>CF!NNFII6E3CDFIN-[J$EX?ESNK0;L>.]=PT6+RUC#%7,(HPSA7**5[
M*\%5;UU[9M^Y?2?U?@S(+,J)#LVW[F&W6PZVJ3;KY"DI64*`_>)8T'NU5]F'
M%A=OMYXW-%2T\4SU_28]4M9!*[*PMV4KO':$<]#*+>OTL=-(L"/&CQ+.S=;2
MPW&:2A(3"G.<2#EJ+_#LI@OKV3G<YS:]E5(64ML[3V6'+`#`!6O#?2GQ31_,
M*MGXKZ3.J(1&"G;4]M6\L@9E7D]Q0@7N`T\LK(KGPPZT]S[F47H^0NPH,?#@
M,<%K?-A,/(H,H4*?EL;IMD?;>X+%-EHBOWE,"=&<E'E-ER&VIHL5)I]X#4'O
MH*9XEM5LIKNQ):XE^'JJ%$Z;+#9WK0`,N/N*OUU)5T\8VY=FNJDC;2-F*8YM
M[:W.[!?LTF#'I)"D17G@N;-;?0CE-H27"3X1QQ78+"YAQ:"?0I^:YBFVT"K#
MMSUI]$9>R(DF+$O4=Z%YFV6W9.U=N3)DF%:;7.D6VU56I,>W,M3;9%:?0$+5
MH0Z`JB@H!Z_2I;IC<Q+3OWJ+&J"SE<QK0X#MIN[BN?O7^<]ZDNL&U>H-LV%N
M+:5JV?9'-O#\5D,&=>XR[C)N#+KIBE;<0-KDZ-"2X"$UKV8LNB6[;=PMY!G9
M0[<-@5;UB=UR#.PY'U&S'?Z%/UQV[NS=^T;1MVZ[@O/X5!ML>W(@B?,::3%9
M20EE33<IIAX%)XK0H@9<,34^FVTWW0/0HF&^N81XB2D7;/1G;&UBA-OA<A:5
M-K*T)'/,A""R%O2*E3R`A1&F@%#A_%!;PPMC#\&@#8,%&S7%Q+</>]OB=6M2
MI;%O>2AAF*SK<`#+30":NJ(J!51"4U">W+&KVR&@MVYW5V=G'>EX0QY.9X:0
M*XJ*>H?5+9G3N.X;]<&7[NEL-LV&`$.SW)55`,NK'^&902/>*JU[,6K2M*NI
MP,S"WVKFO4W6&GZ,\MF<#Z:*A?4?K=O#>SIMXOXV7MM_4G\#VZ^1=7^:3X9]
MUTA9<4DT<;2D)U5`-,=-T_INUMVME<<SB`2,H&[9M7#=6^HU[?E\<,.6$N.5
MV<XMK@:9>':H<;CVEE21$@+>65\POK"G'WI!R,AYQ0)=6L$UQ:,ENR(1Q,#"
M-_'T*HV]]=7<[W7#B6D5I7>G1`M^XKU_@VF5:?LA4<,I"2.',!)PW=$YVR0C
MT?S2DEO'*:NVJ5;/L7\-BJ3>PEW4A)+*`%A8JDZ5.`DIHJF=.S#([:+'EV;G
M)SQ_*V^.XW$#4=&E(""RE2EA((`YA*2-.,(-(,0<U4BORWWA0+4V*F@K6G'/
MLXX*K'F#P6]I!/@)YBSP7PIVG+/B!C.:/BHZ%\DQV41Z-`<?64U*16E:5^3+
M+&"69:@J1%LZN%2G);[$YS"`DJU%*0K1F>`KIJ:<<1UQ>B.K0`<.*D[?1G2D
M',=HW?S4D6K::PM!`+E333RP,B>/O$98K$VH.A&&/I5WL]")=0./J_FI<M.P
M8SZ$F7'4Y6E`1I&G(T!S[<1<NKF3YBT5';_)7/3=`A=&1+B:[2T<.]/<]-X(
MADHMX*?+DI3HXC0:#53MQ%R:Z[.(<H&8TKFV5PKLW*</25J8'2$XAI-,HQH.
M-57;=NVF+9,+B(;L9Q"_`ILE2D*HHZAD",NW%OTO4&,BY,SN9AM.'VKFVK:3
M);2\VW:00=@'Q6FTRUVS;YG/3)#K)NLA(AOJ4ISG!J.52$E2E*"5)(`%*"G'
M"D\<#I*PM;EI[4[T_5ICISFW56SYR`*[J"GQ37N\FX39$EQ"WQ&EQU):=6.4
M@*6-02IQ1"4`#M)QM:,@CN8WSM`A#@7=RI>HS7[[H.$;GVU<<3B/4E?8/3C<
M^_@XO;]@?W!%;U,/S55CQ([I.@+:GR2TV'4*XZ-1I[,;ZQJ^A6[2`R,N.S$#
MX*Q:+H&K:M3R,+F'O/V+I1T/V_U,VE89&V][)C.6N(83]L>9G)FK;99%50>8
ME.DE=/%XJI/8<<1Z@O+:_P!3==6C0R+(T4QV@4/!>FNA](O]#Z>9I^IU\V)9
M'&NVCC5NWL4WDN$DAJ@))`U$T!X#W>P8@WNR,+MM%<&.R.#N"U/+>2TX4LZE
M%M20G4?M"E:Z3PPV\T?P^U)S-YHQP5=-T;8FR+F4.>5"92]6EU:@MO("A3H(
M.K^@XL.GWC^0Q@-!C[U4M1LV,G>_:</<BL:T0]O/-QUP2U(6K0AYHEP)UT3F
M`D#,&G'$K.YS;<REV85&&S:5&6P9)<B*F7`X]R2MZ^9;0F*IB.IMQMQ2-:0Z
MMP!0';0LTKP%:X7L;K@T>O\`DHG62ZW/R'.HPLK]WA3D%+!;C,#DM-)6I*5(
M)KD=)TUJ<33A%*S$`%5B*]N^<<A(%=G!2EMN9>HTUR0Q(E1TO)6=#;J_#4I-
M`NGB%/8,0>HZ=$Z+,UU'9AN'VJX:3?W+)1S"7-+3@2I[VS)W%.;+CLT.04.A
M#J9COWA7H2KPK5F$4(_3BJW,0@.!JK?!.^7$X)[+0A"%+$B'1*2K0)*5'(5T
M@TJ3AB;.:0YP#0X[%88C:B-H?)1U!7`;?6B+DJ*6322PI92>8WS!4(SS'Q&M
M,L;-M)8C60$!)SRP,:#"[.ZNS9A[4VG+39KJTIX,%U?,4@UJD^&AR`K4>+(]
MN)*"[,`H&U]*B)X^<:UHJ_;UVO)8E&,E@J,A:PSH25I0*J4C61PT@4Q9=#U+
ME/(R@YCQ_DJ#U'I!>WF9SAV?S5?+I"N#]R7"YGW[6H/*7D>6,D(I7@"#VXNU
MO"V5QFKB0%SY[G3@VY.0,QJ,:UP[$PKGMJ5/8E/+#3984I&2M87IRJ>%*TQ*
M1N,8H%5-0TMDK\937N_FHV_#VN[[6CAV_M<,6+*>)V*J4;_UJ*4HO1_:D=/W
MC,Z6_P#83+71@@'/F%M2"/#PSXTQ#?N\NZJGO]/0\![%O7LK;%M%8]CB(='O
M.:7722.%.<XX!2O9A:+47R5S$X<5'WVAQ1%M-]?@DB5'8;2.7&:1PX,-`#.G
M#1EARVZ>2-M*J.=I<+14G'T)$G405(2$H3Q\"4H-0<O$D!7TXGCM5>O-A3:?
M*UK\:EJH2!52LA7LSX8=6I`::\5`[SWI-4FKN8-"L5S5PJ/;AUF'$+*R?904
M#PGWAP*NX]QP9F\0LY7<"G+M*WI=EA0!`"Z9J76H`/&N('7[CEV;FC;16[I3
M0_/W(O7$`-=EH2!LQ^*FJ/$C*86PXPVMM)*P%H2K[ROO@JJKZ:8Y''<OSN8=
MZ[Q:001210%M:N`KN';78G9!2VM(*T(HAL(31"&R$C@/`$U`PQO\10<%<X<E
MN?D(JE^$LI5RT&C69`[-1I7,U/9BLR@A^.VBL5E-S8`YQQJ0EIK]XG]/]!PF
MG68'>$KQ.*_D'])P+9*`<6D4!H![!]6!81])(-0:'"4SRQA<-JV$(G/*=L/P
MQ6+K2)&GFHUE(4!4'($U-*4XTP^L;J1NXJ(O])CW).ELH;0`VTD99T;2HTKG
M4D$\#BR1W3L@P/J*KUS:1QMR842?&:;+@\"<DD@A(2<CW@`Y8W\T_M]14)"V
M*VNC)M%"./N2F<Z5)\(H/$<A\^#S3^WU%2'G(/PCU+%2:)40@5TFBM"2K@<P
MK3J!]M:XS6=WS`X'M3=S;Y[B^+*(SB-FS<DI(6E2E@+U*3I)45*&DYTHJH'#
M&*3_`(O:%J72PC-?`.BV`#CZ.RJ]"W$9)*D`FM$J4D5[Z"@[,%)_Q>T+3S=A
M_P`KV%29T??=9ZC;96'G4"1<)S4@EQ6EQ'DT)0A>I6G22*4RKB*ZLO99NGWP
M$$@8;.%5:NBM1MI.H(XV,RFH%:$<%?YXC7Q^P*Y\/$>/=CB,(/EFX;RN_P"5
MWG'.W<L>]:L;4*7H5PM_-+VU=;AUVZ*72S[;NVYI<G:%VM:8MFM+MTE+0BY-
MRA%4&V7$(!4"X=12K2#3%ST'476-L]@-*DJA];:$-2EBE+"2*;`3L)[%URZ`
MV*[;:Z.[`L=[AFW7*W;?B-/V]4=,=</F!3Z&%I2M:>8A+M%"H(4.&*UJ3^;=
MNE&.8JR:+;>3T^.$C+0;\/>I>*$*J5)!KQKW</Z,,:%2V=HQJ%RO_-8->BO3
MY8_?,]5(2&59:DH78IJ5A/:04H%?9B?TV0V\^=G`;.\JL:[J$4T%'MH,1L*2
M?2!>'+5;-L7"42683:'%A3:=>A]DQUI2I2-::A78<7*:62^TJ9D@<*4`P/"J
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M%*!5A-K75&!]2D9OT7'^Z?<N*GIOVU>M\]0=V=3KU`3`=WCNF];@1%0%Z&#-
MF*FK%>RC<MH#O->XXN5F*6-",:+GMT:WE1LJNV]CE0;=LNU.RYL*(AJ.&E"5
M+8C`%![2^XCC^C%3FCDYA^5WJ*N]A)&+<`N;6IWA5C]2_4?II>>B75'8T?>^
MWKE?MR;3FP;9:+=<8LQV1<F5H>C,4C:SS67&U9:N([<*V,3W7D;2UU,W`K74
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M$@^_D<XO-<4\%[+@,@.-Q8C11DGE)Y:0%9'P)*4'+O&%60Q1.SU`]*3=<F09
M';.\+2]9B-"4T7I0541GI0.).@FB1WG#H?-X<>[%)&2-NUS1Z0HBZ@=7.G/3
M=I*;Q=&9=YTE#.W;2@W:Y2UI!"5ZFUI8A.+5EI6KPDYXG-.Z>DNW-D((:[%5
M;J#J>UT^!S6/C,C13!PK[U1OJ+ZF=_;S7(@V.#'V'MU7^&3&AO>;W!<$D$!R
M;,(6B`E2:ZFVZ*U4HJ@QT;3NE[?3_P#,RD.J*4V[<=W<O.O47U#UJ\)M-++F
MS!]2?[HJ"/60H"A[?O5T=*U"1/6ZLJ5)FN2)*M9\1JI]3F>=:G//$Y')!;>!
MH5)GO)[^IU?.XG@#\$\;;TPG5UR6([;:_&\[1OF(2HU6M&K,*'93`;N4FHK0
M]BRVVBRC)@RF%>&Y/N+M*SVUM!*&Y+M0/&G)/$ZA0@5J,:^:F[4K'$V,DU&*
M76)#$1(;0TA%,ZH0D&AX9\<'FIN)2N'$(@Y+JVZV@D!RM02I7VJ\55(PZ!KB
M5!NNG9B*';\4F*84]2A%4YYD]O\`[,9P2D4W,)S841IJWZD))H59UI\II]&,
M5"<#'9BEN#;"1K*1J%`%457/+$&;IPVU4I9V;<U!6B?-JL'.4DH1P*=62LS2
MOZL:F\=E(5OL=/9(,:"E-JE:P;6U$:VZT`*:A5*YT->W%=O+VM0"KC8Z.P@8
M$X\%,6W]K)4A"BVDN=_:/T<,5J]O"!2JO-EI,8=4THI<M=ATA(4UK`I0Z542
MF@R.GVX@#>T::D5JK'#I[(R,HJ"I(MMG2XA"%MI*:)1I(52AIW9\,5^ZO7M=
MS!M&/J5B@LFF(M.\$)G[@Z*Q[Y*=EH88`*59$J[3W%>%;'J*=KJDG;O3!_2M
MO<8/`HF2KTM0+S]Z].<@*B.<Q;+,(R674"A!*C(0"LFH(`K08G!UBZV'+=4G
M:H:Y^F$5U<BXC($8`%*CB4_[!T`V?;1&5=HTB[(CNMR&8\UI'E%J3XDAQE%#
MRC\*B<LL-[OK2:>!T,6#G-I7'V*<L^@]*TZEQ>-#X8\7#;4#=0*;(=LM]N81
M$M\")!BM`!$6'';CQD@=H8:2EK6>^E3WXJS[RYN,2XU/%6JQ;I4)'[7%D[P1
M[T<JI*4H0-"$DJ2A"$MH"B34Z4)2FI/'+/&T0<&T>:N3^>2663/-3/0;.&Y9
MH<7K2%&@/>`.P^P8Q/\`I%(HUW?1B-J$)&NEN?FD+:+:'$"B5%IDJ`H*^\V3
MG[<.K:=S'916B9W-NU[2X[U#ES?D664TEQ"9*.:E):=2"%:E:4G41J&DFHSQ
M/"XSP92<"1[%5;V!UL#*P.KW'?@D"[-P9<Q<RXQ@PE*4\M+?,4A:5"JS741X
M5`<,2ED17:%!2QNN/$#Z0F<]Y>7*<:MR*--.C0$)U*TIH:$>)0.',MTYDCF@
MX`J,98AEPX`&E4Y8-PCQ2RTMI)<+S:7"00:9^$TIIK3"1N3+\CE/0PLC:"-J
MDNUMLWAB2TF2]$0F1H2VT5A*ART'549G,T_1B!U'`UV!6"R<UV`()20YL2XJ
MDK#%[F@*>/*02K2*J\"2H@B@]N%8=7BCB;'0$AH'J2LEK,Z1S@Z@)*,(V1<&
M'@J1<9"5I-2ZA1.O/W2*%-.WAV8TN;]EVP,:*$&JWMX)(W$N-<$_K?',5E">
M<M]Q!_>N)"5<!1.D)2FB?DPS3O*[@4A[A=B1H4QY#*$OAE:@L^)>LD54GF%5
M%**NS+!IMQ(V?8:9N!XICKUF#;?+7%H]RHEO3S+%\ERZN,N/:@*I*%%-:UTE
M(J"#QQUG0YG2!P.YH]ZX7K`-H^M*9B1ZE%DVZ/L,N-<U82XHJ<%3XRHDYUX8
ML`:3L!5(O+MU2`H_YROC'OUXC%DQ_P"JJ[7WJU+O[M7Z/^\,5E79(LU"EMBE
M,J_JQH[:$WN-GH*9DZ.X&_L_/_:^3%BL3\F"JMYXRF;<HSJU*IIX]I[L3&]5
M>\.!3<?:42`*95!S^3&-Z@OO%%""DT/$'&5NSQCO"VL)0I9"^&DGA7.H_5@4
MJG+9G3'?'*/W=:FOQ9`Y?)3$+JO_`+/VJ>T2X$3PT[W?8I<BOH>9;*:DAM(5
M4$5.D5/=QQRZ_J;@D\5W;2;MK[(M&]B<<?\`=)^7]1PT4Q8;4NPG$I8`-:ZE
M'A\F(2__`*@]P5IA_3])2ZR\C4CC\WLPS3J']5O>E^*D@%>5%`4_I_7@4DC>
M!"4`4]X^?&KO"MF/$;LYV!>+>6T-2"*9ZJ9Y]G:,2UEM47?7@/=WI"=NYYCB
M/%F=-=)[10\#BSQD\MO<JE?O$A+QO6J,^V'!4GW%=A[\;U*@(_ZGT%'_`#+7
M>?F."I3Q**/O&DZ<]:`$UR]X4&(R7]1W>G\?@'<L#&=1F0GNR5_IW83*3N/`
M._[40DQW%+!\/N#B?:KV8$T3KZ?.HB[SVNV\3J<O<)*=(J,W"14D@#A@U7'I
MV8#@?BI_IZ]:WJ"%KMU/@NA"R1(D?=KTE3=%%*=)\&="5XX872"%O+%75-5Z
M-_-N9.7`X-+6`G^`O"M*4ZE%*1[0FN7>`<)Y[O\`"M_)WY-!)[_M6M4=/.:?
M4TA;R"HH6J%'=D)U)4D\I]I(<;)2HU[QEVXTYER!L-.]+AMYER\RC>!.'O6\
M``@%*D%7Q-.I'_:.C2/TG"C))W^)-YG%@!NG!PW?'?W)I[HWYLC9,-Z?N[==
M@V]$8_>.W.Y1F#[NKPL\Q3ZLNS3APV*Z?X6N([BFSKBR:#4M!IV+B1ZO.L/_
M`-5?O'9VUNGC<U[IMLJ?-GN7Y<94>/NS<#K09$F"PX`ZW%M\5)2AP@ZZG@*8
MMNE:4^V=G>.'H[%0-5U9MVW*TU&./'M5F>E&VE[8VQ"CNEPNZ&"`ZDC3RVRD
M@$G,5.+>Z4.AY=<%2S--;S9H02#M5@[3U7W/LZ.AI%N:OEL"2&X#DA+4EML@
M@B)(4E26``31!!%<4O4M(=</,@'L5QTWJB>WHQPP)"]E>K';=M3IN.P-X-/I
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M4-PPVL`BH`<`%%#OP5**!2':MI6>V-&.W!;Y20D(SKP%.[&$)31:($=WG,0F
MM5`*E5.'Z#EC*$=;BH0L+``4*T-3E5)'Z\;Q?J!!V(C(C/!94$ZM1\*4'4HT
M`K08>K6J2)<9MU.E:5-NA-7$N_=*33,ZBLA(&C/CPPK%)<O/*8"6A1U]/:0-
M+IB,_H4+[MZK;(VF'V6YR;W<FJ)5;[2IN0E85DIE^80N-'"N!.9[L3=AT[<:
ME,(IVD1$5]6Q<^U+K+2=)!GE(<T84PVG!4ZZ@=4^HF\PY#LLV%L2T.A;88M&
MMRYB,I7C:DSB0'EN#M30`98Z!I?2MO9MJ:+DW476EWJ3C^U8#<H#7L"VEQ;S
MUPDR7UJ+CZGSJ7)=)U++[F>LN'B?;BW,C$3!$WPM%`N>/=-*\RW6-RXU=W[T
MI,;<M,1"5(B1$.)*15QL/(IW!/8<N.-@MHY1"<QV42@Y*99*6R&6Z)!`CL\M
M!%2*E(^UE\V,I;SS`DMV8M7,":4.K2>!H:T^3#QM<H[E#R.#I'.&PDGVHGK=
M5DNE.S.N>,K5:'&U*544I0=N!"V-PW"I.H#3VT-32G=@0E*/#:U%)2:JI3PG
MV]O9A";<D9(3,6@;DO0K7]YDD"OMX9>VG?A`*9L[)V7#9W)ZVZQ.*3I"4DD@
MDE5,@21V4X8AKR];DQ5HL[)Q=AL3YAVV9`""E*-*P"JBQ]GA0=U#B&BFYP<=
MP5IM;!Q=FI@%,&UW(QCMF<HIH@D:4E7BJ2`*'OQ!WGC*NUA=BV90\%*]B\L\
MIKRZ@:G@KP^'[7:<5B^V%3^ES"[=E;M4\6VVL-14=I6`I5.^@'LQ69_&K]90
M.MXBT[S5."'%89J30$YISJ:TJ,OEPW?X#W%/F>,=X1O$6I19I;4L5%*5IG@0
MCR$DE*12N0]F!"\)`445J0`33/C_`.S&$+U7A0'%$!.8XYY>S$A;_I>E";EZ
MF):86MM7WB0C3\I4D<>S(X4D9S&%G%:2O$;"\[`C%IF+=2A4A;:4T&C[SO/B
MKV#@,-O)=B9>=:G&\BOWR5-K;5324+"O=`2<A[1AS&W(T,X)Y$\21AXV%,:Y
M;>B7AVNAQQ="H)">U-2#XN[!)X5B?](J-]V0EV=I'G6U)C`*0A+7WKI!('[M
M!K0'$KI^P*KWI66W&MLR8K0BM&+.0U5Q]3?+6^^"2DK)J14T&-YOU7=ZCHOS
M"&#:E*\[0:@PG+JAAE];S"W9`+@\*Z5#B<O$I/9A(/RNKOJ!ZT[GTMT%N;C<
M</6HIV?O86B>_'N,EY33\\\E*6U++:-"$::`C2@$'$MJ.GNN[(.`W*MZ=?MM
M+VE14%62M.X;)>5AF!=(;SX(;=;YNA:':A*D+"N"DJR.*D[1W6\0>X'`+H\-
MS:78%7#.[%+3I#1(4<ZTJDU!XYCV81MR!*8^`4EY."W8)H=KL/0B3RA0.5\-
M`GVUJ?KP]6.]1%O24MQ+BLDMH2HE2CI`"%5!)/948EK0G!5'6-1NVL(`-`:>
MA5?W/"OF[9#\YJ/S$Q$:5.N+T)4T/"GE$@\PC3P&+QI,W)+CQ`]ZY-K$<^J_
M*\?IDGUX*!MRVR;&94'8ZP4E0(`)S-<_DQ>+*]&2H7-]3A-L\AV%$Q_)M^WA
M]/=QX8FJ^Y5WT[U;1]A(:4:J^SW?$/9BD>:?P"Z-Y1G$I(?:!2$U.=3V=E,+
MPR&:I.%$TN[9K0*$[TV;G&0D:=2LNW+OKW>W$K#>/A%&@%52\MFU+JE,Z9'2
M5K.I7`GL^K$U!>/EV@!5:^MFAM:FJ9LE`0X0#7,\?EQ(D8`\57)(Q&[#>B*F
MDG4JIKF>RG]&,+5GC'>%H0O0:@5RI_1]6!2J6K7)0%G6=)U9<:4H/UXC;^WY
MPKCX:)U9G+,#VJ4+7<8Q0A`74E*4GAQH`:=N*'?Z/'5TN9U1CNW+L.A7K0UD
M1(QH$]&9;26VO$/$?HH<\5JX8Z'PXKH5B65P*<$?26@4$J22<\N/;BNW3I))
M<Q`!HK/"YF3;O2RR/&C_`$[,-Z/X)Y;&-T[02:53@CR7`G3H31-*&IKV\?FQ
MBDG!37+A_$?8E)M6M`4:`FN0]A([O9@QW[4<J+<3[$7#$GV_Z?HQLQ@E=D=L
M36\C_P`N[E5,F'O7I6\PDH6*\S.I)KX>[LSKB3A')\*IM^V]'W0B3;27UJ2@
M54*:Z\1[?;08F8KEW+&`V*.+7/C#9,'=BVJB-LIUI4LD'30Z:9U[AAQ%,Z1^
M4@44?<6[;<<]A)=6E#LQ6O#A,_-/X!+T!YM:6T$D*1I2`/B!`S^7"#K=KG%U
M34J2CN'<L8#8E=:`H4J1G7^G",L(C;F!.U*!QG.1V`VH@^R-8S/NCN[SAO@M
MO+MXE$FG9L&;'N-LD"/<K>^F3!><:;>;:DLDEM:VG04.)!X@Y8Q<#S-DZQ?A
M&[>-OV+:S@%E?MU!A+I6[CL]F.Y-[<W4_P!3$^:^;9OL6^,I0+:;?9K4WH`3
MH"=2X[A4,JY]N*S;]*:?`W*YSI/\0;A[%=9^M-5F<'1AD1_NDX]]:IFJW%ZG
M9:-4CK#NAITJ-1'1:XZ`D>Z`VW""!EQ/;AQ_IS3?P^P)O_J[6J_J'UK4[!ZY
MS_NY?6/J1R7!]ZEO<CC(-!JH%-,(4D:QE0CNPH-`L1L'L";?ZEUC_G.2:YTX
MWQ<@L7/J/U&GCX7][WH((574%-LR&DJ!IVX<V^E6EO4M:"33:!AW)1FMZE<_
MK2.<!L]*U6_T\6N7*3,NQ>N"\RZNYRG[HY)()2"^N>Z^I:DC(=P`PZ\K;_@:
MM_W&Z.&8J7K%L.PV1:1"@16DI80TBD5@*94WFIUA26T\I;PR6!D1AJ_*[8`.
MY-6S/&W%/^I"&V\M+:=*10"@R[ODPGRQQ*?V]Q\IS,:3Z4H-(04-%:0N@!`4
M!EF#W>S"GRM8<`<"MG/#AX0"O78T1]>MV(PX?[3:2/Z,1.'`)*C_`,16;5NM
MQ!4(49*@:`I:1W?)@^7@$\MF.+#\QVI5:*6T)9:0AI)2ELZ$@$IX&N7$XPX-
M<"*!.FM+7!U3@4HH64)T@`CV_(!^K"/(;Q*=>8=P"RYRNX?3@Y#>)1YAW`)4
M;DFB0H)"0!4U.0IQQJ^$!I()JLMN6-.:;"$;:;:=BW>99^,?/_5A!CK<?K.(
M[D/O[,_H9G=Z]\PS\8^?^K"+Y6.DRVWS-XE.HHYY81<#*(B3M.."2;MN>Q;?
MCNR;W/B6Q#*=2O-3H[)"20G5X@20">%*GAA];6&JRO#F1#E\<4QO-6T?2XG7
M.JS!EJSQ%I%<<!2O:0JZ;M]5FS+:T_'VK#F[CE-:TKNJ&51K9'<%.6&U.$.R
M0LUJ4\-/MQ<=-Z5NKPCG9FCL'VKF.O\`U<Z?T^O[41-M\5?_`&:*J6[.N&\M
M\%Q4^ZF+#=55N'`4['0VV`&RWS-7.6%!)KJ)X]V+[I_2MG9QM#R\R#;4#CV!
M<GU/ZE7VLO=,V.-D3]@!=A04WGL49/W98;&@MZ6Z):8:0&64I.1YB6Z%]21P
M*B2,6F*&$1\AC`WM&U4>:_>^7GRGF#'Y''Y<=^&-1N28[<G72"4(30$>$JSK
MVYG`ZR:[[[AZDRFNWR&L8$?^'^=424ZM1)*CF:\?KJ<+,MPQH;4F@28G>!0X
MGBM#[B]`\1]X?T'&W)'$K5\AD&4HF25&JC4\,\')'$I'*%ZD:E`'M/9A4"@H
MLK>64]ZOG'U8U>XM%0LA><E/>KYQ]6$N:[L6:)8:80@H6"30`T-*&HIGE[<'
M-=P"<"!M*U*7XD=MPMJ(H3W4[O:#AK<W+F!M`-J<V\#<QQ.Y.V'".L:$!21I
MS/R?HPT\X_;0>U6JSMF%M4_+:EI`"E`!(.9]M:?TXJ,SIIL'"BL]G##FI4IY
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MZE88;ZXFP#65]*7([RBK04@`YUSKGE^K#:.**5N9A-*J39S"VL@`<LY4A;"5
M%(%0,CGV@]V%/*MXE9><K"[@$F1IFEUQQT^\D`5KQK7Y<'E6\2FGFG\`A.G(
M4T/&0FO#.G`_3A:-@C;E&Q'FG\`F?-E<]"QK.602.!H>VN'5NT.F:';*_!(7
M$SI87,H,?M32E726VE24+*`*4()!S/RTQ+<B'CBJW/-+#L`/K6,?J9,LD5N,
MN(F:IK6"MTO$JU.%?V%I]T*QN[3+9\7.#W9SNPI[DC!U)>P.\MRH^6W?\U37
M'BI'VWNRT[DMQ=E!=M?6I*0T5J:-"16BBK6"!B&EM79\C:EJF8]9?.RDC6"O
M"J95XC,,WQP(>,Z($K2I+SJG4@J((.:C15.`PZ@$L`^4`]Z0E?!-M=3N6A?X
M5`@RG66T"=S-#(42&U-J_P#&6$T4"BM<N[&7\Q[BXTJ5'Q/CM9B]AS4.]*,K
M?5@%F19'IG.N[T%P-I0VM+"B$@>^O.M5"F>!L+I7@'8,<.Q2MSK;KJT\HYC`
MVH-16N%?1O4",M6^&Y+?N3*#*45HCH54)U*\22,P:U/?BPQZA,R'D\MI;Z5S
M^\LH6S\X/=F]%$E/S[ZPN.\PEM*F5-O1VV4B.26U!3:%N-E*G>`J5$D]N%3$
MR^C#)!DPW?S6([B:S=S6/<[L.SV*4+;UWC)?B0-R6AVWNI93&0_'6IQIY[4G
M-96I1U:03EEEB/EZ3@@_S,,LA>XT((%*;<*=RG=-ZRO'2&"=D?+:W`U=MKWJ
M6#O"S2(S?(?2LN)2X!J&05F`?;EB)GT]T)IB5:+?7V3>(-'=5(%R,*[QGEK;
MYC*4*YB$9ZT]WRUPI9-FS@.&"TU#4+:6/PMK11!>;@+9'\A!8>2E3KA2DM@%
M51P.D9I&+9;@-VDA<_OYI(R!:1L=G)!K7#NH56K?Z+DM3JG7%Q5J"#R?+NJT
M@H!2JH!J5C/%FLRS+XERKJRRU$-YL<8)/>H=K_QAQI_#O^]W\,6CS@X#8J'R
M=3_Y8V?QO5LGT+Y2_`K[/V3\0]F*>NL)'>;6--4+X*^R?9[,/;38[T)E>;!Z
M4D3F=0%6B<L_![>TTP\57NXY'`Y6N/H*:$YD!:ONOLG[';\V)FT>S#$>M56]
M8_)L/J3(F,$.%7)-,ZGEY>\>)I3AB>J"T4(."J]PQ^88'9P2.M!U*HDZ:]V5
M/FI3&$BUCPX8';P15U`TC2G/5]E.=*'N&!2:]9!2*T(54YTH:4&%FMB=$<Y`
M->*>6^#"[?5+]I=5SVDEPZBXF@U9G/(`5S).(#4+:,QO+:4H5.Z5J$S-0@B%
M<IE:I/BO\M#0<\>8&D_9XYTQ2+RT:ZN4578+.^R&I<T=Y3H;GE*4H;J,JZ4@
M]O;0=^*U/8.SU+7##@K'!J,9CP>RM>(^U*8O'+`65'PCM4.ZG<,("T:791XD
MZ_<!&.:2`T;ZX!&(U]<?<"6RO(U5H)-1G2M,;_M[OPGU+8:T'>&1A](^U/*)
M.U,H!>2A>=6RXE*AXC2J544*C/$/=VTL<Y:&NH*;CP4S::FQT(S/;FQW]O>C
MYN_+!6H$@4XG+,T'9[<:P0S<T?*[?N*>?N38AS"1E"U*NT20`7PL%-0GE@GB
M<]5!D:C$AR9OP.]14->ZT'&K!5'&'8J4<]A2$%:2224I<.5*+J02<NW#^*&7
MECY7>HJ)\Q')^82`3N)Q07/C^5\8:U:T\2D*S)RSPY@BD$E2UP%.!3'4)8A;
M>)OB&\+)A3+\9Q:4(U!8"<@32@.5!6F'N5W`J%#FN\)!19HJ0XDIJE6L<*@U
MK_3C&S!2<;VB,`D5IQ3E2\>2FK@UZLZJ&JE.WMI7"%P"YF`KBG5N]F<XC9Q[
ME@5A694"?E&&61_`^I/,[>(1.@4Z00""HY<002<&1_`^I&=G$>M&TI2D>%(`
M]@IC!:X;00LAS3L(*%`>(&,+*]`)R`)/<,\"$9821JJ".'$$=^!.K9S1FJ0-
MGQ1H+6*)U*"0>%2!Q_KQ@[$[SLXCUH]B-64:CH0I*M20:'M'LQD)W;["C@`%
M`!0#@!C#_">Y.%M9`*C4`^$\17M&(I"-@`#(`9]@I_1C9K'N%6@D=@4A:1R.
MC):TEM=P*-HY=$^YJHGNK7^FM<&1]:4->Y+.(;XL.];?;W8"Q[?$"/0L!S7;
M""L4N(7[JT*SIX5`Y]V1XX3SLS9:C-PWK)^7Q8+<ZMR.V77DZ6DI"E<Y09;T
M9`J4M>D!(!K6N,R13NB/)8][Z8!H))/91(3WEC9PNN;Z1C+1@J\N<`T#B2<`
M.]1%NWKGTWVA)DPWK^F]S&FPL0;/$$L-/?:9=FQ^8CLI0G(XDM,Z2O=3(%Q%
M)&/[S2WWA4C4?J7TUIH/DWPRN'X'-=[JJLV[?5+N:[EUG:-N:VQ$%$LRY$94
M^Y+4!1U3K+Z0P$*6*HI]G'0=,^GMG9L:Y[FDUKNJN3]0?534M1O'G3I.39D-
M`;6E"!0X8;3BJVW>_;@O[XDWRZW.[O@E0=GR7I!!))R#BBD`$Y"F6+M:Z=:P
M-$+6`]P7-M5U36-7B?%<W',A?2K`ZI-"#LJ=E*[$DK2XZI*UI<6H"@)2HT_0
M,L/AEMO"PCT*+MK6"(5N(WT[0:>T+$H<K[BOV2/U8T>\RN,FRJ2GD`E(MFGD
M;L#_`!MJO`VY\"OV3]6"/!U2L122.?1P-.XK+EK^!?[)^K#C,WB$Y0Y:_@7^
MR?JP9F\0A>%I9XMJ/RH)_5@S-XA"\Y)_NC_]C_JP9F\0A#DD9AH@_P"H?JP9
MF\0A>EMSX%_LJ^K"<I!&!0$:9:3H\:/%4^\*&GZ<(K*64MI(`"$G(4`2#V?)
MC5/QL"-L<Q"TTU)2*]A`&1^;#*\\+?2G-O7,:)TQKL8S2$!!6H5)6`36I)I4
M'LKADK19R1AE'.:.\I98W3%2I*'8X#)-%!M)K7[)X=^$?+,.."5M+X--'.`]
M*>L"[1U<M3"W="Z:DN9`'@*!79B,U"-L3F4W@J=&HL-&M>PGL<*I>,QDE)(0
M"K32H&9-!EWDG#!I!(&"V=?&,5<0.%=Z;5[D75"E-0IKL5M2@VM2TK<9`)-4
M!%".8H<.W#[R\/$)M,^ZO!24.C[75'O487>,W&=.B>9[ZDE4A9:+:H[M2.2`
M<P"G/].):Q;%';O`&:KO@JQJNFF!S7-N&$TV9AQ[T^=B[@N%G2TXF0_(R:6T
MVMQ2VFM)!2DIKI2A)&?8!B)U!C9V/A:PYGM+1AO(IP5JZ8U^33K=S"^KLIIC
MB33"BMCM3KG!0U'M5P9<$I1`4M`^[%2$FBAX:Y_-CG5]TI*!BUP-.!]JZ?TY
MUA+(\<\$#MP]ZL7:KO%DI:>BNE]"VPZHE864%0/A-*Z4@#%:DL7:>[D&N./K
MP^"Z]9:A%?P\]KFTK3`\/[4HRYB75H2E(*5$`D4*0*<20*4QC(_@?4G,I'*=
MW)!DJ<0X2DJ2BG$5">)[>&#([@5%YV<1ZUICZY+A!"GF\@*`K145U#*HJ.W&
MCG-::.(![5D$.\.*48NW0`I;J`KB0E:!G6HX$5RQCG-9\S2*CM2\<+W.%6G)
MQI@B3NVX[B)!7';0H!.C4V$E1\6K14`DBGZ,9\X[C[4TO;+.#E!)[E'5ZVT4
M-CEIHL$FB4T4,P14`5X8DK2Z>]H:<&\56[FR+*N#79^%$Q;C-N<%T(E-<@"B
MN:!RU`CW:'(C4<L3K([9T=2]N;A4*OW,MY;U/+>&C?E/OHB0WG+8*@U'#I73
MF..IU%92*)-2#7(X4;:L?X<>Y11ULM=D<^CN!.*5X4]=QI*D$)4XG7RB1H:K
M4%*4\$C+&?*-&W:I"*\?)&'\0BUQ0B4Y52DK4P.8RLZ24*0,M"OLG/"T%M&)
M*N(I0I07+]RCR6J3,G5D(><2TH44XA:DE0-0L5%*@'CAWR(.+?8HB\FF=@UK
MCZ"4XBI+D<)=4%?<A)2L@_9X$'"<``D(;LS)9P=Y=E0:Y17U**MTL>!?EZLK
M!JVZWX2VH5.I*AP40*8M5C#','-E(H!A55'5+F:U#9(022^F`)PH>"/67J+:
MT61RSOER+?F@M#<QU?)Y@HD-J0ZO3K<)!K3"-WHXD=^6TN'8*^Y:VO4,L8',
M=E/::>]./;74*XJL=QCR9KC5SA36UQ%B11,QE(H6G%:J.-*&9[*XC;C2VQ-_
M+'S=@3ZWZB,TF5TC:=Z>UJO<3<3T.8\XEN0TI8D1G%)#>20`XA"B`2LCCB#F
M9=1D`1OI7\)5AMM0C+VN:6NQQIC3M/!*5\DV)^SRG9C33D@*6A"RVVH@(44I
M2VHBITI%,L2=I-.UM'-('<5+:I)9W5N/`YU.Q0SK'_W$@<?_`"C?N_'[OO8F
M_-.[=BYAFB_!]^G\8)Q._NU?H_[PPFGB2I'V/^U^K#RTV.]"8WFUOI^"29GN
M_*`/]H8=G8F)\)[DTKBTI*E*)33,9$U_HPYLO$%3KS81V)G3&RMMT@@4/;7Z
ML6B#PJL7'C396DI*DFE14>S"Z11);:D"I(XTRK]0[L"%KPVF\7H3J#P'O1IA
M+C3K3R2FK:DN#CQ&8[,-IV9X7,X@A/K240W,<QV-<"G`S<Y:EY+'AS-=7T<<
M0OD'*U_OD?8G/`NRU+JXHZ@*=W"E*YXC[RQ(J1MHI"SUMNXX53E\PVXG2#FK
M@2105%3BN&U,=RUXV`_!6%^JMN+1T/XF_$%9,NOQG4EE:*KKJHH\!PX#VX?+
M-EN3XM7,>*777$:U5!JH\$U`XCNQ"7O]0[N'N5GMMH2Z\L.M%":@G2<^&2J]
MA.$X/U1Z?<IVY_HSWCWA%VT%`(-,SV?^P8D%"K4X^ZE:DI(H#09^S#R/P!0-
MU=9+A[*["M9><7I2HBFH'](KC=1]W<<V+)VA+\5Y;38">T5^@8"G%EL"/-+J
M6W%=Z5&GR@G#-_C/>I!WB*4FWDN$A(4"!7,#O`[">_&J<6OZA[OL6[&$^623
MI4">`.!"-)<"Z@`Y4XT]OM.&USX1WIQ;^(]RRPS3I&$-*2H*)305X5[01W8$
M(Q@0A@61M2CB,4JCL;W5?ZWZL`3NWV'O1H9D#VX'^$]R<(RVVI"B21PIE7O'
ML'=B*0MX4E/O*TBO'2I?^P@*6?FPA)<W$4@BA&!%5D1WK_FMWY(=_?Q]2'-0
M@*><6AEAL%9>DJ1&1RTU47!SBA6G3GPKA[Y74)87/8"9*5'>LYK>W_.O)VT8
M*D5W#$J/]Q]9.G.VTJ3+W'%D3D**4P(25R'E+"%*&J@#(0:4KJXXD=)T?4[E
MP%TPJM:OUEI-L";5X/<H"W-ZHKQ+:<B[4L<:WI%>7<+D$.*<56A5^'M%;1;I
M2BBX%'M`IBY0]&0&3FR>+!<JUKZP^5G.GQM+I"T$.[ZX>Q5[W+OO>FZE<W<.
MXI\QL5U1H[[UNC%!.;6B*5J#::Y``F@&+IINCV=FYH%``:KG6I=6Z[JS7>8<
M3ISA\[>+>&SCVIFN1T,!R0VA46WA(6N1,="6VW,]:GI3R@0D@<54Q(7-[96E
M<SA@HRUMI[S"RMW'T)L2-Z;*B.+:D[PVRAU'O(;O$24H5S%1$<>-2#PXCMQ'
M?OE@_P"8.P4I_I'K.?\`,M+`N@.PD>O=Q2I`NULN:=4"X097:!'E-O+(X^%#
M94I66?L&,C7+1IS,=\^Y:2=)=;6S#//9&.%NUP&SV;]B/5S.1RR[N/<#GB3M
M[SSHJ"JZ+F]%UY.[KMH@<S\V%)&Y'EO!/)8Q%(8V[!_:LU-*2*DBGLK]6-$F
MO$-E=2",N^OU'`A9<A?>GYS]6!"Q4VI`J2.-,J_4,"$$-J6*@CC3.OU'OP(6
M7(7WI^<_5@0AR%]Z?G/U8$(<A?>GYS]6!"/H.A22>SC3Y*>S&J?C8$<:(>5I
M3D?[60[>ZO=AG>;&^E/+7:[T)1Y:F@$*()`KE6GBS[0._#%/$40TM2D@)/'M
MX99_JP(3Y@S6&/+H62IP@D-H&I:@"*D#N37/#.ZY%6\ZE:&B?:=<QV]R,["^
MI3I5)8D(8:U*9"U(0''$%--:@G4D@$U37#%YLFL+@14-)]05DU"_A?)#&82"
M9&#9Q<`IN=Z0*N%CMTNQS9GFUELNR7D\QA2LZD>\HY\#3%4&ML[%TN;IU]V2
MT`HZYZ:DW6`AV=?9,6Y+3XU-1T!E9IDNN2B0<N'`887/5<MI.V*$_EN%33C6
MB1'TXCN(733-_,!H/4HOO/0[<FTI+348O75#KZ&V'(H65/`K`;+P6AM"-=16
MA(&+;IW4-D^+G3.&<"N/9BJ;>]":BV<0VK2,S@`>%30(V_T.ZB.1$75N,S"2
MVYK"7'G.>:!:M&EMI8S^7#B3J/3+IV0.%2$_C^G_`%/:XN>:?QV)]]--R7S;
M$PV_=;KT5EQQ32')%=`31*0LE1!Y50>RN6*IJ]C'?3>:@\`8!Z14_%7+I^\N
M^GX3INH.K.YY>*\"`![BK5B7'<B!Z,ZA]M3"5MO-&K:PM(4D@G/-)Q5I1RG9
M';:KIEM>BYM">+439=4^L(7[I(KGWXU39.*$RVPX&VA1%-5/:H5.(+4/ZD]P
M3ZT^*<RE!*-1X`#A^D89[U8V_P!.?1\$56IIQ.I=0$=^GM[JU[L939(LMF!)
M%=/C-*E6@<"!V*[AB>LS_EF^GWE0-[_4N]'N"CC<^WX\^&\Z"WS04*25$\`L
M5^R:D##V+QJ*OF<RU<U0!(C%N2^T"G[M>G(Y?*,JTRQ9=/V+D=Q95OB>U*4!
M3K)0"H%!*4T"C[M:'L`[<*2_J'O5CB9RXVLX!.<IB4(J>T<4?7A-*)/-M#I4
MI`2H5[*&AIP/MP(2'<8CD-+BUI"D$*/@()0G/-0-*:1A6W\?I4;>7F6K!N47
MWZ0TMMP`YBIS([E=Q[,6>U!HJ;J=Z,F!W_!03>W$)D-N(S<:<*R<J:2?"`:^
M\*8M=AX52KV]%:E+4*Z+EM*<B'E!"1K2\=*EJR"@C05#/VD89OL27D[R3[4A
M:WH<[M3J@;@FV[E2$/)R2H.)2HA1\(I0&@XX:7-B0T5V54\=9DM&!T6UQQ[E
MKD;PN<R.62^-!<=4D*4<M:U$Y?IPS\D$G_J:Z[5Y_FB7_>CW=/O#C]6#R2;_
M`+XWB-JG)UA'+5FKL[1\0]F&%5T'DL[4EOQVSI][M[1[/9A1DSH_#3%1FH,#
M"RG;\$CR&4*6I)U4213//L/=WX4\U(<,%&D8)N7..V4DU5F3VCO`[O;B:L?&
MJU>V\8:3CL3#F)"$/`?%V_Z#%C8\L%`J^ZRB?\Q+J^C[$W7&$$+7XJT4KCE7
M/V<,L;<UW8H>9H8_*W8DQ0"Q0]]<O]/;C/-=V+%%B&4>WY\)N<7&I3F`?)Z5
MN`I0=P_HQJG+&AS@T["5L0ZILDI"<Q3,$_KP)WY2/B[U_P`D>8=7^]K11RH/
M=R[:=^(Z[QDRG91/K>UC#`075KQ_DG!$G)<%5+.I)IDH"M!^GCB+=8P/=F<7
M#N_L4AY@VK#(-C1O2S%EJ+[820JOO:O%0'NH<1US#;PCY":]_P#)6'2-59-3
M/2G9@I*@LOAI#S5:*'`@E.1/9\N*O=D&=Q&S#W+HEDR.6!LS:XU]Z<"U%*20
M*D4&?M.,6K0Z<`[,?<I-[\\9C?X$5,EP.-HHFBZUR-<J<#7VXE^2SM4/=2QQ
M8,/K1.3(<0^ZD!-`KM!KP'MQ)0VL3HFDUV*AW\[W7DA%*9O@%XP^MQP!030#
M5D#Q%/:<:SP,C9F;6M4WC>Y[J'8EMF0LII1/AR&1X4[<\,U(Q74D7AHE)I]=
M&TT33PC@>&7MQH86DU-:E2C+A[VAYI4A*#3JD*)`&8IF#WCVX3DC:QM1Q3F"
M=X>:4V)1967$:E`5J1E7LI[<()UYF3L6](!4`>!.!/6FK03M(6\@-E`2/?50
MUSRRX?/AM=>%O>G5OXCW)04R@,A8KJ/MR[/9AFG2U<]?<GYC]>!"VM+*]50,
MJ<`>VOMPA,^1E,E,5HYEP\@0`'C5;Z"OZ1AOS[C>!12<%B]S:RX%'_T4_P#;
M@S0?WOX]"S;6^HO(YH8!V#^:/1!J"P*GQ?J.&TSI2X>5%6[Z_P`!2IM+F)N9
MKHPW?7X8A$[K?+/8@'KK>+7!;'B6F=*1&+24C4K))=<6H)!(!2DGAA['97<K
M#5OS4PPWJ-FU6UM:FYECHT5-"*T&VF)QHHQO/J`V#:RL0Y4R_+`HVFUQ=3*E
M'@HONN(4E`(S\/;AUIO2][<D"X!'=_!5;U'ZD]+6PK;EY[S_`/A"AN_^I/=,
MH.#;ULMMC":I;><6NXSUYU#O,2XRS'%,M!0H@BM<Z8N5IT/80C/<NE,N[$`4
M]17/-5^J%Y>/RZ-D%KEHZH).:NXU&ZFY0I?=[[QW4HN[AW%<YY<)6XP7^3'&
MO-30;92VH-9TI7ABSV>F6=D`V%OR@[Z>V@"H&H:KJ5_F?-/(*@X--!\4V4K4
MV26CRBH:5$)2M2D5KI*GDN*I4=]<23BQV`8P#L"@091MD>>\_P`EXD``Y\34
MU[SQ/<,;QP0S$\TN'=3[$O$&MS373&&U`P=3YJC=6M*;,**/.JN^G>G.V)5]
MBM(GW`QW##AI;+BXSH*0EZ4@*!6U0\,NS/%'ZKU-NCV\C[)P,S6U`=C4]PI@
MNE_2SHJ+K/5V&]YHTILGS9"!5OI!W]BX?];>O'4_>DF2S<MVWB)9WYKR#:84
MIZ%&0C*J5MMN54DC*BB1CCEYU1JE]^J6#N!'Q*]EZ#T#TWTZ0;.$R4_YE'>X
M-4I^G:XVEB3%=:AQ.86SJ6ZRF2I:]7B<7YGFZE+5F?;AK;7TI`#WFM5;[B."
MF>..-@IX6BC<.S';M.*^@+TWOV6X6Q#=PA1)33GA=2[':S04&M"E*2"@&H[`
M1B>MIN4X39W%P.RN&.'!0=Q!;:@'V%XT>4>UU:8'`%PI6N\#<FSU"V^+!OO=
M-N#9:CLW+_`-"E$P'&6W8ZE``5<47%5(H"`,L=JZ:ADGM1/":OHOGU]38K'2
MNJWLA:X1"0^_N3/Y"`?M=G:./S8E)X]4$Y<\,R=QX=ZJ[GNO)R^W+>6ZE*[=
M@'$;UFI`4FA[QP^C`Q[JAK_$G4FGW$$!N)'-+*@8=OI6*4!%:5S[\*IDLL"%
MBI(6*'A6N6!""4A`H.^N?^GLP(66!"&!"&!"]KC%$MSG##!&XJBE14*5%*5X
M=N$I8FRTS5P3FWN'@FE$?5)<6:D)X`9`]F7><)>4B[4Y\S)V)2$IE.;:4%?8
M%>(>W($=F#RD7;_'H3W.WBI/Z/2[6G>49N[PHLQF2VIM"9#96$+.7@\0IJ)S
MQ7.HM.B?")@YX>P&E"*;MN'8K?T3<1NUIEC(R-\4IJ214BA`PQPK7@5=^3L3
M:]PCQ6WK/&9Y2DJ2N.VEM9JOF)U*4%@C/NQRLW<Y>Z,N^6A]Q7H&YT#1I;ED
M9C^04(I2M1CPXJ0;?$9A,-0XP+4=E-$-C33(9$^&E1B"YK^*LD-K%`:LK7M2
MLA12"#1>=1K`)3[$TI083?\`F&KMJ>F4FF`H-RR4['7DXVAU5*`.)!"5=FFA
M!%#PP@ZWS-+<[P#P/\ELV?*00QE1OI_-)%V;D.Q`B*I31#@)#950HT*!!"BH
M4K3&(;?D&K'R5[3_`"24[W7`H\D`\%5;JJTEB=#1,\;I;;4`J@JDN.@5&1K4
M''1NFY^9I[H)"#^8['?L"Y7UE9V=O>-O"^3S0C:!4C+0$[J<2=ZEW8#S:]FV
MU.M:E/*D*J5`Z>0K0VVCN;"0!3/%;UQCX;]C6>`NQJK%TC)=WMA)(_+D8W<-
MWK3QBJ(?;&7B4`<-U/I]M-1T:5J*M92FHUI`X99&AQ!W['NN"6[*!2MDR/E!
MY)S5*]7/004]GLXY?IPVCBD+P#L*D77.2(M!%$W9UU4"&TE(!K6G$\/[66''
MECP*A+G59(1\F6O;_:F?==PIMZ1I4->15K-1F010!0[#B8LHG&-K!L4)<:D]
M]9G9<Q]7O3/N6[UAM;;99.H4.M*CW5X+&=,6.UTR-Q!?F]?\E!7.N7#`0.73
MM!^U15(E!V0\ZBA*UDJRR![*"O#$Q%;1P^"OI5:?*'R\YU,_L1AN2VEI-2`I
M*:G,<1GPKAM,R0R.(V52INW$UP1QB4RZ@*4ZJN5:*`^C/"627A[$>:/8BD^2
MXV`J-)=0`,P%Y%6>9H.-`,&27A[$>:/8F=.G2R5<R4\M#A(6%*J`E5=0&60I
MA_:P-+AFK55?4)WESR*;2HPOUQ2A2T)62,QF:]_;EBRQQ-B:"VM2J;>2/DP=
ML!477!:5E:DJ*A4@DFN?;P[L6.P\*J5Z,3B5KM*GT.)6H@-)62L"N::4SS[<
M9-U(TD4&U1EJ^Z$E'`!M>!V(U(G*YKB6EDUR4%9@#^SGE7&T3C<U$H%&\%.R
MW<C(VD9:U102'4B@5W]_::]_MPMY:+@FWGYN#?4?M7OFGOB_I^O!Y:+@F2NT
MZD<M60[.S^T,4'.SB%WA);X2--0.WL^3&00[9BHS46.>6903M^"2W@C6K)/9
MV#X1[,9`-5&F&6GA*;\U"5DT0%)TDY)!'R\,6&T<&.!<:8JOWL<F2E#5,R;%
M&AVK">*OL)[\NSNQ.MN(3L<%"".2AP*:4V$*)4GPD@$I`I[=)`(KGC831DX.
M%57;F.3F;#M2!*2E*0F@"M0J*`&E#A1:9'\"B8P)Q$"&T/%>XU)`%3L3B+]1
MO>%ZE*E9)!-.X8TYT7X@I1'F`=(10ZZDZ:9T^3$?<R1F7`C8G4,C`W*2,U=B
M66((#B"5Z0350X#,=M"!AC<2AL+BP_-1/&6QNSR?NN3XM5NCJTN%:*H"5#A5
M5:\?DIBIWMP_&BN&BZ!`PC,X`)^1Y@:90VE.2:TT@4XG$2&R2#.`<5>X8XK6
M(0,<"T?'%;53@H%*O`"/>50`'B,Z]IPYM6.9,'/%&X^Y:7<[60%S2*X>])@F
M!I;E5:@H@I)-:4`KIJ<@?9B8:"_P8JGWUZ`2*HH[)YCBE\PC4:TU'N`[\2\(
M(B:#MHJS+-&9"2X5JMC"UZ_>5P/VC]>$[EKG14:*FJVAEC+]HV)PP%CEKU+S
MU_:/9I'?AAR9?PE.^8SB$HH4K6FBC34FE%&E*CAGA$R,:<KB`X*4BGB$;07#
M8CZ5+K[ROVC]>$99&.;0$5JG4$T1?@X;$=86K0?&?>/VCW#VX;YAQ3GFQ\0E
MR.0K00=6D#4:UH:9U.#,.*F(R'-`;B:)8:941J4W5)II*@""?97MPUNGM#14
MC:G]O#+4G*:46#Y6%Z/%32,AJ*:'Y*IPRYD?$)5SFL-'FA7C:#S$A0":U]\A
M(]TGBH@8<<B:E<IIW+9WR"KL`B4S<5EM%5S;Q:XB$ZN:V^^US7`D#)L#4:IK
MG\N'-O8S35^1QI3<F<VN6.F#\Z5C7/V5/#;[PF7<>M.P[<I:XJKA<EY`IA,A
M^.5``4;61PJ,SV&N'0TF<FG*=2O!05SUO"QWY,C2WL*8MRZ_7%U"D[>VY"8=
M.G0;A)*@$U\9.JM5!/`=^)L=*1#::^A0US]3)VBL(J>Q1G?^JN_;F@MR+_(@
M(<2L&';8@CI4"<Z36-#HT\`:X<V_3D,)H0""J;J_7VOZ@YOER^-K00>U1L](
ME3%<R8^_+>6=3CDR0[+>6L_:<>?6XXXOVDDXL=MI5E&SYLM0J3<W&MWDHEEN
M'9:BHJ<16I'I&"T%A"25EEL*S\>@5S[-5*X>AT<7Z;?<G#A;S821FB&A`X)0
M/]5('ZAC5\SICF<"*8+#8H(L(!1IQ]*]H.X?,,:(=BTCL6.D=P^88RFF1_`K
M+2D!.I(`4J@-,B<LO;3#>>?DM+JTP3HEMS:Q:6<'OF]CBT*F?5J^L765N1NX
MNJC1G(,F!%3S%-F0^A89;;CBHJYK2#ECSQUGJMQ+J38`28W.H>ZB]]_2[I6T
MZ9Z9BD:T"29@QIQQ7&?JU;;C"W2]ME5OF7"]-1(TY/D&''4!F>XM47GAH:2X
MXVFM2:D8JJZ-S(^(3^Z8VWJ587&'W;?#@M%`TIGNJC/)!^)`]T'B.TC#8RN;
M<91L%%I*]A90$57:?T8;CWOO2/N9<"Z6FS+VW<K'$1`7!FW%$B+<8DF2N4HR
M9"4ELN1%HK49BF+#;RR/RL.`J/9BH<QGG9G81XX]XHNB5XZ1WK?5S<O$W=%M
M9FNLQVW";,\WSRA&D:2U)>UA`33.E*Y8Z38]6S:19".W^9]-@VKC?4_TETKJ
M+4#=S.;4FM4GR/3%O+1KMLRUWVHJEA*W+2_E7(%\K2XLD9`<<L+6OU$O'D>?
M8Z.-QVN7/M4^@D[>;)HCC*V/:&`G+@#C_&]0#.MZ[;.?@O(4B1%>?BRFG`0X
MQ)C++;[#J3[KK+@HH=AQTBPGBOK47D+@YIWCM7G[4[&ZTS47:?-+4M)JPG&H
M[.Q:-([A\PPZ37(_@5ERE4KHRXUIV8RCEOX%>!%<@FOR`8PC(_@4"BF133Y0
M,",C^!7FD=P^88$9'\"O0W7@FOR#`C(_@5[RE?W9_9QE'+?P0Y2O[L_LX$<M
M_!9):6/L$?HIC!2T+7-)J%ERU_"<82Z\*7$YD$4[:?HP)GGN.!4E=*=N3MP;
ML@O19'*_!W$SRBI!DK0?#'H#XPH`FARRQ`=0/8VT^8T-"KAT+'?2]20/BC>Y
MK=I&-,1M71%`NA2VYS6M(2A2M/`!*05I_P"R01^C'$N=$9G`$5Q]Q7J%SKAV
MH-`:XTI7L2]"N;3J=!=2%FI!*O%0$Y5XX8BVN/P.5JYD?$)2=?2B,M:W0GQ9
M**NR@X'NQJZ&5IHYI!23[JVC-'O:">)1:WR6E5674.'B@E6HDC212O><:Y'C
M:"MVS1/\#@4ML2$NJ*5)2!I)\0`!S`IF,^.-$HH]ZC[-A;IMBN2TTBY1D!3#
M_+118!44M:@*DI-33VXG=&O66S\LC@UA.]5;J?0SJ5MSXAFN`*91B:#'XJ*^
MGDW<,=$BT3+'-9CVQUX(DKBJ0PZII90OEJIITN$$]QP_U::RN7!\4C'/X`U*
MBNEG:OID#[6YMY60.%"7"@`XUX*88\II\,N)6V%ARBTI*0I!IG4"E,\0N*L_
M/A_$$KOSELD9J*=*?%4$<.%2KLIA-T#975/B61>,8*!PR]Z;<J_DMN-CP+4*
M)((2OWLZ$$',#"\6GEK@]S2&#>D)-5A+2T2LS\*IER+PI!<YCJP5:=&I:CPK
M6E5>W#YEF)/`TGN4!?:@P5^8)KS[@IU.>MU0[2%+[OBKP`Q*VFG.:`2PBO8H
M9]^QT5`X'LJF7<IH<J1X$Y56,AQ%!4&N>)YL`9%0>)5Z[GE<"X5VI%,Q#?ND
M+U5)(S^>IQID?P*CN?-VKPW`=J<J=P^O#IEF][`ZFU:&[>#0G%:';N&FZH':
M!1/M]@.-O(NX(\V[BDU^[NO$&JT@"E`2`34YTU4[<'D7<%CS;N*(.2TD+4IP
M*.9T%5<Q4Z:$D<<)16TS9B2PY:IO</#V8&KBFI.AHE:W5)2"1PTIRSXTX8F\
MCG-``-56[B&7$Y32J8<ZVI\SRTT\=-"$@`*54\$U%58FK-S6-^<T56O89<:-
M*7G["B-;64J/*D$A2FR-+A2149`5((P@[%Q[U/3::V&W9(6T)8"?4"FQ*BML
M:=.DJ4:*H!7(=N'5GM=W*KSO:YV4&M$4H.X?,,/T@A0=P^88$*\3D-2D*`6/
MF/80>_V8Y:N[I"DLG4$ZAX:YTXUIAQ!O]"0FW)*>8)6L:AP'8?A&'(VA-SL2
M4J*=*O&/</8?KQ,?:JW>;/6FO.8.ESQ#WNXX<Q8`]Z@CL=WIH38Y&GQ#L'`]
MF'#/&WO'O5?NO$FI<(;B?O@0H%03I`.H5!->Z@IB82"2%)4DT4"#QH>[`A>8
M3E_2=W%;Q?J-[T9B^^K_`%?UC$2I1..VQVG5ZE%(5F,P3D.[#64?/Z$[MK4S
M4=VI3##BEZ0DYD@&F5/_`&8;R_IGN5KM+7ET=N"=]M86RV"L$:DIIE3A7%7O
M=A5KT]+*'0E(3I4:5X4IQ.$K7]$=Y]Z<S78BD+#N7CCH4@C2H<.-*<<+.\*:
MS78EC+.*(O<4?(?U8E;#8JOJ&]:/M#Y1^K$L%6Y/&4IL^_\`H/ZL"5MOU/0E
MJ&%*J`G(JS42``:#(UP)^EEL!)0"I'A*<RXA*<B,R2?"/:>&(>:R+Y7/XDE3
M4,MF(6AY^;**]Z.*D1VAJ?EPF$$T"ERV5`JXA-$FM:`_-A/]O.]+LN[&$YBX
M"J*2=RV&W-GGW6*ISWPVR>95)R!UI\()*3EC'[>E/W6P_$%A&Z@6)HH;:$N4
MMX@(2VUH!*J$#6YX`*=O#&?($I&WUMG-(:?EK[%ND=19$=!\G:TN%?A"9R@M
M+>50I/*J=1X?)A2/387$\\T:!@I2]UZ6.%IA\1./=1,ZY[_W<XV5QI+=O4:T
M9BMU92!P(Y@UZE=OT8<?M=CV*GWO45[G.U,"9.O-R.NXWF\2%T_<)=2U&<XY
M.:2%T%:BG:,2X@LJ;DE=#62S-S\2*[4V%610?+Z')!4HU4EUUQU"^ZH632GL
MQNQD#/T:=JKL@O0[_-R9^'9Q^"(3X3Z75N*0D:M/A;04I'A2D4'97"@VI([%
MK8B.)<!)`%#V*[O:,32B*HRY"2Y0J*32M,CV_I&!91541M)(`%1VT/'Y\"$3
M?C*#==0XCL.!")<@_$/F.!"'(/Q#YC@0AR#\0^8X$)"W7=W]N;5O]VB(2N9`
MB-O-%P`M@N/!E.1!H4J54^S%>ZFG\IIKKD[`"IOHW2CK?5L5F!4L#'>T_8J,
M[T:D[ABVFZST:77'9,DAH:6U+;4L/%0[0M52.['FF[O?W&\,HQH[^2^@^GD6
M^GPV&]C0/8H!NMG@Q+K)<C!R.N7;+6MU]UIEV5)$5MV,IAUU:5$-(752`G,5
MSQJGB:C\9*7%!L@)K[>/:<^\X9O_`*CT+(5Z?R\;RJ/U,W[8'G*-W7:#%QAL
MUXR;!>6HSBJ'WBN)<R4TX"M<6.T\0_C<D;C](_QO7<;;;9<+-"!I"/IJ?_=Q
M)*.4XVEE20E6KW0%#+[2348BM5N^4UC.U/\`3).09X_^<WX`?!<X>MMB%CZJ
M[UMZ6]+;DB#=6'`*(/XHP)$A.DYZBZJI[,=UZ&N1+H@:.Q>%/JGH_P"V=9.=
M2F?.5%/(/Q#YCBX*AK>!1(3W)I]%,"%K;;*"22#E3Z1]6!"#C96000,J?2?K
MP(6'(/Q#YC@0MC;90220:C`A;<"$,"$,"$,"$<$7/Q*!3VBAS^GOP(4J]()[
M-HWA&6M80TZTH+2`?$00`:DD4&K$#U!;F>T)&X'VJ^_3Z?DZR*[R%>2+?H*V
M@VBJDA"AJUIHL'4<AQ'&F.*-LB+ISNU>@HKX#4CV-^!20IY;DD+BGDI`)TKS
M/^SB03SSZ4Q+?=TL./`)(SX_)AE=>(=R97,W/D:[@$X+7&-6QK334D5H:4JG
M/Y,L,W^`]Q4U9>$=X3I2SRSJUI544H`?EKG\F&"F5ID)4XDM(22I0J*9]XP(
M2M;(+P96SK(0ZC0XA32-)"P=0)"=0%?;@S9/GX(,7/!A&UV";HZ=,,/N2DRG
M%./.$K0C6&TH.8"$G,$'&/.E(_L;NWV)17LAM]H)$E2#VZ]9X99@8VCOOS,5
MK)H;N7L4<;AV9Y11;3(7S372L:Z#,DU''W<6"*[YD.0[PJCJFDRPP/ECKS!]
MH"A>^V6;'<3R[C*8(4O7R2#S/=I776FG$OI^*H-[#?8T!JF-,:N3*RHWB?I)
M'AHBM,AGV9XL47@&*B!<20#E2FD@V^G%%WG%\LZWDJ3E4`&O$4PHDYKX",FJ
M3'9#;9`TJ76O#LI\N"J9?N`28].5K6$ZDC@!3AE3$K!^DWN4;->@R./:B27U
MU\94H4X4[>_AA9)^<127)6%IY9*1IS!';4^SNQA'G`M(EB@U)4305/>>T\.T
MXRCS@6+LM);5X%</8/JPK#XCW)&>]`9Z4TYSJ5.-%"5)<9=4LK-*$$Y``9U%
M,.*JK7U]C0)1>G<U`4\YJTI%!V\!EC.*D[C5Q-`V-I!(:!ZA1-V4V'B%)6GB
M33N%,L/+,?,[N"K9;1Y<-Z*>45\8^8X?(Q0\HKXQ\QP(Q5YL<M7>$DS([84E
M0!JK57,]FG#F#?Z$A-N2.\RC6KCV=O\`9&'`VIN=A2:ZT@(-`<Z#B>&)A04D
M;9?&FY<8S24Y`^($FJCF<_FPM$X!IS;*J-N;-H&6`&IV[TRKBRA*`0#6A/$]
M@KA5L5W*X26[F\MIJ<*X#$JJWL3H6D2M.>AIW[O:FVXD+0:C(5/Z0#G[,._-
M2]GJ4;:LG<?S_=1($EM*VUNJ'C02@4J!I`*A4#(FIQGS4O9ZD[FAHX<OPT]J
MT",A2!I!UJ2*9GB1\G?@;</>X,>?D.WN6D<4N<=Z,1+=(6X4IH,O%E7*O#/M
MKA&Y,452S9VJ>M;8S&C@4[H-E*7!S`K50$`*(&>*Q>ZA,QY,1%*<%;M-T:62
M,.B'R5/;BG]"LB'$A10HE(%#J.67;BN2ZYJ(?R\S,I_NA7&QT&=Y#)!5AV[D
MK_A:M*4TH$\*$^P9_-AE)?7$OC(]2GHM`Y/@!]:UJL]P4:L15.M'W5A61^+Y
MCEB1LY&^7&;;C[U%7NEL%PX2-)=AO[`C#FV[LVDK>BEIL4U+.8%30=W$X>QN
MCD?D.],)[!D41>QI#AVH@_:76]',[0JG9W>W#^-QB\"JE_')4@I$F1WV5#EE
M/O)&>>65<3L!B="US_$1CBH4VQ)J0:I/D3I\9S)3030BA;23QR^C"M(/X*U=
M"^(9XP0[MQ6`FW*6@T=T)!H>7]WG0'BGV'!2W_@K3/<\1ZEHE-3@R$^8?*7&
M]*PIU1"@I.E0X=H."D';ZTV=#(YQ<2ZI2*FW$'-"7/8ZI3B1[0":5QFD/;ZT
MF^U,@HXNIWE:G8Z&EA*H[%:!5`C+,GL/R8Q2#^"DOVX'>[UE.ZSP5IY3NM92
M-*M!62@)TZ@G3IH$BN0[L-S2N&Q6""Q@C:TC-7*-Y3@?"0E.0][N]F$WQMD%
M'5]&"<R$L;0>W%$7&6W1I6G+V9'YQA/RT7][UIB^&.3QA)IC,@GP=O>>_!Y6
M+^]ZT/C$@HXNIWE:G66T(4I*:$>VN'=K$R/-EKC3:5'SVD3"",QKQ)*0'8[L
MGQD)*32E!0^'+B/:,/$W,$=-_K1`I210@?HRPOYJ7L]2C/+1=J+.I"2*#B/;
M@\U+Q'J1Y:+M153:3J53/,\3C+;F4N`-*56#;Q@$XHDM"5C2KA6O=B13!:O+
MM=Q_:.!"'EFNX_M'&":`G@L.J6G+XJ8(>6:[B?D)PD6W4OZ%!WBJ0\U'%\LP
MK(HQZMK;B;*N[1D0FOQ+RD)"),CEN:0\'%*T]B2L"BOT8IO75QR-"=97A!NS
M4X88'9AZ"NQ?172Y9^I_W>-IRT#:G9\M?M5:)+(F;7@9(/X?*NMKDJ2,E/E#
M;K!21V46<^T8\X:=`6"5V['WKV-#62Y>YWB"K;O.'RKC;@K)+_.B*H2"664(
M<0/8K4LY]N'R?*.Y32&4KT5\*U`5).55=^$S$TNSGQ(5A/2!>46+U(=/RA10
MWN)%YV;I.8<E7JV+EQ$T/V@JV-$'V'O.)*SE>9VL.S'W)*?](_QO7T:;6M[P
M:BK/%P*2>P:F'G8Z\O\`70<3:CE.=KB@)0A0\2DT5F<ZY9=V1Q#W#+.[EE;<
M@DQD4H:;@?BG=A'S[QD8VJDOJDM"VM_P+PI*1&O>WV`=(`4J;;'S$4JHX($=
M.8^+/'7/IO<QR6+H6U^4X8]Z\Q?[@='DM]>9?/V`4]9HJT^7:[C^T<=,7GE#
MR[7<?VC@0AY=KN/[1P(0\NUW']HX$(>7:[C^T<"%BJ*%#[L9USJ3P_\`;@60
MQS\&KU,5*11SWO8:9=F!9Y,J]\LUW'YU8$R+YP:8(>6:[C\YP)2)TCB<Z'EV
MNX_M'`EUO&9"<@5D(0>Y:_"GY?$<9N'Q1#Y4YMH1,ZBEK:NWI%M6S.<0GS:4
M56M2=20E>8THX)J,5G4;U[F<JHRGL5XZ=LO(S^;;7F@BG]BF2T753\A3*%`+
M;4`0`=-30D4'#CB@W-G*V0OB&W:NFVFI5DYSR.:<-R>S=Y8BG_$?O/=RR&9I
M6GL.&_E%*^;[0M[-SYTA#RS1H>$4%,JUXX3EL&O;F<"2`G5O<PN-'^*JD:UR
M2\TA48^$("CJ%24T'?VTQ"3P.C-/NJSVC\*LV"B7(S[A<-2/</9[4X:<EG:I
M'G2<4J09*$SD<P55I'`=E3V8;3QN8*Q[*)>&0.PD.-?8G@RZ0NB`D)<5G49T
M/MX@C$#<7%W7)AE[E.V\-MA(/$,=J4$DIX=O>*X:YYT^YT?8@34U-*_-]&'4
M+97-S_>3::Z`.0$9:)J[C9;<:6^H#6A-4D$@>]I-13/+$M:370E:RHRUX=BB
M;P0OA<78FGQ5==T2(@U:11QLK*R34'A2@[.!Q<;!UPTUPIW+G>KSQP@E@;OW
M*#;[.:#96#XE$YBIX>RN7#%NMHY7P-<=N/O7,-3=%+<OF=A(:;-FS@F@J:V0
M0=9&7:?KP_MK8OE#9?!BJO=7%`6-(VHF]-921[PJ/M$GYL27[?;<#ZTPYKTE
M.REJ<64$:2<L@<J#"S8(V#*VM`F$LK^8<=Z+N35MIU**:5`]T=OZ,9Y3$GS7
M\5K$CS`U9'3X>`^7L^7!RF(YK^*\4:)412H!/S#!RF(YK^*(O/N!&6G,T/A'
M"APYM8(W/(-=B;W,T@8*'>D60:N5/$BOZ:G#[RL/`^M1+V"2N=%RD*!!K0Y<
M<'E8>!]:&L#=E5BAM*"2FN=*U)/#"D<3(ZY-Z4))P6S"BPA@0KRN_NU?H_[P
MQRU=\Y,O!(LW_P`/_M_^[AQ!O]";SQ2`BH2(][ZOD'_=&'(VA-C&^APW),>]
MS](Q,*"49]5+E/LG3??]XM$U%MO%OV3N>=;9[T1,YB%/M=CN5Q@SEQ2I/,5;
MWF2\!6BBD`X0U&5EOI,TY($@\/&M$\TBTDO-<MK8-K'*[+WN.('J!*^<:=ZR
M?S,?3AN'I%O/J1LK;O4+T<WF[]--N]1^L74."\SU`C7;?Q6NX7E^!9YSJ+%%
MCM2O_HUQ,-ZWD%#9DZU`8YWHG4'4EO+GNH'MTUS@"\EN#:XG!U<!V57:-=Z*
MZ0D;-I0G9_J.*)QY(#JA]#E;6F7%PI7-]J[I[?W_`+3W(M+4&9(AW)QIJ0BT
MW!2423#D)2XS(#?$AQ"TJ!&5%`]HQTB#5]-N<+>4.]#OB%Y[UCIS4-+.6YA<
MQW#`^XE/)10%%M1;!XD**1Q[R<JG$B*%N;<H6TL99:M<W\RN_##THNJ`4ZG:
M99KR(I2M<LZ=N$#<Q!V0.^?<,?L69(H;6Y9!-43/<`!0G$]H!`]."/V],AMP
MJ;96LN)TITBO;7L.(?4+AXVUH%9+:**+QBGH4A6*SW62X.?_`(1HDT#FDD'M
M/O%6>(7Y[B,O:*[E<=+NA'$&Q"L>8^OTJ6K;M&W-@.3)!FK%%!;96A+=0,E)
M-*Y'$'/9737&5S#RQOJ/M5QM[Z5L?AQ3L::B1.2W#CH-"0LK"3J``TYJ]I.$
M,CMP*6_<9OPIVQ&R\TC2R@*H:I2E``S/Z,QA!]SR7<LFA"V:/,_F/'SG^Q)$
MVU7!QMQP1'%M)%5'PD9@`95J?%AU8:A$RZ:Z5](\>/!:W>FRR6SBUG#AQ41S
M5!N6\A=4J0:44A0H>T"HIQQ;[=[;L#RYS5]'OHJ)J=LV&HE%#V_R2/-2'4@)
M"59BIIP':?T8=ET\7Y;@01W*(9'"6@C8B*+0W)%``I/&M.[V&F,&:7<"M9K9
MLK,D8^:JR-D0QX4H-#GX:#V8.=-P3;]ME'W?<CXLA<:'W9(4V`"2GM3\N$C=
MN!H=JS^W2?@1%W;24()4DI!J!F,S0D#)1/9C9MU(\T::E:_MLOX?<DIK;Y9>
MYP;*S7@HI4*?]HXVYLRS^W2_A6Y460%*HTH>(Y"@'$Y9'LPY%W;@`.=\WI6_
MD[@8!AIZ%K7'D`>)M7'*I!_7A6*>*4D1FI";7-O,QH+FD"J3GTK0X00H&@RH
M>[V863/(_@DQQ+C:CK"A7,9UR)RX$X%J\&,5?@%J))[33V_UX7@.WT)G*1-3
ME8TVH@ZVX7"4I.GPTH0!P%<J]^%TB89:;$2=_=J_1_WA@49RI.")%24\2!7&
M[8WOQ:*K5S7-\6")K(*R1PKQPHV"4.!(PKV+1V+2!P6.)-1W)EX(4QL&DBHV
M+!BD&T(HIMPK71"S1:1X4DU+I\`30'6<\Z5T]M,:_+L>:-WK1M<X:`2ZH4=[
M]ZC[<Z?LM?BLYER[2D+5`V^Q*C^?N`"%9.L%S6S'"A[RM(U4';BI=0=1,T=A
M,+@5;ND^@-8ZAU=KG6[S:EV)JT?&OL3,OUV@]7_11U(WC<+':K=NSH]ZCNE&
MX),Z+#YMU1LJ^NIV\B+,?"R\(D47R0:Z2UJ1]HT(\_\`4?5MUK6KYYB1$(VM
MINVE>X>E.B=+Z2A$``;(69O21L]84&ME"K3>XU2DM3A.=;I5344G1SCI!2::
M@#2I_1C$?E_+.,9&8A2EG&]DT[Y!1KO#7?B%"?4J`Q"M;%R>D,,JMUSAS`'9
M#*"8Z@XEY5%+!*4I()''V8:)TH&=F0W`EYF9&>;<0ERK<AI?B4-2AI2HJ\)-
M.&,@%QH-J%9;HEM&/9KVQO"?-/XPV\'+,Q!F-"3:'5L+84^'6"\D.+CNJ2"F
MJ@%=F)"RMI_,-?E.7'AP24_Z1K_&*[(]);]U/E-0!;[Q>)3*@V6FS_CU(2-1
M45*6VGEZB:_VL3$A$?ZF`3-D,LG@%5=6WW_=%HM7XQN*1Y:.VRI<F?,;::7X
M"I.HLUUZP$T`":FGMPKIEA87SY61FMP\^$5VT'H]JVN[B/IZV&LZ@[E6S?$X
MXTW;!4^Q4NZQ=2Y74^]P7DLL1+1MUIR):6VK>B/(N*GAID7"8Z'E%',&:4TX
M\<=9Z,Z==HEE(9@YLSW`@$UP[*8`=B\;_5WK*?JKJ./R'YND.:XYQ@*C$8&C
ML>Y1#RG/A^D?7BY+EO(EX>Y><M8^S](^O`CD2\%KK\OS'ZL"QR9>"`(*M(J5
M4K2AX?-@1RI."VEEU)2"VL%=-/A-#7AGP`.,T1RI."W1F@IW2X=-*=YXFGV:
MXT<YK!5QH$]L8OS#S!04^*=;5G9E`*2:JI2FD]G;4@<<8$T7$*898\S%C:HG
M-V^!XT!1T9Y9>S@<9YC.(4:ZS(<?DWI`>BJ:4$(0ZM9)!2EM:B*?ZJ*8U=/$
MWQ."0GM)``8V'M6LQWTK0VIEU*W/<2I"DJ5\E0,)^:M_Q!,'-<SQ`CT%/39E
MC5)O;SDE&CEZO"[09Z%`$(5QH>X8B;R:7*3O5GT'3;QDH-S&6BO9]JF:?`:@
M14O!PG2DDTK3*G93.F*V][WOJ5T.Y;;V\3`'`/(QVI@VVZ75V_.+AO#D(U)I
MI*:>'(&H3J-3[<2D`L2PB1P#Z8;=OJ4"^XNC.SD@D%XX<0GY$5/==,B:[7DM
MJ=2T0?$M%-'LXG$4^V;&*R8*YO?.R3([!WH2E+?W#%C1YMLCK7YYP+D(HDZ&
MQ]V7**50``<!GAG+-91MR/>`3V'[$G,W48KJ,%AR%M=HX]ZL!L)TN1(X6L+>
M4PUKR(JM21J%%`4S.*[?F%S#RB"NE:-=0-@RS.`?39CM3P=6AN6M*B$T0<O^
MTGNJ,0*E.=%Q6I:-2A(8\3@`0`,JTJ:9T';A1IBR$//S+%)WOYD()B&%13;Z
M4K0+\MI:&G_`I2DMT5GF,N(K0XB9K822C(*A24-Z&`1N-'G<EA^^Z$@MK2<_
M%F<A^D8SY!_X3[$X\T>*1W=RJ*\EY4'"M/Z,.HK*C/F&*C[BZ/-V[DWK_=UM
ML.@%2G5)&E%>)J*CNX9X>6MJUL[2X?+7X)E<7+C"X`U/\U7Z^/AQUUU9TDGQ
MC/P]U>_%QL88\%SO7)936GP4*7^?I?>2BBD52`<Z>ZFN67:<72T@9Y=NS?[U
MS#4+EPE<ROS?R36>GJ+:@$CB.P#M';D<.V0#-\E"Y5XOD$N9_P"GQ28^^IY!
MKDH9`5_74X7Y$WX?<E.;'Q1(25H1RR#4)T_1WXQY>;\/N3.0@O)&Q%*D]I_2
M<'EYOP^Y).<U@JXT"&8X'Z<'EYOP^Y:<^+BC7FUAO0!4A&D<,R$T&#R\WX?<
ME`014;$5YKJ\G$A(&8IWX<6T4C'DO!`HFUUX!WHNZA2E5`J*`<1WGO.'B8K7
MRG/A^D?7@2W)E.-$.4Y\/TCZ\"U=&]GB%$.4Y\/TI^O`M$.4Y\/TI^O`A7I=
M8^[5X^[[/]H>W'+5Z.21*C:M'CI35]G_`%?[6'$&]-+K:/2D1^/1Q8U\!\/]
MG_6PX&T)F[PGN*27F/![_:/L_P!>)E591+UH82>DG5-I:@@/=.]V,MOE-0V[
M)L=SAI&FHU<Q4H#B,0^ODG27M!VN^"ENEHKFYZQL((*T:XO/HJ/BFQ>^ENS]
MR=(AT;WG:FMQ;*N^Q(>Q]S6J6A"F[E9WK-#@3&F"\EXPG&'8J'X:AJ5"D("V
MR#AQIFB>;T-N&T4]@6W4/4M_:]9ZEJ^)Y=RUN_\`&</:H1Z9]"&^G?2/9/2K
M=V[+AU+D[%@R;!:M]72(U;=V*VW'EO?Y8A/W*,XY)E7"R6<MQ')+RW/,<I*]
M*>&%;+IWR9K3`;5!:E]1WWMX!=PUQWC^26463J#MM9_R[/9WG9H;?.-EO>A-
M_0P"1RXT_3R9VD)\*2E*ZUSH<2=Q9W9.>*O(`Q[_`.**89KW1VKY=/NVF+4G
MBK7#`4W8TX@[T=@=:NG?XM;MO;DN:MD[@G(4HV?>#3=A0A39"%M(F2WDQ`@N
M^%"BH)(H>!PR%Y96\H;/3F@^U2,W3FKZ=8R2Z8UEU;%A-=I`IM&)Q5D(+7DS
M5$1(;7RS%E`H?C3([C3;R)45]HJ:=;45D`I40=-:YX?YK"[%/EQ[E`VMUJ%I
M_5VY`[C]B<;$A_S%%+'N#W!I%.S*ISQ#7D$5O/RX?!E!]:E6ZFR>4/8W(W`4
M3H9NSC:"V4GQ"FO52E`,R*>S#"5N>,LXJP07U(_0C#%U/-1]YV_'[#[,,?))
M3SPX^Q2-9;N$LM$M%P^(5"P*YJ[DGAB!OK+_`#+O1[E(V=\<*%/"->);-4O:
M'VRE22DIT5J,LSJK0X:&TRBI5D-YGMRT':F=?=N*OYYT5MIIQ.L*HFIJLA0X
M%-:4Q,6%^;.@KBJY?Z>+P'#!1G>-HW2R(0Y+;*T.$!);;42:FF8J2,21U(3N
M,H-:JGSZ%>-E<V-IR`X+9`MBUMZ>4ZT`"2HLE7`]P*3G\N#SGK2MEI%U%/GE
M!R4/K1]-J06UKYY44*TJ!94@U_2LUP><HICR78LA`<TC2:Y>$4.>60X]N-@[
M.,W%8\EV+6JWR%"A;)%:\?Z\!EY7S(\EV+P6Q?VDE)[J$Y=_'&OG5GR78C)M
M,4(U$`FE3X>WM^G&U:X\5CR78B,F!$2E/W8/B/#Y/D.'$$_()/$*.U&R_+;A
M]X^Y($JV15NE5-/A3E2O`?HPZ_<5$^2[$V9MN;4ZA.H9UH=)/83W]PQ+UPJF
MMW8T;2F";DV*ELI2DTIJSIQX>WLPX@WJ#$')<3N/P26M.E136M/UBN'"V.Q(
MSK#O+5X#V=WQ#VX%$HD8BE^\=%.`(U5^90IA]:>%W>FESM'<BJV%I64C,`TU
M9"OMI6N':;+WD?V_]G^O`LKWRRRA]Q"FRF*PN4^5K2VEB,R"IZ0\I1TMLMH%
M=7:<L:33<F$N2)M9[^X;9VPK*[[5RI]2/J`WUU3O<[I3T!W-(V9LB`\^WOKJ
MW;/N+Q?G6%J9F[?VC(D:X[3,<!2'UHU+7Q24G',M>ZJ=:QRM8?F#'47I?Z=_
M2ZT;;MEUMH$AH1F&_P!*HW_TAVYMNZ0I\;<F^KSNU>J,_=;IN.X725<9#CR9
M)<6F4X_Y9LJ;]U!TXY%?ZO?:N*8D$+NVF]-:9I!#K,`$<%U%Z*[CWG8>C?6#
MIG-ML=RS]:+'M>SW*\7%"Y%QM1VQ/>N3,JWI;Y0<EJ?<;*2Y5*"W6AKB-@T2
M4,YLP^>I]2F;B1TCZN_"!Z`DBRHW,Y=KSMEG;UP1=]P!%ILLVZNQHL-P.*"S
M<Y;P*RAL(;)("<U$<,+?I#E)NJ&]7#=?/7:V7>0)IAW*X07U!2C&4Y%<+2D,
M@*X`IK7NP+"K-9R(EU26E/I4\LH"4/K#"$MDI3I:-<R..>-X?U"LA='.AM]$
M5V&VVVPE)=\2U!2W!1LFH630'OQ9[':U(7/Z)]'O"^@WTEWXRC'C>89:+C$9
M6O6E'!#N6G0HKX]XIC34,`4I9;`I[]3<!RX=*'Y34A8<@;E@+E*CJ-9$&55J
MBEH*0$-N-FN1KPPKTBXC7.6?"14>BE??[%0OK`;L=%W/+KDP^"YX\C^T*_ZO
M_P!=WX]&L_2'<%X2B-US;835R9'?]D(<C^W_`+/]>!2J'(':JH[13B.[C@0E
M.-:&Y*:ZPC*N:*]W]H=^&]S-R(\_;1+00\Y^3LJCS5F:86"4I>X&M-'_`&>*
ML,/W'M3O]O*4G8ZG0D5:2A`%$<L%6E*:!.K5QIE6F#]Q[4>0*W6S;G.DK==2
M$-J;&DE.JIY@RX@<,-KF_!:*\4XMK`A_H4APK)%96$>%60.H(T\>&5>S#/SH
MJK19V.&S#!.9JPP9#:CRA6F::5U<"<\@,0#KZ^S&E:5/%6IN@V!:"6BI`2S;
M[!:XA!8C,<URG-YC06:(%4TK2E23AI<W^H-#=N]/+;3=.LP\F(/S`#9LI]J]
MOVW+.]Y:8Y"9#[8)44("$KTFB0`!1-!AH-1U#B?:HJ\CTXD@6X[Z?R3&G;=,
MNY0YT17EWF=?-6VV=#P4A2::$J32FKVXM=W?`MP.%$TL[(AU*8I=ND.2B)&:
M<:+@*%ZB?#JIISH0?;B)@FYQ=V%.=2L0#'QH?@FH(C3$1Z0PP&'V-6L:@HK6
M!5))`33L[\.VTS#O48;3(,X&(Q]6**V&=>KA<8[3[/\`AC5QQ0^T$4.@Y4`5
M7/#F^\*CK>XO[R^:#4X]O%68C0VS#;0TE#:5H!"%MZ^6:`$5!2""<\4N^_4'
M=\5U']OG:V+G;<F_@E6"T[`1K:H5:=54T1J(%<A4TJ<1[_`>XJ=MK+)'7ABE
M:(_YI9+J]#F@D@T.1*>TD=N(Q.$>7,;A(H?O/M^\$CNI]JG##N"W,K,PXIW%
M="&`LWU^Q-FXW=A-7`0E5=0\0JDD'*M,Z5PYBL3S`.U0MQJ'+?G!V)&5N#4D
MCG4J..I)Q(_MY2/[YV^U%F[RA":%[4:DU!IQX"E3C/[=Q"/W(3?/7^/6C7XM
M%D+2'9*5Y$?,#2E2>&-39<H9Z;%J^]&0XJ.-U.PVDE2'TJU\PD``4"0FGVC7
MCB6LU1]=OAB!VJNUXE(=E/(0*I"A1=:@^%).5._%TM/Z=O\`&]<VN7\R=S^*
M;JG=0TZ:5[:UX9]V']M^J/2F4_Z96O$DF2T+:J5*U>VE/Z\"%I0G6:5IE7A7
MM'R8$WN?T_2@M&@@5K7V4_6<"8+U+2S0TR-,ZC@>VE:X%*1_IM[@O5MZ`#6M
M33A3L/M.!(77@'>M6!,EOY)I4*J:5I2GTUP*5;X1W+4I"DTU"E?:#_0<";77
MA'>L<"9HQR/[?^S_`%X$*]+K3?+5X>[M5\0]N.6KT<DI]IOP^'O[5>SVXV:Y
MS?"F=UM;Z4DOQV=:SHSI\2OA']K&XEDKM30[$WGD)T<.T=^)'S$O'V!1?EX?
MP^]0WUR0'>ENY[<CPN7M>WK"@]I3>]UV&TO-U_XK<ZG>!PPPU.1\EID>:MS#
MW%7'HB."UU@WS&TN8X797;:8C<<#Z0G7>6V$O/J2@!"7WP`5*%$H=6D#,]R<
M7O3'&#2(A%@"&]NVG%<QU>[Y\]Y+)0S/N,YP&+@ZH--FW&FSL4=7-QI:J-IH
MK4#D2:`"A]F)(N+MJJ,[O,/YDP:7\:`>X!):5+244*AH5K3F:)7\5,A7+"PE
M9'9NBWDGW!(W>?RADAH)@<#05&S?10#ZJ.BR^M_3"1"MIVZUNS;T]O><>5?K
M2_-,^#MR"_<'[7&N;:QRU/MQS1I[4QJ`!21ECE/4M@.3+=0@B=C"YIJ<#NPV
M%=@^DFO7C;J&TU&4O@?(UI::4+2<0J*_E.]->J?2SK5ZU=@;Y]1'5/K7M+8T
M[HJYT^@[[N\FYV:!9^J>Q&.I:;K9VI2E_A3\14Y=N0PP4L<AJH37/$-TW-?/
M</-/)Q[/@NA_56]M;%D?[<V-A=0&C6GWA=RX:E*?J5`^$#LX`XOLL44C@YPJ
M:#BN4N,#@V1X^<M!X>Y.3D)=3IR)4.Q6=:5[\)\F!OS%N'I2[)JCEQ&A.Q';
M?:$NR$I4VHBH^TH<<NQ5<1EU-''X"`%)VD,DIH^I3_;@+AA+<>K:4@$)]^A4
M*DU62<R<5R>Y:Z4EVU6*WLLC`6C%.BQ28LG2U<2=:@K[S-`24@T\*=(-2,,+
MJX_))8:.P]ZD[6)YE#)/T\?<G>S;XK*%O,.*=!(*2"H:!3M`-#4]_=B&=*]W
MB*EVQ,::@(T(L>8PUYII+Y`K]Y4T()[*T%*8W;<3,;E:Z@]"WRM.X+QR)%8:
M(:CLH&2:!M)R-:C,'"\-Q,]]''!)OACD&5P%$WI=A@R&UK$=(43GI6M()X\`
MH#MP\YC^*3\G;_A]I22+7":1I#`JA.7C<.8&7VS7/"PO+EH#0[`=@^Q,WPQA
MY`&`*)R&6VT!26PDE0%:5RH33.H[,;LN)9CDD-6[?XHF\[6M;5NVJ2G@2H4'
MV1P'M/<,*90FE2DEY)HYD>)[^_$LSP#N"9NGE#B`<*\!]B1I23H3D?>]O=C)
M`.U,KR:1S6AQW\`D9Y)U\#P'?C&1O!1^<I,>C,J!6454D'2=2\J_(JF)<3RT
MV^P)F][GX/Q"0IT**4ZRUXO%GK7[.S53#NUFD)=4\%%7<,;0"!Q31=9;YI\/
M=VJ[A[</>:^NU5VYE?'X#1:'A5M5?9_2,.TT1!3:%<4@T^4?T$8W9(]F##1:
M.8UWB%4GNIHM20GPUIP)RIWX5;<3$@5W\`M#!&1@,5I+2$H<=*2>0CFAK,<\
MA:4!@GBD+*^(SRP[,HC_`%-B;.C<[\J/]4JB_JNZEW:[7EGT\=.+E^#7FZV:
M7N'JMNM;G*3M/9L%/,-IA.I!4NYWE84VE"L]*@1GBG]5:V;6'+;NRDL[#O[:
MKK_TMZ2;-*[4-2B+[MLU&.J11N4&E!0'$G$BJH]>9-CVE98%ILD!V':;>V3:
MH,C4J0RI:*:WBHK6N:_D7%$E2E$U)QPBXNI]0<\S.S&AW`>Y>JI1%%%&;@5C
M90T&&`[J*=.@_0^Z78-;OW7"2FY3%!^VQ7-10FWK6E;<K0"&]?!.8[<+:?`^
M,AS4NR1DXSVM6L]?OJN@]EV%%C)C..1T%+*M:4DK"4N4`4=`.DUH,J4Q;;:R
MNKR1F<5B<ZA%`*[."J/5W5]KH6FR1-<!JH87!VV@(^7`X;CN46=8(L;;.^^F
MNXXS#3+2YD>.H!`6E6N6EIS4AS4A0)6>(RQKUOH-EI`@?:1Y'N\6+C7`\2:*
ME_2OKJ_ZG?<Q:K+S7M)#/E:VF.'A`KAQ7-7U.V@1^H^Y4MH0TR]<)S[;302T
MT$NOE=4MI(1J)5Q`J<4)=E5*W8Z8EXC)0DIHLJ)J5`:L^))';A$&83_(<#1.
M(S#EH\?-WJY'1V>WJC9BO-'VCW$'Z,6*VEFMVB60_(.P;\$G.R*6(QL%'G[:
MKZ+O03>;,+U)A715N',VSYV$9\MB/25&D,MA31>2HK(;D$$5IGF#EA'7+ISK
M+F05:_B/:FT4%S%X7>[[%?/K+:HMZZ?[YMT<1W%KL4B='7&=2XRA5N=0]'4@
MLZ6R6E+5V9UH:TPPZ/NKUFIV]Q._Y7N.X<2.'`**Z^A\WT7)!*`YV0EW>":;
M/0N6O*10>&HIWGV>W'K"^D9'%$;;`.;CO]Z\$L#7V\HFQFBD`:=E`30C#;@-
MZ')0>"2?TJ^O$;YF;C[!]B06Q,(DI50Z"02,_=J*BM:\,'F9N/L"S",TE';$
MN1&DH6$)31%`*9G+4D<>/##>YE?)&&O-17[5/PP11`/8*.(3D:AI6@*;\(H*
MBI-54%3F<,<C>"<8K:FV)UH4I)*=0*LU`$<3P.6,96K:#YY,KMB=T:*E;"$(
M2`$'4*4RRT\202,-;MK>6.]6.VL[:M<N[B?M2HRR$`%0JOA6O8.`H#IRPPH%
M),8V,48*!*UO><2#15**4.`.5/:,(<Z3C[`E^?+2E4I-.+#P4#FNNHTR/ZAQ
MPF][I*9\:=@3ZRN[B,NRNV@;0#[PEB6A,J*ANA+H!JH5X$FGL!IC2@X!+OE?
M*:OH3W#[$AQEB$I+;B:DUH33L!/&A%<9>3(*/Q"18QL1JP4*WW&X-NQ25@$M
M`A&0R!&?`"O#MPFP<@TBPS''?[TC>7<<8'/%30T4.W2^ML./M4\*W@74?'[N
M7>FHRRIB?M8HY`'/"J]YK4;`X1C"A]R<^QICTYYYY,1+$-HE"<@HI*B`A.I5
M2:T[\;ZJ&9"(=J:]-7LEU.'LP?AN"G&)-T-`+-34:>S*@'`#'/[EMPY_SXT7
M69[V[S1"[D#G!F'RM%!7L`WI;;N0Y;8R]P`#*M/FKAN8Y2"#L*EH+XF$XC8?
M<D.9="PZ7&5!"S5*CD:I.=*$$<4X3\IV*'N=0DC!+'4]`2)*OLA:M*G2H%(X
M!-.VOV1B2L8'AN4;*_8F3-8D=$2]^-3N"9MUN^G4I2B0G42*]@)J._%D@L6E
MM<OS#>J]>:OXAFW)CR-S%MPI2I24]@-/UX<>4*B?W4?B6K_-[:/"M1*N-0`<
MCPPYBL&N94MJ>\J/N>J'VLO):["@.SBB#V\M#R4QN8M9KI0>!\)/$]PPJ-,@
M><LK*L.W$_:FLG5US*PQPOI(=F`^Q-2Z;DFSE<I25,DUH,CJK2H%0:4_7AVS
M3+*/P,IZ3]JB9]1O+G]=^;T`>X)N%*TDAPZE\5'OKF.&7`X>-:V-H8S!H41+
M+()"`</0M09;^'Z5?7AS;?K#N*1=(]PH3@O>4W\/TJ^O$FM$66FBE``TK3MP
M+%5J2V$FH20>';^O`M7-:\4=L7JFPKWDDT^7`M.3#P]I1P`!D`#@W0?LX$H`
M`*#8B:D:A122>WMP+#FL>*.Q"QY*/@_[WUX%IR8>"V"J:$`BG#+Z\"5P&"VA
M(>R=&H)S'V<SQ]VE<"U<QK_%C1:7&&TJHE&5!VJ/Z\"TY,7!&N6CX?LUXGC\
M^,J/I[U>%YAP-J-!V=H^(8Y-SXN*])<F3@DE]I?AR[^T>S"C'M?X4TNH),,.
M*2GFEE2\AP[Q\(QOLQ46][6'*[:FZ['<Y:CX0!XC5:1D./$C#R.1DO@32Y_R
M@)FP`X8^Y0-U?N$25;=JV;F:A*ZE]/W)"0A1(9ME\3>'U)H"%E#-L4J@S-._
M&E];ROA$;1\Y=7;N4KTM?1RSW%W`2;>&!V<T((Q;L!Q.W<MDV5,N!"I*$I6`
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M#0[4>6),I<`,F..8FGHK52_&WOLIU2&6]X;76ZX-;:!?+<%.A7`-!3X+BO8,
M25IJ]C>0"X@?6,[*@CV'%0%QH>LQN;'RC5K&@T-<0,<1@GI:K]9$%*D7NS+6
M%52A-SA:C6F6;H%:'OQM=7UNVW>0[&B6TW1M7\]%S(G!F;'U%3[M&797VN<J
MY6];NELI#4R*\0?%FH,O+T5[*TKBH75WS?`5T2TT^6(?-&1Z"I095;Y(20RW
M)410O(4DI4`*"B@JAH!3]&(*;S`.<CY3VJQV^GO?"'-;AVX+!BR07%:H:VW7
M<]*$4*B,]5`"2:)KAD+IKY.2:AQX[,/8E?(21_/39W)PH@NQXY0&'R?#72P\
MH9#^R@CMPMEQI5OK".3)P2.RZ]'=<#FE"`:46I*'$CMUMKHM!IWCAC<0R$5%
M*=X2#G!CBUP-1V%&%NM2&ON76G"2,D.H4?:=*5$T&%88WLDJ[@LQUE=E8#7U
M)-?:<U`:>&6>0/R5IJ'M&'E05B1PB-'X)-<:6%+)ID2>/Z<!3!Q#G$C82DN<
MA3C20G,\P'C3[*L+6_C/<FMSX!WI&6A39HK(D5XURS'ZL/$Q2:]P<^4_TXDV
M>`=P4<[Q'O22_P`$_*?Z,;)I=>$=Z1I/[W_LC&4Q2,MM20I1X#,TS.9[AA^-
MB9)OR&7"EPA.1X?3A[:#Q>A-;F-\@&7<F;)2IIQ16"![!7L'=7#W>JM>025(
MIBB;@*D$#B:?T@X?IFB_)7[/GP(0Y*^ZOL&9/L`[3C9E,XKLJ$5`Q.P)E]2]
MZV?I?L;<^_MR.--V?:=ID7>4T[4MS7V6SY"T^'43)N$];3:4#Q55AAKVH16[
M"03ZBG72UJ_6]>$-FTN8'8UPPKVT7(VU(O<2+==P;L;5_P!0NI5RC=2>HCKZ
MD@VV%,;4[M':*W:\MQ6V+?H?HDFBGB@^($8XCU'J<EY)RX22[+W;SQ7M?IO3
M;&U@8(Q0LP?A2CJ>W"F*4NA72:;U5WPO=%S<7)VEMB2N/:PYI;:O=Y1_B'7D
MAP@CR)&JI%"109XAM+M9F@F<``]H*G=78V>.D7Z=#7N^*ZPV/;$&W0XL>/&#
M"([*0%U!JH4&@>R@K7%FTYL,DX@;^IPI_`3#5+ZPT3IYUP'T<&UV%.1QETE)
M`J`E*0=0^SCL6C:?#9VC&7@RSB0NPQ^4TH:CN."\1]4=32Z_J$VI.>38Y>77
M&M6UJ*''[PQV*N7J5MSC>U;)<W$'_P"A+M&8;T46>1.UO@^$^\5(.7'%<^I\
M`O+)M[9C-;6[<SSL(&S`'$[1L74OH7;0B\#(W#F2OHVN`)VXDX#TKF!UV5,O
ME[MLN/:IMRE7*U-+C!F*ZIMF,GP-.2W0DM10M8(HL@Y8XK:VTU[_`$XK[/>O
M4=S'Y/\`J'QC_IM/N*K4OHIU(O<A;C+NW+$7*:4W.4_<VD@"B28UJ\NI)4,Z
M<\D'B!PQ8;3IS4B!(Z,;?Q-^U5B[U^R@G,>9QH!BUKG#9Q`(4Q;-Z8[NVJ_'
M<N'4"$M#))5&VYMIB)S#RU)31^YR;Q+311J2E0J!GEB=;H<[X^7(T`=X*:/Z
MCMBTB$OYNZK'`>LB@5NMA]>NH?2V6Q<+3NA+@BI^[_S#$M4EG6WDVAIA#++B
MBNN8`56@Q-?L6G26G*D_4IP_DDFZ_.[86^DT^*NCTH]</JRW_=FHW^7]LW7;
M4UMRV79M_;4BRQ9EJEZV9DV/);;1S%QT(%!]I0RQ!3=*W&>#]L8'"-U35P&\
MG"I]RC]:ZUT./29M.U"8B\RD90QSACCM`(."F[R[@R"30<,QF.PG/M&.R,9/
MY&/G`!S0`<:KQ?<2!VHRQQ5R/<2,*;*G>C3"2VE04""37O[/9A"BVY$G9ZT?
M0RM>C+)6GYB1^K"9>T&A2T%G.'YR!E/:$YXD)O3HJ-5*FH[J`\*CB<:2/:YM
M!MJIR-KB`T;4?3;-0JD`BM/]*X02G*?P1Q#6HHC@9FC7LRHGCP[,-S<1`D$X
MCL2MM;R\RM/:$YH,$M#2D`K"0"*@95[^''#:ZN(G,`!WJT01N8*NV42AY9[X
M1^T/KPQYK$X6(0I2M(!J>_Z\-=ZPEE"2II"1Q1[P^4?U8$X@D:RN;>E*.^ME
MI+?<5=W:HGX3WXPG/F(N)]22[BM+B]"351H0""/=`)S.7#"G*?P6[WMC\93?
M>4G2I-<TJ`/=7Y<:NADS`TP3"=]E<#\QQJ-F!2"-NQ;XM2'G!!54!,E'C4\L
MT"5%*25)S[\2D5PR&$EU:@'8H&;3+6>0-8<"0-G'!*KFV+IL1IMV-/7/AR:+
MD-@9AWBE>GB0C/#.UN!?$9"2>W!/?V9^AU?$`".!'P6+6_:N#[P_=40YX%:D
MJXT(`KP.'MQHMR:2-:TMI^(<5J.H`^0"Z<1(,!@3AW]Z?%KO8GM<YQ8',;UM
MUJDG4*I\)]WVXB9+3E'*\8JRVNK021T8XYCV%)=PN*DK74C-)&1"OZ*XQY8<
M%&W]T6CYC@$U'[VIII:4K2`5J/B4`:D`5H:'@,25EI[Y&YVM&6O$!5:YU%P!
M#2:=Q3(G7I]U1^TWJ5K(.5,ZD'M&+##;MC90TK15>ZOY'N+6DEQV!-AY]3SB
MBH>&@I6A-?Z<*<IG%,L][P'K"PJ/A/[)/]`IAU#R&,RN.*/+<[YY\)$*@Y"F
M-I'09#D\2V;;0PGF`G!8TPTJE.?&B;K#BG%*`%#2F8[@,":R$.>2-BP\N[W#
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M;WZ(V\I\^=P=29K+[;JRWRXMNZ?[TE.24Z0O6J.\ZVL`T%0,\*ZE#R9HP-[:
M^U6CHIH;I^J$;[8^]BE01](TE944@I*J`5*?#6GZ,/[7P^A<TC_IK;N/N"QY
M`^(_,,+)XC3#`T'Q'WCV#N&!".QF4B0P2:@.H)!`H0%#+].$I_T7=Q1GY7YG
M#%0)O6':Y_0>_F=;(LP;5DW^S6Y+U5`&U[MO%I9F@4'*=5&KX14"M*XH5[_Z
M:NO\?Q:N[Q/\W]1X&\;`>YRYRM[4N$V:W/M=XE6A5J0E4%,0,!II]MQQ+CI:
M=2HJ+A2":FF*)9SW<=JQD).3*/<NI6%O#!"8WPA[L[C6G%)]SW3O#;^LW?JS
M'@L!*W7W;L+'&CM-I!<6MXO1BV$)T\5?TX<.O+P`F0G(-J?M;#4".V',W8!2
M+TVO75/J'$GSNE_42W]0+=:'&8MTF;6LT#<3$&4XV74,/BU0%JC**#D7*!9!
M`X'"/[AVI;E3?_3>P?8I58<]3-O663)<4IOD59>V1-:DCS+I99;6%"*@/.N@
MZ4A(JFAQ,V6I6DD(BDIGQ]ZP;0O^9S,A.[A_:E]C>'J`M[COEY^W5OQ7DQGF
MBS>XLE,@-J,MH<J]H6.0YX3F,N/=AS)!:%O.CIG'Q2$]B#&<."=<'K!ZDF2A
MM$2U.C,K+%XW/$!H,M8%Y=U'C3A3"%!V)CY`)^V/JWZ@''%%_;<>0NFHK3N_
M<S04KXDMJ==":#O*L\%$X9:V8:&R`9QM4^[$WSUAO4N!$NL=VR,W!],-4Q.Z
MKA+,<O9A:&WH00M7AR!IC"0NX;5D-80,]0KJ6N1)BVV+%N-S5=9+"5-JE.2"
M\LZ5G)1+:-!)STY_+C#6@'`#%5"_\2.+4%H4L<%))';D1C9,!L2:ZG4@^SQ?
M,#A:W\9[DA<_ICO^U(#Z];ARII&GZ2?UX>)BDI[@Y\I_IQ)L\`[@HYWB/>DU
M:`L`$TIC9-+KPCO2:_&!<KK/`=@^O&4R2,Y0!514"N7"N>'XV)D=J(/.H"=/
M*3XJYDUI2GL[:X?6?WO1\5J[8FY,AM/*6*!/=X0>P'V<</-ZK=[XRFRJ$M"2
MI6H`=M.\TP_4*M7('Q'YA@0M"@0HI2HI(-$KI4I/8JG`Z3GC+?$.]9:`7`'9
M5<]O7GNVU66;T-B[ZD+MG1>X;HNV[^H$LMR)$:7<MN1%/;:L=R98;4GD3KTP
MT4I4:*SRR&*MU/\`I.]*ZU])+:Q_U$[`;?BJ,N]0O^KESC6;9DB1?+CNZ[JD
MNO(8=:CML79_S"T(D%(<<;@L.!*$D`)2D#*F.+7G]9Z%ZH#(8W.$'AKCWT79
M'I+TUM_3_:-@VK'CI"+/;6FE+"$H<E7AU*#.N;B@55=D.5!34@`Y'$A`<L+G
M;@%DLY@R<</6IA<B-(8;36CFLZA09#2<LNXXO?2FD^8(NZ;-Z\Y?53JTZ<':
M56E<*(MR!\1'=ECI$AJ1V`!>;V"MFZ'\4CG>NGV)@]3=@1.HVR[IM*;,1$1.
M>@R!,=:6XA!@K*DMN)94ET-.ZJ%2/$*98C=4M!J&GS65*B5F7VC[%?.A>J8.
ME]2@GNJ^69)5U-M*%5;>])E[;0PTSNZT&(P%-PTF1=:)9%*,J9,4^!/'-1XX
MJUGTFVSH0%V*\^KG3%YM;(3W_P#XEZWZ1;F^.9,W?;X;)RYEOMLN34BH]USE
MYUX^W%CBL`Q@;P4*[ZH6$1R6<0,&XFA/;QWIS6KT;[,0`-Q;QW?=TZJKB03`
MV_&?IF$N"&R\\$I4`K)8K2APIY()O<?4V&YA,/+#2=]!A0U4P[;Z`](=JK;D
M6[95LF3V2DLS[WKNSZ"FM5E,@AI2U&F=.S&/)`J@ZQUEJ+_Z1SMO%3#'@M-(
M0F+HAIH`$Q6FV$`5II2EM*$I33L`Q(Q609")%78=2U*]?S;PDEQWGT)4,)KN
M'9]D8SYK/^0?XHI.YM[5MIS6@<^H]NU:'([2"`$)-?8,942CS+2*-@)`]T9=
MG##-_C/>I&+],=R5F6`VHJ"B?"12E.T'O]F-"G4/C]"4V/</^L?Z!C"<I1AL
MEYU)Y(2$K]_B<C[U*#B,1#_U'=Y3FU\:<K3(:4HA1-0!PIAM-X1WJPM_3'>L
M77RVK2$@Y`UKW_HPV6$:4XV$%1;2G*I57A7MX#&4+6W+2%!**+UFASX``]U>
M.,(2D,P#WX$)!DR#SP=(R"A6I^&G=QP_3:]OJ,[4@R):4<S4D"I!%2>P9]F'
MEI")@X\**O\`GR"35)\&<`Z5)<`H00!0\.']&'3[(9'"GW3[ENS4J/:>!'O3
M]-\%PAMM.Z6]+9;YM2X55%*%*@`-6(2UA\I0J8O-5\V"*X*/)&U@9ADP5)2A
M=5/(50)<<K[U:Y>&G8<3/[EF`825#-LQ)60\:(I/F2HCR8+1Y9:8)\"C[R![
M@RS!(QN+03_F4JL&]-I_T5[`NRGG&8TDC6\L-J5J.I.H&J@"!6F,^2&X+`U'
MS>_:CLVV6]:U-N.J4:BBZ4-.[2#3(G&CI/*?E^G^/4MW6G,C)*;4BS("'>6\
ML@!>@:!2E?",CW8WBN\\@;7$E5VXLQ')GX)L.QU,N!"JBI`!(IVTQ)))+<5Z
M!&92T^E:W`2HJ"!0A1J!Q[,"$CEE)42%&A*B,APSQ@I.7],H<@?$?F&,)@AR
M!\1^88$(<@?$?F&!"'('Q'YA@0AR!\1^88$(<@?$?F&!"'('Q'YA@0AR!\1^
M88$(<@?$?F&!"'('Q'YA@0AR!\1^88$(<@?$?F&!"'('Q'YA@0O>0/B/S#$S
M]B%=AUIOEJJD$>'LRXCVXXR)&281KTL6Q1^,"B;%\GP[3$,B4M,>.0I1=;4G
MS"EHIH;9;)*G$*U>(@&F6%(H+HR#(X@;P/8H+6=0M8VM;'1KJ'$>A5^W%N)^
M_+65I6R@KJVPDJ"$I31*"`/C2G4?:<7;3;*W,8-RP.=Q-5RW5=0NG//)>X-]
M";)4XK(UIW!(`[^``Q)M&3PX*LM<6^$J&=Z(2[UFZ"-.)"^4CJ_<([9XIG1=
MH6B''DH2,U.LLW)U`XC[X]I&('5IY7:G;QEQR%AP_P"DND]-2/CZ-U.ZC-+G
MG-9FWY"S,6]Q(!]"G%3:*K\(]]SZ5G]6+,8V,@:6"A5"MV@VD9.UNSLV+7RT
M'@@812RS"-.020/D.!"4&4H2XTH@"BD5)RH20*FI`&9QI(`6$'91*0L9+*V.
M0582`1Q"@+?B$1NA_5R$D`.VK?U]MSBP?$3-OC%Y+9[BHW0FG'/')M4N9VZ-
M<QM<0SF;/^%>CM%M+8ZKHVHE@\]+92![][LO.I7=A0;MRYXMS1'7?@@FC+"%
M-*0?"C4"I6D@TKK)/RXA-)<3%&P^'(/<NG12/C9$UAHUT;7'M)&)]*X;>O;>
M=S=E&W)GS`Q-FN09+"7EI0Y&<:<JVXA-*ME8![.&&&N3SQOY43BUAW!6.TK5
MKAXQO7=K_P!--ORW;'Z2]28BG;5'OW4G?EBLD$W5V?"A/_Y1VI=[[=9,Z;`M
M<^-#;D1W0EM<A3"'71I0I2JC%;E@N[AH=5Q#3PXX*3==\O\`5*[;];Y_7SU!
M1.A4_I5U0M/1[:3/7G8]^W(JQW"0])ZD;$V]=+FC<VU+G*N$&)==O+>:AI<#
M3K#++WA5S*$8=VEI/%(73`E[14_+N[*#'T56LLUA+`)2UIF=O[JKCAU@W9U-
M;WUOBX6_J:Q;+<_NK=-R@PI6VK/*+4=Z_/QX[+3C?*9RC`$554I%17'2+:.)
MEM1X%:!4VX?))/D83DX;E6B9ZI=Y[3,IRZ]8MLQV8P6I1E;4LBG7ELI45,L`
M3@5KT\4@$XC+JY8S]/`)/DRCBL.G/YE\FZ71%N5O?9MLMS:+A-G[QWGM&+9M
MIPH,%E:UJN-R&X(RXE"V:#EI!J._&D5_"]@;]^FU)FS+CF+:DJX'H#]>&]O5
M?ZCH>R-JWSTT;ZZ6VZ/<;A*W-T[W5<T[R?=M<%\B3;-K7J12X6AJ0#YN3$#[
M4=24A2TUPYCD:'9Y?TZ?V*/U*UDBM<S!1V8+O+-M,B.E3B%K4BI6CPT>?0M*
M5!QQ`2""HDZ32A&';9;<[A542^9<$UJ4:9KY1JH(5R!4$44#IX$<:X1<07$C
M95),KRVUVT1<C+,&ARS&%K?Q'N2-SX!W_:D]YAH+R;3F*GY:G#M,4B/MH^]\
M(XJ_[V)-G@'<%'.\1[TE/)2D"@`SQLFEUX1WI->]_P#0,"9)NO)5I6=*J9]A
M[\2`V)D=J2W4GPY'M[/DQL)'L\!I5-+I[F@932M455%<<)6"`#V&H.0I^K&P
MGFKXBHQ[&OQ<*E)+\%Y3:@I9(RRI7M'LQ-<Q_%1O)C'W0B/X:YV5/_9QCF.X
MI":&I&04"3GX#J5.42HD`D`#,D)J``,ZG&1(^HH3M3=\4C6%U30`GU!50]5M
MV@1]G1=HS(<&8C<%U\U,CS(D66A^#!;0MALMRFG2VVF4H%*D:25"E>S%-ZIU
M!D33$\_.NQ_0[2GR:D=2N&YH#QV;5!WI8Z9VR9N:X;DC6:'#MVTHOD8D=N&&
M&6KA<5G2MDI2G4_&2K414E*5`D`4QS>WC9/FEE`<_-@3P7J&<Q-CDY`#79L*
M;L`ND$2WJ3XU`Z6J%NO<G@03Q&6).T@9)<,@(&1[P".()HHE^ILL-.N)KEU9
MF1/<TG:"`2".XT6#B*OK*DDBE02#2M>_Y,=FT&W99,$36AL?!>*>NKEVM:US
MYCS17&J*/`)709#2,OG'M[L2UZV(34B`#,H]>*BIX+>-[>2T-;D&Q:PI22"#
M0C@<-FDM.9N!":FWA<<Q:*K&A*BKQ%1XG4H_KH,;.ED=@XU"W#&-\("R1S$*
MU(4ZD^Q;E/V:Z<:@D8#8MZKQ04M06H$J'!1!KW?T8SF=Q6'`/;E=BTK<TD'5
MJ'=Q_3C&9W%8:QK/"*)3:;1H3X1P_6<;F:0MR$G*E1)(!0'!;ZG#<11A_,`&
M?BL%[G"A."\Y>O[!53V$_P!&%%JE-IE`0WX`%!*>S.M!AD_QGO4C%^F.Y'64
MU4=2<M)XCVC&J<P^/T)48;1H/A'O'^@8PG25XYT*0`=*217A3Z<1,@_,=WGW
MJ5BC8UH<!C0)3YB?C3\XPF6@[0G/,>!2N"(R55<J""-(X4/?C'+9P".8_BA'
M<4XVM+RM0)(HJ@R'`=F#ELX!8YC^)1=#J([SATY$C305`H5</T8QRV<`C._B
M4J-7(%":@DYYD>TXSRV<`L\Q_%)-T=+-5C[(^:M!\V>'=JQCR,XJD+PV]/"*
MIDR;@%AWF#410"N78?:,3L4<<+/R@&UVJIWCHVO')PVU2>PX=(<;!2#XB`.[
MOX]F%,QV)ES'\4;%U4D42IP)!!H`*`]G9AN;6W=M8%NVXF;L<5M-Z?4`.:[1
M.0X"GS#&GD[0.S9&U]/VI[#J,[&%KI#0E$GYJ%E;RT%;P;4`X157`T'<<.F$
M,^5F`*1GFBE8[-BZA2AMZWMS9!DOH&394V7`4Z7-2*$5(&H))PUNII&#Y'$+
M%D`TC*EJ\P7(Y\P'*)TI!349D$U-/DQ'Q`7+>9/\SP:5/!2]W/-':U8XA)L`
MI?.AU2?$:#61D#PXTPXB@A:]K@T5JH^T<ZXA>Z8YC3>DN\P4-K8("5@ND>'.
ME`3GI)H,2)[%'7GY=<F"1I(<0YI;2H)T(X)J*Z17.A[<`V)O;O+HZN-34HH4
M+XE"A[=)'ZL92Q`(H=BQHKN/S'`M.5'P60![C\QQA-)0&O(&Q"A[C\QQA)H4
M/<?F.!"%#W'YC@0A0]Q^8X$(4/<?F.!"%#W'YC@0A0]Q^8X$(4/<?F.!"%#W
M'YC@0A0]Q^8X$(4/<?F.!"]H>X_,<3/V(5P[S=H-CA&9<5%""G5'9`"G9;E1
MH0R@J3K2%$%>8HFIQPO1[2ZD>&NIB>.Q=[UK5[:.,\LNI3A_-5KOUVFW^>N?
M+4$!14EB$A1+$1NHS953WGP`5Y<4C'4K*PCMH@)<2:4W[%R?4=2DO)1RB:-K
M6N&W^Q(?)77[/SGZL.2T#P*/+BX?,O>0O^S\_P#5C*BR<NU0EN5M3OJ%Z.-D
M:C:-@]8;NG3GH>FO[#M,91X$!3IH3V`8KU]$Z?6[:&.F<QN./^)=%Z>E:WH+
M4Y75R^<C;Z3$2IN+#E*'3J"4I5G]I*0E5,LQJ!IBS2SLKY;'FL%3P_C!4N)I
M8QEJ?U2*]E._T+9'CN%9`*?=/:>]/LPVYS.U.O+R=B.>4=[T?.?JQCG,[5CD
M25IA5++%J;?2@*":$)*^^H*3EE4^+&LD[&L)-:`*1MM,N1(V7Y<H(.W^2JMU
M?>3;NGO7N`JH6_U8V[/"0*CEW:QV26%$U%-1:[N(QR;6&%EA-;G]1[ZCANV^
MI>A>G6&Y.F7$?Z=I;O9)7;5W-IEXCYQCAOX+G/*6TQ&OJL]"X32\AG]X%N<*
M]RQB(TG$,;^%H!]"OT;@X1@;6QM:>\"A7S[^O*>Y_F!.@BJYHD)';RFTJ"J_
MVP.`[NW$7K\C8IQ(^N0'&BM-I(R("1_A"[-?DU6^V->G2>N9$1(=D;OD%0=;
M2I`3"VM,4[0J2NI.K++%FZ=M(KF,2D#(5#:O><S]&H]BEGUFR8-KV\X;:_-M
M<R'>>7*39+BY;Y:^9;H$9.DLAOF)4MY)SIX<\3EY%:PN,@!R@<,>U15C)=3-
M$-1@3C7M5-=C7+U$^K/I_OK<?1+I[9+K"V)O"X;`CR[UU;Z8[,NEWO,&W*F-
M+_"-V[KL=UD(66PA;Z&U-"N2CBK76NV?].SF9S_=P]=598=(N81YN8LY8&XU
M..'#B5\\'K&W]U*Z(^H^3L#KA$>VSNO95P@R-UV"R;LLV[+-"7<[,B>VNWW3
M;-RNEDNX>:DIU%#]4+2I)'?6;[58P33-3N_FI".S,N+,JFC=VUMV^HSHO>T]
M&XD[<\IW:=MWFY9K0E+;]]LVV),-Z\VD()*0_<(Z]+J>``J3EB*@O'L+[QYI
M;#';L':G,&D3SR&*(-+QNKM[L,5]5GY9W478?J#ZH>G*+T:Z0WOIPQT3MK=]
MW5<;QL=W8CVR=H(V!+V=<>G[<B6A*MTO;GW2^>8(>J,XAKS2W`HA&+7I.O:?
MK=N8M/<7RM./`4VXU.*B.H],N-/T\R7;,C>8T=N-=R^F]QMQURI4%+0A#:B2
M<@A-&T#O2A%`,2@AG`P`IW_R7,KJ%LN+-J3'65A;A)3D5$YGL_1AXP$-`=MH
MJ_(W)(YG`E$7_<'^L/Z#AS;^,]WV)I<_ICO^U)3_`+X_U1_2</$Q2&__`.+_
M`*RO^]B39X!W!1SO$>])#_!/RG^C&R:77A'>D]QI2E5!%*#C7ZL"9)/=25(6
MD4J<O9QQ(#8F)24^PM.FNG.O:>RGL]N`BJ;W$3I*9=R+\I7>/I^K&*)KY67L
M19T?=J_1_P!X8DO-Q=JC.2_L1/AA2.5LHJVN"V:&Q_J;2B;BM"U*'%)*AQX@
M5&%00TASO",3W!)W!C?;R,9XBQP&&\@TWKF/ZJ+NJX]3Y]J#B%QML6>VPTD$
M:1+*E7*2E!K120BE#E565,<4^H%X^?4<]M7E5WX+T_\`2G2/VWHZWYX'G)F"
MA&S$;SAQ5K_3?MC\&Z86=Z6@(N>Y7Y.X9H352*S2E$11)"3S##:1J%,CE4X8
MV,\9M<^.!H>]=#8V2%^6>F!H:8XJP+H$=HMJR\)2G3F!E0>P8MF@V,MW>PW$
M>7E,D:34T-`:FGJ7,_JB^YT[39#&0!+$YK:'>1A7UXI&=3K``XUKG7A0_7CK
MAH/`O+(@G>*S4S]]5I,=*LU4KPX`Y?ISQ@%Q\6U)/:]IH_:L.0V332?_`+&*
M?/2F,K1!3`10H%:\:)^K`A`,K(KD/8:@_-3`L+WDK_L_.?JP+9C2]V4;2AR5
M^SY_ZL"6\M)V(P@%*0#Q`P)%S2PEIVA98%A'HON*_P!;]0P(1Y'O(^5/ZL,G
M^,]ZD8OTQW)10DJ-!QI7^C",DC8VYG;*IU#X_0C[#*]!X>\>WV#"/FHNU.4H
M\AP("CIH$@\>RGR88O(<XD;"5,1_IM[A[EIQA;H8$(((6L('O$D"N0R]OZ,8
MJ$W-U$#3%;RRA'[\IH?=I0YCCQIC%5O',R2N6N"U*Y8-$*3I[,P/ER^7!7O2
ME4W+E<=94A5:&@X?(>_O&):WLYHO'E]!55N+\2"C2ZJ;:4M*4XIP5J04^&II
M3.M<2M<`%%U<XU<E2WM1EK*0"*Y'P@9$4[\80!4T12Y6PQEDM%'*R%-1U5KV
MBG9@3CRTO9ZTEAE7;I^<XP0F5S!.UPRTI3BO2V0"?#D">)[,`J#5-Q%/45.%
M>*=%ME--QDI5JU)H<A45`]IPVN(7R^&BE;:5D1^>J+3Y,N>[R:ITZ4@:E$=I
M->!'9AK%"^!N22E:UP4A/,RYM\D5:]N"3G&W(Y`(!4*`4J4U`XG+(879XQWI
M"U'EH7"3:1N6'-<70+TT%"*?^S#RBC[L\X?(L2:G`$A`QT;,KMM5@L%22!Q(
MQE+(OR5]Z?G/U8%A>\E7L^<_5C%$WDB>]Y<*40Y*O9\Y^K!1:<A_8AR5>SYS
M]6"B.0_L0Y*O9\Y^K!1'(?V(<E7L^<_5@HCD/[$.2KV?.?JP41R']B')5[/G
M/U8*(Y#^Q#DJ]GSGZL%$<A_8AR5>SYS]6"B.0_L0Y*O9\Y^K!1'(?V(<E7L^
M<_5@HCD/[$.2KV?.?JP41R']B'*5WCYS]6)#S,?;L6.0_L3VW!>)>Y)RILPA
M3*0!&CH*N1`-*$Q@2I55C(ZB<CBL6FCBSH=I&]6*YU9UT,NY(1BM]Z_G3_NX
MF,Q(`.Y1.4`EW%>>5;[U_.G_`'<"';#W+TQVDE&I:PE2PDD4)%4J(I099CCP
MQA(:?!YMU#L*@9$M,CU01[0^TV)5B]/ZICZ4OM2"T_N3J%&*LFZED&+9VM(5
MXC4UJ*4A'U_U';'=RG4_XA\5TWR0L?I[?-_%>QG_`/E.4]B,A24J)54I36A'
MP@?#B5E_\QE_P'XKG;?ZV/\`\/X%9MLI;)4DJ)(IF1W@]@'=ANI1&6FG'5A*
M0-/:<ZUKP[L86O\`W@3C:BNL);4D5`+:E:OA"T*7PIF$IPG/C"_CE*L<'Z7H
M5*_42M$;_JW;G24(N<_HO/:2GCREV:\0GWQQ&M;]N`)IV8YMKFPKM71W]&N=
M5Y4E$&[*;.H*:;C^+X6F4`*RIXC7/$)I.WTJ[6XQ'>OG6]<DU)W.RK5532I-
M$$>$Z>8*'MIEB$ZIW^A6=O\`3GN7=G\I=!MGIM@O%("9U^O<NIK3F*VZU'4E
M)R)0E$DD5SJ!B[])_P!"WN^"KMZG?ZXDL.1X+<9IL2)6YG&7WZ*+BTI?M3*"
M14)5I0!V=F)&\^=YCW)*R^1@D[3[US<WG^5I9-G7]K?,7K7>+Y<+3?&MX_A5
M^Z?[?DV>XRV)")B;=<F(=[;DOVLZ=!0D@E!XC%8N](:&NG4V[5R;<P$[:>PU
M7#SU3^CXV;=]UN2.HCDS_,EUG3I%M:V>85KMCMR4HO-6V.W.F.,,MI4E+:2N
MB4H`SQ5+VR"?6-\:4*Z@_E=;8>V=MNXM<V7,F[8Z)=1+DS(@V^6J4[&B.L^<
MF-P(^MU,=JVLE:DJ"CJ!/"@Q":QI5S/TE?V]K7S<C3D]05QZ3U2VMNIK>XN:
M&T8X9^W;_)=Z/R0?4GTEZ[==NM36S+SN*ZS(&Q[0(PNFTKY8(T!JUW-QBY"/
M<+O'9BW%J5(-4B,E(3]K%-_V_=.Z_H&E7,>OEQN'25;7'`EQW=A"EO\`<3U-
MH6L113=/AH@8Y@=3CA]A7TTN3VVUDI(.OQ&O80`G+AE08]$T7E+SSNU$ER&G
M"HDTUUK3V\:<<":/=G<7G>4C2I3*5:-60H03F>'R#OPO;^,]R:W/@'?]J(+>
MCK-2L\*9?^P]^'B8I+>\JKF5>Y8)42M13I2*DE1!"!0#^T,2;<&#N4<[Q'O3
M8%TL5Q+K-KO5JEOQ@XJ52Z6Q1A(9!4ZY+C(E\]""!1/#Q8,U-HHFEUX1WK%M
M:'6VWFEAUIU`<:="=*'6U>ZXBBU@H53(US&-DR19;20%*JJHS[*?T8D!L3$[
M4E2__#_[?_NX$(GC*#L1!W]VK]'_`'AC10J)'$A9^%W>FT^T+6&D%P*6334"
MKA2@S/$=V%[AV6WD=P8X^PI.-G,D;'^)P'K-%QCZ@3I&ZM];EE+55^[[G<95
MH)TH"KFBU);;U%2M*(XJ*U\7LQP+5YO-W8!XKW'T[I?E>E-/(W,;[@NN]C@"
MU1K-9DM)91;+1;8"$I%"41HS3:5J'N\QP"JJ4%3PP[Y'E[;+Q-4I<$$2..Z7
M_P!D)P7!A)TU4KL[NVOL[L=!Z0V#O"X-]9M5+8[6WW.>!ZZ),\JWWK^=/^[C
MHJX>AY5OO7\Z?]W`F%S^IZ%M+2"G33LI4<?E[JX$@L4,-HKQ57XB/U`8$+Q4
M=M1KXA[`13Z0<"$GG(D>TX$K!^J/3[EY@4BCC<="T)42JI'813(D?">[`HZ;
M]4K/RK?>OYT_[N!)+:VVEL$))-37.GZ@,"$81[R/E3^K#)_C/>I&+],=R5HV
MCF'62!H/"G&J>_#.[_2]/VIS#X_0E6/H4K0DDIXDY5J<J<*<!B-3M*C@HTH=
MR*?,,;*7C_3;W#W)+QE;K2MTH50`'(=^!"TJ7HJLFE,R>ZO_`+<:*&=XCWHG
M(G(HG[P\3_IPP]LX1,7`[J+1TY@Q&]%?-K.:%53V$_3W=N'_`)(<%IY\I/>0
ME]6I51_JD?K!P_5?6GRK?>OYT_[N!"WL)#!)14U^*A_H`P++?$.]!Y//-5J5
M\@(I](.!2RT>5;[U_.G_`'<"8W7C'<O#$;((U+S!'%/;_P!G`FRW-MAI.E))
M'MI^H#`A;$I"7`Z*Z@*4[,J_I[<-9O'Z$^M_T_2MCY#XHI*4Y4JD4.0XYUSQ
MHSQCO6\OZ;NY$O*M]Z_G3_NX>J.0\JWWK^=/^[@0AY5OO7\Z?]W`A#RK?>OY
MT_[N!"'E6^]?SI_W<"$/*M]Z_G3_`+N!"'E6^]?SI_W<"$/*M]Z_G3_NX$(>
M5;[U_.G_`'<"$/*M]Z_G3_NX$(>5;[U_.G_=P(0\JWWK^=/^[@0AY5OO7\Z?
M]W`A#RK?>OYT_P"[@0AY5OO7\Z?]W`A#RK?>OYT_[N!"'E6^]?SI_P!W`A'4
MH4D%*4*2D\0$D`T->%._#0RR':X^M2(AA&(:WU!#0KX%?LGZL:YW<2MLC.`]
M2&A7P*_9/U8R'NJ,2CEQ?>`R[\%BLJ":-EL/*:3(80X4Z7T)D-M+\*Z)6T=1
M"JY99G`YY%Z]N.0`X;AM25['I[7PRV,IC9F%<IR@BHX%?._N';/K$Z]^M/U6
M[!]-O6#>OI5ZK=-KM$F2M[[[V#&OVS]T;#=M\A>PK/`C3G9\5.TMQ[DCNMQY
M;2',VGBEK2A:QR6:76[G6)9[225S(W91\SOE!`-!P!VD+U-;WG1]KTI;V-[#
M;RF>/.[,UIJ6DMJ:@U-,*KM1Z5]];UZC='-IR.K5GO&WNM>TX\[8G5^RW:R-
MV*([U$V@\BV7[<%E$9(MTW;.XI+:I-N>C%4=]I:2V3B[Z?JNJ`9+F',]Q`+R
M,:'#:0O/?4MEH[]0$U@]L8#A0-H!2M:8'8=E%8]IE.HZFDTH>*!2M1WC$^F.
M1G`(R&]'[M&G_433/]`PRN7O:\!I(P3ZU@A<S,YK2:\.Y*J"Z`DNIE+:`!<0
MP0'5M@:EH:+B'$!:T`@521GPPU<^4M(S'$;]GI3T!K10#!<1_6IZN^BG3[KI
MNG;.]M^0MD6M^/LC9$FY[JG.6_;<S>6W!?[U)MMCDSI+'GS%LE_C.NR6FPTA
M22G57'+.HIIA=Y,S@WA4^Y>D.B+:W.C9S&S-3;0*,[O*@N6&Z2X;T=4*0XJ1
M"DLO..,RH;[;+L:4PZ\HJ6S(96%)*3I*3498?Z*UIAJ0*I^`!-0;*KYPO6X\
MVO>K@0XTI#9=<(4XD-I2AQ:W:YT%4`_+P[<5;7OFU-D;\8B[$;MBLT$7.C$6
MS,OH1_+(VMU5D^F3;*]I]-O\U6)%KW)N5-ZCWVUVF6S':1;V+MYN#<9<4.IA
M-L);;*=125$&E<[+HNNP:8T,<UKF!1U[I)_%[5.GJ:]-'J<W>YM^[0NB.[G;
M0^VG=%U+;]D)@6S\1M]P?EH")Q#"8-J*52%Y:4"JLL3<^N6=],9HVL9FH*``
M"HH/:4R;;\BV$1Q<*^TU1_JO:Q(M\L-JU(7&0V5-FHHH)3HU)J"#P]N%&D2^
M/&.FPXCL46PL;=`O`RX^Y<'?4/T+O^Z;^A<"/++;4I]]Y7EWE`MM$%%2$D:$
MBOSXK&L6;I,810=BM5E)``!E;ZDO^EIG<&W]K[_MNTMX3NEW4'8.V;QNN]WY
MEV]VA_<?2^S6RXQ=W]-K;^%09,BY7/>3]Q8:$1ZD>0VG($BHAI)7BS%BT4E:
M*$C:36N)3V*W;#=.NB[\IQKEW4X47U9?E;]*;ULWTR]$-UO]7MUW*RW[I:B8
M]T@N.W=GM;;VS<+UN"ZRFGFMSP&QN21=8#41.N.^HE`D#6,QAETWH^H6^N^;
MGFE=!RW#(22VIIC0X<<:;TRZZU72[CI@V-M!"RX\Q&<S6@.H,U<0*XUXKI-.
M7I2X=>GM0:TRRS2>[Y,=,R,X!>>KV5[#\CB.XIJ*N;R5%(=70&G%1X>VN>)"
M."$L!+&UIP3(3ST\;O6M*IY5FKQ'O()/TJPH(8@:AK0>X+62YD:VKWNI7BL?
M/#X1^S_7C;E1\!ZDCYP?B]J)&6HJ55)0@ZZKY+;X2DA0J6GP670>Y0H1AQ<-
M:(@``,!LP2=_<-(:(C0D"M,,:*@GJ]Z2[2?VQ!NNS+)=-N]5W76+DW,V%:HC
M,3<]N#JO/6[<\5#L2"J/,:5X'/$0[BO76J#3B'R_,UV`![,5<^F-"&J1/$[0
MXM8"*BN^F].'I;U^A[5V)M/:VXMA]18MRLMFC091<M<24$J;U*`\XS.4T_I!
MXUK3(X:_ZJM_PBO\=B1U3H6[+SY<EK:[L%(3'J@Z7R$J3(NMW@+]W3/V[*::
M;(/B#BD-Z\N%0<SBPMUFUH"*;%`'HCJ+="ZG<?L2LWU]Z33$#D;WL153[WS[
M,R(6:^[HYJD%6JAK3A3"K=5TV7]>3)390TJFEUTGU#:Y:P$YJ[CN]"5874W8
M<]I+L+>>UY;1J`XU=HB1Q-04/2`Z@BA][NKPQL-1T6OZY_XOYIF>G^H:'\@^
MH_8CDC=NU4:&5[FL"'7TH4RTJ[P0X\E24.!3:.?58+:@K+L-<2?G-!_YP]85
M=_:^H?\`Z4_\)^Q'(\V%*'^&F19'=R)#3O'A[BU5KA1FHZ:SY;1X>#MV8)*3
M1M7=\]S"8Z;!0BON6%Q=Y,"Y.:@A<6WS7U9T*`S%==*U9C3H":U[,:7LA?83
MN8300O[*?(5C3GM@U6UAGC:<US$""!OD:."XV=/XKFX]_;-B.)47+GO6WI?"
MDDJ>'XRF2\7`:E8*$DJKV9G'GNS>Z1X=(2YU-IQ7MX/DCC%NPD0,P:T'`=PV
M!=G5#GWIY\-U"R&TC2"`&#R12@H-00%?(1B8GDD-&EQIWI"Z:/*`@8NFQ[?E
M&U;Y[9YP&@Z0X`1IRIJ^3A3'4>C&M-JYQ`S!NWT%>:OJB!+U%R91FB8RK0<0
M"-X&XK3RT?`C]D?5BWYW\3ZUS7*W@$6=1X_"C*@]U.7;W#&0]_$II,QA?B!L
MX+5H5\"OV3]6#._B4CRX_P`(]2&A7P*_9/U8,[^)1RX_PCU(:%?`K]D_5@SO
MXE'+C_"/4L.0G^Y'_P!C_JP9W<2LAC`:@`%#D)_N1_\`8Q]6#.[B5LL@V0*!
M!`'8$T']&#._B5J6,)J0*KW0KX%?LGZL&=_$K'+C_"/4AH5\"OV3]6#._B4<
MN/\`"/4C:4ITI\(K0=@K6@^G&NW$K<``4&Q;4@DT`)R[!7&KFM<*.`(2T/C]
M".12M"_M)%1QJ!Q%>/LQIRHOPCU)REE'.4I.K66R16N:2D_T@C$:_!Y`XE3$
M?Z;>X>Y'/+(=R`2FF=0*?HR&-5NB;UO&OCV#A_61@0DAU/A6FE>(I2M:'NQ)
MMBCH/E%:<%#.\1[T05"Y^7+`TYYIIQ_1[,*,`CJ8_EKP3"]8]X;E)&WX(NN*
MZTK0EJH%*:0:9Y_TG"O,?^)RCN3+^)WK*T:%?`K]D_5C&=_$IYRX_P`(]2&A
M7P*_9/U8,[^)1RX_PCU(:%?`K]D_5@SOXE9Y;.`]2&A7P*_9/U8,[^)6R&A7
MP*_9/U8,[^)6"UKO$`4-"O@5^R?JP9W\2M>7'^$>I#0KX%?LGZL&=_$HY<?X
M1ZD-"_A5^R?JQ@DG$K8`-P`H$-"_A5^R?JQC9B%D@$4.Q#0KX%?LGZL;9W\2
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M^0[B$*8*I.1O+I7>O14$$"I!!`[R,P/TG&:I(O:10UHJX>H_KC(Z*V.S*L3&
MW+E?[\_<I$ZV7ZXN046W;G)*1.4IAQM]QE$]=`R@ZG2*4Q`:IU#8Z5<&2</?
M48!M*U])"Z7T=T3IG4]NR*V9(TM(^9_A]A)]BY!]-_4KZK]E[F]0OK'ZI;;Z
M/1[+/VWMJR7'9VVKS=4C=^T>BR=^2]GHM=[D2==BO][?W"RVMJ.U)6M:5:].
M5>?1ZY<VMQ->6E/+RR!Q:?%LIW>U=UN_IKIDUE#:NE8V:*,MJ2:;:[@NVG0'
MJ-*ZP](MB[]GVIBPWC=EAM>X=P[28(<7M>ZW"(W<'[<Y,6$2)C<0NA`<<2EQ
M9&8&.F:%KL6I6QD<PMERG;3APKM7F_K+I:'0[]K!FD&<4+3AMVFM,%,Y6VFA
M<=;:!R"G5!"2KL2"?M'$N(R8N:/"HEEN^1N8$+8A9`IH4H$Y*:TNIIE]I*J`
M^S$6]T=P2]K@*88]G]J=P-=&PM>"#5+##Z2IH%MS2%-A2ON2$9CQ*22[X4GC
M5"J#LPV>0P$U!2KGAK2['!?.3^9[Z-^D'6+U';+<A[8BR)"=R;,ZI=>T2I,R
M6_\`A3O^:K7(9L#<@R68CV[HEJA17$H<:9>A:U(H0,<HU]W-O\K01BO2_09Y
MFAU&!R[TVM[;EL=@L;UJ8AR+)"0RMBT0?PQVW168=O9:CQXL5E;KC;+33+:4
M(&L@@5K4XD]*<Z+-`&.>6M!J*4QW8D'<GS87.D+\`,Q7!3U1=.^I^]-T)N6V
M=@W?<4!_4K_`R;1*067'-'/4W'NJWULHU5)2A5"*'MQ5]0MKS5[MS[6-S.7M
M+OY5XJ9BN,C0UN#^)V+Z6O07.ZC;1])/1#;6U?7'T-],KD:%O2'U)Z2=1-F6
M._[A97N*X27$7*'/<=>D0KSY<,*0%'E(H>.'FD11Q3<F\CD>X'[M/B0L7EM>
MF`S\Z'+3^]7_`+*OYM[J%U3MEMWE<]^?F)=">KVRV.G%QM4;85ELEFMUZOLZ
M2!!G26YC:VGTW&3$:`+YTE*O"$%(!+C4K2>#4C-;QN9:.#:--,PHW&M"1B:D
M4)VXJ&CF+H,KR'/!.(V'%4VW1O39T]I4=J^1'4+2@9!W2-.DA)5RSF*8MEKS
M/VXSY3A3OVJ/DMWN=F:0%#+-JVG<+ESFKM";5S`E8<96ZTXVJI4%U8)!%,J#
M/"8FC/CC>?5]J>VSGP^,BG8K?]'H?3#;+Z76WMM(=?8<C2E+3!0I]F6ZVN1'
M=0_&_<A384`O*O'+#62.U<XR-A?S#V#[4/GO'2&CQR:X#>KY="K[LINYS6+;
M=]JQ7PV[&90Q(M$!QT*DK?7I;AOAEP%"AP2C,<,*V3)73Y0TAF4[5#ZZ`_3B
M<<^=I]ZN`'VG6UM2`H/-D)*20H)!2E0\844J"DD$$$Y'$P+=Q%011<HN9!-/
MR@"'=J0W662IQ((U'4!F.)R'MP\8TM:&G<%'23-BD,3@26FB2'D\FH4:TJ?#
M[/EIA1C"\T'!,;V82Q`,J#F^U(DB8K-QNH0FJ2":**DDU.1(H:X4Y+^(4923
M<45,XK20XI!0M"P0M(<3FDTU-E20L`\17#NYM7B(&K?"./!)-O0[\TUR,-#Q
MPP50;^QOVV7::=][BM%_>E/./;=>M<-R&JW[?*SY>WRPM+84^VLU\.I/MQSC
MJ8<N.,O!/SG9W+T)T/(9]/%U:#-F;0@;0*[2F;<[C%3_`!,MA@Z154AYN.W3
ML^]D.--'+VXJ.>(_<D]GVJ]ATQ%)(GD^C[4@SDT!<+RWT)2%.!;S$J.E!&2G
M2VA;01F"*J&=,#I+UHJ,1V53H:Q."&9&@=P3%GJMZE$2K=;9(7FTMZW,R$A!
MRU@-*24)<]N9IA`/EN,+D2,`V;,:[=Z7?<23@%PB-.`V>Q1CU'9L-MV!N^\L
M;?M*I,#;UZFLR84=Z,\N4W$"XB^476T)#7)4#WU'&IQGD0_CE2=3^"/U?R2@
MJT6_<VU+`^&T1+K.L-EN,-WRT=#D=;UNMNF(\64MN)>!R4$DIIWX=UM?_B^O
M^:WY=C_R6^H+#I]OIR+<6;#<WC;K_;W76`LOO17&PA?@*VDN.(?Y]*H)X#+#
MVRU&*RDRQ\RCC7&GVIA>6.D7A%K+#29S3E(`H!OKC7:KYV+>C]YV#N2U39#9
MNT':]T>B/+*1)N47\/EZU5255=2D&M32@QTJUUB"32YVN#JF"0;MN0]JXKU/
MT5^UZS:W#<A9YF(_+7=(WB%SFZ'QI`ZO].FG'&U?_G6U+\)731RWGZ9@>/0V
M1W5QQ?3_`!>A=Z=B3WKL5`<"[@0`119.=/\`Q`E0[>RF)>;:%@L-U&+5F#VN
MSU.RE*4[TI7#Q.D=I<I]*ACJW1G]([_`5YD^HSQ/U%)(W`,81BB?(5\0^G%K
M7.,5X8ZOB3]/U8$B^,O=446*F%)!)*<OE^K&:A:<AW$+53&*HY#N(0I@JCD.
MXA"F"J.0[B$*8*HY#N(6U+*E`$%-#WU^K&4<EW$++RZN]/T_5@P1R'<0AY=7
M>GZ?JP8(Y#N(0\NKO3]/U8,$<AW$+-MI2%5)!RIE7O'LPG+(V-N8UI5;QQEK
MJE;\-_-Q\#[/M2ZW"0Z``"*`4''@/TX9.<'.)XE/FW3&M#:'`+:U,=;))/$4
MRJ/UXQ4+;S<?`^Q&DW!)%5I65=XH<NS,J&,51YN/@?8DQ1JHGO)/SG$PWPCN
M4>34DK-M816H)K3A[*XV6*-/B6EYY&LY*X#N[OEP(R1\$0I@JFW)=Q"\I@JC
MD.XA"F"J.0[B$*8*HY#N(0I@JCD.XA"F"J.0[B$*8*HY#N(0I@JCD.XA"F"J
M.0[B$*8*HY#N(0I@JCD.XA"F"J.0[B$*8*HY#N(0I@JCD.XA"F"J.0[B$*8*
MHY#N(0I@JCD.XA"F"J.0[B$*8*HY#N(0I@JCD.XA"F"J.0[B$*8*HY#N(0I@
MJCD.XA"F"J.0[B$*8*HY#N(7FGVX<\]O`K/)=Q"/<E'M^?#9.%BIE&7$?I_J
MQD)6.W$]:[DV-Z[A8V7L[=V[UVNZWD[.VW=MSN6:UB,;E>F+;`=E(AVWS*T,
M)6IUDA:UFH!R2:8U.9QRMVDT]*5&GL)#3O-/6N$&\.F/5[U]=?-M;LM4/<&P
M=A-;=LM\W"=R-O?@D"#=:28VUY38:9E)GMBG^&.A<A0YX4AHC')M1TJ[O>KW
MZ4\G*TG#TG[%Z(TO5M.^GO1K)[@`7#Q@?0/M5^=I^D_HS;-V0^CW4?:MIZL;
M8AVP;JL;>\[<R]"_S9&\O/:E1+=&4TPU$AJ44(;47"6Z:E$YXUM-&?!U/^RS
M>%S"['LH/BF>K]1W<_30Z@A=^6YP'KK]BL-T\A,['ZK[MV(T#"MEZ9_&[5$9
MTM)CQ2\7FF(Z4I2AF,A(T)0$T"`!B2L+@V'4$NFM.#0?BJ_JDMOJ733-0GH9
MGC`[ZD#XE3QN54^/:"BSW$6>Y3KG9;7%NCEL:O+$!5RNT.&[(?MKBVC);2PZ
MH`(4%!9!X`C%IU353:6!(V@+GO3UOYO5FVAV%U%\A6_O_43]:>GO4O>_3Q6S
M[+NQK:.Z9]B9W%;1$LK-U8BS[A&1*_"Y:9+L):D14@HUJ`.?;CC;>M)&W3H@
M<,R]+N^G>APQQ_N%&S/C#ALV&OQ!5B_3E^>)UFZS0)EZ=V3MK;ULB0$SI+D]
MMFZMN#S"XZW)#]I=;?BL\]LE5$ZTIRI7+%PMM:?/;EYVT32ZZ"Z:%K(;<M,X
M8<NS;N4J]7>ME@E[;WYOM[:UBW5UTW"Y'D[2#<C<-K@]0KD8$?<=LL-F>N%T
MCIF6^W"YJ0S%:0IP)-=+8&DM;JUYT/FR,=J?Z+;_`+=`+9N`7%&-ZC/4_P!<
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MN$FR;*NET?@[HN3$%AV?8+8E:DQKG%4ED./`M)!4P=16HU!`RQ;]5@L3:">@
MJ0JW974L-N(Y#\X+O>5,;>TK9;7;>-L;GO6XVI49]\R[S:HMCD>&Z2(2>7!:
M+RE(5';'VLCG[,1ME>61MC!A0_!._//4G;?L=X1,,>M6@6:DH25@E)X*TTS/
MLPOFL>#5CSSZ*44;>G,NY-A1)3K4I3NI8(`.K0M">'<!B4@M[%\+74;B$>>>
MEN-:IT=3KD$NP9*8TE++\5^8RXVZXRMMMU*N>?O$K6*'OPWOX;6.WS1!N?,-
MBW8\WN:`_A)]2^C?IC=WKSTUZ>79Q]R0;ELO;,]4AQ14Z\])L\,RU.+XK'F4
M*T]PRJ>.((`XUVKCVL/%IJ!#<`"G8IQ:7"H*)HJHJ30T-<Q7AC91KG\QQ?Q-
M5J>67:E5,Z@TRXUKVG"T'B/<D9O#Z4ASXI#!Y+J(Z$*+DAZ0-;:6E$`Z0"FB
ML.DUJ`<527?7K$Z:;)ZC6/8CS,ZYV.1O&'L7=W4&'.BFR[-W!>&PBV1I4()+
MDF&U-=::DOA0#"W4I(KA)ERZ9QCW;/4INTZ0GGT6:\%<27>NI5C=R]/[1N*5
M6;.N3<NV(7;P[!#;K<C0I*P[RG-(0VI*Q0ZCGAOJFC,O((W$'Q5V<0M.E.K]
M0Z49)$SY@1EV\#511NCTXVC=UN\A=7F+Q;=2M-LO]CC36@2?$HH\ZU4+.(3_
M`$Q%^'V*X_\`W?U3\'O5!NM/H[A=-YL*[=-MW[EV=>93K4H?Y>NUSC[3D%#R
M-5L59IKLZ(IXMUU!14D#@`:$,KK3H-+',G&`72NEM<BZFMRZ+QT7/M._?51L
MF#-W'=C=]XVA_J!<+7"7$79YBF(,.Y.6V<SY%^7:W0DO1_NP@N4H:TRK4-2U
M.RU`M9:`!T=<U.VE/<5-:;!/!=3LE\/RT_ZU5;;>'5BS/[&O47<=CWM8W;_8
M)$!"+KLV[:!.<B,-J"9-N7,8*%MOD@@D#MX'$6IE2XVI";=;_*RT%MN.VTVE
MLT6A#49F.WRR#X>6EE)X<<"%''4"Q2[R]'O-G#:=R-\E`2A8C&:TS1/,>>-?
MO!P)[:XV:VKLYW))S/S6S?A"?NSNH]_V]:9,'=UIN,/3!GLLS8*F+BX1*B.L
M*:7+2^DF'1>?@RSP_&J.AA=#7:TCUBB9ZAIK=5D9([_NW!WJ-4E]$9"#UCZ<
MNJ(Y<C=5M9CT[6))7&<)-*%0:>-#V'$/88.IV*378IF*(TM+@K5Q*'!J-10!
M*1V#$M+N2MG_`%1_\,_%'WC'<E"*MR-YLMB4$"8@.<H^+]S0JUT[*XZKT<2+
M-QQ\-,!Q7EOKPC]]N`2*_-\5XZVE"016M:9_(<6Q<\6C`A>$!0(/`X$+7R4>
MWY\"$.2CV_/@0AR4>WY\"$.2CV_/@0M@`2`!P&!"]P(0P(7J1520>!('SG`A
M&>2CV_/AK=_I>G[5E#DH]OSXCD(<E'M^?`A#DH]OSX$(<E'M^?`A%3Q/RXF6
M^$=R$,;+"UJ;2HU-:_+@0O.2CV_/@0AR4>WY\"$.2CV_/@0AR4=Q^?!0H0Y*
M/;\^!"')1[?GP(0Y*/;\^!"')1[?GP(0Y*/;\^!"')1[?GP(0Y*/;\^!"')1
M[?GP(0Y*/;\^!"')1[?GP(0Y*/;\^!"')1[?GP(0Y*/;\^!"')1[?GP(0Y*/
M;\^!"')1[?GP(0Y*/;\^!"')1[?GP(0Y*/;\^!"')1[?GP(0Y*/;\^!"')1[
M?GP(6_0Y\)Q#9W\3ZUE`MN'[)_TI@CSNNHWU-!NJ:;MJV<2VV>6X'#XKE%^9
M[ZE+ET=7T$Z01;-);MW7?<LV+?MXR;Y'L]FLMCVVJ.Y<HC[0*9TQ]"Y3;Z@D
MAM;(TFHJ,4_Z@=:_L<;88A1SB!48&I--JZM]+XX9B]]PQDF5I/S-#M@KO!72
MSIKM3;6UMM[?3M(1IEDG6FU26-Q!*&Y^X8<B(78<V:$H25I=B*2I.JOA-/9B
MU:*T/TZVN'_-=N&+R*O.S:X_,?253]>ZDEU74KJWF;6`$@--"T8G8#@/0%#.
MX)Z+=ZA]JOMA"FVY-HMCJ`/NV5R[?.26BFFD%U8`(&1(%>S%)<][^OS5SC\I
M%:G8<JZ886O^E$MNT#,Z4$8;``[9P]"5.I0%EZY]-+P#H-VLLJQR%>[I,:6P
MXWK4,U*4PY45^R<.M8#6]0->T`/+A4[]O%,NG,EQT<ZU<`Z2.)QQ%=C:_!3#
MO]Z3`L)D,(=\W$O6W);7)DM1)+>B[Q70\Q)?!99<2VDJ"E94&)/6P/(NJ-RJ
MOT[#7=3G,`<<*^A?ER]<Y+S_`%XZJR'7YRWWM^W9QX3?*\]IPJFKY9?@!$>4
MD!04'`!4J..!%K?..-!XN"]6QGFMK+\Q&`KC0<!7=V*UOI2WI(Z==*]S;AA#
MFO6[94">$H`D/&YO;GM\&/&9@J>#$Z:Z+AS&VW"E"UTU4SQ8K5SN60":4XK6
MX8P0/(:`<IW!?0WU/])G3CU)='/3KU6ZJWOJU:]Y=.=W;QN-D9A;P1M86:YK
M>LLHW"^VBQQY-@3?'E,<I;T9U);:`:KIKA?G3$9<[\O"IIZJJ!!(K3>H1ZSW
M[IRGJE;.G.\>H#4W='4'9;-HL>VYKC?X[=$6QW\?L81N)33T20[/7$4E&L`@
MI-3PPI;:N-/DY30`_;7#>FTL<LC\P)I15Q-SV9#9GR+C8IU@L]MFM09MYO6\
MK-'LLF;*:?2Q"BO2K.F&B2^TPX`JH0M*%`*/`VJRZC>T92/E.T;CW\?2DC:R
MO&5Q(!6#>_\`I4^MN(W>+8@K0A#2XW4+8KQ6A'A:2I3GE`VAL#PU)`KE3$@-
M>B!J(VAW<%@Z<XBAD<1WE/&%<]F#(7=;C*RAP*_ZC=/5MJ4.!-;J4E2>'>*8
M4=U)F;E<*MX'8DOVB+BIPVA:(\XLW&SQC<N0E2&T_P#4KHRI02O42E$<[Y9E
ME-5E1TIH#F>W&UOK\8D&5C?4%K)HK9&Y6GYE--N;W1'>COM;*O4A;*"4IM^\
MNDLOF)!3XG0G?I43PH,2'[^W\#:=P3?_`$Z_\2D4+WI)"75]-NH0==:0\IJ-
M.Z?R4I0HZ$*28F^%(4E9&5!QPZCZJ9&P,+&X=@1_IT[W8I1>A[^;M\I+72CJ
MVW*4PZVRZ+;8%\IU:%!M:E1=T/.$!=.`XX0O>J62090T5J-P2D6@/8XD.(-#
MO*[+>FSK/8[/T5Z6;2WM8M^;4W':-I6FT7)[<EDCN15364.*<25,7.7(:+25
M@%`'M&(8=0@$G+M/!5'6>C?-$N;XN*MXPAB;;XUUB/)D09[/.A2VT+::E-E.
MM*VVW*.(!&=%9C$_!.VXB;(-KF@]U5S^]TQ]J76],8SE]2*$@<2`*TJ2*=N6
M>%P2-BKXB<V4EQJ%2+UQ]=[IT?Z<-VNQ+D6ZY;MB7#F[G8AF;^`6R*N/$?<@
M0^%VOT^1,;C164D*;4YKH<J9S'C[5=M'MX7Q_.QAP&T`^\*CC/HXO=A]->^M
M_P#5N?=6M];UA6V[-[/9=D/1=D[#6ZTZ+9<'R?\`';W>D2D7.Z35`N.2$H:0
M4B.:HFQ##S0\BN-:K:\ZJ?>:FS2K=F2)E&$-``.6C<0,#Z5:GT1^I"U]4-DH
MZ7[RW!;5=;.F*INV-PVU^3_]+;GLFWFP;9O."VX"J9&F64L^;6%*6F0VJO?A
MU:7$;9"U\A.&\D[^U06N]-W+;TS0L^5XV`*VUNWSL&_[@D;7L.^-EWO<\5MU
MR5MJS[JV_<]PQ6XU/,+D62%<'[HPEBOC*FAI[</_`#5O^,*%_8;[\!]2:O6S
MIC+ZF[18V]&N\S;D^WW:S7V',AOF%,=+!(N5OBO%MQ'.F1=;02H:5*6!VU%?
MU^UOKN`ALT1;3#`?^ZI7HG5AI=WC%<-:"=A<!_VE\POJ!]/OJPV,[N'<713J
MFSM+IKMJ\73J'>M@=3I:AOW;UF;WC8[8\&T)\]$4]?+I>W5("\ULU4*%..1N
MTVYT^9SIW,=G.&4`;.-`.*],Z?KMIK-N/+1NC?&!F)VG-LQJ=E"KBV3K;L7K
MALS=&U]N;@@G>NSFKK8KS`FL>2#=_P!LR8/^93!N$Q]'F6H[:2XEP)&IA2:5
M&6!/E.E@VKN:P[1LTF[R4/1!'<==?%SMLY.A*:ZU.1-:O#Q]X$]QX8$+"1+2
MDM*2`X%MA:5*20="\TD:T@A*AG@1M6J2IIRW2BE#9<7#DA+82G4I:F'`E`%!
M4J5EC5P!:>-"L@ENS!(?3NXHMFX]A;B"@DVG<%BFG,)"4,W2.V^<@/"@:J_)
MA*Q\?H0-B[H/-)0$2LB5HY@!H0.:HO*0.P!&L#NQ-OIE0"0:C:IBZ=[>L=\Z
M=[RE2=MVC_,4>1=$1KRNT-KFB"JU/S8RV91<+J7^:TI*5@#Q"H!RPTTZ[NHM
M:MV,ED;$9V`@.(!!<!B*TIQW*#UVQL9-+NI7P0NFY$AS%C2[PG?2JA7EI2D!
M"^<T-!YAJ02L'3F<_$$GYL=OSOXGUKR1JP:R\#6``=F"UD#N'S8SG?Q/K3B-
MC"P8#9P0H.X?-C.=_$^M;Y&<!ZD*#N'S8,[^)]:,C.`]2%!W#YL&=_$^M&1G
M`>I"@[A\V#._B?6C(S@/4A0=P^;!G?Q/K1D9P'J0H.X?-@SOXGUHR,X#U(4'
M</FP9W\3ZT9&<!ZD*#N'S8,[^)]:,C.`]2%!W#YL&=_$^M&1G`>I>U/><8+G
M'`DD(RMX!"I[SC5&1O`(5/><",C>`0J>\X$9&\`A4]YP(R-X!>4'</FQMG?Q
M/K1D9P'J0H.X?-C.=_$^M&1G`>I%G$**CI!I0<.&#._B?6C(W@%[H<^$XTSO
MXGUJ'7A0Y\)[<\&=_$IY;!I8X$"N"R#3JSI2DE1J0FJ=:]+?,5RT$ZW*(S\(
M.#,X_*YQ`/:4SGL9W/#XZT!KO]2Q6A;=`M*T$M*>`6"@\I*RA2]*@#1*P0>T
M'&39MM\63%__`$B?BG0EGN,'1AH[@%X`I3:'4I<6VX3H6A*U@_L)4>.,![SO
M*#9N"R4VXBFM"TZJ4U5''AEC.9_$K5UJYH+N`0T.?"<8SOXGUINAH<^$X,[^
M)]:$"ARA\)P![Z[3ZTI$!S6]ZUZ'/A.-L[^)]:E,K>`680Y3W3C!>^NT^M1U
MR`)<."]T.?"<8SOXGUI!#0Y\)P9W\3ZT(RVFB!J&>=:C/B?U8,[^)]:$'$U0
M=(SRI09\1^K!G?Q/K0BVASX3@SOXGUH0T.?"<&=_$^M"&ASX3@SOXGUH0T.?
M"<&=_$^M"&ASX3@SOXGUH0T.?"<&=_$^M"&ASX3@SOXGUH0T.?"<&=_$^M"&
MASX3@SOXGUH0T.?"<&=_$^M".:1W#YA@SOXGUH1KRQ^(?,<8HGGE'?B"'EE$
M@:AG7L^3VX6AC.;G5^1F)&\K6:W<RU>`:N-,/6N6OYC'IAZ9^IZ?TAM^Z[M?
MK/N7IKN%^[VVZV,PEM*M=Q:C)N=@N$>8A2N5-#`4%H((KCE76L5GU#*(VL+'
ML<#4D&M.Y=Z^F73$]GIW[G+*TL?49,I!QPV[%=/H5N2VO[8LNPT.K3<MI[?M
MNW;/'>=253K?98Z([*]67WR(R:$FI.+WTUJ44UI'9EI:Z#::UKLV>I5'K7IV
MWTVYN[V!H+:G`>E,*Z!F7UMW-K00[:&+%/:X'ES&[I"BY$<%(1)4*^W%)ANV
MS=:270:0UCLM*[<`:J;M9W6O0T8E:7-D:74V4H7!*OJ0!MMSZ9;C-0B%NQ^)
M(6D&K3+Z8ZD$_P"LF,0!VE0Q-ZZ.7JL-RX_*][1W5<,?:F?0=+FPO6DT8;>6
M@.[Y'46KU6=8=A=.MF;8M6\9\ZUW+J9=7[7LY!MKLQFY3-K[;F;KDB<B*^)$
M&#*@0G$H>6`@+2*G,##G6[RW\N8<PK3;_)1OT]T:];U,YS&ES*[0.Y?F3[M;
MNFY.J'4%S;EFF[@FO[JG7)JVV<-+U1'V:,K9>EOLM)0M+H-"NHH<<8FM,ER7
MM>US2:X!>FV1\JK":FJE7:UZ<VQT.WKMF_[8N=KNKEOL<>XPWS&BF0$;RLU(
M#ST"Y/2T^=$4I4XT-2`JH%</8)`WY#O6EQ^@^FW*5]=2%-[F]!.SXNUXK"I=
MYV[U0E0K?M>?(NDMJ9+;AIMD"V+?<<E.M1$J`;+BDN)*JD=N'E&\57/FX%<C
M.NFV['9O53Z)=M0+A:[UN7;.R[RK=KZIZ9UP8_`]NS1#;W3Y=;_X8EY]Y26B
MXK4,ZC#%\T#;OEN:7&@QJI2UBK;\PTVG#N5[>CWX-=E)G[@M6@[0F^FNR;>V
M_.3$N-BAV+=5OW7*O3;K+D5+5U4U+N+98D.E3Z!45H1BTVS8&Q<[*:#^,$UN
MGYXW0L^5Y&!X*Q?6WJAT;]/NV_\`-6^>G,>\6J[[_P#\GPX^UNG-HO3D-3MC
M-Z;DW,EG_!P4,MK&H<2">`P\F?;PP&<L)`W5"@8V74DW)$@!KMQ50V?S*?0<
MM9:>Z.WU#Z5:5\OH599S:C7)3<I4-U3R%\0=1%#E3$='JEE(S/RW"M=XW>A2
M4NE7L3\AF:<!N.\5XI\V/UT>A3<J)_D.CTAX6EER7=&[OZ?;0V(K#"2ZXX9D
MBU(2M20/"D9K-`,;_O%E;_FF)S@-U1OPX+$5A>-?4R@CN*O;TJ9Z!]9NE#'5
M7:72_I98=M0YBW)(O?3C:#$M^&S&9>//BKL#JX_-1)2I-5`4!XXG(KZUF@$X
MC<!PJ/L6+CGP>)P/H*/;8Z,;#W;:KA>-N[3Z,[BM]TE*@P[A;.E6QT1X+K*R
M\N.\M+<>0^VRWDI:@A.1KEAOSH)?S&M<`=U0D!<S<0E.Q]-O3Q'=L4N_].>D
M]_A3=YV_9B[WM_:.UX\"#N6Y+?C0(,R/:)#\AE3LM.D+2"@'BH98P70G`M-.
M\?8L.GF(H"%1OU'=([3T?]9Z-][78D[>M5MMG3O=-KVY;YLE=I#:;VQM_<C1
MCOS'HS&GG!S2&PD)&8J<:_D?A/K66SO'BQ7U3].[G%N/3S:JV2'F4Q0RRM)3
MI4E3"=+B=*4I"36H``Q;=.H^%I8*`,:/4N8]3!MMJ1C<,QFJ^O"N-"FQU!W[
M;]C/6^(];1<GKC'<D(*G4H:82A0004J25%9)R(RI7$??Z_%8/Y;XG./80$PT
M;I*;J6%T\$S(0U]*.:37U456.INXMD=38UD@;SZ:;<W5'VW?[?NRQ)N]QN[#
M<.^VMWF0'7&;<XVV]&9<`64'WUI37(#$<>K8"?T9!_TF_8KO8="W5FW*ZYC<
M>QKA\4E]0.JVZ=Z;=W%MQ(VC!;W#;Y=NER'6;Q*E,)EY.NLZG^274YTU"E<,
M[SJA]S'RXF.8*4&(6UO]/X8-4;J1D8:&I&4U.\XJK]CV+M'9>X;1NS;-ICV7
M>5CMDJUL[MMCTF)=Y+%P3HGK?<:=2TZ[(1X?O$N)T94Q6/-WXD+A(,I["KTW
M3[,SF29F9A:`!P-=J9373#8%EW??NH>VK&SM+>^[26-U;LVM'MEHW!?F%#2H
MW"Z0H$:2^O3[R`4(=.:RHYXV\[?_`/,'M^U+>0TK_DGV?8H"==OUXDW6WOWR
M[4A7:=:5D3[F7@8A"FI!YEQ=92EQ1%1I)&=*9$.)87RMH9)/7_))ML;*,UCA
MB'H29O;I;9D]/MXW!Q+\]3EH,=R!,*W6)4=3T>4ZU)<#B9C[8E10Y1QU8!II
M":&K$VHM\0YSB[BG5&#!C6M[A11)T5Z.])IT)O<K6R+3;[_*FN*F+M[LN.Q)
MDR'W'9#\EH.J+BY+=$O$DZZ?HQA"ZZ^G_I+T\W#"N#EWLJ)CCR'$N*>E2-$8
ME!TO1&&W$1T<DC5F@\._#KRKN(0H,ZJ['O73?=]SL5V+TJ$4-W+;=R=`::N=
MBE+^X<:)R;\JV#5)J:#&S+-SWA@<!5:R.Y41E.(&Y0QMS=43<[]Y3`0^B+:)
M(C(EOITQ;G1P(=,-W)*DH%>^M,(7\)LB&..8NPPPVX;TUL[QMX2UK2VG$U2%
M;+K$#2&6):$.0'IT4(!&IQUA4J4VXGL2G4$BG&N&T##":DU3VJ[O[(W`SNC8
M>T+VRO6+KMVU2EDJ2LMOJB-(D-+4F@4M#R#4XE6/YS#040J$_F`?F#]=?R_;
M'T3W)TOL.U=P[#ZK]6W=@=5)FXK+,N-SM"%VA+]B7MYR-(#49]R,Q,0@K24J
M=1F,Z8;1V31>1W$IS1,D#BT5%0#4BO;L3#50Y^F7$;,'.A>/6TKHA8+JSN>P
MVB]QCH8O%NMU[8U(T*4S>(;,Y)T#[*%N*`[N&.T:=,-0B$C!D%-AQ7D_6],E
M9>@N</44J>35GXQ^R?KPXH!@3BF,[S:TC`+S2N"'DU?&/F/UX#EXI..Z+S0L
M(7GDU?&/F.,5"<9^Q8>671XZ726@"@(96H/5%2$*&54G(XS\O%&9VYI(68AK
M/V@/T'&'4#:MQ/!;-+BZC@6CB5[Y)7QC]D_7A+/)^`^M*Y6?B"'DU?&/F_KP
MJT@BKL#P1D9^,(>35\8^;^O"L<8D=E!Q6PC8?OC8AY-7#6/V3]>$&%[Y^3E(
M[=R3`&:E<.*\\FK+QC/V'"\\3X17Q)!\T;9',K7*=O%9"`ZLZ6U)4LY!/"IK
M3B<AAG;3&XF,3V.8T-)S'$84PIZ4HUS7D!AJXK6N,&W>2N1'4\`"XS'>;DNL
MI.6MYII9=0D$'[.-N?%SN37'BG=Q:36\7-H7#@%GY,GW74D<0K2H`CL(!H<Q
MC=SBW8*IHPY@,V!(7AB$`J+K+;:02X\^M++#*`"2MUU9"$)RXG&C9":EPRM`
MJMWMRTR_,2:8)#M%[VYN&7+MVWMT;;OEQMZRW/@VR\1)4J(0E2ZNM(65!)0D
MGY!A**\AE>6-(J$K-;3PQ\QS31+1BJTZ@H*%*B@X@]Q.7##I-<_8M99<%"I)
M"*A)7QHM63:-())*R#\V%(V!X-2!1;@/<QSF-)RA,#>G5+I;TV5':ZA]2=D[
M)>ED)C-;BOL:"5J/V5DA9:5GP4,1UQ?PVSLK\?2G&FV=YJ3\K(G,'$X^Y/JV
MR(-ZA1[E9KA"NEOF)2[#FPY+,F++8=\+#S#\9<AI277"!34"`:XWAN89AM`*
MAI+&^C-#$^B-IC*4IQ!=8*FCI<#*R\E*Z>)!5I0-23QPIS'&X9"QI(=OW#O3
MJTMG"IE(8>!W_P!BK-ZNI?4FW=)8[/2S<<[:%UO^]MH[;W3O.VP8TZ_[6V5<
M%3G=PS]JF0E2(=S6W&0A+A!TDY9TQ$=2ZH[1+<N=&Z0N:0"T@4)!`)KMIM5P
MZ.@M]>U/]OJ&%I%2[$&AK0`<=BH=Z6MR=5^G7J:VUTPG]8>K'5CI/U1VUN;E
M#JF(\^X6_>.WX0O,=ZSS66Q(2Q.4YRI*5:=#CB:C*F*'TCK-[?W1@EDSY=O!
M=+ZWZ7L-)L_,Q-`#NS$)$]57YHF[>C/6/<?3/I7TPL]YM.PKJW8]V[PWK)NT
M>`]>&TH>N-FM<>UI;$?R3;B4J<>4HJ621X:8MNH=7V]E-R'VTE6X5S-Q[=BI
M&E=&3:FWF1SL`<?PDT]JOMZ/O51MOU;[`NFZK/:T62_[6N<2S[NVZQ-_$(EK
MDS(?FHL^WS2A"G;;+H2TVNKR4^\3B9TG4HM5B,K&EE`=I!W5W*N=4::>GY1:
M2_FND.6K10"N%<:\5:];!;27%J`:;"E/.4-&FT@U<(K50K04'?B8Y%(N:7#9
ML5-#29N3OXJ$.IGJ,Z#]';W:-M=2NJ^S]H[BO38>BV6[SG6IR&%A2FGY#;,=
M\,-/)2=)4030Y8@7:S;,D,4@RN'$A3S>G;Q\?-C(<SL!3W<ZD=,FMEPNH;O4
M/:B=E3VGW6-S(N33EF=\NTE]R/&F!0$J:&5!7)2D.#A2HPZ_<;7ENE#@:"M*
M[4E!HM[YID3FD`N`K0X+'8'4/I]U4A2+CTXWOMK>D*(M2)3U@N+<Q<4(.E2I
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M%`Q5#[0^;^O&6EQ/S"BPZRH/E>T^A>>6/Q#YCC>BT\H[\07OE5?$/F_KQFC>
M*4\BW_F-]10,4C[0^;^O!0;BL.LJ>%X/H7GEC\0^8XQ1:>4=^((>6/Q#YC@H
MCRCOQ!'6P%+`/`U_H)QE/D92EAM06\"66@M]\`D$QXZ"\^`1FDEI!S[,,=1O
MG6=JX-VN"D]#M6ZAK=O8.%6R$^PM^U<S>H5_1?-V7R\K<4HRKBZJ*<PAN*DI
M9AH2@'35,5M`)^T:DYG'-('FYNG..*],00#2&,L&8-RUP]:4MH39,*?`ND1P
MLSX+WF6)"``K4RA3J@X*@.MJ2DU2K(X5T_4GV.L/@!P((]ZC;_1H]7TJ[F>*
MG'XJ2(;[4_KYN*-'*N3?]OV^7#"B5+\PZ]:+D%*6KQ*3S4DT[LN&$].QZ@?(
M?O/K[`H?6=(;;]%0M`&$;O\`M.4I>J&RF9TLE7*,C[VP7JVWE]6M2?N&G?*H
M`4,VO\214C.F++U34OAR[2]OO"YU]/)'&66U&Q]6_P#$"%\QGYS73[U;1]Y[
M.]5O32U[ZW-TI=Z3P8$'<>SE2]RV[:VX-M;'W!!O4+<&V;8U)<LK-VGC2[*+
M:4+2E*5J\2:TK6X+NAJXKLW1%]IVC:I)92M!G[@ODCZ87CJ$Q>;Y=]H[*W%N
MVYR(HO,IBWMS4)=VTAIMN=*98?80ZF8E^6RMD!)U(U#@G*JVK9&,<),79O@%
M<@<TDC]SGD^P+/=W5#</4MUC;.S]CW"1/O=L-NN%A8AR=Q;D2JTSD7-]VW1;
M%&DS)7+=:3J6XVMUJE*<<.'NRM+N`6Q!<"T;PKR>B_U$^L/HEMGJ3TIZ;=-M
MZ7VX;A;1<%6*Y[5N\:[VS<5Y?@VJY;ELJ;VS;I!5`LK`K!;4TR<UD5KAKYT<
M4U\F$0E6_J%Z:=P('415VV9O*L[?.\XH3='.H.\=N24-S(,"PSKQ,?LCEK?*
M)'->0M3OB*%J(2G"<<G-N@_N2W+$<.7O7T2;)WMMV\?EW6+U,;60N-$NNY/3
MNPJ%>'K;^-6^%;^H2MB3VK@^S5J9/@/MZ`TT2K2YJ/#%]@_HCW?%04OZOI2[
M^8Y9HUU]-V[5)CRG56[J3TPN+#<,.JEK=W(;IL"4PAY(<;9:F"]LH5S$+2"`
MH4(PK??^7GN4;:_UX[U\Y5MZ028A9+OI=ZCO-"59`VZ.KZF[8];6&I^V)W+?
M.WO,,Q[ONI#?+D$\F+,2B)72LC%!\R(_EJK]Y5L@#SM('N4W]-NE5UVAN_9]
MSE^FCJILIF<U?;.+[NWJ$FX6Z1=H:'C/O-SLKMEM,26+,E/+3;E/)<6U5Y25
M%-,`N>80SB4WN;5L4)>.(7TH_EA7<S>B>[]JR&673:D1X`MLYEUJW725'9N=
MME1Y"9CTEW67K6-*JBB54&6+_9_^7CN54U!7?Z4OW?\``9;5^V/9^FK,.Z3H
M,6U6&2'6[S$*7`7G65(I60VLA:N)2:8S!^DWN^*C1L3>W7MNQ[MVQ/V#TE9M
MQW,-S;4OS,&V08D1%DF6'<UKNLN0A##+=7!"CNI))-0K"JRJU_F';=?:ZI[!
MG1VT,JW/TMZCVMS2@:U3=ON1K^RM:CF7&FHA->VN!"[)^D'<9W3Z?^G5T:67
M'%V6UO+6K/4%6YA2LN%2,6_2OZ<?X5SCK#_S>'_P?@D7U#L^:OVV4$E',MSZ
M%R*D(BH,AO4^I'NJ'90Y9XI74/\`4'O5F^G']#+_`(S[RJ!7'K+M&W;T1L^9
M=)#5RD;AG6*#%9BH>$M$:/%<9F)=4-0YCKZAIX>'%=724]9;TE+I9;2TZXI9
M11Q"6>8JI'C4D5;U'C3A@0F[-?N;>I+T)C0*:3'D*<76F>O5P33`A,Z7>GHC
M1YT65R]1.EN!,D#,]C[(*23W=F!"@*'?[%&WKOJ(?-ZY%PM]WCI\A<E:&;A&
M49=$>3;KJ?;33Q#2.&)8;$)T7>_QKMMK<5HB,3I#KUEFJ;"+:^T$<I%25\\4
M7JU94X?IPUNON^E"K+T`O[C:;S:W(5S+]JG>=52*D)$4DH4"*?&3GV8:#:A=
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M]_NAE/NF>O1#@P(B0I;[BE9'4*\>%,%[<&*?+7<J;I%B-2U`1/X#XI'Z4]1[
MGO>5?K#N&UP;3?MJ(MKUP-NE*F1YS-W6ZB$L!7A8"TM:O#A&&Z+YFLKM*?:W
MHS-/O8HA2A/P4U!I&MNB2LE8'*'%VH/A!&:3EB63;R;%2O?G47J;;I%ZN\/=
M5HV_;[)<9D=JUR[:XZ^RS'>4VE;JVT%+O/`U`G.ASQ5]4U*2VO'0@X`#?Q%5
M:=+T&.XLFRTVEWL*;-\]1/5`VFT[NM=FMT';\Z$V]Y0LLS),EQ+J4.J;=?0I
MQ(=%2!]D'"%GK;F7#3)BS&N/84O=],M=;N$8&?#WA6%C=<]MG:>T]P2;+N>9
M<-Q[?CWR3:;!;VIB;-&4Z\PJ1<IDE]EF(A]3*BVDU*PA6G@<3?\`J"'@H/\`
MTG,DRX^J/HA;HELDKW).EJNJ'%LQ84'_`!L<L/.,/-R8JUNEM:'6E`^(@C,9
M'"+M1$Q,K<&E15QT[<1S.9C@>W@I+V_U+V+N[9;G4&P71$O:UO:N#TV4THN+
M4NV-%V=%EC_X1Z,!]FE:XWBU1MLXRO.`:?6FSM!N&TQ.+@/653%KUKR[;>UW
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MDA,9Q)I0]AQR[_4TQOB:G:NUV_2L=U8-)`2]TK]?/JFW]LEW>FUO30.I&U(4
MA4C_`#==]QV[8<C<5CMFIV\3+!!7S(MPDJB-*<9KH#A(X5Q8+#K1DDO(?M!I
M\%#:A]/711\YFPBJMQ>.K&V?5?Z4+IO+H[?KS98VY[E9]NW1J:RB-?\`;3K=
MXCQMSV2>EFC<>Z-,OZ6G,FRV-8\6+!J6MAVF.ECI@TD^RGH5<TOI@C5&13#`
MNIW+G3L;I5:.C?J6Z$W7I_(ZB6M,_J98K5N^WW?<T&]?B/XM:IK:H=PBPGG)
M\N,O1K0'*D!>.2=)]62WFN.MR33-Q[5UWJOH>WL]#;<!HJ6_!=]E15H<6H@)
M2%K.C0$!(J?#H.:-/"AS&/0#35H/$!>?G63`2.!63;B&'V'E-AWE+"VV*"CK
MVI"&ZIX*TZSQ[\,K^Y-M"7#>"D#+%8W<$3L1,XCU4^U?/ONOH]TFZQ67=^\_
M4#*W3/WY>MU[LE16&)LQJV6^SV_<-RLEL1%A,QW(K56X2%&G$XX#U7U;/;7!
M:'$"O%>INC.F=.DL67#F-J6@[%R7E[BW3T'W/U*'2G?^_8#/3@[3WAT\NSE_
MO#<2)%<N:U7"*+4Y+:M\N!(BLJ0XR['6@H)%!6N,?ZRFAU!D`<<I(WI;4^C-
M-9IDEP(VU:"=B^S;86Z8N\.G&SNH,RXLL0]Q[%VWO!^1.?8@6]MFZ;>MMSF3
M'I:PAJ,GF22H]GS8]"Z1=`Z>RZDI\P&-*D5[.'N7E&Y@&H]1FTM\&QD@C=B1
M]BH_UQ]<WI5GI1T8L'5NV;GWWO6^[<VK:X^SFG+W:['<KG?$PF[Q>MR-&/:8
M\:T2@':(<47:\OV8KO4.H07\3K:@)((KWB@P5LZ4T&;2-<=<@T#?F]6)]RIO
M"ZB*]&O7W<75;KU%@L=+FKA<>E%FOFT%JW-=+1O7<;L>]W'<GDE7%R3&/X<R
MAR:RD"0VVM*6Q2N*%T78/T?4GNF%6@+I75NJLZCTR-D6\JE7J"N5R]97J-W[
M'Z&2;K:>C-PWO_\`36_[E;VF+3>YK-KM[UZOIY3*9"[A'@1%'RC:'',PIPXA
M^I=9;>:DXQ89#0]^U6WI+I@V-I&)=KVYO1L71G\JO_)>P-Y^HWH-MA]^X1;-
M*VAU)MNYY(2B=NB'<&Y>V51)1;0VD"W/QUJT)2E(/8,7SHF[<Z"G$4]87,OJ
MII$8O8W`8AXW=H795]A"VU-`$AU*D%-20I'O+"AV@I!QT\U\L1N`7(?)-%\.
M%5QRZW=']HIZR^H:_P#4S8^U-]SMZWV*NT7/==V9B/[2VS%L%G:M35A8>9=+
M/-F-R/<(U*)QYVZTO+J#7A'$2&<EI].9R]']&:/9SZ$7S-:7<YP]C50[HWT9
M>ZD/=0]M7G<=YL_1/8V\%S=NV.T[C@MV&V7*[(5^(:4W1898EF/'<0ET"C:C
MJ2!B-&K7D5J^5SCE:VJ>SZ#8NE#6M`=7#!3AZ:]FWKHYZU>DNV>F<:\-VG<[
M<]6]K8[>HUS*]M.0Y,N)YYV&HMNMN*;2I)(R5F#7%WZ/UM]VX5*9]3='P1Z.
MZ[#1F#:KZ!D(2VVRV`VE:&TI>#:`A*7C5:QI&0(U"N.M.<7G,37!>9"`Z9T6
MX.(]JA+K3UNM_2!BU1(FUMQ=0MV[B>N/^7=H;95$9N,^WV(I?OMTD29O^&AM
M0FY#30"LEK(`\1&(_4;OR-D^\(&5@%?20/BIBQZ8.KRMM8<)I*@>@5]P2?T&
M]1FT^O?X];X6W]S;$WOM>*U+OG3O=D4-7F+%=,@(D"4@!F0TYY59!;R`'M&&
M^E:_!=@`TQ2M_P!)3:)^MC13_I.E)2H+4XVEQ![!S4A:$'OY>H)/R8E[Q[>6
M9V"@_@*$@I+.8QL!V*H_5KU-[AV%=MPM;;Z4R-U;6V0(S.\=S_Y@BPS&EJB!
MR8U;+<ZKFRO+.>)78$C/+%+?K<D5UEK@KM::)')#F-*T5F-I;GMV]=J[=W=:
M67V;9N*T1+I%3*>8<D@2&PM:'D,'2T4*R`.9Q;M*NS=`5-57]5LQ:DTW)<-<
MZ<:<*@=G>K(?*<L.YOU7`<5#,=F8'(FN\6%5X>VW'O=F<W#;XC4N?9&KM$E7
M@,2`DID&$RK6B.S4!2AD-0KQP@'9J$5H>Q;HYC9"B'J/UQV=TYDLVB3'N=[W
M`MH27K;:&^<8D()U.2I)%2A+2<U>P8C9-=AAD,)&+21ZD_9HEQ,P2MKE<*[]
MZ?.T-W6/?%BC7_;\YJ7#=HA]E2M,V'**=18?9&24I`.??A:VU2.^>8F"A`K\
M/BDI]-ELFB22M":?%+ERN%NM%LE7:Z7&!;X<)"G7W93VA00!\-0`G+(X>;Z;
MTU3!@]7^G-RC/RXNYV5M1D%Q:6FB^I:4\0VANKBZ]E,Z8A7W='D5V$J1;H5P
M]H>*T(KOWXI<VYOW:F[FU/6&>Y-2A?+<0N')B\HU*0H*?`#FI0I0<*8=V4_-
M<X<`$WN-.EL0'25HXT]2>P910'/,`\>\5&)!-D.2CV_/C"$<Y2_A^E/UXPG]
M$W-WN.Q=J[C<"2!^#RZD&I'A`RTG4*UQ#=0C_P#-$IW_`,BIWI;_`-1VW>?>
MU<KKFLSGEH7DC50$<3P]M<L<[@PTNHVU^*[UJG]:W_#\$ZK$X8S19157@6I/
M&I6EM12!7XL*V(J^N].K&;RMH<VRGP4F7Z<GI[U8Z.;\N*$_A-XLMI9F:E)I
M'U)3#3,6A)+FAIUY*:4J?D&'ERX0ZA#.=@:?>J_?11ZWI%U1WS1OR@5XMJKN
M[CVVQNK;]WVJ],8=8OD>:QYLK0`L3V76F9`0H@\A2G04+II41D<6^YN6:IIL
MD<8&<Q.'=\IV+ANASS]/Z_"2#R_,QU/9G%5QS]4W53?_`$^_+N]=>T]ISKQM
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M_FU6GJUTH]24VP;CM%WMO3Z=T]V1M?I7N:Y>;D0-Q[1V_8(QGO1+O)`3+N=O
MW+*E1YC8TN("0I2=!"BI(`+888U*UE_3]:Z"^E.^W'?OY1GJ"V[-;5*E]/=Y
M[>OEH#1T!$BT;@V->6]*:A&;SKN8XFI[:F8L2?VN6OX1[PH4?U;._P""^A3;
M=AZ7=4;'M^U]:]GR]^=(-][9V=<MWV"!-FVZ7=8,'\-OD=F!)@/,28MV;GA#
MS!<T)JRH*4DD5E,38FGBRX5V54*[_P`R[,WQ7*_K'^518;_U(ZF7/HEMGIKM
M/IA>-UW:9T\LV[IN\G-R6S:<B8)EMMMZ5$\U'<FQW*J<4E92MWQ^]GA"RT:*
M[MFSOIG)/L)"DKS4YK:X,+!5H`]H"3=M_E2]0XE[L]QDM=()46WSA+<1;IN]
M3=I"%-K:DK*IH<C"4IMPD*`SIF</H^G[=C\V"9/U2>X;R7BC3W[ET_\`19Z=
M]\>FO_.$/<<NQ3;7N&1,?APMK3+LPIP7"Z+EJ%S5<(B"I3*GG77"BM2X`GNP
MZ_:(1L=[4ACO5G=H=/;AMUO<#;-UW#>D7B8[,:9O5Y<<$-3@U)3'*4TTLK]P
M5&0%>W"3HFPNY3=C5JD+TP=-^L/IZZ_0M_QG;#O7:^XMEL;-W+#N<F1`=M\M
M5Z1=F;Q;'FVW'-:&EK9DA2:.:10TQA*P?J>A(?YM][L]OC='^I$1`;M]@ZI/
MVR_N(0ZN(S:]X[:EVN22^6DJ$2.XV"5J`37C@3VBM+^6!N87KTV;?89DLRA9
M7KG:D*0X"5Q!<4LQGDH)U*0MNE*#(8G-(N68L=M!]RY7UO:N,G,&PE3#ZAQ_
M^<=CCJJE+UAN4=ZOV0Y(#"3[:R$:<OEX8@NHYVRN#6_B^!5KZ&@=%;9CO9\5
MP_ZO62\M]4#=8R>5$M_4&';`\-%0_&MT2:Z`4J+@_P`.E2C3(TIQ-,5=7]7V
M2\@MH6XO4HMH4M1!S44)*E<.)5@0FGN)EN5#4KF%/*D1W$T*DZ@ET%8RID$X
M$(I*<.LK"SR2$E)!(!&D`G3Q%3[,"%7_`']>4[2W!)O[L>1,;<V5/=<BQFDR
M'Y)V^H.---M*<;2I2D5))4*`$]E,9J4*/=E=1>I'49B[.[%Z76&9%LNT;UO"
M]VR_]6]J69^W6VP-J7>[PFUVIJ_3Y46W-K3SD:"H+6VA`6M83@Q0FQM_86]N
MCWJ.W!TRW[`@6K=<FQ6J^W"VV>Y/7.WM-[HM%MW+`;@W!^W6E4EQ,&\LA=8Z
M"V[J30Z2<8!!H1L0FCZKOS%+AZ<)#71/H-%:WIUWOD:/!D.M1TWT=/IMTHTP
MEV'%YGX]O*2%\MIDFJ'B-0!&)="]]-?Y)G6GU8W6T==?S!>L^[]OR-X3K,BX
M;,M<I&X.I3-MO,YEEJ7=I5Y1-VUM*.\N4T!#98=D,I5]G21B)U(D.:1MRE.K
M>A!KQ71W>'Y;?4+TE;?W/MG:VU+ON7T_],IX/3_>5^W5"W%N&'9[@\D&/=K>
MR8T]<F,M?B6U%#+:3E1()Q&-D#W-J:DXI8M`::`#!5IO.F+)A7-%%MJ!A25T
MJ$,.D!U:>UP-J0!X:\<22CU8;TP;V.U^J?\`E]UY+,'=C:+6VZZHAEQXHYT=
M)426VUN'(%1'9C:,_F`=BRNIK$A,QGRS[278[["XLME2*E<9]LL2FBA0H>8R
MH@BF)ZW%8B-]%D"I`[5Q_P#0!"?]*?K/]0?I'O9U[;W/)NF\>EK+[B4B?8YJ
M?QS;[D!X*4RXRU%<7'J5#-DUQ/Z3<^5\17.NLM*?=,=3%=0^KU^V],\RFP7N
MPWW<-NLKB[M96)B;FNVPWPD5EL6U3[S3PGIY91[_`+*9XWZGNQ?6O+BVT5)Z
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MP)D"9%6[<I5ICK\RI,-SEH@H=G<KEI*G$E.JIQ&->(W!YV`CWJ58S.<O8?<5
M9"9ZC^F^]-OS+]M-ZX6B!;]M6!N_V66;3;%V0PRQ`:CSU2`XU=$%:%%L12YI
MU*U>\,*]37;6N@IV;/0E>F;1SFSU[?BJ"WF-O&_Q;SN_;T>P*VZ[/NTB/(_$
M[6W*CL!]UX+>A>88ELE25A:064Z@H4KAK?WK<C:&@H$ZL+&KW5&&/O4Q>C_K
M)MEO:G7GI5OS<Z[)MS=.S@;/Y1,I-T=W7=4N6F:N&AG0J*I62E..E#00#4G+
M$W9W`ETLLVXA5K5FOLKX3-%:&FSC@H?W_P!?=W;DF6';FV(H=1L%N-$O,QJV
MP9UCG/V=ABU-7*WN/)8,6,[$CI46WJN*<U*&6(&\VDJW0:K,=/&9M13@KAV7
MK!MC<_0AFV7>Z-7JS0[)=[=O2$Q*A6QN%<8L-YBMQ:;=4\L3[DXA:-8JX!I!
MSQ7;;5);:Z<*$M#L%*'3HKW3(I20'/C!IPJH?](7KIM>S]B7OHW>=M[GWLF[
M;A>LW35,.6PF>Y;;V\[`B6.0\M:G&G+=,5KBE()U:0:)J1?]/US]RC=:$4RL
M+MG"GVJFW&@MTZ<78V%^7UX_!,-.^-J$^K?HAN63-$S>+E_FH=M=ADWN5$B?
MA4ZT7`3V+69"K9+@25%J3JHE3P4H$U-.=7H_SSN]=3L!_D&]RE_T\[@M#'2K
M9-A:W'>YMKM.VX#KD9A-K,4NQ5RK?)@NQRPGDDQPC6TI870T)J,.;8#G>E2-
MG=,@MGM=2I"6.G_J(]+OI<Z7W[HW:YU^W'NOJ5U$N^Y+W8K>B2T-MW/=6XX*
M%7"Z7BY1XC$>T6=M>MB,PIQ9;!2H`8N%G<B"WFS4HZ*F/>%Q^2P>>HGWHKDI
M\5%W77<&]O1QU@VUZA)(V+U2@-[O<M&T=E.O72*[N6-,@29+F\793,12;-<;
M="66X26RKEGQ')0.*9TJ66^M22.HT.)QH*[3QP^"NNN7!N]-;;@UH**\OI[_
M`#5>A77K?>TNDETV3O#IWU!WM<T1K.):8.X=N3KWY1]]%O-WCNL3("RQ'75U
MQE04L4.:JXZ;;7U9J5^6O=_+T;%RZ^T"6%F8C#:K(^J?U2]'/2+M>U;QZLWR
M;;S?94F)MBS6:TN7B^[@D1D,*F,6^,TXPF/RDRVM3CCB$C6.-",2E]J+([-T
M1VO;0=ZJ`T&74;^)[!7D/J?3_8N+.[/4=MKK/TZWYOVP6;J9TRVI;=T:V+6W
M$M^Y+K++"7;]#=E&S2K="@B\W#FK0W(#Q2#I))&?G+J"S='>.F(P)7K+HR<1
MV#+?[S0%S"7"'4)O?G5C?T^%:;:_.8WRYM:Z[C8M74?J)96;I^"6W;FT(D]E
M37E9TAIP/OAI3#+"5K.5"9KIBP=83A\P&!WX^](=;ZZ.4;&S^9KL#3M7;[J_
M^8ET#W_Z)^K<;84^X[2WK+Z1S-I63II?8A,RW1Y3,2Q&'#N=GAHV](,2U+=<
M4^DLJ<*14%5,=J&LPMTUT;:5`'Q_CL7!HND)+'5XM1H?S27'T$?:OF(LUP5:
MG;5<+<\&)-N>MMQANI24!$J"ZS,BNE-!4HD-A6?;B@12\ZY+MP-5TK6&-N+'
MEL`S!AV=RNIZH^O4CK-&VWMVP;53'.^=S2NLTAJTLRIERFW&1M>!M!,!V&E"
MY#DEB:F4\5-H(/,&=*8D;B87/@V]B@^F=-=;VWSC<K?^F&W[]V)Z4+A>Y=GW
M9MF(_O?>8>(MM\M=^2$6:"AN0B"IEEXP7`\XE3FBI*2*TICG?5\!M[,#&I=5
M=1Z5N@V&6-QK^;A_PC!50VSZR>OOIWZM[DZR[,=4Q#W-;K=M/<3^Y]MOWZRS
M[99DMW&)&7=%AD65:O"%GF!YO63[PQ9.FYC!ID$PK5KFGOH055NM;`WTPCI\
MKS3UX+LY&_-_Z=__`%.FV>JCVQ+E'ZM;QN.XK/#Z;1+C7;\>Z[65`:G;E?W&
MRTEZU[5N2YK:H\0I=EKUD&B=1Q??]6R4I2H_C:N-7G0Q\Z*&F*I_9O4?<?6+
M;-R7#?\`?[?LKJE/ZC;0V>P;;;;7'V1&Z8[I4Y$3)D&[2XHM\VPW=*T><:4M
M]7F$K*`A)(J^KP1Z]=-O'X%K`SU$GOWKHNC3OZ6M#I^WF5=Q\0I\$T?2C=]Y
M;UWSUFZ;;5@;*39]B;:W%<8CKLYZW3-P6C:^Y&K='EN72BXC\Q]M_P`RM]9'
M,YM>VF(*]Z>C\G)D-79#054CH.MR:;=OYX^6<T%>TJSW03J+:/25O:!UM]3=
MJD63;?7UZ78=HWNTS/QC_)L2SJ,LW.8]"$N6_;9)`8>;;076]0U)%1B8Z2B_
M:R,^Y,/J%<GJFU;;6Q)+-H!(]R[*]-^M_1_J\W3IAU&VAO9]IEEU=NV]<VGK
MFB,Z*MOILKO*NR(P21J4ID:#[U,=;M[VTNWF1S@"0N$:MI5U%;BSC::MWT5>
MO4[-V59MS;-N\Z1#N.[+/8K[;+G:8TY2YUFL#MP@2W;M>8EOY\Z!`3/8AH6I
M38*PY05SISCK.R/+?<6SBYPH0`3CB`NF_3*9UI<1V=V*-<34G=\I.WT**_0U
M+M>]]\=0NH+]ZLGXY*@6[9K=I8NRG+S=6V;[-O%PW#"M4P,7/\$<"TQV%AOQ
M%A8&6''1Q<P`W&!`W\4Y^H-'9O+?-6JZ9%M]2TJ4TI"EN*34A*6VE(KF\X:-
M1TITYJ64I![<=2<^T<US0X%H'PX;5PJ=EW)DB#2'@FM!VKBSZQ+HN]=88727
M8UYB;I9WK?V=Q;D&U[HRY(@36H0CSF[Y-BN+CQ^1$2I>:M"B*5QR36;:&RU7
MSH/R@$>L$;%Z(Z,O7G1!ILK1F=0[!7"AVJ6NAM^MW1/KOMWIQ&W$_"Z8]1K'
M>I-K1NC<UOG0H^\-N,L2HS\&:9)9@19#1>JATH!4`.-!A?0-9C\[0G>HWK?1
M'W%D2UN)&X+H_NAJZ(V5?Y-D#CURD66YNVE]G_QI;EM?5;I,97VT+>*%I4FH
M[<=&U69DUJ9&':W<N,0:=)`8X'`_+A[5SEE[&MMIM>V9-I887U=2_;)J+ZB_
MW5F^3+PQ+C3I;)"(ZN:R']:5L*]ZG"@QRN"9T>JU)=2CMYXA=>CL&_Z>!RBN
M9NX<"NG[+,IYE*G`7I"8,9UQ8)/,G.-YDJ4$*TNNA69``(H<\=5CNV"R![%R
M]]H[SQ%-ZY5[<ZDN3.N'6:-?'&;>_<+S-M#0?4V'40[3->82ILKU);*FT>[4
M5[1CFMV<UU*:X%[C[5U2RLG>3B-/^[;[D\?2WU#M5OZQ;JZ=PKHN/MS=3MS=
MCM3G$%F1?6HREH<9?%6V2XE*DI"BD$G+/$IT].(+QQ.PLI[0H/JK3'RV#`T8
MB2O_`%2K7]?+$[>-J6.7-)&UHFX[5.W3!72,N9R8ZX\%MM3I;6YH?1XD)U5K
M4BAKB:ZEB=/;?ED@T59Z:@Y%U1XKCO569C>SKOOS:UI+L6Q1I<*\)GQ+2Q!:
M"S&#?X2RX\F05N/2B%:BV"4E)U4Q2[/,'@$FH[5<[NT-,1A]N*L%M&T6R!O:
MS1;(N6\A"%K=#SK91RFT).NB%4!%<Z\<7;2_$ZGX1[U4;^`Q4S;U9Y*%JJI(
M.E2E*2<A5).1H:&F6)BI51O?&O>4Y\/;WI^O#U+_`/NHWC;Y.*WH[@BLRWHN
MT>5:G%`"ZPY5NU*%4L<]NHD$$@*Y9333E6O'$?JMNV[L7VV;*'#;2OLK\5+Z
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M!"/Q%R,RH-L&/.E(:A7>W-IHIE`?0^3DE!-!B`L=9N]"?R9(#+&30NS4H-A-
M,IW*;=T]I^L#FMF$<YV?*#CN^\-ZB[U/[JZ`=:+--GV2]S8VX-R6"Y[+WMM>
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M.=/-U]/NMGJK]16VMD[>Z0W&V;E87L>[W.U2YL^TO-JAPI%U6Q`=5$D5_=,L
MNO.JHE1"23AQY?M6/,=GM3S];GJVV)U\ZS]/>F.U)K&W]H6&!NU6QY'47;UB
MN>UMYWK\7\A<I%Y>NLZ)+MB)K#"/+!%%**BIQ2SC2X9DMP.TI0OSPYJ4VHKZ
M;+7N:U>C/UDP-SVC;ENN;U_D3H5LA1EVRS/J3?MLQFTL>0<=5*A.--:TJ;4D
M)!`S`SFM*CYUC)%6E1M](4*]_+N!)2M#\%(M@L_K.;M-LB6+JSTIA6Z)`MZX
M40O;Z2]&@O0F3%BNN(:+"S&;\/@4KAP&)81TAY-=VU1Q@K<^8KOK1.MJW>NI
MRB&^L'3Y2A]F-=]YM,BN>2%6F0I/MJHY_-@MV26\0B:[`$[N)JI%\T+SF?&"
M[^.Q+MOV_P#F"D@,]9.G(X@.M;LWFVM/'('_`"\:5I0^S"CW3O:6A]$WN'P\
MDY(PUV&/I[DY(NS_`,QUQQ"F.L/35U->,[>V]4*%<QRZ;8<R(XX;Y+C_`)A_
MCTJ-JGM;NG_YF+E5-=5>D2DJ`T5W[O5!/$9UVEX1486:'!M'&KN*PGI;.FWY
MHCFA".IO1U(4:.4ZD;P<*VC[[:0G:`4C5\6=,*Q,YCLM:8+>-^1V9*%ZZ#_F
M,[UV]=^G^^=Y]"=T[/W1IC7FRW3?FXGIR;&MM;#_`.#/7'8[^BZL.+4XAQ*D
M?#3/5AQY7^][$MYCL7=+T">EO;'0#I-MUNUWW<$F1<6)C=]M4NXM3]NO72-,
M:1*G06W(;$I)6ZDELZDI&7A[,(QQNM'O>UU2<?754KJ.6.\>(R,M#3CL]2+^
MK=;,/=VVU1T@:[)YQ21E0.WN15NOL+?'M[L0%\\R.S';_)6WIF-L=KE!K@N<
M>\-K0;F])>6$EU_JI$O+RN4%%IF1;8\53)JJJ@E#*O%E75PRPP5G3WEA+14A
M)U))(2>'AKEWURP(32N\K_#/MZ/=TFNKCGW:<"$GR9-(K1T<6T_:[Q_JX$*$
M>J\64]%L,F(B$X]^+72W*%R=#$.3$O<5<141]XK1RTI+N1KXET%,\"%S[]/'
M0GUNW';S%WZ-]3.FFQ_QWK/N7I9)NDZSI5<K796HL^^;PV]?'+I"=;EV?<-C
MM>J.TVY][-89!.0J)6./F5QI12I^9]N+J_Z+.JMCE]3-_IZF^H>;T,V-;SO:
M=$9LR+_.N5IN-FB3C;6@J,)ME@6Z.TX4*)==9)\).,1ECA5FRI]=<?:E3;]O
ML2[^5%Z&VK"PWZJ^ML=N]=5=^.FZ[.;NH\V]9$+J\[N%[S!6MR\S7CSF0XFK
M;7B2JN)A-5],EKW!<6]N75#<E1DFV.3FW'?O71-@I\\F27%?>+5(E1T9$T21
MEW89W5KSZ.S4RC@G5OL/>I-ZR_F0^C;IA<=U=..K74#3>[=;-LQM[[>B;9N]
M[$2V;WVU;KQ#?E/18ZHC+*;;==:W"NJ*<*Y8KSF%AH!X2:8]I]AX)P<<%\\>
MZKAM*3O_`*S=-['=8,M73O>-WL<4QGD.I&VKRZ-Q;*W-;PDZI=KO^VYT5:5+
MY9;<44>*E3)P/YYH<#ZTPF;RNU-*-(ELB`^EYR-.@/-OZFU%+S,R*M'E70X"
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M+D*=2].;9+<2;-2FB"ZZVI2D@8>>>NOQE.K?0[2`[`?113MMOU%M6/TH;^V!
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M3AE<6_/=RL]`*"M-OM4C8E[+<3OCH]U3EX8G?3T[%4+>G0]_9?4;8-YVU.%Z
MZ==6;_<-N[6W-$+KZ=RVBQ/B#=KG"E,E;+$)QQ*W0M2O=345K7%DL(W06_*)
MJ%`W\`N[C,\4`.S:JV]6=JS=D;^WA8[+<[B[8RMMMIY]V3;N>PY5Q*E04/J,
ME``*4N:_$,\,+S:5(QW,4<`@$`H!MK_)6E]`?ITB]>MV[[3>"JV;3L34,7%<
M%I*UO/SXZA"CA;C@0793I"WE.AU>FH3I-%#:ST:&\B$A-'4KL3#4=5ETJ&-[
M1F81@VM*=FPU41^H_;=X]'_J0N<?IS=6K=(V^S9=T;6D/P(LL6J=>K0F2T\B
M+*,AMQVVJ>46W/">9165*%JR1NBWCBUO,S,+=M-I'?P3J%[M<LF2._+H\.X[
M`<-W%1-T]Z\]0M@;OW#U%L-RMDS<V]K3<H.XYE]M$6=YQ=W<+TZ<A,?R:$RY
M$I2W5E04%*6<L0,S>=.9]E3L5J@N^1`(,M:#;7^2OKZ&;!N/JZWU.E.7MU$K
M;&X=KW&Z6M$N+;K*NU[JG,&?)7&1&)98BJ><><*2>&G+CA_I\'/>75I0J-U"
M_=$``W;VKF)U[N)'7[K%/@W5Y;"M\[DC6^3:I2%PG(UON<FUQWFW5M.)4R!$
M)"`$T40:Y9[W=T[,;8"E-]=OH244;980^@#BM76'U5=6.N+&R[%U#OT:XP^G
M%M6Q:)D*(W`EO(?MD:TL^84U5)>APX:1K()4I1.6(J"/D2<QIQ61;'[SJCN4
M6>G_`*RW+I5ZC^BW59B*Y<!L?J=M>Z+MA'F5SX3MU:MLQD`I`6ZN#.61EFJF
M)VTU)V<`M]O\D^UJ**;23=-`!:*4[L-JZ??G7=:E[Z]3.V>EJ(S0M/1S:9ND
M+GU\X_=^H[<6\.3%MZ4I91;(4=F.$$K^\0<QPPZU.^DD=`VA`S.W]@52Z3M(
MP9Y7BO-:T#^[2IKVUKV(GZ)]TR]F^B3K[NAB;LJ9);]0/2*U3HN_[=,W*+BU
M<XK4&/;X<!AV#Y5ELRGI;BTN.`H:T$"NH0VO:?'=P-<7Y#W5^(70^C>;<ZR[
M3VBC17YMOL_FJ9_F-[FM6[?6/U<FV!NW1K1M2\P.G]J19HD>';8\3;=GA-3H
M]JAH04VN!+NO/?"&E>%2M)*LR7;G-+0&"F"@-.A\F3YT^8=4XGY?_>5%9EWG
MN*=89<D(C+1R7(XD++:F544MM0TT4%JSX=F&[I9(8S%6H?[$_FG9+@6`#=CL
M]BTQW'GHCZE**%,GDZ1V@IHG/(ITI/MPE9SFU)J,U<.&W#M32E00<05U@_+"
M4K;U^W9U':=$V_1;U9-@;/DW!EF9*M$67!_$+DW:Y$EMY#*)+A2%(#=1HKJP
MM;WIMYQ"\5QVUHKMTYTVS4]&N;ILO+,`/RY:UP=OJ*;.!7</U1]<>E71FS;+
MD]>+O='['NB-<K?%D)M%QN;C]X=MK;LEIQR`I$=EE:B26M->VN-^J],BU:.*
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M-$<6#&N$^[V9MVW,N)4AU.HRHU$I-:*`/9C<7$D9SN^9HQ(XHU:UBO8XC".4
MZ$@\<U/53VJ>/7MU+:O%I]-VPK4N-#;V#TMF/7-J,&T,*OMRODB&J2Y$8:8T
M/3+9;&G'`M2PI:]66-)-1S>"/+Z?Y**T>T?I<\DT[C.U^P$9:>FI7.*T[QOV
MU[['W!MS<-ZL%ZA@ABYV2X.6R>&W<Y$;SL1+<EJ(^>*6U)5[<*6E[<Q2<]KC
MEX?S3X:?:7#C-(P5)V*X_I.ZM7C:/62)=7[[+:7NO:6]MGW.^2BB[7P+OMCD
M2;2^FX7CSJG2Q>X3`4EP*UMK(!2:'$DS47S7C);AN>('%I.W`[_Y)&31H]MJ
M[E/W$"M/:$__`%2;S;@2O3%O?95TO%AW'<O3KM2_7"]P'F[7>A=G=Q[BCS&W
M9UM;B\P-2X;BD#0FB5T-13#BXN1)_3#D]QK]B3;HF;^IDYG_`$:?$JX'4'U7
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M;*#WJQVQ?S.H6S.EO13:CMM1?MVVRTN6GJ;N]WGW`V6VV.Z+M5O_``*U+4RU
M>[K=[:A!*"\P(Q-25@8Z<S6Q/I[(',H<E*U_E\5SB^T%K;]Y#S1K_P`/\U8:
M#UHZ3[UVI(]3NW]W[TVQTUV-=Q,O=DGV^V/7J/NF'J#\%AMIUQ95<77T<JJT
MH(U#LKBM/L6NN.?S*=E/YJQMO`W3OV_E[Q\U>%=U/BDRV_F66K==AZR.66U&
M!N#9.TYE^V;?.66$;D5<9UNL[35WL"D.,PI,,3E.T;DO)*TUR*C2PMU'+!R*
M8<:JK.T8.GYY=CPR_P`URN7OBZ7J\7.]W2ZR7;U=)DJ;/FAQ3+KDF8\IU];B
M4DYJ=6:YXK+KCF3O!'WR/:KI;3"*W9'EKE8!Z@G!9=W2K1)1+M]U?C369$23
M&DMN*YXF-RFW$.<P*2JE4YC[0RPZYQL6BY:,QKLV>W%8N(F:@SD/HT5P.W[%
MT#G]6+IOK:.W>JVY=_N&Y6N`'YVW7I5+%)GVA2VX;KUJ!"0Y)*?$JIK3AEB^
M0/CU+13>2?)E&S;[</<N;W,;M.UH63!GJ?%L[-F/O17I)OV%U.ZI[>DWFW6>
MTV]T3%0XEDC^7"[@E(D/2'7W5.+<#ZGB=*0BG8<<_:X12EPQ&8KH-K"V_BRG
MY<N''9AV*^\EN#MG>3;=A<4)`M2G77U*UDMK11"$HJ=%%5SKGW8L^D7V9SQE
MH0!O[54=;T\9Q$'4RN.[;AWJQ]@G.W.V09#P`=7';2LCM*!IU4H,S3%JB#96
MUK14.]TT9_'OX?S2M]?^G9QP\^7BL>3'XMW#^::WXTO^]_[OU8@?.=JE?)CA
M[%BJ^A(TK5JU<*&BA3C0I`4*^S#2ZO78-&]+0VXC=F&!4+]9^G,+J-:GKM"6
MW'W7!A:HZQX&+Q;VN%FN1J%)6%(U)6V$N$$#5B'FM_,`N(W%7#3=5?:AHKA4
M)(Z$]-6]H6YC<FYTH_S;,!7$MI4K18XBDE/,;HH(=7*0JA#@44]E,--%!#Q4
M%;=6]1NOG>6@J&G#`*4IUZ<@]3MNS&UHI<MG7BUI/+:<(=M%R@7!E0U(.DMQ
MICB13CJ->`Q<+J]BMF-B<*AS:^U4BWZ>E@K-F\9JG5/1:;S","[P(MWMKK=5
M6ZZLHN,`\U&:C$EH>8YE%>]34._$7(;.<'F-&6AKW)_GO+1A=&XYVXCO&SVJ
ML'J#Z?=*]L=`.O&X+5L/:UJGVOH_U*NC%P@V.&)D65%VC=7&9$5WDJ7'?:=`
M4E:**2H98CKZVT$6+@6TP4GT[J_4=SJ#<[MI7P%>GS\R*=Z=.DEMV";9`WWN
M+<;\J9=-Q;W3?+L[;8EUO-ZND65#N4=QQ]5PAQ9[2-*EDI#8!&.8PMLX\XL\
M(R\U[Z#^2[[,;IP8;O&3(/5BG;M;\W/JOMF3/M2STTW1;ER6F+3?MU&Z"3`5
M'@M&7'99;+21J?U$!U)*3EEPPZC(S@5QJD2#12WUU];ECZRVS;<"5%;,N\QF
M$O1K&ZY)VZU<$1R\)"&IBW2T7%-E%10BN6'QPVK153ZM[EM.\=ZV=%L5'O,3
M9NT!9+E=DMJ+4?=LV]S+G>XK*5`,NRH$)]EDN`%0(X@UPWN_T!3B4Z;_`$_I
M*[S^C?:BKMZ)]SV=]Q3K]YV,R7)L@KD22_-OL%<E\OO%;O,=:82`=7A'NTQ.
M:)_3.4)<?J>E-4]&=P-MI:9W]OZ(R""EB!O:^0V4Z6TMI"6G9KK:$)0@`!`2
M!B5250HSZQ].>H>U-A1;GM[K/U1VS>-P;^Z?;'M5R9WO<9:XHW#?TQ[E.0S+
MBS8BW#$*FZ$*`"2J@-3@14*28'H_ZV(<2Q$]:7J=;)J:BY;06*I!4K->WE&A
MSIC%.]:3.'+.#?X]*DFU^D#KR0T'_7'ZFVZ4T`R-CK)!S4:KVR33(5^7!E/:
MF1<#]T?QZ5*=F]'76Q;;?_\`O#ZJ%J(&I;-ZZ>,I5F<T-':2W$?)F<&4]J,W
M8/X]*E_;?H\ZK-E")?K3]5LURAJVYNC9Z0I.1*J)V4@@C#BV!YGH*U.)5I.F
M/IFOVVKBFY7CU(^H'=#D-#;K$'<VZ-MF*5+5H<(+&V8SNE2,C2M.(H</T+L]
ML!RW;>V3MBQV]3JXT&UQ^6](EF=)>D2$I=DRGY:SJDO2'O&I5`">`'##:X`#
M"1M*YEKMRX7SV;A(?>J8^JZ>9&[=K`*S.U`5<.*;Q.-"*<0:'%6N@0<0=JOW
M2,[I6Y3L#/B%2;<#[K0NBFUZ5<ZRS3DDTD*?=96]0@T);%.[#)7='I[JTZ0E
M5`"`*`9`"@SI7`A->ZT,1Y9]XZ03WYY>S`A$5^)ME"LP&FS3A0T]F>!"BKJ8
MI7^5K@[R5R1:U-75AIHZ70[$E,NJ6TL45S`TV:5)&!"X4==_S..N?1/<W4WH
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M5QG$C@&F@)IVIR*;5QD]2,;8JOSKV^G_`$!OL,=/>HG3#I'L1!AJDJL]W?M>
MPH-NALN2)`2[.N,466.X7U)2HDFAHI57.GM=FQ!K1,+PBA.Y3'NNS77:>Z+K
M:K]%DQ;I!EN6F\P74IT(NL)9C"5&*$A7(DQT(7QI4FF%M0:[S##0^'AVE,;)
MS7-<6D$9MW<I$Z1]1Y?3;=,>4[K7MN]LKAW=@$!++[1"!<`W35KC&J@1DJF=
M<25H0,M<#@G,@_+/<5T]MU\M5UMWF$\FXV:>RA)+Z&WF95ON,9429%6TH%J3
M'?;>*7$$*2H9$8F*@["%%T*Y->KW9:O3IL'?CVU:HL_46\VZ!;DM%3L>#!;\
M#UO+;Q>:;"6EA*5J`<&6E0H*0NH!W/V891\4A);\QV8\%RA=W,?,-L(<*2LD
M*0-!TY<*9E*0>&&D+@)FBHV\4F;;*"X;D31?2F6HNK4L:A05X>+/@$UQ*5"2
MH4^;.FY;D>1'LS2GI4?0O172A!`<T*6?=40'E4*JTKC%1V)1EMS!FHGK`Z1;
MJ==2]=[I!MQ2JI\J>8Z!0Y)"]:<ZBO'#:Z>60.<W:*>].(-)\[*+489OAC\%
M+E@MC5@AR(*GQ=^?)M$UUZ2RVIMA[;TT7:)KCE')D-JDM!10M*D+T44""1B&
M\W-VJ9CTB+3L)`'%2GZ/-[1O0_!W/MWH[MNUQ=M;KF7Z7N2RIG7!V5=I.YG0
MYN);5RG292K9'N*ZE;->7EX`D4&'=L>:<SQOKCQ&P^A+30QRQ\R/Y01L]A77
M3HQ.Z6>HS8]LG6G:$*UVSIM)_P`D1=MWM0MR]JLOVU4F0FTRV%#7!FL/*2AU
MG0ZLFJE'%F@(+*!5V6S!DV8II==/RY^FW72]_P";/\\/;*W#'M$&QP)5H(NU
MF1;K:T6X*;G;$!MU^3%0=(6DA;B,UE2L\1=X"2:`K7R78DCT5^G+<OI?O'7'
M8-UW#:]XQ7MX;6OEIW-;8C]K9N%HE69KE+E09#BWHLH%Q1+(44MJQ-Z-7RX_
MPJF]8-R0L;P"XY?FOS)$;U670J6LHF]/]CS(=?=3&>ARHB6TU%%EL0P#6I!&
M>*OK7]6IGIO_`,M;_'%4$B37HS4%IYPDKC(=*2`%!)4H`4":CAB(5@73C\LG
MJ%#V]U8ZNVF4%NM73H+O.]NLE:BT],VHPFXM..-Z@EQ;,=]0"2"*&M.&)31]
MK^]16J_=7(.Z[J?G)NUV<=*G+G,G7)IS0@'3>9SUS*M*4A)J\\X2:9:J<`!A
MA=_U;T^M?Z9J;Y4%6SS!4"_(J'%A5"I'V13@`*]@PBETT65O)D2EM+<0["2W
M,BJ;6IIQ,B(ZB2URW4%*TK4MH`$&HK49X7M/U<>*9B=T^C2,=7Q'WE6S]7?6
M>+U_Z_;CZMP%GE;DV]L.V%;FGF//;:V78[5<5$4`12Z-O5``U*JHU)KB2NZ$
MQ'`T)^"TTF$6]M"[\1-?4%(7ISWJ^YL7<O3-,IT1G=]0-^2(G,TQWD0MJ7"T
M1RXG)*ELR7%%!/NJ-1G3%0ZIU)]O&&MKBNM?2W38Y^I"\[*'X;U2S=F[+ENS
M=V\]SW1):G7^]7Z8\5*"U/R%W'G.2%?9"UDDU`&67#%H!&4=P7-W^-W^(^]-
M:%]Y#4^OQ+U'4LCNX5IX1AM<4J*<%HM,5QW_`!":D(6H+(TBA4!D>&$&^(=X
M6S!5X':/>NI/H6O<;;^V%OZBQ'M?7/;DU:TC5I84Q`C2AXM06'6'U(H:TU99
MC*.UJ5UM=![.*ZST:2VROK8>$U]/B4]_F2=<-X]1]L6O;4[:S;,;9G5*<+*D
MI\*FN3(L$EK4$A15)6VV]11*@1X:"N-_W3FL;G.(%/:M[_0X[+1A<M'SEV[;
MM*;MZZ]7^9T0V1TQM-F=M2.GVW+/LBRM-K=#-P3.:9B7J]OM+U)4]S7%OND@
MA06S3/55&:\:Z%XKM:?<D='T>.WCBO&@9WO;W[1N]*Y[=:[5<CU#W)%E2`ZB
MU/VN#"\+:"U#:MJ`AA*D(2IP`]JB5>W$OH9'DMH55ZV_JJ':HS:<6RB.6U:5
M>84VHBBJA(349@C(G"\!!#J$>(JGL!`Q4Q=/91MN\]ER6BI)C;DLZVR"5J2M
M^8A@D:M6H'S)\)J,^&%),6'N2K&A[@T["5)/J=N2CUOWK`?6M;=F8LMJ;0HF
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MJ,L1,?\`4*9A_0=_X;O<NBOK7]6%BZ\=*?2F]&><=W!9=K;AN&_8JM(#6ZX#
M4?;>MQM`2D>:::3)TT""7C04`H\4%TOA//FPQ.WO7--N[NNN-/->%Y:DK;31
M*&#(<"4E1:2`U1Q?O99X7;=9&AM=B<3VS'S.<=Y4M[=ZL[FL&P]_].K7<&(^
MUM\7K:UUOUM6E(?7<-KKDO-(AQBDL)M[DE_4\0`7-*0JHRQMYSM2/E(TD6S<
MTUF//;9F.LMW&,NW3$-*0TE^$Y+9N"XU$I`0V9C*5^&A!%!EE@\WVH\HSL3J
MB7Q]"65!]>I24%1)!45&E22H$DDXUMW9GEW%WQ39S<KBT`T!2PC<#_-:47U?
M=K0X"2F@4DFA]T#$K=`.M*"E0MHR6RM-#XO@IJMF[KE"Z=2)45<21:;I.?L3
MPE0'YALDVWE%R:E(6VZE*DSF7EHTJ!`IWTP[&HOMNF7M9XLOPX*(&FBZZEC>
MX?*2/>I%Z)]0W-M[FVQ<I;Q6(]T9N#.A"6THBK*8UP;0@#)N0LUH:E(X4Q%Q
MN+HF..TM!]84YIS>7),S8!(X>HE=8]O;V=W3O*Y3HSJ@TDQHC(TI*1#4VD\H
M'20H:B?%F?;B0LY3&\D;U5M:QG-.)5X]KS3'MT5FM-"<DF@(!)*>([`<6NSN
MW$8;0%1KT'/O3HYSGQCYA]6'GFRF].PJCE[ZO1[225SF4-(?;CK4:^!QYE;[
M9(K70I"/>X5-,4S]Z9Q5I2"UUJM\V1'<-RU);=2U6/(#'C>S2%!1&JH0:'LQ
MC]Z9Q2$T/.I3<E^%UQMT^\1H7.9>9;EIM<=2W4NR3+<:6ZGG`'4&]25>,Y4`
MP?O3>*1\F=J3Y_7*,VO6N:$)RJMQM24YUH"3C/[TSBGJ17NLMN>O&UKHFY,/
M.0;I,AN<@\SEPKI;RU+*@,PL%I'AXD?)A&74FS$$&M$YA_2=W_!/M?6J(AHO
M(N#'(#B66P2`XIQ:2M#8;/B*UI%0.T8U9?ACPX[`:J'G_4'>/>H,]2/6UF1Z
M?^M-O9G+7(N?3#>D`1V'.4M:)5CEMNI>J,VN4552>)PTU;4FW5:%2VC&M^!V
MKY!/23TM]*.YO1O,W%UJZ';1ZF;JF3K]#V5/??FVJZ;>:?OFXF%W03K;=+9+
MDJ86XTH,*5IJ21VXK45E#*"]Y`-5WZ/])G^$*-]F^F#T]6JY+8W9T?V#ON$7
MO.0VE]0=[6&[-+6LN-QY3<>]KMRXZ`0"`I3E!2I.>'4%A;QSLD:1F#@42'Y#
MW*1NJW13I;:=L196S]D638$<RK>B/&L%SGWVXMA,EDEMJ9?'IR4IS]YO0L_%
M3+#N_P##Z4R&Q1GO[8[4&+:=R;;<9EV63(OVWI=K=6Q'7`O3%PN$N7<5H2XX
MEZ1.:DH4XH?:%"`<1C_Z0=Y3AO\`3^DKOEZ&;5+>]'UP>;Y!;7MB($U?0%G\
M*>L4>9X#G5#CHI\0S&+'HG],[N^*@;W>G&E"E4IVJ4@?ZR>.)11:@KU+W!VT
M;'Z8+79IU^4GU'=+2Q:;=',NXRRU`W;-=\A#2I+DLI8CK)T\#D<"PK+VWJS<
M`:KZ(]<2FO!G95I0O,FFE1W!D!](PM;_`*H]*RI"MG5RXU0&>A'7U^FG45[6
MM#92>R@&Z6:@_IQ(H4B67JUN):_\%Z=^OSBAI+KAL>T&$4!S4@S-]-K%/[21
MP[L"%)<+JUOY*`Y#],76>8V5!*9<Z[=*K;FK@"M6]W%)U?)0X$*0;/U*ZSNK
MCH5Z:-VQF9,F,VT]<.JW2:`N&''$ID3'(\6[723(;;8^PE:2HB@3VX$*^-OW
M%*CL0HS+#K*&FHS:&G"E1:TI3X%N-_=*T&H*D^$TJ,L,WW;6/+3N-%S/7+4N
MO7O%<9#[U6[U!S7I.Y;$Y(IJ%E><.DZAIF7!Z0P:CM4WF1V'$7JER)K=K1^,
M'V%7[I*W,3,Q_!\0JC[K*U2I"&:'SFW)Y74Z:JMSS;[217WC5>0Q`*[+7#N3
MDVVPI!H1,BI7[V>I*$\ZHIEI77Y<"$B7AYM4%YL$ZP['72A]UMT%1KPX8$+4
MM:7%<Q.:5@*2>%00*&G$8$)D[GCJE6"],("BIRWR@`G,JHVI10*?&!3].!"X
M!^IC;FWNG5GG;\-CM#V]=W2W(<-$MD/2$WR3'@V>#=;=.1S1;)UAM4)IAMPL
MN!245JFF8A-GJQ^7-8970#HQO"XWZ\6WJE2[[HGIEN<ZTR(EU7'N`AS8]$C\
M3DMJ#CCY``U4-#@WH5W_`,J/UPW[I3OJ)Z.^O`1:;<ZN+%Z;7B03$B[?N<EH
ME&WE.FC4VTWY0"XCB3RTJ4#B70OK,LJF&FVVTN)6XDZ7N6=:$.)312"H9:TU
MS^48$*4HL:TQV(,V)9[3&N4U='KC'MD9%QN$E&97*E,(CR'G2`!J<6LF@X\,
M8.S!"^96SRU]5_\`U"&_+D@L/L;+W7;+*])>;YB8<38_3J'$<D):S+BH[KBD
MBG$U`PZL=J:ZO_0N&[*N\G5?H'TSZBWAO=FYK?(-]<ML9B7(M5REVMJ<E',<
M9DR&6&'DKD%EP)))!``'9B2N3\P9Q"XSI_5%UHET^RA!Y;Y,QIQH&_!<HO4'
MLB%T<W#<6I%R:M^V)GEY>V;Y=YR4,!F3*Y#MB$M_2IV2T3RJ*`*R*X@I]*=-
M60`X8KK^DZT+VW!D-'N"<?1#KJ=JB-MZ]21.VG)>2BRWD(4ZQMIE]06ZXDHK
M2,ZY]OA4X3@9Y6E5)*YV\-M[,ZN[(NFT=U0(VY-H7Z*5OJ9`4\Y1-8-VM\T'
M0S)0233BF@Q*.G\S`:=H3"YQD]"^>SU(^E/??IXW0]>'#+W1TSN`<_!-YQ(2
MT)@NJ65QK%?&TA3\:3&CD(UN`)=*=0-#BHS:6YMTVYI@TUJF^*J1*O2`E6EY
M*6WUPPF4E6IL(?E!@J;4,E*2M=%`9I[<.5A=']D;2MVS[''M\<IDRYD1AV?=
M00I3BWT![E@#WTQPL)!&1I@4C;_I#TITN)J@I![@"<N!&!.X?U!_&Y)[JDLZ
M=9]ZM*9\*5X?+C*?(F\@G[X4*%^[F-65$YIXC,8PF$OZA717\O&^N,S>JVVD
MJ"BMO;&X^4#XENA,FUNE'QEL+%:<!GAY8?U([C[DFNJK<A]00GEKU'AF$CLK
M4JIB=65`?6CKQTTZ(3K6[U)W':-H_C4.8Y;)-X<<:CSE14H#_*?0VMLJ;4\G
M5W"I[,;LO6Z>#(XT#E1^J=(?J5,HJ0?BOFT_,9ZS[(ZT]=-NWW8=\M6XK7#V
M5;;2[<;8_P`UC\1B767*>922E)4WR)"2%C(G+%2U*7S,IN&^&OO3W1[%UA8"
M%PQP^*I,_/$G<.IQ0"G$!MD'M0PTDKJ>"<R:=^(Y2:Z6_EP[?C7?J+UNW`DI
M4+!Z?]ZICJ)`4;IN^VBPI:0DYJ2N+$750R%!7CB4T?:_O^U16J[&KDE?XQMS
MEQM#2%H_!)4BQN-N@MK:$*;)2$J0K/W@2.PIH>W#"Z_JWI]:_P!,U:94:-&M
M,0DTD/)HD`9'AQ5D!A)+IN9C(YGMH*Y]O#`A%WEH2XPE2@DK6H#5EP`KQX<<
M;1_J!(S;!WJS'I[0H;AOB@-27;3`CI4CQ)YKDYPI!(R`SS/`8K75OZ35V/Z=
M;^XJK,T\AZ<TZ"EQ#\]A2:5TN,27V'`?8'&B`>W%B&P=RY&[Q'O/O7MI;_\`
MHIXGF:E-.:#S0(W@/,4'V3FZ0E)IC*PI0ZI=/-R]*KYM-&ZN0ES?G3_:O4:W
M0X#B)$7_`"_NVV*DV%\%FJ&)$B/')<8-%M+R5F<"P5:GT]Q=P;!M30OT2YVB
MVW6[,WYR))_P93&N$`ILUQ:="9`U(G(0H)I44J:88W_Z:ZQT1_3A7NW1)8W"
M]$>@W*\W31+MFX+PU<WH]_B2MT,!$MR^*YBHAC-J*@G30YIK7LQ2K_\`78?[
MOQ72H;2&X8]\AQ!^";U_7<[A:D72?<[1<HHO+$NXD65<*;"9@12TRU#EQ24"
M/YNC^E1(24YG#YK2^T<P?>81ZPHPV%M!>,F!%62`^H@J(;[T^Z1;MV-ZE-U;
M\?\`PK>=GCVMOI]<57R/:V7%M0EW'F-0G2%RK@M472D)%2A2CV8=Z5<BWB\N
M<#L7+^O+8W.H^;`V%<T(TM]Z#;5);"$ZT$#(%2G&T.K6HY:E.+623VUQ/VD/
M)C(_$XGUT5*NIA,YI&Y@'O4V;"EHC[PV9,FN)9A,[ELJY#REBB$,SF%K44TK
M0:,.DV3[]4RN9ULW).YC2A<H-GE+TN)*BZB$AG5I!)TZ`*'`A0*O."%`U'F$
MLY9G6[[@H.PX?0?I^DH3FAJ2[$:4W529+'-;4!D$I6$GF'_PU5'`YX56DOZ9
M06VI%-5,ZTH0>%.[Y<;)FK;;,M$O<7I'W=Y5<5"=F>H3;%QEKERFH;;43>/3
MN]6PI;<>*4NR9,NP,(0V/$HG+AAV/Z<)@?ZD]X]R@J)#:+4J2L@.R@5Q16NH
MI\7CI^[X=N(:/^H]!4O_`/+^I%IC<)42,"H^>*'1-3I)2%Z@&]+@!2OP]W##
MY-TCO(T-1T).F@H%<=/BR73O3QP(1_S+*(JF5GFO9?XDY+<%:EHBE0%]_LP(
M2@[<84MNVHCQ1%5":3YE*1^_*7%%3B:>^L)4`0.`P(2Z9;FOFI%&JZQJ.A81
M[WB0<TJIQ'?@0M;UU!2,_M=I]A^7&[)1"<QWH3TL6\51MHWNQ?B#H7/NUOF1
M[=H7R%ICLNHD.K?_`':%$J3D<SA3SS.*Q4J1^GNXB\];&GU46RWY6@JI*7%.
M`(&H>&E!QP>>CIM36Z_377WH?N%(1%6RNJ8J(K,@G(I6#6B17Q#/B,26F7K,
M[\=P]ZJESLKVKHW:-P-N<C4Y1PL,FAJ!0IJDU/"HQ+>>8JQ><$[?Q]C^]'S'
MZL27GA[$UP7S&[L]5NVG1?;HC<)6B/%@1%,)6'4B5`*0N4VDGQMO,E0)[#PQ
MP3]ZG_"/65.OB#+>&>N,IH1P[EJN7J/V_`@0'YEX:=4XN-(MQBK2VW,4^BX*
M:CE2,R\@0O&!FG5AY::C-<!Q<`*4V=J<NC9;W#X":@!IKWJ+9GJ6CP;E$W';
M[](AHNAC34M-NE:8;T53B7A**S5IQ2M0'#PT.'?F)%FL>Q-&?ZT&KE<%6^+N
M%]M"9+">?^]44!U(4E32CH&I*OT8/,R)#DQ_B/L4N6_U*VINXV5H7);ZG]T+
MVTVAFJ7WI*H3$A-P?:3X4MA#Q349`C"T=^Z($'>E6,C;&X9L:I?O/J%8796F
MHUS";G:+78;VX@2EB3)F2IM7BELG27[9`THT\"%U5@FU5PB<12N4^Y5^Z+A(
M*"N(57/4OZNKIL?TX];;U&DE&Y9FWKY;+.]>'2(Z^?<8MJ6RA#(<47GXTA9%
M!DH4X5Q%VNJ2R`%S17TJU=.V+9K@2EQ![AQ7S'[7WMU:NEBLEOVU:Y>X(UMB
MN,Q=LV66EZ6WY^XS'W&94*&ZWI=1(D*<33.BQ7#V2:1Q!::8+ML7Z8;P"0';
MGU:C;F,*3T]W>BZB9Y=VW.Q-P)G*<#_+4VU%:;6X_**_#RT',Y`XVMYI&3L?
M4FCA@A^4,.;!M%?#K/</4KTVZ?[;C[LVA?\`IM)NME8NFUX5]L$QB5>1#:3<
M$.1&K@VS=G&I;,<HYBVN2"??)H,3$URZ84(`30/M?QE2W&O+\G85A7*GHGR+
MU$C[MDJ0RN+Y>XWZWH=F1EQUI2XV[&=64JJ`3I![<-JES!`?#7;WI<%AM_RS
M5M2NP'HFZM?@/3&!TC<+;ER5MNXR)+:WEI=3'G2X#R3RD@I.D0TD5XZCW8L^
MF<N&+EM-7.XJOWFPJUC'_=<4Y\O,KE^BF))1BKUZD)<=^X^F>TRFT+<N'J*M
M;\%M3#SZW5VS8VZEN(0XRZUY<-B:5U)X@=^!"Z&6J(I*JB"]4&E7(*DI[0-2
MJU)PM;_JCTH4B6Z.I/*_P0&:>#0;X<??S/Z,2*$_K4J*VJACQ&W!0.$R6TK'
M>74+#26@!QHI=!G@0GFSNO;EN;Y<K=>U+8XD@J3(W%8DH`XG4)S\:GRZ:X$)
M;L_5OI4+C!M!ZH=+47>;.BMP+;_U#VDFXW!UQ2T.(C6]J?YB0\D(\*4)-3E7
M$?<WKH#@T'THHGRCK/9ERGXO/EH4W+4RA*6DELQ4.E'."C4Y(%>T8J5QJ#W3
MO.48N.\JL75LRZNG-=A1Y46=0-]0=XW-AZWI*VK9"8MI=))"_+EPA:J\%KU\
M!EEC07+IOE<`%<=&8(1RAB,NWTJ&=RE)=V_*)T)1<WH4GN+4Z(XE"">T+<3P
M]F,J>3)VI./X;Y9PA2H$B;#0",S]\M!)^$IT]F!".71/^&>7W@"GZ0<"$5YY
M;0TG2#1EO.M.(P(38O5T1;K9<)KH(3'8<7X174HD)0A5>"'%J"5'B$DD8$+@
MRQ9;CZCO6/M/I],T7#:73V6Y?]T);)<MZ+:Q,>DS'%J5X!+!*8R4\"APGB!A
M:&(25J:40NK?J3C_`(E9+&PRT.6AF0RRR6TI#++S:(S3*6P`D)CM-I`%,Z9X
M7\JWB4+FQZL.A3V]>@EGZX[,BN6WJ=T.N$E=]7":!NUTVS;Y#3L>>DL447+`
MZ/,H6BJDMH*!X<:>:=^$(7T6_EC^J]KU2^F/:6X+S<8LSJ5LIMG9W4".BB'Y
M%VC):9M-^+8HI4&\00E2G3XBL'"\,IE!)%*(74R+>HT6S1[Q-6U'A6&3<ILB
M05_=)AVQMR2_)=4K)*$,,E1[*#"JP30$\`OF6_)FB/=;?61ZN/51<TN267[G
MU'ND>X.#6TU_FK<SD:RIB/K\;B1""T@\>6VCO.%87F$U`JF.H2&:Q-<,%]%M
M^W/;F6'&D.I>6TAI(U&F092`G*M*##PSB9PD?A3"BY"RV@CE>YS0YV?:>X+E
M7ZW]@3M]NV*_-6Q&[&-O6R0+WL5V0M(FV.:Z9JKG:VDU2+FQ'KH5Q"@#QQ)0
MW[<G(#6DNPK7C@IFSOWV\S,@&5KAACQ7/^QS6V(6FQRO.[;=68:83Y4V_8UL
MFKEHGL+^\6^T45!]TA-<0NHV\IKD&-%T.PU%EZ:.HWNJ59'IWUCW/L@MB%/-
MSV\E.AZURGG`F*J@YI:+84H-D4HG@*98BK6>XM?R'L!QKOWJ0N;:,R58XD4"
MM?8^M?3??%L=M&Y$H2W<$%B5;=R--R8UUYB?$VXEP%HI2BH;60%I2!B:>Z.6
MT>'4#BWXIOY5I&TJC77OT,=,M_V^$[T,O>WMFW>%"N#2=LW.2X]9[S(ES_Q)
MZXBXI4'H4N/[B&Z<K33MQ#>79^(K'E6\2FBS;9FWX,.U7-#2)EJB1K=.4P^B
M2PN9#:2Q(<9>1DIE;B"4]M..$)&!CLH-0G\%LT1`5*+"9"FP1+@7.%<(K[*9
M#$BW*7(;,<NAO6MV@0A6O+Y<L(O.1I<-R7;"&.S`E)3BDJI1Q3E*UKV5I[.W
M"'F'<`EDD)<O`O#A:CQG-NQK>'YDMUUQ,U%R+E&X<9A(Y3C!;HHJ/B!)PX8<
M[0X[2D70ASBXG:K=^B*\7>%UN6U;W&8[DW;E_C%E]#[L>;'C,JEI=>0PI#A6
MP3X*&@[</K#^I'<4F^$,;FJNP1>W:XM*7;O9(B7`HA3EK><6D5I5OS3RB$CM
MH:8G$@N*'YU$*ZPMA="[_)G,76)"W9O.V393,`1?++F6R#.C^7*)#B5^9+3B
M`E2:)`J!V8@>I7N;:LRFF":FX$;R"T.QWKY[A<Y4-Y$L0'W8SKJWH]RDN-QX
MJFDRU1BVW)*4H704*@,]>0RQ4H+]W(Y;P-NU:!PN792`T;<$I7"^:+^%MEQ!
MB#06G]25ZGVDJ(6=(R`55)%:C&_G&IC<.,!H,5<+TR^K7:WIRLO623<TR9VZ
M=Z;#@;?V3:6-0_$YQFRQ+F3'6P2Q:[89&ITCQD)RPYM-4?:5+&!U3O)3>>V;
M=M:7$C#O5+]P;^_'9]TNTV,B//OEY=N$VA4$.KFK:1S!J`-6M)IWZC7"$MZZ
M64REH!/:G$3!%&(QB`M=XO$=_E1$.E*H=$H"5?O!0$%0/`GV8U\T[@%LI)Z)
M]/YO5^][UA6NYVZWQNGW2_>/4^_7&<W*5#8A;4;2D172V-1_$)3[2$:?$2HT
MX8E6Q1.`)<<1V++_`)+YMI]UP!KOV53,BV[\6LM\W8FU725MRUW"UV.+?$VZ
M3&M,K<-TD/<NVLR'QXG$P(CCR@/$`E/8<(7#FVQ:^/YB:[4G<-RW9MONMH:_
MQW*8.C_4G;?3M[<3=]M\U;<NVPY41^+H60Y&<YRFD!9J4\TE*CV4RQ!:I"-4
M:&R')3AC[UT_I+4&Z6W,T!^&_!5JO=ZASKWN&71+#,Z4_(BMH.I*/-3792TH
MKQ".>1[0,/Q=.`I0+FKC5Q/:4FN7F/'LTEL+`1%"G4N5HIQQ:%H#*AP"5#M&
M>'-J\7$F1V"W#*POEWM_FNC_`.92Q%LEQ]*#K32?\9Z.>EL5YPBBA-L+B8K+
M8`R47HBJJKPU4&6)"]MH[5@>UQ<5$6]^Z:7EN:`*TJ"H>V[U-@[:Z3Q7X[+\
MJ1,BR8\`W),R0\6=24QIXDRJE,$E"TM)15M*TT!Q`S2<YM#@NP].W4>GVU8R
M'4XX>Y*5N]8M]@;?DV2+M5E8E1HK:9US<B19_.CZ=4EE.H:HZ].G2<B,^.(>
M;2XYWB0O<"!38$I/UO<M>61Q1AM?Q%'[IZP[A<+083NV3`NLYGR4R1#>)B&W
M2&^3*0W$2/+`%E2J.)-1Q&',=JV%F#B:!1CNJ[I\@>YK=O$J:-M(L'6AB)8V
M+=-O#_4'\`>M<N"P);UD;;B2[9<WWH[E(P7`8=4XDN4U`4/'$'B[4`=@KL6G
M4.I1OL&W#@,SMRY^L76$EQB(F1$<>1-4@!$I"%2$M)0PA^-&6GF!A8:IQIK"
M@,AB_$C*T;/E"IYLXV1A[7EV89MFRNY+-PO:&F3%0Z4J;>#B5!9"D+0[S``!
MW*3C6HXJ+DF+'Y*`HM>-X7'<%SE7>\37)T^3RD"0X2%,Q6&@VU%33)2$TK4Y
MUQG!8YYX+?!O89AI4XV9`>ND=MA"'D`K>;#%&5)4DJ2ZZ7O`!QIC1UZZ`\MK
M01QJE&F9XS-:*>E/JZ;BM!FSF[`)#4:5>GX-O@+0D2E(8#3`#J!^[YTQRF7;
MA2"^=+*V-S0`=ZQ)S0PEX`:MSKK]N=E,WEIV%(A2784R$X")C$R*'#+;+2Z$
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M&$YN&[;DLW:1;IK89E4>=0PVQKJ.*C3AA+S+N`3^WMHYJ$N(!1WIC>%J4A:2
M'&W7FW6W2HU#:CS$+304-4T_0<.A0@&N)"B;T96D#8"NN'0#<"E+8C*<:2+D
MMA>IQ9!;*#DEL9:Z]M<26G`9WU.X*I7.STKH%%W)R+MRI,D,AN/&0.4O4E02
MR@)5GVJ`J?;B5HVGB58O=J7O\TI_O)7O?W8X=_R8=\U_'<L^5;^([.Q?!XN]
M;L_RMN1QFU2(]^NCENA16;A*(CPXW)4Z\FV-.%)=;+B/'HU4/''$`0X_+BIJ
MYCD99VL3VN$K78@BA&.\'$)ZJWTB[;3Z308B5LOVNW3KY+0M2DSY%\'FF)["
MF5GG.%E]BK8I]LT&)?36N#7U!W?%,-8NXH[]P:]M<K=X7EOO:)6Z-L[,NDR>
MPK>SK3\]Y96RU`:9C-RW?-,+"5K4ZPG2%"@!-,2!>QOB<!Z5'"\)&!J%OW)8
M6MB[LVR],VU<6[3>4QK[->+;SRFH<J5+7:8*$!!47)<%+:UIXU&,<V+\;?6$
M>;=Z%+VR;7N&#O"'N'<#D2WVV0]-O-KD)?;;2F%,:0BVJ2M:@V)#BTC3VE::
M#AB.O;@->W(013=BL>;>7`#85(&\4P8N_9<^4AJWP+C9+GN2P<D*Y;K5VMD3
M\,ARFP<X;*"><G@AU-#0X8NNBYI;0U(4HR.*6)Q+FYP#A45K1,_=]_Z>;)Z&
M;GZD=68C\^WJV^FR6R&N$Y?&IEUN\IZNYXD1LDNQ2M!`<3J2'PC.HPYLP0`'
M8*T]+0RN>*-=ZCQ7#^99_1B_U<VM+7O?K1MWI5<]XNO;_G;4VA&NFZ(%A<A2
M'5G:Z[Q-CP[K=I=WY80VZI,=AA9<!*AIQ.'YJ9<<%UR-CVM`<"#3@IHZ)]>^
ME.RE]0YMPW7U"9,2WR8'2YA=MF7V[&%%G/QX3EXG&6PINYQK>AOG.H;510)`
MIC+/E>"[`56TMO*^%P+7!A::FAH!Q)V45G[3^89TDM\/:\>?$ZE[WE6K8.Y-
MJSKI>8%L:5!NM]:'(;C+,B24P&V`5)6M0(4>S$HT.>W,P5;V8^U1;='E<,S<
M6\0E;?'4^W=9[R>IUIM<ZS6O=]KL\J%;+@EE#S"(MLCVM*$-QR64MN&#5"4Y
MYU[<:/<UK:U&9/(H#;V_*.+JD^M=#O3=TOW_`&?K)<M[7.Q38VSYG3W;S%JN
M*VHP86\N.CS*$,H67HQ)IJ414]O'"&FW\IU6&)U1$7&IQH,"H.\BD-2&N/H*
MZ(L$56.T::CM''CCHK6N<,S02WB%%.:YOB!'>JU>H?:5BWOO;TN[4W%;8]XM
MMVZH[^N"X$I3P:\Q;NG\2,Q+'(>9=0N.):DA84-)=IVC&E6UH2*K`)W*R-O]
M.W0P42]L$+36A0G>>\G%$BN8:<O:$$`\:G+#BW!Y@-#183^MOIUZ`5;KTRM[
MV0(-PO.XYJD9?^$7+XO0D]H[<2"RG];?3MZ?%42OHOL:4F@!7,;N4I3@-:\S
MS%S<UU&1K6HRX8$*4+%T`]/,+E^6Z!]'F-*AI<.Q=NS7!0Y"LV%*-,NVO#``
M3L6%-ECV+TUL#:IUDZ:].+*]`8DR(KUHZ?[.MK\>6B,OER67H-D8>3)0V*)6
M%:J#CEB'OHI7-+VM<8QOH:>O8MMRJ\_U%G0&P(-NYLUJ.\VY&=:55RVM:S(G
M-2B-!<0U57*!U=E,4B:2/G.`<VN8[PH`X7K_`/&5(VUIT69MFT3XRV5-W9,B
M8MQI:%I==:=#:M2TDA3C>NA%:CMPK;^+T*V:9^I_T?B$7W<DKLKSS2JJ@J:N
M!;;(*EN1I#/+=T@%14RVI=#V`G#M32C>RO(;NV[HB-.A-S@W**I)!0U&N-7U
M<H@D!MU3O$9$X$)4NSTTL,IAAAX*E,IDI=4FH8*LRV*@DUX^S`A8N_O70*T2
MXI*000`D4HE%1[@[*98$*O\`ZC]^1>G/1_?&Y92^3^&0Y;B%A24+6LLCR[2"
MH@G4ZH$#N%1PP(5!/RR]BNO[3ZF=8+VPEZ_[WW0_;@^X@J=1:HZUSG6FGE#4
MIF4[*;#@&6ID#L.'5L0*U(&Q"O)U@?\`Q-J`R25.A*^8DFJSF:A2:5&I)[L.
MB]E-H]:%'?1Z?!CR]T;+N0#MGN=M6E^$H!YIZWWEER#<H894%<Y+<5]2EHS(
M`J<1:VRNX%5V_*TWC-])WKZZD>F>^2WHVVMWLRMN0DM/%J(^^J8N[[,N+:%_
M=N)=BZ&N8DD>):0<L/+4C$;ZK!!&VJ^C+UL=7ST5]#GJBWLO1&G6CH[NVU64
MLN):,?=6[UL;<@HB+*J@M,71Q"*5)<&D>++#MWR^+#O6KO">Y43_`"-NE:MA
M>B_<FZB4MO\`4"Z2&D3*!#OD]MPTMEDO$#4SYFJ^--1.,%S6^(@=ZC[EC_(G
M`[."ME%ZE0+Y;+I.<G/M3X\GR;38=`9442%--K<)-.:^@>'XDT(PTGNF,<`U
MP(IN*Y86/,CR`:9N"B+JGNQ")'XBF9Y9#-JD1E/-+YB8R5QU)>DE*25*;3FH
M]F&[M1Y##,#BP5]6*0GD+(W%I',#30;R>P+GSUF@;=V?M^/U!5=Q;=PW%3'F
M4V[RRK?>VWVXKC!N<%*P69#^E12YI"E>("M3C-MU.V<_FX=Z<:+JTK'!KR0Z
MNPX'U%0;M3KAMF?+E+M$^#(J\N/,@MR**;E-)1SV1%?*7DM)U"GATU.1.>)=
MLUK>MYK'LYFR@<*X=FW%=4L+D305D($E3@3C3C3@I6C]0-LW9PPHE\MB)I;"
MEVJ4IJ-<"#2J8[+JT2"E*N"@*$#+$?<B\:"UD4A'8UWV)XZ:%GC>T=Y`3CAW
MF0,F9#Y2@Z4AMY9"5\2GP*]ZG9B-<Z\;XF2#O:1[UNQ[9/TR'=QK[DIN*D3T
MMJE.K)>5RVVWCI4M0\(2E)"2M2O9F<*,>7-J_!W:GT=6LROP=P."0V;-%AML
M-LQVF&(C'E6&&4AIIF/KU!A+3>E&@.9T(.>,2D.80""5OF!P!%5O##*>#:!7
MCEAGD=P*RB#R0%J0!1`6%:1[NK2!6G`G#Z($1@':LJ;/37>18.M^P)0.E,RY
M/65P"@#C%UB/QUL*KQ0XH)%.TTP_L/ZD=Q]R2F_3]*[:I?4G6VVL:4*3FG24
MJ!;0<B!G184/E!&)Q,ES`_-NVXU?O2U8KM*C2'8VV>M_3%^?Y5I9E&U7>?.L
MES0RI*24"4S/;!/`E">[%?ZE!=:M#<<%&2?,]Q;B`<>SO7RR-=7#!4O9MZA<
MS:W3[>;KIM<F-S[H+._N&)(6J8@HYJD-I552"*T->`QSN5YC@P\6;9OW[DI:
MXOSCP4I7=7A5/7KKU=M74KJV;S99$&;9BPU%AN6Z"U!:8M41BD9F2AE"&U<E
M951PY$95RPR\Q)^$^HIE>M+G?*"1V*MMPW$]%OKKS3OF4-H?;:HI+K:6G%*Y
MC(6*A#;@R4*@'$U&]IC:217*/<AA`:`2*T2??-Y3KW"3(0TF&65!#!:\"2]#
M(D:%'A]ZA!2.\Y#&^9O$+)>P;2/6G9<]]P[U<%W!JVP;,2S%8$2&$M(/)C-)
M5)*"NO,DJ)4H]N#,WB%L"';,5?\`]$5XD7/ICZV(41QN-<KUT)MEEMLIV*9#
MD6"_NY*[BTPPTCGNMRH4/24IKJHGNP[%TZFPT1<2,CU9CY'`,RC$D`;!O4B]
M1N7TE]"/2#I^Y*3)N&[O4!N+>MWGMI2U'FM6JQ2(=HTA8J6V8BS3.@4\1Q.$
MI)L],V")7QOOY)&N:64%"""#B=A7,.X;J1-O,I#3E$E)"-+GA0R^2Z6A15`F
MJN&$LS>(3EFI/@%&G!($ZY)2PH_=EWP-LEUP-I0MQ:6TJ4I9`2A)5G[,8S-X
MA-<S>(5AND/1!WKOM)RW[2NYE;[D[L<M,^U)@KC6:Q1F7F4QW[]+4.9;[5-B
M\WE249J>`2FI-,89,Z.X8YFS>4H9X8[61KWM#CL!(!.!V5.*N'^;&\FU7;TT
MV_S:WY.U>@-KL$P-/J<M\B\69R"S*91)I]XTQ&HL$^(%8)`)P\U2_:]K6M<T
M[-A56M325S^\J1>N_3=V]^B?HKU/V<]8&86QNA>VX&];3':?7<WK276IZI,"
M0IE"93C3\U:WJ%2P2:X:YF#>%9[#6<EMDD<!(1LK0^I<9(VZO,O\Y!"U*<<:
M0L$...LQUAIA9][,M@<*<,9S-&\>M,!>7#GN+P1\V&!%0E>=N:0$)>C%QR8V
M@160VO2YYA20&XP/!MQ1(HDBH&>-'O;E.(V(DNY6QN..`/N7T)>B#84O8S\J
M+`Y=NBV_8^V(4F^W:$N,Y?+M>>3)N:(9DH1R51I3SC14GWVT((R.*Z/ZT.^[
M7:F>NZXU^F11-D:9=XS"N_=6JY([IW?;-G.]0>EDC:EL;O%IW_N#R]Q<8CO7
M&/:UW5QEM,1\)+S*8S++266P<FR33.N++>7)YC>4X%N0;,<<5,:5>LGTX.E>
MT/&%"0H7O%Q>=N"U-I+2&&JO)9KR.:G]YI4*I("ZYUPS\S*-Y3*5[72X$'N6
MINZ1'0CG2U-I:;>?>Y3B2Z0TWJ2A21XM*E<<'F95@N:-I`73OTQ=$]\Q-J-;
MLW?;MO'9=MN%AWQ<')2(BYUN$BZ6[\!9`>&MF7.!Y:T*\1:)RIAS$Y\C,SMM
M4QFZ@BLI/+!S*@5VC>JH6RW&\^I(VZ.E*F9/5"8Z.4$K89MMNOR[K-;0$`MH
MCQVHGB[$Z17"[7.8<]#@DYM>?<0NC`^4[_:GKZH+[`D=8]]7NP(;,+=0M>ZK
M>[*TM.M&>PIJXML!6E.A3P<U4!%5&N%?-.X'U%1PNI7>&I[EUS]//6)2>C?2
M5VZQX5]MW_3>?8[C8M;2>876UQ!#EI4KE/K="/"T155*4J,2K'Y[1KSOK[RJ
MQ<W3V:J\OJT5&W#[HXKDWUSE0H/5+=\.WLI5*$B/'B,EM+;`AS5"3'DMA"4H
M,I+7@RSIB!NGD/K&07]BN^G70EC`J".^J@"\7I2P;?#5)1<&4I:7(2E06I];
MQ3H87IHM2<@0*]V&1NI1XC12>9O$*^_JFL-@V=TN]/JK):G8\I5ND/7P,NH9
MC_B+EHBO@R$<4O.*6M02JBE$F@PX9/&Y@<YS:GM"BG7\PN7P"O+!IOHJ:6Z0
MZRU$N$IZ1Y2==YD8O)!+41E4=@H:6NFAII`4H^(BE<.K:6+F^)NP[PI:)H>T
MN/!=CO2+>-C3.@^T]HW^';KE:[M>]R[JFV^YOOH8<1/E+CM(DLL#2I/)CA(U
M',98?\V+9F;ZPJ;K.J,@<6QO;F[PN?7J>?M]LZ^[];L+;#=ONBF-RH9;-(T)
M-RBN-O(CZ@FA1+B+72@.M7#$>_%Y(Q!*LNG2MGL(I00?RVUIC0TW\/2D;TX7
M*)NWKKTP@27?)-P-UV^ZK*E);K^!ERXJ?<UD`(HQ[QRQK0I&]N8S&.4YKCFQ
MH0:8;Z*Q/K$W-`@;_@[CV8XBV3+YM&XVBX*AAIAJX/(NDV2^Y+4A/+>4\[+1
MJKQ-._!0G<E["]J,C2">&TIGIVPG8VYK):VT-O,R=H[/O4]+@TAI^YV:%+F\
MM)TT49#JP?:#W88NN902*F@6+N:)S"`YN;O"O+TKF,24*4U(5;Y%JLERNL+E
MK#)6]%2PH)34C42#1/RX?Z?>.8YYD<!4#::*L3_,/EQ/K5N8G4%OST470Q_*
M7*T6V[,S6'4+Y+3,-L/L<Y*BA)=<!U)K6M<2G[BW_F-_XA]JK%XQ]=A]2F3_
M`#VQ_P"?A_\`)/XA_"G]Y_YCA^]_M8LO-9^(>&NT)QG;Q&Q?$1>Y%WO.R8S=
MKD*?EQRVZW<%\U*VGFWVW.2%Z#I+H3H4/A)QQ&S_`%!WJR:E<BZULM!W?`I1
ML.TUW:]Q;T[/5$NUH7*D1+8%J#<F$')B9)B9?>/%YP*(.GPD&N+&V?DL/:N?
M:M8$:I(:8$JT-E<@JOCEREPH3C3ME@M;?NCT5A;C%Q8899F14O*4%)!+:PH]
ME<05W>C-B=Z?6ED<M!@%&'4OJI#N#MMN5];G2&;(J>ZB+&2DI?\`*.F%`9;=
M2[I4W'875K,:O9A2G8G/DCP1&Z[V3NS94.WVU:[?=$[CVSM^TQW72I/DX[GF
MUNR3XE,I;*]/A"O%@3>:+DN#>(3RO?4.0U%MT6YVTWNS;86XF<W<#S9+"W4J
M,B!%D1SS6T7*6@(0RY1+056O9C(.4YN&*Q!3G,KLS#WI!W'M&W]3_P`0?WK*
MW*K;\K:-CNELVHT\;/:K:T'W7O\`+KZ(K[FE=N=80=`!#O,U$@BF%O/,[59W
MZ_-I.-MNX**K9Z0N@T.)MJ=>-APG#<-ZSH=R?>OMZ%M_"4VM=S@VI"E3$%$U
M;2DC4$`%PZ:Y5P]M[VK"0:"JVAZ^UBY_..:C33^/6FJQZ?-AS+C<KC.MYL5H
MB2).V+3MY2DW6/=+-!99ER+"^N6&Y<:*A]X@S&7A(6`494KA22[+V%A.T%2#
M?J/JDK?(OJ!*,OK5Q=H^DGTK2MQ6!^X]%]FIAR.A%MW1)@//W6,T;S,GO18\
MV0E5X"7'7(JFTT.05VTSQ;M'_H5?M)UR[-CA78HNM73BQ)ZW6[IGMVUP+;MJ
MWWTMQK9`2ZB%;;9`B,3G65:Y$XE:$O:04K4A2\A3$3<_K%2VG7+[NWYLGCSN
M'J7;O9LM$>-;X+*'3%3!:MP;`2%Z2IM+616$Z4H`*C6H`/'"<;\CP[@4[D_3
M/<M\;>&T)>Z+CM.'>V?\P0G'FGH#T.YQN88R4N+,:3(A-PY`HO+2X<^-,L=+
MT^]_R%.Q5S4-BBGJ`\V_ZA_2A!6%%,:-UHW`4@=IC[/M#*_^R\?%W)%<^&(]
MLG-G+^*BF[%<J)5Q27,LJZN^I!!I^DXLL7@"R4]H'O,_ZOZL*(3_`+6440$N
M)4L!.M"0X5-_Z_@TB@SR)RP(4A6B0PI*UAU*>4Z&Z.!:"LJ4:%LJ2$J3EWC&
M>:(6N>?PD("7-XW=5DV#O.\-.(:59MG;HO!*G&P1Y:RRQ$<35>8,@D=F>&[K
MX#0IO3[UE<*V.OS)EVTSKC+;N2(CZYC!?<\,N7'U\H-@\NM55I6E.W'$8G9Y
M\W$U4`?ZU_\`C*OWZ6]SO;FZ4LRG2ORUMOESM\,+2$K\3O.D*"4E20V5TH:Y
MXM5MM]"M>E_J?]'XA6`G)+\*8VV1J?B2(R`33QNME*2JE2$5.?$^S#Q3:@^V
MONQMSP(Q.E%TVPN'(J1I\]MR2IM:.S(I15OM4.-,"$\7%I0IHJK37V>P8$+>
M^^V5@BON)[,"%RQ_-'WC(M'2*W[:B.*Y^Z-P6V/)2`.6N*TGER$$UU!92K(!
M/S8$*:_1W8_\F]*']M@(;\E&LER2D$Z>==K.Q.D*!*4J\2W.[C@0E?<-Z-TW
M"\E2CIBJ"%ZB`31M'NT)U#`LC:HAM5_;VUU%M]U%50X]Q;3);2!K<CR-3#J-
M)(!!2Y4YCAC*DE6OU8OJZ3>M'T]]7MO.:'K^WM:%(G5IS7-O72.DO.JI0+7!
MGG[1]W"UM_4M3:?:%V$_.7Z@J5^7DZBVOZF>H_4KI;8IB5:0M^WR7CNR1X0H
M@ZW(!TYYKI\N)+4MC/\`$/>FVY7O_+ZV@SM;T#]&[9#9Y(N.P+S=Y!7D@7*X
MR+@ZZHD"NCDL4)IQQ&W_`(2MKO\`H7?X5S=M?4%$7_,#)EI$60EIV.T%#G)G
MMLLN1'7$5HAE*30JJ2#V8K<MRV%V5W>N0377*D?$3M=7X)`WGO6)+FPFG+LI
MJ*_%A,W!;Z5)AMM38R'G5K6G7_AD(40I5,N["$EZQ\;F#:04Q=;&1XFX&OJ5
M.NKER@7>_P`Z#)N!EQ),9MZRVTI<+*XT:&\NW235-$Z&T*T\:*(';41*U;9%
MLOFQ7*#5<HH"KG8=YV6RW!+T.[W%U+[[J92VI#\*=<Y:(SRDH%*@`ZLZ@#&]
MA<7$&I@Q`Y0!\5<='O&WT@F&-/E]2M?L.Y.7'IDJ\S+=%W%?6-[7F&U,O,AQ
M-TD;?L#+LZ9%9EQDI<9"8J0&<SJ(H:<<7&^ZMN[1@..`XIUK1#:$[`%-NW^H
MNV]E(OM]AVFZ1&92XS,FWV^8F<ZX\VS*D:7!<UOHC-?<*"5MT4I1`.7"`EZK
MN[O`U6FF:RVT-"<%//1KJG;>J3&[UVS;DVQN[<OUHMTN5<)J93DQV1;U2FGF
M`RE#<:.EMHI*TI!UTJ#QP\M)GSP"63QDGWJXP7@OXQ=#$.P]6"F-8*TD#[6>
M=>^N9XX>P_J#^-R=1?J#^-R*K044K3.O"O93V#OP]3Q)[K"U+4H::'/C[/DP
M(2MM"YN6;=NUKLRK0[;MQV:4A9X(+=P8U*)[`$$X>6']2.X^Y)3_`*?I7=U$
MI;2EA+B.4M#*V:*IX'$J?)[,E%_+$ZF2J[ZY;:=T^D?K3%6VM][;]EMN\V&V
MTE:UN;0NMNNZ"RE(*G'0T04CM*2.S$'JOZ9[E&M(B@NY.+G+X=NNMTM\?JUN
MY6W9BKA#O#L>7-GVU*E,S#<X$24EN,7>2XZMM04VNH`2XVH5-*XYO+_4$J`T
MW5FR6CH`=DE?57[5'EOE<N6DVJX/E"+>B/-:/A=CCF.J6T\E*BE+B0NM*\#@
MQ3WS@XA&X%V9A7*WMR)"4LS)"]#ND.!#2%D%;R%$"M.S/!@HU]\S,:\2GIMF
MR7+>&[K?M(2$R8DA5PGMN,MML1VRS;Y)9+SM0<UD```YX$TNKUI:T#\2@S_,
MHBW!<-QQT28XY+K+X2'^9'4J,HT2M0Y2E,52:U([,"D+*]`;V+K3^6X_"M=J
MZW76[MS)3\J+MNR1ITN0J/';CLNS;G+9#"5*0^`PH(`/%1[..%/.$8547U%>
MMS"IPHLO73O^;=MN=,+5;W(S-JM-\N9B6V,O[B'%3:F9BBH!(")+S:*$"HJ!
MGC5TYFPX)72)Q-$0-P"Y6RKHI,EJ4FYAEV4AO2R%T*="0GQ)["0*XT4NL+SN
MQX,H<>4I;+I22$T*PA*DE1*32A2!7`A=!O0YN9O;>VKEN>!=;A)W'NV_W8OP
M6G7&DOVC;LF/+@(!2JBUERN@'++CB2L8#,QY&T$>VJJW44XAFA!WM<?40L?7
MOUIF[^_Z>P;@P([UKVSNF7;4H5YB3+MLE-G<;=0MLK0IQ*&_&E2@H!2>(X1U
MU9$/K3$%:VEZ`W%7EL.]KQ=O11MS9!UNN7/IQ:;2U&10J6W<+<[I8TZ@>:AQ
M"=0I0`'`FLMXTW@Q%:K@_!NKL*9;8J4K;D1T2F)25"@,EB>^PZ&\R5)2MNE2
M`<"ML]\T,CK^#XI\V=!D;^VE&>DO"#<=W[=D36`!GS@R7D!-0#5).-)/`[N*
M97%\SD/_`,!]R^A.Q]8[K;VH@8DK$"XP750VE$<YA=H2AJ,)2-12S1,)9%"K
M*F(Q<IO+P>='&JY#==KW`_ZM[UOZ72Z]>KX9Z'F@E2!YB/'4M3A*@4_?!7?A
M[;?IGO70M)E$UH'?WO@%!4W<T]F',474?X@R$1T!55NJJM2=(H`=:1EARI1K
MLC@[@4W+-?9$ZX6R`TQ),^]KCLL-*0D&0W*4EIUE`2LDN-EU.L=@K@32^O6K
MO$Y>KY"Z>Q;,JXRHJ'4[?C7&#')2Q=[OMQ$:-(@%UTM,J1%8:YP*B#4=F-Q<
MF(9*KGE_()=6<_\`N-]RH!TGW5(<]1]UOL5U#-S<O.]78EO(0J$Q&E/S6GW!
MJ(2IY4,.%0X5.1.,F\/%6H/Y>G/?P`]X2IZIY]Q;N^P7[CR(KUQVG*7"*F#&
M2_:W)LA5NDI6A)"FY*HSN@>\*<!7!YP\<5FQO0*45O\`TS;Q\WT7AWFV2FXJ
M[:I4%MV0KFN&ZVQYVX27/**JVTSY*6A*%!6HK!R''"O[PT,Y!/S!0FO/$MRY
MXV&GN"J7Z@HQ'5Z_NN7A2&W;5MZ[QY+3A4A"G$.1H[3BLM+OF&3K`K1/:>&$
M[<YYP_L/N4WHS^799U%M@O%FN&^[%9;I+6FVMW:V37IC`2N2XYST(<9HI2$E
M#LHI)S]T5PVO-ZE/.A7L]4N\O\R[3VDPT`Z6=P<UMEK26VFK;;5QT)>S&DN%
M*=/&I)Q%M\(31M[_`)@X[U3%JXW"X[50V*PWI]XFL)A/DMH0B3;FW4R"$ZZ(
M`;H#GGC=D@B.<]RFGWP;;D[J*^_2+<-DZ?=,>G[TI<F[S+I:[Q%>@JD&,[`6
MPZZ69;80H\Y/-/A2:5IA;SS-I7,+B+S=\2-Y56/5+>'%7':EVMDH.WB=LIM=
M]?=5I$Q4.Z3&"J.I.LNK<=?30'348D8[S\L4.Y6KI&:XY5W:R81L>YOH!(2/
MT*1?;1N&X[CJPS=[!8F)+2W'2@#\=+<9I0*D@D<IQ0709=E<;>=/%2EQ%;6>
MF\^.G,=*0>ZA/O5K?4;$%RLVPYL*.Y(E-V"XRY:4A"5NNFZ[?9=Y"5J05E3K
MX*>`*03@\X:[5%Z#>CSF/%.+>%W7&E/WZZ,N%Q^S[>AV-_2%,/1+9+M]JE1E
M+*DGG(%P30`$42K/(5C77S<Q[TRGO1SW[/&[WE6!Z1;U:<>W4E]$60Y"V8Z(
M*&%:UNR9+B#RFM6@%:4,C4,J5PD^X$^`W)6VO<7<*)\[6WW<6VX\2^16/+VV
MRB`^RT>8ZB4K6M+80KE@DA8[1A/!1M[?#-0+/_JQ??\`SC?[_P#RE^\5^X_N
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M8ZXP4M02D-(`\04:87BCC>PEY.8'#8F$>;4+X02"C`#LV^VJF:9&MT:1>E6N
M4XQ(OEIME\W%`DJ;=IY=7FFGPVI%6I,I;='3P(X`8CYG2!^1M,A-/0DH+8OO
MGV^.5@)''"I^";4?>$U'XO$GRG'777H#4AK0ZM+"2?,,*90RE:T%]#6E>H%-
M.%#C+K,;8R2G#X)7C`5[TN/RU[B?MUJN$&Z2K2R^N^(1!M]Q6A-P88?9;45T
M2*H;=&5*Y)S[,;,L[\#\AORJ4TVSO'P%C(692_@:[!V\%CM/;6\M_76R[6VQ
MM:[[GO>X]UQ;%LZPM.?AMTN5_NLORD*D^:R8=NL3@<<5<);B5>72WP-#5S;6
M6H/N6-G%(BX5IMIO4[:=*&2ZCGF:0T/!-*;-^VJ?WJ4O/4?TZ^H>Q;7=OFU[
MCN[8.P]I[*ODBPP)<G:<E$H!N3&;BW53[$[D(&DN:U(4X"I(`I2_VSC:P\F/
M%O:NAVUM%;1<I@JWMVIW=&'6;WZG.JMR>0T7(35[1&0TVAIAAS\13'4III*0
MELAML``4`[L0M[*YEP0`-@3ZV8V.+*S9F)]:Z26F<XRT&PA*DZFP*:@L9HH0
M0H4(.&3IWN%``EI*EA`VHC=-TWI/6VS[/G*M3MB;V;<;U&#;*C<ES5)BH7YJ
M0MU0#6DBFA*%$C,G'2M&ABEL/SG.&&[N[E7+YKSA111U@N>\T^J?T[P^GQV3
M(OUMZ.]6IRHV^I=_BVU,2=NNPP4/).VK;=)Q=0Y!2E*BV.VM<&2&!](B2T<>
MWN3.&V<Z,$[U;':UA]8VX0A%KV5T76%^'G-R^I\B,F@J2N2]883:1EVTKAQ+
MJLL$)<P,)'$'[4XBLL[P'U#59G9?I_\`5Y,?AR-X7;T_;8M/-9+R[?"ZA7BX
M&-_XS2$OOP(;$I0R07%A-<Z4&&'^H;W\,?J/VIU^VP<7>S[%;3_H:A#33<?=
M%XC+2VA*UQ?PIE3RM(UD-+C7!M*5KKI27'/"17M&,?ZBO/P1^H_:G#-(MG-!
M+GU]'V)M;FZ"[]NC;/\`DWK,_L_RX`?5<NF^RMUR*TS94F1(MC22Y_>>64I%
M,AGC237KN5AC<V.A[#]JP_2;=C:AS_9]BB;='ISZ[W#:N[+"_P!<9V]S?]OW
M6QM;<9B[+V1:9[UTB.18_P")QT[#;G\M+BCXF912*`:JC#7]RG-HZR(;RG;=
MM?1BD?VZ#B_V?8N0^Z_R^/658Y%TE#I>WN(Q#'=0WL?<FVMPJ*4P%6TMB,NY
MQ;D:L^((#:GB[P23X<5,69A?\E2`=Z@Y-$F%PZ2,$M+B0KS>E;;FZM@]-Y.U
MNH>T[]L:\VR_7(KM6YH$^VS5I(8*Y:G%P7(ZFTJ-*5''CB=TPOEF+)J!@;N[
MPI2PM;F"0F44;EI[0K'1[E:)3R?*7BWNT<Y8*9#+[3[J<U1&E,N'_%HJ"0:$
M5%0.V;Y,/$J54,;IUVN^)<2C2Y:MU"20Y6J;;N!A#+J'`*&B7@=(%*'C7#0B
MA(&RJ$]9:&B26E**$.)""2"3J:"CJH`.)QA"+$E1'?D,L"%Q:_-#NR9+'3!:
MU@QFMWRP^D$@%J&M#?BJ3F4*)/M&!"OCTZG(MS5]9CI2F.NP[.7%%"*Q4[;C
M-LK52E5K"3JI05PM$QCZYR0A1&]>"K<-R)4!5[.E?@0._"W(A`K5U5E1'>IB
M7;I,HX0MQQ#22"*I4M=`I/<H'AB)\P_@%(JNWK5W*SN+:'I_D/NMMWZP;TN=
MM)CE29#D4,02E1*U+47$Z`<J#5V8<6\S@_F4%0FUQM'<K[?F/;M.^_RW^DTU
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M:5=K!<(3UT:G2(B'+AK"41Y3`#JFEK6-%2S+\8I7%:O(H],QM1F(_%_*BI3K
MRV=]XCN_L5F/2;)EVOJ[UFL"Y:7;9*L>UKU%CMN)=83^&R56B6ZE2"$\VCR-
M9^,GY,2.AW\]\6QSM8T5/AKQ[25TCI"YYUHRV;C#F=COQ=C_`!17VI2OL)'S
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MM;:I"`G3]XTFA4>&D#!R[?BZOH4[SGI.A6[SR]IW0KGRX+UPD0Y"(\5)2RVB
MW2+FY<'G>:NEN7R@@*T\:X;.I4@;%N+=COF)-3BGOL"7)D=6=KQ&KBN!;W[A
M98C[_,4VU'9N*E)>4M8I2J00FN7?7"$LAC`+>*8WT+8V-RDXN^"8?5*T0]M;
M[W-8FH'^-MMREL><8JHOM*DR'H[P4HJ!YD9U"NXDFF&_FI.`3JR&`Q717TFS
M+O$Z4.F2?PF=?KQ>;U'$IY*V9:(\5JV6QIZ.WH?>C.SE*!2%!7"A&-Q:L/S$
MNQ[OL5?ZCG?5HP3:]0]S95"A,W8.QI$+=\R-+<Y+C$=:WK,[`<9MW/*S]T6"
M:$JI486BA;'6A)KQ3C0;Y\+';#4#;V+F/;KLY=77)2HZ0]%`++3@712<PV7`
M%U\2`#D1A57."<2BKB%G(F/7:,R4_<QTN,LE"B1)4A=6)1%:I^[D+%,LAQP!
M(QW4CX3(0*A=L_21LRP[4Z8],]VR+E;$Q5;(N<%%E7&6_,O^Y-T&7"B%4ALI
M3$$!M*GM9%!2IKA6/4I]/:60M:X/Q.:N[#"A'%4#5[J^U.\8T-8&1U%17>1Q
M/8M76WI):7^D>[$Q&;3;[_MZW[<GVB='#D^2[-F2H=NN\*$EQ;SR%3;=%6E;
M==!T)4`,ZMY=5N)3BU@[@?M3&\U%FEAK'$%Q(&/::).V)N*^V;8.W&T-7),?
M;\B/94JE$.,OS6XH=0RE*$HY#D2.LZD*SJ<-/-/X!+EU9A+(<1ZES'ZB6F3M
M#K+N^V3$OM!F^3%VZ-(H$!B6X)D902`C]_Y@J53B>%,.89#(TEU*U5DM[OST
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MQENF2=1034UQ`Z@[EW1;&3EH%SV&\N9[PR.#=M-^[TJLFPMOQ%]6I5ZN2(5J
MD-3MWVDV\%Q6N<MB:8SK#C3B>4XPMT.IU$BJ`""*@LN:_BKK<7=-'E.%:#_M
M!2MUIDV&_P"PK!+N$O\`&9]BF;2_#0_R5"):(UL\A/924(2YR7G@ITIU:0Z2
M10&F#FOXIMI#V3$%Q*6^C<6!:MF[PBP9RD6F;=[A*L$>,XFD28[8K>AZ//%"
M"AP-E:`G2?%Q.&]S6("Y:27NV@[/XP2VHP0OG<PDT%/=7@JS]8YZUW2;=%P+
MD;1.MEE=C7RX.I1#>DM3%'\/4ZAFL9;1D*\"JDF@Q*Z;J$SHLY#:@=OVIW8R
M-RBSK^6=^_#'^,$PMNP[:]NQDN<EMF/<(TD2(\CFJ4FVO,2G&%+4TVE+KC=2
M!3/#:\U&:AP;[?M4CY>+\3OX]"M]UJ<:OG25S<=L3.M#DAZVOVY+JT-N*,RY
M&$$@J;H''DH%#WJ[L1T%]*]V4AM/3]J@))3'>R,;BT.P]2J5<MW,VPQ83CC[
MDBS--6>Z*D^`QKE;X2I#;600'I$EM=%K3E09`8?SMFEMBZ$`R`[-U,5)OF>Z
MW#3O("N!LS<D3=&U["VREB%=#"B.H%PUAE,)UG6[^')"T*#KCSB\R5#(98@+
M:]/F>3>4:.S^=5&W4#-.C\W"2Z3@[9[**(.NNVW[3=]BEV>Z[:86UEL(<EK2
MJ4\&KPF4/-%*4-J4I2:*TI3E7%HL6,N7.:''EM/RTVTW53_0M9?R9&!D8,M2
M[`[36M,>U2=9F%W1O=MXM\6+*A?]/]M+<,?FI\G(BSH8$E&AP`4;40=51GA-
M]6W+H03E`KVJ-NK^)F>WF<>4!4<:_93^U6.OB9'4;I_L%,81[OOBVTL=SC1G
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MXQK^%^?W?9QQ4O/_`-U_CI_&"L'D&?C;X>(7S+(N$"W.V^VO2YURNEO0J5KB
MQC]_%6%(<6^^BJBPI!(-201EVXLN9O$*QAEJ=CFE/^#)GVI]#ULN#2V)+#BV
M6H[29:Y*+A$?*H2TIJ:1'6D@(X!2AC=K2_P8TX(<RU93.YHKLQ2]T]@)I$>W
M*&?_`*3<,.+(9:1&GV^X(+KQ>?`2ER.^7G5A1R40H]YQHYS6X.(!08(7,<6$
M'`K?U7,K;;+,V4DH<F<E]V-:P6FF!-55*G&F=*4M_P"'I\B_;@:0_!IJ>Q0U
M@0RVROP=P*V6O<\HRHDI;$9*V&MOSK>X\A/*5;&G-+A4I0H6*BA[*982F,T<
M@`#LI'!.M"A'GGS2X1UI4IE[LWM=KCO^\STOO-"]M)AN^1>6W#00O2]#9#*D
MH2S$;-=`R0.S#V-D9B+GD!^4]^Q/HK9K=0GE.$9:ZAW'`JQ/0&Z7"QV#KSOB
M7"$FX;9V2S/LLF\Q7ID9V4W*DIC2%K4\RHL\HI&K4133EPQ(Z-"V=P$BF]&L
M89B`^E%$_P#]75UVD\U5KM6W.=&B1E36[7M6=,3%48J4N%1BS%<E*RV=0RS!
M)Q=?+B$!L3"YI%:@5Q5W9:PV9$<+:M(K4;/XP39N'K+]1+?+=:LD6,XTKFL/
M1=D7F-(C/$+"7HSX</EGT%TT6`:5/?C#FORG\MPPVTV*:;/%Y=S*`.+2M2]_
M[WZI7O9^YM]MRIVY%2[%;[FHVUYIK\+M5VB):5-<?0DNGRRUJ(76C>H\*X:T
M*8JZGI$W);I_J6ZDVWS4:6[=K9NUQM)=2\XKE7EUXR$"JB2B,M*]7$((.(/4
M&.-S@#X0G$3VAM"16J[";'V+>MY;HL.T]NQ3,O%]F)@P(_-\NEYWDN/+47BT
M\$AMAE2ZZ5$Z:#//#:."5SQ5KLO<GD<9+@78,X[E>)S\OK;&PK]*ZQ=?.KMN
MVG;;;M-V#)ANRK!M"VV2S:`]-OE]OFX0JY*MP#:$)>/(0E7`DJ`Q<8[MT%GD
M8?F`V;TVO+>-]<M"K$=%>B?I:WM;K3UEZ.6'IWU;8C6^1M*!U-LDYO>TEB%*
ME&9<8C-XDR.1%BIGMZG&V@A&M-5`J%<1\-S</CS/S!U3@>](06S1$*X''WJQ
M\>U&*I<5H&.&^:'&$(Y21R3H<"FTA*26U$`C//"G-D=@XG*MW0!K:MQ*R\@P
MA(=U(0'59*"0DJ4,LP**!S[1C"2R/X%;C&0VK2IM.L4JM2!KKD0HE0U`YXPG
M;`0P`[5B(+22M27$)4LU6I-`I1[U*!J<"UE!+:#BLO*4!4'J5*:J2:&J"5(S
M!KX2:CNKC*;9'\"LTLC06@D*1I2A0"<EI;]T$4\=.SCA=L,+@"7"M.*=LN',
M:&Y#@.">%GV7N[<BDMPK+-E1RE15(EN&%$0VLH"U<V2-#Y5E5M/B4!7LQI(8
M[<9V.%3AM2<TKI6Y0PC'@E/>OI=V:K8&\MQ;Q<L27]O[>NM\AHMUBBM384^#
M;GGH3HO"F1*9#DJ@7H4$F@QJ)YG>&I3?(_@5Q1ZB,.O0(UR<;^\O,(VZYN)J
MI:)C7_TI9'&G/>Y[<MHM+5[VA8'`X>BM,=J30MER_&=OV>:TK2_+9::=:;/C
M1-3)$(L+`-1(*DTIQKC8`G8*H5\^FWIRV#N/::[CN6[7F%(DQA%;FV6YL)DA
MR0/O"W%F17V&W8"O"I0.H'",L\$`K,]K!VFB%3#U<_DY[9]1FV[=:-D=<U;7
MN=JG3+S:G=X;8<O;:@['<0B+,F6VXPI"7UR=*BE*"33/*N`S0@5+FT/:E.5)
MMRGU*;NEGY8UKL=JM$?J1UMEWZXP+#8;'=_\J6$V*),<M$(,+?:D7"Y27W&G
M$K"4J2E5-!!PD^X#@70.#FM\1!V<*K&1X(!!J5*&Y/R[/1Y`=M$*X-=4H<^_
MLW1UC>\._P`]VR6M4%E!;_S`IAAN!#=E/:DLZTT4`..$([QTQR0NS.X`U6LC
MA#C+\H[<%#-\_)UZ8[E9_%.GOJ'W)$B.T7'DWFQV+=["W$&J=<JT.VA[Q'($
M$4XT/#"G*E_"?4G7F;?\;?6N?7J2_(]Z]7^Z[-N>V.MW1*Z6?:T]ZXR(&Z&]
MR[0F3$^996N3&=7&N\4RBPUI-%IKD,\/;2UN901'&]QKN":75Y:,(+Y&`4WD
M)H^JKT^[[M/ISZG=*+XO;DZWWBP6MRPSK-=57:,UNS9"D7O;[A+K+"XOFUV]
MZ,VHMMKY;P`%%9KS6MS`/SHWL[Q1-F75M<-(@D8\T.PUW*6OR8_4M;=\="W.
MD-WF/P-X[`<N4N);G%"<X;(XIR#-BP4/++CB(<O11E(H%$FE<+,>P6I:2,U-
MBWC:X6I:1\U-BYK^JWI_?N@O63<NWMW6]+MH\QN29M*^LH47MU;9?4+DS,6\
M4Z7#`N3KS26PH\LM9`8Y_>_DW!;+\KCB*X5'%4"[8^&<B4%I.(KA4;*J@\K<
M,+>$F3?;'M^7Y9N0[8GVUONM^=8653C-#?AU*?!R52I)P@""*[DUD!$+GD?(
M&DD[MB<[FX(<'IM_EB$I,>XW6;MUY4F6@0Y*FK:MU2[>V@A#DD1JBJLZ#+@<
M:F2,;2%&0L?<X6X+SV8I&MNRU;FW#MRR,HDS=T[J?2V^B(I838=LH=<5<&W&
MD$:EW$I"N4J@6VDU!&+=H4<3K3S!(`SG'=A16_3;5MK8E]P,EWF/RG!U,*&G
M`XT4A[YN*KG.M,&,_=;?;K-?S9)-O>@N0HUV:VRVM>WTI:`2VZ2^R^ZW49(3
M4<,5O6[S+J#.4ZK0[:.Y5C5H[B]<<[7"/C3"BWW%Y^^KGNN*;3;[B)GDE0R$
M)1<HTM+JWY!;TCGR8J$-A1S4G*M,,GR,F\;AZ57_`-J;^).ST@;BN*/4+*CW
M5A=K5==M3+8[!<2J,TZF0I-\2I<<T2M6H))J#X@#QP^T>2W@O0TO:&]_%=#Z
M.=!:!ELZ1N<$X5QQ-5UO+;@3J4A8!)(44G/VU[<7.0&65LD8S,`VC$;"ND7#
MF\UKJC+_`"*T@)6:>%1'&M#2O?7A7&<KN!6O-C_$/6BSR-#@30$KIH0BBU*R
MSTH1J4<_9C4D`T.!2@!+0\>`[UZJSS765:8+[;;@4TMQ;)82$J0L%*BZ&Q11
M[.W#:ZG9#"9'.`%1B3Q3:XEC;&<Q`-58>S>I_;^U]F;1VD-W6EBXV"QIC3V6
MKM&?N34B.IU:8CL-D2YREH90?`E!``PK9ZU:1BAFC'_2"BY+^QB_5FC;WN"K
M'U!_-+VAMHS5;9E[HWAO*W3U1K5;H=MFP[!,E36E&)&ENW!FVH>8336I:4**
M6@5`982U'J>'EED+FNH*8%1LFJZ8X/:RXA+CP<%P,ZA6^S[TLSVYDR6X^X+;
M.O<C=]LCM!`L+0N$J=)L\9]("PVTN<@A(H*"M,4"?5I[B8AS7!FVM%S1L;QK
M3YR"("QP#MVUM,>VBK?:;'(W*B_65E;Q;8;CW.*W57F'6'^$%\&BUK<:;UE!
MXH4#P.!LL[_`QQ]"F0TN\-2B9M"[7=8Z;1'6S#3#:3-81J88;8>:.II'+TI9
M:6'%`4RH</!6GS"CMZ>->T-`)%:*-[+>50[K:F;Q'E1)HOL+G3H4I]<=$2-.
M!A)D*2:)+"E!2B>#8/9A*>.1[0&`FAW*/U)[,C,1XO@K==1MGRMX7"X;XM_X
M8I^>S%7=6H3"`^8L2.F$S(@*<08H\PS'"PI(!.JIPP<US/$".]9M+FW90/>T
M'O4X=*;)=;/M6T%ZU28.X+5;Y4BV2;E)<Y#);4JX-"?;G3R8;!:272J@25>+
M$FW8.Y5CJ.YMR00]I;7BI,]2'3T=0^D5KW[;+H'[M`;<W3`V^L"29LF^P_,7
MF3(02I32+:JWK4RNGA;<-,L;)CI^H6TK>7;2,>]M,P::D<*\.Q<@+):XDIT(
MBW#FD[7NSC[Y0(RQ.3'TH;*!0UB/@MM*XY98%<+.XDR=B;MO:=+LVWK+A,6/
MS&I2B25(D*">>VYFHI4\H'4.*O;C+@6>(4[U)V\L7E7?,*T77?HS*W!9NC^S
M;5;;?,N$ZT].U;D5S'GT,HMMOO2&KA)<372H,17EU6?=1J'`D8C[J2,EH#A5
M4.34/+7QB8,P>36FZBFUVZ1I&VK'+8A,AB[;JM$>;-<N7,,7D615U;\TX5$@
M+?\`NT!7'(81#7.&8`EJC->LF7;XY7NR@/:<<-A"2MT16X^SMG[-MEXE6V#<
M-P/]1+W=8S1DSI]^F7!UMZ+J3]XJUFULT&HZ4`'&M%MJ=P"#Y0AYW9<5S9]3
MKKDSJ2-PJ:EAK=,Q<>/<)06%!4!WEQ5LN*S9Y\5H%`!%44IEA[;.:UI!(!JI
M+I&686DPO062<W`.P)&48BNZN"0-@-WV[7:RW2##_$&&-Y6Z`IQ$=4AMN2F8
MQ<Y$9QRBDI>3';*7$G/16N6%I9(VQN<X@-#3[E:9GQNA>"1ERGW+H)=[O;KU
MNY4&Y7!:G'+TZSY$R5>3BI?4\B(KRY46FD*.A*,@,P!AA#%+<,YD#2]G$"H5
M+OF"UCYNQAV'<DWJ+TANMZWE?IMN@QE(_!(K*1%7Y:J+7;#(CR2AFB5*>Y;B
M4KS)#)%?#AW`US6$.!!JBQO\D625P:XNJ`30D<0."K=MGI_>;PF#?W:3/*25
M3I5J4X7.=%C"KZW0HFK:THTJ6>(PK(XM87<`I>.>1U''&/>=RE;I]M2S;AZI
M6Z+<(41J(RRG<DA!GA+#"GT41$>23RTB-X2E!]PD4PR\R_@4XU1\?D#B/"KQ
MSMSO;5?L;UGVY$MP;VA%AR=49I4V,Z+JY&7+MT@(YK,J06/$I!"B5Y\<,KDO
M>><X$,XJDZ:R)]OS`079W>]5WV]LJ?-ZNP;BU?7?\L2-_67>4V$6RS,:3,N,
M=-YL4U0(4G_#)6DM*R.JA&>$6M<]N=HJP;]R7U-\\>G28'ET&-/[PWIT;QA6
M[J%>=Q[,V=;)%G97NJ^N6MZ0QY=$:U6H7I4JV.*`2$(AE*#RQDBJ<N&-5KHD
MTK6A[@X,X[DTK)<V-A[4W`\\]<&9-XO#,""VXZZB'!\M$:M+UVE-E6AL.J45
MI=(J4(&>6-;ICY;=K(@7/X#$[4[NIYKBZ<8*O&&S'<$;EQ;_`+XVV=AVIM;L
MZTIC[NO!EI4[&NK$60TPZF(ES4B07"4K32M5J!XX=V-M<6]L7SL<QG$B@Q2-
MI>\N];#(X-FH?E)QP'!,CIQ"MEVW/>'+U;Y;#;+\EJW07&%(6F8BW/MJ9+2T
M@>9D/(`0.)IAA=`N'RU/<I[SI/WAZU,%]D2MY],KX;E'N#<:RR+:UM^(L.AE
MR%`E,%2'F#X%S6Y`(&6H+([<,K>*1KZN:0F(<77#I#O*CBS;$VG?YVY6;G&G
M/KC&,XZ_-;4\6KM<V4A(?<="M,QMNB,_$$FG#$T^\%I;&08O.%.]3&=KXVL8
M07U&`4D[9VS.ML%++#4-]RS2OPQEV[R5(##++:'O)04((>:GMAS4FIT`$98J
M<,(O;WFS_E@G?@D]:&6RQP3-ZU-3)=KVZIQN1,5)F2[>R)[XDJ;=<*7$PW)`
M*DC27$J.G+.O;B[:2QL!<VOY=<#N(QH1Q56TN>2&ID!:P["<`0I/Z<V_<*.E
M$^X6^0Q&N*+1(MFY41XB4MWIB/*95"CICI2!&$9UH)4D"B@DGOPE-47CI#X"
M-N[<HV]E;<W@8]X:QQP).WL2M8KT]L#>&[ME7^.L&Y3RFY38DI95;5-Q(\UJ
M2R^E6M;;S+X2ED'2G108,[>(4GJ.B06=D+G.T5%:U4C[A=@*L,&\WF2])>5<
M;1Y!EN`&I;C4;S#A=U:>:AQ49L%U7:FM<L-KAULP58]I=WI*Q:Z_8!9`S4&.
M3YMG<FGNJ]/V"^,[AB2%2Y5SM+D&:^W-4EN/:YT=J2V\TA*Z/.L)0&5_"@A/
M`TQ&03NED+7;!1+^7GYABR.YHVBF(]"+;MOC,%K;6V[3(<=;M49EQ4IM!C.7
M&;N.3;OQ*4X&])??M\=_0MU55!M.9IBT69#8_FP3:ZD98#/>D1-XO^7WJ>OP
M;H?_`/IRG_S3_*'\,G^#^'W_`.(_XG'VXKO[Y'_]))XZ>'V[$G^VW7_UC-F;
MQ;O6OG<V1+VS8[&HKE.2ICDMYEQR<I*Y;MJCM*D%#"B2*KY=!4TSSQ:?)]BZ
M/<VWE14I0V<Z_;I\VX)DK>T7WFP6'UZF_*.%L,M-)J:*:\P-79W8V;#R@>U0
MC[CGO`_"?>I#V=N%J\WF^.W-#[4B+*GMLQV5-I:_&HBZ-(;2I0*1(8TD5`SK
MB"N_U#WJ>M?T3W*0K_,NEVVXN1?XL5U^.E:%*2\RLN-J(;@M(25:M;3CE37*
MG#&UC^H%!J`[W>Y$Z]66UP7`J7;[%'B16V%I;96ZEQUESS"5%*ELH4GLJ0<2
M5SXF]RF--_3?_B'N3UVW8V8G.M]W3_CVH\,0Y#SB.5(GSF%/2%!TG)-!0D\.
MW#5VP]RD'>$]RLMM",TC8/43:DJ_66Q2^J6UGMI;3E7.61"<G6I32I,NX.,H
M<7;K;K6E`=<&G403EGB>T/\`4'>IG1/$.Y*'HSZ5[BZ?_P#5:+NYN#^,+NFW
MD6];7F7A'`_$69[12X6F'D.I4VMM:`I*V_%6A&.AV_Z?I5X=L'<KVS(L.ZPU
MO"?Y1^2F6A`E3&F"IUE2DJ6S&==2AQ#B_=0#2F6%G-S@LXK552WGT=W!<;BY
M/@/Q):FGDO)*IA"M(5GI:YKC*5$99"OZ,)>3[%E-WHCT]W/T\ZZ[;WDK;\],
M.7?5VZ\2(K27D.6V]1G(\BCR%<LAMS0I8)R`[\5?6=.NO,F6(?)D'L6&_J+O
M'Z>KVK;?7'IE=U2`6+-N_;JICZV'PRVQ=I"[6A8.D%2@J1D!3,C/B<5VUFNV
M7\<,G@+L?45/?_+'N76/U=^@;HQZWK.O;_4ZY7V[VMK<2;X[9)-TE)VX_<;%
M<'5VQR^V5F2'[A'<R2IA]]R/I!HBI)Q9TS5:_P#ZDWU"="K.B#TAW(Y9K+#:
MGV:#>.G5OC-Q=AV.:T$(78=BW'SMC\ZTJI!=A/"F>HDUQE"YU^N;\W?U*>F%
MFS=++)T-WZ[,V6RB'NGKAU8V:[.M'46X6Q`+=SM4Z/;$;>MMLD-_OJJ;>4OW
M*&AP(5QORU_6=ZH_6+`D7KK5Z==O]*]@-0Q*@]3K=NJZVNY;E*&]2%6'IG=V
MW;S-@OZDD22IN*NOW:E`D@0NK;\:,V\I!>=>`*:2%P78VM"DA25K9"WPR0@C
M4-:LQ^C`A+EFV9?-P%0L]JE3$)6$A]+2FXBT9:G4RG`EJB01E6IKE@0I7L_0
MJ4%MOWVZ>52:'R<&CBM.=2Z5@(#@5E2M*8$*:;%T]VK9D-KA[>8N<IM"2)EP
MI,<2\C,2$LN:&V5A0K1%0#PP(2].ND2$TEA^1&:4%C3!CH:#NJAH1'82IU('
M"I`3[>&&MUX&_P"+X%"@_KYN.9%Z)=4'V(KD1D;8E1W1-:"')*9U(C99"5+&
MA*EU))!I6F'UEM"`N#]ZM"+]:IML?J.>&7(A;-%,26FLE5-<N8,J9TP^.TJ/
M=XCWIA]+++?O\V-[0F0ZL-ON[A0\E*@T\_;FB[)CQR0%)"R0L:@!49X2EO(=
M/;YVY(%M&"75X436XG$#0X[RNE-OWW;-OV*UVJ)`B3!%AL^;E.2D,I,]P%R6
MWI*P?NUJ`X9X\F==?[E])T;J@Q1P\W2F$@D`D8'O347XHC[74G;ZA]]-N%M<
M--*I#96A).619*JI/`'#_2_K_P!!W+P;F9P:<=APKZ%O^^,V8>U+4/?EL#C3
M+5_CKDS76V8L:4[Y=^2ZO5I;BI?*><ZH?8351QU70OJ?T7KU;;09<SQ025KO
MKE^*WBU43S-H=A]ZKWU>W[<[SNX;39DI7;X+5N?DK9>D-+_P[RWK@PZV*:75
MI<#8!R!2:X[1TYIMB]GF,/F"9]17H$0H=B0=L[TW7LH7%.T[S,V^S=%!4QJ,
M\J6ARAJ-")1TL5/'3BW_`+/8KGW[Q?(E+OUZO\E4JZWF?<GD:@KG27$I\9U*
M!;;44"I'9C,=K#:3-;!L<,4[ANIKNWD=-M:0!Z0J[>INSL[LZ9#:[TEVU*F[
MAMCT2X0U'GQY,>.ZZSJ4NA6SS$BH[1V8C.H]H[E-].4SE?-=N>-UQ]$?78=2
M-O,S+(T_<H][8O4-M<FT760I]UR<F<FB8D:),;TD(/BU:C3%-5S76>T_F#^C
M+UA]/8.S_5?M.!MB_P`5B4&;^AB?,LT:X7%IF.J[V*ZVR2B4R^74J*HSR0V%
M9C(XW.DVU_"9Y?U6X#NV_%;.TBWOX3/+3F-P'O\`BN=_679?0K8W7'<]OZ)]
M6[?NGH6BU;9D6N^WN:Q$N`W'_E]"[DW&@H2X\L6VX?X=P$DEP9$C/%+N])O&
MW;8H@>67#U55*N]'N770@:/R'.`/"A-"H.W)N>+O>\0)&T[<=SWV%;(,=NZ1
MH7E-MV&?!UQ'[BEQX-*=DR@ZFB5(H023G3%@L=&MXS_F\!VJ3@TZRT<YC044
M@6RS0-J[.O4UFY3+MO2XS[8B\W1E"PY;PXZ%2+5"<10M1FU@..*33,`#(G&F
MJ7MG8/\`)V1'*+0[#B=ON4+J^IQ3WF>$C)D`]54P;MN9Q&XIZD3YLUE]"HLX
M26&5-N7!Q<N4F5"""I2'>8X$$FATE0Q2+D\V7F;ZJ'FNL\3F'>$=<GNNQ[;"
MM3#V4M.L.:&`5RFFR%)YJDZ@A7A53,$834:DQG?LGIKNZ)O&&V/\Z[>N%L>@
MVRJ%JNL0OIARH^I)Y96ZR/!J-`.-,9B^2;F+?3+H0:F2=U%<>1ZS-]J>OZ(_
M3G9Q>C1),JWM?CEVN"%J@K;,E'+CI0TIU:"K2-8`/'%G;K+FVQBC_4/VA6/4
MNIRP<N,_F%-1GUC]6;O:)]TAO[%M[$-<9I;5LVFF3-@*DI6HI4_/G%IY3930
MDI.:3AM^ZWO:H;_4EYQ*C6]^IOK3=)_-5U0OYBLM25I186K=84K3'8:<<:;:
MMT9CE`EW3[YJ02>.(^;5[X2D#BM)M4U>>+F12Y8SN32>Z@7:]2GW[S>+I='X
M]J%S@OW"_3WXSEP*04QE\U]K6Y`)JYEG]FIPWEU&YN6<F7P''U*N3:AKS9*B
M0O[*C$?R27`W/>K$EZ?8+LZ(YN,`3G>6E*VITUA]R0`'5K>DLEMZB%)K09&F
M&Z>VMQ>3XW=?2G3U(?C2?(+LS[EPN$3\(=5<)$1IA5LANP&'G&0AL5<<:E.A
M"5+&H()!QA:M`%TX-\.911O=UM73VYF*]<(^XMQ[XDRFHD:`AUUU,N%(;0S-
M#(4?*K4UJ4<Q[N,.W=ZM-GR:?YC!F7VIKO[0?B6:#NQ*'&KE-W]L:)>%H2A/
MX1;X49N$^)<5K[Y<)Y4E95H"CPKB;L]HXJN:MJ$D!(M$UMR[6MU@=N<G;\DR
MVY,WFLRI+K;(9AMK66&4M22A:WG&@-"0#7!)^H[_`!%+0:B70L<_QEHKWTQ3
M$W=TSGVBQV_=%Q=_'[?/DQ)-O587517$R9$=<@LR2MM"E<EI"@H<-68PM;[7
M?X?BD[FY$[0W>"KO]-8$N];!N%Y0`Q;H$"UVMUIS3)<$AZ*XZ07G$)\30318
M["<JXB[W84RWIO;BG2;KRX=N,N4S+VY(8E)MQ"92IC)3H4WJ4A/+T-Z5YUTD
MX<M\([@H"_C\R"Q.^SIN\>'9+Z_YF1"=ML^#.MZ7$R;=;[/^%MQ+OS&D*)<=
MMMO2Z^H)!TIKVG&<4UT+3S933/(\8:/43]JY&Q;M;+-=)Z3&@2&_Q.6EE14\
M'EV9V0ZIH*"0$)=>9*5`=@.>>,C:NBV7@]"]*8O^8FFHJDD26;9;HXH0V];G
M)K/EFJD4\Z7R`H^YI[<.+W:E+;^F=W+MSTWM\BP[=V_;[DTY`M$OIN_MZ\\Y
ML<F3;X<9B9<#&E"J5-NSE@*"370H@YXJMQ^L%1)O_-!WK3>XNV[?L78]PLC$
M-*;KNQN99%J<DB)':6W>([(N27`"767XI*2`I.C3GB7MOT?0G>L4RL!V5'O2
M8[N&WWV]MN.Q%*9$68Q?HT?3Y2ZS9#424Q&@2"0TPTJX*%%`I2&M0[<,U)65
MM89]H5#/4!9KO*M5G9N3:%2&M\RG'I(&I<14J,E4:UI+?@4(K!2$%'ATTJ:U
MQ8-'AMI8'F>F8.]E%.NLHG,YD/A"?7IIOS&W-G;SV7/4N1*M5^:W%'93;3YR
M/,0A31<7+=2E"HKK654DFF)&>PLI87Q,IF<P@=Y%%!:A=BWA>S?E/N4Z62+$
MW&[N._SH+C32F6I4%"`A*[A(B26-+*7`<DE6=4FM0,0D,G[4WRIP*K6OWH.D
MQ4[/BI_GS[K;]GW:XPW)J3'O'GK9R(PD%,!*=R1)-J==(*EB'';2XH'+2YE@
MKF^;BHOFB9\3O[C1[2JF;2W:BYPKE+?3!CNJVP;E;+<Z#&%\-TFQ6XL!LI`0
MV\ZW)"U:J)":YXTF_2=W*]6W]$?\)4J]-K-*E[_MUSW3:?(V23'F3;HA##K4
M*R*GI8M]L97,2D)>15*4D))&I8([<1J1U7_R]W<I9ML7<L_<&X(UL@1BQ%W9
M'BVR1<9*/PUJV/I=A./+=4I2N0F=.2-(%0Z@GA0XS=_^7_\`2*YE:S7+"6QU
MR9C[T0ZBLIVEU?<V[;(RY*+_`+VC-Q!:Y$9]46#;XK<JY.+TN#4"4+4DIKPS
MIA*S_P#+I/XWA3EW/>/TZ1LH.0@5_P"(+3&V]:!(DS(@F.6F$J_3&'UJ<:N[
MUUNS,QBY*2VCQ28SKZ`NHKI0DUH2,-%+:=_Y>.Y-BR(_S/+@\NRA=OEV^T3I
M5N?;41'@09R(ER?7J!\3R5@=^L*KE3#N'Y&B5-678M"7;":JQ+6W&K$&38+2
MS<MRNWRV?A]H?<2PE.QY$E+;KL9=0IU+JBVM`7D0D]M,*SZGSH3:UVT]BQ':
MF:Z&HX4`(]>"1DV&-#WYU`OL2%&N3.S+3O2"FU.1RQ!9OK<>&F!<6W-"3(TR
MI:N6KLT*K0TQ'J148V`WD].;[;-SP9T?<-JB-;CD6IJ/2:BW2;BBX1IBUT$9
M;/+0!DK/`F4EV&/+.")+6U"V[R;3<YBE[NW%#W'>IBF8^J*S$>888;4H'4(R
M=94L#.E*8T?&)6Y4VGU&:)H=;_J9P/0DRZN,S[]/:3-;A1US+C+BOPW7`S/6
MVV&C)6E=%!\J;TY"E`,(^2"M1NXYK(>;VT3+%ANK-GL&XH[%QW#=W7)K]K@K
M=;,)U_\`$(D0/EMY8(5':CG7EF.%<+BY$31'7PX>I0L^7E#E^"F'<KB1KM;8
M3TVQ/-1X;=BVA9G;H6"VS"G[F,V4N4RUKTJ4AU+NGQ`&J3C//$OR\,577P\V
M=I_"ZOP^*9#&QWK3U&O5PNE;X_#?GVB26E!MQU=Z=1*L]W7<7B$&);F''&G4
M_O$Z1I!&,JP:I/YRQ%L,:"B8F[-_PMV7)N?#GLQGK=/NB7;8I95%_#S;Y%LB
M)8>15EV7$6V77<\T'*IRQ&0:?=-E+[@'EEQ([B4IH]U:Z/`1"?S"WV[TEW[:
M&Z8-VVN;H78D;=]FM4BV.2EE455E:CO25W0!%5(C2D0RE(IJJ144KB^Z#8Z3
M-'<,E(YV09>^IJJO=:OJ$=^ZZ%>6[X$IN;>WF]=+_=T36$VRR/IN\MV[W30M
MNWV^'Y7R;+7EU..!^0W$HF@TDJ'MQ7I+6]LKMQG!%M4T4@)[;J%G*N3\P1CS
M\#_R=N_?_CO[R1[WQ^[_`!'T8D_+V7`<?2N5?O.L<'?JY?0N)UME3Y]V;8;:
MBKN4>6+%;V>4XF,MB8DQW"^RT5+=D\MU6E>5%`&E,7"XAMHA5M?6O65R3=MR
MS>S!6.VEM=IJ^OBZJN<9N&X5!'-9Y*YT4,JD\M*D+<#2%M-U2H#(X@+AS7$`
M;!78HANBQ-<76X=4[:FO<C]DM\([FOUU:D32Q=YC2V4-L5;%R@*+DUQHH`2D
MN,.)2:=F(Q]E!(ZK\U>]/F6EW&W*VE$K7)B\79;T%NW2H+29L29$=2M:3Y6&
M\'GFG2:ASF`4.0QF.SAA.9F:O>FW[3-P3LLFU+-981OP@V^?=4NF'!C3WO\`
M%JBRE+DR92>"EMLR7"*]G#"SXF28NK4+81RV/R8?-C\%Y<5QK2;?*+";Q(7/
MENKF%U47;]D:$=3!1*D!+B9!@LJ*M%:DIQH;:*F];LG>YP:ZF4FA[E-?0#=N
MW1U3V=N'<4E-QM6[9&YNFNVU7%B&_"%]W#M6\.(N2(+[(,=#2XL9ID*0I*T.
MK/$@B1TQHC?\BMW2+8+S4G6LM>4W90X[5:,=4]N0NK4#I.E3UQWQ/V?<=\2V
M(4)+<2U6NR)0B&Q.D-BE93,@AE)S0A`SIBTLU"2,AART[E<[SE0SD-KR6^OU
MIB];'7''-J,MJ]V3(1'=2M:74`.D-K0M"DU4`>-,3-M+S",I^<G#O31TS'M+
MH=WI3=C^>A!I`F2M)9"ZJD.%143G4FGAQ*9+KL]7\TV\Q)V>I+#-ZN;)*D2W
MQ5)2$A]\(03_`.(A*74A+O\`:XX'MNGLY;@S+_AQ]:58;E_SLI3N4]L^H_=\
M*!TZA(G+@S-M;JVM<KG,CM!MZ1!L=XB3(J)CFHJ>;):&L'WAB&ET*$O\R\',
M,>'8GK;J_#<C\O+WX?S7VOQ/PV\0(EQ;C--OW:-&O!G,%;,RERBQ9K:DN)7H
M"27B0"DXCKJ".$?)7UK?GO[$IH>O,5Q3S,IRZZDH2&I8$=]`0E*`#<6@TE[(
M9`I\(RPP!J$XC<7,#CM38W19]B[UANVCJ'MRT3&I380_`W=;#<(LD(4'$K?N
M38>;:D(6@*;<J%)6`00<\;+=(NU^F^UNG]HOK>V$ERV7J>Q<&6G4M2V;=Y=A
MQE,.U75593]OTK_=J-&Z`=N!"W,S91+;G.-0I*@`AH(\*LAH"`G3EPIG@0KH
MID(B6^WM+6RQ',>,LEQQ,-"W7833U-38;;4M3BSI33,982F>6,S-VU0L6)KT
ME*TP+6ZM(714Z4L18J%$5"=)*GI`H:ZTBG9QPT\S)V(2%NB\6_;K6VI&[-RP
M+5&W'NJ#M"WPT+5"8N-VNL*4JW6=B0"[-DS)KL92TG0A*T95''!YF7L]2$ZF
M(D6,D(8C-,*2<W6PH2"!]E;VHN+17,@D@D8;74\Q8,M*YN'>FEW++$QIAIF+
MJ'"N%"JX>KZ[1K=T!W>9SJV3-?LEG9D2'8,2-,EW6Z,-Q8+;ZRR4NI"%$Y$^
M(9X?V5R\-J^B5N9.1;\S8_\`C<N(]XEN6Q7*6A+,I0.E"W/`EW.H#P\*D)5E
MJ&1&>)66=HOHX8S^4]H)XX@5^*09"][!)4?,`=G$50V3N&]0&[_>[G^%LZ;>
MNU6A]@)<DIDW5T1WG.8%U`:BI4HGV8X1_N/ZW;TGTS'IVFG_`#-_,817YJ4`
M<3V8*#UX20114I1SR-G8I"=L&\X$^Q(C;)LU]VI/;C)O>_HNZY=JW%:GUP)4
MJ1(>M?(G1'X0*&^2`T"4UJ37'-M`^B70=Q].H-:ZJF=)-<@.ERRM:X9A4TJ"
M6[2E-,M;"X:#<YJ]AI]JBV+U"W`+E<[<YYQ4.(E*XETGMPWH=Q*5`I3#4VX)
M6I-`3K0D4!QX]UOIDZ=:/N(HV96R.#</NAQ#:]M*8JJO:,[J5H"?>JH^J+?&
MXTL0MS,7N="F;7OUBN-O?@O+B^1E*@QY*9#*4&FL.K5QJ*98Z;]%(6QZY;L;
M5HNGM$E,*Y2*4X>(\4YM/E)>-H4S>FS>U\ZC[;N6^[W-_$9=QDNVMF:X*./S
M&7W%SW'_`!'F.K;H:BE#CZQ:/IEM;VD4,6?(6`XNJ:TXT3'4[B2X.26E*\%.
MNY[^;,[9X\6.)#EXN!MR0M=.0F-;')USET%"YY1*"L('O`4Q,_-Q*8Y&<!ZD
MQNCN[=W;FN74EK<UABV:%8]Q6VW[:D15RW47FVNVPR'[BIV2VVDK5(4*H14-
MUH<)&5[)V`&H(.U:R/,4)#``"4W?4E<51K'M>&VH)DR[_(<3[6H5N2ZS05XA
M3BJ]^6(GJ&>0@$TVJS=*Q-D#GNK6BKZ(&W]UV.1M[=<.%=+;/:+,F'<6&94=
MY*DJ3H4'T+4DE*C320<5I6Q5"W1^6IT7N$YVZ[2AW"RIN&D3++$E/FS)275N
MF3#4$K5;Y!UZ:)2L``'#VV\!Q.U*,D>SPG!2_P!.?RLNB-S2AV['J!,DM-NF
M(T-TPEPT/26]*N4B1$8*VN8=22YI.K,TPZ?)*UA,(;S@/EJ*X[O:MI+J;E.:
MP,SY33Y=ZA+U)^@#K_T7M4[<&P+/&W_TR3/B3KL_L"((]]V_;(J5.J1?MOK#
MTVX,I"`EZ4RM;6L@Z>T4_5HM=N11^4=S:?%<YZ@@UNX8<I'H;_-<R[+N^ZMW
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M\J%#Y2F$4&E0RK7#%X#7EHV`J,`:V[<UGA#C1(^X=T(;WC;-K[:2SY.Y2X[+
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M8+B3'CD(YT967*:BQ7`5#,5-<(22OE'ST6'2WDW]+E](JHSN,B/;[0_N!DRW
MK9'>:C6%$-]3$F[6YB`FYR;LEU`*E,-2FM#G802#QQ-L;;9!MK0;^Q$L0A9F
M'CVGOWI^[LZ@VS;4V^WDRW8"IUGBR;5&>6DLM1WMOQ5R&A&2E#19FFY.(?%*
MN-T!.6%(XH))`T5IWJ.;-J4TS&VN3('?/\M<-V-<-ZY_;;Z*R=XRK[O&1-@6
M7:K+_P")S;FEL.J3"6/\0F%;R:KTO52FA\(^3&NJ1,LXL\-<W;BKI^XV-E;C
MF'\XC''>G'TVV>Y)W3M9\V]B^1X&XH41(D0/+Q'8C$N6I`E.%1"G*1DD&HJ<
MNW#"]N7.95E*IP96MM'&';3O77B>\[>;3^%75QFT[:LK,U,&$RZ"YR[@N*J?
M"BOYJ90\J,@:37$'&UTSG.FVC93!4:SAO+ZYFN#3\IPIAQJ?3L6CK%?=JFV;
M;M<VV1K+;G(;F[(-N9;#'X;;K%"*6X#R1^\=N#*GFSPU//)5Q%,/XY',&1OA
M1J5Y&6&.Y_4`-*88[O:JL+O$5BRS)3#[]M;4PJ7;]NH>J\];W`SY=`J-<-[D
M,4H:DG#ORT7;ZTWT7GNASWAI+3=@FANC9MWG6^WW]VVW)$!UUMZT6:<\7U,^
M:;"VKG+U)!?*`K34TI3#*X=+!(UD'@(Q[_[%;M+U&XBMI8W$%IDPJ.P;TG;3
MM=@M4]%LNJ(\B[B=<42'8"W8DZ^W25!=G(A<Y+BTJ9BI&2--!B0M#,"V?[[3
M4<,,<5`:H]EP'5.)::*S'3239;W:[_:GF;C&1L)-GD[:B^44AK<4M^_VN'>;
M;)NU"'G&TSJH\(H4T[<-=6>ZXD\Q)^I7=@/4JU=,EO+=MM/^DW93`^M3[.NM
MOVW'O&W+?=([B+FNS2D6EU:),W;+NYXUUB/2KR"`I"%.,J'*(%$I!KGABR^N
M,M/EIW*6TS3[=T`=+FSM=08TP%%`]Z]-\.WB(I5R64VMNSP+>^Q&,B#)EQK<
M\Z\Y)=1I#4)UEA*TIJ`CC7&XNYG_`".IE/8IZ2=T-H]D!&;*:5Q3QZP;PMLO
M:G2K8-HNR+8U;46^Y[B>AZ&7KZ6)(::BRI`"ENL(?`7I/:!W8W0Z5MU8%EP?
MS*;L$V[_`-08FV=P[AN46/`2;DBRV^W0FY)CN+E+C,^=GEAQ:D%EJ0REWA^\
M)5VX>VEA-J/Y)>T6U=F_MQK\%0KB^BT=IA$9<\.)J<=OH4;;`CNVG<LJX72=
M.>E2(5_E66<\\J9?;7/;?;"7Y94-3$:ZH<*$*T@!HG"6J:;<Z7`]D+VF+"H(
MJ=HWU4W9ZG!J^GNMYHR,],1AL(/#L5C-H[YVY%F,S[G%N#;-QV7N>Q;>NDB&
M51X=ZDVN8%+CI*0A];DH*TOFNJ@`]W%9$MUNIZE,/@CM+#\FNS>:I^6>=M5C
M9\^]K'X1+VALYF%.@W%*8,G<5YGNLKC.Q)12/\$74:EM`$*57//$A'-(Z$,D
MIZ`JY:VYU%V6?P`[L$D=/]Y1M]=8MJ[DE#\.VSM;;;6WYLE=4,W%RTRBF'*;
MH:<EYY"0!VG"#;>)DO.QS`'?AL4B^XFL!Y)E/*G;45=AL^;^*H[U5O*+?8+[
M?+5.2EN]VF[;;>A-T#]PF7B[(F.7%E2:%+L9T:`JA*4T&(Z.YOC=9'9?+UX8
M^M/+9T<PJXI;N<5]G8"'E7,3-UR]D6G:K\=`3YQVVV]U;OFY9`*GF505)2:\
M5`G$P:5--BJU]YDZE*R,@0A^&&Z@WJ"V;',>LLINWIAH:M$,3Y#<@A!D0():
M;<AM.$C[]]2T&G:4G"D1(<2.!4G8VQ9()+CP4]I43WW;-Q8=-T=E/0TI4Z\U
M:WV5,O,R9J2]H:42.9%4AP$"E-1.%=.N8Y[CE7-,M=V"E]:M6267Y688;BB,
MF[3B]M^#&O2K.;-:(R';>I5)',0XB1+G-+J"AEYY))%,TFE<)W5G8^:DRYJ9
MS][M[DPC:66,3#M$;1[%:_;=CCW_`&G=;_>X2W77+T+/)2I2D\^)9";]-G('
M9(>9<:;2O.@72F>&ABA@DC$-:O?0U-<*$X<-BA);EUM*"VGS&F/#;@D)W>?^
M9I=QN$J')LS4>=*>;M25J:0M$A.BUJFIH52`I-:U(J*8VN7<K4V6K/T74KQV
M\5/B.!D(G!.>G'#U*+X'3.'==K7EN.DP5-26PP\A>EJ&Y=''8\IU`IJ"E(00
MBI\)4>-<2=UK3)F^7D#0QGRX"APP438:6ZX<^5Y-:D[>U+>\IBY-@U7.[7*7
M-MMD9LVVG&G%*C1K/&MZK.N*WD?+A#FI057WS7%>$S+:_@ELG/S%_P`U344&
MS!.V0.F>^UN0WDM&%!0XFAQ[E5"!?6X%U%FORR4Q;:S,7&;D<QB1;8"@L&2:
M4>6Y0<RM*\,=&ZBU&2[TEC&AF;*-@H=BQ;:)86DIF@Y@>>+JCW)W?YBC_P!]
M`_?_`(APG?NO[G]S_#_V?=]N*+D/$[.*:_Z2O.,6W-X1L]>U4,L5G#L*&];(
M+C%QM3[$AB4A;4=U?.&HK,BBE!1BZR"<Z#%UN;I[Q\IJNOW7^1-+O\L]O\JJ
MPUGO2Y+3B66;DRMN/SILR-/BJ3)"``\\MTQP7%-GWJ$DUSQ&P\TEQD!&RGM3
M=FIQ-QMR'@[:)#O#$^?+@^0N$]$;6M+:D-L*47G&^8L*<0&RMQ:*5)`)%!A?
M%;?NLG!-^)9;A>!?';G>KNUY&USI,*$A09DW!#2$DM,-AQ*TK6#0:M)P8K>/
M4IY?TVU1:\WZWM2(L"Q6U=Z:B6EV$IVY/J;39U.1$.RFU/M+*GI2)_AH"JAX
MX4;&]XJT5";7TT@>WS0R.IA7>.."35W`S>0U=(LJ4[<C&D,VN05QH3$F4TE3
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MND#7VYSN:=W%1?2^JP7<,D;Y`9B"&C'$G9N3G_ZW-,.VEK=W3??VP6;H'V;6
MSNNTL6.9/1%4$/JBQI7(FOEA>2P$'030T.)B36[R']4959.3-^$I3B=8;"\_
MRVX%Z@J5)\K&D2$QRVZI2TMLI">8HZEK53,#C4X0_P!2/I6H47?ZN_2?EF&6
M*E:GM4U;=O5FF=1ML=/+MM>2M%]B[GBW;<4Z[@JLC.W-KKW(S+6PRCE.>8=U
M-)&HGYA@CZD9)((I7@,.U9T_73>CG-QLV^)^X#MW[:#8OMW]+'4.'U3]-70;
MJ-``9MN\>D^Q+U&:62MY3CNWX<5]XNFJE(<,,$`FH-<;74T4XI"X.[E9(G-F
M9GB.9G%3X9#9`27*I'`9D#,\!PPQRN9\KA0I[`08Q3M]ZP<D(Y:D50ZA0HII
MQ(6VL'(ZFU@H50=XP)5-N=:;=Y5WR"KO!<54J$28AB&A5#0\A:5MIXGW0!WX
M$)B_A$Y!UF_78Z#J(3-8IX<_"/+T[,"%>R!:[:W#M[Q95<9,F+#=<G7`F2^R
M?PUC[H:B(Z=7L17+(C#>Y_2](0ECX?[(HGN2.-$C[(KW88(3;O$*')O&W%2(
M<22I-T<EQU2(S#Y1,B66Y)3+9+K:RW*CA=$N"BT@Y'`A.4?Z?Z'#BV8Q[B'[
M*?$(`C)`D(`KAWK@;_ZD'=#]D_+TL]CA/3XMPWCU]V!;VI-NFOP9B(EFM.Z+
MW,6S(C.LO(2TIAO710)!'&F3&]<Z)U&;.Q0O5$[(;2D;L%\;_3CU]^I'H0EJ
MQVN:SU`VD^XRMZW]1YDZ]/6HV^(^CE6R[HN*ID-2F5(T`I<"014$XS871?>,
MED.&P=XPI[%58-8U=T;>5&XL#1CAL'I7=3TZ^K&V]0>EVVMW=;;+M_H-<-VW
M69#V9;;QN%I^)O"'`8:<E76WS9+;3C"`X^D!J3RS57AJ<>6_]PFE=2WNKVT$
MMC,^W$KG!WRT;5A`=XJXG!,Y];=<GDWAR%AJ*\?0KKVW<CUPM+PL6YH]VL=V
MB1G&U1+NW/AH8>')8=*6Y+C;27"K2`0"*T(&/*4TGU$M8+K3]2FGBTX$B)KC
M@1C2E*[J;5O#=S;;:I[OYIMP;0N#)G2;;9$-39K8;FK6ZZ^J64J"8[4-E94E
MEQQ\)%*)R)[,1DW4U_J=NW2)F.\Y7PTQ[\,.W:M#7?M5&_5%N*(-FW=I*BLW
M#=L,6YXZTA:K8E-NY>AQ*5:5K96**`%4''>OI+ILHZ@TZ.%A,\;ZR#>VI;2O
M?0[."<V[VL#LQ5Y?2GM7_*?I^Z?6MY:%2+I847>2[I`4EVZR7YZ'"0-7,4S)
M2-7'2*''U1TQCG1Q,:*N$8]RA[R6//MWJ=W[);YEPMDZ2RM4RTHE(C/E04Q6
M4P6'G`V:_>+:44ZJ5IA982RW'Y:0AG-L5HA-`A!-*Z4@!*:^P=F$7,<Z=A:*
M@`IM<O:&Y*_.553U.2'/,;*CI:4M2&+MJ"&E+*2Y*980LE*5!*BH%-30]G#$
M%U$YK<K7&CB1[U<NEHWQL=S!2H^"@&W46B@!/*=2A84A0TKJ:"B@,_DQ"975
MV*SY7<%(UCOLZRZ92-3\9)&N/JJM:@![NHY)T]F%XIHH6ELK@UQ-4E)(R(TD
M-"K%;1ZH6>4TR6B+7("&B\W(6I(6[I&M(.:150[Z##F&]M1*TEXIF'%:BX9_
MW9J_<.)X*<[%OM("5(#SC:U(*7[>^6BTI*TN!:BA*D2&5TTK03122:UX8?W-
MRRYPA`=W)"6YW7#:*MO7#T,^FSU+RYVYH6VV^E'5@B<K_/'3EEN"B[3)Z$AR
M1N#;P;,"\-A0U*;2AM1/%1Q5=1T<7<G,D!;)0"G8-FQ0UUH]EJ;_`#<9!=2F
M'9_:N`_JO_*R]5_0%R5NW_+4KK1TY:YLJ9U"VESV5LPXB%3')&X]F2D"]V.1
M"B-UYK:G&"$FF5,5>YZ9D83+"PN>,0J_<].74+'31L<6-QW?:J.Q-SQKXVJ3
M:8[KBX\*W<N[.!/(A-H=2A:I2&SRE-GFI"10N`G,#$!*1!)R9OEEX%5Z1S8G
M\N0TDX)!LT-+,JYW1Q;<A]F=+7*U:5I;^^7H>`4"`AP&HIV'&'.#3E=@4IRW
MY<]#E3_@7Y3UODPT0'8ZOP!MQ;BE(2W%9F3?)S)*O$`E4Z6*M@>(!)R`QM2H
MKN6D,D+YQ"2,QKAZ$4E7M4*+'AQEE]WSS]NN481WY2(]M\W)Y4QV.G0AY#J0
M?=)509]F,44CY>/@LT)LMQMR/\U-MVAR9;Y5KLDZWQ%P7&8Z)LDM.R8"U+4P
MN0L``U*BD@Y`TP43$PQ-N"3@/Y*&WDBX-VFT26&BQ"OK@>3*"T,RW8^;3,@Z
M3SB"*)"J@X5@(;)5VRA4JR6WBB)8X9Z*5)=C<F0;"Z_;C^'JD/,R85H?++J;
MBY(#<9U:@XV:<D::#(C+#WG1_B"I\S+QUV90TEE=N"D6P;V3LV7?+>MVY.6J
MX6JUQ&E%DE$Y^.M"'[:\Z076VXZ4:6ECWB!4TPS?&][RYHJTG!+L=EG+I,#5
M.O>6Y[;=NHTJ3M\6J78$7%Z5;VG'G(+H3-98_P`6F0U&4\I$5]Y3>A0":FO`
M8T<Q[15PH%-"YM'L#7/'\>A"!+O*%Q$2I@D7&^W6/$97,D":W$A6/SC\-##C
MC:1RPN8Z$E-0*'/&BQGLOQ!3)TZV>^UL^(T[,M+C,!^^-6&Y07W+:)3MY+\R
M2M.I#@D_AC[U5&@0A>8H<)&6(&A.*B=19"YI-N0YW8E-I3EMV^ZC>[\N<9"8
M-AMUO1(1<%7"YQS$6IB2M+54,QE-*6HZJ%0QLV1CS1I!*JD%E++.[SH,<('R
MD[":[!2NY,K=NW=O.)V^Q;9M[+IG;AG79I`0I@+N-E?9AO)CI63^'-R&=-%)
M\13F,L;*0%S)9_TXS?QVJ-+-`8O%CV-MZ\:78/\`EU<)-P:+;#2'FUN(DA1J
MV6]*Y+6L4`.L#/"T4TLHK$"X#@G-Q()(Q0_,0M=TV9$O%KBV#=MJ;OH%SA&Y
MQ5I0/,,6BS*:MD%F9I4IM2_+J4I+:M*Z#5P&'NGWC&SD3N#2WCZ4CI_F(63&
M)A<\M%-G:CNUH%A;9CVR1:CMG:4Z(UM5,9#*%SXLR<K6N*\TVA31*I"CH6*C
M005$8=:S=6]Q#E@<'.[%""WOKF<NOFNC97?_`"JEO_)VTX4V4O;")4.UO%<5
MEEMQ+KZN8A2(L=E&HTELR2%J7E05SQ`6T5R2.<QP';_:K-I>J6CX3')*W,=V
M/V+$S;G$87'<N5U;;@W?:Y9=D,I6F1;9J),B=#""5K<?=E/(2%4.D)XTIAS=
MB&'+B`X@K,4TMJZ46[<S)#6O=7[4H]2=Q7BTVFS76WM_BDB9:K0PVU.::E7.
M)+B2)<5NW-L.:T%$AT^.IH:5/`8:B:*H-1M49+I8O+ALLV`S@GT$*+.G5CCW
MJ=`NTI[07;_#5*C22KFL%]:T7Q*T/>,L1FU%24BH33PC$KSHOQ!2FJV[&S_Y
M"CXZ[OYJR?4)R/>H#/DVTV^V61F!MMJ<MQ33VNS,3H`G(#A0UY:4A2$^(@ES
M,]^-";=[PYSA@FDTG(8(Z@.<*T[=B@U_:LJQO72Y_A<J39YMFLMZV?=9$;F(
MEOW.L8J3+8#I+K3J5(>4A6H)!KEB69<6+87`2-SY33;P[E#R1W;WB0L=R0:D
MX4`&T^I3)TRN;EQC6[9%SC384[S[S#9B0TOQ'`\NT71J0%%QA:EJD6Y02I1K
MQQ7[MPD;1F)2O-L?^8WV_8GIO$,;A1OU<,L.3G;M987XZU#_``^>B!96T"`X
MTT*KFNN`+4"LFM:&G:SBLKIT1E:PF,';@D)+ZVBDY<<C<17?]B7M_;LB6WI%
ML@7&3<;3<MR2'9JS"($Z6RJ4JR194AEQ26V7)@:U%O()*B*`8;B6*.81R$!]
M=B=6DKI9FEQ_*J*GL4:7+9%HO^XVWX*6+C=K2[95HMUT'WDEQ#"(DF.XF*YR
MXY9D2$E134%9'RX>9V<432O9=4;^AQ47S=OOR4SQ*$..[MR>K:4@38GXB8J%
M372V]^(N*:"T^<^Y3F5HI0FF'-E$UUQSS<".,X4-=W<"H_6KB,.RV\)E9E'S
M"FVF(Q(V;%('3N8U:MM2+A>;9"<@W3<$G9#U\FRDPKE%?=C2FX2V7G`I7+9G
MH2#6J=`(''&^H6S7S![+D2,&X5^("6TK4K?RCH'Q".1U,>&([TP]J;SC1;2/
M\V^9?O5@WUJL$%4TR6H=OA*4AHJ80VEE4>4PXM8TZDD/)KVX9^79Q%58;D9[
M#Y,<%,N]%WCJIMURP66#"D*@1G[S;(J)`%RDJ>O#,Y%N="5IUNQHJEA(4:!*
M<L-)7Q1/+"5'Z.V"TMQ<7A$<1KB>\\*K1MJX0XMCW!9K#:WXCMVN;<-UB<EU
M*XB51`A:0D`O--I?XE`HE6?MP@9XWG)&ZKZ[.S>DM5Y6H@G2B)I*X!O?CMIN
M2YM4L[FNHVQN"6_(@.SYVW7K6P7!;XC3S2'8DEB8PKFLJDOLZ=:RE05[,2,T
MFE16V;F-Y]-F/V*/@CO;7]=CF^K[5,5[ALW*X[ANT6W+M&V[6W!@V8B25B7'
M@V=NTW:&X\MPRE0H#R%+YA'B<.9(SPQA<)(FO&((51NM1OCJLT<,9<T/PI3'
M`=JK/N2ZW:[W&ZV]J(TQ`VS&@JB12^VDW&W1(3K,J:I41U1<0T^I(5J-2H@T
M/'#N!S6N.<T!:5-QS:MRFON(7LAS#$TV[MZ5>I#,1T1W[?&!EZHLZ;#6J4OD
M-EIII,MJ:LJ#.2-(;(TY5[<5QS;Z*\,D3'<NNW#[5>.;`;$"=P&&]"\].X,V
M+9-U7.VS6[9+88D.7-W160PU;TL2BMUK2XID2:I4K2&RK/AGAT^YE+B75S;U
M#SRQ<H97#*`%(;FZFK)LS;\R`%N.;JO=QCR+"%*=EKT/,00PRVDJ0E<J`E2M
M0(!`%3D,9@?))<,)!RM=4]F%%3-7D)Y?*-3S,>ZA12[6B+Y23=W4*8:<4RY#
MO*G$^1BVJ+RS:K=**5DKG*;?3&.H%7-;)/&I?78,FK1SLQA%*G=M4A<:G%#9
M`3/`/:DN!)E6I^^6"&M%QL5^MCJHS82XJ>W>;@T5/PI9"*MM0W4>`I-14:>W
M`+&WN'N=&\'YB=_%(Z)KEQ('-C&88T]>":$*T[AD;*<9F--1K0Y8;8ER2AF0
MMUIJU27VKVRM3C9=2ZEY]""1F5FN?'"8M(&2@1N#I`=BE-+NKJ:_E;=M+:M&
M6M,34U`IV*`-N[+B?C\I^VV%5U;_`!!R%,,GGJ?@Q7E.F&P\'@/NGF&B?#5-
M!G0XL#'.;'2\^6/M_DITS1-F\N2.?PWJ5_\`*%I[KY_$_P"8/X-S^"^#W/X+
M^S]&$_V;4O\`DNX[MG';L41SY_\`G?>XGU;%STVE:Y4R+<XI"V$VV1$9NC[;
MR0(K4*.L*5KI1U$DD)*000#B0]RZ3U'<^:D#4M;6Z@V%^24-:$6MB>J`VP@A
MAI3+"^7<5H2X%*`65)4JM?=P+%A8980X#:M_^;K<VG=$M$B+%BQY:A:7G)C6
MI"FU)")*6]()YC2?"FM348$^\G5(.WKI(W8Y?I-L$N)%FVEV?<K].;4N2A`D
MAI46WJ26T17Y&DA*C4"O`X%D0>4QI1%[?9PU>(D>U,J7#8DR)CD%2_'(8FH"
MEZGU5`>+HUK400H\`,'/Y.%=J:78\^YKMN04]>*ERQ6/\8<L+%ZFVH;DV];Y
MT"PKB+0[)\DL+1:&YFA24H\BA02XE55*'`C&/.=J8R6#N6XM'S933U)L[<VE
M(MB9D.>VS<&HSHBO3'Z:)-V7)<4TAB*LJ6ADH=6?>-"D8/.=J@?)W_X2E^U;
M9=E7"W7]ZWM:U2%VA,5R-$>?\JER6V^XI]]I14@<L*I2@2*8:7DO-AS)S,V_
MATET;@>67D^P*V'0OJA:^@'2KK+U+NKZ[JU8H>VUV*U1IRHYW!>UW"[QX-H>
M=CCE0H3TIU*=)0HA/A!K0XF^FS2,GM5W^GS;4V[G/ISJ8=^Y3+LC\OGJ7ZQV
MK=U]]9G5'=EEO>\K9`NNT>FNQ&[;";V#M66@O6JV*N4U,I^/-=9"7'D:$2"N
MA>4HT.+6;;SG:NE*)O5)Z"]X^E_;]MWWMC<TKK!T9CW6#;K^WO>+&1O'IHN[
M/(M4/<<:793&%VMC;TE#9+J/NU'4I1X8B[[2O+1G"E!7UJO=1Z;YVR+AN4(7
M.[.V>W2)4B>(21*NVWFKK(24SY!8B1[4^[%;"N:1<HX)20KW*\:XH8NJ:E'!
MQ=\"N5NUO]GMI=/)H7X>T'X+['_RA]WQ-S?EX^GEN%,-P8VG;]U;#+^O4IM6
MT-V76W1VE`U**V]3*DI)JE)IGB]V>Y=5Z5OO.6(%:X?!=)>>/A/SC#JX_5/<
M/<K;$W*RBWX12B#O\&_^C_NJP(3-7[BO]57]!P(5W[;_`"JW_P#VM!__`+<S
MAO<?I^E"-X8(2)</YYM5OMUWV57LHS;'&BBG>HR*U]GMP(2X./\`IW8<6WB/
M=\4E+]W_`!?:OF+_`/4^[L3#]/?I3V.TZZ)NY^NN[+B&$()2[%M/3UR&E9-?
M%RIMV0?9^G#"_P#U%6>J?Z1?%YMUX2NH=@A7DL2+/;=S17]P176:'\.;>88E
M-+"W$@A`:))J`1AI8_J1?^*?>55=/O:0EO91?13U*V#M6X;2]/O46Y;BL-OM
MVR[AOV[0K-<-O/7B#N6VR)<"T6ZT-K8*HEHC+9BEWGE#I;"LA45Q<[WIJQZG
MZFFM;X`MCM&.;7B7D>Y<WZE^H$/1ETRYFBYPN7\L#$Y2!FK@#W*&/0_>+O8O
M4UUI>%V@M6'=6Q+<+/M6RN<RT6.1"W#&;#\%U+$)N2IUEVBE\M+JCFI1QXS_
M`-R71\/3%N9+1H`%37T;/13VJW=.=3Q]3QB5C.74=WV+I?U7L5_WE:KQ9-E]
M1)G3;=^X[SMV_P`?<4M#5TB-"U2&4SK='A,S(,EL7%M!`(*@DG,'CCSKTU<6
M_3[/W&>T,[B/%2M*^@J?.VBHKZJ')DQ6R=HI5SKG(O4M2SIJ\\M^XJTRW`FF
MM*"\304/MQZ(^@]N-<ZNEU1C<K'NBHVFS%R#X2NQ^W+0WM_;VW[$TD);M%EM
M5N0$ITBD6$PT:)ST@E-:=F/I!#%Y69C?[GP4#=^+TISX:)\MB'T,@A7;P^;&
MT7ZP[DQN6UE:[L7&C\S7U"]5>A_5#I8-N;:VS?=@[LV)<4OHOGX@RX+_``-Q
MM)DH:FPGV0VX[$>#@)'@`SKBG]7NRN#^&/J-5-66L>7`83BJO[7_`#`.GT%[
M\.WAM*ZV"3&Y`DO6";^.6UQU[-*QYD,N@("3GS%'N!Q2/WT=BF_WL?P5:_9W
MJJZ`;P2P(74BU6XKTH<C[ACSK(IMP@*H7I;"8RDA*@-0616HQ*6.IVL\1=,1
MF#J>B@4E9:A;7$9?,1F#J;>Q./<WJ"Z';,N-LMM[ZK[/@G<<9^;9Y+<Q=QM$
MN&@\M9>GP$N-,+\P=&@YTSKAU)>V(8XL(ST-.]/?.6$?YE1ACZE+VQNK#$QF
M-<-H;SMU_M;Q0E/^6+U"N\-;6M*M*H84W,:4H@`ZDBG?A2RO=F*#?Z?>;PNJ
M,O>VSMD;9CW6_P"X=G;4B6RUVN3>[A>[O;K%%85-92\9$A]QY3S+KH-$I<<0
M'2GP5H<6*.]M,GYQ&=;F.**/-#3EX^M4)ZQ?FG^BKI['O-M<ZHWWJ/,N%ONU
MAE6WIAMZ\7J/N9RYPY-O6Q$NMQ7'MO(BHD%+KOB0G0<SVM=3U"RBL)9(R,[6
MX=^"KE_K`:'6]?$*+Y!W;VC;]]N]CM(D&TW2]2Y4-R5'$-_\!<5->BQW6&=<
M1UT.R&R7D+)):TD=N*`[23J!\WZ5R34;W_/8G>O;;+D,S+@8H<<AIE6>-(:*
MB5/_`(@5-2985P2B*^@53F3K`J.W271ZLYX'\#!6.TU:S%NV&4C.GPH_AZYL
MZ\H<<VY?)TAIIR.\&G526H>J&R"4JY;"KDW733BOV8K\WY<G+3IC;-[Q+%3F
M([$NMKCWNT*OS4VX.,HFNP]OP%K91,;D\V8ZFX7%JNI<-*$)30`G6>&-$X2Y
M=4VW>K34J/:U;5CL04W.VQG)+DUMZ'S2VMU"G2F0TIN8A0*5J45$$B@(`RHZ
M?]4I15MQ5SCN7)VWH3;&[Y:YRW4%*7`NU--LRF0*<;D^=0/!`R-<822EM_:"
M9D><]8FBARR71J:MIUP$)8BQ7+@2!X:EU3>@=Q-?9C*PJ]/JE[L3:[W;+E(=
MCS`^A<2($R$L2$OT#C[:`DLMI"BLI.82DYX/.B/Y."T-ES/GXJ9[-9T6R9;-
MRVMIEZZVNV369<>8ZE,&ZQ_).+E-*0H'07FT$(XE*J*[,!NN<,GI24UKR&9^
MVB4'V9%Q1`N<M45A-A-V0Q%@RD/NQ&7(*';?'1'0E*E\MTJ1JKXE.>S&J:I=
M1NK\%V5MBU-72,7I,Y,*V04R4LR[=#N;OFI<15=13(ES'#S214`Z1C'D2[YN
M.*%NV1?Y%\N&P[3?;SRH<"Z[FN]Y;95S7FQ`)>277CEI4WJ0#3)2:^S&1:F#
MYN."U=%S?E&Y-E_<MNA]0K*Q'N$V/:K'NF8[?9KI(>NEHG/R$Q8;DM0+18BM
MN$I1I)`/MQG%:^2/!*5]EIGSU;!EP[<S$F[J<=M\BU+_`/I%5D>BQI+5OBA'
MB1(><MR5E=:4413"VD_IO_Q%1KA0D<"G6YNJ(U#VK:HC\J*NV;UM<:6F1%,>
M0ZU?%LQ8J'I+VH/%F`5/*`'AUTXYX9__`#<O\<5)Z;_WG</BGMNW:5SL,7;%
MTY\6<PU,W(Q=V.6`N-)A,.3)7.=JI!?=M*FU,G2-!/;A5-;P;5!FT[[9DIZ@
MWG;3JYR]A;-E7*:B7)2U'A29NX(D-N6I3B5)68\>20`!51[L2_<F8TKROS43
MLVQN&-N.#9KBI8G7>'<V%QS$B+D,3;+<6T0;8_(9206%NW*+1`54I!KAE=6_
MF"T\`?:GUJ[,'=E$\51;1-Z@N6%^!.:FN[!FW7DS$EJ-%N+2GF7)3#BD%"W(
M4U!5I%"21PPU\@1CN3EQHTG@%(.V]A0D3MSSX$&&F)M?IW>=VRIER94Z]&N2
MWTL,-%#:FPN0D#5P\052F6,J+\^%'&ZMGQ-SSV]NS+[.D6O<L5,_<K84IB)'
M;AQ8\F5,C("M;(9<XMZM2B>.!-+B832M=P"T[LWA"O4_:>R462=M[9FW-KN;
M:VTS:'I*'&;?'LK,>-N9QQ?W<F7<):ENJR"=7#&%)L;FM7-XL(]B1]K[G<A7
MBVQK%Y^\I1.C2FI,QODSFU6YQ,=Y+TRA0M+C+BC2@P8*`\D."MGL^)M_=TJ5
M=[7`7.8MFY8ULND1#Z&@RB-:VKC/EN+4@HDHYL=*$@`$5.>'L5T([<PUVFON
M3.YL*/SC@F%Z@[_;;Y/-NF;?;?AVF7)7:78,!Q(7&CRUW)*6&DJJ>8%!P4-*
M'$)/:YY>?P-4VEU#RD3CLRA$-D73;]^A6*3MUB%$W&Z+Y.G/-S4(DN)89,IB
M,EU:=+$E*XXJ"#PP+-EJ`O*8KS=UNL=UM6][K;)EOFV>%;K$N9"=>3'B7&^N
M:;A.N29N:`ZN2LI6-)JH5!IEAU%X!WK1USS-9.F;PQI_X@M,K:MBW9TZ9:W$
MR50&[9:]PLNVI"WX$RZ3-RO1&UMK8*2IV.A()-:G4,*]JD[JT-I,UFXJM5PV
M(N;?[SN&%)FQD;,B6JW+3.C.-VJ4P2J'SBLN`0Y"PS4E>LKR'9C&]6D?^6_]
M'X*;K-)VIM5C:DV'+DF\W&_24(:M$C5/FLQ-*7F'ED*0RAUXG02"`BF(6<<V
M]='OP]P4-#EN+<02?IM)]Y^U(=\W?N.#U+W!;6"S:)T"=N62N%,93^*OMVMA
M"0B.^`AG3.>="/<-$@G/$M!HY:WG[_M6':SI6G-\I`6^;]O;[$I;87&;B/;D
MC.KMDJ7`$B^1DN>8\_>';Q&\G'6E&@M2D,J6E*QD$URQ&7UC6J0-[YS9O4[2
M%.7#;^YK,FZ6Y,QVQ_=PVG"U*8$R:%3FH>I9`;\FDZDYJ)5QQO;LR0M;P"@'
M6F2]?-Q<HECVFRS(SK^U3`:N=UBEC\/0_P"<GHMJKB(TSF$%L*<0G2OE4U$)
M.>6%\%*276>W$']X>Q24AF;<H>\;DPBU+B.Q9%GCB0^TVY,;M3D..\(:5#4A
M3BI)56AT$%.?'`I2Z_H_0HWWU!O5MLD:T/J81:FK5:8T1G\6DNSO(R9+;[S9
MTK#!8>9)1HT?IQ#R_J.[RHN3^F;_`(5(TJ)"VRY+C7E,,R8,^#:+$_"A.-NV
MQC<"H;0F(;6ZYJ>C<P^(4*JY4PXM/&>[XJ)M[3SEQDX8_!1A;MP6&WRMRQ8$
MIRY;'=O\JWW6R7=YUR=!<MSBD0IT9A+*U)>E2SJ4Y72H)`IE7#].]=T.EJ*C
M<I^N=WV#;KAM>^;>GPS&0[MN^W^(EU"YAN#$=L.6]@E-$+44U55)][,8-,^_
MWGWJ-T:T-K$2-R974&[RU[8MMB2TJ3*E2[BY(;YZHS;B;E<""XTI@((;6&T?
M=FM"FO;B/DGY%Z#Q*=Z5<\[6<@^[_-1SMYBU;"BSK;N*5<(%\E;;N>I;++CD
M!3DRXAN"IN2ZIQ2Y/)*E5KX->GLQ*:G?CRP[0IN6O[\WT?!,S\9M'_XKW[^`
MY'[V1_`?W_\`"^[]&&/[MK?%VSMV)/S%EQ'B]JY6V_<-RM^QD08,B)-=O-^9
MDO2H[ZS)<M\9UME]E0)JYJEE!).=*CAB]\F/@KY)&V9^>3%RAJ==+W,O,F(V
M$0F+>]=`TVRPRT%,RTMIEE10@%:REL44<P3EA&5C64RI[%>7$=(V$9>X).NF
M[X=RVPBUP0$/1WV&9+A2''5B.ZEL**EZE*4EM`S[>W"/8INWD>\#/[E:S9SH
M@0+Y9X*KF[%F1;>B._(2$L(AE@3GV3\3CKRB03XD\!E@VIM?7#'`YMJ<6RGX
MLR1>VY=PE1)#$=3$<QHS3M6@T2"I:DDA23W<<)R0QRFKMW:5'VKX66LCV^,.
M&_L19MNXQ;'/O+$GR<.U28<1B>8[3<^X2U/I2'7I`1SCSED5373[,(NMH0TF
MAV<2E;"X;.'&3&@*7/Q-U&X69\N8XV8=UC,L)!HPX=+#H2ZP/NG722?&H%0&
M5<,<H[4ISV;Z>H)Z;=WHN]MQIDI!9_#+G?T/!`#27(H6ZTVK2V$@*YLKCQRP
M\@C9)"6N%6U^Q)2SLG8ZSDH8,N:E`,>_;N":NX4SK=LF_I<MLF;MVW;KZ=75
M=KCJ4O\`%[1LZYQKEN5:FR?OW&G4/.**JDC+AB8TMPMYXX6X0.>`X=F_':FW
M1#XCJSH1A&U^&/;[5]6^R]TV[>FSK7O#8%PM$RV[JL3,S;5TU:MO27)$*,JR
MSW>2>>]%"2EJ3HHI"A7%]ANK:`_E8'OK[UV@PYOTSW*NWK?ZU[,MGHHZ@1MQ
M_A,'?/4BWN=);7M9]W3.7O1RYVU^[%IP?XANV6-,,S'RHZV6%MFH*CAIJE_#
M-&0^E:*(U9UU;VYC<X9*5I0;U\ZFZ=Q2Y*[TJ1%_$(MC189$8NCF("Q'$=Z0
MU4>$OL-`_IKCFD-I:'6X97M.0/)VG@>U><>KO+RB7D"E_P#<=4T!J-VPX5W+
MZR/R.]_[9V+Z,=T[9W/<W;?%V[UWO3<=;H"H%L<W_;+7>XC<V2:O-H?=2HMB
MM*U[,7]@MA^@/:2NP_1L.O-+>=0^:9C<-V[LHNZZ'F)"$/1G&GH[@'*?965L
MO@9!QI1K5+G$82EJ7G-M7282\L/,\69WJ!('L6_G+]GS832JVMK4ZEUM>:"V
MM1`RJ4C+,9]N!":G$$'MJ/T5(_HP(5TK(ZMRUVS60:VV$X<@/&&$-UR_L"F&
M]S^GZ4)7PP0H^W+<-R,;[Z=P[-8XMRMLQ_<L6_S)=UCVY6W+0FSQI2=P-LN#
M7>O.3CY-MAG-M:@5U.>!"?KBE(`*<CJIW_95]6'-MXSW?$(RAVW=BOC;_P#5
MBW6Y/WCT%V.WS9,4VU/6C=DM##JFPXR)6R[4VHZ"/&%((![L1]_B]4W7GNEK
M%)C'4KY7[[LZ]74&YQ2M!N\6<]>;HD`AG;L1:DW`EC)HO^7!',IS-1K6N>&]
MO-:OL&FV%+YLQ`-:["=VQ5&UB8V0L`^0E=JKOZH9_I^].'IP]/\`U>M$_;<7
M<O3&!U(M>^9+[,VY3+9?=];ECV2QRH,)`D08$S;-M9=YRC5Q0H<R3AW!K&LQ
M]5EK)@+DP-#OD;X<QIA2FU):ET-H.N9#=P9WL=F%7.P)%.*1O1QU$V#U2ZQ;
M\FV#=\3<%Q@0;3+9$)E<>)#L$YT/O6;RJ@D*>C7)E!+A!4.`-,>;O]RMWK&H
MW+;.\D#K9P.&1HKZ0*J1T[I:WTIN2P8&`#B3[U<3K7M"1N+J[TQDV]^;'OEK
MK+1(9FRFD:'6GGHX5&0ZEA83';6""D@UQ3^DY^D7?2B:\B@'[B*@.<XNV$#8
MXD)79AO2+<+2=Z^HKI3;)M9*HK4,R`2I.M;EU;:D*4$%))6EO]&.L_[8M+@=
M#=:O(W_,ET64X@#QD_+LX;EC[I78IYPN.%:J:R$ZZ``:TI"54`H`*IX#+'N2
MZ<XQMF_[V@Q4#=[5K\^U0Y9T-/%VTR[NW$>M/,2\?8$39+L@N*D*U)2L!F@"
M-*"#4'32M3WXWB_5'<M'RO?XER#_`#F;);Y/2OH'=)2;@AB'U'W);GY+;?@:
MBRMLLRI(+OOJ82ZD+S.5#BE]8BHH=X2(8TO!/$>]<`(.[X&WKE>H,J*TN+*9
MA)LTEQM#J9I40EN4E*TJ&2:_/CE_E8>!]94ORF5W^M%I>YP[N.5`\JF3Y>.T
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M7R4?B15HS8=FP8BA58ZPTN]MIC/IN#`VN..W`'&NPE5.C3.?'BW1QUU+R%OQ
MD<ID+;6Y%2E3[;BB"(S!+B2`F@J3A>"ZMK:+D0T$?#;[3BN72Z7JTS^;(09.
M-`/=@G9TQW0+E'ZB_B$F,RY:ML)EV]EA*7$,3&;JB4Z^75`K?+D9I/A42$FM
M`*G$9<WDE3#$1R.%!OVX[4_ATN-K0ZZS&YWFI'=@,/MVJ09LE4YF;:$+)C/V
M^T7=MI9*DMSW6S+4^T59M!2V@=(HFG93$#<6D#JRN'YG>5)QN-O\T)H1Z?>E
MB3$AM;2V>PPY.:ODY]^\./QRIU^1"GW61;4-%UPJ4RE#,1:1IIQKQPTY$7!3
M%G<2S?J$'T))LUXN<^(]"8B2PJ-;VY\M+ZB9*H4:08Z([9/[E"U-5TIH%$U/
M$X92@-D+6[`G$\;*%_WE+\+<',M2G)DQBS1URFM=DNBBQ*<7*>0%+2$T-01E
MV834&Z:42%H.'<GS&OET?,AZ/$FHBOSI8N$PDLLO,QG/+1$L!NB7&DATZC]J
MN>,U6>=)Q179^RHFS+7+8;;0P]%W;!CW!T.+2AV'>4S(^E8J0E!;4*D9Y5XX
M1=#&XYB,2E1>W#1E#L!V!96>\1W7Q;$.6JXRG8<I,:()#B5./N*DQ3H"5`J6
M8U0`<NWCAQ;01<S9NXIEJ%[=N@%'"N8;AP*8NZ-QV7:3T=UB!.FW:\LQ)=X;
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M.&-QC%'D<2I.ZFWU]KIYNU=@OA5-G;L@2I<>1`ERY*3<+3&0XJV*JII0?AQW
M$K2D`"M.S#E5#59[H/\`R305X`J)]I[1L[?3C=(CR8+R-][?1:[[+CRGN9)_
M"MRV^[2$EK7I0%QN4DA(%./;BQZC'!#'6V!#_6I_3;QUS$1JOS.[@WW45DMJ
M1;%8K!N+=ML1&@/6R/$$^QLM(2+;(A&(W:(P50U#+KJW1V$KSQ68;FZ)=S2*
M`X8#[%@-@8Y_E\&UXU3@Z&[GE7<W"[[WM;*+C%M^XG+9(E1VG7;K%O@9G176
MBI%&V6VE%(0GPZ@32N'!GEH<5%SW4[7\L$92:;$_[S<X$9FZ74RX$.+NF!8Y
M.X(Z9#B9T2,VVMUJ*N$%<@1+FX05C30:<N.(_FOXIE<L9&#D"K[U9N`LPN+E
MD;-RT>3F/RFE*9+3MS?7*<C)""/N'&M)*/=TY4IB6T]L$L;C<"K@[#$C"G8D
M(2#9R3']5KZ`]E!N538W6&];HBJO+T1UR9MZW(L#S,4I@B#:+4Z\TJX!MP<J
M8N)*<+IT@\P)T'++#TP664Y6FO>?M2.FWFJRW`CD<#!45HUOA/:!P](5J>E5
MM@6-5H97.E7.5NBS;FGMNW%"8\&''AHC3E2)4AK2Y&0MI*FDE!!UN)Q%W36Q
M#Y,"I.YNA%=")A&0E6!Z6RXUOVQ=Y,:(]:PY<U)M\5;BPZRJ9;N8HR5*453>
M:E8*5.ZCH(Q%-E>Y_P`Q6U_)$R2,']-U*^O'N4#]5=T.38<"3#GICO05P+.Z
MY(1<HK$F=<[,Y$DRUR@X$16HJ8R4$HHBH)`SQ/11L?%1PP(Q5*ZT@\O=6D=@
M"VVFD:)!MJTC'$U(]"*]-X3NV5;,MMQM$=N$)]Z%ZN\-:U-N+N3D9FU.(DUY
MQ(BSG$JS\=:FI`PQNX8XA^6%*V&GVEO9\Z%I$M-M2?82I/3;K'9]HWBQ-6<2
MHCJ6[9<XJENO,V*W0$`P+Q<UK4I1$]#I7J)JKMPRCD?EVIGIEE-=ZV=3K_F"
M&MKNHW`8;$1VOOD1X=]MC$:WLP=M=.=O?B+<-Y;,83QN>.8,^VVN45I,"X(5
MJ*VP"%)/83C9TT@%0<5;-3M;Z21KY36G9]@4:=0V[]:WWHC5W$8;KN+;]U8=
MAN3HMP@+EN/VMHQD`M,JC-,O44`%*U>S#RTI,?GQ]B6NKMT5CRF&CZ+<Q8;?
M<+%(GB4BWS(]W6[;[M&9<B,ZY+*$_ASVO[R$XII(*5)H>!''$;J4;;>]8^+!
MSB*[U%:3)++:2&8_.VO9O[$TMQ76==TC<\AIVZ7=B[,H$EIIM5R<C1FV;4^E
M;P`<=2M:`IPDG614U.+PU[(YHK>2GEGL)<.)`J,=NU<[DTZ*:234VAQU!AHT
MYC0!V!^6N4X'>,$G;*G7W;VX9UKDP4,R)VYEOJ1N!U3,5<)`$B"F.D$)#K2G
M#_K$YUIAG?6]F\T8-_$J8L+B\B`SN]@5I-S6^!M"-TVW08@>FWG;RI4U*W'!
MI+LB2TX7B5>-(;1D36@X8J36RMO7Q']`.H!V=ZLUJ^*Z)YN+_5[E!T5J6]>[
MI<83-LVY*VO;Y5VM\>-*=;=O*%2V'8JBZ%:U$\Y0-3F#0XG;JWM([(21BD^8
M;SL-=RBFME_=>4?T`#AVX;T^XUUN=XW?*O4BQ-)MNWK0-QWJV0IDEN$VS*88
M,AM+34=YMM3XMBUJH1XE5I4UQ#JZ77E'V61@_,IQ1*/O!6Z94N_W/;\!_;TA
MQ$6`V)3\)^)9TP/-PWQSN69#T9[2Q5(!6H5XX=2:*71"<#Q`'UXJMPZIIDUE
M-"YO^9A);6IVBHV5[$X.K[]]N\:'>K=%FW>YOW39UP(M@#+GX;$O=O:7-+#6
MEI:7X04=)&6BHSQ#RV]Q9.S5^4X?%*:`Z)C?-R;7.R^C;\$G;IV->+%N#=S=
MN4W!V[?DQ+W:U6R2Y,NK]BO2W6):WU2%.+:F0IJ%*J"%)R`RPCYF;C[`KGJC
M+>XM,P&-$6LVU5Q1;KLHAYF/<HJ9++S:><V+?;3%;O4E?O+-W_#G@6SX`LU`
MKGC-I<RQZ=)<,/YH<=PXG=L5;ETB9L5+?`$?!.16XHVY)LNVW.$EJRV2YL7.
M-);D.M7-5L?E(2_'@EM252UI<"E$+U:`12F&K/\`,6T=S+C,7G'9N&[8H:PT
M6YT^Z?=NKS"!0^G^:9N^(TD[QNMVLMQ?F[:MM\C6^W,W)*90:0^42H;+K;X<
M"U1U*HK575VXFF6T-VP,N!F;WD>Y2;G-%SYJ7]<;_P"6Q6/YFX/_`,2E_P`G
M_#?W:/X'_P"[7#^3?V_>QKYR_P"+>'A;L]7\U5O+0]OCKXBOFLYSMYBQ?PB3
MHG2'9LF(6DJ4HQW8CS)4$`#3K!H014<>S%VYL?%=K\O-P]H3HB6V"W8S#<?Y
ME\6F!%>;*%@K=4'M8YA3H!`XFN$9G-?3*:K1T;XW`O%`4ZMD;;B1(^X("MO6
M"2F"EJ]VF^AM2+JVZ"EI^/)+@2'W@\E0"4U.BAP@I6"ZA:*.=C2F]/2-+=2W
M/4_5$F20U$:2=6MQPZ0"452VG03FJ@%,'=L5?OY98SRW>,C^.Q+$:YQ;0VQ=
M;<ZEYJ2WRHZP".8+6?*.!2"`M!#A(HH`JXBHP>Y)1Q7<-J\2-^9Y!&(V4V[4
MJF?+W$RR[=6D/MJD,W*%'YB$48;6EU"BG4`"G1P/BQAXJTC>0FMC.^WS,EP<
M[`;\3@-B?US1:I,>$XTVVWYR[2GU.I4E05#$%3FM-*E1#S(!`S';B/Y$W!;/
MN'Q/Y;S1R9K5P,N-;)#0^YN*V?$1R_OF)S[;B"A02I/W3:3F`#7"\3A"W+)@
M2:K>L[)"YVPLI[TM[HO5V/W<&[-2(\*>E'X&4)T-..N:6GG''&EQUH<)\22%
M"AH1A3S,;3F:?F"8:$V_L;J>4MH]P.3$8G=OP]-$L6;JKUG].%IEVWI9U8WI
MM6.Y.9DW/:MN8MDS9C%XW&THK3MNP7)B[JM<@O`!?D3RB"5%(&%/W*3B5==.
MZPEMY1!>DME])]HJ$G[TZIWO>K]GW%O>\WOJ=O&[6Y%NW1?-X79,E[;,NZ1U
M2'86W+?#APK=:DQ4M(2\XTE3SFJA)(IAO+/=S.S1XQX+3J+J:YN+WEQXVYC;
MCZ/6F[%EW5%PMUAFN@'=#$:XSF/>2FW_`(D>2OG4T$F&V5!).O*E*FF$G,G#
M3(T?F#9C_-5:VTVVU._8VM;AQ-!3;@3M.&Q=@/0[ZE[1T6].?K8?W3M1W>UB
MV5=O3AO6\[;MUR;@;BA[<O&X'^GFX-SV$N+#(O=B8$93#;Q92Z'5`.MGQ&Q:
M-++6D^`72OI8&^;N+2`@Y*UW;CQ7:W\OSK=:>JVY_P#,_1OKM&WQT-N<"8Y=
M.GFYY#,?<NTMY+A:K?'GVEX)GVV[-W#6@,)4R'$T6A3J5!Q4W.YKY2YGAP]R
MZ-5I<[)LS'WE=@>8"E#AU`.J(22E0J14FH(JD9<3QPDA;`A0JLCPEI:0:CBK
MAE[<"$VPDMH*59%(57M[SV8$*Y=A<0JP6E*34BV0LJ$?8'>,(7/Z7I"$H8CT
M(@\`N]6QW(HC6:ZI<4>*"_-@(;`!S.I;2N'"F>!"5W7ONUH:\2G$Z*<,CF35
M0IV8<VOC/<LC8>Y?%-_ZH&^+D>JOTR;<C`E6W/3_`'2\H==4EV$U+W!O.?%+
M<B*DE])4B`#K*0DBF>6(^_\`'54K6OU#WE<3NDEBA]8-^[%Z7--I$C?MYL&V
M6G64+2R[#D7^W6V8E`4$A++$:--?(--213,E(*=G81PWL,+,9''.1WX_%52V
M>UTY`.-?BOJG]6OI5Z4=8=N[,V?N;9>V;W;=LVC:\NR0I$5UN3&VO`BW&U1;
M;87EI0(B9D>"VZI#I24E?`&N.$Z[]3+'I[ZPWS=6FY.G-LHPUQ:XU>)'5%`#
MN[%89[E]A&V0C!QIQ[=RYB^F3TP6?I/OGJ8U;NF$'8*7MPPI5A6PMEZ<+)$M
MI8B)<DL.NLFBWEY:JU%:<,<;^LG7=MU9?-FT"7S$0&VCFT[LU$T_?#Z>XJ<-
MSN%'J-V-;7JR@Q`$MV84J0EN*U&>`6V5!(D+U``I1J4*DTH,1%A%8:7],W6K
M)?\`,/=X:':7`[:46O+D=CACCM'VIJ](VUW'U5PGWTE,>R?X9IW(I+ZH\XOH
M]N@H1F,L\>L?]M,3H^F`7@@NY>WN*'1/$;G$8#M"Z@%U3H2XH4*D-_0D`'](
M&/8-U_3-[@JU.YL[RV(U<-NY;HJDM-T<.DY]Y[NT5&&W*DX)O4)2C/H6X6U2
M$ADH40R:@/2,^4"L@)0*5S)`&"-KA<-81\S@:+8-<X5;L"X$_FM;XN?4W9?3
M*!&=\EMBT[ZZII?BIJ1<&H5A@V)4E-*$59DOT''P^T8HG7=Q%9/:VY):YV`P
M)Q)H-E4I'!([YVCY6XGN&*XE6;:DN3=-N/J<;N37G[2TVMYIQ2;(@N(%K):"
M>8\%MK-2D$(^U3'/$X\];''-[#]BD#;^V8TR9>F+F6FUIB2H#<V.TXAB=+U.
MB6"M2?!(:;0@`*H2*4QLV2V8*3&CNX[%&7MP))`Z$U;E]M4ROPW=%N38+DW6
M9$MD%^8+<VXT/(.(O+S3$]]>H!)0[')*2=0`S&,.GM@TF%U9J?**'$[L>]-6
M/E<\-XFBE+T];VLO2.W6#?LR.[YQ^[[IW#O`QW$J=%GD&'"TG3K4ZC6"K0C4
MJJ>&)3I[5[BTO1-?C+'7$[?=56&U:^.F?!=!!ZINENVME7G=VV9MUW6\85QB
M6>T1&I+)M\[==DEVV`Y=ER&6T-0V3/405$`9UQUB\ZWT62"9L4M7N@#1\C_$
M`[#9VA/;.2S@UD7EP_*P,:-A.RO`+F_O9"NH^T^FG2S:R&;?;=A.S[U+D7(&
M2U=-P)M'DYMY:+-0S!8M<<PHR%44E14LC20<<AU;5[JXM60QXAKR3NH,?M4I
MK^NV]W^79NSQD4.!'OIO3:MG3_D;9AO(E+_%KKNJ',N,8.M*C)LCS2O\)!0%
M5=#RFTZE)J`%9\,5[S5QVJJ^8/X0G)"Z:IM$UE&WTP&[9>4R[>\E]M2N5'L#
M!#K?/`Y;Q;BM!5`22:I][+$E;7D8A`F=22I3"=KY92\#:C,;;$)YV4Y<9J)#
MC;%PN:H*??>M!87"1(;`S/X4E[1H'C4#4"@PJ^Z@D:6,=5Q["FTD;VL+G#!!
M@Q#:9=V?=,F"PNW[0@05I6P7&7$/R>8V7$H\;3S367$ZLN!PCL2MI>VT'ZKJ
M>@GW)7AV^Y)V_%,B>R)\F<;7`BMNM+?===<+BF"VVI2T):;<H5JHD$<<1T_Z
MI_C<I%]]:S15C=4'L/V)V7\%%UBPS%9DMMVF+98C4A&KS$J-3S>AL?>+2PD5
MYGN=QPBH9V,A<-BSMVYTW!*+))Y,"QV^-,LUVY"'6-+4HI=2[$<=`2+AYEA"
M`03X%8%E2+O!3:?\PN6R4%K=M\*4B#':=<2B/:+;RHPJ$D57.*4=Y)KPSQH)
M&%Q:#\P0F8H1H>[MMR)M(]Q-QM$2[VU;90\5(?C,3XI`20`D2`0KW54R)P^M
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M];:4-,NMZ`@T505IAZ'V].WN3V;D&,&$U)`4Y].MDR[-:U)FJBQ3(E6];<4!
M#S\AER*V517Y+1<C+\S6F1\)K6F&]Q+"T#*<>Y0TAN6'YA\I[0G7U`O(?O\`
M:-M0K6WRH,BSSY5N;>8)F/1RXZ(Q6E>A/EX:"-1-#3OQK'&Z09F"H6H:Q^$B
MB^T6^"^G:.W8T5EE4I-SL4R2\A:V;=<W)9MMI66FP5OE=I;94"@*"51Z*()&
M)N2WN@/S6T'>%'ZO,72`:?\`,P>CWT3BMELW!;8._=OVAUJXOQ;8W)N!O@+<
M.[6ZSS`A]V`RYI=+K@45!--7A&6(NZ8QA&7:1BG-A>,CBR7)I*>PGW))MF\K
MG'LEI8NT]MZ$XU(3`8/W3K["9:VV[4$*TK87'?>3IUZ12G9AJ<0MWVTUP_F1
M"K:UV@>\J2;%#-UM]RWXI$QVVO6-UN[VN9)CA+[%L:4E,9*%N!:I`<H2E(*D
MC,T!PUY;Z4HDKV&2A-%&M[W)N*[IB1YT*TR4;KE6BR0(5R94N5;'1;9L2*WH
M:;#J8KK#6E+I<0V>-:9X<0NDB!`&]-[2RNIK601-J,_$#=VE>V78FU-U[:O&
MS[GM5+<S:]MGJVU+L(&J(\;U9)!B^5<><>N+,GSBPJA<32H)PNV=^85\-5*6
M$$%C!)YKY9<CJ;\:&FRJF=[9LNR7.Q23(6JR6E4NS.Q?)1XY9:2F(;?KY+BG
M:O2/`44RXJX8+MS96T9B53+ET\ER)68MJHBZL]1'([&TKNF"_:TN*NL=]*D.
MI:+BWXL1+[JTCEH2J*HD%5`-.(^*TN'',&X=X3W4#/<6C#;_`#/:['&FRG%>
M[=O;6^+GY'=!:N%MN-QLD9,")*CK\H8]RYLJ;YA"RRE+;?BJ30CAB=B!CC^?
M"BQ?6KKZTBPK<1T_C%3!+W&/QO<5M6[;8J+*8XV_.4DH8N5GA-ON,BWMJ2%.
M242%)U.TT'@#AC>$2CY,4\A8YMGR7?J4V*0]IL_C.QMS1Y,^;$:WC%*I]RDQ
MW7EI4JH4V`TVI7*:`HGV8C0US/E=@5&Z>Z\T^[)>T"+;6H/N*-;4Z8QXFW9U
MSE65_P`JYMAQFR,/!+?_`-&PKFY)G2EK61I_&$@%*%D*1W#&'^$\58X]5-U?
MQQ/_`$S4'_A)^Q0KO.&VY9=J[ZLLB(+9MZ.XC</G%<MQ=SM[ER=MK\1MW0X7
MX3,@MJ(!!:*@,R,/[#[%#ZCSA=?,/R*[>SN2E>-QV_=R`\PQ%C6^\.EUY-O0
MM4!,Q(`=,8(22AI^0A2DI/B2#0YBF&VJ0R37+'1BH:<4YMYK>"-Y)I%*/DP.
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MKTF2P7&""A%5*H*`X2K+/^4S'?PV*3K;O>Z[CQC`+2:':=@X[BG!M?=KEPLT
M^(VVQ:8<RT2['>1!:<5&)3%97$?CH">:IMQ2BDT!H4YTP>3N?P^T?:HFWEN1
M=5F!Y%=O\8J(]P/[>BV67#<EWBXRMU34;8LLN&T\H6-*'`F=-;82WS2EJ6KA
MIJ`.[$C)<7T<#8PT4:T#:-WI3QVGZ/:6TTKY*3SN<X#*[$NJ>':K$;R8C;+A
M-VXHN$-EVQP1>94Q6MIVXVYR&TM;"F]6M9:>!HFN1/<<5RX=>71+7-&5N.T=
MW%1N2[9I\38!4">IQ'ARGMXI"F7R9<&U*MS[K=UBH:CPR\A3UN7;9!+*W%AM
M*BAQM3:M:54(%"1GFPCC?*_(P5<KC!J5L;41SO.>G`_8GKTJM]S=3NFRR(2K
MH]._`I4IQ6F*PR[!GJ*%(=DJ;0&%(;J#6E#[<*Q6TS-/DMW#\XN-!4<3OV).
MQUOFR\MIJ`ZGJ4*WVR(ML^Y35`JMRT3Y$AW51JW7)JY/1I2$N5H\G[]L`HJD
M]G`X5LM.O);-L3&`OC-78M%`:#>>S<K'<R1"U,UQ\K&BM0BQVK>;5LER_7&0
MY&MFV+Q=&+DU0O.7.=.EP),)Z.TT5NR?*1W0FJ`K(8FK&TG<[*`,P[1]JYOJ
MMTU[#<6YK!QH?[4W?_J@'?\`\5MX>YY'_F!W^4?^;X_NO^%[_LP^_:+C\(V\
M1]J8\R+\<6S\;?M7';I="E66Z7"6;<^AZUVYV+&5((+39?:6T72,S4I<(`I2
MN':[YVH]#:NWXK!ENLJ>;$UZ9*=J4!?*4GEM:0"$@A9S&!,[K[OI4E6N])EF
MXL0$):=;YEWT*71`>TJ8\OKT^-HA%:]A/#`FK?$.]-B\2-P6V"IQQM3$U]F(
MJ,TRKS#I$M6E;B4J#>3*<ZXQN3/5?ZP!.C;ENNDFTQ(CT)<:/$)FOSW9#)U)
M)UO-B,5<WF.G.B:X%)7'Z+/\*3;YN:2JZ,OV-F<J"R^W$4IUHQFFTAQ*,M1U
MZ1GQ`.!5F3&X9_C'O4SQ5:+#MIA]*8*DO3EQ5I?+ZE-JDO,R$J"DM^%\H"J_
M8X9X%B]_K,.*:E]W'"M<L6<A+;D=;5QMO)7S&I`=<4V[%4L#[I;?**S2I\?#
M#&Y_4'<I.;:W_"GAMA^VKMN[+K*85,#CL5^(Z'**4\XGF/!L$$$QG33VT[,-
MDG&<KP[@4D6O=ELW5<H$*5='YEPAO/3GF(L1#L>WR8"%*:+]P6ZE2'@R"D#0
M>.6!2/[/SQYRB2+-MN7Y*:9,MM:KA=W[@A]E/,TM2Y2Y%O<>JI)$AT#D*'8*
M'V8D+;]+TE05^:W![``I<GVJR76^747J6NV63:=LL;U\NT9=),)N"MF2(,,:
MD<Q<F2I*%>(%*2<CPPL=BSIMQY2^CN/PD^XCXKH=^7CUT],.Q?4-OW9OJ@M^
MWXO1?U8=*X?3&\,;GAS)VW7[B=S6Z?M-O<4Z&E$FSPXG(>?;N%`EA]:"I)%#
MB2T[:KET%?'3M4E?7]8^^OVJQOJI_*?]1OH=W9;O5-^7CO+?&X]H[=2-QPMM
M6)Y:NI.S;2BBG%.-.!=KZI;+BQJ.>%"WS'4DN-%/BQ,+KS10=Y)]>*O#Z!_S
MR.G76QRQ=-?5JQ9.C75PH8LKG42&E%NZ5[QN+;X96S=A*4T_L&\"7I2!(2J*
MZ30."HP+9?08T_SV$/-%ER#("7+?*:>0Z)T524K;GM<HN->3EH6%,*2M7,1X
MN!&!"0I0T*>'&B3_`-VN!"M[MD:]NVIWA6UP/#QXM]_Z,-[G]/TH2QA@A(3]
MTM</<5HLMPN=O@WN_0;B+'9WYC(N5YAP'VITZ7:X85SYB832TEX)31D&JB*8
M$)R+:2AIU>O,HY*4`5=*I!#`<:0`2ORX67%]R$$]F'-MXSW+(V'N7PE_^HZG
M"[?F+/LINK4/_+?0_I!:7;3*4E:D6ZZKNVX]84DA,?S;-Q0HBA(KGGB/OO&J
M5K6$A[RJ)^A6Q,6OU6^E/RNF<PWNR^ONR`GDI8_P]RN%I4I+^E4@(><TI*:U
MI4<:8<=.W+':F+FXID9AZJ#X*F6/]4[O/O7VT[EZ<[;W?9+0]<&'FKG'L-KB
M1;A&=+:T%$-#J5J:``6FLA7AU4'&N.>?4'Z6=(]9:S)J-\")"/E+=N;';0C"
MBN\UGYV%K/PFOL57]U=";TPXEZUS(4]**:Q,2F+*D)2*:'%(+I"$_9.=1CS=
MU)_MRZHEE)Z3ERPUPK7^::_L?9[%`NXMF2+47';E:'6W(463Y5^6AN:[$82R
MX7`B>(K3X0!4I&5<ACB6H=/?43IM[-%U2WDY9?C4.IMVXCL3+]MOZX5HJ4=%
MK,[,N\C>32'&5QMT[@CKDK86VZ\PT6G8SJPL)T!Q+*T#B**)[,?2#Z(Q36_3
M-O;SQ\M[6LW4K@.S<M_+7%O;R<_"HP]%5T.?D`NK(:Y8*D$(U5TI*04YZ17+
M'I>Y_IV]P5-MOZAW>41F3D-_=!2$US+BU40@`@E3F1H@=IQLDU2?UH>LKIGZ
M2>ED_=^]KD\J\79+UEVKM6WOQ#N&[3Y;7+$QJ,'28L1@JUH==TH5P)!Q$ZAJ
MUOI4\;YR`2TT]:E-+@-S-R6XD^X;5PBZV>K/8/7/I'TGM&SK;N-4^T'>ESO\
MK<,,6YY4R])6%,LM-JD)?2'8@2'`JBM67#/G756K66N$'`N&/J-4CU%+^SY8
M]@>0/6:?%079'I,*YQV;6TBDS;RY+;K@HXU.M5K6M,1+%#J+C[:1KJ"BO#LQ
M3U!+3^)S(%K_``Z0T7`O?!G2`A)0M"[S&9(=U@*)1%0F@1P72N6&-UXQW(2!
MN*)>;FZ6(DQ7E;DIB,TB-'$2L:UOR'G&WBEQ?.%S6]5=0-/MPC'^HWO"V8[(
M\/X&J2;/"D1HBV&X480)\&9;GVG2)3:$.+`<90A010E:=>KV4IB4JGW[B4?>
MLEP3MZ\;>A*:CVJ[W*QOSA#;$.0VS$*4\A;P4LNL.!&0HG34\<9"V$O.&=;Y
M]QA[8N5N9M#@C(?MUPMEQ25<PPP^P^T%ZS0N*<;-<]/'"<OZ3NY97NTKBU<;
M[;XC3BW%V-#%KM`%5(46+-*F`OIX:I+E!7/32N>(U"?KTN:E?2[8<=0;D-L7
M1ZXNE6I3TZ\LJN<QPKRHK_$<K34T`X]F!".W>],0G9SD^%"C+L=NF;;7=&VM
M"G47-Y`$M324D(4A2@G3J4#6M1A6#]4*.U67D6$DO"G_`&@$WH.WE[JZ?O7.
M%-@RFMO;I:OCK2'@T\A,1E2$/%OBXDK0`1P&K$@H:R_SE.U/#9UEL<B:SN"X
M6^X,NJ9=D1ULGS"+<J0DIFW)314BL*(5*+KF2FZIH#B-G_5=WJ7,7)_*X)O[
M@N%QM5\@2-N.BY[=M=N9\A)N"0FXH1(E*A/O:R5J7K0-2OFPDA.:*-O7/;%N
MFR&7)D%Z7+E73RJ4I6]<TN%#"5+!J-"#4`5K3`A(UL>W9!E[GN=I;N$DJA6>
M!;X$Z(AIR4RW<F9,F<@EQS_#\E%%9&B:GV87M[/F29SL*%$)O^[9O5+_`#-?
M'W;I(AL*OTM##7):GO2+\PU#MK*4E:4.,15I4%4)6$\!B;FMN3"'=JSN4_7J
M]KONUC;GY2VY\G=%REI:?0L*BIN$]V:^9!`(0Y"B:]`_\12$C+5DT6$EW"Q-
MW.S6.;,FQ93URVFB5:TKDKBI=7;I#L:Y%U>E0:4U&:1V9A?LSBY/&>\H3HFR
M;=8-H['3+<;DPXD>VLJ0N4UH>=NDEPNB&ME3SC[\5E0\)2D*2BM1C1"5=\PI
M-OB6YNW3+E'2]N1GRZ]?(4;&ER$)#G)2I0")2))J*Y:?;@4!?>-)]E7MZ=(;
M_"I\)RTR):D.V^5*=DW!E8<)6NWJ<:;*G"M/``>&N>!3K/`WN'N4IP[U=X$.
M`DCS<"%=UQ^9K*'0VI]A#3BD`+_=-O4`KGIPUN?N]Z;76QO>4TMO*DWG=KM^
MBSWP^U.2ZMV4SI0NV^:N-NDR25+\*8#JTH_M5S(Q*V7Z:9I[6AJ1&W7;V8<<
MOBW[U#;\UCESX@Y3RG&G2[$+C<5N2RLE*GM'B`":DXD[R_HS:L_M^]*&Y+A8
M]IBZNS+E);=W/N]FW*D<SS[XA,HEHD1XZ26_(L//RD:P-0)2#V8@.>9B2=R/
MV^GS<$T;KMB=;;7T]V=YJXN7+\?>OLN0$M.ENQ7?<S<>(RG4T5/A"0":J!H:
M=F,H%UY=PC[0%*]Q<_`83[4N(E.WI\G?2&6D/*06;I<+S"BL2W$I04^7;M<5
MP>*B$\:X$O?>%-&Y7!N'ON[V&Z169,9EW;LFTWAIO2FZ6ZTM!B$S#D,I=;CO
MO09]"6U."J*UJ2!DI'3[GDV[V[RZOL4W],6MO[.D.[IMR%)D0D6F+M6USE!Z
MY.QGY)N-P#R%92BQ#@"JB*J`K3&%&WMYFJT;Q[TV]I;GONX9\J'?6(IE7Z+?
MKLN#%D+D2;?)M-^@3+=<9+:V6D--7.&'&U)U#EU!&K&%#)K[FLUEOEWGN;C4
MM-NL\4/38#S"%,KCMQ.;%B1XP6`M$Z2ZH*?!JG3[IIA_:_I^E.K!QDNQ:\17
MU_V*)K"U9=O[NM3FV+!Y=N98/QJZ6HR5R/+J<+B/+QDK:27N:BJDY)[!A64_
MEN.ZB=ZN3ITC6;*J7)2-R[SLNV';5!@QHEM9:L$"?(M32GEV1Y_S[-:/)K)<
M6E:5JJ2G33/$8HK]P[4Y]E[POL%JYV6\J\I:V0TJ$REOG(<YKQ1,TN'04ICM
MH*Z4/=EAM-X_0$T=?\RYY?8%(N[NK,:5(L5BLOXGY"*U,:G3'G0FUOL1-(=@
MQ'$I/F5*:47"#2A33"+_``E6&RMZ4N>']BKE$O\``F;<FVIHF=9;UN9BY%N3
M&`6S;Y4F7;W64MZE4::U:PNHU\*#CA_I_P!BDQ9^<VA(^VITR.S<+':8K*;?
M<-T1[_;W2HH7:X%G><>N-M;8TJYK<UI>M*]234TTG"L_ZI/=[E$:Q;>4?!;_
M`(3[R3\4\&;',88N=P9A.7UMZZI%K3$CI<$*!<(Q6I5RCR%-2(G,2K0%)2K3
MQPVE\">:C_4P_P"%WN2M*OET$:P[>EVZVJ<BP9T%AJ'.605R?O/,RW`Q02&G
M0DA.?#CALD5&5MF2++;]PW.Y1R_<K.RE)@IE*\M)@N.%N.:Z#S9*73JK3(X$
MK9?HW/>?<%.=EO6U]QVW:&X;K;'K=>;BY$V];%ONAL.-K>E2)C4P4!Y+X^Z"
MB"*&OLPI%+R7Y^Q,]),0M).=3)G&WTJ,]T[>%AZD-V*TBY3;9<MO(0TS"*F&
MH,EEF;YN2X4E:7FU28JO'D:&G9FY\_W>M/\`-8_W?8GKTCL,=G?E@BN6MN;8
M(L-EUNXSG#K9OU$JO:6HZVU"2B0_JY;A4DJR-,,+KSTC7/97(<1W*`URE&Y?
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MN:'&N<>QV,";*$G?//=4S,4W&A*FPEQE-2V$H4`PT\M+B,S70!EQ$-IEW?NN
M36M*I_J&AB+ICS)I1P^!1+_IT]_Y5CWO\O?O+?\`Q'_FOW_'^SQQ*?ZG/'?3
MTJG>5A__`$+)X>W_`(O!_'%<(M@PWG/,R$3I+]Q=N*F'4R%.)#D?E*/+<0NB
M`GN)`->&+6O05RT,'R"B?,.X2VK-=(\AEA#J;B['1*JCF1F:D*2$UH`H=I'9
MC*C8?SBX2_-2E$G%B+8;:\^[.=F&>V/(N(2#RV`NKK>MD`%!D:JDUI7LP)QR
M8ACE%5E-FG<5QL[4Q;S$Q$5YM09"R&(;#"U.$%%!]V`*5SP+22U@F?GE:"_C
MBFLY:9=REPH<FY28%@CLQYJI;#TD7>ZRAJU$C7J810:2`$CMIA>*-K@<P6EP
MQU!D'R@4[/[4K;LB$6:%*@R'V(UQGON(9>DE4AGR'WA=E**U'4Z$<5&A/#"C
MXH\IPI@JQ)'+'.UVVAP3B:ZA0W+?94S"%IAABVR)"G**ALS):''Y*0%!-5+!
MS(^UEAFEGVSY'YWBKT44(4B4W#?=T143[M=F)^HN/NPG`&&EJU%10"&"`,AE
M4=^-'1L>:N%2GT-O)(VLF)!IZ$[[?<G(NQ(,6WMB7;[A<S'=DJ<4EQ$)]S2M
MP%*DJ&E*JD\1A*2*,,)`QHG,=D#(`1A5$]NQ+?9%2Y\UM2)"H*&YSS(<0J9<
MESY'+><2V4I+B8:$I(``(XCMPP3NXEO8(C!"XMB.[#[%*T*?%C0Y29%Q+DBX
M+L[D$:&4J8#3A=8"&FT)'W+@KF/EKB0MOTO25$1V(F;S)6YGDG%,.]76ZWB-
MNBVD@6J<W$G/2DK'.NUP2I\R?-)3XA5+6:11(H,AA=+QZ;!G&=GRU_C>E[?.
MX694ZR3+7$2&%[5A60P$M!U#A_#F64J<2I*U!M*E*[@3[0**,EDC_3-%*001
M6SQ)`W*\;#_:NEWH_P#S@O6!Z6.J=JM^XV9_J%]/U\C[8A;FZ<76\Q$[ZV',
MA16+9^.]*+W<'2N*^66.9Y!ZMO?>)1]TOQ8F+><NB!D-7X^]773^KK..(6=[
M\UZW:XUJ:[-E!@*#8NO7J/\`1/Z)/S4>E]U]4WI8W+;-C]641F'K_,L5NB_A
M]TNI=1&79NM73^*T'=OWU#:U!VZQ4J77Q5<I0N6R-)H-JMMI>VL[A(0.7P]"
MKO\`E5=5_6OZ5?6'LKT!^H>1<8W3'>-AW@=KVG<<>1N6/:7K+8+E?[1>NE.\
M#(6T_8+@F.$JAA:VF`H:6D'6,*+%U-&:\C!?4W*45E]1"05A:@$D*2`I)*4@
M@D&B2!@1"7&,%V+E;[:ZDIVO:"5``VV`D$D`%6C@"2,_9QPWN?T_2E.3)/\`
M)$2'[?XJEK2JNDI4%5`TA)K4\!3C4]@[<,%H8)HOU'X^A1!U6ZF]%^B,?_JC
MUKW5LCIU8-OV.:XSO'?4RUPW8?X@ZPU,1L^4X@7]Z7/A1$I?AVX*6\E.E52H
MU=MY&49@,U$W=J-K&XQNIF&"^4WUV?\`J@7H5QOW2_T);`7"FP7)UM/J*ZN6
M@MJ9D,J<9%QZ?=-$.HE+>42E4:5=E-(+6I1;4#A6/E5_+VT6\6HVCWT%%\S-
MRZN=1>O>^]^=2NNF^]V=0^I.\X<>7=MS[SEJN=TDS4/(9A^646FX<2VQX_AC
M18J4Q66QI0FH4<1%]^HJ=U=>VQB/D0&S=G\ZJQ/0?K/M_I)ZC.C&[MUW;_+F
MP^G.Z]OR[[>DQGKTF99GX\V).>FML1Y,R%&@O5J6&RI*3VC#:T8QK\K11I.*
MJ&A6=V^823O)KCC3?CP7W+=%>OW1[U`;*L^YNC'5+I_U-M*+?%:F/;#W3:]Q
MJMKZ&6VQ$NT6,ZW<K7-;0@)4S(BME)'$G+$\V*WA&9H`)_C>NNPPV\,#75`<
M5)<D)4^5K2E3FE()6A!4`!E4$94'LQDNA.VB4Y$DF$;O<FS<;?#N+#S$N+&D
M)=24*2ZRVH*0HT4DC36A&(G6;.TZ@F;/K,;)Y64REP`(IL\.5(YG#!5PZH]/
MMI6BS0F[?:H-G,E^X*6J$R6$N\FV27`%T(2%<PBAXDXMO2L3&O\`+L`$+,M`
M-@_BBK^O/?RV-!P.;X*N,/><.[R[[`B)4^]8;C;X3[J?$MXKMT5YUL@>$*2M
MP@T`*2,\=:NYK.&V;S`*T7/)VMA?6(92523U/^M/;G2%3^T-CQH6\>J"6E&:
MPEX)M&R$3#R(<[<'B6FX.Q7%:BRWQ4**%,477>KK6",FS.5W9_.JCKISHQ5A
MHOG+ZJ7R];YWS=;OU!NC74B7/EJNM\F7QI#C<DJ64"W0;:^DMVRW,%=&6F`D
M+`U&I`..776N7&NO+KEY>(ZM%<*`X[J<%%0ZEJ-O=MEAE<UH&-`/L1&S6^PV
MUU$AE#<6':(;T2!;62IYF%%6I;H0RA:G%.M,OO'Q**J'PUH*89B"%KLP;CZ5
MMKUY-JY8Z9Y>6EIQIN-=U%B-Q/QKOM^?;8_/)BW=*K@10I>D+8!JC]P'%I.2
M:<.`PJD>?+^)2'2/_E5R^"4F3,F7]4=QET-!)>AVZ,IA>82`&.93+('CC1T;
M'FKA4IU;N<]A+C4U3"5<KA"LC%T=<<0NV3GXDM#;84M2IKL)I*D)#9*DQU/+
MS'`\>&,"&,&H"<-`+@#L)1YF79+0VPGRTF6U-9E-M!&H-19\)!D39SRUGW7A
MX2*TJ<@,*T"><B'\(30N.^6(-LB2E1D7!V^3HB)B(Z)"5VRUH=*6G%-`A86G
MQ$DBF8SQAS'F,N8F%[>LLV^7B%)-M>_OP2)</PFY3DEM3LMVX04/M@APF;_B
M)+)F/:*<MZ.T$H"1I!`S!XXAY)+KF!CG')OV8^Q2NB6LUW$;J=^:)N)!X>Q2
M[L':;6VFV;EH0J:Y$:O#KB2I;JW8R'F,T$J"5^5<**`#(]^-D[NC;L\``]:W
M0XTIRZ,W^>5LLVMNY7:'(H4OM)N*U18K820"3&2!0$'PBIP)DQS7MS-V)`O.
MY!(9E.1E)FL3G`Y*FNI;4EUUHA94`4EE:AHS`&0S[,+0?JA-[R&.>W=%,W-&
M:5'<01[4F;6<B3(6XE.3G[+&MT!:%M-#D,RQ<5A]T+"@$K)7"21Q]E`3603&
M"&*U_IP&_P`=J?FQ[N;J=Q+M4MUX6-C;[RYU5*8DHO/^$;9<"06"R%HJXV``
MM.:@>.(V?]5R6<YSW9GFKBE.%:7+ON./M:X2(OXQ9+)=&;O-MK;K,`P(<AYQ
MYYQ+O@3S$N(Y:J"M,B<9A:UTE'8BB1F<6QU;@:J*IC%S8LUB@V:+/8;GOO2Q
M'AO*2W&)F-*8==2\I:N9(C)43JRSP\Y$7X0F7.E_$5*MTW9+ND!3EF3)BS+!
M^&&39'BI$E<&;/D61V4F20`8R'XY=*=7#V'"4,LC)G,:<`:!.'SCDC+XZ8]Z
M*=/8$^>Y='G[>T822];7HSJ=+JC'BNO0W4%5)`\J['2L%)[,\L2-[/-Y,8GQ
M#W%(Z>ZXDN7"<ET88:`TVU&*FNYN1+-T]_!;=+MKNY[JU$9,B3&;?DB["?:[
MBU-Y@;52C*E)^$BM01B&YTOXO<EK61TESRWFK>"%HE;;`V-<)\V,EFR76YL2
MX*XC#D-=O3$0]+@H;4TI3D%Z0R.\D#CB3DMX>4UX:,Q:"3VTQ4S"+8O+7-!I
M@FOU>@P_Q#I_`BR8"C;&G-PW"W6J$TVMP366#:(<<AKEE,>(^H@^W//$0[!Y
M;N3V\;I\$#7Y&@DTW\.]*NWQ*O,3<T_=#5+';[+._#I@4XMZW2BVW*?4O22`
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M3X*>]D3=MW1B!>YUR;FKL:;A;+/?'XQ8<7&CO,R;4J1%.0,68OQ`A6IQ*J99
M8V.RJ>ZG<6`RN9&`\D8X[:]ZBFYVN\[KAV^.S>ES'K%?US+K<X<=3-HN=JO<
M6XI5;5..-".ZE,AM1*1XJJS[,-.8_BEGQ328/-4R[YN6\6J%)WS;#$$>U6V`
M41)48.<E4-"+7%BQXQ;4VPS)7'`71((TZJYUPZ8YIMG?\_-@>RB;BUD;**#\
MFF(XHYT[W1<-R[HVRA<<N,Q8DR]05)YH";@Y!>:DR%&H6EN$P^M+:5GED?9.
M#3P[$7?S$[%7]?A>UI=9?*0T[.SOJI,M-_:'3?=VXX:4-W*1Y2U+DLI0):A<
M+Q.AQV5.)3S&FV8K!U`4\/B/?A:[:V-OR8%0FEB^D(\TXN[Z?`)O.0IST?<E
MUF,H3)7M/;-NCEQUQ\0;8\EV',NL$)6H.7%$UX$\T+2`:TIAM:S3#&IR55OM
M8[6"Z%R&@2!HQQXGM2#$<M&X7)VZ+?9[S8KQ&8MFW[?>C(CFTLJV_HB",S:B
MI3[3TYUHK=D+*V]:C0`$#$\R:U?$8W`&0C!,==YVHW<<E26-</8IHVBT_;+1
M:Y%N\LBWV2VWF7<;5+==(E%,Y2TOLZW-;;\<OK>1F`4GAI&(B\:(A\F"9>1'
MX5#?4/>MZV_N6-;(%K7'M5O1<E0F)!;4=Q&5:C)=><<HI1CNJ=J@H4,N&&D(
MYC,S\7)>#3K7.'R,!EXX_:F%M7=DNZ6.QN38_P"%N>:G29-AE/+><C*N,=V.
MF=#6E1\"EN)4224!`PL(6O.0#%6*ZR6^FO='\M`/>$O;.WK8+O-C,J%O@16-
MM2MKS.9J4^[?K;.E.0YS$="M16EUTE1"=/"HPLRWDB_3-"F%AJ<S,&O(]2PM
M%V:M4!,V4EAZ\(NS-E\S$4KP+AN&4V_R4J*&^=&>0DZDC401GC#XY@_,\U";
MWL[[R^+ISFH12N[`<*)YWG?]Z5=+F];)+C%TF2)%D3X&F?-M6^/$3RU!383R
MGF%K1S``:$T-1A&5\986CQJ3:QLX#Y15[1AV>I-P29C+5O$R28L=N6HIFM%#
MC[<IQ!7Y(DI4I;#\K2V5*J0@U!&&JCKIQC/R8(W)MBF>DU[W9N(HMK<B]7&T
MV-]ASF/S7X\'S#T<IU*YD=IPJTJH<^W"MRT,-N&BF<`GMQ*C+.:\,=T6O-*G
MAP'8H\<A[L;VU8[A?+@F*8UDC3DSI#I"56M<M2VW"TV4-LS6$--Z:)2LCC7#
MJ[MF><9#&`&EA)';A]J9Z;<OALGOO*NAY@P/'&FRFQ6"M/4J`B+M15XE,31<
MX+P@7J*VDRD6\1;B)DI[0D*U)<=26PH:5E60)QKY`<$RN]<M(R0P4]:D").6
M_,MZXLYY5^VVG;[3D=+#;+4EF'R1YMT-M(;2])H*B@JI5,9EEE9ICB#\[)<H
M/8,*)^VZBN[=CY1F!:"/8G;TUO5HFVZ-?)H4UYQ=VL]PMP"TH<_%[@VB*W)`
M(6A,>0V"0:9D5XXTO`V*1@C%&NBJ>TU2CYG.C$4&#0:T3LZP2';OL2$5LHAK
M&_+=:D3F"26%Q8ZDNJ*$DL,%2@"?",,61QQNSL%'<4A_F.)1R[[MV^O<4+8B
MKA:+C>]JV_;]WN@O3>IR99Y+*OQ"1"=9*&C(-Q4V[H3\-:4Q'.N)@X_,=I5@
MEMK)\37,8,^45VXFF._BH_A-P#,M\MZ1:W[6J^W5;MN#LA:WIMPTO<YK4\5)
M=2\"3GI&JE*8<13RFVG=F^8-%-G%0?D',NXG`4BS8CB%'E\F.;<ZFV68BWWK
M\!:>_'U00&UQA(>$QYA;J@@J4II"$42M1`%*C"MN!%I)NV87-?%OW^CV*Y=2
M=2VMMHC;#+6,#$>CUII?]=+/_P#<-?\`S=^(?P2OXG^__=__`%N*_P#Z>O\`
M\+=N;;[=NU(?_<3IG_\`2%O^GE__``^':N,EE5+C>69EH6@,B',>F@:EW!B0
MX]R1)%:H4A491H:T('?CI:ZA<,=)X4@3H,BY7.XRV92V(#<IQV2V"$^82]0L
M@I)JI:4H5E[<9JFMI87`+CANW]ZTS+PZ(8M5L\<-NVSX4<,^)QEV6MM8YR4Y
M-_>E1/=E@6T@,1H]*FW'GK?#>!GN.3F:H5+<\!2A63B0HUKK&7MPMR).Q:PU
MG9GC\/;@F;>]RSS)CVRVS$\Z5<&WI=R"Z/-,H.A<)(S);>3XC[<+1,+`0[:G
M-HQMS&_*/"ZF/<C^YH4IZ\&$V^M%NGVV*XFOA92IL!2TN*S"4``YG&[O">Y1
M5Q:Y):D`M!JF\_;'K@\B'!8<?A79^-'4XC2`&XX4VM3A4I(2/,:*<24DD#+$
M>:):(PR'Y`0>ZBD"WK6FRM+D(*;L^95F0"D\DQK>2C-X@"@*C0@$'`G\4#&M
MHX8U1([IE,6=,-I"66K6ZEJWQ$TYDYTFDH.-TJA#SPR5GJ!KC5X+F%HVD)=C
M(FO#CL!X*4K+<ISEI$FX,..3YL1<IV&VGF<E]E(^\C$E/-<\OE04-#AEY:2F
M[UK-RV.4?(/6FRFZOPYDJ;)DMAZ"\TU&3(6E$A4IT!0CMM9E11J%<\L.H6.8
MS*[;5-H8&L9E=MJA'W';9#TFW08LN//4I*IL@/E:87-=27WGT5\*%ZE`5[5#
M"J4=$S*<OB0_S])\_.MUNCE;D0MVUF8L<H^6;J00>_4LG&:I#DO[$OQ)]SM3
M5QFQ&Y5Z;M%I>G+8C($=R+<'W"L)=EZJD*0NH-,AC!+_`+NQ8&D12.\VXTE.
MWT8?!/3IIZN>MOI@ZE;:ZG=`MY7WI[=]N3"7$6-XRK-NJ&ZRII-OWS8)VNP[
MO@2BX6W(\I`&E1(6A0"@XM)"R<.?X<?<G4>HNM?RP3RPOL`_+Z_,V]._KQW/
MTV8Z@6C9O1;U<;9N2YLC8-P:@.;4WY,O-MF;??OG13<MUT7"T7IPR@Y(MI6W
M(*%J;0'4A-)GS,>^OJ5JTNX\R0&DT[</6NY\Q33#CJ%U8T.*CMM.))<)946`
M"&F@VA14C-)IH/A5F#A9K@X9AL*L[1E%%86\=2=@=(.D<3?O5/>&W>G>T+9;
M9$B7N7>=XB[>LD5,<C4MZ5,.J>WIK1J(E]YP@!(PWNWAD-3Q"R9G6X,K30@+
MYP?63_ZD7IS89%^Z?>B"S_YYW/%1.9C=:>HL!YO;#<V.E3+4K:/3^L>5N6"E
M^JXLFY+80"0H)(`Q&"XC[5S?6NJWB4Q1EV>O!?,=U#]37J`]3]SNV_\`K[U-
MNN_=]2=Q%B*[N^YO/6JS1UQ'"&;+:6%"T;:80I6D-1&$@)`2M:AAH]SBXN!P
MJJ:[6IY975+L]<>]1%==AVS<M^L<V[)B2YDXRK@AEIA*%_A[R4)=?U=GW3*_
M#VY8<V<XAD+Y2<I;3TX*2L]1N(\SWDT+*#?C4(H\U`,BWW".6M<F]0;;#0RL
M+/X5:5/M-+6G_P`-8#]*'&MU(V9V9FQ1#77DEQGN".37C7V)*ZDV>RV>.S(+
ML&)>)/*CSFK:Y,D)D0TS'73SW)#JD<]3:TE24@`+J!D,)0$1O#G;%(6]U>L?
MEAI2IIBM_I\N>XNG$Q<_IAN2\=-K^Y=8CLC<>T[Q<+)=U7(R>8]<$S+9(AON
M..1O`4J44GM&'%_>Q.B8&5K7AV)YJ&HZV(HRPMH'?B[%VUZ,_G.^HOIC>[?M
M3JO;;'UTVS`5<]5^W`D6'><&VVU;"#)5N6R--1KK(4EP:4W)M9&=5JXXC3=#
MB5*Z=U+<0-'F"<W9BNP'07\U/T<]='DVD]06.E^ZRZEIO:_4I%MVU'<E.`T;
MM.Y([SEGNJW5`A(<<9!J*9D#$V!4#8K1'KEA+X7.J>S^:L-ZC[[#B;8CJ3,C
M.--V>1N$.1GFYK*H:UP51IC<B$J1'?8=C%RBFUJHHI!IJ&+?TE'FEE)+0!EV
MGO3+5IH[GELB-3C\%QAZZ]1MU;!]/.[]V[=NTG:]QW9O>S0EW<03YX0-P29\
MJ8BV%*_O9/+;)5("@6E>`YC$EU3J'EXLI<-FY4S4[6:V&>48=F*X@[HGP1!3
M?KC<)3MZ\E,B*OC\GF.2')<T$OW)8)5)F3VE:,ZE*CCDT\0F%":J&N(G2CY5
M#'4F7<;:T%Q&HK-S97:$1.8REXS7VW$/OR6EURCQ8RB7%?9[L:6=D8&O+=A<
M/<HJ6V=!;O?+@XG"F.Y9;0L3U[B/WN-,$A`M+UN6Y%32.T]*NZY3K)I^['*6
M33O/MQN^5D9`=M*CM)<Z4OYV-`?<D_=5\>MT$;9M4#G-HFV20X\VC_&/2(D"
M7^*L1T#Q)6LQVN6O[5.S"B5"<&[UR;=MWIAMRV,+5*N]M;W%+B/T"XKQ'F9<
M"X/*->=+;*=516@`P)]:^`]ZT[>?G/;@?LDM2`PT)<PK+G@7'N&J5'T*&2G%
M2E"J>P8$Z:0UP<=@*PWW"W`;1$@V2T2+NZJ=/:<:A/!*HR+D\WY:2XDT#K06
M*+'97&:J0B>V8_(F#O6V75C?46$;@MJY18MC1<41V2RAR&M<=4VWRUC+6PVR
MK//65`8?0S0,@R25SU.Y(WFD><\-/,TW[*;L4Y-N7]3+=POEJL#=Q_%)]PVS
M!92/O;=),YWR\MMNE<V&O$>RN(ZXC9(26#%:6EU<Z7_^;IJ`R?**8]NW=L3_
M`-P;C1`VXQ*<;4U<''W[8ARWR-*DS7VFQRRI(!4$ZL^[CAEY:7LIWHNF7$N$
M=*=]$(VX_*N;>V=.*TJ7#5,G72:Z2ZL+/,4TIY7O*:)TH':G"3V.C.5VU-VW
M#+"W#;JN:IV"NU)#]DM,-<VS1WDF)*N*3&C']U;V)1#3JFE5H5/(<(4.XX4@
M_5"W9>P7<1,.:G:*+99KI;MS;KN%E-AF/6-FZ6=$::RW]TFV1W6X,K\094I+
M:'E#46D*5520<\2"T4\M6J)LJ&;7;HD)AJ''?%Z3;2R6)YC.N-V%]P1UK:!:
M96A#E"="DYXC9_U2A)EE5^)RK[>5SHS<JY;93:MP$/CFL(@N<E%4D>-`=2:D
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M(Q*/NX71-8*U#0-G`+=MT6S.>*Y2XD>D\$[A'MES?O%UELJ6FWV^VV>Q<R2U
M%^[MZ[@E#JRE;A2B2ATH;[%H92K$8[%^;<4CK5X^XMXF6Y.8/J:X84I@C5D"
M[5M#>T"4XW#AWV-:VW67)?/;9\U/*WU(>HG4J;&C<I8^RDX-B2LHI7LJ^GK6
MG;F[6]S;C9FF,U$N#NTXL?=;RJI@L-VF3=9-O:@@ITA`8CMH+@I7/"WEY>Q)
MZN]TFM11_P#<917U#<HIVBBX7.U&],M2@F_;M5=!'89*I(87='8@2TQJ"E16
M5S6U:JTS5W8/+2CAZTUU*2"ZOFV=G7.WC@/7Z%,-J=O&TKP]*M;3LB2AW\$4
MX-.E>X6I;=NC"H5G!2B2X"]P'=@\O*.'K2D$C8;D6;_U_9ZTT=J/(L,WJW(?
MG3VKQN"=!=L_C4;?:&)4B2\_'1!J$O(9ANJ4@C@Y3NP@K/<-AE;1NWN1R%O.
M[K;LFY+ZY(78X\^/8=L-MP%-BX6YB)+=?_$F@HF*F8XR34ZAJ`';A1D3G@EN
MP**&EM?)YB4#(SUX_P!BL#8Y5OVWLZY[K4PIZ5:G4(8L:F>9'7(F)9N$!3HU
M4T-RIS5>Y->["$DC&'(ZM=B<365G?%OEB?D()J*;#5:K'O\`W'NN7M[IU/NM
MNMVUKS)D!^WVNW(8=A7*9"-T:G-:%\6'BNO?JPCR7=BE"ZV../J3-O%PC.)M
MFSY+*V(5YBRH\G3'*9DIM,A_R3TE_P!Z)*D(;!+:@:9&N".L4X,GZ-,4E->6
M,<1M3F\R_$?+A39MW8I"V!#G1MY1MNF)=K`TY%;L(N*F5.(5!D'R:J2]0#TU
M+*ZZ.)5AU=3PR21FUJ`'"M1380H40-B:YMV,7@@4QVX8J8MS[8_R/M>=8;&T
MW/+C;*YW*6E2GV5VV[J3<E\/&X0$I^(D]V%+IPE%&*)E@CM_"-BA_:VXMRV"
M[ZIL;SMAN]ABVU@..M#4](0E8AZ%+%'6T1U:A]D4[\:06LC;,RFE,QW]@49<
M7C<O+97F>SUJ7+K=-N"38K"QMN&T;C/N]KFM6YQM3EPD><BO<_F)TB"F(G)2
M<P\03AK;VE_).VY;E\LQU7?-C0<!O*F-.N+>.SD=>9L^4TH*IJ7'<=U@C<S$
MMMI_=$_;%ZM@M2-++,"&61"@SG1D`6;>I5716JO#VX=7K@\?+7!*&:U$?.QR
M=R9U]GS7MO;>D-NW"_71>T8%CLG(9C.M1)$)GR")25OMJ6CG1*U/#4@CLQK8
MV\D_Y$=,_;@F3+RVG?GA+LFS93%;6-O1W]W;5VQ;V&E.S]NVPO2HRDK:9L42
M"EN[%QX!*$2^8VO2U]H8=2M&FS!UY@P;<OS;E(:D[GZ3+%#^H0*>AP*B!_9M
MKVYNB1-CW%,$Q=UOOMW.4>08D*:XP$I2H\52I2U@@'@FN'$6IZ;+X,_I;_-5
M;3(+N=CY&#Y&5)K\%(5WV]%LT6[7MQA95<MQ,'GP9X5&?5#991'=9TI`4%R`
MHJ[B<*7%W9/BY4>82?X:)2VO(IG\SYL21B,<,/@I*=M*;Y:+`T_"<;N>Y)MU
MMUGN@`YL=EMMV/%6]XJL4D'Q<=*<\5@VMUYCF_+R:'?CZE9[>5CF916M%FNV
MVO9;+>UWW(=_M5]LSR%[AD/)_$[3<(C3#4Y2(Q!4"IQM0;\7C`[,..4_L49<
M2-GEY4?CJF3U-E[=N.RK#M*(J9$;L]R0K;[KKBV$37"$+<DO,^+E0UZSJ.8.
M>%)V.D,!;LC`!]9V<4[L;4V\$K)0.8_93'<AU_N-XO$F4BR6Z&JR2X]HNL:U
M,1O+I>M=J8CPG9``255E3DN%2:9ITGMQ(F6)U^V=U>2(R#WFF[T%1-S8<K2Y
M(Y1CS`[#'#YOM2]LZV;2N5MM.X7F]#K6S;39YMM\SY1NT_ADA+O.0A0!</FW
M2$&@U8EXQ;R^#VA4*>UAN(GSQ!V1NVH4Y7':@B[C5>5[@F6R&[M"/:[FE-7&
M%[D@,P)\>2M\$)<=/E2HJ^.@Q6+F:.1DVGQUYXG<=E!3-Q4E:,F=:QNC_3+`
M17#"F&"B9KJDK:%FMNU)]F7);N$R3NN7N)AS2XZB',<5/C3'!30ZAZ*E6@UK
MX3VX7U*)[.3,[P%H9VYMOJH-JE;&46LI==5+'"@ICCM^!4O;9ZBQ]QV2UVN,
MAF9`W'N6^[@7%<DAYMV4D*+3)=(($M:'F_NN(%<\-I[62WBYTE,G8:GU*1N=
M3T^TCYLP?D[&U34NT15[EN7N6EZ#=949F`[:H\-<&_&$RA"5*MRW&EM`-LH(
M+A--(.(8VTCCF%*'';Q6+*^9,[.<V0XBHW'9[%CL?=,:Y[CW%,FVVZ0MIVZZ
M3XMF3<F&24-SFH\-F[,O,I07W6Y+1#@)\%`>W"S(7MMY8S3,]H`]!5CD8R1C
M1!3F5QK@G[^,+7'>LSBX]RE)N%[MR)Y=!CRG;?:M>@R,T\Y3--(IF<.(VENE
M&T_[_P!F_>FEW9Z5$S-J^:G]UN;XA5[_`!+J;_Y;;''1^ZB_P_P^_P#O/IQ(
M?MNC?_I%_A]O#Q[%R[_[/]"?_13?J<S;[?"N02[@(EH?8N<XL2%1[7$05I&C
M3$GSD)4J@UE2T*-:9`^S$PO6:C3<,AAV;`,>>F7&MLYB7+C-N/,>;;S!:?"5
M)*FR`>&8P)W:['>CXI\PF+'&AR'-O.U;GOF:\RMSF3+?"(U.Z0:G]^%`:J^&
MF,C;Z5$7?ZA":]KW=#DW'<EGCPW)<J/!%PB1ZZ')4=NBI1J:#F--D%('$\<2
M*F--L?\`*'#<H]N3B;;?D>88D,$<F8I*2AQ'WR>8E&I-35`-".-<82=G%RA*
M/[R>+FY6[Q!E/R'9;*(X6TGDH228Z4D%%5I415%1EC#O">XJ)N1FE+>*+R=U
M1K5$948[+C<R1;A#A++G,C_>);\TUI4%A1!S/><1_:GME8XTW)SVZ[K3MM*E
MMEEBSR;O/D+ER'WI;S4AU8:1&YJBFJG$D!(%/TX$[NXA#(&C>T'VE-^Q1BNZ
M0[_-N3"TW9MF/`MTA+B?+/OH2II(I3_$MG(URU5QCMW)N:#Y:8@[5)[C]TFM
ML.AU)?3`?$-,=QU'EG'3Y=;J=*JJ):)&=14XRM4VV?PB//E(O*91;<>CSV)(
M65N-71"4B04%RH5J4V*@\#PP(2TJU09C-Y=L]\B-7VYNM0I#0!29#6I$IE+J
ME?NUE;8!I0<:8$(O&;784J=FQG)+FL+N+T=.L,RB=);0>)0`*BN=3@0E9N4H
M"Y3(RY<=J:Y'>GPF7%AV<RU$;8B,RFJT0R\ZFGA`)'MP!/6?T_K2Q,LXDP;8
MR6FH-O9UNO<[)YU;:2XTE6O+)P#"L/Z@5?E;F?0I2L3UJLURMVY8\^1$EVZ5
M;I;2DD-EN3:+K%N;#\-;?+D(=CF)K0ZA:'&ET4E0X8>^Y2%I?FTV+H+N'\X'
M\P6;NB7?-F^IW?>VK.O2S:[/&:L$^W,P&X[<9ELB[6:8\X-#=5*<4M3BB5*)
M).)*'])O<NC:=/YJQBN/Q-K[2JO]=_5IZI_5G?+9=.O_`%HWGU2GV6"EBRQ=
MPW%IG95ECPVUJ'X;M&TQK;MJ`Z[I'-<1&YCA[1AM?_T__2"1U>?R]BZ3M`]=
M4Q8EWM.X+VE]$5EF0_:;7&>4AD,O&:B&A#A0L?><MTBJ:G(8A*KD!9YN^J=Y
M*<MQBQ;9;(UG?"V)+SS9?4'%*>TJDEUYTJ43J6AE3:03V*/LQCO4#,SEZA,S
M<)7#VK.R/W=,^2!=E)G-0`W:7I*DI+,&`R[_`(1@`@$3$N>.N8`RQLIB/],)
M<;M+<I;S,&1&MDBU1S>9K;CA#C0D1T.H1:DJ/WHYX4I>JI`.!;)D;JL5RN^V
M+A>VGF95S;82_;$.N*Y$J@0777B#K%%G[)X8PEK7QX[*K5M=2[*IBVR+A'5N
M)YQJZJ;B.:K6T2-*6GG22\G/^U6N&USX&]Z?W_Z#/\1]RDN&^J4W<E3E+#3]
MLW`U=6C30IZ:XR8X96?'R5I8&D\37CAFHI8.,O*MB+8Y'$JZA]4&)'MR&H<1
MD2+<TZVY(0TD\X(Y_CU'W17CA^+RF%5!VTU_S"`32J$CJ'UTW#T?OW3K8O5#
M=^S-N*79E3K99]QWRV0KY:8R7W),,,MS6VK<ZQ/0HGD):#J"C5JIEO#J]Q;3
M-%N:!QQ]&SWJ\Z+>F!];S::9:]FWX+5TWWKU1F;5GV'JWO7?NY([3D:;8K1N
MS<LZYL1H4!#UN:E-M.+*#JU*<2<SF,&NW-]=,:7$[D\ZBU6R=$*4JF5>=S66
M'=KO%C,S?\)=HULAP"M<IAZY&6CEQW6WR1H5&&HD44#F,**K(L8]UW,Z^^D-
M-[C3N),U$28\[Y1C;\QY$.8R@+45H4\Q4`#+#F+])W>%'ZE3RSJ[**<]BOV+
M;L6_VV'_`(6RPC>K\XWD3)2E"8L=#Q(\+2':D::'(8B+GQM[Q[U`:.<7U_"?
M<HPV_&3NS<42Y19B8;;4AZY!^J"G7"=:9#(#@((=1)->W+#U*IRWFX6VZ[M=
M+L:)+E6>4RR7G9#[1+*H#"E$(9<2@("7Z"@IX1@3ZU\![T?V9M%%K8F3;A=F
M)!NJIT>U+6XE:[?:[5S^6_(*?O.:6>24C@HJ.!.#L*);F8O#5C<Y1>3,3=(!
M:CQ7W$+EP$34A<EYYA06W&H`:`@ZJ=F,)[I^U+NYK`T-WW*7=7JFX[>E*M+S
M:6RHKM"TL,-K64U<6HNDK4?$33&4X==&/51#Q8T^]1D1/VW`\M#2W8^7+_%4
MN/#F.KDH0I2U-E-6D)>J:E0J*X,5OJ%KFN&3\#7V)8AQ&+A%ERI"BJ!%FVRY
MQEK(+;MPG,I5+Y-10E(2/D&,I-'HEMC[FAW2_*+TAZ-N=NUQF)(2VIY$&`F;
M,;C:`E:D>4R3WN9<,1UQ^J?0F6I6G-M1)OQ25;MM7O<%V3(C-7$0W+A=XKT@
M)0E')M@AF.N&M8TJ=?\`,E0U5&A!(QB#]4)&RM!%9.D[O>%EM'<%TLE[W9#%
MGMS=J8GHN:IT]OS$]YVV.H"(3&EP,(C.J42[X2HDBF)%"G87*'"AW.UR)*';
MYNBZWB[VUB4$--)L,.BC`DAD(4TT9164Z:&E.TXC9_U2A,N'MJ]7)_;2H>B(
M9[=YM,I@J6B-^'.L29$IQQ=0X_)`R25DCMPDA*.\X20BT6-MWE0[?&C6]2Q(
M=0I<>;;66WYWA4$K?2[0`GPTXX$)X-6.X;9VY:+%)7-E18P,J'-4J,ZIJ5?;
MA'D<QU*@1RFHJ3_:*:UQE9\IG^>FU9[MDS)Z&KO<8L"V69;,.XV^<RPL21+=
MYMHN4<H'W8&IUM;6522:URP+'DDRW?\`+=VN^W8VV;4^I&W)[<8WB8J5'4Q'
M9D)<F1DQ4E,1R/=)K7WJU)*O#1)RP8K/DD?7?KJ]OYBWOWN`W;H?.CS`ZE[F
M2GEK4VXQI40PH-&J4>SC@%4>23GDV^<;=?(<J/`A3K6K;3;:(310V8D*:MMI
MV9XB\M*X4M=0BE30X%&:I;\F)CN+O@E'>5TMQ6U$7'0+9.O46&II*U#F\B(9
M$-]@5KY=Z25I<"JE*0*4.,+>R\*1[-<KKR-VAK\/G6O<4(V1EZV-!MVUVFV2
MF77)CW,',#CH<4THC*ARQ+#8.X*/U'_S=G</<G`MR-M_>^[H?EU-6R!#EVW:
MS<=2T)A-S5VZ8RM`20%.*DF@J*`)[\9*BH__`%`?XXIA3S=+?O%JR),I4@0V
MWD0&Y$A$E<V-)CR537E.JY9>E/(U*T\`K+!]B<O_`//Q_'!8?C(BQ);-T2R;
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MX"B=VU[I'O$W;`DW!R#%V_>HJX;DM+2_\Q>=DLIAOAQ`UEY*E`D5H#QPFWQ"
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M%5.$-7`T:Y+FX#*/:JOH$IFM0\[>8[MWI9<&V(,^]/:518#.V;ZU'F,N:);4
MF/)89C1T.`T2W*1)UHIFHI[L13KC]TA<_?\`S5OEG9;63IGTR"GM('Q51@S=
MM\0+P_=I3!M.WK:U/_!I*2U+D_@<UE5R4\ZW1?."WD!O4<Z8=65D,,,%)27%
MCIVGM(I64>\?S3DF;A,M5L95+0FPHEFYL6Q+J77H\!:-:E.$$@J#I/R?+B2N
M;$1Q\RBI$K(V7A;%^G6H](K\5-3$F!:]G=/MU0YCRDVNZ7A;C!?4Y(-ND\EQ
M+[32B0I[5*('8`,5YMT77/([#[%8[/:.X^Y(FU=OR-U)NEH#BUO-W:`]#N,Y
MYME2TW&6Y*CP_$0@N/,:@L)X$8>*/B_K?^DD/=#-U:N#4%U3:5LW-ZS--OM1
MU"RPHKI#*H[NDA9D.U"U.5`0<L"L#MI4P\B[PXC&^FH<2_[SN%E-ALT']]9+
M+:[7)YTV0XIM26ER9"E)TI4**`RPWNI.5&'?W@$I$V)[9&S>#EN30WU#DPME
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M"@`R&*[(WER.C_"XCU&BWCMA!`R4;"QI'<0"E[9"V=\[0N^S70JTKL(W<Y#N
M;R$M.3Q.DIN-MYBE#0J"F0VEMI2?$0LYUIC3%-)]8-O+&.+BD:Y.PK%:]@1)
M0D1Y%\N-VE/KB47'CR51XUHN5T6\X%$&*XXHM()JN@XC`I/49O-VP)V$+1_T
MAWY_]W]R?\U_A/\`*$?\O_\`W5_=?Q'^Q[,:^;O_`/Z:W]9V<=NU/O+]+?\`
MU\_AX?>X>%?.W*WC/N$"W2YW(9>?<;+4AQ',>?27C0LMJ&M^JUGW:^\<6:H7
M9LCJD`8A-_=,R1>9UHC6R44/R92=4N%'5%5R6J)?2M:`-;9)\6>1&>,[Z*1L
M'QLCD,C03A2O<5*NT;:Q:K9<9[SS*I*VG8K\MQQ(<6W582TXXI7!0I0=N#?@
MJUJ397R`QDAN;<F39+0JY763N$./VXVU#D<O,:V79B`G2IA*J!3S-!18%0!Q
MQMS'\2IAEQ/&PLC>X,.X)I)N?-OUS<GI=:B.-*$)"0H-*6'4IKF-)>(_33&.
M9)6A)RK8N/)#FN^<N.;CV>A.<.2XLZ';J1TP9XE264-Z=194T3&9G(%=.I5`
M0H#CC/,?O)3<,8YX<0*U"RMC%OO-PL+]VCEF9#MB6I#1:TM\Y$RJ''@H``IT
MIH3[/9C12[3DP9AW*0-RM!F.Q#?:CE,FXP_O$!/+8B1N?*5SE"B6TO.*J=5`
M2<"U>!(<TF)[4PIESE;BO&W;4RZ8JFD.3V/)*TM*D(.II4GE^$.(^U7AG@2;
MXV"-S@!6BD?9LV9%<OWFG6G68T>4B!,2L+0%!L4;CO`Z*!W,`$^+VXRHY-B1
M-N,VY2X;G+7;GIA,=PD*?B*>#22^@$ZFVW73X5<%*X'`FDKG":@)I1&V'W+4
MEN7(UPI,BX)COPI59$MY<9P)YBUTUQUA`"LZ42?;@4KD;R"Z@S44ILS$JVW?
MGE..!^5=8#D=ELFDE(4OG*4FE7&TI(J>&!-4WG=QPX4PO3:M7:[EIFW^6($5
MQ,`\ID2E)\-&E)J`>!P+;.X-R@G*MMSW49LZ1:[XN0EPFD?EE99;+(#CB4GW
M02E/B'=C()!J-J;RL:&EP'S+%6I<9AU^,F:Q;YT9*6D2D-J:B2V72L2&JU#<
ME*:5-`0,;\Q_$IH6-<,0"M%QO,1E*"U"3"B(BO!;*!5+"$)<`25I\%0D5&-A
M<3MP#W`=ZE[:\NX8&Q0R/;&T4`!H!W)9L,]<F`Z_$HY81%AK=*C5"VRD^8J:
ME)2:^/.G?C5TTKQE>XEO:M;J\NYHLDLCW,KL))4DO1-OVEJ%>(?GGYT^,S+8
M4F3Y=IA+`$9IMNI`T-H0-)&5,:*)8QL;LS``[B%HN%VDW2,YN*X2EMIY:H9=
MEN\Y$-Z*A"2M;JCIU2^4D5K]Y04K@45-%&9WR.:"\N))IB2=Z3FKK+1>[+(\
M\U=DI2TRV%L*2VXAEQ#3DEM9\#@D<\(-#17#`MV,+_E9N");HWZ_,W'<WH\5
MIF;"=N,*2EOP%BT-0V$I5%`((5K*TGY/9C"B[MERT_(]PKP*P5N[<<ZQLVFR
MVQU1MUAM[J"&'5'E2G`I2)("3I,B,H*4#[PSQ@&HJE;1\S9,KG',-N*D79>S
M5Q-PW*[$6I=GN-HMZ%1KH6UJ9N"8G/E(C1G5:]3SN06!]VO,X;77W!VJPN^=
M@#\0.*=CT6=)<@+ASV8#5Q9E,O19\E"8LV3:?`S91*<4EH20WF,]3B<P",/+
M6&)],[6GT*"O'.8[Y"0BFT]V0%1C&G33"ODE]:1-4H*0P\H+895(6>)4AGEM
MDG,@`<,9NK>W;X6-'H6EF27XG>I(NUXCO*WE;H$)E2([%M$UR%&\FU%0]"$C
M3+80!S@V%4IEHIGQQ'6T;#*XD"HI3LVJ5N0"&5VBOP4;/3/-[=MUR-X;EW`,
M7+:;[TIP,I@-/2X]UML@(<4DQD)B,+9:4:!55!)-<2#W.>VCR2!Q3*6*.<4F
M:'#MQ3(ML5*[M.EH<3<$1)YW2Y.?4E^8Y/91DUS#51D-HJ%#WDIQ%<V3\1]:
M<"V?VHC:I>X)UXM5QD*CQU/0TRGSK2V[(B.RYKK!F5()0P$I"2<@*8>6TDA8
MX%QVI*>!N0MD%0>*=UQN29&WF++;')";YN9DV:<^TM24L--71Y<H!Y.344M+
M25JKI`S.%',:[%P!Q5>+&02@0@-!<`:85Q6VP0+KMRX,6NZ6J-'ARQ'9MTRV
MRFY-N:1&03)D25LJ4RB3+=2DE2E#4K&ZD+N&)E<K6CT)@P=TPG9NZ9[Y83)7
M>H;"5.N(2ZB.P\N(\V-1"@TI+0U=E*8$VM(I'M<6[*_!3#MJ/+;O,%U;GEV+
MW;`S;X<U?)B./2&VT(?0V[I2M"2E&I0RHD8U>"6FAHZB=>7E2=`W)>8:-UVJ
M8VJ+>D+7'89>"VG"PF0V\7HB'*+4@I235((TD]F&?*G_`!N]:V;%<,\!([EO
MF[NO5S#\Z;';\M8E38D%9J9$HSI*^<N&?>>;2ML$E%148=0M<UE'DEU=Z<11
MG-SI16XV9CMIN%4L6?;,K=&S+E<)4EX6]EJ=;6O,*5YJYW%YE;I1)2O[QY+"
MB`.Z@PJG3I)'^)Q(2DY`A;;Z=V5JX/AQ,<W:0TZJ.929#R##CQTI*005Q$)4
M$]H%0,"T3)7N!5E9<N$>6XN%:+PO<:"$JCM(92F"AX!LT2AMQ)6DG@H5QI+;
MYXS(`*\4SD>]TW*))CPPW*7[1N:9<T%FVMK8L-P1:KU:X;;GE;5$/G8T>2Q&
M<\+#2U0"I!`-2@TX8ALLL<X-2`/L4KD8VU+6@`%,BW;<7>[I>_P^W+MR5!JY
M3%2%E4<MB[EA+;:E>!*+GK":?^+I`%:8<\V3\13/EQ\`EK=%D3&OGX_<KHLN
M6MZ);WE*C+<CLHN$MW5"5*IRT(?"FT*22.P8=QL:]@<X`N*:20/+R6^%21#W
M`BW;7C0;C;'6KS;+?*F(N"I`>2E5SF*C@Z@3XV8[E`>Q)[L;\J/\(29BD9\S
MMB;DD62^3+FB\SD,FSP+7;V;<S07*=<93K;T="55YB04`)":9]F,\J/\(6%(
M>_FW8\EJVQFC#DO"%*N3,MW[N'$9:0B&VPXLA*M*/"LC())KB/D`$A`V54A&
M3RQW)4NEXA7G9T>%/B/M.,3+=#4U%84=+,-:G&949*4FOXC(*%)4,G.42*Z<
M:+29S@RH)!JA"N5HC[A5;WXD6<U=8+;'C;;<C1)41UV4Z6B!H0I:W25T->85
M5SQA-N;)7Q%1?O';/F;_`'1(=$1:XL2^1'*AI;+#LY<AQ3)HDAMN/[Q&00,\
ML3#O+.@:&,:'Y17#;@D-*-RZ>1T[W.CSF@)J*5*5]I7B1+O-M@7Y4PWYRZL^
M=N+?,6U<+2Q5@(E2*<M]3*RG4"3I''$4Z)\;LQ/RE:ZA(R:=L)`(#JT]"(OO
MQ6]V6:W72&Y/M@O=X<5+?E!MP+<8D*0R0X10-`>#Y<L:)>\CCAMZQ`-/9@GK
M;X=OA6/;MP@Q&&KD^F][<W#&92D)$9^?$7%6^$9>8$<)'B%2,*"62GB-%".:
MV1XE?0RC>=J/70+A=6[S'EM+G6JZ7S:C[#CK9>@6QMDP&Y-N#F;,?6E!<4V2
M#I.HBF#FR?B*8WC&1_YA@`N/Q#;ZT@[[D2)UXE[N,=UY;DR;98+G+6I<<V]P
M.O2V'$IJE*P`A2AEE2N#FR?B*UT,">Y,T_SR@[3B4VK<])EV^'O"=MQE,Q4V
M):9:!+;#=S3$EMEY^0I1H^6.)XT(SPTM'E\E'FHJK1<W<#A2$`'L2S9MKM[G
MM]TW/:KVN5,C(B?CD.8LH%CNSMR\JJ-#6HC_``28RPMLC+2%$98L,/*B8ZK1
MC3<JQ?<^1S69G92#A5*F[W+PJ3-M;;B'EV:%^%M!E?,<>="TMO/LA!*EK3S1
M4BM*XA;J2#/7*-J=VEF(FES&@&E4]7UG:%HD;AM_)@RUR['<WHNH1WA)M$5J
M,U'4T2EP3)4E.MM%-:UBH!P>]/K2[:YP+C4=J8+MLG;LNF];K"==9F2K--=D
M)D+4W)=EW%EE:VD)40XYR'4:E"ATKK7/&KY(FMH\`N.Q3D#>=,TQ8,IC1/6+
MOFWV/;.WH[ME:&X-H1X#ERC,,AMRYQ+KR;A;)UK)HJ1=(R@F/(6BJFEKTJH<
ML1+N<)VR-)Y;7`D5P(!Q4)U#IH?,RC1S,PH=XQP/>-R=EUML=VX3[FBZ7&"Q
M%?>;-O:YID6]=_3$E/)1-'\/(?8;<2!D5U/=B5_=+;_EM_CT*+=HUV_QRO/I
M3$ZN*MUQW"U9=NV:XVZVV)];]G3/>60Y&2&U/W9]Y8Y;Q=*4I4UF4H;23D1@
M,D-VVN0<O93<I&QT]MK%DE`<_,34[=R8&T&]W3T7YM]=P9:M-V=GW&ZN1))?
M\K,UO"X6ALH"G82(U-:FP4I3Q.-H8X('`AK0S>*;>]*7XD;82BW);+RS0C`@
M]G:B>WK?;-VWLKL[+LR98$SDS;C+EI;;NQN$14B`XB*XJLIUI=`C2">P8>V;
MKEMWS('.;#78#@HNXC$NCF*[&>;+M.)3ZV?M'<#%MNERM<]BYRH3=MA;ELJ;
M<\RZF%N9QR''8#]`5*=>221VK3WC$WKYM;FUYD[6ODI0DXG`+E^D.NK7476+
M<PB#LP`V?,>"E"_HM3'3NZ7-:P_+9O%FM7X:[#7'><9=:N,F/))6`HL0FH8*
M5>Z4BE<QBKZ:R&2,P0AK"X[MV]="NK"22&CWN,)I5AV'>*COH5GMC:D*];>G
M28EL@O+W"W;K;=IS,-+;LYNYHN:G@MD)UJ'F&4EQ1%%+TUSIB1\RS3<7$.`3
M66WDG:(YB71MV`X@=RKE%Z7LPI<MRQN%@,!Z`XN23*BI0V7!(9$7Q>60XXVM
M2@:`G4K&YU-EXSF5I$=C=W#8H^:WE;*<M=WN4C;,L$VZ0K;:+E%G1I%IO)BM
M`RE.Q$15LA?)+7N<E;:4$#A2APT#+$/YH8SF<:"JR#>L\+WCTE&Y=FOL2U!I
MV=$C.N;B?NMJNG.2XLBU(A-QV&DH4%*<"EKY:A73G3MPJ'VW!JDK*"5[N8ZI
M=Q[5*]GV%(Z@/[><:?:\]N'=DMQ$=+Z(ZT1XCC>N*Y)4H";$:<1K<`)`"R#B
M+F>>:[(:-KN6\YNXY'$O=DKQ2_<;',L\S<,-C2;?#DJBR;@RHB&W.UJ9;,%]
M!Y!9"PI)*32N7'"#_P`P99,6]J0\[(ZL0>XDC''UHY;'X$FQ-6.YRU,1HDLM
M0VF8BI1>N;*"[5>@$E+29!*J\-1/;@:UK/`*=R1#6AIC`HP[1N*:_4&QW&_Q
M;;;S);MT7<-IGV<&.1'5&@VBV*;<N$=I5"TS<IB=2%#PK=.1)QF&`LEYI!Q-
M:J,G!:,D'RTP%$W;I<6+?O?I;MGD-R'8-MAHW%<Y(=_P;C\MA$29&D-ITHER
M4I&:B`H5Q<-.O&@/97#)\0J[<PWS7M+GOR%^&/8G^GIW%VQ=-V1K]>1;YMP6
MWN#;$HL-AZ<EC=$TQXZWV5:'U);20$FJP%<,QAMIMQ$V]);0&J<ZE;R/L_F)
M."4K1/W!<[KU;ON]VH_X'?MT38T9B`L-RV(D+1&BRH+8\;)O:KFAM"$BJ"PH
MXKMP:W$AXO=[RK$;IS[2*-I/RQM'J:`ILF[<LMGCSOQ*/&MD>?:K-M[;"K>E
M$]B:;==9;LE#WE]24K8;6RE?:"`#GAL^X;;@%P!JH.XTR:ZM9Y03S(V@M.\$
MG:."BC>^SU.;=M;$J[0UNVO<-TOUM8C.M-1'HT!$)IMJ:T%>!IF8VI%#0<Q)
M'&N$_P!RCVY&^I/M`TS4;C2W.GFD>X$T)->*5/\`J[<?_*;L_=?B?\1$X?#^
M\_A_9C3]BE_YUEMS;&^KQ[5:?V?M'A7S`V"XR]WR]H350(`MENF-V]28J5@-
M2&]3^EY);`3S$CPD5J<6ZAWA=RN;=UIF#B:^\)\7NXR=OM1[3;X/DY,EZ:TL
MK@QWD2TH?UDQGRL.M<M$@`T2*D^S&4P9*7^"H`VI*1+E)CR+8S`FJ89#4B:=
M*%H<6MQ*BEI1752DZJD$"@P)<!A\2(LR;AN&3/V[`_P[$.7+>=DQB4\TKKRP
MRK(J;4?>J!EWXQ7%8+:`&NU:46MAMQ-MN"6U(B)4EYQ.<HR%&J%M!0"5)">)
M)!KC*4CA=("00G2(EM3"2[&8DR9]O8CK#I2E0+9(Y:5D+*@OXLL"4%N]AS&E
M!BM,`+N4]$=++#3\DI;YE2$MJYC:REU022D41W'A@2OFF<"G+N9E#-T2PX'7
M)*V0E#5`8JT1VZJ<J2%^(U`\/9@1YJ/@?X]*RV\FU0X$BYJ@-+NT%F2H)92D
MZC-27([;>HI)6D*`4#2A&5<86'3MD'+:#4X)@Q][Z'&K/$A!+CJG&3!6A*9#
MKZW>:I3:`I22C0DYUK7LQE)^5DVX)Y75<.[1K6Y;FU1;O;RAYQ.D(8D*@2FW
MW8TM22I9TI31.1%<"8S6[VSU-"*)SS94?<.X[O<HD.._;$-PYS3E*H5+<8#=
MQ:2`%?>!PBG#))K@3WG-Y)CQS42;)6[;;7>9I<4M*G+?'A,(ST+?=?2X$`Z!
MDD"N!-UZ]M>7>4VQ4=M*'4O.-,/O%09:=;CIER'75I2I2605$5`)U#A@21E:
M'Y#6JCYV\+>BNQYUU\^M=P+Q6S$TR>43IT-N*"`..>8\.!+RP.,6;"F"5UWF
M<S$A,.EDO37M*DLE2G'H["DMQ`NJ4CF-MN$'L%<CC-4SY+N(1R4'85[1J4VN
M-+9I)@2]6M#JV@D(2@)4FA%.WMQA.&#*T-.Y.6V6N39X4BQHD`Q-QM*=`;4H
M_AY04J$=(*1H:6#G2O#`L2-+FT"?=P9@KB1(HEO@6^(U$3733P^(T\?NZCEC
M-4AR7]B;#J&9*+XPJXN+B1[=;HYAA7^'*GTA`E*22*R&*ZET&1&5<"CI+:3F
M.Q&U(Z>?9;2B5*_$3*LT.0[$::0A2I3+;S<AEU@%P5:"FTDUH<8.Q.K*`ME)
M?2F7XA>OEN_W?\5D<]$";'=:E6]I"&W'2Y!8?=>4\E6H*<7(((]F!-KQK`ZH
M&*6[;*")=BB-R9=OM[T62:Z@)+J[,R@1XTTZZ&/Y<``U)-.&,`4P&Q14<3Q(
M97$8FOK4C1[O*M\*XCS'/:N++3,)VI4\D(="_,Q,J%*SX"21A&>,R9:4P*D7
MWL431F#O9]JT[@O]XCV:SMW)#3;4U+J>6R2J5%=CR@($^.A00D29%*/'4*-\
M"3EAW;O$7BJH:YF9,:MJ!VI(WG=V(6U]K;E@M-HA72]6:%-?:`+S+MLGORI*
M7ADE/."PE%":DYTXXVN)!+X?:I&VL)8SF<6TI7"OV*8&-Y'R3Z+@TU!>ODJX
MNS)N0:D0H);9<0\NH5SBTI&@$4.>8PRAB=&YSG4H:?%.[H4#0BMND6UNPWJ,
MIAE],JY6R9`?`2I)8B,2DI2X54\8+Z:`5&1SPXW)H-J@^T1KQ=MQ,.W9#LR,
M_>'#+E6A\,-(C./*ARHZF4EI)=;!JOL",ZDY88^5?Q"G\\'`_P`>E2U=[;9Q
M!LEOLR'(<FZ6Q=O86ITK><98DK"75&JM*$IRRKGA>&-T0(=C51.I2Q-RY0=A
M1!JUG:NUMZ3U/^;E,%B!8^<O[[5N.0F'E2NE:.4LK()H*4KA7[?>J?)<-?=,
MB`=F+Q[^]-.P0KFY%NOX:FZRYGF+;)N23(+D:S1[:KEK;3S7$Z1,4ZFN520,
M.?+._$WV_8K-<V$TOA+?;]B86U(R[GNR_P`&Y1PS&MT^6Q<%FA0M^0ZN9&*5
MI)"E,\P<RM*#A7"+F&-Q:2">Q.;&Q-I%20AQ<:^RAW<1@I'4YN6)9(]]D2'7
M4B:J#8FWG"E0B,-ZYS[!/@3%::!"55X]F,L`+P#LJG3Q&QA>1@!7U(G;XKL2
M)+\I?)<Z]S4%42#<EAQ%B7+?:#D9=R*EN2$OMDJ3D2D94IA]RHN!6EN8;@X4
M9_B_E5.JXW.3%M\?:KH#=PN5PEPI#Z0ITP(;JPZS)8<92NFHNJ/8:C"$T-/G
M;X?:DKV(0S9`YKAE!J-BE=R<ULNUVN"IQ%IAL7B3+:G3)8<4^(L2+%D2FXQ)
M2\IYS,)-/>SH<,3,T/#,:DILT9G!HVDIJWW<L.>U88YBEZWR6GT(G./*04R)
M<Q;B7F8J2MG1I4-6?SX52_EI.(21/VS=Y#EIMJY3=PM=XN7X7-N`!#(@.*?"
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M+>KZ5NQXLI_<,V.H`KDR8C"!'CR$DA):86"49^[AIYEG`J/1N_[IM=\WG>7K
MBT3^)OJ8MCOF%A*&F0AUX.-^ZCEI4?"FH-,-7N#GEPV$I_'^F.Y.M]U-TVE>
M7+>XZV_$N>QT07M26T/(9D2X[S#:]>3A+Z0*T22>(QHDKEP:UK=[G@#VI;FM
MP+1MV#/C\E;4O<EPFHEO(=\TW"D06>8Q1#:M"V)<9Y*@2`%9@D&N,)I.X6]P
MVV?B]W#8F'N>\-/%F.4O@P8ZHAD.I`E7%N2Q,2S'B`+5S(RT/ITZBDT'##RW
MBE:<[R"W<MI+ZVTNK)@XO/``BOI(7FTMPV\6QFYVR5`FS97/A,*?6L<J-;V4
MNJ?3X%*#[RE4<RIS$TJ>.'-])$Z%C6`AX=B?0HV"VN+JY-V"WDD8`UK[J*-;
ME-8W>N.ZS=4VUV%>G)#[3P>1,?+R50R8@9;>;6A+B]6:DD(!/'+$6INZA=/#
MRF4S=J6W/,;9L_E+>'YLF]"1`BW!4IUU"KU;VTNLRT)4*E#S;IYA(J-(H#A<
M6S^(52AO8IBYK`ZK20=FXTXJ=>G-S2_LZ;$O[C#\^$B9N"Y3WU$S/-AB/;V6
M`5)JI27&2I()'@->.6-)(G1@9J8II<74=Q;S.8"!"`75WUK2F/9V+#:,9N^B
M_0P]YRTV>YM1Q*)JW%EWNSSI,AU^N:8S<[1J(!("3D<))7IMW,C-T!2(UV[?
MX]*=V^MJ/[HA7FV6"XQ(;VWF+2EI7*$>P+N=VY9E/JDL(<D<G4:@\K454RPT
MMW")^9VRNY.[+2]0+Z/?&?2?L2;LS:LK8STV7)D6R59;IMPLW9YIYU^$JYQ[
MI:[>Y(<2&0ZW1RX`M\Q"5*0E9IEB0DN!,*15%`IFXTR2%HD>6D`;J_8F&NXP
M;?U!W"W,<>=M[EVM\Z`ZE*2L6Q\R57+F*4M+;;BW$-J0G5FBE:<,1,MM<2/#
M@6Y01O/V)2T,5PQT,8(>01CLJ11)%[WY:Y\:"JU_B%RDHNYDW1$^VS(L65%:
M=>Y7D7Y3:&Y4B`IL*73PI!%"<2)4`_3[O3)!'.YA/]TD^\!%)4QR]W0)V[=)
M=HO:?)71Y3*XJ7#'D,)=?)8>D-I<B\RH)[ZXC;V*9\S7,(#0W'UJ\]/PGD.N
M'D%H=2F_8$_[)#E[BCWQ[=DJ!^(L\UNS3X#@3(N,&+*MDM'+Y+:FH\V4TV0@
M5T!PC.F>'EL80,DH))PP3#7;V"24-C#@\'"H'VHWM_96XKKU`M6Z(MXNBK/%
MEQDS-KQ4-36AI6EA@S;C+>C(DOEU84L+2`@5TD\"K)^VQ5S,=ZA]JJ\FK.BE
MY3@[-V4HI8NFWKG>51;I?+@S;3+O5R5%6\U%0W"!>;8=@W10<4EN.IFV$HY?
M,!UCVT9^>M<V2W9)E[AM]:D8[NI#9`<YQ]":NW8UI1NK>UT?CSV;3=;9ON-9
MJ)DNI0FW[<Y[,IQMA+D9J`^Z_5NBB*$5`PN_/+`[(#7*I-D)?&9#3EC:-]%"
MVU]NR;;<[W-BV<.VJ#;;;IO,I]^!`AW>%$B)>;CNH0HS)"&W"2D`I"`36N6+
M#I4D/E^6[]7<=U5!W[0W`>%6KZ:P=OKA/7_:CJ;WN#<;#MMD1;E)5;HDN!9U
MLS7;=$4]2.]<E.M@QG"1IYBB2G$7J[I&QFS<09=M1LH=G\\$UL=+LW/\YE^<
MX>I(G4.^1]OS%JN]K9M]K7)B34VR6$J>=_%T-V_\-:"2IIY^SK9D54%\L(6*
M*))`KT++J"-W+<.;N./V<$CJ++NVD\Z\M-A'XFCQ$'`4%`-I&T[*I3C+W''W
MUO&)LH&'MN-LJR2+8TIE)I?4SV9;:TH3K0EKRSRQ4'45'A3/#IIDD%+LU/9_
M`2SI8&Y,P/S[,/?BFQN&TKY]S:MCK:)<41$WN/)1Y1YRX7&)-9*&=(6RHJ?E
M!6:@=&?'+"O)-/R<(MU?:D[B)C+MT!Q>VF.[$`_%(5O?W+L7I5>+Q*MDAFZL
M[NDA4=MH3&7H:8UMA1W6YBBEP<I:RK,`:<8='*T5)%%&NN;?S0LRUW,-<=V'
MI22Y(DQ5[&1(2A^$[:7)UP=<S:B/2)<QQ,H'B(G)6V%&E=793/"?YG%6&R8S
M#`43HZ9W]VV[RLEME7%+28U[N$^+$96HQPXX'/-.JD*"76$.%M"DH2DA0XTQ
MM7"AVI#5A&&.#0:IR[SNURN,:_0X#JH]O,1FZ/,*J)(<1,ENK>2TV'`IN0\4
MENA)(&8&`D#%4.U<]VJ",['5:.PGCV)K;0=L]BW/<Y^Z'U368=NM-UFV)4PM
MR;@XQ;WKK';@MZ@E1=?<H^4J"BG2FAX8UYC5)NG8VYEM37/"VI.X]W\P$U[/
MU(NMVO\`*OE]M;$APV)R\6R5#FRHHD6MM"F[=9VFGHR1;G8T;2XE24**G!50
MQ+\V)UNUK0<V4;AP32SD;<.$U"&/Q`W@'''M4T664QN7;]D5!MDV3,O"6+[;
MW+H6)5P96927W8$V:BCA;BHC*$=(2H%*JG3AG"]]JY\LF+"R@IMK4%2M]9LN
M8X8HJ!YDVG_"45W%.W%NRZLW"X7/DLV&&N6[M\LHHQ;4NRIR7U2!5T/O%U`*
M*:04'/$7INJQNO2`'X'@/M6E]IQ,K-.!;SG8`_=])I7V)^V7<33NW[ON"\P&
M&HS[=KG;=A-E"Y%Z>;DQV'%LQRH*6EA8+BR:>$5S.):XMWQW(B<1FD&8<*''
MXJ$TBVFO&RR%S6,A>YISFE2UQ::4!PPPV8+=?>H;C^W6++9#'GR+/N,W"')>
MJV([EV>:5,C.J<`(Y>DE(2#X@*]^(F]N+6TG\O=![GC\(!'M(5BDM'R:=(+5
M\>:04K4[L>".63;#&\X=KZ?>?D&\63:]^O4YTA:YDX0G7YS,5+C0=2MZXR'-
M02HI![2,+0BQGQ8UX[P/M4=I\]QI-D;6XHZ3'P[/;3CP3:_Z2_\`%W'^\\O[
MC?\`#_W7\1P]F$O,_P!RUVT\;_\`W=J=?N=[_P`N39P'VKYXMOQ+>Q$B2=N&
M/`_#YC4&X0Y$1Y$"XD+"FYT4%Q*TSPN@6LJ*2BHTCCBW[EZ#O23&2ZI<O)5P
MF.7!R5<%P9"Q-EQF'%-J+,)#BF@Z4@N:DK704J3[N!1%M][T?%.B-'B6*WKC
M0I:[G-7(7=%K?4AUM^"MFBDI"$MD)#NI(S.8P)VHD;LM^=>=O]O:DVEE(UN,
MIJC436@4"*J'?[,8600`11*@;1-91>)CBT+9;++Q94$(7))"F]84%D^'VXRG
MEKX3WIT;2F)MD>[2)#:'IMUMKSUN8=!+*E0I*4.I"*A5.43P5QI@2[_`>XK*
MUL>1O<9Z0P]'@W^6SY&2X:)8<6>6XM2M(`92^I*>_/`HM.:^SX<[JC!V\IM2
M(UMB^5>NIH(KS:6U*>=)I36'U+%:^Z`*=N,;UFGRUPVI@!19NEY@QYB&X\FY
M/LQ9BC]T&6'UHCOUK0MK;2"<96T7ZC>]-F7;(9O$>\.2$Q'6EKC>%24RU/!!
M+,A@D$)2ZYEF#4'&%*5-*;DL0[K+BH:N7D'-*)RK7)U))2MUU03*<(J/O%!0
MH>%>S&5'W/ZOH"E?9=N2V+K<(^M,=R._JAJ(,1HA"BEQIL#4ETK`U$J-?9@2
M"39*'A9VF9Z4I\N';HO0G3J>"J1TK*E*JR".&1]N!"6)LN\6G9T>XR2@*NT.
M<(3$1*DN-IEI4RZM.I:R'`D>`YT'?@3)W]3ZE!6W;%N*Z6I-R?EM0!$*5SG;
MDA(A/B0X&8\>*E(;6)3:E`JJL@CLP8J=FY?*=DJ6;O8GKY`1_*<]I4YQ(YB)
ML0@-1RC2*&NNG,X\>S`H]/1V(S-_!9Z517I,CF\X+!*U".A2D!("A1PA`';7
MNP(6N1=&HC1N$YT1%I(2RPMM;JT/.5Y:0VA0(;R-<"$2M=R3N:%>)%K?7+N$
M*5`COLZ3$89,ETI6M)<*BYI:`H@&M<862"`"=A3&W%,GQ;I`8;U,-PBARY)"
M5,N7+RZPIUL(4HG[P)(2".)QG%,CESNKBGMMV\294-J[E0>UQ;@E4"Z#G+7%
M"%-O1(24%DI<#"BI-=5"FM*8-R4@%'.'8ERQ,2A:[9='8X8+Z+@OD.I-6VPV
MA+"5BH(<\N$U^7`HV\(JBMU@B^PWG5OKM2K;&%QD.-^$IC&.RV\IE-"K2ME-
M:5XG&=R9M(%#M"?WGX7D6?PB5$FQYD1ABR/2XKH;@AD!3RGB'$!:7%U`I2BL
M\"V;")CE.Y$MTR1.;LBIBG`_%*@4H(2TXOE<E2D!0)+!!U(%:@]N,8K;R#4Y
M7MEKW-TW>8MSB)$*V;G8OOE6B"MUR&E(N<9.1JV$YH2!4+XD\,94D,!3L7F[
M8Q?VXGG/-M/WJ0XS$H=+:&"IITK@"I4BJG]#E2JJD=F,II=[&^E.!NV2;9"@
M6R\L/QV'XL=4.7!^],E++:>+("U)JI.E7><\830;45LUN%TBS'+;:!97Y0ND
M,,QG%1G4%W4^Y*:6^IY*)2U&BE$$%.0%<\"EDHR84JU67;+J6`9>V8;EL<D2
M'4RG%!US6EUU;8;`?I7/('NQ@J&U0_F,:=[3[TPV'9,V/N."Y/"F8%QB26E3
MU<Q4I]3$F=!CQRDMI+S*M2B*'(#&":"J1@TELKA+3%I!4L;"0B]V*)?XS#4:
M%?&VX5ZA`*3(=N&WDK??+I2K]S+TH412JN_"'G1Q4\F#N4V:#9-SM[;L;\-J
M.KSURN;B^=-DW6^NI<E%:$I0MV/$8*4,4`T)%"5'"L<HF&8<5E(&^-SL+@;?
M@K@7*;;6-NQ;';H4-"FI*Y:FT)NDZ4V4K6IIY>K4`$JT&E:YX69XQWK9C0]X
M8=A-%CTWV^BXR8MF5-<NSLUN\7%N(6G&W65VB1&#37,)UJF)C.*2`:C37+$A
M10FMV-S0BTP*6[7.F6K<5VN4*,ZN"9TJ&$W&0RHI<A2'(KC\<.-A:4/\H*14
MD:2,)R?I>DJ/TJ*ZAM>7=FLN<GT&GN6[?ML<WI`V?K0DOVN?/\PH/+;2J%<)
M*9<Q;ZU*4V7&D-T;50)`[#B#?_4,K^)2!?RVYQN3RFJAQ$;;M+UG>4QS8\>(
M^P\V\@00%O1GE:6\G5H`U*X*[`,/$CY]REO:FWQ(@(5:W)"+A=$2[DPXA25\
MJ5;HLA;:&4+0M*6BMY06*5.68Q'S_JGN";F0RW&<]B1=Z%],&\38,F/<5R+>
MC;,20E""&92'FIL1D%L(("T,JU]I]F"#]0?QN4M<_P!`[T>\*N4]BX0+GL*7
M94H;D,6N*[/DJ"E.JEW&5+AR$$A:!RG(,A)H:G6`:TRQ(I#3MRL#:[=#BM0]
MR2A%D7J))C74H2/OO-<D"V1Y-25*C-.J6I"0003QPR']4[O^`4E/^F4DWF?<
MK]NS:DA_E6^.4(M0CJDH5YAU]_7'6^V#5Q]R2H`J%!3L[<2%S_0GO:JV[]53
M-=+C:U[I&V'?.-0>2S%97K0&G`]'<:G*62U113*84$4I1(H:G/$*LIF;LD0?
M\U;B9MML,E%LMUH0E3`)/GE\M#YB4]TS!1)XUKC*?Q_ICN3CO>T-S,]/6;@B
M4(T&0P;Q*AHUH#:F[O;%M1GR%:PY'<0E3="""#6O#`F]V/TC_P#%'N*.QKQ=
M6^F]Y7*>>Y<%$B3S7TH4ZX784J*P_JT!(#KC)U4`!-3@WIKJ?_FT7H^**[4M
M4SJ/>;&U`*-=KC[>E7=<Y8:294-A0N/+=2DAECG,Y5"Z`FM<2<?@'<%&]0?J
M^DIA;P:M]KWK;[=M2$PN(8UR8BB!*4S#1+%XNT%P.L/,)+B5@LE2PH`J^441
MNO"._P""E=+'^6'<BK=DO<6';;0WY")N:%<[NYH$IC_'NRK=YA,5"5`N*7'6
M?"*Y$X9*3&U+MJ%QN0EJF4B&S(<>:BN?^#*2ZU;Y3K()J'5M,$D\-1)I3+$J
MWPCN50TVR:3(=Y>[_M%/VU.&;9YW,C/Q+DY<FIEZ*/!#?AN\MN,U'005(:*&
MD*4"I55+/"N36ZV-4%J+1:B:,?\`>4'J)^U/3\*7MO\`&9EMFAB/=I-I%\M3
M2@$)?>@3)$Q2$9*1H84"W4G2.-<,]RFH(?V_IWS`W_S2S"WM$8;O-I:@R@N9
M/B)7*54PFF[4@.LOR``%$(2BJCJ`)PQWJRV7Z@*<;#-MM.RGGXES:3=]UW%2
M[I&6YS&9,R/S#9PME9/+AOH<6O2DI*B@&N6'$&]2&H_H>A5FE[?NMNZ>7]=S
MF3'KE,N4J,W.YJ),J>EISGLK`;;2N/(;<:#;?V`D"J3GA8;%":1^L>].I>T=
MVR]@Q;\9D<")'M=SO<9ZX-K0[$O,$H"[4A1/EI")`*7`FJ%*0K+N!V+.OX70
M3@1MEYN38TV&X6>3N=^R18,VULQD-7D6MI3H4XT9(=1)=N#?[FA2"H'(X;S>
M(=RS%J)LX>2#@X5^":6VK)N!BP;R<:E2HDL>;AI=6$QG8QFI$=;A;7S$1'V`
MT"FGA0L'(XTC\8IQ"9DBYG;Q+A[U,NQI]P>LC>THJ)CEND6R5=6;XV5-S=PN
MVF.IZ3%6Z*<MU,@`T`!<2DD4QI>8U3.]LAYT5XI0W':D;SVW?K6NY"VON/6Y
MVT,E]QM,2'$<<\XE\*65&062\I2JBIIE3"6FW-O$TME`S9BI_P`C2,24V!,#
M8^TM\[7W#)D0),N3MJSV.Z1;@^W<UR6/*W"$B(EYUEY3B-+R&B"F@&DTQ:&W
M5K+;.C8!G<TCTIH;K)((<?F-%(MZND/>=E>VS&6&;1`0+G968NE@,OW2.VS/
M+RT@\]M)%$:LT]YQ#2W7E-B97^Q%;RVO9#-GEQ6TW:!M^2[94AO6H,RYT*+&
MCR.6TM#/GDAE9*].:N(PU\R;O\X]WJ2FG?TH_P`11J\WZR=4(T&UW:5"4JPR
MKY;K<\U(<>OT"(E<*YJ3?HZF0PJ.])D*$52"%I3D2K`C4HA-9/C.PY?^T"GG
M:KBY#W;=+9$GR4H_!K(^AXM*92I]"'7`%E0^\B<B"4E(H=:QGV8R5":[_DQ!
M3#9\$AVC<+&Z)EY@WA;,=B7O?S(E3X3ZD*1'M`NL2-YAIUK4$..Z'`3V4%#A
MU'X`ALIFO'2[26M_[("FB(IJ7N%>VKHD+VI:]I[UGW.)&2!"7*@;=2_!?>+P
M?67&Y:4D&HS&"4?(>]5N]DY>JM>#L#O<JCV:%)NSEF;F7%3$E2(^TQ"+*W8C
MS*HK4N#5"3K2XXTV2OQ>(Y@##16"POB,"M:]S;?9ZAVMBQL2)-_9N34&[&7%
M<BVB.FZN2HZ)\92M"O(MMLI;KK/WBN/9@5CGMQ/8MF..9M4\KKNJX[49L6X9
M4)#UQYDRS2K;(!9<M;:7EIA7"Y)=529$=;<7RE`)3F..%[>(329#P)5(\JV*
MY?.-L;'.]2C_`'A&@6WJ!MW<5S6RRJ;9V[M:HC?-E(APH<V&U(6[RW`%//R7
MTU"ZCE+H!F,/O(LXJ(OY3'"R^WW!R^VGP3HOTR^;COH-FV_#7+;O"T*#*DQH
MCL%^`I=O3Y8**F6GZ@J3JIGV81+0PY!L!HG5I'RG"+\.'J1W9.Y!":M.\H4B
M[0Y<"ZO6A.VI"TNP^9;+=+;=>:T-(*XYF-NITA5?=SR-6]P:M:W\3J*S!@,1
ME_Y8S?#XK#:5UN5\D[AW9.$NW088+$UF4=)N1F599@M@C./1'@3QJ3F<:3:4
M+*+S/8L1$W$!U$>)B>.[+D+IMW9J=NPVDW^T"^M,265KM[\=AF,CEQG&I*W6
M74-\%$)!)SRQ)WIKJ$!_^"W_`++52YX+C6].E.DX.$CJTXU(/M21O&=(A3(%
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M^M3#*98\3R'S[KL@!2*ZJD5XYX%J`!L`"=R76K+":DO,,L/QX[S#$6J7%/L*
M6ZZ4-*()<0"NH'`'`LI%LDF5>FQ(5*>C6VA+L:2\X%&@J-22HZD@YGC@0FW>
M)#+,IV&VTXXR]*;D1"P"(J'H8"]<AN@0IEX51F#4XPMFEP!(-/2EQRROE4!Z
M%YE,1<IB=#?6I9#3/E%/2HJ5ZJI9,@4<0*))XUQE&=_$^M'$3KE+D,(>DL+8
MBE9AEY07"B26QYEI+B%U0VVM;5*4H54[<"U1:/:[C=O(/+E4GPW9TF]R2LAF
M3&D`/>7CJKG12RD)[,"$UIBDP6KTI;*D!A+,J+'?3]X(:!JJ$D$!`0!JIEC9
MGC%=E4I%^JWO4<;SO<N0_;6S'7'4^Y%Y;NGEJT!0*="P$J`KPSP\>&BE`,2I
MNWC#\Q.QK25*T*YO7/;WX&XTN#<8MRE2&7Y!"$35.<KDJU$_>N)T\34X;38/
MH-BA+R81RT-/""I2BF7!VBXY!+S9N<:W.SVU*5SH[[#JFI##9!U(+RB%*`]X
M$5PD$S?<!PRBE40<GKN[<ZW4#:VH]J;Y[@TH:4Q"3YIITD`>%[WP?M<<92.9
MW$I.W7?+Q^"W*VJ:\W-M\:S>7\FG4AEI;AD:XZ4BC.N&G4O32H!KC!3J%H<`
M74KQ*CZ9?G6]A1(#L9R<';E.68W-4E:W'9[1A+)!U5/V#W"@Q@G"J<L!>[)F
MHVGHV*2[3<6W+*X+C#:M[2;G$$=J,[4KBI4QYCG@9Z4`'(]E<922(6R_Q8S\
MM+:6RF([+=B%T!7+;6\Z65I)!*4+)`%.S+#1\+W/+@XT/:4Y9+$U@#@*A)"K
MHW>Y4AV<H-W`17RGQAN.AP`<`I00%@\*9]V-HHG,?F<2<.)6)9(GLHRE4X=J
M1)-LL5P=G.Q0^[*1-;3'Y86N.A"4-R'RW[[B'@0E2JD=F'*;K:TA%^EF/<6M
M+LDZ$RGD`OAMXZ><V^H%P$!50H&M<"URMX!$9`CMOMP+<T^7+7S%LO"NA3:3
MY=UX*%!I4IX)41QU4.%H`"\U%<%JY[8AFH.">4&[W5$2(JX1H,B'$D3DW12G
M^2I,(QV`TPAL4"7Z5SI4@@8=96\!ZDD9XG>)K3Z`B;LZ`M]R5'D)%IG663#;
M<<>4ZVVMP`,0G5J*BMYI`":'NP96\!ZE`O-7NI@*GWI0LZXSEG78Y;S\9+[$
MA<%3+06I*HZ1)::93_X(?*2!IIJ.6$)@`!3BG-IXW5X)>NLBUWZU.7*US$38
MR'+:E+H0E*V?+RFVYC80FA;0TE!"J`"E:X;I_OH5)&V=PL[2M<RP_=):NTZ\
M%E\A*0EIN%$##[2OLIF*UD$4U%)P)KYJ/8D/<4MN_(M04J%;S':AV*'$?2VC
M*4XXIN=%92"$*=4@DK2`2<R<(3,<^F4D4X%;LD9-L%:)=N]Z>M3%C290D3K#
M-1$DAMPK=+!`2E;N>HMZ5#CEA#R\GXG>LK?(W@%NBS$IO$YH/ZELI6\&-9)'
M-0M*%A'9S3E4<<(YW\3ZUNF;U`B7O;UK5>K2)4N;>[1#CHC<]]QNW3TJ4AZ9
M)MQ4IASEM+\2U`E)(P[MRYS75Q-4SN6L=(TO%0![*[DGV#:#-LV[N.+*O(W'
M=+A;[5=?/R%+CQ[+(0LIF,H=XHGM-:T"E%:33@<.*84.*2$CLXRU:VHP!*E"
MU*8@PH+ED>4W'FVY]Z3]X4Q8KS"H[`*FP0AJ5/2Y3534L`@G&O*C_"WU!2*;
M\RYV?S=\CRT+B%<UAEPK(;0\41V$)2G@E:4O`A([%5IAI<?(\!F`INP3F$`M
M)/%.O;MHB7-R-,=CPFI-B;FO\Z3*_P`2`%%$93R5U-9+J0-)R433"4;W\QN)
MVC>E'`!I(VT2%MRZS+/?K5.1$MR6D7.0U/E>"&8:9+JBZ^9#:4+;6^/"HU\0
M.>)3.[;4^M0-_)(!@YWK6N^V"UH*9+K<A+B7%RT6OF*?CW60[*?::@KF$J<9
M#K+H4D#L`.`.<10DIE;.<Z.KC5U3M2K;+%)8MD>!*M25RW(<MH,1Y3LM43GK
M4AE#S1J7E--*`%0:@5QKE;6M!5*2@<LK5>WTVG=,:R2V7HC;2+#`AN*2IEM"
M&(;A,A0%*(6\YRZ]I%,"CZ!3#M*YOP-L3;@EU,V[VE<!%GB,GRL5J,NX"VWE
MAZ0UH6N4HN!:@>`5C&5IQ(%4]A:W(#053%W>6]K[8O\`"MSB9%K<W-"E6].K
MF3X\IJVR7B''#5RI*"D&M2,&5HQ``*?6[@)0'XLX'$;.&Q-JR;7N-]59W!,A
MB'^$2D6UYLH`5.BQBZRI]:::T,.OA.?!0'=C.*E!)`WPL8.X!.Q%N=3&MK"5
M%FZ)MC7XNIZH0MR,VIHOJ[TME)T$\.S$=,2)G$8'^2:37,6<@THD2T[:%YW7
M;;W(3(0S:HL!]AELE`6776EKFMI!"3Y+RVHK&:==>W&AD>X923E[RH^[?"Z$
MAC6A]1C053HBSKA+O2>>42(S\B3:^;37*8:5*DRQ*2Z=2T$(7[X-:*XYXT48
MGTA49%NN$NWO178EP>B18\IL),M\Q3S'6DR`GG+EQV6ROCJ32N)*)C3&#05I
MP2=L]W,>"30$[UKGWN[BTBT-RG';2MV,_*8DR%///0D2&E/:4*6LG.BC4=E<
M)7#6B/`#:J[+/.=8C87O+,^RIIZJINW"]N1]O1X,=XW%-UW&:H!6_&AVBT^9
MEM0Y[9"D%+GFEJ4A0*2BE1AB%;=<:!=1$8.H,=^]2[TM(LD2?>H[C2Y-QL%W
M?EMLZ0(BH;*RA92FA0EXYBG&N-\[AL)]:BM>#>6QU,<H]P3`ZB[KME_MVQ+A
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MD:RK/EW*E^9<8#@<@RHRJ-P5+:)4JE*@5.,!K>`45JLLL=R!&YS1V$CW);E[
M9NMMOD';TECRUP,NT)BP7/\`$?AHMJY[6J0]]X5*FPW%!NI\*@*8*4V*7>V:
M:Q#\SC0<2DVXW:^6>UM1WK3'1=;1="V\N3;AY!RV3*<Z3-26M#LAEM&@K558
M<)SJ<!V&B4T*5C7.C>!F((KWK3<&K*Y+V9`F(EVZV2K>)$1MM7EK1/?,Q]UF
M'*CJ*EF-#2\3XO"UJJ!GAGF=Q*E)-$,AK(\N/;C[TH72U^5C3[E;(TAG<$9F
M"W8YJ7U.2H+3$Y19::4I8<E)0O4IE1/@;.E-`*8*D[4D_3X[8ACP'UQ%0#3U
MK=O:]W.+88Z(;<!*[Q`EKOTB,Q'>_$C.:+!E2&@/\*9+[E$D"J%G+/"D1#96
MN.P.'O2;V1L87AK00*[!N3RZ+WABRJM+]PDRYT#;%LO=^DVE<0%+T*Y6"Y1E
M&-*6.:ZN(ZI*4I^SJ-,/+LQSBD8%>X**-S$YV9U"[VIF[;WW8+[947*/:Y*#
M%BS&8L>:@*FSFRMR9*?=YE7)!:;<"%*42=*J<,0+[-S9J4PVK?SH(H7&G>M>
MPM[Q[G-7L3;HD%Q=P=LT]Y:W%>:\PS<6W%R%$_?M09)`&JH00*8G[2V+:.W#
M%-YIHG1DMIS*8'>GCL;I\-O;5A.;OW.BUS;:J7!4AAM#LB[N2Y*TLJ7K^\$!
MAH@(5P"\A3&-08PC$#U*(+WN\1)]*T0T.PY-TM;C$E=N\T)C!EJ4[YVZVXD0
MI*.:5:^<E=5=IKB#.EOD;YJ-[FL.%`2!AV#!*3:NVULA:-:`_,36F./;M19N
M_6/;-T5*?FQHX:N[,B?;XMNBRTRF[A%6N)&<?Y:BA<5#*D*!X+*4]V&QGE:?
M*T-7;^&_:E;6,S:>^Y<]QI3`D_B"=\F[)AV1[<UOGIF+9OD-MY%R;0)";)/B
M3IEK:0IVJE(51T$5I1L=PQ+6=M(?%4]^*@.LWO#;?$[M_<DTW*W2-LQI4]ER
MVOQ$O27(RJQ^9(D)><2_RDZ=;KD;@K,E`XTPK.UT<I9LI]B?ML#-I=I<0N(E
M<#FH2*T<X8\<.*=42^3&;&'`\\5;A:>:D7F*WSXWX*BV0O.PE*K0ONI0M#U<
M^-:X1J3Q3+5M0M[35H+*6-F8M-26BN`XD535W/9H]AWK=7DI_#['$N5BDPBS
M)(DE;T-IT2%);76,]Y97W9&?*)IEEC!4A>R0266:!K6NIN`!]BC:WQK;=Y,]
MVVB>P)C[T6Y716JZ.Q[="ENRH+++4A2S%<+P!T)H#48VY$CAF;6A3V"[++*P
MC>X_IBN.W$[>*F3;UNV_O)R^R>H3\J_1G85OA!;3"8TY,V"MINP1@P,TQW'%
M%+R!DHD5&-XW/L7<YP)&SUK/4MNRZ<R"V`82`3EPJ!M!I2H-<0<"FM?;,U9)
M>ZHB]KHW''@MQ8+MQ2XXF?';N(9EML[>4HEFD5:$-NM@"JV:'W1A?]Y_NA0M
MSI<,UFVV!!+=@X'LX*$(&Z[>WN>+*@7B]WF=!O<V->6]"H:(=F@PU.+>F",I
MMM^1!4CD\P@T4*#"]L\3.,A'B-?6G,'3SXH&2/<:Y1C4[:;U..T;1&E[,M]R
M8<4AQ6R)NYY\YU5+7:[D_NJ9:4.+*B&XQ7YB2M2J`E)03P&'.JL8+)I:T!^?
M@*["I/3G/L9W.B8V:K"'-<,PIQH01MIN4L[<LED3N_8VR+M"EW*S2K-NN3<I
M,%!?:N=T6T95JDH6UK;6U$;(6VI9HA.:2,5"WBO8Y2ZXDD?#P<YQ`]!-%#G4
M;&ST4Z7J3A%<^8YAI@<E6X84-,"*;,5$&V4VZ_6K<%EEN.N7RV;EM[T>[<XN
M,BTNSY5J?89D%9*"8[22Z`:*4037%]F:QS&/H,V1M#05&`2MEIUMI&CRW%B\
M.9(2X4X.)/Q5D+SLU-IZX[@,F;&F[>9L5OWC:8[;+,I";GMVS1KE9+3-*PI+
M+ZI<124)]I&(DR-AMKN79(8QCOVG?M36-G.LK>64YBZ0X'&F`XK&SWFS;SWS
ML7?M\B,VMW<VWKQ'<92LF(3<F5NQ/)E0HGD7=15I2`$`4&(K2[ILVF/DE^9X
M)Q.)W[RI*_#8;<&,!I[,/<C_`/TXA_\`W!N/\1_YZ1^\_P#,>_[F&'[MT_\`
M\N/;^%NU;Y^H?QS>'\3MB^=>Y_SF-_"?R2]<?X'^+;_@O_FOB_LUQ=5UM.*+
M_P`C7G]U_/I7[OW_`-Q%]SVX$*-KG_#6?]_^X<_B.'[YS_0^S`A(Z/?@_P`9
M_,(?\M__``OV_P#A?'[,"$8WC_S&?WW[H?O>'`?NO[/?[<"$_;=_*]M^]Q?X
M^Y[GVO[&!"8Z_P":7#_\(KW/W?O#A_:P(3EM/[I_][V_NN/NC]Y_8P(3+F?\
MPR_<_EY_BOX?W1[_`/PN_&\?ZC>]*1?JM[TP^H?";_+?X2%_$?O?XIO^7_\`
M$[_[.'K_``J:MOU1MV'9W>Y/6)_(+/\`R;]ZOC_%\&_?PTN/U/0%4M6_K#M\
M`[MZFNT_RN#Q_B&^/\/[Z/WG]G^K"*8Q^,;=JVW3^"N?\%_.HW\+^]]X_O/[
M'Q8V3U-B-[NYO=XL?O\`WOX.=P_X7P?V:8P4[B\`4:S_`.)L7\D_BH_\/^Z_
M>?T]V,)4)?:_=7+]Y_%K][]UQ^S_`&<"PM<3]W<?W'\K3P][]X>'M[L.&>$;
M/BF<GC*8NX?W4?\`<>\W_2?WW]K!)X-VU9M_U-^PJ8X7\@'\'_(&_P"#X?Q:
M_P!]_P`7]6$$\2VW^Y8]S^3G]U^__AS[G_%[O;@0F,Q_`QOWONO?_;7\:S^^
M_P"'W^VF%[?QGN3*^_2&WQ!/%[^,F_O/X5KC_#>Y]O\`XG?[*8=J)W_>3.LO
M_,4_W/X,_O?Y;[J?X?\`^8[L:[UH?#NV^GT_QQ3YM?\`S,WQ]^U>]^Y_BE?N
M_P#WO[.$9]@[TXM/$>Y)D/W+K[_\RN7\D_??Q+GO_P#!^'#9/@GSN+^&MO\`
M$?NE\?WO\.>']KOQA5<^([=J5-C?_?(V[_#?\O2?YO[G[M/\'_\`._!A6+:=
MBDM-^_MW?%->%_.]R?S7^:N_SC^(_>)X_P!GX/[%,*GP[MBE4\)'_,=X_??P
MEN]WC^_'T?JQ7UE/#=7\DM_\P_=R/X;W?>B_OO;^K#VU\)[TSNO$.Y>V;^5R
M?YC_`#&Y>_\`N_W2_P"*_P#EN[#I-V>(=Z3IO\GN_P"]_P"6W_X7]W_&VS]S
M_P`7X?TX%*J.;C_)8_O?S=O^8?O?XL_N_P#YWN_LTPQNO&.Y.8/">]39:/X?
M=_\`%?RM'[S]_P#S(^]_Q/UX0C_4;WA*/\![DB7WW)'N_P`KB_N?<_C8_O?\
M?]5<2A5?O]B6-I_\SVWWOYK;OYC_``_%/#V?JP#8F5K^EZ5+UO\`^>W/XC^:
MO_R[]_\`Q#W\)[.[^SC*5E_3*;W4G_[YW_P_\%`_F'\3^]5[_P#Q?A_M8PF"
M5K!_$WCAQM7N_P`/_,+KQ_XG]Y_:T8RGT/Z8]*CB^?NO_"_YF1_,_P"#_D%T
M_?>SN_M4P%+-VK=`_D,+]S_%G^2>Y^\3^[_L=^,+?UJ3W?XQ_P#=?\NK][A[
MBO?_`/>_3B.F_5/\;E&3?K.VIIVC^,M?[_\`Y9<X?P?[D?R__A=_LPBD_6C%
MG_F]MX\7?=X<5?\`ZS]6!"D"7_RU%]S_`)ING\L][^4ROX;^U\/]K$I%^D.Y
M(VWZLG>5$8_B+C_^1)/\K_G/OQOX[_B]_MPE<_I^E5F3_P`ZC_Q)0VS_`"S;
M'\9_-]V?S'][_P`LI_?^SX/[5<,%=-=_J(NY/;;O\)!_G'\@E?R_WOW2?WG]
MOXL"B]>_19_A'N4:R/\`FN__`+G@CWOXC@/WW_RW_OTPZM?&[N2&F_I^A';!
M^]VU[_\`S+=_WW\)_!?_`!O_`!__`"7Z</0I-/#>?O2?=_AX?_VS^^C>[_Q>
M_P!M<1)VGO42?$>].K;_`/)I/\;_`#>-_*_XW]Q(]_\`L=_Z<82T'BW>E&MP
M?OK'P_Y+E?S/]S^]7_'?VL95FM/#NV+5TZ_YDV?_`"S^9,_Q/[CM][V_W/\`
M9Q@*EZS_`%([U8^[_P#,4S^!]^_?N/YG_.!Q_P"-_<?\/5C"M%I_Y6_T>XIO
M;X_F&]OX3]Q;/YO_`,M_P4+W_P#C=_\`Q*X#L]"A=._J3MV[DQI7_P`!_*O=
MB?P?\#__`"SV?'ADK;O_`.]6U_\`>S_XC^7W+][_`/:S?[KV_P!W_:K@2$WB
M'BV;UC=_Y3;_`.5?R2T?N_YE_,6/X;_YWX?[>!WA/<FES_3R?X'>Y*NU/YY%
M_C?^4I?\9^]_@+A_&?\``^+VTP\LO%Z/L5,W?>5>Y'\:U_$?RB_?RW^&_@T<
M/[>%[C^H;L\(^*SOWI[=._\`FQG]]_$-_P`F_F?O=G_S??[:XEXOTCLV%8]:
MM=U(_@K-_+OY/&_?_P`S_B1^\_\`F^[VXB+_`&!"AZZ_O(G\X_G]C_B_XK]W
M]K_Y?XO9A&W_`*8>+:>Y1^I?I#9\5`<_^=7C^*_YCN?\+_+_`.+8_B?9_=8:
M']4?I_%+Z5_1.\>[NVC:IBW'_P`J?_#?RS;_`/,?Y7_([I_$_P#'_NO;7$U8
M[1LV)EUILM_1\$^^IG_,&Q?W'_+MB_@/Y9_RTO\`C/[6&.H_UK_1[@I72?T[
M?Q[#_AVE+^SOY$W[_P#&7']__"_PCG[G_P"7^+V89<56>OO_`#^#P^$^';_'
M%*75G_F:U_R?^3;+_E7N?R/_`/C7_P`YW?V<8.Q/;;^A&W=\5"T;_GJW</XI
MC^7_`,#_`!"/XKV]_LQ-VWZ#=FQ/G_HV>WP#WE3EMK_FRT?P_P#S[:_=_@/X
MM7\1_P`'_P!ZF$[O]+[NT;5+7_\`6M\7Z)^"2+Y_S7U"_BOYE:/_`+6_F,K]
MU_;^/^SB,&W_`+M5RV_K3^IM57]I?_?CWG_*_P"2;O\`_P`G>Y(_?_\`%^+#
M^SVJ[W?]&SQ^$>Y7.>_^]-OC_EW_`.]6W_*_X;^?7O\`B?\`Y3_]MIP[U;^F
MB_\`%_\`9*K^D_U5S^K^B/\`\HQ)O3#^8=-?YM_(YG\!_$_R17\Y_P#\>^'V
M:L,[_P#I#X=FY<P^I7_J5VW^F/\`AV.]O\E%NR_YE?\`^1?SNX?\N_PO\9$_
M>^W^Y_XU,3,OZ$?_`(;?<%9>A/\`R!_ZW_[79Z.SAV*T.]__`+Z<3]]_RRG]
MWQ_A9'[_`/XO_F/^)JQ6K_\`H;G;X![U-0?I1>+QGNW;$F?_`*+/X/\`E</^
M&_<\5_P7]C]>*[I'_E3]NT_%2VI?TX3R_P#ZG_%_Z?HQ`_\`^-XOX]*L7_\`
%%\"__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g53110424ifc.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g53110424ifc.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@#*@)R`P$1``(1`0,1`?_$`04````&`P$!`0``````
M```````%!@<("0(#!`H!"P$``00#`0$!``````````````,$!08!`@<("0H0
M``$#`P,"!`($"`<$#PX+&0$"`P01!08`$@<A,4$B$PA1%&$R%0EQ@9%"4B,S
M%J&QT20T-1?!8E,V\.%R@I+20V-4)54W&!D*HK+31&24U)75)I8G5Y?QPN)S
MD[-TM$5E=;5&5G;6=[<X@Z.%9K;&1X3$PZ2EQ89GAR@1``$#`@,%`PD%!08$
M!00`!P$``@,1!"$2!3%!41,&87$4@9&AL<$B,E(S\-$C%0?A0G(T%O%BDE,D
M-8*BLG/"TD,V"$14)1=CDX-T52:S_]H`#`,!``(1`Q$`/P"R%R"A:%)'4FG2
MBO`@^)IX:^NGC&?:J_-S^42\/6N,VX)[CO\`WOPTC)*V:E-RU.C2$AQ&`1M`
M?DV]-&924H(IZ*D*IM)\R5$)H0KQ^@Z1(J**4MXS`.6<*X>=&C<>USU>FT^;
M/,-2ER,E?V?M2*K;4V4[][@Z)-*#QU&U*D_Z<C^9<DRQ2(A"EQUN-K!5\TT"
M\TL`TW.+:*@TH_!5#XZ5CN.55JR-#,6$9J"B\-$^5(24]@=PZI[=`55.EF7G
MOBIPJ%DZ1(UI<1L"S;@*4JC("E;5$BH3Y4C<HU4JG2GX=2?C8_M5-_!]BV?9
M<A<>/,<8<3%EK<:CR5(4&''&A5QH.]$!Q(-=I(---&W]K^8M8]P#L@]93V+3
M;]MJ;NW8XV[7$$@;Z#V$+!R*V_;YL-XT;DQW&:CJ"A2:5\M>FI&\C@,\4[""
M6N!47=V$FJ6,['`AQC</0DO*A(E2H^_<DQVPRT:';M2.A4OZJ!T[J(TY,MM<
M?7<&JKWFGWD]LRWMFESX^"/(:5((W#RI\E00H>7X%-:C49=L@9-EMB'14&SC
MO4Y:/G=;M%R,LK1EIW+N2VK?N(`'F-24CI0GQ(TW"=-9G<&<5W(B>LE"E`;5
MBJ**%3\:@*JD_AIK.*<^"62[<EM12H$$4-*D]Q4=B?`Z1?<\MV3@GT-F_EB@
MP_:A\BVAUM*@00M*J'<>B2"34?`:2?<\T9.*=P6;^8,PP1\W":*I2_S7BT6C
MY_,$H4"?B*$^--(I_P""10W:_2E..*20DK"DD=:D4([$D=M'K3,6;O$D`;_8
MCINY?9#S-U+)>^0=1*#?8U;)-?B2G3:[M77<!@;MV^933KV/0HFW\P)C#FM\
MI[DL,KR2WY-8%/VRI7D2K7+NJ/3<;++]HEN/L"KJ4!52JG2NJSIUD;6_#G;6
M'#RA6?4^H=%ZBTD6\E0XBF]-<[$.XNFJ''%%:5=31Q1J#T/@HZN#J.<3NJN:
MC3Q$.7`/P6X-[AL7<@O!H)>E>MY@=@0H4-*;NU.G7\NMF2<DYAO3BWLW9_>X
M+Z(J'_.:]/+XCMU_NZ5\=3:GO@TM</Q+*+[<%VW%+-/O,]N,J:MN`PJ06HZ`
M-SA*:I)3^B#NKX:K6N]6:=H#,^JN#8G>U77HKHC4^J)7Q:2TNF!(\M4;WKC7
M/[.AZ=>\6R5A.Y#22Y99Y`><)I38PK<#3KX)'?59T_\`4?HV^N.7I3QXIV#M
MNS=N&]6W4OTAZ[T2SO+G4XW&UY0RX#:'5.P\$@&S)CH=ES;8[)A-)*E(51`2
M`2""5*31=0:I^LGQ&NEV;+:>)LK)`)'##[Z+A\&K:EI]E+;/C-6DUPX55JG&
MGM$PF\<;`98U'DW/((EKO%BOL,+1)MUL5;G)0C("NNX[PDU'91UX.ZZZXUJZ
MZMNKV$CE,N`W_"YK3OXA?4/H+]$.D-/Z!M8=>/\`KI+5SQC\S7.I0`\57-CE
MG;MW($>*A<I?V5G%RMT425MJWP(C<EJ,^C8HA)<4E50JBNFO6XOK[4.FX;J\
M`#'VC"*;R6>\3M[%X%T;18M"_4B>RM_Y5MY(&=P?_8I;PY[C#;"DI6ITA(6D
M-J(2-U/K`;35/P.N6$`W3ANJ5Z>E_F8NX>I*IEYM4B]K"JI6\R4&BNHW#PI4
M:94."LZ)[HVB0MDCKM0L=E>*@?HUDJ+U"!TSFENX'UHJ^33\/^>_TVL44?X*
M1#Y-/P_Y[_3:*(\%(A\FGX?\]_IM%$>"D0^33\/^>_TVBB/!2(?)I^'_`#W^
MFT41X*1=42"CUD;NGJ$H1Y20I0\*U-#U\=9V*6MXC%!;-.WQ#O6Q*"R1B[?L
MACFB/G<;D)8#BDM>H'(KS#9JX4A(4ZV1UI^332])Y-6XT<WUI]<87MU_V/\`
MRIB<$#BK+/"15GYAM+2@I-%*;26W*=:^539'TTU?-;_W*T_[?WKD.@_[=>?]
MS[D:24*3:9C9'G!42FH)HHE0[$@U!TC+]0I:?_;VKFLK:G;<_*=%-\YQQDDC
MS-K94VE7E/EJ5>/76K=OD2+/]N?WM_Z@NF0PZG'KFTI-%K;82D$IH2J6T1UK
MMZ@:9V7\Z._VJQWW^P?\/L2WQ])1Q'CJUE*$W"]/+AE2DI]9,F\34,$`FJ?4
M4D]Z4\=,KP__`.QWG\(_Z&)[H7_MG3>Y_P#_`-9$I<B:<*XE$U]--%=1T+@7
MM\>M?25^345IY'A)F[R\'T_M5HUZ,RR1,;MRI.?+%?58H1V[_P#I5:4HH'P4
MB^?)I^'_`#W^FT41X*1#Y-/P_P">_P!-HHCP4B'R:?A_SW^FT41X*1#Y-/P_
MY[_3:*(\%(MS$5274*0FM#576E$_'S*Z]?AK("?V$#H9'%V]OM2AFK2Y`N12
M:@*MB3T(ZBH(Z@=M&]2FY%4Z4Y\]`2I#@1ZC6Y10J@`(-2:=NFM[C_:W?Q*.
MG_W/R#U*+G+S29-Z;FM>947&[@N-^:%R57!U"$>:E-Q/<]-=/Z0-Y^2<JS-'
MO;CY&@A>9_U:L=/N]0$FH?!&_#O<:%3HXI]K.!9'PE:,@A1%.YWE^*MRK??9
MJB8%EDR2LE+<<*#I*NY.TBNO)^M_J+U%I?6MQ+'\-K(0?(1AM[%[0Z&_07IG
M6_TE@8\G/=1APQPQ#CP5:^<6AW&<JR?&8:!+>QV^O6-5W6XVRBX(C$)=JEU:
M2UZ3IIUH#X5U[.Z7UIVL:+974E0PY33A4`^U?/+K/1;CI[5)-*8"9+=Q]!/W
M+KQ[#LIR%I#EJQF^W4.)2I+UMM4V;&-5O-"DF.TMCJXPH?6\/AIIU+UKH.A7
M=PR\>,SLM/(%.Z#^FW5G5>D?F=C"[E.(QIWH]RCCC.<:M42;D^*WJQ6R0\N)
M"E7.&N*W(>0RJ0IM/JT50(J02`#2E:ZANE>L.FNH;AS;9P,K<:;]N!\ZE.LN
MC>K^E^GX6W4;A&7`&H[17?P37JM:4BI!`_#_`"'73?'+FO@U@MEQAI3;$GT0
ML[BC:I6XTINK0@=-)22\XYN"9W%F_,*<$6*AJVJ625O;5*KU&]=":]:`5.M!
M0$'@4@VQYCA'*#RG&A[CM]"7>$S;;:)5PC7'I;+@67Y+J@LAI3"0JNU*2M5'
M0!0#Q^&H36+<W33EQ*O'0VHZ+TU=S.97`'CV=BT7;(T97<7Y#39;82KY1-*T
M(9)"5?'JVH:-!M'6=FZ)VTR$^@*-N^I(.IM8?>6^#&GE^5M3_P"))R5',IP-
MJ!_5J]-%014(\HH>E.@U-J'U32WNO8IJ8!X1A'M31;\_E+0"AW/7H.X)ZT&A
M*^"**);;CLDI;05;4(3TH.P^FFE6W'*;E3&XLW\WW1A0+G7!;2H)75*E=@=Q
MZ]_#IK+KKF-R<4TELW\LYA@A\@W\0/I)('XR:`:03#P8X+B4P2XM#-'$IIU2
MI-.PK0DT/4Z>Q?3";O9RW%G!<;R"IM0%`32FY014^`!40"H^`[DZ4$#;DB)V
MPFOFQ2,DKHF%T>+MGGP283"!?5(=2I"F7`V$J2H+!7Y@%)^LBM.E1UU-/%K)
M;>#S"M**!;:WC+CQ64TK5*JW0Q%9G(4.EP<^<E]*E].T!F&*`D%A2`JO8_'4
M3(YEK"(#3\,4"N6@MD@CNK_]^6I]`"[!:IKJ_13&=>(:=?7\NGY@--,K#;KC
MQ8WAE"%J`)50#4"[5X[.7FN.TY?.G'3^F:EU`^=I8[E,:Z2M/D_M7/\`)-]P
M0H5[IJ0:?!0)!ZZEP<\7B_W2F$UF^Z$A;_Z6""8*5;J(4=M>E%)*J5^HE1!6
M33I2M=(^-[4Q9I4DC!)3!PKYUN;LLR60F)$><(HIX!)26VNV]P+(VH"B!4]*
MG6DER)0&DC:E6=.ZA='+9_$W$]VSUT1DNUP+:H"5+;=7M"U0&2'@*UZ^NSO9
M2LTZI*JIIU&D0:C[U*VV@Z=;8:L[%%L^:]+0;>RU]GVU`W):A4#,D^*)25D+
M.X]54'?4BQH`&\T3C4(V31<N'Z8&'=N]"*$VX&H2*_YWP_@TM'*V(DNWJH1Z
M7)#*Y]#BNQJ`$H`((/7\U7Q^A5-+>,CXA+^#DX%9_)(^C\BO]-K/C(_M52?@
MSPW):""FO5``\3WIJO4_O?;SJZ_E@X^A8N6Y"J;0#2M?+^"G?2T4@CKC6O:L
MC36T(-,>Q:?LH'P\:]A_+I;Q(X#SJ,GZ>,KLXDI3^[^U`6I%?,DJ'P!V]?`U
M'73>HXA9\)<?.?-^U&L-<V""(SB@VH@K8>_7,+(%`5MFE33IW[:8W5<P+3N3
M^SSVK7-D]XDUX?>MZF(%S6HOP(\*5U*Y"%^G&6[W]7TM@##.[J0"J@TV#GL%
M:UHGS)&W#Q`6T#R&UX9L*^1<[EF=C%+Q0'(R%)]67'HY&+;I#1]-=05K!<J$
MT%0-'Y@[Y?3^Q1]U8-M[X6;?>:33-2GH_:I8\?X?9[GQ/&LUXA1KBW'DW+,H
M8;*6Y"&F&UVX(=6`I2!(=935)^K3QKKE?46MSQ=7M?"2Q@@CC))-*YG.[*T!
M\J],=(]-:9!^GD]@]K9[R2Y?('$`$`LC:&TQWMK7MV**5RQB?9''+?=H2H4Q
MI*2615UL,O\`6&0Z0C>M;5-Z:>0].NNJ:;J,=V898IN8UKA4=WE*\_ZIT]<Z
M7/-S&D-(-!1%UBBQ8ES?,ZT1KO"?8#4J)(WMNEOU`0Y$?1O+#Z2.^U0(Z4UG
M7A-="EO,8NX5]H4;TFV'3M0>;N`3M>=YRTP[BC^?A\1UIZ9BCTB[QV1ZLFU/
MK;^UK:VKJ4L(4EKY^#%\2V-Z1W3J)TG5;C2H/`W?XS^8XAY)&#B*`C'9WXJ;
MZAZ.;?7;K^R/*B<P>X&UQWXU&WN2,1;T/J]-9=2IIUAR0RZRIDAI+[2B`5'<
M`X!3J*@'5H9J8DC+FM',I@*_L5*AT&XAOXV2U$.;%U-F!W?M3A7+!W&5.W:U
MDN,RUF2Y$*-HA->FC8TVYN)>JK=UVI_!J,AZA>V86UU%0["[-M[:4]JNLO2<
M(MC<039W?+D'KJ4G4H2L5=:*%@E*DJJ%#::=J>(&G5W)').7Q2580/4%%P6)
M8SES>X\5PIV^3;M78_!;5):":$J4!2G;=T/Y-)PR,;('2/\`=H=WFWI[%919
MP0^IX4_:NJ5$>2ZXPTU418RGBL?G^9(":`&G3QJ=;B]]^A:!'QJEA:G-3)[O
M%;F;>8<MD24>HB2VEP;O+LW`&E#7</R:4==QBH9B.*59I-7<P'`X[/VKANMN
M+L@H0V/ES3<.X4!W33PKI:WU%L#^92IH1YUM>65N;7)=Q"6+,,#ACN.P[%T1
M(;?IIAAH,H[('U@D=`>E$]*FNHZ1T;[CG@T[/VIO9Z1IY-60AK?/[%QS;=L6
MTV$[@E02#VW!)`!`';M\=.Q=LHM9=.8)79#1E304V+7\A_K5?QG6#*V<90<I
M&/%-I;=]NYG*;S"]^4[J`@FN^NS9VHP@6TONA@M[$J0XH+%5?K0G]2UMZ#]<
ML4K7IIC)*Z(T>^@XJ2=8Y;MMJ1B[?39Y%-+V?0+A8\CN^338EVB6R-`<MCZX
M[+R&TSGR"$.(4A"G6$^*TD==<"_6:\M=0MFPPRM?(*>[4?N[:4)Q]J]<?_'7
MI^_T:\?//$0QQ)!(V@DD'$;U8@_E&/2(SZ7)+252H[["6[DRML.NK8=`^7]4
MO!3S1.ZG3\.O-VF6LYO6.@8Z'(\.)!KF%=G[M!OW]R];WU[975I>V6L,;)!-
M;Y65`]QU<2..&%,.]4Z<F8'8<:MT:Z6TW$29\RY+EL2YS0MS[@,B4IY*)"FF
MT!^E*5\NO:G1^NSWEFVTN)6MC#6T=B3LH:XX\5\[.O\`HS1M(NIG6WXH>YQI
MD#=I/::JYGCY83Q[ARE!(3$P^SH)Z%/IJL3+BECPH@=NX(\=>*>IG7$=_.&/
MS.ENB:TV4DV]M:>E?1SI/3[23I:+4M2_'?;V8`:?=K5E.VE,W`[%21;FR>3G
M'#]5W,;G)95_A&539K2%CX!7J5_%KW%I-_)<=`V+I!5PM@P_\+&KYC:C:5_5
M6]N6>Y`+HN:S:!G>["N&RG!2RBQ7&([8+R0VA3B$DL@E6QU::GS]*D:YR;G_
M`%+CE[=J]`3:<!%%>YS6@PI[:^Q"(*BZ'X%I7X=O6GX]:J4/%=<-D2F0[M'4
MD4)/2G3N*5KI)\F3=5:.--U5U?(#]`?E/\NM.?\`W?MYEKF'!#Y`?H#\I_ET
M<_\`N_;S(S#@A\@/T!^4_P`NCG_W?MYD9AP0^0'Z`_*?Y='/_N_;S(S#@A\@
M/T!^4_RZ.?\`W?MYD9AP6346DA@>C7TE^I6IHJOA7PI3Z=-WWI;)R@W=MKQ\
MB)'$MC<!]-Y=W[,/0N=+9FYDRW)CEU)LB6`AMPM52RZZKJ4I/50=I^+Z=;O.
M6U>\;3CY:A-?&.N=0<S)03MR;?AP&.S'9V)D<-C)C-7B(T/1CQ'GV$,$[B%1
MILEE3N_H:N@]J=*>.KIJLQD;;ZD1BUM,O[?+P7.M/MG6C[K31[P<XG-L]'DX
MHT1'6[\RL@J;D43MIT06P$UK^=4BOAK#9.>.;2F85HE?#\ZU$3C2A(\QHN*V
M,K79&H[9(4I2B%`5(]-6\C;XU"::V&"QX++:N@#J@T-:<"#Q[%W9`A1Q!3S*
MMKXD1`I(%20T[ZFTFOY^VE?#3>!G)N0_:-JWUO4'6NA1@,S<QV7;2E<*[$KX
M#3=FQ7C!XPU,)E-V^8\METK4\M"GY0"VG4.-H!+VVH`Z)KXZAYKHW%_?O(^(
MT[O=:.S@K'!"[2M%TZW'OY6G'9\3WNV8\:)?7.&M3\;<GH[#CR*'PJEX;>]?
M]6[_`$:A=-N,UO*2-C@-O;W=BNE]$7MBNSLR[.\<5P_(#]`?E/\`+IUS_P"[
M]O,F&8<$/D!^@/RG^71S_P"[]O,C,."'R`_0'Y3_`"Z.?_=^WF1F'!#Y`?H#
M\I_ET<_^[]O,C,."'R`_0'Y3_+HY_P#=^WF1F'!8KA!*2>B*=:BIKT/3J=;L
MDSFE*):%HD)&R@JBV1Y+=.'?UI4)L^&W:3U\:UTIV]B;33&+"E5W.[U)!=4E
MP(2#3TPDD(Z@5!-#Y>^D;F;+%X:F+M]?+L_:LR6V?4&NKM:#L[`HG\OM>E>8
M3#2-Q5:5LCP]1<J0Y*;21UI13>WZ>_T:ZET:966AE;)E;;QN=EI\=6$#&N&4
MBN_:O.OZEZ='J&I'37UK-(VC_EROJ<-^;9M%%;[[>G&T\+<9LMT(C8U`CK(-
M*/,%;;R>@--JP13Z->&.I6W+=;U>X>\O=)<.<,/AQ.&TU7TG_3.XAB_3K38F
MLRMLX6MV_4H#B<,/2JL[KAL3+.;N2K9,*DPAE^32'3&DQD/DM3&V&VR=SGI%
M:U`]$K/AT[Z]G:#KT>G_`*?6$\`;X@QL!!K0'**G"E?0O`75^AV.N?JOJ\#R
M66X!H<H=O=V@*R3@]VRX_P`58K:FY)A*@,W*.RU+`=?\EVFI*_F8Z(Q>W$#Z
MP-/`Z\J_J#>WESKMS,&\ULY!J"12@`V>]Z"%[C_3&WZ?TC]-[.VM8V/GC#@Z
MH`+L33C3TIH?=BU(RC"+?]E(=N0LEV<GWN2RP](;BQGXJHC)"')2JNK4H42E
M(IJZ_HS=VVBWQDO0")&AK074-:FIV;JA<R_7S29>I>G6?E[!&]N-`*UWTW4K
MW*M*;:GHR`B5%<CO.$*:86DAS8/K%X426ECX=:Z]8"^$CJ0N#F\?M5>`M1TF
MXTZ(![*WAVQTI3R[?0B*1`JI/ZK\WQ)^.I&"XR,]_$E,Y;!CFL=F]\MQ%-AK
MLV\.Y:1;R2`&JDD4%3U/PTL;MA%%K'I[.8W,:MS"HIMQV+>JUL);/KH)W':6
MP2GP)^L._;X:U%Q&W;BGC-/TZR>^1UN)`X<:4]!7RW6J/&<4F,SM0I9</4J\
MZJ5\/@!K<W<7[H`'>JYIVB00W[G6HY<;G9BVF\[]W#@C:3`:D.,ICHVKW!*J
M"IW]B32G4JTF^]:R,O(J0*\%;+BW9+=Q6KA0/<&YN';3]J+W;;);<2@D@;Z$
M[?K#X$5UM:WL4X_%_#/G^Y1-]";2Y\.QF<<=GWK%V"VS(*U?6V(JG;3K3XGO
MK2Y<.:0'4&"Q+I^8"4&AILI[5SS8L=MQ#CJJ(`).U&XU((2D#<*[ED#2`FY7
MXF;-3=L4+-'+4Q!A(/VX+HBX5=;ZRA+K*;?%<5ZBEU]1:VD=0"#Z6S>/I--'
MYH!B6CS_`+%-V/2KKB,37+S%'QRU]H1%=[4S`NLIJ$T&HK08;0T%^HD*2PUZ
MJ_5(`/J.`J/3I7Z-/8M3#+8.>`9,>S>:<=RHNLV,<.N3:?9O,K&%M'4I6K03
M@"=A--NY&%MP]5VC";+/V?9VG`J1-EM;1,"#52+&TI27)[[5*[R$-?HJ4>FH
MN;JAT;BR.(9ME<^ST*<TWHR_F<V>Z!;:4))IV8<-I[5GDEOMC+;5L@VPLI0E
M+PFOO%R=+0JA9=F(],!#FT&B=RJ#QTII@N+NX\0^<MKNI7VCU*1U*W@M(/#L
M@#C3;6GHH460K>Z^666HCKLMQ]EB*PP@NK?4XM*&B1TV%2U`4U-7KK:LADG`
M#0:DC@*\4WTW3)'V[([6,RR2TJWY<=E:&OF"F5QK@:,=PN:N3:46S(,DLMYQ
MV<FZA*G%N/2I=Q=D(*JI9<<C1TT2#T^.N%=1ZR^ZU".VA<'V\<XD!:=H`RT-
M-HJ25Z<Z7Z6LM`Z-FN)XFB\FCY>(H1G!)/DH.%>*AQ`LX=:9:AQ]C1+P:]99
M`64ON(<JHCH`X"!\1UUW2WN?_P`$!^_E"\PPZ2VSO;G3R<[97&CZ4RU[*FNS
MB$=*@Q(02B<VU<G$`),<$L-LJ3T+1=05J>2D]*^4GZ-0T9>Z,&M"0$NW31:M
M%M0.Y?NUI2M,*TW5[US/3;BM)8BO*A0J>6''V;!X44Z4^JXBA[$TTZMF_B%S
M\2!A5:3,N;=M;5W+>30D#:.&[>B4VS<2HH;2HFJO3;"`HUJ5*&Y55'Q/CI]4
M<5"7.FR7AK<N+CW(?9?T?P#3@7``IAYU(Q:5E8`75``W=G>MC=N2@G<*5IX?
MR$:3EE$@`V4[5M+I(D`#2!3LJLS!'@BH^-:?W3I"G]Y(?DI^?_E_:OGR(_P8
MUFG][[>=.?RP<?0EV[:@6U`!->G8J/YPU`>,E^U%=?"'AZ%RIM2TUV]*]^BO
MY-'BY4&S.\>A9B&A-$+2"H4!/7Q[?#P.CQ<J!9UPHM[MJ444;VI42""#X>--
MQIH\7+Q3O\GC[%S"UNH^NL$GM3:?XJZ6BE=*"7;E'7VF,C>T`5J%@JU!7UNO
M>HIT->X([$'6[C[IV;$Q\&V,<P--6X[#NQ6;<+T*&JBV"DAH*7Z06DA2%>E7
MT_*1\-,,5B"U-S,+APQ!X)<X=EUXQ1]XVY8EQ)49V#<;7,H8QMKSZ9+WR:R/
M53*<?34@*"104I4ZJVO:#'K4K6T`E:`0=F(K0_VKI&B=3R:0P!U3#793;L3G
MW48[R!9I]P"Q&?@R6E*+Q`D-/N$39I40?.5(<].E"E)%$@:A+..\Z:G;;/)<
M'.I48@55PN8K'JRS?=-#6O:PFF`)PX;2F=_=PPLDDI7&3$+,E+3,9&];7RQ:
MW^NHJ*R%K52H)Z5U<K;4'7(&<KF$VAMM;W,UIV\$8+@!EUR6VD(=C7"/':6T
M"AY+TZI2MI:*+2E*1503Y2/K#6;K('5&-6U5IYL4;!"6U(`]*VW2QQ+P:71<
M>'=:EM%_AH48TT(/DCW&/4)<C$I`,QM+8;52H/C`NUF73G\UH>8V[J$]F&]-
M7Z5;:C_IV@->_?LIO7(W)NUH=;MM_2[#<KLCR&O2>M\N./J?+/I0H2PE/4O5
M2%5IM%-2CIF:I;&XB(#\<-]?MN48(#IESX>0%S.-#1=T_$H%\/KPY)1)<2E2
MGD)'F``"30`M]`/`:S97$D%L(IC[X)V]Y4Q==+1:G!X^&@#QL'$8;/(DQ]D&
MWW&)\Z/4!>0//N35*CMW=-O2I[Z=B3QM;=C@'4)V_**^Q4F31)K.\:\UI79W
MX)0.P6A!D3T!)6N2Y'6I/51CA0VMD5(":#O2OTZJ,?5<\NI?DI8\4=2I:0//
ML71)="MQH_B&AIDRUI7'8N)N.+O=4(*DEF/&);3V2@(:Z#<*$T(\3WU;N;X;
M\`FN7?Q59MK0F!I<*&GM*^7.V%I,4-@)#C>Y8H>JAV)KV(^C6?&`[*I#4+,&
MV_XA[5P1[6I;Z:IJKPZ*K0=:4'?1XRG%8L;+"H!\R^/6]2I!2:*2EVB>A[;O
MHUGQG>LRV+.:XT-:E;Q;VV_,ML$=NQ[]_P"YK'C7M<W)6I-$W=%':O9(YI/O
MTV'@4X_%&`Q,\S>SXPY/5;&;FIQ[U&TA6U5N'K%1*@JG17X#35=_4'69-&TD
MWK`20-W>/O72>@.E(>K>J8H"6@$@8D=JM,O;;MENF!6F--EHAHL>31)7R:BT
MB>+-8F/D9#\5L)CR%-OHWC<@@DT->VO)K)GWLDUP\`N=*'8XD%[\14X[#N\B
M]WZA;VO3$,%E:QG.R%K#E&W*T"N':%TSY<A[CRW7-284J6MNS'[39BQ5@N2Y
M[,66VMM;2O1E*:<*5D!-*]*'2#7L9J3F,+PT5-"3Y*=BDW,LSIT=S>MJ9'4W
MU&%<1N21S'B3`(<>-=%8XQ.:;FQ8GV3)D-2827[I.-M2ZF/<VYA!/J^;K3Z!
MJ8LNK=3LV&'F.R[B!CL!V@CT*M7G0G2NM/SRQ@D[CV]Z6CK\^SVNY6FUK;85
M;+.[%%FG[$I98^45;X*8+[82EQL*6A-=Q"4ZKLD;;YK)G"KS)M\M<59K.>2R
MT&>S%0`TM`/`8!5/'#\@M.9VB[3K%<(<3[;DP%&:`F(93,A3CJ(2T@*4RVX_
M7<HG=NZ'IKUGT_J%H_I&*Q$L?B(HJEN89@'-`!([<IIOP7@+J/2;FWZS-V(9
M<DDI][(ZF#N-.WBI$*B31#0S(E6])#[ZBTK>IQ*5R7%I22V:'R*%-5#;.2/A
M(VKL%Q_MD0[`L$H0@W0(3M%!TZ^';O73A!1OC<<O02=P&U=.M/&I\=-;AS6D
M5X*1LH!,UQ.XA*'Y$_II_@TWYC.*>^"8A\B?TT_P:.8SBCP3$/D3^FG^#1S&
M<4>"8A\B?TT_P:.8SBCP3$/D3^FG^#1S&<4>"8OJ8*@K>E:0>U>G8:92N:;D
M$<`M9+(<LT"(D,OQ\RM#B7TME:9[+JB$`%I!CEM"BI-$[=YIX]=/IG--@\[<
M/:HFVM&-U2('`9M_<4SEMA)C9!EK"=OH?,79:&T]4A:9CS@4#]8]55[ZMUZX
MOT>W.TEH]BIL5LS\VN!4;3[5NB**?2;3T066UE/3ZZT!2S7J:J6=*6].2T=B
MCGLR/<T?,?6N*,A,=J"EH>FE2W=PZD$%*Z_6J>HTLE8&9Y0T["#ZBL\C;"+&
MJ/&/I^H\I1VFHW(8>4@]2KLNFM1BZHH:!(=3VC7:-;MPS<P8;]VY..[#<,'!
MX;;R=T2QPW`E)0OTW$Q$T.PA8!":"E-5:(CQ%ZXBC<Y]BOE]9@Z?8-&)#!7S
ME.')BN./J"W$J]*+;4-]$^5"X2'%@4`J"Z2>OCJ"T]X8QX=A5WJ5SN;2/P<8
MW4"T?(G]-/\`!I_S&<5&>#C0^1/Z:?X-',9Q6?!,0^1/Z:?X-',9Q1X)B'R)
M_33_``:.8SBCP3$/D3^FG^#1S&<4>"8M+\-*6EE=%^4T`\#3OY?HTI%(W/2H
M2<MN(F%S0D<ZW%7`D^J\I!^T(WE0`KRA70CRDG3NI!_NT59O!4$C%="V'CO2
M94`HV.42G>'B`E933<=N[H*Z:753*W#&OL3\_P`\SAD'J"8'-\4N>19%`8ML
M*7<)[%O;N#?RJ=U/D%*44.>4I)<2X0!^'70-'U.VT_39C-(QF9F7$@8D$`;>
M*XKU/83W?4S3'&]X:X'!KC^]V!6+<1/7JS\88I&F)8L"(CRX:[<PE<Z^?.7!
MYV;%CR(;@(0T[&>2X"#T0H$TUY'U)C+C5+\.Q)>XUW4#J5KLJO<O1[I;?H2.
M*CL^4>[0YMAW;5M@\4X->LGN(G8L+>[;D,7]B7$GQV95U?R)#DAU<M^&S191
M+AK<4%N#J:#I0:E9.KM3MM-?:0O/+:*$%I+0&XU;4X$U`P&ZI32+]/\`I:;7
M9=3DC_'F;CQQ!2_Q>TLP)616B+%C,6RPIL7V6@1PIJ"FY,N2IYFORE/./*?D
MJ4NHH`*_BB;B\YEM97$H<Z2Y;(7<?=(`IPVJ6Z<TNWGN;S2[,.C@M'L&(H#G
M#COV[-R2MKG2YF1XNR]<+I(,^-F;ETC*,MG')PM:@;<8T5F.F,XTPW]3P4:U
MKIS=6[K2%]RS*&M+:4(+A6@-:FH*4L6PWVK_`)3<`F(&AK\)[MRA)[I>,XN%
MYA'OD6YKG-Y@]=)CD(MMMMV[Y9YD,,,I;2G:AM*R/XZZ]"_H_KTNNV9CE#J0
MA@!)K6K:KRQ_\B.B+/H[7#K<&4PRN-&C&F/`=ZBE(B>HI)0`*`UJ/&NNM7%Q
MRY2S'!>;?R]A`N3LF&8#AN\FQ;46X)#:J`*HE0/]]T-0/'KI#QG>MX[)G,;3
MYAZUC*MI<`4H54I70T(W4!'0"E=8\978M[VRVU!\R^6^W*$Q+=*(H"4BO4DD
M$DGJ#0?'0;RF!4;8V?\`JAABC9ZWLP&X$IL(2XIV:N11145^F\H-U"E&A`[=
MM)RWF:-P!W)[J=OR9F3`$EI!\JRC0&[DZXZ^^6VD,/O)2A*2=R6R4UZ5Z'K]
M.JIUMK-UI#[06P>0]PKE!.T[Z*QV.AP7UOXB4#F=I1!(@MS'8"(ZO4<=2E+S
MA!"UE)H04CH*`>`&KBZ].5CI,'&)A\[05"76GM;=&`#``(]CX?Z5)-SJMEY:
M/0*DD?+E"@K=1-*UI3S5[Z;RWH+"&'WE*6?3$,SFOD%&[R<-G:<%WW&<ZF:;
M;;$RICBV`$N-)3\M'6V*-M2MJ*I9D;C50IMV]QJ/\9(W:<:[TSOKMEQ+^26[
M'<,U#3AM&"X8N*08*S)F.Q[W<E'U9%O:+AL]N>5Y]CL@*#LUT)(I&2JJN^ZA
MII`ZA.Z4PG,&\1V\/O6UOT]HVF,%M<,S:DW%SL3B?>&/<0NJ:P_-=WSE?,.$
M)E!)2E#;4)X[8\2.PTE#4=EA1J$(2D)IVU)PQ,Y0RBGVWDXD]I3F2.[Y98`/
M!^2O8B:\6:&VS%#2#^JC/)8C5<<+C[\AI2G5O+*GE>GX`J(2.P`TZ9?>$^$T
M*CI-%;=[D[N+X]8,4@W:^71M#4JWL0]S;9*GF=H0B7\J%J55UWUPI)`-"*BF
MJCJ]]=SS.DB),4KCQ[MV["BO'373MET_$W5+DL.89LM14=E*U"3>5\A7&\,)
ML45M4&R,RA/@E]]UVZ2EHCKB&2[(4M:T`QG2E2=P!K6E=2.D],1R4U.6G-I3
M;3`X[.]->I^N?&Q'3[9I$.8'`<*A-8_$4MIN,T?3CH0$!M/EH`2>BQYZT/>N
MK:+DLC\.-@"YH;,.E\13WEQ)M>R@2H=.@J5*/3XE1))Z:>14Y;>Y8=:E[BZF
MTU7QRVR%[`TX`=XW4`/2AZ=1\=8EE,3:MVU6\6G-E)#AA1&(M!11*@A2B*]S
M7K]`.D/%R\4O^3QKF,1!)0$@*Z@'KT.CQ<B:FRH:`;%J-K4KH2#3Z#_<&@7D
MNY8\&>"ZVK2`VD$)KU[[AXG1XN5'@SP]"V?92?[S_1*_ET>,E1X3L2S,-"15
M"1N';^[\/#47XZ/M5\\$>'H6/R[H[)'XB/Y=9\;&FES8N]V@._V+C=B!2U;D
MG<:5Z5ZT`[]M8\;$FPL9*["NZ3;$F+&6!4,@-KJ.Q4`!0>/71XZ-2G@CP]"^
ML6DA))0GJ:BGPI^`Z/&QH\$>'H7*JV;G':)`],J)J*?5%>GQZ#1XV-:/LCD-
M!N*YOE$_HG_0G1XV)1O@I.U#Y1/Z)_T)TC)*V8YF[*41X&3@5UL4831IOT$;
MFU/-IZB4E#B5J2L@=/4II&3X#W)U96SH+R*<C!CP?,G!G/MW1"IL=A#3TJ3(
ME3.H!*E[$,TK]:K8Z_`ZC(V<MH8/@``'D5KG?XO!NU$S#*0^I]25CY9T2%':
M3YC$<B':.YJTX=+B8-;D.Q,A8/;L1BW"8?C[EM!UMM*$LL+.Q]0\J/YS(/1Y
MK::A/AT^&LNN7.&0';]MBUDM'QL+SL"+9L9QN!>;>F.U*BPVXLF"AQ:4"#*D
M/&.5M@]_52Y0D=@G459_[@WC5+WO^WGN2-LE[?QR2HL;I<5*`AB.M)2E*`.G
M?H*FNK%J=LZ5[GC@/4%5M'U>:PN,I'X(.![\4Y,&VVW*7D3'GVU.2K>&WHBR
M$)MCL>K^R,3^W2YLVDIZ==5B,RZ;="[:#F;@/**>U7Z*RM-9<VX>1FI[$E7+
M#,CA$^,4FU.@K#06GU7D)6I`4MCZR-I20*^&IZ"^;J`I<DA0>J6CK`DVPK1:
M&H3-P4X8C8@%%5**3^TVBI!'A4III.1C(Y"R+&,'!145N^XC$T@]]V)P1G,C
M^L(+"@=Q:"P#V\H'<]O'2UG)RILYV4*V=9&FST(R@6P";%=_-8:>4L@@J"5-
ME(H*5/72%]>MJIJQLG`>M%TRTJBM1GFD@[TI<710[$U[?$#1%>'EMQPH$2V+
M^8[O7(]$6\VDJ3Y"N@^E6T_1\-+?F$L4<CX\2&>T)A>6$A#&BN+P/04^/MXB
MQ;3R;9+C<768L-J/=D./.K2E(+T!3*!UIV6H5^`ZZYKUYJ5YK'2DUM&"7TV=
MQ!73?T@TBQTWK&*YO"&C,-M.U6#W2>)%[L%WM]QM\J)9V+HAEEQGT_48N,=&
MT>H2=R5+34D=Q^'7`;73I.5DD:X%P;6AJ:C##A1>R=7U(C5XS#,WE4]W'=A3
M>HX<H\C3\$AVRP0F;=?(.1+=O]SE*:EV]J/<%7IF4PPPAO:6HR0RGR'\[KJ_
M:!TJ=<,\MR',=;LHT&AKNQQ../>N7_J!UKJF@7#&Z</$>)>UCZ8EK00ZII7"
MN'!2!=R-N^X?9;BY#5$?D7;'GI$5A#[U%O3XTY^0V@[Y#D;:E1*Z;0=4R:RE
MTO4)(&5>T!PKYP1A@#CL718KZ]ET[3[^&V_'<UIIOK1IX57%F&061^\,V9%R
MM[EPC8Q/6N$[(0V9")-PCN-LM%=`X7DME)`ZBNE-,TZ:*W=*6.#72888@9:$
MD;@"HK7NI(K;66:,]P$KA6E>.-$D.5V8LK#X[DJ"A42.+C<VR%!?R\A,GU(<
M':*D>@%DG]'=IQH%/S-[3\0<T=^W'RK3K,EN@.CK^[7SJ-<=2A%CO.MH:+K:
M72AM6]*?4\_0CO6M3].NWM-;=H[`O/;_`/;S_'[2MA96$3W:#8\!LZ]>_B/#
M22>%*/"XPD0I2"3OCOH0L#M5:5*%#X]!J`UGZD?\)]84_H_TY/XAZDKS`0#0
M[^FH6@4P@FWH4:#=\>O310(6?V8/B?RC10(0^S!\3^4:*!"Q5;DI%25?#H:Z
M*!"P^SDJ/U7"*'KM-/P5IK5OU`G%N3F2#O+26<FMK[["),5^X3(Z65*%'5".
MPG8X#]1((K4].FIUKLED:X$!534&9]=MV\9/84WTB$Y&S.[^FRAE,@S:L(6D
MI0D,)*2DCIXZMMA<M?IHKNH?-14"&R<-7N`-N/M0CVH-(;?<%&U-HI0@FM.O
M3OI6&02-S#B?6E8+)^0\,SO65H9AM2H3#1)^::4HA/YM-Q[*[=@=.&2<HEYV
M!I]12PLGU%=E1ZUQ7^$$18C/0!;X*^U0&@'%?CV@ZC-&O6$7'>?:F6KV;OS&
MW.^H]B<M=K:1>;)";I&=BV\.NOM]5.(Z@]1WJHTU%"0O@<^M:N-.S'8NB1LY
M<V3@!Z@G'3`2HK>VK"/E8K()%/.VKS"G>GT^.J]<UKC3:IQL?-AR#::+'Y%O
M^^_(=-*)/P+N"VBVI(K4TI7O]&L4"7:TL`8=RP^11_?Z*!90^11_?Z*!"`@(
M)`\W7XZ*!"URK>6H[[J>S<>25U4.B2RH=!X]=8H.8S^);NKX*X_[7_B":B&"
M+>#X+D0E#\!6JG\6KK)_*M_@5&L?]ND[S[48NI2N2%*2%MH]0K2KH#M2L@=?
MI&DFU\<W*:.R#V+1NY._P:ELW23($*+\PMYV))W`*(2Q#?D-^B\*AKR/]3]-
M/#7-.M*>+NC4[&^7WCM70?T^:YVJ/<-C0WUE.4G)L>M%YQQ-PN,6V+>OZ$M1
MILM*Y0,O&HL!G?W4&W9+9`/8)IJO0Z7<7&E/>UA+.6*4']YV'?3SKI1ZIAT[
M76L<ZF-,3W)=09\5649)(W+5&,.RLI=:;4M+ZHBI?S(C'_5DI]=/4>%3X:8S
M6,DFGQ"F+G.P.[817AL4W)>V7BY+N9S1*UN'IV*-EOY?O-^Y/O..*MEOBVB\
MW,6FY3)GS'K&-!C2V(BTH96D`?KC7=VKKH$_2CK;0;>[#7$QQ/<..)!-*\5P
MN#]2M7U/JRXTF)^6T9*&DFM-]$^$%E$)S%O6G8^O]VH%QMX=2J<%AMV$W&:*
M2HEN@4@U)-`GKJ@7L%X6OB@8\1R\1OW8"OI75;JX\"V&X;*P@N&;'=7'8>'[
M5&SW7_*Y#,Q5V%(C3#%:N1>6Q(8<0GYEQE;-%-N*W%24&OPUU?\`2EUWH5O(
MPM<T'*,00<&T."X[^OD>F:Y<V4UDYKCV$'Y5#8VM(<4T1YTH*SV(V@T)!\37
MPUVBVU*28.>_;F]B\KOT]T=W,QPV/%/\(7R%`1/="!3]4L!O<-O5)`'7X@Z6
MDO3RW=Q2L%E^.R@QS#=VHPDVDAJRO$)"61)2L[JD'U!V%*D:TL;UM:*6O;-U
M*(I1"<:NBW$I!;60H&OT_#\6G5Y)S90[@T#UJ`@LG^.&!I3[UA(M[0F-.O)W
MM^OO<3W*D[B2*4TU:[([.-H3N^LG>-B-,,P7Q,"9<G$)M3*8<5;Z8[[I<#:G
M`LD(2$D5("A72WC2,:I]X%Z4XQJT6^VP)OS2&5)>>6Y-*OYUU613T/KE*2GH
M?'4!=7%Q-J!8`>5E'[4Y;IT,<'B7G\6I]"2>398]<E;F%.,16P$.-!!H^$D)
M2HCZ30ZMFF:1#'EO,#*VI\XI[55=8Z@DEM9-,QY3Z#S$'V+=95K9LUVD17%Q
MI$Q^U0W9:`2X(4A4D2H6T=2B8``KP&W5;U$`ZB:[*[/+M\BL6AU%@!NR^Q*1
M$)AI"6VV_2;;3M0V!4(2GH`/Q#4JRZ,;0RNQ9?:.D<7C847+90M:9#*5E()%
M5)*?K4`Z'KXZ4%\6FIHM#8/<*%&,2*$J<=E1VW&C$F)0HK3O2^XSM:3M[[5'
MN?#3*X!N_AWE.X'>$P=@B&^W%VXRWO4;"$@-(2A/4)V1VFJ`CP&W3^TB$%NR
M(?NCVDJL:C;NN;Z6<#!SJ^@),_*)_1/^A.G4<C879W;*)GX*3M0^41^B?]"=
M+>.B1X&3@5T*M)0VAPI04K2%BA!4`14;A7H::/'1J1CLG9&U&X;ET1;05!2]
MB=NVO@#W^'4Z/'1K?P1X>A;F+8DR00GIVZ?$5_'H\=&LBR-=GH1:N$DNK2$F
MOJ+'U?@H^/;1XZ)1;K*3,<#M*W-05MDD)`K3O3P_'H\;&G%M8NJ:U70(:%"J
MTC=X]OQ?'PT>.C[4\\$>'H7)]FG]#Q^C^71XV)1G@9/2E]\BO_!#^#^34%[O
M%7OPS4/DEC_4A_D_`-8HWBFMS:@Y:=OL7&[$4'%?JT]*>/T#10)L+7$(P$9Q
MV&6RT!^L0:@#NGKXUUGW>*D_#,[5T-1'%)IZ0%#\?HT8<4>':L'K8IP5"-A`
M-=M#NZ=:U'CK5Q`:2#C1:OMVY#MV%<B+05F@9<5T/[-(40:@`J^"!XG3)MUC
M[]`FL.G<[83YEIDVIZ-U6VA2:5W)-0!UZ*^"A3KJ1M[J+ET!QJL7.F302!@%
M017%:$1-Y2`V*+I3\!_%\-*.N'.&6@HD39DMH30HSCQEQU[C7;0`))HFM:_E
MTE5+6['P'#WN]*2(EEUEU19;'K?JU`=0`CI4?2:ZBKR1S9J`[@K)9VS;N`3/
M]TU(H.Q:';<M2T%DK#:#YJ`=0`*#IT[ZTMI7&9H=LJE+C2HWPN;F=B.`XHKG
M0UHMU^EFH<=-I82W0;/Z4MPFOUJ@M4_'I[&P0WC)&FNTX]E/O4)>V7^G,()R
M\4GK=BZWD)0M"O(5C=M350"U$5KXZDY];.8QEC=V\\%"_P!/LGLFP@D$$^\`
M*[3Y%TJL,F"XB9;TN-.L+2H-)*MBP3M6%=*T*5'49)>"0U:QKG<-R<6UA/H\
M!>V1[FCC3?AN1U9E-MNI:N!V-MP7(Z&^Z5+"EJ"O-V)4O4?*VZD-6#)W*6M9
MH;BG/HB2/$],H0%*0I3A2JE.RG54_%M(T[AGDCB$;Q5X&)XI%[(C<.9&*1@X
M>9'<Z$M;S`V;?1&P$$5()\?AT&E/%D;0`G#K&,19P35=2(KL<A2$E>]DH->E
M`2>HIII-RYL7.(*4A<810-JM1B.J;"'`5("=M2/JI(I4>'ETC:-O)9'1N`$#
M31KMY&ZO:5M&))I3F:`VJV2;>E$-E;=7"'TU2H`"FQ?7IIU%<OM[A\(`<"P@
MUX5'!.[BSB@C9-4N<'#`@<"LVX%Y>93,B17?0C1YOG9*P"Z/EVU(*T]1Y7:Z
MCI9-+CMWVMRZC7''LJF\=EJLM\+ZQS->W8!L\Z^N6N[P@FL6Z-*0VTZW("2V
MO:ZZJ,T[ZJ$I<2I;J2*A0.HZ$Z3%0,#7`8#N3J[NNJ+B[%PZ>Z:YFX!I&&&T
MX[EE(AW5&QJZ1'W0I*#_`#M^6[6,E6]M"?6==VA+GFJ*$ZE;>YAFS,M&L:XM
MQIA@4U?)K9FDGN[BYK(T`9FL-*'-45W[NY.-9N6,_L89:BW1,N'';2Q'BRHS
M7ILL)%/02MH(?4D`4J5U'AJMW/1MG=2.EFH7/-3W\>]7;3_U"ZFT_D`7$DC(
M```X-H:4VT'9N6Y[-&;_`)Q8,IO\"-&3;&V8LA$,N;7VV'1(0XM2SOKZR4U'
M:E=(7_3,-G9.@LI'O<:D$@8$[L-P3^[ZD.O=6P]07M(7-I[C22TX;R<5(CD7
M+K!>L+=3:)#;C-UD+!:0H*5%>F)92\I(J:U]$4!Z=]<_T3IZ\L]0D==Y@*`@
MTVT)^]=FZLZATO4M%8+"0/ED:<[?DH!2G&M36O!1^MJ9$F"Q&$22M;`4QZC9
M:VJ2RXMM"B%&HJE()UT/Q4K8\N44`7(+*WCNV&UF<6,!)J/VH^^3?]-3)4R4
MD5JA=5].O05(TA;7LDQH]H'=5.W0,_=)(2FP>(&T71M2E;W)+*DB@ZA+2P?X
M3IKK36YHW--1E->S$*?T.W:Z*7.2#F%/,4XOH!`V$>9(H:T_DU69;@Q[`"%,
MFUX'!8+92H4I3KWZ?R:T\4[@$>&'$K7\J/TC^0:/%'@$>&'$H?*C](_D&CQ1
MX!'AAQ*S1'2@DFJJCQI_EZ/%.X!'AAQ*),B=?B1&5QWE-!UPH4`E)":$>8'H
M:]?X-+0R&1]=A3#4+F33(VS1M#RXTH?V=Z;>8'G)ED4XG=6ZN.>H:5_G`2A1
M^'394?AU8'1A]F]KB0"VB@I7.=J]E=$8NE&&[$.2>G)2UFEP53U-ZG6R%=``
MXTD$BGB-3-K`]FFAT9J2%7KYK-.ZK-@RKVR@DD[1\6P;-RUNCU$^EU2ELE`(
M[T35-2.U3K-E<74</O,92IWGBE;HMLXSRP74<=O>44V]D(;8>W*)=+@*?`=%
MGH:U.E+K4G,@=1HS??@MK(FZ9G>*8CUKBOR0XY":)(&Y:JCO5QUB*?HZ)?)_
M"-,[6'P=L^9A)+QL.ZJQK-LP:C;\*CV)S9'GR)+K?5UFUJ;V^%/54D*^-0.N
MHN*Z?'#R:`BIQ\JLDXRWSFC91O\`TA*_'')+LE]IZ2X\VR%`(4E("JCHI5.Q
M3X:C[R2D9DH*U4[9[NY+/TD?H_Q?R:B_%.X#TJ0QX+48PW;JGO6G2GX-'BG<
M`F[K?,XNKM6WTT_H_P`7\FCQ3N`]*U\,.)0]-/Z/\7\FCQ3N`]*/##B5\4T@
M@BE"017IT^G1XIW`)VW36%H)>ZI'`(INS09M<Y8)43'<10@`46-I/3Q%=+VS
MS/,`<*8II?PBTMG-:2X2C*:[M]1YDT[%H(MS80\G:'&OVE`JK"B1T'@K=JYQ
MS<V,1N%!EW*A.9X.%ULPYFN.T[5QR1Z#+[[Y4AM*7-ZF^J@%^0%%:`G<O2[6
M!MP)]X`%.ZBUDC$300=WL3C\*7J#;W,C3,=7'84TA^3,>4AM4%#[?R[;C25D
M;RL1C^75`ZRTN>>=L]M4NG<<PW"F(IWUW\%;.A=9M=/GNI;LAI#&9>W%U4WW
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M.-*;?,N"'&4X^^HIW5970T'@2#0GX'4E*Z`D<IU!1,Y+9M[,^X(RDG$#N646
M*AE+3B*AQ(2O:`D!2Q0T/CU(TB<K@6EQH5AFG-8X/!Q!JLEL//HB15)*4MN.
M)"P>I]8E9K7I4$:&".`CEN)/:G$MOSMHHM#,!2):T%.[TU%`4:5-.OY3ITV[
M>1B`HWP+(+@2U)=3[UPW""$.A:5**PLD((&TJZFA/>@UDSOD!8T#,43Q1RR-
MF>:!AK@N]3C$>UP8\>GS34U,IP"@*O32=K:B.NTK5I'P]SQ6'3Q#X<4FS:)=
MQ6E,CU/32A*`@$[:56:T/B=VG<-TVT9RI8VNE&\UKBFTMK->C,TN;&<*#L6*
M\24E!/G53\TH%._X/#3N#5GB4!M,O"O8H:?I2.;%[W@\0`C"VPDQ[9>634^F
MY;)5"`**8?<0$?YE0>-3WZ:9W,39KD3DT+CL]*F[*R;9P<AKBX`;30)3+@J<
M<6H;@GU%)Z;:40HHK^/;IA<2N$I`V8>H*<M=/8^!KBX@X\.*ZBRPRPH!I"@*
M?6`'C^32+7N><I*+NV%I`9V',X$"AV8FFY)IY#CZG4MDH34I.P]M2=O=OMR"
M&AU.*K5PU]QMP[D5*A%*BDHW$&A4KH3^'4D+MT@SD`5W)`61:T"I)63<!;CC
M;26AN=6&P:$I16OG6?!":=3K5\['MI(:-[$UN8;F')D8'9I&M\]<5V3+*Y#%
M5M[@EX-+<`'I*JD*WLJ'UD=:5^.FI?$<6$T[=JD=0TV2Q?&VA.?;7=W+8BS$
M!5%+<0L';N"0$A0Z4'T`]-;C+3:GC;5K6AIK4!=*8CD9NB6@NOEJJG;J>E`/
MAK/NK/AFKY'A.)5ZH:%2H]/#O_EZ/=XK/AFHI^447S^K34N*-/PDG6*!1CK3
MWCWE=7R2S_J0_P`GX1HH$O;6H!-4/D5_X(?P?R:S[O%._#-67R:_\"/CK%&\
M4W_+F<3YDK_D7/TOX/\`+U7?&?WO2%<?"P]GH0^17XG^Y_+K'C#\WI":W-FQ
MV7)V^Q8&V`DDBI/C7KH\:?F]*;BS(/9W+>Q;GC'4`%E0(41L-0!U42.]`/'M
MH\</F'G"E/!QTV8+<S"6A`4LE*5JHA1\J5GM1)/11K\-9%[F-&NJ>\+3P\`W
MA8.0I`6I.Y836FVAZ#Q&MQ=EKFB0D-)&TT6LEK&Z)V05.4[.Y*+#8T5K([>U
M<"#$E+7&=00-B@M)4$N`]D51]'6FF&N3OCMW&V/O4P(4ITSIT<\H$H%>"5>5
M\?Q(:5S+8AM<9TK^9C/)VLI25N'?%!^O*+8Z`5-`.FJ[IVM2/DY9-37$=JN^
ML=+`-$[8W&,,VY33:=]*)IY,".T6S%ZMI"5MC\\L@50I8[@[:5KJ_P`=TP6I
MSN`D+33&AKPQ7*;ZWABNN0'-SEU`*BIKNI6JX7T$^GY"05_#Z#]&F'BI-Y*3
M\'[V6GO<*8KH`,=^HJ&=B#Z/9(4?K*I\5:T,P<:O(S=ZD[:(P1\IX+75K0X'
M%&L><$.(3Z6UI;@"P1Y2%*'UNFL&1L8YA(`&^J>QL)<,P.3C3#SK1+80NV3=
MQ3LD71;:0JG:/M6T!7N&RX2/AK5M\'N!:\$TW$%-KZQ<T9LI`/9M[DI;5:MB
M6PK:I10E142#4E)56H_#II/?M;*0YPS=ZD=.TAO@V\QM'5.!%#M[5T.65:T%
M"`0HTH4@UZ$'IT.DVZH(CG;[Q&[^Q.W]/PW;>0_*UIWG#9CO17.P.[R;-,OE
MNMYFQ;>ZAN6XB.Z\XV7`H^H@MH5T:"#N/9)[Z3DZNMX9A!*]C9B*@$@'TGT;
M4QFZ'N&QF6UCDDB&TM:7#S@420$-+0;#B"MQ.TEU:3N4JI4"20.HK3\6K!;3
M.NX6W%,7BJIDFGW5O>/C,<F4.VY338.Q=S2'7Y#*255+B2HD?FU.ZM:4%-)W
MKG109R"!F"F+:!SZ,>T[."/7H*B\M*"5)!`0$=0!0=!0D'KJ'\9VIYX#@T^9
M=4G'GV(K,M:72T\A)*BA7II*A785TVA77M747H76T5_J=QI40#W6\SHSE-2"
MTTQI6APWJPC0KB.S9.V&2CF`UR.ILXTHBEZ*$,H41N:4LA/4*02`02D@4)&K
M@^:*.8W$CFM#FTQ(&W'V*`ELY9G\DM=[IKL/=[4<67([U:&%PH'R3D!2G'GH
MTB*9%5/!`=4H)!VM+#2?QC4#?Z'%J;R]DC*NX$?>IZPU`Z:,CHG%W\)^Y&TG
M.\EN""V[]DK82VVQ\NJ)Z>^.PZI]AE*E`>1MU14GX'3!FA00FC7MS`XX[]A.
MWL4K_5&JG!ENS)NPQINKCM64O+9-W98:N5GMCCL=R,L/E"5.*8:<"G8Y(4/U
M;K?E(\=:2:-<#^0E`>=OO84\_%!ULW0R:Q;M$0Q;0;]_'<C*+=\%EONBXXQ\
MFVZZMU!M8]%+;2OJ-I;!)24TZ_3I+\FUUK*"<$@;W>O%8\=H%?H>C]BY%8EC
M]Y*YEIO\>WJD[T1[+-2D*7ME20?UZU!,<_+I'57<`#Q&GHU&[LRUL\3WQ@8O
M&S8-VW$\$E!TM97T9>)HV/.(!<T'TE$#MEN5A=;B/-J:@..^HA387\H\XR:^
MH%]6U%&_H0?'3F/5K'5'EA+&NBXD`X]_<H1NEZCH=T8Y<[H)C0&AI1O;LWHV
M#Z(A5+91O0X15QHJ*"H@`U6@E`\W?3AL-N\>Z6E/=0N1:1A\)!=OH:K.WW-]
MNZ,A]#+<<H>2I06`G>ILI;%2:5*M1-U;FW%6@U3W2I_$.`?L[4OX2WHE9C4@
MM-A]I3Q2L!"$FHJXJM$@U[F@U!3RET9YXR@<</6K?7EO8RV]_,,<N-#NK1.T
MG:\AMXH_;);4E1'196FJ*'INW@5%.^JU,^)QRQN::<"#O5VL8&\G-/[KJ;'8
M;NU9AH%*EALE"5!"E`$I2H]DJ4!0*-.VM"YHP)`*=-MHG?#0]R^>FC]'6,\?
MS#SH\-'2NY??23WV=._;P^/;6PH=F*QR(#L(7STT?HC21GMVNRND8'<"X5\U
M5L+6,BH&"267I`B1=HH$NDJ^BI3U/P&I*S]X^[BJYU';1NM6`4-'?<D!)<JU
M;E[QN3+3L5N%00KI0ZLCG1^',3W-:XC>0/6JSJS&1QV]Q;^^Z,@^[C3`C&FQ
M05]_ON.S+V[67%8G#V`?VD<\\M7U.,\5XBI3B8LJ=&MTB7>;Y=HZ"@R;7:HZ
MVEK*G&FZ]"H]M4WJWK.3IC37.%<H!Q5GZ-Z"EZRZXA/+D+2RI(::#XM]%3-=
M/?+][E[:LS@YA[E.$K)D_%C^Z=EMBL>(V.`JSVE3*7I,BR7ZT2'7+<MA)J/F
M4/%([ZY!HWZX/N91#<$1QN>0"XY0<>)H"O1O4W_QT$&A.O;2.25P+JY&%U,3
M\H-%Z"^$>3L/YQXGP+ECC]Q5TP[,\=@WBWSW'$MOQ9!0^S<(TEBNYQUB0A2'
M.@*5I-0*'7H/3;O\TTSQC<0ZE*8@XC81@O(&HZ;-H^H.T]\;VT=O:01OV$=B
M<"=':<F6=/HI<WW!A*QM*BIE;B5T('7TU*;!_%JR/J+#'#W?8HG5FNEU"`Q`
MNH16F/#@G#0RC]XI;@0`G[-4CU`/+ZF\^7=VW?1WU6V.#SE807#ACO4]<1O?
MJ#\@)IEK0$T]P;4I,4BK$Z4I14X-I44@5%%"B5&E>AKT^.FM\6B(L)H^HPW^
M96;1872RYJ$Q`&II4`TWG8E\6TCNBGX13^YJ'HK*;>(;:+YL1^B-%"CP\1X+
MXE+:C1("CWHD@FGQH-8.&)P1X:+L6?I#_!G\A_DUC,WB%GPL?!:W(Y4A:4((
M44D)(!J#X$?370'-.`(JF;VEI.!#:I!Y.^\7?DV9"FV/3'K*2H!MU78H6?JD
M]:TK74EI[3SB2-RA-8+3"P`CX_8FFOMSD0)4*)&0P^R6)+CJMP5YR/U87M-!
MM_-KJXV>P>1<_OOC1:W=Y]V3\JMAMIHI`D!/="4T(4H=P-R1WT[JT';Z5BXQ
M8*8X#U(GE,7"Z3FH$,*<=<*D.]5[EMIIL!"*;TH-?B!K5QAIFDH:;%!FRN+I
M^6/,VFWM1XG!(EO;,B[Y'!MP<.U;;/IK>#E/*VLI57>1X4KI@[7;B"K+.*1^
M[W6N=Z@4Z;T?9S#/>7$4>_WWL;_U$(V^=P..W$"[%-N*Z/E<@.%B.I346(M+
M;T9=%**W-U/@2=:_EFM5JZX8.\CM_O*0%[H&P05\G[$0C(OE)2Y=GQJ#":G*
M$:,'2A3L18J1)`J2P`!W/QUO'I]X<)Y1(?[IK3OH3M63K(LSETBW;1_Q9@=H
MV4V=J,8N=90W)>G!B"DNK9="2&E*#L)"V8[E"-Q4WYBG_-?3K4Z2UPR.I0U&
MWCM&W>L2=4ZK#C/!&P$[\/-4K!W,LAFI<^:<B-,NMO-K$2,IA]7K@!Q)40/(
MY^</'4O::)$UP,A%`014[QLW[E$W^KMU%E.66D]A'L22B0#\P0R"E"@HE"/!
M!4"010]#74A<`VQ#8ZN81M[5$6UB(VN)(%37T(YBXY\XN(J.V2EEZ8J2&TE5
M4-@J0'=H-$BG2NH2_P!;M+*![KF>*,M83[[VMV#M(4I#HU[<MSV\,TC!O:QS
MAZ`0N!RW+2VI75*T30$G:0I"=KG8FM!K?1=1\6UCVN#HW_"0:@]QW^1-I;(0
M.Y<U62<'8'S&B+IS*V'P6PKS(2M2TBM5DJ!)(%*T&K2)&.KE(P-/+V]J@-5M
MGQW(`:ZA8#L/$HJ=96Z%%#86\*E!4*T7X$GP[Z'3"%IF&);BHPVTDPY5",V&
MPI0V?C[(9\"=?&;8AZ-!82Z\Z67%-K3OHH-N`;%+1W(!J!J+EZQL(Y6V\DK!
M*XD`9A7`5Q%<%;-&Z'NKI@E,4G)&-<AIYZ4]*.8EC3\NT^EJH6@*]39T!/4H
M"J4H@]-:3ZF)Y.9LJ!_:IF;I^"S?R&92`*UP.)V[%M=M)#:R$=:?`G6(;RL@
M`*97.EQM@<6@$]@[4CXUL`5D`4@+`MI7Z6PDK<;E,J2H(J25(%2.FGK[F2K:
M5^+V%0ILXV_$*+<J6$K4E+)`W$B@4!YC4GMXDUU@R!SL2,_"N*68P,8`WX/0
ML%-^J/3Z#=3N:5^C2T;7!V8@Y>*;7&2>,Q-(+S3`8G#L7$Y;U-JH@^FH]5A)
MH2?`J!Z]M.,S>(4:;3+\6"V1K<AV4E#BDE*HZ]Y4H4#A2H)4>H`6#VTW,TH<
M0VI:."5L[5DD^1YHRNU.)BN$.WK8HLM1[<&5,NR&T'YF>%$)H:>9QATI.XCQ
M'?5;UW6O"P-C:XF<O&%=V-:\%T*UZ5CO&1N9&7-#VG`5\O<MO)UA@VW[%MMM
M;2TPQ#0'(Z$E&U7S#H*BCZW:G4ZQH.I3S%[YG?$[#'=0(ZUT6U9-"(2TD-%:
M4--O!-]\H\#M2Z0!T2!\!T`'75E-S)7"M%3G64;7$4V(*AOT\ZU$5_.'2OY>
M^M#=/&TD>58\''P72Q$(1U7UJ?$#^"IUKXP\?2$>#8-WH7$;>C>2"G=N)Z*%
M:U/AK;Q,G:HUUBXN.!I7@L_D5^!_N_R:P;I[?B)"6M[)K">8*>3[U\^1<_2_
M@_R]8\9_>](3KPL/9Z$/D7/TOX/\O1XS^]Z0CPL/9Z$LODF_T/\`F1J$4IX%
MR'R3?Z'_`#(T(\"Y?##:%?+U'A05KX:R`"0#L1X!WE2%SS.\2XQQ&^9UGV20
M\0Q/'8+D^]7V>[Z3<6&T"7$L)H52):U`(0TD%2UD``Z::Y>6&E1E[R``%(Z-
MHVH:C=-LPTDDT5,%V^^WQ&'?9;N+^V_.LFX_A/J0<MG9/$CY'-MB7_37=HV,
M+B3&8&YO]8VVMY!4@@D#7-A^H^F6MZT9VT\G%=JC_0?5WVS)N4:2-S;_`+E:
ME[=/<GQ/[H^/6N1N*+VY-MS:VH]ZLES=8_>;&)[Q`1;L@C1U*;;DJ4JB5I_5
MKITIKI>G:[8=06H?&X%S17#CMXKEO571^H=+7;8)FEH<X#SFB?Z`RXW=8<E2
M3L;?0I0`)52O@*`?PZ?7=?`>11FFQFTU!I=L!2UY[YMP'V_<*9IS/R/.>@X9
MAML^U9PBOM,7"X366U-6NR02ZE:$R[I*?"$]14`]>E-<BFU)NEO?=.(%"=N(
M\R[C8>)U=[+"$%T):*CMQ7E'Y3^^DY[8OCSN%\><;X[9927+G:<?O&/7B[7=
MUJ2HR(2Y\Q$J(],=6RM/J>EMW*KM`U7+S]7(#=L`>/=>K"?T5LKNZB<ZS/BY
M'#*[+L<=_G5@WW>_WDA]W^4.\:<A\=,85RO&L$Z_Q[ECZ2QBM^M5J=CHEQXT
M&:Y]IL36TOATE06G:DBNKYH/7<6K$`.!!7-NL/TTFZ=O2YS2*%6[W.R/QW%J
M>CNH1U::6EM91(V+4VA3"DI*5(?4D[*TK3K35^\=:<OFRD9M_F5&N-!==R<Y
M@K)E`\R0.5\A<:8`]#@Y[GN&X7<ICC*(]IR3(;3;KHZ5K3L`A.2"]Y^E#3QZ
MZC7]0Z5)(+69S0QV!QW)G==+Z^Z%PAC<64'K'8E,Q=<>O]DB2K!>+7?XCMWE
ME,RQ3X=X@I66XWZER=;W9$5M\[AY2NO76?&6`=6S((IZ4^U31-1LX(/&M(-1
MY-B=6%!#26RIM50TVE2=E2A81M6A0H`%)/0TU'7#S),7G::>I3#[0.HYNS*W
MU!9R67H=%@H4H*1T025%)(W`#:.I2=%O((Y0\[DA-8G(:!/EB28D;B>YO^LB
M(U-B7E<HO[D%"F%)4*I;2XH[P:"@-5$:Y/U;>C^IX:[*CV+KW25D_P#IN;+@
M,I]JBQ*LS\EAJ2S&>#3Z$.LJ6DM%25`%).\`)!^GMKMNFW4QB9EE#6Y1A78N
M!ZS81F[E+I'AV<X"M/6B2.RZR\YZK90II7I/)44[TK7]3:@'>\A9'12`I/Q.
MK-G$\7+GD#F4KYE6(;1S+FL+WNEH<#V^5*2!$D+?0`VL%8JA*D+05=>R0I(K
MUU0=?ZAT[220YP!"O6DZ%J%X,`4Y+45V3:(=JE(6AQ^4MU*%CHAJ-*;C.H=[
ME+@4X*4!%->;[3JJXZ=UG4]8T[$7-W))4?WG$^U=M&F2?DEO:O!SL@:#Y`D+
M?[0BWQK?&#9(I(<!0-P(+X;``(J5DK'0#7?NA^IX^K=++KP_CM][S5'M7*M=
MT.;3V.O&#&OV]2@C[O\`WF<4^SVRV]S,(EVS'-[T_P"E8..<0$-^]R4^DMT3
M[[+;;?-FLM&5#>\1U2:).C6.MM,Z>=D<\`!.^F_T]ZFZLTMVJ6,;W-;P!X=R
MAY[>OOB.+N8<\MN#\@\63N)6LA5&CV/-$Y9#O5C^9FNH9B0;XE5JBF,WO<2E
M2FR22>^HW2>O]-U2>C7CWCV;U9]7_2S5])T]EU,QPDY;2=NT@$^E7%&$I*0I
M*"@J4X`DT)4A!2`ZDHW!33@4"DUZ@ZZ=#=6S8A+"07.&*Y#<6]QSW03@T8NB
M,PAM6YU*R?[U->@_"4Z5\>U)>#[%T.Q60A2ZE`!"E+2$A2$@A2EDD@!*$BJO
M@!K2QN67,+FS4ICM6-0MI;:9IMQ[^"-TWC9`0+A+C+AU"(2KA(9BL/)4:%R)
M)DN-Q7`N@Z;]W3MJ"+-"L[E[LS0Y_=NK]ZL<#]2N[9K+J)SHV;.RO]B/;;!9
MF-RK<&O3WH2Y'1Z:T-.[VPZ4LK4D!2C6OP(-02-*>.@8,UN?<'J63::>?=N(
M2'D<$1MPT-O,J^7#J@\T$M*2*J*W4H!'X%*K^+4H;D7UN9VG"E5!<CP$X@XE
M5+_>)?>2\E\`Y]:?;_[;\9M%WYDO5MM-RN=SNMJ=R069N[J*[78,>QF.M/S^
M73HR5.AQTA#+0H`H&HXEUSU>S3"('G]UWH*]`?IIT2_66OF:W#.T><*)UG^\
MY^\R]N>6X_R+[EL"<OW&MS=L\3*>/G<+LL2)#L3(].1>L:E6:0NX6O)8<=Q3
MRA)><;>6G8HH%2.0:=U_%)=!@=B7`><KT!??HW.^P=/D-&QEU<=P)]B]1>"9
M?8>2<&P[D7$;DBZ8QG^.P,JLTZ,I*H<JWW)E#\5Q90I24R4A2D*2"H!:5"IH
M">JV^IB[-*U*X%J5H[29A`<"CRZ3;;9+?-N][NMMLUIMD5^=<+I=9K,"WPH<
M5M3LF3*F25-L,M,H34E1%?"NI(RVULPNN-NU$=A=7=RRV@!(>VOK5:]R^^&]
M@=JS=C`Y/,+SCCLU%I<RZ+CUSE8/&GD^DI#N0-(*5QVW>A?;;6R1U"BGKIA_
M4FGQ3MA#A5S@/.5+W?1>IVC0[(:%6(8AE^)\A8O:<VP')+1F6(7YE<FQY)8I
M0D6FZLM.KCOJBR'`T/YM):4VX%A)2M)'72S[:RNI1=F@IW8>8E5.>.^MKH6I
M!KL73D<(&V)4YZ86X3Y"XVET`]BE"RE3P/6A1NKJ4LM8A9?""(^Z`/.E=7T.
M=FG\V4>\03Y,$ULN(VJ%$*!U;E!1JG:KR+J>G<&@\::G;O+<7,;G?#5<U>'P
MVTK&_%3VA11]Q6,MW;F+C3-)#=E7(P?`LOB8V;^A0A#(LC1$99=^8;4'(I;C
MQRG<D*J54(`ZZ\W?KQJVJ1-CLXFGPI=CVX[5[G_^,5II=YJXS.'B^4</^%RA
M%[B[URAEF$Y1`O&1<97*3'Q)-TSCY&XH81A]IEOOP'H\1E;,A^XK5$C@("F4
MI65#K0UUYKG%Q/>6MI"*L#@?*:$^M>SY>1HO2ET;DTD#YO,7N(]"E%]W9BBL
M+]FG#F+/6V7:GH=IOJ&H<YD,/^E<;Y>KG"G>F"=L6;$G)*%=R0>@IU^C71+K
MFQZ8@AF!`RCUA?(CKRXM=2ZGNI(35V<J9T>&&;A:G9*D(:2[';]2I(#D1B0^
MMN@25;G4)\G2A(ITZ:N=_>M%CMQ(5!T^R/CZ;J^U1VYU]\WM?]NF6/8=R9R3
M"A9J^%/JPJPQW<GR*`VIE#U;M&LOS4:UOI0X-S+[J'A7ZNN?Q]5:-I;SXA[1
M-O\`6KW8="]2WU[+=64;G6MS0MI7$`!O#BTIQO:A[P/;_P"YR=DT3A_-_MR]
MX_9+9<[WC5PM-RL>0V^UR)(B,7-RVW)AE;T)<D;-[96$GO0:3GZFTG57A]F\
M.FKZ-Z<1],Z_TI.;74F.;;/Q-:[=VY3+?752O22[)#3A94J,RXZG>*;Z$)J4
M-DT4KL#I+QRFK:P-V/="R,=S>AI2%)4XWZJ4K0I!6U2I<;+@2'$4\03H%]4;
M5M)IKHGF.FPT6UB,E*R44KM/>@Z5'PKH=<\X9?*D);9T+<YXKK]!?Q3^4_R:
MT3=?4L.$^4!1HJB4_6505H*@"O36T!`>2=@*0N?IIFK@]'E194ILA^.V^ZM]
M3+C*U1=BO25\P@.;V_,:5H1JUVQH0#O5-U'X1_$?4FQN$=IZ3ZB6U!"T-E!4
ME(W)-:+'4^4^&K19;!Y%2;[XD;,VIN)969@21-N;3JP-HJ&&55(<Z5!(3TI7
MKJ+??-#R.!/K4JVS)8#0X@>I06]\GO*B>RO"L>>LV)77D/E7DVY3,?P'"[$X
MXU(GS($7YF7-FNM-.R6K=#2ZG>4()42!3X5;JCJ6/2;5CW4]\N]`'WJZ=&]`
M:AUA=R16)+?#AI=VAQ('_251!>?O>??_`,<WF0O.^'./XD9]UF]Q['?\!OEH
M;BPG64.HCJO8?;7)E[%BJUN)"SUHGMJCZ/\`JQ!;S.87X&N]==OOT'9X8&_A
M,CJ;:*T;B#[W/VI9AP[C7('*F4,<99M))MV48`Q:;U>[@U<FU>:Y6UFW1IJG
M+2Y6@<)2OXIIUUT/2^L+6Z>&W!&7M7%-5_32[M&$VS23Y5.KA3W%\">X>!(F
M\0\CX]EJHD=$JXVQAQV+?;9%=.UJ1<;-*::N$9MQP;15!-34BE3JU2ZUI[,G
M@G`YA[U/154=_3NM6$PDN&N#1LJ-P3Y&(TD$A-"*]"FA!%>A_&/P:?V\G/`D
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M!@FBH62C/7OP]BK.HV<YF:)11PC`])6^T6,N%*EA.U8"UDU^J4E7P[ZRZ^#A
ME&]1[K1S&YCL`4K>.6&!QW(86I*HS[%Q<6R#5UM*6EI"%HZ`+KU[]M<#U8?_
M`.U#^,+T9TV3_2KN&0IA[7&?]'Y8M*4PEUTM;16B%.*H%`TZ@:[,X@-:?[C?
M4N7BVYKGN_OGUHQ<B-)0H[#T!Z`"OPUM&<KPX+62SHPE-T(OI7.7M009,20R
MGIUW$#;N^CKU.I,WK2!7B"JW?61QWHG;ADH2%).Y(V*(3451Y#U([5&DS)FD
M\0-A2,5D9+<1CM]:,85ED2W$>A&<<*5!PI2D;MJ?,HCM6B1IP[6&9.4XX+2/
MIU\$@N:;`?2L)L-)E.GTU)/0%"DC>D@==PH1UUKXYJ97MEMKM6J+;1N><*:A
M*5+IMZ^5))H*4K0:<PWS<KB.";067O,PQ"DEA=O5!LEO4H)2N+;HX6!6I*WG
M7AMZ"OD6/QZY;K-QS=1<W<23ZEZ`Z6MC%IV?A'1-3FI5/O:WG1NHC8WT!(0'
M%FAKV-2=6+1!^&.[VKF.N_SKCVI+&W)VE2=H.W<!V(-*@=N^K-XT,]SA@HSP
MI=[U-JY_E2*>JDJ!-`$U5U^)K3I36DER)AE&[%8\&5M5;T)-"V>HKVTBCP91
M>B$GUA5)IN/YH^G3GQS6BG!'@SP7?\DW^A_`-)R7`G`'!-;FR)`P0^2;_0_Y
MD:233P+D/DF_T/\`F1H1X%R5OR;V\)<AN1*]FY*?UBN_;HG_`-#47;ZU87.$
M3P7J_2Z!=VXK.T@+/Y!7Z"?H["OY=.I9IQ3DY2/MVJ.=;,)I#F)&W?[%Q.0F
MDO&N[>%).T$;:BA`I3MI$S7U-C/,?O6OA9![U#48[%7+]YUBBLSX"LV$1V'I
M4B=R?8)TF"RRI\2X%K<^;G-R&4@EQAF<XV.O1*>]>^N._JWJ]KI>@&\N)'"\
M+3A49:]U*^E=\_0CHW7>N.IX9K"",V,+VFX(!JT`U.6KL,`[:"HQ)X9]JO&_
M"6,(Y,Q/#[)R#<XLAJ1<+G<)C=TNJWF]S:W(<5U(=9]`@$*34*``H.FO%]GJ
M5WJMPZ>9Y#:X9<,/+5?3"2PTJP?'8NC'*9`<I.TT(!KNVUW)N_NZVN,L6]W<
MNQ\/7*-^ZV5X#E]NRBRVQN2Q;[E)L)M]PLUPEHE*4EZ?;GY)0AU(2I38`()Z
MZ]'_`*,Z_J$MT^S>0Z)FPFM<*[<?8O$G_P`C^F;5UA%K-DTF7GM!&&4-S-K3
M"M:$[U?P8ZF)*$E"=N[HJG6O?OT'?7IR34IY8N2X-R^7[UY'?I-LZ7G5?F[Q
M]RK^^]SQ"]<E^T*T\;8PZI[(<FYDX^6W9O06\F\V:!+6J[NN[?(EBR-NH?4%
M`[JTUQ7]2KBTTK1Y7%QYQ:7#U<%Z#_031+K5NL(HLC76#2!4[<V.%:TILW*+
M^<8QED!K`^*(?#=JY0F8]QXA^=GJ8^.P5BV8U96V4R8Y%N2L-KCQMY"]Z_B:
MZ\86][)?FXNFO/,8'.`&RHK0'[!?32_A9I5GX:6RM!$(\'Y'9Q0;0<]*^1,W
M]VQQ7-R[W:77F]&(C"K'QYQU<L:-GDN,+N5ZN.;266XDZ(J,VU'<B)B1UGHB
MM1WUZ=_1^UDNHFS7)>';Z+YZ_P#R*OF6ERWPS6>^17#O[0K<_>G[B;E[:/;#
MFO(:7VI5U?<CXAA3#[0=:%\R68^['E("%M.J^S8:%J118VJ'6HZ:[5U?<VVF
M6CI&/<)LM3P.&&Y<2Z+T1VJZQ':4)B<&G#;5VWR+R5Y/PES)SB(_+N2)O$F/
MD3DE]%VRQ]URY38?K)=ASV4W+U78=LE/+`:6T4!0%`:&FO,5UUH^74.4]^5N
M;:*U]-5ZV;^F-[:V`=;0![2T?$*^HA2"]B?N,Y%]J?N9Q+B/*Q=#QSR1>[7A
MN5V!,U)LS"L@E>A;LKM[3A4F),M,TH6ZH5]5I1%*@$=%Z,ZLD-VV)S@Z&HQ-
M:KD_ZE=$-FL@^]88Y6##)0#TU7HNYY]U'(UDY7<]O'MHXRM'+'+=OML&[YG=
MLDO)LN$\=,3UI=@V^^NMEM^X72Y6QUN0A#;K9;#@2H$@ZN76/ZFZ+TVQS0X.
MNV@5!J1BT$'`"G=CW[E5>@?T>U?JRV9=@.&G/<X-(H'>XXM.)J-H.Y,+:?>A
MSWQIR;B>,^Y_C#CBUXAD5XA6&3FW'>47%[]U;O/>3$@NY#9KHF44P5SG6VU;
M7@4A5:ZJO3/ZQVO4-PRR:V,7#W4%`0*#$[3P4UUM^A^H=,Z?)?1\Q\,8!-2#
MM-!L`5Q5^NILW'N2FWKC/R;6U+>CQE*"5/LKMCUP9(6I7I!J1(BU%4FJ*>/7
M5BUK28[[5?&.<ZL;,PI2E<-N!P5/Z:NW6VD^!?E#Y'93Q`J1@O%!GOO=]RUY
ME7R_7[G;-L-$Z[W!;%HM-S?<A0T&6\RU!C,1R6FF4(2`@#H`>M375%NNI-7Y
MCKB.0->3\(K04PPQ[.*[;IO072XTZ&.YMA(\,Q<[XG5)-2:4[-B7WM.^\CYG
MPSFO%F<XY)RG->-LFOUCQ?++#ECJ)$IENY2F;7;[]C,M]I!CR;?/DMJ6VHJ;
M<;4KH*`B3Z7Z\UV+5LNH/9X/DO&P_%A3&JK76OZ>].,T7/I%OEO^<S93X<<V
MY7N^]#[SOBGVMRW<(LEB'+.?6!$!ZYQX-TB6JWV25(CH=79[C?4MOQOGF`0M
MQI"%%(6*FO337JAPU\D\Q[:_*1[057-#T5FF@-F9L3%>W/[[KACE[*K-B?*O
M'UWX@O5WF/VRU7N+=X^6XE(N-RG,B-]H3T1K?-MC9F%&]9:6RVBI*Z"NJA';
M3V,`L&AKXCA5^+O."!7R*:N-.=*'RM;2,U([MRN(RK:$6H-.,.3(BVG6T)0I
MU(:<#,I$D2`KTG&GV7`4"G5)KKLGZ<Z8-.;+*'.#7P.%*BE2X'##L7$NK[^_
M+#8Q,B+<V-0:T\ZIOMG'[%BSGW/YOEG&,CE&X9CSGD]G@E4>3.G0L5M3%KMU
MDMT:4J'<&X,9^4](64J#;2O/2E3KS1^JFJ:A+U.=,D=EM'.Q(P=M.\X>A?1K
M]`-$@T'],X)K*"*6>Y`S<T9MH;\.4MX[ZJM?WWX+Q58[7*Q]GC6V\;7YZ`7;
M>Q#G0VY%LO,1C?%N`:MZ&0EE,UI*]I!ZTZZ9=$R7EMJ&7.XQ-=05VD`T!/D6
MGZMQZ%#I18]H;=.9B!2@=3$##``X#%6C>Q[W]<'\F<<\0\7Y1FURB\T-XM8L
M8N?[VV]5HM=_R*U1/0E-PKX\XXRJ?*;0%A#@'J*IM/AKV+HFMAMO&Q[@<U`:
MKYYZMTA=2W<U[,PMLR/<(%"37?6N[N5ICEN<:<4A;:DD&NQQK:X@$5"%A*E@
MJ`\:BOP&KU++$V`2QFI*YX^U='<F!PP!35<R\BX[PEQ1G'+&324(M>'VJ:\(
M!VF1<;NE`:@6UI*AM)G3'VV@"#U7UZ:K6KZM+8V#WPTS4^V]2N@Z/=:IJ#&2
MM]W-3#[%4.8=P5R/]X?F^2<B<F<P9;B7&^-SX\:'%@3S#:@7F?%;N;>-XW9$
M2X%O#UMB-($J2M+H2HH-!V/DKJ?]1-7MKXOS,HUQI@?3[R]P_I[^EVFS6ACO
M8B1(UFVE1MV8=JFQ[3L]R+VS^XS!O;1D/*-\Y@XTY1;R!6#3<EGL3LFPG(L>
M:1+;LL^[,!N+-M][@*<,="6]Z7!0+(3MUU+],_U%N-=A=;7O*:2T@%H-:[MI
M*YW^L_Z;V?2S?$:7$7.V^_0C8>`:KA[S;P)GJ0FGGMJ5$-MNMM.`CJ%-N+;*
M/4014"AJ1KO^EW,MOI+@:&0`TKOP7DK4].GOXH=0M\K;MSP"#\.T;J@[^*I=
MS;@K-\$]_?(7NTM^(6CDE%RPW'K=B^+2KU#QV\1KG:6V+3(?MLR\QI5OFY`S
M!25M(95&>(*BE5#37C/]6]1NW:NR.[HV-S'TR@[,P[U]'_T1Z!%ATY;WD;Q)
M=W`:YX!!#2`0``,17M**N<.3.:,XP.3)R?@'&'K/<L@NMEM<>=>G47&)%C-K
M=E*GVDD2[AN:4H*<;4E!77PUR&R-M'=QOMGO<_F-V[*YA3<%Z,U1FJ6.GOAE
MAA$+HG`G*:Y2T@T][;2M,%;']WUA5WX\]F7`^(W2%*@?9^)W&1$@S)3;ZH-K
MNV476[66$PE*$K3%B6N6TAH&NU!H2=>MM!MGMTQM_(3S74PW=OVJOG#U];6T
MW4IMX*\EIVU%?51([[Q7`[CRGP58>.47N^X[B.4<H8HWRG<<<??B7:1QS:X=
MYNMYM,20TV0!<'8J$.C=7TR:BE#IG^H=Y/8:,W4[<CG!E*?N_%PK7TJ]_H]I
M=GKO50L+RO*CCJ"V@/<:@CT*F?E3V.>PF%@-GE8GQEFD5]^(^X;^_?[@N1;T
M,S?09N1M\R6F%='F9-"6VV7$N@;0DUUYBN.KM4_#OG%F=K@:4-,,>/M7LZ7]
M-=`U5L$4QF&>9K/=+1@2!O:<>"0WM1]V?.WMYX#N7L[X`LLB\<IP.3>0[C9K
MM/C&\'#,)??C2FGH5J4XVD.M1$+F*+B5M>JXI(2"I-.O6W7L\6BLF<8\SQC@
M?1BO-DOZ5Z;?]57L3N=EMI"&4+<:4^+W37;NHD?D7WD'O!X.G-O<C\D3<LRU
M,B)=9/'V7P[>W9[U87YC8?CN%J`PU'?;BK(/RRV5-KJ%=M/M'ZH<V]9-`6N#
MJ$UKMWC:$RZRZ&TYNDGGF5MR&8`$4I3#]W:=^*]#?MQY]P?W+<%8GS3AH5`M
M%ZBR%W6WW!^)&1C%]@+7'N6.S%NO@K=:<27&3T)8*20>^N_Z3J+-0@:^X(!I
MNP]=5Y&U3I2^9-(VT:XMJ=N._LHB3EK*,,Y$AKP;`LQQ').2H&..WS[%L5]:
MNETMEIM\N''NC]WBP%%R-%<^=;;0%*05K)VJ\IUS+]:'^+Z3Y]NQKKYK\`=E
M*MKOKQVKN'_QPB?H7ZCLEU%[VVV3B`*T?V%>?GW%<OXE8>:+U8+3C>8Y1>;-
M>+#`Y%Q.T1D9&\_9<7EQKA/QF-<+)'??E/S1'\B9!\K2RFA(KK@?2]A91W,%
MU>YJ-#2<1MP)&S8#L7K[]6^H[^^TR2RZ?#'S2EPH03AC2E",2K8?:U]XC[>>
M>[RUQ\T+QPIR!:H,:%%X_P"4+8YC`EAUU+<*WXY*D(;:F)BM?52K:0FHJ3KV
M=8=8Z5=Z.RQMRWG>Z!3L<*U\E5\T]<Z$ZCT7J%L]PQQ?+G<<PP^%QP\RGKR+
M.NN)83GF1VQF/(R'%,&S:\6N&M*Y#9O-LQBXS;7(HA:`]$;GMM+.TA7E`W4.
MI?5;F#\KF,#OQ8XLPKLV;#L*:=,P-O-9@M;P%LLLP:<N'[P&%:JICC*Q\-V3
MCO'_`-]\,QG.\YOV-0\WR_*[AAT?+LE<R6]M&Y7R[Y!<'VH[KDN1=93AH75M
MMM;4I2`D`?/SJ+7M2UR_N[JZ=RY`\X1U`]VC1@2X[!4X[5]8ND>C]*Z<T73=
M/MX^9''%@Z2CG',YSSF+0T8%Q`P&`"BI'S&1Q1[XO:7R9Q+9[;&O%^Y.@<5Y
M`W8$*L</(\#RC9&G8]=+4RU%BRHD4RR\RMP%;2T`U)U9_P!+-1G;<B[GD<[+
M5N)PH12O>-RYU_\`(CIG3M3T=TELUL-XS*YI%`*M-:'O[TZWN:S3WZ_>$<G\
MD8G[7<NR#B#VW<:9/>>/8+,')I.(2LRR'$I!8O>12[Q;PBXOJES_`%&T(:=9
M0A"`%)4KS:Z7U/\`J`W2+AD6GF)Y<!FS`GU$+BGZ>_I?<:GI`U"^E:V0OH`V
M@%*D;ZFN"83@7G?W\_=S\PX5;/<IDV4\F^W3(,BMV,9/&R&^G,F,3C7;;!AW
MBTW6[%^ZQ3`F/)<IZI24)(VUZZ3M/U(AN[V&R:8^8^@=2N!)W8_>ISK']%M2
MT;3Y]8MW.<T5<VI!!&[91>N9KT74LRH15(A/M(?:EJ6E)6S(88>C'Y<@.`N!
MPDJ)ITUURU+C,UP^FZ.OEP7F=OYA,Q[+\1@-?09,-E>)*W5U)46OAV<3]O(F
MRYAY8POA'CK*>2N0+PBSXYC\9:$O)VF3<;BY%6ZQ;("%N-I<FR%@(2*]SIM=
MZA9Z=&)974=C6IP]2WT_1KW5K@P,'X>:@H,:*@^T^]/[QKF>;/Y#X9]N."L<
M&69PKCVC+KBJTRLF9]1QP/VJ],RH2[V_<FD4;JVEMI:NH4175/N?U4MM/ES'
MDY":`G,?_$NDVGZ#OUN&D#K@3-&8XMI39\O%62^W#GS'/<;B3]XAVN3B>:V&
M>Q8L^XZN;R)%TPJ_;DM28CCZ$(3)MWJ*JPZ$T6FO4Z['TWU-#K.BC4;0L,N4
MGLJ!48;?2O.W6OZ?:OTYKQTR:@MZTJ?BV\:T]"EE=H2`L.,"L:$MFUQP:;5`
M[#)4H`4+G0TI0#X:0L7,N[IT5P:.H3AACMWU3#46R65FV6``TH#7'9ANHJMO
M<UQQ<;S[LN,>4YMBF9+;N+.+,G7C=D@L>NY(R_([NS%6L(6X&PIJW*&TTJ"!
MUH*'@/ZP:K?07`L`&"UC+\IH<QJ`#4UIN%,`O7'_`,:]#LKR&\U*LOB3%$7-
M:1EP+B,,I.VN],-[S.7XUXX'SE&8<.RX4RT89<YR%WVUP[D7G8S"7(:)8::]
M=*`A200AQ!V_#7G;3I9;BZ)>YPQW=Z]B0:G:NZ?GDM[9DE]"2`'M)!VC$"A]
M*K>XC^ZSQ_*;`[G7,O*UDPN*;1;KFC%\/M%VN>0L0KA!BR4N7&_..1[%'9]:
M50--H4ZA/=5>NN@:CUE?VT?^G,8-.!^]<?T;]+;V_FI=-;E)W4&WO)3.97AC
M_P!W_P`^\;\K<.Y5.NF(2[K%@1[JW)<D2+M!?EPVKW8,B;#OIRD3[>^M3:31
M2-A*3JQ_IK^HEQ<7TMKK+F`.>S+2HPH:[2>Q5']:?TC=H^EP2V+"[/%(75I@
M06TV4XKU\Q7$7B#`O;"5HC7:V6ZZQFW*`HC3H,>7':-$C]FRZE/7P'77L&VU
M&WBM8W6A!:^E2[@<.S<OG%?:9>6NI2,D#@0X_L4#/=%[A^>\3RS^S+VO\/VG
MDO,;+$8N&?7G*5+&,8>JZM`V.RI#;\7Y^^N`%YP)71#)'0=]<OZL_4RVZ=UH
MZ;&8G0-WD&OH(]2]`=!_HY<=7Z*S4YFS"5PV,(`](/K4)L?^\G]Z'MMS&W7W
MW:<$V*7QY+FM6BY3<.M\ZR7"TQY#@29=G*9=VBW5J-N*E(6@.*(("@*:I5S^
MI5MU3([31R^12A+00ZNW:21Z%T35OT)N^DM(_.-/$SYP:D2%I;YFAI]*]!'$
M'(>'\QX5@/*F#W9RZ85G#,N5:KK+BK@/HB+8N+BF+C"=4I<2XMO+"%H4?*10
MC5,M='NGONH=/;G/*?EKB:Y74V45;M)[41Q.U[\)X>VN3`4J*[<R/G;E&:N/
MRL6`F=(<EM10XI:41D-*6/5=J?\`50VDA/7N>VK7HW25_I_3^6Y?*'RFKL1A
MMV8;.^JKVIZWIMUJ4EC9M:ZUK@3\7GV>A59>\G[PS@'VI9C>,#R#[<S?D1E#
MMP>PW$1$*K1$D)<^23?+Q*6(<-X^BI2Q0J"2#3J-==MNJ]-T[1HXKB0>(B9E
M%3N''SG915!W0.O=0W?C+:(^%SY*M'#'CM]Y1]]MOWR/"G,.6V;CG.,&R'B6
MXY2ZS:L9R21=+7D&+S;G-?1&ML>;/85$?B%:U`.$(4D$]#I/1NN8]0U"*W9R
MZ.D`PK]Z4ZS_`$GU'I_3V3QME.=GO9J&F&-*`*]G$9C]EL>31W76UEAIY0[E
ME<IPMLK,=(4"(:F'=R14G=XTZ:@-2BFDZB$\>(S!:Z3>3Z=HQM+EK1%EVT-?
MMY$@+DU)AW.4U%>=0RRI+;:1X@-I5N51-"I16>U-=8CF>^V:Z@,E/)@J;XEK
M)SX>AL:[3B[,?B%<!ANP1^TAM4-J<5H#:4..25/N!IE"&FEK6I;NTAE`V]5&
MH2.NHZYUF&U8XW):UH]'I4[9VS-6>VRL077DF#1M%0*G#N!5<O*'WB_M-XKR
M2X0+[FEQOB[:[)B3G,.LSUYB6^<R4I>A*F/NP4SG&R?K-)VG4#<=:Z3"*-D:
M2-J?2_IMU/<?^B:=Q^]+#VZ^\?V\^YY<^W<5YDX_D=O2Y)>QC);2O'+XJ"'E
M`W%J,^^\F3"`\6U+77\W4A8]7VM[:M$3H\IKZSVJO7O2FLZ([)<1$2-.-1QQ
MXJ=#;:F;>Z+6`AFJ:R:`R!50!2E8`11?8^7MI_;.CGF$CC4&O=L2LS7_`)2]
M[V@35;ZTC'XBUNK4M(*U$[E%"BI1KW41TKJ6I'Q52EM.;\0([EG'C*2XE`;2
M0ZI*#5*OJJ(2:?30Z3MYIA)(U^46X)H=^SO3@:?:AD?+SF<4J,./<GTB+>8M
M96MH(;#34:J4*`(:20@U)INZ==4V[A8[4B]KL*$[NQ=4T][K71L![V`]::&]
M>DY,4M("CUK7KYMZNWT:LFFFXB`;$&EM-_\`:N87D#+F^)NLS65W8?>B\0"H
M!?4;@%`>'6AIV[==.6S/?.6S4'O&M%(OL+=D0,&8BF%2/N"^F"D$>HD@`@C:
M*=?"M0>E#I^]\4#`^$^\<,<?4HA[;ACL&BGV[5L7%]0A24`@#;U'B"?Y=)>-
M?Q9YOVI/_4_(/MY5H%L4%;@@5K7PI7\FD2)B:^[C]N*=@P4%0:T6SY!9_,1I
MU:OY9<9B`*8436Z:7Y1;#&N->"^F`I2=K2$J>'<$`IZ]N@H=)7&J0Q8-(2T&
MF32BK@5N^R9'^PIG;_8#W?X_5^KI'\_T_P"8>=2']-WWRE20-EL]UNM[4N,X
MZMA#?IH6V%J:JXE)+84#LZ'PITUYQM-1O]->'`NJNZ75G;ZDTLRC+W)#7W$V
M6)D)F`^EE4Q3J5-OG:2M!;V):!^A1K370^G>M9+EDK;K`LRTKVUKZE5+[I:.
MQ<U\32[F5K3=39YZI*7#%+@P\LQ76)=%+*U-@.%(92@ODD`T#%?-\-6$]9VC
M2`Z6,>4*,?I`#3[CJT*C[S3QY+OD&WY"4LRU8BFX7IZ$E98+T1SRJDK%$_,-
MN%.XH-0[MZ@TUS;]8=(LNINFW36LC7RL;6@.W#=CV8KN7_QFZ^?^FO41TJZB
MRQZB0UY<*<O-4&M0:?&?,JT^5KCQU*R'$[OFV%XID=KQ9V=>ES[X^TEF<NT1
ME28L!U3<5^0P[.6X&D))#2^@(.O&NCSV]K<&QG>UD["0`30GR+Z$Z_8V3[8Z
M@V5G*Y)R.K@X.(<<O&AP30?=P66S9I[J<KS[$<4A6.Q6&SYE(NS4>4B3#M*<
MD?BM6JVHE,M-M*EMK(0!1)4$@4Z:])?HS:746HR321O;$[82,#6J\/\`ZR:F
M9NF_!-&>82;!B0*MQ[AM\BOV>M:J!:@5!"@I1HI1`%>M*$G7IQQ#<78+R(YI
M9\6"2_(]BM=UPJ>+E`@SY<=*&L4>?>:;F(R.Z*3#BPH2W?.B3-=#:$H00M9-
M*=M<T_4K0+?7M`E=$[->-80&C>.SMQV+J_Z0]9ZETUU1!%:0O?;.E#G/`J`3
M@03V`5\JHUYMS>Y8SC.91&9T:P9?`BNQK[#R#(+OCM^@-%+UN9@653$J,XS;
M[B\DH*"/2='UDD'7AS2M(U/2M6=:7D$L<+Y*5<T@4KM7TQZPZQT[4^EXIK::
M%UT8?>:UP)'NBM1N4R/NQ.';MCG!R^7<IN,69=^1W;<S9FH4WY^)8L/QMJ1"
MLT94C>M3-Q>DE];G8J24U\->W/T[TN73;1GB(W1YVU;F%,PXCB%\V_ULOOS>
M\9'9NYQ:X9@W'+MV\$W?WU<&[1/9[C]SC6V3+L-@Y?Q.XWU<>,MWT+;-BW&$
MEY"DH(9:;?HD*Z`*6/CI]^H,(O;5[HG5<&T(!W@?:J:_IG?0V>N0RU&5K6`]
MXVCO&]0\R7W,\,7G`O6_LP@SIEPQ_`L>C/\`[Q7YRTQ;-%F19:H<.VH9$*SH
M;:;*-K.Q(7T&O&NJZ;/%=N^+F5P\Z]Z:=UN)&PP&.ML1[SJ8`4.TTXJ#V*X;
M;O</[^_;_B>`V%<*TJR^R7ZYL-IGW%VW8]8KLS>)+MSDRBZ$H+$0(25$>1RG
M8Z[5T/HY\(V=YI*N$?J/K=GJ-VZ#,P1DG>.*O4PS#,TMV2^\CEO&[4A_.L\Y
MFF7B";Q>8U@C6S'X5OM$"S%V1=(ZF1#AOQ%E02K:E((`';7.OU$FA'4EQ;7[
M2(\L=''8?PV[%W3]'])@B_3^R?I\C7.+Y\&XX\YYW*%ONOP7DBXOYC;[O_9W
M>;;CF/6:Y7B7$R:)'E0[I=X2IK5Q^2=<5,+:I24(;6GJ%D'IJ'Z9%O8ZW;.L
MVGG&04IPW^C;V*6ZETL:KI=U#>N:8!$ZM=Q#26U\M%>K9X\_)^%[5"<D)C7[
M(N';#$=?F/;VVKA<\%8MJI3LEY6]Z5"<?#H<42M"E5J"=>W&10/T_F/($CX1
ME[30&@7S+NWR6_5O@8@3`RY-:;`,QQ*\NW#OW<=\NF.0KMDF<8I*DW3D&19G
MG)SK\B%;[5;9]QB3GI"77?E?5I#6I1`^N*J^.O&FO]17VD=07&F7+71O9+0!
MV!V`[/*OH;HG3-EJG2UKJ=JYLD;X,Q<W$8$C:.Y13Y^X6>M]'&W\>8BXO>;C
M%@R,=8<:E2[?:[F^PFX2)+2MD>0VF,AQ!!W554'4[HVI27UP(9_PZL+JG#93
M[USK7[2QM8RZ)['NS@4!KMKZDFL)X\Y1Y-LMPSVZXM+R#C]<J4^,@NLHLQA>
M;<\(SYFW*6T\N;>)TD!*MZBMPT!J=.+KJ:WL9#%#,Q\@W!U4AIW2?YNT/;&:
M'@$H,N]O\7%\7E,W:-.@9K/B&\-6^;'=2NWP;A%5,CK"?22EMTM'<E::5`J-
M('JETSV'_P!0TP[4]U/I-UK8NB9$XEC2-G!>NCV7<A/<V>S[V[\DR7E2K[?^
M.[;:KE(6XM]E5YQR0]B]V>EK<JIQ_P"5@(4@JJH5)UWWHJ_O;B$9HWMB+=M,
M-J\;]:026-],2P@[!AOJ"FDYMFN<8Y#<;)(N4C&<5S6XRLI5ELR--F6N)<9"
M=_R4Q,)3<N),9D,K(="@KS].NN!?K;I-[:ZP-2;#(+;:7Y?=VG>O>O\`\?.K
MK.]Z1L]*;+&Z\90&,$%PP;M&T?L7F+]P>86>]\G<HL97,EY.6,J95:+FB1-5
M\Y;'86^,B*]>5OW%N%.9?]<(0H$A-3U&E]%M8HK2&Y93,Z)CL.UH*J/74<^N
MZM<1SDAL=Q(`.P/("B]><B,..XSCT%^TK0\W<(TM$ITSV9\%+DJVS8[R%!Z/
M(C2F$D.I(6*]#JW0:]*R>*%KO>S4HJ7J6EF72C:2PEL<=2'$4!)%*=J]P_M;
MR^;RI[;N#>1+JJMXR[C'%;I>7"I2G'KI]G-Q9C[[BJK=?>=C;G%J)4I1)-3K
MOVGW%R[3FRSAP;EVG#<O*W4-@RVU%U`!B?6H%_?+WB3C?M*L##;3R&\DY4QN
M/+6V5($DPV;E<?EI.U21(;6_%9*T*J"0DD=!JK=4W+H-/>)O=PWX*P_IR;B?
M5F?@N+,VVB;KV58M@+'M"XSY-C3,BD7.3B^47C(;.[>#'BW6^R9$N'+^5C7`
MNP)=P'H,(J4%T-("0::\<:W`W4[F<`@N!P[:UV+Z*:(Z6WM;-UK$7-`.<@?#
M@VF;A7'S*/=QFX<KWC>Q>/@K%W>NT_EVRW&Y.RY#TLLRT6UU%QM27G#N^7BO
M..`-BC:4]`*=-7+],M,O-/N,TP>QE=I%,*A<L_7/5;"YM!&YT9ERTI45K0KT
MEW6#]G/J$UU,=I.]U3\QU##;8;JK?ZCZD)\M.]>FO:++VT#,C9&!I&.(7@75
M="U2[>(K-KXXP=M"!M4/.=;YC^5*9L/'SC'(.8VJUSLFO>/8;=(<B[(Q*'-C
MP+C,^9A/.J9FLSI#8#1HXM)Z=-<&_6#IEFM.@FTIAEF9#)7(,QQ<#N7K7_XY
M=7:ETE#/9=1W0,#IXLA>[!H#2"!7B?4JCN:+_8LOY%XLQ#]\%08&/Y!%:RUY
M6(7"RW?%\8DMF1?UW.^!#,A@6V`5!U]Q>U).XFFN*]!]!:SJER^6.VGDBA=F
M<0PD-#<23PH,2O3'ZJ?JOH]CIP@\5`V:>,M:"\`N+@0`.))."]/&'?NL]CUB
MBX-=;'D.-0;':[=CLNR7&WW5#MBBQV&+4MM<!YX_K&FZ'M4C7J.!UI'I0MF.
M&=K=G;3^Q>#IQ<3ZH^ZO&EK3O<D7S):WCBWVP&5+7B=TC7"1'(35,=YMR-.]
M9E9!#:8SE'0138JAZ'5'_4)DM]TN8+5IDF`V-Q-*[5T7]"]2L=/ZWD=J$T<+
M'"C2\Y<V&[BJ;^7N9\BP#*,FF91N@X9&PF^VZRVYZP6/["MCCK[%RM\Z'-5:
M&?F)TJAI1Q;C1KM77KKR8;66Y#=/8TFZS`%H^(5PQ"^@C=3L--AMKV[ECCA%
MPQX<XT!`<#6O"B@?]V9&N,OW!>Z/E1N_V-KDRWXE"N&%RLN==@6A-KRZYOSV
MG5N;%*>;D1(R$I22$*13KT`U;-:CLK'1XK1T[&W;:583[PV[ER+I`WVK]4ZG
M/:P22V\DA+7-;4$>[B"$[?OK]H3_`#K$N&46[D#CFSW[%;$Q?<IMK5TB0K6Y
M-NT*7+G)M2TIF.QVI4]E(+:5(_6+KL!5U9Z#J?+N60-D#GX';Q4UUATO%=Z0
MZ[N&Y)V@M+2*$9>SRJC_`(XOG(EGP6[X`SE>06O"G\@^=-AME^ND2V7*Z[0Q
M,F2H,>2S%FAWTJ>HM!*D`5UZ6T75I8M/Q)SY5Y'NK2.WU`Q<O\/,<:*YK[GN
M1>;#S-[AIU@M#M\OP]M=\CVF!&CB1<KA>I%_M,6Q(;><2M"(\:X2DNO[ZCTD
MJ/@=/[QGYS))%-3\N;&27GX12II7C@*=I"@X&2V5Q'/;,<V^=,`&CXJ$@5[L
M3Z5/GVMX;DO"/"$&P6[B<,YI)>;.<W/Y(.W[(LPO)>N>47B?=GHJYUX*9TES
M8ZIUP(:`2DA(`UYJU62=C7Q6`+\LT@&7'`/('H7L73M*AAM+6_G(=*Z)A<T[
M0<HV^U4=_>+8QG+G-%KRO&8<PWRX8O\`:EP,=O;>L<>Q=WY]NY*>4GU8;B$Q
MO6WU!4$:OW1%[!:PMFO;AD=VTX,<ZCCNV=@)/D5#_5328]0D9J-C;%[8VD$M
M;6F8%N[^)2J]@?WB?-.;\T<<>W_E#)+;G.%<HF[8`]?\DMA<O$%NZXVN*R6I
MT8#<S)D%+:B^3O50)[G78;#5+K4IKB*.LD#HJ`C$$[EY6ONE;;1[B#6#1ETV
M8.+3@0*@XA3>Y.1D^/XYDN$8PI,"3BCK>+76-&8LT)R':HSJ76I4MRX12I,>
M0AP*W`U\U>^O)6O6LVEZM>6-ZQT-R7X,>,KCF`<,.T&HXA?1_H[7M*ZAZ2TZ
M_M+B*6?D^^&N!+2USFXTV8`>=,9P9QO_`,*'WD8ZMN\M?9_"XA\A7YJW/U@0
M)^-*C.6*%;51B6ES[Q/BA"UCSN5-2=73]-='OF121W<,L>:-[FU:<2&X4^]<
M9_6K7])='RWRLD@YC&N#75()=12UXPL.2<'XM=K6SE^.XY:F\XSJ[YJF^^N[
M<6;CD=^G9!+GQH3)*T*]::AI3BD[R6]M:#7/M09=2ZO/%>DL<UQ#0["O<NC]
M(Z=HCNCK2XTNVFFCJ"\L!(;\5<Q!P4'/>W*RKDC`[&U<KQ9,FBYAD.-SK&BS
M,)3(NQ-X9$9I$`I]8O*4S3TR"4D:==,Z5S.H8)F29I`X9A\IKL(W)_\`JNXG
MHZ46[Q'9/C/*J:5:1A3BO4#9X8C0;<E20O;;+>T5J%2DH@QE>E4BHVH4DT\!
M37MFQ>PQQL92@B^Y?,TV$UM--+-,'DR$!M>TXT^VU'&Q'Z*?]"/Y-2*%5U]Y
MUQ*_S5COMXP6YM3%\1O<YP9/+<>/)>AMNQ(M@G/XZF3*:\L>))OQ;;<4H$&H
M!KKD?ZGOFCTPW%JZM*YLNZG'@NL_HV8[_5G6TK1G#Z`':?>(2.N-_P`JLN'P
M,%A7/CAN^^K.M.+XC#N3,*S*Q:V0UBU(0^Q;&VH:V4H2O>@#S?3KS%<S,U.R
M<.>WF,-:9L:[*+VMH>DW<5^Z""%S/PO>]VF%=I4:/N\+'>A[P?=_(5<(LE)Q
M[BINXMPI3DNU,7YA^2JY1&91;:9E/Q6U#>Y0K*3U)UZH_0VYO6Z$8Y<QBIM\
MB\8__(GIETO4589VB>IP!QV\%=;-A.,0(#:$J?6X_P"HXE(4O]:$%3JU=/K)
M`54_#768I+B'6&R!KN0=II@%YKNK5OY.Z*8CQ`)%#MP)W=NU0]]TSLG&;98,
MVMZ67$PI+L>2ZJ:FWM&)-5"C`R9H*7&H:)!0%K0H+0I2=I!.N4?K?:A\%M=0
M#,7&7-3=0-VKT5_\2NJ6Z5U)-I%S&9(KED;3_=H7XGA6M/(J;N8>?M[]UP_)
MKP_<K?R/><;QAFUJF6&_IM6%L3BSEDJV.P6U*8CKBOGTI$PETMM@K54:\X:!
M8WEU=.9;1/>['X17>O:G4?5>A=,37%K"QAN)34,%*FN-0/*IKIS'$+9"Q]C%
M(V*66U7JVV^5D24XM><BF9+!CNM-QS;9=JK"6T\EI"'%RM]&J[:$#4%?27MJ
M_EZDQ\1_OC+ZU.:%&+ZV9J&E7,<]F\C*]CLS2>`(P4<\^Q?%/<#[CN,N/KGB
M\:98F[\W)P[!(-J9;MSEY1%4I<Z](6U6WVY+2*K4L=!T.K+T;I3K[4V7;21%
M&X5.['';Y%4?U8U%UGI)MKIPDDR.K7$M[Z[*[5?KBV%,X[9K/:GEM2W+;:[?
M`<0^4OH0[%BM,N1JKW!3+"TEI)[;$C7L*/4'0Z?'#:NYKP`/=-2OFCJ5A9ZA
MJTLGN_%55\93#L>/<L<B7!BZ7\P.3;C=)=W;B>JNTX?,MZ684B]SY+4R,J+\
MK"C)+=%!2F04CITUY+ZVGCU+KI^FW4[67F8C(74=MX+Z(?HGI@T_].FWPMW.
M9DJ#EP^'BJ1?>C[@?[9S<>&,`M-TRG%<24_->Y&N85'NMV5"<6U<KO9X*7Y'
MR>/-K3M:4\:KH5=CJ5T/0(M`U3-<2AL3QFJ30<%`=5]=S:Q82Z-8P&:5KJ%K
M!F([P!@I??=B^^S",&P'C[V@9K:LKMTDYG/@XQG9E17,>DRLHD*F6FWR&:!Q
M#CTVL<.-J"`5$`:[ET3JUE'J=2^-T+G#&H(-2O('ZA:--/;'EM<RX8"YS:>\
MVF)KPI1>@-%H5'?2)#"]D:>PB<V!1;8:D-)E@5H0^A"B/B*ZZC>:@VZ9+'E#
M;:F!V`]RY98Z?;6SXI1,UTY(J*X^54FQ^#>)[%[GO<GEG).)6_,>0[QR=FUT
MCQ\B@0+G\WBFZ.[91:6KHX3L8M&SS(`2$TH:"FO%_7>L:O!U`;.'F<LL!`%<
M15V/=@OHI^C^G:!+T,VZ>87/%X_,<,"&1FGD51?OF?XJSOD^PRN%.-+ICEYQ
ME41"[IC-L3&A2%Q)+3SB68+$=<12X4EC:IQNI%#0ZLG2FJ3Z?;_F%P\LN(O>
M`)H21N"A/U@AM=4ACL]*B$[3[IY8S4J-]%*6U??*>YO$;W9+;F7'_'TJSQ8%
MJMEZL[UHNMKEWB/&#+#TY%X5.<<%X=C-5*G&TL>J055[:ZUHG53[QXG?BY>;
M-9Z(@DA\#,.7>.&##@X^3SKT)\+<OXC[CN,L6YGP82&,:S2'\W!M\T?S^U/1
ME?*SK5<'@2W+FP9;*DK>1Y'!0C7:^G+]U];<^088CS+AVN]/LT)YTF099PXN
MH=OO8BJ@S]Z+S;=\&X[XY]O''=SE,\F<XW:"^T^WOBBW8V_/;MT&--7&4AYH
MR9P]1:5='&FU5J*ZX?\`JSU"+)TEK#(T2.I05[:KOWZ.=!6K)8>H9:.Y))Q_
MO-+?_$F&PK[MKV@VWCZ`_G:W\ES9MK==[Z]E"G5/9!19NSD6WNRC'9A19Y(3
MN30IH`.FO.%YKVH/^%[CW$KV5H^A:?+EY\`;FV5:,>Y5+\GVJ=[0O<3:&L4N
M+R)F-OQLYP7(+=(2ZZJ()2Y,B+>3"*&S"1':]#::IVK`(ZZN?1?46JYF0.#S
M&TFIQIMJN9_J]T3H\+9;AP8R=P'NF@/PBF'=BO7APOR+#Y7XBXZSZTPU1XN<
MXI9LB4P4_57(A*]1":=#M?;5N_O@:]1KUKH%P;G31<MQH*5'DJO".NPQ6\[M
M/J!(XU#=Y`QJ`E<]!6M:UK0IH))!)30=R>OX-2_/E5?\%V%09][/NXLGMAQ>
MPV.PRX+W+&?K<188KSC#S5DM3"_ET95<6W@XF$&Y1]&,A2=DEP]0::J?5'4\
MUA;&*U!=.W`@;1WJZ]']&OOKL7%U&YMJ\U#B/=([#O7G3S_WO^]^+E]XN,;W
M!<EPZ/*FQH42;!59(X:6#1RV&W"$Y'ZT*$I!->E-<GCZUU-TV:1KP]=LNNA[
M%MH(X2TBHV*YK[OOWXY/SI-LO&'-B([F=W"*XO',D8M+=G:R]5NB"5<+1,:"
MRTW<GF*N,N(""O:4@=-=2Z8ZM=<`,+OQ/2"N<]7]!06MOSH&U?3<%;\AE##*
M6TK#?IM;4O.)#A;VIH%+"@=Y3XU[ZO;[J.9IDC(=+M<`<0=X/"BY7%;21O%O
M*TMIAB*;%5?]X5[_`*3[6X;>$<6V"TY%R9<(J7+I)N[KT^VX-(F-*3%08[*J
M39TE#B'DLN$!+9)Z4USGJ;JXZ>QL<$@,^>A:#B!0XD=ZZ7T[T)-J-9;N![;8
ML]UY:<I-1@#QI4^1518O][1[UE*B+NEPXZEFTQ5O1HJ<%8:B92U'4I=P8F&-
M.$N,$I.U+_K`D@T`IJI-ZZU1_P`#7GN5M;^E]L^F5E1W*^_V2>Z:P^\'BN+E
M\*/&QWD.U(5%SO#(SWSD2QREO!A4N+ZBW'A:IR0/1<63Z:ZI!KU-TBZZMS&Q
MKY6<S**C-C6F/I7-;SH">VF>)89&L#W4):0*5*G=&Q!$>YLQI\A+[$B"X_$7
M'5N#KJTTVBGUBD]OITXEZI?<,!C=@.!32'I>*W=FI@4JY>.6>!;V2J*L*;>@
MJ>D>D`I*/23ZWJ.;=VU*OK5U7KO6;M[JMJ58;31[-H]XM'>G(W,_I)_8?$?L
M?C^#37/<<3QVJ=R6W`;*;$T-MNDZ*^M]947)'20H5HL`$BE:>.KU=]/6+AF"
MH=GJM\74-:HZ7.A3)$*3(JTN"[ZGGH2X%`5V;>Q!2.^J[+I$-J2(OWMM.S^U
M33M3F<6-GV;O0D+GO)7'?$F,3,NY!RNR8]9T(NP$BX341WI3DT#TV(,9='ID
MA`1U0V"HUZ:KEW8EKZ]JE;6U\201Q5'N9_>FX%E/N]XEE/6J[_\`!KX\DF+?
M?MEV5$E97>;Q#<M0S&]VY'DG63''7TE$59HIH56*C6]S.)]/=:[W#V*_Z/H=
MG'<B_?07337R[5)7WH^VR_XU8+CRSP3*Q_)N-LN@19CMODJC)3:Y65!LQ9=D
MN[\J.B7:[I+<"60"?EU>4>4:X/?]#PV=R[5IA0\Q=_T7]1[N2S=H5VPO=E]P
MTV-`IZU'WV:>X7VV^UV3=?;UR7,7QWRO=Y5JR')<^?CHN.(YG)O<94B%"D9'
M'=DB!]@.'Y:JZM;25%72NO2'2_@]&T:WNZBLA:!WF@'K7E?K:SUCJ'6KF.%Y
M:V)KG$<0VIIZ$XWNJ^]=XAX-N4K#>*X3?,>?18S4ERX6^86^/;(_*9<5&1<+
MPPH.7Q1)!]&,0"*DJ%*&TWVMMRJEZ1TU/,1XL4;VJ@[G/WU>YGGRX6^9FF<R
M[?$M%Z5D5CQ[#G7\:L-DNR/ZOF140R9,U^TK2'6E2%+4I8&XT`U`3ZL)K9T5
M=I73]'T+3]'/B6T#@5;'Q5S)Q)]Y)Q7B>`<OV.':_='C01#R;DYIJ.PWE%FM
M(2U8KTJ/%BI^;R&^*;3$<0Y1'KA2MU#77'NJM#+;6?5`,(8W/\PJND6.N3WN
M6WBKR30'N4<K)[[>5O8CR*UQ78<-M>2\0VZW,.-8C>U.1;W;+DS<[I$NL^T9
M"UZSC+-\=:]9;#K2VVS3:!KM.GZRTZ58@G`P_>N-:CH[[O6Y\-M5]YZ^]*F>
MY/$KIQ[><1M.'X=<IL*7=\84TNZB^0F%/.F/.F*WE4@.J!0XV$]`?*G4)J>H
MB>*05_><J#>='Z]!<&]TMY:W,13M!4/\"P7(,DPBX+XOO/S$*V71Z'*MD5YI
M;JH;XW,IC!ZDA"(+:U)Z#<"!].N&ZK9&>]S4PS+U!^GS+ZWZ<EEU66MRQF`)
M%3B/84NO:I[GLN]D'*=_D-8_B66VJ_/07LBMF3VH-7UMR-$,)3>/Y*`J?"2L
M54XENFXD5UU'IT>#L0>SV*B]1'Q=^<NVOM5P^3^YSCOW:X0_G7%^,YKBD>R-
MVNW<O8];HJ)%SL$:--7)@9!9(0<>BY!;I[GE=]-'K`DA8K77"_UAB+KENIG8
M\C_E%/8O3'Z):K=6^C_E$50V,//^)Y=[5"*/8.*^7/<F(Z.2(#.(-;LQY*O^
M2L'&V8N,X=\NX+<0]&8<DWV\(4EE+"*MA*C6FGO0-BRZU6RNI0.4T.K_`(31
M1'6G5%YI]O>0&H+A3SX*R_DK[S_VV\>6=R/@$;(N0[JARWP;)#M5G;AX^W#3
M(CLPOG)]S;VB.VVM8(;!*FDBG;7KYE]9/D@LZMIE`PK790^RG;5>*3HM]-J%
MQK&4XO)]*AUDU[RKDJ/S+G]GM-OM47$,EGQ/W?X[LZ7XEL=S+%8MR;R.T1;L
MAL7J1=G?51<&@TV$#JCN3KR[^NG3C+'JV2_CJ8Y)FD$[2,K14]N"]D?HGU8;
M[HV+1Y#^)%`YI'#WB?:J:Y[4T/W&TW5]\MN-/R$LR&F[?M6N8\])1]C-+6W;
MBZ@@A`)Z=]---MPV..[IMCIYP%&7<4;K^6.7X,Q=CV$JR_[M3GZT6SB?/>%"
MY:X66*RN??K);+LQ`5#NF/W::VEGY+[13\DY=(TYA84A1!(`VZK.LZ0;>0W9
MV;5T[H&_T^>X%H"#1:?=WSCDMD@<NKRZ)'MIO\&%8<=>>L,"SW6Y3H=N=MC*
M8#D036EQ@^I)=6WZ:5(^K3IK?0K/QLS9!C2B3ZXN6V-Q<Q-^'F/`[JHK]HGW
MD%Y]NWM1PWA#%^*K?D.68_<<BD1<JRF\2GK%#%\N$FX,+CVR+27+5$4]132R
MTA1)(5T`/?=)UF:R@9;0?&W;W+RCKO3\.JW3YYJ9#L[U*7VL<D>ZSWBQN8?M
M"?@N:0[1,LDK/,3RQB+"M=QPZ+`O$RWX5QX%()Q6ZWBY[UN3G'"=K205]*:7
MZHBAZGL>1<\%*]#W4G1EYS[:H34^W2/POR)`YI5EG!6)W7)'+C"?LF/S[D+I
M>';*U%E8^)ENFU+\EFW7)#;)6S5QS<%)%"=>?>IM&UG0698Y2V+8T5_=W>8+
MTCTUK6C=0R&22+-*35V!Q)VGSI!^Y1OV^6^-GMBMW`MDQN[6[&+;;K??!#4T
MR[<VH+J'VH:8W\W]1Y]54*7^N-/,-1G3$.L.OV7;WF1@(/=BGW5;]"&F2VV0
M1R!IR]I[%:%]VYS]P=R![?>*.),.S:)*Y$X]XVA(RK$;A&DVRX6SY)U:7W!\
MR@-N10_(2VA0/7OVU[;Z;UB.YTN."?%P:`?[%\[NJ-+OVZY))*"+8N-/.BK[
MU_$N'<W]L5TL.=<@XMBF5X=>F.1\(Q^^7MB).O.1VIGTG+&;:PIV:Z;C%<<2
MUY0G<03TU$]2W-CJ-N8R074IYE-]&6M]IERV2A`!5:OW=^-\LY![:^6<LX^S
MZ7CD7"L[DVL\?2Y2+PQ8(-SMT>9&>C1Y;2U6R/=I3CP:+05ZBFC6FT5\T=3Z
M`^VO8);(5:YS\U.S+3UE>P>C>KIFVTD,YI@T>M)*;RKA_"CN7\BY]Q[D4;W5
M8G8<A/MXYCO8NEPLB<KNBHD>ZL3\6D,,6E-SL$![UK:^4AJJ5;CVUU'I.VMX
M[8&ZH'T7.?U)C_-'YQL)"K1Y#]Q'N`Y9N<Z\<B\O9]EDZY;3)9N607"/;$J!
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MG5L(H/.V`:'I355%^W+0UHK3+I]C=DXBA5I/MB^]9]PJK]C/$O-N0V+D/C[(
M,@QNT3[WE=IB_O;"L2[W:(5Y:^W8R&E3'9-ODJ_6/54`E53VT,>+Y[K88DQG
M#SJ,DT6/1[V+58L&L(%>VO[5/OW(^U;VT3+OG'(,CD[)6N.L?<O%TBX&PF:Z
MN_7K'(TF^2+/9UWVY10<5=9CAIN4VA2"@T2">FN)LZ?&D]4.O)&U8V3,1W&M
M%WC5NL/SWIJ&V:X"3+EKPP`!]JJ2]K.>)C^\*R/6UJ+*M7)T*;C4RURRBUQW
M(0/VA:[/#E/M_*,W&#+MS+<)14DA:B`>M"CU6+&X)NN1@.PJ3_3^[O.GI,YN
M`!)AM^W!/O[X.8,/QEK,&,0L7)!RO)'HF/W\9ZEBWOP78CJVELL-%#DV?)8*
M2!)6XEMY.W:D`=:?TY:,U/5!>Q,+8VD-I_#_`&KHO5.HR6NE.@E?G=("^M=S
MM@]"J3QRVRX#[\>2V78S*F$^H@C^DO-AQ:CN/U@20?IUZ&LXRWE6^\X>A>5M
M5DJZ6X&QM3Z5:=]W+FQPC-?<;<X;LVWS)GMDS%FWR84A468S.;O>/0$.,R?Z
M/'4TQ=W'"XZ4MM(0I94"D`V71FBYM9[*E:M/J)4/>N\/=V]Z=S@?2I_8[R+%
MBXEA>973(K5%1B=F8M4*!<;C>S>7_P#:AN*DV^.N:W]JMR$H]=AY<=)]%8*^
MIUYVZFTR[TC4)61@AF8GSXKUWTIU#I&I=/0LE<WQ8:0:[<#0>A59<VW?)LO?
MR>18[BNRG*E2;+*OUW]*9=HUO6DK=A62:]5IB2\V"AYLFOH*5J:Z-Z?GOKR.
M_N@?#MS5/>T@>DKE/7_4QM8I+&W.+J4\C@?8HQ\=8-BW'6>XEET;+;C'RS$+
M]#R/'+@Q*:2J-<++(AW!D2X[)]!YEUR%M6"?JKH.YUV2'_\`&_RNP+B<_P#^
M3_FO2O1%GO#.&^X/VV\/\O<E9'/Q+F+D.T7#*<DR:R6%Z5:;K:UW66I+EW@-
ME,=$ABW.,-,(37UMG3K77*.MM+@O]8CU&X`$LCVD^091Z`%T[H37YM`L);*V
M-(6-('EQ]94?>4EK^Z]S7CESVZ/1,JOF36.=E/*;N8VNBLMQN6TVU98UQ:A.
M[;"Y#E.&1%;:45)VG>/#73=,CM((XA%3/RG#SM5*UGQ743)WOKDY@=_A)*<2
M7SG>N3K#<N:)O$=WBXWGZ+A;/1PR].Q"U?;.&47:>S-9:$AVV/O/`@/U4D@@
MTUP?J[1S%JCKSM7IG]'>I`WIR32*XAM/2F0]KO)/&.5>ZS"KOS&]C^%<<X9:
MK^<)=SJ\LR(U[S1;+*H<&Z39VRVIN$HO*?CA)JW3K16K?^G>B6DMRV]?3/(0
MX^54_P#67J2[;H;-+CQ$,>0>1>E.+<(=SC.7*VRX$V!-0W=/G(,MB;`?:6RV
MVV[;Y4-;\=3*6DI&W<%'N!0'7HB%L$0:R/$_#AV<:^@C!>,>3=93<3`Y"[[U
ML2\TID/@K+1&XE#3BEI3VW^D!O*:^--.B?.M$T7*6/VK/,:>AWI#HM\1]=P8
M<5'$1"9EO2I4&2L3DAIQ"%(%:@U^G4#KVEV>I]/W+'`9J..WA4'TJ0Z?UB_T
M3JNU.FU]\MK3MRJC/FGD.W8W<V2S`R%CD)F!=BS:9UME.1Y"T^K%AR8U\4I,
M)NW.,]V4I2H'KV&O&#=.MV7[[6'8)/>[J_>OI-8:O=1:`-2/\Y)#E]%59K[2
M,,XTM?#^)N\=#'KRS?X$>Y9C=K)-;FRYV32&/G[PN^3`?G(S4"6HLJ#M`DH\
MO37MWH5NFZ9T@SP)'.R5)W5I0#O7S5_4;6^H]3_41[+T.\/G-/\`$J]_<E][
MS$QF_P"18=PC@4#([I8;G/QN5FV92I$>S_.VU7HONX_88;B5W(1G4%`#Y0E8
M&ZM.Y^=`85&_BI2VZ69<&MT/=..*CY[<O>#S)S!,]T7)/,L1/,L'!>!P;)QT
MI%NQ;$,>%SR6$W=,B8880I#!M\2$A(65./NK4@)%=0^L10:_:^'DI[E:>7;Z
ME;-"L[7H[6+?4M-P>7>_3@VA'K*:?WJ6[AKBSC?C_%>.L$D8/SIRAA\'(N4I
MMSO[&83L*P+(!]H6?'8)*&&(TC-V9*/40A"9$:*M)/7KJI:%T]8Z-<NEPVD*
MVZ]U#>ZYK(OVU(`]@2Y]GO'_`+C;][<L:O6!W*?<[9,Y`OO']B@MVQ<^XPD6
M$P2[;8,N2DI<,E-Q;V$FFTD5KKDO773[KJ^;AM=[5?\`].M;N])Z2%@ZX`=;
M>\<=FQ+3D:./NYLHXZY5S^Z?VF^Y;*<@;O)P"VR4WJVXYQPIU2,C?O4EA+;4
M2]R[:\6X`;JCUD+W$!.KUT9T_#I-K2XI^)E(\@/WJ!ZZZAO=6LVS-?S!.UV/
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M;MBT5EO)(`A(2+E:GKB*.1;7=H`"24'>0E0'77G_`/4'I:[DOCJ\+3D;$&^8
MN/M7JW](.K[2QT@]/SD"1]RY].QS6#_PHSLAXEQ_B^S6I/&4>R86ZPK'H-VA
MV];3K]P=0F,A#%R3!?O#UR2I/F#B`LKK4UUS>QDNYB8GCW`:%=\ETVQ=DG-,
MKB"J%/>U[=LFM?+..6?$K?.N5NS!]R^6=N0M:Y41420$KB2W)#3+Y#J2-HVT
MH>NKITYJXBO6VA.^E%1_U,Z-$%W%K%F,!%6H_P")>F'V,^W>5[=/;)Q7Q3)F
MHO=X;CNY!>'(Q>]&#<,SDJO4N*DR4H<1'M:I`:4*=%`TZ:]2:%?MT_20XG:2
M?:O"^LPSZ[KLLTF,G,+?(TD!45<B979^2/O6LI9SS++XQB6.9W?L2QYVW/O,
M/VB18;"\B,W9)&UQ#"'ISRUH`%36G<Z\Y?J:X:A+)?#8RA]-/:O6'Z4QQV<$
M.GSX,><?)C[%;=<,6XT79(F',SN1H2+2),R7E[D9$BY14.J$AF8W<)D"X0I4
MU:U+W,EHKI2M.FN+KTOJM(1!X/L]BHT^\!M^)S>2\=_=R5-N+EGL+UNGW:YE
M@SKG$>/K^K(3&0VAJ0Z7*J1L0$GI04U<NEX[QHDFB^G_`&*D_J='!=6D?B_Y
M@M%?-0>A7/?=)\CY#EOM>;Q.Y17#;N+[T_BN-W!X!2I-IN-;NVPI8)47;8M"
MVU5Z!+B:>.O3OZ<7D\VF.AEK0.KZ*>WT+PG^HFC6UKJ;;N*F8`^G!69*C25K
M)604*))30UZ_CUTA<[7DS]\N/\I^X3[R'D'C?"$RKED5FNF/X5CEH>4M=NM5
M@M-G;N3EX66]R6F@_)6ZXD#U%$)H-<'ZOU?DZG<Q[Q)[`O170=GXG2;0`8F,
M>LIZ,?\`NTN6$VAO(LLY&<EV^VS25VR'C5[;D3)T5E\O--PY,$S'XT9Q-%+I
ML74$:Y,_6V^*..XKO,/2;I+)LE-X43I=KY4]K'/W'ZLGNCRIC65XCF.,SFHT
MBW*3!>R%NVJC+B2F8\AJ(_"><:<0I-2KZ-7?HS6V^*V[US?KW1W6EJ=U`O8W
M<ERD6>[7RUL-.RHUHG7:`EU),=R2U`=F1]Z0"?0+J14=]NN_0ZM:-LGOC(YI
M;4]]%Y7CTRZFURDC3R3+AW5P7FAPSC'./<3C:LLO[^`7C),GSZ_Y'?X^59K!
MM%T^R[=+<B0/E$?KI$:(ITR?20^E"=GIBNX4UY-U[J&YDZFFCE)Y(9AWU'L7
MO;I;IJP/2<#G`9ZCU%,/R9PM`X^N*7KI8;7:[7\C.MT&=:<B@9-;YL^?.,41
MA)@K<<ART./I/H.A*E"E.^I*QUH91BH75](N('$6@-!78K4/N3..9.'83SI>
M+U96+>O([A9$62^K<<0])@179+4F$[%<H4K5*0%#:.@%#UU8.DH?SRX<&X@.
M/K7+?U/A=HUO&]^#G,:?*6@J\I<V(A^UR`KUS`C?+J2@4.\*)WC=TVD?'KKK
M=GHQS.B^4!<6DNZVK)OF)]07)<,AG/-S(K32"P_3T_4!)34>;=2OC\-/_P`C
M/!-O&HGWS_\`9;OU:=S_`*'MV^C4_P#E5G\O[OI4#^9WG;M1@8\@@BB*&GYH
MKT_%K5URUXRN."=1B:(U8!YDE,YRBV<=X5E6=7]#KEJQ*Q7.^S6X[)=<>9@1
M''$QPK_40Z]M!5X#3&<,;&71U)[2G,;77ES&VY&`.%,-M%Y*O=M[J^2?<KEK
MEWR>-(M>*VF=+&&X6VM*K;8X._T8\Q>W^EW&6RGUE.JZCU=M.FJ%JEY-&_*V
ME*\%U*UL+>T@:^$&N&TU4,'XSOI*2E+20?*0D*5^I4"EUC]8I9]!Y!HM/YP\
M=1+9'M=F&U2]2)!("<P/D\RMT]D'NE1E&`R?;KS)GUSBV'CBRW#).'VYSD5Z
MT75YE!8G81DPEM27KHQ;&I29EH00`RMI2!6NH?K"1]WTX\FG.9*VE!3"AK7B
MKITUK,XU-A>V(O#"![@V*O?W:6&T-\Q/FR2/M*&UB\$.7%6X"4[)*D.N1$;&
M1#A.!9V,)2EM"32E-25M+)/TK9MJ>;'(PX'@6G$>14C5VN@ZGFNK<G/(3F&Z
MAK7#N)48)-H06TI$="-I0E*DU24H2E0V)`4$;5=STK4>&G\E]<38/(\RRYC#
MA0#N"Y!:-O382/I->_TG6UN]V4FN-4C):Q2MR/+LO>GJX`Y1NO`O+F*<G1]S
MK5JN\!R^QFT!2KECB%,,R[:$BC:4LQ6RXR0-S;U5@DZ1UM\EYHEU8OIRI8'L
M-!0T(I@>*E-*N9=-(CM:92<<PJGB]\TZ)E?-_P"\%OE,3(=ZPZQ7F*^P@(8E
MP;\_<+O">80.B?0CR`VLBNY7743HUY?.ABMYJ<F(4;AC3MX[4VN&MM[AUW']
M9VVN(\RAHQ:EQYL%T%26_65TJ.IKUJ2FI'PU*W(`>6#X3CY3M24$SRS,:8G9
M3#S)R(AD,3`]!GS+4^Z`SZUOE.P0V5^3U0B.IM'JD&E2"3744_3K9[L[LV;O
M2PFF;()&N<"-U?=\HWKOG86U$E0UR2BZ7(*7*,R:MR7)'JA!2I3KJS7<1J19
M(Z.+DM^!-WQMDEYKOC4JO;;G&3\;<B6F_BZOP\2N"38LSALDH9G6]\?J6P$J
M"&G&:A2%`5"NNJ=UQTPS6=$8^<.,322VAH=IK7CC5=*_3#J^?0NH'PW)C%BX
M`8M%=@KCYU*[W0>V&%>L'S#E&T7U1;CXXO)"F-;0WZKK3D54E2T-;0XAYAD!
MP&H(J?'5$Z(N;^WUF'2G`"T`?N][W6DCWN\>5=&_4K2-)U#1YM:L<W+)97WJ
MCWG@>3:JJX60W*8[:(UTB6Y=OMJMCBO3W./0%.K:B+4$+0J,_'V^0CXZ[@R:
M5EPVZ:X\UFSAYEPAD,3+5UFUHY+]N&/G4]N".9LMX?SA,F[S;E>K'D%NA6JX
MV".NM[N%D9M[CD5<4.ER/*$)ED;'W2'0-PJ0=2'5&CMZTL8KC5ZND`J,GN;"
M>^J0Z=U"VZ,FD&DDMD<3FS^^,>&RBCIR@]&S_,\ORY%NB6A^=,5=&H4=OTGO
MD)#>R&J0^K:F1(6V/UJ604(5W.J.-$EM&BVI_I&##C4?#4J9BUW\VO")2.8\
M$F@HC+VGRL0QWEJTG*K%)9M$RUW6W?.M5?GL7<^I*LDIORU^4-P46E(`\RWD
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MT`V6VU!]J<8W,`][$[=Q*L?ZN31SVT5Q9&@8\N!&PG+3&FT=B;C[LC,<HX\]
MV_%J;8Q%E(RVQ95AF2M2BU'@H@7''KC=A-DR5I4HOV^7`;4RT2:@&G?7;;26
M2#5&VL;J1&G?YUYSU=LFJZ09KL-YC=[1EXJ'/(%VR3+<OS#(LEN\^_7R\W^Y
MO7"[7.2Y<)#X1,D1VVF?G52&XL5#=-B6DHI0==,W@EQJ7;3O[5*01LA8W(!7
M*/4K/_NC^4;9B?.MRX=S127<)YVL#6*):=E&&W%S"SN/73'K@'VPETRYC8?B
M[JGSN((I332X:T`5`/?BIRQO9V.+FEH(IN5FWWL7#6*3O:)F&50;+&>OF-YU
MB4W[4D2'9TDVXW$8^Y&,MQ7J.1GVYR`M-14I3^CI`/<#@:!.KRYEO6Y;BAIP
M%%Y5W[*AMTI2.B4+4*FO5()'A\1J8Y[N#?,JSRF\7>=3U^[?REOC?W4<9Y3)
M4642K9G5H6M/^J%[$+K)$=8_.8=>C-%:>R@G4EILH8]USLF:W**8"AH34;]@
M6T5G'/<QL?4L#P=JFU[)LK=L'N,YCN4UXJD<@\#\C7#SG<U)NV/Q#E+RU-5`
M+326WBE->@5WU"]-Y+F_NK>1SLA#G8&F(%?-@K]^ID7,TNRF<UH<',;@*8%P
M'M5+5U;==1("`C<S62\2GH$RU/*BD?"J4_C.M@T$*IQ64,!K'F\IJB*W1W(]
MVL#[<<2I+DD!II`.[UG2`%)([$(:)3\%`'2]K,^SG\3#3FTICB*=R=7(\7:&
MRF^@75PP->]20YDY1OG,&<KRJYB2R';3:['9TK=>2Q!AV"(W"=CVZ.IY;,7Y
M@,[WBE-7'?,?AIE>01W4SKN4#GGS>9:6T3+:`6L9=R1Q./G3;.MR$1F"MZ4V
M;4Z_<8#T5*Q,:G[TR&I#<MDMO1GH;K?J,.`_JW$@]>VHZXM!=0>'E8PQG^Z`
M?.I,W)(9^(_\/9[Q5TO.GM2Y(Y<^[ZL7+V5VYJ5F6,8E:N07\D-T4]D%XQ2#
M)07'KN"%+G7&1:I+:_7)!_5DTZZJT/3%_IUYGT=H%B<3F&;WOWL<-U,%?9>J
M[.]Z?Y6IO+M2:2T4-!D`&2HX[:E4A8S87I[RH=OE3GBPXU<I!?CE27?)1!4X
M:;6B%UU<+>>>%S9)J>)9LPPKLV+F4F2[9(P_1<#ZU)+C5[*\$G72599+<-[(
M;(O'[BM3+;WKVI5RMEY=AE"SZ:V7I]GC*<0L+;<#>U22#I[8ZK=Z?*Z6V+<[
M]M14>0;DA<6T5U&V*:N1FRAHKMO8GC6-\U^VS-\>Y#Q6;EUUQ;EN]O,90U(C
MQKGCS.2615\?2FX%P2/E9[Q>;0VH;6U4"*``::W]I!KE9K]M9';<ON[,%(Z?
M>7.EOYEH\@T`Q)(P[%&/[S_%<?Q;#O;GQ_AF#VWCR++M-XS:99K<]\[<)C"G
M!:8]SOUV7_.)LMU\N56=M:@4Z:=V[ORW37V-H`('4K45=@0<#Y%K?7,NHW`N
MKHUE'#`<-GE55#/'=OE07W@1">2P6WYJEJ_4B1^J2]4]@E:MO?QTC'?W$?PD
M>453"2VBD^*H[C17L6;WJXAQ_P"R[C:Z,8O?,HEV2?,XCM>(/2H<>"[D.&V>
M`\W=KG-<276\>:1(9>1L!?\`76ORD*&H'4[7\XN@^[K5I%,IR^JJ>6LS[.(P
MPTR';7$^=5-^X3W!<C>Y'/9N?9HNTV^1.ML*TLV;'69#%NB1[='>8AMS!)`<
M=E.EWSJ\N]76@U/VMMX8LF;FS-%!4U%#@<$YM+N:")]O'EY;P:X8[.*MO^[U
MSQVX^RSFSC-6`7#/;U@>>*E6RR1WHK$RV8UE5O;N5RR-<^6I!;CVM<!Y24)-
M731`&H?JG3+6YM"^0',>!]2F/T\U:^L=8,=NZD9<:@BM>S[;U5][Z\IQSDB[
M<46*!@</CK&+5Q[%R*XV!I#-R1D&19/*N`;R&X2([1=>D7&UV^,]'4L(##+J
MDBH-=;=-:?;Z?I\$UMF$AC!Q-4OUOJ=UJNKW5G>93`R9S104-!VILN$?<#SG
M[?G&GN)^1,GQR*F7#>_=L7&3<L:F%EQ%8LBS7!R1&3'=:!31&RAIJVMU2[C.
M<%I-*8BHI]@N;:EIUN;(0-!R"0';CL._RJ]U_P"\,OUQ]J/#?(4F+$8Y8YC:
MRVV7.19]BH=BGX5<7[5<W'(*%%N*J1(6T0T#Y*U\=2]GJ=R]@!RT&S#[RJ]^
M36^TA_G49[[S'R7F&-J3?,LRJ?`GI478KUS=$8QGT%PL[&PA09HJE*CIIA<:
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MSSNIH#T(K].I:XB:UI>VN8X[<%%ON)'LR&E``,!38D?@617W$X&4VF!.=A6/
M.X5NMV3QV:H-WM]JE.7");)#B5)4JWJG.)==:[.+;03]7JSM+B5KG4/#VID(
M6"NTUXFOFX(CRMZ\9!>)&0W^=(NMX><;6Y.F.K?==1&@L6V`IPN$[OE;7&:9
M0.B4H0``-;7#!=?5)\AHGUO=RVK,D66G:*J[WVZX]AV(\2^V"9F-RO=JPW%<
M-R;D_E&WV^_7&U1;M\XF]9/8/3^1>85&G71BS,,NNI.YUMYM-0$ZA[NT@OI1
M-."7CA@/,HW3S+$R:W9))RI\'^\=AX<%4I[@>2LBYWY/R[D_)IDZ1<<HN#DN
M*Q.?=,BTV5*W462S1Z*`8@VVV;&$MI`\Z%J))4=.9ASFQL=@(P0*8;>/'8I2
M.NG6L=G`7.A;6F<YCB:G$IC'+?'CPE3YC+<A;`*(S4AIEQA'0[2I'I!3JP?%
M2B?IT\@OKB#W8R*'!-)&LFD;)(T5:X'`<#5/MB_N1Y8LGMYR'V[6VZ08N&NY
M4O(!CMMLEGA.7MF>]`N29N0W),1<VY28S\#T6'%+3Z;)].A'71K+XG:>YK\9
M*4Q4IIT44]U/$12WNW?B4PVDURG]W:?0KSN)N6[URIA>.9MB-[QMJR+L<5Z]
MQF9=FLD6PWN+&;:NL3(FU-H?@O1%M;T-^JD/"BNYUY\U:SEEAEE</Q6NHVFR
MFW$;\=Z]5]/7>F/Z?@TB0D6]NW*RAHZA)=B=YJ3CPP53WW@&<V3E+(8EKM-^
MDYB]:W4(RG(OES'M4DLNNICI8]%;XD(0IU00I*U%20*:D^A&W0=2ZP`.X47/
M?U"=;74/A&.)8`:8XUW5.]31]A_O^RFR9%'X0]Q&=8FW@=EP!;F)9W>%N6]V
MR#&XD-5JL=R4ACUIY?@,N-H`3ZJW`FA[Z[]I>KSP,Y41;D[15>9-=Z8,CC(U
MIS]Z=CW'?>OX*XY<L;X/PE>>I??9CIS#)0]9+4_24S&]2PV%U*KE<+E`)6&G
M%EM"MW0=].-<O'3Z#+![I<XD[,=VSO2/2ND.T[5H]5U`O#&$-P):*#B/+M4E
M,=SK+[B]<+@]#NYMS3<1N#8[G.MZ;3:W%L)<,]YUM*+I\RVKJMI12E)J*Z\T
M75U=Z3SI'!O(`)/NXT7M7IUVF=16T0C<\VP`#Z.QIV'CVJNSW*N\I6[)G.0L
M&L2<WGXRU^].87>Z69[(;'CV+-3VW)J6'`^VNV!R8&FPZ%*HFHIUU)=)Q:;J
M-XV\`?SZU^+#S*-_4?7=4M[$VEB8N4UA:,S`XTQWU[4^O$?WP[*K1<+3RSQ!
M#%Y:LTMFUWKC&>&F'7FX*G@;E9KNL.1-BT=VE*J-=TO]1O(-.#&N%.[U+R=H
M735M/J;YKQKN:^1SC0T%2:X!>??*KYD$?D6X\HV:\7>-?I&7S<AMMQ^90N4W
M<9#RY[;CZGD;55VI;=)_U$J'CJD/M8=9@?;W]3&_;0T.!J,>\+J]U):=.VGC
MK8.SPT(%:[2![5.>%[XL$&--9`QQ;E\?G"XL%N]SV+G;E<>N7M3:67<M1YV)
M3ZU@`AIRJ&E5V_6.J#==,VL5T61M?R?XO:KSI/ZH03VC'S,S3LI3#?VBF*A3
MF-WRS,[G,R7+;HAZYW,N>NMYD!9;6JC:AYJ;5H2"DCIMIJPV7,TQ@M-/`Y7]
MX9CCB<5"]2=2S]33ON[VC833*&C+3*`WV+TM_=)1<?:]H<1%HFLR;LWGN6/Y
M8PFBG(=R+L&/`861U0EZ"?50GK0'7=>BYH[6QY8H)'?<O,O7+'3W.=^-NT[N
M_#%6<-M(6#N3U!IT*A_<U=O&]H7/N3;<'>?]B\Y/N<C.>VW[TAODVZJG6C&.
M7+%"N4:^P&/FVQ)NEI1CTMP$@4EVZY04AY-?U2%5UY\_4#3I(KR>^%<DCZ^@
M#V+OWZ6ZK;R.AT]VR,!OIJK`\MS3D!:H.;P<RLT+"K=!B79ZZ-Y3NCWJ+\NY
MZMP>@K4MA<RWH40&@`%[S7MKBM;65^6'-XHG''"F_#S+V1#+#;:<))!^"*>?
M<J3I"LA][?ODP^QV:XG)8LG,\<MKMV5&8CL0\7L-R3>+O=`RPVEM+$>)$4*]
M?,2KZ-=+Z3TR.-PE9FS]I7G;]2=;M)LT3R"WL^]>OZ2RPW&EP(Z(ZXJH[D)"
M5-A33D?TBP/+T!;<:'Y#KL]CI\$;FMDSTE;4^\=_#@%Y\U&];;PMN;3+G9LJ
M`>ZJKTS'%>,^*\C?MSN#-SH,V[M+MT2;-;;L=F;FLORHUPM\!-EGUD1REQ02
M-M4J)KX:\^=;Z4VVZED8`1;Y*CC6HWKUG^EVHG7^E8V3NK<L-<,,-FQ(3D/`
M.+;U9[U<W[&)LQZW&-#OEZ;6XS+E/.B3'58HS\&"U%47T)27`THJ2FB2*:KS
M!R6T9L"O$H;8N_U+08ZJ9'`G%=HXRP"R6Z)&B19+UIM[CT=**@I?91,*P@D'
MYGUGE5<ZDZ]-=`])1:+;,O&!WXK`[$UQ<`X]V)7BW]4.MW]2W<EI<9,D4KF-
MR@--&DM%:;<`GJ7'W@!I*4D=3M%.A^/X]=!YL,$[BSZA`JN;%D_@XV4_"!-.
M.P;U\$=\"@V_C'^5K<W@.-1]O*F_*DX%9>BCX?PZ8<Z3B=J>^'CX)4_+K_P0
M_*G456X^5WH4KR&(NO6/6O);/<L9O\/YJR9'"F62ZQQL5ZL&?%>9?%#Y3M!"
MNOPUMG>V)XDP=04K^Q:"++=1N'P@FOH7B^YFP%W#LXSS%TH<4QC&77^R,J5W
M1$AW20S`;57J2F(&Q7KVU3-58Y\A+!4572XG-FMP(O>."8[['>/J#:H^F:.#
MRG:>W4:C4[6^UHDV2Y0[Q;FT*N%NEQ93#;RE-15NQ'DS(Y=6U15$OQPE5.Z5
MT^.H_4(9+F'D-!+3CY4XTV<VVJQS/P@##4]M=B<#F:^L\@9DK-(=K;M+-RM4
M,?93*BMFWO/(0J3$2I?5P,/%1!-13MI;26/AMS;W`RL`PKO.Y+WIMYK^2<.!
M80:'MQ3*+LSA>4?3444Z=4TKT^)&G*8+Y]BK_P`$K\J/Y=/+?X#W_<A9"RE1
M`=:6M'4$%2#T((IWTLX-<TM?\!V]R4C(;(''8"NN=$NUR%L=NLCYZ5"MB;<R
MX@](T)EW^;0B%D4#*!Y0GR@=M(9+:/Z;A1%XYL@HS%<?V,N@JTKIU'5'0_$=
M>FD)'9GU36%I:RCL#5+;%+*Q)NUMBOE(]22FH6`KZB%.]:@C\SKK1+)67-EV
M)<7[B^P$*:G.(:0I*2E<8I0$+`ZC9T-*]M"$>MV]3H$B&HNH?"'%-MJVH"R!
M4[%%"=R".G32EQ</FLFV);6,5]))]J<VS(,W,>\-<.].:]SKS2G$[OQNO.(<
MG!)%N?MK5HE62&NY28,A&V3%%Y;'KME;9H`1178TK72=KH.BV=L;V-[/S$'!
MN-<<#NI@*[U.R=6:@^U.ANJ[3GT)=N&4YAVXD#<HM"V+AJW)C[!)M\JV%HI0
M5QHP97\NIQ77<Z'#3<*FIUFH4;SX?F"?&#<;N8&!7-,>W-+A1A&2\PI;ESD.
MO1S;W&9GJ#9ZB&JF@)`3VZZD(M1O8XQ`QA,0&&Q1TUE:3RF9TE"X_;<OM_M8
MM5Q@SB"IJ(TN.HK`4AL/41MVFH`(\!TZ:'S.E:6S-HVFWMW;$I:VD%M-S('U
M?0BG8N6+B=S:O-;1<)4!J-N5$GLH:*%_-^A,W540\DM/(Z=.A'34!!9AEV7N
M'N5VJ3YDJOHS?.F^?_NU\^N%P(-SQG"6\8R!M6TRI&58Y=+9-C/K%26_FFV$
M.HIY0'*`UJ-7^5MAX%A8\&3(./#N58U^Q-Y=P2Q&N4#-V'"H7GMO&,Q&K8)K
M2D*<7/ALE(2*BD1\N'S`4HM(K\3JG%[FS'E_#Q4K;PQLN`^,YOPZ'T(N39U+
MVKH2H)V!7EW!)'5(/<)(/;6W-E[5(^1:4VP>DZPG:VX0I#1*:AHE5-R`!1)0
M!44\0-,GV[KN-S+H;S2JQ#-/:0.D@!\34T&_:IU<E^XC'.7/:3:^),O>OD7E
M+$)EF:LUX;M;=SM%]M]G?+<:5*6MY#D:Y?9A]%PFH4.O?KJJZ5H]S9:T;@QE
MMN?WL*;>]6>[U2+4>G&07;P-0#C5IVTH*=GI4#8\"3"CQ'K>\[;+E:$A$&XQ
M'78KKP`6$J#C"T/(?2VX4J->QI6FN@P12.U5MR`3!QW;O*J'<-MV:4ZV<X<X
MU]W?]R2R[.M]*U!OU%J)4H[4U*BJJB:BI))TT=\1[RDF_".Y*7'9ETPV\V7*
M;*Y\I><=N4"]VET^52+K9YL>YP5)6BA1Z3L3>KJ*H!'C33:=CWTRBNU/K/\`
M>\GM7J4]SV06?FS[N3EC-+8EL-9+QUC69OQD47\G)G7#&)]U4GH`A+%S:DT"
M>J=IH.VD!#+7X2GIV+R;2[.YZR26U#OU!2*C\NGZADM<,DKQV]V&\L*+;UJN
M+KZ"A2D*2J3!<AA(4BA'J%S:?C7KTUNR4MK&WXG`J7T=C'7`>^E`X*QOBE;=
MBY,M^0G:TE7&G*-J=738$2)O'5]BR&5$`$)V.H-?J*)%"3JO](RR0ZS<\ZHS
M,?\`]+ET;]1;9L^@6KH1F`>P^9P).*JF7"<G-)?2A57'75>6B=S*J>ENJ15(
M!-`>VIX'!<V-Q#MS!&=DL;WVC:W`TND>:MQ:ZHJTCT4A*@:U'F)I3MUT5"/$
M0_,$K[A:RAY)"#1MQ2DCI1-5DDI'AN\:=];-REP!V56'31EI#""^F'>M2(I=
M2ZA>X!32P4#H71M42@4Z=0-.,EO\P]*;UNOE/H7I\R?W%8"C[M:9DTJ.VRW<
MN`F,$1'.]"9F1S[.O&;;;(J`C:J2%/N+],#_`%.O@#K5U[);MY$+,[-M<-^W
MU!+VEE'//S;M^1NRAKNWX=Z\V/']L<";F\TA2@PTB,X4T`2[1*0RKK4TH?HZ
M:AY8YII!(6D8IQ=!L4[8[7WH:XD</*GB@VM*6PXI1"U#J/$?345`KK')E^4H
M5MOW65U$>^<QX0M03'O%DL>6M))\LB98GY,,M[/JJ51]M)W#LH>%=/86EL8#
MMJ%$_P"\(R5[).<K?;7Z_P#>7A=EQMI)45!+LJY9!?)D?J2D>@N:FH'3H*=M
M9F:71D#:A01D.L(C^FI24UD,+6@@T4TWZA7N%-JDI41T/CICR9>"$EFY-U?L
MD^S.25O8VYD+V0Q[5N65F\+M[EI5<6`H[&D*CE.XBBE>F*UH-/+>&-I#I,')
M)TL;20X@."W1(ZW4?K`H[B"I9ZDJ'8DDDD@^/?4K,^W\/E8X9@1AZUM'/"'&
MKAL*F][.N4[GQ])Y>PB"IU1Y>PJWXXR^'%I,65:;B[=)*]P(\\JVH6RDU%*G
MX]:YKLC)K3EQ&LG!3?0\4GYSS:?AYMJA5D#DZYWRZ+F2C)$=+>/6^0I2E)@V
M:U2'$0X+N\[BI#'ZM-`0E/0=.FE-*:YFF0,?@X1"JUZFGB'4-Z"X5\0](R31
M4UJ$"?E0I2I:4;DK7'#:TE#:A0A9<4FA^C3YV(P4&713>Z#7>G-XOR.^J-IP
M=;BH]@M2<CEVN"Z27&U7IVVOS%-]5(0X39TJ4H$%174U).I.SFBC;[YH5CD1
M\%:BU9VS&;#+;JXI"(S7HI:)4=@;2EM#P#94`?SAMUB")TSI,*QDFG<2D+ED
M@+3"*D)E$>[OW(XSE2N,;;D^V#;;@SC-HF)M=B<EQ+:\H18RVE/,'<^II9`4
M"%`#N-4>\T)UWJ/X#"]S'5-*8#97%7?2-:%K:/CE?E<64`/>E#R$[)A13'EO
MKFS0RM^9,>`#DN0$+D392PGR)4:$D#ITZ:OL%NZ"T$;1[P&SR*I3N?/=F1WP
MD[5`?FMIZ79+2&MZD29*5IH:!:%J#@-"1T(Z]=*WQY,8;+[I("8&"7-L.TIK
M46-Q;L8A"_U#:%*2#T&ZG<5`-=NHJ#W*O?@T[.U)NC>P#,*51M<<?7.:+FQ6
MY;920*"@2G9UZCP&E^;'Q6BEGRMR5=9W&W&^$Q9*8ID8CCZ;]'35MR1;K9:X
MMOL=OV)H&_4BP!(*30%`(/4T+(+6UMIV/J]I`44[I%9A15NN$;I"DHW*&XA=
M%!#8(!/4J-/#05(7$;WY<@)H$C[S9Y$6)'6XVIM3H2I:544$;E&BE)&X$!%#
M3X:RWX@3LJFKH)LIHTUHC+"XEG?EF')C+AM2'V52I3ZJ_/K8=0XTII("G%1P
MM-2T=@4/AJ,U87<\^6!I=#7:%+:01!#6?W9>W[%7-<%^R'B[".`)W.5_9N]_
MAS.)\IR7*H=IR)V%:[Y?WK\K[-@&SQUN):,)#:0XK=7H4U\-0&HZ:P21L(]T
MLJ>^JLFC:UJ$3G#WA%F[."J$SRYW+*[_`")<JP6VWA7RC<"W6MUU#$2.V\"U
MLZH2\8K0'574D:<VMI:VK:0$&0X`!8UV]O+D\R,%V7%)U^PJ75R2A1(((6Z`
MM2E@':*G<KMJ5LQ=Q.!>T@>158W5U+A)&1YOO3A<4<0Y#S7R#B_&.,HM#&19
M/>8=NM\F^/+8BK><)DL-(<01M=6Y%/6H.IEKI),):\BF)4/JDSY&BQ8VCG8^
M?^Q>CKFOC7%\1%EO?(G*[&-V2+8L7A\I7](6Q;+4BUPXENM]KQRTL)2[(4ZM
ME;KKJPIQ:%;E"NJ+U!H,6HSBWB'X$IRN/`':5TGHW6;WI_1YFMKF,9HF@]W_
M`+M_;]PY[?U\2>W2XXER!DG*=CG65%YM0:GX_C^'3G`Q.O%].]4F==)S-0U&
M6?U3AW$`C3C2.EX-&-8#6BCM7ZFU#411S2[S?>O.I8;`J/,6]Z`1$C@H;D;@
MXI3`)`==!\S+KPJ5-BH2.E3JPZG?0^$Y4K@)N&_L3;1&$#Q-R,A).WL[EQW&
MV&Z240D0H7R,=:EHDLEPJ6H@@D)6`"H@T-1ICIUG=S1%\+"X=E./>E=7NX)7
M97G/!O\`MWT1[9<1@IF1@I"'F4MN^O&"$A+R0$[4E!'IJ`^GIIWJ-E#':$OH
M)Z;$ST>]@BN@'PT@KMW>M<EQM<6=<9,6+%7'BM$);CJ`*FTI;1N`ZTZJKMH>
M@U`Z/;$R\RY%(ZX$I_U)=Q2O=^74+<*`=V.WM4G_`&R\T9A[=<^L&1XC>7X-
MFFW6QQLXQJ6A4BQ9#8!.CQ)*)T8N):9N;<9XE+J!O)2*D@:N=A>B#4F-:?\`
M2Y75/DP5)NM)9J%@YEP*3DC#N(5Z/N&^\4X>X$NTW$+/:[QR+F$)BKF/8VY%
MM..6-Z521%@73('/6EJ>CQ7VU+2SO!2KJ:BFK3^:VU/J#T_<H#^CX?E4`XEW
MY7^\;S:P7W/[;A^)\5<4W1^Y62Q6"$XN[W&YREH6;:O(Y"OMF8T%"KI'ILJJ
M:C7-^M+Z:_8^W@;F8#M[%V3].NB;&VC&J9J-9\9QHT\#YQLJI`<P^T[`;3:+
MAD=VN!M%HM-E$_[!5)]*W2#$86Y\JP%K2/5<=`0$@4577*=-T&5]W6-I=<4.
M'9O/##!=VU"6#\I#B^ED2*/W5QH../=N5:7LQY@Q+VN\^9!R5>\)D7+'KY:;
MK:6E0Y;/[RXBBY7*,\9N/Q@5Q9S[S/J(=9<4A/HCH>M-=BZ?M6VC:7/N'M_9
M5>7^O+&.ZD=X=V;N7H]QWW4>W3*L31FMNY<PF#CRTI]=%PO$.UW2V.+1O7`E
M6-]P7!N9&!*5MMMN)"P0"=7^\NH8W02L<.2&-J=U,%QJ71=:?:R1"!YJ3EQ;
MB-Q&._M42^5?=K@O)V567$.#L09Y859]J<WY"4S<(_'^,Q"AUR';HC[T>)*R
MB^O20A14$@,L[TTH=<F_4>ZTNXY=Q:2-?*9*&@-:93MP&]=O_2&#J_2&\N:T
ME;`6[RRE,PQ^))NS8QRMS)?FG,K<AVO&K/*`CV.WI5&9?4RVMZ.]&4ZEM$6-
M%:0I;@*BAH?654ZY>&F0>YBO4.HOTB[TYHFF8V[IBW&M<.Q.9[3/>!;.2^1>
M3N$^1\KP"1DF$Y&]`XWR&P6X8Y;\VQN)&:BN,>E,ENIDWVT*;#"G4J'S"TE:
M4D*&O2W2G4-T^SCMIFN:T1M;B2<`!VG:O#?5W25M%>S7%N0XF5YP[7'C16/)
M@-DK2%`+;4$.M*\CS2B-P#K*@EYNJ34;@*CMJQSR2<PRBN5^(.[SJINB9R6Q
M;'-)6"VDM'90&@[]/'K\-)<Z3M]"2Y#.Q;/L]O\`N^'Y-2-3Z$TY<GRHQULG
MZP=07$$)5L6GJA5*[5&@K2H_-K^73.\^$=Q6/W@O-%]X%Q4[B_N6SUT0OE;1
MER&<VLJ?1(9G1Y<-EJ>VEVNSU8US94%'KN*JT&JG>;U?])^E]N"KO-A,.7(0
MZWZ@?)-=FP)IUZUW5[ZA%((OD6!(75"0`JIIM'>I^D:RA82[.7X[3:4!)90D
M5(!"M@[4!!%="$2_8CG^#3_H?\O0A9"Q+/=*1]&RO_IAIW;_``'O0M_[N';N
M*D@;=W[(?"O^$TK)3(>Y"P7CSR$)7Z8*5&@5LH.Q/QU'H6G[$<_P:?\`0_Y>
MA"-;3:51;E"?%$E#Z0"$TH7`6ZU"O@O0A+'(;.I4>6R6_56EW:E^E`2A(65;
M34^;=VKH0DA$-P8`V`[`-H3VIM)36M#W[Z$(VCP5/NA]9VI2%U24[B24;1UK
M0"HT(1'*@*<E>F(YH:T/0BGQZ#QT(3AXCC%YOLBS6JW(0\_'FO34QW%!I/RD
M9!?>6'35(*4(40/'3Z+Z8[D)9YU9BY%2IM&Y$CTG`K9T2$G<`1XUI]&L3?3\
MH3BU^KY"N5;3C284AD':[$;*F^GE4V`U]84!J$_#3122D#Q?RA<,8XNYSP9V
M4Z;!F^+P750W%$-"]0+I##X9!"AZLB*XE)(\$>-=31_E&_P>Q1,OU7?Q*&]Q
MBN/RE1THI&<D!]`Z$)7120/`'RJU!CXREK3ZA[D>L6`I;3V-1NZ(`I4#IU5]
M&ME(+[^[S:#ZA;!H=U-J17^'IH0OBK,TX`/1I0U\#_&=:NW+4HEG6A-2RE`2
M``:D#QJ>PU-V7TQW*OWWU%Q1[`A3"PAOS4H#M![*Z^-?#4*[XCWI<;$6NV/U
M5".ZR5,DJ+B4^52@I"FR$FGE.Q9T!/K/][R>U7O^VN)=;E]V]ROCUU;?>ML?
M`<V1;WGU>H';=;9\Q<2(E)%?YNZGO6GE[:RGAV*@YRSE[8H)"?*.A2#W`_OA
MK50RZX-C\LO<E)+;"7T';2BT.IH?K'28_F6_P'UA.;:?E/`XN"GOQY;EW^#;
M'5+#LAGC_,DH0E);7(FHQJ:DQY#E?US)024)`!!3U)U"Z%_O,U/E=ZBND=77
M@_IV!O$CUA5](L7I08R0R$K65(`([!BB22/'?7\6IU<N1S8K$HR!N"4^?]#O
M]7Z=90CBXVE0EM-)9]0*D!!(%`D%RA/8Z`MXOJ-[PNC]V]RVR$!`;<2M7DKO
M2GZR`:IH5`]^NME+I6Y;GV>W?C/#^')ES+N#X9<KA>K=:F$+:$FX7)T.)E3#
MO4'G[:&@F,3Y6T*7T\W00N+`;,Y$QW(+C(0`/GT*+>W;4A.Y1"CX$]NG30A.
M9;(@F18[P9+27HR'TU\PZJ*-E0E-2-M:_3H0IY_=VSTVCW*0;.M]3361XAE<
M!QP(.UIR-!CW".VM-?UI<<9J`"*;M"%$#W!37\OY\Y>NZR?EVLXOT.&E7GVQ
M[5+<MS386:#IZ95VZ`TT(49[W;U/.MM(4(P2Z-[A3O"A5)#>T%/5?AUT(2H>
MM45F,AY4;Y9*FD[6E;200C;7=0`^H1N[>.M3M45/]9WVW(E@6_U&]OIT^GH>
MP'X-+6\?-DR=A1"W,ZG84XF"2CC6466Z!LA$>:^X\Z%!`2T8$EG8315-ZGOX
M-,[^P)).]3W3E_X.]I7>FN>@J6B4ZI&U=PER)0-!^J+CRJ!7;=\:]-9A;DB:
MS@$PUR;Q&L7,_P`\SBBJS6-,V3)4M(W,(6"=H.ZBD=14B@_+I8)I:?4\B-+'
M!<BY;$D,#T_2@W!&T4!)$=P[MP[5W?#PUE2*L7R;)LAMCMIC1/(S]BV^5V/[
M1<1E95T[FIU;]-LBZWS4VM!]"QO48&Y=T;Y1O,V9&3(<CJ$]#^P)_7N(#<97
M4**51W5!=?&E!J%A@,6I2N(I5E/2%A.;E-UN-WQ"X^LOYB[O3(<5EY`VE$9]
M:0^YLZJ4E#.Y)%>N[4BL)A>6+0/LVTMI1TB.)4D;1^L2A-`D?HF@^G3'7]K>
MX>I9.U("UP!+BNSUM>@D)::#2@%DE)54[J)_BU%N_EV=Y]B:7?PM"5,:Q*4(
MR6D^HIZ4RPT@)IO+H"U*[GH@JI]--(IDC#)K4],RF]7-^K[BW4VR,4)V,-Q[
M4M,1I+#1)],>FL]O#IK93*0L^RJGWF)`V59CH<<?J@J!<"D%OI4`%-#XZ%E=
MEYM3"66_62E>T#:"D43LZ)K6M0*#0A:\%X[NF372-`M,1VY9%?KU;[58HL5A
M2ENNW!\1T(98!)<4'5I5TIY03H0K:O<?G+'`_#>.^R+C6[)4<5ML-[F+)6G_
M`)F8]DUS/VU<<4@2*J].'%N$DN.^=0!46Z`BNF%W;&=X<-P3F"Y$#2WB:JJM
M^V0_M%IHM%;C4?:75$$N*2*E9%.A4=(1V&1[7<""E77P>TMXBBVO6F.IIS=&
M!VI*AU'0TH#]4?'4LF*4'"5OR1/+W&LC$R6,A@\@8N_9%(6&-DQ-UC.R5R'J
MT3'3;&WU*)H$A!KWTY;_`"Y[RHZXM>;<B;@T#TE2?]_/N0=Y_P"0+E8,<0Y&
MXPQ2ZNM6AY3;L567WUA)B7.^R7$%!7$2XVI,5OS;10U.HB3^89_$IJ*Y++=T
M&XMHJ_469*PAIM"&FH[8:82E*4A#145;-B`ALG=UW4W'3Y-D=0;1LCOL)_6+
M>%*`4*>H`/0FM1\-0NI6QDDYFXBB<MNN3!E.S%&\?&(;*=I*`2!5>R@'QKYO
MCJ\:#:<K37.X#VA0-Q=\U^3BMHLB$H=](AM7DH]M)`3UW>7=4U_#JO:YO4A9
M;D1R+<U]J!IB-4NA"C(%-JBEM(4=NWQ(/CJ#M?H#R^LIU-]0_;<C2Y6U##,<
MML-%;JVW*.I"FP&EI=H0""22D4->AT_M_JCN*27WY1-P1<9LV.Y,N,V:].FS
MG72ZZ_(D)0"5*7O4$H0RE*17H-2"%<U]WIBJ++Q=;;G*HRJZY+?KB4%HE3L&
M&R$1T`[@%EU[ZOT]-4S4+K->RP<'4]2[+HT/Y;T:V?9X@!WG('L4=_?1S//Y
M7SU'&^%JEJMF/?+INSCF^(Q]J,U&V2VGZL9C>H+)41U&E]'M3'>\[^X1YZ*&
MZGZD%I8V^F$_$T.\P'WJOO+;1`M]P:1%:95*4TTW=A%'\U%P2-BBPZ5*2\V6
MMOF%.O35J7*KZ[\6:K@59D!FBF$O^6I]5EA3G44])DAJ@!/0%6X_3IW-=<R!
ML-=@`\R:D93&.P+TC>RWA>R<9>WC"+*[9F/MR^1EY;DA?8I*?NMU<2I:6V%5
M!$:(04I'YM:4KJHW^DPSD&:F7-AWXKJ5C>S66FQR0_$33R4JHW>_/W*LXG''
M`7%DEF%D=R<=7R+D$!QN([CUE<CK+V.P)R$*$>5=4A!E*K4((2!XZ=66@6%`
M"!50U[KU]GVFJI9CV5,5U5Q#KT>=$>BR;9*B%$9^WK97ZCSD.9'")(<D=*.;
MJ@"O4G4_:.%F_P!WX1@J=>M-W4N^)QQ5Z?W;ON3Y,Y5EY?QER!=&<F7BV/V^
M]8W=Y>U%]^5,_P"0D6N5-6%/W2/#C[%H6Z5.@UJ:'I:K6_;=U:-K0/3AL5`U
MK3O!!DGS.(\P5J;K'J+4I*Q0%2:T[[%%!/?Q(T\4"NC4I]R%]TQ\1+Q]`0OO
MA^'^YI1GX[3S,:+<-&0O_>&Q5H_>9X-;+[QEAV8*AI5>+'E\?'D3TK<;>3:K
MC#>N,F&H)4$N-KE,(4"02FA`(!.H&]AC#B`,%8-`O+B0ECW5:.P*C*XXTIUT
MK4$UH36E.OXB-0G)CX>E6M)5ZQ;%E+B0:$TZ'L#]!'CHY,?#TH6A=@5L6I*0
M/(HIZ`@>4D=U&NCDQ\$(1,<6ZVI3B4J(16H105H#7I31R8^"%QN8\YO(-.AH
M*#P\.P.MVM:P4;L0@;.-NQ21VVGHKPZ'QUL0'"AV%",'K0I<1EM"0`A=>J0?
MS:=R#I+DQ\/2A<'V,4>5:4D]Z[?#\5-')BX>E"^M61HNMDH[+2KNH>9*@I)^
MMX*&M9(HVL)`Q[T)R!84SX94X@*4JJUJZIJI2:$C;VZ#L-,T)*NXM`2M4<.!
MEY'50-5`;_,GJJH\:Z<QNMLN5X_$[RF\C+K-F8?P]V'G]*QFX<(<1UQN4%$%
ML[`!U"EI!->I%`:ZV$+78M&"(I'%^5_V*XH>*R)*'GZ`_+%(/E`5184KM2O4
M)^&C-9D\L?4[RGGAIP.80>6EE9,93$BMR';@['EW)BZ.6E<=:F'(LV+Z845*
M:*5.-J:J"VJJ37J-2,4<+8P'#W@.*:/NHF/+*;$L7[2F[V=EM$D/R68RFGAZ
M:45D4HVYY0`D(^';6L\<)90#&O%;PW8+Z1X.HD\SCRWV&(J%@SX23Z[/^';"
MBHT)'E^'333E1\$[\1-Q]`1ZW:477&;[`BQQ'?MT5RY.IZ[DCYMEJ2@J42I8
M+#('7MW'7KI;.[(&?N`421)<:G:4U<3'S/G-Q&D@%9.SOT6"`"2>IZ'Q^.D>
M3'6M,5ECW,-6[4KXMF;(>:6BJXKZXRR-PJIM*"?$?I:.5'P2GB)N/H"^+LP4
M5(">Y('0_P`IT<J/AZ4_:XEH)VT7QO&U$+-*T%1W[]:?#66P1.D:TC`E(W$C
MF-!:=Z)_W:+TE0<2%>4#I5/;MV(U-7,,=K;YH!0]]?6HZ1C93F?B5QMV!UDG
MTP!U/=&[N?I)U!\F,[EFBP-A5ZK04E)<>>;0%%-``5457K3J#IE>,>S+R<-M
M=_#BGEI^]Y/:K><<Y%E<;>QN/BILX;M>3XO<,6=O6W<&+IDANUUFK(6""'PZ
MD`=D4\M--`;K>[T!/"<%34O&TM-[BCZH2/'Z!X+KJ8Y,?!0]%I1:0VH!":!]
M26'!U\S94%$"I-#7Q'73.\C,<?.APD`I7;M23CED:YWP54K\8OD?#K?C%SF0
M-\6V1;FQ\DAQ;:YPNL"7`8G*=2I+NQM4LDHKM-.HU#:-"X73IQ]0[3WC'#8K
M_P!5RQ3=/6XAVYF^L**C]F/J[U!):5*FB(D#HAD+2-II3<3\34ZLO)CX*C;T
M<V"RMN3%A;8(0R7$@5310/?H>NCDQ\/2L(Z^QVO7W%OS*=K4@TKN[CS:SR8N
M'I602T@C:$8+LA6TX&H_JN!/ZM"-P=4X2`VAI(/G6XH@4->^CE1\$MXB;CZ`
MG2YJX`F\7M<<7=V!/1%SSCIK*%N7-):>M]V8D.1[A`2A)"%LM!QI22:D[CIM
M*`U]!LHCQ$O'U)!0\=?_`'+<AMT$I^079S@`(>;J`*)ZI;Z'\VFDJE8\3-Q]
M`2RLMD2S;(C!3^P;#2*5-$#K0FM2=Q.BI1XF;CZ`IM>P^R,GW%6*5Z*2+1CF
M679Q1!KZ[D*';H2B>OE2IU0V_557J-;#8GT#G/C#G?%4J%7*%D=MG*'*T6H"
M4\AYJML$;U#=D$O=52JJ/X]!V+,SBR,N;M"9)ZPIN%WM45U-67[@T)"1N1O`
M((`4DA2>W@=:U*8^)FX^@)99+C:W7GHYIZ;*DMM)`(VI2$(0*I.XF@\:Z=QQ
M,<P.<,4DYQ<<SMJ(8MA5$4&G$@KHKJ/P#Z1\-+1M$3L\>#EECW,.9F!1HY9T
M+M\E*DGJH=4E:2*)KT4E0(.LO_$^/%88XQR<UF$GVW)*3;6$LH(33:DD=#TH
M`1XTTER8N'I67O=(\R/Q>XU*[[%C26F'IJ442^VI*ZE1JM5"#U/2NW6>3'P0
MQ[F',W`KCL]D6]D:%('E!:8'E_-E.+9?'C^T:-/B/#1RH^'I2GB9N/H"G1=X
M-QEMQ;E*9MRH4.!'MZE`2'7TMQF4,@_*QEMNON`(ZI3YB=6ZUFDA@:V,T&0<
M."/$2\?0D@G'[.NYN7F1;?G/F4A$NGST'<VD5;HPZ]ZC9"@/'2)@B=(92/Q#
MM*/$2\?0L56NW)MLEY$)3$J1<4QK<"\\XEIET@'<A:REQ1'8J!(UGDQ\$<^7
MCZ`FRY3QD-VE3JT`N17K8ALU/02$/!\;0KS;BD?@ITU#:BT3"LF)'DV(\1+Q
M]":ZS6!,FTH;V':'5;P*I)H!3J%)-!J'A_$!8_%K=BT?(^2F<UHE]BV.K<OU
MA:6*MLNK>;21V<;)"%*(KN`'@>FE^3'P2:+)T5QIMQPL^NI$A]U*/$NRW:O*
MJ*$@J-:=AX:SRH^"7\1-Q]`2=MF/R42IMRG$0R^I'I`I"O4;"5>I0*%$T)\/
MCHY4?!'B)N/H"3=^MR'7G&VU>I'W[6U=JI--W8@BI_)K!BC`)IN1XB;CZ`I#
M^U[/+9Q'GV/<A3[2W=G<.5=7X$==3LEKLMQ9@OI3U27HLY3;B5&I!3\#IE4K
M'B9N/H";Z]W"Z7^ZW2XW*8N?=KQ-D72YW!X)]:7<K@Z94Q;QVC<I+KNWZ`.F
MBJ#/*=I2<CXVI=S+KHW%$92R02`2$UJ`#3\6BJQSY./H77+M01%D+2GJEI1'
MX:CM7QT5*SXF;CZ`N3'W+CCLIB[6=Y<.XHC7%IN6VVE;C0NL*3;)CC)7N#3Y
MAR%I;<31;1.Y!"NNMA(\-R5]U9\3-2E?0$1.662ZUZ"W'76`$):;>4MT-(;<
M+C?IE:B4*W*ZD=5>.D3&PN#R/>"TYTE<U<5K:QY+86I:"?+TZ*%#4?`Z4J5M
MXF;CZ`C"SV%:PJ0D`+^=CL`]_P!6KHL;34=?C2HUJ6A[@UV(6'32/%''!=TC
M'7:.BO92NE3X+^CKTU:K25\-MR8S2-VWU[=J;F)A>'T]Y;7[*N/`42.JBE/T
MTZU'4U\=0FJ0QR?&*IPR>2+X#181\?C(E)?2R`S!2@/@K6JI>2ESHHJK^?X'
M44RVA8T-:/=[RMW74[C4G'N"PD6=N5\RHH)8AJ0EA`"JI#BMIJH&JOQG2C8V
M,.9HQ6OB9N/H"ZK/8T/-SXS"-KB6!)%:D_JU;54!)J:*TI4H\3-Q]`5H=KS%
MOB[VM8M-LLB!!R*[V@V2P":ZMJ-$-T>>5)N0=KN<GL-)6IM*JIW@"FJ=<68?
MJ<LE#4OXG@%W=U_;_P!`Z=&X_BBW!/\`%F*K>G3W0JZ,0%.SG+@X\N]9'(6I
MZ9.D2#5U*G'"I2$R%=:)H!3I35ALX71T-*8+C.LW+]2D;<7)S21C*T[,#2HH
M*5V#$XIO6["9"D,T*F6E'8E142%$A52LG<14_'4@H<>[L3B8=BD6\9)C]JFL
MN.LSK[:83R&2H.J:?N##+B6]JAYU)4=OTZ1F.1F9GQ*6@ACEOK>)XK&\-KVU
MHK]><>7YO$W&>0YA;(-K;B6VV0[/C4>:\N+.>NJJV>&B,EH@>K%(2ZH=EI;(
M54$ZC[>1]Y(8K@YF-%1NQ\F.]=(NN19M%N!2#+4`\>\XJ@^^Q9F07*Y7K(G7
M;A<+M.=GW:3(6?4F3WCZC[JUH(*D5(2!VHFGAJ3CC;$*,P'>J!JUX\./((IC
MN'M24N-M"J("`&J$)0@4`0-H2D;2#0)IK8X[5"B>6E:X]RF9]W;'FV[W/8T+
M>^[%;F8[EL:>@*4428[=F>F--N!1(HB5%0H'OTIXG4CI;C#(\QX$@5W[^U,-
M6:V]MP+D9LE2VF%"1V;5Z'FZ>FW_`)@5/Q)42HGZ23JY6K&RLJ_$KGL7O7!8
M?@K[5G0?PTT<^3BC[U\T>'EX>D+"^_Y?\6EX8W,:[-O2@^B[R>U0O]^4-$O@
MMKU*^G'S.S.N$`JVH4EP!5!4GK\.NH.]^,J6Z<^-RHXGV!E*B5)(%*=OR#MW
MU"JX<UG%)5^Q^BL[4FBZJ!I7I6GT4IK&P9CL2C/Q!5NP(O-A>><V%AP)=<#2
M2I)1OWG:"BM-P->A&FYNH00TG$G@5J7!NU**187K/;4-*8<0DK2@***I%4K[
MJ%:$TZ"NG"V:0[8DJJU)2H^FE1"CN)*2/,>_?Z!H6Q!&U9G'TI!>V*J!OK04
MKW_#36"0T5.P+`!<:#:5UN614B,@%AW8AU(#A94&E*7Y$E+Q3L6*FE0336T?
MXGP4/E6)/POC!'D7&]CK;#JV74E+C9VJ`&X`]^BD@@]];/8Z,Y7;5JQ[9!F;
ML7QNP,+4$!*B5`T\I'7:2.I`II&0%S"!M6R7%CMY@68HD15J2M:O2?3Y_10@
MU?<(34@[5"@[GPTUY,G!"D3*]M*;CQ^C,,2O"[C>/L]=UE6UYLNP[E!2M256
M]*0*L.JVU(50UU2K[4VVNMR6KR06ANXD8M!VC!773=%EOM&9-$T.<<VUP&QQ
M&\IBK3Q5FV8R6(^/X??+HB4OT&9"+>^W;-ZNFY^8ZEN.8K'UE^;JE--7BSO;
M7PO,<[=P/DP5*NM-O8=1;`6>]7'$;O0G0Y:Q/#L-L%JP3&HHGYQ:XS0R7-"H
M(7,N;NQ=P82VO:1'C]&VAX!)^.JA&Z^;JQG>/])FK7R\-JNES+ID>D\DN_U=
M*4H?72BX)?#EDCXQQG>E9&6IN11ID^1'C(<=,5+#KK$I#S[:5,Q)5$;D)64J
M42"!JPSZG;.N7MB>:5X'L4#:Z)'+:,N9<"\5])6*+)C\)2X%E8FMQ4$M2)5P
M4'Y<^2JH:>4M%0@5K6M-/+=SWNJ?AHFUQ9V=NVL3JRUILW;]R2,_&'6I;DII
MHD,*V*(4D4*B5]J@J!2?"HT\3)+3#<53?!DK#C3@`PF_OMJ+:DAR>66)++25
M'RJWEA5#VZ?3K;*2D77$326DFH["FIMM@>B>O+0RH+9C(6-P"""ZKR=%4ZG8
M?P>.L%I&U;,FCD.5A)/<CB)8%(:+@1YI*U27.W[18"5#OX!`UA*+2Y9G$E9*
M!0*5XCX_AT*0;/$&@$XT6+=H2O>AQ!!*%*31)-0@$KH1\$ZP'M8]KG;*I.4B
M>C(L757*U86-@44K`6G>DE!%4JZI/5(I4#4Q<RLNH`R`U=YO6D+B)]JW/.,K
M?/ZDZUEX\Q[)^+,C5%D)CY3B;RKTW'2DG[2MJ5)1)@!ZGI#Y=A:W@"KS%N@J
M2`8*:>*W(;,:'S^I.FZ9>OCYK6#)2NT?>F(./L^NRIQO>TPTW/?;/D2J)N:7
MO*E4&X)/U?K=>VE>6V5H<3[NY-8KF&W>YDIH[#<>U6N<H0<9OOMHL$IUR4C%
M[?$3-3;(S[98F7-ZV1XS#;8%3ZA=024]P:UUGPS.(2_YA:_-Z#]RJ1DV),1!
M;;02GH?CUW`>'7PT)FBPVBCK;VP[D5`&WPJ"?X1K<B-T#F.^,[$UOLSK8LB^
ML3AW(_D1GKG%AQ7T$(82A"/&H"JBOP%3IOI\#+?-S!2M?4I0:@V72V6LY/.:
M=F/8BQS%BJ0:-UH@DBJ1T!3VTM1,>:SBNVV6%34Q"4(Z5&[ZO0U\.HKH#2=B
MSS64K5*29:5AQH;"%!:4]A3OXG6<I29N80X-J:GL*^_9CC:5@I"%K`#;R%E#
MC#B5!:76W$$K0L;>A'76J4YL?%&EXNV59+&M=MRN^WW([=;Z1[5!NMT=N<2W
M;*!+\%4@"0P\JO5)&P4%--IHGN?5NRBV:X.%1L1_;,=:19VFV/U@E(ENBJDU
M"&PL.%WKY%A0[&E?#27)DX+*,[/9$,VBW!()5Z!"J]0/UBJ4/8ZSR9."%-'V
M0,&#RW?GT[?4_=((].J?55ZEUAJ2I#?5:VP&554!1)'761%)P3Z":-D8:XXJ
M(G-%A0GF#E%V)1UA>>Y8_O"AM4B3=G'VE"O<*;<!Z=CH,,AW+$]Q$8B`<?VI
MFH%E0]D-L<4D[(DCU75;?J(Z54!U*ST[#KK'(EX*.YK.*[9T<1\@]1()C+<=
M])1!JI*BKNFFX"I\1IU&TM8`=J.:SBNB38$N'YQ*25I4$]O!70]#]!UN33$K
M=CFO.5NU;'+>WZ265+0VM2?+ZM&T$I[C>NB`?QZRUI=L0YP;M24EV!U]U@!H
MEN2ZI*5*H@*"%?K:;B.R:T[5UL6.`J=BP'M)H*U[D;W6#&9BQHK*E$MH2@CT
MU"BMIH.H`.DZBM-ZWH:5W(XXYQ-<_*+0E3WRZ4NSIBTD>7;"986RLFE"2\NE
M.X[ZRL*34C'KB_(0[(C.>H7=\E22@I]0DEU25)712=Q/4=QVU9H1^$S^$>I9
M6#MF0VI&Q*BL*\VX*%!3XDT/4Z4H5JY[6XN6Z18VY`B]E+^T(2:`#]+QT4*U
MYT?%-[G6/VF[29";B99A.79+#WR9]&20AM:2&7'*)0I*D]STI7XZ@KSX#Y4N
MR-\AHS'T)N?W1MU@=^6@RUN6J63\JF4=TOU!YG4K4`=YHL=M1%J"2[L`1<1O
MM6ATXH';*8^JJ4&-VEB'D,9D*2VG:5)+IV=5)W&N[MU/CWUO)<PQFCRDXOQS
M2,$GN(]:*UX^PME,Y[:`M]UIL@@DN("E*2I(J6_*#WZ'6([J"3X#Z"MK@&T=
MEGP/G]21U\`64,M`J](+32A'4D=JTKVTXW5W%:@U%1L*2"L6?D5E*871=7%&
M@[)[GX]`G6#L64LL3QYMN%)4I*@EUP%'2M02>II6G33+DR<%A=,O%PITJ2V2
M#4@C;\?RC1R9>'I0LX-B=05I],T35/6A-!3QKHY,O#TH7/>;7_-'&@DEQ1"0
MFG<T)[U(T<F3@A%3%L4&6D[""E`2H;2:&I/>OTZ.3+N'I6CGM::':N1VR*6'
M`4':K=X#L3\*UT<F7AZ5CFLXK>U:&FV"EL$JH-U4D?PD=>NL\B7AZ4<UG%=U
MDL2'$>H4G<5K2>G3H>GX^NAL,H?6F'>CFLXK-BW+1)!".J5+I5-/S5#N3J:C
MEC:RA.*R)&$T!Q6ERU*F21ZC:OU1-.AZ[Z#_`-+IE>?B_!BE$92+"PEE"5`C
MIU%#4@JK0]*?5U'92#D/Q+5Q#14[$[$_CAO$."\>RZYM^I=^4<PN;UJ2HI]6
M#B^+,%KY@-BJ]EYO$Y=`0"!&!(HH57-I.&YR/=[PD6W$3W\MI]_N*9&U^K;K
MK'NL1!4Y;GRZV5CTT[UH4BA4J@ZH4=)\F3@ETZ'(][D7W#N*[$\4"V8WC]WE
MMQMZ?1E2YMQ63*=?_9,*2M[RA9!410::"PD,[I"W`GB%9+K4Y':+#:1$DLCI
M3AB?.F?^R5=1M5]/E^GX?BU(F&D65OQX*K13%XY;OB77'M92D^7NKQ3]`^G2
M/)EX>E*T3@\76]+>:XVXM]J$A&36A:Y;ZTM,QDIN+*E/N.+(2AMH"I)-`!IA
M>S1PLR2&CE*Z?-'-JUO'&??:&@[ME.*F+[R\^MF3/X7QSBMQ9=M6+IDWN])8
M"UH<O$M`8867"D)7ZT9]:A0GIIMID$KI'2@?AEOM5JZRG=%RF1G\2HKW4*@A
M=[8A0!:8+`2VD%-0JJJFJ^AIYM3/)DX*AYW/^HN&%8D*:<+:5%S:I8!!ZE*2
MI74FG1*336.3)P6_(EW##O4]?N\\/=E<WW2\K:I^[V'2=BZI"4R+\]'1$16I
M\SK<15?T:=:5U)Z;;3.<]S1@T`G$<5&:I(RT@'B#3/4#?4@=BNK0HE"0OHXD
M%#@^#B5JW`'L0#XCIJX6L;XV>^%S^/W;@R'X25E_+72?(EX(KZU\T_6%]_R_
MXM8=L/<E!]%WD]JBM[R&H\CA*?'>/ZU>3613+9`.\`N5/Q%#JMWOQE2W3OQ.
M5,MQLX6O;M4.Q^J3V)^D:A5943N6)(*:HW=.Y30C_FCH>?PSWK7Q7)D$?S"J
MDIPQP[A=PM[V6\B*9+4HR(F*VR1<'(J9JHT=:WI:%MMN*;7&>`#:-I"U=R-0
M,OUF<,S?6%8+2S\0W,4S')&(6^RY!)@VMV3(M\E9EM(D.;TQR/*&D#J%=%?6
MZ:GBF][$+3$)OTX^E0J&0?Q?Y1UA1]K/XAA?P=3U)16#%F+C<6X<E`:0DM*I
MMW>LFH);(*D[`L=*]:5TWO,QM),GQY#3O4E9Y1=QY_@SBJ>/*F,1:Q*[6FVP
M$-S5/,/0(^P`6UEE`"V6GZ;I1=>&XDA)&H+3V7]<*T4[?OL*8TVJ.[UE*E[_
M`$@XIQ*7%E70I6H>9'950FG?5B8)0VDWQJN/,1=6'Z:UILRDFHC)KU%0>HJ"
M*_5\*ZW6B5ENMCZ8"8GH)4UZS;KM>I<;%26>QV!7B>NA"D5P#E=VQK)I-@<7
M*>LEVAO_`"L1AIN4NWSU+4ID(;>6A#R-A^K5/35=U+3+6:=URX5N#3T"@5BT
M'4[J&;PP)\.-G#'%.5R#FU_LMN$B!<'+;!M`I#B6M:8[K:WU!GS.,(1ZB%%?
MG!1U37\.H>PBNOS!L3J\@YN[8:*9UF:U#3,*<\4IY=J@K-@W2[29-XN#A>F7
M*3(DO2:DE[>L;0IJI#9;!H>IW5KJS^#[%0KV][4KK.M4>PKAR4*7*C7!IV!*
M6ZHM,,*24/1#$*?3<]=2Z[]P(/AK/Y.`/$4Q<GEGK)=;,M]X'M2AA6>;&A2'
ME0FGTON)`<#I"FE&M%`!!W%-/HTK![LF3L2MQ[T>?M",$V=M^&VMP-)=2Z&%
MMK(!=J`OU230]":4IX:>I@E-%X*R:X6)W*(.7V3&[?)GBUJ^=N4A,CTI+@:(
M1#CM+<6WM5]5-2>PU&R7661S:["I2+1Q+&V6GQ`'9Q6>9<-XQ@.,,1U9;$ON
M77.;ZY3;B^[$^S76'%>F1*#+Z%M/(32J:T4=*VT_->6]B2NM.%G&)>)HFH3;
M`TIF-Z=2EI.]5"-JJJJFG7L!IZF"UJLS3BE(+A05%0)V@[3U^D:$)]>!<-P/
M,YUUL]]B-3[J+<\F)#DUC*CJW;52H,A*]RY"D="DIH!J,U.;DL8[B[V*5TF'
MG7!;P`]:ZN6N$\8Q"V-2K#?BDB.T/LF\.!V87Z'U6XDI.U3J$J^JE24A(Z5.
ME[*^JRA*E.H;(&W%1N2`XRMD>$\AL1JMRBXS,05':^AYM;:D+%*4.[5=U>]_
M'!/%3.BQ^)@+.SV(BR;B&\VZ\HMS$)=SCW%],6&W&;'S,IR8ZI3$/TDE0;0@
M*"=U?"M-2L%Y_IV"JK&M:1R;C-3XJIRLKX?YSQ/#K3AU\@N_NS(;7?8U@C/H
MD7.SO(=6A*)+14D+2I`W@$BB5#2HN\=JACIX&*B[,QUY"O4=9/I_-/QZ4Z?J
MTU"O'JHCMJ46JY#8V^GZGX_F_@^C60F\^T+N9LC>UL>E3L*T/3KWIK*06IZS
M>D^I025`I4FA012M.O<Z$+HLV.^O=K>PMQJ,+E/B6^-(DU1'$J3*C1PAY0J4
M(2F2%5IX4TQN9^2\"NY:UK(&;R%)KD_VV7+C_&W;[-RC'KHZU(CQS"M#$]]2
M?7-%*7(4VED.-U\/(3XTTC'=YY`VNTA3L>DYK5]Q3X6D^854;Q8?TE+4/@6_
MY%ZE%"+NBVB+'DVYR;ZB81DK#[C;/J.,BB?.&BKS=#\1K!3J'X/*G-O]ELDE
M$A6)IWQWF6R3$`?:C48V/%XKV*;+SE5*`!VJ-!7OK"5139[*IFTQ&7-REQRX
MP5;2"L)5N"B`:)[]NNA"7.+<G9%Q,,C&(0X3=]RRQ_N_]N26_4F6B&9!DK7!
M04D>HZ32NY--"$T#L2>^)$NZ*5)GR');TN2L$.2I$Q]#JG7.Y2I&V@[U!UD;
M4G+],HKL=E2F;)DEK>$^F""*4"@OL37X:RFBY;Q84.W:,&:GK4IVTV[J'P/@
M3H0E(U9%-!*%-;D*6-RJ&HKXT[=-9#<V"WC=E=52`XJ]N]LY'QF_W.^SY45V
M4RJWX_;K:ZA`]=+GJ*N\F4X@---LTV;21J$O]0-G@#BK-8:?XL5(P1UR7P5Q
M;@.$TMEUE2,PMP1(NDV2I^X-W*9(1LD*:V)$6,WN'E+:E)TRMM;,[\A.U/;K
M1!;LS`8J'"[&)+Z/)5!4-IV5JH&@!_%])U9&"L8?Q5:D.63EI96^RR;6MA]A
MOTW41Y;:%BJ24S$LI*N@Z>GZ/0>-=96J4B;]<XY"Q;8BWFNOKEQ\.+<0.KIJ
MLI"U*%>U*ZD&7>5@;P`6:K9%RRX%Y?SUN<?;<0$)$4^HII6X'U"E24U%.FMQ
M>$[TA/BT=Z56-NIN5XMUOB^NI]^[1%.,RVPSZ,5ME;[C]4J74(V4ITT>,*:K
M1R+:@S9Y,EE`*WKV0E0`HD'>0I)Z[@=(71K'5*6MZ<U#M376))-VM@FP8\^*
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M.(0VEU3.TI!/1(.^M._PIK"=HCN-L=>+@9C;B*41U`Z)%*=*]::9/_F/,M)_
MI*6/-%F:O/!7MFN+;8#<3'\CL;ZFP/3;FL7$RWHY0*)]1JFTJ[D:FG_R_E43
M;?S@[CZE%N)9BS)1)B1(Y=C':1(0'67"34%QE0"5GI\=,E,I57.+<K=%!FM6
M)2,RMA#T54,.A##L[TVA!8(VP2PN-N2$DC<=`3T_RH[DA_W>5_@!^.GQT*&B
M^N>Y<[V/K"A1D#IX=/'\FA/%U0;)<U!:[1#2]<8[S!BL*CN2VWRA8+RUQFDJ
M=?#*AU;2"5]O'47J]EF:U_$!+Z>X0:O%*>SV)6WQ-RR.=+OUV8C1[E)$1F<W
M%MSEN3ZL-@L-D1WTH=;&P'I3OI[9VW(M6NXE2&OZD;S53!N;&#[$C9EG$A)2
M`0X/+MV^`-:UJ/B=+J(7?;[&D-D>F:A&VNWKNVT4/K>.LE'CRWW>"L_]AN'F
MUV#.LT=CELW^[0;;;7-E`(=KCDK]-SNH!YPBE`!J;T0$R2<,HKZ57.H[GGQ1
M#@YWJ"GXH@DD"E>I^DGN?PDZL@%!151?-"%J==2TVI9H=M.@^E0']W64+C^T
M4?`CH?[GQ.MV1YVD[@F\\KV4:TT!.*B%[O;TU(QG'K%3K/N*)BD_WEL"EE2D
M@U`67J`]C3IJ&NX(JDD`E2^G2/A;6,Y256O-M*@Z/)3IXI4/$_13KJ(Y,7`*
M>YTO%%;UE<<*2D[:`U[T[_YDZ;3P`D!F`IBMF/C<\.G%7#8G2PV[3+?9GH5W
M5;56FS"4J,7&U.WE9N'5N-%K5I,7UJ%1"=X'B--!81EX<YM:$*V6UXZ&`\EU
M#EP\R;K(F_M>YF2I)])*"EM*@:)J0:`TKVU*<F+@%$S7,]R*3N+AVKCC612F
MR6RE"=Q%!TZT3UZCZ=,YV-8^C1042$36P-+8AE:37R^5=C5GDQGA):<V.H`\
MZ:5HGM^;32!`(H=B5$L@-0359R(DF53YA?J[5%0J`#4]":I2">^LL)C^#!:O
M>^3XR2N06-H5_5I%22>A[GN?QZ>QM$S<\@JY*Q2,C9EH%F;`*)/I%(<ZMK+:
MDI50]2A1`"@#\-8EB8V,D#%;.G:6T;\24<"Q!MKSA*JA-!0]*5^&F5$CS'\5
MKEV5YA]B;$<<CO1WDR&'(ZW&7$/-A*0L*04D]!2AJ-,)[?/*74JG=O?/MQ[C
MJ/1[=[J;S5N9;1$+@`])'JK:5TZE14I0K7K^'1;PEDH=2E*HN+U]P*O=5Z1C
M.-I27/22$-E54H&XA-:UIN/CJ1S%1[V-D-7BJTO8\M6YM5%-;TK*.P)30@].
MOA\=;F:0MR$^Z%AD;&&K!0IRHEK2U;(R6@E&](+@J34T_."JD$?BTWY;`[.!
M[_%/8YYG'EN<2SAW(EN5@0Z$N^4*1U!"U"BJUW4!`\-;)5*RP9:NQV=RWKLI
MG7%MWYB#=';DVN$TZV:L`PE,J4F6EP#QH%>.HR2S#Y'.R[37>IB'49HXFQMD
M(#6@4P^Y-_?8\Z^3_MF82BX+74@K4O834DC<5)`KX=M+6ML(9"[+3"B:ZC?3
M30AKGDC-7=P*T0;.XMTK?'JK4LE3A!J>@H/*`G3Y0O,?Q6F3C;A]<A)`*ED=
M%=`5$CK7PT(YC^*=C@K&[7&S)R_WATLFP0?5@E*BV5R9SGRGFVE`6$)-?-4#
M4-K3"^*/+M#SZE8.G[EL4TKY3^X*=]5U\P2?MJ8Y;T*0N07UNKDC8[OBPCM4
MT%^9+?K`_FT)TG96[RW8D-;U6[G)8R0Y-VS[D1X3;V8H:D%E)2VZT:=>RW`D
M=*^&[45?V0>2Y[?>5CTR]-N!R74%`GX<9D1;D_<82BS*8EV)^,\E(6XPXCYJ
MCC8<2L`@FE:=]-[$2>\R0U8VE!PK6J>:I(VY$;GXD5]B;K-[UEMWOLY*IMPD
M2XJRRY/<D/E>Q^CBT.*"@V*J60`0.U!J0#6UKO41RH^":#(L36Q9(\EQ&XN7
M*05G::N!0HE73N*_#IJQ6CW2/H\U"B=3BC@CS1#*:%-\;&G_``/Q_,7_`*74
MT(8N"IYN)G..9QP6Q%H(*0$$`$`#:KX_YG6>3%P".=+Q6Z184NBNP;ZCS=:T
M_)HY,7RA'.EXE?(=H,&;!EM$F3#EM2T,K;"V5AEQMU"B'$E`6'F@?CT'AJ%U
M*U8^9I#?W>WB4_M'LRYY:&0'`I_\]S=6;XC!M[C&R\F9%E38Z6DH9>CM%*E2
ME+;2@%X)!-`>I\--(+-HG8<@^(<>*E9-6N&VSX62$,<PBF&\=R9"3:-GI[6P
M"5]0G<3MVD]0:]*ZLG(B^4*M\Z7BMSML4RP?3;V[AU\I7^.B@=15XV1L](L&
M90GK;@LM*D^_F./F4CO;9@&+7E=Z?RB&U-^2EL.LP5EYMAU@T+S;HCNM?JEU
M\Q)Z'3&4W(C<YI(-,%-Z6^":U>^8!SP,"DWF>.V^#D$Y%HBM0K9)#4N'"9*R
MW#;<+J%M>=3BT^9`-%$G6]HVY?\`&XGS)M=S11@EF"9VZVS=?HXH%(2&ZTJ1
M]45K3H-3L<#,GOCWE#/NYBZK''*L;A;EJ<0%]07&TGH>Q4E/<#X'67P,RG(/
M>6&W4M??<2Q/!QAQ]BT_%LJE9&V^T[\XPB)/AJ_G4?:F44,ALJ.YMTTZ[3VU
M!W8N6?`XCN4K:.MY?B`*9Z=CS$7)W&&&U*;C%5%+5ZC@;V!2%NJ15*2:@^&I
M.P8)+-CYL9"#4^4J/O9"RZ>V+",$4'D"-_LMQT*0D[2I"@30?5IU'8]QIQ+$
MT,_#%'+%K,3,.8:MH4H\/R"^8O$F6)J1(<LKZ'"J"'5-M`;BI2`I.UVBE^8^
M;^#43/I5O<G_`%#`X]M?8I^#5I[;Z#RT=G[0B;++K><K5_.0Y$84&VDAIUT)
M>8;Z-MK92KTT(VBE`!IO%H%A"<T,36GR^TI*YZCU*8ELD[BW_A^Y(T6$Q_2[
M!"744`!Z=ZGZ.E=2\$!:<KL64V)A%=-?*7.-31.UDMBCQ8N-%AE#3DB$I<F@
M5N<\BBVI8420">H-`#ISR8_E"<\]G8D,JVU:)*1N**DD4J2.I^/76/#0_*$B
M97U-#@M3%E=6HI`4T=N[H%I)36GT5%?'6?#0?*%H7N=@[%.!@%ABIR-GYUQ;
M*4PIJC):"U/)*VBW0UJ0"V2!7X]-8\-!\H]*U73RG`M@CVVV0'S1;J7`P.ZG
M$-T2XYN!6"4CXZ9O<YU6DU:DVQ1M-6BA35VS'D)E-K=<(6VMMUEH"H=6TL.#
M=3J`VI(-=-S9Q2@U:#19>Y_-CD!-6FH]"DS;L_C2(HB9M-N83"!6B#%MI?CW
M@.'U$"1)CK:6-J2!T*::K]YI<-:Y`KW::BV]@$.HGF,`P!_91-IF>/6"\7-%
M]L"$&V72(B5)M9!:=Q^ZE82ZPYN.]]#B.@/FH3J09;NC%&-HH/69K68%S6C/
MN2'F6-UD-H97L00JJ0`>U`/K"O0'3Z'F4/,\BK5I-.[,U[B0"*;%T6_'EEM9
MJ-Q0=II2BMJMI[TZ'2R><Q_%:9%K"GK>TAL(1#:>2\""`X\_0*<J:FI(.A',
MDXHP-I0@)V)0FHJK;N/6M.O?KH1S'\5U?9(2V%A"=VS<FM14@5'?Z="V8]Q>
M`3A4)81<#LT_B;.LH?*7K[9<QQR+%#A4DQK5,8E?,L,T*4K0^ZE/<%1\#K"9
M7-Q.RYR,<0RO8FA=L&PI48Y0'M[K:%)=04M%UQ+=`JAV[4]-/+>-CXZN`)JG
MTVT'^Z%SKLH"%$-`4!Z^?I^4TTOR(OE";2$M82-M%P+L0?`2I*?+U%?R:SR8
MOE"8<Z7BEMA7'L6\6_.ILB1\N[C&-MWVWLIIZ<QUJ8E#T=Q1Z!3B#M`[D=M)
MR11AI(&*S%='GY'DD*4O''!W'N98=!O4Q5[E39!^<5+@*0PW&:6/2$)Q#U!5
M#JQ04W&FJ[=3RL:XL<01]ZN5O#9O@SAC>9QQ^],?RC@[6'WL66%$OJ(]'%-R
M+M`;9:>3Y"!%DL+=3)V`^:H%*CXZVM99'TS$E1U[^'\&";=G''$4=21ZA\Q7
MM)-?#XCH-3L=M`X![F@OXJ"EN)\Q;F.7R)]FVG,E]N;5F6K<]QQR')EI6I(J
MW$R6.&G=E`"&')+FXDU`/04UO.UK8C3L6MNX\X._>H4QK.'O2)"G`3Z332_6
M2-P27%>9)5XA03VTP4ES'\4:W!;LJ+C;4:U.A5@MWV:]*_4$/)2^\ZIP)=2I
M6T>J3\?IT)RVZ]P,<=@18;4"/52`&_J[*?'QHH5\-+0-:Z2CAA1(N?'MC`#^
M*P-I0OJ6PJG2H'\FGG(B^4+3F/XIP^)[<S9\R@WI:$J:LYN%S*!7R-Q[<N6H
MU!\M9".A/YW0?#3"<"0EK\6@T'8$_P!*_&F=)+B]IP/"B2-]4N]39UT?WJ>N
M$R5)J]N]39ZQ"$T4*C:D]/HTK;@._#.,8%:)G>?[B^7_`-3+2O9A@D["QWUG
M2ZI`^N14A0Z#M_'IV((OE"TYC^*ZW;"J.V\XV0"G>H)`)*E`$A*:UJI2J``=
MSVTR@:USB'#"I]:97+BUF9N!5OW`&-.8?Q#A5A=3M>5;5WF4"@I49%V>5(/J
MA0W)=0@A)2:$?#5GL(8HJN8*$@*L7DLD@#9"2`31/'J23%#0A)]QUM2"`KJ:
M?Q@Z6Y+^Q(\]G:B]ZG2A!Z*[?YW2T;',8[,FT[VO<VG%0U]SK#CEYQE;HJP]
M:)3+6RJE[HSY==W)IY4@."A\3J$N]I"F[+",*+%RM@6N@2G\:P!W/TGKJ,Y#
M^Q2_/C[?,BE5K""`I*>O7HL4_'4Z5CAH#GVI"24EX+/A6(MR20-@J30>=/<G
M\.MS$RAIM4C!?L8,CB[S+>FQ>J=I0GH-W1:3VZ?3\=-^2_L3OQ,7;YEWQ\:1
ML-4)^L?ST_!/TC3*YMY"\4IL^]'B8NU`V0!124^4$I/F2>@-/C\--_#R=B/$
MQ]J^_8+'Z'\7^FT>'D[$>)C[4/L)BGU:?B3_`"Z=0L+&97;:IK+,YSJL^&B>
M'D6P6G]T>'C$C(B2Y6&R[E<VVR@I4XN>IF,2JO5:TH)(\-;2-+F%HVK6.5S7
M@O\`A2&MN/LJ:\H'1*>ZDCX_ATS\/+V)YXF+M7)<K(0XII`'E`_U1(`JD'IU
M^G3F.(!E'#%-997.>2SX5RILBED)50@^!6@]NOZ7T:Q)"'-HT>\B.9P?5_PK
MZY82W3:`*UK1:!VI]/TZ;^&D[$Z\3'VK$61NE2!N\>J#U_#NT>&E[/.CQ,7;
MYD<0K,"R`XD4[UW)K6II]%-'AI>Q*P7$9?05V+3<;&QZ==O6GZ2?CK'AI>Q/
M.<SM1=`L+*]Z`$@J!2"5)`!4:>8]>E3ITV(!H!VT35SGEQ(.%5N<QT-+*%-]
MOSP$EHT\`L'JKZ*:UDAS-HS;5)ND+!5]:+ZBU-L^0E"$_6WK(2CKTZJ[5Z:0
M\-)V+3Q,?:@];`D;/*2OHDI4D@U[$&O8Z/#2]B/$Q]JQCVU]CU`VZ6O52$+*
M5H)*0:T[_'3>XL990!08%8-V6?2\JU_8;?=2BZH]2M6VOT#ZWAIW;VW+;1X'
MD0+ICOJ$^:J<#$K#&>:=CMJ07&U-K6D[TBB'$.':M381V&H6YY$E0WU*PVT[
MHZ$G!+:4:W52&B`R^Y;8Z=RDI45M/A:JC=T&U)(U%"V<TD@#%2IOX74!)-$)
M%IC.R<NJI-9ERMCB?,FA293OUNO0TUGD2=BQXZWXGS(@Y'QV,WC5O1#V*]`M
M^H%+2FNY8`VT)J-3%DZCU&:I=0R1Y6UK0J/JK:E)VE":@FM%@_W=62-CGBK5
M2W/:QQ+MZQ^SD?H#_1#^72G(D[%KSX^WS(?9R/T!_HA_+HY$G8CGQ]OF6AVU
ME9!0D``4/G3WK]*M:FV<[;19%RUOPUHE#&@A,1A2MX`*&*';4KH$U`W=6Z^/
M:FL>%(-:#SK/BZX&M%P/6T"0*I2?\\GKU-/SM;\F3L6O/C[5W2;?1BM*]/TD
M#Z#X^!UHZU<XU(%4A<2F2+EQUJG2<B3\$L/'E^QZ6F++RRP7N3/C**5M/?+7
M8;$2$[J`*;36AKU&DY+)SXRT`5(XJ2TW4&6MLZ*4G.13`52;N,BXW1+DJ:N*
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MHG8=9SY'$*/S#"7VW@KKT`"!0^.D.0_L\Z=>+[TT1M5$E>T.)I785I\P/A2O
MPT<E_8I%EQ'D!)QH$LLEX]?Q!ZU)?D_/(O5GC7B.\I:2MEF30IC*%?*6_$>!
MUJZ-S!4K;Q$7:BFUL_(72'/ZLHB+#CP;*5&>C_`/`*&U"/#6B/$Q=OF6[+6+
MI/NCB[G`A1/F84>;$`80A[Y64GU8Y2NM0LM#KIB;>0DG!'B8^WS(GL<-J#*>
M<>A-24N17V0XM:`N.MQ-$J;'2N[Q_!IU:1B/-S=X%-Z/$1=M>Y='V?0)`ZT0
ME))*!U":$?6Z@:0N+82&K=E5CQKV_3)67V65-EP;2D4_/17J:=!4=CI?EM3'
MFS./XFSO7#)MP.SI3H>RD_1\"=(RPN<1D3B&1D=<U<486JQ2+E+AV^$PN1*D
MK6AIM)352FQO4DG=T)';XG2)MY`*X)<7$1PQKW+._8S.M,]<*Y17($M#3;JH
MKQ0ET(=J4F@*O#OUZ:;YNP^9+KAAV=EZJ55*Z^45K44'04K4U\-8Y@&!KYDF
M^1K/BJC=RT_L8ZFULK0T%!M]2&U%E('ZT`J)#8`K4TZ=]*!I.*2%[`V05S;>
M"=CB7^98AGLJ7':D6J)D&&OR6W/D'@\S;92S)2VU(6I"RD.`IIU(\=8RGB$U
MN)6RW'-97+W)-<NX^Z<@?OC,J-,M4QJ,(:(K\#=":+>Y,-3$=2$H#6ZM>]5:
M=P2,C9E<<:J1=<Q24+,U`*;$T*H#2TE*B**!!!?C_P`(];2W/BXI":9HB<2'
M;."Y_L:+_K?_`+-'_P"CZ/$1\5$>+BX/\R7&.V>5;\?R20&/3M>0,QK.U+4\
MP&5S(KHENH4KU2$)0RD^;KYNFDWRL<*`XIKEFFNN=$#R\!C@<.SVI].!XV01
ML<N8:VOVXSU2+>W)DQVFI8H4*""IPA2FZDT^`U!7%I+*UP9EJ>U76RN/#Q9I
M:Y1P":G/+O-R'(IR)+R2Q!?<C!A;["?0<%`Z$`O>9)"1U^C6]O:RQ4S%OG2=
MW=Q3?!F\R1AM;6ZC:F=G2E9$:O7O_JI\=33)XVL#2<0JY/=1QREA#JCL[$['
M%5C;NF.\LV(E@Q9N.)F,H5)8"W%VR4AQ-$EVM?70/PC6)96/9E:<5FWO(N:,
M'[_W2DQ9L`R>XVZ9+A6T(C/*5*<,B2PPMQIMM*6U-)+A]16U!Z::4[E(>,BX
M/_PI"R[%)C;79$1^.AU1#9>])'Y^RO5R@&X?DUC+VCSIH^Y<7DM#LO<N.59R
MEJJELD;@*"3&)\?]=^C2L#FL?F<<*)2WG<Z2C@ZE."5N$\8W3,7'?D%-M1V'
M-CSSLN,U'2L)0LA3GJ&BMBNU.VGG/BXI]S6]OF3Q8%P^]:;[DUMR'THD.5C\
MNWHN3,F.ZTIN=)6XS);7ZB-R?17NKX'3%X#G$BE"5/Z5:31-,SJ9'XC'<4T>
M0<8W.VW%Z&RT;NTF4H0WX:TRGG6`%!-4-U(-.NE('"-Q+J4HF.HVTL$QN)`.
M4[`4Q-=NSR(C>LWRB_06E+3B``XT\XTVZVOQ0M#BT*2H>/33KGQUVJ.YK>!\
MRYK;&B-7RW!Q+,U$:ZVN0^REYIQI;:)\9:FZI6:K3M[#Q&M;:UES9L*5XIA<
MW419E]ZO<K@VGF7=JHZ0VTMI+Z&D?40A^BT=1^?M[CPU9+5I:#55N=[7&@XK
M?IVFZ&A":SYUW_(I7\NI)1JVM3RG=ZE.HZ5*OQ_'0?@*U=M'>H]\\1_GI&)3
M2@+C(?D6Y[OM2B<6PLUZ$+`'3\.J]=[2K!9_32(D\98LJ3M7;5H317F3*>)J
M"?`J(T@G2Y7>*<2<((@/*H*?TET4_P":&A96">)\32I*C;G@`H$GYEWH`:D_
M7\-"RWXAWH^3Q!C;;`F"W.JCJ4&TK,A[JI55`5!IV1K5/E\3QGBZ!3[,6>M:
MF4_^#P5]&FL_Q^1;!:CQ?BQ)/V<X*DFGS+WB:_'2*%\_LNQ;_<YS_KE[^70A
M;T<48NM&[[/='?\`Z9=\/PJT(3E9YQ1C'RN)(^0?*&<?C1&D&4Y1MEI7J>7S
M="XI9KX:$)&1N,,:2DI%M6*!(K\R[4]Z5\VA"U/\78RIPDVU9)`_Z:>^'T+T
M(6M/%V,)4%?9:S2O_33_`(BGZ>A"R7QAC"Z5M:Q2O_33_C3^_P#HT(6O^RW&
M/]S%_P#73_\`I]"%WQ>-<:3^K^RU4H>OS3WA_GM!6KI>2,Z[$<3XK<)<.(Y;
MG6T293$93B)+A6E+RE@E(4HBHIXZQ4I/\P/:BQ/%.+1'7D)MKBPVXZD;Y+O4
M-K4!7:H=]NBI1^8%-%=[,Q;\VO5FA,%J)`38D-5><<*OM>W_`#SQ4E:BD*8<
M1M13\T]:G0%NRZ,QR'=BCJWX['?O]MMTAGYB+,DB.XE=!M3Z+CN].TCS533K
MTIK*W2P7QSC#Q2LVLI/1=$R7PFI'@-W0:$(?V;8O_N6K_KJ1_IM"$/[-L7_W
M+5_UU(_TVA"7V/X#C4+YHKMEQ2W)0E,=3UQEJ:41M)W(*MI`">FHLV`)JGXO
M'4I5%EPP#&S*9>;M[I+3Z7]OS3P25-GRI/FK0U-?'1^7M6?&$[RLDX%9G%RG
MA;%_SUV,ZH?-23L,5U:TA'F-0LJH:UT?EXVK'C37:OF1X+C\B"F/+LTI@,E&
MTF:I2%'<#10"J]?HT\LK$9DUO+TTJFI7QCBKJUE%M60%$?TEX=_\]J;,(AH!
MO4(R8S$G<%B>+<8`)^S%]/\`JI__`$^L)5<W]FF,_P"Y2O\`KM__`$^A"V#C
M+%BEO_:Q?J./);"?FGZ;2`:_7K6NA"5MTXPQ&.MEMFV*4J);[=O;,EX)+SK2
M/46JA!"DJK30A)U?&>,K<]0VM0/P^:?_``_IZ%A;7N.,:=;*#:2.G0B6_7Z/
MS^NA93CYEQMBKN/X.V(+H3&MKT9AH27=J$NE*W0*GH2KKX:%A(!WC?'$(0D6
MU9`)[R7?A_FSH64(_%^,K]63]FK*6`DR?YT]1M/YI%%#NFG?0A1V:EHFS[VT
MTBK=JO-RM[02M22ZS"DR([:G%)(*5K0R*[>E:Z%A/KCG&>+W5^PB5;%E5T3%
M$A:9+NX%]6XK0%*()04=*_'0A/;RAQ9C$U&.W)V`Z$VQ0M#Q$ATA;#382TEP
ME5:D`'ITKH64T*N-L4H=EN<4KX&2]3Z?SM"$=XYQ+B\R3=)#]J66(-F??)$E
MX@.;R!NJ30;>OQKH0D2K%N-8:VVI$N!%6A82IN7=6FG"=P\B4&4E06>P!36O
MAH6%L.'\>2WT?+)8=W.,GR79"E`!UOSD;R!UZ:$)X>3,#Q6?(QAU+25.1;>F
M(TA4Y;@*$,%P5*%>4U<[=M"$@+9QEBTB3`8^06I;S\5LI$EXI4I:T)('7L:Z
MPD3>%IRU."?7E7C3%5,8RI%N<<1$CS+>E:I+X51MU"TH-%4HV.@^C2$_PCO3
MJTG,KRT[A[4TT7B_%I,F%'5;'$IES68BU)E/;D(=(!6G<JFX`]*]--4^2RY)
MXPQI%\MK#D)UX,V&'%0M<A:5!$!LQ6E>0]5+;ZJ^G0A(ZU<2XU.G1X35M=4Y
M*=],`27B0E+3KBBD;NI&P:$+F/&N,)H#:U;@**'S4CHH$A0'G[`C0A:VN-,8
M:24?9SB@>^Z2]\:^!';0A:)/&V,>2EL7^=_TR_\`1\5C0A=5LP7';9/M\^+&
M?C/0W%J4&Y+H]4.C8L+45%2*(/0C12N"*TQX([RS!<5N4UN<BWO.KDQVT*]6
M;(?4E+(\I2XXLKZUZU.CP127CRF3OL&TXQFV*6J)'^69FH5.E(4XIS<VR^ML
MK&XGH0W36'6'X9?38MH[CGO`4Y.%.'^'^>L?R:_9)CJ9$FUY-,L;4NV7&=;'
M3$1%C.^BXY#>;435XI)[D?3JKWEV^"3(TX*UV6CQ2QYY!4[MR>F)[,>!X,*?
M;HU@OK<&Y.MO2XHS#)?26MI)0CI]HUH*U[GKIMXR3BG/Y)!P])^Y<H]DWM]#
M2V%X]?UMK30I5F62K`/;>*W$T73^+6/%2G80G<&CP-9LW\?V+D3[%?;;0)_=
M2]$@`;E9ADM20.Y/VC2IT>*G&\)4Z3;@>_4MW_:BR_X"?MO_`/H2O'_ACDG_
M`'0UCQDW$>9)_EFG?($9*]EO`9M"+`<?OOV0W-7<$0QF&1[!)<:4RXK<+@%4
M6DU(KWUGQ<I&T52!T>V=-FC;[E$86KVD\(66+'MUOM&1,Q(JBN,S^^&1E#!*
M2#LI<`3N!IUKTUGQ,]*U"D_RR'E%M,$1N^R#VZ/NOONXO>UO27W)#SAR_)=R
MW':;JG[1["G0:QXJ?B$A^40=OV\BP'L9]N70C%;U_P"&62CM]'VAK'BYAO'F
M23M+L`:/:"Y&EL]F7`=F^:5;<<O<94R"];WU(S')-RH[[OJN=[C]<J/?X:!=
MRUVCS+>+3;`/!:P51O']J?#D9EB.U:LC#,=H,H1^^61[=@[A0$\`[O'6WBYO
MF'F3K\OM/E'F6JX>TOA&Z1FXDS';NXPT@MH1^]5_&U!K4!7SV[Q[]]8\5-\P
M\R/R^T^5OF26/L8]N!^MB=ZI].8Y*?X/M'1XJ8_O#S+1^FVSQ1K0#V(\LGL\
MX'QU:W+18;]$+G5:4YADI;4:`;BV;CM*J`=::/%3\0DORB#M^WD1\[[7^(I!
M*G[;?W2H,)JK+LB'DC[?30`F<`$>7J.U-8\7-Q"=L8(V",;&BGF7U'MAXB86
MVZQ:KRPXTK<VM.2WEPI44E)(#TIQ/4'X:!=3<0M)K9ETT,=N-4D[C[+/;Y=9
M;L^?C5Y>E/G<\ZG*L@9]174E2D,36V]QKU-*G6?$S\0FWY1!V_;R*,ONMX.X
M0]O?"E^Y4Q_'9L2?C=\Q2(P[*R2^26";UD=JM*WG6'IBVY"V432I"5`I*@*U
MT^TG5I)K@1UJT&A\B@=8T>*&!TK<#ZZIT^+[\G),4MUV"%)^;9#B*UV^BV0R
MV$$U)J!4ZZ7&VD37<5S-Q'.<P;DXVMEE#0A,AZW^N_\`-_Y>K-RX_E'F5:YD
MGS'SKZ%[P?-NI]-:5/\`=IK5T<=/A'F6.9)F&)36\JCYJV6.(.BD7EEP@=U(
M"T?K-O<H!\>VJY>1LYFP4JK!:229?B-$<2+>I04KJM0))/<@5ZDD`D`:3Y<?
MRA.>9)\Q7'\BX$!P%26R=H6"H(*OANVTKK/+C^4>9',D^8H"&LJ"%+5U4$D%
M1\30@C;HY<?RM\RU=+*&DAQK3BG#?C*3C5GAELMJ+CCCJ]A3N*=R6PL[>IVJ
MZ5\-1UZ`P>YAW+6SN;A[J.>XCO1.U;/+YP*DU&Y)K2@I2J>VF-N.9'5^)KO4
MUG?Q*W?9(_0'^@/^ETXY;.`1S'\2A]DC]`?Z`_Z71RV<`CF/XE=,2U$R([92
M2E<R,-FTT4T3^M&VG5'Z7AHR,X!',?Q*<7.+>E35IH4J2U^J13JEMH(-&TT3
M1*.G;Z-&1G`(SOXE(004CMM'X#3_`-+HY;.`1G?\Q7Q4)NJ0O8%+Z)W$`JI\
M*@5II)[XF.RD"J>PU<P#:Y-YDN=81AM7LCO]OLL<$`O7.;%8&Y1"$)#<AULJ
M+BU`"GQTF^6)S<K0,W8G0T^X=[[:Y4B8W/?&5PE)C6S(H-QW':50669=":[1
M5@N"JJ&GQT@MO`7'#TIR++D%BOJB(<A;BJH\H3Z;B2M8;0'&/KM;E]*$5.LI
MNYAC<6.^()9FW%!KLV'M6A'\.S0M"UKA1PJ$:V*`E=X@[Z*"5.K2#U`<;;*F
MUCR]%()J#HP6O*B^4(C>MSBI;P\Q"GW>E%&M5J^BAKIZQC"P&@V)D]K0\T`I
M51YRNV*')%U"4J2MQC%5.``A2U)LX2E2@!4D`]-;<MG`+#?=-6X%'L2V.MY)
MC9VK0M5X(KM4E11\F[0&H!*?AHY;.`6W,?Q*<Q,0;4H],`[0G=M[4%*UIHR,
MX!',?Q*VM6]`*BM2*=.JCTJ3]([G1RV<`CF/XE.'CV'VV3$1-FH4I:UN)](I
MJ@H0JB5)20/K#1RV<`CF/XE&V8PVFK&EZ,6V$QIP]-MK:C^;^GM-$@#]6":D
M]JZ6N(HVQX-`.7;1,[:61SO><3CQ[4R\U_8VMY#=TD>BK8[]EV^3<O3<*FTI
M1*^5;=]!2E.)"0JA45=-1D#F-+G24H#A7RJ9K.UGX$0D)&.%:<%]QK(&VISS
M]RM^4%B*=@B2L9N8;<J.I#:XVT[3I4ZK:1?AOA80<*TQ]2A+FWUF5]8VN8.R
MJ2N297C;-V><DR)D-IPTCMS[>_;XZPKI5MV0AMORCM0]=337:2WX7`>99=)J
M+_CB!\BQ@_(35H=@/I6T[YC1Q*TJ)ZIVE)*3T.B2:S=3EN#P..Y)B.Y/Q-Y?
M8,*KJDL*:><;V]$JIVITH-)<RWX#T(+)V^\7.P[5R%+2>Z4C\(&CFV_`>A)>
M.=P]"Z8++3DN&KTTJ2)*`3M!`[=#K/);/[["&@8(\>[AZ$9WH`7"4$4WN/+0
M`D>9;;)4`D`&JD-BGT#619Y2'%U0%GQSG>[3:B;:OMM57X;3_)I?E1_*%CFR
M?,5T-H&WS)%:GZPZT_&-'*C^4(YDGS'SI?7]E#UOQE&U)2W"4*T!#3J@"/CL
M61^/1RX_E".9)\Q22D0:!/7Q/C]'T`Z.5'\H1S)/F*[HT!L6>:K<VE3L^*T[
MUHIQLI%4+-`2@CPT<N/Y0CFR?,5!_%K,DW/D`!H'T\GO?I@(/D_VTF`[1MZ"
MA\/#1RX_E".9)\Q4UL%LN]=@=V`_+6Z.Y3:3M6`=BQTZ*%#0^&CE1_*$<R3Y
MCYTXF4,N2K+*WNK=3Z_K!M2BK:XGR[RD]-]$]]'+C^4>9'-D^8IH66`I="D(
MZ'J1M_%6GCHY4?RA',D^8^=*AM:[-A^9W0$CT+:`:%0*D)9ENN#L*I2$`G\'
M71RX]F4>9',D^8HCY=R[".+/:%QMS3/]OV'<OO76-8&\CM%[NMBPZ8U:[K#N
M,B?D#N2W6#)`9BQ8"G#5:.AKN&N:ZI>WD6I3QQRO;&V0@`$@`<`NJZ186,NE
MV\DL,;I'1`DD`DGB5`+%?=G[&<_L^,Y3<?:ESEA-CSI<A&'Y1Q'F=DY!QG)T
MPUM)EJQ"YXCF3:+XU$=<1ZJ6&7'$':"BITA:ZC>B0UE><-Y)&T)S<Z+:7$>2
M&*-KJUJ``:)Z8W(OLFREE";)[J.6^,5M^JEB)R1A>2-BWK94IAY$N=.L"F4O
M-.-EI>Y^H4V0>VI#\TN1\5?([V&B8'I<;J>;]J<O$<65=I=NN7$WO&X!Y"::
M7&,.U7J\VVVW.2V@),?]1\X93,MY`%2&MP5X>&GS.H(VM#7L-0.^OF4%+TA(
M9'%I&T^OM3RWO&O=6_#:;."XCG,1M2Y$69C&6V]QAU3B=SCR79+;*DI=;Z@U
M\Q(&G$6MVDAI*&AO:DV]-W%I61E23A@F_P"/N2[?>,V=PV\6F9CV98K=X#=^
MQZ[*93(@R"4K]-UM-*LK0H%"R!O2:]M2#713BL8%#P4%?&>W=3,X>5/SGZ%2
M;G$>*:J5"?27*5V;GZH1OIY?+V'PTKRV`4H$Q\1/3XW>=%.%PU)R*&LK(]-N
M0H*K]11:*00?`T)T9&<`CQ$_SN\Z*),!*9<M)6E-)<BB2:427ED4%.U#TT<M
MG`+'B)_G=YU@8H7Y?3"*_G;*4IU[T\::,C.`6?$3_.[SKF?MQ.VE5=^W7X?1
MHY;.`6.?/\[_`#KD-L34[DBOC6G\-=;-8S,,!M1SYZ?&[SK/[.44I)W%*1M0
M3]5(_12:4';4KD9P"TSOXE1NY3MP/)^%DTK^[TP>';Y^3_!I"1HYH93W",1N
M2;YYF8L>X'L*G[[#(Z8_&V:-I;"/_&1=U*HFFX?)P_36KIU!Z4/;7/>I8HH[
MMH8T`$#8.U=3Z4GGFL2Z5[G$'>:[E.C4#E;P"L]2OA`/<`_A`.B@&Q`<X;"5
M\VI_13^0:R@N<10DD+[M'P&B@2?+9P"%!VITUB@X+<>Z*-P"^;$5KM37\`UE
M;9W[*E#:G]%/Y!H1G?Q/G7W:/@-%`DRUKC5PJ4*#X:Q0(#&@U`%5]T4'!;(:
M*#@A?"`>X!_"-%`L@D;%\VI_13^0:RLYW\3YUE0:Q0<%K5?"`>X!_"-%`L@D
M;%\VI_13^0:RLYW<2JY?O5$`^R/DX;0:9#Q<I(IV6>3,:05#^^*.GX-/--C9
M'<MY8`J2<$RUD!UJX.QP"W\"&O&&/)J/U;)0D=/(@!!"0/!-3KI+99.6/>-.
M]<;NF-;,XM`!)3R:.;)\Q\Z;H:DON0H]>NCX*_(/Y=6I59?#(4/V9*:_6KT[
M=NQU@BH1O!2`SHE\6E=>K3K2%U\2J0*$=^@!U$W%A+*[,TMIY?N4I!>Q1BC@
M[T?>G#5$<1O\R/,%(Z%7YW3KT[::<A_$)]XAO`HP?@,&TLMIZ.,J"W":#<0:
MC8>I/3X@:.0[B$<]O:B93;*G"I*%@J545`H">U>_2NCP[^(6KIVEI%#L3@R&
MTK@V]E0*B$H7T[?5(\?PZCK^V>10$+-CB]9FVA804H%`@#K6M17X'49;QF-A
M:=M5/KH$!(`&Q70#X4Z#\&EUJYP:TN.P+[\@C]!7\'\FA(>*CX'T?>NJ%!2F
M9&=V&C*BI0Z5(KV`IXZ$LQXD;F&Q'60LF8B*$)(2RLJ6%="4T50)INJ?-H6R
M39@H"5**%>45I45(\2.GAH65#/W9<O7/!,8DV3#5M&]2K>[<9,Q:A_,663MV
ML+;WN)>4!7JD#Z=0-\]XN7`;,/4I_3--FE8VZ#F\HDX8UP-."\V6;9I?K_G[
M-VRJ\7B_3ICVY3=SN\V0W!V@D>@TDAL!5`.J--1<&(\R3%@X*[0FWCAR%ISJ
MVOVM9G&1]E,NJCI0#$2E+8C1E%6U7D*GF]\A=.Q\!I[#<QSXM!\JVSP4^$^8
M*7'-&?0L&YBX*OL*X1;?9\VM-^L]]!DL+CR)=KN,:1$?>1')*)OIJ*:K2D4'
M>FG(53U*S>ZYDG86\LFH&_<IP6FX6N[P6),>;%EMR5I"'X\EEUM-2>JRE:CV
M^`.MF-+W90J_-.(31S7''[;TLK):DM75MTE)1&;<65)57U$K04@M>4`@'O6F
ME>0[B%JVY8[<X(N<M>UYQ0'9:R#7Z30_5[:<M&5H'8F[B"XD;*J--^BK>Y;N
M[!0240L:7]'E@>@>W7ZS9/X-;+5.`NQK3D.,OJ2`E%Q=<*37<4M1E)(`VTJ2
MZ*:$):+LCB0I1VT34FGT?#R:$W-RP&E"N-VVFB6]I)<6D5%*"G4E7E['6\<;
MI"0*8(\2S@4YL!QIB(PT`KR(`-*$5\?$:5\,_B$>)9P*),K4VJR$.*V!3;@'
M0D@FM#1-31)ZGZ-;WK"V(UW?<FUA,)'T:#4_>FO]L?);-ERGDJW91/A6>PWE
M]+MMNTZX1XRX\BV-K9&QDO\`JK0\'RH$)512$UI77/-6NF1R1@@TJ>'8NBZ*
MV:**0-RU<!B=VWL1#,Q?FUB3(=QWW=X6B*[(?7"C7VY7=+R(;CJU10Z([+K8
M<4R4DT!'7QU8K#J3I!L=-3MIWR4_=:PX^5X55U?1>N[J7-IMQ8QLKL<Z0&GD
MC(15<9WN[L$.2S-O'%O,EH4D-*BC),4D?-1W3L<;=@WV+:'5@(/YI"AX==+Z
M??\`16H.#8C-&:[74'J<5':C9];:<TF00R`#8VI];0F2&1R+(^HW/VM9QCR6
MEK7+E\>Y%?8EI+JE;EO-P8@O%M=43]4H\H'0#4[<Z'8$L=IM_`&.!)#R:UW4
MHTX*$LNH+]@>S5;.Y=(",I8&TIOK5PWKIAY_A4^:XX_@_N$K(>3LA(CM/.!2
MB$)C)??Q@.K6M70*5UZC2!T0T-+ZSK_$_P#\B?-Z@B<X--C>T)`^%F__`(TX
M:F;5,BI<MOMJ]P%P7N35^[7V_P`4J3UW?J+=:8+(56G;MIK^5`$A^IZ>#PS.
M]K5,>+LR,-/O"/X6_P#G6A$>P15)=O7M_P"<,=7&(E+DQLJO[7HPT=Y"DW"S
M3&U46%#]HGMV\2E+9W%N*P7]G(RG[I=M_P`*WCGL'X/M+B-U?W@W_P`Q6KD:
M3#P[%,=YFP6=D-SXWNEU3CN?0+XAJ;?\/FSJ-6^?+GIV.HM+LM8:<4IM":D%
M6T$T8PW=T+UEO)+&07-Q!-"":&F&[VA/I[*U\#)<QQO]UCCL%<!4;]Z5-BGV
MF[6Z'/BSHLMF8TEUIV.\A\'=U"%I94I:5@'O2GTZMN'$*D>+_P#X<GF'WI0_
M((WM-D)"GU;4)75)(K0*VDUVJ\-*PQ<Y_+86YD/NQ'%S7M>!7@*^M*"[-$1;
M:TD@E#J4$@U`*6R@]>_<:)X702B)Y!<XTP2D%PR>)TK00&\40R8SB@C:4FA/
MQ^CZ-9Y#N(6>>SM1G%B)%I6TX/UCLQI\$?5V,FA"J]=Q(Z:.0[B$<]G:H88F
MPL77D)50?^^>^"@K7^LYFCD/XA'B&\"IHX&A3<:&^H>1%MA)(_..\/4H.U!3
M1R'<0CQ#.!2IN;"G;>^T"D%Y16":T`)/0T!->NCD/XA'B&\"D.BT%2@-J?CX
M^&M7Q%@J:+!N&#''T+;E,79Q[F3">BWK1,2"KZM5P9+(/0=`%.CP[:23F$<[
MX<.]5&??IOW*+]PO9+S9KW>[,];L]]M"S-M,QV)<T,S^28N-76&VZUZF^%(B
M3%I])0*5H51236FN4:O_`+K<?]UR[)HS2W2;=IVB)J_.)QKW0>Y[BO*./L<P
MWF?-;+_8KFDESB.VSIGVA!PJ\KN@@JEXQ:[FQ(AVE,QI[]>A*4H<H:I'2D?5
MP^':I*KA\.U3?PO[WKWT^U_.,[LEJY"Q#D=%_P`JG9ED:<HQ5RX0KQD=[M5M
MD7&7&3'FQ7[<R\VRA)9:"6O5"U`#<3HYDN\K7-/O(^WD4PX__*$^:,<NZH?-
M/MFX5SN7]E6N5ZE@GW.RK81<X")J$[9=NO'HR&D*VN()!:<JDDTKJ1AFMGM`
M+79P,=GE6#S.(7H\^[NY&M'N0Q#@SW38G9<CX>5RED+CETP&U9KE#]M0G&LL
M8M"H\A+5WBP#!E?*+4E`C`%*@2`:C6UY`>7&^WP)=C7A3LJMXFYFOYP%,N%.
M->U2NQS,;E,^]G]TL,2Y!M+%_P`2=;MY<]1AI+N.VQ10W4BO<5KXZMFAP2F,
M9R"5ROJ@#F.R"F)5RN2H$N0VI`J@@$CQ`H"!XCIJQ'3YJ[6^G[E5!.RFPKFQ
MZ*&;DVZ!0)0O<#W-1TITITIK'Y=-Q;Z?N6?$,X%%TNWA<J0I1353RU=">Q42
M/S>]-9_+I>+?3]R.>S@5S_(.?IH_YK_2Z;^&?Q'V\B<.%$#!<'Y[?Y5?Z724
MD;XS2E>Y(\UH-#58*@=ZI)53ZP^J33IX5IK1N;,,#M2K2UV\!!F"X4>BL5ZU
MZ=NA)\1].I="CWR995N\H84E".OV!,'6M*_/2>]$UTVD^NWN6WA9)XR]A``-
M,5-OV4QEP\&SEIP4IG\U(I6G2#!Z]0-4#JC^;;W>U=.Z2C,=DYAVU]A4S]5Y
M6=#0A#0A#0A#0A#0A#0A<K\M$?<IU*DM-I4XX\2@--M(2E2W%J4L42@'MW-.
M@TJR)S_AI4[DF)&F0QG`A9,269*$.QU!UEUM#K;R"%-.-NMH=:<;6"0XVXA8
M(4*@Z;/D#)Q;N!SFO=@G!C(;FJ*+HTHDT-"$-"$-"$-"$-"$-"%75]Z<@GV4
M\EHZ55?^+B/AY>2\<6:]/@G3_3C6Y9Y4PUF1K;5U:[ER<#/H1QOCY(5^MB^J
MF@'1-4IH:D=:C71H8W2,HVF"X[<R-DG<!N3V(6'$A0J`:]Z5Z?@)TMX5_$)%
M:OF$?!7P[#^73RB0Y[.!VJ.SL>YM-J6J+Z:4TJM05M`)`Z]OCJU*NKD,HT`2
M$[Q7>"#0'PI17CH0DEE*B\W!W4'\Z8^KT[/I^-?AK!V+(VIY%QT*)!*OK5[C
MP/X-1*EED6P0!55$^%1U_#TT(6)CMD'IWUD;5@[$MX$1,B.TOJ5M(2A/6@VT
MJ21XGIJ.O2GEABX%'[$4%'ZU-%`T&WMM`%/CUKJ%&_O4\MBXK80HH'FH=M:4
MKX5Z#6R3E^F[N7.U%>62"E'0>`'\IT*,1G&@NH&\(JKJ/"GAX?'0G]O]/RKI
ME->NVH;1O"0``*"HIWKWT)=)^>&K9;YUPEC:B+$?6.VVOIDG<*$FE/HT(5)7
M-U]7D=ZNMS@NFX1KO\W:51JE;C+#+I8=+-#1MPN-]#U%/#4!??S+O)ZE>M%_
MVV/O=_U%5B9%P/;;EE%YO.0W9Y,5V>686/P@XS+92T"I*I-P0"E"D$5Z!.[M
MJ.N/I'R*53S<56VUX;FF#R(PD?9L/*+,F<U*F27T.PW)`C/AS<X.H;=%*4`/
M7KIQ8;/,L[EZ!K#A6(RTQ47#&;)<#!+KL!4^WLRUP7)*E%YR*M\++3CJ54)^
M&I11DGXDYC[4X,_B[$I%AN4^TVE5IO<"SW-ZUNV1]Z(X_-9@O/18:HZE.Q7&
MI,E"`L!L**1T4.^E82X/]W[#?Z$L_0VR1EY"0?M@Y5/)6$P+N]Y9@$NVS&7`
MH.1YMN>7%F-+W*)%)#:J`]AI\J=J=IX-QH%(];;Z4+7L04I2I52#]4`FOUZ=
MM948PYF@\0H].Q$2.<LF8V@ABT8PI':OZQITJW$]^O;0MD[%U@MLW_'4E)2?
MF)!Z$?G-H'P^C0A'KD=TE:0E&TJ4!T%:5Z>/PT**?\9[RN-V.6@"M*34T'0=
M#^(Z=6OQ'N6JU+FL0V@IXD"I[4&GJ%"#W&>XVTV^W3,/QR2S-OOKN0),ME(=
MC1&7$U6M394=KVP%()-`HCIJ!U:\+8R`I?2+.LF(WJ'?!2G'>4[7,>V.K>@7
MA"BXA+B'O3A/2O4<:<"FEN>HT.NWM^77,;^?G2#LKZ5TBWA$,8IO1U[JOO(/
M:+[*<LQ3#?<KRG'XWON:V!>48S%E8S?KA$NMCC246V6^W)L=MF-Q_3GA2>J:
M>4]*C3(-+L*&B<@.VM&(3'6K[['[L*_H2(?N[XW2I92M4>XQ;[:F8K8-5?,2
M;M8&U;R.B:4!5TUL[2[%AI`]S3NW>Q(?F&I'^9BJ$YEK^]:^[BN%7(?O.X+V
MO%!C,N9\S;#3:=P=*FDH!KVWH!'PTB;26.M)G4[UN+F.3;;@$=B<&Q_>(^R^
M^NE..^\C@R6I1%(4;EW'$EC=0!L.2KE!WDUZ40D]>@UCE2_YSO.MFS1AP=R!
MAV)T+7[T>#9)#=F]UG';IH:1;=S/8$N!/8K/IY#ZGIH-*^'76.4__./G3O\`
M,V_Y+?,EY;_=#BER96FR\_66]K=/IK:@\GP;HVM*@*QW?1NTIL%237::*(/P
MTZMHHV^]-.:5XI&4VU[^/,P-+12GI]J:-[E/G2=8,SM-I8X-OEGRK(\BLESL
M3^97!$3(^/?19_=L7UQIF9LR%TNNAT,)!W':E72IFHM8T.V`',!N1\/\6[TJ
M/?<60/A12DAR^=<6/C.K?951X'%6#PKD)%JCQH=HSBZLVGT95RCQ9I:EOH3)
M0N+$<6XVG8=ZTA)I6NEOZGDWE:_D]C\H2FY(Y!:XCM,"^IF7!^,G*;187%R7
MI"VTRKG-$5YO8^=Z%M$43M6I'0$=R-3V@Z^^>[`)WJL]1Z+"+<RQ"C:>D*8.
M,W,Y%BUNN)HIUY:%D@4%%H"NQ).[KKH<QYLK).!]BYW;TBC?&W?]Z/6(;A*N
M@[#O3^Z=*K"ZS'&U+2^E#^;0=S^/0A0MPYC_`&WY!V5*OWHOE`JA'6Y3`:@4
M\#H0IH8Y'+%J@$BA<MT(^'YJ7!X?AT(1ZX`ZD(5V'PZ'O7Z="%I3':0=P!J!
M\?C^`#24WTUAVQ)[.`!A63T_W*D_^UJTQ&U2MA]O.J??OOHJ+M_R>C)D+D_)
M+A7[V[+:E[PRF*X.?<=@B2XM27`E,=J0I=:="D'PIKE.K_[I<?\`=<NRZ3_M
MD'_:"_.1>C\GR,IEBZ\1\9Y#*@7X/_;AL,.WR?EX=U5ONTAZQY!8YLB.ZAE#
MX<<0HK2L$GKJ.4@DYE\5#M\N$2]<&W3(;A;U,1U9?B5\RV`+BTTW';B3?6=M
MU]AJ+<=U*'"#0[1]6E2(1#GZ.-G<KDQ,FMF?X[=&$J8N4RRW*PW^WR`\XY*A
M*$67"M<G<PT\&'MSI*G$FM.HTM;"KC0[T%>\;[GA?R7M-]JS(3\K&<RK(XL2
M"[\LJ2W"_M-^79D.2(+[\0O/L.$J2DU0HT/;4Q/]&/\`B]BW;\#_`.'VJ5?&
M4@R/O4_=/*)W+<R#$PK]'RXU:.@'<#5OT7X0N5]3?4=Y5>VV^M:TI4$D'I6A
MJ!3PZ_1JV#8J.C!EUN,X'#T4`0FO8U%#6I&LHHN&4F.-TE<EMMM9K17U@1T-
M>M*5&A"25RR:S6PK^8N-O0A"%N*6)C!4`A)5V6M`\/C_``ZC:%;Z?<^*=E)Q
MJHL95[T^+;+?[9B5IN+5XR:[W=BQ6^V,L2W/7N$QP,LI4ZTTIMMMDG>M52-@
M.FES>PV9:V;:[9Y%=K;IB748#+$/@I7R_P!B<R%[@;):>3Y?#F=N6.QY[#M%
MKOILMONB+B\Y9K\=EEN2-I"S'E.M+%=HH>GAU;C6;1S@W"I-%7;[0;JUEIC0
M*3=O:;FI]>,"6J[>IKWU*))-%R#;2CE;!T!`(7C\M1*J5!^>DCH10>&FKS6X
M:.Q2-K_+//\`>"E7[7&$Q\9S1E(VC]^9F[X[ODX9/;IW3J@=4?S;3V#_`*ET
M/IC"V=W^PJ46J^K&AH0AH0AH0AH0AH0OH[I\JC56VJ:43T4:JKX=*?CT(5;/
MN*]R$NV/W6T+CR+/$M$_Y5Z,PZMRY>HU)3"<?D1B&5>LI%P94TPDJ$AU^$Q5
M/SR7&[STUT]/J+&31`G.#3#@:;=VPU)V`$T-%7]0N3!.XUV4]2)_9][SK'FN
M6(X4R69:X,Z6E]?%LT3A(BWOY>UQ;[<\`-R.U`O%CLDQ%SLVY/\`MMC\A"DT
ME09[+1U1TA<:3%^8/8X-!`)-`14Y0:;<3[IX'L(*1TS6O%W@LR=Q._&@^Q5G
M@"NM>HH"%CINJ2?J]:`"GX3JC*S+[H0AH0AH0AH0AH0AH0J]/O1T!?LOY+"J
M^6^\=4I_K6>8^^BO^?[_`$:?:9_,CLK[%$ZY_*./:/44D>`Y97QMCQ=VC9;X
MX3M%/VK:'EUW*Z^8]/HUTVS^$]RX])_,.[O:4]R+@EM.U.T@5[TKU_`L:>HH
M5J]=7P3W^!_EUBJCOO7`XIA2%)<+2T$$%*P%)->U4J20:'2W(N!^\[SE-.?!
MP'H3<7JT1F`]-"FVVP:DI"4)!_-!H*=?X-3.E->W.)2232E<>-4PO)&N+>7@
M,:T\B:K*FT)B6B0ET%3EV:6X@*)*60M"*J'Z!4.WQU+%HIL"9!SJ[2G=*E5/
MF5W/B?CIED9P'F4CF=Q*Q+FWNLC\9T9&<!YD9G<2NH.I],>?KL'B?T=)RL:8
MW``5RGU+>-[A(TDFE0E999S"&MBY*4K":E)<(-!M%=5[PLSMM2IP7#&_#@E/
M'N,+:4KEM;RHD`N5-*"GQZ5TSGM'M?2F[N6WC#Q*^*G!14A!)!)"5"G45Z$$
M'Q&D#;N:,QV!*Q7.>1K":U*.XO[%)\>O7Q[_`!TDI7(S@/,NH*4.RB/P$Z%L
M`!@-BR#:S^:34'^*O>NLM(#@3L2<P+HB&[4UG+]S;MF`9)/]=M`C6F:D[GD(
M25.-[4@[E`*4".E*G3:\N6,&"F=&LW/^,5QWX^M4PRH*7[!*;VI9FL7<+>4*
M(D,&15]2%+3YT;O4J>O6O74!))S7E_%7>.,1,$8``'#!1MRN&J)=[G$02M;W
MV=(4FI*G`(JDN.JK];];0$GKNUI0'`XA.(0#(*I#OJ<C!Q]*35IEVE.A;<;"
M9274G\UQ'RW0]Q761[OPX)YE;P"]$O%5P_>+%<3O;2/6%WQNP7%2T)WI*Y5L
MAO.U72A(<4H$GQ!U)15Y;2=M$PD8P2D@`&JDS8(I7)ALE*!ZCR!]9L[1U*E]
M"0`EL$D_#25TXLAJ*@5&Q;L>_$5-*'>JW/:(EO$>2>=N-EN"N(\GYA#CM+)J
M8TJXIN<>4A!&T-O,3@I*AW2=.[-SG$9B?*J1KA))KC@K'7PD^H$T*2D@4IM(
M*?AVH=2*@&?`.Y1NCI<;YXS`+W)4;?BFT$T)1Z#_`&_O:Z%NGER="C?<;4A/
M7U9'4=^B$^/?H-8.Q".Q6@KWH*_AU*,:W(,!L"BG_&>\HOG.(*`G<"H'M7J/
M\E-(S#*YF7"KMR;3D@"B8OE&_2,>L-YG)0XI+=M<"%5Z)>()1L-:A9\".NGE
M_P"[;U;@4VS.QQ*\O'N:Y(YIP61R'?<78NF7/P+S9_L;'X\JWPI<T7*]V=BZ
M?-3'&DK].VP;XMT[B31H`>&N7RRR/)#W.(J=I)WJ[2U9*S)[NS9AN[%9QP8F
M0G/;3ZZ5-2Q8[DEYD/)?2RZ+2TR"A]"4)6IQ:CU`%2?IU#:BUHRT`!Q]BOD!
M)MV5VT7FD_Y3-=+_`&_WQ^Q:9CZ)$V\,<5W)-MB1WTUD)/)TJD117;KBAEEZ
MJ@H*8?3M-2".@CP`8W5V?VI<"K'</[5YR7\WNUIS/D6Q?N3G&,W[(\CNL6_P
MY64)1%L]X9DRGY$"7!;P]AM]+3+4C8E*8X0"E020D#32VC8UK35NS"B8O;:/
M8W/.XM`P]X[*[_>J<>*C*BQY"N);KQ\LW_MI>W;2CYR&EPIE1&H[BGGBXQ0M
M^G-!42.O0]]2P:P`';5.HY;&)A;GP`KMX^7T(X9B7J#&N!79K6XW:;BFPNNN
MV=G]8N2IS<X7?EB2JD912HFH!UL"T&M!0%#KJQ#:M?5V4D8_M]"<>'=8Z%W!
M4_$L:CM6N%!"DN6]M229`"&G5(2(^XN;J[MVG7.M:UHW#L"BOS=]&EK:EU?0
MGOQW+K+9K:_9GL&P=8@VZ1!-U>L91=0K*&$--R8URCW1J7'7;O3"FG%)4EI2
MZBA)U)Z?%HTS'FZRAP!I@-G%2VEZMISXI/&T$F-.ZFU/K*PV;B5MLU_O>-<P
MXO8[PQ":MM\D9?D%BQVX29,1$R(N#=4>FR8[T98=:=0I0#9"@=5C3(=#EOKD
M`L>]C7%@(!H<:4\M%`Z-J^D3:G.PD.+0[*"`:'&E%CR7F6=\?X7?UX/R=S3C
M]WBV-RZ1IEKYDR*?'B+MUP@&0''D7)AX-LUH:$D'I33CEQ_*/,$YTF8W>HRL
MJ2T5PW#8O8WPAEUYS?[IOV0Y;DMYNM]OV0XQP7<[Q=[W-7/N5RN+N5SV),R7
M,=4MZ4^^6O,MPJ<5^<3J3T,!NIM#<-B0U*-\>CRMD))$SZ5X845^W$Q*L%LI
M2:A3;*P0?K(2PA*E?2`KOKMH`Y3?X5QT$\]W>G+#R4D@.4/B`:'\=-:)9?0Z
MDJ%5UZCQ/QT_@:TQ@D"J83N<)2`310LPYU`NW(1W@']Z+Y0UH:_:4S^'2V5O
M`)'._B?.ICVM\?9-IHZ?ZMC=E']$ZQD;P",SN)1@EQ1(.]1%1UW'^73"84E(
M"D(23$"=J,@XA1H%I)^%=(D`[4JD;G3R58U=6T.5W0I:5H"NBOYNL[5#L1^'
M6,K>`6P<YOPDA5!??%`W'_D]O+MM"@7X[/'5W4MZJA%^R^=\:2A:]X-&6&UA
M[I4)`J-<;UL4U>Y'_P#&<NXZ"2=%M2<3R6K\P3D8WYK-\I&13W+C?47"2Q(N
M+#JG8CR774(85%)H/D5P%!+24]!0`=M1:ED89=F'*5OF62'=;U?+$[!Q/'H5
MNC6JX3K4R;(NW-/VUUQJ'(:;4_*BNI4XI0W+/UNHT(2DG<O<JVFWXY;?M&Z6
M1MG'V@W)>::?=R"$_/=E"Y27;G!>7/"W@I(65*2K::$C2,51(2"?B\WI6*XK
MW`?<W\CH@^Q/VAS;U;I-QFSLVO,160)])QW[1N7+ET9BPW6HGF8$F0$I2I38
M!4!57;4SF<YK*DG'V)1OP._A4]N$)9G?>;^YR74$/9'CJD%)!!0FQ6U`ZCHK
M:4D=_#5ZT3%@7*NI<9#Y5;URQSKA'#$=3V3W>):MXF^@J=(6M;S]OC?/2VHS
M;'J//JC13O6E`)2CJ>@.K/<:G`UF&7`*N:7I$G4+LD)+:888;.Y0OY%^\NX^
MQ9^/:;5<$W>;<+/'NS3=M@/RU),E.X)7(?`1'06RE04G<#7Z-5^76<KOP\0I
MF^Z#BT\,-Y-(T.)I[SMU*[U%O(_?#SAGFYG#K$+9&<VKC2WI#LV<XA2>JEQ%
M!F&A)/U=JB=M*]=)?G<APHM[?0]$A;1\Y)'$D^U()W$O<YRL!(O5UR-+;BDA
M;,<&/#50A:/41%0R3Y@*?2-:?DUP<>;)_B=]Z;MU>RB/X<,3>YC1Z@N'C;B;
MG/B3W!\2Q,B@-W*Q\E9]:<2<R.4EQV7AD2>\PBY3X3;V]M$Z7;UN-M.$I4AP
M]"-16J:;+!&"]SGX':2=G?5670M:,[W!A+6@BH&`/D&U)\XERARW]\5[D<CJ
M]&@8%E#'%5@^SR[Z,GC?"7&UV.,765!#ER)?+CAKT4I776O3UGF=^(`X[<17
MUI3J2Y9DJ-M%Z>L6MRK9CMKCK<49#;5)`4HEP+H!1PGS%0IXDZN=<50$TG(#
MBCRCA0WJW_84O;YC6GSTGMUK2NFS_P"8;W)*5[VMHTD#O4HO:]4XWF=221G$
MS=4U-?DHE:GXZH/5/\TWN'_4NI=($FP)/'V*3^J\K4AH0AH0AH0AH0FOY6RV
MY85B<C(8<JW0C'2O<Y=@%1FG5$>D74_.6Q*V_B-Z33L0>NGNG6_BKQEO3-F)
MP\A/`K20RAA,`K+N'V[%15[I_>Q[B;'<(]O@\GW7&+),BQUMR\'M=BQ"W7(K
M4O:(5_7C/*U^2\UT]0&Y0DJW"@Z^7N/1OZ>Z'K!I?D-!&)=6K';\S2YF!'PT
M%3O5'US6=9LJT93;LPKW8*E+D/W>\E6O-9-_Y0R?.\PM]^<:MV17/,V[QE;4
M:"T'K/:;];Y"\@=C);MT&Z+AW"-#MZ7;C:')#:_3<2RZSZ'TS]/]&M+*/3]/
M:UMM$'!KVD@G,<SJN&)]XX5K0C#?7GTW4$\\ADNGOYI.(KPP'H24N7/4SCS)
M(5^CY8_9'+)/@Y9C]\;0]-E6._XY=%W1BYPI\(MO3KMC.0&3,>`'HW"&+DVF
MK=^"4NKOHFRGLI-/EBCEC,3ZYAGV`TQ=4\"-X(!W"F]EK#8[H/8XA^..S=Q"
M]-'%GOSS3E*W8?E=^M8P/(KM:;`7>/XDE=S1:KO*AVU-V9D!/IJOGS$NX-2T
MM[D/Q8<]B.KT7&+B^SY+EZ`%I<SM>2Z!A<*D4P%:4(!!-`<<-FS$!=0T?6&S
M4<\UKV^=6>\4<F0.2+(93"2W/M[<)N<4%]V.MR8UZK+C+SS#"G6WT54A90D.
M(HM/ZM2">:ZC;"TN)(FFK0XC@?1]N.*M(>V09V["G8^&H.)Q,Q!)IBA#3M"&
MA"&A"&A"KP^],<+7LKY-<Z^6\<<GIXD\@V))_*.GX-2>B`&[97'%RBM<_E7>
M3U%-MP1)+W&F/@532%#/P[Q6QX?@UV.*.,0M(:`>Y<,U-SFR^Z2,=R>IM:0@
M;E=>M:]^YUME;P"B^;+\SO.5OW*_25V^)UG*W@%(_<F+C91<"\@.NJ+?FW"O
M]XJGA\=6?\J/S-]*IOBNPK9<[\Y*BJC%1`<4"23442:D4^)KI6/3S'7WABLB
MZ&\%-_D,DDPZDEGYB/L0/"CJ`>_@3I0V;LI.8;%L+IM1@4^*GQ4^4]SXCXZA
MU-K2XL+((!%-"PMB'D@)2012@)Z=/"NL(V8KO9]3?^JW>;RI(23N)-0.G:M-
M-IIHX<2*A*PQ2S&@("Z)B+A;E,.RVW&B\4AMLBJB@GHY7ZNU1\._33,RPW!S
M@4I@EY+26)V4N!P[4;VLSY$AM:SZ;2'`2E8-5H"O"AH*ITWN6QB!]-N4I2SA
M>V[C<3AG'%.C%_8I_'JO*X+L2@$;E+"$_%0--8JE60E[<P(39\E\T\<<2V=V
M\9_E5@QFWI0KT7[W=(<-$UU%"6XD9QY,N6C;6JT(V@ZU?4L.Y;QV[W2AFXE0
M2LWN&M/N@S7)^/;5"M$W"<FXYY+CXM+A2@_*=R2+BLZ5CUVA%A0!+4N*5)2>
MH.JQJ+GM%0<*J[Z/:B,C-10_QP&1BKZW7RIUV'9[B\](4%/.4ML9$AV04]/7
M]=*M].@572%L2803MJ?6I:Y`$Q`V4'J3"\J7FPV*Y6B7)GQD/R8B8LH%P("5
M)-4N.+(*0GIV[UTH]XC;G.P).-V1^9)3%6[+EEX;B-W>!*MB7V!.$9_>\ZVX
MEQ*VF4T2HJ4W4?#2D'XXPP3CQ`X%7*>WZ=F35HLV/XO/DRK39[=$M\&(MH!U
MJ)&0&TMN)<%5=`>GB#J7;"8X0XFHHF[SF<7<5(_E_P!P&.^V+C>;R+S'/AVZ
MV,J^2@6:)`9=OV4WQWTWH&,8U`A_SJZ72Y``%+?E902I?0:92D3.Y+<';:]R
M1EF%NPO<"1LP[5#_`-G=RS7E'.,_YTRK'HF+R.4;RY<QCT1M8^Q6&HD.'%CR
MC0(,MN-&1ZQ'0KK2HT[@')&.-%2-7G$IP!"LW4*536M!MKX&@I74F'9AF&]1
M#,&@=BC@J0EWGW,"$D>C:\50:TZ_J7NH_)H`H%B201BI%4\E^E)7?<<0$J!]
M:3U)'YS:1K*1\4W@4=GOJ59\`[@F9-22D_,.UQ1^`!_(3K1\9D>P`TH?8FET
M[+'FVT4:/<?-+?'MU4TKTUO-E`*OS=H(J:=::5U=[8;89L2FUB3?/,;!E[UY
MN_=[QW)Y+RO-\*<N656MN[S\*F6^78946-(:E6!W$\ANB$*70%L2+4VT\/SF
MW"-<O@'BLSF^[0GUJYW,X$S!2M*>I6@\1NJ=Y'M2W>LA5ED%Y:MOJDF!`VI=
MV>0K2GO3N:ZAM0>"\,WMJK[92B2U80*4"\K'_*E9F00?=Y[/W\5D38F1-\%7
M15B>M$E;=Q^U5\D7(,I;V;2V[5*:"OG%-,F4RFOPU%?2GK:9#7X<*^E>;7D>
M_P#-L+(+EEN463*L(O-S2;M-6B)=K1"6]*E(@3;L4S5O+$B[W);A?JOS/NDI
MHFB-)001QG*TU]:816&FO&1K<WV\B;%OE+/&&&XC&77]$=F0N:VV)JMJ)CC;
M33CR0KU**4VP@5^`U(5(``3Z/2M+:*OC))V46Q7*N>N(D-O97?7$RYK5PE!4
MIE0>E-;]CRPJ.2IQ(</4FG76"7$$+?\`+=(IA"<U.(^Y!WE3.7TRDOY)<GDS
M"R)"5_)T<;CU]`*_FIZMUZ4Z:1Y.["GE^](_E]K\@]*5&.<J9B_,*)MW=F&=
M(MD0^M$MSRTH:D(HK<Y$-&VF_`=]/;"UM)9'1SUSEN!K@M6Z?IO-R31N+G-(
M!!%/+56)\X>Y.]9GQ_CG&69<N8!?L1Q)^VO6A&.86X_>;.W;8Z[;$@WE^.([
MJ9\.-#"'4H4E=>HIJNZ=IME8ZK.XU+CFR[JG%1MOT;9:9<RW32"^0'+_`'2:
MT)[!51CROD3&<ZMN0LQLBL%PFQ\)R%N';HF+93:UN%IGYR1,;DS[A+C&X.(:
M"?,D(H2=3HKOI1/-%THZ5=.N)7\S-6H`IP7MZ]K:MWW.WL/ZH(3C'"+8V+#E
M`C-KFFCA3T#@/<>&I+1/]T'</:DNHFANFOIL+B?4O1-P_)2C`;(2E1]&(&54
M(\Q<2A04/H`UV]C<S&-XA<+<[),\G<E_ZPWJ70T([=-*>%=Q"QXIO`K,/"J>
MA[CX?'3F-O+9E*83W+3(<"H688X';IR`H`C_`+Z;YT/T7.8-;I-DP>[*`IE6
MK^J;5_\`)\?_`)TZRED=M?43U_R5.FLEN7O+JC%.H[@,8&T."ZP$LU<W!=`1
M0=#U%/'6GA7<0M_%-X%([)D&79+JA!VK5'EA"2*E2C&70"GCUT>%=Q"/%-X%
M54>Z.;PE[I?8SEOW>]Y]P&-<-\FYU:'K:Z[E:'!(@RH>;6O)XS[<:ZN6J#,L
MX3;/2VL2TN*4L%/37)-7TF:35KAP<`#*[<5W'I6]M;K2K>#.&/;$T&O%>=^\
M_P#)@.4EQX,_&O>+PGGMDB+1*7*R/A2]B1+A1G?F&XB\GLETN[JVUA2FPZEU
M1%4=*`ZC)])D@9G<]IQI2A4Y)/$R;DM(<:5J%'K.?^3F^[R9*NI9Y*]IF6J<
M>E_9*G[GR79;Y;+-<9ZI:+7">5;&67X]G8=6AK]4^M!405;4I`9^$=Q"QSQP
M*:'D#[@?WWSK@Y'MN"<-9K:K=6UXU,B<ZG'+C$QB&RVQ;K4\U>8$6/,*-BU[
ME*2%%8!ZUTG'IEVQY>&.+2:[-OV"U\5!O(JO2=]W7[:^9/;-[;.&>)LKM]HQ
MR7@=XO2)EDAY'B^4N,VB;FB;]]JHN49Q!><6DN4%5+:*QXZ?\J=H!>QS0WCZ
MEO'=P.!:'"I"6'MF(?\`O#^?)3+90R[.Q18`"O3019(""&U+ZK0HHW5ZU*CU
MU=>FY!<O$7PD<5S/K`LM`92X.&.`4IO=ICF0WS,LWR''<@L>,S>)^,<YY-QF
MVY-9&KK:LK>QZPN.W6QJAR`XB))NS;*D^K]0MDA7?3+68Y[5Y!<#5QI1*?IU
M,VV8^2A)-3Z54S]W+[+>0><\NN?+G):FWK1EV37?(UVV"I2K59$WN2MY-MM,
M5L!FVV6*AL!J.C]6DUVZTT:%K<\MS[X<!2F!&W;5.M<U'\PNW1W`<6L^'$85
MVKU'<<>U+B'%&8ACX_$DOL,)84MUE!0HLC:"$J23^;J;+;2GNQXJHW.G1S&K
M"0I*0,0Q^WL_+PK5;T@E)VNPV"V0DU-=B`JM!T^FF@SS`;4Y\+#P42/=)Q]C
M5SE\:+5;F$NS.1L5C*;;:4@*9=O=O#Z"MEUIQII23W1YOITROIR(?Q?>-,%)
MZ1$!>-MXO=+]_=_:H*^QO#HS//G-^5-.$NSN1<T4P`V7%M1F\@N,=MA;[RG'
M7"VPR$U*B>FE>GIXW%WNG85KK[W.N?"5Q:*UW88JW]*MCE4>5JA\GC7PZ]NF
MINJK'B&\"F(Y`>`Y6PE=#TL$L4Z?[/DG6@B,LP(-*!:N>'M+@I5^UE07C6;*
M'0*SF<:?A@P]4#JN(LO6M)_<KZ5U?I#_`&\]_L4H=5E6I#0A#0A#0A#0A)#.
M,68S+&KI89;;#PF*0N.F0I;;*5H6VI(>4VV\L(JDUHD]]*PWK]/E;>1@E[#N
MVXX8>=;,=(QV:(@2#95>5#[SV_Y-PORC.P/`+3@,VZ6W&,2R&Y7UN=D33EDF
MYD[DQMED;8L0PZ>I]^V8R9;JWYDE@-R64[4DG=ZW_2*SM=>M?S&_CD,0JPBH
M_$#=YK7X345%*FM=RXUUYJ>J1SN@C<W,=]#A55#<.P,9Y0]PG&6`>\CEG'.+
M>#LQG7YW+;_8L8CP;JJXQ[+\Y9[>[>GH&2.VFTWEV]0C]I*;3%2=P=<*ZG7:
M^N)-1TOH\772=I(^6*H#217$FI)%*TX#$[%RFQ8V]U*.QU"ZCBN),7&CL*;,
M.Y%>?87P'B_N?S2T<7<OGEW@#B')X,#B^\.3OM--]E0X33BI%SGN-,Q,H9Q&
MZ,N1(#6U,>Z+CMO2%IAQG%G;HV]U?4>EF2:I;OAU*X97&AR8`D$;<0:=F]/9
M+.&SO9(HKJ.4Q.I@'#-4TW[%9A[:Y>=\E9EB^*X?:I5UR?*I(QK'+3,ES949
MPIC+N<F3?9SB6KBYBUOM=[=NN537?1?$&;(86&Y>1H98Y+UY'%TU8R/N'1EI
MHXEGNNS<0T@BH``9V@;FJ]Z`ZX>0V,EQ/F\_K7KUXQX_A<=858L7AS9$YV#%
M#USO+Z4HG9%?)E)%]O\`==IV.R[S<%+=V@!$="DM-!+:$I'CZ_N1<W,DM*9G
M'R#</(/.<5V:P#A91A_QY<?.G&U%,B+)"\G:G:&ET(:$(:$(:$*NK[U-6WV3
M<GGO2Z\<G\G(5BU)Z'_-L[W*&Z@D$=HXG'9ZBFGX#EH1QK8*@C^8PQW'^Q6S
M_=UVJVB,D`H:47!;ZZ;<3EK01E*>]#[:TA0/>OP\/QC2_A7<0F2,O41^D/AI
MI[W#>GGB6\#L45VGG%N)2HBAK7H/!)/]S70%2U]E$CTZ&GUO_2Z$(CO3JPQ:
M!7Z]V98545JV5I73\.X]]8=\)[BLM^(=ZD`KZROPG^/575H.U?-96%DALNK0
MT.[BDMBG>JR$]/RZTD-(W'@#ZENP9GAO$A/ACMCAVY#!]'<ZN,2LNDN"M4&J
M4JJ$FH[ZJ-[>.(I4T[%:+*S%:!**5!B2P@2&6W0VH*1N%2DCL`:=$CX:86UT
M<A(-,4_N;)A>*_+]Z+9=L;94E2&TH03N('2B>]!]`&G+KHO;E)VA(LLV,>'#
M<5U)2EJ*E8[`G=6IZ==-T[45_<Y[F[1P1A:9+%O:R'+[XZ;9AF+,R"B==[](
M(;CH=0.J+>P#ZKKG@A)\-8WUW)[:',\1]J\^^?8S%R[*;CR3SM)9Y-Y`O*78
MT-B\/R)=GL:'7"I%JLUG#Z;=#:CE7I;DHW+":GOII?R&*SDE&X>T*^6.D,>P
M2T%1BI(>VGCS+,`GVK,L9BJQRX,NRU62Q0(H`AQY;#D>0M#A),6*[%>(H.A!
M.H"`^,P?BE9QX2M-R7$2U6ES/+GQQ"RNV291MEOM63V"RI0_=<+<O8F7.&NX
M/22&W%WJ.6_2/=NO32LD0A?RQL'MQ6D4O.8).*KKYBMST&[7*'Z\A:V9K\=I
M;KJG7$,M))H%+!\U$]3XZ:W'TCY$HBOA2:(]VAGU%*>:D)"75D%Q%5$^10"?
M\@TXT_8MMR]!7L\NMPNMRML!AI]R6^M59`<(4ZPR@KZD"N[RT![ZG92&VH<[
M!H"P$<_>=<<VW).+N',LO$5+SG&_-E@FO1G5J/IHRK'Y6.R33LI+LQMH_$$$
MBE3J'@%;K.#4%IQ^W>F=_7P__$%*3ANTVRS8%CR+;#9CA5M8"E!`*U)4T`D%
M=`3Z="E/B$]-2&Y4?4-J<,N*2LI!Z!5.W6E?CJ0C^`=R9-^$*-6XIYZS<CO\
MABH_^\R-;I"Z^`=Z=>\R'#D..=1^VD>`\&TZ$Q2G,AVIZCN?`?'4JSX1W(7,
MJ.915\2/-^#K_=.FMW-R3&X;2[V+/*YK'`[`%%7W40TQ<#6A&[<\5A8J3N%.
ME.]-1/4%\1;C@E^G[(>(QVDKRUY9[I\1Y4]X7+?!_'MTNLC*N'TV\7>=)LR$
M6Z7=G(5MMV61(,GYE9?B65U`;<=*>KBT_#51TDUC=QQ4E>L+9VN.PG#$;NS:
M.SBKD>&4%K/K002H&PSEJ4LE2U/HLT1U9*CUV^HD4'8:@K_ZY5]TW^4;W+RP
M?\J7-G=]W_M,9OT^YVVSL<#79J1+MK2';A%2GDBZJ+MN2M2$^L`H$*4H"H-2
M--F5RFG$>U2;2<AIV>U>;/DK&<(QG+[_`(^[GN97>R,+#MBDANTWU<^SRGDR
MK:J9)AY$_`9DIC*"WFQ7TWP4T!ZZRTNV@"J0M7O>`7-:#YO0FU?@<<)0R(]W
MR]UU<I"7"NRVQM*8Y0=^Q(NBRIW=V\-.&$D>]3R*0>7`"E*46ER)QYZ,CTKI
MEQ?]:D5*[1:BE3/Q<VW($J/T4UO@D\TE=@64B-QVE,E4:?ESE&8WRP=MMK02
M]T$LN$7"A2%'R#\NC!8S28;$9VI&#M3V$MR\H0GYR`Y&)@VHCYI#L=20^XJ?
M1N,2H[C\-9@MY9[L"/8&)%F=UVQYIE`\NU6]^Z?D_(^;^%>/_;-CWMKQ?$\N
MQZ\6C(;?R)'NV(1;QG5JM5IN]F@R(UL@08DI$>]Q&/5"')3I(94^:K43JN6N
MGRQ:Q+(]Y<0344/'BIR]V-JH`8EPI<8V)<HYG"FX_.3A>#3D7EF/F^-S[E"<
MN%IOEOO"Q;8*T..,-W%$=M+02MY!_.I75C3)>XWVIE`^YH]ABT-(;7^[_$"7
M"C9^L6GD>_@.K"":.*0$@U\QI4ZD=$_W0=P]J@NH_P#;'>5>ACB!U:L"M@)%
M/U([>'HHUW&'_P!-<'E^I)]MZ<S3]-%FGNG\(_CUJF4WU"H183(4W>.0$J(]
M,91?B>G7^M)M.OX=9"Q#]0*:]E>0]:+7M_-MT6O?Q2KX_@UE/D;>JM*:`CH#
M3IH0N,2'1V5X$=J]]"%S/-KD)">A2%*413N5(V&OT%)[:$*O7W2>P7CWGJ-,
MO=PAJBW1*2D36HJ4/I;;JXE+#S:`5$J'51J5:@=2TQA#K@4S'$J0L]0O+.5K
M8G$-)"B9P1]SWSY%QVXY[Q-[OLKQ&#<HN0P+'@.)7^:U-9G1@1&N$CYF=\JM
M<*0TDF+LVND@$4USC4Y`UQB-0`0:[M^_BNSZ);SOM6WTI)!%/*<?8K;.%.",
M&M'MML/M?]TM[O\`R#DCUHF)S/E3/;.UA>57Z_NK7,:O5NO-A=B+LOV>74ML
MK:=2HJ:)4""!J*/$8E32B!G?W8G-#LNY+]O/NR2O"T6V(C&+=</^_G($%IA/
MK,Y/DD)TRHVX#:S*92I\'SN@JKJW6O4NFQP,AD9[[&AIV;0**!FTRZ=*Y[3[
MKG$C'B57A=^/?O),<2Q@TRU<B9_DMG"+';DP<78MRG[E%=F,V:_2,I0(F/0L
M6E(3'-QDO2)+[R07=C2JITI-J%EK,9AMP`Z,9CZO:M&:;=L>,=I3^X[[<9_W
M?O*&$\D9_G3V5,<UR;+`R*#EV2INN58;F*K5`3.A19P0T[=,%A7$O")+<!50
M!NI%-1ND3&UNB&\4PZDZ9N+NVJ:U(4R^79ECE/\`*V107H]RASO;'RF0M#25
M1@Y+L`:<=0TL+2CU!(5V[5T[ZB-2TG>HOHAN1DD>]M1YC3V)VON[,=BQN"+7
M':CH8V-,;?12AO\`4I4XEH'8E))H#4GOK&F_12=__/R?;>58C#AMQFTA*:*&
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M5C4+$<5L]O>8)V/-R'N+[BIHD>3YU8'US7UK^DW44&FZ&+88RQQYG`D>\'`O
M):/[I>`3OP"Y?U-9B[OSFWGVJF#FOC>\M<_6ZW18KOV;AN#Q+B+--BR9$6+&
MR2Y7V[L72.TTPBXVP"QLVB,)45Q+$5O;5]A>XZ[UI'4=U/TS+>M]_3Y"<E<:
M$&C@32E0X.KPV+F&M]-:=;:Y!=R.RS.&.[9AQX):8M[:N.N2KG;Y=SMU[P;)
MG9Z%0K[BSK3;UY??"?5N2TIMEYL60O.M(2I0D6[Y1P(#BKP]0DQ]YU3?V5O!
M>M:#9-C?7@"6T;484%=^.PT!P">V72EG>QW4]LXFX$C/-FQW\%Z;/NM^`<0X
M-@7MB[19&1\GY3'?A(Y$<AMML0,$B.N28.#V:*W=;_#MR79\EVX763#N,]5W
MNCZI$AX.(0VWY!_4[JBYZFO^8'%MJ!@S9[U?C-:&M`*!P!:"1O76^D=*CTZ+
M)*T.?V^K[U<[%I\NR`%)`0$@+2M*@$DI35+@2L':/$5UR`,,8R$U(WJ\290\
MY<&UP6_0M$-"$-"$-"$-"%7/]ZK_`/:2<H?_`"IQU_\`9"L6I/1/YMG>Y0/4
MW\D[R>HIB>#)'_BXL*73Y1#B;=O0U^6;!J1X4&NX6/T@O/LG\R]/&F8VD``J
MH/\`-?A^&GR$9?.-_IJ_T1UOX3LW(4>:GXZN-`J-4KXHDTJ3^724H&"R"44W
M3_I/Z)+!'T'UAU'TZ0=\)[BMVDYAWCUJ1.TJ60D5-3T_'JK*[':OA2I"TH4"
M%*ZI'Q';N.FL.^$II<?4:E-C<5M5S96HU(2A!!22/6*J)3UZ5W>/;59O'.S$
M5.]3E@!5I/S#UA/A'0I"`%BB@*=P2!\.A.HC:K;L6_6*`;%E:ICB5HVI54A.
MTCK4$!0/>G;0!0)&X&:![1M+2D;DU_CXG;)5UN)2B/!B29[X=6E+:(\-E4AR
M2XJI2AF.A)4HD]M8!3.RM9'&IK1>?;-L]F\MYO?^8KL]_M=>WYMOXLM_5(Q;
MCZV/O,72>2]M;^;RFYMJ4RX:*$0*[536-O+D,?RJ[ETK18@RQ`<`3F<NW@SC
M*;R5>QG=[1Z5CA.N1,;B>E5M3:5+0[+2E0*E-APT25@*Z@ZAXH)'73934LKQ
MPV*7-2*"M"GR]P7+0X,Q2V8SAT!B^\KYRF38<%M+A(1;5NI99DY5<6QM4F!9
MDOA;52`Z\-J0JBJ3%`-@":373;?%^U1ZXOX%O?!2'LMR&Y2KWDN=SK3D659!
M-.V5<[O%EK+LB2%*+B5+;.X('D2#1.FTMOS'EYKBF%CJ#)M3<ZONFG=@`HZ>
MX9RWM97?E_,,5?FNO,4((6VZF@*2FH!454`/736>V<R(N8#FJ%/SSQ.N&L=0
M#'U)AN/ILF)>HKK-MR%_TG:K;B8S.D,.[C5)5,?98CH[&E%D'3JQ;<[V8]RS
M_I>(\ZN)]M'/=NXSN=HOEX@7.V+:>4DM/P82UM,.)*"M;;$UQQ'<FA`5JPG1
M/%6PFD-'.&(4*^YC9>/:PX!WL4JO=W[J>%>9_;?RUB]IR1N;DKEHQ^=9(:;9
M<(_K7VQY!:[@S#3.6IR*Q,4AAS:E2DE8!`/QK[](\!)S6FHQ&WBE=6N&RZ:0
M-N9OM4A?;I=YUSXKQR>\HNJDQFE-I(*5-,>BV6@0Y0@K"R>VIVQ:'-Q&"YS>
MD\4][RE%IU2NA]-9/T':2>WPUF0`/(&RJC6DT489#J1S[EOGI_M/BI/4_P"!
M=ZZ6M\7FO!)7!.3RIU;PO=D&.$*)'K2AT)[^D@Z>4'`)G4I>-,N;D**?+T)-
M4]OP5KJ.>3F/>I!OPCN1BGH>G3K_`"Z:S$E[*\3ZDO'\#_X5"_WF*5^Y<%*"
M=WVG&Z`D5!`-#]!U'=0?0"?]/_S![UY-[)[7L'XZ]YW,W.6-\AOV[,.:+^G'
M+9$N:HO[NMWG(Y_VLJ!8UM;W')$],1QLEP);0:E2AT.N0ZAU5I72TOA65=G.
M.T[5<;6CG!I`(!.X?;<KT^#O4&>PFG.S-DG(->N][[$C%UX=_*[T(T_BEL[J
M)M_:$DS8NVX;QZU/8#*!L7E?_P"5*Q;#/]Z7M/@Y-<9EEL4C@BX,W>Z6:UF^
MW:)!/(5\<4^Q:''HC,QU%#M2'4DBNZE!5PSX3Y/:INW`+0#O!]B\J62V^P1[
MI/\`W/F7NZXVT^IF!=;W:8]EG3*$*'S-NA7*\0XKQ1UV(DK--*M=LS[4&U)1
M(BV7)U\QFXDI4E#J&5,I9<]5#SCB&6VU(IN0M;CB4@&A)(&E!*UHVX(\,[8L
M1;;AYC\M('IR!$62A:0W)4E2Q'62`$/%*"0DT/0Z.>WCNJCPQX+ZJUW)"9!<
MART)B.,M2O48=0(SLG=Z")`6D>BI_8=NZFZFL\\<1BCPQ1Q&L]VASFF94.2R
M($NW2)^Y!/RK$UV%\JX]L)VI>2XG:#^D-9;+F]YI\RQX5V?/3$*T;DGC>UPL
MPXQE6;VSY9D\C'KM=;[S1<,>YDR),+E"QW+;.M5G"!;H,KC"7#M\GTY"X?S3
M+:G@`H@BI3WJ[U(&8-A,9VT-?,?:HFON8Y.L.)6S%.#LCX^ON-X7RVUR+F<J
M_9)D*.1Y,UJY3;+)DVR?;HL''$8I;Q\G1E3B9)_6J(5TULHE>Y+VBT/W,?L3
M(H0;9Q=U%#U3R=D*#7X$%%/Q:D=%_P!T;Y/:JKU42+%U.!]2]$'#O^(EK_\`
MN/\`[2C7<8?_`$UP&0FLG>G2T]36I0'UA_D\1H9]5.:#PX.^I4&,1_K7D+_Z
M9[Y_\TYNIF4#P;O)ZPH2<D/PXJ9]@)%HMU#3_:V)_P`ZO4.I&S)(%4;`FG<_
ME.LJ5=\2&A:KH9(2DDF@*PD?2HCH-"%WW:S3%V*51IXJ6R\ZA"'$A91Z2C^K
M)6$A5.U:4.HPW3&OD:[:"5)P6I>Z-PWT5;W'7/\`)XBI9\CA7?%[/;+M-:M.
M?6%"IN-1Y<NZ.!QG)V6O4FXVX%K2%R)8?BK-*/M5"%\IU>=DE^YK>U=YT.!T
M>F,<=F'M5GV&<]8SGULB6[,F+;=/M&,T+7D(5&>AR2ZVE35Q;=HMMYI6ZA*2
M1N20>H(U&TI@,`I2@2CF\0)ALBY8SC]AD)4DSE3\?@1$R75._KC+W0-CGS#N
M[>21N)/QUJ2P;:(HD)<<<D.I>AW6)<T(=*U26W$7&.IXK%%EQ2),13BE>.Y2
MJ_#6X.7X<.Y";^X\+<77_P"91=<-MM\>DLH8^9R")*NLN,A%2E+#]PERULLH
M)\J4*`'P&LU-=IJL[=N*C]R5[/GD89S'?.)[=>;5=[EP_F6.IMUWN\EC!FT)
MMD><VLMS4H;MPDF`I"5(<4-Y`-$FNE+9YY@SDFIWU*A;1C0R3*`,3L`XI2?=
MHYA;LIX*A/1W&?FFW&F)J6T$_P`\B0FFY(;D@[7HR2FJ>@[U\=6JUP![@J)J
M/\V]60+=;)!"A0H21W[$5&G83-%R@M=`FI(4E9ZT\J3N4>I'9(UE"C-S8".2
MN'VE=_WHDR=I((]./8[E*6[XI'IM-E?QZ=.NHG4#^+'PH?8GME]4$;:J$7W=
M=7&,QEH),=V[7=:7:TW)?N4Q;:J&B_.E8/4>.GUAM;3B$CU"/<!WU5CTV(XP
MLR&TE=/+7<.Q^@JU<**GJ+7*D]Q/*&%-D44;!,Z&OC.D_334A9`%KJ@*-O">
M<RA*FI[+W0[@N:'=52<]EA8Z^57R4(D?#7*.MO\`=&_P^U=JZ$QTUWVW*9>J
M8KBAH0AH0AH0AH0M;HJTX`%J.TD!J@<)%"`@J(&ZH^.C-D]\BH&Y:N&9M!M4
M+;][7YMUD/3OM*%,G*E2IC[TQ@)>N$Q5PDW0.3*5;+$B[7"<\FG5+<NGATMV
ME]3&U#:`MRC`C`CN]%0<,$U-FXXD`KM:]FO#>9\:?N%S'QWBV8$WZ9D+,M49
MR/<;%=$1[?:[1<<6R**ZS>\?G1[/9XJ5N0WF:N)/0]RE==>:]#J[KBPDE9!E
M`H",CA2IK'7*?>)QI7@E9=-MY[<,E:QSNX5'EI4*(DC[K1C#;U(NG%^<INMB
M>D2+BG&>0D!O(XEP=W+;4WG-GM\VQY2A#A!WY-C=\FE8W&9N(6FSL_4S5+RV
M%IJ5>00*Y1P%!^\"T<<CAA@*5*K4?3C;:\%U&:-QPXU\E#Y0IR>W3C27A<:\
M3KS!EVVY/MMVUR'-6EQX>FM2GWBXF3<?4]1:`4N(E.L*01Z3<=-615]?U%MT
M0&4+:YJBG;P[]XKQJK):VV09J8J3X.X`TI4#I^#IJK`UQ&Q.G#*ZB^ZRM4-"
M$-"$-"$-"%71]ZJ"?9+R@!W-UXZI_P"<*Q:D]#_FV=[E!=3?R3O)ZBH_\)(4
MGCFP;DGK#BTIYO\`I9O]&M-=OL?I#N7G2\J+AW>G=;@B2:BNX]TUVT\!W4GO
MIZFM2NWY(?I#M3P[_ET^\^Q2'AH/FW<4QE=63FC@J11;F652%;4]*=SW[_DT
MG(_-Y$K''GWKDN]JF)5%"&BM(D1Z+[5JZD]NM.^HF?41%5N2OE_8EF05>W'>
M/6I-VJW;7?F'STHM/H[>I*NE=U?S>_;5<-T2/=%"KUX7';Z$:R;?'?H4I#:D
M@@*IN[]?B-(R7I8,KFUKVT]B97%M^*T5W<.U*3'8#$<LU2''*M^?;M\P(.ZE
M5:A[AW,S.V8%3EC;T+<=C@EZXO8*TK4T[T^)^!^&HM65<;JEN*!2LH`32@ZU
M-2:^'QT(6[T?*"55Z`GIW_'4Z`*FBU?3*:[**M_[Q7.GK!@=OPZ3>AC&/Y[?
M;?C>5Y<X\IAFQXPZP]*NZ77$)*F&[I%95&*]PV^I7K2FM9"&-S=BF-+@$QH,
M%5U;&(7*V0XY@F"2(L^TWEN#"2]9%*>M%MP^W,HAQ6X<I(;2LB`TDD^4K62K
MQU`75J;JY\0'4;0"E*[.VH5S@A\/&(P:[_.K//3Q'AOCZ?=;LMFT8E@./S9M
M[6`EMY=MMK;?INQG.I5<+BX`VVV`5%:J]>VG\+`*,WG"J5=*(@9'"H"B7[1N
M+K][@N4;U[FN5;<ZJX9#<4MXM:GFR[;[!BEM=?;LMEB,$H1#>9CJ2](HC]:Z
MX5=.VG'A^U4/J'4B`<C3YU-/W=X'/E87'FVEE(7!)%8L>I<0DT0WZ2%#TRTE
M.VO6M*Z68QK6Y2*E1&B7CFNY[FFI.RO;15`Y%F7'=LN`GWN/>'[HX"DMQ\'O
M9>CK(VT#KC6Q05V)Z=.VE!)%`>:]F=HW5I[#L5HOIG74!EC?D?AV[^\)/.<I
M2)A^7QC"\[O#:OJ)19[FS''Z`<$LL-L[J]`"!I];Z]9P?_1U_P",#_PJ%I=?
MYY\W[4<6C'_<-FQ#>+\8Q[(E5*2KO,]1Y:%&F]^$EI0;4GN4A]=0._7H3ZDZ
MZ)DB;RXW;&UK3LK05\R&7+H74<<SAOV54GN'?8AR3D=YM^0\IY//G08\I$U6
M,P6F(%D^99(5'/RC*@XYZ:B:*<4LC41+%)*?>?AW?M3BYU@.M\F3>-_[%=3A
MN/(PO'K?94-)`9;30-^1(0@!MM(1YMNQ":=].K<\@4VJOS3B;=1*1Z4%-.C8
M>K:Q];XI(^&G7(YGOUI7%-@*"BBQ/=]+GO*SMW;K3BJ.]*58>Z]C\-*1P<LY
MJU\B1N/@'>GCN)K?<</QD2O_`&I`_N:63-.,F4`E(V'HD#O\!3X:;.MB7$UW
M\%(L^$=RVHDA2@-A%3\?P_1IM-:D.8<V_@GEM%S6O%:4;[5#[WEL4P^U;5[E
MOW2,G8!0HH``:UZ@_BU`]2R<JW!VT4IH%M2Y(S8D\%3IF_%N"9)\]D^1P6X,
MAO(+4](N3*([#2;M$^3BV%Z&TTR!;WE74(!4W12PZ032M>5:CTUI&IRB:XCJ
M\8[ON5XAT_E.S9Z^3]JD]PQ%?C\B0V9$=^*]'LLV(ZEY.T[V[?'B!"17SI0@
M!6_\ZM*"FGK;.VLH606S<K!^Q/\`+L[%Y<_^4VRHEO\`?'[1[S<]J(4+VZY!
M<DI+/S55,9ODJ0I;0H7@I?3;2HI7KVUN/@-.(]JD8;D,H2VM#3;Q_L7FA:LT
M=G%[?@[TRTH5+S)698_<"\TN/?;2ULMBD1)R"L(<5&:6KT9/RYWBG?6N8UK0
MTHK-2.E,*UKY*_<E-&NUM7EEXS6/<[0Y!OF=6&Y2K:AQJ++:C8DBY7R?LC+"
MU);1+@QST&UPJ"17OI*1CY`&[,#NXK#GVS75<X`$^I$9N&+S;3)M9R2T-IS;
MD-&:1KF^A+"H!@K>*K;>$A2G;1ZK,]W8H>HA2@GM7I@12E^.P-RD4\E?/BM3
M):9:->,U:C[ELO.78SD`SR1+O3+#?*][M(?;99;4Y8G[&_'E1')#(*5-0O44
MZCU4#SI4#MZ'2[;1[<A#Q[H.[:3OVI$S1XX;3QV+GNN2XC,>R1M-X=(RM6-8
MW.:C-%UR,]C<F.&[W&>6EH/VR2J(PFJO24"M7UMGF7MX3"PL+LV/"BV==V[(
M79OC.P*=ON_XNB8UP;`Y:D>XR\7;-+[>[1!A<4JON'(=MEB-TNJ&?E6<9G+O
MJ66&D+>:=F;7$M,E+R2?3(7-54GWT\MZ(A$1":^]7]F_O57V(7V[2+G/8G7N
MZNQAC&8I0V_>)KC&U6-791:\LA0<*W#4I(HJG764_7Z`'M';+?W+GL2<(`"K
M;QDI*4BFX?VIY+YB?$E5=2.B_P"Z-\GM55ZJ_D7?PE>AWAPUP*U'XAD_E81K
MN,/_`*:X!)MD[TZFGJ;(?G#_`">(T,^JG0_EQWE08Q#^M>0O_IGOG_S3FZF9
MOY-WD]84+(S/,&[,5,^P_P!4VWZ;;#_YU>H=/X1R:;Z(VI3IH4D'YQGV50T+
M61_+;FI5'=E@?/2&TJ7L:0\E2R4[@2!T'UAIE<7G('PU/?\`L2L#3-LP3I7M
MF&U8I[ZE%M$:')3YTI0E:41U^="UN)!!`U4+JZFB+GL;S'..XTIWX%7J&R;#
M;03-(<XL!(I2BI#7EEELTW)6Y;TP+AW>\NH5$B.R$26I;RF/EVU*1\C)?D>N
M&Q'4I7J!1-.FJ:;,3W;KF:3(XM/NTKO&^H]2ZMIMWS-,9$QGO`C?V'L3D\+7
M*SN-Y/9,7B-MX["7'R&RVKTDPV[`B_0G)MTM\:$7_2M`7>HLB2(C:4I1\S4#
MJ24)[>X9]!AD[L/84H;N&/ZQ#48WKE'/<)9,_&<IN]B]5Y2MD"XW-U2"5$@E
M(0]&:*?T540GMVTHVW!8#([*^F(IL.\>1:^*><6,JS<:[1YDUEZ]Y/-S`4Q.
MS-V>R@DLKEP_6DERA!*W@4D^6OAI5MDZ3"$AQ'DP2D<TLA(R8TX_L4=^4/O&
M^2.+,5R++K[?$IMV.V6;>7TLL(1*?;AH4X6&FWBA&YT)Z*J:?#3*>*ZA/P`_
M\7[$K6;Y/3^Q1TRCWT>Y[FWB]S([%<DWSBW*N/+Q>8%TP'/53GXLIRVN..66
M^8[\DP^M]3:R@@+H'>@!`KK+)'6TK<S:DIH;<6K#[V8NQX4KBK3_`+ETMM^V
M['1\PE;JX$9$Y+S]76YSD<MO[@L!9?06Z.I(!0NJ:FE=6UCA!"R4>\7X4X4]
M:HFH6KN<9B<#V*YE3K0.P.`^F`BM*5*!0FG@#34A$PRMS!04TPAW57"F<'`X
M@)].K3OGW;J40H]J)[TIWTG[W!(^+_N^E1EYA>>E\G\?HCI#SD2W9?.ZKV&.
M(.%W=XOTHJH_-^BM=1U[&72,)PI7V*7T<^*F(^&GE^Y0W^[D058=?9--JGE!
MSTP=U%$J-0OINWGS=O'4G8VU`'9N&Y1.M:B+B]-CDIE_>KV5V4]JL78FK5)]
M&0C]66UDJ*S3<.PI3QU9U`J+/,B6T\MX(6S4*QR63]!^TI7]S4C8['*,O?JL
M4S?9/_B/GG_UPIG_`+QA:Y/UM_N;?X3ZUVOH3_;7?;<5-7K0T%3TZ?A(!_(#
M75,5Q5?7/?OGN_"?NEX=]J=OX#O_`"#E_/..95D'&^0V_D##\<L,HX5%<FY'
M`OK=\*)]F<C1P@LN!MY$A3FU-"DZO>C=&VNJ])W75,M\(19SB.2+DN>0UV7(
M\/#P#F+B,M*MR[37"NWO4#;/78-%=$3SV9@_-0#;A2G9Q"5O`?OLXAYQ8YI@
MS?5XFS7VWY1/P_GC">2;M9K7,X]ND1*G8MS>O3,IVQ77%+Q&0IR)<67_`$W$
MI(*4JJG47K_2.L:,ZT%HP7C+V-KX2RHS,<`:THXU%1AB,=N!3VRUK3KRWN)N
M8&/MWEK@:'82*UKALX(F]RGO\XQ]NN$<4\GMVQOE7C7E+EG$N(6\VP+,<3=L
MF+7S,IB(-KN%[ESY[$==N;>*U/>BM;K*&RI21TU)=+=`ZMU+<SV#R;748;1\
M_+>TDO#`20TU;484S4I4THL:EK5EIT#+AS@]CR-A`I52<@\W\1W3%+SG=JY,
MX]NV$6"9+MUXR^V9ICT[&[5<+>HM3X%SO,>>Y`@SHLFC2F5N>H%$#;UU6)='
MU."5EM/!,R\?'G#"QP-"`01AB",<U*4">B^L#;"Z$S"P@[Q3#MKO3*\W>[C'
M>/>%HW,/%L3#>;X]SRO',9LULM/+^`X=`O";K>X]MO<NVY7D<X6*5,QJ"XY*
M<@)7\V^EI2$)"J:D-(T">^U-NG77,@<Z-SZ\MSMC7$"@I@:;=@\B2EU6PM[)
MU_G:YC:85`K5S6TKV5KLW4WI[KGR_P`<6+);'A.09SAMBS7)8K,C'\3NV562
M%D-Z+K27?2MEK?F-RYSGFHGTDK"^E*@C3-FE7\UIXZWA>^WJ07!IRBE*^\`=
M@./!.)-3LH[MEH7#/(*C$>3!<43GGAB;>VL:B<M\92,BD9"[B4:PLYSC3]W>
MREEE<AW'/L]JXKE_;S2&E[X@07T[#Y>ATU;I/4G*=<2V$K+4`NSXD90:9OA&
M&_LWI!M[;7-Z^UMYP9VTJP;1@#Q[>"B+[ZOO"[5[#CQQ>LZX>RK->/\`.Y\Z
MWW/-\6OUFCM80;7(M;=TN=_LL]D7!=B@Q;JAY<ILD`"A2.^K=^GW1;NO8+UL
M-V+?5K5CBRWY1>9B`3E:_.VA)%/A.VJ9:SK#=#CYURW,RK16M*`D!QW_``@U
M[>(1%=OO*,6?][&&>RC!^+,@SG(<TQT95`Y,BY7C%HP%JTQ,=M^7Y"W'7.=<
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MQ$L=Y5;K9=QG=D>8QO?>X2FY`B%8?94LM>=22=0^M=.:CI>M/TBWCDN"V%L@
M<&.83FI@6$%S:5VGVJ2_-(,N8TV_,/6G6O'N!X3Q[&[-F&0<M<:63%<C"U8[
M?[KG..PK5?4H4`M5JGOS419J6J_K"VI0:%"J@U$G3]5=)+#%;2NFA:TN`!P+
M@2033"E,./D3IU]9-C:]TK?>`/[-J9;-?>7C>&^Z/@#VR'![[?GO<7BN8Y5@
M_)EDO./S,.2QA-N-TN\:2VW+7<5D0W6%(=0DMN!\%LK"54M-ET?/=],WG4<D
MPB-G*&&)S#5U6@US5PVT`+<>(4=)K=NV>*WB&=\KJ8$8"AQW[Q13&2YN%=I'
MF6D5\=OYPJ`2DGMJFQ^^P/V5"F93RI6Q;<WH5='WK2RCV0<IK'<7+CI0ZT__
M`$@V$_W=2V@,YE\QFS%RKW5<G+L'FE:4]JC%P??I+?'MC2TD`B#"JI9WU'RR
M*`"@IKT#8Z:>2#GVCA^U>:KJ^SW3VY=AX_L3LNWF6X*UV.'NM)('3H/+^#3W
M\L_O^C]J1\5_=]*S^=E?X8]OX=+>"/S>C]JCJ7/^9O[?O3>MH+BT(34E2TIZ
M=>A4*_'PU(5";):1;$_%D+<W#T%);(30&G115U-5:U)!!HEX-_D1C>EEIF"&
MPE(]=@?42K_5A7JH$]]5N\KG3MGQM[QZT]2%J4Z:D?G>`'C]`&H57PD572.O
M;K_Z!TTN-H[DRGQF;3A[4H;8T^$I<2L`)&\5`J*"H[CX#320@-->"FK('#O2
MH"U.,@K-3N'6@'@KX`:C5.+#0A;VEJ4M""?*2`10#I^&E=8)RBHVA:2?`>Y5
MX>^]=FF66UVVYVZ#<V9VQ,N)<(S,V+(%%M_K(LA+C*@$*(^KTU!WUXX"@5@T
M0$D&AV)BO:_QW9['!O=_MMH@6Z(Y)C6RV-0HJ(R(B(24-J1&2TE(;:(4`0*`
MTUK8O,EOF/S%7-^T=R0GO5G7;+[CQ5[=;*DF=R+E/[W9FE*A1&'XF\A<1MY0
M\_H3KSL94@$!0:ZUJ=2$7U`H[5)>5I\L@(J&^T*TKA3CMK`\&M%HC1VHRXC3
M3?D!(Z,I!40LJW.*KU4:J/QZ:?+GDQ\5M3@7BTP;A&7!EL(D>I4O!W<I"J]1
M1).U-`?#6:'<M.7X:(9<"*IFY/!7'<]YU^38[7(?=(+BWX_K)400?V;BBWT/
M;IK9D?-=D.PI@-5D,HA/P41E;N%^/K:KU&K):&W4D%I;4%I"D;?AM`&G'@F;
MZ)QXPI?PL=L<!#:8UMA50`/63&;"UT-05';UIVZZ;/8&.+1L"CI;N0R&FRJ/
MTO%M&QIMII/3]FPRCM]*4`ZU1'.^1V5VQ:U+4LU4HJ/TFM/P?#64X7`^XL)=
M`/3:L#H/@?HU*1C\-O<%BJC)-45\^96%FM+3BBAV%#Z#O7I3XZV*1N*9/*G>
MN#SO[R8VV%>7UI)IM3XMIJ:TKK"95"<SUF2G8$IW4I6IK4?CUE23",H[EOBA
M*EG=UH`1UIUKI"?]WO4C8$?B?P#UJ)?NZ)D62QQQ7?\`,^M^%;9'IG_.C\NJ
MEU5]`C<IG0#6Z/?[5!.#`M[5LN#$Z"Q+0N\,N^E):#[1=:4EYITMN@MDMO(2
MM)(\J@#X:I@V*_H[XMC[N67'5J<<2_;9SWZQUURCBDMA125J.T$`"@Z"FFUQ
MN\J%Y/O^5(R[C9?>-[0;M:;E"LMTA\`WJ5;[C=6694%IUKD&\H:2Y'E,2HCJ
M"5*&UUM2#4U';23*9345%1[4HWX3@3B/:O+U<[&V_<)R\SR"!"OU[??O,.]P
M/DI^.3$2''/F6Y1L#;CD!+TI1+>QD,MDU4$IZZEO#Q#`T1X^9V+`:;*&H-?+
M@BE_CZ[1TID*O.**MII6]LY/9Y47TR`*AN,^;NI*`**1\N2#TIH\,QPPI1*,
M?)/4D'W>.'K6*Y.,VJ0;2_#@Y%'H4S\@MWK^K\VZE6U^S"0(@7%C-&B4.MI2
MI0ZCH#H\-&&U[.*T,,U<S7$-!P'8M*<>Q9^LB!FT*'&24++-ZM5PCW5(2H*1
MZ34)N7&EKKT\CB`=-:A*\^7@:]BZX]YMED>8A6#UKO%DR$*R"7=K9%C_`#K+
MSZ&3$BLN*DO-1T[U*"R4N[U?WJ:8KC@L"VENG<TF@;AM\N*L+Y=M=UF<59OR
M]8\6XUQ9>.Y2WB\Q,+AEA%XOLA]4*Y'(Y>57./-M\B5<FKHRPXEMI+*C%WI2
ME3RE'-#N4VR."*V<TCW\I]2CP[?,VBXU;;O^_P#QQ+ME\P[-+:_C^"N0D7A+
MK>*7B6].R"UBTQOL\(2ZVP2T4-EP`!-:G65%KW&>TUI'_$G>P]S;YC;>,JJJ
M?_*CDI^-.YU(Z+_NC>X>M53JK^2=_"5Z"^&O\0;3_F6/_:&]=QA_]-<"DVR=
MZ=73U-:%#\X?Y/$:&#\5.A_+CO*@YA:0J\\@)(J#D]\J.O\`NG-^&IF?"R=Y
M/6%$?_4CR^I31LZ$HM-JH*5ML2O?P2KX_AU#)ZC$@D]/&E/R:RG\(/+"Z8=N
MERGDM(6!5*E$@#LD5('2E3K#G-:*NV)9D7-=D2P^759K:_-1Y!&#C\GQ+B6F
M%*_/K3J/#4)?$'9L4_8V;6BAI4KRU^X[W]^^WW,^[?*O:7[1E83B8L$N^P(E
MSRK+['B,B?*Q%EE5_NTJZW^--5)@.LRM[%KM,*3<70@K2I"01J.UMD>@Z=#J
M$E'"=@=QIF5PT>+Q+^0[8S`*">?\^\^^QW)K[[?/="ZK/.76>5>'N4;KEN'Y
M"\[C$7C&;&CY!D]OM#]^BQ)5POSZD$,$,!K<LI-.@U%VFAC6+5NIQN`#G4I4
M#C]RL4NI_DSZ.:2RE-B@GS-SY>>:>9N1^2;'>,KQC'LJR0/V"S1,PND-^)8H
M$80[.U<4V:="CHGJC.*6^@"GJ+/@!2^Z'H5G`*3Y#Y0JGJ=]<:B2Z+,!5-]&
MY6O^(VV\*_X0'*F&/B<V(]DQV[Y(Z_>X$A5;I/2XY<74.OVXD[0?*X1U!TWN
M!TLR=['-&</(/>#WIQ%9]2<IO+)R913NIAN24G^X22I)=5[G?<;ZIKM$V9=D
M(<-*[$[9(`5_<T@1T>\$3.Y0W$;SPV^5.[>TZF#CCN^VY(:[<^7>Z-.1W^=^
M;)7J1WXBTR[I*6AV(^*.(=C3''PM*T^*JTKTIJ!O8.B"<+A_I3PVO4PVN`\O
M[$]WL;Y6]QUOYRQ?#?;K;L[YDE7]^<[>>-IRX;UC?PNT6X7?*+Z\MAEEJ`BR
MP-SBRFBE`&I*NNJ9KULR!S71_!N[1N]%%.VT[Y@&2?$!CW[UZ>O;M[C[9Q;D
MMESW%5IMW&V;WYFV938Y13&3C&2LRUP7EHBL;6X[JGBIJ2A`2WZJ`JE5$G:T
MN.;"UI_=3/J"W$4$3AO)]07HWL650\EM4&]0W678\YA*VG(ZR6G$I&P+3WZJ
MI4_3JV67T_(N<WI%=R,US4I0L@T\B@>O@10_F^(U*>#8FE0HM<NSU-<IQ7XS
MBF_LOBGE6XJH20$-8)=*]%5&X.4-3J"U:(1/B[:^L*Q]._S#E&7[NE!B\:R%
MM':I<>.O<3OJEQ*G$@E=:T2H#XZ>60]T>3UJL:C_`+[(=V/J5@ZW5N'<M53\
M:`?\Z!J=3*H4:.4T)<Y6P@J&ZF.S*=3_`+H2O@=2-C\+E&WOU6?;BIK>S!"6
M\(SD(%*\A3*]2?\`I*'\2=<GZV_W,?P'_J7:^@_]N=]MQ4SJJ'U>]4CL5="H
M`]B".GCX:IBN*IX]V7`?N5RO[Q#VD^YSC3BNU9IQQ[=\'Y.L%^C2^4,>Q.\Y
M/<<_M[T>V-6F%>&'4;+?)2E3SCM1M/D(H===Z1ZOZ;TS].-?Z1U,/.KZFZ%T
M+@PEL?*>'$DAP^*E-F%%5]0T0ZAU#:WN`;&QP./8X[/+N4.L]^Z?]PW)&*^Z
M;EF[93AN*\^^XKW3\9^X-/%EHR60YA;&!\4+G&R\4Y!FQLY:N&07EB2M]4]4
M-ZVQYK**I=8W#5JT;]6NG=+O=/L'V[WZ=;Z*^S+RT%^>3E.<\-KL#F$#&I!V
M"BJ,71&H2F_N.;E?)=%]*T!%7?>/:C;FC[NKF[(>'4V'CCB?=>L\]ZG$?N7Y
M$Q//^;\:R=$:WX+'4UEDN9,C8YC6$0+CDJ7$L1[;9(?RP2P''W%*<(U!:!U]
MH]CKSKZ>Y?1NF2Q@LA+/CSAH#<SB&C"I+CQP2O472=[):0LC<2W,TD%W`[S0
M;=B(,B]@'N]FV'WH6##N$^(L>Q_G;WA\5^X;"+/=\SQ.7#LV)X@_;&K^NP6R
MWP4V3&^1F%6L2X+\MJ3;E._MFEU4"_TW]0NCQ=V6I7IEE='HYMW5::2/Y<;:
MNJ:EM022"#7?M2UQTYJ++#E1D-:79LM?A[`:`85IP1%EWW=OO%>]M?NYX2C\
M<X+FMRYF]X&%^X'CB^2.4\:]>WV,7+';SD2+\S,Q2T6ZP7?UL>5#+ELCMLO"
M4I2`A"5`S%I^H?0PZGT[5LCF65IIDT;XQ'0.<X/#2WWC@*\3PK@:L).FM2ET
M6:#-[SI(Z'-P>WT&NW9@G8RO[M/FK,^?>=.0,O@SLAPSW#W?A7D2U-Q^8(V&
MRN$,GXKCVYU[#\G:@8I?\GRFP6:[-K7:I.,S8J'@%H?;2AXJU4(?U`T^/1K.
MWTUC1<0.D#B8ZYVNRTRN+@&EP'O`@^TV"YZ7NWZO#('DLY;?WJ4(IM&T[^%-
MZ?/V\>P>XVWWJ^[GG+G?@+CA_!L^Y:POEGV_Y._>,9OUYP[*\,L#>+G(H]CM
M<5E[';Y?OUDXR4N+6H.A#^Y84=(:U^H/C.B]*Z?TDOBU*WCF9/[HI('R/<VK
MC4FC,M",14BJWT3IF]TOJFZUB9V:*8C+CLHUHV>0IXO?G[<N2/<[D.!8`QQK
M:\GX;G\9\[X/R%F$K.;38+S89_*&*0,>QV9:<:N;`?N:;%?+7'GK>2^%J0WM
M0"54,'^GG4EGTA'<7SWO_/!=6\K,K26Y8I,TK30['LJVA%$]ZKT=_4&:SC]U
MLD4D>VE"]I:#Y":[.Y5^\%_=Y^ZGB'GGV49?<L;AY!:^#O;MR5QOS-RE;^2K
M,C*;MR+S/&?@2<LQBV7$&YRX7'L5J'';4Z\V^XU%;0TE3:`-=#UG]4M,U_I'
M4M,N*LEO]0CN&`,]UC8@:L)W9R2ZHV9N(QINC=&W6F=76%\2##IUJ8Y"37,7
M%A![<!Z$:>WK[K'F;`<<A81FMQ?M^6\?XS[C\=Q3W!6'D\_9%U:YSM.106L@
MB<9VO&6,GDY/+7<HB[FJ_P!SE-,EEQ<4[U(`:ZW^J&@ZIJ$%]I]NS\N,L3FQ
M&$!WN4J2\O(P`.4!HH=Z=Z+TMJ,$SK61[LS+5S:YL,<Y&%-N/'LI5:O;[[!?
M=AQ#RM[`\KOG"G%4G'/:APIRSP[R.]C?(E@%VY-GY=#FM6[,HL:=9($9^W7Y
M3C2Y3$];DQ#CCFY2NI.NM_J5I%[TOKFAP9\]]J,%RRK".6V-CFEH][#$`C8*
ME%KTM=V=[9W;J$1P2,(J,<SFNQPW[-^&"*N.ONZ/=K8.#_;7;+A@O'J,K]L_
MO4Y+]Q,SA:5GUL7Q]R[@W)%UN<YFWHN]M@2K39\DPEFZK,)F;&5#^822``4D
M8U']1>G[OJ34K@<T17^F11->&4=&Y@:S,!4':*CN4V-*NFY6&GN.)VX&M,/0
ME3RE]W+SFY+X:QKAKBOAWC[C2SX1[IDW2!:,S$OD/C_*>>'%IMEL5F><VW.(
M60XW-"A)O3L"W_,(D*<;@%EE&Y6VA?J3TI8.U%VJ-?-=/%H271FCLA>Y[FL8
M69,QP;5S@,"X.&!)^F;J6,.8X!K@3@=E=U<:HQ]OWLN]W_'')'W6]VS'CG%I
M-B]G/%')W&'*=YM_+-INZI*LRAFS6.\X_%D6B+=+T_;[=`9>?:]-E*0^M"'%
MT(TSO_U#Z9UW1]=T_3RZ.6ZN8WL&0Y1EAB:02"0*T)!*C+70[S3[ZVGE]Z-K
MJ;<<2XX=WEX[%Z!V$A""@`@I<<"JTIN*4DJ&T"@77=0]02?"FN)P?19W!='N
M\;N(C$*NO[U__P"T<Y4_^4..O_L@X_J:Z<_W)O\`$Y5OJ_\`V]_D]JBUPBPW
M_9U8E;/,84.IJKK_`#5OZ=>D[$CP[>Y>7YP?&2=Z=KTD?H_PJ_ET\J%K0K?\
ML_\`I'_0I_DT5"%NMEF1"<2Y7SIK0#S#S)4#VZ>.H5._!]B/_$)ZDJK2B?P=
M_P`NDGS"*G:CP91/?D*4F&@#S)?8W`T`ZNH/?L=)F\&4X[BMFV;LP[^">UJ)
M))+H8<+0K5V@],$]@55[GPU6/'#L5F\&5DS,+$E+02X%*%>K9`-%4Z*(II9D
MPFC)X%*Q1<H@'>4KH;Z4J)<)2I9'2A/4_@'QU!W/Q>56>U^D$<(?;&ZJNZ%`
M=%=S3Z-(IRN`]U'XFO\`%H0OA6&@7%5`0"HT!)Z?0.NMF?&.])R_2=W%5)^[
MS)'+SR%]F-J#B+):G$D"M$R5K`*!7HK]2NM1TKTU3-5_G?*N@]-_R04E>+[%
M]BX;C4%":+5:8LI])/5,B4@.K3]-`1J8MOI!/Y/WN\J(.`6X<J>_#D_(G@78
M''$2P\8VAKZJ(3D2W1+QD,ILJH'/FKC=%(J.AV=-.HOJ-[U4]0^F_N]JNH0E
MF.AR*TJJ`E!;)!%4E`2/#IU&GRKZ3]P24I(/>G\>I*W^B/MQ4;/]4HB6DJ20
M._3^/3J'Z@36;Z97.U+2SN34U)%>E>WX0?CIY2J9+H3.K3X'QZ#I^#;J'N+7
M/,YX&TI5MSD&6NQ=B93"C0*-?\R?Y-(^#/!;>,'8L_7:_2_@_P`K1X,\$>-1
M9-ELE*@A1*D!7YJAU34]Z4[C4S`W)$UO`!(N=G.;BHF72:Y_P@LN[?U1BO<C
M_`.?$:<Q0\PY1N";7/P#O3MR+D4Y)C@/B_*/3K_J3>EO!E,$Z3:PI:55'F.[
M\O73<C*:<%*L^`=P1JP14]1V^(U'W_PL_B2\>QW<HN^YDAUG%6D=5B4Z:=A0
MJ'CVU2.J_P"7([U:.E?YA0FN$AN+ZB'B4J)(`"2KJ%?14>&J8-@[ETP(UX=!
M/(T9RAVO09S39H>JUA!`([C3:XW>7V(7D^_Y5=#M-P]W?LNMF07Q%@L<W@J[
MP[I>3'D3U8[$=Y5N@G74P(K3<F1Z,<;@AM3BE@=.O32<=<IIMP]J49\)IMJ/
M:O.?S+PGPUC%JQQ'!_.MX]Q637&:[%R*'BO#>9XY9+/;XS`$*5&N-\4[(N<N
M9(\OI(9;*`"2!IW12GBF'O1C*]K>493%A(X<X5]VN>7$F(B8'N#;HW:XLM;4
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MO<F+&<<33<$[>_Q!.)M2@MY6%C).:6U`#:U&RNY)-R2..HR4BMG[W$`$[..W
M!3D8_P"3#^]N^MS;CFN4>TK#&;M<4R[O$F\M\NY&TNZ3U`KE?*VG%;>PEY]U
M1*&DKHOH$J['4C:7T+R?#,<;N7W7"AJ*X8X;O,HJ;51I_,N;N0"TRDM)(H=N
MS''<E1D/_)I[YQ]'MD;DOWB^W#`7[W#N%M8;PCA[E+*+RTER$GYOUKAD.9P(
MZ(*(SP]5]R.$-*(*M2FE=.ZAKTCVPM=^&.'!5CJOK[2.DK.&^N'-R7%*>]3;
M7[E>Y?/;E!]I_P!W![=O;S9\ZC\G6OBJ]<88_$SR+;'+,SD;;V<S[LF:BV.W
M"YJBIVW$)2D.E)2D$`5ZFDPS6^LF"<4D:X`^<I#4KV'4="%_`08YFEXIVBJM
M=X<:6,`QQ1I3[.6>_P`0C7<(?W.Y<9_]5W\2<ZA/8$Z?)1;D-+5M(3TKXCZ=
M;MN1&,B0DM7RNSMK11#XZQB5/N'(?HC8%93??U@4D%%+G,-`":FM*:TFO!RS
M7[8K:"R?S16M%-FT8JY&M-L#SWK'[.B=R"442JH\>Y.H\7S#52'@BNS[*0D4
M'U0.]:&GCTVZ2<\2.+QL*<L9RVAG!'-HCMQZ!HU:VD%1Z&M.@H=(3?33F#ZG
MD*,[C':EP'8ZU#:\EYISKV:<94@D?$U/;3)/%YHO=Y[6)?"_N`:Y_P`6ML2#
M*F72TW->;Q80<N.+WW'94EVR71""E:I$9IF8M$PA*DNL[AU&J]J%JZ1[GC>5
M:M'U5D)9$:5:**0?N6Q>3[J.!.,YV<<*6'D1ZVWB/?,FS+$%XMF>+O6B1!E1
MOMU$AJX?O/B<0N+&^W2H[99<42D`4U6Q;F*4D\%T0W[;FU;$T["#ZU3M[B_8
M/PK;\><NF*<?6BPN,H$E)MSEQCL/-JW'YH)3)CI4M9&T[0?J]]*ILJL[Q[=,
M88?4DVIG]JI*5?-7))(!(!K\ZYL/;NDT^&LJ19\`[EIM?MVQ9V4E+EHANI(%
M0_(DRP/,.J4OC:A5/$=::;77P#O6DGQ,_B]B=_&?:99<QY!XOP?'S^[JKY<K
M\Y<)$-F$&)\41+4R6%*D-E:%-+53J:&M1J0LO@'E3'7_`.6`[%;[P][:\?\`
MNY.2LKY+M\V*\FX\*9YB;<Z5<(R&K,YEMG7;%I:HD>I<7D3G`EI%5)W!1Z#2
M.NW(G<UFTT`5;Z?U?4'!S)6D,!(QKL!P4&_;AE^6\AIY\MU[M\>VX'+O4>_<
M7MIC*CK2Q%@IAWG[1E+`0[<KSD$'YL@G<0Y7MIE-;F&*%WS$^H*<B(O&7-/B
M:T5\M5ZN?NZ>2)?)'!M@<N:T&9;(L!"T)((2X@*;4@J%1N26Z'KTU<]&^`=R
MXW?V1%ZZOS%6'QX*''2D=U(<`\.Z%>)[:ERZ@JM/!2*(O-K#<#->192B`NS>
MW/F*Y$UJ$K5BIALT(Z*)7(`IJMZT[-+`YNP@^L*S:#"Z&VG#MY;ZBHV_=ZI6
MWQ,SZHVK-NM@6!UH[Z:`Z`16H#E>O8ZLNE?15<UGZA[U8/0_`_DU)*NJ,7+/
M^^M@O_TO2_\`YH2=2-CL<DG_`!M[U-OV6*"L%S<`]4<@3`>_^P86N3];_P"Y
MM_@_\2[IT'_MSOMN*FCJF*XH:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(
M:$(:$(:$*N#[UX%7L=Y62.YN/'0'_G"L.ICIO_<8^]WJ4%U+_).\GM4:.#6U
M(XYL.ZG]"ACO7M%;UZ'9_+,7G6\_F'=Z>-++BQN2`0?I`[:PFJ,J'^"GX]9J
MHK[T;X];EW$+;B,2Y#:R$QWW6"A+A'F5NI4)HFNH^\U.TM8\V=KG[^"M=A:W
MUV^CX@UO>2G19XTNK28KQ;86)(4H)*O,@(*>A`K0G=JH7/4PN'TC8T9>WC_8
MK&>FI0P.JZI'!%&<<:S6K0F:V\B/)0M.U(;2XE+@4`VLI)!7M-#M_.[::C77
MN]W*WSK'].3`U][S*O[//<;R-Q;R"WB^6,V>_0'?5*;W9(\JW2(I2/*W<K2@
M.ML./$T&TJ`.L?Z7_-/F'WJ8@T>XF=0MIW*56#\_8%?[?&>GW:+&EJ2V`)/J
M-^GN0%*%5)!-%:6CNF0`MB=F:<2M+[I^YC>S*":CAVIQ6N3L(=>4&[]!<VK`
M;6AY!;<H?*02:A*C_!IO)*R0[:+,=G>1,IDP"4<7-\=E!/HW.&\LT);9D-E8
M2>ZCN(%`3_#K7,SBC\;Y4=?O!8-@)NL5ITBH:=>:"B#V4-JSY23K&=G%+QPR
MOC+R*$%:9=TB+A2'8TN%(0AA:W-CX*@`FJ@A(KN4-9SM!J#B$QD?)FY):*.P
MJJ8>27WK]R[?$*/K&5DT&$V"=Q+3LA`6D5'7RC5,OG\V_H<,5TG0V\FRPQP5
MEEOC,(G)9I\NQ'81ZR$`%,9$6.P@(36E0K;7KVU+M?R7"$8C*#7O3A\F:$RT
MQ+C@H2_=^QOWCRSE_.)":OY)R/E4]+GUQZ1O4U"5)</F6([3*&DGQ2D:DH(P
M??KL5*N[LOEY!:`UV%>"MN+U5[Z#ZB44K^C7KV\:Z=)MR6<2BJ:KU5J213H.
MH-?#4C;G\(?;>H"^DY5RY@Q`IZ@DT_)+*]H0%?233PK\-.X?J!,G3%[2VB*U
M'<2?CIZD5J4A9)(=4D'L`!0?E&C#>$V?;YW%V8BJ^H2X@U]51Z=B!_<T>[P6
MOA?[Q\RV[W/T_P"#1AP1X3^\?,M;A.Q9/4[5$_3T.A.6MRM#>`41[X^H\^Y9
MM\I-JQ'J#^G;P\?R%VGXM.[-^20DBON^T)K?/Y<0.WWO84[+:B]D^,M*)&^>
MZR55)(#L<K*@">Z?2_AU(ON`&DAHP"BO$'@$Z33SGJ(&\TW`>';\FH5YJ\GM
M*GHS6-I_NCU(ZCN+!4=Q[#X>-?HTA+;BX`J:9<5K+<&````YL%&_W(/QX=LM
M%XN,EN%!MKBUN27DJ4V:D$A7I@J&W\&J'U'%)<`Q`4'%6WIR9D!$IV\%".7)
MME[>$JS7>UW**O<I)8DH>4VH@J`E>F2EA*B:`GK6@U39K>>)N#:FBZ3;W4,N
M#C1.'PY'+>>6@/MH0_Z<LJ0BBD!(2C:4K(!.[48]SW1/DF&5S!AVUK]R>71M
MX+1]PU^:1M*#C6J</W'V_#+/QKE')MPX5XPY=S/"[4ZUC3?(.!XAF4IAB1=X
MJ56RUNY+;Y4MJ.N3+]8L1UH"EBO4G4CTK86VOW'*NY70,!VM`=AY2%6^L=3U
M+IWI?\_TVW;=7%/IN<6C?O:"=W#>N[C7D*WVCVY(Y7F<4819,QM>,/WV]85Q
M9A&-0YKEX3*?B6^"+9:[0N=&D_,-I4XR2EYI-2L4&IFXM>GF]8_TW9WDDFG9
MJ&8L:'4J1\(<6[N*KVA]6:KJ7Z5?US?Z=+!U.&U\$VKHZT::<PT?M)'P;EHX
M>]QG*O(/#.<9G<.)LTM6:8Y+N4?';#$5,M\'+Y2P'XCD1%V,5UUZWMD(>],(
M;2JHZZF==T#IG3-8M]/LM0FGLY&$R/,;`8W`C"@>000:XD;%!],=9=4=4=(W
M_4,VEMMM3LGM8V`O?EDS-<ZN;+44RTP&]%G'W+ON3RGA'D7-<UPEFU\E692V
M<&CW7)&&(%\:="T+*;<R[,DBX6GZRDK%%>G2O726L:9TWHMS;S6-Y+=Q\UA>
MUS&MP#QF&#CNJM]$U?K;7^B;K6K_`$Z*RU+*]D;&R/<,Q:`UU7,!P+J[-R1&
M/YWSQ_P?LO&>9%Q?CO+,>X2&,7R&]WR-']&!<$H$JX!J2PMN)=83,@^@`@BF
M[J-2>M7O0%S>^,9"YM#7+E'_`)DTZ6M?U=ONB)=!U&9D)D;]0$ES<#L!8`=O
M'<FKN'+`C>V9.$YQ[M.*+%RO-G2K9(RVS7RV2+O.Q:/)_4Q7U-3'%-WA]:2G
MU4MBC:4T&F\746C'6X]8TO2H;FUBMN28Y'%HS9G.S5:'8T<$N.G]?UKHX]*Z
M[K$UG=PW-6SQ,:][F``T+7%H&-1@4V_*'-W"N;\0\>\:WSW6W>YY=C*HZLAO
M&&8WDUUNV1"*VTBW?:5SMML#";C9U-@I=0M27UBJB`=(Z5JO@=6N;X:3;N%T
MUS0TO>!$75HYIRU);7`&E:+/470C-?T*RT4Z]=Q&T>UQD;%&739<M6N!>``[
M+C0G:F/]W/+_`!KSNWQ/_9]?.7;W=<`Q:9A=]5)P"?$;R)FX-PW)E[0[.GPE
M.W5<FW-)+:D[%M+556KOTGU;=]*OFD9ID%SS@1[SW-RUILHTUV+GGZK?IE'U
MOI-GI9U:YM19D$/9&QQ?2OQ`N`&W=78G*:SBX<N<(\<^W7".)>3+2WAU[PN7
M<,QSUFUV]MR/8;HJY/.-Q8LZX2'@XM1352JI10`>759-B[4]8?K4K1`][OIM
MQ:,2=IH=_#<KYT\_P72D.B2/,G(&3F'!S@`!4C8-G%7!\;V%^T8G;;>\HJ3"
M8^6#P30.!24U6$^`J.GT:OL08V(2$XM'G5<GM!$]SF$NJ>"7;$"2%JV,^HW0
M56:B@J>OPZZQXQO8FU'\$<1V%;PSZ*?*4]:U/FZD4IX:U>!*WG!U"=W<G,,K
MQ^'E"CKQ>PJ),Y%6EE*R,GOO?RT)N4P'J!X5U%32UK%7:I>&+8]RE+"E.B!"
M"VP`N!$VC=VVA9/;OX:;<OM*<T'!<ZW2%*30?^B/\O4C"*1`)C+]0T6H2U1F
M2$I"NHZD_'\6MGMSMRI(R\@<P"JU&YJ<0I*R&ZU`H1XCOU`TEX<<2M/S)_R#
MSE(/-<3M&<V1ZQWV,U-B.*60HL-*=]-22"V@K!`*DF@5UH>NDA:LN"YA-,M=
MVU.!,;?+<--2_&G"NZJH/YH]H.)<;\Y-R\7N\UI%QCMR%6IN\SQ";4S+2\E<
MJ'%DQ(CCU7-NU6Y-/S3X4W4XQ#,8QB*KH_3ES)<8O%!D.\\0G4YDQ!7]G,R5
M+9WI7`0540_)4-C*4;6$;`EMK:FH2.E2?CJ,5L5&N>6ZWPGW@DL!*G'A5P^F
MXV-Y`JV>J5#Q![:;NG()%!M4@SX1W)@[YR'B^`PGKM?2ZX6G/11&@AM94I?[
M%3[SE&XC*UT!6KRBNE8877[C&,,HK[%I,:97<"I28?><$Q"%QMSUG_-/'&#V
MNQ0[S<(V(X_DD+.,INTRY""J%`2NT!,"WON"(`XA\I6R5>;PTXI<6?NAF:G'
M!,KX>.CY;O=[1BI;<6\Q<&\L\L<?Y9R[SGQA>L2Y"XSYH9-FCA[*;O[?YK^/
M2X&-7G/+7*%OA73*PE:UA#:E18WJ-D.%0.F,EOS9!*2<U:T3][K:WMQ%'"P'
M*!7?LVJ-?M_R"Q3^%[G"BV:X14VF1;[=`EST-M7"9%M]TN$6+?W6HBGH83?F
MF4R4)2XI0;<`5VTO?W/-9##E`R$X\:@?<H/2QX-]W)7.)6-%#A2A<</.KV?N
M@;F[*XTN49)6ED3W*;B=Q49DE2U;3T3578#MJU:-\`XT7-];F%M<F0-!-5=D
MESTO/6E$UK7L3TU-2M$;:[4SAOC,[*6@*#GN'NRS<N?'&P"N)[:.1R%A74I?
M@0HZD&@\HHNOXM4[6;DBXA;E&#7;^T*SV#28)<HWCVI(>P:RI'$D%]'42&HC
M1&P42&V$KW`^-3JR:5<GD;-U53]6:XR&O%3LEPDJ95L^L**Z`>%>FGL-ZZ;:
MT#RJ'\(./H41>6([QY8P<;.B<?F`=>_^V$H_Q#4U;2F/`"M4SNHS$YN7%38]
MEK*F<*S=*@1ZF?3E]>E*085/RZY3UG+FU$..%!3SE=CZ#N'^!<S**5'J4SM5
M%7U#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A5Q_>M_\`VD'*
M?_RGQW_]D&Q:ENGW<N^8\;:N4%U-_).\GJ*CEP:T'..K$*TVPXG\,5O7H/39
MO%P9'C*&#OJO.&HR9)R>)*>-M+@/HLH#BAUZFG?KX?#69I&Q'B%&.NI0?=8#
MY2CK[*F?['?[;OV9_DUKXNS_`,S<EORZ]^0[*J9,&R1+*PW"B1F&F$5]-#+:
M2E%>IH>IZ_AUPA\EU/7,XKT*R"V@^!F/<NI+*4J*DMD*\3177O\`B&DLDMKB
M"3F]G]J<MNVD4+=G84@N3Y)A8N_(2TE]\$EI"MP27TBK*%J21L"G`D&OAK/B
M)R0,:+8W4=/A]!57$6Y2\D$ZX9-:[>C)'9<Q%T:+#,@QG&YRT-,L.N(6XI(;
MZ=SY=.S:/^<><)S8WL1(HWT),W(8BIUR%2Q/34G:[$;DQ1+;6HC:AR.T\'FU
MGP!2"=*QY[<%M2ZO#'U*8DG@>1F%,."34RU6F*2V;:8A)#;H2N2PZC=TZ$K)
M:6$GRFG3O36_B7[:.IW%(/=;2,,8`JX$>=-_ELN-B]M^VK;=[ZA,6]8W#D16
M+XMU2F+I?(%N<:6TXVA20I,GKUK2NM?&#BHS\F9\H2DOMVO>/.LWB%<;O.@;
MU1)L23*5);ALMNKWS4*;KM40:=33RZR+RNPIW%I,382'``U2B/*616O&Y>3X
MQ,DW1F!&=DW2VNO>ILM49'JO3&&D[EN2%,IJ`*U/AI2&Z#I&M)VE0%_I66-[
MV-)<`2*"J9/"[\UE_).(Y$`7(>2Y1;+M&*QU=B2)`2IN0!]1V.ZG;M-"`>NH
M>X%;ZHV54SI<4K;.CFN!IO!5JCFU+=^G;T@1[=?I$D;@"^EB`MQNO7LVI`/2
ME*:EI2#<U!%,H6[HY&V9):ZF8[BH<_=IQW&>,A..Y;DV=?)+KX%23*N<F0M2
MUBH!6MRI^G4W;8QX+G&HO$<U=A!5GPF>GU6=U>@Z@T^/Y=+4/!1QO#Q7$_.2
MIPD#IT_B'PU(0-/*&!W^M1MP_F2EW=ZD1/E)25*(*A2A)%>X'\6G<+7<P8'[
M!(U`VKC!![$'\'73[*[@5C,WB%\W)'0J`/X1HRNX%&9O$+YN3^DG\HT97<"C
M,WB$-R?TD_E&C*[@49F\0N!UURKB0H[?,`!0BGP[:,KN!1F;Q"BA?`H>X#+!
M0@?9.*>'2HBK;'Y$(`_%IQ;`AQ)&Y,=0(="`W$YO84[S?ER+&UIZ+$V2I*AW
M#B64ANG]\$J--/"`10[%#Y7<"G0;2KU4G::;ZUH:4K\?AJ,?\9[RK)%])O\`
M"/4C1*E)[$C\&DW&@IQ2=PTN`IN*2^5X[;<JMZ[9<4!]MP?K&7F4O,*3X>5:
M5))/T:;2:?'<8OHDV7LUO@ROF*KTY!]BD)^X3;S@-ZO>(W251;DNS2DIW+2Z
MEP!<)3ABN)52E-HH#I*YT*U<RK2TJ5M==NFNQS4\J;2TXA[L.)KTBX08^,YR
MU";<8@S,BAS(DED)`%7_`+,)^<+P(K4>7;T[ZK=STK'<^XW`;_*K3;:P^ZC<
MV1P`%-IIQXKFO&0^_#.?YJ]&X?L5L1+$V)$3QR[D*8TA+C3B7_4R1[T'G`\P
ME?U*)4.W32%MTG^6'-"=O#M4E-U?%-9C3+@9HV]E1@C^U<3>_2_1BVYSM]A0
MW9+LM].,8!BF,M.2GUN..ONR(EJ,Y3[SCJJDE6[=1733B/I;2=(N_&/:7S'?
MM/J3.'J.*YO#RKQ[=.^3([U9$8H]F/N.N["8N1^XKF!Z&X0IR%"R-5MA*[E1
M:;MC,-39JHU-=QKU.GD6BZ3G>Z2IDF((.W+3"APP\JB;W7+BT,C=,D=);22M
MS`M<W<=Q`J/.M3_W;*[HM+N2Y_R'>U)32EPRZ^/("3^T_5?:(;!6/K&E37KI
M4Z'I-E[Q;G?N&W'=L'%2.K=27IEAT>WHVR#,[B-F%2<:TK[NS:C6U_=F</,/
MEVY6QRYO*4IQQZ:OYYU:RE""HNR7'5_42!WI]&M[;3Q.??MXQW_VJ&N.K(N7
MR+>61K2.!^Y.G9_8;PK9'$+AX?!H$A*U_9T'U01THA:FRXCI\"#74Y%IUM;M
MRB)@KC[NSVJNMN96ESHY2X.-<=W9N3D6WVG\40&2P,694VLDI;4Q'*%$]@ZI
M0*G$'\[>2#XZ5%M;M.;E[%E]]=1L,@=\(KMX)8PN$L`M2FT-8U`8+`HRHPH:
MFD4H`&VVFPVE=/&G;2N:`_NJ,=JT]R/?S4[:I5V[`\:MJ@Y!L\!MY*W'`\W%
M;;<W.4"_J@5!I\-9,4#F<P4!X5"UCO9V.Y30[(>PIP85O='H1T[DLE0(92CR
M]14B@%>^H:ZNG1@L&Q3EO&^8`N!Q["G,AVZ,Q"ZM(*U)((Z5Z=>U:^.HWQ3D
M\\&=M"B5$&LU10`VFJ:`B@ZCJ0#IZR[(MJ;\5M'9@25(.*C?QLADR^1-P1M.
M3WT`DBA(N4OL:T.HR&:1]XT&M#7U%3#X&1VCC^]0>L*1"&TF+;P$@@6^-2@Z
M=0JO;\&I=1:XGFT)4HE``[]>G@/CI[$YN0"HJF4H.<G<DQ+EJ6HH;2I*30]!
MTZ$_ATME=P*97!'+IOJN=M)6"5@D@]*C1E=P*8+6]ZE'$I*DIVJ`\`.G>OT:
MUMQD>\O%!4[<%J+ASY6Q[@:*M2YW"=-RO,74IA2VXEX<M[D>ZQFI#>TE2E%"
MUMEY"T[!V4*`_3JB:NX.NG4(.*[GT];MCT]LH%"0%R_V8<:<@1YEMS/&;S%A
MEM3DB;B&8W2PH<2:[F3;WE3&'9'B5@"J5`4Z:B5.J'3_`+5?NWN7;ID.)X_D
MON`8RRS,WAR4W&>>BV]AZW^NV\ZW?KUC42UW:,S+:VE3+KJ5^"C4$L'_`!GO
M4BRN4=R\F-]3,SSD>?8+5(<EOV?.CAL"#(DL.L7$LSKM'B&9\L$QI4U:(Z"H
M`$%::4TZLKTV+W2`5S-IZ:I*<$M%`=JV<:P8G[XW'"KK"A2;A"NUPMF1,K88
M<;<N#;RDOM/,[=C:PD`4VI-!IM>Z^^M`QU.P%-LC^!5D7NLX;L]O]N.$6GB;
MAK"XN06%NPYG>K_CN.16<CGV0PIKF4?O5>7'U27L29C!!4VE'5922=HT\8\/
M:'`XD52ER]N4"HK3B%V^VCD"W7OAJ=$L4<V=%KA6=R6VEL1VHAAF\N2[<`X`
MAM+<AH*(/F3T':@TVNL'LKA4GV*-MP2)2-F4>U>CW[H^W/1>(?M,I6A<Y$.8
MH["E6Z0775`@@>:JNO35UT5KC&"`2*+E_4GUC7BKC7+C^J>)0I80PM92!6OI
MI*NP->E-3MXP@8`T459_4\JK_NCLSFW-?=+AEGN=OQZ2>#',4@9)=EMFU6VX
MY5=HT=)<;4I'S#BHUO=2IM)*U)50"HUS_7/=NHB>!]872-`@,UM/A4@M]13;
M_=><V0LZXC@168:XRHKHC+9=D-2W&S'#D8J<?9*FW/5+>\$&FU0U9=+]Z`@8
M^Z56]:M6->:T5IDF2DM$-42KIU'>G6H\=.K1CQ2H(V;E5%%SDM@R.7,&JH#_
M`+W9=02!N_VPD_@\-6&/<AT#96U.T%33]I+;;6'9DD!-4YS-2:4^M\I![TKK
MDW61_P#R`%>'_4NN=&V[66+B!]J%2RU6:A6S,WB$-8+FC:0C,WB$*C6,S>(1
MF'$(:VJ$9F\0AK!<T;2$9F\0AK&9IWA%0=B&LU"VH4-%0BA0T5"*%#14(H4-
M%0BA0T%S1M(10H:QG9Q'G10H:S4<44*&BH10H:*A%"JYOO5J'V1\I5IM^U..
MJU[?[X5A[ZD]#(\6SO<H'J8'P3O)ZBH^\'I"..+"H)`"H<05\"?EFZ"IZ:[I
MI\O*@KLJ%YGU9Q-R&MQ]XJ16-6)Z1.AR%MK0T\5!>]M24%*#0$J4`-I';4?>
MWCLU:JP:1I?B&`EI.'!/YZ+/Z#7U-GU4]OR:J?\`J/FWJ\U@^4?#384YVJZK
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MJ6K+X-D#B<`0GD7[P7[O;+):<AX?Y$?=9EV-^^W2#;X[@FBU/(DN/(C/(3+6
M^9#22G<NA%:^&H/P+^*F?SN+B/.EM(]W>'OB1NXZYB<;F,I9D1).+@ME)%7`
M%-3T(*"HD"HKIY;V1##7'%,KG6F9Q0[MR0UD]U-KQ"\/2[1A'*4RUOK7ZUMN
M&'*:81'4I6^%N^T5U82V=F[Q`[:<>#[$DW7FL(=4X(SQ_P!W&#V3-;/D"N.^
M3X%FA7^'<OLVSXJA!@QFEEV2U'0Y-*'O47YMHVU5XZ/!]B6_JAG'TJ9S?WF'
M#%P-QM\?!>>4NW838J"_AT1IKY6=$<8>"U_:2@A16H=*'IK:*S/,V+2YZIC=
M:F.O%*OV6\CX=QKQK!MUTD9)"<=>FUBKQR[JI\Q(<?:0XH1TI.Q"A4CI4=-6
M:RLB:`+E>HW@N;G,-Y4TA[C^,U?M9U[^C;CEV/X:_J-2?@')FL3[C^+DFGSF
M0GZ4XQ=R/R^CI=D?*:&'<A$[_N2XK+2@9U_2/+YE8Q=@D>8=SZ.G-O\`5'E]
M21N/I'R>M:&/<KQ.V%!5SO?4BE,:NWA7_6-2&.Y1R^+]QO%3BBM-TO%%=0#C
MEWKVIV^7\="%A_PBN+OSKA?$#])>-78#\%?0/764+[_PB^*O]U;O_P"#EW_[
M'T(7T>XKBZH/VA?`BH)<.-W8-A/BM2RQ0(`ZD_#0A-^B[0LNY4OF7V)3TFQW
M.!8FHDAV-(C+4NW-J:D!;;S:0FJG`4]25"O;6K:AH!64[TZ6Q:;E9+E,64QX
M,P3'TMI4X[Z*F'&D[$``*7N\*CIK)Q"%M7SMQU$`9?G7=*VP&UA./W58"T#:
MH;DQRA0!'<$@ZBW?$>]2C/@'<%K_`.$!QG_NA>?_``<NW_0-:K9;$\^<;J%4
MS[R1_P#2[=Q_^S'0BJU.<\<6%*A\]>J_3C5V'6OB?0T(1>[SKQ7Y=\B[/4KM
MW8[=O)VK3^;^/]S0A:?[=>)SXW2OQ_=R[=/I_H_AH"QBEI:>?>+VV-HN%\]2
M@`)QN[TZ=^OH5[:97B<V7U!WHV_M]XVVJ4+A>2E).[_O=N]>U>@^6ZZC[7:_
MO"E+HXMXT18[[@.,U^I_/[W104/\7+MV(I_@-/6_$.],W"K"-Q!1*>=>,6AN
M1<+T5=J?NW=NM?P1]/ZU4*+*FP+:WSEQ^ZVIUM^_+0D[21C=W^M0*I_1_@=*
M,N&PC*=I1X+L7"[[@>-@'&_FK_O&Y!'[M7>H4*@@_J/`]];&]:X9=Y6?!=BX
M/[>N.*@?/7H$]@<<NX__`&?2*QX,\$;0.;N.''TH5-O&\@>;]W+OMH:T&[Y;
MO732?X_(EHHS$0S8E8QSMQDT\T4S[TI2%=$IQJ[$D@4H/YL*Z:2_2<.Q6:W)
MY81M_P`(#CC_`&1D'_@U=?\`H6HY+KE5SSQV\]Y)-^KY>^-7<?Q,*^&A"1&%
M0O3;R5^.A09NEYNEQC!22EPQIDN3):]1!^HYL=&Y/6G;PTK!]4)&?Z12WF<P
M81CB(D*ZR;FB0W&;84F+:)DY(<C]'`51$N[!58ININ\.VI)1R2]T]P7&(2K=
M<;R@_!>.7A)[`=OEM:Q?62<_T_(DH.?^-3T$V^CH.^-7A(_*8^K+%\`5<F^K
MYT%<_P#&J:5FWPU_1QJ[J_+2/TTJM45W;W'<;Q(:7(XRF[NO2$03#M&,S7IL
M=3ZPU\S(8DJB*3$9*]RU(*R$@D`GIII>MY\7+[$VD?R9FR;JJLGD+W8<"<2W
MW,9'(-XRJW&YY+*GQ_D<!RV].>@ZUY$NLVRUR7FW#Z1KY=HIU54@'GNL:5-`
MSG1C$NIYZKM/3>M6_@FQRGW0$@<=^],]CULFHD2\TY!:2`L43PSR6ISS%O:H
M)3CM*52?'5?\->\#YE8_SBPXA1%XQ^\$]LV.<A9)>KA=LRA6!4"^6JRLQ^,,
M_P!DE4Y?KBY.(<LD0LKDS07*E22-U334<^VOLYP.TJ29J^GY![XV#>J7/;_.
M]O=LON897SCQ%RQ=LD3RE=<GQ2\X[<+Q:H!@JNETFVV<FVP,1N\WU4MRT&CC
MC9!J*U[Z>%O^!6WYOIWSCSI-^XR5P_(G81??;EQ%E%MRM'($W(\\R">SFSU_
MG6J2E6QZY"X6QAMP*4L[!LI0'6?#7_!R/S?3J_&/.K&;;[B.&\HQZ?C=PO>4
M1I5XX%O>!+4G!<P26K]<\93:6VOF'+.TR(IN'D4Z5TVFH![:F+.Q>7`D*%==
M6!<34;2HJ\1V^X81@>>81<[9E$.ZY'<X[]C*L>NZD3$3[:ZQ,>?<$6K3:[@X
M2DT-4'=]&I*\THW'*H/A)/J2;]3M[9A$1Q<,5ZQO8-FF%\8\(VBW79V^Q[HS
M!@.2&U8[=RLK2W^MVGY0;@5?5^(Z]-7G1(?#P\IXP(7,==E%U*7CBIVCGOC:
M2TX@7"^->JVILJ&-W<+`<24&@^7IY@>OT:?7GT_(H6SOFYJ*A'W*WRV.^XW&
M<=RV^YCBWMXF99/Y7S'*L<Q_)!DDK.^+L<O4_A3$E?9\;YAS%\DSN[)1<VBE
M32VD)WD#5`UFP?>31/8*Y*CSD+I/3VNLLK6=CC\1;Z`?:I(?=:2\5XBXD1"R
M3[4AW4J1)DLM8Y<$4*RXI8]&-&,=DI)^HA1"!T)K74QIT?AFAN]5'6M0;=35
MW55K`]PO&)('SU\ZFG^+=V_Z!J?44D)>LDM&=Y]C=]QI4N1$L]ID0Y;DN#*M
MZT/.RGGDI0W*;0MU.QP$D=-+0FKLG%)33<EE3L3M<>>ZCB+VW8YDEOY6G9)#
MDW7)Y=Z8-APW(\F:$54:,V-Z[/`DE+P6RKRT/2G4ZYQUAH\\MV)8Q5M/37@N
MC=(=16S;4P2DYO92AWA&Z_O:O9DA6TY#R83_`'O#/(Y__H/TZJ'Y/J'RGS*W
M?F^F_-Z!]ZU+^]P]ER#160<G5I7_`'F.1^W7_P"(?HUNW0+R49G,Q\RQ^<:=
M\WH'WK,?>V>S`]1?^3NU1_XF.1_^X.MG=.W3!F#14=O[%G\XT_YO0/O0_P"-
ML]F7_P!$')W_`)E^1_\`N#I'\GO_`)3YEC\WT[YO0/O0_P"-L]F'C?\`D[_S
M,<C_`/<'2K.G[N49G-Q[<%G\XT_<[T#[T/\`C;/9A44OW)Y)(`">&.1R:J(`
M_P#@'Z=9=H%Q`WFN:*#M\G!;Q:K922!D;O?/8/O1T/O3_:&KZM[Y+5Y4J/\`
MXGN1$T"J[?KV)%:T\-)>"D^4)[XQG$_;RK+_`(TWVC?[L\E_^:'D#_N+K'@Y
M/E"/&,XG[>5#_C3/:-_NSR7_`.:'D#_N+H\')\H1XQG$_;RH?\:9[1AWO/)@
M_P#]0<@?]Q-'@Y/E"/&,XG[>59#[TKVD'_X7Y/I\1PWR,4_AWBPE%/IK31X*
M3Y0CQC.)^WE7U7WH_M&`\U[Y(I_]://_`/N+K!TZ6490T(\?$S$DT^W:B]S[
MUCV<M`ER_P#(Z*&G7B//Z]J]/]INVM?R67@%G\T@XE8)^]?]G12"F_\`)9!`
M(IPYR,10CIU%A(/XCIZS1;K(*-;2GVW)F_6;8.(S;_MO7T_>O^SH=\@Y(3]*
M^'^1&Q^(N6)()UM^2W?RM^WD6OYU;?-]O.M:_O8_9PVG<<@Y*4/BWP]R(X/P
M`HL*DU_'H_);OY6_;R(_.K;YOMYU%3WB^^+V]>ZGV[9EQ!Q#<\TN^6Y'<\05
M`9NO'696.VJ-DRRV7B<W*NEQM#46(L1(;FWU-J2L!-174CH^D7$5TV1X`8"5
M7]<UZVO+5T$1)>:8=U:[^Y/=P)CKHPS'8,V.M$9F+$+H(.X%+"$`!-!YMZ==
M.DG$-LT';BN2LT=T]TZ5H4L@U\HPA'^I(%$`$D[*>4$>!H-5F\O0#7]Y7338
M?"MRG:NSUD?3V^&MLWJJL5]:>#575U0T(4</<UR6.-\#?NMNM[%TR!:D1[1"
MD)<5'?E+4G<B0&7&WJ!!J"%"GCTT#`U[5G::*K(\N>XF6F_RLGX_P"9>FFGI
MF+0(.1.6^VS8CR3\E&O,UY4]Z++4>BW&TE*?!L]M2/YE+\C/3]ZVGTB"?!SG
MCNI]R(4^XG(+?8K2,]XYM=FR>YK=C7"R66:J^V:'/2HEEF)?)L2$NZMNQQN4
MH,-!)Z4/?2;[V1YK1HIW_>FL/3UK""&R2FIK^[]R;G(^=KQ*C3)=LXIMJXD:
MW7R<94IN*VR@0;?(<@NO*2`IN.NX(0EWN0W6E#0Z3\4_@$LW0[<D#/)B>S[D
MR_&//W+N3W24[D/$O':<7DRW19+KBUX:<FF%2,EIFY1YB)`3+2Z72XI(0D`(
M%`3USXI_`)U_3EI_F2_\OW*7-WB95&Q[][7,3AQ;(A;34A]MN#<A$0]M])^1
M\M':4E)6NA%.P[Z:RZQ=V\HBC9&6$5J:U]!2$W2UF\9^;-7_`(?_`"ING,C*
MBXR^BQ)*U%"`JWLH,HJ50>@A0W#U1]4'KUT_CU.Y<S,YC*^7[U$2=/6V<1<R
M6CC3]W[D12KP?F9T?Y"R(;A/,T6[`9!4TI20\32@WI0HD>'36WYG+\K/3]ZV
M_I*S_P`Z?_E_\JFTQ[<,.F08-R:OS\=+K+$R*$V^U+*FI$=IY*E+3;Z$%2E4
MIX#3J&\D<!(6MK7MHE(>B]/G?E?-<4["W_RIM,IS_@?"LPQOCC#N8;/F.;IN
M<NR\B8O*88^T>/[LQ;6Y\6-<($:+$6RU<4._JG%+6"!J8T[5KAURV%T;`W-0
M''$4V[<.Y5[6NE+'3'&2&69SAC[V7V`*3T'C9N=%8D-WFT?KF&GZ?(]-CPJD
MCKVU9_$OX-5.N#ROAQ1@.+E)`'VM9C])@FO7K\=(O>7NS':DX7F1F8[:E%2^
M+`L;5W&S*2>X,!5#3J.R@>^LL>6.S#:L7'TCY/6M7]DL?_9ED_ZQ<_T^EO%/
MX!1RU*XAC=5"?9TGN*0G.A[U`*].XW9V!QVE"T-\3H<5M<N]H<30G:8*NX['
MH1VUK*\QLS#;5"Z/[((O^S[1_P!9+_T^FWBG\`C%=2.+$I"4?:5H]-(":"$4
MG:!2FY1(3T\3VT>*DX!"*(HA6+*Y.+$-N384:V.R2VXX6DBXI<<3L;W>FD@-
M"AI6E=9%R\FE`F]S,^')D`.9]/)0GV)SXEM>R+)<<PI,N+;%7^7(93-EQDR0
ME+<5;J$LH!2HN[V^M32AZ==1VM:K-IEN9H6M<0-AK["%-Z/IXU+566$Q+8G4
MJ1M'GKZDO'?:%D3_`)EYS8:D[CZ>+2BDJ/<A1N8J#^`:IW]8DXNB&;?CO\ZZ
M"[HMK'%C7OR`D"M*T&RN"T_\#J_?_1U9/_!:3_W4T?UA_P#PQYQ]ZU_HX?.[
M[>1;$^S_`"!`H,YL1'TXK*_N731_6/\`_"'G'WH_H[^^[[>1;5^T+(%I*?WU
ML":^*<5E5'7P_P!M-(?UI_<;]O*C^CA\[OMY%H3[/+^FO_?O8E5_2Q62:?@_
MVTT?UKQ8W[>5']'#YW?;R++_`('U_P#_`*-;!_X*RO\`NIK/]:__`,-OI^]8
M_H[^^[[>1=$;VBY&P0$9O854%.N+RDFGX?M2FDI.KQ-@6-^WE2D/2)B=5CW$
M]O\`8NQ7M0R<)4C]],?`7WKC$M1[4Z%-T33OI&/JAD5:-&)^V].)>F9'D%SB
M*?;@N,^T?)#WS>P=>Y_=:7X__A72G]7#]UC:_;M6@Z5<2!G.W[;ELB^T.](=
M"GLXLKJ0"0EO%I"%;JBAJJXK%!^#6W]87HVQ1>G_`,R=?T<#^\?MY$J$>V"]
M-L^BUEUE:1X[<:?JHTIN-9YZTTA+U7=2NJZ./R5_\RW;TA;M'XKWYNRGW(M:
M]IER:6^\,NLSKCRUN'U<:>*=ZS7\V<F@KK5G5%PUX<8V4![?O6'](VF4Y'R9
MJ8;-O^%$TCVAY"X^7OWRQYL$4"4XQ*4*_@^TQI\>M*;8V_;RID>E7#:33[=B
M[V?:?DJ4=,RQNH/UOW8EI5X?_&G;3:7JZ:1V9D;,M.W[ULWHL2GF%[@?)]RQ
M3[4LG#@*<XQX*"B13%I@H?H4;H0*:3=U-=.808XZ'O\`O3]G2CF-RAY]'W+J
M_P""MEW_`-'5A_\`!J1_W1TV_J&;Y&^G[UM_2\GS?;S+ZCVKY<TKU?W[L)K0
M$?NS(-*'P_VQ'?\`#K+>H9"ZCF-R]G]JV=TTQD57/=S/1ZE'[!,ZL]ZNF:V"
M(IEV3B%_OV/RW8@/IA^R72X6MWU@I2]JEO0""!3J=7"!S##X@'WP-F[%5*ZA
M+7F'')Z4YJL&MD\-2VC$@KD1VI#RW8_KE];H4>E:[0UM_P":UOXI_`)IX5G$
MHGN_%$>:RD?/V9('5*S!6'2:]-_F">GX.VG4+B0)*>]Z$E/;,Y=:E)&3Q0ZT
MOTS=K,$TK7Y`[NG;K6G\&I6&]D)#*-IY?O5=?;L,AJ2M*>+5)J/M>S&OQ@D_
MW=.O%/X!8\+'Q/H7Q?$[3ZT%Z[V[=N2A3C;+V\1R0%LM(4I3:$%!(``UISW5
MK0)*>PBG`!+A3A10J]S_`!;B=DMC-;!8<FN5P?;6+=)B1V93D<R4Q5O1''(Z
MW93S"']Q:'520H^&H[6-3DM;0/;'&XYP,:\#P*LO3VE1:C,;"221D;6%U6TK
M4$"F((ICP5*7"7([W*WN7O7M\O/MI&`VVW9+<<=@Y_)L4R=;YZXR77H\SY*7
M:8#?IO,M@T3(H=XH=5C^H9_\F#S.^]6W^BK+_P"YNO.S_P`JZ,#SV[Y#[A,R
MX@R3VM7S%L;Q*==XUJY-E6:[_(WU=IG2(C#C%K-KBHMB)J&`M*DOR&VPKH5`
M5*)UJ4FO)AQ['?>DSTQ&TY6SSY1AM;N_X4\7$%WX1Y,XVBYW=K'(PJ\2)-V8
ME8]*XCOSZ5.VZZS[>%1;DAU#$Y+Z(H7ZB0:5-='YU+OAA\SOO6KNF'GZ4LQ=
M_P`/W)N<UY&PK'WY$?%N*?WM<CM49:FV6-@L!^6[N^7;FWJ]208S"R.I6RM/
MPT?G4O\`DP^9WWK3^EKJGU)O^7[DLN$,UP+(<SQS&LSXVPC'KQ>L>=ER&[+,
MM>01[=-#P;3$#S,='S\-N0#OEHVI&W:$U(.MK"0R@R$`''9WI'J#1F:06-@E
ME<2!7-3:1V`;TO[SS%Q):>9\KQ6Y\86=FRX-D5IQY_)Q.3,5-5*M%KN3=P:A
M`(,*.J1-6A"%;C1(_"=_SB9EVVW#(RVNW&OK2]OHD+K$W1EESD;*BGJ5W_%6
M'63)L1MEWL-QL[,"1#0]$9^04-[*OJ)=!5N-/B*"FKO&XMA;*!B?,J;*,TQB
M/PBO>F-]RW(D3A''KQ.8B,W>^6^*CY2Q1&&C-N]VE2&HEIM$!)<9_G5TN$AM
MA!)-%.`T-*:K6M:[=6S@QC(R#QK]Z4T#INWOFYY7R`]E/:"J#.-/O1^0^<^3
ML_XQY']M%@P^3QK=7<?NZ'^0+?DL]_*FYKD*9:(46+:&K<\Y&:2I.XRJ(>;-
M#VI"3:Y>0L:8XXW.?CC7T4/:K4SI>R95LDTP'_#_`.56@\0\RW;)YN4M8%9;
M?<+#@N.NWC(6$VY<.ZVQ%L*/M)JXQT3YC+=OA,'I-2MQMU8*0`>R$6O79D:)
MV1MJX;*\>TI"XZ3L'`R02S.<!6A+=V.YJL$XB..\NXM#RJQ7BW&-(2EP-(@G
M?10!"D@[CM%?'5]@F9,:&E51KE\]O.(RT93Q3BOQK=B-[A6UYV-*ESX9?:(8
M]$):]93)&T4*CO3WT[(;%(V1E2:;TK>6<<L;07.&9M<.]==QP"UYVPYZK<4_
M+/EEY,[SM*0#1PAN@)!37I72-RUMT\/D`J"#AV)"TMA9M<V)[O>&^F_R)-#V
MTX:'"Y\OC1)&VAMZJ#J#TZU\-;?A?Y;$MD?_`)C_`$+XOVT86L@JBXSVITMQ
M[5/Q)^.D)(XW.S90&TW+.1],)'U\BQ1[<L-WI2J)B^P*HHBW*KM'3IYJ5UEK
M;5OO.VC<M.7<UKG?DW\:+I5[;L'/[.-C1^.ZWJ_N$>.E"^W/P,:E`(AC)+(/
M-]RP/MMPWPBXQ_VN5_IM!AA>W.YI:[LI3[TWD<\S9;>1YBH,3MKOW)48_P"V
M#`W)#,F1%QY:6E[BVW;:A9H0!U"NQZZ@]2Y1@?#3;]X5BT2"1E_%*Y[R03AA
M3X2G<C\$8(-WIVO'V*)0D^G;E(W!.[;NZ*J1JM>&B'%7[G/75_83A/\`L.R?
M]8J_TNL^&B[?0L\Z1#^PG"?&'9/^L*_\\VH:QX:+M24MS(QF84JM#O!V%-D`
M0;(017^K^U/\PVC6?#1=J;#4)AN'I6D\(82:_P"UUAZ^)MBBK\.[IU&CPT7:
ML?F$]=C?2N.7P5ARV2EN+:`K<.OR*NW6OYI^.EK>WB$E>Q:/O)9&Y30;\$C7
M>`,)=W)D0[.3N`!^256GT>2E*Z><B/@HJXU&>$T;0]]5R?\`!WP44`MEA*!3
MS*MJB2D>)-`"::DH[:,L![%'_F,[O>(;4]_WK/\`X/6"?ZG;K%7QV6Y233KW
M(%:5UI-"R-H+>*6AO))'$.`I1:7?;I@SPVKMEC/TFVJ4K\I&F^'`)QSG+5_8
M]A.%6^1=WH=I*H<UE#<=$(L(<:<H!N"`@*6D+%*].G76[9<AJUH4)!`'2DN<
MZI<?6I$XM;[=$LT00&4B.XVEU"J)!&Y/U4[0!M&MIIWS4S4`"L5O$R!I+14G
MBCF0D+'I$F@ZU'?KJ,DLF2GWG.]'W+=WO%:J?R:>T]5$QIZT\Q<;2I2%.("T
M_625)"A7IU%:C565V6IY71!2KH=W5)Z'M\.^A"@-[O9[B9UABA2U447DM5)J
MZ4@%X(KU7MZ5T+(VCO4#;M<DMJ4%;4;B@J!H`HI)*2H$]2GP^&M<[.(4M0IG
M>1YT&3!LDUZ5%0;/DMIE$NO-()3(>^54CSJ%0L&A^C600=B%K:>L;5LO-M-P
MMJ'7(-RA[?F&-ZBZV\M*0D*)5^M4"!^D-96S/B'>$PG!61L_)7JTEYM,JV7N
M274E8#Q9D/$!Y2.B@W)+8HKLJGT:RI%7!\626KSA\BPN1E7&+<8T=%QMPC;Q
M,BF/($=#,C8H+D>L@E*!4@T(&M.4U\@<Y:O!+,%2)RSR[>\,YTC8[)P2_P`C
M'L?O%PMY8FHF,7&W.R$EN!<YRUH]2:B*XFJ$+Z%0Z:E0VW9;..=N;*=X4,^&
M4S-=E=0$8T*<2SY'?,KR%$IMA,2T2F`7D3TEM#RJ^9!2Y1*W2@4H>M-16=G$
M)UD?P*N&X&R4Y-Q;B[RG5.2+;#-HGMJ<]1YI^$\MH!X$E:%*;4D)W==H'AJ1
MMB#%48XE.+8B.7W\.]4S^\'`$<4^^C^T2V,.QASO@%AR1<P2RB%,S/C.2NT9
M$R(B2EM+\FUQVW%FA6I*ZGH=2=@YK;N-SB`T'V%5CJ:*29KC"TN%-PJKQ.&\
MJCYE@6.WB&KU7YUKB2'?14'&PG;Z:66BFHHVI!-!VKJV-DC=\+@?*N1WXR.R
M/P=P3HE;@-"5`CH0>A!^G2B2MP1$`>)]:UZ%M."Z,@8E#0F/*D^4^9"FI*'Z
M0[DF<#0X%?`D#LD`_0`-:S@NCHW$U6*CBOM-,N7)\I14<5]6RI;:@ILJ0I!J
M"DE)21UK44((T<N3@?,M\KB*@&BB]<3M]P66-@[6_LG$Z([(W)CNA-!VJ`33
M6I!807X`E8Y#Y98Q0T#Z[-F!Q4@+"'4\T\1+"5A)R0(*NNTH-JNI4BO;:I2!
M4>-!J`ZN>SP#J$5I[0K[TS;L_/8Y&T+1OW;U9<DG:FI57:*]3WI^'7(70@N)
MS;UV)T[0X@-)%>"^U^E7Y5?RZUY']Y:\\?([S(5^E7Y5?RZ.1_>1SQ\CO,A^
M-7\/\NF_@W?-Z5GGCY'>9#\:OX?Y='@W?-Z4<\?([S(?C5_#_+H\&[YO2CGC
MY'>9?#UZ'<?PBO\`=UCP;OF]*/$?W'>9``#M4?@%/[NCP;OF]*/$?W'>9??Q
MJ_A_EUGPCF^]FV=J!.*_`[S+#8?TE?E.M^=<<"E^<WAZ$!N3T'6OQJ=8YDYV
M@HS,?B<%])*@4J34'H>G@>^BLS_<-:'!8.1H+AB0@`$BB:@?0*?W=:>#=\WI
M2/B/[CO,OBFPHU->U.NMASH/<;4A*LG]W80OGI^&XT^%3K/-N.!6W.;P]"^>
MBG1SKC@5GG]ZS0@!030$5'6G;K7\6MHGRF0EP*3D+)6XTKZ50+[45F1R%[HV
MB]OW<^\RM`%95^J9Y"R5338ZGR-FNT=AKI>G/F?$&$.Q[%S;5XX87NJ6A_#>
MK.K>A$6#`"W$)WP(M`I0'8+K2I^G4ERW\#YE`\R/YAYUE+*'$C84JK3JD@^(
M\1]&GT0(B`.U)S/88R`15$4YA(>W%:7!2FTD*\?AVTZA(:^IP5?>UP>20:(K
M=;%1M;';KM3_`"#3O.SB/.L+46R`26U=`3Y04JZ=?*H"J5?`^&@.:6EP(RC:
M>"VR.(J`:*L3W:^XOB/!?<+P9QIG^5M62^\@G*&[/\ZB/&L-L$5AMN$W>KE(
M4B-%:G/$LM^HI(6XL)'4ZB]8M+J]T\.LXWRM$@J6`NI@>"LO2LL5MJ3GW#A&
MPQ$`N-`22W#'>OMZX.LV6S@Q<HK;:6&XDQE^--FQ[Q'$UL*8D1KI`6E<5ET(
M*6DI56B>G35$F:ZV-+@%A_O8>M=0B(F&:'WAV8J(_N,X+5B5BNDBPYOR4R6+
M1=IS'SO)-_D1H[K,"0^AQ,=\U=:;**A)56@[^.L`@C,#4$)R(8J>\0#OQ4$;
MPS-;]J?LKGHG3$,Y/PA-D2VF9+Z"_<4W9NX29SB4K'JSG_M?SN&JU4ZG6"0!
MB4I&60G,RCB1NQ3K\EX'Q9;^#%W>!$QYN[1H-KNUGN3;!%RE7@N1F9C3TF(/
M4=2Q4KH22D!1.L9V5VA*>)/R'S*,GM?M%HD^YS!7Y(4XW<['?XZ$*JI@N1[G
MZZEL)54%(=4%#_-`^.IG27-?&X-()[%1^M09)6&,$X#9W+F]Q2%QN9N>(C!F
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M;=37+;9H9;D&9P-`#B:<`K"??%[Y.%_NYO<)=,1P_-K?%ON=8;D=CY+L$=F'
M=)UEQ.X6ZD1-UM\=2GDPK^X\=L8I$I;H2MH;0K4-U<8(I8ORQS9*/;7(0:#-
MC6FR@Q*WZ-9/-G_,VNB!:0,XRUPV"JL!^YUYXL')7#\5=JR(WQJ2F<[99BWT
M)4JW.3E.,QOEPLA4R,AP,K`ZHV[=633[PRNSQ$.;V8JK=5:<+6YJ&G`\%9'R
MP'?[3,,5ZBW-^..DT45;2F[R04FGB-6>WEYS"=X*K;R2&UX)X\,;2MFX%Q`4
MI,Y9!4D$@CMWZC2ZT2XH/@/R#0A:7`O=1*32@^J/&I_%76LM!"7#XEA@/.%<
M(^.[SJFO[Q_WR\X^UO(\>A<1X/:L]@C%\OR_*+,OYQK(L@N&-16F+3B&(*;4
MW%@JO"Y:/57(*5+=%6ZDC5$U&[O8Y"6,>1V`J^Z;IEM=P4+FT(H378.-4C/N
M^/O=;#[N,+E9#FW'U\X2R6PY/+Q/(L+R.Y-W65;Y4-B.^9/J2$1;A$C/%Y5$
MRFM]4FBRD:D=)OB32X(:WM-/6HC5>FXV@^'(=W8JZS%LBLN1NM?9MQ:F-R4I
M=9WJ;#JDN`*\K0)(;`/E/8C4W=7\(]V)["*;C50UGI4T-(WL?GKP*?FW6]F$
MTKTTMJVI!4M`2=A-!4J3]7KTU6YIWO?0["K;96CH*2N:0T;_`$(P0X178OX;
MMI_#2M-)8*4YT7S-\ZS]5S]-7Y=%`L\V,_O#SH>JY^FK\NB@24[V&,@$$]ZQ
M4I2J;B33M70F*QT+"UNE00=E:_1WTM#3/CP6?N28?*PVXI50L+-"H=:4KTJ*
M]].U"WVTHH4^\D>9U:0>U5$`CZ*]"*:DX@.6W#<%'C8%T1GE@E2ED)(H"HT!
MZ^!/3PTG<-):`T5Q3FW<UKB7&@HNU+JE=0NH^((.FG+D^4^9/!)'\P\Z:3FM
M]Q''%Y>W*4XF5:2%`DK\U\::4`0:^9KRG^]Z=M)T.S>FMLQYEP!VG<E=A-Q_
M[W(R2*[%(2D'\Q/H(.T`GH*^&C%3I&1@S^[COP2I,MI?F4XV@G\U2TI(I]!/
MCHH>"3YD?S!=U6?BU\>Z?RZS0II0]J6SEK5\V_*:?42Y38ETJ('7KO`K7IJJ
MJ[(S:2XE`2XI)IVVUIXU[Z$*`?N^_5Y!C;AZ@L*Z#OV`\:#\W6#L61M'>H*O
ME"IWJK0EQ`0X/36*@DIH#XCRG3!3*;_-XMNFX]>E.6Z(\J'$=N"$.0HDEQ;D
M-0>:#)?;64E#GF(Z`_ATY@^$]ZU*8.P\BW2_\AMX#C&'V"1D:)R&8*<FRVTX
MK`N*VK<;HP^RW;+?/F-0YC31#?JI;4L]-+K+/B'>%P89BV0\:<WY9B^?)LV.
M2;WA^,\BW%46ZJG6FVVBZ6MB_?SF9=F8,IB/%B7)*5CT_P!8XG]7N'765(IF
M'_=%[I/>QR-=/;A[")3G'_'UH+T#D3W#1T/PV4,MR'(L@VBY.GU+;!#*:)4R
M&Y4A1*10;3H0I[\,?<S9!Q3:)>:XCS/EW.7)U]GBP<KV_.)L>WV*?!6RS<(5
M^L4.8_+N3<^)*DJ(+\I2W&D^9"E5&D)I6L!:_`%N!]B.T)!9)CSN+39EFDP?
MD+AC%YD0+I;U,N-2&Y$9?RDA*2I"4.-M.*!*@:$=M-%A28]K67K@W[(,-DRD
M-QKC&5=;4\I7\V$B.-S[:ZD+]5\@;-J3VZTU-V'\O_Q%,Y_J>1$/WB?%DKD#
MA*+G^.PP]FW!UYA<B6Q3"%F5,Q>(GT,[LZ/30HK5+L`^8VFB%+974CI5^SX@
MF[FYVEO$(X]A'([-WL`L3=P1)B1=DNQ.(40W)L5U8%YB/H"B%@'YLH2*=`FF
MK%9;5R'7[+_7D]OM5CS@4XLN!M:0Y18"J5`4`17\6I@J+?'RG9#N`7Q#*UJ"
M:4K7J?H%?#6%HMWR;GQ'Y%?R:$+),-TK3VIN3X*[5&MQ>",9."2=:&0Y]Q1S
M]FM_`:S^8!:^!*Q5;T)IY*_@T?F`1X'C5:UQ7$I5Y3L"3TIUV@=OR:QX\*0C
ML*L'<HP3[8'_`'!94NFT)M.**\_2H^7=Z=*]=-9[D2M8S@[V%;FU,(+SPHGW
M@)2CF/B)*!0)R5L?C%JNX--5GJO^3^W8I[I+^<;_`!!6+I^JG\`_BUS)==9\
M`[@ONA;(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+ZGZWXTZ!M/
M<DF_5=Y%YZ/:=(]+DGW0(`.\^X'FL`]-HIR%DI/C7MKJ&F?`WN]BYEU-_/%6
M=LNK=@VW=^;;X]/Q@_R:F*45:74EU*4@$*J!\!_+H0N5U'JK*@:#Z>^@I&?Z
M:U>@?TA^0ZPF2^A@[D@D$$BH`[CIT_&-*,/^BF'$E/H_@'<O'A]^1)?7[B<`
M]8[O3Q7)X[2"E+C2VC>X=69#;@+:VR!V*54(!%%`$=!_3^"*YL712_"?O334
M72,@SQ?$'`^@I1_=">ZGEF=S/C'MMR;('LIXTNMCR*XXU"OK:KI<\&N&.VLW
M,(L%YFR';E]COM,%*(C[CR6G%J4E02K:F(Z_Z1M+6$W/VVJR='=0WEW-X45J
M"K=/=['E2;!DYB`JE''LB4PT@)]1Q[[)F[&FDJHV77%':E)-"H@:XEE#?=;\
M(V+J1K4YOB55UK;NG(7W?WL>R6TXYFJ$V6U9EA%QMM]Q698KQ:9=CCP;?<&)
MD*:EIV+2X0]Z%.42XTI*@3I"X^$=Z6M_B/<H\W#&;C;8K?V_D%FLRFD!I'[R
MY?;+>VVP-Q9W0%RW0A(!/4IJ=-4[1Y[=UVF1[E>,X^,Y%:,DGQI=^7+@V54A
MYVU09,>/)I*6MI#)#BFZI+94D@@@TU.]/?$Y4SJ/X@EI[R<9F8_S7RQ(=84P
MW?H>&7QM90L)=?MD%5LD)%0*N"/':^B@TEJW\]#_`!'V+?2?Y*;^$>U>CGV0
MW6+=O;YAQ1)27?LVTAVB5K#5&:)WJ0%"M!X5U?&?R;>X*B._G7?Q*B7[VW-3
M8,/S!<=]P7"ZYQ*M,)+"D*?&ZWK@NN>=1<]%[U2!M-:'J-4O5/\`W(/MQ5ST
M>W\-;ER0?W>F,L^TWV:\H>YN_6U7VAC7'>6Y6TU)0D+F/VJU3+A`0S\QZ31+
MER]%+FY0!;)I4T&I.:?DV]QVT]14)<CQVJQT/P5'G(^Y>(#D[D;+.8^0,LY5
MSN[S[WF>>9#*RN_W&5+>4ZNYSI+\I"&WEJ>6(<)F0([;%`A+;8IUUS`W@,[^
M!JNC,LB(V$<1ZUZL/^3<Y=DD%Y5E;EW)^SR<AG3(<>4JK,6W2);0$:.G>H)4
M'T*)`\M".O?5\Z6_E@J5US];SKV)\H,*5R7AZP4A#E@=4VGKN0#=9%0L4I6O
MX=7/3_@?_'[%SR3=W)X</94EFYFH_IKA\>P_]#4@DTKM"%E]5&\]J@$#OT-?
M[NM9/IE*'Z'_`!*ECWA\>N\B<Z36Y4XR8,SC@8T_;7&P'8ZKMG,"[?/0EH2K
MTW?0QQ492JA6QSIXZK5RSF.R<2KQH+PS3I7G<PJ/2/NT;QC7+6.<M\;W-C'K
M=D]DG6?E''!&EEG)FD0TG&KU;VVHYCQ+];G0&'G%%(<C]:E733;\O*V\>U3`
ML/&O/O#Q@7K#+]<9,1!*)V/7MV;-A3$I"4DIEEA4EE*J=$@42.@TWDBY+N6L
M,D$LN<=BE%@_OEM5G3"M?,5FF<=7IE;@=E7.'(-FF(0A=#%NC1=A+!*:CU%)
M[_'IK3BILLSVSF<1[0IV8GROA6:6R'<;-?+3.B24K=1,@2V)<<Q=Q2F4MV,M
MU.U5*[!YTCN!76*[PF'@TXQ0@M(>;=;=0X-[914[VS38X*THEQ)J*]::R#5-
M)6<MY9P6O64FAH0@>G70A<ZY"$BI"OAV'C^/2T(J_P`BR-_<B&:=S2R/%5?X
M-/-ZA+W:DS,=31M%%5\@["E:$?'Z-2<7TQW!,&[`LOF4>FE&U54GOTIX_3].
MMUE:S)6GHCH/I^/XCH0D)S!1SC:ZJ/U1(LI6/$_[?-UIU^.HIWQ'O*F;/XPE
M[@EM1(L*%)`'G;/6O^`13XZ:SS<D`\5,7<!G8T#=5+461G\Y()\3T_NITV\:
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M=#73KK5I+A4BF)2RN_\`:+P5@WMOXLQ#CS!+9%:8M,)`N]UVDO9-?%,LQKE>
M[@I(:5(,ER.`VE=4I0E*DBI).R%([F#W?W'VI<>-Y79^.+SR7(R?D#!\5-LB
M.O-0K*+U;KW!<O<^5!8G7-,-BX0V&CY112^BM)21<P[:8?=Y-R%6!S?[D;QG
MG-G'=VY)X]3Q7/\`<1QY>[IB&/.O2$LR[_@64W/$[XTP_-BPY21D,9,>6RMY
MI"PM"J!0-1HRWC`RU)(0BO';Q-QNZV^X09(<N6-/EI]I(40Z6E;@E?F'KL&N
MVH("Z'3N*1T+.6S96N/:F4_U/(%9_AF;VC-L<@W!J+'GP+TT8ERA2DA45Y,E
MDQKA99:5>4MS$+6A8/=E1'TZ<17$CI`,$@7N8,S/B"@%QYAS_MEYZA6!Q#KF
M!WN9/<PZZ-U#*L:O,I<ZRV:0`$ABX8R_)=A.(IYF4-F@!U+Q7T\7PY?-^U5#
M4[!L\O.>#F[%=U;+9]I6Z'(C*2]ZC"*N-CR$I&T@#KU210]>XU,PZ@]\(?(6
MYC7UJL7%@UTQ<0=V_L2C5C<=M.]*7=P'2JA3X'\P:T?J+VBONIM+I[6LJP.S
M=Z*%0T(DH:>4&6EUJZH=$#Z32ATE^:R?W4M;:3SA[X<FTY@Y3P'AC&YV3Y%<
M1-A0TQ6?E;:I+]S7)DNI;2XB$`5*83O%3V%*UU'2ZC(Z0N--O#]JL<'3!?"U
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MJOY=3*K:Z-"$-"U<T/&4[%]K]`_A_ET427(9VH;E)(4FA4DU2"*@J'4`CQ%=
M9!I&Z+]UVWRI5K0T4&Q>/3[]IEQGW#<=52D)79<G;)`'A.M[XIUZ>=TZNW0T
MKVW+[(&D+8G/'',"T#'AB<$UO9G00YF`$DTQ%?ML4>_NBG5(]]'%`3MH]9L]
M874?ZF]AUV4NGP55A-#^'4O^HDC[CIB2>0GF,!I3R*1Z$=R-0\0P#/7?L7HP
M]QJ$R&Y*7$A04B0C;U"5`[A0T-:4&O-=N2Z!CCM+!Z@NQR/,DCGG:XD^<JF#
MW"/_`"N-RSF&57B!@F,2;C=X]K5?+G'MT>5=/3;FJ9::E-A2W@T#196`*ZUN
M&2/:!%MJACRPU"@G:<2P^ZQF\GQUB#/MTY2E1YR$(?+@!!*5./)=4M:*BIKX
MZ;`.'QI3G/[%9']TCQ+8;W[BLSR!<2*Y<&ID)E*VDA*DLRK:TAY#:2%;3M34
M4[:M73T$>0OQKBJCU5(Z/*6[5.;[Q[AT7/(;@S;V$Q)=]L5PM]EG!A,IQNXQ
MTN)90J."TJ2'EH;10*3MW%7AIOK,+1<1R-K4$^Q-^G[BXN&/A]W(0`<,57-[
M7?O*^6?:?B%RXHYFXCS_``Z_VY+<>)"OEFDQ47!:=RXL^PREO+3=+7<HSB'F
M%MU"FW!34O;:H70B*4MH!3!:ZOT[+:?ZBV!SD[S4>;!,)SC<<R]T?-G&%EN\
M5VW-7EYK*I6-/)3\R$3FUK1)2XS-E%4*,M(;)DQXKQ=(\OAJN6TS]1O_`!MQ
M3G5W8#S8I[?7$EK;D14Q&]6,_>WVU'MX^Z*Y6QVVH^SIUTP")C38515%9)<[
M/:WDIV!JBE1WE[3X*H>O;4SK,+&6I<VM7MQ\VY0&@_C7KI'_`!9@OSP$[`VD
M]FU(0Z:'LEQ(=-._2BNGT:Y=;V<,DSW.S5QWKK,TKHXFY0-V[M7M8_Y.%QVX
M;'CMVEL@;K9%?94V0C=)D27I+F_HK<D,A-!TIUUT_I2",VV-<%S/K%YEN,KM
MG8O5CRD-O)F')\4V%])^`(N\D=/R:LT9Y!<UFPFN/<J?);QT:<:D>U.]A_5F
MY#XS'!^4G2G/?V)+D,[4KO11]/Y?\K6>>_L1R&=JQ6VGTI`Z_JV@XGK^<21U
M^CIK26=_+W+%S&V.T:]NTR4]7WJK+-6C>_<IEJU=6+?;<*M$/;04?F2LBND\
MN5!W*!?;V'IM%1UU`<][KMC32F96JILM,8V#9,VCJXX'AP5I6&8U\Q8K*[(:
M"O18;`KM[;!W!!).GMU<R0_!1(VMO'-\5?(G,EV*US&$1WXK9;2GLE*0:GOU
MVGQU#.E?.>9)\2?&)EN[+'6G;BH>^X_VQXWFN!WZ*S:X;C<VSW%EYO:7D.E3
M*E-NN(=64MF.Z$N!3>PI**]:4*4KBUA<WX@GUO>2YPQV7(=N"\D=GC>ZCVM^
M]KVQ6[&.?<KQCC;*\ZR+C;,N(<?2X]B$YS!\$MV:.274W!$AZ5<,@BWH%Q22
M@)]'IWTS\3+7<K7R+7PO.H<U./[%[9>*K[+OV(6RZRE++LF(A\)=:+2F_54I
M0;4V22DM@T_%IY$XOC#CM*J\T4<LI>=I3G:427AH^U#0CPT?:OBZ!*C\$D_D
M!TV$S^:YF%`:)G(`UY:-@*(7IC(0#U'4?'^34K"QH;GWI"1Y8VH17*E!;1].
MA'6M?C3\7@=+*/E8V7XDG'#ZA!5W30BG3M6G\>I.+Z;>Y1KFAKBT;`5\UNM4
M-"$WW,LEQGC2[A.WJ]9>X)_^'FOI&HEWQ'O/K3^T?/G%*>9.UQLLKQIE9I4K
M;KTZ?L$:8WD390T.)`'!6>W?*\>^*"B7]?H&F/A(^+O.G%%T_,.?WOP['^73
M*G:=JD:]R/PM)-`H$ZPL+Z2$BI-`.YT(5=GO(>:5?L;*5@@M&GXD4/\`#H61
MM'>H)R'FTR"2L#RGQ^(4/X]"EDG9;RCZC:5&CA518400#T-#W`(/QUE.8'M:
MTYC3%41_>$\/W_D3.8D]B_R;'C^$V[-(<E9==?BL#)DL/KO:X;*V8_IVF"B8
M&TN!>V66%`5).A+<V/B%`;%CSO[;D\/\Z<9X2S;>/9E_,>3<6K:NY1W+589"
MHPMDV,TH+B(ELO/2#)2BCKSOZQ7CH1S8^(7M$]IW.6`^XCBS&^2..YS<NVSF
MV(=UA$)3<+/?F6F43K;<HB'73&>#IJV/JJ:*=OCH6S7-<*M-0IF61.26R]FZ
MV*7BJ%_)R(,BWY/8%Y,VLRYL*6S,#4=^&TCY%^)N;*U$ME1H14DZNCY@R8[=
MQH5M4#$[%37]XQ=LCSK[R'[O_%\ON]IR&2W9[W<7G+5CXLC:+=+RU4<LM1?M
M&?\`M?EGJ+(2HEL]?`[QVSHAE8TT\ZTYL?$*1O(_MKRV!EF07K%(;;^*Q3/E
MI^5FV]%U=AR5*<C6T1)-%>K''U3V.[IK?DR_*4QGEBYGQ#8FKXTY*F<9W1N/
M<E^OC]RDEFYQ2ZD_+24NKC"6VVA1;CEAX!IPI`\]?`ZV8UT3P^048-I6L4D3
MI`"X4JIBYC8;!RCBIMM7#ZPC7;&[E%4%2+7>FSZC-P;D)\Y#*@E+B-U%H4:U
MVC3^,B;"+WNY)7=NQ_P8GL4A/;IRX^[%1AF;(1"RC'&OD7&"YZ:+@6U'TY,`
MGRRH\ADI6E52H@]>NMGNFC/+((HJW/`QDI:X4=@I*9OF%CP3%[EDEZF(9M,"
M*N<J2I:ZD,^9(9H%%;V^@2D]">ATC--*(R2,$06C)Y!$T5)]BI'Y6]X/+&:W
MFZ*QJ]3,6Q=U]YB#!MYCHD.M(('S3[KJ%K1(>202E)"4UTRY[^!5CL]+9'\8
MI@HHWW(<AR-Q;U]OEXNDA:MS[UQGOOJ>\3O;]4L@4`%`D#3*1T[GD@&BEQ(Z
M`<J-M6-V4HBE-VEPGFYT&>]$G,K8+5P;DO,O0TM/-NE_U&U!Q:&4M_4KM(\-
M$<LL3LTE<M%K)<N+:/8<OD5T'MRS!>8<1X7?,AB0;M=5Q)$.=<IC+[K\I^#+
M=9*W@TXE+:PC;44)/>NGK)Y),6`E(<YN]OH"(?=1>TXGQJSF./VR/#EV+*<6
MGS)$:*EMTP9M\7:GTAY*?F!%H^D[5*([$Z>6[;MIS9'4VJL:O91N#I0,7$GS
MKNP"\?;G(<VYA?J*GXWB,IP[BHA2HSG0J54GOJQV9ED>&D'#%<XG8]LC@1[M
M"I)0*JYGXD2FI5^\FZG7]F+9==Y_S-2*Z8]686=#M_L4WTE&\WC33"JL5%0`
M#WH*_AUS%=;:*-`.VB^Z%LAH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH
M0AH0OJ?K?C3H&T]R2;]5WD7G*]K)/]I?NA%33_A`\U=*G_RA9)KI^F_`SN7,
MNIOYU6IV]*E6RUT%:6Z-7_0G4RJTNOTU_HG0A;&D*"O,GI0]]"%T4'P'Y!H0
MALW>0`55Y1T'=70?QZ$H(I"*@&B\@?W]49+?.G&3Z5;D.6[)DH7W"_/;%FAI
M7ZI!U<NB/]TE_P#[9_\`U,49JS7,MVYA2L@`[Z'!1#^ZC?>8]\_#&Q"MKD?-
M6$J"J!3SF%WPH9Z'JI03TKTU,]>?^TINX^Q2?1WX5\(9,)2<!O*]('/JU+>>
M5N-`M]2ANJ$^=1(_%KS;:_RT?\#?4%V)P+7%IV@J@3[RFXR;=P5=GX9;4Z_E
MV.QPTL!0D-K,\NL[5>52%="I)Z$:L&BPQSRR-EI01U](6I>UGQ$"J8SVUQ"_
M[?<*DO!H+DF^O[6D)2@)7?+@&P$I2!Y6T`#X``>&HC68FQ//+6[6E_P8JW3[
MG."W_;!RJ^E92A&2/);='0)]*(UM2@BA2$TH!X:F]`<(XP)/=)XJG]6RQT:*
MBH5T7O3X@N?)F$OW3'H4=W(["U]J6HO!*4-OQD)4=X%-Z9"4D$&M?'6^IP2/
M<"UI(QHH+2+^6V>U]N,P)]ZFX;O:JS+M]Y<WP][?<JXIO6/Q6<FM\>79;$+W
M8Y%POV&R[I#VWFXXC.?;E0OEIDA:E0T+"/D75;A5`2D5*YMM5#R8(9#7ALP\
MJOMQK,4\`#LN:BB?]VSPIF'/'.DCG;.[+)MT!"XT''1<!(<>1'84IUY\E\*2
M?F*><]*DUU,Z7I]]"\.EB<T=M/O57U._LYHLL4C7.QV?V)X?^4L6*Z'[OO-U
M0O50S9)&"NW%"$K4AF)&R6(7I#[;8(]%E.TJ)!`%*ZE]<<!:`'Y2F73G\T1O
M+FK\\?#\7O6;Y38,9M229MUGJ:?EH9)C0K)'2T^^^\WM\H7'4=II4@BFN=6-
MM/)*X,8235=2O)(V0ASB`T`>C$K])+[D?V^*X]X<M5[=@N0TO6Z'&CEQE#8^
M780E+4ANGU`ZD=Z`D:Z3TY;SV=N6W+"QU-A7+^I+RUNYPZU>U[>(5MG*R4?V
MHXG0)4D8^NBJ#K_MI(J?PUU,[2257Y'`AH&YOM3L8BD>C=``*_..TZ#XJIK*
M3&Q*CTU_HG6$+GEGT84UQP^FD,_6/2E*_#KTUK)\!25X0ZU9&W%_,V>95>VN
M(+ISYR'.;6IPHS2/;M@*B!'LV-XJKU@%=*)?N;B>G6H.J\"!>L)V9@K3>M<R
MPMV/%'FE`K?\9<2BS6QM-$MH@L^8=`5!(!'AUT[O`'U+,25FS_#/OX!']0>H
M-1]&HUK7-%'"A3B9P<^K<0N.XQVI<"5&?1ZK*V'-S70A>U)4E&T]#O4D#Z=:
M3_2/VWI/WABW%RH?YNX4XSO?N)&691$C%_BW)X/)F/SY,EV.JV3;_AC>)S9^
MUI)]:*VS&?9<!ZU:`H0!J-5DCFEDL^6P$OIL"L(QCWC>V['X$&`QR%C*DQH[
M+`2_=0PY1*4A)6T\AM6ZG:HZZ?P2,R!E1F"81Q3M925I#\<#WIU6_=EP;(Z)
MS>W;3^<9<1`\"/,I0`T[$;W"K02$IRW\"C:'[F.'I-1$SBT@DCRNW&VU77L4
M;WATUDP2':TK&1W!'J.=..)*3Z>6VYSU$THF=;=AWU%*I>(VGXC3=MA><PR<
MMW+)P/V*C9HWF1V!VHF?Y0P9QVC5YM*QX)1=89^'@'M2K&.8RCQ0II<,<(_>
M&\(#.\8D$>C>+6T"*;%7",HJ/Z0VN$4\-93*E%L;RFR/K#;5TMZU*.SR/MGJ
M33H1T/4ZDXOIM[@HR4'F.[UV"YVXJ2@38Y4HT2E+FXD_YT'6SG-8*N-`L,BD
MD-&-)(1[:WHSJR`MM>P56#UVI/8FH['29FBH:.%5AS',/OBB1_,[;9XYNU$(
M(,BS$>5-*&_-TH-NHITL=3B-JL5D+<D"HV#U!.+@90C'&!Y4C>CM0?Z@WX#3
M>9P<10U5@<(PP<NB6'J(_2&D4DMU1J-Y4G`[4]SLXA'2%;5!7>E?X01I%;+8
MXZ%H4FA%?'\>A"K?]Y:_EKYC%1O_`%2ATZ=P#X_AT%9&T=Z@C,="WZ`$=#_'
MH4LBR2H)*2HT33JK\?PT(5.GOKO-YRSD&R<)XE1F;RODMBLTQQH%Z2F#`8#=
MSD!+-'&HZ@X7%]15((T(4I.=^/+3AO'G'&!6Z)&B6C$K4[:&K<XV769K*8D5
M+S-P#=/6$]:G0Z>Y2L>(T(4>/;7EZ_N^/>/B%N-RF0/;3[HV(B9+>\-6O$+^
MY\M";DQ5KWL(D8[<7$J!&U2H;QK^S)UD)Y;_``>5>K/'I"2XHM*0^5,H:0IA
M0]-W910>9)*JM.)3N3WZ'OI2+ZC>]*2?`>Y4K768CFG[[.3;0TJ99O;?Q7:K
M5+=J'F(E\;Q]S))S;2T#8RH3;ZTDUK1==22CU=&M"5N/.@$./;&I"'#N;4AE
MM#=-OZ1*2?QZ$PN?J^0*E'W#8GG&$<[Y/+N<A,"/DT^9<<7M;D*-%P#)L<E.
M-N(A0KAMK:<CAOU4IAQ1<>4-PH-8='SF\K;5:P?5;WHYXXYGO>%/>BW(NS]L
M:4AF=:I*2Z84@*47FX3E-I:"5#S=00!3MK1H\&5)*75FY&PG-Q`F0KPW`R"#
MZBX+CDE$*?;G%N*4X'2=OJA2JE-?S::4YO/_`!<,5&W%H99C)QIZD9<Q\J9A
M=N,+MC4A]N\13!#3UUCR6T-4]5"DCY=84Z=Q`'?24_TCY$K869BNFR'=7TA5
MQ./),Q$9Q<>*N4V94:._*:0\X"EM#GHM&A=`4D5([$C4<I]%KKB4N+2[^J4"
M0M)()3^$5Z].NA"3BI:OM%R"(CCL(V=J<;D%I2RIV6\[%^1#*DE?K-!.\JK0
M@TII"Y^EY4C/]/RJS[V79+=7.+[K:&[:JXHLN636F7?M"/%"6KA%C3DLH:>0
MI7ZOU.IK0G3JP^%,T]G.K]XNO#'*-O\`L1E6_!;](1'<G1Y#J9EKMTNX1/1"
M6Q5Q$UE*DTZUU)>+RG)P6U]:9[0.XMJD/[0$S\MFP9X752L1PY3@756RD%!4
M"H4!\SE/\Z=;,U0V[P^NTT5#_*O$SR-IB&D^D?>K'7;1#MW)_$Q6$?."_2C4
M?H?9\D#Z>I6?R:QK]R;NT)&RGJQ3O0;?PEY0X8J9]:]>U>M/AJ@4I@N@;<4-
M"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%]3];\:=`VGN23?JN
M\B\Z/M98/]I?NA.X?_;`\U^!_P#*#DFNGZ;\#.Y<RZF_G2K5[:V6[;;`37_:
M^*/R)5_+J95:7:.I`^)T(6[TD@E)<\]"=B4E2J#J32H[#0A:M\92_3;?]1RM
M-@000?AU5WT"N]"WH1M6#N&]LA2VZ>9!30D'OU%-&T=BDXOIM[EY'?O^(7RG
M(O$,XHW5<RN'O`IN*(EH<*@?@H'MWZ:N?0_^ZR__`-L__J8H3J'^6B__`+AO
MJ<H"?==SE,>^3@?:%4=GY2F@52A_<C(^O;KVU,=>?^TINX^Q/.GO_<<7\2]'
M/.<U?S,A!)IZLA)->E-Z@2=>;;7^6C_@;ZEV:?ZS_P"(^M4&?>@O(C<(6U(<
M"OGN0[`R`DTV[69B^O7J#75BT/ZLO_;]H3"ZV-_B]B;[VZ(2Q[=N-5TV(=LT
MF6NHIZ29%WN*QN^-/CXZB=:^(J1LMBN$^YJA"=GO+,V.D?*_O-.4Q*'F;?2T
MEN,XING8!Q)U)Z?M;W#U+G?5WQ^5>DN7#CRXZT2$!Q#[*60E0!2!0A>\'ZP4
MDZF[C%C56].F$,=>("B;R%[+^%.1KLU>[WCUM-Q86'&'?LN$Z&5T`4I.]&YP
MK(J=U:$]--5(>-"?#CSB[#^,[4Q:,8M[<*(T2I2&F6&PI0!V$;$`BBJ'4NHM
M,=[R/;W9O<;PUEF`WRT1[[$OUIN%MN-MDM!UNX09D9;)8*3V6TNCC:OS7$@Z
MC-4MS/!0;`"EK6^%G=,:33-[*+R?^UW[A2=Q7S'<WY#%ZNEG&3"3`EWIU"Y$
M7&XKK9@VE^OE6^PTIQM:TT2ML(%*@Z@='L2)BX[BKIJ&M!UKEJ,01Y\%[(.&
M^+K3Q7@MEQVT6Y,"/$@QXI"`E"5EE-`I*!U"5#X]M7&HK3>J*D1R<V5\F8D0
M0*8^X/\`^:R3K*$[^(,$,W0[AY9CI[?!1T+`V)6:PLHJO@K:9H^+1'Y=:2?"
M4WF^-G\8]857G`$JX93RGR7<)I;?9:YKSRW15,M[*P[2_`LX"E5(.U=O2/HV
MZKK_`.9;WJY:O]*S_B;ZE</;6$L6Z$A)%`PV-M*%/3QZZ>[TFN]+H0*4)TTF
M^-;#8NM("E!*A4*(13_-^4?D)TUG^DY*1?&%3E[C[2U$Y)S-+KB$KO>,8RAM
M&T@IAQKUDL28M1)\R0M:#X4W#48K'IZIZN5JBWRZOQ70IAM<AY32FPSZC2$.
MG:%++)4HH"10UZ4UO!]0I6?ZI^VY)C)+S$Q)MZ9<>3+]98T="GW)<Z[J+"6$
M=7G")!>:-$#IY2:]J'4Z9.7;9^%$0Q\R0,[$I/;W?KE[F[U=L=X`Y&NW+5\Q
M^&+E=X..LPKO,M=L2OT')KZ)$.,EEI,BB2D*)5WTU\;3>GO@NPJ6*O;9[R+6
MM)=QG.Q'42!ZN&Q5MBBZ,H<E)97'4W+&[:LD"H(II6WU@.?R*XC!1\NGDR.(
MXI%OVSEFT2WV)-U9@2XCICO1Y^,6Q+B'$FCK1:98;4%-D4KOI]&IE[<T',[0
MB+3XLWXWP41K#NW+3:D^E<+%,(\7K`PPL']%*43&`I/XCU\=-4O^76'8E[9Y
M_+[Y;4A&..+44DH2U)8<))!*:L7,+:4?[RA'AJ3C^FWN"CWZ789R<*52BS#D
M;/N-K)9+M/M]NGSKQD-OQ]B+&N.21GXS\U#[PE)=>N,AEY+8C$%!3UKWTC=?
M`.],;VSMK:+/!\1-/(K:.")M]N6+6BYWDN^M/A-E;;A)4WY0:%:C58%?'KIB
MJA>[2G#YG\G&UU\=KMD'X:7YL?PZC3M/>4\LOB'D]B6V$R!^[L<;3T<1XCQC
MMZR%9V_"$L$JW)"NU:_P&FA975ZX_1/Y1H0E%J'3]:'WTL;=WYU:?BI](^.A
M(32.86AN]5R>\UP/7_&Z]6_2)'AV2!W!T;E(6\;7MS.VJ!+[JW+D/3Z1]CE4
MD`DFGD.[OWT)\N:X[?1=6[4QV&D//`$@EOU5!P!0((JE/<=M"%47[?VXO,OO
M9Y5Y1G)*H?%=OD6"P0'EJ4A-PE%ZVO75E%=N]QIRHK6AZBAT++15P!V54X>7
MG$7135OD#YAY10X%.>90*U-)64D]1T0*?#64]Y,?#TJ(7N&PH<N>T:^PK<RB
M9D_$]RDY=CREBLJ&]C<]<F;&0\/.MFYVE]]M2%':4H[=!H6[6A@HW8KLON[>
M<T<R^V?A_D";.4[*A6=C'<J4Z$EZ,]B:V[;*N4A8'ZQ4R`EM9KW-3W)TI%]1
MO>L2?3/<H;?=,[^5>;_?3[FI;6Y>9\I7K'K$^_YWS9)]^OP:.X_6(LUHC)2K
MZR4K'PU)*/5TCSRT.KVD#<K>>@^LH"I^CMH2;HF/.9PQ2$S[!,6Y,Q>9B.9V
MQB[6:5)$YM+KB8\BW7)("6KG;)Q*7($UFGE4A0W?5\=;,<6.#V[0D)HQ%$Z2
M+"0##>JT^1_:!R_A,EVY\6W=GDBV(<*85BEOM6W,4-J\R8KD5[^;W%DH!2AT
M`K\M2>NM9@)_J8^A1WB[WB/,/N4*Y',&*1[E.L=\DOXU?[7*D6^\-(M[TQ^'
M=(KA:F0GIT3]4XN*^DH('U:4[C6D<;8VY&?"I.WF+X0Z8CF8U3BXWG+N0VMY
MZUWW[1MQ1]GR"BX/O!4L?MCZ"U%'5'8?FGJ.NM+CZ13ADH#@6GWEW/VJ`^[#
MFOQTO2XS*F8\ETJ6ZPVHI4I+*R:HW*`)IWIJ/JE^?)Q7&[$92XI7ZQ:@0K<X
MZMQ2B**\Q4?,/[FA.HR7,!.U%ZU>KT4$@5)H@;`:]:$)IY0>P[#2%S]+RK2?
MZ?E4ZO9C=4)CYQ8@!ZK4JU7EBO7;Z[,B&^3^GN3#30'H".G?3JP^'RIGN4Y;
MHRU=;;<H+C+:V;E;9<1:"A-5HEQ7&5))'7J'-/#;Q.=F(-2>)3V:9YMFQFF7
M+11K]@61K2JY6=;@^;M3$*RNK`"36S3IMO6GH*FBVN_?IIK=6D!#10_'Q/`J
ML2/DMGOEMZ"0M(-17"O`JSB6EU/+O$WJ+4LKO<E55*)Z*@/T[_2-8U8F*SHS
M93O3+23//>5DQQW!3<U46FH!.VBO`%!1#64(:$(:$(:$(:$(:$(:$(:$(:$(
M:$(:$(:$(:$(:$(:$+ZGZWXTZ!M/<DF_5=Y%YW_:>D.\D>Z(K%2/<#S6?$?_
M`*0LE'AKI=DXMA:X;:+FO4+0[4<IV']JM*MZB;?;P>R8$:GXPK3WGR\5#^'B
MX+N`J0!W)`'X32G\.G',=R0_]Y9FMXF1->T>\>WM3076XWG,KAD,#'G[@R,9
MD-Q;J+4V%3ENNK*$%I09>6AL*'F`';4!>:G>0M)C<!0C<%8M)T;3[N'/.UQ=
MV.(]28;,\6R2UPY-QM]ZS2S75JJH\Z=(DNQEOBI3'=BNLLL)861U7M)3\1J-
M_/-2^=O^$?<I?^F](_RW?XW?>D5AON?SS"$&#RABQEQXZ/EDWJS+$H3$(!3\
M^M=.J5(\Q/T:E[35)I`WFN&8C'`*)N](;"XB!I$8V8DX*@K[[[E#%.4KEQ+=
M,=D2A\M<;R7(4AA*-ID6^,'GO6H'#^Q0`GMKH_1=R6ZF[*?>="X'NJU4[7+5
MXMQS?A;(".^A5;/L6Y3PKA7W6\)\E<CW5-BPBPWV[IOEX,61+1`C7'&KK:4O
M2D15N/MQT2+@@[DM$]"*ZM/5L$MUI;K/;;O&(_;M"2Z9N(AJ(N9OJM.']BO<
MYI]Y/M:N8D2;;[@>+;I%?#SR)#>41H\CT'2I:'3;U1Q*:=4VH$LJ3ZB3T(J-
M<#GTF:W'+B!#6X#?@,`NL1ZC'-*2\@U*H>^\/]RG$')F`X]B7'^<0LMND3.8
M%TEL66#<9*$18\22AMT3%QF8NPR5I3T)K7M31H[+Z&XDS_"64V=H3J\,+HF&
M+XLV./8HF-^\G(\5XPQ?B_"<4;MDRR8VU:KI?;XXU+<D2T7-U3S=MC("HK#C
M;<H=7A3KI+4;=TKCG3RR.Q>L?[C*UH5QW,NSJ%&;+=D2)3JE54MR>KYJ3NVT
M153YZ4Z`=!TT[LA1P'`!476(H[LN,XK1Q[-Z]#162E*3V';4Y<?"T*LLM81[
MH!RCM*QK]`TT6_AHN!\Y7S2_B)>/H6?#Q</2@.AJ":[2GOX*[@C6KII'M+''
MW2D9+"VDD;*\'.W9B=ZXDVV`DE0BL^HI6Y3NT>L36M2Y]<Z3MP('5BPJ>]+R
MQ,D91U:`<5WK6I>S<I1#:=J4U(2!]([$ZEJ*.4>.2_\`?*Q+_P"0'/\`YJ2=
M-IY7L<`W91.H(F/:2X8U3R8N`B/<-O3?,<"O&M3U_!I#Q$O'T)1T$8:2!L"4
M.CQ$O'T!,43W]]$>U2G'/J;0"/CUZZS/-(+,R@^_FIZD]L+6&ZN&MF!+0>)'
MJ59WLS2[ZUYN#NU:KQRORW<UK*02INY<DY%\M0>&U$1L=/!/TZ864;+B-\TN
M,C14;E/:MC+!&?@8X4\BMU:6I+3!'BPW^#M\.VEDDNE"BH5/?32;XUL-BZFW
M5%76G1*UCI^<A"EH/XE)&DLC9#D=\)*SF+?>&T*HSWB1Q!Y,3+<KN>P&Y1VB
M%43Z2,CL;YW)!VJ6')[E#W`5IM<P11GW`I>QGE%""/,J<"^47"-(:Z%[U5*[
M*!*U+WTK4"I_)I/3XV22D.Q4B\ESZG:JM_?O?Y",=D0TOK3&;0P`VE9&X&0V
M-JU`A3@->H/?6VJS/B;R6&D9I]JIS95\2*;:%3#_`.3J<@6SC'-^5<AN=VB6
M%K(YF(X!)NDF/&<@63'[K>+G)N-]D1'78S#R;<[`8:4I1)_G(^&F<$$L["6"
MIIABIP3QL^HO0C[G^1.(_<3C''%KY"]W$+C.UXKSOAF9QV;!=&L<5-MG'^5R
M+HM>=H@WE3$S%<AM"`Y&0GSH5]8%/31'ITT-RZ3*<PQV[338/VI&8V[VYX_B
M*J!Y<R*U.Y=F5_@\B9@+;=<COUZMLF)D-P;M4FU2;E(3"G6]Q+E'H\Z(A+R/
M`!5!JX025B$,OP[?+WJ$DY[W%O\`Z:A-DGN[PW!IZ()YDS"3<W7'Q$M<6[OR
MILQ]""EN*TA[?]9Q/?3&ZF;%\)HD^1+N)1#9?O,CB%ON-UY#SW+\$C!42#BC
M4.*G+LIRK))1]&#C5KQ=JWB9)NKKI2IVK@2E9VA0&F$6L3Y\A<,HPV!:>#<3
M4UKWJ8_!W,?+7+@QN-RUF>3SYZ.6<5N%LX[Y"XW8XVSK$[#/LF12H<NXPX[L
MN!DT*8XA+:)T5P):4UZ;B-ZR=2PN#.P5(*B]5C=;P-<*XOICW%>K_CB(VSC5
MF9V)`1%:"=H":(])!'4=S6NA5B2-LGQXKDYK_P![:\_1(LP_%]O-:0Y,?!/H
MXF1T+-M`E7AI*<<C$=RZD'\4=K1R8Z[$\%Q*!M]"4XGAH!"NX_!X]?[NL\J/
M@CQ,O$>9#[31_DIHY4?!'B9>(\R4Z[@ILT74?P_3X5U`\B;AZ0I[F,XKD?F)
M?VU5]4*\#XT^CZ-;-M9W"H;@.T?>FES+'F;C]L%6S[V;AZ.082T5;?F+DIEC
MH:.*#"5%)-*)IU[T&D7,=&/?P4M9S1Y`*XJ%#I_G'?P5I+FLXJ0H4B.2KNJQ
M81D=[2HAVUV2]R8XJ?UCJ;7(*D]/T6DE77IT^.MFN#OA6S8WN%0,%6-]W&R+
M?CCF<O';*S.\Y^7@H[U+:9D19+:E$%1-`KH#U&LK=L4@<#3"JD[DM\%PO]\1
MOJE+#ZTJZ]"E38H">WUO#64]2&XFOD9>07_!Y;[;-MSNUW:U27G:I;2ZMHQT
M(W$;0MQJ8X1\:4T(2O\`ND\YE8SP/[J>-W?U2^-KIF\J,RHU<]%K'KPT5)(J
MD_KXX&T&M1VTI%]1O>M)/IGN4G_N-6(Y]EKUT#@-RR;D:_W*6S^>D-QHBD%:
M^W54U70FOT:DE'JVY;B0M:5*\R5$'H30@_&G70A:G%MJ0I-:U'8@_P!T4T+!
M`<*'8A%;<6\T6W0E2940J13]:\%/>FE#:_K`A3@['QT56G*9P7EVFX5%Y<]S
MGN!Q^TSI]OA7CW27%<>39[DY;7UM1K?D*)9#R&UT0EYQ.Y-!4GM4:%$7@E9,
M<@_#P]2M1_XMW*[)CGVOB&>SH,Q41YTMR6FRRA_TCZ97MH%J*NQ'CI*9I=&0
MT8IO;7C([AO-=08\>"CQ+MTJT._9<\E5QMR1`N+QI_.9L4EM^2`"0`ZKKJ-D
M_"^/!69D;Y(^:P5CXHJ<0HK4H#I\:CP`^G0TAPJ-B>18QA<$@`-F@'<:2G:Y
M\>5NVJUG^GY5(SVH74P^2I]KK1%ZQQ\J)K]>TS&)[(Z$=5>;3FT(B%'X)GN5
MC")KCS@%"/6<I2O^$7V[].BM20(<`1L2TCVNB:T'$!1K]A,P.>X3F>(0/0;Y
M`OB>PHA0N#GE":=!U)Z=-)3L<\-R[G5]"B'M;&XOGP810;\?)56Z7BVL,\I<
M1OM*JO[8FFE#W^4E?&@U':K(U\!8/B6^D1Q1S&1WPG>I>"M!7O05_#XZJP%`
M`K`2":C8ONLK"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"^IZ&O
MTC^#0W:>Y)T+7EY^$KSP^TD%7)'NB`ZG_A`<V=/P<A9,?'Z-=)L_Y=O<N;:Y
M^)?\QF+!O\ZM,MK+I@0*)_Z0B_G)^"_ITY48N_T'?%!ITK12`:4ZT.[H::=_
M_3#[<5FX^@W[;U45[BN=;3[>>4\AD9#_`&D0867.IA6FZX/9,GNHL,F.PN6I
M_*&<:A3;A;H)805B6\A$4@$ERFJCJ;VQQ%SL!4>M7/IR-\L.2,5=3U*/GM<^
M]6X$Y/?OF)X/[J[5E&2VVX)-WM.92;B(%RA3IKL&.W$B99&@1[KZDEM37ZAU
M5%#K\=0\9$OP8JPOBDC^,45@5[NW%^:1=N0XK]COJ1L3DF`/LQC&;=!W%>(R
MU3[,Z17=1"@V>W8Z<1.FC?P`3OEVDD#<Q',IBJ1?O:?:1?+WPG:>7>([ZSR/
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MGL(6OU*A(;;44K!%.M1J6DO;:8`1NK3L/W*HS126I_'!;4X;]G=5.$W<K<[3
MTY\-=0""F2R0014$'?\`#27.CXI'G1]OF*[&U(="U-N-D(I6JTI*JFGZL*(+
ME/[VM-+L8Z0T8*E;->UWPE?=;21214Y@I5;THAK1N#@>U:N%6D#@AJ0Y\7'U
MIAR)>'I"C]R,TX[R9BB6T[BG'G%$52*)^U)/7S$#36X>U[@6FHHG4#',:0X4
M-4\&,_T:<?\`JU?\>D$HX$M(&VB4.A,>1+P](2;RUS;8Y+OC#7'?1\"XMW8E
M)KTI6G?H-;3@^`<1MS?<I+2VF.Z`?@JX/8PXJ?CE@N*1N;NL_([G'7T'JL/Y
MGDY]6AH4U63T-#X]M(Z8"+>0GY5(ZHYOB(SN#@K:/402VO=Y/00BM#]8`5%*
M5UND.8SB@7D>"_X_Y--I(WN=4#!;"6/BOK<Q7J)]0T1UJ:#M0T["O?68HWMD
M!(P6#(QWN@XJI+W^)6W=,>NK52J'`S1L$$IW>M"M3A2>HK1#!('T=.NF5YM*
MF++<J?Y5?F7>E%)3ZRA7ZJ?JK(/;HY4?Y6D=+^L5*NV^15'?>"SEBW24E(!W
M-M$=/K-OMJ<'P\J16NFNNUK[NVH]:=V#FMN@7GW<I]6"D+]R]$W6CDR6VG=\
MW=[)'8KT#CS%QD3'D>8@#:PV5=:`TIWU9NEH(Y`.8F>LS2U(AQ"G%[NWC-Q%
M]*V6WD28[$,)<"-KBW(#"?25N2K:"A=*TH`=634+2V8]Q817N2>GS3<E@GPP
M[U5Q@_+N'<S8WE>(\A^ZS#^$\\1G-QPCC["KAQ%RKG"Y&-6ZW)AV:]MS,&6Y
M"]1JY-J`C^D)!""=FWKJI7,A@Q)HVJL`GL.6,SJ/[C]RHM]Q/(\7C'W$WR'B
M><1^9['AN0F)#SVW8_D^+P<K:CMLB[W:'8,NCQ<@M3?S*UCT)#+3@4/J^.JO
M?7H+MOH2C&P2?`:JQ#CWCO/.:6<`YNXE3C;N3\&9IQYR_:,2S/YMBPY"[*D2
M&VK=-D-I^9C&XLQBE2@-S9\U*@:K&IZ[9]/Q>.U>3E6KL0ZCG5!QV-#CL[%,
M:-H%]K]P;32(^;.#0BK6XCM<6A>@W@.?FG*O(/$7*>>6>TXC<(&8RN.+5A-H
MO0R=<4Q&9F1Y/=KM?TVZT1Y+CERGQH\5EF,$(9:4XM:G'54N'3&KV>N6GYAI
M\G-LR*!U"W'A1P!]"JG7.E76CO;IE\SEW[7U+:@X4.-02/2O6'B,<QL:LS=*
M?S%E7AXCZ"?AJSU7/>4_@DGS4ZW_`&:WCS?ZO9AV/A?FOHUA.QL'<CS#R_\`
M8#)93O!<17S)3T$=NGUB-"RE`IZ0DT6W17CYD'\'6NA"+OF'OT3WKW1_+H0E
MR\]ZIKMV]?C7P`^`U'J97QMO>%&M*#X5_NC3F#X')E=?&SR^Q5I>_>D5>%O@
M_K&;\F0EV@!0@L-H6BGPH":UU#7>_O4K9;?*H</.I6XA]G]8R]7T%UIZ@/44
MH%>&H=6%,MS#(=N^.W?&(G]+N-END$-CS'YN;`G10WLZ5+:5I5X5K3Z=.K?X
M3WIS!\)[U6;[%\F:M?'46QRZ,7+#,VSG'KM#4O\`7MN3(414606RD+2VY)0I
MKX=*U\-+I=/3>LA2W>KN\HAH*#S7UZ@[B#2I`/7;H0F=<OZ(LI^Y./&(S:W6
MKLT\VY127;>XJ2I>^@(0=J4D=NOXM"$:?=U99,M;?-643Y.ZSY]E5WLUU77T
M@MW)W;A%,I:.NYF.J;6AH%`=Q72D?U&]ZTD^`]RG']RWG#>*X/S!P%<WF6,F
MXMY)N+KT1V4&W9=J<?DP7)$..4E131AA8"5*!"^_2IDE'J[]4UB03(C$NLO?
MK$+5Y20KXIZT/30A?/7_`+S_`)K_`"M"$S7N"YIL'`/#^9\NY!)^61B,`NV>
M/ZJ4.7?))R'85ALD0$*6[/GW)UOTTA"O(A:C]7J(5(7W;W'V19;R;:+G>&BF
M]7.Y7?/\D7,"@XY=\KE*N47U:U"%+B/E0J20'*4Z:%&7VU>M-$!2<=7"D-MJ
M2TTFJ/3H7:>%>NWM].A5EWUQWKSW\Y6W[*Y4RZ*AGT63<G'VDTH*/*4I0'^9
M.H>_^]=&L_\`;QW)HSV/X#K6'Z0[EF'Z01:M"5I*5NH9'0[W*A-:]!TKU.E"
ML3_3\J<;A.Y)L?)EAG./M)8]*XQY+K;M2W'D1PD++>WU%C>FG04/QUA,E.B9
MS39;<@33;7O2CT?=4_*1&;#;)"EK0XZTD!.U-05[1\::DXOIM[D)&_=Z(<N'
M//+ET*4L1[OF,^\00'FI"G8<]T2670IA2FB@^H14*-::4W*.U/Z#?XQZBKD+
MU_OF<2?_`"Q-_P#>DG5?U#?W+>P^`*6&H$[5/-^$=R&L+9#0A#0A#0A#0A#0
MA#0A#0A#0A#0A#0A#0A#0A#0A#0A?=#?B*UE^FO/5[1V=O)/NB7NK_\`]`<V
M=*4[\@9+XU^G72K3^7;W+FFH_5=WJU*U_P!`@_\`N")_$O3A1B,%UV+IWVFG
MX=O33O\`^F'VXK-Q]!OVWJFOWG\-\<\I\Y8H>2WLZ9./.0[MAZ,%RV]8>^Y>
M)#"8;KLV5:ID<7E,8$J5'E>K%<;*DEJAU4=3CYL99V@^8JZ]-2<J,/[%Y6^9
M[7[>?<;[RLCXLX)L%I^S+'D%IQC-[IBF-IQW&&,JQZ^S%SX$*\P(T%5PN`4R
M?7=&\)>4JA\-)V5ELPQ4G?7VX*^ZU?=_^Z+A/%[+D'!_+^30;9]F0Y:\5OT_
M]YK`6O01)V/0KFY(DLE*?*?16CIV%=21LB#L5;DUG(\LW`\5U8A[B>:N.\RL
M>'^XOC!JQ_;$Y-GA9_:FE3<8N:[DE44,Y':GXC+3=FNT9;C+S;I=;.\`@U&F
MMR+BRR3P#WQ(*]V*6M]6MYWF&XID(]*B![J/N8,WR"[O\D>T&_<7RL2R65*N
M=PX4S#.X>$W_``*?*D/OS;5B%VOK8LM\QU3RPN$R\]'?CMN>D2I*$J/6M+_4
MF.*P%G?$T``KM]`J?.JYK'2LKZW=D,"JTL@^Z8]^4%^1]J\38E:(J0ZHSKCS
MEPVB."DDJ-(^8272T.]4H4JG9)TQN^K=/<"YI]PU/#T%.]/T1V1F<>_E%>_>
MD`Q]VKR#"VR.2.7>+,4#+Q;DVW"57+D_(V"G<7&HSD*);,<CR=E07%3"D=NN
MJQ/U-;2DB`BN]6^TTX6=7TVBGM3N8;@/#?MD7;KUB5LDSLCN%V9M5QSW-)S#
MV0O6F4I(NK%F])`MV-)>'E5Z:G7T-**/4%0=5R]F-W4[4]5T/$L_V_9?;XB8
MLF[6604M%<ZT3(.5VD5:"OYVTR84_P!$=@$EQ8-*DT)TR`HM/%>(]P&M%(FW
M\9XB]N<Q#.K!<Y:P"F`B7-LUY4E-=OHM34HC(<K7IZA-='B.1CQ6K])MY:.G
M;AN1[%B9!9$HBO7S*X:@I268EPN2V93IW$J+:5*)4U4U0>RDT(J-8_,.STI/
M\CT_Y0G1P?G[)^*,]P+"\YOJ+E:N0TW(X]%N2WH]\MYAN*;:==3(;]5V%+:!
M4E9"*D;:=:ZGK.]J14XJJ7VD>%&8#`>16P6Y*)EOBRD.U]5)/U:]*)VJKN'U
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M.MEM+@7V^L!TIU[?'4LJZL]"RL5G:FM*]4C_`$2@G^"N@;5LSXPJK_O$FFXM
MKQ0>K1R7F+D`G;U5'F8O?'GD?6Z@JB(U$WFTJQ6>[N5.4A?J2'G-NWU+8%[0
M:TJL5ZT%>O72.E_5/VX*5=\7D5+_`-X/+5Z:V`NI=N+R"J@%`5IJ:=:TI\=-
MM;^+RCUI:W^J.XJ:/W.T=4;C#)I3&WUI6619)<4H(+88MET=+0[[PYXGI3X:
MM/2V('D3;45+7W924)Q)AI3;:U&1&):6I2FG"EFW1/37L*%%MT+JJA!IT'QU
M9-0^-W>M8?I-[DPV<^SOVXV3Y7)K9Q79K+E4%3&0JOMJG7Z#<?M5;32S+@O-
M74*A.[WE]:K%%GIJHW<7-]SMJMS[50+[HO;MQE:,SG?8V')9F/BY.R)C]SNT
MY^5)D+2^[,?5,F/.*><6YUHH`TK357O;+;@IFR.S@K#O;9(=XW]N7*\ZS?NX
MQEEEQ3`Y.*8SD=];QMS-DX[<'6I%JQY]Y+SLVY,.7%"G&$^9,<;]W6FJIU-T
M]_4.BNB(KRA3978*>Q6OIG7ATUK3)*TYCJ^<JY/V:8KS#:97`T+F?$^/\5R6
M\YGFF91H6"<FVCDQ#EMNT'&GHKEY>LTU]-BN#:)&PQGT)>%.M.VI/].;0:;I
M!TX?N$GTJ$_4^Z_,M3;J-:YZ#T57JWL"=EDM2*D[830[4[5["IZ:Z(N7)NN:
M!NXVNZ>U95H%?_P^@Z$)780?]H&D?HN(Z_']0WX:$)2N1_465;Z5`Z;:]OIW
M#0A%7RW]_P#G;?J_P_6T(2N;`*P"*CK_`!'4>IE=B4A.Z@I4:<P?`Y,KKXV>
M7V*MWWTVU5Z<L-K;2#)55^,OK1M>T)->H3YATZZAKO>I:RVCO5=T._?8=F81
MD=+<Y8GY8<3W)8920WZ84"IU/J4%>O0]]0RMG+9P356&YR,ER]^X/MA/R$A<
MH.=%-KE2VPL)%/U:A$82EL=P:]:G3JWV'O6S6M;\*JYYLQ^[^T/W!3^1(%M>
ME<-<J353I[L1+DA=DO#[ZG)MO:9<*TF;%#RG(Q4:.-5"B333A;(S_M*Q#.$O
MW;'\JQZ1!D$_J9EQ;M5QC#J?5F17]Q$A`_-!V]>VA"CYRQR;;I]N1Q_QT_)R
M#*+\ZFVRY]O=:D,6Z,^Z$W(!Q3(;*GFD@$D&@IM(ZZ$*7_MSP7^SVQLXW<'9
M#ELRB(E-W**!Z*^EH-L2D`4`E1%$$$4W$5-=9!(-1M6"`10[$T><SN;/9?SQ
M;?<9A\14['+@4+R:\0V52[9=6X=(RF<A9(<1'7);HGU$I3YNO?KI3G2\5IRH
M^"NUX`^]5]KO*%NLZ<IS&%QA=IC"7+E:LHWNQ(DQ6TO+@7.*D-FUO*)+*%`N
M(%0HGIIW"XN95VVJ:S-:U]&[*)\>1?O'/9-Q]:G)W]LUFSV4ME]<+&>,R]DN
M3S)#25>G&;>99%NAEY8IO=%&Q4FI%-++6/*7C-\*I5YGYUYA]^&?V!JZXK)Q
M?C*RS3<>/.)X$E<F8_**D,LY5FDYM"%7&<AII*A0I::)/IH2221-[J>./Z>"
M]$GL#]KZN(\8^WLB8#=^R"3$N$AQ]E+KS;SS06`RI85LAI20&D"@0B@H-.HX
MV&,.(J55;N\F?,0'')APX*S-?ZY#Z7#5(9>/8#ZJ"1V`^&B1C6LJ!BD+8M?<
M`RXC'U*FOW?\'Y@G+[CE^)V%V^LRVFBBW-2!&;]=SK5R0M+A05'K\!I@^"*3
MXVU\ZLC-1DCCY3'4C&Y0CA<.>Y:[N!N%QK8;2HE(5]LWVX26P%$4VNPH26W?
M*?S3]%1K`@B:*!N'E^]#=1D:*!V`[DY%E]H/N@NSR7#*PJRI4E0+,3'9EU],
M&E5H?N4P44GP)K^#6>1$?W5K+J$SV90[T!.Y8?N^.:9KH7>>6,A9]9(0XFSP
M++:$M(^LIMIVV142FQNJ02YOUGD0_+ZTV\7<_,?1]R=&R_=?V:2\7\RR3*<G
M6E271]NWFZ7!DK"MRBMM^:M!;-.H`I3PTH``*#8FC-0O#,6YSEJ=P^Y2MX=X
MCLG#_+-\L%@APHL2!9L7$=41E#12IR,[OW`54O=_?5T)Y<RO?;C.:^]["I<7
MK_?.XG'PO4L#\<%\G^$ZK^H>Q/;#X0%+#4"=JGV_".Y#6%LAH0AH0AH0AH0A
MH0AH0AH0AH0AH0AH0AH0AH0AH0AH0OB22NGATZ?DTW#W"X+0?=P2A:TQXKSY
M^TK_`'Q?=#_]?_FS_P"R#DNNCZ=(]T8#CA1<YU:-C2XM&-?:K2[7_0(/_N")
M_$O4FH%&)ZI([5!%?A44K^+6V=V7+7W4.]YH:[%H40?=![8;)[A\779W94F-
M+8AN,M7"$X_%N#+A!`5'D,.,N-J)/UDD*3X$:;/MX7_$VOG3ZTO;J#\.)Y:S
MAA]RKJ]J?W0&!\#9@UDK+;#98D.RS'>CFDEQ4A^0Y*>\]),UUY]2EON;GEJ/
M51Z:V9&R,48*)R^ZN)/C<3YE=Y`ML6#:V(K3*`U'C-H`4-X'HMA"#Y]U*!(Z
M:?.:T0!X^.BB)(VR2.H/>)4._<EC^+YS<X..3+-`EKA)B7N876@5*%M>0XRV
MM2%)6D"2I#@34`E'8C5>NYY2,I/NU[%)Z-I;);K-=-S1!I(%2*.J*'"FZJC/
MR+<8?'F%Y3G=Q0E5OQK'K[?GF5+*4%`B*;&]-0E7ZZA2%`TI0=.FH=UO$\YG
M#'O/WJ_,D>R+DM-(AN7F3P7WQY3?;OEEFEV++,Z?A93-EL.VNU..%J#<4+F0
MHK3S10E)B>J$U;VT(\.VMS8M>VA'N]Y3</B8["@<G(5G//?(*D0,$X-RF$J>
MX=TRZS'&XR0X-@==@#NYO4*E94*:UCTR*)Q=&VA(H<2E77>897&H3_\`"WW3
M_.'/V0PKWSI)3$LT=Q;B;4VY)%N88J%(I';4TV7U!7G-*]!IRV![/A)"A;J_
M?$?<=3S*P6__`'+=DL5G9E\;97D^+71I"3&78KC,AK#Z4I0E2$B24`$$]QV.
MIMMG;EH):*T[4Q9>&,YF.H2HQ9Y[4?>OP-#,]V^HY'QBSS&'';1>(_J761$*
MMP>:NT5IE<:1&0@GSJ5OZ#I33>YLK;*#D&_>?O3INIW<\K(W2$L!V4'W)F;A
M]]AQCC%NN_&EPSWD/#\IB*_=O[.R#C1FY_.7>(`AT6*[OVR6^J/#4G8E:'=I
M"?Q:KES&R-^5@H%:Y8HVVX>T>_3B4E/:MD>?>\CW'8AR%`EY7?\`&K;(C7-K
M+L@D/NH=A4<0W#ML<A*(C(=(W(2A(`U*68&!53U"\,C2)#4+V2XU#<A6*W-.
M&JDLI;->]6D(23^,ZL(^$*I/;$'$Q"A)Q1YK*U&U=6QOY<KH-^X"M>M*GPK3
MMK"=\MG!1RY&0%\HXHE2:I&,NJ`_OOM:50]/'0CE,X)V<49]2+-)2=YE*.[J
M**W=_ATT8K26-HC<6CWLI]25[<5T*)<<&T#KNVIZU``'0542>WCH3.UCFD-7
MFH\BJP^^-QN]Y9['^;[3B>4VG#L@M>$W;+HEPNL1=P84K"F3D:[8];0\T],<
MNR("FF_34E32B20H$#49>\I[LDN+2%8].F%G<B-S=N*HM]B_LRO']K7&ONYX
ML8QS$.1[W;,=<Y&E6S>_:,SQK*<<MDK)K)<+8RZ8=IRF&\\783Z$I[_K=QTC
M:,MX90V(9:E.=;OA(.73:O79A'S2K*T9J?3D,I9CJ;J2`4M!2E)4?K`JU-*K
M)8>-/'X>.A96QIH/NMM&E%+36IH*)4%&I\.@T5IBMH_C"\\?WU7.>?<8V[CM
M[#,6FY.B"YE>6SXL*QNSY%RO.,V*:;1CC=U<DQK581D$.5*"W9!-6HZBW10)
M,5>[2KCHT,4M,XJJQ>!>8[GS3Q;C'(][XWOG&<[*;*W+AXY>9R+@9=F5.9CL
M7>WS$M,_JYS`+R$+'D0[05`"M(:7]4I]=L;'<.:P4:`/4JKO?_+2JYMMA)*!
M-FO%/4@I:;4O=TJ:=-(ZRTODRM19EHG&?90JS?[FOBS$,JX,E9#F/-EHX@BS
M<WFVNS-72]XG:'<BEQL??GL0;>,G>:+SKRU*8*T52D.4)"MNG&ESW\%.2XM'
M8![0I&2*QE/XC`?*?O5G.=^TCB/EJS8Q%LGNQPVZ7>)9+SDMXQ9B7A5WNT]R
MQPX]S3:8L>!D3$EYEYV)Z'S"$A6XG:E1%#877EW**S/)=OP'W*)F;&R5S8A2
M,'`)C,_LZ9UM0M]G<I^(AJA*QM2&T[$':4_4"`/CTTA4US;TFJN.5_:Y&SV\
MO7!;SL.>D.(B/D*7#?=6KHQ(`)6"I(34B@I].DGPQ2_&*I9D\L?P&B<'C3V8
M\L9IQ?D.*7C'[`K,K)<X$SB?(6<I<MEDQZW7*YDYO)NEK<MZY=XN5VL5O;:3
MZSS;,7:/1"ZFL>VV,0?%"*1/)J-M:]_L3E\D<[V33G-,P"AV4IW4"O):C\?N
M^XS@"W<>8'C_`!XFTX7/_>B!8;#8["N[7@R+'#3=KLS8U.LW.4MJ"0B4ZI+Z
MD_6222=&GV$-G(YT30W,.WBHSJ2]EGM8\SJD/[-F4J]*S^6UP!\(R/Q]^NI2
MBIW-?Q3;<TU'&UX([B5:*?\`;]L:PG8V!+#"`/W?95XEQ%3_`/J[>A92MT(6
MKT6_T1WKW/?X]^^A",J'33DO4Q4+[VK7Q&E&_A-(?M*;SQND<TMV#]BKU]Z4
MM<>58DMK2TIQH@.NG8T">B3N/0J!/0>)U%W$+W@EJD+5[8W#-Q57G(4%5RML
M5[*'(]SC)<5`C>DER'/WDE)*@G8ZTVBG4'RGQU!M8YVP*W.E8PXE-7;K\SC[
M:[5:X$@-0JE!F.1RV$D5/INM$^4>(7YM.XHW1@AXVK,<C9`2W<DYF4^P\HXI
M,LU\LL6ZVYR6N#=[7<5_,1'ULU$>5&V=4@K(IMZITJ2`*G8MS@*J`>0>R;B6
M;<7[A\I>K&E4@.IM]HF1OD"D`DHI(!DIJ/QZ0\3%Q*2YS.!\Q2SP[A7!N/GT
M?NK9&/FEK_73+HZN;*V$)2=KKI)2W1/1">@))'?6?$1<3YECG,_O>92.@1$-
M*B+*11`9)+:*(`2$UVC\U(\!H$\;B&@XE9YS.WS)^+'(M=Q@BUWRT0KY:74%
M$F!<&TOQG4+24'?%=_F\@[5?5<!3^/2RQSXTT$OV!^W;+;XJ\VS$(T)$N4Y*
M?@PY,N&PT^X27BU$:4EIL*)[(&WX:=0S,8S*ZM:IO*X/?4;*)WYOW9W#UQQN
M&.,T_P!FF815&4_?GW6KZY>4MBJ+-,1>/FW8<1Q7F#D5;:DJIX=-+-FC<X-%
M:GL3:5Q;&7#:`IU>T'@?BSA]N%$S&TE&4I<;?F7Q]YRX,SI@4M*E1Y:@ITI2
M`%%!.U.X4TLH&Z\1+@Q7"V2X663#CIM<Z*882H,++R$M[0I50%;B*I54'Z=.
M8Y6-8`=J@Y,T<G+D!YGVWHZ(4.R54_2`)33Z5=NNLN>V09&_$5D9F^\%S2;3
M:);8,AKU716E4T":]Z5'6ITER9."SS7K3!L]FBT!B)&WZ@[^)('T=3K0M+30
M[5GF2?8HW0VRA56XR&54(WI54T\1V'?6$K#*6OJ\G+1;:U[FOY="=>(BXKJ2
MZA*`"3T0*]/AK";1$.F+AL+E'-A)//N9K'U?L_%A^/Y=_P`-9W*4G_EQ_$GB
MO)!Y0XH3X_;,L_B^0?U7M1]BDK#8I8Z@#M5@;\([D-"RAH0AH0AH0AH0AH0A
MH0AH0AH0AH0AH0AH0AH0AH0AH0L4_M/R?W--?_J3Y$K_`.FO/I[2O]\;W0?_
M`%_^;/\`[(.2ZZ-IGP>1<\U8%Q<!MK[5:9:Q_,(/_N")_$O4K50/*?P1AK*T
M(+30[5]&L+:-P:ZIV+[4?'^/6$OSF)MN0+_.M[-ML]H6I-QODWY5A(;4M22I
M+JG)'I#JMMIIE:O[ZE!WUM-=P,BR.)S`4V+:Q@DENBX_`348[NY,&C"7D2KW
M=WI4FZW&[2H[ES4L>JXE45MQMHM5(,=O:K]F>HU6I;F*9Q;'6O<NB06;60@Q
MCWU!S[Q7`<BOGM$Y5<Q>](L;]BM[%[NB78Q(N=LBN4>LTEXD(:9F*4.A\4Z2
M2;WMB^),+]SW[0>/+KQ)!SK*;%:9]PNK;\^1OC`T=F(3*>`I_KCIU88HHS"T
MG;E'J56FNVF5U":9CZU>Y9.'^,<<V"VX;9:I`"5F,$ENA"@L`CJ:C2G)B6@O
M`*XE."W!@16TB&RS'V]$LL-EMI(Z4('Q-.OQUGE1J,N72R&K%MZ?1_#K9,<T
MO%-1S=&,KC3)D@*.R"X:)KT!&VI^`!.FUS@T>5/M/F$=P'3'"H7@TY<]QG!4
M*1E7MXG1Y;_.-IS&\66.A>%QY[<:;<KC(N,8-9+,3NA1EQ)2#ZC1">NJK>$%
M^"Z<R1E[;!MN:FF_#=VKU0_=*<08_C'`E@NOV5`ASI]L;*G8['ZU*MWFJL#R
M[B2#\:ZGK:TGBIF`\ZYA<NF>"&XE6^MA:4AHTV-^5OK7R_@\.VI:N`"80V\[
M2XR`8]J-&HB%H0LDU(J::"<$X$3ZK9\FU\5:2YS.*=T*CQR/%4KE7#VV?-3'
M'7%;C3H+K)'0TUCG,2T=M+*PO8!E!IM3SXRVH-35&@3\ZLDDTIY@>M?HUAUQ
M&QI>XG*!78DG1D'([:<$2<JYS9^/<.ON17V6(5OM,-R7-6MIMSUXZ$%:H\8.
M=5RGU[6VB@A2'%`UH-*1ELT7/8?PQQP/F3NQ9&9Q!3\3NP\Z\8ON$Y7Q7WV<
MFY19\GCY>YBEVS\F[1;?D]ZM=D;-K*HEMLT6.S="W.=EQ$TE!I-75[@0*5U6
MM0?XB?-;_`UH'#$5^]6]NCPVMTU]\`"6`BF.&--B5?`>:R<4]T[UJXRM^4\?
M<<\389><<9PX7`HQ?+<UN<ZS-KO3L%R6MQ@VRT026EK"BLO$=P=-X#)!.V:7
MZ37`G?AW)'6-.L[MA\'C-3"HICY5ZJ?;KRG$Y%P>US_7><DF(/52MAQ!0MD$
M.[Z_4`V&GQU;8)67$?-BQ9YE0IK6:WDY4H`?WU1]F7N)X@P"[3++D.?8A:;[
M"<:9D6NY7>-$N04ZAEUI3<9XI4ZTI$A-%))'4_#21NX&NRDFJSX2?@DBQ[Q.
M$)((3GN,*2I+J2#<&`31I1K2OU3V!\3TUF.ZAD>&-/O%*P6-S)*UC6C,>U55
M_>39SB7-%IL^"XI#D9E:LC:<3EYQJ5'$FW8X[:YL)R4TOY@%Z0J1-0V6!YRA
M:E=DG2-S;RR'W*>=7#2[>:U^L`.XU52>7Y;C7'=NL&*M7V#:Y,>WIM%CPZ3-
MC&XL0,?@KC-,-LL.2%+<3#@5/3JKIWTQL_\`2W#F38.'#':G=U;RRRF=@'+.
MS'@*>Q55\HP,)Y[N$NZ7"3R+`MD*]2\9@WVVMM*Q^1DL9A3JK`QD:K0;,JY>
MF-RHZG0X$]%)!Z:=RVDEW<!\8!CIOP4<]YA-3M5@/M@Y`XT]NG`-MPK/_:UB
M'N&QVT9=<<JL^6<F2I[%RMTA+,1MQAIJS,QX*([$QIO<I(^L`=2MM9F(4>`M
M/&=I4J<?]]OMSAWJZ2;'[,.*L:SI6//6/'[SC.07EB\PV)33L5M$*"L>A+5`
M6[\SM=)<J:5U+NT'4'PB\C:SPSA4',*T[MR:#4[5\Y@J[F@T.&_O2$C>YN'?
M&E-LV-LO(<6PZ4.B04*8HAPK91<&%A"E&@56FY)&HOPTW-Y-!GIQ4E)&Z.+G
MO^F3ZT<63E.,[*"UV1&Y:P>K91^.AE3#W_OA^#2O@+C@/.FW.CXE/MC_`+A8
M=B95$:PM2_5;]%R0F>A&XD;"ZE!%4U[T\-/V:9.6`Y=W%-7/D+B6GW:I:X5S
MQ:7^>L#SE^#)LD&/:E8W*MRG#)CAYZ[OW!$U.SIZBF]H)\-QTE<Z;.R/.&@`
M'BFEU!<73`UE"0:XFG8O2AA&21,GQBT7*(I"FU6]DU;Z@H"=P57Q)"^HU!B:
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MC-N$&WR\:Q^)9ID.1#68PA2(412VI*)+HWEU7G2.@Z:KH=F)'`JQ.FY`'][%
M3KQR#F&,S)J[UQSFGR[CKCC,:%`#[2U$DMA*G$U\W3K\=;9<WN\<%AMZ`07'
MW:^A=<^V\BW^07;3Q)FOHN5"!*;CQ:%72I4XD)Z5[=];^`':G?YK8]BX'>*>
M:HBTSYG%]W8BE(('ST5<@BI-=J04TT>`':C\VL4:PW3:6EQ<GMUPQI]Q'I(7
M=8CWHH7VW*?;1Z:6TD?6[4U@V08,^.&*P[4K.4&-GQ'`)=6.Z6M_:Q!N4284
MA)WQI;)Z5"02VK:M()/CXZT2"=&%.N5O2%P)CD:417<@H=Z=`#4$IT(3LV'E
MER,&_MD!WT]J5/I<<CR4J"0V"U%=ZOJ4Y2H3TH2=*P?5;WHR<SW.*E#@=^?S
M:T_/VR>V8$9Y466W("`M#R?K-A-#OVCP)&I*JSX+L3GQ+FYBC;MPM=SN#,DI
M*F(D=A/R:BV*KVL.H7'1N4"24JJ3U/70H^\T<.!N*>\?8I3\$<HN<G8A$O/U
M$RXJ'W6E;MS:PYMV(W=2FHKI6'Z@52F_#DY>]/?IXM%C^</PC3.7XRMAL7=I
M-"&A"^GZI_S/\NL)6V^/RI@(W^_MF?\`[BQ7_P![2-"F)_Y=O\2=^\BG*/%"
M_P#XYEII_P#J#^J_J/L4CIYP'D4L=0!VJP-^$=R&A90T(0T(0T(0T(0T(0T(
M0T(0T(0T(0T(0T(0T(0T(0T(6*?VGY/[FFO_`-2?(E?_`$UY]/:5_OC>Z#_Z
M_P#S9_\`9!R771M-^GY%S_4_J'[;U:=:_P"@0?\`W!$_B7J442N\]]93.7ZA
M7S65HAH0H:^[#DA/$]PXTSY=V1:$X_E=J,IUZ+(FNOPRAUWTXUKB-NR[I'4E
MU0>+*5*914J!U$7@J'#O4SIGU6K++/=?Q6B`QDT_C*7>I+T9FZL3L6RAF':K
MJMR.M:5OJ,21M>4HDJ:*6E-CHH`ZKT.;G'*1OW?M718?HCN7GI^\']\6:<V0
MIG%\%^UX'AEX<D1DX-9;F]<[YD4ER4TTR+I+90AQ#:$A("`-A4D_'3[<H>\W
MJ\W[LO!;C@WMWQBW7.,[$E_9K1,=U&QQ"!"9!"Q0>9([_2-62'Z+/X1ZE3)?
MJN_B/K5BFE$FAH0L=;)@=J++O;$W>VS[>ZAIYF9#?B.QWCM0X']E%@]][6SH
M.W71RA,""E[=H+B>"INY2^Z)XESGEQ')3..8];[C,GFX3I*8,+YUV64I2'GI
M*XZGEE(31-3T334%>6(#J]JL5KJQM6Y0K5>'N*[9Q1BT3%[;&8@QH<9J,RS%
MVEM8;.[U%4Z)40/#IJ;&Q0N].UZ`_2/Y!H0C)H;6D#X)U@[#W(7W3!;)AL[<
M#7*>)JV!95CKC?6O0&ZR#7IH*EK'^7?_`!>Q.S9@D1KL%=$"8_N\R4>7Q\Z_
M(CIXGH-&7F#)QP\^"83_`%17B/6J*/O1.9(F6\CXOPY:\UOUI3A[D[(\RB6&
M5'3`N%LOUOD1(./W$)6N8J<A;H6G:G8FF[ZP3I%UR;5WA.."G;*R#1XNF`Q4
M!N#?9#=(5FC<T715Q99QZY.WZS*00V6U10LPTNL*2E(66'R'EE)4^%550Z:W
M,/)DH/WA7S_V):?5S</K7X13S?VIW<0PJQ7"9GEW;@LLWYQU-\#S#+;:D'[/
M6@-)`ZAH@A7B00!IE/\`1=W(M[TR3L9Q<I\^QS-)D9R[69;H;:V*?+6Y1"$O
MQE`L)![(2I5:]ZZL.D_R)5?U;^>\J\WO_*+\XR*UY+PNO';K*M4F7E^?.+F6
MV'*AS%+B7:+"83)O3*DIG,M(A@H:6:-;BD=-5K4+D1W3FDJW:1#:/LFNF`,E
M2J#/;QRWR7<.6+'"NG(^7O0FK?;5/QY=^5(CNC[;$=]:XLB6RIQ2F6S1*6U"
MIIX5TE9WG^I9CO\`85(206;&%T0`D&Q>@#'>0\XL/$7(O*'&%KNG)N;8"+H]
M&PS"<;E2,AR%,ZZ8[:UV>[OSW?EH]LMPDNJ<E,A2XYI5"M_2?\:>*:J#5H]K
M\*[9MA?N4$_DC#,\S>YO3[IQ7G:ODY&.W.8+@;C"MMP<<>0Y'5(DJ]%6U(=9
MV*VC<1IL'\R=S^)'J3D_RX^V]*'#N+,XQ*T7K&F+CG/]GDG,E9](XXG,H=L]
MOS>1)#SU]AR9$$71'S,FCCD?UTQO5&]*!VU9++:.Y5V\W]ZD*<QR-[`)''DV
MQW&3:GU2Z/&(M,B.S.=;>E1T!#;J%)=>:"JD@BE-2:CT28HRY8\AL>2PHUP8
MO./W%5P@J?BI=2AQ92/EWV%H`<9`0!0BI&I8:L6VK+6N#11,Q:ALYGXFJ>R/
M<;GDTIIRYPXWS3;+C2)4&PMV@!@S'IBFW$,,LM/*]60:*4=U-1\0S3F3?0J5
M?=&2'D]H/F3D6.SL-R&05/[*#<KT$]%>(IZG:@T\39+\6J+Z@*7'MN\$*6R@
M)I6H4H^H:"GT:F8M2LHXFQO^,``K*TWEN!;;9+G.R`I49*'65,D?,(=0XE0+
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M<\\7#,4F.APJ2D"BST.I/69Q<`AJ;Z,VW@>"]H4@?NE_8-F''D>!.SB"]5EV
M5<[B9C*UH<N-QE&6MN,E:$I2F*E90D=RGKJKV%JRDG.:''-A7N4MKUV'R0^'
M.4",UIWKTWIXOPCT6FU6>&I+;2$CU(;=0`@`UW`$=M2`MK<8AC5`&XF(H7&B
MZ(G'&"1UDIM,$C:0$IC-*IU'6GFI2FM^6S@$GF/%=;V$XA3TT6J*6B*E!A-*
M3NZ@FA;5X4T<MG`(S'BD-D?`O%N1,N_/V6&]ZC:O40JVQR?."5I;4XT0FGAX
M:.5&10M%%EKWL<'M)#@<"HKYO]WSPSDI<E6^TJMTPJ4XAZ*IB*ZDJ20*>B6_
MJGKI/PUO\C4Y\?>_YK_.HU7K[O;*K`IQ["\^R&+0[FH-P:CW:W)/<D-K5ZIW
MTZCL/#49=VP$WX>#:#`)S%J$X9^)(ZO>F?A^P'W`6EV]71ODR[2$R97VI!B7
MFV0I[$-I@%QV+&=N29#T)AU8)2E/84`Z:;B![#FJ<$O'J4@>#S';>*BAD_/O
MN*X.O,[CS"+%CN67>+=9=XNK2,?MS<FY.HB24_N[#DR;DVPW>Y\AM)2EMKU0
M6P.F[:MR-/ORWFAS^6K!:7Q?3.XD=JX?:!>>1_=I>(61<L\R9I<C)FQX$S`V
M;LU9;9C<U]+JEV@VJULVJ,Y,;^77N=;:0$%"@H;@K2L9.05VI/4;N>I8Q[A'
M04&[M7IMX=P&U8!C$"VVH?S5MKTD*<3L4AM(JE":TJ"=.(?J#RJF3XRYC\54
M\.]'Z2?]$/Y=/$FM9DMI5MV))!`W5'Y=,Y/C*V&Q=#+NY=-X5T/2H.DT+JT(
M7POH`*-HW4VUH>_;^/0I&)C`P.`%:*/;:E)YTS(@D'Y3%1__``TC6#L2LCG%
MH:3A5.W>'%GE#B8;CUODK_WB_JOZA[%+V'PJ7:>J4GX@?Q:@7?$>]6!OPCN7
MW6%LAH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0OJ0-P/B?Y=,_\`
MZL]P67$Y0-U5Y^/:*E)Y-]S@(!2><N:%*![>L>1LC"J_W^W72--^F.Y4W4V-
MR.=05P]BM/@MT@P=B?\`I&-7:#\%TU**OKJV*_05^0ZRM2UI-2!5#TU?H*_(
M="QD9P"'IJ_05^0Z$9&<`JX_O(\2SC+N(Q9>/KXQBV87N5&QVP98^E:EXG+R
M%/V+(R"*IHIDH=LUOF+E)#*DN*>:2D'<1J)N_P![O*?Z>`)P!LQ5'O//W?7*
M\SB6WHY)]V63OYIBC<RUQ,ZX9GS>/IG)N)M14EJ%R?@4]^?99.3Q)+=!=[:I
MA<AKH^%+ZBLESFO)::%=#A^D.Y1B^Z]]IV(Y=[B[@Q?F\@R-S&UL14W'(KI]
MM29*FY?J+=+K[CS;2W%]2D4(/AJ8L@)&5>*JJ:Q-+&\ACB,5[8\9Q6WXK!9M
M5MC-Q(S#(CMMM@)*1L"%*7MZ%;@%5'XZL+``P#=0*MU)Q.TI1_+!OJ2%`]*5
MK_=ULA??31^B-"$/31^BG\FA:<MG!8EEI1!+:24FJ3X@_136[7O97*2*K9H#
M?AP6>U)W`I!W=%5`-:"GC]&DW`/^/%8+6N-2,5\0VAL40D)'P&LK99Z$+-*U
M"@W&G]S0A==4_$?E&M<C.`151ZY!4?[6L22#Y?W7=70'IN%VE45^'IIO*T`X
M*0M'.$9`.%4Y$:4MFSWAXN(%%RU*+PW-+6&U':XG<DK"B!4`@G2379'!_`U2
MQB8\X@%R\:=_P;E3'/O&_='E5RPB[2L!RG-8>16_,[G+GW=J?:5&`T[!M(>D
MRHS#4)U/D:;`V`$:J-TZZN-7$C'NY6;R)T#>-CY37N$?#<O1MDMUQ][VQ.R[
M%Z&QVS`.J2&D2`LQFP6WVD"K:^W0@'5WU1L3H&2-:,XC`KYTG9P-%V(GM&4X
MT\ZK9X3@R+MF.3-J6[Z+N.[7FS7TW%)90WL4*"JD[MOX3J(MHHY;20R`$Y3M
M3C5FMM9&NM@&$8@A.K[6;R+/R#)MJD;5+CS&I`(*5%QB7(92AP&E%MH"4T/4
M5`\1I*.>6)N2)Q:S@$:K!%R(9LHYKJ5.\KS>?\H;O27>1N(;:J0PER)DW(+J
MHZKA-3(C^ID2@DK@%(A-)4KH%5!4>_747=,9),7R`%Q`Q*L=M!"VW8&M`&4>
MI46>W[Y=S.?1=;]19E6YDN[EH2EMFX-S&XY4EAII(5*2"FIZ+->I[IPPQ"4$
M-`*WDC8&$@"J](_W8EZ>N/'?/,XOE/VCDO(<QYT7R1</10KD&QVZ.X(3P1^[
M4=08`;CDI6I3972A&I'*W@FB8OW;<Y\E0N)+YF?'[,/'9F`<])P);^06R+=8
M^0-,2F[<S)MJ'UI?CQS.WQY*CTW(ZGKJ*=/*R\>R-Q#13#R!;9G9:5P1XOC:
M;E%RO=^LEP@JR69CN7Y`_`;DOJQBQ6[')&/QGKR_;XMVM<IZ4F;+DI7`#Z4M
M,E!&ZH!L-C<W'SNV<4DZ&)_Q-!3KQ_9GR6JXW)<'F?!5LL/-KEQ8^!Y>6XID
M!2VMZV\V<2$.>9*`2"G84]]2?BKCYW)/PUO\C4KX?M*Y10E@L\CX:^GR$/)L
MV;16'A7ZQ8:S-2F6E=B$@FE:#3AD4SP)>8ZI[5HZ2R9^&Z%A(PV)SK9[=,_@
ML!E:N*[O*2L!<QF_<\6QP@U*DJ:M^6LLI2?$;1K9[[J!F<2NX;4WE-G(VD43
M6OX@8TX(WF\%YG;&2],:P"`RC:'OE,WY]:6%JH1N3(O=R6%J2H4HM-13IXE#
MQUY_F/\`.F_+9P"XVN.KNW;W93K=O<4T^J$&_P"T#G1I*U))1ZJ&W<:N!0V3
M0@D/@#ON\7#7O<T.<27':L\N/@$X%IX"R*_.PYK6,8[-B6T-SY#8YSY*C.RB
MU]:&8,WBQ"4.RTG:`X4!5:5KI1LLC*Y'$5%#W+(:UNP42U]G7O3R:YY7D&"V
M[`;UQC$Q9B_R$VV5EQR&UWU&-2W6+BW'D2L?B/-R&MB$ALK2IM1%4@G2(CC#
MLX`S<5HZ"%_Q-!5^5BY0_M4]N:LI0M6RX'&EMMJ<2XHLN2T/E51]=(50E0Z$
MZ:&1]3B=J8&"('!H4J,()..L?^N(_P#>[>M2YSMIJMFL8SX0`E7K5;(:$+F^
M77\4?E/\FCWOE*Q5?0PL>*/RG^32D<K(J\SW:\4'%$65--?8U%)43\PQO*4A
M0IZ@J>M*T%-*>*@^856I&"(+_@&!Y$^M5SA6R0Z:E+CD.(F0%#J*!2PD)KWZ
MZ6#Q7WG-/E447N'P51O:<;Q>QPV&+8S'CK933]2(;*%&HH5;'^I`%`::VK'7
M`M`^W8M<\COJ5)1WZ[1^NZT0:!5'X_;Q_P!5T59\S45["LDF)7]4XRE7B5/Q
MP*?#HYWKHJS>]J*G@4%.M)-/59/2OE?8(_\`;=8K\M7#B,45/`KF=EQRE:2Z
MTGH02IY@)'TD^J>FL@/<:!KL>Q%>PKC0N.LD";"%.O64T/\`TVE>3(-Q6<>!
M6\-QB`2]&</Z2)#)3^"I<';2;HXZ_BN:'<#M6IM+B;WXR`WM_L6<]B.N!)0A
M;!4M@H`5(8V^8!)K^L/@?AI*9MN(G%KF5_:LLL;IKPXN;0?;@O+Q[P>,LEXT
MYRSC.'+??9EGO&0/7:TFRICR767%38TE+S2'I,5L2&DHZ@*-*CKJR1ZYH;=+
M\*YK_$Y=M!2M..;V*8MG20_&<.Q$'W>W"_(TWDZ[Y?+M$W'X-]SZ[\AS6D+2
MW;H[]PN%R>BVF`Y7SQ&8MQ4'`0G:X2!4=34VQ->,P>P`D[^WN3N6<2-IC5>J
MFPI;:M;#3SK%64I"TID,$UI0;:N"H!UL&MA(<Y[".P_L43);R/=44I5&^^%^
MFC_V:-_T72GB(>*3\++Q:OA,+]-'_LT?_HNF[WQN<2'"BSX:7B%DVY$;5N2M
M%:$?MH_C_P#==:YF?,%GPTG8MWSC'^$;_P#9H_\`T71F9\P1X:3L7U4J"$E2
MG&TD))*B[%"105*BHN]`/CK&9GS!/&`M:&G:`F`CGU^;LND,_KF'6<>:;?:*
M7&5JBL.)=VN(4I!`+@IUTF^6-K:EPQ2@893E;2J=^\-J')?%;_E#3%YEN/K4
MM#:&D"`\05K=4AL%?@*U--0MXT2-+FD4`4K:D1>Z[:I4"[VM*4A=QMZ#Z:5T
M5/A@T*0?%_\`A[?3J"<WWCW]OW*=9(W*.[B/O7S[;M'^ZEM_[8P?^R-:.`;\
M1'V[UMS&_8C[T/MNT?[J6W_MC!_[(UIG9\P\ZQS&_8C[T/MJT_[I6[_MA!_[
M)TKE[1Z?N2F'$(?;5I_W2MW_`&P@_P#9.C+VCT_<LX<0A]M6G_=*W?\`;"#_
M`-DZ,O:/3]RQAQ"'VW:/]U+;_P!L8'_9.C(>/K^Y:<QOV(^]#[;M/A<[<?P7
M&!_V3HR=H]/W+9KFNWC[=R'VU:?]TK=_VP@_]DZ,O:/3]RVPXA?1>K2?_A.W
M#\-P@_W)!UC+V^O[D8<0OOVS:/\`=6V_]L(?_1]&7[8HPXA#[9M'^ZML_P"V
M$/\`Z/K!%!4[$8<0A]LV?_=:U_\`;"'_`-&UIG9\P\Z*#BA]LV?_`'6M?_;"
M'_T;1G9\P\Z*#BA]LV?_`'6MA_\`PA#_`+K^LYFG!I!/`+!H!58_;=H_W4MO
M_;&#_P!D:/?^4^C[TGS&_8C[UL1>+2HII=+:>O83XA/?^]>.DFP2&<RT]TCR
MK<D%H.ZJH8]IEMEQ>1_<HZ^V&V9O.W,<YE[<'&?E9?(%\7&>+K6]M2'TRT%)
M25=]7^Q>(8@7UI15+4P>4[R>M6A0I+$>%#]5YI`^5::2?6:5N4R"%D!*U*2!
MO'U@"=2\/X_P>E5RB[4S82@#\W'%?`N)K_'HDRQO+'D9@EV6[WM#A2A05.A)
M%?FV#^!Q)/\`'K7/'\P6WA9.(6O[2@_[):_T8_EUG/'\S4>$E[%&;W48(]R/
MQE+9MDL-7*VO.R[9Z,AE"G949M3T4^99IN?0GN*?'3&>'F@Y7-QXE.+6)T,N
M=]*=B\M'W@/-WN\NN-6C@CB+',HXOR21=2C..5;=.L\XKQ-NTI@.V;&X?R2E
M-7"Z7)XNK>64!I#?2I500,^G3QC/F8ZIV`DGU*U1ZM:L8&N#ZTX#[U91]S7[
M,+_Q/B<;*LMERY5VN3`FR[I<9J95R=EJ2PZ\NX3'$LF3*>5YU*"4@;MH%!4N
M;5QA;1[75[%`ZB]MV[-'6E=^'WKT+*=C$JV3(ZZD[07D>HKKT!Z[=Q_#2NIQ
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MAY;9*Z^":]>VF\K7.B<UOQ%IIWIU"`96@[,P]:I+FWM-VFSW)DIA<V0_*2^1
M(C@)8?=#E4%;J/.%`=-1]O9/C]Z2A?V*Q9(^+4?IY%O-@QZ5@YN/KV2_(<=C
M.KEQ5)C/14)5(1*2F0IQMLM)3Z92E6XU[:DI"Y]N8G?'7T*/D8(K\38<L-&S
MRI9^UJ`9V5Y!*=>BF/)A/".3*8"W`\_'>;`!6/-L;[?'3>)O(MI&OQ):=B;Z
MF#>.!BPIQP^]1;YVY>NWMJ9Y7Y)M-L9OEUP>1=WXUI:N[\!,^5<)\0PRF1`+
MDE4=MMU140A1"TCRGOJ/S=A3FXMW7UO'%"0'MI6OLI5>0CWQ^Z#(>>[[Q);<
M@5>KOE%CM%Z1<UWQV7<KD_(O.9W2^09#EPD,H6\R+>\EL;P%)V`=1UU&W5P&
M2Y2UY-!L'[59+>V?R6@EH(`&WAY$R]JF\76B&SF^,1[19YK$F*N46[C(O5U;
M>CR6DR5LAYU4MMQ2@H!+;:J5IT3U"++QK7!Q9)3N'WK>2T>YA:',\_[%-7[N
M;W_VKACD+*^*\VCQHG&_(SF4)7FLVV73[2A7>_Y#!N-I>?3Z"6FX#+K`^9<)
M6IH`%"5:<_F,7R2^8?>FWY=+\T=>\_<COW+>[JT<N9'?^/L+M#R.#;#?K7GZ
M9OR%RDY7FN7S+Y)FW%JQR/DD1&X#U]27/UBQ^IZFAZ::$NDG,[6D,/';@*)K
M+%R7F-SFYAVJTGA!:,OXXY)Y<4RS"<_L\Y4=O<.U3;9-;LZ)TS%;R8B!%FN)
M5($2&I*T`D[Q05[ZFK"8&01T=6B2D<UC2XD$=B<CW>WM^3[8\XR2QR)YFLV?
MB?+K)(L%\D623/D.9%%DR6),V"ZU,::=9N5'D#LD*KVZS";^)C[50&WGWN`E
MS4^ES);[.9=RCH9MUPY_N5O=MPN4ZX-);DL2[NV_%CVIR)LDJ6D>AZC=?KT$
M)<7UW%.Z-CO<!P3^.UMI8Q*XBKA5.?QSEW-@ND^+E?,T21"NV'7>[I<L?-R<
MQN\+T7*,&W6!.1[YEY,E@)2V*`-.*.ZM`=K6_N'RY9R2RAV<4WO;:"*'/&07
M5"]&7L^REW)_:1#CSK\,<N[*_5DY!?T/R+DB>_%ARU.3_M5]Q\+VJ!2`2E*:
M`:?^*CX.\W[5%*4.,_+WW#RQ$OMDOUV^3])60I7%7'>G>B4B[2(2GX^]E3OZ
MQ3:%=1T!U)QW#.6W`[$+GQY,S&.1>(TS[U&DG)<;R6P7=N!Z$*W2[A$W7FWS
M9$=R6I#4I"[>$))5]51UOSV=J%"_";<UAWNFR&"RT(UM7R=F-G>6Y)AH2;?F
M5KAW)IQ!,@)6S]I-K]10Z#PW:/$,[4;U>[[5'WW/;;<<;>+9DVN6U!BH2\PM
M*F;9=BA):VN%Q:5L)&VB>NFI-22$P.T]ZL^PF.XG'H@51)<#;J4DFH264)\P
MIT-1K"PE.I)2:&E?HT(6ST%_%/Y3_)H0OI9`'E<2ZKP;:35:O\R%+2GH.O?M
MK)UNUX+"UJ0X/]3=;_\`7&%*K^#T%NTI]---;C4-+NLING9,M:=M=J/.N.Y1
M428+D9[TU(?20L'>A8K5%`VI!4*@]NYTUY^@#$RC#[<$4W4P4=KWPKC$^5ZC
ML>X(%#5IF'<VVZFM.G5=13XZ1_..GS_ZOI_8M_!#@BI/`F&D>=-Q:->@<9NH
M)^D54-'YOT__`)OI_8CP78OJ^!\"0A95(G!:$J)3_.!12033:N8A8[>(!UC\
MXZ>_S?3^Q'@NQ%/]B^`GZ\F:D?%/K@U^'6>>FL_G'3W^;Z?V(-EV+-/"_'H'
M])G*^DE[\G]-UL-4T=PK%>MB;P)'GV?:BQX*FZBXU\-\:;E[[G'[JW-N7!Y*
M@:FJ5I$@[5#L17H=9.IZ8WWOS%GG"SX)?$</<5-$E4Z!0]/ZQD=^_P#LC6OY
MWIG_`/D8_P#$%GP0'!;?[)^*QT3=HK8_11<GPG\/5X]=1EWU#HC)LLERV5U!
M[P-?)LW+4Q\HY12BWKXSXG;;45WJ(`E-#OGR'$CPZH0\%*_$=)1=3=.LD#WR
MMRC:M$A;YP/[?K^DIO%VLTA*E%7\ZD2&JD@`A)4']]*?133P=7]*[.<WS_L6
M5MLG"7MXQU"V[=?<?C!Q(24IN#Z=H';:4,)(J/CII+U/T\]Y=',,B$HT\><-
M-D*.6V9"!WK=Y:4]105+A;0.OQ(T1=3].QOSRRMR?;L0MO[B\+>&7617X+N^
MNGXV7'0/QTTZ_J_I3=,WS_L0A^XO"_\`]%EE_P"VLW_2Z/ZOZ4_SF>?]BRA^
MXO"__P!%EE_[:S?]+H_J_I3_`#F>?]B$/W%X6_\`HLLO_;6;_)H_J_I7_-9Y
M_P!B%\5A'"S:2Y^]EE\@*_ZUF_FBM>NT=*?$?AT?U?TK_FL\_P"Q8*=G"+WP
M_B;ST6/G^*H#"F%H7<,GM:'7'5HW4<2^L/G:.@Z]M-[KJ_I/(*S-V\?V+1\G
M);F&]'W(5_XKS:SKLMPY!PYQM;K<IH0\I@B2RM*'&MS'RDE$I(6E1K176@I3
MKIB>L.DA_P"J//\`L27C3Q5=.1>S;VTW>Y/S7LJ@^O*=<*U(RJ[CU"ZM2U.*
M)4Y5:BJIZD5.EAU'TDX9N:W'M_8I)M\[*.X(D_X#7MF_^BN*/_[KNW\FMVZY
MTC+@96X?;@L^/>OO_`8]LYZ_O6?PM9)+<1^)3TV.Y7X^6GX=;?FW2'^:W[>1
M'CWK#_@)^W$_5RA1^'^W\L_P-7);AZ?`'4H-6Z3I]1OG_8M/SM]:>]YUFGV&
M>WEROHY&E=*;M^0W1FE>U-\GS=OQ:/S?I+_-;]O(C\[D[5\/L*X#"J"[[T]/
M.C)[AM-:=OYP>W;6?S;I+_-;]O(C\[D[5T_\`3@'_==?_A-</^CZ/S?I+_,;
M]O(E/'O^U5]'L#X!_P!UW/\`PEN'_1]8_-^DO\QOV\BT=JTD.`KBOG_``X(/
M5-U41X5R:X5I_P!<:/S?I/\`S&_;R+`UN3M7P_=_<%$?UJH?2,GN'_9&C\VZ
M2_S&^?\`8C\[D[5A_P`7YP7_`+KN?^$\_P#Z/H_-NDO\QGV\B/SN7M7W_B^^
M#%=$W9XJ/0!&2SUK)\`E'S"=ZCX"HKH&J=(N.4R-H</M@C\[D[5N:^[RX462
M#<KF*"O];3O^Z!UOXGH_YV_;R+'YW)VK=_Q=O"7^ZES_`.VT[_NAH\1T?\[?
MMY$?G<O:@?N[N$D`J-UG)"17<_>I[;(^EQP3R4I^FFMX[CI9T@;;/:;@GW1V
M^99&LR/.7'%<*?81[>T*6W)R%E#@`"`G*+@`5=:@UDDTT^K9<`E/S!Z[X?L'
M]OS*O6&0L*4:D)5D]P*!0T!H)0-:?PZ2;;1RSYX_@3QM\3;^=35XMQCB/BVS
M)LEFRK$&MJ7?G&',GLSSCKL@[W9#CGS3DEV0Z[YE%6[KX#4NZV:VW)`/F/%5
MZZN>82S<5TWG$>/<DD&4S>F9RTE1/V;(7-9:+A&T+69*4)W;>FT"M#]&HN2_
M=:;"F*(O[)<04KS29()(K1E5.OP_GGPTO%?:)<1B:[DI<.^(>CAP4E`/P@NH
M<.X>/V<N2I7P+1(IX_\`38TIXCIS_-^WF2OG67]CV+_X=[_V$_\`9FL^(Z<_
MS1]O(BO85PN<+80ZM0>8G.J4>JMCP;#AZ!U(3.HDI/4'1XCIS_,^WF0D;</:
M5PW>)AG7.SNS)1'5XMEQVM0:DN25]*C2%Q?:)#&'6SPZ2M/)YD52XMO!6!VF
M(U"@1[BQ&92$H;2A:1L``V'9+3Y:#L-,_P`WL^Q%0C'^R3#AY=[@0.GI*E.(
MHD=`A0WJ4F@Z=R1\=-'7Q<XEH&4G#N10K!?$.$+%-A30_FSY/T]_UATXMKQQ
M<=V"`"L1Q#B:0`RIQ*/A\VZKK7KU4:Z=^+/%9V;5\_L@Q7XJ_P"N%Z/%GBA:
M7N'<-6$_,.J0!7;^ND*J>E?V*TD4^G1XLH7,>'<`2:*<E*/Z2%3MI_!5TGIH
M\6:K"Z_[&\/_`,+-_P!!(_ETZH5LLD\/8>FOZR8:_P!X_P#W2=%"A?#PYB"B
M:.S*GMY'_P`7CHH4+XCAK&$*"@Y))'@42"/XQHH5A.#AF$6:P3?6BK0E9-/U
MJ5IJ"*5"72I9-?@0/HT4*$TWN5X\XSS>VKMN=WJ!:XY0\EM4J2J,'`I"D@A+
M:D>J@U[=2=8((6<KG>ZWXC@%5]/]D'M+E2W75YO;W"XLNEMF>ZV$J_2`%5;>
MOB="V_+[_M2TQ/V?>URSI<1;,LC*?<6=KGSSSP:JD`EM"ZH"E]C4'PUC%.(H
M986Y9OBKZ%(KBOVY\%6U;YQZ\Q+JZEY:7I$&<M;C+H44K#K;9^LE70I`%#TU
MD-SG)Q1.XLA<\;0$1<H>T+V]*F*E98[:X;\Q+SW^VCBDHNE$I464-RM[4B40
M00"D@?#6?!'@M+*]-<#BH79Q[//N^+)D,BVY;R=PQ9+[;$*N=XLETR?!;->L
M?MOI;R_<(MQE1)S`<<>:*%%"6U)4=M>^D)([>)V24>\G\TUU*_-$2&4`\R3]
MR]GOW<=HB6^Y9%RIPK!BW,_[7.W"_87;(#RMF\JCW$38T9X%)K4*ZZT_T?`)
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M5I-!IPG"U*^[^]EA2XG]X,6/J+W[E+:4L$J"Z!116N\523YD`D)(!.F$EFR2
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M0A6/\&\+<2XBPU%QJ[(G)8?2M"F'W760Z@;2M"PI3#C9/91W`@UUM0I@=I[U
M/&VQ4,1&?1<;<;"$MI#?@$)'4TZ==&4\"L+K4T%&IW5^C_T-9RNX%"V;5?`_
MD.L4/!"\ZJN8^2I*2RYR)G3R%_6;<O5Z;0H)\WF7\V-NVE?Q:\&_G^N__>W?
M_P#.D_\`,N;>,N_\V3_$[[USJY"S0LEV3F>9RO6J6-N1WEP(V]'`*S#3=4=N
M]-:/UO69*<R[N74XRO/K<CQEW_FR?XC]Z*6<WR)V[6%;]^R]PKOD-IY3]YNR
MPLNK0EA#Q7).\+*>@/?6K=5U0O`-S<4J/_4?]ZV9>7><5EDVC]X\>]6%NY#?
M0X0Y/N^_<11<V7NK7Z7JZNG/G^=_G*NAGGK\;_.5B[<+ZZ6_4E79*E`^F%RI
M55IKW35WJ*Z/$3_._P`Y3RVEE<TU<XX\2L#)O"5H2[)N(W*2FBWY'FJ0*&J^
MM:Z/$3_._P`Y2SY),A]YVP[RNI9E._JU2)""/-U==';IX*_OM'B)_G?YRHWG
MS_.[SE<4A4B+N>,M\H;1O<!?<*$IJ:J5570=.^LNOG/C\'0NG<:AV\`X;=M,
M"G$-XYK<CW$N)XHFAKRN[N+5CV.&_M@J6LN2S$64$[JL%:VVG*CZI4H`CQU8
MK#I2^?ITUU5SI1&2T&IJ:8!/FQSR#,USJ=Y7QQS,8#BC<N.,R2A/<,VU$R&B
MG4J1)A/2%+Z=/-1--0_Y'KW^1_R_L6>5<<7><K2G)I,^08-NPW($S@E)(>M,
MK:*U[I+5*]-2%GTIJ-P,\X<R2M,HJ,!OIAM6#!,34DU2H@\>\E7TAW[#L^+1
MP"I<NY2W%.-HIN];Y$%*W%*[;1VK]&K/!T1,Z/W_`'AVK'@9KC\$$@G>CM7#
M7*$-*WFLBQ1T-A!?2_&N#/I^JG<S4-LR"2XDU`('332Z_3V>;Z0INP"D;71W
M0XS.)[_VHND\9\U1GBMJT8I<TJ2@H?3-7'#PV`^5B0VRXFE:5*17OVU&?T?>
MV7^F)-6\:UQQ]J0N].U`SDVC`;?"A\F.P<42FT\F,.4G\?31(`408+D*:B@2
M=U(L22\MRH'<).WOTTC/TQJ)C(A;GD)%!2OWIE)::C:LYUTVD`VGOP&[BB&\
M92Y8?3-_P_(+2V$J+TF9!7'8HDA)6%*`&U)/7\.FC^D.HK:/GR6_N?P_L3?Q
M,2-;3?+9>XB)EJ2U)CJ.SRA#BVECKZ3M.H<IUH>M#J'DAR/+96-;(-HIL*:/
MD+GES2<I[4;-A4A6QN)Y@-_E:34A/<&GAK3EQ_*/,M<[_F/G1A$?0I"V7H#2
M%!=`XY';!I0?G%/0:.7'\H\R,[^)\Z$IJWA392TK<D@K6E-&P10E2J"FP>/T
M:;W#6MCJ``4]LB7!V8U[U`;F6=Z'-]_MBD1FMMAL$@(D-H2@*=0YN=2@C:''
M10E5*G56O)'@&A.WBJ1K]S<LGRLD>&YM@<1N1IAFV/G>,*+L?>^^T@K8*$I6
MCT)2@RHIIN"5"NT]CUTYZ;)FN0)O>';CZTVM)YW?$]Y\I4KVV31AU]NJE(0L
MK<`))4D$J*E=223KI@MK>GTV?X1]R?FXN`:![Z?Q'[UT/MA*4J"``HFA"0`>
MGQ`UL((1L8T>0(\3<?YC_P#$?O7+2&31UI];E.OI!5*>';QUGE1?*WS!8\1<
M?YC_`/$5M]%>Y20V:II5.WJ`>B:CPKK;*W@%KSI?F=YRM4AN.TE0F(900XRT
M@/I2"''B=B$[AT+FW\!II&63ET8UH)=V;$K$9I*@.=7O*1M\Y%Q+"F$F[/0F
MW=CJO3=6W4H0M25*;:H5%*5`@T'?3F'I'4-5HZ%\C:G<2/44[9IE],W,QTGG
M/WIN%\]8Y-9#D&XP(S"P5@2+9/2\4HJHJ&Y6X)`!KVZ#7:]`_0W7KR"KI(W.
MXD)-T5]!B^23_$?O1=(YRLT.5CQD3HK[%VFH3&<:2]"9>86A14I(DK_G"?&J
M:@4U6^MOTVN.C-.>-5>!--[S"W`AK<#0X4Q.Y9BFD>UV9SB1VJ05NN#<F(RY
M%*GVU-!U)!]510NJP2K<=WE/?X:Y:!I\>G-)D)F)`K7$G"F]1$\\XFH'O`KQ
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MX>'@^1GF"?9W\3YT?,W"U/2X$>07(:C/C>HVU`0IHL4&_P`X3YT&OFKTUNUC
M&#W0`.P+/,DI3,ZG>57'DJ(Z,AY(+*IL]ZUY%FMF27H0@&+\I=Y3L9SY9%$I
M]!E`2V?S4TI32F9U,M3EX)"3X"1M4U[%)N-MM-CDP'YB&39[6XMF*\ZVT7##
M:6I2T-J"2M1)KTK723H('_&QA[P"FN9W$I=6_D5U1I<H5P>"1T+%RDMOA0[%
MQI*P1^#Q&J-KO0+=2GDO[6X?')+0AC7$!M`!@`X`;*[%L)I0*!SO.4OFL@?D
MHB2K?/=6S);<7(CB2X93"@FJ04E>Y`KWUR?6.B>J])8;MTDYM0X#XW[S0;UI
M+)<.C+6/>'5XG[UD<A=J0Y+N*E`T_529%$^-%;7.AU5W?G$'U'S5_B=]Z:?Z
MS_,?_B/WK:J_STMU^=GMLE!*5.2WT@(IW)+M>@TB73`<R6ZG:XXD<QV'_,DC
M<W33EYC\/[Q^]8)N]Q1L4FZ3T>HC<A2)DD%:"1U3M6"4UI]&DVW[7.Y;;N?-
M_P!QW_F6/'7,?O9WGRG[UN%XO!&X7>Y4^)N$A/\``IX'6_BG?_>7'_\`,=_Y
MD?FESQ=YRM1RI39._(+NA;=0LBY25A*D?6H@OT4`1VTL+_6@`(Y[@LI@>8_9
MNW\$N+V](!!=B.)1;+Y%MD9!,C.YT98KL2N<4.+4`:H2CYG>I5/"FE&7NOO-
M&SW(_P#ZC_O2L0U"^)C:]X+17`D=FY%".7G$L//,77(YL./53L])NJ(R!W(4
MZE/H>7XUTIXGJ/\`^XN?\;_O2_Y7J7^9+_B=]Z45JSY^^Q#(BY5(6TOZCK%Y
M<6CP\GJ(D;0OP(K4'2SM1UV$>_-<?XW_`'IB^\O(,'%Y`PVE'#&2Y'ZB6F+[
M<$T^LMVXR2EP$>7:KUB%4II!^NZK)1HN)VTX/=]Z1&JS7)R-<X%O`D;5T2<L
MR=AXM*O=X)2E!_4W&8&_,A)Z!+P%>O7Z=)_F^K?_`'5Q_P#S'_>L^)N?\Q_^
M(_>NS][\D)`&37NI(``N\[J:B@_;^.E/SS6__O+K_P#FO_\`,CQ5S_F2?XC]
MZ!SC+RI;3>079M3&T/!ZY3-]5BJ"=SU>P.C\\UO_`.\NO_YK_P#S(\5<_P"8
M_P#Q'[UR*SC-VG"XWEUW4'#Y66GY+X03THA:G2G\!/CH_/-;_P#O+K_^:_\`
M\R/%7/\`F2?XC]Z[8V><@(=J_DV3)1M4*R7&UM;O#RL%+F[X>&C\\UK_`.\N
MO_YK_P#S(\5<_P"8_P#Q'[U%[G3G'E/'N0\)@6?.L@@MRK%+F2"@[(9#5P>9
M+DD/L24G9N2.I`%1TU7M>ZAZ@B8'17UXW#=-(-_8Y(3W5V&9A+(`/[Q^],1F
MO).9Y=86W,]O<V_F+>YL5,ZXL%AMI0<2EA*)*DH0Z@%Q.V@2DU%`*ZZ;^EW4
M5Y=QY-0N)IG&@]][G^EQ*M/2VI-?1LQSO)H"<34[-M4V#2F$R%H3Z8>:V^LE
M(`<0E8W)WT%0E8%1X&FNX^)CXCSJ_P!7<2F^YGY.N&`V/'+9C,XM99F636JW
MVN+'9]62W9O46+Q=P&_UJ8S-4(+G9*B!XZ@M4U002Y6N(]P'`]ZC+V<,E`=C
M[H]97W#N9<YP*Z+NE@O5QQZ\HE%Z?`#*OE;M'2Z5+>]-PAAN3*^LI:@3N)KJ
MFWVOW65WAI'\ZGNT<=NY1MU<GP[^6T.DRF@I6IX)].9_<M/Y7X_@.Y/(D/W>
MPOL38I6F&A]IUM*6W%QUQ4I?!>0*'K0C3:RUWJ1Y]XRGO<Y,K&YU$&OAV_X1
M]R\W?O\`?8SRU[C^8'^;.$F<;R6Z<H8Q;,#S=B^9$;+>;*MI3(%^FKN[IM5\
MM3=OCAMU*3\XTM*0AMRFK#'=7D[>;=%PG.&T[!L5UL3));!UPP,DJ<*?L"<?
M[R"%></]CG%WM4N&/P>?_<+<X>&6!RY8)AKH9LS&.*:GS\DCJ@Q_]K9MV.R"
M&0$&0$E1%1I5KI7G*'.Q[2G>5O`*DSAWV2^XN_W.U#%/;YGUCY%B7)#EANV3
M62YV^R6VXH]1)<NCMP$>V"`A2:.>LOITV@FNE>3-\[O.5G*-E!17[^]3B;B"
M3[4^*N'?<+CO'.5>Y":,.C62#CF40;%=,4O#[!<R"X0KX^W';0SD(8])%M<`
M:DO-*4D*H%:<,91@#\7=J*`*-WW<_'&%<<\@^X_#\-Q_+[):XW"$Z+>;/E4I
M$]Y5PN,2X.&9;WF@$3HC8(0A8!"12AT_L&M%R*`;#ZDE.T&(UXA2'X1]R.:<
M<\58+A5G]OG)&36BQV5F/:;Y#L%Q7`F1UJ4XH6Y]M)0[':=4?J]$J4?CJ>3'
M(S@/,GA:]Y/)VU"T^V+/BD/>@`]C.1N.^L@!2F7"TDH4ZE/<#PTJV^NXVB-D
M#',&PEH)/H3"4T>0-E4=,^]?D^.?7<]K'(/IGR`LXEEJ5%2NPW-1)"J=/T?Q
MZV&HWX-1;L!_A'_E2=>*,XWOEY)#B0KVP<GL`FNP87FLA*NH&[<;.:'PIK;\
MTU#_`"&_X1_Y4)00O?7R47%H3[6N5EE*B$*3QWG*@:&@*5?8933\!TP?=ZFY
MY<(&XGY1]RPEY8_?9RI!=7*A>U3EIJ66'4!^-QSG*9'5)4D!QFQ>H/.!X]].
M+62[E<YMU$&,#</=IC4=@0F+Y1NN9>Z+.\'RY7"O*'&N?8_!3'RN_9IBN=6?
M&+CAL!B?=&TO2IEGC1_M&$\PLA*G:NJ6FH[::79+2<I([D;U.?B'W/<K95Q[
M?L\PF7D^%X\U9,-@0(QD(HJ:W,$2;,$=:'5Q6Y/J(*DE)4$K2E5=</\`U&ZU
MN+6+E64LD3VBE6.+348;00JA>WIC<X-<0:G>IOVOG#GM-KA*')N1+8$1E;C\
M5YH)2^M`4MIU:+>/.D>!UP*/K?J21SC^87H'_?D_\RK<FH7+CE9+(/\`B/WK
M8/<!S8>W*^2]R/Z6GN.A_P"D-+?UEU'_`/Y&]_\`Y\G_`)DGXV\_S9/\1^]=
M']MG.?\`Y2<F_3_KK^'^A_P:Q_674?\`_D;W_P#GR_\`F2'Y]=?,_A\13!"5
MO:6IF/'#H2H)04T4000I0ZTHE-2=1%3LH421\H5<0BU60,LM1XJO16MOU=RF
MV7%HJ5)Z5":@BFLC.XT#24R\4S90K4K(8R)MH2IV(E7[S8ZG:I*D+!,U+(JE
M0W))4Z#^#4A;Z?<2N!`IB/6MH[IA>T4/Q#UJPN1=X:&W%R5%*PNB5GL5$G:V
M`#7<H]M=".FRU^)OI70B,49MNSY$)J;Z*@UL.QQ2D_JD]]JT@UZ]Q32$MH^(
M@$@UX+=ETRW]UP))X(-7Q]+>Q[T74I20E::[J`4K4COI$PO`JLG4(G-+<KJD
M=BUL2?FGD*^80R'?(G<AQP[U4(!#8)[)/72/XGR.33G#@4E,WER8$/:B0E"U
MO%EU*DK076:#S)"A4I))[ZF=!BB?JD+98G.DDD#!2F':<=F*3:U\UR',-&T`
M]*<3B^;*@XDQ.2A:GIDM]I!10+:BL+*=RTJ(*PI(%`FIUWF^%MHUTRQ=-$U[
M6!U#7WL`<H%*UQ[ETG3K1OAO>+:Y>U+T9?.;4H*7<(XIT6TLQDNG_!K516](
M[TIWTA^>1$^X&N[FG[DOX4<6H'D"8R"E*)"7!U$AF51T@]@5%OPTD+AUW/SL
MN5E`-E!@D7QM8[+@5M;S^25H"%R/56=B#O:*PXOR)4/42M!4%FOF!!.I=EQ%
MEY+7M,CM@H?N6A]VI93,%$S(^:WH&9WI_CQ<*Q7G*)CZ[U>HD=M4Z6Q8W#;6
MI5S2*,*,J6V]Z80-H2*]SJW:?IDAA$KW,+:;,54=0UB;G&!M0[CN3@XA[K+M
M;[=(@9?8Q?'D%Q$>=$<;;D*4%KW+D>LML#<>VVM!K:318[MW/&05X@[L$M;]
M2ZE90BVJ#2N-.)K[4D\A]R.>7M2HUH<8QV"Z*+:AH2M[:GJ`'%=MU*'KV.M[
M?I_)*'Q\L.&.(/E3;5.IKV\LG6\U.6XMK3L((3+7"5.OSSCUPN,QUQWUG)"G
M9#BVWJMJVE:%$A!2XH'IX5U):U6ZT21D+6-?&*$D;>ZB@(2^;X31)KV69K/R
M_#I,NX2T^2_71'ZPDA243)+;.VE?JM)2/PC7CS6+28W\TTCFYB_&E>`4BQI8
MT-=M"FX\\(J0XP\AQ>Y*"E-:[%?6/44H!J#:"Y^0;5LNAF7&74OOICI2VIQ;
MKM2GIX`)JHDC2G)=Q"*+A5?[,)#;"9B)`=0%U;2JBD'NGJ!U(TF;5]RUS&D`
M@G:EHKEMJ#G!->"KTYBN\29[@<S=VN/J19L3:9:30+#9@E\)J2`:!P#\(U3K
M^W<Q[HB148]BH?4$[7/$U#3-L\A2CQ"8U,S_``R/'8=0Z)[0+2]NX'Y:5X@D
M:STX\177O;0F]E<M(J`<%+]Y$9Q+:&I#IEMI0D1R:A3R1M+8H2*!73756FK0
M>(4K6N/%!-R>CH4F4$PFVD@J?DH4ZTH]@D!JJDGZ3TTE/,80,K'/)-,*8=]4
M4<?A:2>Q%JLK^7D%-(SSE$*2AE*G-S9ZH7O3N;`<'A6H\=.;>.:X%6L<.]9R
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M)5MM4*SL7R\7BT66:[-B0HJRAB`K[14$)5M6%)-1374N@FZLY@SNF\[55NJK
M&UT^L?.C<>ROM"*KQB3&60N/')EYN5L=PJ6W<4MVU<=*9LAN&MI#<CUV'28Y
M]<&E1T!Z:M74_2EMU)8.M=1+A/L8Y^(`W_#4[5SZ%T$0=FE:<Q[?N4A;;R=>
M;:S&:;EOK6PVT@O*4WO66P!N(0&VZ]/!(&N0WGZ%P2VPCM[F`2M-1424J,1^
M[Q"9RQ1229VS1[=F/W)3,\W7Y2SODNO"A.Q:64BM1UJA5:C4>W]%-?<?YBV!
M[G_<E"7<%UHYQNK+J5.(0J@KU96\>_@I`4!V[:W/Z(Z_NN;4^1_W)6*-KP2Y
M[6&NPU]B,4<ZOK4DN_9["5$%QSY>?Z[23]9=`WZ?J('7X5UH_P#177(VE\MQ
M;<MHJ<'[!MW)S%!&)6GFL/O##'''N1E'YVQM,EEI]K[0F25!,1<IYZ''>5XO
M,I:JY(*3T*%@)H:]QIZ?T[BZ?@9<WCXI6NW,#O\`Q`*9RLVT2]FY)/R&.R\'
M68K;B4MO,P61%8+"/J)V(/G?HH[EGZW2NIZ#3H86-\,`V,BM#Q*2?"'.J"`*
M+G38H*W69#LK>6Z+2A:B:=.@5U[BNI:$R4Y51BM.48_?J*#O6V5<8T-I32"5
MTW`%)30%([FI!ZZ7\*_B/2L\]O`KFQM3=[FK>7>[/;5VU25K;N,IQMV0%D*2
M&D-,.4H.GF/73.9XAD,9Q(0)VEV2AJHS<CV3!;)D?.:$YE\MES.=9<\C"8MC
M6&WV9KBI)?DW4#TF6VH[Y4*&JE)IXZT9,USJ`)S-"X0&2HIAZU("W2U?8&/E
MM80@6:W>HDUW*_F4?;2G3IU_+I=1R^J?;7^M:JA1ZJW4JJG0CRD]Z:3Y8:[F
M,)SGS+"W*R-F(T0[)5!9312W2M*0DCL5D'ZE>]-*27,TT1M]0RR6!VM'Q5'P
M[<,"G%LPR2A@%30KIM^>9C+5Z&,XED.2-..I0Q*MN/3WXL@$4]1$Y]J/'6E-
M*$I*A].JEJ.@Z;=G\!@:.W]BD/!O^0IR[5BO-=[6LHXV9Q];WUI]\O=M9^9+
MGE]94&6\M4,J)J4)%4^'75;NNC-$FBY;FGG`8G=7LWK<=(WMR/$-EB:U^(!#
MJBNXT"7%LX;Y7DL^C?LPQ&U+2L%#-L9E7:8ACJ"VH4CQ@D[NJ@NM0.G75=A_
M3;38[DS.(+"TBF-=R=6G2$\,N:>2)T=-@#MOF2T@<`6TJ2J^YID=P1_JD6W1
M;?;&5_$^NLS)22?H(%/#OI__`$!I'`J2_IB+^YZ4JH'!'$T1Q+LJQ3KVI*@M
M"LAO,R[!LCJ-D5HVUA:1X(42GP)U+Q],V,<;8V@96@#S8*5CT:S:QK2T5`"<
M"S8=@5B>4[8\+QJ"\4!!E-6*VID;`L+`WO-S'!120>BZU\=/;30].@>YTC,S
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MTJ;=!VJ2H'8H=4[J?3J-:YSOW2$NR,/_`'@"MJ'4%GS>:2LDONBFU9'1%*^;
MH/CI0@C:B6,1THX.KP7UN*\4(\M$J^JNH`/A4=>AK_%H`J:))8[%P7=SBWG1
MM*:%:2FI/3IT->FG7@W\0A0X]P[R9O)6'--U0I.&W(453K\Q>?(12IHGY<U_
M"-57J9O+8V`XN<*@[MM$RO;AK8_#$'.[$'<-R.K%A4+..-;_``)#2R[)NMX0
MRXD>=A;3$*B@1U"P>J:>.I?]/9)+&02/-6!P)IPJE="9/;74<CW`L$C20.%0
MHC7*Y3<*N$VU9C%=@3+'%D2DR/3*A-M<1:"T]0?K'7EMT;V]]RZ]JZ[Y%K]K
M,:#,.\A=6_.[?Y7>A-YPUB5_YKY(NG,5\LDUNT1VTVK"K/-2!\EC\61ZZY+K
M(W,M39CZUTI^:E-=5K7;_GZBVWA)QB&.[:Y06I:@V>X#XP0,@'EJ?O4Q3P[C
M^>V=E)9<MUT2P]#5(82D.[X0]!>VE:N*6@D5U5KDW5I<,DS-)K4;5&NO7QM,
MC/B&(4>\C]NO)MKF/LV:2+G:D!>QB>R^2`D':HEMM25$TIJ7M^I+N':`?(E;
M?J:[A-7`'N5+'NR]S',?M_Y^M?'-SR3&\<L+/%&59:];)EI+C`R)R9$A8DE,
MG:F2?FEM/K<!%`!TKJWZ=?.U&U%T\4<21YET#1K]VI6#;IXHXN</,:)I+#]Y
MWCB[GCD[-<-<R%(85%N%^QM,=NYQW`VM3<FW17KBH.5D!/174()-.FI6U+1.
MTNQ%?8I123>^\3P:^<?WB^X?<LOP>X1W9EL8FWGY2(XJ-(:;0V@!MUY3TKU@
MX5J3]4*3\=37-@^4H57?*V1(R_C^+*GWF;?+_E6?P)4*5/O#LF]N_8+5SN!G
M,RGE>O#@L.2VFPKRI"E@>!TW>6N=5N#4*T/[M\73.K1R%?\`*'U7C)95BN^+
M*O"F4KN+]HA6ISY6!)D)7&6N-&5(200=RZ$'3FQ_F1W'U)O=/$<)<=E0E59+
M3S;B]EM=EQFYX?#M=N@1XT1N7B,Z4\"VDE:EO,WR*%!6\=P3^#4ZHSQ3.!]"
M)L[Y&]SN"8E*R)A_CB]3XUYQ+'[1&EXWD=KB*GY?D4/'&')"H60N..EEV:''
M*BI:20*F@TW<_4@XB%\8BW5!K1,WNSO+AL*7MNE?>#-^G_-?;6LEMIR@8Y,8
M.UVI`*T7!1JD#J*4.LL.KO-!)%YG+5+J!=?O"D*0&[=[9U"E?UBN4B:U["DO
MMI7E:Q_FP^9RSCN3F6B^?>%D-I<B>V%+=$!=9/+"MJ:C=^I#:TJ('YNX@]JZ
M=L?JC6@%\50.!0G:QFZ>^WUP)8]M#3"DA*C&A\J*=4-Z20-SK`3Y?ITO%XV1
MKS<.C+&MK0`UK4!:/>&"I"?2]3.>+-P]RED67W/C6/)M.(WR6W%QZW98LN)3
M:)!JP[=KHESU5U5T)"1TIXZAM2')L7:@[&,;M_W+07#:["N'C/'H^.^TF8KT
M8S7SK.-!:VVUH*7'+A;)"UT.Y0!^55TJ350Z]SKRIUGR;YSY*$`DG'O*YWJ$
M,I<]P<,7GUE._C\@/VQM`DE2([X4$(J`=T=`)<W4!%!KC\\,<WX5L`Q[3B3L
M/"E%6P76[R7^\#PW>=&<MZ,7&5*2A2W_`"!+/9.SRU54CJJFF_@+@?\`J1^E
M;^+;\I]"ZOMJY_[E*_P?9OZGZ7UM:_E]Q_F,]*SS[/\`RW><?>F+N%QN:[F\
MPW#?ML)/D5*=)(:#@].BE$"I<*MH^DZN7@AP32\O3EJ=B^E$EF.N&'S!,5;?
MR$@@;IOS))D*>615[TRA.W]'<?CH#X+%X$H^+9Y-JCK.8S.>3L!'M2?F8@^_
MDUL>N%S<47+K:+@2ASTP9$23&>CGH"`WN;%1XC5BL=1M#04%:J1C^HW^(>M6
M9?(L+:/S$A$AY+R'$M(&U*BA154I'<#5MQWKIQVKZ[<'&'@PJ1(3\R`L,^H0
MQ1/D%&J42-9$'.QX)K<?$.Y$-PN&01GU+9LK;EK0OT5R?FJ+4:[?42C\WZU=
MOT:W%H&D.=\(..&Y-ZKOBRK\XUZD)"HNT;TNE&X_#:"32IK7\6G/,LOE'H0D
M#=6;[.NS<"Y29+[*FI%QD2WU;O32A*@EIL@40VA3=:=>^I#0)+2+69KT@<NV
MM#)Y1G^Y/+8`#/O!6U_E:`^+9;H%R<M,*TV]N*%-N>FY)G(:2V^^E?<I>=25
M)%.@.O%/ZG?K=KVM=4R7/3TP;=03EK*NPS--!48888J8BUE\(Y5?31;VN1+N
M!5F_"4U3RIG($H)ZUW)J4;5>%?AJ-TG]>/U@LJ&XDM3]N]*_G<F\GSKI3RC<
MH;,B1.?L3K$9*92UN_,QG/E&>LL;64N-B@[*K4:OME_\F^OHVLAOK1L[:XR,
M!RTX8-(J-^*69J,DK<^*:FQ^\GC')+CG%A4MW%KOB]JE/1'IT@OMWMR0@LQI
M<`+""EIMUU)U[#_37K8=6Z,;B[M.7<D"CJ;,1_='<EX;I[Y6QG8?N2%Q)X34
MS;J?2>=4U`M(E-HV)7]GL*<F%(J:..3I*UJ->I5KT)8_R/D5/O\`^?/>E:HU
MJ:4H"30'L.YIUTM;?1'>?6B?ZGD'J7!!NL%V;'@B?;U2Y,+[18C+D!J>Y$55
M(+4,]7-AZJ([)!.GL'U/^$^HIE<_1/>/6CN0ZMJ',4BFY$1:TDBM%;D)_)0Z
MC+G_`&NY\OM2MELJFH]@UJ]7C=]06ZD&\W%85ZA'4RI2R2=O4!1/3X:\E:S_
M`#4O\14H[:K!XUO,1'S7S:7U$%O83447T*J'Q%-52/\`F/(@;%TQXD=Y3BUO
MI0^L%M+3IW-*0>I46^E>I[UT\0NAB);(952+%>?2RJ.%OM_)MHZ%.Z-7I(*:
M^7]+1:8N?WE(7/PJNOEA347W"Y06HJ7'W(F)-1TH``]7[/?:3Z@_U1'IL=1X
MGKJEZG_-2=Q]BHVN_1'\?L*</#FO3SK%0J/\M)5>BMY70.APQ'00VJE4-`#H
MGPZZ::$/]64UL/@KV*6#:(:##<2%!UQF2XIS<=WKLK*4K!IT->_TZZM']-O<
M/4I]OPCN13$O,>UWG)G+MC!SJYX]A.29%C.)N51"O5^B0P;7"N)2ZTXN,X\H
M`I2:K/3IJU=+VD%W<3-G`+6Q@CSJS=-1Q27$HF%0&#UJF7#/O-/<3BD9Z1[D
MON^>&E+RR6\K#(S-US#C.Z,F"XI,^(W"MURN[USBI9=:4)3C;;8=.Q-:UU99
MFV5K@P!7(6]E3X:^127XX]]O&N2Y`97)GLQSW`[5-BOM&\\9\Y7/+'3>HTJ.
MD6R+8;KCT-H-B,I2EN*<\OTD=8<Q]+D_$W,=NQ01M^EZXN%?(B?W?<S_`'>6
M6^VCFFZ<P8E[K\5XU5:[=B>92K/=<1FY*TSF&0VFRVD6*VWJVRFI$I4Y6QQ0
M*0&U%*@=X(G]";I;>;^6$'!N;TTV>52FELTIF?\`+379FI3MI[5YP87&_P!P
M'ED^V6BU\[?>58W.O$U$.VBZ<5<3WGU;E(GT88>,61'1Z2RM*?*A-$FO<:VN
MR>?VU"NUK]+LHO5MS=C'M*QVRX1A.3\M<[8>O$L)Q*QQ&7^-;!EZ(\(1($."
MT\+5D$=V(\X&4)4R$T;/4]-=>Z:U#7[6&K(Q2F^H]F*Y[U,S0[N<#/Z0BC]V
M_:TA;H1[E<N8(=<01=.#KFE:D-*+3);:M^3J0T`TV-V_S%74:L4/5>OASVNM
M><01N)IALK0[57IM'T$-9[XQ!X(YM."^V2X3HY>]U"H]L6W1[U^'\KA24.J-
M$J4MR=*CIV]Z!>WZ1I8]5:\0::>1VY?3\*39I&AYQE>,U13`;=R;WW'Y-[)?
M;-Q]`Y1ROW9WFZ6"]9E^X-D@6#AR[7FXSLE39U7HQ5M1;VEYB(8E"X_126JC
MH:ZK6I=6=16K*EA!`[U.'18QP\RA#CGO-X*OT)FY1>5;1&@S%NKB-28-WM\[
MY8.%+:YD-R'(5'?4D=4[C3438]<=07+'.<UV#J;^`3JWT#2Y&%UV0)*X;!@G
MOLG+N'Y)&@2L;S7&KPW*:D.CTIWJ/*0A.YFL5>QSU"*50I()/0@:D(>J]:N)
MF6\K7<J1P:=NPX'T+>;0=%AA=-$[\5K21B-HQ"0>67N;!Y8XA#LMANSR(]ZV
MJGRQ#BR7X\QE3;<<$`/20VI7E'Y@.ISJ\'\LB[Q[5!;E91:;_%N%LAO1$)0M
MQE)5M11LK`HI3:1T*33H?'5?B^DS^$*-N[DQ39/[H7R7=U,D!*S7\[H:5\:#
MPZZ<P_5;WINRZ+W!IW]J3LVY..%L(57U%*"Z@]C3M6E#J23I*JPK6AIH)<<0
M$K4H[%%-:J*CNVTJ*Z@;X_ZIW</4M6?641O<-:G<:Y@S&;(O5QR&1E.-.Y,N
MX79@1I/\_?D175);0AM*T;64I34&G?2,/U`IN:O@CY/6%)RVR&18["V"K:;)
M:CU/6I@L=B1I\H98*EM-$I05>7M4D]:5[T^)UA":/D[*8<&7:+=*F-Q(URI\
MRXZ/*MP=6VDGH4>HKI\>NF.I2&*T+QMJ/6ISIPQC56\T59D?ZD^_#_N0SSC1
MV+:I$N5D>$)#89MTU\/.6B&4`.KLSDCU%L1ZG<II/12^NJYXYZZ'GLOE'H5D
M6!\B8QR+9Q=\.NK-T2Z$.36O4:BW6*%_MH\^VH1O<*!4+)/;3AKB]H>=I6?=
M/P?!N2T)52@HENO1"$-H0#\1M0#6GTZRLKYH0L-@KNZUK7N:?DT(6U*RBM/'
M0A9^LOZ/R:$+8TX\IQ*6U;5DD!0%".AK^4=-90NIN`\MWUHL-M+Z`:.PD!MU
MHJ^LI+AWJ:4Z!1133=3KK1\D48I*`05H^6&,4E`(=L3?YCP/C/)1'VWB\%-U
M9\\/(H4H6;*;>2FJG(EVAH:D$J[_`*WU>G:@U&3Z=876UH4;/IVGW6UHJH;<
M@<:\B^WF=&^T1,Y%XQD*^83F%FCJ:NF.T_:V[*K75;3#2>@3+0351ZC7.=2Z
M>9;,+@`%S[4^FKBU:78HVL4^+=8"+E!EQ9D2:?7BKB/B0A$=8JTA;@K5T"N[
MZ=4.]C$4@`[55HH9H7.;*:XX+MN#<R2VTU&><204C:E5!7<.G;M731OQ#O2R
MX%0)\91=>=<6_3;1:ZM4)Z_JZ=5#P-=32PH?\\-S_P"TW$WV=GS#>$W12*I)
M15BYR'6ZHKU\ZC7Z-4?JSZ\7\'M*B+_^99_#[4]O"`OS>-W1J4U;_2<ODE6Y
M+B4.CYVV0)#Z@WN)"O4-4I\.VGO2X)M9,OQ933S%2=H[*,W#%*3/^+;#D[L<
MW&UM3)10EPRGJ&2$`$%I+A02&25"J2#JQV3+RM:E2/C5OQO#(>,6F<Q;H3$(
M!HA+;2`E`1M2-VU*0`M5.I'?4O&V5NHM$N+\@]J<1R\UN9-?@5X7&R"ZV9V&
MZ5PK],0TI)H3%?;^:65'\Y1<62#X#IHU;ZL?>L2_2<>Q2+ES_4M"PBWK"FO3
MHJB=R@Z=AW*H21\/@=,%%KQC?>Y89:.1??VK&;U&E>D_P4^8K4:08KWK0KQC
MXCN*=2A=5-?:#I!ITWZZ%TY_M;?XW>M=4Z2_V5O_`''^M5[7WV)X!;<@MMO8
MF<@WF#&@AS(;-8;YCEJDVN6M6\O1I]ZMZS(0TV:^F10@4KJQ0?5"LJ?2P^RW
MA6TXO*.'7'ER\-(;?GOMYI?L19MIF[-Q;;3:HD=UY,9:3T-=W2E*G4BA-?\`
MV;%O#4Y';V$W2XXVIJ/>A)9<`BXL_<+Y&98C,+61&=?E]7':DNI;0>@`UE"N
M"^ZR@/OXIE_RM`69=[3,50U_6VUU/E/YO[%/\/QT[L?YD=Q]2:7W\L>\>M2C
M:9VM-,J)_4MM`4(KYFT$U-.O74ZH),?[C)UOM/'6-+O+TN/;WN<.&5.J@PG)
M[JXS.7MR"'$,)6ZE)5&22E*5*/@"2-"$_43F_BA&U7VU<$T#;*?5PWD#;L;)
M"!1G&%+W;?&E/CI:#X_(A+"%SKQ.%H_VVNSO0=8F`\HR$`5[*6SASJ4J/PJ#
M33Q"<BU<]\5);3Z3^8NNI;26T1^'^4GE.KH-J67$XGZCI4>QVU/PT(3B63GK
M!WW$I9L_*$M=`4M,\-\KM+!J!OK)Q2&T>]*%1_!XZ7C^E+_V_:$A<?".]9<Q
M<M6R[\+\I0&L.Y9C!S#;@RB?>..;MCEH,B>IF"PVJ[WIV.@;6GU;DJ8H"0:G
MMJO:U_[<DKP/J34;4X,&"[']JCC,IL!3$;&UI1Y>CK<Z.S1S;5*P`2#2@)[:
M\H=24Y;O*JA??O?Q'UE*7%(<=^R,*4V$?,MMN.%K]756P#RD5H*:XQ/-RIG&
MM*E5YD(F<0=RV2+$U&G0G$EXQRI12%NE1W$G=UH/SJ_BTEXS@4KX(?8([V,_
M[(G]_P#8BNW\GTZQXL<4>#'V"B]>7[[,6V+9*0VQ)4A`:>85+]4Q%!F.2UN\
MP<0LKJ2`-M3VUT95$X[<4818]YF0/YO>++,=0_Z*UMM!J3&>9-'&&DJ==:6A
M1/GZ@IH*:U(:?B`/>L#W?AP1@KY%B\XZFZJC3IC-^MC,Y%OD$KM[C\V&XPW&
MWJ0VXV\P@J7O/0E0'AK9H`<*`;0E(R>:S$_$/6%8[-C6'<X_+:>;AA127FUK
M1^M43Z20$^?S'IVU9\SN)\Z["=JXX:+$@N2HT9];J5_+MM.K4M2FEC<IY)65
M!*0?QUUG.\;"?.5B@WHQ2ZVIP0D(7Z!<2R-[:BFBU!-2HIVJ(W=^NC._YG><
MK&5O`(S=@1HC:]TD(5Y$I1N4*J+B"`!VK0:Q4\2B@X!1XY+R5-ON65L)>2E4
MN#$M24H4=S;;JEKDNMA%=I0E*:D4/FUSK]7NKF],_I]+!&XMNKJ;EU!HZCL@
MI4$&F)WH8")@[]U(>X81S'/PG&Y/%E\PZ`ERT39EXL64V.SW5<^]W66XMJ0X
MNY6F:^+>BV--)V-R&""ORE)UTO\`^/\`T9T;:?IW9OU=MM)>7CVEY>QKY*/J
M3[S@75QXJZ6=[:M@+"QF<BGPC[DT?)\VX6F<F';X.-1+K%19[3-BQY`MT:=<
M$18C.07BUQ&7_3"%SP0E!H0D&@UYQZJT+IG6NL[^UMHG-M[?,1EJ`:"NXJ-O
M9H6C!K:]@"2^472YMXY>F6KD5)C6^5&K5U-=CL+>`:`J159%3W&N%:7<1RZG
M.RW#F01RO8&DG]TTKM.U5B^ES1YF8#LP58W/]R7AG)TR6P=SMR@-O!"20"VS
M.3+2$A-`&U[`-O:A[:]^_P#QS>]UH]KR2*["<-H4CIA)TZ1QKF`V[]H5OO%;
M19XWPL*J'IMDAW>2%5WID71M,AU*R>JB"?IU[GTP`V&P;%`WN\[UJY!F3D-8
MK;H,HM_/9S:DR@V'`XU':MT^X-I6XA(JU)>@;:5(ZT(TK;AO*&`VGUI.V),(
M)VU/K3?8;PK/M'.=SYADW!],>YX8]C[MEDO+=2U</F("XLR&T5N-1FT0D.-J
MV;:FNEP`*T`V'U+6Z^B>\>M2"O:G&[+>7VTE7R]ENDA?7ZK3,53SCAZCHVAH
MJZ=>G35>NO\`:[GR^U*V6Q)#V#NQWN+H]T6\EB.[#3(6[Y@VFKCI+BDA))\J
M:DTJ=>3>H<)7?Q*4=M*FS#R^SJR5NTP4I;#*%R+@ZY5:)*DMH6V\RDA6UJCH
M-.G?4;E:-.S4&;,,:8[TC-]/RA*E$EQ,AN$['0AU"7''04MA;:'7%+;)5UZ*
M:((H>@U'IG4\2N]R:R%ML.%L^0%I7IAQ:6QV<:W)*0I(ZCMUTG<5:S##!/K/
M%KLV*KFYI<C/^Y',&43)*DN8[BO5QI+26U&.7`ZVII(4'-BQ0CK16JI?_`2=
MJY]U#]8C=F]B5N&F0C.\4^:*EH1*:98BDGUY*4QY13(2H^#A505->FH_0OYL
MI*Q^%2L6U+F,1YT5HMR2!#:8W)!0I*"FB@5;:U3U/B==8C^FW^$>I252M>$F
M+%YKPS]XI2U1+ECUZMZV&&T23(EKA/*CM.QNGS("TU2-R=I%:ZN71\C8[BX+
MO\H?]2L'39/CZ?W54WPYP.UFG,7)N67FZ72^F%FV4(LC\V6Z^F+:D71Q,6!#
M:?<(@QX_IT])%$@CQI76VLW8SFB;:_-*S7@UKWAN&`<0/-56#1.%,?BP`[\J
M?FIR4/)C4;J&T.H<<>13R`JV=3T)U#7\D4VE@,:`^NT`#>HVU+C*:XXJC+[\
M"YVW$_:K=[);2(B<LY6XYL3WIDLJ>8M9O&1.N4:`W!E^U-DU\2#W&KAH%N8-
M)B?2A>-NRM`-O':NH=)`?CX#8S_Q+S+>V;%%YE[CO;[B,E#B?M[F+CJWS`*;
MVFYF46-,HFA/[-$95:>%?`ZEP`7"NVJN52`>%%[)O>7>DR^7;Y\I)I`BYIB5
MK27'%K<D,0IT-OU?442I22X-JJGK\*:[?TM"^"'\0FG:N6Z[*RXN``!4G<!Q
M349OEULQI;J9,I?SS:G6EQ(J%O7!3Z5J!0W1*F"JO3S*[ZEINHXM,+HPUOO&
MNP;L$ZMM,DDA#J#RI,6KD*_NQ@_&LLAM,EHK9^TKF(LU94%!OYZ+';4TA9-*
MI"B"/'KJL:AUPT-?E'O!I]2<,TA^<8#:%([VT<5VSW&\M8[Q=S98<6R_C69/
M:S%O'K]:;==;3;\DQN/\W&N\`7-QH1KG%C(=1O0=ZFBI)"ATU2(=;GUKW7--
M#V*RVVGQP&LCO.4T5SX:LKMYR")\JN!#&1W\16H,>SPH42`+K*3;V(3,>&4M
MQTPTH(`)'75ET_I*:YB,H)`S<2-P3+5M:ATV9D,;6N!978#O(7;#X)P9*6P[
M;GIKS:?U;SMRE0-KM/VE("VD/55U-117PT_'2$]N>?4^Y[VT[L5&Q]2LN)&P
M9&^^X-V#?@FU:P!K(?<'@\3YF=]EV'#X[D:"^^N3`CR57BXL>O'+[BU"2XA0
M254!*>YU7KR"9]Z&.<XLKL))]&Q9O&M%:`*U>RVU5EMD2.DK]9AL)+9))32M
M/&G;Z=6B&(1QAIIL5-O_`.8QX!?9;A"%EQ1255(!/B3UI^#2H#>`3/9L7"UN
MWMJ-:%0IU_'_`!:%G,[B4N[6ZEI*"M6T=.]:=S\-1MR!SCY%-6>-N"=M3ZU$
M_G?#[WBTNWWW)<UN>7G+H>82[3]IL-MC&XK=]7Z>/0G$5<?@LM.A2"H]*T%-
M(T%4XE)Y9&Y21LBD?85D)((38K"A1(K1QJSPT.I/3NEP$'Z=;)FM\E/JMA;2
M0H4)J`!7;W[T/AJ0A`Y0P'V*%%?W+1VG;+;[FW528JHWKK2DI^70MT(+Y)`(
M2W4'I4Z8ZNUO@78#XF^M3G3@'YJVH_<?ZDS6&\HW#'W6+??61=[2A28\>4PX
MOYV"A21N=`60%M-E0)KU^&JGE;P"Z)E;P"EEB683[%,@Y5AF1*BS%)94S>+8
MM>R='*@H,W2-Y&TS'@-J@I-=9658CQ%[H;3D:HMCS5EFR9&Z/EXMV=>*+=<U
MJ6@!AZFY$>:[7<DJVH"4JJ1XB%+`.!2=Z76W$JHK>TZAYL[D@C8XTM:%BA[@
MD:$+<AM]W]FV\Y]"$.+4?H2E(*E$_0#H0MES2,>M%SR'(Y5MQ['K-&3+O-ZR
M*6W;;9;(JW6V42)<AY:0P@NN)350I4Z$)OL]Y1L>-\%9SSIQ>Q;.?HN'6*_W
MNW8EQCDUA>EYQ.QQA\W7%L?O-VD/6.9>Q&9<5\LBKP*:4*BD$V8H7C0Y7_Y5
MISU=[G<+'PS[6N/^'+>RE;361<AW&X\E9Y#>8?"51Y^.R!8L<C/1RV67FDQU
M.,U)4.@.IMG2D3VB0R$9@#M._%:J9WW>7W[W.7N1Q+-/;=R%?^/97NPOKUQR
M3V]\KWNWN8SC>3N(F0YK''UTL%B?$9R59`"VPQ11F,K`J"#6*U;1H]+;&YKB
M[.2-M:4I]Z2NH#-92$;6@'TJX[A+"OO$<ES+'\]S7*;1C[-QM;']H''S-O79
ML7<S&%<WI/VO8)BG';U$M[R/VT9P)#:R4"J0#J'K1/+65D&@U>`7\:8[]^U7
M!P(3CEM9&4QK6XJ>A35XM\"LF"8ZDGU42$2DE"TK2#04/4C6\K6NLW9@"<IV
MBJQ*&NLW%P!P.WN7GX]N?(\;,,EY1BP`(6)#D7.X^&-)W);19(V0SH\&,E*`
M*%"V'*5`HGZ*:XKJC6^*=@-I7%M7`%V:<3ZU-MUY+Z6DMD>J`TE:$^4@I2$=
M>W4TKJ.RMX#S**6<Y[:['9D1EN,AA>]:2/*\*>EN-:GK764*`GN==R!GD+"S
M:WT-J_=UU3KVT%(A_;$H+A[1YBXY2O8U'CJI]2@$MJ/W/:FTX!>,,:*0/"ES
MBNXK)=$)\+%W8WN*K^K=3!]!157KY7J)/XM)=-DX\$DTG.!VIYA=7&5I<4-_
M7;YJJH#U^GITU<@2-A3Z@6NZW<R6NB`E@H"%.I&T5!55)``)Z$>%-:YG<T&I
MJM@2!0*-<.[HMW+-U4DI#-SAVVX;J$(3\C&DPZI%!3U7@`J@J3WU-2,YEB\;
M7Y,#P6'.--I4G42(TBR_.2$N+;6=C?I;Z%TLO.-)(0"0%J:`!/35)AMY?'`$
MFE>)4C9AIW!>"7[VWW&9$O[Q#ER%C$1+,O`+':>-HTZ!MF3E_.18-ZFH1L*V
M5/QI+;;92E174@4UVG1X^78,;VD^==/T(`:<T"E,SO6JRLJYDY)?B09=VB9Q
M9FW736<_<KK!^;2S4K6A;[#;<@[4$D;E43J;MG9)VNX5]14PI'<5<L<HHXFO
M=VBV+*IMBI(6YD>0,W25C\1LNLEMU%W^5%N:0M"5E94Y1(`K2O69\4.`\P0G
M-XBS+)\CX^RV^72YXT$3)5RPU35IF`RGFK5<)%\A.*:*TQWO4>G*;2I&X;4C
MK32+GYW9AO320G.5:-]W/R6K`$9':7U-LO9-D+8::?<2E3K*K>]"<6QU*5(^
M;4$&GYQKVZZD-(G9;W[99*90';>T)I<D\DU.%0I^-+JA#*NCP&]2?SOUB4$=
M02"`4D#KX:G+FYCG^"GD4:F#]Q\F0FR\*6AMMW?>O<IQDV]L2LA#%OCY9-2M
M:TC8E.^-NZGH4U\!ILT4:`A3DM"GTH'ZP[]]2$O!2J!1KT2LJH-.+?ZGD*$X
M=F>DJIM<D*HL!6U3IH13H:5[:>(2]M9EJ<0E/S*E*6$A(#Q*B5=`!2I).A"7
MK'S#*1\QZ[*4J!)?#C2!T'YS@2GM]/;3B+Z4O_;]H12HQ34^X^^0U\&YS$BW
M"$\X!C@6PW,86LF1D]K;0@MI=JKU?34*4ZT-=5S6O_;<G<?4H6[-":8)Q[HZ
MXGVPSVW%IBSV&,94AMSL")\=M152J"-ZJ'KWUYCZA#>2[!5>\^`]ZVX[>HD$
M-)E*2RNC"%NE14RXIQE(;0A#84$DJ^@:X=J,(DEI38H**41.<3O2H=F-3892
MRX%O)?D)V)W;D4<4*54!2OT'4;X/L3CQ;5Q>NO\`P,7ZM/VTKO\`D^MI'*EL
MQ]"8::Y`M=LCMHGIDRPU(4PJW^>2M:&EJ#*&**4I+I&U74402==05%6<06&?
M$8E(@,P5.0/F'85G0XER/,:H)9N"2HD/25+24]OJG36XNA;N:TMKFKOX4^]8
M+B"`!6JZ8D.WPKW8XH@LR(5QR3&GI_S3:Q.==4]^K6ETJ/I>F*#L:@?3I>"0
M2D&E,5*6MCS7-=G`Q!V=O>K,;BU%<?EQ2W_-V5FJJ@I6L*.PTIY:JU:5TDW`
MX(JM<=A:WUE(:2TZ$I2K:=X4FNX?5I3MH2L;^8*T72[*;]929*ICK;#E8[<9
MU"$I#9JV"GTRIP`CL"*CIK+1F<&\2MUP7)Q,I/ZQS>%+;4D-.;]AW)`]90Z-
M.=?J&I^GIIWX,[W#S(4.N2(@9RRXK1/91+F39"8S$AY*EK;A1H[KZVXP47W@
MWZP^JG\>O+?_`,B+&_NY+2R@:]]NQK9"0"17.<,*X^Z$JSD9?Q)`Q_"F[BD6
MVK*8FUZ')NB%)*70['D7*,EHI(7N2U+4RVV`>R0E24]J4URBWZMZOT-]L^WO
MGQQ#*V.(QR>ZZ@`).8"F'`),.C9(',E#J'90I*W2T+GSF[G=[=&F2TS'I2)D
M]2GY.]UY+U`M"D)"P$TK2FE[3JKJ6"YENWS,=/-7,<KAM_XD3N=-V(BS2:M-
MGN8?2-]Q6W#CA)"4I^?D-A``IYO0^5Z_I;OHTTT^"<S.OYB"^1YJ`",:[=IX
MIK-;N98YR:^\56#[@]V6<T8Y;&%['9";-"]$@N[Q+N<*,X`$E/[-#A)'C37O
MS_XZ6CHV,A)^J=M-F_R[$\TZXR:=**;O:%>;;H#=LM\&`PD)8M\.#;FD@4`%
MOB-1E]/`+4G<!X5I].O;EJ_PUOR"*GBHJ<<ZM,%T.--.ELNM-.&.ZB3&4M`*
MFI+:'6T.U\=K;ZP.W?6\<PC9EI7:M(F<M@9MVHW;3N52M*@ZW-T&@G+N._L2
M=S]$]X]:(,R4J+A^7OA80(N)9%)6LCHM*;7*;+`ZU2IS=6O4"G;4;<Q'\DN)
MZX4)IYTK9;D5^R&,R.&,>M3;);5/L=O6I8(H!(05%!2`"20Y\=>/M:N1/=/C
MRTRN.*E'"I4OK5AL*W7W[5>HPJ,TQ#D;U;_5"5*]18(IMWMA*?HVZC^>/"^'
MIC4&O<M'LSMRU2@4&9LV6HI6\M#2VT2D.;4N-E2BWY*$^1/3OIM1(>'/'T+H
MM,9]QV(I#1DMM1TL+"G`A30`VE9WA7J;!UH*5TE<_!Y$O:#+F'`E5Z\\QGA[
MDLD8MTAMF6]9<102IK?Y$V9M9!"5"FY2!UU6KJ+F@M!I@51M8MS<W196AK5'
MN++O+.68==;F@)#-Q6RE#:@I2VX\&8\%C;T&^A%.I&FFAVI%Y\0\R1MX#`VA
M-2I6VD35ORH[SZD,2HJWHQ*2/04^GU$K^MYBD*^COKIS,&`<`$_$)(!JC'#+
M8VKF/B9%%NN*G/M+>4:I6EV%,2/(>HVD?'5BZ=>!=/C)IG:!7RU4UH=8+X&F
M:HIW*)/`Z$Q\GSMJ/'+7S.49*0=R3L/VS,2JH`%:D5TEK$-=0%D'C,?WJ>RO
MM2&M1NFU]M!0?M4JKC<XT=JW)?N*&'&8RHCP*2LM[R:.J`6*I)(%/I[Z8:7:
M7M[%X/EN;[QQ_9^U,[.W<934TQ7GP^]4]M?N(]Y&*\?8W[=<#?SN'8\VO]XR
MM2;]CMB;B2&[(Q`LH>3D-UM:G4O+N+ZD+:]4`,J"@-R==>@T^YATZWM<AS,K
M4\:TW>1=&Z>DCLW/:]P)DR]E*5^]0<]G/W3/O'X4]Q/%7._-V"8=BO&O%>41
M<SR1M[D/';K?Y0M4.<Y`@VNSV=RX.3)TBYN-;0E1VTJ>O:1M]$N92'5IB-RM
M5[=P6L6>N:H[MRLD]PUX>O?JY).BW.W[\LQ^X24W",N(^4KOD(!-5J--JE=3
MKNUK8L@M26O!-."Y3$R2YG$IJUH.]&<^SQ&\NR$2VTS4*N+BD)=2%%(7N6TZ
ME2BH`*"NWT:YCKTT<4A=,??QH.*ZEHK8YK1SL!D(![<%U"TLJ<0AII#BE+0A
M6P!(:JH"NVIJ$A5:?1JN:=IT^LS-I&6LS"I..%<>&Y-[W4X;:K,I+J'?^Q3$
M]I-K8C<UXLVXTQ*]*U9J^CUD+"$NQ<*O\AMU(0M*O42IOIUH*ZZ7==/V>@Q-
MG:`_-N`I]ZI]S>74X(:_*?.FF:<6XTRIQ04LL-*6?`N*"EN*3UK12E5ZU.KK
MID!%HUX-`_'V*N77,:\<^LCJ8$84'#&J[V7"5-MH2%+)2A(*MH*C0"JC7:*^
M.G<T+G1.:'8EI6MM,R*XCE+#1KP=HW'N3(X[,3"]P$)"F7C\IA\7<ZXD,Q75
MMW:9*<:9D**DK=2V@FE*T!/AKC]Q<Y]7=!RB"P[:[?0KJYT5W`90\-P[U8,N
M\_:#DA^$`J.RVV4K]84=):2XHIZ=`"NGCVU,0W3+IADR\LM);E)KLW[MM52+
M][G7)$8S-IM1'+N1D)Z+VJI3;OW&M14=*=M8=*&@FE0$@QCGD#8C"VNK<#04
M:@%)%2?HTEXH?+Z4Y\*?F]"7K7EC(7WK44_'\=-I'<Q^;8GT#N3&(SC1-'[T
M8BHUJXO<05(8CP\YC.)?9>C>H^U,8?+;`6@I<4`*GJ*#KI.B4?*'-RT3@68_
M][]E3_A;3;7O\R'(3!V_21364BLU*<;J@+-$U_!UZ]J_3J1A^D$)@^?Q(FX3
M<6J-NMF&%DH;H26W$.`CJ?%.FNILYEH6UI[P]:D]'N1:7[9B,PRD4V;1105;
M?41N6#^MH\E%>K:7$)\A/B04]]4V=W(VXKID;N9`)]@.Y*;$\QO>)7`OVZ07
M8#[J52K1(<I#?)4-[@4K<&'RGLNA"3UH::&.S-#N*&NS-#N*E9A6:VG.'8[<
M)3GK-R$)FP)!*'&U`T(;4"V93`)%7$[16FMELKC>%9L@6>UP9#BDQV$(9;86
ME:=C8;;H$%Q:U%`)Z5KUT(4S;#*CNEMI*&D)0`UN2=KE`-@4E:2E25"G<==(
M&<`D40HV^[[C#-.6..Y^#Q52,HPG+K%-PO/<.;9C!Z]66[)4A]QB<\T\\VI2
M#L"D;7FET6A8(H=?$#@L*K_V'_=*\^^V,Y3C]\YA5<>(;CD/VGAF*WRVJD77
M$&HTMTPY*VF[L&%7P6AU$5V0RVR'RT%J34FN?$#@A<',7_)I?8ESCS]/YXSG
M-.6K>QD*6KGF_&6`.8IB.*Y=F.PL3\G<FBSW"Z65RZQ=HD,Q@`XM&XD*43K3
MQVHC`2FGE^]"LI]MWW9?L"]H@MDC@#VK<68OD-I0Q\GG5_LZLUSM$AHJ*IR<
MDRQZ\3(L]145)=CEG8H]$@4&DWSW,U/$/+P-FW!+LE:VWEA<*\P`5X4KYU.^
M7*D2?U?K.+;I4O24LJFK60"LNOQVHZ'`%=$DHW;:5)/72:93Q.EL39M.4D[?
MV)#Y]>3C&"9ODKSF]G',.R6_.(*PSO3:++.G[`\HJ2V5%@`*((!ZZTN9^7;F
M,"N!"W?<?Z,X;CZEYQO86MJ3QY"NCS(5*O-SN=R]0.)44+G2G[@M2CM\Y6J;
M6O37+-2LAS^9(\-S5H*?M7%-7NO]6?=.T^M6"&6J$LJ6\%%2JT!VE)%?B3X#
M44ZU>`2PYFCR*+\3_=*-VKJQ(8JMT%70[BH'M7I2OCICG/`K//[%"#W(7-YO
MD[`TQ$U>?QY]E)4=[;:4W64OUE(IYQUI35;Z@C=*&G9[OM3>YG#(C,1@W<GU
MX+NSTC$KB'5QU*>OTI*U-HVA1CN`+*!N.T+IT^&M.G;=S075V8^M-+*\%X20
MTMRX[:IZG'8[B2%)VA/F&Y0()`/3MW-=6?,>!4GS^Q$;\J,I;C2G`RVAL*2D
M^;U7#NJE-*`$@:5CC+SS-E%GQ'8H_9S';L]\M5]6`V%N/17-@W?S:33TDK6*
M`)9=.X_AU,02!]+<BF;"J.?F]VF)3CS.0K?9L+N1N#:D?(1&U"4F44*8N;Y]
M*'%:2E(#BI'J$;C5(![:RW1F-N.=S&TX9?;53-DO"5]YWDOMCY"]RW*M\5?[
MI@W)-NNS-JN1L^*2BUD>0PH*6KHJY%%=\MAT-ML2F5))[D'MJ[VCSR`(VU:.
MU=1T+)^7-S&AS.]:@7QUG6/6N?B5KO7)>63L:;GLNW"!<FYMRL=B07"EQIBU
MR3<G7'G`:'<E0J?JCP=L<]S@",HXJ8`C)IF"L5;]YG"]DPS)N-TY+G^5VE60
MVB1"QB+C:/W:8M,-\O2I@@W27`MT0K;!26FV2A^OZT$)2-;N+V[#58=E!H#5
M=N:\[<;\\V>'(XVQLVBWXW?<@=F1';#8K/ZB[U(=?A+=79BA#KD"*XE!`%"4
M]-HZ!_`\BW#W;?VINZ+,<U:*07M_XVS2]Y'P;DMJQ^[2L9MB+RY-N#3[4%MU
M1>=2R9("G5+47%"AH>NF[;WG2<EK2UW&O!)R6AE:69@#W*WD)#;S#004%A/R
MZDJ.X[FB=Q*^F[ZVK%I^8M]XU45-;F'::J/ON0LMORFX^WC%[RU(D6V;S5]H
M!N!<KA:9S4BS8CD$AJ6W-M[[+J1'>G^!"@14$=]2Q-34;$VK7%2`9X<PE3`#
MLKD-Q*G`-J>6^3&34E5"7&\H"S3X>.EH/J>191S!X*XY4M*GG.1U$TI3F+E(
M^4D"E3E=:UT\0EQ;O;YQ,X/U]NS22A8_7)?Y4Y+67T*IO0ZHY5N5Z@-"="$O
M;9[=N!"AMMSB;&KET%7<@EW_`""1W(J7[K=I+JU?2I1UL)<@,=/J#+W;Z^A9
M&PI%<Y\2<58=Q]".'<<X=C$^Y<@8);WYUGM#,.7)8<NQE>@E;0]2B%L=RHUK
M]&JUU?<#2]"="X9RX'$8?>H2\4Q^0VF(OM=N?S`4VZH6-3KH^N6U7R.4M@?6
M*DD]Z]3KS-KDPEB.%%3KVY%"VF_BFZQ>-Z=FCON(5(2NXQB9;CJ1^J2VA24!
MH@JJFOQURQUJ'3NJ=RK$TN<T`HEC:[FJY3I;=K:+FV6^@(+H:&YMPH7U*2.J
MAK/@V]B1J[BE!]IROC!^MZ?[5SZWZ/\`1^_\&JMRV?-^]P4KXU_^6[9Q3/R;
M9ZY8?M5H]14)U"F)L5*0^(R5)W3DI^JI$A-6RD^4!1Z5UT=5=:H4=E%QGJ?B
M2H;=PD0D,!7\U4Y\Q(2B?54<H4[N!32M?3_-I4ZB=2^./N/L4C96XG:]Q_=I
M[5UW*!+@Y!9I"G%*@_;]D7#2?.MMN!D`A/!3JJN.;HRDBJB3X]]/K+:!VK62
MX=;S!@V9AZU9-(;W(EGN*JDO=ZJ2R2LT/=-?HU;5T-<T-424PW(C(*&W'8B:
M;EU_622T[6IKU3^364ZM_A/>M3$)N0^^94[Y%"77/2Z`J=2E9"0E9JI)52E1
MU&MX_J-[PG"YV8D!+<Q8=]8I<HE"*M@KH5)><""/56DI[JJ>NIA"HR^\ZPS+
MLIO7`ETLN/9;DT%KD/,8F61,&N:;)?E6.5;[$EN0+F%M,0X460A*'2Z3N#I]
M.BNND+'IN]ZFZ@;8LM&7%ER@2XM!H:NJ-AV``^55;6.I=*TC4&6=^:2.C#O(
M21QX@JO2\<\\A\/^XWB7CKC;D+,[O@-UY)B8SFYNMZFWB)&B/7&VQHUB=1<U
MRD);+3ZVR6RFOQ[:B_U,_3C0K'IO4Y9+&..\MK.5[7!OPN:W`CN4_8ZYH%Y#
ME@^NX4;WG9O5X%U=EW1"VK7=(]H]*YQEK?DMHD.FWLOO*F1XC4A#C;K[T=%*
MD$I'44.O#7@HTYJHUS7>;I?)6:C,\?M$;A5AS&)G&-]BSK8W<Y%X=NLF*];)
M,)N0NYRX"XZ2XZ[(;:#;VU+;A23J?L[*`6,9!_&YKJC=3W:&O::X=E5FZ)_+
M^S,5#:V6][*O=SAT(U<+.8VF(E*DA-(L=2YKS:D()%28YZDDCP.O>7Z`VH8R
M!_`^PI&R_P!OEKP]H5ZC*VWVPH)\L@JF(ZT(#RUH5V\"IKMX:]:IHMGI-_H_
MPJ_ET(6Y)*34=#_D^.M7_">Y-[GZ)[QZTF,[MURON"YK9K8\&I]RQ.^1(2RA
M"MDMZ&ZAE>U0(4!N/0BAT7/_`+<G']T^U*V6Y=WLV90CBW'$QD;9<&+'M3JM
MQ(4Y:FOE'AM)*4[I,=777B[4OY^7^,J5.U3+CVQ<_P!9=P0Y'#Z5EUXO.;2N
MO1&P*"4E53UIIBL+"*ABTNB*TX'FU`@$]2E)41M*E54KXUKXZ$+H0F.N0TN/
M,4TIAU*BRDT!*%))0JE-X/;KI&Y^#R+6V^)_>579S0N3&]R677A:/F$-6K%F
MB@$)HR8+K?0#L0AI(KW[ZKTFUW<53K[^?<E!@4AQW/,43L6W%<O*U,QW7%O)
M#3L*0CNZ5'J%*'T:3T3^;*0*F4IZ.ZL+<3L5Z:6E.(%`E``2:(2`F@&NB#8G
M[?A'<NS')T&#S#P\S%FI$A_+8D%A)0E16VN',4\T=X5U4GQ[C4]T]927FHM8
MRHIC[%/=/1<V_`W`*$'"UTR&\\A\AXWB>-SYEU;S3*XL<6UH3Y0#5\F@$I="
MXT0$GHM\%*O#70AT8^YUMKG'"GW)_J=FTZ^TC[;%+VYXMB&#)?N/,%_1=,E4
MS^JP'#I*)=Q"G`&PC([NT4VZ$V-^XF,$+"DTKJ^Z?HUA;.!R"H[$PN+<6^(V
MJI'W:0>0[K]M9/QG<Y/'=OM]HF0[;9[`FXW"2I+,!Q4)UJ4ZMX2[P/E^@54+
M).ZO34]>/M(Q&`T9<?8E=%;)?W):TTR4]-?N5&/M@]RO-KMZM-XY%SCEG/I6
M68Q?;<SB5VI!2U=+%.=3&OB1);2U;I,S(6X\9A+/II<1\P#]1-']M<VHC)RB
MH"M^J:5<&%H).-$<Y3SO[JLNRBWX%FZ<?0;]):NJ6[LN$S/%LA.IN#;;?RUV
ME+*D*CCS>F2?$C2VB:H^[MR"<*>Q)SZ9';"K0K;YUP0]=H,YY%95YL=@EOAF
MJF$R9%JC$+;/B@NE9/\`E:H_4FG2WVMVS(Z\LM=7;\P3O2;CE6\S?[P]12VM
M,1R!ZA>`5*VJ]=:@"%+*:E00?(GRD=M=@T32;32K(%P!D+?8JMJEV73TWU'K
M4F/:M-2.9K4Z!YH^)<E26SU\KC/'V1J0HC\X)/AV.F'57\A%QP2*C5(S6V6]
M`3)?AQ&4-,`ORG5)6D^BV3M1N`4FJJU^.GD=R8;2!H.V.OI*2DM^:04D;CS9
MB4`+6U?(#BF-QI&H[(=4BO[!M8*%.J(\J2*$Z!J&0YW$91B4D+`R?A[W8>=1
M.>S9I_EN5FZLG$;%[4A,>+;Y@N3\I4EYIY+J$QX#K80M4:4\`I=4"O:H33CL
MG44)Z@FP5KM>G[@66W<GUE>\V-:8)A6&PW&4EMH,M39\R)`A*:0G:ANCR#(.
MVGUU$J->NFD>N&2Z<UF#2Y%CTV!8NEE%7<QWL4EN(>68_)49F0R$H<2VR7FT
ME*@APM@N)2M(&]*5U`5X@5\=7.W(FM'2;P%6;RS%O)3@5*&U?ZG_`)W^YILF
MB<&.XUZ33;B=PJ.FX@]5?0.^A"K$O^?9OE5WSV-D^3WR^1+=F6?L6R+=I;TF
M-!9%P>:"(++WD8'ILI'D`[:$*Q2S/%&/6)U9JENPV<GL.\%KM0=^FA"TKFE\
MJ<10-KK04KT'E/7OX:D8/I!"0'(T`7+#KOZ21Z:(JD`$U(;(.X5/F_NZ0O\`
M^6/>/6G%I]=JKF`(\JJ;FUJ;Z=MK9*4BGX/RZI%^NJVO\@WA1?"`0014$4(/
MB#W&B+Z8[D1?3;W+JB29,:="FQ94F)(AN-EEV*^Y&4E*5)\BO24@+;)`J%5!
MIUTHE%<)[;N:\J>9L\&68UV;2AM)>EJ2R\`&T#T:M)05`4K7O4Z$*W?CZ[,W
M:`S+7;2VZMQOU5H?=*$@^9>T%=-J2>AIU&H]_P`9[RL)X&Y8#3C,?]6%A%5I
M/ZU'IKWI+3O[1I6[Q20:=-:H6+A4\ZI]U:UO*^LZI:BXKZ5+K4G0A?-"$-"$
M-"%$SWY98G!_9G[E<F6XEOY'B?)(VXNADG[581:E(;<5Y4/NMS%);)Z!1&LV
M\7B#3<F3_P"3=_"53![-N._G.+;$>$,[L)R)$1N2KBO/WDP+TXRTUZ*562_.
M5B75(88`4E)W[MM>JJZ>S]/Z1)'2]'XQ'N>W?QHN27$#9;F0G<Y/_,Y`FV6Z
MKQ[D_';K@MW2EQ#TFXL%B"X^VFO\SW]7&U"FTFM?QZI>H_IWK-QFGTW"V8"X
M[?A&)W<$@ZS8&D\!5*V+=+9+@PY%ENGSS2PE2UT`W4-2:4Z?BU2O!-(K3UJ%
M43^?KW'3RSQ\E7F6,3F)5XFOVI+ZT/8_3JOZW9-H-GP^U-KW^4=Q3J\!WUE>
M)S@P2DL95=$+J=WE1!8DD>:O^K.$_P`';6>G[)F1P--BCM%PS\*)^)>2L-PT
MN+-2IP(-!X%*CX#Z-3W@V*9J$1JEQKL$+9"DK:<)0K>H46`#4BH"A^'IIM+$
M(G91LHBM5QW;&OM**N%/6KY24%>JX`'7F@Z"I:V2JI2H*[`=!K5CLC@[@MF?
M$.]->K!ESRS'F7BYSX$%QU$2*J%&0WN*=K:Y6UL&:IN@V%W<4GJ.NG7C"K#9
M;54%SQ]R[PWR9GUZS]^R7M_),KO,B]7&=)O-\>4Y,E/I?6\TRJX_+QDJ<2*)
M;2E(`H!33R'J2.SCY#MH-?.I&36I+)WAVG``'SIH,A^X_P`#C6BZL65EVTSI
MCL::F=#?G39K,R-(8?0MEB5(<:VK+6U:*;"A1J-.8^J&7#Q"S!SO[5F'J.5T
M@!.!*BGR-]W3Q#PY:;*G.<4@9-DV2\GXK"7=)3L^&\N$Z[*1=8S\2+*8B);E
M-J:`2$>7;TI4ZN&DGQ=`5=])O77=`Y,1S7Q'QEQOD]FQ[BW#[;A\:^/RWRQ;
MA(HY+:>LT?U'#(>=4M/J2W3M)H=WT#4Q=1B'-&-RL#QE<0%;7P[9V,%QBT8]
M;H\)MC%+;':FRE5CMB8N+\[<5;T$*W271Y4CHDF@Z:@+7^<'E]2P-J<*YYGC
MT#(HF/OR)<:YS66YT!N1`N#L*0W,HLJ^?BPWV4!*R!^M=0HUZ"FKEI_P^51%
M[M*:[EA3[_,?M>M:RR7%YGR+<#\N?48]&WXS:FGMBU%14*7%=%'J"KZ!2546
MW8I@)41M0.B-Z33X=?B>OCI>W^IY%LE1!(*D4^`_YY.G:$M+>XM((W4&V@Z#
MXBG<=="$N;7**%)*S4=$CH!UZ'P'TZT?\;/XO85L-A[DTON2FM*L/'+!'ZJ3
MRQC9=3N(]0PX%VF1Q7N`B0PE1IW`H>E=5?\`4;_:O^'[E!WFTJ2G+TSYGV\W
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M^S&;6PPJK\M/S"T;%`#9Y?K*3L[:87GQ-[D+E?)>847^RFU%OT_UIZI--X;J
M6S4=:TTR.Q&Y;93LDM088<]$+9(0H`*#JEMEM#*BFNPK4ON>@IUU(66Y8*KA
M]UMJ2OB.Y7)S(;KAC=F8RXRW;+)::F7U8N%A2B-N4H^NQ$=05*"*[=PKW%>N
M?IKUU:=.]1LT>];^#*S/6GS5;2O_``KBWZH]$:WU;=02:6"8H6-)IQ#B>(W+
MS_9[\W?<RX_M-OOE_NN3R<EQZ[6IN9)C1[>MNRW)B]3I5Q;=4TI5SC0"'&1]
M8GR@%734_P#K7K73]KI=Y';4SWML]@[W-[NU9Z"Z+ZBT2_.I78/ABW*:\//V
M*XNV91D%ZQZ06'1]NRK7>46I^01'CNOQ($J7'3,<>]-N*VM210N%()-!UU\W
MNEND++6NK9&RN`!=Q"[Q9#9WJ/O#?,&>YM#NL'/T0A)FY'%DVM^WLJ;CO1X$
M1YAUM:"DJ9<94R:E=`LT*:C4]^HG1%IH6I16T#J@9'84_>6NHXW'9E"3?MKM
M;-[]UMSOAW*7`OUWE,$I(!0+:XG>:@4\CE:=]>TOT;DFCTRS@R_A["?(5&R#
M\,JXC7HA,UUM$!`ZCQ_CUE1UQ]4^3U(IDR''7/08&]E5255">J14=%4-*C2T
M'U1Y46_U1Y5V6YO:NCO0DC>.]&.GJ*Z5K2G;N=-+W:>%5(;$GO:5<78>3<EX
MBN>VS`LN=Y(U%;/57HW"0S<XR=J0:%U$DFGA6AUY-ZXM2[J2]<-AF_\`"U/H
M_@"L%0U%*I7G(]5U*D52NA`K6E0`#_#JA06YCN<VZA6X6M^/#;C.2D--R931
MHVWO0ATII7R-*4%K37Q`(U)+*XVU)<C)<5;1ZZX+OJ-AQO>V\J:)&UQ(42@A
M`J:]NVFSK1[W%PV%8M?C?WE5I\[2XC_N.R6([#HM=HQ)2`EP*!48CBQN4@E*
M1Z;P/6FF.H!EE:NEF:75P%..WV%4/6?YL]Z7UHRC&<9S7`X4MZ$W<'YB'&HB
M'T/R%H$61N5Z;/J*2/*:5^&H'HO1.J.H=6R6\3FP9L"13UE+6>Q/5<>0L@ND
MB-;,9B3$O3BW'8CPF)#LV07:!H--1FG)*5N].R:C7JC1/TXCTQ[9GD&>@S##
MXM_IJK&WX1W)8XOQA?,0Y-XFR7D.^V?$<DDYK:7++@K3Z[QD5R7)6E(?NJ4%
MU-GC/M+(2MPH5OZ'5^NH1#!%%08../D4GIU,[OX5$G$N6,ALN?\`,N(8:D87
M:VN0LU@7B3:'%Q[W<DMWZ8I1N%V4!(?C;UGTD)J$)Z:>V7%-[WX^U92KM&A)
ME3'G"]\HI7S?J$[D+)\WS+BZ!"QNW*W$4'4Z?O@-OB[8HEDMS<FC6E-R<BE<
MI+O&*<>_9N2W2U^BFY1;1=;?*^SQ-$E##DA]$CY9#BA&7M3O*B*FE--?Z@L-
M/.2[QS;/)M]84G;:1=O.>1I"KN8]FG)&.YIF61G@O-DKENQ[1`MMK8L=RB/6
M!N6[=ISC$UJ>I+:IUXFOOD**5)4NGAIY'K&DW3?=::G#S^13ELQUM0.XJ//(
MG"%VL,N!DN0\<9_8+YCC,N-;[Q=]B6FH"IH7`MSH^U)?IK6@T3N3WZ=#HT_1
MX--<'O<``IV>?Q(HTXIF.0[YS5?,BM-ZXZS')\,:MMH-G+Z+PS!B24MJ06I$
MJ(IN0XZMI.Y():40-1W5FNWL4UNW2*.:(W9J8XU%-XW)?2=&9.V1TF%'#U)M
MGYGN?C+'VI[LL]@K<6`XC'(EKF&JU"J$/W2TQ4@T50*"!0]:=-5/^HNICN^W
MG4J[I^!K2[>`3NX*QO[MV1FJ?<*^K)N7^6L]DQ>%N>I*&LKR"WHM9>9XKR0H
MD?(VFU15"6V"=BM^U-34=1H/4/4QVBOV[U#>$*BB;Q,GM1Y#STA]Q;+049,U
MZ2I!#38VI6_0A/C0=*G3&ZOM0OGB34*B4"@[JUX\25)647*C+3O=[`MB)ZW$
M;$I`5T:&^B*KIM\JE@;DU_.!IIKG+<:G#M*>B)LI$1I1V'G7`]<_E=Y?(:VJ
MV^<[?4/4U9K^V'3NFHTO';>+V;2M9;2VM#1SA1:K<B_97/BPL3M,Z=*<<].7
M(DLJ;MB&4_5&Q\-E;B:G=MK73R'19(Y@^A43=ZW!;,-NQPI2OG5HOM?XON^$
M07)=\W.7*8H$H`'I,(6-P"2DE*4I!H!X#5WM!RH.6=M%0KR\;<2DC>5839D*
M;90I8H"4]:@]CU[$G2Z9I?6E:7I]K:7^R<ND'TU4J3ZC@8'EI45>%.OX>VMS
M_*2G^ZD'_P`S%_$FP]^42);K9B:6+=;8Z59%RQO?C,;'0?FHO7<E/4D]#JO=
M(_%/7C]RM'48&:VXY?84=61A+N-V):E"@L-GVT(-?YBS6HKTZ'5U5>7-+2EM
MA*`11/3O_?5UA1T_U2DK>%MN6Z2V5>5Q!;7T5T0L$*/;PTE/](]X6C/C;WA5
MLSFFK;=+M;R=HCW&44BA/E>6IQ)J`=56\VE=@TG^0;W+5N!&X'RTK7KVI\.^
MHYOPCN4E%])O<L6W6UJ`2JIJ/`CQ`[D`>.LI160>VYQ"9%IJKP0>Q/38GX`Z
M$*[SB1U!L[0"OK/-4%%=?JGX:CW_`!GO*PI%(_HR/\U_<.M4+'0A#0A#0A#0
MA5<??%9(Q:/89R-;&9#>_/\`,.,\5::)H[(=F95;?FF4MFB@$0[>^HD@)HCZ
M161T;Z@4%U'])W<JE.*8;=JPJQ-CUML1*'6!%(;E(D(/ZM]EXT2WZ2`DTJ*D
MZNER!DC_`(?N7+[;ZD@[1[5+W'/<)DC%O7BW(MJM7,F&S-B4V?-K?'?N=H:%
M$!BV7T*^<A*2DDH+8(2H@UZ::YLGO#=CYD]2QA<=\9<E+^<X'S:=@V41JM.<
M:9W(<:"IGA%QV_K"&9D4J`!]9:2K41J#WZR,D@I7LHL;57/[LLVY,XFYJX_M
MO+7'$O'51<8F6Y5V5;@TU<6E7:7M>MUSBE^#."Z]"%E1.N7=0_I^R:Y9.S:&
M>TJM:W8.NYV.:*T93TE2(]J68XUDV&R9%IN"$![*;]&1#N),2XHDICP7E17&
M)26G7)`0.FT$*/05.JE)HE_IM71,<<F(\F*AFZ.]I#J'`^I2J8AK2U(^9VLA
MQXJ;2XI(4LD*HD(KNW'X=]-O%WDQ_P!0PM3GP974Q94HC+??0XTCU%4\CA)3
M1/4)2*D5KI-P`."7BCY3<IVU7:[&:0AMKU@TMY"`RM06*52"E1J3MH/B-:UI
MBE#L6Y\Q6B](7<!(0Q':0H(;6?36I5`5434`T-3V&G45J;G`#:I"P-'=B:"?
MSYQK97%M2,PQ@24'SH?O$1IU'50"5H6X%-J24D$$`Z4DZ=F>ZM$[N+6ZFD+X
MFDLHFOY1]Z?%^&XI=[U+N$3*Y$>"XJ#;,==3.NMQE%26HT"*TTE>Q4AU:4J<
M51+:"5D@).MH>G9F2!U"E;'3;R6[8Q[#D)QP["O-Y[O>=.4^8>/3R=EL^/C,
M2_<J0[CA7&$8.2%XI`M5@F3;;=9UT4/YW<9'D+R=U$E(`ZG5XTBR=:4S8473
M-)LG6M"[!,S;LJO?(O('MME95<$W6\W>'`F7J=L*/4<5EF0R6/(0-P#5O93T
MKVU/3NS-)4K(ZMV2-F'J"M:M#BF&34$*+GU:5K576O0CH#JJSX.\OM4[$/<'
M<N#+LCO+'(/$ME;G0Q8;F_>I%RM#T1UV5,FP8FZW2F)B8,J/&;942A25K1U(
M-*"NKAH>P**OTA>6W<JE<X>VR!AESQN#D;UBYCN7VAEULGWJUQXK9PUN0#$M
M,JV../I6TM*3T2:#K0UU9G?$57)/J'O3]VNW^X+R_,\@<1J:/E/H<8Y*X[N*
MNGE>SME&WX]:CX:PM$OH6.\O.*07.4\+AK(`].V\2NJ:5UZ+<-PS>2[ZGAY5
M!-!VKH0EI;,-Y84=ZN="VE1"UM1>),*0R@5\R&/M&9=GBA()V[C7M74@SX!W
M(2XC<<9--:0)G-/)+4A"@M4FQ6[CO'6G.G[,M1</D/MH\U>CIH1I5FU)2;6_
MQ>PIN>5<+DVBY<1M2<WS/,7W^2D%'[[W:-?()2WC5U2IN+"BV^SM,/-%U-22
M`=W0GPI/6_\`+]E"F>O?R@4U.8_YIP!=I3C06RK[(2AML#STO3:0@-(4XII(
M\!4@=JG7`]5^D>]<GO?A=Y4Q]BN\95N@MHBO,/18S+SE&G%A27@$H\R4E).Y
M/@:C5`;:1W<A$AH&BOL5='Q&B4`R%42Y+5*@/*!:8(<V*.Y);24U2!6H3\1I
M7\GM?F6Z/OLF#_L]WZOS']$?_P#8_P!GWU7_`,QGX?O4\B?T'H3<6C&++<Q)
M-S:?EL!IAY+K+ZX<EO=&=FGUGT)<,E(+.VA">AU8_$?W1]O(D/#]J4;=CLB$
M-R;:VA+,&*F3O0D!U;#E?7#CH5N>=;*`$U`K4Z9W5Y(US1&*`UKCW(,3(F&5
MPS$+*+<835RL32`4..W2(RAL-^H8K9FQIH*7#12U.!/44%"H_#3RU#YBUSGD
M8C=^U.=,U..60,Y#00?F_8K(6ID!+W5I:@I130I5TW&@/8]M77,WBNBFY=\J
MYY,X!<Q<2.7W61Z*$+*FZ^H"NHVI)Z'PII":)LI!S4H$M%(9`21186*8MI7R
MST=QF1(BK6\%@NI*UH5N0BJ4@)/:OAI'PK-F?T?M2M5TSYC5KLB7I2@IQX/2
M0Z3M,41G`$-)I7>'%$"II32MH`+@0-Q'%8[50U][+QASQ>\>X9Y1X*CWN^7+
MC2R<H/9K8X5V8;MD6U9C-LCD:?<L:DNM-7^J;<X$K"M[10"!UU<63=/Z;>P6
M%^UKM5?E>UYP<&$D`4X5!4_HT_AXY78$2-+:$;/[WIV*A^WY[[O\BY1XI:NW
M&<BP,'-K5)DWJ99V+=(59W+>EFZN--/K2^4IB1O5JD;O/2G34A^K=GH\W3S9
M)I2R7E5::`XT%-_VXK:Y+OROP8?\+BZM!CM]T]F*]%%K<?D8#D7S;'ZV39"E
M\H46U1'1`%"TL)J"'1N/:O;7SWTC5;G2.M>18O,H>^E?AIYJJ&AG,.ZJ9CB6
M/&>Q')I_IH0[;;U:O0D)2"0DPGP^V/!/J%-2:^.NA?J%->-ZCMK2X>7.=%"^
MI_O;J=G%8GFY\G,I3`"B,_9TVS*Y>RNZH;!7LO<CO7TRVAB&`%4ZA2>O;7OS
M]*;:&'INV(:"_**'SIE<.R0N=V*T+YL_X/\`YK_U.NLJ)\4?E]*W("W4AP.%
M`57R@`@4)'<T[TTLR+,VM4VDDSO+J((C!M6\+)I7I3X]/CK<-Y)YFVBWMS^*
M/*N&\7V!C-NE7JYNH9AQTL1:J4$ER7<)3,*$R@'OZLAX`_HCKII.WG=BD4T_
MM/=AY!S!S4ZQ(<:6>1)WRX%5>HJ!!AQ75!.Y-`'XRJ4[C7F?KUK;36[M_P`7
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M/+7+]R'$'&42Z+6Q<\O6W;\ER`R(*U,LXQ8WT&?<5.)<&WZK9-:&H.NO6^C:
M380&'2(8X)VCXA0FO;@*)2'3V0T]^H[OVJ94_F^R8##=Q[@*RN6F86%-W3DW
M*HS<G,KDV$^FL6Q+[*F;9ZM"IL))6V#2IIK2'2I6NSRSEY)J1EP]:7\3E]T#
M`8;5'[%,A4[S3Q;D667I;[JN1[%,N5UNDEUQ]O\`GB"I9><4XM:"I0_5U2@>
M&LZM`WPK7C:PD]]13R*5T>8S7/*(IF%*J*<C(?EN9N>GDK8>:7R/F3C4IAPA
M"V7;U)<:(&VE=BA71IUL)-/-[FH1NI[5KJ(Y>HBRVC#']G[4_/M0]MF#^]OF
MSDS%^9Y5Q8X0X`Q*TW.^XUCF0R\6A9MGN:7"X^DWE=\BR6)J+?:;3:U/H0A?
MZY7E)2!UUZEU9ULUL<<8S$#$D^7#]O:KGH-E;/\`?<T8)#.\$\/<,^\+W96_
MA&R7?BWCVQ7SBK%,=9Q:9<';/>9M@X\M#EZGQYUY1=E7$/W.\.;W&WB/4"J]
M^E+C-O=/$MTP.QP'"NW<IK4[R.*+)%"T%@._;7R;EV9KR!?<NN<7`,1REMQ$
MVY7.++R3(PER1;(%EB!VYW!*(J(B)CC<Q264(46TDFA/3KTR6#2=$T5NI-MV
MR.(^$F@'EH?4JA%(_492S+D'8:_<JDO>A,S;$.6N/^-X_*^0Y)CUSQ2Y9/E\
M!RW6FU1Y[\.68EH4XQ;F]S(;EI#H(7];I0C5`U;7;BXC):,A[#^P*Q6^CB`@
M\TN_X:>U1GD2]F]+1>*'`#M>=+NP@4.PE(H%5J=56UN;OWR9":E3$8,8HPT2
M$R.26/1<V!9+R%&II^>D]P#\-.O$W7SE;YY-F8T4]ON[Y"AS[=Y@;W!CV^^X
MNX+3N(`3%XER1PI)I6A/C3I\-'B;GYRM:-X*(^(X_E&8N1X&)V&XWYU24)2;
M=%>6RT?3;%94EYMMAD#Q\Q(&FLUS*9`'^\:;4'*&UV*=_%'LFR_)'(5USZ2Q
M$B%$6.;):4IF.I2K8%MR97JL>B^E-0HI2H)/:NGD%J;@!I-,V"CW:@&R!H&%
M=M=B:GCGV^V',.4>0C*1.?L&.99+Q^PPG%EYJ%$MDER-).\J3ZKC[K.XU'EK
M3KJVZ1I;8'4SEP[OVJJZ_?S93D>58QB_'&)XFRTS9[3#8]#HI1CMJ6IRB0I9
M416IH-6PV\9V#<N?<R>5Q>YYK5.C:VBD$-[4A:J%*6P*@=:`CJ!IN^UR-+P[
M9NHG,)=S&C;BG,M96II#2T;*`4-2:[B/"@[:04BE[C<<'(<<9"BYZU\L\?81
M39ON<4[Q0G<?YQVZ=M;P_C,F@.`#*U\B0=_-1?Q)N/O`/U%AL)4`ZIC,.48H
M4?+4//H?WTZT*?0I3Z=5[I@<FYFAVU=M\RLO5#\GAW4K[OWKBQZ0ZFPV8;JA
M=CL^WI39M@M=OC6NKJJMXH_+Z5\FI<*>KIIT--H_2'TZPF[WYWE_%%$H;F%I
MV;]_EIUZ;JC=T!KMTE/](]X29=D(=VA5W9Y'^5S"^MTI_.AUZBM4D$T/PU5;
MS:5U/I^]-S;B$MI0;:_L2>#R`UM)Z[*4^FFHUOPA64,Y?N;:8+B3NJ"E6T@I
M-:5KYAT_'K995C?MHDA3ML]0T5O2/CT]-!KX?'0A7D<1J`M$=0ZCUFB/"HH-
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M@A"QV2HA5*4.U=*I5\#X'27A1O.'<MO%'Y?2B,A0DH]1#I+*2(SY?>1)9`(\
MJI#2FG7*T[@I.LOM(S]/W4>*/R^E-SRO[N>0N/,]P+&\FL./\S<=+Q&Y&[8)
MR!#CWB.U;FK@^VZJR39SQN-ME;"0E:%KVJZ]]1=S8OYC3GS8<*(%TPN`>P'R
M_L4GN"^._;1S?C$N\^WG()?`^6/7F7*/'&>79#&/M3EPV6'(^-W]XE)0X\W1
MA#GZSJ!7QT&WM1$X2PM?4?;<I!L,,L1(PP*7]\'N`X"N,2#FF.29MM121&DR
M[:Q/@7J+_A;=?DO+AC>FI"ED&E>FJ?JG3MGJ((B')[@#3U)AX1G%+C&N9\;S
M%Y3+TU.-7!^JA:KKZ10':`'9(:46?04>@*:CH=<^U'HK5K)Y=9`W%I2I>1EH
M=[:#,,!3&N_8F-S:_B>Z<*)676VSY"XCK#*Y;+ZT(;?8*3$6M0'^K)45(9/@
MJG;PU6'QQQ7`M;QQC>XTV5IZ0FK[=S&%QX)O^08'V-CM^<:<E-W9BWHE1TH=
M4VT%AU+:D+I7YA!2[VZ4IJ?TE]M'<B&)W,%=NS[UC39GNN!#EVG;]@O&#[MN
M:N5<7YVO>(X7E<FWM28]E>CVMF%:WTKN]V6HR`')<.2_N?<=W4W$"G0#72V6
MD645`K1=GTB*"UL6Q2QA[\Q-:TV^?8FID3/?JVX[(C(S1IJ@+;:[?C2FT=15
M:7%PT;0M/;M2NLN@BC;G#02%*-EMVG,R$!PWU_8D/-/N'N,6=#Y1BWGY1E")
M%L:O#]N2TF0R=DE<5%N80`KY>C:@NO10IXZ:NQV"BRZX!-0RGE3NX7E\#'>6
M_;XU/<6$6IC$[;-2B-,<;97+O=XWN>LTRIM2DLSTKH.E>A.F=Q.^-A:&UHD&
MNS35WJ]"*RV@K;2@':''*U[A`*NW75:DF<9,KFX$JP!^2+-MHF[ORTKYHP5+
M<Y:HEMQC(ENPRVRF0)4E#2VIVQUP'Y&.A)0IQ))"E#IKH^B6`;;"?,:TV44%
M?753L26R*4'_`'A<&,^9M%LX4Y'DN0U]VE7:^VJ'\TKKT4?D@H?'?W%.LK7-
M[W%1K8><.;6F;%3;@OM[4]?S@?#]+0M)8.6W-6N*6<)]O>WU\!_`?P_3H2"6
M]NG-A)%*T%._PI_=U(1_`.Y92NBS4J0`"6R5TKT/2@';2T8JY(R_$W^+V)F>
M9P7<GX1AM/E;J\]GS:;14>A876PB@5V6%UKX4[:YO^H%[+;P'+'FPXT]B9Z]
M_*#N4NN7K9<(O`M_D/*0XTEJRA#9[,J5?&$>H!U"B-U:=.NN):F<UOFV$@>I
M<PO+:H..U,]CS?V395"1(2^6V&A\PMA*%*4$;V62G<KHM9I6NN<7)>'58XM*
MKWAP'D52H26[JY%D?-08S+BH4647*E45:F4I<)%`%;%#L2*Z;<RX_P`PK/('
M%=^S(O\`<]S]KZ7U$_T?_#_YGZ-:>+L>ST;4?ZG_`"SYS]R:Z(Q>;,[-MS]Q
MLD>WK:2B#.<0X4RVT-J:6W\P%*,H_+*6E)VM[2:D]-2>=AV.'G"<5'%!S[6M
MK##=NAS40:!UQ<AUE;;*45]%P@`N/,.)4HIH3T'72\<4<K27$8=H24^,#P,3
M1'./!\7;&RY&BR7;A>V7&']JV@V?70WM]-PI4W5U)%%#J>WAIA-=&!X:P[PF
M&D-<+H9@0,PW=JM-@Q(J%^G<B$2UDH0AI*5H2LGHOR`CR'K\-60W4O:NX&UA
MKM"$^#%B.I=0@+;9%)TYP;%EY1JVD5*6U?JSX#61<S'8"D)8FQD!N\+@G/H1
M<+;\BX'$/M,M/&2$,^GZB@DI&X((6`>@[ZPZYG`)(=LX)*B1&;L+%CCM20IQ
M,R7]F-J(4$M*DS6RC<I(`30(KU.I7IQSY]0:UX().%1M10[@FIY8L%IO.!6:
MW7J(^[:\J;RNR/+:+89]-*(D*.VYO_0=A.*2:CZ_0ZB/UHU6WZ5ZJLM6>U[B
MRQCP:"=DLFV@2S)G1#+0A55<Q^V2Z7WD[CG/+',AP[3A%S>F3(D>QHBO3XSU
MM3`;2^ZPI"''2-VY>T@E1--<TZ]_7/2^KM*ATB'W+F0!@KA0D`#:5EURXMRG
M84_<O$RO%;U:[<$-W:?9W_E60L-)G3_2(;CO2E^HF"'.V_;3PIK@6CD6743+
MN5P)#JU)3?,VFT><*-_'N'Y%AG&N9,Y;;)-HN4NYM+<MTI;;B8CR(;^QR-):
M\LB*2:H63U\1KI/5NK,UKJ>VNHB'$10LP(/P]U5D4W;%\]GC+5CR^:X^A*G<
M@@R_0<)-2;D^7&BCK17]%-*>)U]&_P!+O_;EJ-^4>U-[K&V?W>U624([@]R/
MQCH1^$'74E`Y7<"MR'7$I`2H@"M!T^-?AIY%],+4M=785FNXMI0M2O*E*2I2
ME4"4)'4J420`E([D]-:RN:64!%>]*P>[*"[`=JB1[E\Q2A&`X>76_4R',+=*
M4R-WS?HVIUJ4V&@@[0B2_L0=X[*J--J'@5)#$5&(3I^SYFUVSF/EUG;(BRW\
MF<EQ4.^94"1-@1'Y+!6FK2B7WE=Z]#KS+^H^.M7;&XOYNS?\+=R?1`F,4V45
MD<VX1+>I;=WN"?EO3(_5J94I;I_9(HD;J+-=4C3M+GU!GAPQ^T'X3N\B7BB$
MCLKMB:Z]YFRM)BP$+C,(JV@@&CJB20:N!7FIX:ZOTYT&V=HYM!WX>M.?"1I7
M<?\`#G(/)B?MF*(MCP^,L)NF4Y.Y]DVQE(-9'RJUC=(6AJI2OZIIJ^Q:;;:=
M_I0T%T?NX8UI@L>%C"AER[R]P'[;_<1F2N.\89YLY>B67$XR<[S6.R,!QR2;
M0TLR<;L;J5F[OPW6TIWJ%5!2B#34YI4HEE='D+?</$;P-O'N4-K;66]LU\1!
M=G`]!4:G>9,^Y=YRP#*N0LJNV5S'+U)/RTM;B+):O2B/N-0K%:`?EK9;HWJ?
MJTA(4DJ/7MJ?#0T4"K'BI%)R5*)6B6PXM`0OYA04XM9*B"H]'5+K4G^'64\!
MJ`=Y"0.175X.VR:%D&'D%B=42E!J%76*FH)!V[>Y([#4;JV-FX*:T(@7PK1,
M5*]17(?):W#TEY3>GE$)"`I+LHK17:$CL>X[ZWTK'0BP?'CAO\VU+ZJ"=>;3
ML5HWW)N&VK-\:][U[R.*W=[)F_.6)\;2K?)"W&GX6%8'`DSXZZ%)+4F9F)-4
MD+"DFA%!2M=6N:96M#A4-&'M]"OO3P+6.S"G>O*O[WOO<_>;P7[Y_<K@_"N1
M8:YPKB7,&0X9QYQ_EN$V/);)CUOM.02;,S$AO?/"_O/J7&*O6<><7Y4[B0$C
M53=(]@C8P$O)V`5.[<$_NH#(R5Q!R@#'=OWJV'V\Y5R9RE[TO;;P/CT3CZ)>
M>=^..1\[Y4R/);?=)B,1QK#HMNS7)%8QCUKF6Y2KK>Y%P$.(5N;&MM%5U?\`
MJ*[=_2\;'5#\,-^_=M41I-JTS.<,6UVA1&^\WX^F<6?>#<F<?/WBT9'&Q#BG
MBQ$*X66WO6JW6YO+FKID3]M^3E72[R1<OU31?*G:`4I0'K0+LAT7:K$H4/K*
M6E%*J$`GI3I05K_!J.M@0'5XH2+C.NYSGV)\<61/SV17ZYP[2Q'B-K4TTIQE
MR6[-GKZA:H[31*TH*24BG<C3E"O`]B?M+RGCCE]R[Y)?+3=UWGBKF3'F82;#
M=6F66+UQU?V'E+<7.@MEHLH4@I+A4=_0$ZS0\"L5"='*<8N'MRX8S7D6-;L,
MN\7CO%;G<;=8(5EG6.!-N;JHL;'[=/N,:]/S7'79"E@G:L%-.I[:<06XE=4C
M%1FH3NC-!\--J8G`O=S[JLCM$.XPN(^'[3$6J-,2HMY:XY%9=2AU)<?5+:9D
MK92KJI2-JB.HH::L]O:\MNS$*F7U_E:YS""0"?,EAPQBL_&H-SN%R4PU?;[=
M+I>;XS'2?0-RNLU4UUZ*5U(8JM0`\*ZG+`.!Q!"K$E^^YQ?5/3N<JH@FJE%2
MB!W4>Y[4U.)M2B4]I2XK8$DI65]%4[&G?J"-)S?2=W)2'ZK>]./;G%*1Z922
MX@`[Z&I^@=.M*:C5)I>X*I4G.\,CC=N7D]A#IIT6DW)HT/\`[$GM\-;6GNR3
MN=@WE[\-R;N_F8OXD@OO!$-_NW:E+"=PSSDH5)I16YVH[]Z>&J_T_P#S\G\1
M]2L75?PV_P##]Z)K,$"PV$II06.U;B#T'\Q9I4^&KHJ<LYG5%1U!`H1U!\P[
M$=#H0DT^\XEX)2H[2#2@%*^!K0]M)3`F,T6DFP=X4#N8FDP,S0EQYI#MS2\X
MVA:VT.276G0DI90HA3RT(4"0D$@'J-52](!-<%T?I;8*<$W"FP/-MZFI2:'J
M4]R/C0C4<T@M!&RBN\E<Y[UJ:=*"I3E2D)/0CQJFGPULM%8![9IS2Y$`K%2'
M=HK04'IMT'0CXZ$*]SAATN6YI!4"T&F5(3TVA>Q%*$=:BNH]_P`9[UA2;B_L
MD_@_NG6J%U4)*0`:J-$BG51^"1XG0A?"*DH#;CJ]I(997Z<A83U5Z7E6=X`-
M/*:D4\="%6/]X7]X9[6?:9BCV'<O<QX-;KEE=KE1+Q@MIE2LRY>:LK[;13'M
MN`X=M=^U+DHEI:KM<[5`90=SQ6*)&"3N0O(G[@OOW>7,R6Y@'M"P&'P;CL^;
M#A6[/LY:Q3-^593DJ<NVLM8]C[-M;XTX[N`AN%I$EBWW64E`2?M`K\VA"O>^
M]9G7%_EGV%<9763)N%PQGB*9E.2.R%J==N&03+?B-CG7.:M/G5)7/AREJ!(0
ME3AHD=`)/1FNS@D%5?6G-#'`D!<%N@-,P&4*0DI*EE(J>@`1].K^WZ;>Y<WN
M/J'@N5UEQ#RD-JV-!0VH%"`F@)%2">NLI!<DR*VMLEM*0YN'FKUIXCOK"%7G
M[M(25Y[A;3S2'MV*2MM$571R[RDN(2XD!S:I*14`Z49"V45.Y1MY*^*=N79E
M]J=3VY-I9X_N#OIG]3D]U<3N2IP-J93#<0MM"PI*'&]Q((`(K7676D>0C#85
M*VER_*-N56%<>>ZKD?`8C&.7R+#Y&PAQ'\ZQK,%(N4!<!1`4S$D2$N/VY\)-
M$J2J@!(IJ.\)%Q"D>9'\P\X3NQ.._;9[BP^[QGDG]C/(:5&>SA62-%['YLA0
M"BQ:)X6I1BNN$I3YTCRGRCQ8W5S/;GP<8!MB*GO.!]02\<3)6Y@0?*$W64VG
MG3V\OI@99:9ALB5I<CR)#XD8W*4H[FC;+BV%+2_(3YFV7%`!)`J=5Z_Z5T?5
MK>0.;2\>TAIV4<?N69+,&,T!I1-1R_[M./K1C\J!?3+N&9SK>8UGPRU!A5VN
M4Q]E2T+:W[6X42,E'JN2913&0VDU))`/.1TK)HE^'US`'=BF6EV)%^*@C'@O
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M*")H.VBD:S[AKX@I2QP[F;O4>1=UPAA`%>JO4;R&021\*4/QUE:W&,=!MJE(
MQ[ALK*4KB<,7@O``!BY9KB%K2OK7<'D2Y%$>%=%0F65W`HP9]P',&X*C<-XO
M`0X?*+MRJQ()2I70!4"P2&P0#^:5CX$ZD&$9!B-BPMQYR]QSSJ1;\;X:L[(Z
MJ3<[QF%X6A-:4;=B,VV,\X":T"`2*Z4:\!PH4G("7-IC[WL*/HN<9[D%[Q3(
M,^NV)1I>'W%^Z6XXY`N<2U24.,I9E!]%U=DR$NQF`05E00H*%!4'5<ZLTUMU
M;5<$RUT$VH`Q*LQSO)(61>W.^3OFW9(>8L#Z30^BI3MZM#U*I"4CJ^OI7I4_
M#7G;6&%C7,H:!Q'FJ%SF\-!BD/93#O6/3(_V<J0&'(CKK[;P:+26D@H.Y:TH
M6=P/0?CZ:YE="CL57207G*04K+8S;I%NF?9#)CQ'%(6IE]*%OKFM`(?D54E:
MSO=!*:>6G;36JSBNW[7=_P!RU?5^SOKR_P"E?[*_:?\`J-0GY4_YV_%7:EOS
MB+Y3P3+L9Q:WB[;_`+*@P6G&92'X%Z=2+@J0R?21"6XL$LO/R5H3M/=)U=K3
M0;4.I@JSXYB:=CF1<&ZQ(BL7N=XEWUXV;'+66EQEQG_0F,OL[2?)':<2@-+^
MJLJZ=]2EST_;4;B-_L3NVO10T[$ZUKRM*\I@6A3:%7&TY%;7KJF4Z2Y!=;NJ
M)+L20^04&4RE6U*`23MIIL-`M@0:["GD=X#(T?WAZU9G;[^F0P'FWGF7UR7(
MJ5!LA04C]H2*FC:AV/CJ?\$>"ZT=JW39QD"1$EE^YE;;;263(^7CMJ]1+AD!
M9!2MUL#IT^C3B&$P@CBL+,(@P)<I_>_.MRE*FNF96;)]5L!P_*M=VW1M\AKT
M--;3$\E_\)]2#L35YWE*]OV.S'NC2#>;3+2N65J84V^X6FP"33U:O"OPZZ>Z
M4?\`\S8_PCV)]8G$*0.*V6Q9#Q[9X=\M4>YM+;G^AZQ%8DA%REME]`(-5!2?
MX-=$ZGZ;T/79W#4Q6;+E\F/M)5HM],BO8^;(:.!I[?:FNO\`P%8WB7+3*F6Q
M:BI;JI#YG-NK625+;:Z!E"E=0G\T=-<)US_XT]&ZV]TMFYD5^ZN1]![CSL=6
MHV=X6MYH,`M9"TU?D-$RM^X6R>(I9@Q8MUC-U67(B4HE;0"`76]M2FOTGKKB
MO57_`,>>I>G@XZ<\WM.`)KYBY4[\E?P%5%;GFRW&T<=9$V];YK$MJ.HF,J))
M4[M(.U2$M-+"TKITZUU0^F.B^J[+J)AU&U?;R`MJW*1A7`[!M2S-.,+<M$V7
M#F,2+?9,/OJK5\K(AVJ&AMQX%IP*L\YN0LI0L`](TE=/B337U#_3&L&D,AEP
MD+0%I/:F.%SN`]JFG*?;,CR5])?K."H(/J+D+*^G6G<:ZDHE%3\[TW%)34]!
MTZ^(![:=18LH_!BPFJY)Y1Q;C3%;ADF6W.-&B1FPEJ'O#D^=,4M+;4*!"/\`
M6$P.+%6AO13ZW2NF6J7NC:)9.U.4ASF$"F%?>(;V\5I);-NV^'?\)(]!JO+%
M[C?=][TLR]V\.YVC',@XZPD7NV8]QM:GL2%]ANQUA*OFYL^0#ZEQN"*+=>%&
MFS1*0*:I$W55WJ7^T^ZKQ::!;#3P,*T7IP]F3>21L9_>K('ESLGOJTW.]2BT
MW'7(F*8$9]TQT[$(*5,[=J>P&JE)TL^]U&34;[&]E?F?QK0#U`)BV)MN.0SX
M6X*Q'!./\]Y;G+9Q&TN2TM%2)EW?:+-FM1!&YRZ29"$H1'0%54$540.AU;[+
M38K$!S",U*>=;)\I,3V^\"LA[)Y;7.')<%2?]HK1,]##L<NH%$'U%%0FI;6`
MI3:PI1\#VT\_$></=;4;<21O%-V[''N6V`VXJ/?)W.W(/*;Z6<@NS<&P1@M$
M#&<=859+%%8%?18<@Q2@2?111-5UW`==;VK0V6@K0'O/G36Y/N%4R\^R6F_<
M1E*C4)39,0K0=A]D,@?DU9F?`%3=2^`?Q?>N_C2<&>3,("5"CEUF.I`J315O
M6.HJ.OEULH=3,DW+<VR%$[2ANOE[#8.W765(M^$=R1>73`+2%-$^69$4JH(\
MJ'DN*I\3M0=,[[Z*?Z:/];'W^Q--=)KIS/,'24A#]V<6V3T-%06)0J/S3Z7\
M/3330/YDTVU4Y+_OC5>']R';X>/>QJ\<AJ0II[/>=><L_?<6C:'4V*]MV&#(
M6"0`VJ%C0J>HZ:H_5!#NHPTC9M\H*Z%:?$*K\YO.''.8?=OD5S44/+Y"]PLB
MY.$J"`L7C.OFK@I7?:DQ02/B>FG>B?\`N6*G'VA3>H_^W[OAE;ZG+V-_=88J
MSEOWNN17EMI3C/"7L9OKMKDD!#42[\E\C8]8TL.K4KR+DVBVNJ_SH^.ICK?_
M`'.O]T>H*H=+?[:_O/K58'WE.9P,\^\@]Z>31IK4Y-MY,M6!,NL'=M9PG%;'
M9I32P:%)CW!E3?TTU0U8%"Q4I*5`G=Z+B%-*H*JWKZ)%`>WTZ$*5WL/X<AWK
MW$6*\S&B&[+;[WD6_=VENP46Y@A-!N)W&OP&MF_$.\+!V'N7I$XUM,"+F=H]
M#<4*QG/4#<*>9&&7UM73P\ZQJ73%0H]_,O[/]MLVTQR/5RS,<"QEY![N,)N2
M9LA*:UKM1"61\30>.E;3^=8F>I?[>]-GQW9V(>(VWN%_*0_5!\#Z2*T.KI-C
M+%_&WUKE+/C?W%+IAII"E%OO2AJ#VK7X_1J72*,&74`AKKO[]NG7Z?Q:PA+F
MTLKHGMX'O\0#I.;Z3NY*P_5;WIQ("2SZ+J^B$)454ZGJFG0:C5))=<1H7/Y3
MPQA(!;.3VE]-33R1YH?>KX!01V^.D]2_VWSIN_\`F8OXDW/WAD%*\,A/J'G7
MRER263^;_.&)#J-Q[)_4H5^`]-16A?7'E]2L75?PV_\`#]Z0^/R4IL-GCFM#
M8[,'*@T-(*!T->M.NK>J<NA]:PT&F`GTT#H5$IZ;BH]_'J="$G94U`"6V]_J
MJ=;`JFB=M?,=U>E!K(=D][L2<C<S:=H56_WE_$.><A<60,NXCGW6V\J\-Y7'
MY)Q%=K>]%^ZF)&,6[62.H@M2G9\(DAET%M?I`4W$:K.JZ>;O9ZE>^G=09:@!
MV"BK[//>%8/<KC\JP7:*UCW,6,(6G,\.]0,RIC,,>A)RJQQ9+B'!&<F()EQF
MP5QE%5134&V(P-$)VMP5U-_S/Q=SE,=3S2DNH"@%A-=JJA1`(\R0>Z?IULE(
MKCFNR]E5-KVU.H3*AI)Z^N3TZ]/2:&A.%?3P:Z@VN,R"=]65]C3;M0KO\:'4
M>_XCWK"EG$"BV@)0ZNH54MM..!&U+CE7"A*O304H/F/2O<C6FQ"J8]Y?WUWL
M#]FOVC8<DY(C<R\N0O29B\/</O,Y#D$.<XDJ^4RC)@IS$\3<J**2[(6^T>CJ
M$]`<H7D^]YG_`"ACWQ>Y5-WQ;BZX1/:CQ1<W'2BV<938\_DZ^VQUPPRSE')\
M]QN7'F/H6ELHM8;0`HA%2140F>]F/W+OOS]]4J/F<;"KWQ-QA?9IN]RYUYN^
MW:W:,\\')LBQXS>!&S',WWTDK3.=9:C>85?6GH,(5VO&'&OW(?W8O)^-\;)R
MBP>^GWR"\1(D0S)F-9+9L!S-Q)8BV^1;V5/X!@J&GFSZ2G5S;H)`*5H0Y4#`
M-31"C\/<KR7[Q/>IROR+RHQC\&=A$^Y<9818L85*..8[@]B7#G0(MO4^5.R;
MO(=N*E393E1(<!([:MUA[I`W+GG5V,@JK`$R7&D-M431#:`/R:LC=@50?]-G
ME6>_U!4T"E#M7Q.LI)<"U!M6U5:_0*Z$*!GNFDMM\G<=[@O_`!=F'HD_[IRA
M_<T;DRN?C;W(SXOY5PSC7CPR,VOT>P,7C-KT+4)46XR#/]&TQ"XAI,"),(4`
M*>;;K1WP.[BIJV8)8N4[8[#SX(SNGN[X,;:"6\D,YWU`?E[=C&4S7SY5]0TS
M92JE?'MJ,H$M_3]J=X2?=]U.(7-J,<6PCE"^3&I2C$=BX;=+%"+X"*I5/R!R
MSQ4>'F*J4(UC8AMG'92"&,U!Q^WF3M,^^[W5_NA>L-D7;&^/..I40IE2^04X
MYR#D5KM#;09FG'%W%Q>-V6>F.#Z/SDR=Z2Z;&*`#6DOTSW*S6KL@:\[`4QUS
MXPXL]PUFN5J]O\G+K`E5MEW;F+E7EJ\3DS,VC0HCLF5CW'TM]$:5D5ZOT=+D
M5<RVM,6"!!<<2WND^F17+_X?*DH;T>/&.]5,77G^Y63VJQ.3+;9VU7C#I%XX
MYM4"(PF+!CS+7E]P@6A3T=*BRW;S!80@C=Y"V5$55JM__4GN"O[Y!)`'_P!U
M/5DU_1*Q!F'<'FAE<_CV!?9MJ:6@R3"N\02VGF4%20M%4*KUHFFIZ#Z7D4)_
M]2WO]B8+$8RVK+&9>4TR\@"K3C@WJ]0!U(0$;P3M6*]1K=/4?O#TA5Q)_P`S
MW(^%1V%?XM.(]/MIFB5YH\K(1VQF.1-663CK$M#=L<+<E^WEYHH=$-8>#B0A
M:]WI%.[\6E&V%G$<]5E=UMC71Q:5ICEPK0T]O:"W$[74J4@[D(/<>&M^39\0
MA+:W6#)93CBF+1*<2KJA82$I<%.Z=ZDJ/7MT&G#9;!C0PEM1W*,F/XKN]+>W
MXCF2DM(_=^:E2UI0V'`TV5K43M0%+="`I0[5(&EHGV,KLH+=G8M[8_B>1.7:
M^,.3Y#CR6,*NRG(C2'GFE+@-.AE:@/52T[-0XIM/B:=NNG'+LJ_$/0I`%.'_
M`&5\A62))N%WQ>1"APX+=PD2E7"S.-%A;J4?JDL7)UYQY*^[83O'PKTT<NRX
MM47)]1W>4(CA#(_5.DD]$[?,KH.B4DBIUJY]O`6NB(S$TP2UM\9[D8SD/OXC
ME7IQWRG[%FQR2TK87I25,--;A5"G-[HW)!)2#4Z3UR]'A0>Q1U[\?:K"OFC%
M]I[\=S<EA*,?=E4!-&3=(2SM3^>JKZ>G?OKSGKAKG/:[UKE6L_O_`,1]JPPY
M])LS4.11B%<G%/,KD?JDO(0R@I2C=7<Z2>W>FN57\+IY*#:"J19R\F1QX@>M
M+2U2C%"_ET.?S=2DNN%!#3#04?3+RZT;!1V^C3#P+U(>,/%9_O*W_L-SZ]/Z
MR_\`OG;ZFD/R>3AZ%&>.9V;5'.PY=@6976SQ);'VKD*[Y=&KE)90XN+/]&2V
M^Y+G34[&H[GHMD>4"O9-%4U?WZ-':XLED/?3[E&>%9Q*RGWBQ6:XJRJ6[&R!
MQZVPK5;6[;'>91;64O.2(]N0I?ZY`#B_-(20\?3'FUHV+G^ZY[FANRE-_?W)
M2.(1F@)H5PM7)Z]WFR8Y9E0(,"V7W'LDR"X2E*;8EL,++JXS]T*E2I-QN,QY
M02E9ZJ32G32C;)F8?BOVCAQ[E,VEDV1[7%[L'#AQ5IL:<VIV+Z:P7KI#)CQV
MS7Y9+"2IUZ2#4HE+3^*NK/<1LA%6BJZUSW5V!*B/;Y+J8S2WDH0HN)<?<(#U
M0DK!%/+3I3KX:BC+S,:`41XAPW!<6.S5/WJ#:_4;'SGS(+TE1#96QN]/TE`@
M%M9'6O6FM7-SM+#L(IYT<]QPH,4D>;+Y:L7QB3<[Y<;3`CXRMBZ3[E+?$>(8
MD:6T\Z77>I*FD#R@>`.I/1H8SJ<$KR08J`=NS:IBRVJ0G%LN+,P*Q3H2U2[2
MLS'!=$+`B.*G/*GQRTXI"5!A:I5`X4E-/&M==?U"UCEE;+'[V9@-3N-3@K?9
MQS/BK&:-JE>]O4G]<E`<;`WI0L.-[T@[DI<'1Q&XFBAW&HSP)8<YK08IT8K@
M`EYJW>BHMI*BH%:-PHH(44!0K6AIU(KX:6$A;\``]/KJD?<^4(HN5GMMQ:,6
M7%0]&70N,N!*T.5[[MZ5$UTQEL+2]O/$W$;'7%`,U`#0;!A@L.M(Y&\TX'L[
M%&KF'$[);[/96[9#:@),?)5!,="$I*T[%H"O+]4K`!^BNKCH<#8;B,Q8`'9N
MWJN:Q^%92Y`"<OM"CDWF=OD99>,8W-N.V/&85W?E,$J87<)R@MV"E1)!0QX_
MG=14ZZ3:Q1S4YA(5$\1/\K?2FLY?YQQ3B>RKN=\<]6]3Y`@XOCD<F3<LIG%(
M"8T..P?5C)2>BG'/)K.MRVEIIHBMWEUR*U&&\U"G+.T;<6[9I"0XUP'8>U1]
MXLXOS;FK+D\I<M0U2?D93*L9L3T8OV3&8M:.MVVTO$M$+;40ZZO<X$U(/37'
MX]/N]0N\]\YQM,:MW'##MP*<?EL>Y[P?(IY8U[26>8K^S8L6Q)V_W-A;"G;S
M$A+^40U53GK.2E-HBVY<4#:"@A12.^IB+2K:T&:)Q8T=RF(IY8X>0TG+13NL
MO#'`7MJAM+Y>RF-G&:-M-BV\=8^L-IC+9`4F/=9K04H/!0&XE=#6IT]$3B,N
M9V'[QI4]WV\B1`XXE(/D[W-<BYPTW8K$&N,\'8;V6W&<28;C?,QTC:#>KO'.
MZ0^E)Z)Z!=3I2"U`FS%SCAO^V"3FD=&S,,5'<RF&@N1(CLOR2E20^X%!PE1)
M+KBD$%YZI^LJIITT_P"0WB4T\6_@/2B=VX-H#94K=OIO4KOUI4]/@#H9`V-V
M<$I6(^):0["G!5;>X^ZL-<_Y=Z1"UKLF(-T)\/LALU%/&J=2D$KGG*0*`*CZ
MW,Z"3E-`(S>Q%G%<R3_:S@(<-0J=)4$U-*&$_P!1U^C3JF*8P-YOQ8*?Y'K(
M;)Z40CM_F1\=,W7+@2*#:I`"@HBC)K:A=DD+"U_JTJ?/U:?JD^4=NQWFNFE]
M<.%G)+058VOIHGFGN(OX1N+O8F*OD1^?,OUPB.M(=6N/*+:E$`.O8U%6M/>N
MQ)-!XTTRZ<NGR0.O"!G!V;E8M38+75V2,Q)&_P`BMV]@7N)XPMWW1N?XIB^2
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MJ0K$B9@J7-C,)2%E4^$R$GQ3(DH94?PI2:CZ=(2RNC<``,4O%$)`22<%<I['
M\<9M609!>2U0V^SJM_J%*1^W=2Y11`K4%`'AWT_@B;(T/-:[4PFE,;L@`HK?
MN(&!>N2K3:6WF6$MXGR7,]5Q1!(8Q=Y.P5HG<H3C_H1].I!(*M+W]W4SX?`V
M';MIN?)B[_+0@G];&QVUN.I2`HE*F5RIZ4J)ZT[==/K&!KI1-4Y@:=BBM3G<
M(S;4&5S:UWHYL2?E[-$:"0/5BQW5)\&U*:2HH1_>I/05ZTU=&1";+(XD%I!\
MRYY/`V!SLI)J"C=CNK\`_CT^4>NV.RE;X6200`*"E/'Z/ITWEG=&[*`-B$Z=
MEC-J4R%K6E"MNXBE0-H[=/HT@^X<]I:0*%*P_5;WI8E"D-.)`JT$G8H]S^'P
M[:04DG0X`"5\M<?,E(H_?VTJ5^</.1T\-)W?XMKR3@W%)A@?.QQ_=-4WGWA+
M?J<5*4E(]6)R]FL9M7BI"DW-E2E'P5L8\.E3J+TL""^9$W$&OJ*FM:>;VT$\
ME&NB```WXTQKWIH,;6F38;'NZ+18;"5!/Q>M45T]Z]BJ@U;U4D9R`'([X=_5
M(C*2&W$'JX#19WUJ`:FG2G;6$)-2"'U++:$T4A24*ZU]150@#\NL.;F%"A$=
MXM@N%I5;9K<=`4PXB4"2EU3B5;X[R7#125,$U%.BNQZ:RT-;NJG$=R^/X:*O
MG/\`V&<>S\S9Y3P[&[%CV?179<^+D-AC1[5.7)D((67E1`VFDM)*9`I1_<2H
M5ZZKUU812W+Y"YPS.)H**8L==N7N%NYK0P85QW)+QWGV9!Q_(H3UOO\`!4J`
M']J@F>D)*B\CU*[DE:!VU"ZI"ZQMA-;^^\O`H=E*''#N5]TE\+GYW.-2W[E-
M?VQS0F;`:<H%EY?J5KY5#8@`?11.FMM(^8?B@`]BFBYO[F*O_P""%!<-M?Z#
M+!30]_U2.^FLGQN[R@;%49_REWD;D+`/8_Q#%X^Y"S#`7L[]P=OQ3(489?KK
M8YV6V8X7D-Q3C4M-G=1-N\*1,CH6J(D++A'05TWF>]@&0`DE;-8]YHP5XKS#
M>TO[FOW9^XZPV?+,JQQ[@KBZ]NL?9^09U"FC*LE*GG!.?Q+CIJ5'R"X3)GD+
M1N;L!A()<4\L#9IS!&Z45=Z$J('?OX*_C`>*_N?ONG&K886#R?>3[RF;<TW=
M;5+;M/)"L+O26BI+LU],5WC/CV1'*JT:;ES62#4[ANT^%AGQ][+QP3"^NX+5
MA=&:D<?V*./NW]P'W@GWA6!W_%)W(-_]MO%-^MDJV6[COA^\RL:D2+2@(^1.
M:9G&<5D.4PGFFPAR.V^Q;7@5)4P0!3<Z:VE*N]"K+>IR'ELK6-;NV_>O/WP[
M]V[SQQ-R["R&XR[/<F+-=6Y]NFPFY99D38[K[C<UU-`I<@+?)()(0Z"H==`T
MX#>[T)4]30;LOI7H4]K?M\=X_A2K_>7'5WJ]S9$V=(=#7K.2)CJ7'%[@G<KZ
MB4]>NT:L,,+834$DJJ:G>OU1V:5H;W5]JFM/_F[Y;3Y@$IZJ[]!3PU+02&0&
MNY0D[<@:T;,5Q)?;W)W.*"MPJD4H.O;MI9-UTO+;!]5/G5VVJ^K0]STH="%`
MOW2OM'DSCQ3B4I(QV90)K0_[9RNIJ3HWJ,O92R9K12A;[4X7!-BB7GCB[U=D
M5DY-<%J2'4^DT8L6"P@-)6VOTDN)-7"FA7V.L$5!;Q4I:W3PS8*I?KXPMY#S
MRUI.QNHK'CR$(45)`5Z:D;B230;2%5.F_A6\2G7C9^*9CD.YV7#KK&Q#'<?<
MSCE.\6],JW8@7VK6U8+1ZCC:\NS2Y*$HXWCD1Q!"$EM<N>OR1D%25$-I8Q&_
M*,<$O%(Z7\1^W8DOC_!S5YF1K[R:_`S;*TO-+A1OLY#?'>*@J#C=NQG%-CMM
ME7.1V7/N29DLJ!4E:"=)A@D.0[#@I`7L@CY=&T\J?J?C;#-GEI5&"2W&>82A
MI;K;B/FVUL-,15I<WQXK27*!L$@#QITUI-HD$XHY[QW4^Y,V59/SP27<-R\\
M^<>SKW*6#`^8^,XC<?);#=<LB7K#[(W<&$.O1%W"7=5EN.\A<9J87912ZI0H
MJ@/?5=NM"B@N3D<\B@X*ZV>N1FT#)@`\55G6">R>-S!PU<,\NV:0L3Y@L/$5
M@QVX6F8RVY'B+MD)V.J$PVXD.S0A1&X(43W(Z:'P&WA<X5-./>EH;NUGN6M8
MZKR<!Y"JIN:<+Y4]M&%V[*<Z]P'&D^3/GL1;1QO9<;G-Y#=FU*2PZMM*%/RV
MVHC:&RM2Q2KG33'GNX!2U$I/;YR3Q_R_>XN+W_)H^(9+<'!#@P)OKJ5(E[:[
M%)E1V"`ZBBDA*R:*&HN\GU%KB^W:"W=M3#5+F6QM1-;M#Y.!_8K%L\]H/)MM
MQ;!\AXQR"==T6W,<6D9#9HMO@MNSL6-YC(NB3-5'4^E#T)2@M(/F3TU#1ZAK
M$D_*N6!EOC5PK7#9MPVJOV/45W<R9)XHV]U?:4Z_&/M3Y'Y#O603CD%^AVUZ
M\R_LV`L067K9$;>?:1#`>MZPMI(:&TZC=1UVXL_@-:<?V)Q<:]+#\+&'S_>G
M]'L*R1OS/9K=FWP*O-D6Y;FY/=*BBV@J40/#\6F4>K75Q&)R:%PJJU<=5W8F
M=EBBRU_O?>N')O8QGMNM,F9C&=WF-?5P7_LUR;98]P@L2EME*''X<J&IEYM&
MZH"NR@#IW:ZK<0RYR:X'BE['JN8S_CQQM9E.(KM\Z@7D?L-]TK\"WPW^<LVF
M2H,+(47N(A1A(OS5QW+9<DNLL,J>:CN)]-DA0V(&T=`-27Y_/V>E2_\`5,/!
MOI3F\7>V+D_/8^"6>ZB]XC)P?%H$"^L0Y,GY"=>8-R::9GR%S"^_-+B&_5\R
MCO/?IIQ)K$C8A(TXD5I4I'4M:$$+;B`-<7C-C7?CN1M[G?:AG^(VJQVMCG?)
M<-D9/<_E;==L=;MGVTPXU5J8OY>4T&GX\<N!2DI&X4!\-.-"U:YOKQ\4H`:Q
MF84)VU`W]Z?]-ZC)J<SVRM:T".N%>(&_O2;E>UWD#!\S]O7%''G(/)_N8Y]Y
M4AW+*F\0RF\0L6QO',5Q<I;D9/?V[=O1\O*4Z5J6Z@("4)-"-6J[K>1\IY+6
M]G[58I=*AF=F+W`]E%91D>291B_%.6<-\C86UBO(-@38F;O!CWR'>K3*2[/@
M/L7;'KK$;99O=E?]`#U&TI]-=4GJ-<5ZG@-KF:*EI)V]ZX_U;8^`KRB75<=O
MEX+;B[TNYQUV:2VEU%NN$--L5Y@M@Q4I?=4D@T)D)4$+'Z(%.NN<WK([=K9H
MS5[R00=U.%%S-EN7^^ZHKP2ZOK-TF6FZ.628ECYF<U'F11M"'@XFBVUT\X2T
M11-/#OJ/\4[Y0M_"M^9WH7!^[$3_`.BB%_4?S/U5_P!:?["_]:^GZVF_YIJG
M^1%YW;/.D/RV+YW;>Q1[;1A\.ZVBY)1+A"ZF;>A$MS19@AU4=WTFY*64A"4)
MDI2X:^*:ZZ1=1R.KE:3Y$B\B,TD]T]N"5$%YN_+MC+_RC;/\X0XFU1V'BXEH
M)^5]!]0^296RUOW;CO%?+XZK%T9K9X#FN;FX@C8MPQY+2`:<4<6G'+#8;E:+
M=98$>PMS,AL]VO%U6KYU64H9O,=-M@32[5:G(SC[A9>5Y4[BE/32<4ERY[2&
MO(J-QXJ?LB`YM33$>Q6;-VIJ'=YK[$5'JM/D[6VZN*1N.]-`":*2.H'AJ\WL
MD;F^ZX$]A71BEB_:S):CW7URTU0DP]^U+;K'ZXM%HGRKDM^2E*J'34*P$5JA
M%,F%"2_"?9B1Z1X3IC+;;3^H<2DK>;:4D>1;8-%#N*==*-IF%<!5#?B'>F9]
MTO"D+F?AG-N*YDF9$@<CX=(M<^XVHL*GQV9#L<N(C%]MQIQU=-JD$IW(W=1H
M9=L@O0]CQ2NVN"G;-[6D%Q`5!'M[]GGWAWM(YON%SXH]TW(2N*(3!0_@%X;N
M-XQBXI+888%PQVZR;ACTEEIII!/RWI+"AT(U=7]4%C6M80_W=H-?)@I]FM"S
M;RF4<#CAQ5TN)^ZOW`XG8XZ^7^+;;FUM9#"9^3<=NR;%D)VH3Z[CV,W!U^"A
MISJH!MY'P"O'6UOU,Z:=D+\&.<`2=@JE6]0&5PB=0-<:$]ZD=A?NTX+SY$5B
MWY6,:N[@0A6.YLVK%KVF05!M3:!<T1X=R;"S0%AUTD]:4ZZL0NK8[)&?XA]Z
M<^*MO\QG^(?>I"[ENAMPEAP.,MOMKBK0ZRJ.X-S3OJ-%2*+3XUH=*0S0NFH'
M-\X3Z.1C[;,P@MJ<0:A1VYV6INU0&TJ*$08=UEN2:@($67)BM^JMSHD,*;4O
MS$THD_`ZNNAQN?<QT!+2=P["JOJSXC`]KG`"G$<0JPK5DQA/<J99:X\26N+!
MR>X6Z(HH6Q(78['+5$:J"4F&^\TATIZA>U)U9+R::VQ:"/(56&PQ/^F6GN(*
M:CVB\!Y_[ALE@<H9<Q*Y%Y!O28DJSVJ!&D(9M$!]I`^SV8LM"HD.,VE("E(H
M%D;O'4%$?%WCI;EX:TT^(@;!3>IJUA>R`-#3O]:]`F/>V[C#A>PVR_\`N.RV
M+9&YB5NVCBVS.A=PEEM-?EIDV&HR'&B>JP!0I!KTT2W;?$BSMA5IK[P%1ABE
MW-<P9G@AJ1'(7NYO3UI?PGAFRQN+L&0%1F8U@AI;NLF,GR;WKFZEEUI3R:]$
MJ.ZO72@A=@YP)<-]/9L]JTYD?$>=1/7<7YA<DOR9;SLI9>?<GNI>F..D^9<A
MS<O<X5"O0]M9V;49V<1YT6A]YA]?I%PMK\RT(*MBE=:*(%4DC2L1`?4[*)"X
M<TQT!!-5JER5+:+REE/IG:6RJE>QKMZ$]].<[.(4>DM(G..J;2A*U)*P%4JH
M(%:$$BM`!K>N"?67[RK"]P=#[B,G2JAW6G#P`KQK9P:`'O73BV^H>Y4+J'^8
M_P"+V(ZX?C//\K80X\7`$7:8V@N5`2VF`X4@;AT3YC]&G^](V>Y6#I0I#::I
M4$A*:*(-"*"AKVH=1KF/S'`[>"?HIR%3X@)C%3C?SCB([;9)29&_J6D(-/5W
M)36@K6FFM\QPT^>H/P>U.;"OYC!_'[$TMBB1+EE$^P#T'E.6NR/%X%*_6=E6
MEAHH*@?.L!!;(ZGH1J/Z8:[\L?@=OWJRZZ]C=4CS$`4X]R@3[T.!86!X9R/R
M39;A<;)/M.*W-,]ZT2)%LD34W%H046^Z.Q5M*E0)BU!#C3VY"VP133[5HH3%
MM&SB%*:/?SW#Z-!<WRJG[V-95AW'UYC\G7S&$.WRP\@6J+%R3UFU/0+5?\8E
M)>9B0S^M@>A<$N%WH-V]%?#5+TK58]&UZW-1RY2<QK@*$4J=VU6'7(G2Z2]D
M+2^6FP8GLP&*E#[V?;KS1=LJM?N+X,N&6YQQO=+RB_WVY83D%Q>?PQUVWQ[9
M/D/V>`'%05.KCN)6XT#N234BI&K?U-I3>H;T7%N0]@;6K?>&`XA1^BD0:5RI
M_<DKL=@=O`T75@<=$+$;2@K!7Z;JEJ)`5^M.]1630^=SKU[G7.E9$K\5#+N8
MV1MWTW&#.2MU*]JFZ-G>VI8/EHAP`@GL=-+GXV]WM3RV^!W>%>![2HZF+!DL
M]*BXJ7=XFPI#;GJMM-++S02Z?1=0AT)W)5Y*D!734Q:?2"AKKZB5G(O(_OGX
MY:LDWVG<0X1RUFL[DK.5Y^SFL^*BZ6GB-RP18]C.!QYESM7RUFD(<7]IOL+6
M\B2`E:"G;IVM5!;W,<F<^WCE[A[&N5..<'P_,\>Q$Y);+1BV7W>[VQN!E"A'
M4[?Y#]KDM1KAZ\!6Q*'%M^FE!!.I2P<T"A(KF4'JGU!_#[2IF8O<Y5RMK"WV
M2P]\DRI;;:EN-(=]%)4AIQ;;2G$!71)VIJ/`:N%J^/E[1YU2;W#,3LH4L&U%
M+*36BRJAK]8BGT]:5TZSLXCSJ(:YK_@(/=BCVV@+9*J!2]ZA6E54`33Z=,YP
M7OJT5%-R4Y<GRGS)T+.B7L;*VXX;HFI\N_;L'4#ONTB6/`J0:=RWB8X2`D&E
M4IMZBVM!42`CRI)Z5^@?'6JD4Z?MX(_MIX\0LCR7Q"RE7YJ4[G%+(/9*4)*B
M>P`)TE-]-89]0)$>_MI#G#^2R4K#BV.8KZ8[*'TM.$R$W;U/156J2LJW'XZC
M;+_<H_+_`-)4I??[:_R>L)EK&4L6*PJ:A*:+EBLV]0>#Y7LMT<-U4DJIM;(I
M\135N551E)*Y<8-!M38/5P4V[Z'\XTZ]!XZPA$DI6PA#4<LH!"P4-E*$J2?*
M0=H`->VLH1+-;$E?J/K!4112G%I!4!VJ5=]80N5+,=(VI"`DC:2V17;V.TCO
MWZ:CI6/,A(!I7@MFG(<PVIE.6>+(.5[)UK"V[Y$CEZW3DMT6A]""`RZ^`"EI
M:5&H)\!I"2T\0W)(,!CBI*QU::.7*ZH;3M38\&<FXK@^>VK".2,KQW"\EN,M
MQBQQK_)@V1K)IB!54>S7*Y/16[A+H@E3+16M(%2.NJ]>Q,MC1I"Z5H=SXT``
MYCV&J](7`ERBHLC4URZ6R/',=G^<.7.V"*A:&$J6GUI,IN*H("34J4$T'7IJ
M&SM>26D'%3CVEKRVA%"H:?>)_>0>Q+B/&\1Q?,LELW-W*<?+XF2\<X3QC;;5
MR!=K=E4:"_&4U;<Q>:1A^#7)V"ZXVY*^?$AEI:MC:STTM'`9#B#0+1UU):-,
MC&N-13`$]NY5$YM[@/=S[N$7&VM2/^#APU>5NNO8)QU=9[&2Y';)`&YGD'DA
MQ]&09#)4DG>W"^4C/@E!`36MCLK(TK0JB:OUA/#*6QM)=P%4I.+?;1@G'#*G
M+?:4)F.+^97)<])27Y3B$AV3)2LK4ZXZ.Y65'Z3J?%K'0=RJ4FMW-P*/S8]Z
MD,B%'8C(8:0TVAHJ4IMI*$I7N2`0$IH"*CL.FL^%C323-<XD@4\BYQ;(+A2Z
MF-&:VD[$^DA)2:^90&WH5GJ3XUUCPL:3\+_>'G".4.LI2AIIM#24&J`E(2$$
M>*0.@)TUR/X'S*4SLXCSK-S<X=[E5D_G+ZDT^DZ=VS2`:BB:7+FN(H0=JU&$
ME57-O?S=*>'T4TY39:$(-3N2:;3W'3M](T(4"/=`GU.3L!!&\C'I@2*5-!<Y
MG0`==&%5$7[7&X80#3+[4]?MF04X-<VU)*4');RV4$$)*E6J*O90T&XN4-/C
MH3^W(#:&E4[]_M\R98[O#M4Z99+Q(AEJV7>!#BSI%JFJ<1Z5P^0GGY&8F(1O
M]-Y#B"0/+6E!.$T^#\+6G#?G_DE7&Y76]RTW+(,KR*2;CEV6W-3:4NW7(9Y)
M&]3P4(\=G9'C1]J$(3YJLKAKC)4`D43VW<UK*$@&J>"+'<@`Q$!02\II+I2D
M4+C20E#BS2@4V!T)ZC6D3'\P$@TJE^8SB/.LI-N0ZFBB'`34@[55IU!/3P/;
M4@C.SB/.B&7C\%MMQ2(D9*W2HNJ]%O<X5U*RI6W<=WCI"2!DCLSMJSRXY/>Y
MC1Y1]Z;#D5J%9,9<F>DE(@MN22RP-BRH43N*$;5FM>M:BE=1VJ6S182%@JZ@
MV#M"E-%@'YI%D>'/J:`&I/NG<JU/8?PY8^6E9-[M>5K/&S3D#D#*<HMN"-9`
M6;O9\'Q&PW:39;4NU6^>EYI'SKS*S5I("%-_3JD%KF_$"%T(QR#XFD>13^Y?
M]KG%/N&P.XX]<L:LL>]P(;S6)YA98]LC7S$\NA5$:ZQ[E!:;DP653D^D^SN"
MMM*]QIQ!=M'X)%0%@6PN062CW.W9YTV/L0SW/,@XKQZ?F$6>F9&BR[6[=&4R
MW(%U<L=UN%B=WS"%,2%J?MQ=[D[C74WX"UOX3%[H<>X;%SW5+62SO\T37&(`
M^]0T\ZM3P?/;5#5Z$B#\O(4H%%Q;*6OEDDJ4[O:`!=WN**B?CJDZST<)">6"
M[N%56;^[=4U(`4@+5=XU[9<1:I;4]ST5AR0L(2%U2H%QI'=M0KT\:C5*ETZ>
MP<;=S'!K,-A"B@72#.,05V1X$A2!!G*>=]1A2=LC>2^UT"FD*5^S2NOU^PIJ
M.FG:QM&D9Z[*XK/++_=)RCB@]B349L-I#8CNL[#`HEP)9WD^BI9K\P@FIJ*B
MIII`3S'8T^9'A1\X\X^]?&L:LMI2EYN`AF1(::6"(P;0?ED@M]=HJU&IT\`-
M-X[J[=,6N8\-!X&B;7MU<'+"T.+&X5%=V"IG^\;SZ#9_=+[4[1<KG%L&+-6K
MF!VZR+_+9M<1=_D/XZS#:D+GK98^95;7Y"HH4=RJG;7KJ^=)_P`W(X[>5_X@
MNF]#.87OQ',Y6(KC\0V[TC?N=N0;MR=SM[SO<)=[%>LLR^%-Q[C_`!9-LO<)
MG[$PERZ9#"9MC,FZ/QV;-9Y7V?'4L,%Q+B'JE%"*WNHXKHM0I9^^B_.W?G=J
M`IEJ%<[+Q!Q_'R*+$>:>5!O\C)URFX1=C!*5I@1W2DJ`2"D;J4(US7KZ%G*S
M0^\:;L=W8N;];VT;V9FX^Q*.Q,.P8"YK`:3*4AB0KJD2W$+:0ER0R/KK(`\R
M@.@[ZX5+))*<A!JTKC]PV)K0&$%U34`[.]+`6M%O@.O&0ZJ!/BEZ.IM9,U^_
M2!ZD1E`KO6E0/0"I([:1R/X'S)JD[\M&_P!CM?Z!/])^'_KOT=]._%M^7=1:
MYX_F:F8-DCE;=QVA/KLJMLB"OH8I;!<6_#10CT'$IVU-"2>VI4:S>]JA-9IX
M@):1[9CUJMMID-E]F,EV0I:&DH"]RV%-%2D[TB@6Y7OVKIM<7D]VYO.K[M:>
M534/\NSN1+<KE8(MXQ-4V7-;M[>3XU&3.`;<CR8<:YV]3B(X0ZIW<)3I'F2D
M5!ZZF[/Z:6C^HW^(>M6HW:6JSS'FXBA-3+<4ZVINJY82V25I(4$IZUZC=IVN
MG':NEVYN2[:8\5*Q+E,H6VP[M0N+*0\E*G91)VH3Z-?JE2C\-"PCIN7$C29J
M/E'E-0V#)C/.-H3'6X&]TT**E[PEX)(3Y:GQIK!&8%O$+9OQ#O73!DJ3)D1H
M*RXA<9,UU<A#;@80X$48CI*B/3&_KVH1IOX$\%((D2NU.7IJ<XRF66T)BRF_
M2;;:+:%J6I`2A1"E^<]]+11<EN7MJA:Y[-F$^^MRK5!1;)L9+T-MMH./-)2C
MH%LE(0H@$4`)UNXN#26?'3!93$<@\&<:9/$A3;S#ML:(6'(VY^WM+>??)4\$
ML,L.(>2H(ZU*FZ?'4YH]G?7A`#3BL445YF%<H\5S')7!_)69XS;DJJJSW6YR
M+_C-R!KZC,O';JW)CMQ.U$H7T'CKHFG:!-%1TP]\%2MKJ;;:W\(3C4GSJ&_O
MG]^G//!?#&4WW-.)\;RK)Y+-JQ/#;G;IT_&[)'N<AQU"7[S8Y252)$1*4K=V
M-.H!.VG3H;G'<NTVV,K/C8*^E;LMV:E*(7_`\T/V\BK?]HOWA7)W.^5HXIO&
M&X5A#F2V&YKS3/+1=;O<IK?\S1!<3"Q^XQ$LP5S4/*1Y5!*@GH>FH^77+R\V
M54M%H=G9X5`"]7/#ON`LO"W$L3`N`,;M=D2FV,0;EG<V"A61.O-I_7R(#9JT
M5K?4JJ9`6E/9/0#3RVMY)H1+(/?-?6F5U.R"<Q1?`*>I-#>[Y?LDGOW?(;M+
MO-TF=94ZX2WGG:IZIIOW(45']$-@?3I_;6QCF#R-E?4F-S<\R$LXT]:+?G6U
M)#&QP$"F\A.RH'QW5IJ246L%J2RV*K220:;36E2>_;QTSD^,K8;$4/2Y#+96
MEQ)/04"E5-?A5(TFLH@$J8^M?J$!O<10D@G\'3MH6%T,$-E9-2%;J4[^;H*]
MO'3YOP#N3VR_>5;7/[+;'N-R94E)<0;!A[J0V-Q2?LED`G=M`Z5T[MOJ>14'
MJ'^8_P"+V)0\4**.7,#"@5L+GR74A'4@*A/"BNPW>7KI^4C9[E83;[9;Y`2T
M_,=4J10-MH[H"Z%*#N*0"!T/?0GYVK9>9=KQB9`NSZZ0X2BM4R9;V;FFUNH;
M4RQ<&X;K;S3[[#\A)0A10E9%"H:K_4TLT6E/,.T[5.].112ZHP2[`<%6>)_.
M>(\J6BS9EGUBS&^W!NXSK3E$7CN':),+'3='F[9`N%LAW2'#6^XPZ-K@!.T5
MJ=5/IB\O/RM^W;]ZM74ME9?FS*$4I]R6_O>QW)N3.";SQM&F8Q:<@SQK'[?)
MN>37UO&+$M/SYFJ8?O<EM3<"2ZRFC86**>*45)(U8=4QMZ[Z)#I/#.!Q/K4(
M;_[$?;-B%ROMPP[W?0^-[7=UV:3.XWY,XUNMKFP;G;K4Q&G*A9*W/C)R>"J2
M5*9E-)7&V$%MP[E`4>*UM[B5SIJ5;2E>U7*-V5[QV#VJ-N/VW+?;QF%YR?A?
MW/2,NM5AGI5=K/;+-'FX)F7SR&WA&G*O5X=<:BQFY'I*"$+/J(/34W!KLVG-
M,=OLI3SI.32C=.S`)<3;G-NRIUSN28@DS[@_/+4".F+%AF1Y3$C,H"4_+-U\
MO04^&J^G*YL;>1%R6W..GRK7M`32M2I/<$I%-,[GXV]R>6WP.5^/MB@IB<:0
M7U%+9GR9KB5U`W(DK;<"QVZ)0T:_3\=3-K](*&NOJJ4MJY6=XWY0X]B_NY;L
M@1E-HS+#$&0\MN1;TSX<9]%\:*$DO*'I;66Z_K#NJ`!73M:JC;W6^ZCA3'??
MQF&(Y9ER(M]PO$L`Q:0J[QUL0$/)LL>\*"7ZK;4RT+AL)36BDD:=VUS;P^[,
M0'$U\B@M6M[F5X?"#D#:>6JFC@_+_'F718UPQG)+1<69/HJ2W`F1WO40\$E"
MF$-N*4&E`^7<$FG@-6FVO+)T>5A&<B@[U2KS3[V0Y'`Y78'RI[H\N&XXE)6'
M$.-!:5MK;4G=N`V$;MP70_#2J:QZ8ZTVC8EA:HE:%M:$I*B`%JH:T[]$D4U(
M6WTO*G0=F%4YUM%&P/ATZ?0G6\WTG=WM0C!"]Y<`2H>FD*)4``H$D>4@FIZ:
MC4)X_;D6'N;<'JE>[Y^77HD=$6V4D^)_PX_ATG-])99]0)#^^UIE/!662G>B
MH_+]R5N"2J@"[RR0``5$DLG\1&HRQ_W*/O=_TE2=]_MK_)ZPF,QV:Q^[>.J2
M5K"K#9$]&U)(+%JB,JKOVU!4@TI7IWIJVJJH^:<0^T\XA02&NB@L@&I`I0`D
M>.A"3COKKW-J4E0"%.$A1*3L!-!4?653IH0DU-<#B6T!*DJ=2HC<`-FU5"'*
M$E)-.E*ZRA%;<#]>C^<.;O63Y4D>G4K'0'OMT(7>IY*U+;`6?1<VNB@\PH00
MGKUJ3XTTM!%S7%NZE4I&W-7N5'_WQ?MYR'D/B[%>1,'LSMTE<87RYW2]0T1?
MFY2<=O,%46YSHD<*%9EN4RAQ!!%!NZU`&J?K=D<QP5JZ3U'P=U0[*KS@8GF5
MY@3F%2[S?KACZRVP[9IMVOY@NP5_JO62A=T#$$*:56BV5)3V*::I,#<LKF<'
M'UJ_2WX?*YW$D^E6]<;Y%/YXQCV]6ZWV.W0G\+RI*\A7;[<B"F\/8W#N&/0[
MVXS#>?89DR+?-;00$)#A25DUH#9;;X5'ZAJHM[<FNT47I(XWM:++B5OC)BM>
MN(26JN@@A8&[KT)VBO?OJU6/PKE/.\5>%PQQ2^+J2C;0@[0#0#:#05IUK2O;
M4@DG?$>]:-"PAH0L&W$K6E(Z>-54`Z=>]3\-"%OFR%`,AI79*MWFZ5JFG:NA
M"RC2_4`;+[:5IZ*"EK[GL.B:=0="%U-N(#I0XVM0VJZA(*:^'4JT(4$?=((S
M/)6!.!8;6<?F%._H=OVE*^`IH*:7'Q#N3M>VUW_O#G5JI1RZYR21U"D_9419
M`J02HA/36$BSXQWI^FWTOOK4E#B04D^=('YP^!/QUE2*WNJ#;9=2E9<%14`4
MH`2.O0U%?X=90N*JE>8I5YO,2?IZFO76$(:$+BFI46JA)(^CKVK_`"ZRA(K)
M+,B\P)S2XZG_`%(;Z%,%%?7;#2BXR>]$NM@I)'5(->^D;AF>%S>/WIW873[&
M\9=1?48</*"/:JI.,.07_8W=\EX@Y/QS+E\(SKU><KXMY$QNTSLD:Q&!?YK5
MSF8KD5OMS;D_Y6%/6M32FVW*!Q6JG?6)Q(73M)UL71_U1Q2JRCWU8PB-E5D]
MKZ;GE=^SV%)7`EN8_=[%C/'>2W`.6JX9495]9AOR9KEJ7ZS<9#;B/G/K%/<1
ML%DXR4HG&I:M#%*Z.(_ABE/-7UJQ?[L/,D<`\<V_"N1,+A91B$B&J-<'IK:3
M=0"Y(>D2I"I`0)KDQ<M;CH24+*SY:G5E@MN4T.X*G7.K13$Q2GW"K8KI[;N'
M.:+;(R#V]9LS9Y3S9E(PIW<U&9=4DN.15QE!^Y0''%`A(*"A0ZE0TX4;+8V5
MV-RAWDN+\F\.W9^W9!:KI8'%K6W%=4E3]K="10*1=&-\-`4>H"UI7]&HV]TF
MVO&ESOJ':F#].$1Y3?A"7^.\R-"/;8N0MB>RPI'S;T18<?304H5H4!LZFHKK
MG^L=%@,,UJ*R9AYMZ;W%B<E.U/MCF6XED4M7V5/82DN)0S&<=47FT[$**7`X
M*(54]@2-4RZT?4+3#*0F/@')4.2OD)T.4U%?N$=+ETB/J4ALIC$;TJ<0'EH2
MXRW2HI6H\-)-#@T!_P`6_O31S<CBS@553]Y=[*K%[T.)G\;O,RX6_)K1-8R_
M%LOM[:&I]EN;[33&T,)<:^THJH[3B5,%Q":J2JO34GIEV+.9TAWMIZ05.]/:
M@--NWS']Z.GI!57WLXX#]Z7W?>1OW?BFZ8KG-FR6V*LV8V_-,9FF#<G)+CJ(
M,YJ!#F>@J5;Q12=RP0HGKJ<_/&\5;?ZH97:K(+9QSR%&P?DWF+EN6;AF^:W6
MU7;(I;L8"*4*>A6R#:X$:KC\"';VWV_0;1N)`-3XFKZU=^)C(&PJJZWK#;F,
MMKM3EV&"D6RP2I*DFU+8,A<^3(*)MN0[*9MKS3\=&X@...)]-*C0@'L>FN6S
MVQ@E+_F7-"S+,YPWI7.Q9EJBW9J?/,]%JN!EV5I2=DV:(ZB(BHK0_5EF.W1-
M2H=M(K9-?^_B_P#8J?ZF]7ZH_KK_`&/_`.Z/X/IU:/R:RX_NU\JYSXZ][?J+
MAN,0R+PVIE7INO,B)L5_1DMI.Y3NP=0^I(I6M/HU#X<`K?<P/NGA\F!'#[%?
M)L?Y"Y6BWJ4)T=3YCO-;U%P)D;2K:V$;7%>7RU*0/ITFZ'FFH%*<%(6Q?R\C
MP,K=BZ9MGMC#,A34!2WK1(;N]HAD);E*>CSFI'IW`'YA'I+>C_F!)"#\=.XG
M31#*T"B<M-'!W`@IP[I[QLN>O5DA,<1V122XAU,N/E=SVF3"/KS8ZB;*K<RI
ML$4I7Z=2%)."M1ZAAXM\Q6%X]Z.83),BX(XBQY(<*YT&(WDEV;CNI8D"/'D.
M/BTT0LI!W=:'O36['1M'X]0=U$M#K<,@)J,%S7_WE<EW*.NWM<88^W,D?SV2
MMO*[DMMJ+M2MZ"7$68!4E30*0KM4CIK<26H-<:]_[$L-9@9[[OA&/F7.U[W<
MUA,MN.<30XV[T&)#B,GNKA$=""FBDIL=0"0"H]JZ<&8'X&BJS_5NF_*[[>1&
M"/>;D3*_GI''6,1[:X`L2/WHNC;PKWWQ56@K<4*?6%`>U.FB&PU*^G')8.12
MAP.WS]R=0ZVV\9S;0?A@TQK6OHXI$Y![]LL=N+R[=QG8PF+&/RTM.47-(6EL
M?JI!;7954"T@&A[5UTG1^@XY\DUWS0`030@>PI8:E(TUD#<F_`[/.F\D>]?D
M"[2V41^-K3-NDMU+4.+'R.]279CZB`&6F6+&\I*CWJE!UT33M#L=,-;<.)'S
M$'V!#K^XD-+0-/>"?:%./B?'/<!G-F=S+ECCBR\38-`C&;-N.192^;P_!2`H
M/0H*[6RS&@[34O2E-D#LDZ?7<LCY,&M`H-@_:G%O'(X<^_\`=EK3W<!3=@:X
MIB_=+[KO;7-X[NG"^"^WK#.7H]PB^A=<XS"3)O-MD7!E]3C4F.J?;G'9KZ)*
MMJ?1#`":%)H.K1MH+IX@F!$3\#3`J:9KNEV,1?$XFZ:/=!V5[<!V[U1CQ5Q]
MC'$N;73-<=X;MU@E3Y7^V4>'>+N]'0ZB2J2B-;4R8#R;:P"L#:=P(-/#4I!H
M=C;_``9SWD?<H^;JKG_&0.X%6-PO>%E\=E:/[)K6GUZ%0>RB<VL)`2$%+;%C
M]-(*`*=S\>NG[;6)HH`:*/.L6SC4N-?MV+9*]Y.<JDH@#B>V-..;E;G\BGMM
M@-#U%`K3;5*%0.G36?#1]JP=5B=[L1_$W5]*^2?>7ET=D)<XPQP.`$'_`+ZK
MG7ITZ_[3Z/"Q]JU\?/P;YOVI/+][&6.!+:N+K,JA`W-Y7<P%=?`_8I^.DG6$
M)-3FQ[ON2@U:%HRR$9QM7P^\/-E'>CBBSJ9_OLKN9J?`5^Q?[FL?E\'%WG'W
M(_.+7BNM'N^S.2D*5Q9C[&PE(!RFZ`JKYMW]3#XZQ^7P[LWG'W(_.;;BM8]W
MF8!>S^S"PJ5NVA*,KN(4HUZ!)<LZ6PI7A4@5[G2HM8P,HKY_V)6/7;>*N4C%
M-1DN33>3<XG\B7''A8W+U;[?`:M4>Y"X.Q6+*RW#W/GY9`W.4!W`T^CKI1D+
M(SF;6J@]2DM+XA[">;7'A3S)8XK=DXQDEER6!!<N$JQ.KD_)27D-!7J-*96I
M;JDH3Z90H[1TH1I9,XW&+X4[+WNIR>,\%P^+[`TB.L^DN9E-Q#SZ$*HA8#5H
MV)6M(KT*D@]B1H4B#4`G:4BL\]U]WFXU=%Y+QU88EBC,F7<Y;&8ST.QV62`A
M3<==M8,NK[B*H"NE`=1>L'_1F,@%KL#7V)[IYD9=-DB^-IJHJ\$<H9FS#QG(
M+QBYS&?%MB8\JX7/))'SRHL>[SI4-.WY&06]K#B$U*C5('0:ANG`UC76@:WE
M5\OG3[J*:Z<\7COK`>1.AS+S7>N3;WQY9\GXLM[-B:Y"LDJ9;7+Q<3#S"%"5
M^ML3CB(`^2ARX^Y+I43N'2HKJ0UV&".D32<I^W!/ND=4;D-:53=L<TYC:<;Y
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M<?LG$#%U-E;3'*H^1724RZM1*5+<3#M"D/HVN=D*ZTH#73J*PEC`:W8F[]6;
M([,ZE58K[4_O"^5<8OU\R^X>VK%>1;A<,7-CLJ;S>[[!_=R3):=+$F$)UG?$
M6>I2RDJ)22GH%)IU>_ETBQ^:,[%23[F^)>?/=CS!<<XY*X4REZ\P$/V&':\;
MD62T0(-H1<)4^'$>NST:5,O$A(F$_,/+W[2$T"4@:C+W067,S9)72-<&T]T@
M#:3P*>0:Q*V,MC;&8R<:@D^M:../:IS)Q.IV^8GQ+GV+IMK!ESTS^:U,I+<)
M!>>7&@1[:XVAP);.UM)2D'H*#68M,=9TFB<\O9[P!-02,17`8+62_BF&69K!
M7A@IB\`^ZCD>/%,.XXQ`N;"66'6$76]RY5W0^'BU(+]ZC0'7)+*5)VALI`J:
MDU`U9M-N;NZ(\0&CN!'M*J>LR1-:>5M4YK7[J\S+K+:>,+0^CTD'U$9/=&14
MU!3L59%&H'CJTMC9&`UE:4KY55(KB0-.`VE.S;_<[G`9!/%MM":5JO(YR6P-
MHZJ6+85!-#WVZTF^D[N2GB9.Q'SGNBS),=M)XNLYWU!]#)I[BOJ@^8+M+>T&
MO3J=1J/$R=B>KVJ>XK-KKS]AD1'%D+:F9-(*<BEA556T$U)MA%/Q:3F^FG5N
M\O(<[:I=>^#')`]NM\NSP5#^9Y(CSI##N]2_5NK]V$A#):8=<"$F60D[%$4!
M/CJ*M.8=0CY="^I]14EJLHATB24[!E]+@%4R[[F\FMT*):DX!"N;5HC-PV)`
MO,N*5-LMH:0IQLVPJ*UI:%>W75GS7`^/*%6W21&VYT=2^GD1"/=?E[9?;1QM
M94A\C<EW+WFW00```V;9N2>G0&M=9SS'%N7+]NU,8M4M!&!.U_-WTV>H[EK;
M]UV7%X0SQ=`+E%.C_OBE[E>B-Q23]G=4GQ%-8S7&WW?MY4H-0M)3DA:\2=NS
MU!)B=[K\S5(?W<3PU^HNM6<@EA**"E$@VX[:^.C/<<&_;RK?G?:A7*/==E[*
M-Z>+8"5MIWI#V1S:!2!N2'2FVUH".M/#1FG_`+OV\J.;]J(K:]X&7MK7LXQQ
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M2!U/7P[Z5S7'!OV\J4,]37V%8)]UV7AM2W.,;;O`ZLC()@<:Z'JY6WGH3K.:
MX_N_;RHYWVH5H1[L<T<3N3Q;;:$D#_O@F^!(_P!S_HT9I_[OV\JQSN_S%<#/
MNQS0M*=<XNMPVT^KD$T=S3_<\Z,UQ_=^WE6>=]J%#_A:Y=X\7P#^'(9O_<[1
MFN/[OV\J.=V>A:A[P\LC.+">+,<*N@)?R>YI=K0?62FTE*5?CT9KC^[]O*L<
M[L/F*.XOO*R5QCTGN,\>#I4#5.5W($`5)'6S'XZQFN.#?MY5GG?:A3<9[R'-
MY3OUCR"?C5NLB['`<M[;$>X2+JA_U9+DDNK=?BPE-$%W:$A)'2M?#2L9D(_$
MI7L2$K\Y!1[BO,]]XSL,FW67$;;D.^[/W`H=NDV$X&GF$1G0$B$MLGT&^@23
M17B=;I$DM&9OQ!'T7W<98\X4#B>W,$(*M\C))S:#0I&T*1:EG<:]J>&LXI+Q
MMYP;YC]Z,#[L\P]/TO[,<>*22:JRJY[NHIW^Q>V@*0M99)8\TM`ZN[R+%7NO
MS!+2D.\7V#<I)#?I91<2LDCR[4FSI"E?C&LIRB]7NKS)/4\86A/_`*]DL]L?
MB*+4X2?R:$+G>]VV9T2TCC#'%-M$KE*.57/>$*[;5"S#;T^-="%R.>[?*4H4
M8W'-N2\#Y"J]W!E!!4-R5/&VK`2MLE)\O4'PKH6\<AB>)&TJ.*;++>;WLM2\
MB[\48PS\T"-O[S79Y%0!7T4FSJ](#\X=0JOT:;RVT<V#ZT3EU].=E!W)!6;,
M+/87D2&>'[*]*;)/JIO*S%ZJW#9&5;HS*:#N?2!*JGJ>I09I\$9J"ZO?^Q:F
M\G<W*XU]:>B+[L<GB,MQH?&5B;0VE24(8R>:XOS)IN"%V5"=R!U!J"#U&G1B
M:6<O<F,L8F!#B14[D<63WH<BXS.BW:RX%%M%QB.AU%S8S.\09RE)H4^HY'MQ
M1)0.U'$D`=-)^%C[4I`70?`XGO4[.,/OA<FO(;PSGSA6QYWCKL7:+TS<)4B6
MRD!22J9!^SHT>>H(/F?1Z2@!4)J-0-RV1EP\,KE!P4K:ZI$^7DSTJ-M/L4]D
MRTV7F>S.YG[8+=ABW9;1?F8H[ELMB+$>"2HP'"Y9ES(4I9("$%*T'K50Z5=6
M-Q-#)4M:X92,17;Y59+B/2'V>>)S^=4;QY=R@;FW,/N!X7O2FLUX*78)+;BD
M(E#(KF;<_1Q2$OLW%FR>BXVI2:"M#T^&M+NU@O#65H![,/755:Z>^/Z(J>U*
M:T?>.\CLLVVTY%Q=CT^#'<2PQ(CY)=E2X[3Y#:G7"FV)1(=:0:BH`)[]]4[5
M^BH&1NN;8R&1^-"13''@%7I.8Z0EPHXDI\VO>*K.X-O8MF%XHZ('H!R'(R>[
M,S5F,N=#0F0D6?TR@II4`_6Z]M<IU33]=M749&WEYMM#]ZTY;WBF."[;U[B<
ML2W#MB^#<>6Q(9=N+3T.^W)96+?(82[1QRWIZ!MVI&WH?'4<RZY/\]4'LP^]
M15S+<18,2?RKEO*>2\.S;!KEQG;,6ANW*SWEF[?;D^?6VVV5"F-(C^G&C(2M
M;L5"5I)'0D=#HN;JV#<P)IMQ3,W-P?J4I]NU86XKD8[<KA+:D)B+8BM2K4GT
MTHCA-TB/MOM>0O!EUX43N4KH/CJ!EDM[QP8ZH#35)%[7[-J+Y%_O<AO[9;AL
MO+?B3X+"9+X2B*P\^Z"['9*PIMY`'E421]&GMOH]A**N=)YQ]RBKB]EA=1N6
MB[/F<:_PS'^+'I_U)(_KS_#_`+7]O_?]OHT<NX^23AY/,F^6S^=OFWI&/RY%
MKF>DZ_&FMM']>M"D.NM*75+=5=5IJXH#IJ,\+<?([S*S<J#B$4Y`]>UAAZ++
MC@(6'GFXZ@B08RZ,+;64[5&3M=WMD]4A*J:D+&V<`[FM+=E*X)&;DQTH1BBF
M+=<HM^16E$IR/)LLRZQ+8EYE(+DJT7,-0"R7J;G)C<E!)4>H4JO?3\6["0,-
MJ1$D1(;F&)4X8_"&`3;I:FV(DJ!]F+4EUUN8ZL!N2"VX^\V5;:.H-"L]0-3I
MTY[=L;O,IC\B;Q*XY7!N$%2K4JU.B)&FK+$B-=Y*VI;/J;TMK2%A*`HGH@#;
MXTTUDTR"5X$S@Q^X'`E.8-(CB:074J4;R.(^,84=V*_9&(JW)(E*47)R)*5(
M*5%@.H="`HTH*>7Z-/+?I22=P,32YI(V)<:;",2ZH&[CV)!W;!<"CF4W"QFZ
M+2^RMH.F<\I!"BDT%5T*^G\&KSI71#"[_5-+&]N"5\/8_P"3Z$@Y/$?%\A,=
MRX6*0^^H!A'K7N4PH+"U*^6;;*QZBTE=:)J>NKS::%8Z;^'`&N:<:C$5X>A/
M+>!H92!A:RO#>GYXS^[WM7*H3(9PZ=AN,20VAW*KM=[HI!#H"G%Q6'YJ?7(3
MU2V4A!^%-6)L\4=NZ)HH2*8#C]O(G4=MS)&LF]V)QH2=@&\E2'@87[)_9^J0
M]B6.CDWEQF+ZHN9<=G?9UQ;4$",9BE.0+8D.)W;&0E[XFE1IKR9=F4J68RQL
M?HR,?W%0XYMS.\^X5YACDF;<C8G)?KL8O;+M<(=@MZ`H^DJX1;<V/M9W;]?U
M=XZ=M.([=I;60>\F%W>ONI*`490!1\_L"XE4L26\14M:%%+*47F2CY@H-!Z;
M14*"@W!)H4T^C2K8&-<'#:$Q.CVDGXSIFAPQI7%?7>$>,VR0C'9#"92ZS$*O
M$B0@D"J%/(6M0!!KU(J?Q:66GY5;?YH6QS@OB^9'3\O9XJC;YS*RHW.Z(=?9
M6VE2PL1GVVE-MJ)%*4Z=>NC%'Y5;?YH7.[P3Q,M7J)M$]3XZ)6+D_P"H`?K!
M*_5W@%/T]M"R+"&`\QCP7#<BJ7P)Q2ZIMIZP3'/4"B%/7J4T1U`(&UPE5=96
MZW0O;KQ$S];'$D(ZH4N[79Q9IYJA0D!I2J]NE-86ATZ"8\QSP'.Q(74>#^,E
M2$I;QNY.M_H*NTAAHFO114EP)J*]O'1BL?E5M_FM1NY[>^+WTMN*Q24T`/3%
M,@E`*56H'E=I7KH1^56_^8U;A[<^)HR1)7B(<6P/64DW2Z+>4IL;R"KYKTE.
M$CO3;71BC\KMO\UJB3RI;+)BG*%ZQ#$XT\PX%HQZ8(SSS@C1Q/CN/.NMR=U7
M7T[TU2?K`U/8:$C-916S<\;PYQ-*+HP>R1[KFV+66\P)-ZMEW>D,2FD.>A*I
MZ6XL[&E4>:;0DD%77J=8393`7PEQ4I2D-6&>Y\LC>TEV>\L-,HH&E%*ED!`2
M!]'365(M^$=R;/F#V\XAE'&N7XY8DO8M=+Y9)L&#DB6S<G+/)<:W,368"VGF
MIBVG0/U2]J5>/;4;JD4DT`;$TN-=W<I?2'P1W!-PX-;0;>]0:]HG$%ZQ%J[8
MCRQ8Y-S-IR1V(B]A183?+>PU=$IN480'7YQBRRMM5*!(40`.@U&:):7-O.3,
MQS&]H4OK4UA/;AL,C'NIN*>3W/<"7J5:8-_X=L<@V_%OF).5X_;;A-G90PS!
MI(9O2+:^IZ1-BPV*ID&*`M`(4JH!TVZ@%VY^9C'$);I73-.C!$DK&D\2C?$.
M"<77[7L.N$FVS+;E&2X?)>%T;GS1<(4ZZW.X`O3(1VNAY#*MP:6`5`U(Z:K=
MUJ<\$<;8AF=C7LV*WOT2UD<7,D:6]BA[R9F%FRS&;/Q;:.'N1<)R_CO+[O\`
M:V37&).EXME^%P+;(B6O*;4N25,QI;UP34M(2!L*?HTQ_.KWY#YEK^0V_P`X
M47FI?V[%GS,<A3+E'M\E4"=*B!Q4>%+'1;#ZQM2'D5^KUT?G5[_EGS(_(+?Y
MPD9PS=U\9<Y8_G&?8E+Y>PJRY5:;U=>-WD(L0R.VP1*,JPIOH8D.PX\@.;W%
M!)!]/KH_.KW_`"RC\@M_G"F3R3]ZSQ7<<;:N'"WW=6(X[$D3'VHR\AYUS:YA
M##$EUK8S$QZW0CN;2T2$$A*O$]=9&M7H<*QG;P1^0V_SA3Y]BWO7^ZQO>,96
M/=5*N_&.>OOXT_:L'@Q.2;FM^;+@/&XM0)=B3<$28;+WC,D(6GI0:D/SZ;Y7
M(_(8/G":WDSE7',SSSE7/.'KO?+'P<O)9+G%L"/`8M5U_<V,IFVQ'+H_DC]Q
MGN7"K2EN+4@>4@D5KJPZ0Z35+=TSFFK7Y?0#[4VNK..QC+6FM<:_;N3S8/@-
MCRBTH5<[IEEYC7*&AN6S>,IGL-24RV0'6$_9$6''=2ZEPCH0D@].FI=NGFH$
MC:,WGLWKG&HZG)%/0'>EU9/;+PQ9-OV3@\"U.']6KY>]7%`*"KU"D(=?4V`5
MC=T%2=/([6)GT*./8F?C)+C%]4Z]HX(XU7M6JR3TJ%0#%N\EY`2!T`67.A^(
M\-.@U[11X(=VK4C*:)9M\!<9M[5L8TXAT44EQ%SN_J[Z=547(+)6KQJ*:UE!
M=&6C;187=+X2XY^78;E6&6Z"5!.Z5/>],[0"K]2\DHJ#X]],.3+\I0GY]JO"
MO'%IYQPVZ6RRR4/P&[RZX7)DI$=Q1@DI*FWW%K*D)Z5)/T:2FBDY?PFJD+3]
MW[;T['O@RL77VS\JHCH"(]@RY#P+I/S#?V7>'(B"V]U<90KUO,4D>6NH:%TT
M%XR5C27-KAY"I358!<:2^%QH'%O_`%-4L>)?NLO9/R#Q-QIEV5<1W5^_9/QY
MAM\NTUO/<OB(FW"\6&%<YKZ&K?D332`9,I5/(CI0`4&H'5>H]0BF<UH)`)`:
M!CW*QZ5TO8C3V-N`0]S1M/9W<*)P&?N?/8,AI*$\17O:*T`Y+Y!IU42>^3?3
MIM!U'JAB!=F8>!:"1BI&/I?1X6"-T+7.&_TK!7W.GW?RSN/#MW0OP=')&?AP
M#Q&].2[Z*'?XZ6_J+4_F/^$++NFM'<,K8@T\1@OA^YS^[_/?AZ["GB.1L_%?
MI)&2U)_#K/\`46I<?^4+3^E=+X>G]BXC]S)]WJEU3QX:O2W'%[U'^TKD,C<3
M4T2<F"4C\&L'J+4N/_*%D=*Z4=WI_8OKGW,_W>J^O]C-X0JOUT<D\B-K_!O;
MR0JI]';6/ZAU+YC_`(0MATOI#,7,#AP)K[`NAG[F_P"[\;;+8X?O2T%1.UWD
MSD5T5(`-/5R0$#I^#6?ZAU/YC_A"V_IS1O\`(;YEBO[FS[O=55'AB[J4`0".
M2>0MU/@D_O,*#Z-8_J+4_F/^$+'].:+_`)#?,N?_`(FG[O97_P"AF_-TZU')
MG(B:_1TRC6?ZBU/YC_A"#TSH[Q1L0:>S!;1]S5]WM2BN&KTX?B[R3R&XJG@-
MR\F)H-']1:G\W_*%K_2ND\/^;]BUI^YF^[W379P]?T5KT1R;R*D=>_09.-']
M1:GQ/^$(_I72N'_-^Q:O^)?^[PJI7]C%ZW+IN5_:5R'N53MN/[S552OCK']1
M:GQ/^$(_I72N'_-^Q?1]S!]WBD43PS>P/@.2^0P/R#)]']1:GQ/^$(_I72N'
M_-^Q8_\`$N_=WE.S^QB]!)\/[2N0P.]?#)OCK/\`46I'?_RA8/2NE4V>G]BP
M_P")7^[L_P#(Q>/_`#E\B?\`U3Z/ZAU+C_RA:_TKI7#T_L7W_B6?N[AVX9O/
M3P_M,Y$_^J?1_4.I?-_RA9_I72^'I_8LO^)=^[P)'_B9O0(ZU_M*Y#';Z1DV
MC^HM3X_\H63TKI7#T_L7G\^]PX'X-]FON,X*XPX.Q*5BEFSWB?),LND6X7Z]
MY"B;>HF5&SL/>O?KA<7FBU"C@!"%!'7=2I)-OZ<OKB^M9)+@U<V2@P`PIV*A
M]7:7#IUU$+1I$)BJ3MQS'V*/G$G'&&9YA[UVR2U,W:[QK[<X@=$LV^*W";4`
MIE'I;0X^TVL;?I(U8E58F.F/N`EHVTW)QT<#\4LJ/I8U):72A]&\2'5[:BH*
M2OHFM.NA.?#Q[D9L\&<7KC.;<=N2EME2U$3GRI**"BCYJTJ#H2C&!@RA<G]@
M_%[WR;[N,/!+#$E2C*O<U3*R5?J2^RAT%6X==H[>&A;+<K@;C`N("\28"D`.
M[(=SN,9:D'H"X77RE;9/8=ZZRA;G>!^)GU*6K$G&2M"4+0+Y)2%A`H"H!0"J
M_3K"%RK]OW$6Q6W$UUITI?)-?Q>;0A%;W`7$A*=N*J*DDUW7BY.D5[4^7FQM
MO;QK7Z-90L?[!.+"/\5Y/^=OMP0D_P"=>DO.#\:CK"$3+]O7%(22YB#H1TJ5
M7M^G?I^>?'0A:QP#Q&D%*<54D'J0+W(`/AU`50]-"%L5[?>)G4(2YB3B&VZ+
M;K>Y`0X4'<DI&^A-=(N@8YQ<=I0+*`GG9P'G=5+#"L!QSCZ[M7W!V[_AMWCD
MN(G6?(9B$O54E2XTR*'DLRXKY2-Z5`UVC2,EN&M]P8U6SG20@9#F5A^'^X/C
M7,[:UAON`PBW7ZVW%A,*3?/E'I['I%(07I<)95\A(K4EQG;04\=(<F7Y2I&U
M?"_"=P'>B_+_`+N'V[\@6TY?P*Y'D6]Y2MUG>O\`)DVE)>JM"67&GC*MX%:!
M#U?3'UCTT@S4GF0P3MHQIICV8+9]FUSBY@JPFH/$<5#7(/:I8N*[LY$RC$<A
ML%P:<K%$:Y3TVF2V%*6F2Q)0X&72I5>M:FI.GL]GH]_%D+H\^U:&T#15PHEK
MC3.+P0[#N^/S;G&7'6RS)<F2'WXS#Q&\,R'E%32'-OF"2`::H&K]`Z=?/S,<
MT`\%"WEBZ0U:PE&?(2.+<=XTE73&;2B-?(TZ/!E^J]/4A^WRW$I#K:77C&6I
M,@;22*%6N<:ATLV`%K@<K217L&"A=2M'1P5C:2^G!(K"YE]N[*HLB)#?MUY:
MC0%)<4EIUMIU94A96.JPWMJ*_5(J.NN<ZW#;:5RR'M!>XCS`%56RCNA,_G,<
MUM!2N_%*:\8-'6_;[:MH,6A,BTMQ5L+]1<EI$_TY+_S-=SC3RJUJ:4Z:5T^[
M<]M&&H[$G<V-Y,^L43R.P)Q_1XW_`-CY%_77V5_1D?T/_9?UOZ+_`'VH;E]1
M_P#WD7Q\=W#X5-^(Z;_^SD^&FS][SJ#UPDVT1?G(,>/&N#,I+2W%R?74\@*2
M3(;:222VH=.O8FNKHDT;L2+K<#OCP[=<WEH040W5F,Z$(2=ZT*71M0%17QT)
MG=?N^7V+0[<9GVSB<142.Q'_`'BQ\%IOSMQ2+RWO0I=#O.ZIJ/CK9OQ#C4)O
M']1O\0]:L7F3F(DN;-1,;:0ZPRV&2"7$^BHE9)34>8#I\-7>VLK^[-*':NF$
MBJ2R\ER+((<DX58)5U:BRDMO7`2X#+*I"4U*&DONMN*VCN145U<-*Z2#VF2]
M'O@BG=_:G4$!F:3P*0]\N/(T91>O>#Y0"\K>'(D1-P865?G)5`,DI;/Q('35
MYM=)L[6*@IF`P[TX\$>"/N/L;R3DZ8B%;6V[!!]<1;E>,L4JPQ[>LJ`4B,U,
M"),Z4!4I2A(!`)KTT+'@BIIV]OVK>W*&BY9?D%OY*SR,V';7:Y+L&\H$P@)1
M(C1&'W$6N-ZR"$O/$.5!J``*B49%R1E49N7_`'<<D<GN.66'(;Q#&'"ZVQC>
M,7C<Y-B.$I:;N<V-119=9H%M@[!V'32D7U&]ZQ+]-W<HVI>8=#C;9?3("O7D
M(?=+YW*\I5ZJB5J.X^)U)J,6YA=6`M,9;WF4*)6A)J*=/-K*%S!#ZXR/3])I
M;#BEU+[:SYB:`(1YJT50C0A:VG*[Q(!&T5JKL]T-0CQ!!'C\=80OC[[#4:1\
MNTILR``"2/*4`)42!^D1764(C1&:2H**)72O98^!&L(1I#6AA6Y#"UIJ"1(H
MHU%:;.AIWZZRA*)M*Y(0X(A2':>8*2$IKY:[1UH-"%VMV4()6ZN-*0E)):6'
M0#3L00.A&A"4!M3KD*.Y#BM(07`ZM+)52J3MHK?^=M'Y-80N"0V?4V&WQ/4>
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MV(B26FD):^72D`;1T4!4]]-DY45<3]P]RA!NS9):XYAN2527;O!AJA%#R_VT
MB=#92&'&U#NKJ4#KH0IJP+98IN!W_.HJ+5/M\3#\@O4:YPY##S3IC6J4D*3M
M\S:F'W4@A0!ZZ$)E/;AP9:,SQQF;>UW&'8\/Q1G+[]]A1O7F7`2@EPVZ-&4/
M5,I];U/4^HDFOAH0G*Y`X3X8M&!V;DG%,4O^*Y)>KHL1(64S$.2KG:&_6;%_
M<B)<=]-N*ZG9X*!5VH="$9\(HR+(/GL.DIDIMTN"NVP%VB`JY.Q5O.HD>NN/
M(8$92#6NVN[KJT:'J`L[5\?&2OH`3&\@,XH."M]X\PC/8]CCP;39,KOC42.R
M"Y=[0U#:6TPR@5:3%(;BI6$]/S4#4R[6@X%M=JIE[TR97ND`P&*<O'I(7=)5
MEN5O;M=W@.-LS(ZG2XZTIQEB0E#G4@#:\!^$:?65Z*U5<N]--GCN3RVA*$%2
M$"@0M:3])`[CZ"-31EYU']BBP[-BE&DR$K"O4%`:T\:>'6FL+*VK>K0.N`*)
MHVGN5J\0*``:$*1'MAA.N<J6QU=&C'AW!:FU>8J2^P8Z"DIZ=#YNOAI*;X"I
M"TW)OO=BP9_MH]Q2$*#9CY!>*E0)W4R+PIVU`Q_S@[G>HJ:O_P#;S_$S_K:K
M_/;PG;P!P<FM=O$G'0K\:8E:M<^U3^==_P!QWL71(OY:'^%OJ">)OZ@_'_&=
M:':GLOQE9ZPDT-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%XW?\`
ME&CCJ/>][1E([-<`Y6XH#N=W(;K(`^D%P'\`U?>DOY.7_N_^$+GO6^QO_;_\
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MWQHK64+6['+J$!-&PFE$JK4"H_DT(6"XZDIJ"%?0`:Z$+A2ZI>ZC2_*:5Z4/
M2O30A+S#.0\SP*YM73%+_/LTI`;!3'6417@@@AF;#J6);"J46%"JA6O?4-+8
MYY7/XN)4G'=AD;6UV!3LPWW:XMG<"-B',^.6M+#P")5^:B,/0'U*`9"GXZZO
MPW"'"KU&STI3QUJVUY!S<<%OX@38#<ON>>U#&LEMJK[Q)EJ'8BB9<:SS;BER
MURD+\WHL30%&"BA`VN]$_CTHA58>[G$,IX\XPS"%?K?<K!*BKM*6Y+H6NV.+
M=OC:D+CW-M(CK;ZT2KQ%#K%WI%G=14-*D)E=V?NEU,%&GC3G',\8BHB3(<:9
M',",&#)7ZQ04KW(D,O-U14H401WIJBZM^G%CJK0:"K*GSX*!\!4NKPP3_'E*
MWYS;[A:X&13\;O%RMKCJF%H)@VY%H?+["(LH>42+D@>!HE9ZZYOJG0MU8/+;
M5IRC@J9JS-7B<1:`T79^\-D_W9NG]$IW7_2?TN_UOI[:8^#E_P#MSLILW\5S
MSPT'^;+\7`_%_A2`!=,:'<V6+4XVQ&V2)WRR&(R(C'ZYTKH=H<6A!2%=ZG37
M\%V$8-5T4ZA;N^FEA;+E9)L>V3KQ)BMLF29$5VTK_G(M2?ULIO:WU<4IIKOI
M2'2]0O9`+4>X#CA7;L]J<6[8[NID!]VE-VU(*ZYS'G7N*Q8([CK<G+(#MKD2
M(B8SGR,:2P_%*XU=J'$I`W'NY]8]]=,T7H%ERQK[ICR\4.#B.U.VV-O4$`UJ
M-_:IO7N\/0%29RDE_P!-N2/2I5)]1MQ(.WMY3374;;2[*U=FA;CVFJO5M&V5
MWOI[^*FK?AW%-DN^3RK;CMMB6F7DM\O%V?9CQFF9;SDI3SK\M/H)80TGL#N`
M[#6U_+=.D8R+*&Y=P[5/V]IRV'D`EI..]1RR/[VKV(X0+NF'RY'S*=8GVA<H
M^"0I<R.QZK@:;;,U9@L>D%]W=RD^/8:V@L9I@"^OJ3IEO.Y[6N:<I(W;DZ_!
M'WC'M)Y]N\"T6/+U6:[WF0(]K3FS5M8@R)#M&V8\:],.OVAF6\M8]-,EUM2Q
M4`UZ%*YM9XO@3VZLA&*QMHIDW7@SC+)?F3D6#8W=)ZU*1-E.6H0GE.*_6H='
MH>BX"MEQ)"BIP*!J"01II%S<IYOQ54,^.KO?VA08]W_%6#<!818^3L,CN8\O
M]\<?PR]6AV6],1.9R'Y],27!:?J(3<9+"/J^`^G3F+ZC>]-YXF"%Y'RE-):W
MTOV^%)H"N;$;DERGF4VNA%3])/\`!J44&LR5L.[FW'$=!T"CM[=]O:NL(6;@
M;8CN+:890LC=O"!OW*(J:U[G0A<TEU<A$(.4\JG""D!)-4([D=QTT(746&UM
MI0H':!TZT[]3H0MX4PUYWTU;`-:=#4]$]?\`-:1N9'11%[=M1Z2MXPTO`?\`
M"N)F='#Y2_.8A-K4"TAQM*E.)[*()ZC:=.'QR&TYT0/,IW^A.>7;_8HVCR&9
M,CT8LE;H0M*0ZA12VY6E"E(Z`5--,X(;^2(2O>P5W4%0FK\H<0WX4IH[C$:4
MMB54U9<'11%%>6GX=.&M>T^^]KCP%*K0(R;NCK<5;7J%#:%D-```A!`-%'NI
M5=;K*+U-Q7RF2ZAM"OVWS!2L+0JF[U5%OSE22*].O3IK"%71ST\/[8;TXFX0
M%MKLV-`K$20'RGY`2'07I"4@I(4OMU[?#04QOWNCB:6[<U/05GQC,B(Y1X^?
MC%I^+<KH\MA90E1$9N#(2A&[N5!U2R3\"/AH6MLT2_&K"4O1YCD=QE'IE)0I
MP-?JT+4!YMZ0:*25:%(4`P&Q;W&DH6E26''BL[5)0M0`%*CH`>^A"R=9A;AZ
MK#K*]J24%Q7:G0]:=]"$GLEXF?R.T67/K\Y8L=PBV99$ML7(+[>FHR+K?[6X
MBZBSX\S')FW*Y+1$\H890I!\Q.U).HO6/IGN5CT>VO@\$$4[DXMYN7&O,Z/E
M\ID.8W>X"?D;-G+5N==N\2)6D2'E[*4E5VLS:TD_,L%,ME*C4+J*<\=&V21V
M?<NBPMN8(P)J8[,$T&8?=_V#D.*U)O\`F?"5VMNU2FKUC'(,1G)9:15"5PL6
MN-I3=;B/+M(<4TM-*=>A)X:+@?.E.<]1@=^ZOX@?O=PM,_+;KZ-OL]IERWH-
MKA1R)MS?E+,)*;JGHIF(T*@@_'OH\-%V^='.>H9^\/@#`/;1Q7D]KX[NF32'
M,LCLXA)7>9,/T/1O,QB)+;BQ+>EN,EQV+4)<("FSVU'7WX#VB/80:I:)Q>"2
ML?;1A\(6^4[=T9%;;=$9MN.OW>!?6<;L!M\J&$O6ZZ/OE+\MY9:&ST_(*]#U
MTY@B9(P.=M2JW<Z8QA-LB8ABN.V>V6RYO9'<6GQ;+ZF^N_9BWX+L4S92Y#[T
M<R2LK"``DFNE_#Q=OG0KW^.[!;\:Q^QP(=LM4)<2#$966+9`;<<+4=A"''G4
MQ@XX\44!434ZV;"QHPKYU@N8WXMJ>.$M27&U-N%DOJ272RM;>\K^O4)(3YJ]
MJ4TK%&TRM!K3,-ZR;F,,((&6F*K2LDZ9.]TW.$.5(=<C1LFL[+#940$-JLUO
M4H`_2K5LL+>(NQKAVKG74\L60B!2[M[+M'U,T"4276TU!/1(3W_T6K&Q@C&5
MNRJH=HYSXB7_`!9BE#1:D@)IO('ATK3KTULG2UJ=`+;>U)654<)34CM]0GZO
M7Q&LH4E?;`F2CD^,&E$H%M>(+GG54J)(W'K0'L-,;B1X>6894_M-R2?N0AHE
M>VSW+)4"5?-WZ6**(_7MY$"":?F_1J/<QK7<YOQ@'[E/W#!)9EKME6^AP*O=
M]NSF_@+A`&F\<2\=%=!TZXG:J?EIKG-]1]^X.^8KH.G?C64;G[0T4\@3SI%`
M`/\`)UUH[:G3B2ZIVK+6JU0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T
M(0T(7CG_`.45!*_>][4D+D-LA/MXRAP!24DE0Y+INJ3V^C5]Z2_DY?\`N_\`
MA"Y[UO\`N_\`;]JC/[:W5#`+E(,9;AD9%.]:0E1"%H8BV^.EUM`\J!Z1/;N>
MNK8J)H_P2?PGU%2)0MQ(J@_J*D)!ZG<:4ZGOT!T)9?-ZG'T)52A3^#Q.L(7>
MXAYQ33BS0,[2C:-M`D437XFG?64+0XV7%I0E;BI#YVM;EDH!'F4=IZ=M"%UN
MH;:CN,QJ^NX@(>*R5`+3T);"A1'4>&L(1:Q'D*E30U3T?3;#FX;E=-O97<54
M!K*%F]%VH4IP&J15-.GB`:_P:PA<[0JTFG?S>![[CK1T\+3RS]0+8.C;\8KY
M5R--/-K"'U4<()JCR5%/`I\-)UE?A'M[EL;BQIE`.?O6UU7IT0%;G%@E)6K?
M2G^:K0:,EYQ'F6O.MN!\ZR2RV4!3LI`=VU4V$@45^B.OCHR7G%OF39]PP..4
M'*M`(%:>(IUULQMPUU92,O<LLE#W4`*X'3Z*J(`&[S&H!Z]O'Z!I5++E4=U:
M@>:M:=._?\&A8IWK7L%%)!4$K&U:0H[5IJ#M6/%-1K1\;7BCMBWC>Z,U;M3B
M8'RQG/&]P1)QK(ID".@`F`Z4R[:Z33=ZT&2%LNI.T`C6@MHJ[_.E#<2]GF4C
M^4O<YQ?R?PK?\2YGL]NA.2EV4+NUR0U)QR:ZN\-H/IL*`=M2CW!51I*J`&E-
M0+G7#'N#=E3ZU.9XGQ@/X#U*,&;?=]VR]XTSEOM]RF+=6)\`3X.)Y#<VG&+@
MXML+6U:[U!4MJ.EL'RMJ-:4&GMIJ+[8N\32CA0;L4RFTR6Z'_P"/P<W%U<<-
MW=BJY<IX_P`^P&7+QO+;5=L?O32VQ\O-6AM#*B[\T@-(:\CT1PJ!0ONZW0G6
MTK;B\-80P_\`""H:=FH6ARR!A/:P%)_[1R#_`'3?_1^MX_#_`#'T=M+?E<G^
M5%L^0;?,H;P>D?Y#-M=@^+S*0%_OEN^5E1K0R'8;LU3BWDD!I+)12OHJVDI4
MKI3;X]M4#3NAVQO_`-2R@[:>Q5_3M(MXG5NCE;V_LJF\B2FEOO-P4N2)`3OW
M,)<"(:$A155)"4!*P>M.E!J_6/3-M:M)L6AY-,VZG#;3;BIV[9ID`C;8R![W
M`YJ!VZE-H':E)@^%YUR3EN-PN.+=+R:[?O+91/-JC*E1HZ8\G9(3.D)I'@);
M9VA27%H)3V!U.Q2MM&ECVAII18BMYY2#&TD55ZUY]JV.8)@EWROF:_!Y:D+$
M3$[0OY>T+EN.)C,0%R7MCKRU//C;Z:E`TU'.D9'B\T5VLK&[S#W#YQ]Z\J/W
MUWNYGY1R1C?M#XWRE4;".+L?LF3\CM8?=Z1K]GER]!%KQR3=HJG&DP\2L45S
M>RE2PN6[U!&I32((M0#GQG,&.`\XKO5_T6T#('^)%'9A2IW4[%2;9L61<;NJ
MU8U;'TLRY98MUND20XZ6UH=E,1I,QU44/N)8225DIZ]J&FKG#IL<,+I9`!&Q
MI)/``5)PQV*:%O:,]XTPQ2]X]OT/`KI$>:A7J&_=;@Y9YY?G-O8^_;WG!'FC
MY$-+FMRF)'IK9<]0[7$C\(9.L[6^BYMJ0^/S>NA3:ZACDC,K/@7N#^Z5Y\R#
MGSVQ"V9O-GY!>^&LLD<=VS*[BZERZW3%(]AMM_Q%-\]);B7)MMM4U<(K\U41
M`2:D5HFK0LANLC-F7TU*I5XZ-TOX6P#'O2`^]GR&1+5[9^+8Y]9S(N2,@Y`D
MM-JHM<;$<>3`86LDA*H_S=T`2E1/F-0.A.F$7U6]ZC[CZ#_X2FYL;;3-EQ]L
MN44B.VA\&I]-/I4ZG;0@*^%=2BKZ[8UO;5*F>D[O0P/7>4I=$MM+JH*JYM"N
MB>PK^#64+3(<$X[VU%1;Z`)J$D)Z>(`(.L(6IJK*J.U3OZ(!ZU([TI6E!I5D
M4DGP"M4+L9?=2\\4IW-LI05*)`2G<D'NHBO?PUK+&^`TE%#]N""*-SGX4T'(
MW*5LPXH7-6B3-<`^4M<5U+KSSI("!(](K;C-H5U5ZA02!TJ=3^B=-:AK5PUC
M(BZV-234`8"N\A,I;R#&-KAS/+]RAGFW)>4Y&\JY7B]JQJ)$>"FHL5241(R%
M$+2D+KN47`@5[BNNOV'3W3T,`MKV1K)P*$$.]>6GI6T,5Y<?1:7([QGG+D"W
M>G+M=[B9)`*4+CQY6Q3;3+1%=JH^Y9%4'O\`'59U7HC2;JXD;8W+"ZN#0=F`
M[*>E.7LDMFY;D%KQMK^RJD=B_NB@W`-(R>,W;Y:U44XAE,FW#J/*$;@[ZAKY
M3X:I%Q^GNJZ>\W<+7RC92HV'?C3@DXYXI'96&I[C[5(VT9SCE^@I-HO%A*'2
M/52\E4=T.E(-`AM3FY.PCKT-=5^]CDT\TO6NC(X@GU52]"CI%[0AKT"X5M-M
MEM;L)*E@MI24J7'W`%1VBJ:Z3>>7"R=]1"]H<T\0=AXCRK"KTY\4R>=,E#<4
MHK8\/<:=DJ4J6XDV=L%*F^K*4*)J>QULUCY&"1@JRNU1VI?1:/[_`+"C7BZ4
MV.5>.6KFA$)EJX/*AJ*`4N/*@2%);`92O;4(KUH-;<J3@MK+<IY%N7;Y*''6
MBVX'-X15)J:E5/(HBG\&M-F!3\KIE/.NM,2R2E"W2W4&GF"2H@@&O\&A"Z(@
M8?>WJF34':@$,A"F^G3H5^;<?'PT(2DXKY#R['LN<X[F6YN_</YPQDL[)\<?
MC05S+&ZJ.ME5]PU:JJ:N2U!*23L7M4H#41KCA$S+(:$A6?0[R]F=^$PEH[OO
M6GD'B].%IL[MOEM+LKC4A>*9E#D)"YC=6W'K7?4.+2EJ8RTZTU*2ZE*P4C96
MIU0PUP<7'X3L5^9=2W#<DHHYOM7#QU#@77,[4Q>(R(EYM5;HXVHAD/V\`H,U
MEQ90F1&00"0%*4A-"0!UULMT[L81YEVY!O[,EJ9\]>K?:0\T\)#'^T%CCB1Z
M+R"XTO9/DO-J*202D]Q0D0J)?O0K[]KY=QE@[2PI5^SFW+=:15!2Q:HBIOJ=
MDHIZJ:'KJ&U3ZC.XIQ!L/>N;C-WCRQ81B3N:Q;7-1D.5WJ5)F7V<X(%MMMN:
M-`J$RM3KE5IVI&PJ)-!I]:_2"76,F5A_(W+_``99L2A6UA#LVR(N[%IM2HK+
M%Q5?EWA<5Y^1M<=6F'!!_.04&E?#3I"OOM2%,PY]S4I(;887/#)IY_E&'Y$]
ME->B0J.T@#L/-TU@8NRCXE$ZA*Z.04^'+[2JKK7[X/<;S3)D,\48!A?'MF,N
M9$@WR[J>OV0NPV7W&6I+*5%N);7$M)"Q0K],_&FI.VTV^D<V1D9+01C4?>J[
M=ZU;QQ/9S!S,IH,=M,-R?/B'CW+8,^^Y=GES:O>897)9GWR\1T(:9ERV4I;9
M2VD44CTF.G8#IJT6=M/&?Q&D>94>ZN9;C;L4K(K+H92`D].G0CJ?B>O<ZETS
MA86,H=M4IMAV-M*05J<0D):!`4LE(Z`U`'QZD:RE5SM?+MNN(#*F7$A.X+(4
M>I-*$%0Z'0A2;]KR3(S^0ZWU7`M;JV@.A65JJ>I(!I7QU'7'U3Y$\MI&`@$X
MA)CG7]?[=_<VRWYW4P\P6I'B-MS?6355!5-*Z;N:2"&[:*PR2,=;$-..'K"O
M']NW7@?A8CL>*.-Z'\&'6<'^'7-+[W+]V;#WCZUT'2?Y%G\*>D=M)N-34)T5
M]UA80T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(7CR_Y0\(Y]\?M1
M3(4$-K]N^4IW$$]?[25*IT"C]5)/XM7WI+^2E_[H_P"D+GW6^QO_`&_:HX^W
M=M,?`KE%!\K657!:1X?++ML!E#E.VU3II3O7PU:U0](^"3^$^HI_6GIL<`?*
MUCJ\@<JV1N-*"FXJ^J#K*670ZPVMDE:MKJB5;1WI3IU`(Z_AT(02PLI2VJH2
M0E).X=J`5\=:N<&@N.P(V).9-E^.X7#7*R>^V?'H32PU\_>+C%M\9+BA4)^9
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M7-KM--^\4*KL>Y9;M[LEFY_9-IO>X?.VV]9[@MFE1R._ZN=?FW%)`[A"5$ZF
MI.H-/@LSEDK="E&T=6F\[*8#M4!_1=]'=\V2(^'`-3F:>[8:I)SN?L:;6XA.
M68)'DLK#2T1KC>[U,2XL52$?8-GN4*2*)ZJ2X17QU&6750U`N;9U>6[<"*?X
MJ)=G3D,C^6W%_!)J=SQ:'H;JH^5S''_6#SSMGX]S.Y..-H(4XL.7!FU1$40D
MBH*$BE33OI\W6+MQ(`;4-K\31ACQ=V;-J<#IVT8XPO-)FFA%#@>^E/2DFY[E
M;LU=!"197KI9$);==N\_Y>U7-/JT4P%6L7&>GTW$5*B'24T'32MIKC7O#KIS
M60.!H21MX;:^A(ZCTX8+7FVK<TF8#=LQKM4F<+S.SYE;HMVMQ;2TM.UQ*7`[
M58(*U&E2FA-*&G;5C#FF+G`@Q'>#7U8JKS6T]N:3-RGR)7RDQG=I:<"EFA"4
MU`W$]NP!KH:X.:'-^$A(+E:<;96H.D)-.Q!/6OT`ZRA9;0\^'6P%M;`G=0`;
MANJ*&AZ5&A"87W-MJ7P[FZ4%M*E2K"D%SJ@(^VFBI*A0DIV@]/CI(PQUK1+.
MDG8T%P.7R)F>!_<GR3PBZRG#+^_(LGS#+KV&Y*P9V.W%M-%*)2'"XPFI.S:4
MD'N-)2Z='=T&PMQ6D6N7-BZMN,^;!W8!YE;9@GNB]NWN8MHQ/E?$+!9<JNK?
MHR+9DC:EVNY*8_5,HM&7MI$BT,AM(HAR@;^J"0-)B/4+7"VC+AY/:5-V^HZ?
M>"M_(UCNT$^H%+#_`(!_ME_V!??V7VA_OA#^B?H?L/Z#_?=]*?FLW#^W@H_P
M&E_YHVUW[/,J<K,Q(OMSBVNP6*\7BYS%*9AVNPQY%XD2I"D+*%)98:0MJ$HC
M]LX$)!\-.N]5&SB\4[*.*LEX%^[8S*_-L95[@)\SCG$G$L7.1AMON<=B]W".
MR'%MOWZZK+<:T6IA!`=%5*4'.W33>>YN(*,@K[U:T[%98=%MX6YY]^SVI_>1
M_=S[=_;+#L?&'`N.8W?LE<R"V0Y43$&FV<50M^6U'"KKD*&OG+Q=4;P\M*5J
M"R2-P'0-A;WUR<QS4\J7\186ON-I6BCMS-S!GO+5Z@HR#*75N2[U-E-6Y^0M
MK'H"(K+[E8\%H%27$NE);)-$G6;X#)Y$M9NO\*U7F_YN=]G>,^XEWCGF3CJ[
M.Y#3[<R')\,M\MY+MWO6YUDW&X&2S/2VVK]8MYM#K:0:="-:Z-<W$#7MAK0N
MJ?,K1`=0R89J>5*>S<+_`'>LN;*M4CG#]W[S)Q%R7`M[U\N"H3.33-ZK?D:9
M+T%;\V3;R4@1RXE#I%"0#J\VE]?D#*TR'Y/F_N_\6SRK::?4H(7S$.(8TNIC
MC05]B@GRWQ-9\)YJG8IQU<<CY0P7'(=GN<;-X*L<AVRZ3;A;&;S+81;YS56E
MPW@ILU?.\H*J#MJ;L;+JC4+H,&E-BLZXXT'_`$A,/ZUO/`$B`[.!^Y>J7[BN
M[<B(X[Y4Q6Z6-JQ\>1I&'W^W725CB+//R;*+DF-%N2S<V2(JH5NLUO;:(0'@
MX7B0L4IJ!_4+2X])U>&W8QL9=:M<0T@XE[QC3?@H/2=4EU>&2YE:6/$I;3N`
M-?2M7O[N[F8>_3#,6;D(5!XQXBMK3[;2B\PU?<MGSKR^XV!M#7^UC+2`.N]*
M0>@Z:H\7U6]Z?W'T'_PE*V$66F(T1:=J1&2#()Z-T(HKTZ=:GZ=2JKZP1#2Z
MW*9?*WHZRI(])1:5*1^@%'=LI^/0A=GR[(;8+2?0/U'&"=RF4(30%2Z(W=AX
M==8+@WWG;`A)^[W>U6R,_)G38\9B*A:W)$AU#++5!TW+430K(Z#QIK9EI?7?
M\F">ZJPHBYUSO,N<:;;,3]1ADKV-W4KZN[/*LICAL+*`L$).[S#KXZZ3TUT=
M<W=G&_4&GF5=6O\`$:>A,)[JDA@KY.],2FR7Z[PY&2LVS(;C;5.)9N&1BWW2
M7;GYZ5=(TNX-Q'(,-Z&LA;J''$.(0"2G73/_`,'I=D=.+VLN#2A%`001Z#L2
M;=/=,X/:/>JJY/<Q;?<[/5-%KL$R7@I<6VW-Q66Q>KH6NY5*L["F)S"XX3YT
M(#JTA0--<0_4"#]4[J!S=,FB.C[BT^_3=L=P[%TOIDZ=:`>,([:J"F,\O<H\
M:N;H&1WV`\PXIM=HN3VUQ*VW#5GY::Y&!96?K]:H!((Z:X?!U+UATLYC93+(
MYAQKF).-<5<8[30-6NI`,I'DX*S'VU<Y\J\L%^)=>-U2[?&2T966-*;19F7'
MJ;&@X6JK=7UV>F5I-#U&O27Z?_J'KO4+6VU]9N%N8R[,6G:`*#$;USOJR'2M
M-)AM,HFS#939C536C1+C`FN*A2)$%QI.X/MK<9@>KW]-PE9`<'Q^&ND/MM*O
M36\MP3W?L5'\;OJGAP7D_D^$I8=7#EVVW=9=PF2Q%M<2)'ZOJ-Q6TZS(?:92
M3Z0HXHB@%=4?6>EX;LO=;MI`''**;!N"D(W9XVOXA(7*N1[/GW*&0S8KBKG*
MD6W%PQ<XX`@*;B0%PWXZ%$ASU/60%`%(JFNN;R1^$G-GO;CZ?VICJ/T6_P`?
ML*>#CJWL.<AX.GUTR97VA+6A(10QW&;/-7MZK5N)W=^FC>M[/8I]K;!BMRGW
M?4?2$J7&I12`1U)<.X>/PU'N^(]Z?G:N%]/R[2(RCZB2HR$GZNW>"DIIYNVL
M(6^$T-P6#0*8>>IW_8&A37I]:O?PUA".^,8!E<E25EXE%OQ1^0P4BBFG)LQE
M84DE1`+1'X_HU!]5;6]RM?2FP]ZDA&NQL;<J.]8K%E%@FK4]=L3R&&9=EN,G
MK_/$I0XB3$FN5.Y;:QN-.G35//TVJZ0_5?\`;BDG&N'&=]R06FW>W_%,7DMV
MQQ]>2KO%]R!+2"^2[:(5FO$ARWP6)J54>V#SM`"@/72:<HBQ6/:[;B%V?MMI
MMEDAW7)\TELVVSPVX%M895?)3$=Z-';W!*`S$`I7J'/HT(7GD]]<W[7]TV"V
M\.>HS9X=[NBUUW!EQ$=+:'-M>A"32M=0VJ?49W'UIQ!L/>G?X]Y#PW"^.\9L
M^47.T7V\W!]$VWXM;[+;KC<!;Y7JMMV:YOW"*KY-Y^0M)<=05*V*Z"O73ZT^
MD$NCCAF"]D7O"QM=PQ!K"7K&J;<WK!#<8E0HT6';4JB3E.,EOTUO"7T24>2G
M<Z=(5OW(-\1BO#/(=_<>]-=LX\RJ:UUV$R7['<FXH"S7:5.K:H:'OK#/KA0N
MJ[?^'[U`OVD8_%@\78R'H;29C\9*W));`6KUH[:W$TZJW%2CUKKH>F?1\BY;
MJ'U_*%-6V,I24L(.U">HZ?@%*=-2":)?18]&AY_$_F_B_2^C6$(U#:FFU+*B
MXXD5;/4%/:GB=90N3TB[O<(*%)&Y1/7?WZ>%*'^/6$*3?M0&W.+F[W_VJ=3M
M[=B.M=1]S]4^19BPE\R2',*VU\$^Z,!8J+7G"P/CZ<J8LCZ*[=:,V^0^HJP-
M^EYO6KR/;GUX#X3/QXFXW5_H\.LZJ?BUR[536^?_`-PKINE?R3/X1ZD]>DAL
M3E#64(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+QT_\HK%/>W[4
M'/T?;[E(I\:\B2/'PU?NDOY.7_NC_I"Y[UN<&_\`;_\`$F`]NK:W\,N:U)+2
M5WBX;:^:HBH@*Z'I^TI^+Z=6M432/@D_A/J*?K8M2ZJ>HVD;DMD$^8=@#N^!
M/AK"66TNQS^W=^76!0(V%S<GP7N!32I)Z?1H0NUKU5*3Z3)=J"6ZK"`L;"0J
MM%;?**ZV;'S3ROFP2UM<1VD[+F89HHW5(X@*JCW9YG;[QRGCW']PAV7*K/)M
MS=OOELO$94B/$GW5:DP;@PC8\W\TTR-Q2=O3IN!U2-4NC#?>$/&BM?3]]$\3
MW=G;XT)V=G<D1C-OXOL4`8WGO(V2V.SVV.EJU62'<+I=V)+WKE#C,>Q2LE3;
M+:PEOS(HT:I&NG].=-?I+)HC=0ZQF<S6R]^9HI\`/N'$':%R35>K?U?GU>6T
MZ6MF_D^:@<0:YZG/PWI/7MOC25?),/C7$<DR8)1`;@2[MCN.0Y$F0PE31#;\
MLJA1$NATD*2$F@I4DZ@NK-1_1<:/<:;TPUYUY[0(7$"@(<TNQ#?D#MZL_2VG
M_K.=8M]1ZF<P:`UQ,K1786D-I[WSENY+RS<0<WW1$:9!PRRXC;R^TS]JW5]I
MU+#JZDA8M<.$PR\R`-M)`W$]"*:XT+WP6%=B[;=V7C+ZWKC4CUA*B'[<^8,Z
ME2V9E]NN1/6Q:FY#<.TIOT:(AL4"WV;[>KO;&6_2`4@K6V0BE!VU2M0_4CP&
MJ7%K;Q<VYC`[=K6GAVKU!T]_\:H>K-,@ZGFOA`RY;7(7`9<A+-A<-N6NS>I-
M>W;V`X=RS8+G=9O(69LN0;J_;[C"L;N.PVY28OF4ZV[$@)E[32I"4GIW.O('
MZD?_`"C_`%,TK6G:9T[I4C[HF@]U^ROO?N_+56>7_P".?26C1<VZU-CWT(I4
M$8X8G,0/+2NY-7E?L\R4Y3EF/8KC_(U\M]AR-O%L=MC$#,KIDM[B+E,+?N%O
M=8@K@(AO,E2EN=$M%-.M:B\=-?JK^M&L]'S7T5@8KPM^5U:FO8%SBY_2[HBS
MOS_KXZU^9O\`YE:C=?NC."DX-=IN/XUR3,S]["94W'[,[E<]*9V7*LA,"VSG
M7Q%MK!7=B$N)4?3"00H@5(HO1W4'_P`G;[6],N.HHXV]+R:RS/31)WO\)6*N
M:\YV6;]_\3(!NI@H?J#1>E+2!UO8/9),P4S`@YNW!5P8]]TQ[U'L?LL^;!XI
MP^^*^9D7Z'EN<8\R68D9+JYEL@*L=PO3MQN,:,@KV)0A'E(*AT)^MNJ'_P"/
MLMK<-F?*-2#K?(&@,;7(_F4CRDCWLN_!<$O+>[AO'%U?"8TX5W)O_9Y.K^]<
M1<MF9"M-QFP$NQT+1#ERF%ICR9$-:U*+D=M]*DA5!NV^&JMIPTD7--%+S9;L
MW#T*C:Y\9[_8IRE+<=;#6SUBI3:=P(1N)-*T(5WI\=3KZ9S2E*[MB@&[`ODB
M.UO/@KQ13L*UK7\.M%E8)2$"B>@K70A1Z]S/^\]F_P#[JL7_`,V&]8*>7/T&
M]P]2A7;VF)-J;CBD9Y<:/MEGSANG?R#834&GUAIS;[3W*OCXBC)]U,1(9CK1
M,26VT/E6]!40D`EA2%A3"J]^IZZ=+9'?[[R_]U+Y_5OV=_6DSZOQ_:?4^C^'
M45X(]NU:^,^V*]%=VSGV@^P&P.V>RKBW'.Y$9]PI$Z!<\XN;;:%+BKOUV1^J
MML)UVB2VR4`IZ!))IIG6Y^;T!29BM+/W[493WD^LE5-\_>^CEOGFY2;7,NO[
MIX5/C^HC"["Y(1`<:!JVNXW"0VQ<+@)"4@J;6$M#K0*!Z/K.,R9G3XD4IZ>"
M;R:G<W8R/?5K-E`!M[ACL4.K;=)<[+L58^42[LR*Q5=:;2VAD(FESU8C+24M
M0W$^FFJFPDFG7N:R[)I(FEL9H*'<$P=;Q2N!>"34;S]ZDES5D4EF_?8E@CW&
M5-,$O1;I'<>8MT%U^>IF2JY28ZT.1ICK`"6TU],$U4G7-M9O[N*;EQNHWN'W
M+J6B`30F20`N4$I5JM/-^3<O\8YQAL#(9^#X><@M.5ICHFRWKDF',?E65^YI
M2@RW+>\TGTW0:@=*Z<Z1=W`N&,$P8QV)%&XGC6E1Y%*Q7$[7N:TC(#LH/N5-
M%PNMHA(NC3\*XONQ8,>-$#ZMQ9](E"66W:^HEI*Q3H>@UV"!YCC9ECS$T]X>
MOLXX*7$]JZV>V8`DL=ZBEOCMIN%KLR+0TZ[)O^8-M/--&2X\&;*^XAJ2P%*6
MH(<=+R&DJ%'$[_*0=3]W/<LT]S6R2`9=SW#TU5;$ECDY=&9.%%^A-[3^'Y_!
MGMNX/XEO-\?R:_81QWC5HOETE=5NW=4-N;/C*10(4W"E2U-I!%!M-.YUQB<O
M=,XR.>]U=KG.<?.XDT[-B8FVLF`FU:`PXFE=OVHJ,\EOO]J7OA]SN;!0=9B\
MB,X=;R`E"(\+C^WP\2>C-):"&_3#R7^M*DK[]!3$5.:WO4'=O>`Y@/NT*D,J
M*-A1*?\`3:4@-C:!4@'<$U34C\.I10Z,XZDH980V[ZK<=1+2BD"AZ5!Z#?U^
M.L(6F9*=CM2YST7R[#Z[B%U*DA0(2E!.Q)60`:4Z'6'1\T<OBLM:7D-;\155
M6<<F7C/;W.@3,AQMIJ'-G--8C(>EX].=")KL=MQNXR4OV^>XMMD#8Y0)I4&I
M.NR](Z=8P6@E<T9^-2?6E?"7'`HHCR5VL):O%GO-FD/!(C.S$QT6]I*>C:FK
MBRN3$D(6FA!'Q[#MKHMO<5B`@>!6NX?<HF\T^42F9H_$I]NQ21X.YQSWAN^Q
MI&,9CD[F#S+P+AEF!VF^IM5KR),IM<>YNQW7X-TAV*^7"*ZI"KBPPF0`?K#N
M*OKO2<>JQ.GC:?&FE'9CLKCA6GH26GWUW:7K3=.K:`&HH.!IC2NWM4FWN?\`
M@O)H=NX^G<:<A8WQ`[C]P@W2$I'&V6Y]C^32KBJ7;I^`Y->H3=RL<.WM//>M
M&,V5(4MQ*D/IW%`J,/0>M6SS+%,_-FJ`7/+:88$$D'?C2@KLPQGY-6TB0^^T
M^<CU%0MYNX+]MV>9#/AV?&)F?8@TW:'K9D?(N*0,5S"4^MG;)AR4VU4Y;ZTK
M:(<4M1+@%=U%:L471F@74$<FO6K)-5I^(0]P!=4TH&Y!LIL:%$-UN\L+J1^E
M2&.$G#`'"@^;-ZT6V_'+/C5L@6.R6B%:[?$1'MEOM-J9;MJ4[O+&CL-L`!;Z
MBFB-X45=M7"R\-I5F+/3(XXH01AE:3AVD$^E1EU<7.I3\^Y<7S\=GH&",KS8
M;?B41F[\J2I<%]W]?:.-;,ER-D<TI)3'E7CYI;B+!:'5)HMV25K=(.S:"`,/
MFDD^,CS`>H)'PTFZJ9/,<WN6513%?0C&\<CR2J)B]J646MN6VH&.5E)#L]Y"
MJ?KWBM:SU).H^1[FQO#:4H>"G[<98&-.YH3:\.*=/)]_6EKUE//P4/`J*4H:
MBI*&E)2*)3L#AJ`!N)J:]-<'U4`ZL]V^A]83#67.9;-+<#G]A5A/%L5#7+V'
MO17]Y5>)Y4I1!"7%VQUIQ"4J)!"4*I]%=-0FUC-*6U)4^'4-LJ;=DCU'9+3:
M7"%$)4E:031*3M3U/6E#J/=\1[U/--0"=M%KDH;E!"VD4]*F\U40ING1-3T[
M^/?66,SFE:+=I:WXA5%Z9)3(]-AQ"4):]((\JB$NU]7ZU5><C\7AI3PY^;U+
M?F1?)ZTX7"YCOY'E,QIHI>9MEJ@;R5>5A[>\XU11(JIQM)J1N%.G35?UR:UN
M&^]B\#CP5JZ3MYV@E^Q/](8:`'D'GKNZDU\?C].J*'.+B"?<&SL5RCIS'@=G
MM16N/&MS<N>EI*%!AZ1O%:A3+"J$DUHE/I]CTUNETUBI2K7Q[9D.D[V;0SN(
M'4NW*.J\R7#TZ^JN2WU["E!TKH0O-MS[=1E'NHR]Y3_]28?":89*4CUI5S6H
MOL`@;@J2EH#XI\*:C[V-CW-+AB`4X@V'O4LL*@<CPV["_:^&\-QV)LMOS-YN
MXMXG7*`"S\PZW/FS'9!>>8"J*6GHKN*#2<<CV4:TT;5.&XN`[4O/:0VG)O<A
MR[F:H+,13,";%#8EQK@M#,VXIMS*&Y49"$(0&()`"0`1UU)I6Z:V-M68%36]
MXE[-H]LV=,A10Y>FK'BS)2>M+O=K?"0W3Z64*!/>E3IQ;1L=("X5*J.L2R"U
M,H/O@;<$F>%K-]BX798J@`(\:(E`'YJU,MH6>_6M/'IKH^GPQMMB0,:>Q<LY
MTL\SC*:T[O8I!10$)0M/1:E;2>]4TKV-1WULE$KXSSJ6DN+75NI&W:FI/2M"
M!N[G0A&S3K[K#JD*._;^K.U/E^J>U*'I\=90N=,B0VH)E+"T.';0)2GQZU*!
M7QT(4I?;`$(RW('&$[?2LD9;5*JVK>F>DZ?,37<@4H>VDG1,><SABMHOJI#<
MJ,-'AKW0-;?(JR<B$IW*H5(%S6G\ZO120=:.BC8"6C$!3[/I>;UJ\[VZI`]O
MW!:J44OB+C<J[]2,.LP'3PIKD.J?SK_^X[UKINE?R+/X0GGTF-B<H:RA#0A#
M0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A>.7_E&3@3[U/:DA%`ZOV_Y
M.4J[T3_:04TH?+V6=7WI+^3E_P"[_P"$+GO6^QO_`&_:F!]MD]:^.7TO*WNH
MRB?%*]H3^K7:X#JQY1MH7>OQU:]ZHFD?!)_"?45()#)?W`=TI*TGX$=`?X="
M66H?,]0N,W)*3M]112F@'9%$].E?X="%V/R7&XCJPK86V2O:*>38`H@'X"E-
M*PN+)6N;\0*U<T.:6N^$JB3E=EV3S_='+J&IK4_*6KC"3(:;6EJ-ZFP-]4@E
M*73Y0:T'0=-<TZAJ-4YP^I7;^S8NL=)TLK!S;<-:'#'`'=V@IQYV$R82%W#'
M\<A1;5(OJH\J[NM-MP+>%H+<E;12"YZJPHE9\#U%-1MY>7%Q)FF=4Y0-@V`=
MR<1VEO&7<MN6KB<*C$G%+2UVBQ_O]A]ACW%J?$F73"6GC'2U!H9UWBLS%I>:
MCK)4ILG;N2KK3\.F<$<(G:][&X5QH*[#O3A_,=$8FN=0TPJ:;:[*KUAS?:YP
M=B&'7N(Y:[U><>QVV7K+$0<BS'(784B7;K#*N)B28#4B&P6%.14[$@%2J$"G
M6L7*QMU=\HBL=5/-`@MVW+OKMV'A[%XL.2??7]YO8L;N7(.,>V/@;AK%91E3
M7Y#O$=@EW6W0U71]NPF/(Y#S:5=<C>ND!+9WQ880V32AH25HNBM)M[]^K1VX
M\7+3,XN<:T`&PDC8!L"4_P#V[UI;TTVWU&1EK%@UH9&``<32C>W>H67S[SG[
MRC(I\B)<_=-E^)XBW,NN_&>/KAQUQM>%2I$=:&7IR^/L6N;0;;=(*TI5YD@@
M$=]8/172MYJ+;Z[LH77C6N`<10X@UP&"2FZQZEU&)QNKR9P/;2OFHIF?=#<I
M>X_ES[QC@*W\B^X3D7/&8RLKNDZ/>,USO*H(>AVLLQ#=8%TEQ[0](1<8;KJ?
M3C!"@?,*`#4JVUMM-M76=E'&RV.UH:/:*JH0,.H7_P#JWRNJ:_4>/4X+VBYU
M[:<[S9#3D;W&<@8PY(OLN_W2-8H4:4F:S*0Y\M`99O-W9CVADM.;-L9MM*:[
MMI.HW31!;R.BE+_#AN4-S.R@<`VM!M.P*T16#[*<N=,[P9/NM))H.!)J3Y24
MC![4\5XS.0<O*Y1Y;O\`><&Q'+[[&A7^;C3]H#,;#+S]L6I-C@VT!R/<934=
MQ<Q;BGFO1H%`+57),4=VQENUG(!PJT../%S@2?*5(WEM'-9&0O#X1^[VXT-0
M*^E><#V36T2,<OEX22MJZ29UQ`"E!JDR<M\-L(KY$-!="!3S"NNMV4CG:>&T
M:!EW`#U`+@FO2R"^,0/N5V>16![&PIITIZLE"T=5>4H\PZ5ZT^FNI&(4B:/[
MH48-BU/K:>7ZB4$.GHI55&J>II3ZHZ_1I197/2G?6$)@O<TR%<,YQL311DV/
M:KKW^UVCXFAT%.[GZ([@H/6IA?R3`>.Y)CM"GU?#XH(/8C3BWVGN4`-I1BU%
M:B_KO3);)Z#<M76IKW)/6FG2V6W]7^@WWKV1V^';6:E(^'AX>D_>E9<,BGS4
M%I5P,N3-VM7>[[%/(ELE:>BY$P"2T4`5%.Y%/'27(C2-S<ND%&%:9`AKA?SB
M29L@*0S'C[%;'(L;]F5.TV(*@OL3K9K&L^'>F]D]T1?SL*TIZ486RZ28-SLU
MRM4!5M5%E18:H382ZS<UFZ0E*6XZ@[$!"5?G$5IK)V'N3X7$51CZ"I+62U8Y
MEF93\?N<G%[/(R3.K,V)SJKXXY`F74MVVS23;(-V83(;5<GD(70J+:5%120#
MKG>JV5S=39X`"WO`]:Z9H%Q%X8XGS*.OO:N7(OL#D0<Q7Q0UD&.\@J9Q>[\M
M66_LL8KZ+#[B[SBTNTKMS=QA7MN+5<9;_J,O(/1?AJ0T?1;.:X9)J$CH[EF#
M0`7`C:<0"!CQ4I;R1OYA;4G,-QX*J=/(WW>.>6B\B9Q)SIC.1S?GI<2],3;5
M.A29LE+CK;"HC20(\%^2L5]%("6S4===,?JVHV3HK2UB#[=SFM+B0"`2`30\
M!C11UVS4'-<(FX$'>%,'[OOV3<G9]G6$<^<0<5625QKBW*&-V*5?L[F1+XPP
MI%QM%PE+&%W<K8O2H\1Y!:6&RAB24JW`H.I#5==TRUMW6\SR):?*X^D!5[P>
MK</^8?>O:U>[HUCF/9%D+DF2(MKLU^O[CLYI#3D:!9X=TNDM7IH[>DBV*(10
M$J.U(IMKRZ:>+G&A^+$*6L8KB*W<VYPDS<:X4'!>83VG(-Y@Y+FMS"FYN4W_
M`"3,5C;NW*R>\S+BTLD`E)<<E=0>J?'3B&-Q<UX^&JB+S:>Y3*6VIQL+0*I!
M)[@?P&FI%12XWP/18;*D)<EN+:BMJ4`N2XDC<VP@54XL5[`:;W-U#:1<Z<TC
M'97T!+6]O+=2\F`5D[Z>DJ3'&WMJNV;PH<[DAHV/$W7FF(N*MM.Q[M='7R$?
M:#TQFI35"ZA/UB.E-0$G5&F2L='9R.-S^Z,K@*UXD4V*RV73>J074<UQ&T0`
MX^\TX4.X%4V93QGADV_9/9W,=MSL&TY?F5KM[SV]JXL,0<HNL5LF5&W/J>4V
MT*AVFVG3QU<-.Z@U6/3_`,.FSC^U3\MK;P_&`/(DDCAN]V9?S''V7S+:A-"[
MCE_4_=;)(W=2&PH%;04KJ=WB=3.D=7W\+`+DD4)[=ZB;J*T<33U(LF6G)L?<
M>E9;@,FVK>HX]EW'#RY#+R4FNZ19DIDP9*%4HI*VHW0FAKKI6F=>6K<K72'-
MLQ:54=4TT7,+H[<'F5'9L..U*O%[M;[RZC]VLCQ?+WVVB'\;F^GBF3M[E!(W
MVZ:M-N?EH`)"6GG20"2$]M6X=22ES6C+5^S']JJTFBW<?QAP\J=+"+;(Y"I&
MPY3;_P`JB8[>)]RF1;=;[!%@OJCS)]WNJU)A1H<=U*DI<;*_4*:("E=-)W!O
M'SN<]HS$[B#[5AMK*T9>':BK*,^QGC]#UOXMF.97GC?S,>X\I3X[35IL\D>5
M36"6MU7S3C[(K_MA+*E+[MH;J=:Q"</K(/=IQ3JUA+)<TOP4*B9?I,R9.>G7
M";*N<R02].NEPD.RKC<);BBM^1,<<Z;U.'H$52$TTY4C_IOL$EG#7U".OUB.
MAJ>]!3OIK<,<V)[S\-#[4N*4&7X5\X:MT:5R#?75?,I>9<2[1L^@*E`0/46Y
MM2XV5+%4CKX^&N":E(QVK/:W;0^L*(UO^6;_`!CU%3QXJ;N#_(^!QIK=M;$"
MXW$1WFXJWE1W9#(4AM1;!]14Q#=%*'1-.ND$UL/@4\WYC2I2'$LA6QTJ5'"5
M(;%-VYI)4``E/8?1IFZ)Y<>]6%I&4=RB;[E.?KUPPQ8&+1%M$QJ_S92&F[RY
M/9BP`U$+WS*'(B2WZBCY2'2$T[==5OJ2_FTJWCF9AF>0?(*JT]+:;%JEU+%)
MCE8"//15O9G[],HC.//RL_Q2Q%)"%(L4*-+F(*.E/6(4XL?"O;5/@ZNN+A^2
M)Q+O*%=I^D;>V9GF:`WR'U*P;[MCG.5R=AW)>7R\BN>3-W+/8=M8NLM+C$=4
MFV8Y&<E,M-.I0MW8EY--HH>M.QUK#/<78+ALWIQ:Q6NFMR38/.RF/J5KT2\)
MG-(W*/0`H\JOSN_Y*#2;7L<XM'Q#:M&12,D?*X#EO^''A7=NVA%.>7-VWX/E
M<EBGK_8,J%'!(!6;@!`2D?2IZ8E/X#7L-*)9-AR)-5:,8N4=I2=EMM$.)&)4
M.L6W00A)Z>/K`"G>FMI&F/XUF-KI#1FU>:"1+5E'./+E^D/QF(TC),?M)E*H
MB1&?A.+7*DL.J^HW$3U/@3VU&W$C)'#+N3QL,D(I(*$J=S./XI9(JY6*Y9AW
M(^1,,)DO7GD#-)<R)"D&.N6VQ:L:9=^46TD-@!*ANW"G<Z0!H0>U;M(#@3LJ
MG#]B;/EY+R!7H!VYY!`A$LI]%LJBP/F)*6D+H6X;;SQ#*"*I&G_B(N/H2ET]
MLK:,VI[O>E?%2<!XVQ)M06[E?*N-[VAXQ+(Q,D2W"KZJ0U\TCH>JJ].QU+:;
M$^Y)DB%6!U#N5*Z@D9;VICE-'$5XI]\#M[,2PP(ZSM_512WTK5OTT!)/P-/`
MZZ-9,<VV+#\5"N6P.#GO<-GW53BL0VEKHE5:=3Y:=*_2?CK;DR);G1\4?A"&
M0%LFJQ^;0CZ.YZ:QR9."W:]KA4;$HH,J06PT$CU7!1`W`)W$#NH^5/X]'*DX
M(+@!4[%K6A*W%)"DA]/5U*B$I`)Z46>BCNKVT<F3@M.='Q4K/:RGTKUD)64T
M^5M?5)"A_6'][7XZ3<TM.4[4M`X.?4;$W7(JDN<4^X5M!JI<+D)*10BI/VMX
MF@&DI/@/<K`SZ'F]:O9]OZTN<#\*.(-4JXJX^H:$?5Q*SI/0]>XUQ_5<+UW\
M;O6NFZ5_(M_A">#20V)RAK*$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$
M-"$-"%XXO^4:):7[U?:@%APJ/M_R>@0VM8I_:5\4@@&NK]TE_)R_]W_PA<\Z
MV<"]D0^,Q_\`B*C9[9U/M\?7"*$$%S(KLA"3TJ%PX#R2:_5JU4]>QZ:M=*FB
MH^G-=;M>)<"6FF_<5)&('4I#2$^=1*2":#:0*T)H/#2G)?P6]0C".U`=*X[S
MBD[7%)<"6U&BP!6E!0]='*?P14(MO-K>::=2PE*XRT*JKU$@AHIZ**2=U:>&
MMF1/#@3LJL$@"I5)G.[*&>;6PD^;YR.#T[#Y@>/CUUS+J/\`GCWKJ73D\8L@
M*J27JI'&LQFIW_O-*-*&E/L\J[]NVH.7XAW!2K7A]7-V5*9C")<:/GN.OONI
M9CQ\DPN1)?<JEJ-&@76.Y-DON&B6H\5H%;BST2A))Z#3:7/RSD^/<G$#HV3-
M=+A&-N]>U?)<HQG-.+,KRK%;Y;\FQ6\\>9K-MM^L#S=RMUPBMV2_1EN1I;=4
MK9;?AN)<V56G:*=QI+3H);2_9XT4+R*8UK7N4KJ+Q=Z8^2RQ8P&M<-W:O`7S
M<K%GN",K^S[=Q*_=95OLC4VZVO">7<ROS7IWN,E*KM=KXJ%CV/H0VD`O1"'`
M1M%1U/6;D64=L(GUYP&/NG?B,:47![=]W>ZP\P4='FIB0-E`=O:JW(7V<D%+
M9O;K=%'YW&<.L%E*#3HGU<AD2I"&UGHHUKM^G5++VLO,P^G0^K!=4M\L5MRI
M#^,1L[@K@?N(6%7/[R;C93CT]^/:L.SB>PJX7V#>9+<HVYMEI+C%O2EBUI6%
M=4]0H]?#4=?3Q"M24CI?\_AQ7M>]P/+60\/V+')^+8G"RC(<BOSMI85--U5&
MML9G:'*,VQE[U)<Q94VA:Z-@D%1":G5/U*9YPM<9`<=R[GT;TKH74US)%J-P
M&/;N.XT[<%E[E+Z[:_;#SID3K'R<M'!><W/Y-1!-I7<\*ELB&M2:IWKG2%)(
M':E>VG>EO=)EC?\`7J#Y._8JAU9HEIT]J\EM:2Y[8-<!OX8X>M>8[V71!'P&
M#<$@TD[I1-/SWVFW%].X(6K7<+""1UB"`/AXA><M;!EU%Q9Q4UPVX^0X`*ND
M*%2!U7UZU[=]2<43^6W#<F%"WW7;0M89+KCC'KEA;2/440*U2%!%`1T/57AK
M?DR<%BH7&6MY);>+Z1Y2M:5(.X=TT4`:#XZ.2_@BH3(^YD%7!>7$==D^R;OQ
M7A%?P]M')DX)>YGC$5*XT4$;8Z5QHS;0)W,-!9(*:"@I0D`:6A8YA.;@H*.1
MCW$-VA'FPQ6PDRUM(ZJ"$-J<`W>8_5![Z72JV?9EG_PRNV_]F[]?X_5T)'GQ
M\5\<90VT_;`PXEE\M^@F'1]4GTEI=-5K*`A*`BI(\!H4<OJWFT_+1&&&":*#
MA0ZXI]OJD)]9!1M23UI0GMH0NV''2U<+,E]J.W3(X(^:FLJ"'R94.1Y%(=)4
M?U>SJD:P[X3W%9&WRIU>0$7R%RM=9N/P6ESX\-C);=(:8VF+<,?N`E1]K:$J
M2I/\V)W&E#JK+IF@_P`L>[V*#7WB&5\N_>%Y?CG)W`L;-^1^$.*,.MV-Y5Q^
MBP3(UVLO(4A<MR\W-[$$R&X.1-_-O'T[@PI9:CH`(W&FIK176[;H<ZE:^A6'
M3+FW@$HFI4O%/,JL\MQ=_'F\?<NE@R3'9[$%5ON\2XVJXV92;G#;*76XJ)S3
M/JOJ<31*-H\U!KH-U)8'EAM,V8>>JD9+^R<PM;3,00.^B]M/W+]Z@W3V/V2-
M:;9*M<&U<A9E!4\ZZM2;K-+5IDBX,*<;;6XF(5I16E*MT!USCJG^:*AU.SW/
MQLDN'MLYVM.%(#N4WKCG*+19A*E.-I1<<BC.VZ*EMY*2L%1E.`)I_'JN2_6;
M_#]ZT?\`"52%Q!BEZXOL-GPK+;!+LV0N6:+%4TOT51W&8)0H3HZTJ+BV9!!(
MW`>4@ZG[;Z859O-KO*I"PS&*&FI+CC27B4(4V@+._J>H4I/2@TX44GT]KUIM
MUYY%RF+)M\2:]9;'!N=HDRK>N5,96N4N-*=C!L.I84UL"@2.IU4>IKKEL,'8
M#YU:>G+3/*)Z8U]2DA/YTQ&5RG']N'&F8XAEON8OEGO5TPCCR_7E:K*F99X9
MEJ<RF^0FI#5D;V@K#"/5DT02$4!I2;6`-A==;VX^E7>YNJ7,=N-YIZ%57R9[
M5.2^*)+MS]:Q<N-23<KUR%F'$L!R\8K8L^OE]N5VOV-F3'ERKH['LJ9C;2'W
M8K?J4)H""!T*PO2+';A11^H;$UT1IA"7'%KCCY)GYJZ;Y#:#`BC_`%1Z,L-R
MPI([@I%-/[=Y-BV<[R[T$JN_'<&/?@I#>V3C#*/<3>;A<[18KM8^%+9<UV&?
MR\Y*:3;KM?66U+<L^#8XE+LW)'G%`(*#L4O<=E54&J[?:_)`X"(D2![?^H*S
M6ND1-`N)A[HV^5*?D_VG^WGCV3>KA[A(ULRW)XAO1X[X<XZNC-CSF<LQ'!:L
MIY(S"$IN-@D-!VNN05!V;W24"AU<AU-J9FMQ&X@^[CMX;L,?0F=[;6%3@**D
MSB^ZF39LEMS;PCPF+K?HGRC4F5*A>B]<GMC1;?6VB0Y##81ZI0$O$%>T%5=>
MD=*N'W6G0W$GQO94^<A<RU)L;;Z5L7TP[#S!*YV2@+4G:RHI:;;CH8;3';82
M@4>7Z:"H.J>Z5)[4U()DD?<E[PZ2*44?X]"$1.I,=HONNM-H""Z%;QN"0-]=
MIH"H#PTG>?R;OX4_9\`[EOX33='^1LD9\OHK8MDAIY5$[FY@*RJ@J/U?I@#X
MUUYVO?\`>I/X3ZPHG6_Y5O\`&/45-WCN5<H?+>*Q(SB7$B]I+RD^;TT*C/I*
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M%IJ`FB5"J-WP4G2MYM*6L_C5`WMXE8W?LZ;F9:['59KOR5E][N_S3H:85:8D
MF1'@E3Q_:H<4S38:`UU`_O&G%2EUM;W*5EPY[X9MN-79B!`Q&U7698<PBMP;
M5C*)\V'<!)=A61I^8_$1Z;K\51=]4*);/4:RFJ=[VAW]BS<:MS"_M7?KY>9J
MCN^KZ$EJ,D!0_:#8GN::$)P^5+L,YY-X5Q]#N^/!DY%>)"TGU2VIUNWPF'-A
M.WR*J1U[ZN/37T'_`,?L"HW6/P#^#VE3VMD8Q8D6HVJ2RS5NE`@H0E.T'X"F
MNA6GP>1<PM-C^X^U+2V(2YZCBG$-T1TWJ`!\R>E33KUTNL(U:^5<"$_-LH=]
M527MRTAIIGIL<]2O4FIJ/#6$ZA^#RKOB/150EN0YK4E2G7&=Z2FK>U13N;H3
MO^K]&A;2?`5];;0`ZMQ'KKV@@%114BM>H!-2-93-2P]JY)EY-(=9$5+;$5`0
M%*6#Z#XD!14H`C>>A^&F4WU"G]GM'>FVS)2Y?'GN`BH1U$;/]I!J37[5KTIX
M`Z;2?`>Y61GT?-ZU>Y[=@1[?^#0H44>)N/5*'P*\3M"R/Q$ZX_JIK>N/]\KI
MNE?R+/X0GFTD-B<H:RA#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0
MA>.S_E$SY8]\?M$"EN):>X#RI"]C06$[.1PO=4GN>U-7[I+^3E_[O_A"YQUG
M_/0_]H_]14??;A):?PBZ3$MBB,KD;0>F\2;1`34]*I(!KJV-^(=ZIZD,EU*5
M)4EL`I57OWZ'IVT^6BY4I6AYQU"=_J.*<(K3:5'JGL:@#0A&#C:%Q7DJ?*E.
M,JHDA/D*DD[1UZ[:TUE:2?`>Y4<>XG^:\WK4//Z<V)0'I7=)`\*ZY1U'_/>5
M=(Z=_DP>SV)_$/E>`W(;:>E?5O#KW+EK42D].@&H.4>\.X*>MOI^4J,=V;?E
M0+X(XD>NN.TV@12H.T6\RE:@4@J+:6R2L`>9`(\=(NV>4>M+G85Z[O:*I37W
M<W&BUH?C.-\,<A*_VP9+#L53AS9MHMQ%-,.-)DK;)9JG:D"JNATXO/Y^V[V^
ML*6L_P#8KC^`^HKQI^Y>XW]CVZ/0\CEY5%27;:\S$RSG7%(L,Q&;E#D(N5LP
M7&&&WENJ#FU)DR*I0`2FNNA7U[:0N,<OQAK?^D+AV@V-W-JCY(JY"\^NGK56
MR9EJFVR[R8=JL5U;M#:Y<J]1(N7Y^_$B1OUDIV3-CQT6B$EAE)+WJ+5L14CK
MJJ3WMI.XQPTSKI3;*ZAG#Y:Y`T^D*Y+_`).'EV.9]]XJ6;`^W.79N%,\DAZ-
M8H]FMS3M6"A:'60%R5E#9VESS`=-5R_()P2FFL>R_JX4QW[<*+WK-NO!*%,2
M'`E)+K25@C8\Y^T6I*5I"M_8@]"-1XMBX9Z;5>!:7$3S/I\Q;,_%P!."AW]X
M1=W;+[)/=!<WWOEWY'%EQMI=2`@/R+I<[5;&:`4#?I,REE('15*:=V=ORIVN
MHF.H6L@A==W<IDN]E":X':J$/:%!]/C2`$M"B80?VT^K^I:2$>/0A%:_3KM^
MF_[>WN7#-1_W!W>I3QU;V&E']5O;033J&]P!-*TKMT_C^FWN"CY?JN[RM+C9
M0HK224J\I<(H5`]=I%3^'2B36H`#ZHI7J?PGN=80F-]Q6Q7"V:,N=$(G6195
MWK6\IZ$'PUFB1N_A4*+1`3Z#"@D!A<5H+>V]6Z`;2!V-2:=]9WJ*MOJO[AZU
MO7'F1WF4)8:EE]:Z!UPMD-A7D4`D*/F&A/%\^5G_`.YDOZU.R?Y?J_3H45]Z
MYDQ)4:Y/V!UU:?LSS%"R4*&X$)%31Q-2?QZ%JM[2XXD%N4M<=4<@).P(42NI
MJHE-2?**5T(1Y$9;5?,9F)>"XR<PL34EEY22);3I2ERK:S]12@$U2!U'QUJ[
MX3W%9'Q#O4RLI@0K1R+C]\9I%BSG7(SKL=2@D,N>K6&ZL**2VXMP[D*/6O4'
M53UHFWT47,'NSTVC;N70M%>\.R`G)48*)_%F27CAR_\`*.+6S'1D>,1\EFY$
MY;+?='\:O=ODS@L(>MLZ.V651C$5U;=!JKJ"-1VD3SR6[;B1Q,HW[T[UR)S+
MB(6_N@L)--YJI9X9[M<GEJ3$PG@7E3/VVP67+3GMPX[3Q\7'4^FX$Y/?9,Z:
MEIRNTI:9]0I)VIW4&IB;6Y8F9GR'.T5'>,1Z46EJ]U/FKM4P.`O<US!%:F6_
MEKA;AC`+-%4^O'+=P-E4]<BW,..L_P`WRFUW&UMVV3,<0FKK\?8DJ0!3KJNW
M'43[IV>Y)>X\5,>!N?\`,/V\B?+E7W#1;M@LZV66*I-T?5'N,*'<E0K3&N,F
MW(?=@0+A/3\PZQ!>FE)4^B.OJGQI33?\WC=('%N%*+)L+@L(YAJJ7L#3SBSG
M%XY`]P;+8NEQDI8M(QRX/WK$<6M:73Z=JC34M-)EM+:(2Z\I*-]-U$5H+#::
M_9$"$M',.&]5^[T74/>ESN+&XD8;%+N#E6+O0FY@N,:0676U(3!05%L[OUGK
M&J@EK94&O;4G^86_8HGP-Q784S^>\DYG9SD=TQ+*,@PC'KNTW9,O_="/$5DN
M2XJPHS9$>US))*[5'2UN"I+23U5U5JOW=SI]YJ?AIXVO&1NVN^O!7'0F26UD
M*X29W=ZA/QK[;'N1>7K5R\R_F&)Q\9DKF8K;[??)%NNV2$+=1^\N1W<K)9?9
MB.J9>;24//)*@`:Z;WNFQ6CA*P`6`^)FYPX'?MH5*2YG'FCZPV'>%=AP[B5K
M:M:9V"W6Z<7Y+"E.M>C89,HVFXN;4%VXJAW1:)H3-6GSJ<*PX:TUJS4["./E
MQQM#.`JFCQ<R#WR2G%ON(3LNCO,\G<78/RHPMER$J^V=#&#YJS&<=*G1(DPT
ML,SO54205H65)\=+MU`3PBW@.2'<!N\_$K>*WC;21S1S>.],CR%[S<?XTN.;
M\*\'XS-X*G1+V_;K\<CN+,;(+2U'B1(]O_L^QZ/%9QO%7[FZM3AN/ZV2MPD`
MH)J%K#I@7-XV><A\5"2#QH:<-AQ3V6ZN!`8LYY9IANVJ$J)K[MJS6;-#\J9(
MNE]?GW*>IR?/GG8LM7*Y7627G)TV2%DK=]0I4>VK-8P017S63,#VM.&^GF42
M]HDQD%2JT>+'?4C98^2HI-XG*W*45`_SIW\]1-:^'77H[1BUVEP.8,K<FSAB
M53-0AC%[)0"F;V!+1Z:A*5.)00OMOIX'N*]M2+V.D%&'*:UKV*.F=#`SF.:"
M*T\Z0EXRBWVP*^>DH4]();@VQJAGS)-2$%%.HCD^4FE*^.H/7NH['3;?(S+S
MP-N](-M9KW&V)8E;QKP;R+R]<%7.\,R,:QR(V'%6R.2Y)E,"BU/./A*FU-J:
M'5`-3X:Y;-U1K5P7%ES(('8@84IN&Q3XBAM[5D<H!G:P!QWD[RGFO&"0^-^6
M+]:K8-T6-C.+*04;O4;=5'<*G%))*DUH:UZ5.HF)C9K@S2C-*1M/>JIK4C70
MAK?G]A3P<2*2]RSA@8;*3*G2%S'@%%+FR%(4%.J.X)V`5\*:=B&+<T)O8?`I
MY@2C)^3"G`MB.A]N3L\BO("E#:J;5JH>PKJ.<`'$=JE.8_95(O-6GXMF3+C0
M&9<^T3$W2'#E..1$7":TVX6V!(]->W>1YNH`!TPU`.-J[+P3NQE<VZ87'#,O
M-)[@>:(?(_)&0W+(L33@N7V1*+/*QJZ%+IF.^LZMB;:W9S2')C#Q`6DLA0'Q
MUQB?3;J>]<6UVKOVG:A9,L&\T-)IO5D/L6P&4O`(]NNL%M,&7&<D/I6A2/,Z
MLK=4$U2?44THBGA772>G[9Y@H_'#>N0=17V2?,QU*G!6H\+9^[B-VB\8Y=*I
M;IDI,3`<@N"MS-'I#248](5Y?25M4E,=:SY:JW$]-1>N6#A*#"*.).S>IOIJ
M[ENHG-,AHW+PWU20YGSUA?(7V>&BT;/DUTDN)*PI+8QVT264Q@X*H6%/K(;I
M]<GI75*N(K^-_NO<!5=`MK>-[*O(*@9[G^<+-;\(O4)VZ0(L^1:Y#+$-ZX1&
M9GK.(4ELHBNNI?4M"R"*)[Z<7LLF0G,:K##$36$`%4>6O(3%QVT1'W%M!R%Z
MKZ5.%DJ6]*??7O(4A25*6LD]1WU%6[W/#BXUQ2KQ**<TD\%RW++9"@I]IR0\
M@['#Z"E*#X8;+;8"FNBOU9*1U-:Z<4S>[6E=_#M6H-#6E:;N/9Y58/P+FW*4
MW#;/CL3]T<=@V=A]J/-FMH=D/_:*TS')KSSTAN*E]`4`:GN.VI;2]/LBX"ZN
M`X=I'W*(U/4+T-K:P%I[`?O4N,"S+!L+R2/DW)?)UEOEZMT1<&&TPF,[\LRX
MXEYP,M8^B0L@OIK52M_EIVU;Q=Z/I'X,`8\.&8D5V[*>A4BXL=<UO\28R-:/
M=RFG?[4_=Z]]N!V]LBRV?(<K="#L7#A"VQ7W$CRJ5*NWZU+#I[K"`H`UIK=_
M5-LR)W*`!RE-[7HV\Y[&.);&YP#CAL)QJF9OOO\`<\G>I&L>'V&PLUW-.7*1
M-NDHFA2$48]"(5`FM3TZ:B/ZM?O>5:/_`-?6O^</.$T-X]S_`+@LB;?1^]TJ
MRPY'ZM4>PV"'&4I(ZE0D!3S)W;O%05TZC4===2:E++FMIWMBIL%-OF2T?2=A
M9-Y+V,E-:YL=^[#@E]Q![N<^XY=8MF;SU9)9W9;):G7&5&:R*'ZSH27'8T7<
MB0P-]`F@--;6.O:JZ\C;+<2.B+L1AV]B::GH%DS3YG0P-$H9@16H-1VJX7C[
M-H>7V?[6AK<E-OJ0ZVJF]"$+;"@TA2!MJ@]QW&NH1O,UGS&'WZ;5Q^6.YAO.
M6\G)78I]>UPMR$92M:1MV-(\W0;PFFVO3S=.W?2-HUSX<UQ[TE3B>_#T*:]U
MA_#P%`FBO2W7<0Y\6V5)`C9^D-`"JR47="0E-"I2BH]AK>X8P0N<!C1.[>>9
MTK8RXY"=BOB]O1)X$X0W=_[)N.:UZ&O[H6>M?IKKBFJ?SK_^X?65V32OY)O\
M(]2>320V)RAK*$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%X]O^
M40>HOWM^TY"4J6$<!92M("-U%JY#=25#H34[0-=!Z*`>Q['8L,FS_A7,NO7.
M9/&YIH[E'_J*8/VX6_T\/GH*?38.1W%QUI0*$[FF("6-]>VUCHGM5.KQJ,4<
M$D8B`:"1L[PJ%832RM?S'$T&"?62C^=+2RDEL)*@&P5`"HZU%>G764IS'\5@
M'BP-JDJZGN0>_04_#TUA.(G%S:G;5:W0M:%E%4J4"0:?5KUKV/;0MG_`>Y4M
M^[*(B!S2LMA+:E"VN$)/4.+DI4%J!Z@K3U'Q&N3]1?SQ[UT?IW^2'<G6BN[L
M2NS16"V)\1:D5%`7;61N/B-ZC0?$ZA)?B\@4];?2\I37\?J2G.L?15'ERK&$
MNH5M4/37>X"5I=0JH*%()!"A0COI([$Z8`7`'8O;IR2A#/&7)$9N-!C0X_%_
M($5AII#,%N*VWB>0J:CQ(<=EI@-^E51`V[:5\2=9<YSY&R/-7MV'@K.R"%FG
MNC:T!CFXCC@ORT.!<-XVR^U<T<H7`\L\GV3AN)BDW-TW/D;%./;)&<S/,F\9
M:M%J^WD7*3.CQKS)CK7Z37J)90XYT0DJU,VDD-U)S;\<UYVEV^F`X;!145W(
MTR;+:Q,CX91CCO\`*?*IL9'B7!C.197P_9[OQOB^/V?W`8UQ?EMNXJO?*?N+
MORL'N^*QLCS;F'&?DU2,>OMML$UW[*D,A*D*F52VE2`5:EM<BT.UT5]U86\;
M+\.8`]M<U"X!V\C$8;%M-?WUY&8H2YTA%:4[=BMX^Y`XU]ZUW]YO+/+7(_#D
MW#.-\-X.R[C_`(`RB\\2V?B;&+TGUW8&%,7BT6:!`?D2;M&88?E..EQZJS4]
M]5W3;JPG_GH6O[ZU]83JTAN("V3DDS9?>K7`^=>KRWY^QQ/Q=C5Y]RV;<;XG
MET>P15YI<Y=Y%DLQO[;*GI36/VRX?SNXQ4I"4H4VV4J4#IG?3L9>2"T9EMLW
MN@;`*#`*T1M(A%R#DG>*G'>J7/O*/O'O;WRG[>N0?;_Q',RWD7)>0Y.,V5&2
M6&R&TXK;4-Y';I\QE,VY$3IS[L6&I"?0;]$I*JD4&E-.;+>7(AH<&D^:GWJL
M:O<NMHS</D))--O%,#[?<=?QSCFWM-O%I],*,RM@E(D;DI:0XEQ*JJ4I0[T&
MNLZ.R9D8CG-6<%R/6+AKY#)#@\G:-J?-UM"7%MH1M0%%"4"M`.P2.I.IDAH-
M&_#N3*,O<P.D-7D8]Z^43L4VNE$C<E*NA!J>H\?'6%LN8I;]%1H-WJ+IUZ[1
M2E.O;0A,;[CF`>%<XVI0%+?L>PN':@K^V&S0J)`^.L[DC=_"H56V=(8ML:,X
MW&90Y':3O+3CZ5E(KW:KMVU[^.G-NQKW$.%0H'.YDARFF"Z4(:D3`Z_(>>D-
MI:2A4=EU*$(`HE*4;33:FE?IT[Y,7RA;\Z7YBL?1N?Z%[[[_`-L/V?\`A/J_
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M9ALW*XZAI\CS$_W2"SCV]R0G+GN.;P;*8&`X1CCDZ_R8$6<TR(UP9P_%H\C:
MAMRZ/QF2W<[I-4:>C0;%?GCOJ,G@N;FZ9D<SE%X!JZF%17=P6,@MH'/H2YK2
M<!O`6JSS/<YD$83YG,EPQ*'-<#C=KQ"UQ;7#99()]$HD1Y,B0Z3XJ5UIJQ?D
M-ILYD/\`B_8J]^?7'^5-_@_:EE;5>Z2')2+5R3?,U2V`EF!E]I@RF%H'9/J-
MI8<2U7LD#O7KJ.O+73[)W)?5SR*U9[PX;:C'!2-G=7UXWG,&5@-*/]T\<!CA
MCM4EL-;SM['_`-Z.6V<`XXEQWE1UR[3>Y#EJD,L`AR;/LS@(9G/(25.(2*!9
M(KXZKTK8XY.=$'4::[%889'O9R)*%SA3LQ37<Q\L8+Q#C+638'A,C*Y-WG,0
M6+JRQ$9A2;K,`]*3%M96Y;T(#BPHR%!3J4UVBNGUJ^[N_I'SFB97+;>U^J!Y
M`FTXHYIR?&F>0D<]W2?`L7+\+%(-I<M-FCW-W';;;I,^=>+?'N<Q:+G">O2Y
M4?UWPBBD-;`*:N.B=-W=Q)SW-#I^(-10;,:)M%J%HYE8\P97A3VJP;B&5@61
M6EMO$<QL.5%M96=BF+9<22"0EN*I0$B53ZP)3UKIKU#9ZK;3"*>-WA/WB`3A
M_;1.8+VW?*UN-2>"?AF#&9"$/1I;$E%:H<<,1]@4%'0=Q;<2YX$*\-5G):C;
MF\W[5*\R!+>P7^\6A:1;YJ9P21MC34(E.HW*J0I\+6%]3TZ]!TU@`C&U<.RN
M'WIK)0OS,^%5J>Y_(,+SWF3([#FV,369T*XS=]^DM_:=CAIC)0'USER$1Y-M
M;3\PFI9D+-/`TH<0ZQKME<-+QF@K3W34XX#"@\O8D9&.<P@X=ZK'R/*1;W[Z
M>*)E\@VV,Y/M4B?(N,N9C%S::5Z:W+';)JW'D14IJ"I:O,2*:[YT1TIJ6H1M
MU2_Y3;<T-"[WJ=U/:JU)K-G%/X<B0R=C:CUI!\6NAG%,E<>4H[K@MQQQ2`TG
M>I16XM6\I2E(4230F@UVWEVUA9,<Q[/#AN`!QIW*"OGA]W(\5`+O8N%BXY!E
MEU18\,@R+O(,A#0FQVUFW1G*G]:X^`?4V5Z)"2%?'5*UGJ^S9`Z"SYGBJC$M
MH*;\:^Q(PBU<^EW4PTW"N.[@IU<+^S^/`<AYCGCOVE<)J_G#\Y&#S;+B*(])
MI"TCY9C>@G:.A)KKD5T[4+^[,MTX<DG<:^A*NGCAPM*@=H4^K'98=E@JC6^%
M#B(]0+1\KT:>:32@*0E.P+`[=::<AK6#*WX1L[E&W%S))6I_$]"@WS2VJ=[@
M\B92A$5#MGQ13JFSU<9%O>D%E70>4I<2?PC3FU^H>Y5R_9*&!SZ9<W%=O%3D
MEWE/$1#0RPTW<YS;J2O:5Q'[7,C-*H$FKJGMVX>">M=/DXL/@4]&I#KJ2VI9
M1Z/ZMI2>NP(\B2/P`:BW_&>\J17!<XQE-(9DO.R&%%P.)4"2D*1MJD>).DI&
M!\9;O(66DMD:\;`5%[+/:MQ[GE\8NMPMD!Z\6]PO09+MNA29B2LU2A;TIE2D
MMI_-&XT&HRQTJ**<R3@9:[L599==K`(XB[,.S]J>?$,&L^#6EN!;HT:,ALGU
MG2=H3W'0I32JU&GX]/M$CC@8XOV5*KNM/?/*T1G@B?/CBKMH=7<+K$M%QB@N
MV^3+EPX[D24AYAU,QH+D;RME+72@KUU&:EJ&F\TM?FKCN_:IO1[+6(X2ZURX
MTKB1W;E7-R@]9KA<WYMSY;O<]I<J0XINSW-IA*BZM2@I+J4+4XI>ZJANZ*)%
M=5JY?82`EG!6ZWDUR-H:ZE>\_<JV^8.%+'<<E1DN*SKJ\^D*7<7;XY*N+\A-
M/.J,W*DNMQ]HK^+5+N9&RQY6[5<-.AFMW#Q%*=AK]R:%>#6Y;CLIQ;PVD!;4
MQ]LH=6D&I#2EDM`'I1(.HYA%O42;3P4[<NCNLIM\`T4-<,?2C2WXNB2$,P(3
MKZ4T3Z,.+*4V!6A0V\(X;4"3T*21UTH)X7'*ZN4X;$U,$K?>;2HQ3\X[A-V;
MM26PY*M45*DK5&D3V@!2OUHS[C:R.IZT)UL;.Q:?PY)/MY5J+R^=@^..GV[$
MHHULLEN6)$B>%AOH]]G(4Z=PZGU`XE@%VGZ.X4IUUD/MH/<>Z1Q.-:5]J4$I
M>*N#6GL_L1PK([,VC9$M+\I*D;1\Q(6P9`(_U1"%$MEVO4`]*]]9%Q:.]W\3
M'L_:L/H]I87-`(HBJ1F\^.TM$"#:[<VV4U;BM(<G)2M6Q.YZ8I\.("E#H`#X
MUIK?);?+)_A_:F'@(_\`-/\`B/WKHM"<ZS9^3!L46]9&]#<#=P5%=8AL6UHM
M+?,B:^M4:WQH;+:"5.*7N%>HTJR#.VL0(9VX'S*2M+=D466N;$XUJN%S&IK;
M2YK.:\3W:Z1Y03(LB.3,9DWUYAA*I"T0&(,N6);S;;124I7ZF\4II6."5CP[
M#`\5B]9$+60O'N9<5>W[';NS<N-[1,C_`#*$W):7_EWG'5!AM30`JAU*-BJ@
M@E-0:=]=CZ?`=8@2\%P#J&2!M\1'4>17/>VEH1XF5=MOVA#/3XJ0"?X3IZX-
M!]SX4WC=F8')G)[J?L/FMKKO4_F9'3IT>N:N_P"`:T?$Z:-T;*9B#Z!5.[7Z
M[3VJ^3@#IP9PQ7_R6<?_`,.,VW7$-2B=)?29:>Z\KM6E8V+/X4\6FS345"<(
M:RA#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A>/3_E$+3JO>Y[3W
M&9"V5H]O^3@!/8_^,A2ZD_&B#KH71'[_`/W/_"N8=?\`U8_^U_XBF"]O[+IP
MV[*=EO*=^WBXX.I2HMV^!&<%:BH+OT=M7S5_J1_Q#UA<_P!-^%_\/WI_&$R6
ME*+)2"4D+JHBJ*BHZ#KUITTFEEU*2S*82@U+K#Q?=JGIL(1T2?$^76$M'(UK
M:%??U>]"0M"_6Z(;0H%Q06DD)VF@"J>%=;L87O#&[25F29F0[=BIW][6*7*V
M\@6#)I3"68ES;C,29!75!DQI@^3;J`>JHG3O];I].N;]3Z5=Q7)F=ER5W''S
M470>F+Z":`1,S9Z;QAZTFI]\NMOB*CPH*'X4R&P[(*E)#PF-M@1T*;)[-@]>
MO352(=+[S0:;,>Q6JHMOPI,7;<,1C[4482D0<EL<^YR(S#S^1X\Y+=4\E+++
M*+S!<6XZZYL2VTTD$J4:``$Z&P2/.4#$I2*=AD`QVKV%\B>\#V>PK/DMDRGW
M"\7&->K%?<?N5OMN2L7JX)@WRV/66Y!J/9$7!U$YN,^L(%-WFTKX&XKL'G5D
M_,;;PW*J<]*;/VKSZ6+`/^3T>V/UU8WPK>>:KVJ0Q*7^\-JOE[@W>2W(=E4?
MA91.L]E<CQI+ZG6O7C.D*51/0`G<6EVUM&#%0SI-+.%P3S=^'[>%$[2?O=>'
M>/H8Q[VB>Q;!<5C-(]*WS9UF@Q)*DJ!2ZXB'C5GB/MA+9)HN:1\0H=-.K*QO
M[RX%M<TY!!KCP%1N2$NIZ9I;/&VH)G;@!0;\#O3$YO\`>!_>0<O,2+7;K_)X
MTQVY)<0W;\*AQL8>0R\>B5W.-&FWIQ+:?*`EYGH?$]1,'IHC&/*/+^Q05UUK
M?R?18VG;A[%%MWVY<[\GW(WK.<^N5PNJ]RW+A=9%[OTY]3A\[CBK_.G!+Y3V
M*:=0*4U,6_3$)A:9`TOIBH*YZRN35DA(E&T#97LV>I2$XK]H-KQB[VZ[Y%/F
M7R?;U%Y/SA4TGU!3:L0_,D+2?&O2NI33M"MK*XYQ`^$CST59U+7+J^BY0)IF
M!Q[*J<MMAV^UQHS2(RVGF4J"@TC<@U62E6[I4[>G;PU-Y&M^F%"ASW?'M72I
M:G5//("AM*W!O&TD@E0H.O4G616F.U.6RL#0,5]#25MAUQ"BLFA.W=X5T46>
M<SM6)0P.X(_"VD:*(YS.U,E[DV4*X7RMITIV)GV-QRG7]6;N@B@\5=1TT+6Z
M^"HWT]2A3:UH,-A#.X(:C-*)(VU!'2E.YZ:=VOQ.[@H%WQE=Z?FWT!,=M;3=
M324S7U5$'S`CIT2>@ZZ>K"[OM"1_@I/]5_(?4_U;]+ZWU?IUC!,^5-Q&WBDT
MNZS(KT91=0MN+ZC:&U,M)26%-K2F,HMI2KTFUJ"A0UJ-1*>+@DE%R2X[7TE(
M6E1]&@K6OE.[=Y3MT(1OCZ8YNUDE.Q64H&28]ZA`4);BQ<$1DJAU5M4V0NJJ
M@]1K!V'N6S/C;_$/6K)KC#1<$3FWQZGS>X;2*ANM11KX#KXUUI:P^+M"-U/8
MK1=3>$NP[?7VJ-C$%FV71O&;N^B%*A7!V7BUWE;4NO2'@XV]!?<-$$.MN4"4
MA)V@:Y;KVF3VUV!#@UP)/G70-/O3?6P)_<P]J6UVQ6Z.0;A<</QBT9E=XH$*
M1C2+Q`L\[U6D!,@M/W-DHW234;G%%ILJJ*#4,VTO"X9B0VN/<GV8L]X"I&-.
M--R8^X\Q\P8\VIEWV?<C6<0)"83<N9/LTVVO.D**7HLFT)N`FQJ-GSI0A)'B
M/%[^7L_SSY_V+7\RDV^''F_:BH\M>ZC.G$VW'\$_<]M20A,Z'CLN=<(ZJUV*
ME30PT%(21Y0T0.]>M!)6;K6SB,<KLY)K4J-O/$WDHE8S(`*4'EQ7#<O:SR!R
M&K[2YCS*Y[FT>JZY>IKT1]MLC>Z;=:X13$+P!\B5(/P.E+BXLI;=\3:9G-('
ME2=O!=Q3LD=7*UP)1+R,_:W<BXVX<Q>4[<X]HGP9\MF(@.N1H$!+;3,B<Z4J
M93)>E(2%)VCR$]/'3O1+%M0F6MWGNG%28Y'X/5GN-P8$1`8O$9IIMJ6$MMK0
MTVVA#2=^RH4D#\NNCVVHWNBPB2*/-;@DUIOWJMVM[^%MWE0-R+AKDWC)QR2P
MW=&4QG5/?,61Z6R^"ERB74B.M.]9)J>G6IU/6G56F:U'R-5B:VV=@YU-@_MH
MGD>H&*0/&T)WL`]Z_.7'_P`G:KQ=6LIM;?ILO6_+83:)@CL]F6):T)620JBJ
M]:`:UFZ:Z.U0_P"ED;4\/[$\_.W\3Z%.WC[WX\2Y0[&@9;8;AQ]>)>Q+,VU.
MQY-B2I*MI6\HMN+`=`W*HH4).J+K_P"FMS93&^L"3I[J4.[`4=Z:J8M.HH(X
M`V7ZF/K4&?=CEV-YKFMZCP,T9R>*UF.3W.XL623/M./M17Y$<V2W2%OO*7<)
M#,:,'W25EM12=H`Z:O/1G2UA;0#4M5:#;QC&O$X#TIKJ^N,N[!]O:'\=Q;3S
MBOH4.&Y609O,&+85$>N:U@Q)4V/$].V0T$T:1&6PE#2R$`[E5))'75FUSJ*U
M9:&TTC`4PHHNVMA:1>+NL3M4B,*]F.82L=39K]?)K]MFJ1(?82Y&84TE3A4X
MPVXTRE904DCSU/7OKF_YEK8&21SN6HRXG9=3NN(OIO-1ZE/KB7@S&.-;1",*
M!&2];D>C'"FVBO8M.T^H4H2IT^7NJIUKXCFNH_ZB1*>)J0[Z8CN*]5AHK"&E
M@;*+45D42$]`3T^C65JNI(24@)2$)*>B$UHD;:A(J2:#6R9/^,]ZKUYDD/1>
M=[[<%,E:%V+&$IV!1"5"U-M@K_O-BC7Z::<VOQGN49J?T&_Q>PKNXO:0UR9B
M;S+X<]2:H*VD%*"(,^3M-.NX*Z'Z#IZBP^`*=ZT2(JPAI"5A:J56%$]>M?+0
M:BW_`!GO*D5L4ZI20`A"G0?.DI40D>!'<]]:H6IWUWFO06VCTJD[4)4TH$]S
MZR`'>OX>FA"*[[(5$M$U^.R)`;CEL)<"E>=XI82M.T@E32EA0K^<-,99/"VK
MG[,"G440N;IK51!?KO.R7)\G7=+@Z;K;LCO<)PW.2\\V(T6XOQ8@98=<])!]
M-@[Z"A--<3U/4)[V\>V$_`<?+_8NZ:'I]O968,H^,#T?VKD6NVQFQ]HWB`ZH
M`UC1HJ=R.M0-J`6P2.O0>.F(?>UVE3-++@$272ZXU)A.LN-W%[U-J2EK8'#5
M0_.#?1/7K]&GR8I&MIL41*#&Q^T,NHW%J4_'5+E&I))<3)6ZR%5\`D#6[;83
MXG<M'7!@-!O7V9?;BI#31EK=920EIFWI3"^7344_50TMI0$UK0#6PTX.<&CX
MB:>=:'42T9C\(Q7.S;+M?)2&(UENUV=5YTO+CR7!Y:#<'W-RMP*N@KUT\_IJ
M[&Y-?ZDM.(3J6/@#E+)WF$,62?&94D)29K:]J0>H">@`117Y=2VG],R&)W.'
MO9O8%7=8ZF8V=O)/NY/:5(G%?8IFEW2T+M<D1TJ#:5LQFE)710`6WZCB%I!\
M*ZEK;IEC;B-SQ[@>*]U5"2]32F-P83F(-.]28Q3[OG#X;"#=@EV3M&]<AT.J
M>*%!80`VE)"B4U^&K;^1:=P"A/S[4OF*:RUXEB/MT]P,7!'+.\Q$Y3QN]WFR
MW.6SOLLJYX\M#-\QR<V\GT)256.1\TVPL%;U-J.H.J/U#:PVFH<J&@9RVGRF
MJZ%TQJD\VEYYC5_-</4M'NG]OO`<OBF=R-8<+Q'#L]PZ79;OC_V%:8%GCWN5
M(G-17[0;5&:1$DK<:=6I=$A94":Z@^Y3=U>&2W>P[VJ?'M%L[%LXYMKK<1Z*
MMEEM"6W%K6W1S]<4H]0E2$ME5$I%`!KJ^@?R0_A]BX3U`/\`7G[;RK<O;;TM
M%Z7U*I5V"%U[)#$,/IV]/%70UKTT\.U;0?2"8Q]U3MIYG4H`?SC-!TK^E=/B
M=*P?&?X7?])3RV^NWO5^G`?^\9PO_P#6LX^__)BVZXC>?S\_\1]J[9I'\BS^
M%/'_`)6HR/X?/ZTNAK="&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&
MA"\?W_*%FU/>]_VIM(%5#V]Y0M(^)'(ZT4_!19UT'HG]_P#[G_A7,.O_`*L?
M_:_\13!^W=M3^!W%]0H^K)IL:0A-=B`W`@RE%%055#@IU/;5\U?ZD?\`$/6%
MS_3?A?W'VI]@X6ST`._R&O@#UJ/IJG6B66Y*/06L_P"I/(VJ414I-55I2@[`
M:$+B>6SZK2/0:*04HWU6%D;2-^Y*@0HCKTTI"<LK7<"M7#,TCBF2Y@XKM'(N
M)3[.[`:?DLM)=BRGEJ7(8>:<+C#K)<*D!:'!\.VH_5K078/!3ND7?@R.*K3R
M/BSDJV2T048M(O4L.>F9*'G4,NLIJEE92A:3Z^SZW@3V&JJW0VM%**Y,ZCMV
M-I*??7=9_;;S-D@^9>CP[,RD$+.Q\K;2L%`\CCBPM0W?`C2T6B-,@P2-WU-;
M"V<8S[^[SA.OCWL<NY80K)\FDS$/K+ACFD.(7%J*GU+C06(R'E.E0*BO=_'I
M]^2-[%!?U.[BG]PGV=<8VAR.9$6`B3&"]SC;;Q;<*UJ7U9<]1E!HH`E(%3U/
M74S:Z99QP-;(!GQ]:C+C5;RXF,L9.0[/-1/]:N$,,L:1\E:H82FM$(-5=>E?
MQ:<BPM:_A`9TW=J%W3\4G(EM`Q.)!'\SCQ6`".CX!-0*#;NZ@`:W%@"M/S!R
M/7&PAI#;34=,AI/ZUUI`'F'7<.X[?Q:U+.6<G#!-7OYCR_B46`GU?7<_6N[2
MG<N@-#2OU0/AK"U0<VN$$H2*"G2O]TZ$+85A8;;V(0$[4$I'50'2IK45(T(6
MP2$()84A`2D;D'KN4JM*'K3ZNA"Y'6'G5E10E'2@"0:%/@34GKUT(3#>Y"&E
MWAS+]SCB?5-H=5M(Z*;OC3>T5!\I'?1Q3BY^F.X>I0UMC#3-GCJW'>J6U;DU
MIYD;$DK-!]?K^#Z-.K7XG*`=\91LRR]%DNQ%/NM1VG5!!3MW&I*B35)%23\-
M/4+I^49_W0E]Z_ZEW_\`8M"$W[:?5:=0ZGU'DTW)6-SB?..Z350Z:3Y<?RCS
M(71%B!6](`:KM\M"C?W\`!NI_=T<N/Y1YD+MMK;C>38XVHJ_F^1V%#)ZGTDJ
ME[R&Z_5!=6#T_..@QQT/NC9P6S<'`]H5ETH!N0M34@*"%$*"'*@**B!T!H#7
M49&71#+&2UO9@K'(!*:R^\[MQ2`SG`(F:6]!D-N-38;OS,*8ALAZ-*'U93+P
M`4T^CL%`U&DY-.COHR]X&9N%2,>*T-S=6\K1!(]D=,0UQ`)[:=B::/>^:N,W
M/EU6&#R?CK+9V2[@T(F5PXK0KZ$:\LI,R8YZ8(2MU1W*I7IJC:GTY=^\Z)[P
MRAP!-%<M.U5N0-F<2_M3H6#WH8G988AY-@?.5CDI1YF;9%ME[AI\-J2HB2.G
MB3MZ:JGY+=\7>=3'YC#Q1?>O>]QR\KUL;P'FW)+FA&Q,&7:K796UD*4=JK@9
M;`0:J['MJ5L>F;FXB+R3\5-O8$UFU6-CJ`C8F(OG+ON'Y0N4F%@7']KXQ@75
M#C#LR_RI629`EF62%28ZGRU9F9J6U[AZ?JJ"^Q5WU*6W2TT5RR5YJQK@2#O"
M:3ZLTPN`<*D'>G7X6]N"<"?5D-UNCE\O=V>^=GW>Y-NBY[R=[J)7J5;;2EX>
M2AJ$].VK7'9&+Z30T]@HJ^^YBEPD][OQ4EG''/47Z"U;$J*06U422GH2*&E=
M2<;Y^1R)7.,=3@3ACV*)NBP2TB`:R@P"[WHL%R/$5*7&>?84J&L/EIQQX/)4
MX)!"ZE01]7=3IVKI)UO`Z,QN8TQNVB@H>\;TBPDO`3$YEPC8,I<D&18H2C)W
M^A);CLQU;E`;E!X-@K-/IZ:S##%;_0:UG\(IZD[H%%C*?:'>;6\\_C]Y?CMN
M44FW.LKF,-U0"JCGF2H.'S?173J7JG6;>/\`+FA\MHS8"21CB<,1M*<1FV#!
MS&M+DW2_:;R%F<^)'RAYN!BT)=9@@(4P912VIN,`&]H<!4H)-:^0D=M)LZDU
M2\C.G2,++1^T"H&&(PI3:%ESH`*Q!HDW$;5.[BWAO$^,K1;V;+`B)3$0EEQA
M<1E!6I8ZNH0$>8=]QUH,#4;4G)/-*SERO<Z/@22/,GE,<(>K'8"6-R2D-(HU
MMZ$@;13;6NE#(]P]XD^51SOPSD9@P;`,`NB0IE3R6Y"'HR%I*HJFPIIM4D?L
M0\>B3&57S>%-)AC`<P`S<5C._B5BF,Z"0XEAU^A4\8@2M@4Z`HV`IIM[T\=;
M41G?Q*YU-O(4"I+B6U$["0H)4DUIM\""-"U5?G-#FWF^]1GUR$[;)C!4P@JZ
M!5L:V^NWX,J!\>G;3FU^H>Y1VI_0'\7L*[^+8[K')V(H6PTT'[TKT$LH"4/)
M,-Y*B`!1;A02%?1IZBP^`*>K94Y)0AQP@>I0E:J!`!(ZU[4U%O\`C/>5(K"0
MI;;BDL!E!KYG7-J0OZ$K/1776J%J#CI%5K05?ZRH%%/\Z:5T(7++A$Q'H;;A
M>,E&Q.QSJE:U#8H$'HM*NH^G2,3&2V[A*`X8[<4I,]\,[3$2TX;,%5=S5[4,
MWNEWFYYQ\S&OS=SN=PMUYLR&HEK1:9<!:'US'/62D2Y%Q5+<4XL>;]757?7(
M>H+5D-R#:,#"XG-E%*\*TVTQHNR]*74D]JX7;W2`!N7,:TVUI79N4$\@_=S'
MKRJQS.7>$;?=&9`A72+*Y%0)=MN)\J;?<%VNTSHL60I0V;0\2.QHH$"O9+KB
M[TJV9[;Y6^9$W$>.<L\FY+<\859\9@2+%.DQA?,8NLF^XY?[7-JJ!/QR[N+;
M7/:BM'TWUK0O:YTJ%:L>E61D<!(T.[\50^IM2DMY:02.8/[I(]2L;Q?V'2"W
M">R>\2W"4)6^&G'%%>\;E]R=Q![:O]OI-MRZ\F/_``A5:76+DAI,TFSYBI"X
MU[-N-;&M#QLZ;@I10KUI1:]1Q0(.]U*P5)-1XZ=-TJW:X.$4>!!^$)O)JUP8
MW#FR8@_O'>$_MEXCPZQI0AC'H24(ZA#;C`2"#6H"4BFI;EQ_*/,JYSY_G=YR
MG2MUN@->E\M;TLMLI#?H+VR-Q'7<D!)`!!I3Z-9#&#``+1SWO-7DD]J5C2EH
M%6TEEL"JDH&Q"$"FY)`H`E([ZS0+6N_>C2*D[@ZGRU\J'AX'OY5^!IK:I6<S
MN)3">X/@6S\T6:/&N+LH7:SR6KK8+[!G*CW:S75I*VVIMJE-J3)A3F4+(#C:
MDJH:5U'W.A,U&7Q+@":4V</[4_M-9N+`<EKWB.M:`FE3M4,;3[,.1+K<X$?.
M^0,IS&S6F8Q+MT7(YB),.,N,I7R[Q:;BQ&WI*`:EQ?J.*42HJ)).M;?IFWBF
M;)(QCF`U((%"IF7JDS6;[=KB)W-H#7$'L*LWPW'$XA8K;8F&PIEAE`6\TC]6
M5A"4DDH`3NIWU8XX886Y8FM:W@``JO(3,[/*<S^)Q/I4]/;TD,V&XE*Q3[3:
M5Z@/3<M)0OS?'9Y3]'36>7'\H\R`YP%`2`H\.OTA\RH]4!*IF:I"=XH2574)
M2!7J23TUG(P!Q``.5W_25GFR-(+7$',W?VA>@[@5)3P;PP"FA'%G'X((H01B
M]MJ#7Q&O/]Y_/S_QGUE=RMWO98P9"15HK3R)W1V_+_'J/9\*ECM7W6RPAH0A
MH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0O(#_RAAS9[V/:F$50ZK@')
MAZR?*M*?[2*[=XZA/E)IKH71.QW_`'/_``KF'7_U8_\`M?\`B*8CVWH/[ESV
MM]:WR[J>5NJ"\F-`;+KA_32DD$GJ!J]ZN?Q8_P"(>L+G^F_`_N/J4@6Q')4T
M4,K*4*6ERB5$J%`*'\>M$LM0VA*E.E)`6H!EP]T_I!![@Z$+BHE2RXEE+FU1
M4$I0%4H30`4-*?#0#3$;4+(PPX"X0&]PHI'U.G<`@TT;=JR'.&PE<?V99=X<
M>B-NOI/1U#*5D?"BP#U&L90@N+C4FI1MZ+,=/J,+;4I--K;9"E*K1/U$]20#
M4_@T4`V+4@$4*^+<EJ2`M;KH7T2E16L,[:5H#7T]W\--;5*QD9P"P8COQWEN
M%YQQ*Z4;*BI/4"HIX==86X):*--`NWU0.KK+C*/%QM*D*'PHKP!/3602#48%
M!<YPH34(/2(AB+;0W-D.K>;(=2EQQ;:`#N`4*E(/PUMS)/F*UH."P]&&$NJ:
M7-]0(42V%.?7""0A2016I%"-:DDFIVK.Q<\:/ZS?J.?J5&GD75!%:^!H:#6$
M+X_;5*_6)?V(2**(<4E->_4CI6AT(6]MA&Q#=4D[4H];H36E/4W_`(>M="%J
M?AIC@+2KYE:SL[ATHZ%6_I4I'2E?IT(6#J7FXY"5N*74D$%1*0:42/$`:%@[
M$R?N20E/#67^4`AVQ)[`$!5V94M/QZKZGZ=238V9=@V<$YN?ICN"A3:F5O0F
M$(+`VQ''TI?*`#)]-(;=;W$#UP1T(\VMPUK3[H`4`[XRNF/%EJ+9FO%3I::4
MX5+-%+*>I42?K_&OCK9".J1/]G,?H_T!/Y/J_P`.G65O!,LSN)VI`.+89]29
MM4$3-H;'3<BA!\XK0=O`G35/5T(9<>AO38JT.B,6TNH2H!U/JA120V?,L>0U
MVUT(7VRS)G[P8VG:P\#D>/`N*;<2I0-WCU!"T)4-M:=1X:P=A[ED;1WJSEIF
M,F1<%.-J4D.]$H`W5*CM/F53I74116#GMX%`NJW;0A?HGNDTJ?AXT[:3?X@$
M<EP#=Z1D>'FHJL6HS$EU?J(&W?\`JT.?5(ZT2NE>A\:5Z:&B4X2$$)(.G:X%
MIHVJYKIB]@DL[W;3;EOJ6`I0;Z%)2K=^8#6M-9\/;?+ZD\\4_B:(CC8)8&B7
M(UBM_P!:I.P#S4%?#X4UJ8RS""@;V\4A+-,]U6'"F]*9FVH:/I1?28,5A+JD
M>@V$!"$BK;:TU6-O8'6T?-:\%^4L!Q26>>E"11&#,Y]23'2P\Z0D[BFA3MKT
M[J%1UT_Y\7RGT+'XG%9(4EM.TVR.LDE15)==0[U_O6@M(3\.M=(2.:YU6B@6
M17><5F4L+;5O0?5[H*>J$FHZ5)!H!T'32:W80UP)V+>S**0&GJKI0,;?S%4\
MQ5N/8@#MK%$OSV\"OJRVIT_-!3B2!39WIMZ?6(TLR=[&Y0&D=J;R$N>7-V+1
M5++*FXC!<)((;4!0]>I(!/U1UUOS))_PZ-%41DM?F=B%F\W)E&*V8[;)VJ%=
MZ$`?5KNW*!-/HT>%?Q"<<]O`K,P`TOTW)*@XD@*#:]S0/0@!050IZZSX5_$)
MNXASBY?+FZVX_&:V+6&&R%*%-JC_`'GF!/X]:/@=&W,2*+"S:W*47(X+2`R6
M5(6:$K))W>7<-M#32*%BPS)C`$.(>!2?6#Q4K:.I7Z/E-"!]6M-+MMWN:'`C
M%"K=YG"9?.>4(?6M+\JVXFJ,XCHE$=NT-H+3AJ#N*B#T!'32\,+HW9B12B8W
M\9DA`%/B^]*SBGTV>6<%A.>LLHFR5L.+V[4/&$_U)W5">@\"=.4E;/$(H['N
M4Y$-.`I4M25'H5$$]3XD5'B=13_C/>5)`U%>*V.[*#>"17I2G?\`'K597/LK
MU;2=OXOQ]M"%DJ+ZHV*64`T(4V2%A:2%H([=-X%?HUK$WEQEAVE9F(DD#QL"
M;9KD9K`<RQ_#KK':3$S?)/D;-<_32\W'R!4.5,2Q-;<*5^G<6F2A)2%#>D`T
MJ*T36M+F9(V4EI#B>.&SL71NE[Z*6)\+:M+0VM=]:[/,B/FCVO>WKF;'<M8R
M3`\9L%ZF6V>M&?X_;X>,Y-:[NAM<F-*DN-H+5WM!=J76Y+"U)42`H$4U6)(^
M6:$8JZLA?(,P>VGE5;'W=N#18-J<4ATSD19]YM\28O>0F)#NCR&^JDUVN^CN
M3]"AJUZ)`72`47.NIHY)W<QKF@=JN1<9ZAL=/20A/C3ZOA]&NDQ6XCC%:&H5
M(,SI/<%068+<VF@2GQZ#QIU.MS&TBE,5K[_'!=[$<(75VBD[2*)K6M13O337
MPK^(6R,F$(2L+;!"014'N2.O3J1VT>%?Q"2DF;&:$%&\<!Q+J?!Q+@_$H@?Q
M'1X5_$)/Q+.!1C$>5#HD)0X@^5*5`D`GKN_(-'A7\0CQ3.!7<\AR0H.4:;\H
M&U`-.E>O;N=;MBN&#*QPIY?N3J.\L>3DE8\R5VX4IYUT'Y%!0WZB7%F@(1X*
MH*CK3K4'2C1<YAG+2W?]J*/<^'FB2,.`![%\&X$BHV#ZB>O3^YVTNEO%,X%3
M!]O_`/BM<1_\:M_\^K6`:NR[TLQXD;F&Q1GD*28_+P"@2;KEG8C_`&3<?ITY
MDM7QV[YW$90T\=XI[4JR-TCVL;MS#T$%>BG@SKPGP_WZ<9X&/R8Q;-><[NGC
MYZ?.?65W*Q8ZXL(2T4RM&WN3J[B.FPGZ:I_EU'L<S+\04N,KA6H'84-ROT%?
ME3_+K;,SY@LY6_,U#<K]!7Y4_P`NC,SY@C*WYFH;E?H*_*G^71F9\P1E;\S4
M-ROT%?E3_+HS,^8(RM^9J&Y7Z"ORI_ET9F?,$96_,U#<K]!7Y4_RZ,S/F",K
M?F:AN5^@K\J?Y=&9GS!&5OS-0W*_05^5/\NC,SY@C*WYFH;E?H*_*G^71F9\
MP1E;\S4-ROT%?E3_`"Z,S/F",K?F:AN5^@K\J?Y=&9GS!&5OS-0W*_05^5/\
MNC,SY@C*WYFH;E?H*_*G^71F9\P1E;\S4-ROT%?E3_+HS,^8(RM^9J&Y7Z"O
MRI_ET9F?,$96_,U>03_E";*I'O<]J831)3[?LH4=WP'(SJ*>6O6JQKI'0L1D
M:]S2*<S_`,*Y5^H<C8YH]_X.[^(IG/;LTRK!;F6B$.)O%Q]7=^<N9!@R4[:5
MJ`CH?IU?M4MW.DC-1\0]87.M*N&/#P`=B>AEE3:BHD$%)'2OQ!\0/AK7PK^(
M3Y!YE3B@H$`!('6OQ)\`?CH\*_B$+J#30#:604JHD.%78FGF(H2>IT>%?Q"%
MDA31+K;E:A`(I3J:TZ=?#1X5_$(14M%5'8A03X`C_+.CPK^(0NPNL)%0RZ%`
M=_+2O8_G:/"OXA"^MNI=W4!&VG>GC7X'Z-'A7\0A;4G<LH^K3\Y71)Z#^71X
M5_$(7,]\PILA2@I/2H!57N*=^G?1X5_$(6#`?0%;"$`D5W5Z_DT>%?Q"%TNE
M3:6U)\SBQ^MVUZGQ^GMH\*_B$(,J+SK;(2I)=5L2I5-H-">M"3V&CPK^(0NL
MQ%)81/#@4?.E,<D[5!"RDE::4)*A^31X5_$(6MM*GTJ=HELA)<4@5`305*4B
MGAH\*_B$+%*=WYR1_FC31X5_$(626%I7ZREH6QT'I(42Y45J>M$T-1XZ/"OX
MA"8;W*4<X<S=:1M2B59#0]Z?;#:0.E>HII:.9K_=`-1AYEFZG:(ZD'#V*%]I
MAN&'"7N10,MJIYJT('T4KTT]Y+B*U"KYN&%Y-"CE]A71P*2:@#:"=U0*=13L
M::.2[B%MSV\"N3[/=_3;[U_._P!+IPFM?6DS\HJ(VTXZ_&?:BUHT4UW;P6_-
M55#M*Z_BTR4@LH;X0\9$*/&+B!0E2"I*-]:%*0M*=W3QKH0LXL]$.[V^YW!?
MZFWW.!-ENJ`JER++:E-UV@#8D`5`%2.FL'8>Y9&T=ZF0][C^&8DAY:LL3Z;R
MBI9-ON'>OEI^H[=-1*EJ+ZU[F.%'E!MO*DJ6>U+3=7!^"K4>@)/QT(6B5[D^
M%TNJ0O+G0IE5-B,=OJ:E/YGK%DHH?TNP[Z*A"#/N9X3=5L?RF2PDCRK^R;K)
M\]1M3Z;3&X`BO7L-"*%?5^X?AHK#ASF6RQ2E&[!=V:TK55'6-U37OVZ:Q4(7
M6S[D^$$>HM[-),<+8+(];&KZI4AL"@4TM+`25.)%014&NLX(H5FGW*\,(`+.
M8K#=*)4JPWB(3XT]5Y@I7^`=="%U_P#".X8<C>N<M+BZJ3N^RKNX.A`'F;C[
M>E=8J$+AF^YO@YF+'6SE9#[SH;.^U7@)!!%:;XZ4)\>YT5"%U.>XKA2M?WS;
M9+;2'`7+?/(4I04#_J`[4T5"%R'W/\&@[7\MD.NCH7(MGN*V%"OEV*#"JT30
M'Z=90MS'N5X5,F4A&9/?J?J5Q^]QNAH#N>=8],=#^/2UO]4>5"Y#[CN%'%K+
M^6AXH4-A=A7%6RHZA.UE-`=2%4+<CW&\+MD%65N!E1_5>G:KRKI]"@PI*^OP
M.A"S=]RO#32=[>524K"@"M[';N\D)/UAM;92NI^/;2%S3E>5&*YS[IN%1T&9
MK!'U@<<O".OX'4!7;3!"Z1[G.&W6J-9FHK<00C_O9O9\RTD)\RD!GN>Y.WZ:
M:DXOIM[EFA42>0KC:,VYAO&1XHY)F6`6+&E1;@ZGT2[(8BEAUM;1%=J@W7OT
M(.E$UNJ\L=Z5&-7J%CV<XKDEWD,0[?:UR7I#R427GTJ2RI"R([+:ZMAM?0UK
M70F*D6][DN%&9`93EQ2REA"]RK;<''4@I!ZI#`W*^BFHI_QGO*E6?`.X+G>]
MR7"[@2(N8+>4"2L.6.[I"4TZ$%MDFI/QUJMENC^YGA9AL-OY@6W`I1*4V&[J
M%#]4U6T%=1H11<G_``F^&-P_[\7:;T__`#KW_MN'^M:$43=<O<G\#\@629:5
M9=+3*"X4^%,9QW(&)-NN,)P/P9T22W'#\>0P\@%)2KKV-1TTG)9"\;C^[[?[
M$X@U-^FFK33/3T?VJ%>9Y[R#E4![!+I[E<AD8=<&VXT\L6*3;[S>X+:$@Q;K
M=V+<S<'FEK!*@E394?&FJ[=Z(W/LPJK/:=3R%AQ.Q2.]OV5\#<6V%,$YHMI:
M*D--V.X@DK+14HTCU*B6@2?I/QU9;?2FVF(%"H"?5'78H22"%)@>Y3A9PJ6U
MERW:T"BJR7=-*"@`"&#W&I5CJBG!1X9EQ`VKL;]QO"^U*U9610`D_8]ZZ4[F
MAC4Z?AUNA;D^YCA`J`.;.]2!TL5R_P"A:$4*/&_<3PNJ.78N7+=`712G+)=Q
M16VM`&V2*4I].A,KJN<=R,8ON,X;80AR1E:4I6D+Z6ZXIH%`*I13&X=O'J-"
M:KJ3[C^&7%I*<K!:J"FELNCAK]/I,5'0^.L+*-'?<?PXA0",N4@;0:#'+Z]U
M)/7>EI(_%X:$8K7_`,)'AYA"U?O*QMH2756.]-J`)%5!;C6ULGZ=96%F?<IP
MT4,^GE:5..DC^J[HZ.@%*!EFHJ3X]-865,C@7W"\6MXJZI.0EP/W8!:A:[FV
M*)<--J'&-XH/CWUAOU5(6X_!'>?6D)'C2)4//)D9(>9OUSR:3&"G`T%0KC)<
M$%S>?SPF2LD4JN@`ZZL`M77UJZV9\3FGT"OL2WBFV7^I?\+2/3A[5//&/OC_
M`+OWB+"\*P'.N9;E:\CQ'#L7L5V@1^-\]N28D^SV>);9S*IMNL<N(\$2XJ@"
ME7AKSW/TQJ7CIQ"P$!QVFF`)76]%ZGL7:>VI-0T;!V=Z[A]_1]V(?_T[7KJ:
M?[U')9\:=_W:U#,Z:O`VE!M._M[E(MZ@T5[<\CP'G;7`^;%=/_'O?=D#JKG6
M\T_^M3R6/_S9.MOZ;O?E'G_8MOSW0_\`,;YUI7]_)]V(@@?VZWGK_P#XIY+/
M_P";(T?TW>_*//\`L1^>Z'_F-\_[%A_Q\_W8G_EUO7_FHY+_`/J;T?TW><!Y
M_P!B/SW0O\QOG_8LD_?S?=B*K_X];S1*2H_^*GDL=!3_`/%H_'1_3=[\H\_[
M$?GNA?YC?/\`L6E'W]OW7[NXM\[WDA*B@_\`BIY+/F`!/_SM#P(T?TU>_*//
M^Q8_/="&V5OG67_'U_=?CH>=[U4=#_XJN2^__@QH_IN\^4>?]B/SW0_\UGG7
MT??U?=@*Z(YVO1([_P#BIY+/3_P9&C^FKWY1Y_V+/Y[H?^:WSH'[^K[L!/17
M.UZ!_P#K4\EC_P#-DZ/Z;O?E'G_8L?GNA_YK?.OG_'V?=??^7>]?^:KDO_ZF
M-']-WGRCS_L1^>Z'_FL\Z'_'V?=??^7>]?\`FJY+_P#J8T?TW>?*//\`L1^>
MZ'_FL\Z'_'V?=??^7>\_^:KDO_ZF-']-WGRCS_L1^>Z'_FL\Z'_'V?=??^7>
M]?\`FJY+_P#J8T?TW>?*//\`L6?SW0_\UB'_`!]GW7W_`)=[S_YJN2__`*F-
M']-7ORCS_L6/SW0_\UGG0_X^O[K_`/\`+O>NO;_Q5<E__4QH_IN\^4>?]B/S
MW0_\UGG7Q?W]7W838!5SM>@"0D?^*?DON>W_`,[>C^FKWY1Y_P!BS^>Z%_F-
M\_[%0A]ZS[LN`/>S[G?;YR3[=<UG9AC&"\9W;#LMF2,3R&PJAR[CELF]HC-Q
ML@@6V2XXJ-Z2PZVE;8!*2=U0.A]$V,U@U\4PHXR5&.ZBYOUY>6EZYDEFX.C;
M%0TW',DYQ3R3@''F)R(V3Y*J#)GWB;):99MEPFK4EF.B,RVMIEH^FLLL)"@"
M?-4C5ZU+XX_XAZPJ!HNQ_<G'/N0X9]!+G[S24*)`/K8]?6F^J2>BE1OK=.WP
MT*9Q7UKW%\/NIW(RBHJ146:]=Q2O>./CK"%I_P"$GPV%E`RYE"PHIJJW7$!*
MA45*5,@BGP/7644*TJ]QG#+:PZ]FR55Z`1[-=9'4=?.AADJ2GZ3TT(70Y[F^
M&$,!Q&6I5U(W.6>Z1R:?%IYG>/P]CH0NI7N2X0?;],98=RP.B;;<%=>A-`A@
MK/;PUA9H5I3[AN&6Z^GE9Z]]]JNJ.W:F^.FO?PT+"VGW%<,J0E*\J(H:U1:;
MP2>M?K)CE)Z:RA?'/<APRFKS.4U:2:579KV>Y`'41Q_%H0M2/<KPPZXE+F5H
M2/@+7=6B?P>M'!/XM"/4M_\`PC.%6W%[,MW$F@"H$]0^@`!@'\FL(6Q/N,XA
M"VUKRIIGTE[TK59;UMW`%(21Z(K4*.A%%J=]RW#K(;:&7-.H0E5-MEOE!O<4
ML@T84":G\FA"XT^Y?A])6!F);0YN"_\`O8ORTH2H^8A0;3N"1X^.A%%DGW&\
M*.5!S@NTZ[4V*\0R/[[U'VE)4!\!UZUT(HNB-[D.%FI"4#+MR>AHN#<">M:]
MF*4Z:RA-AS#S'Q=F_'&4XQ8<D^<O=S>LZF(B84QOU7C<E2&VTK<9"&P0WXFE
M-1]N?Q#WGUIK=_23&0&/EX<5H]TQVP036G3\`U/#X!WJOCXBNI(VK*QU)IT/
M5/3Z-86RZ?EGOT?"O?P^.A";QR.PA.YPJ<0%-E2$]2H;TUZ4';OIBC,[B?.M
MRTQE//O1$K;0A+-1]5*R0KL!T)33K^'6$9G<3YUT6NTNY3<[59+6V@7>_7FV
M6*"S(4E+,^\764S"ML-)7^K0N0^\VG<:`5J3K#G!K2\[`"3Y`LMSO<&-)S$@
M#RFBL4<^YR]]KLC^<\68*ZQM4"E')F*K._KMHEV8E!`/6M=4[^L.G^+O-^U7
M8]#=2`TI_P`RYV_N;O?7'6MR-Q+@@.ZJ0[R7B0*O\SZ4UP`#Z2.NM'=;:9'A
M:C,T[:MW^E8/0_4@W?\`,M2?N=/?TMY]USBG#1ZJE*2$\LXD&DUK3:T72I*!
M7M6NM?ZZMJ_"W_"/N0.A^I"*T_YEM;^YT]^K:MSO%.%/II0(9Y5Q5A854$*W
MN2%I*0!V[]=9_KFU^5O^$?<L#H?J3@?\2Z5_<_\`OU+)0WQ9BK'4GTSR_B1K
MTI6OJ4`/;\6G$77]FQM#&TFOR#[EN.@M8>*W#G-?PS'9YUBG[G3WT_J@YQ7A
M+RU!(4M[E/&'BTH@54"J70[3^B!]&E?Z_P!.=A)&T1[_`'!L\RP>@M4;]-[S
M)N]XTKNWK<]]SM[[D(2&N,,*<\W5+7*6+,4%.Y+LA:2/H`KH_KKIS[!`Z%ZD
MX?\`,BU[[GKW^!5&^'<)D(H/.YS#B;:J^*=H7MH-8/Z@:6PY;=C3%Q+`<=^T
M(_H7J7A_S+I_XF[WU*"2YQ'QZX!17I*Y-Q@441U`=3)"@0?$4KK'_P"PK+_+
M9_@'W+7^A^I>'_,MA^YR]]9^KQ'@+'@3_:ICS^X#L*.2R$@?1H__`&%9?Y;/
M\`^Y']#=2\/^9?4_<]^^YIM#0X=P!TIFM.>I_:OCK(+/IC=5M$P)"4J[BG6E
M=;#KS0G^].*2[P&@(_H?J4[C_B74C[G?WW>B3(XPX_7++B%!QGDS&$HV!P%8
M4`EDJ\GQ5H_KW0F>_;BLHV5;YUD]#=25I3_F6N3]SI[[5R5/,\78"$@)VI')
M>-)!-#6H$H#H?CH__8EI\C?\(^Y8_H;J7A_S+0[]SI[\7(I!XJP`O^NVXE/]
MIN,CHA22:+^:JD&GAH__`&):?(W_``C[D?T/U+2M#3^)9O\`W/\`[^9+M'^)
M<#1'()JWRS8'%;_S1L<F[:==`_4'3)?<N6@1?PC;N63T/U*-U>YRQ'W//OQ:
M8<8C\48&@.*W*4KD[%RO=3;T5\W6E-9/7/3F[U+']$=2?*?.L#]SW[[VPPXS
MQ/B#DB-Z:S7EW$$,K=;(5U;<6X/3*AV4%"G<'6E[UOI4T3&V]0*#]TCTI6PZ
M`U)DCY+E[LQ)J,YH.S:H4<J<2YU[=N7<@XAY3MD&VYU9K?:+E=;;9KQ#N\81
M[U&1.MBVI-M0S$#1BJJ``._8:LFD7\-_:MDBQ!%>WTJN:OH\VEW!+WN(K2E2
M1QXKGM-MF9-<HMFLK*53Y16S'B37EL,O.I27'4AQLA6\-"JA^B-2N4<`HG,>
M)2BE^WK-EE,ENQV=:J!S<U>K>$D$5\I71WT_-T"NOQTR<UN8X#;P2PBN3B"Z
MG>5Q_P#!^Y!=Z-V&T5'4^I>;8L4^C=4`ZURM.X+/)N1O=YROH]O?(:115AM=
M>_ZN^QFT=?@AA!;!^/CK.0<!YECDW/%WG*U?\'7-*U^Q;4#6M?MR`*'O]9M*
MG`?P#1E;P'F1RKD[W><KLC^WS.1ZE++;'-VT*KD39[;J5W,]>^LC#8`$&WG/
MQ%Q\ZP/M\Y&4Z4Q[-90E!&Q'VZQN14`JH2Q05).L%K3M`*P(+D'`N'E*WK]O
MV>$=,=M>ZHZB]6P'N*]?P:R23M61!<#87>E;7?;OFKZ6]]@M.Y"2D[KS:J]3
M7Q&@#@CE77S.\Y^]=3?MXS1MM-,<M%$"N[[8M/AUKVKTT($-SQ=YS]ZZ&N`<
MY<*2W8+8H?6J+W;"*#XZ,4<BY^9WG/WHT<]OF;O!&ZQ6KRIH0;W;:=R>VG$0
MJW'BL<B<[2[S_M1BU[>L\*&DKQ^V>B$H&]5^9VI;H.H"6E("0/ATTNP-:X$@
M4!2;[>8,.)V<5U?V"YIT9^P+.4)\P6;ZS0GMT_4?#3SG0;FM\P3`03;2YWG*
M[HG`F;A8/V#:BW7O]N0%)K\/UJ$J_@IHYT'RM\P1R)OF=YS]ZV?V$9<EPE=C
ML@2%'=6^Q_B>X$<C1SH/E;Y@L\B7YG><K;(X$RMUBILMD3M6@MJ%]9!J2*[2
M(_3H-'/M_E;Y@L<B;YG><J>7!?#&16C!8B'K';%/KN2W`$Y"V-[8?7521Z%.
ME-(C(^<N:!3#<I>SYC+<-<36IWGBG,:DVV.B=%6J,A5O==B3F$-H(BOL.K:<
M:=0$;/U#J36E:4KWU.L]V$EN!`W;478=);N94FM/6%5]R1[9[KD&77J]-V6Q
M3(]PGR940-7&,PMR.\YO2X\U*3LVN&I3M^FNJW?L8TDM`!-:X"JBFLN6#*U[
MVM['$>U-L_[1[NDJE_NO9T*<Z^B+S"0E!'D'ZMI@MI!V@].]=1C(H\H]UOF"
M?10W)C!S./;4E<;/M.R=U?K+L%CW`']3]L05`@CJ=CK"6SM_*-+1Q19_@;Y@
ME.3<_,[SE;C[4;T>CN,61Q0Z>2Z6;R_0:H[Z<<F'Y&_X0L<FX^9WG*XU>TR\
MN+7LQ2U*H34"ZVCI^()^C35\4>8T:WS!9$-S\SO.4$>U&^M;BWBUF0I2"@EV
MZ6A2:&A-`4$5Z:UY<?RM\P2L;)V.J\NI3B5Q,^TV_P`=X_[08\A+A*R/M:`D
M5)IU#$=2#]7OWT<J+Y6^8)?,[B5O'M0G+>_7XO9EH4L^J6[M;`5`GS%"DM>J
M*^!INT<J/Y6^8)HZ*X+B074)XE<TCVCW8.$MX]9Q&/1IH7F$74JKW7ZK38IM
M^GOHY4?RM\P6\3)F.)D)IWE:S[2+TV=IQ6U*[&INUI)H?P@Z.5%\K?,$OF=Q
M*^?\$K(Z^?$\:]/Q]._Q5/4\-K;D=+15]!--'*B^1OF":&*Y)VN\Y7T>TG(5
M?L,5LR2/K>I=+,JH\*;D&FCE1?*WS!*Q-FCKG)Q[5@OVG7M#T1+V+V?<DJ];
M;>(24`$G;N2RP6_JG1RHOE;Y@E\SN)7/']I60!X,1\5M*E+WT<7=K64I"05'
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MS;B/52'4EP)I6O?2Y`=\0JM69A[L9()X8>I;7O;UG;@0LV6W/$K`]!61(6E-
M03OV%DIJ.WQZZ,H*5Y-S\SO.48)]NF:I`>./6A*P``U]M0#4#\ZCJ$FIK\-&
M4=B.3<_,[SE8K]OF;J0Y3&[0:`UI>XAI\00IH-U_'36K@,IV;$<FY^9WG*X/
M^#YG`[8[:4__`(<MZ/\`VE"R?QZ:+/)N>+O.5FW[>L[W^HO&[46>P4J^L%NO
MB/V%*Z<QBK*E8,-P#\3O.5T.>W[-"A0&.68DCH!=[77\54@Z4RM1R;CYG><_
M>N='MZSM54IQZUMA5-RDWR$W^"ICH77\=-&4=B.1<?,[SE="?;SF40#_`&@M
M$EP_6*[U;G55/Q4^@.&@/B.FFLGQG@CDW.S,[SE9CV]9BL>F,>LH!ZT^UK2!
MTZ]@G68Q5X6.3<_,[SG[UDGV[YJU^SQRS=>I*;O:A_Z73G*-]%GDW'S/\Y^]
M`\`9M4UQZS5\:WBUU_YW3MDL#6!KFBO<%CDW'S/\Y^]?/^#]FB^AQRS+\:?;
M%O'XZM-J5K69\+V96@`UX!9Y-Q\SO.?O0_X/.:'_`.=BR_\`;>W*_A>;2K\G
M33;*T(Y%S\SO.5]5[?<Y4A38QVT@%)107R*``12@0&_2`^BNW1E;V(Y%S\SO
M.5S,^W;-F%$G'K0@+&PJ-[@IIU"N[*%J\/P:,K>Q')N?F=YRNIOV[9>V9/\`
MM19U;VAL)R!LG>=U4I)8Z$:*#@L<FY^9WG*35WX7R+$;=(O=_@6M$**&%O36
M+VA\,%;WHQPMD-)+[B7E;4I/YVL9&`5`'F2ETYXC`J=B+$10([:FZN>4$D>:
MB*>4]N@)T]M0"YP(!%`HFW),K@>`]J^1H1??4NBB/**=`.G0]#I]D9P'F3Q;
M/D'/TW.]/K'M\-&1G`>91>9W$[>)39H"5J"5"H-:BGP!/\8U7N2>*DZ+<8XI
M5M:4)'UD$=7">U*=/**_ET<D\5I(_EMS'&B5/'M&N3.'%-)]-2^;.,`0:$BN
M76*/UH!XN5_!I*>'\"3'#([_`*2G6D@WUPS)[I:]NW'>%^@FI!W'ZG<_FGX_
MAUYJY%MO9BO4Y==5P<RG<?O7S8?[S_0'^72L8BB%(VD`HS7?SL\Q^]#8?[S_
M`$!_ETIS!VHS7?SL\Q^]#8?[S_0'^71S!VHS7?SL\Q^]9)%!W'^=%!_'I"5I
M>ZH)`HLTD=C(07=B^GMW_**C\?721AS#*\DL.U&5PQ:1F6&T_%'^@/\`+I/P
M%G\I\X^Y8K=_.SS'[U\*"?T/]"?]-I5D#(ADB+@SO_8C-=_.SS'[U\],_P"M
M_P"A/^FUMD/S.\_[%G-=_.SS'[T/3/\`K?\`H3_IM&0_,[S_`+$9KOYV>8_>
ML@@_%'^@/\NDG6=M([/('%YWU'W+&:[^=GF/WH%!^*/]`?Y=#;.VC=GC#@\;
MZC[D9KOYV>8_>L?3/^M_Z$_Z;2N0_,[S_L6<UW\[/,?O0],_ZW_H3_IM&0_,
M[S_L1FN_G9YC]Z^A!'Z'^A/^FUJ^!DHR2YBSO_8L9KOYV>8_>ONT_%'^@/\`
M+I+P%G\I\X^Y%;OYV>8_>L25)!`(Z@^'04^BNAC9:%T3@(HR0!V!(OJQW+=0
MR/W[JE>'_P"]?NDIK[UCG.&M>^,U@G"GHH%1L4[AS*G30U'F.NT=$39K$28Y
M<6T\M:^A<0Z[#[>_<QYS-KF]":OBE#AY0PQ++!4E^?+3NWI319M[U201UZ'7
M2+B$P0\XFHX*B63_`!LO*;[I[5.)*5IC(;IYDLH13IW2@`_PC454.][BK0V,
M,:&':!3S+".E:"K<*5`IV^.BBVRA==3_`)`-%$90N9MC:X%*4%)J:I`I6H/2
MOX]%$96\%U>0?LT[?CV-?A^36CWAI`.])2/$=/=K58J!-"V=JR0%*^/7Z*>&
MG,4$LHJUN"W8Z!PJYP;WKZ3YGDA0)9<;0KL.BU`%9KV"1UTCEE^7TA&>V^<>
M8KZ$N+>4TV$N)%*.I6C:HD=@._36")!^X?.DWRQ`@,]Y=RT*;"6S12C1*P*>
M0GH:_&@.D\TH-.6[SK8/B()7:VA#+02A!*J@5'8#K4]CI1Q`V8I#Q`^0K-9(
M(V^>J033:-IJ>AKI2&6C<0=JSXEORHW:?4IIMKT5#<VA&ZJ2!5(3NIWII4R!
MXR@4)P6'3L<TMR[0L_EE?IC\G^5I/PSOF]::Y6<%TH26FN^]6X^4``]:?'1X
M9_S(RLX+A11;M%5HI1J*#Z336/#R?,$96<$:J#*F0G8KR*1XBAJ:#P\*:SX>
M3YO0C*S@IB\;I2G&[8!T`4\?_ORS_'IW;-+'93B4J(?P\[=BAQ9KD_,O'(B'
ME*4?WDR#J2*"EPG$=*?`:L8^@>X>M,7W#6$M(JLY+S+6U+C1<6Y!B^FH%(]/
M;ZM:@@UW5&J[J%/6G$`9/L%$FWVWWA1+H2D'H"">@-?#QU'-^$)WS&0_ATK1
M;6J,*]1P;TA)&U-`:J%`:D>%=*,<&.KM"4CE9([+1<SBD*42A)2"22#0]S_)
MI7G#@EZ-X+86E%"5-$(-`5DCZW3J!3XC21:]QS!N!21DA!H2*KF6DN`))V^8
M&M.W0_@TE+S(FYLI.*;W,@,?X(SOKL&&'E6*HC2:56AXD5JD4V_WIK6I&D/$
M/_RW>=,<UQ_DN\X6"H[20I24T(!(/T@?@T>(=_EN\X4DQTV0?@NK0;PN%[_4
MZ_I_#Z-*PN?*2,I%`M)<[@`]A8*[3CZEU.#S?YU/\6E'"1N`:2M6Q1NVO:/.
MLULJ2I*2H>8#K2E*BNBBWY[&X4K1<S@>"B!5`!^M045^`4UFE$E+*)*4%*+&
MH'1QHNJ\5U`K\.E#V&A(KZ(9+:G?5HE.VH2**HI6V@5X:Q1._$,^59;&4`>D
M'*GZY<5NW$=B/AH2,L@D(H*403YB0GS$=P.X\?X!K*3!H:K[4_Y`-8HG?B&?
M*H5^Y$RE<E8`AI[TV3C5U;6""05R)K[:5=/!`3U^.G$/PGO4??.#AS@*!HV)
MY/;U^MQ">VM6\HR&[,(53I4P83Z5?@&RFEDSLWB=X>!0-(*?=##I4/3`<(ZE
M(Z=/C6GQ.LT4[XAGRKK7ZE1ZB"VH)`VDA51UZU`'?23Y`PTHCQ+/E*P:!+;X
MKWWCL/%6M'2@@BBQXEGRKG]%7Z0_)I"B/$,^5;6`=_IK.Y`IY?I56O\`%I9D
M@:VA"/$,^5<H3N7M!IU-.@\*G^YK;G#@CQ+/E6T?J>YW;O@`*4_]'1SAP1XE
MGRH;"YYP0`?`CX=/[FD7D.=F1XAGRK)#:DJ!W#Q\-#"&NJCQ#/E6^GE4K<*C
MLF@JK\&EN<."/$L^5<Q;6H[B=M>NTCJ--G@N>7`T!1XAGRK)MM2#4J!Z4[?@
MUM'5CLQQ"/$L^5;NOQ_@&E^<."/$L^5`5)`^)`[#Q--+#$`K/B&?*OKK"BCZ
MPZ&O;\(_NZS1'B&?*N,-*-?,.A([?`TT41XAGRID?<2AV/Q'EJT]"TY:&@OZ
M7;TVL+`^`!TE'()'Y`,:J,O#5M5%:S2'H]LC+JE:WXK:25"M-H_NUU+6\)CJ
MXFM0H..41RN)%:A=34I;;I<<;"R:?LRE`Z=!T/T:<I?Q3>!77ZD/_9:/C]17
M?]'2_)[4S371[:I32G*'>FE#UIU-#TKUZ:KJEED6F"442?4;/F.XTJHBG2M/
M#0D+GZ12GX_^67REQ*AU"BIOE_BY].U1`]7]^L>2#T/4!('32-Q]"3_MN_Z2
MG_2_\R/XQZPOT!CW/X3_`!Z\SKU2OFA"&A"&A"&A"&A"&A"&A"&A"&A"&A"&
MA"&A"&A"&A"&A"P(JI(/8[AI&+Z,O\3DUF_F8_(O#C]ZZA+OWMO.+*Q5M6!\
M)D@&AJ,)01U'7N-=<Z&PTP?]W[UQ3]1O]R/\/W)M>,T@<B8,XTMQ,K[064D+
M4$@.1Y39.RNTG:C75M0_D/(N>:'A=GO4ZD`H"0>JD@`D]:D"AK\:Z@F?".Y7
M`[3WKH1^MJ%`4'7H*:V6%K<2$JH.U!H0MLEM.Y*HX*6P!O!)43T(/4]O-30A
M<JI$6*`]-?1'9WI:"G$.+0X\YT::`9HZ7%J%$A/<ZPZ$R,,NYGM_L6S6MD=D
M.]2?X>]H',O+RV;H]`''6&.)]9.2Y?#?AS+A'W$%['K"Z/F9[8VD!3RVJD5`
M*2*TK5?U)MM!<Z!WQ4(W;=RL]C^G]UJK1*PD,J#OV*8LGV=^UW!\?=C9OD&3
M7V:_Z8>R"^Y&[A@G`K2"Y;(5F0XVI*>YHV0!WH-<?_\`V'U+Q/V\BZ..B>G#
MMR_;RIH+C[%.,LJC2)/"G-=PM\ZI<@6.[.6C*K8XD^;]?.<=M%Z92D]`4I?)
M!K2O0R6G_JQ=Z>XQ:MB^0@M[AM]*97OZ?V$[,^G4RM%'=YV*/^4>TSW*8(I]
MW]TK1G\%M2PW,P>\"7+=9;%2[)LUZ9L]P8D*`/1L.I2?!78]!T[]2[.]9D`%
M7X;M^"Y_J/24MHXG<,4PMQO#N.2OLS);3>\7O.[8[;\LM<RRK0.RDLJEQ([<
MWPHML[?HU<])F-T\#:H+P8*/X;T%QD.MN,/I7YBN.Z7D`D#H5%7E-/#4Y>P"
M![6C>VOI*CKR+E2!O%J[VWB5(2G;L)2$^45VU`'7O6FFK/C'>F:-&D!9(/@-
M/%LL%H2V[N3W`'?J/R'IH0M,5EIU2UN'80M?GK0)ZGK2M*:$+L=;;0T2V^EX
ME;=0*>7J>O3XZ$*7/'CJTV"W)!%/UWA_KBM;Q?43MO\`+^50AQM]S[=Y"%1U
MR;(0>@[?:$X:L`_ESW#UJ`G^,I1S!'"HY>223!8I11';?7L1\=5W4%):?N2?
MFS;9"\SLM+0411L]2FOTGJ:ZCF_"$M/]4_;<BMS),=2DLKDJ<?)%`RAYQ70]
M?U;#3RR!3OMH/'6RS;_5'<5@B:T^%")$NTPJ/E7%MEQ<0V"#1*R;?T41UZ^&
MA2"/6(&136V1;\.S23Z:4>HMO'9Q:DI'4^FZMM`0EP=-U`!WTD[6X8#R'#%N
M"P=$FG_&:?==BD-F&0QN.7[/"Y",S"7\C2\;#^]C<.S+NRH;@3-3#,MZ+'4T
MT7D#<5#^/3:XZA@R8C>E(^G-2>ZEG4RT]&]'ELCW2ZMM2K-%M=S@/`*3)BY]
MQJ6U+-#0I7ESSC:]A!VJVD`]AIG_`%!;);^F>I/E/F/W(T<M61H2X5PL0;0@
M*W_,\K<81UMI'0^N7<O0VRM(^MN("3K'Y_;*19TMU)D!H=@X_<N.]62\6BV1
MKQ/_`'-^2=?+:3`Y?XCG/)4ELNDJ8CYC(?6G8GLE)).D)NIH(,I:,7&B5;TE
MK#P?&U$8&'?_`&))V_,<>NCYBM2VA(0=B_2EQ9K8*>E`_#<=C+_SJCJT:5K5
MO<BK@"JGJFBW-JXM:2*)7JHLI4>M`-I'2HI0'\8TDXU<2-E2FHV`';1?75%U
M*$+I1%=M``>H`()'4CIK"%@$)`H!V^/70A?0`$%O\U5*_'H=PZ_AT(0$=GTG
M'"O]8BFQBO5[H2:'N*&GY="%JC>BC<OT2R^\"%MK6I>U1\HH%=NG7\>A""FF
MVP&UU+V]/6O3:30B@Z:$*%_N5;]/D3`"/V*L?EEP4JHJ^T974*[@4\-.(=A[
MTA=_RSD\/MX:93ADEQH&B[_=G:E1)*A'AL`]?];4=*A,=*V.3\NMI2D%)4#N
M`J%$>!^&LJ76E(H.ZC]*B2?RGPTVF^+R+!62?*%`?G5K^,UTDL(:$()\JMP[
M]/X*T_CT(6`BN!6X'KU/8'O_`)[Z=80@IE73U.O?;TV_A\3764+)+3E!L/E\
M/+7\/6H\="%L;9<W#>?+UKY:>'3K4Z$+ZZVE"T*%:@'N>G?Q'CH0L%$J))I4
M_`4T(7S0A#0A!/UT_P":'\>GC/A'<MEVD`@@]CK9"U!AL=@>I)[GN>^A"9KW
M%,ID</YJVHA%95A2%T'D'VJCJ?CVTTM?K>4IM='W:*($"`I,"&A,E+P#"/*E
M`!14>-#UKJQL^$=RKQ^,HV:M[FP=O'\WZ3].MD+=\JQ_@D?#MXZ>X^A92!VJ
M]1+('ZQ7U4U`J`-QZUV]$Z8T"Q4H.6YAJBEJHMTU4*$]4_2.GYVL.`H>Y`^(
M(]P9"(_)G$RF:+4KEGBZHI3I^_F/^*M5C4S[LE/D=ZBK+IF$\=,/?;ZPO?D>
MY_"?X]>;UZC7S0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A:E>
M'^>T,^F_O*:S_P`Q'Y%X?/O6$*<^]GYY0@56<`X4('0'IAK"CU-!V&NZ_IT`
M=+\OM*XG^HW^XGN^Y-SQ6D_VE88JG1V[J+1Z>9+45XN4^`3]--=#.*YWH?\`
M-E3I]5M1\JJU/3H1W_"-1#P,Y[RI^3ZCN\^M;!IO-L'>DUBIQ`-%'K^`G^YI
MNBJ5W&W'F;\OY=^YO']E7=9K30D723+9?9M-FCK!VOW:2M+:&P%@?J`2ZOH-
MM#74)J6KZ?TI;N?$\.>1QKB59+'1KO7+AI((8**UOBOVP<+\`0F\YY#DVWD'
M.+:RIQ_(;_"::QBP7!"2I+-AMLH.1`(*E]`6G7G#2@33KP+7.N+WJ&ZR1APC
MC)V5`][RX[%V?2]!BT>V#:`N>!6M#L_M2?Y.]V$Z<R^QA,=^2EA*PW?+HRX&
M72&ZI-GQU2B/12ORI]0H5TJA-*#49%HXOOQ)CC6N*DZEK?<P-,**G?E*SY_S
MC=V)G(7)]TNS!6)T;#I")MF<6XX:S;>C#LJ^3<ENI17;(F.39"CU:,9/D%NL
MKF(NH0/,%P;KR#]3I0;BTC.4</[5$G*N0.5^&<E7:,*N>;8V;6XVY;G517'K
M(U&2L)1:I6(W^0];9ER<)_5?9Q*RBI'6FK!RK6ZA)D#*MP&`^Y<6AZ__`%3Z
M=NVLFAD<2<,"=GE5L/L^YO\`?9R')@PI]AM,JQOQ$"&9D:=;K@K<G]5)ON+W
MA<J':H2U&KA5-C.ANOIM%6T&@ZO9VQ>6L<`"",/,O5/Z?=6]6]7V@=JT.0-%
M35H&&T\5<\UBL"[8]`B\L6/#LIO+D,HO%J-H:N>/(6H;51X;5QCNN*:J2$FJ
M5`?G#QK43W:+1T<CB!_>/WKIQCB/[K?,/N4-^:?9)Q%D>.Y#=>-;)_9]F\&W
M2[UC,7';I,@XQ*N$5#CKMNNUD?>DQFF7D(\GIK2@$]0.^K;TS^I=Q%?MLS4M
M<=]3V;U4>I>DH-9(U!U&F-F2@H-Y=[543Q?F:\SQO[1=+;]R9<>A266DE"5/
M0U*9F!"EA*`$N(4`:_@UZ8M+]NI6S)C3-0%<+UB!NG7'(;LK3SFB=2-Z!;"D
MQRP\?K@JW>7X="16NG*CUN+B$FA-#^`_W!H0N4KD$D%H!LDU55';P--U>OX-
M"3E^F4*@)([%2FP/I\VL)C4J6&#I4W98"E]$E+G6M?SR.P).MX:\Q.:GPX[R
MH/VA]MNZ<EA2]I-^R4#H:U,^?3L#JRV_P>10Q),X\OJ2HRE:X5KDS*4=A6]$
MAE-0=[J8D924=*@`H"CUZ=-5G7,#YE8=/VI:8UB]O5:K;<3$;D/SH,::I;L"
MUO@JDM)D`E=P;D[P/4\$I(`H/CKG%TYPN'8G;Q[%U'26L.G1$@5H=P^8IV++
M?KS9$AMBW8Q*2GK1VRQXX4*=O6;W.I_!V/CII(U\C,@)KWE2\#&<P>ZW9P"<
M&)S0+1&ERKUA=HBV^##D2WW[6NC[ABM%UQQ,8I]-PI;%?,0?`:;>%FXN\Y3W
M)'P;Y@F)R3[S?@;#8#KM_O&76F:AGYEFUM\?Q9[:K<H.%&R7'N@#B%H:4*J2
MA=.Z1K'A)#Q6<K=@`\RK<]W?WLW`.57WCJYP&L[N\7'(N965(O7&V.2&%Q;R
MWCCSC,9N==)"41U/6\CS(W"GP/52*!\3LSJTHM)(C(W*S;50VM?WCWMB8O=R
MO:>`HU^0_;(L6.P<'XYMBS<VY+[KLQ;;EH=226W$`DK)-*>&G*1\)-VIQK9]
MY+PW<%I<L_MULR6MX5-1-@X=`C*!-7$R&(UB4EQJM:I20*=!I4:5"\9R[%V/
MG3EM6@`UJ`E?'^\\PYYV+9[+P+Q+\\EPN6F--@V`):DMI)*_53:6&T%+8/52
MZ4TC-H$4X`:[8:[5N'4VU2Z'O*QCE63=LZY#PKV^V+(,/M%L@"3=LX:Q>U6F
MR*2XEO;:K3D%D:N3\E!5N*(\I73J.VGMMI\%L/>=3RJ,NM--T:@56^'SMQD+
M1#OO]N7M]PN/&?+<:R7OD*_O3;ZR^2\F1:DQK9(#2$(5L;2X4G;0]NNGL.M1
M6[O>.`*CM1T)\T61C<:<`GAQCFW"<M-O8LMZLLE^YN,Q(I@7EB\&XO.;MBX[
M[*BKT%;20%A)2#YJ:<W/4]O<AD;2*@FOH7/;[I:]MG<UC2:GU)U+?(CSF%.1
M7$O);*@X4]"E5>J2%A))'T:G-/D\2T%IJJY<7EQIQY<C35=?I.?#^$>/X]2"
MD5],1+5%-G>I?5?AL([`;O#0A?/2<_1_A'\NB@0OA9)_:"@^/UC7P^J:Z$*$
M_N59IG^'ANJA^[#Q-:BA^V)/@H_#3^T`R'O45J>$?D3W>WQI:L,F;4_5R*Z+
M/4"B$6N&VL]QT#G33B2F1W<G&@C\!_<?44^#2%I42H=*4[@]:CZ3J(3Q?'4*
M4H%(J*4[@>)^)T+*WCL/P#10(6#C2W!Y$[MO574"@/X2-"%S!M9Z@5\.X\/Q
MZ$+)L*WBM?'\'8Z%A=)4$TK7KVH"?X@::%E9(!<44H!)'<4([]?SJ:$(+JV=
MJ@037P)[=_J@C0A?`0?C^,$?Q@:$+[HH$+)*%+-$BI[TJ!_'310(6SY=W]#_
M`)I/^FT4"%B@%+J`>A#B01].X:$+LD(4M*0D5(54]0/#Z2-"%R_+O?H?\TG_
M`$VA"9'W)LJ/$&8!0VI<?L3E:@U;;N[86J@-?*?QZ<6@&9-KOX`HL6&$TFUP
MUJ51*V&]II4FB17I6HU8`!D"J]S\6"/4LE(`;\R/`]!XFO0FO?6$UJ5KH/@-
M"*E-@&`XX'G'?06FNU.TKK5)2>M4TZ?1I'D]J<>([/2L%H>)I0K`/0_Q^!T&
M"K2:^A8\11PP2CP:.?[4.'VU$@N\K<8K/3ZNW/+"*4KUK3Z-5C4[;\.1U?W'
M;NPJRZ9<UFC-/WV[_P"\%[Z#W/X3_'KS,O5J^:$(:$(:$(:$(:$(:$(:$(:$
M(:$(:$(:$(:$(:$(:$(:$+4YT!/P"C_!K,>,;N\I-T/-N&&M*!>(G[TEOU/O
M<.=4UI_XON%SVKWPEOZ==P_3^3EZ4#2M74])7`OU'N::TZ"FQE:U[DW?%D?_
M`,8G'YW]KC./U?\`J5\?'Z-=*G;R8>;M[%S[1+BEYLW\5.1ME'I(H`%>FGS=
M>^T=:5U"$YCFXJS/-7D]I608\-__`#/^7I&8597@DW&@JE5@G'=\Y6S?'..<
M3+*[_?)H+[KI(:M5ACCU;M>I-*))@L54VT5)]8BFY.H?J+4(M`T?\UPEE'_I
MUR[J_%CZE.:)HC]9=D#\GDK[0KYN.^-<4X)P)O$L)C/(BP;;*EY!D`0AV_Y(
MN,PN7+F3GZ%R1)+32@PC=Y24BIIKR3/J6H:_=$W$Q9'F)IMPKLVA>B]'TZTT
MJ(,:P.=08[-WE5*?.ONHNV8<@XQ8K]9,JN>(Y(BYRH35AB']W</C61R0I%QS
M)]U<<)N"8[!<D5"3V`![ZOND:5IL=NZM.9A4T&*WN@\R9W.]T[!P2-X_Y=P/
MD2WJN.#YG9,OCH?>CIC6VX-FZ(>0M\^G)MCH1.A@ML*6C<W138!35)!TWO8N
M6[+#)0#L_:FN.[:ES=DV.\1UQK]!A2XKZVT.K=@-37@2H!LM!U*UAP+IM4DA
M23U!KII46A#LV8^934-S>M@,-R\2UWEM/:5+G@KV?.9U:;1=<]MIQO"X,DR[
M7;'(K+N03[<D%Q*GI4_UGK8F6I(*%)"E^G6A&F\^O2TR,;1N_']BA6Z%IDD[
MKB]BCF?7W:M`IV;U8A8;9C."V.)8\.LMNQZV17'E(;@-JWK2I*D>J^_(6_)D
MRE@^=;JUIZ^5*?"MW3[FY?G$A:?/[5+AD,,?+L&-A9OH!CQ&`:*>E%5PR*,R
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MZ%E@M[=VU*C6NVNY>[M0]M9BM<LM,WH_:G(-;<=Y4"X#S1O'(_G`KD.1?B/S
M\_IJS6]I5E,VX[N`JH.5_+E#J5H?7@ESG3F['[PHIIZ5KB^F*U]7U833)\!M
MV%P'QU2]0_UG-/P\ORUI7NX*>M)>5<QV]*\RF/#9YT^^.6\Q\<Q]E3E2U8[4
M@G92M(3/6F[I4:YK,_FRN?LJ?5@NUV5@+:U9#FS4;MI3;CQ[4<F+7\__`)G_
M`-5K$;LCLQ%4]9#D=FJB;)XR$XID6ZBZV*^4Z4I_M>KZ3IQXD?+Z?V)=>=_W
M%)91<W0XH+`L<-D)I38'8=RD#K4U"=E/I[Z=-HYH=3:%A5H<^,LJMF/K9:]-
M/VG<AO%37]2S04(3WI_!IK>N$<0=3][[TXM\9,>"8*QQG')#+"7R@/K>Z[*[
M2TVA7;<*[NWT:B_$#Y?2GU!P3DV:Y>BW,BIVDIBJ4K=6CAV&J5)^"B/CK;).
M?>$A`.[AV;4V=;9G%V;:>";R=)?3<I<A+C3*A$E%G8TH*:7Z1.Y*@Z.NWIK1
M]S/9#.7%^;#A3?7>DS9U_>P[DV-MD/O2K?&3*EW&9<[5=)#D-]W9$<<AR4,,
M%M827TN#U*FJR/``:B+B[N)ZT<6J1MW,@'O-#E(#@_VW<H\^\CXKQ-C>8P[+
M?<A%XDRGY=UF7N)B./6BWI>O-_G>DE$Q(B_,(998;VEQUQ(W`5TXETQT[!^-
ME-!N_:E6S1@U+`?+^Q>L'V<>U7C#@/V^7[A>;:<;Y&Y/FW+(;CB_*T_$K?!R
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M84]=-1M4\\1V>G]B%-%4>([/3^Q"FBJ/$=GI_8MB%[`L4KN`'>E*?ET51XCL
M]/[%FQ%W(KZE*J5TV_3\=VDG/E#J-95O&O[$JV>$M]]U'\%DA`=!0&5>L3M2
MA'F437OUV@`)ZGZ-*,./X_N,WGAZEJ9BXY(AFD.P<4SG(',V*<?.KM4BX-S;
MRXE1,&W%$HLENA2F2XDT84HKZ=#V/PU$ZAK5G9?`0_RT^]3NGZ->7OQ-+/)7
M[DR%JY^RK+)TB%BN(WRZS(R?F)$:VL2IK[,1/UI"VXT)>U&T5-2`/CJKS=="
M.4L9;9FC?GI_X5;(.@S+$)'W.5QW9*T_YD;V/W)1IEP@0ID=R");S33LVXS(
M<>+;VI4M<"-*G"JWVHRY+:MR@A6U`W=M;6_7+)IA');AC#7'/7_PA:W70CH(
M3)'<%[P1ADI_XBG!A\ZXF[-D09-QBOKBRW8CDB(XM<4EI6WUHSKD=E,F.]W0
MM/0C4];]0VD_`>6JK]QT]=P<2.ZB<VSY;CE[*1"ND=0<H&JK1514=J:C<-M3
MJ0CU"&3X2/.H34()K&,/RESB,1LIZTKF6RV^4*4A1"3U;4%H\.RAT.GK7!PJ
M$S9-FM^<X4=6E*^W]B[J:VJM/$=GI_8N?Y;]9ZF_\_=3;]-:5KHJCQ'9Z5T4
MT51XCL]/[$*:*H\1V>G]B9;W%L!?#^7.*/2.Y9VME/K^I>F^M:^6GX].+0XI
MM=W'N5IZ5%"RQ2JVQE>I1(CMD)V]N@\=P_BU9H(>:W;2BJMU=4</=]/[$;M"
MB`/@5#_FCI?P8^;T?M37Q?\`=]/[%J]#^_\`^9_R]'@Q\WH_:CQ?]WT_L3=R
M6&UO)JBO6O=7@BO@?CIBGBVA(#9`%-I30?"M:_Q:V`]PK4[0CS#(KBN1N(9(
M-'/[5N,=JO%(_?VPUZ4IU`.JWJ8/)DP_<=ZBK'I1!DCH?_4;_P!07O3/<_A/
M\>O+:]<+YH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0M3OU3_F
M5?Q:S'\#N\K9GUV]R\27WIS1_P"-BYV<9.Q[]P^$AO[G:K"V0I(!"AU!^&NU
M]!@G26T^?[UYR_4G#J!W_;^Y-[QJTMCDS"VNM$7(E`I]4.QG_4%:5-?'X:ZE
M?`BSQX+GVBD>,'>IQE.TE*11(-$]^PZ#^#5?&P*WN(S'O6QIM2U_!*02H=MW
M@!^&NM7`ES6\2?4FT[B,H&\JSG[O+"VX&,9IRE*CL+EY'?5XY:YZV4*E0[-8
MHZDSF8SA3Y6[A<Z-K4/-MZ5IKSQ^HW4<OYM^2D_A[*>A=N_3+3&W!SN&'F'G
MV*QJ(DOH.Y(*R-^Q1Z`).]2.IH0$@BGB.FN0M<8#45VKJ!%"1P*C%R)[3.*^
M07;A=("W<>N5U,X3&H&U%FE.S4H3*-UMSP<;<;=V]`R$#JJM:C3Z+7KB(Y!6
MA3.ZK[OE5?5S^Z[>Q/-[?F^$6?!;S+M<H)MTN+>SC_REQ5"=C-RH\*4E"HZ&
M84I;2F_56VHU4$@D`3%OJ#K@!SSBFH!JID\%>T,8I.:RGE.9:K[>K<^)-FLE
MF"U6&*XFH2[<W7U*-T=CGS-A-&]X&Y)'33>\O#3$J44OKI>6VF]G5+#)7N;2
MHH02JA`&TBC::42D>5`Z``:C()N;F)W%937W;)TR%K;C*+0"B.E*4H!0;@13
M3BHXA93097F%NMR'6[E*<C(4*(6FA4MT]$(`IU2JAZZ*CB$)'Y9R%;;9Q;FU
MT?D*;3`P?*94=5`3ZWV#<419/4$59<J:'R_$4TOI7^]1$;,OM*C=3_EG=RH#
M]DTFTIXSLQ^<2J0Y'DO.!2D!;CCJ%.*64^`<4JM10=>FO66C/;X)E7#8-X7G
M#J9KC=G`[>"FOZK2Z!"=I/4557</@D'O^+4V,=F*JYPVX+[_`.A^`_#\.MLK
MN!\RP'-.PA?1I2`$3-KQ65]`K2GZ:/X]2J%(^R+6FV0T@T\@Z4'Q'Q%=89];
MR)P"!;CR^M5]P55O/(PK7_OCR+Q_ZOG:M%K\/_"[_I*@+HC/_P`0]83G\@(=
M587@VK:%0HZ%CON1\A'6D&H/0+2#KGS@0VYKV^U3D/\`N5OWCV*4EMCA%MMS
M:DDENWPFQWZ)1&:2E/2GU4@#7,2<3WGUKT$SX&_PCU+M]%/Z!_YK^715;(BR
MMI(Q'+#L-6\:O2T'S>51B[2?I\OQUE"\^?-7'&3\@7^^IQ%-L>./V6R-3XKE
MR0V^]+N5NGN1@67442\AI12$;@FIZ^!U)Q?2;W(JJ\_<#Q!R=:+#96Y^!Y@Z
MEB?<UJEVZRKEP$*2RR`3,CEYCJFM.I)`Z#3/403`/XA[4XMB.9M&Q1EL>*9,
MY\O(AXUDKJF"I#BXEBN%P2V^0`ZAU:6&D-N[*510T'6O74-E/`I[4<0EI'X\
MS*TQ9U^R/#LJL./,,.-.9+/LUR@6I]R<*PTN/2;>&XQ:"P"LJV5\3J09@P5X
M+.9IV$)%Y9A2(EHM]^AY/CLYFX1UM_)0I;DRY*<45[RX$-AM"2T-M1XZC]1Q
MB:!MS>Q94=\:EO(R?`(,R))M=&)F]^0D?,+:F7%\N*I049>2P@IJ*T'34/LV
MK"F1Q/S0][4N6L;YLM]M_>)J,S+L%^L(E(MIEV?(FT^HPNXEM:F_5=CMKW&M
M%I`Z:<BZPIBLKU!?=^^[_C3WL6C)LUQG'<LQ&Z8-<;/;KQ!R&?!EM%5UA*EQ
MW(+\"2IU]`V%)4\A/2E"3724NKLM`"_$NV>1!TY^H"C"1D]O]BN-3@V%<KX3
M+Q_)XD*[V&4T5!UU`?;=HI0]>*\RH>BXVL4#K2DFH[Z;_F=Q,08G$"O%`TRV
MA]R1N9_#;Z%65R1Q1E?MQR-QN\RW\HXOO"DBR9;#11['GU&C5ER=C:-\M;A2
MA$M%&G%*"0FIKKI^E]4LN'AKJ57'M5Z4DMV%S:[UTP51YL1F8S1QB0G>RY4^
M9/2IZ'IWU<9+EERUKF"@`5#DM9+5Y:\U74AEI!*D)`*NY!)!Z4Z=2-(T*TJ#
ML626D)-4I`-"/'L>^LT/`H4(O<JVAKD7"UMIVN)QM]:34D[S=I220"2#Y=2N
ME@\PJ,U(C)CP3U>WZ(4X;-=!`WW^[NJ%>I5\M";_`"^B2*?#3?7@?$,_B'K2
MV@FL3_X3ZBGQ]!K]`?P_RZ94/`IZAZ#7Z`_A_ET4/`H0]!K]`?P_RZ*'@4(>
M@U^@/X?Y=%"A:94A%O9]50VM`$FIVI2!]92E*H$C\>MI;^.SMLL@QQ*3CT^6
M[N<S:Y#3T*"_./N04AQ[&L#E/-ON(4Q,OS(0&D`*!<%N44JHX0DH57\TFFN<
MZYU09()+6'!S@*'R@KI73G2_+O(KJ458TFOF(]JA$[+E2'''WWWWWW7%NNR'
M7%+>6M9JI2W5$N*Z]@30>&J+(ZZN?B<NF1-MK;X6>A2E]N<+GW,(N9XCPSE=
MZQNSSX]MM^>*CS?L^VSXTMYQ7R]P>C!%S>2XP4)):<!`Z5`TVR&/W'&K@GK)
M!*T/:*`_V(SR?FGD[`+TCBGD[#\*N:,0AQ;0UCT_#[43]C0V9,:)*CW9R(N:
MS!<:EN!(2Z''%*JLDT(:WN?PYY?Q5'K3JVR<X<S%E#ZDS^;Y=9\FF1WL9PNU
M8F4L$I:M<N<XPXE"D]"W,E/H9V=0D("10ZS9>+`]YQJD;X6I.#0N?`IN27+(
M[!:K&M_YJY75`E)#I(9C)<;2XE()(`0D%5134OI^MSQ7QMGD^XZBK-WH,-^U
M\F44VA6$\%YG^]5DF-K<4](ML^Y6U]QPU6I^VSWHSBS^%*0/ATUV/2IW3Q`]
MBXMK,/A+XVK!1F/H3_M-I4DE236OTCI0?@U+4/!1:V?**^M5.WZU*]=O>GQK
M310\$(>DC]'^%7\NBAX%"'I(_1_A5_+HH>!0F2]Q(_\`$[EX_3%K<4/TEHOK
M80K\0TXM`<R:W9'*45;`FMLC`CH8[?Q'YHU;;,'*55+LBH[T=IA;AN11*37H
M*GK7KX'QT^H4TJ%\]!/Z!^'YW?X=]8H45";9B/(V?.1DIDQVOKR(ZPZP@+\G
MF<3Y14JH/B3J$4PNE+'J)4XWU4*>K4@?';0>/2NGMI\+_MQ3>Y^D4:8I\R.1
M^*`E(V#E7C&E5`&G[W6FO34'JGTI?X'?])4ETI_-,_[C?6%[QCW/X3_'KR0O
M9Z^:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+4[]4_P"95_%K
M,?P.[RMF?7;W+Q.?>C-J7][+SD4THU@_"#BZFE$C#&`2/B:G7>OTR_D//ZUY
MH_53_?'?P>P)%\;LK5RAA:@!15WF$=?#Y!7\FNH:W_*+FNA?SA[U-EL4;;!\
M$)'Y$C51;\([E;W?$>]8NJ*=A\$;G2?@MH;F_P#F].[;]_\`A6IW=X5S/L[B
MLVWVU\5IW#?.LTRZO!)"J/7"[3G7.U?$:\A]?_\`O,]_M7J;HS'I$=P]2DTV
M\WZ@-3X^'T'5>.U6,;`NOUVSV)/XM"ROOK(/Q_)K!V(7'/DI:96D*`<)2`":
M5JH5ZGP`U"H3'9ED[<9PP@Z*A#GK`&H"MWE\W0&J="$QMWS2#$HTY,;`W;/+
M5Q0)IT4EO<4`5\=`%2!Q0FRRS(K+<Y$>9<9++KMM84^P%.)##;#("ER):G%(
M3\LT/K"M37Z-._!+"J(]W7NJNJI4?$,81&FX[?A.M5X>BRI;+.00W5B*Y#LJ
MF"&V[86%O)=D?5*PI'<:GM(AY#2[^]]R4\)#<PGF4SUHD9A/*G%3>/LX]-QV
M+Q_"999A1I$>UHN=H@1&VTL-S%KM3D>\R&(S8W%M;J-P%"0>NNC6&LMMXLH(
MJ`J9J'2L$[RX4*D/:;0@,6RXX9R?B.76&XO1(J[FB<739%3'6VVW9UAO26<G
MMUN;=4$K<CK?0W7K4==6G2NM9K5P)W*C:K^GT=V"!O2IO\O(<-G7.WY"S:[W
M`M,I<>5>\7G?;MI>0GT-TZ/(;:;6+>/73YU`A-%5)H=7VQZ];>M#'GWZTQP5
M(NOT]?IH.4>[M1[$E1IK+3\1YI]EZ@;6TL.(-4U20H?F$=CXC5HMG>*:)QB!
MBJW.WPS^0<"<$9M(4COXJ;\?[[3Q)*0EL<2F'%!K4,H\/P'6K/JI*7Z:KD@O
M-_;7(YJ:#(\D4>G@F?.4?X!JY:1]9O\`"[_I<JQ/\7E'K"?#/6E+L324T)D0
M;4EH$TW&4BWH9K7ZH*AU^&J3??#<^7VJXV/^XVW>WV*749AP1F`0`0RUX_WB
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M[UDI6P$N+0I)>3NH`32@/YU!I=OPCN6%?W]T#[=>0/;[BG)6:Y9+MBL*Y>M^
M&W#$!!EL._)1[>N4],<NJ&Z"UJ4VX*)>(/EU$:M&9>4T<3[%,:+<MM[K*?WQ
M3S*0/MO][/(OM^]PMXXSSB0]DWM\FVO&F\;;AI4JY<:7!EIZVIN44,;F[GC5
MTG0W9$IE=1ZBR>Q&I/3NGI;A@<T5"AKK7&:/U*97$`']B]"S\+#N8\'EB:NV
MY5BN3VMSTU,K3)MUXAN@;'XTADG8V7:;'4^9M8!'4:BYW7FF78>]IP*FK>.S
MU2U<UK@2:\%4[RUQ;D'MGOS,AEZ5=N(KFM#%NG3W`_(Q%:EAI-LNTAL%(M[C
MSZ41WU^91%%FI&NHZ)U.;N`,DP+:#SKCG5G3`M`]\>(=6OD7R(\W)A-S(Z4J
MCKH1Z)#@3O5TILK45UT;3WBX9G&RBXY`WP\[F;ZE=&I-/E"'W*_[Y_'W_P!+
MLO\`^:<K3^P^J%7==_=[D]7M^_Q.E'P_>:ZN_P"<1;H;"C^'U#33;7/JQ_Q#
MUI3I[Z3D^FD5/(:$+Z`20!W.DY'9(R_@%LQF=P9Q*V%*F6UK)`("0@D]-RC0
M5->@&DG$16_BS@-JU:'37'A!MV*"_N)Y<N+K<O"[-/7&:4XEJ[RTH55IM`(<
MA-4H'D2/$IZ#7,.JNH([N)V4C93S8+J'3_3\MK;MS`_$3Y\5!QE!D/)CM4W.
M$I1O(;02`3U6NB4U`\?'7-H:21ND'VQ72K0<J'E[R$HFL4O:$MN2K3.0U*>8
MC070SZC<V9(<#3$**ILK+TR2XM*6VP*K.A.$N,-O&7<=7R<<6O%YQK(X[KD2
MZ,LNJ8>B2V*M/0WVNGH26"DH<035"P0>VA"T7>#?,IN<B\Y!,N%YN\M6YV7=
M)'S<E-.I"9`J*$?3H0BM>(NHH%,GKVZD]OQZ$)YN(\>CXR<AY"N5(MNQ&SS9
MH?)W._,",^IY*(X_6.*#:-PIW!'QUEMH9)6O";R78CC>P[DZGLRAS)&%O9%+
M9+;V07*\7=.X@$L7.<N>DJ3W0M2EBJ3U&N]=+VYBL&O/"GG7!NI;D2ZBY@XE
M3@4=P12IH*'H>^K,J\OH:60#0=>O?0A??17]'Y="$/17]'Y="$R'N/:6.(\D
M4:4#=J\?_CM&M[7ZOE4#>;3WJ*]G_JN#_P"YF_XCJTV^Q5>Z^+RHU#SJ!M0!
MM']]3O\`B.G*:+N^9;^)[?`]_AVT(2$5$3Z9::6J.TJFYF.`TPJA!&]I/E50
MBH^G4-X-OS'S!3GBG<`N?Y9$<BCJBI74((`"BGXD?"NG5O:M8QY#B=F[O2,]
MPYT1-`C+$R7>3.*TK2&R.5>,:A)K3_OULC/C\0Y7\.H+5;9O(D-3]-W_`$E2
M72EP?%L%!]5O_4%[N%=S^$_QZ\?>Z!5QH%[:6'F^`_+I%\S0?PP7#L6'9OW*
M$+[YOT1^76G/=\COMY5K^+P'I0\WZ(_+HY[OD=]O*C\7@/2OE55(H.U1U\>O
MT=NFE&&1[2X``=NU88YQE$3P!A5:U.E*05)`)["I_DT@Z\AC]R7";@E9!ED:
MQN(<:(+=*4U"1]8#J?CX]M.(98I`,YRN*S"UTDKF.P:U9[CW\O45ZD_Z76SV
MS!WX8:6]I*2_%)(:!0.(\R&X^.W\15_I=8:V>OOAH;V$K9K92:$8+[O33KW^
M'^0:WRN+L/ITVI7EN\B^@@_^CK5S@*@8OX(R4V[4*]/`GP%?\K2;Y6\MSXO>
MRM)':0-BP6@+`J6*>4=JGKV[?1].D8YY7&$/:`9&U/9LV>=).SCX0-J^%P@T
MIIW&.:P2,(RE+QQYF!SL'+ZE94:4UB0.C;FI7N6)(RUM68E9^;]$?ETASW?(
M[[>5(?B\!Z5@[^S6?%*%&GX!VTH)"R!SZ8XFB4CKXA@.TA>*+[T+R_>O\\+\
M5X#PBFGPKAL?K_!KT9^EUJV31FSDFI.SRE>:/U7.76W'^[[`DAQQ^KY)PUP=
M2W=':`]CZT-U!K_F::ZAKEJT68Q.*Y5HER1>;!M4W4Q$[4^=78>`^&JDVS;E
M'O'9P5ZK7%:9,!3C#P:<`5Z9315`HI64H44#\Y2=W;6W+$!HW'-4>A:N-*<*
MA6J^RZ^_;'MSP%<%QMZ3C:+EBEQB2%%OTIMMNTQIL*V^8*?"P?H\->0_U)A?
M;=6F9PP)]J]4=&<O^D!E-7T'J4HD7^.%%$U*X?7:IW8M2$&M*TIN*2KH/PZI
M1O'?*%8AL'<CEB8E*/5ZJ9=H6724T<":U*4@E0I4=]'C'?*%E;_M)H?#^'1X
MQWRCTH37YYF<>U*??=4A*66RM:2^AEM"4@DN//.C8TRW2JE'PTS0H+W7E&3D
MUVNC-ML>4/1@[7]XOL26S87&DA17\BY*<CR9"$TZ.`;'.Z>FG$$(E!)-*(2;
M3D:8[;SEM>2EY:'2^]+A(B/R5`*WAX*4ZLJ73;U[C3@6K6D.J<,4*/O+EQO%
M\M3L:+'M;SKD11;A2V/YN^H)-&ZH4A6]1[`FAZUU*V[VSNH6@+"JSSW'IN4W
MFTC.;+(P6[6=:HMOR"UQ69N*HAJ=6IIBXVF.HW"'&>?6H*5%!V$[U^.IRWMF
M!ARD[4PN2\/&1Q`HF]NK2L:NKF/79UB#=(VPQ78;PEVJXQ'&_F(5SLT_:4/P
M7H@"@I8J%$`C2S;?+(U^8D`@TXT28E>!2J$?(C:G4W&)/=3,8"Z2H<I<>;M<
M06U!#K("037I5)Z_3I^Z8']T!#9"W=530]O&?Y=D./7^PYA&NLVTVVTW.[6J
MZR2ER5)LL.*Z[/M,]QU*!(9VIJA9\RBH_#3G2V/=?-<'N`PP3;4N7+8.S,&:
MA1A[6<FFY9A8O3Z-D:?,N+T2.5J4F)$3*<^4:05=24,;1]&O3/3Q/@,AQJW:
MO,_4ENUE\9FDU::T4IZ]!T_/1_'J9Y(XE5[Q+N`3X0W2F/&&VOZEKQ^@?1K,
M5NUTNTI.:Y=R]@5;L&03>.2O*/Z^R?Q/^S+AJWZ7"&R@UV-=_P!)5:N;AP=L
M&T>L*269L)=M^+(]7TS(;Q="]U`VELKMY4M2NE"G^[J@WOPW7E]JN&G7)=J-
MM@-K?8IHB"F2E+D)[U8VU*424,K?8<#0#2RA3"E*Z.((-0*$'7#9B[G.H,*E
M>C\V<!QP]T>H(?9SG]]^0?Z;6UN7<S$840DMFT)U&'Y30$UQV[GK0?\`2WX=
M/D*HZQVEJXY+R29L1B0F/>L=80A32$DI1BEI4"IP'>5*^<(Z?HC4E%]-O<F$
MGU#WI2)Q>(E8^4-QA%84D)C7!T,)Z%=?07O2L50.A/72BT3EV>V75%DMLI^]
M;BZ2R&1:H2$(:2K:DJ4%J4ZYWJHT)T(17EV)Q+[C>3VF[2'[K`N%COD5ZV36
M84BVO+?B+<9]:&J&KU6F9#04&ZD'XZ;77TO(G-J;4OJ7G-Y/*O$M=KI=/E[=
M&N-U=+\!B7:%+;]2+MD0[I.:>BJ892PB0Y1*5;U$J2!0"FJO-(^,UC;4DJP!
MT!C!C<25S1PN3;'(`9E_:)=6N/+]<PO5+M/38<0X"V%JH=A"ZKKVU'R0F<YI
M?=[EC,T[T\&"04V^WRWY*,BGR(ZVH\MMNY3&5VV71*VPPV4.O.JJ*':#TJ1I
MUIL#;TEKCER\.SO65ZA?9_P?[4>3^&,%:?LSF9YE&QF+)RVP7+/>1IK2'H1"
M2Y<;-*O3-KBA[U#0,-)%44/2FL7=@P2M]X^[V#&JTSF"XCN&XEI.'&J)[7A.
M/V'W%W[#6+3#;QL0)]EC6=IGTHT6RP\DN3L"(S53B]K;,S;N)*B$@GN==*Z-
MBCG`B<``N:=?3R278O![KN`V;%.WA#E[(_:A?VH5Y,Z\<#Y'.<E/V]*Y$R9Q
M_*>;6V;Q;X[6]URSMN*27X8HE#6Y3?G`TRZNT*"9I>T4(X!)=(]37,+N6ZA!
MWDE7"W5.!<PX$J#LL^78GE]E2L>FMN9"N5NN+)]&2RX*I4-OF:<%"AP?I(.N
M6ME?IDGO"@!P[:+IMU&W68,@.T8G;2O!4_<@X!E7MDSB/B%V,J?@&4.-JX^R
M!ZI;<8`69.,W)P;FHU_MZ1^KW$(>9`/UCKM'1NOVEW#RY2&NI1<)ZHZ5N=*N
M.=!F>TFN(IZD?-N(?:8?8/J-/(*BKX'P`_#JZEP_=Q58!=M>*!0G]RR:<E\?
MK\1C\P4__"4HZE](B,KZOP(*@-<+3ER[*)YO;X=V%2E=JWR\_P`*8.D]?MFM
MF9B<'#UK?IWZ13[:CE/K<AH+34DCK30FTLQC=E`W+8ED`@U)H:T^.L&%MP#`
M\EK7X$C:%JR^?"\2M:"YIK3BB/)Y?REN0-WI_,26F/64:(9W5HLGP.Z@'Q.F
M'4CS8Z*Z"#W_`'=IP*D^G&"_UELTWNX[!B%4%G-X<?S')[-<F)L>Y1KU.1(5
M(;*4=7:M^FHBJFO3H4GQ!UYKG$EPUS)'$'.[UKTQ&(FQ-:P"@:,?(B2#%;4M
M#LF.EQA%2ZV4!T*0*@J*"178?-W%*:VMQX>$PC$'>L9,:A/7A5[G8`FW9%84
MM.9?/GJ8L+<]KYVSV2WEIQF3>UP7RXR;DVW)!C*50-.)J.NLK='UKA2KBTJ)
M->^;0),M]V6]&:%RF2I,IY^5-F3JEZ0]*DN*<*CU.[0A.?9\:C)2$ED+\`I2
M4`GH.M-"$L8^`QIRVB&]C94E+C@0A081]=UYPT`2TVT":_'0A,;[B)Z<<XZL
M6!V6J;WR1DC4-+;'ED"SP5I7=)3C:>A:D6L(937H5$ZG.GXGZE>>%>,K&&@(
MQ)WUH56^HI6Z;:FZ8[/(\5(.`&Z@(4U^'<-:Q+"+-;$H+?HP8RDDH2@D/(J4
MT'0!-!KT'863+6T;;M)(H,3M7GR^OI+J\=<N:`<13<G;:VM@C;NJ:U)[=*>&
MG7)'%-_$NX!`D$GI3KVKVT<D<2CQ+N`0K]&CDCB4>)=P"%?H_A_RM')'$H\2
M[@$S'N38_P#$]EFTDEI5D:2.GF]:[M+)/TITM:6S<^:IVIKJ$09%S`<2*J(U
MN2MBUP"I/0L(`J?@D'P_#JU6MLUS:U*H=Y=.$E*!&"%;DA5*5KX_3^#3KPK>
M)33Q3N`66CPK>)1XIW`).B,LF@>Z_P";'AU^)U#Y7<"IS,WB%\(2M20MKS-`
M@+4FA4%4[$@5IMTO$#D<,:X+29[>2[$(RQ!H?VG\7**.AY6XRHHIZ$#*[.L4
M/;ZZ0?PC4#J[7LM92\$#E/VBG[I4ETJ]OC(Z$?4;_P!07M6YEYJXO]OV!7;E
M'F+,;;@>`621`C7?*+NW,<MMN>NLUJ!;Q+5!C2G6&I,QY#?J*2$)4H;B*Z\>
MZ?I\^M3-M;.,RSNV-&TTVKW&YS&"LC@UO$X*/$C[P3V@0W<J;E\X6'U\-;P=
M[*6T67+W#8T\CEDX$)45NP+=9.6(E-+AU%9*7$%%01J==T-U';Q,GAMS%;S%
M^4O<RA,>#_>S`8'`XX':HR^UNRL'ACIHZEM?B'&@^]:,?^\/]FN42<<AXYSO
MBU[DYC)R>%B[4.W92ZYD5PPQ"G,KM]G938BN3+QU!!EM-A2VJ@*`)%51T/UB
M8'7+8*P1@%SAE+0';"2)*`'B33:F(ZJLW.#621DG9[PQ/`=J)('WFOL6GVO(
MKY%]QF%O6G%$V63E%P7`R=B-C4/)W?EL=E79QVQ(1$@WJ0-D1YPI;D%7D4K6
MS.@^M)2&Q6^<N!RY<KLU,32DAK08K#^J[!CLDDL;7\"X`CR5Q3J*]VO!\S%.
M:<SL6=(NMG]OME<O?*3<:T7F&_CK3./KRMJ$LWFUP$R+A<;#L=#:5*+3;K2U
M42M),/+TIKWYI8VMR1&;B4-`JW83EJ0'$TK7'#8=Z<RZI'):/O0X`--*U&P4
M.%>-5"GB;WB>\/G'VXX5[LN/^(.(YO'7).06A6*<92;UG<SDNW<:W;,V\39S
MZ\W>T1G[-<+A$MRG+E,M,6&`U';W)D%0.KQJ_2'3^E]42]/7-P1)%":S$,#>
M;D#S'C@&C<<V/PU6-*U$WC#<@M>1B&@U)IA4;:X[O0C'V;_>B<;<^0';'S1<
M<8XJY;>YKY.X=QW![5(R:[6G(KAQQ,>;0Y`O\BR)@?;5_MT%V5'M:I!E*9Z)
M;43I/K;]+[O17P&S#IK8PMD+AEJW,78.`.``H2YP`Q&*CM,ZICFN)'/PC<\M
M:<:$@;&G82,<!4I2<$_>0<77/CZ!D'/W+_"UNON8<S<G<=<=N\6M<B7&Q7R)
MBES<;M&,S!?,5:FQ^4XEL($^UMA17(20P%`*`0ZDZ`U#3;UL5FV40>$AE<7%
M@'XK:AS274R.-<KMAIA5*6W4L;FR9Z![9GM(WBAV$;G#>#BGW:]_7M.=Q'$\
MUB\RV6YV+.<BR7"\/:M-HR:Z9-?<NPB*Y*S2Q1\4MMFE9,BZ8W$H]-9<AH5%
M;HMP)20=0+NC>H8IGQ2129XHA(X'`!CC1KJUQ#C@#QH-X3H]0QY<PQX`"IPV
MX*)G)7WA7($WW.>U;ASVZC@_D/CWW:8+FN8\?<HW2?F<B%;VL#9DN75FY,6-
M:6)_SSL5;(V)9<B/-*2I*E52FS:5T1">C;[5[\W$.I:?)&V2%S0UU),N5Q:X
M!XVFM:`^1(#J</;$(@US)_ID$^]3:!\U-^6OI4>>7?OBN3>.^/>5W6N*..+;
MS'[=/<[AOMNYOPS*,HOW[G.HY&<]#$.2./LKMT-,M>/K2P\[*8N$</-;"*T&
MXW#H[]&K?JG5[>`7+FVEUI[KB.0!H)R.8',<'?QX4H<#6A&,'>=<>$DD+L@;
M$X,?4X-<1@"=@.!P)JG0R[[QSFYCW*7OV^<:-^VCD2/8_:QD_N5E<@X_E>29
M)8`<(7-A7W!)*<>N<@0KQ/G,(>8<4O\`4QU54@@TU7-(_3*!_3$&L2/EC=-J
MS+0-<W+4O=$,XS8[''BVN&U(3]77;GOM(@UUTR/F%HJ2&@5Q`Q%:$8@8X)N>
M#OO=>6.18/LKR*Z\<\.9:Q[N,OG8A>N,N'LTR#(.5^$V(,ZX1'\[S&U2!.B*
MQ&*8H,DOHA*9WIH5_FR^O_I=!H]UJT`DG$&EPM>9I&-;$]Q;FY8?@"[NX':I
M/2.J7WF6H!D<:9!7,-F)&VF.'<5;1S3[M_;S[>+C;;1S!RE9L/N]TLUWR2+:
MG8MWNTYK%["$F]Y==HECMUQE67%+.5@2;C)#4*.2`MT'IKD%ATOK-U:>)M&O
M-DUV7/@&9CCE#B:$T(P5H??L;)RW.:V4XAI(#J=V!IY$EKM[ZO:;;+[#L,GG
M#$E29+>'N_/Q';G-Q>&]GT-<_!X%\RZ!;Y.-V.YY7#'J0(<J2U)E)(*4&HK(
MVW1?5,Q:88)72.:XM:6^\]K"`YS&U!<&U%2,*8[PD)=8MX&&0R,(:0#[PP)V
M5X'#O2'3]Y;[('[LFQI]P6--7<93?<&,5VQ9C'/[ZV!E4FYX7M?Q]M*\O$5M
M3D:W`F;)0DJ9:6-/3T'UHUH)MSB`1@VI!WTS[!O.P)G_`%/:[.8RO>/MW*3O
M#_-/%W/N!PN2N(LSMN;87<Y]SMD>\6_YYAC[1LTIRV76U28MQCQIL"X6Z:TI
MIYEQMM:7DE*D@UU6-5T^]TI[[+4HW17(W.!;FX.;7XFG<14'<2IFTNH;LLGA
M<UP(K@0:=]-B\?WWG""Y]ZWS]N25;<)X1":@FB?W-9Z#Z->B_P!*<=!:W?F]
MI7F[]66O_."^AR4I7=6@PJDWQVTC^T;$`4"OVJGH1UH8K_QUU'7&N-F,#L"Y
M'HW\YY5-K:?T3^0ZJC6NRC`[%T',WB%FVREQ8WI\R4J*%D4*%=#5)/0'<D?D
MTFYCC=0-H:%Y]2UE(\/(YN+FMKZ5*;V*9W]E9#R)Q)=6W4F5+B9[C7IA6Z6T
MI"XN0L(12KDAB8IJ2VE(*O,M?8'7GC]<M%G@U-MU!%(YA&T-<1NW@+NGZ6:S
M#<Z*;666,/&&4N%?-6OH5DINB5+W*6VXZDD="A1*C44'>M2=<$#'D5H?,NLG
MW1[V"1V0N9;'B/W#$,?D7FX-N`*A?:,:SL2*=5>I+N$>3#WM)J=FPJ->E-:5
M\Z*@[$G\>Y/3,7<8N1PEV:Y6:-\S?HR%%QRV-!.X/1(J*/76.44W.LI*-Y(%
M#TT5"$5<2\N>WCG?++U8;3>Y\K.L;?*5XCE]@GX^_=8[(4X+G;K==5NLSF&D
M(+FQ*E2$!-7$`5UOD?P/F15+?W#VS%IN`3_G`Q;9UCA&YVQ^$AIAY]+3@0+<
MT&]@6P^H`[`#4#IIY:G(UP?@:[\$*L.X3+ED44.1V[/;H<9V/%NN0/JCMQ;1
M<9"=T:UF&\XW)FW)]L`M);"FW%]*TKIY\0]W'N6%%7G#DV#B-HN2Q<7KM<K.
MN+%),2/;G@Y,+R([CEOC+66_64RH()[D$"NG-C'(UWO-(\B!L56N6W;/\NRD
MWZT7B=;'U.M/Q&HDMQ+#D-205(6"I394MPJ!%.HU9;?X3WIC<_&.Y/!;V+SE
MF)*@Y=:;#,O5F0\Z)K08BR7L?E_J7'&E+4A7S]IG>BXII/F=0IPI33LX39--
MC'%]VCW9<^\ORG;<Y.4BT6EKU/F[Q(;!>$)MJGJ>B([:G"0"`$Z$*;UBOD^W
M\=<KWB:AN"U9>,KO%@1V*-(B5MUR<:&\42N8U4)60:]4@ZDM(<WQK6U&>HPW
MI"_J-/<XX-QQW)0>T.W?9?%>.QP*%=J2I2*4/J%MLK)2>N\JK7Z=>E>G\+1N
M;`T7G#J9S77#\I![E*UEM:I,=.Q127/,-I(-*4KTU8%3D\T10#+(*@"$)%"0
M*`4H*:4A^HDYOIJLZ&ZM%YY*W+*?]O<H^L=O_3EPIWIJU:>YK75<0!E=_P!)
M5:O"`:G`9AZPI,Y^I2L9M2P2?1M..N[QV;2DP-[A4/JI2.Y[#7/;XAK;G-A6
MM.W;L5RTMKO'V[J'+48^9+");[E;5_/V*??[))D!,A3]ON+T=AS>-Z7$L.J+
M2FW$G=2FU=:]CKD@C@J1(YK9*FH)`.WAM7I-CFB-M2/A'J3A67DO.[>@"YIM
MN4QAU<0Y";LUU6?S5MR[<EV*E"#U4@M><=*COH?'"UN:,M)["LA["<H()[PC
MZ_<J66^XOD%IDV*]V>ZR;6XQ'2$"4S(0]^K?V/1UOU!KMHH-J(\*==(K95ZX
M;"W9AR=!?96TX<HBEI$A"FG9,:-BEB;2XVAP)4ZTTZVI-0"`I)!ZBFI")S1&
MVI%:<4PD^H>]+A=KV%!`(4%CX5I0@^'P--;YV<1YUHB7+LIN&*1L<ML*!;)@
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MMNVAQEXWB*].+"KS(=6A+0;;"E+"RD`E6G5S)')*1&YKNX@^I(S$>[7BG$M5
MYB9O[H;[=K62VU8D38MT2TDC;/NUZ=N%NM+KB:I>N5LQYY@R6QYV994VL!:2
M!T3H>.1KZN:X-[BN7]=21@8N;YPIV7.SQ+G%DQ9#`VRTAIU:FRHJ05"H4""`
M"._T:NM]8,N&THN:65\^W=6NQ?>`N5KK[8<WB8O?9,B7PIE<Y;(5(6M<?CZ]
MR%A,27:V5^5JVW:0[LD-).QM6URB0DG7+.KNDS)")86NHUKJT&&Y=2Z1ZN;%
M,8IWMJYS:`D`^DJTKFCBK%>>N,KUA=[CN.IO%L%RM5TARV6)=IR2"VU*QZXM
MRU*_9(6ZD!U!"7&B>I&N7Z2ZXTZ]#<U`'BO=4+J.JQP:C9.>&9JL-*"N-"J7
M.+K_`'?TKUA65^HSE^%WBZ8MDD5P*;2U>+/-4V7H[:PE8CS82D.)52BRKIKT
MEHES'>R#*X.;V$'U+S7K=L^SC]]I:[M!'K3!>Y9"O[2<!\JNE@EU&T]/]L)7
M?70+2-L4K0W@N?7<QDC)?ACO3O\`M]*DX-+*0"I-[O.T*[%?I0EI2?\`-)%?
MP==1_4/UF]X4GT\]O).(V>Q.^U/FJE['V4(:4D[2V*@*)3MK3Z*ZALKN!4]G
M9Q'G2F2E+*4I+B25#?U4FHKX=_HT97;:&G<F5P09,#N7#=;M;+)$7-N\YFWQ
M4(4LNO.-H6M(%:1VUJ2J0X?!*:DZ1FE$4;GU`<!5;6T+Y)V-RDM+N"8W..6N
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M5A4:2ZA]14XLI"4))"NAZD:US-XA`!=\.*=A/L?S=EW;%;N!(]-M*HUN:=0:
MGTVT)<40M55IVCI6HH.VL[J[D'`T.!7?EWM8R#BN-#>S>[/V3YQAR2W$^PYK
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M[.1M'PA1-?04P;8A*2`(C:BD`]RA/4CZ::M%H'!N((7-;MP,IH:A:VS1`!Z$
M5J#T(J3X'3M-5M_TGJ?_`'/]/_,?3VT+&9O$(G0TI*@HE-!7M7Q!'PU$*80?
M!.V@)Z*[`GX:4A^LU(7'TBC7%`1R)Q4"*'^U3C/H?_ILM6H[JK^0D_[3O^DJ
M3Z2_G(_^ZS_J"]I_,G%>*<W\6<@\19O!:N.)\C8E?<0OL5YL.`P;Y;WX2GVA
M4%$J$ZZE]E8(4AUM*@0177B71-4ETB\BO+5V6>%X<T]QV>45![U[JO8?$1F,
M["**I3VU_=+95PCROPQRMF/N#N7(UQQKC.!AG.T&9;I+$7FR^\879I[VX7V2
MP\^ZU:V^)+-'98(\RYKD="E=S3J.L?JR^]Z=ET2X@C:72YXW`#W`\.YU-GO2
M.<34;R2:E5-_2D-S+SK@5</339Y!A7L%$F\V^YQO5TSS.\RX\]PU]XWCI]Q=
ML]PG`=ILT61Z7"EYS%+,7W$1(3A>4JY_VHP''TQ4*(CP#Z?D44UT]LOU@M(.
MF_R,6L3G2VCH)I"`72`-/(X8,>22"/WL%B'HVTCF;(,,L@<`-V(KZ$YWN4^Z
M0P3G?DUG(['E(P#C?(?;@_P-RIQ_:F);0Y"=PS;<^!LCN<Z(\P@2.-,F2W+<
M4$AV8B.EM1VJ4-1/3OZF:GH6G^&8.9,V;.QS\<@=[L@;C4$M+@,:#-O`6-2Z
M$L[[41=F@%,:"E:;*^6E>*=/"O9-S%C/#_#G"=YYJQ[,,/G6;-K9[U)&18>N
M?D7N+<S'"OW62_9+T9;<C$9%F*&$QW3ZM(T1M.WJ1J(N^KX;K4W:O,S_`%T)
M:Z'Y8VM<7>\T$`U<2XX8U([5.7VC1_EPL(S^&1[W;L'LPX+@]N/LX]QOMMX5
MQ3VR8KSGA[O"O&=UD'"LQ8QZ^VSFV?@K5\G9';^/+_<4SI6+1"N3)3"EWJ,R
MJ0[!W;8Z7#NTCKO5ND=1WLFN3PN\3,P-(S#EAX:&YA@"30;,!ZTWZ=T233&^
M':0#7`T-<?0HGX-]U=[C\(Q_A2U1>4."0_Q#[YLT]ZK;J;/R!\M?+GES4\C"
M'FE/E3$6"[='$_.)45K0A-$)J0+SJWZIZ)JMQ=S203M;=:8RS(!9@UKR[.#Q
M-=AJ!VJK:?T3K%O;6UOSF_Z:\=-^]O!PI3M_;L7WCS[J[W'83%X1M+G*7!\^
MT</>^/.O>D4M6C/8<F]W;-'+RM6&%)=>99MUK7>5*:?(*UEM-4BG5+7/U,T7
M6HG%T$[7NTFUL@:L(#;=KAG..UU13;0#M6+;H_66S7$IE80^_FF_>QSN!H<,
M1AZ\5PXA]TW[E,;-LMZN?N,6<3C>XOG_`)YO&-6NR9[;UY#)YP9B_)0I63VR
M[6C*K<O`WV%)0Q#E,0KNP=DE`35.I2Z_5_1I)9;DVLO,DL(K8U+*987L>TT-
M11Q9CA4$X;$[@Z/U:.8/YPH*G][:X$'=NJM?#7W5'N?X8S#V5Y';^6N`,CC>
MRS%N5L3QB-*Q?D&QJS:W\I7B\W>2]>FHUPN35B=MCMR0E"8JGT+2A5:;M-M:
M_5#1=7AUN1UK.R;6!&7'\-P:8QA0X&E!O!.WL";VO1>KVT6DL$S2+"1Q_>V$
M,[!\O8MG*GW._*&>\?<L"+R[QQ*YK]QON;P3W(<Y9I?<9R1&)$\6S5RL&X\P
M7'H$YR4S8V6WEIER9RW''ZGR4(2%.D?UEL]!O[2X9;$VUE9/MXV,+2?Q',<]
M[B[M8``#O).)PVEZ#;-I5[:7;PZYN;SG.=0T/QT'F=1/%R!]WM[A,C]T.1>Y
M+%LG]N>)(O/M8R;VS)P:)CF:QK2W&S1*I%^S"0Y:_DHTJ[-S"$,H<94E3``4
M1U&HC2_U0TN'IZUT25EQ+';:JV[SES7',V2-P9[QV4;0;/2IB?I3/K-UJ5H6
M,GGMF1#`C`%V;9Q!/EVIJN(?NGN?.$;=[)[MQSSCQ'B/)'M,;Y!P_(LKMF"Y
M$[&YFXUS]M#CT7*X[=QM\J3?+-/)=CLR5R(04AL@)H09?6?U@T[J"76M.OK6
M9]KJ9C?RW.:1&Z-A:W*-@&.8D'XL:8X1>D=#:KI^HB[YS1E)Q%:D$UQ]2>)G
M[O[W*2^8K1[C\\YLX7Y?Y7N/$?(?MWY,M&9<3RK9QKDO#F297(R'#F[?CT*?
M=%HR?&F'DLSD2@Y`NB!L<0`-VJG)U_I-OHLO3MO`^&S%RR9A:\!S7@#,';00
M<1@<0=@P5FO-+DDU0ZD\ATD8RFHVU'KQ_M38Y3]T!F$ZR\X\4V#F;#V.%?<E
MR_P[S=R2W<<%+.=67)N+VK<_=;)@(L[T/%K/C&37.SQ/DF%QR+'&;6A@+*AM
MG+']98;>\L+^2"MS8VLL#:/HTMDR"IJ":AK&UXFJBI^G2896`C+<2-D.&-6U
M_P#,5C8_NP_<M9K]CM_/)G`L]ZQ^_'(/?`[%>Q[/$)G3KK8'[';N/5RER)4A
M4*UID*7\\LJ=<4?J)'32EY^IND7S7QB.Y#'V)M*@L!;&227@##/LQV"FQ,6]
M-2-(=[E0\.Q!Q/#8IX_=_P#M>Y']IO$^3\:\@91@N7N7;EWD?DRVW+#;9>;6
M(S7)642\KN5JGIO"W%RW+;<)RT-.BBG$)!50]!0>N]=@ZKU.TO862,;!;,BH
M\@X1B@(H3M^P5ET"P-C$^,Y<#N]*\T?WF/7[U?GTU'^)/"7_`.1S0UV?](G9
M]+=38U]/6N$?JC<B2[?#PDKZ"D[Q\VI?)&'$$=+H@=:_[&D?0?CKL&M?R?D7
M(=%_F_\`B4V:4Z?#I^353;\([E;G?$>]?1_)K=C,TC7?*:I>&0,9(T_O-HD-
MEDG)L6F6GD+$+E(MN2XO(;?M<B(M;:E)4KTYL66E'](C2(Y/0^/3MJM];V+M
M8MA"W8`I+I2];HUX9W$8E3"]M'N^Y`Y=L^3W+(\.3<6,?OD3'(V0VI0MDZ[W
MUZ.B68<..OTV6'K:@I+J]QV+\%#7DKJ+07:(_*\$5/K7J[1]2;K4(>W&@]B;
MC'+9SQQ5[B'>8%95+Q'AK)+@?[1\6Y!R-VZQ<FM%QD.)<AV>U,2KG(.4(EL)
M6T_%2T@CHO8"-5%^GY6B3<[[>U2$;ZO='\O[?N5BMTFV,7>%D5@:C-LW^"[#
MO669`_&9FP\?G;I#+5J$EQN/&<2ET`MG?M(H55TGX/>EE6).XJR'"^;[%R=A
M&075V!@N71\BO&90DOKLD'&T*6+_`"[S-<2VB0V+0IT;&/62M2@"0#73U94B
M>:>6YF;SW'6)$F-:U(:5:8C2=S4V&_\`KC<5D+_5-R]X6E)^HDTTA)`9GM/!
M"KVY[S:VY):).`?)V::(7I_O)/A/Q/F\7CI=;7:\@$1]Z.BYWRV*)4%1WE.L
MCS%'2AF[2S(;6E/V+"C3GKN+702;7BDQR?9YUV:G7"ZSI!F3KL8#Y39RIUPJ
M=9])AUQ9;'E]19%?'3]81G9.+6&K/9IR8NSYJV1)+0((4IMT+6A78CQZ_3IW
M;_">],KGXQW)0N6-N);5"+;6/M-IPD.24%+"VT=$^HL(4NJO'RZ739$1QWY&
M8RIWYN\Y9-%+;%0/0D)#HH(UO822RQ';K5R4I:-C0.[H="$CN6LYM&,8M<>$
M;4S^]')O*$")$N-NMKY<B8S:9#P1,^<?);=9#C#*PTHM[G%"I`24J-KZ3T-U
M]J#;P#"M/-_:JIU9KC;'3W69.-"[S_V*:W#&+C%\)L=O=1Z;L6&&2FNX@E"=
MJ2I0!*D@45].O1EM:&W8P<`%YSN;L7#WD4Q)3SPOZ2U_FA_'J04>G`1^9_F4
M?Q)TI#]1)S?25::BE=ZY'2E::JOV6TZ_[&N,UMRO?NI0I\1JQV\?,86<55=2
M&9A;_>;_`-04O;W;_G<7C1CM67L:MK>T&M4_(LJ4#T[;DC53UVS.)I@KI!?"
MT-L":?#[$?\`%5YCY'C=MM-SO-FDY5`COQIMC9ND-5X;1'DR&H03;G76YCE+
M>EH]$:X]JVCN%W)/3:1Z@O0&F:E9W5K&7D9RW%.$JR--H0L#:ZK_`%%:5)>;
M3^D\T1N:"O"M*Z@X_=GY?>I[PMLV+GQ$9_O6A5O],@%*NO4;0?P?#OIZDDUN
M9\:0[Q,:O]L6NW92P"F-,15N/):!JF)+2.A]<^53E"0#76%'R?4/>F]C3'DR
M%V*_L-6N]MKJVPZ%#YQ*?*3#<VE#J%%0I7:=:G=WK5-1R[#+4_CF2J#\VE%^
MRBT.QB&E*!NF+/I&YE*BX4+4P!N`(_#J;LEMO4?\WXEM7)5S^?N_&E^N,S';
M3?UVM5LGWRVPI4F=)M9=A*^RY,`K=<7+75"EMUH?,-,^I])Z<Z@8R"ZC!>T`
M.)&\``[U-Z)U+U)T8YT^CR$<PUP--N/M1YAO$UCP'(F[S:L4QG$)!FS+0S>I
MET<C7-5@7:8CD1<*5>[Q,?DA$Z(6WD'8I-:C<-&FZ!TWTQ9B71FM;<R>X^GR
MC'CQ`3/J+JOJ#J?))K;W.`?F%37&E/4F=]V_&N3>X'VV^X_B_C1BUW_),@S/
MBJ9:(C=W@1;>N4W<K0U,WW.0\B$#ZC%:)6HBO4#4-J$!NR2-B:66(`546(_<
MP^\Q,M;UTNW#>)C:AM4.ZYX_<6W%(&U8D-6&QW1"@*$TWCS`:B?R1QW*2\:T
M8<%-OB7[J;F3!;M:,ANW/O%=GG6=YF6'K#BV3WJ=;'$)<;+EFEW2[6F!&F*:
M=6E,CY9Q;/UD)"J'6\6GFUD#N)]20FN1*]@&XE3'XDMN'>W_`)1R#C.S76ZY
MJ_%QNS9E?<DN;#TD09.1W&X0HCTBZK"@F4_/A.%7S#BG0VXVIQQ143KJ&A:J
MVUCRD[E0>LM*\5'F`5C<&<Q<(S<J.HJ;=[5IN!`J:[2H?PZZ+VKC_8B3++#$
MR.SS;=.80\PN,LME0J67MR?UR.AHM+8-/ITVO6&:T?`/WD0NY=_%,=C?O"L/
M]F^4W/)^#[1:[^_]H7'$KM?<3FW1Y59,]BVK;?LX43U<2U!>2V:TV[:"NO-?
M4NGOTVZ<\B@*]3](WXU*R;'78U5J>\*SQN-O>JT]9B(D+ECCV!E\F(DT2+M9
MKF;!)ER$]`A^<UM4JFZI2-7_`/3J]!A'<N;?J+9'G8[<5#SW,S9#?)W'ZW%`
MM)QV1ZNPU45FX2E52"!N%#XD:[CI<PFDS;JT]"X+K4)A8&_W:^E/1[>YC$K!
M[BIG=1J_3Y"@H`*#;MOAQTB@)&\.*ZCM32.OX7#/XAZUCI_X'=Q]2=UR<Q&6
MDN;Z;J>5(/7K\2/AIDIU;;QF5GLUM=ES'XL9#2`M"IJDMJD*%?U$<`J]1T?`
MT'7OIM<W(A;EWT3FVMC*[-N4$\WSNZ97<WYLB4^J.B0\W&MZZ?*L10ZH,O-T
M4JC_`*=*BE*UZZJE]=AP<W:2**UV5J6EKOW0:IKW)JG7UI*O)L(<23U4D]`$
M#M6OX-0BF4RN187,:G)R/%<CN^'Y$P\7(=[L$R9;+G&(-4J6]$?:^90/S4FE
M-1=_;&0EXV$>I/[34[BTI%'\`-4T4O*^<,7NYNMXFMY?)7$9MLBY/+E_;#MN
M9#GI)=E/^LR\N,5T0`A/E6KKJIW&GF5^2FU6:+7+@P?B5R;TI(W,1B6IN7<\
M?N=M0TF3NFV]$Z!,0X4AYY0N-M#LEMYH,>HUL],E:/$THV_)'<%*V.M-XKUQ
M\;Q)7"W%>`W_`(^QC/6.$G^.\;O4ODC^T'*EYS<3>\;AW2X36G[ZNZLVN1'N
M,A[T6Y#207#3H.NH*Y=X>[=8NVMIZ17VJR-;XB$7@V.]F'L59GN+S/W*\7>Y
MGDWB3ESDBY<[\:N\;\9<K<)Y_DS]DQ/)H^-YT]D`N/'O),J.I%DNUQQR9:TO
M,2(\=(=CJ0=V\[`X;'<Q0&ZLVGG`T`'?0J/??Q6\H$Q]W[Q@H$\H>XV=)9=P
MW$1:;[FUX4Y;+;C6$R)%RMUL>E_S=VXY#=E+:81%A,++B4-!"EN@'L*ZD>F]
M#OM6OJW+34E,>H-9T_P/Q#8I2>UCC6-QEB<%B>J0;U(<,VX39(;!EOR-RGU%
M;:BDN%Y1``J*4ZUKKTAI]G^76,5B,!$W+Z_O7GK5)&3322Q?`YU0I>*ND8=P
MZ/#ZJ>_^CT\5:A^N?*OJ;@VL50S(4*TJ&T_Z?0GJVB8T:#:YN-!MVC=4_FTW
M=ZZ$+:'A^<VX@?%:0`?H%"="%\+P\&W5CXI2"/P=5#0A,Y[B'DGBG(Q10*'+
M,RH$#Z[EZ;4GQ[`=_IU-V7QCR*/U/"'[<%%24H(8MY->L)@=/H0-6/<N?'XB
MD[<''5?T4@.=.JR4CMXD!5:?@T+"*OWT=_V"O^K/L[ZO^K?I_6_9_3_!K9,:
M>M'^FOA8^)]'W*7\3)P'I^];F0#NJ`>W<5^.E(+6/G-Q/V\B2FN'F(X#[>5&
MV,L(/(W%:NHKRKQGT%`!3*K5V%-1W5EK&+*0`FAA?_TE2725P_QT8H*<UG_4
M%[BB*$BOB?X]>"(K=L3LP)/>OH(#0U7RGTD_AI_)I=P:XU<`2%J\9^SN0II/
ME15S915:AE#6I7VFM9(1(:DD=R5#C2BQ*:]:D=NU/#\1T1P,C>7XDN;E-=E,
M?O0'D<"OA0%5J20>E.E/Q=/'670QEC8P`UC7APIQ'%;<PX&@J%\],=>I(\`:
M4%/ATUKX>&@%-]4D`YLCI`XU<-FX=R"6PD$;E*J2:JI7K^(:49&R/!H%*D^=
M)LC=&W*'O..^GW+,BOB?X/Y-:/@B>W*X856]'?,[T?<A3Z3]';I_!I6,".,1
MM'N@((<:^\['T=R^;>W4BGPIU^GMK6*-D.;(/B-2LT.8.))(%$-HZ?#X?'\/
MX-'+C%:-`J0?*,4,&2E"20L?21]/>M?'^+2E1S.909Z42IE>138OGHI_24?R
M=?P]-(0V\4$;8P`[+O.W[8I`LS1OC)-'FI._=]R^I;"36I/X:=/P=-;F.(BA
M8U;4^#^XV@]&WS+(I)_.4/P4']S2C,K!1H%$H'TW!`)`'<FA"JFE21\>FM'R
M.:UTHV[*;DDT!DA:-CZD^7@O%K]Y8TD_>L\^IZT_<?A(UZ5K^YS1^&O2WZ01
MB/130DYY,Q[\=G8O+?ZM-\)JSS&2<QKCW=E$2<>H".2,/`K_`%FV>OTQI`^`
MUU[6OY3R+DNB7#_%G`;?MO4UEM)"5*J:]_"G\6JFWX1W*\UKB=I6#20HFM>@
M\*?W0=*QR&.M`#4(6\LM+9=CNMI>:=`"DN#=2GZ/8#2=`79BM96\QM*D=R'&
M?+7$7$UDR'C3FLO8MC-XR9W,<?SB`W/E6J!<9;+,5V/?7[$R)K#KY92/5;;"
M:G:0`2=<>ZZZ1EUC\:1KFD8C+0>NJ[/T3UG'I8$#2QS3@<U:[.PA*/D/W,>S
M7&<#@6NZ>ZZQS85C=D3K;;./X%TS#+GWWG`\S%B0C:9%XB27%';5U80>E2*'
M7)7=*Z@:6Y8<D>PTQ->/F73V]1Z6UQN&O',DVBN`IP\ZB-8/O(.-K9E,=JT<
M7Y](QX+5ZU\YJFN1[W=6U*W"9:+:B5.L5L2XDU0VZAU93M*MBB0-#TA>TJ&&
MM"M_ZHL#L<VJG3+]\GMYS+C6>)^52L:@3+3-MKELO%B<<?+=PC.1BA`M?SK"
M&ZN5(W[33S`C51ET;5;<5GCH.[]JF;>[=,:.R_;RJI7DSWYQ"JRXG@4*;,BW
M&R0_M;+'7&F')#2I,R&!:(2E%:HJXD5.^NTI4*#1:PUS9@:@IQ<R&++DH:CO
M1;BV2XGDA*;?<X3+S[:`ZF[,LN/)=<(+SB/6+CS4I\DI6K<5%)I6FI9DCV-H
M&C%-Q<O)`H,2G#;Q:TLJ5)9@PENH2=K\4+2S3</*EO>45K3Z=)IZI*8:P)-B
MMJ9:$J^SXK%OCI"0/YM'0-A6""2LE1J10:U\1-$\1Q@%IQQK]Z977QCN6[+6
M+);X;3LB.\[/DJ"(=GAN,JDS5N]&E%7IJ$9EU1'F6"$@]=/P9W0N>T#FAIIP
MKN2,889&B2HC)%>[>H3\M<P.X"\<#P,#,.9,DCKCQ9#+?K1<5@2%;B],+90Z
MTF$H)0IHK'JJ(W`MU2;%TWHTFKO#;P.8#\N'KJJ_U'K46DL+K,M<?[V/JHG`
M]N/MH58?7RS+YCN099>BBZ7>^W/S37GUT6IA+JD)=3&0H%*0#M2FB4T`UW[I
MGIJST:V`A=(XYR[WB#MIP`7`>INI;S6KDF81M&0-]T$;*\25.YF.U%C(892E
M+;2MZ0GM\-H/B@`]/'Z=7*20R4J`**FA@A:7-))[5V0W5>N@T'0CX_'\.DDE
MXA_`)>,25J#9(36@'8_FTIX_1IY;1-<<YK5(^)?+*8'`9`!WXJKD3D"_<C^<
M]+_F'2H_Z:N,UU?Y%)\OT:M=K`R,!S:UI[%6M3G?'<MA`&4D=^&/L4\H[R$V
MZR.(JYOL5L2M+O5-%06.P%-5;5)C+=&!P&3TJT-A;>VT<\I(>P"E-GEK5,5R
M3PU8L\2X^A)@W8$N-72UO&WWB*XE(*/E[C'")35%`&F[4%?Z/:R-+:NKY/N4
MOIVO7L,^49<@P&W[TUUTY@]X_'S]KM-DBX5GUEM-N8MK36865:[S):8%`])R
M>!(C7=V2H?64HN[OT#VU0;CI1K9^;`9"_'`TIZETZVZLE@M@]^0C#C]Z>+$_
M>C:0F-"YJXNS;C&6E(;E9-98+F7X<M^@JO;Z=LOL*/N[E;*R!UZZBKG1K^'X
M6^<*T:9U'I]V/]0X-/9]BI183FW'_*D)Z7@V7XSF3+)J['L%S0Y<V6.ZE3+/
M+3%N40!'UPI(4CKTU&RL="*/!YHV]Z>\QL]PXPD&`NP.\C[=BT9C@T+(6%-/
M[H<J,C=`N+306[;7&P0AU2MBG5LI"J$$]R.NF4%U&^8LGJ(P-W%/WV?X8=&:
MN4:<EXYR7)X<*QW*S92N39+PFYVW),?G*C"Y>E&?BH?=6VXDM!U,E84B@5Y4
M]:=-3$6H6D/PD^5)>%FVX+B>]O-SORTF[XU=[@PE7J+9R+-;RJ$IPD*6\N,Q
M+#FU:T@J00OL!0ZR[4;%Q)(;4K2"SN8'N?G+ZDFCM@[!LP2LM7MPB0J.-XWQ
MO!^J7'&&G)TYH#H''3)9:<4V.U`2">M*]=,9'6TKJPN=FX;O4D[FV>XA\IPK
M@`EXK@5N[VW[+CY%'M4!R9!G/2<5QYFWJ<EVV5'EM-N+K1S8[&2%';4@FA\=
M#3E"(G&+X4NV>',5;6/MAJ\RRH^=JYY//`EJ56I#;55MI<6=VT)-!TTX\<!A
M1J7\,QWO5.*ROW'_`!'A..7C+LKLMKM-BQ:US;[?[I=DW>;!M=LB^BDW!V5=
M%-16(S*G07EIW*VTZ:0N+B*;+S*"AW)W:V=F2Y]PYX+1A0CRUJ"H$^X#W)>W
MZX8_D'&/#%RMF5YKE^)V)^)E&`6:#(Q)N!>KO'=?CW:]LE/J.-V>VN!H+"O2
M=>!V@U&I&TAM7@'.[SC[E`ZW=Q/'+:`6@>5/;QQ=K?;L1AHGSXSC[80)+S,P
M/MLUHEM*6RP@E2U$)ZJZ5UU@234'OQ;./[5YZ++ZI_"=MX%.-;I\R^/"V8]8
M+WD$Z:/1CQK;;W)*UESRAU;B/U+$=-?,I2NGP.FEWJ4%BW-=/9G(.6AW;Z[>
MQ/K#2-1U*2C6.:UI%<,<58U[9N*L@XUP)-OR-#<2\9#D5RR>;!9E-RX]H1,C
MH93$=?;0@*61&2?H*B.NN$=::K#JDQ8``-@R_MJO0_0^G76CP8`DTQS?LHJA
M/?5FMOY`]_MDQFP.!]'$W%5JQ[(ID<GTD9#D=W7DJ[4%5(#]LMSC`>3W"W/I
M&K;^G&E4B`>7#9P5-_4?5?Q?<#3Y_O47?=!4<E8"R?S<<?J37=7YZ3WK^#7=
M-+MH[:3(PD@FN*X%K=R^Y:'O`!#:8=Z<?VWOKA8G=&U$%$[)I\7SGZK?R4)]
M)1V`45]/$4TCKHK<Q_Q#UK'3PJUW<?4GWN4?URE*2H*#S5-II]=T-JKT/9*S
M3Z=1,\SXL6@*3Y[_`!'*H,M5#;G*\(EYO/LL:0[(MUB#$(,.KZ(FH"GW75!O
M:"[1Y(^%`.FJKJ.H3.FH0WX>WM[5?M/T^%L`<"[$UW=G8FL$AM2`FIW%('A2
MM.OC74(\EYS.VJ9:`P91L2=DN*;DIVT\R@#7\)^!&A"X;@=TBI`H6VQM'1/U
M3UI\=+B)KX*N[4-NWQ2Y`UI';7[T3*=22?7;;=310/J)!(!!2*>'34!+&V.7
MF-V@[-W!3W/=<VQ@>`&NWC;N.&/8E[Q%8;-?<J1C,J"U-A7R')84VZ/-#EI4
MV]$N;.S:G?!=34;PI/6A!!(U/:;8PWGU:C9L^Q5=O;^?3:\BAI7;^PA6H\H>
M][W$IX:N'&'%_'4*S\ES/LNSSN5KFN#D^(N6*Q*8CLOP>/+PS*@QKH]'B(0O
M<%M*(4I*$A0`K&K=`"XUZ6\C,IA=EILW-:."MVE]>F+I^&&81<\!U<#\SJ;^
M"KUO'M-Y&Y^S2[<A\]<DY%F^6W^'!>NDV;+?B15L0VVF+=;HMKA(CP(%KM*$
M$QX[+:&VRM1IUU<-%Z4CM9&F<.+`#6M-X[ES[6.KY;S-%'D#B0:BM<#7BI&8
M![8^/^+(B6K7;(#]P?#;1E-1TM/`IZ>J^X$!;TA-:)))`36H.KA8Z;:Z?+SK
M<>]V[%6+S4[N]BY,KJ-[%)R'CD1A+27`LJ"&TAHAI#31```:0AM(2!W_``ZD
MI9'2R&1U`XG<H@7$D,0MA0M:*5.T]Z[6K`F7&9==><8*GW]RO*E%(Z@$BI2=
MNZO4GIK,+6.=20T;1-FF0.S1T+RN"<+2B;'A'((%O66`0V;K"4IS]8H>HH!(
M*":4H>O32%S-##\)\ZE;>">7XAYD<-6IE<20MF<J8MIAQ33\54=QO<E!*'7'
M$NDJ0#U)`!(Z@:RR6%\8<#[Q`6KXYF2%I'N@KJAV-:'8_P`S.<?0^R"4)6D[
M5FAW)JD^6G33B",2O(/PT2,SS&T$;:KD>M+[[SQ8G*CMMN*92C<`24?GGIW-
M=.O"1\7>A-_$2=B:CW%P&V>(L@7O6I:[ECS:R2FAI=&ZJ'E'4D:>6@I(*;BH
M_5KA[8<`-E5$:X=&X:/!N"P0?$U2!U_)JSPQB0>]5<_,[^810)-K65*)-/AT
M^C\>G'AV<3]O(L\YW8N7Y&/^A^=7LGO\?JZQR6]JB_%2<&[>W[TJ_0/^"_Y@
M?R:;<M_`^93>=G$+Z&5CZK9'QHFGB-*0M<V9M00M9"#"ZB,\9;<'(G%54*Z<
MJ\:'MX?O5:M1G5G\F_\`[+_^DJ3Z2_GX_P#NL_Z@O<$>Y_"?X]>!E]"E\T(0
MT(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(6*NB5_YD_Q:2E^@[RH'
MUV]R\8/WE#:G/O6>?6T(*W58/PBM*4IJLH&&-%2@*5*1XZ]._I'CHC*?-[2O
M+?ZR?[L>X>H(FXZ:*N1,.46Z@W1-"4UJ!'?'0T[5UU_6()GV?NM<<."XWH?\
MV5--3:ANJ@T%:U'2GX-5)L,H:`6FM."OPD8!2H6L)`[)`_`*:',>WX@0M@YK
MOA(*S"%*%0"1K1913?<9M5\9<;N++7H+:##A2TV70SO2L-I)34(]1()';4K>
M-$L='QG9P45:.,4E62`&O%-2G@CCA$TS46N.MY9W';!C;Z@]:J]+=UK\=5HZ
M;;%Q.3T*R#4KD-`SGSK#)^(./+C8Y,9VVL[&_*E"XK&T`CS)`4W1(42:Z#IM
MK3Z:RW4[D.!YF]0JR7VP.%VY#";_`"+5%E)4VS:4/-S(D;>"G:DOE49I1KT%
M`2>W75:O>F[/4`6N8&^17BWZZU"%P,K7-';@H_S>*V^/K!:<6Y:A7JZQ<?\`
MM!JV9C&CM-O6Z-/E?-HA*D1$)+D1IP[DI4JB*D`"IUS'J7HTZ7-'X&-TC'M<
M7%HJ`0<`5T7I?JZTU2&7QDT;)&.:`'.`)!!)]*X+=QZ^]'%WX]OT#)(AH\`'
M6X\F.VGJE!])0<5)3MZ#N54U2+B"*W:1,`QU#MPW*\021SD&`AXJ-AJE78^6
M<YPF7\O-C/34LM++]MNSKS;;[04@K360K:TYX!0ZC5>:0[X353+@6_%@I]<:
M<V8YE5AB-0K1-;NSZ%._9,5Q3D!$MM#>Y$R\(/\`,HC-0JI("Z[>NG=O"'N`
M/QDX!1]RYM<]1D`V[DR'.G/T["[L[@.#MQ,BYMR=K9);0A$FW8A!DCTV9&YL
M*VK05@A@T#E*4U>]&T*ZN9XF\EYB<\`D`TH3]RK.K:WIMK83N\1")VQ.+1F%
M20#2GE2K]M/M\1C?JY?F3IO>7WB9\]>,BEK,B;)?D#UBRE4C>\B+''D'6B?J
MC7;=%Z>M[-U2T-\B\_ZSU#<7C:!V;RJ?#1C)1L8\K32?ET!9'[)%=J$@_P"H
MC<:#MU.K8]C(R&QT+:*J1O>\9I*YJ[UFM2=A`4GM0`$:31("6$#:M#,E+3J=
MI2HDT(!!(Z_#6$RY;^!2D1<5@M@;OQ=!U_&-/[5[0*$BJ0CC?XIQH:4"JH<N
MS*+[R2"XD*.0Y2`-R0K]5<)R'/'NA2J'X:MMN]KF@-()HJOJ[V_F#&U&:NSR
M%6)VR:%66Q*V!0%DM-5;01U@L^/75-O_`/<"KO8?R`[O8NAM;+BBM'I!Q7UM
MH2%].GFIU[#6DE'7!#L&X>H)NUKV^^T$K%YB(X0)#+#B@I*D^JVA12M)JE0W
M`D%-.AT_=':10\UKF.D&["N*7$US+^`X.#-M<:8;$67G&+/>H3J9\-IQ-?K&
M.VM*NGUG"I)W$#L3J!O"'_!&3Y$HV2ZA'X;C3L4?LA]N6'WZX-WBU(?L-]B^
M>/?;/-7;+FPZ@[VGX\B$[%?0MIQ(4D!::*`ZCOJ/EZ9LKN(7#W-$CQ4@[03M
M5HL.J[VVC;$6NHT`56^P\B<]<%3)4JZ7^Y\U86Q!?C-6')W&(%]9EK6RXR^Q
MDC41V9,8:99<06'_`%_4*PHN>45J.K]'-;"#9@NDSC8*FE"KCIG6N9^6X<&L
MR[S3'!%'_&'K7(=8C>V#.7YQ<)<@HRBVB`5_5*D250HI:"MOU2"1\>NJ[_2=
M_P#Y<G^$J;_K.UWRQ_X@DG??>/SY=V7YME]NUGQ]A+BQ`D7[,ILUZ,L#U8S8
MC6F%',F0TV4U;2\DGP5XZUDZ6O(1FE9(UO:TA*Q=5QS&D+VN[B"G6MN-?>79
MZB+/CP_;;Q2W+C,2@Y*MMZR"[HB7%*9#0?BR)#Y8F,@`[5GH.GCIEX)MJZK7
M`N.%%*07EU?5#V.#`*@TPX)T+)[//>9E"T#DGWS9!9(;GU[5Q#QUAEA970=$
M-W*\6R=/C.=?.LC:>E-;4*<<J7Y3YDM3]V/QOE42/;\WYC]T>4N)?29LVX<^
M9I;I-WJX%+:E0;2TU:V8H=\Z0P@;0D`4`U7W32AQ]UVTJ4;;W!:/<=LX*1T;
M[NKVM3<:=Q/(\=R[-+&[$C6=ZTYMRER5D%OGL1%^LMVX1)&0Q84MJ42D*]1I
M25;!TZ:C;^YN&9,C78D[NY*,LW25$ON#MP3J8?[)?:A@)9:Q#V]\6V!IA#*&
MG!9Q<DDMT7N/VC+?D%7JC=YE&A[4&G-KJ4S&>]4&B/Z?LI#5\C/.GX@\8X#;
MU!JVX7B<,J/U(..6ID$@5Z^A$">@&D_SC6/_`+G_`)OVISX+1J?RG_*/N2L;
M@6_'XSLI]VVV&W1V%O29,AV%9X+$=H>=QY]Y49A#3:>]3VUJ;W4KIP$TIDIP
M)-*IW!;Z/"QS^6V`X;0`3VCN5;ON?^]!X7XAMU\P3@RZP^>N:Y+0BV;',,5%
MG81CEVJ`)N:YE",BWMM0EK2XF,RX[(>4G8MI*374[9=-2WU'N:3CVJ&O^I-/
ML@YC)8Q[I_>'`JL/@+C7*TW').3.3+T_DG(F>7&9E&77J<TXV3D-WD)>D-1`
M^5N)8C,-MLM`&C;324"B4@#MG3&FML(*2-R.IOP*\[]3:B=0FK&[,.S$)(^Z
M-:!R)@%5I*QCLH%=05*_VRE"I5W/X]7+3@Y\I+02*^Q4+6GQ1,:UY:'%NSRI
M=>WA:7,4<JM*RG+IW<A132VPSXUI32.NL=XB-U#3,/6E>G7-+'%IPI[%(_UD
M"6TE.UU:WV$)0`%J)]=)Z)Z]:#4'=,>X$-!*?<M_BP^ARUV[E7H_C.:9WG&=
MM8O:Y<^3"O<]^Y3'7XR6U-KD.-,L(^92I9E^FS0']$`#MJHW]K<\ZO+?2G#O
M72;&ZM_#@&1M>]-@Y*DPI;L=Y#@D1)3L9YE=%J3(CN*:=:44FBE(<00:=*C4
M8]CHP3("`.*DF.;(:1G,>Q'EMLMPR2?#AQ/U,J6ZEMG>*;EK-`D#I4U.MXH9
M9_HM+^X56DLT4'UG!G>:)9YOP_F.),Q1/2F>E[9\TJ`T7'H:5"J0\I`W-D`]
M:ZDA97C(*.B>#CN*CC>V;YZMEC(['!,%<XDJ'N#/S$A()W;?472BNN[\`[ZK
M=U;7+27.8X-XT[59+:ZMB`!(RO>GM]MD:X7#DRS.0_00(T:6J4EQ*?6<CD(]
M3TJC<6T;?/\`A%=6+0XWX8'<J[K3V/KD(.W8K5+=$87%8="6P4*>+54I"D'U
M7`"WTJD&G2GAKID,<0M&N+:RT\JY_.^7F&(NRM^Q1S^M;F)4R5H;^S66R6R4
MH]0$50:4&X>(TP+YWOY?+<&<:>U(QPQL?S2\%P[>*+GV7G%!2FUK4'T*"E)*
MB!W)!-2!76>5+\I3GF,XA**3<;7`CR;A.E1H\2W(2].DN*1MC(2-VYPGLHA/
ME![GII,@@T.U-7M<YY<T$M)45\VS//<KMS\/&?7L=B+\Q]B<VMYF1<(8/],$
MALH7'84%U*0=IZ:8ZA))%;9XP2[,-FW>I'2(!)>99L&93MV;E!2[3)4"XR?F
M)$E]]M\LF>ZZZM3[OUCL?4HJ5U/Q[ZHM]J%R"<P-5T2PT^V=3*6I0X[E=_A2
MF%1KO=(8]=LJ*9\IIJF\5+H#P'ICQKTII;2]3D>\!QPP2.J:9&QCBT8JRSB;
M.9&9V>*W.$=%]M:0Q/3&*07VPC]3*:"?,IDH^LH=-W?KKI-C-`6U#FYB.*YQ
M=Q3!Y!:[+7@G(BH"@^M:0K?)=4E2@%;DG:`036HJ#J3:,_PXI@YP;\1HFB]Q
M)3_9#D"5;:BZ6)P!5*AL7A*=X!_-!(%=+6L<G,K0TJH_5L8:C9E4*[JLE2`A
M9JW"90H)4?(H"NT@'H::M%LUS02X4"Y\YS62NS$!)QI7E\ZNNY7UCU[].^G2
MSS8OF'G774?'QT<J3Y2HCF,XC:EGH4VOH_R?E&DG?69Y4H/HO^W%&&.?[XG%
MG_UTN-/_`,J[5J#ZM_DG_P#:=_TN4UTC_N$?_=;_`-07MR/<_A/\>O`Z^A*^
M:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+%0"DJ2>Q20?P$4T
ME+]!W>4`TG:1M`7@T^]UYON?'GWQ/-UJ:2PN.G`.$7%D(*W4M.X1%/G!_-3Z
MPK^#7I?]*I1#H+#L]^GI*\N?K)_NQ\GJ"<#V\\C0<^S;"G6G&U.QKF&'GT`-
MLA:(SSI;],T=*TAWJ:4-==LOKW_1CN7&M"_G".U6+N`*W@*%"545UI2O?XT.
MH%IS`'B%;W;3WHH=?;;44DUIXCM_"0=-;OX6]Z7MOB/<MC4V.E%"NAJ?A_+I
M@G:3-XO[,9A]HN!*B@J#A4`A(0?4.[S5J0F@^G4A=7ON;=R86MD<^/%,O=^2
M&U6XO0'W$NB06]PHN@0K:LG830*KTU`>.&8TV*>%B0T5VI,Y9RO#MEM2V\N6
MZY-:2L)::JILH0`K?N(ZK*:BE>AU@WHIM619&H[TWEDY!@Q-DQF0\[)GP_FV
M(CKC14T%#HA\;Z;T^%*BNHWQX4[>66%"C#)KY9,NQ&Y?O%";(9ANOO[_`$5=
M4G:CH"3VTH)+>ZA=S:5&Q0UNRXMIOP0<I-57W<L'$2X&]X'DLRP7%YW=LBNK
M,"2E:AT<85Y6W".@H*5USS5NG+*\N0,*%P])73M*ZCO;.W)QP:?4EO`Y$R.Q
M&'!Y:P2!E5L:4E#-\LT!$ZXEKP$Z*ZM@+W)KN4DFA_#J%U;H5D#2+45*F=)Z
MZ?<$>+-`C_)?=/9K9C-\Q/@/CV;&S&^(8A1KU=,>%IM..*)VN7>2AUQ2;C)M
M[9*HR31L.*))Z:A](Z4NFO+[AIS!V'<I?5NJK4L#;<C(6X]Z4OMHXP:QI;V7
M9'<7LARF[O.2;W>[@]]HS9TF0KUNDEX;0V7E'<4$"GU==AT2Q-L&`[B%Q[6[
M\7!>1O!5B-BR$!D1DAMMA*=R`WMKNJ!U["E#JYJG)9,7,DAL+))Z@BE.OY3X
M:$+M5,*4E1=J`"?#^36$(D%X].5W5U4.@V].OTG64)4Q[L%AI7FZJ'?;X$#P
M6-;P_5\B0'UG]P]2J)N%V+.3<AI*B:Y'GE:!/C>I/?J-6G3_`(O(?4N?:N/_
M`,PSO/J*L[L$U3N.6&CE-UBLYZT_V`U\`=5N_P#]P(70+#^0'=[$8VUQTRE-
M^JFJ3U/6A[*H*)KVUI/]4^3U)2'Z8\OK1[,D(#XZ*_@^D?'Z=(I1?;I-]"WJ
M()`V&HZ5/;Z=90F\@7QYQZ0$E02A2_Q@5^!T(2RMK$>ZM[7X[3_K(4DID)WM
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M2T-E`^H5I4FM#K3\BU`XY2H-W6T8<6@X`I(R_O._>W>G$M8M[<^'<:CN$['[
MK=<ROTQ(50(W^G+MT12D=^B!6NGEGTM=79<)FFC:4\J:W/6[*-HX(GN'O`^\
MORA&R+D_&&#QU4*(^/\`&:+@_'K]8?-7FXSO5WJ&[KVK33_^B7?*4U/6S?F"
M1MWR7W_YJE3&2^Z_E.VQ7RD2&L2B8_AK1`4%A(-BL[,IM)6`#L>34=#4=-6'
M_P#7]EP5>/Z@WM=J2DCVFW[D+TE\J<E\B\A[5I<4WF&9Y7D#*@HA3P3"G7@0
M6`ZI()"6]I(%1TT\M.A;.%Q("97G75Y.`*I\L*]N>`<?!MNPV>)"#"$H2R(C
M!*:>8@K#:2=Q->U175RL]%M+2.@I4!4^\UF\NY*FM"?MZ$ZSC7R[)@M,-,M5
M#E4IH:IJ`.P[UT+"KS]U[X1R1Q^@/);5^[LSRD&JO]LY74$`].FIW1OB/?[%
M2NJ_JQ_]O_Q)U/:_%7^Y%QFOK0IO][+J&TT(43]DQ-IZA(UC7_C;W^U/^E_I
M.[O8GZ5)VS6?3!#QEQ2T?[Y,MI2T]#W6T%`?2=0BLRY,`Q>X8AD/(DA%O;W7
MS)C<X]1YVX'HI7Z3AI3U"XZJE/+I.6VYT9<MF7/)>&^50HY4X_O&.YN^E5M<
ME.9-)DS;)#M[2Y#LMV8^M]UU'IC8VF.MRBZ]:C5:NM.=(XQ4VX*S6NHM8P2U
MV8IX>(.'LJ8NENR"^01;(,5V-(9;EE7S#SC;H4XTEI()0O9^E0:?:=IYM#F.
MU,=1U`7@H,05+7+\>MN0EAYT)08DA<AA*NJ7=]#Z<L"NY"*4%*]-68P&>#F;
M]GF59YX@FY9/V*AMRGB\"TK?^S[4S7TG5D(;%-U%*53IX^&JKJMD>0_R>L*R
M6-Z*@$H>VCBB1]N+SB0IZ`B#<?DD,**A\PRM'JS$MA(*`E2%H`K3MI?1+$X;
MRB^O@.!*G\II++BFT;?32X2V$UH&U*WH2:_G)2JA^G5QR<OW."K,S^9(7\5U
MJ4$@J-:#X?2::$DOB7$J!-=H'<G_`"B="$TN8W-=TR.'C3+C9B,L)F7)M-=D
MO8H+BQG0.ZO5`WUZ;3XZBI_JN[U(1?3'<FNS[,9Z&9N+XHR`^HQH\A^&VA0^
MT).Y*+7"!H4I-3NJ`/)IG<LYD>7M3JW?RY,W8FW<]KG(5U@N/7&_1&Y;@2ZA
MK8M"HKKK:70AX+;&Y:=W4IJ-1;]`-Y[P4K'K[;/W24VEPX0Y#Q8!=P9CS8[3
M_H/SF'%%*FT+VN2UH4$DHV@JH!74=^2.LWFHV%2(UL7C!0[0G;X=N,C#,YLU
MM<E/*9$N/9Y6Y?UV[JM)072HT44.@$4[(^GIJ4TX_BEO`>U16HM_"#N)]A4_
M5-AEQYI)"DMO.H2I/U5!+BO,FO7:3JZ66Y4R\3'^XW_>GR'_`#5F_P#F^SJ5
MM-I[RFNI_P`N/X`H13Y*/FIB-JJI;:->G^"2/C]&K`WZ0[US6\^J>]$`>017
MJ.I'6G@:?'6$T7'\T[^EX_`=M2WW)C]Z=_T4?3^7_*TGX>/M4QXF3L6091]/
M?XZ;R01B=E*[_8E1<R<E^S[51AC<1:N1>+2FFW^U/C3;6M?\:K5]'QU!=5PL
M-A(<:\I__05-](3R&^B.'U6?]07MH())Z=:_3UZZ^>@,P/O##N7T7(K\+A5?
M*'^']$_RZ5:2_9@DCS&[2%\I_DH?Y=;!KJXG!8S.WD47ROX-*90L\UO$+Z*G
MMV_`3_%IG,Z9LH;&/<IP2C3F%00OM/H^CL=.&URU=M6V5W$(;3\/X#K&8<"B
MAXA#:?A_`=&8<"BAXA#:?A_`=&8<"BAXA#:?A_`=&8<"BAXA"A_R`ZW%"*T1
ME/$(4_R4.LT",KNQ"G^2AT4",KNQ#\G\.D'<[,<H&5:$T-"15#\G\/\`+K7_
M`%'`+&8<0M;BEI^J@GK\#U_@ULT3';1.8V,=M*Q4I8;*]O7832A[@5/Y-)_B
MF3DO'X9.U:AC?$"I&5?FS_\`*"&[[$^^0YXG66<N!+3QOP:Z%*!4AY`P2VT8
MV&E0JE>_AKT-^G$[G:6VVCV`%WE#B/:O*WZU/%GJ(FNOH.<`",,2T4'H*:/V
M.<V2V>=,"MMPGNQI?VB[\VP\:Q;@XS"<(;BL5`;>5XGK44UU-]W))'RIB,@X
M8%<>Z<;XNZS6VPE>E['\CAY!;_6"2V\Y'0X4#R^FMQL*V$=>J"2/Q:>LH&-I
MLH%=W6<P<0=M>"3URD>B\YN5T`&WOWJ>_P"+2%VUSFMR[:H$$T6(-*\0DTJ\
M&I\Q'AT)`_)73+E2+;\;B/-^U,7REF[=CM3TR0M2H\I!:92@T6I2EI;\JNI[
MG4#JMS+#&<E,.Q2.F07,LGOTH>Q0HF\BW",%P(TF5#`=6\[Y_,X'%;FO,?T:
M'\NJA#J=U)(\.+:"E,.]7N'2FN8"_AW),WWE*]R$MH?>D2!'1M;7THH*'7=T
M.ZE::<>-GIM'F2OY2S=ZTW,7.)TFXM2`J3%=;92A*@3Z(;9\P;],?5+E*$UU
M&>,GV^[YDZDL)911X2_MO,#P??ASX[4>%/9^4EA<OY_YM1/D<;3Y?DMHZ%/7
M=6NEXKV,`^))KNIA@FGY:^W-&#;QQ6]4O'Q+6[\^^PXMQ*OE4QR8[2O+M0@^
M"*`5_#K9MSI[I&EQ?\0W]JRZ*[;$X-#?A.[L[T]]CO6+SK:&)[=L><])30*V
M`HA!H"I.\K'J#P5JTC4--:=M>\JJFROSA@.[!9OP,9;C_,VYAA19J@N(0T*C
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MBK5<4N*#C./$J.XV&SFG44_F+/\`+J(OK8F8S8YUTJQ$W@!0C9P2JM#@<FNN
M)4:*((ZD]DI']S3$RPD_B@\S?C1;0B;EC$;]W:E,XXIU6]9%?H%!^2NL<VUX
M'SI7\;B/,BN_.K<MKFY0\H(%!3I2O7KUT<VUX'SH_&XCS)!V,"KU54J%U5\!
M0U4?H`UH:_$!^&=BV`D;B\C+W)<6J_P+<5-KD-NJ2TL)2CNE1`%3]%%'\NEH
M_#DTD.[BM9;F%S0RW^L#COPW^Q%PNMABH4N>ZIF.'%J$EY9*4I42HI)H!T))
M_!IE<7,$7PE.[:)\V+PDA)N..Y#*O5LBR(,EF0(;3'KT]%1<3M;4M1/1*JUK
MJ.BU;3Y7F.3%PVXK8Z/?-<7[(R:CNW>A*^V<#<:SK$6\H9L4FZ".?E'G%1WE
MEE:]P9:2EI(20KJ%=33IJ0Y-E=-'(8`0:E9D;<6C1RGNS'`U-0D:UQ3A=F<5
M':LD,[%*+;B&T`EM1\@"@@*H`.FL?EK/E27B[_\`S!YOVK;'M-M8=2AJ''0V
M%[2TEI(;6`:`+`I6E-.@;("A8*C[<$@7W)QS^A.;"8ML6*PH0(0)['T?@D?!
M7TZW:8S_`"S0#OW]R3>)I*9G;%TQ;D[]H.M,I:;82&]J&VPD`EL%1[GN=;5F
MX#S+3DR4^)*)*GI#:G2JKJ=NT"@0:FA)33J::><EW:F6>?\`N^8?>NF+\PV2
MI:U)(*2G::#I7N*:W:V)@I-FJ=F*QFGV^[YOVH/3DAQ97N4X#4D]:F@I_!K0
MQV)VY_\`%^Q*B>Z&S)YD3R[@RZDJ4*&H["GC7^/1R['@[_$CGW?%GF5>WNI=
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M1^:GJ`#7Z-*.?`[:T^=:-9,S81YE&N_\T&.^F(E#<!YIU05%E-AQVX"OE1&)
M6DH-!].M3J#K=O(C'X>W$5./:CP3)W<Z4_B=AIL[$C\AY$CW$19=SLB[;\\%
MQ8<&513TMYU"FD(;40.JUJ%.FF%Q)XIIC`.9W8G(C,#*Q$5'E4E^-L9E8IB[
M#4YTFX7=]5VDQB?)!2^VVAF,EL`>FXAM'F^.BV-[:?1#?**IM(V:7XW#'L_:
MG%0I12%$@G^0ZG8I+F>,2S4YAVT%!P4<]DL;BQI%`MRG5J!!I0_#\NE*2)-Q
MN*>Z6U^W:BRZW!JVVV9*D=&$,KH0:'UZ$M]?A\1XZQ212%K$UX_&/FP43V,F
M+5UNUWE.GYJXH<;:4FJ4(H"ECTDU.PA0!TPE?`)"'USUQQ2SSRW%D;ARP<$L
M>/8D=S*W&#Z8799"GW''T^HIRXJC1U.O/DT]5;<IY6SMM!IIK/)&8_P!^)7>
M:X;TC)+,UM6%N;N4I5M!,5.]T3%KW.%URJEDJ).RH(J`3T'@-2FG3W#6[&T'
M8HR>*6?&0BIX)'9$U&5`+3L=I32D>HL*2HGS)JH5)/0ZQ?QNDJ]PQ/`*5T]A
MB:UH=L`"@I>%F!D-OEM+6D0;G<#&<)*ENNVZ='?B*E*%/74WU'6GEZ:K<<#H
M+D.CV.-#W;5.7SY'6K:%I][V%61P9'S,.,Z34JCQ5*(_3>C-2'#](+CII]&K
MPVW=#;"5GQ=N*IEZ)\:$4[DS7N&HYQ'DJE="DV@CP'3(60-%I+<9J8''@MM8
MY#;-N3X^6-^^@4"'7UNRYBE[:E2&^@IY4H%/'OJVV372@MEV#9N7(KN>0SD&
ME$4/Q7%.*+9\II\>].O\.GWAHNU-N<_L1K\@S\%_5_2\?AVTO1))ZTVQ:DE:
M4+*1W-%?@ULICDR_*5D87H17I*QM;;`45K\B``%;BI:Z)3^,C23HI'RM>T$M
M;6O9LHLN:Z.%Q>**(_-W/KN+,L,XE<Y$>]6N2T\S,A);K%G1UIDQ)<200%(>
MB/;5H6#5*TU';4'K[1/"86XU%#W$$%*]/ZM8VLA+I6B1IJ-NT8C=Q"K9Y,^]
M"^\V5>;D;%[_`/W%6.*VZMOTHN;.-Q6RW4NA+[S+2DK2!T`/77GS5_T]T>%E
M+=K<.`7:NG_U7ZNN_P`66.4\<17S545[U][=][1'6XU;_?\`^ZUYM@J2W/&?
M25,.]:DU(!4!^/7/[GIJ*UD,8BS`[#0+J&G]>W<\8DNI`)/EJ:CS##SHEA_?
M%_>GU#%\^\/]V++R/U8-NSZ>K>Z#0>N#L2A)5];;V&DHM!MR\"2(!M14TV"N
M)\BEY.K-2D87VY.4@G%_9NV'SIQ+;]YW][:N']L1_O#O=3=K6ZH+5+;Y`E?+
MP4JJ?0?2^[O+U!W"2*`]=66'H:SE9SH\KXN(`^Y4J]_5>**Y&GRRB&^I\!<Z
MI/$;1Z4YV,?>>_>E7$M-C[PWW(.ASJ52>1'$*2HT\M#$?.T?A_%I[9='=//.
M6=T7,KL(/W*/U?\`4/JJP>SE1S.B=&'`@BE*D<>Q2FX]^\3^\&O#\>%?/?W[
MD&)"W&HY6KDITAUTG8M:`FW*Z*7VU<[']-.F[K*,L5"=M#@JT[]9=>A?EDY@
M>32E?VJ;N'^X3[P/)(:)L+WV^Y63'60DO)SUZ4CK\$_)M*!!\>NIH?HYTT[X
M>5YC]R1__=VKYN67OS\*IRQR3]X>M*5-^_#W((20#M7F+^[\/5@FFEV_HIH#
MA5K6$>5.#^L>OMP_$\X^]?$<E?>'$]??E[CU@5JE.82`30$]"8X`IK/_`.DM
M".QC*^58/ZRZ\!B9*=X^]-EFWN=]^6"2&8UW]]'N45(DH6MAD9G)W;$@462A
MA22%;J"I\-:._1?I]GQ",>=)_P#[GUKC)Y_VIJIGOC]]S:2MGWJ>YYU=3Y4\
MB+8%`:)/I+B$IZ?3UU$3_I?TW#,8&MB=2F-#O%5O_P#N;70W,#)E[Q]Z3TWW
MY?>$%!<@^\[W&;@0`?[0ILE-20FA83;TK63_``=];#]+-$.(AC\R0/ZWZO7*
M7OKWI2X![KOO-,OO19D>]?W(6ZVM,J>><.72SZB4@J"DJ<C`I"0/#O70?TKT
M4_\`HQ^9`_6[5AL>_P`Z:OF3WO\`WC5IR*/"L?OQ]R=MLD<2&)\R'R"Z)$N6
MP$[EI:=@DL(0I:0H`TTRE_2W2@\AL30*\%#7'ZY:\V=X:YQ97C^U,@Q[V/O5
M9=WB-1/O"O="J'*6&2V<]6I:4N*`]8*,+;1NNM!^E6G.=A&#Y`DW_KSK<41S
M88[:N\WQ(XY$]U?WNV._K+3]X)[JGU-1P2RWGZE*6H@NUV@,`GTR#V)IX^&L
MN_2:P(^B*]P3ZQ_^05\PCGR4'>?O4=F_O&_O94/_`"D[[P3W3B2$*=6POD61
M&<])%5.;7$*W->4=QYAX#54U/].+>&;+#'0`XC!6!_ZW7]Y)')9/SB@K0G`^
M@>=1FS#DWFKESD"=RQS?R9E_*7(=]@6:)D.5Y[<C>\AE1[$R[#@M2Y[B2\AN
M'%*6VTI.THI7L-77IC3M+T1GXSVQ_ATH:X8C@"J)UQU5)U8_DWA^%V8&NTTH
M/6=P7(_FEXL=X@91A<Y^P9)9UAUB9`E,M3)C$BK;B8CBFWFV7FPD^8T4`=;:
MI>Q.)%H[/W;U7.FKB;2K@._],[^'>/NJK$/;G[O.9;Y:GH5UY>RQ-YM#@C0@
MF84*^QW2!)B/."(4.3&QY0Z4D5%0=6:PD;<P,$1S/#&U`W&@KZ5<;CJ"XB.:
M44#C4=M=ZG+D>;\P.1;;<;=RQFZX\^"B1Z_VT@MJ)'5*=T"M4D]>FG@#`_ER
MG*X[*IE=:[?RQ!]NTN:#C2FSRIJ9/('-:%U/+F:@'H*7A!J1T/1-N)%-2'Y5
M/E#\IR<<%"?U7<YLG[W!5L^Y7W%\XR,TG8K$Y<S1V'C@05K:O:`V'G*?JU4@
M!)4-U?PZY5K$\+PYK7`N^XKHVDWNK1.#Y87-;MKAP[U$.X<Z\Y!:_4Y=S8K5
MVW7M*B:?`_(GH*ZI<!#)'EYI6E/2K@_7+TQM$3"2*UV>3>D\/<1S%;%*5<N6
M<WD(4E6UE-\%4DI[G^8FM3UTX,L8!J4,U?5)'AK8R/MWI(?\(?F9OS1^5\Q2
MY]6J9Y9.U717ZQ4=P`$?1UU'>(BXJ?.J7U,6^D+HC\V\YRG`IOE3,U)60IQ2
M;PUY5?FDGY%)K3QTYA@M[EAD>^C6FGG3.YUJ[:*N91U-_#SIT<=S#W$9"REZ
M/RGR(ZPIP1_F$WMST@\:#8I9A^`/6GAJ:AZ8GGB%Q`USHB:`[B56INN[&&;P
MLTL;9\M<N-:<4\35R]W&(QX;JL]SR-"N:VX+%R7<UNL+$FI&UUR`IM)4&^A)
M!Z:=/Z6U2,>_$\>;[TU_KO2?\^/T_<G)Q?)O<VB4['NO,.:IM;#965"\M@.R
MJ5](%,'S$HIU[?3J:TG0[J*!TCXW9`_;Y!VIA>=;6,WN6\K'/IL%?N3K8[R+
MSJE:DIY4SA`"J;?MEH$4/;I!^&K=:6'B(RP`TI0]BH>J]5W\;_=:<O%/K8>0
M><764!?*^:B@W`JO#9J?A7Y#2W].Q\5!_P!87_;Z$X\'..<=R5CEC-MG;<+R
MT!4#K_TC_<T^M^GH1'[V.*7BZNNBWWSBE$[R!S2ELA7+>9A12.]X1\/C\@=+
M_P!/0<$I_5T_%)U'(7-"99W<NYF.H'6\(_2_^3]']/P=J/ZNGXI91^0N:/EO
M4_M<S3TT`[U?;*-J2345'V?K:/2C"_*QIY?'[%1]WUG=$F(?"D<OU`MR;-0J
M?-N"EN27$JVI2XM?J+>?[;UO+ZJ)!W*-3J=AMXVLH[`JM3Z_=N=S&BK@E(CD
M#EI#+,6W<DY5:X49`1&AQ+LPAIIOH`V`F$M82A*:`*)IX:87=FY_TQ7N5KM.
ML7LLQ&]U)*;%T6?/^;W;D^AKES-E$*35*;T@;?*CP,&G4:CAH,4@SR`AYVI6
M#JZ?E#'[53DLYIS/NJ>7LSVA*B:WE/0`5)_H'8:R.GH3@`4K_5TXVE$F3YQS
M0FTN/,<O9FNJ5;=MY2*T^@V\>.MOZ<BX%8'5\W%,LOD?F^+8+PZGF#-6G_DY
M<MQ2[PE28[)0MOUE#Y$5:0[2H!ZZ;7^FF"T+XVGE,!J>%$MI_5IO+P6<K@'.
M=0=JC(OW/<VR(.-_:/(G(,Y^'!1.#]KD/1@\I;C^];[[41:766V4I44J_2&N
M7R7[II'^&.<-!K3<%U6+28[>%MQ*:2.&SL.-5A(YQYHD.Y6_)Y6Y!2@V>PRU
M1GL@44Q4O78.$^DN&0@JC)J:"I3T/PU7;J_G>QTK:F,;3N"L-O#'`8XY?==)
M@W^\>Q$=@YUYPD9*PPQROFZX;TR-'2&[TA.]'S"$(1T@BI">@U&:&Z.YU#E%
M_P"(]U0,:XE6#J(S6.E<YL=&QLHXX8$#&O<IOL<A\JVU=_ES>3N0I$AZZ.,-
MLHR!(,)%&EI=2/E-J6J^4!/B>VN[V.D>$8,^$CAL*\TW_6CV3ESG4BS4!W53
MBM9OS.J)$DKY:SAAIYELM^O>45((Z44J`2=2K].EB;S)!1O%-V=8RR"K#4(K
MCY9S4J4T1RWF:@YO=12\MJW-@D%?2!V"M8'3\+O>XX^=;_U=/Q3@Q,BYP4R'
ME<KYML;0H@F\M;25)Z=/D._36[=#Y9I;M)<5J_J^5HJXT"3UESKF9N3=VI/*
M.=*DLCUG/]NV:I8/5#@_F71.PCMIL+9CKCP@-;GY=_V\J<.ZDOA;^*+3X;YL
M*)THN6\P*B!Q/*&=;'-I0O[<92%=:FA,'P_%J>_+I*?3/H^]17]3W'`K='RS
MF#YD!7*.=&K+G3[>CD="/^HP-9&@ONQF+"T-6#U3.#0I)77/^7(90T[RAG:5
MN54W6\H47$!2NJ5(@JW?QZ2=T_"TT<X`GO2K>H[UXJUI(1;'O/N%OSC8L6<<
MG2MY!"VYY2V$UZJ7ZT!K:@`BOCK$F@0Q8R.#5O%KNHSX1,<[N_M3KV7V\\N9
MI.@7;DO)5RU1V?1ARIMP-QNL>"M9=6V@AIMM@>LLDH/6M3XZ0CLF02@VYSQ4
MQ(W'AYD[E9J=W;F>YB<T-PQILV\5)G#^%OW)0P[C><9,TE3ID/*9E16V&GV%
MI:DO,M>@X&'67`!V*Q0=]1.LV[KF1C&@EI<`>XE6#IZZ9%;2!A'/##0;R:&@
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MYK=;2I7)6?\`J+4\\Z#?&RI"G7W-K9/R?YK:013H`=+_`),?D3S^KI^*W#D?
MFL$?^,O/NX_^'&O^P]*-TR1@RB,T\B9R]4W#GEPJ?[$8#D;FLFG]I6>]>U+V
MSW_ZRT?ETO\`EGT?>L#J>Y)IBFFYEYHYHQ_!KU,_M5S=@)2B$X'KTV:2)"@6
MDI`@*HLI!I324EIRL)&T47>=87\5>77T*$5QYFYH$_%+6.7LT5ZSPF24B])*
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MDQ%3XJ?7*E1G-S)W`;:5-=0K+9LTXY0K0U-."E7=7W36\J7!XW*V:VYWS6S;
M;>A'(&9.GY&&HJ>OZ$.>>,VM((1#I3TU)(/>AU>A:MEM`V,5(&Q0EUU->2?"
M"4?0;YR9D$F3:LAS7(;A9`TR[+A3KU\W$F#U$.*8=CF&D.I2[0TJ**%:Z1MM
M/>QU7,(3F;66W$0#W^]E&'#!)NYO)B7&YL-J"RB:0:5J!Z::?#IJ>9&UC<-J
MKMPYCC5IJ47_`#._S%923X5/A^/6Z;(WW_W_`(5^M_EZ$ES6<=R7,'GNQ*;(
M5&4$I\ZRA2'"4H.]20@-I)W!-*UZ=]"F/S!)GD'+W\W;N@M1GQ+!$Q^1=7F4
MJ$-J4ZEL*:0XZ4^9+90:D>!T.EY4+R=G]J2GO>;&8^*\Z/N)Y_RB)?+G;(+S
M"519:T."+(2II@)0@H1V551;I4UZJ)UQ_J/J86LI:"%:.D.CQJDG-?7+MV5J
MH3#E%.0SC%O<IE41`>??6Y529$V2D!E`"2E27(RZDDD@ZY^>H_&>Y7`KKKNC
MYK"Q<^U#N93"F[^U+*1.;DP(L>#(>6"T4M-,E"U*!57>$!.Y#0I0DU`T@&/N
M:N.[`*GVL.H03/,P(&;?4;O3Y$7(L\!UI;4Y,%$HMJ0ZO>B0ZMU22#U;2FJR
M3^761:$#WL"I-FLW<$[6C,;?,*X$>[7'CN1EA=^=LSDBT)EMKB$K2XPZRH)+
M>X#IN40%=>GCK9NJ"S)M@<-E%&:]HD6J3C4(&$O::APX)4S[9U5-MMP]#U*J
M2AL*&PGJ1T6!TTW?;7+YA/#7(1Z5*VNHMEM.3?'\9GNBOR_:J56-9QD.+_9J
MKQ`C[)"R8[Z21)$>.=J)95Y@%NI`5]!.K1INI7MK)&'U#`X5[E!WNGV,[B^+
M%V[#>K9?:=S[*1)MMLN=X;7;EE"V8H8*G2XI:4[%N%5*!![T[ZZKHNH^,(`V
M+E>K,\)?5.!JK@[!>8=\AN2&5MN.IJI+(6E*O2(!;2`":=/'5\B:6LHG?YC4
M#?@N>XW)Q<ER,VIML-LG<`@[E%2=H`(I0I4>_C32[?B"2EOZQD)I\VQ2R7J.
MW=<@;^8%KBK#CR1M(2!7<*U-"$TU%7F]1_C1Q46%<D<,1)*;<WC2[@L/.M&1
MLWE2D.*2:J#=%4(I3P'34+"RT,M9:<S?[%-VS^99!_?ZRGMP_(,!<C2[S<,1
M@6.#;)*HSSDV$&GZJ3M;<0TL#HI9`^C5AA98\K"BAI/J)92.3,%O5LFP,/5:
MQ*+2HH<8:;:)+H(`!'7I3XZWR6&^BPJU?<)CWV/*C-SY;$7YW&<J8!J%DW1Q
M<.?$FDA8("T`L@=]W6M.FJO?!@NY!'\&;#S!1LU!*>%4WJ;M^ZS%E86[%641
M;G!6`D%WYV(Z$M2/5J12C>[;WHKOI.#ZGD4/J\G+LLW]\>U<MSY!O5QEINJI
M3ZBT4QOEF7$!M3?HA'K+W((-"?AVT\57\9VJ+7(?K7289+-&Y\5Q?\]0`E#I
M;54+<0D`[5'N*]M5;4K,R/>X;W%=`Z7O<H%=E`4C)$&!<V/EKN[.QB[.1?30
M^ME3D"Y))20X9"/32VA9H=O4]*UZ:IMW9XY7BAK]O[%;XYV>),M6OB`KVAW:
M-M-N.Q--+M\FT2WF''HSK;226)-N69<5Y55`?,.H45172/K52H`4TP%FT;A3
ML5HMYK26CB27'<<#Y.(3Z\7O2&9C-UM"RB[!MA%UAH2HA^WI"`M3?U=@*>OJ
M$&HZTZZL?3A&=S1N/M5;U?4G&YY1KRZD#AA]L1N5T<64$X%B;CCX?"K2V$N"
MH"ZI2I2@*F@2>FI.9N:\!X%62V]W3\WS"B8S,\M_=6QY-?T.M(5!@^M%2]U2
MY(;2:,()Z)6\>Q_@U+ZCJ_A+4-/!1.GZ2;JY+MN*HBY"S2X39ESD!]29=WG*
MES)#JBZM2"X5):20`:I53K\!KSQ?WV+C7$N/K7?X].I&T?W1ZDT<R\R7&T*+
MA4IO=N4:^:M.HJ.G;4/:S\]SSMI3VIY;6!&9(V9='7WE^H214`)KT%$@:='8
MGK;,-Q`H5P!]VH\Y[CQ/\NHBJ6+`EOCTQUJ4VM=7&4(0MQJM/4JI**`FH!ZZ
MG=,GMHK61DY%72-IYBFTMKSHW2?*TKT>_=^X5Q=F_%;EHR*WPE7F)-9F177&
MDE3BET4VRYT"C59`*JTIX:]/]-65A<]/0R84J.'$+R+JUWX?JB=A.X^HJ<V:
M\:VJYXW<L5N5O8;MS:%+A6]IEDMI>90YZ4EE83N2XT%$"A_.U8+W3;`MW)IX
MW=55JWBP1+7#?@!C9\L](99W#]8VVVZI`#I_U19()KTZ=-574((8+9S(:9=N
M'%2FER\V<.X&GH29L=K"%;BD*"U;MP2!0*/C6M:#4;H_PO4EK/PCN3O6QIM+
M"$H3M*#4F@ZCX?1WU+*MI=6U]M;8;)VG<HU/7I0'MTT]@^GY4+"Y3:50E)!H
M0%[O%([TIXTTLDYGB.)SSN"1T&:I]];BAT#NP)*JFH)J:]!UT*-_,`G&B2`Y
M:Y;>VFU-:UZ=?HIH6.;SOQ./L7&X^`T1M/9/C](T+*T-RPBOD)K3Q`[5^@_'
M0A'>)20N[RCM(JI/C6GD2-"D8/I#[;UIY"S-_&'&VX=5.R2$)<"MJ4)5]8%)
M22>A^.DIW\N+/VA.H8N=)RT0/YZ)6-+3+>"WT"B0E034*25$D4/8Z8^+[4[_
M`"](7),H@2<`O,B,SZ+K&(71J2I;J5AQ45PK<<.U`*4N!/;PUM?G-H,[N+7>
MI,-,9R^IH6<)`/2JV;CG5JLT*R0YN9Y399*\?0XRS9K<J7`D-K;=;])Q\*HR
M@E%36NO.L$XMV7#SL-1Z5Z:U]MR_3HO#?&`VO=3^Q*21E0E-9F['FN30O',0
MCI=<6DOK+X>4%NA(\B@&^J>_72.G1>+TF4C';[$Z_,8K:?3A>&ASM]:X>.,M
MBRLCL;*7J/.7BW-J#BBE#;JI;*5)<6D*H$J[D#4)TXW)U'"S@0/,0KWUF]LO
M3ES(SX'9B.XU(5A.3R+PU-FSV4RUP_MBY//.M1)"XK#5O+#94Y)4EMM:7E*Z
M4'37I35W3MY'(VU%>ZA7CBS99OE?XVF0.-._^Q*#E[/,O;N^(P;<Q-E8W'LM
MG<DW&T6QV3'6Z]'+C[)6VH4=:)`6.M#I/4GWW@\*UHK=8P:#A4MKY%(E#F+;
MK&K'YQ<;5;8[<TOI*5I>=9;>=)25504NFA'@=6B&O)97;D;Z@N>S4YS\OPYW
M4[JFB6C]SBL0&VTR$U6""0:=DCPKU[Z=VWU0F=T:0%,',O<A'(2X4=XJ8EVH
M^HI)\J_(GPJ:T_#JIV__`+G/?]RM$O\`[7'VXJ0]@=F2+/$69JX10%G>AMMQ
MQ*0"20'06^J>]1VU?%7DJ,0M>29??!;,=FW6X+#;@>D_)P&XD<>*G7E,%(H`
M2!XTUATXA:1Q4EI]B;PN-/A(]*EC@7"5EL<=NXWIL9->91#CTB>E#D%AP.J!
M^48;`2@-A(I3IN&H"YOJ2`UV%7&ST/`5&&]/'<A9<5M;USN#J+;;HB?F`VPR
MR94Q2`2F,V@)2H^MIT9_&>X-Z=73=/T@9S11*N_(>5\GY'!LG'JG[6S(D.OS
M8S%&GX5J9.U-RGUI5;[X+:4C;2E>NM70>'B(^8U4$[67ZK,(+(U@&#J<?[%+
M_%L0DXW8(%DD27Y"W7')<RX3?*7YTR4B6MY!6LE+`7T*?$:KUT<IS<"KQI$-
MGIV4W-,SBD5S-Q@[?TP,SM-M#>0VJ,M$^,R0IV7:6OKJJF@D27'@V4=*A-=.
MK&_-<2F'4_3L>IM-S9BO"BAKDR]\9:?33&6OS/,R7/2>8=J4J;=;4G<%B@U:
M+>43,SC95<JEMI[1_)N*YQZDRZ[F(GKM^HHN[EI:"FE%HJ!(%36A1].ETA*[
M)&7\`HU\U8Q/RV&NYB\2XC]K494..P74L./%/IJ3)2AQ/J,J3X?'47J'PJ,_
M,`D#QK/S:2\BD&):EV5L%B59X[L9ZXK_`#O74ZIP*/3K6HKIK;_2\I09.=[X
M4I8EW?N4DS)A=^8^73&:0L'<AD44M!40`?U@KIY!]4)2#ZH^VY*)A]M"24JW
ME5-R1T**5I7OWK_!J24DNMF0VXO83L(ZFO7PK]&A!1FF0PE0*EJ-"*!#:G%*
M5^:D)%/K'I]&A)3R<N,O41_=)<RBQV:UA*P;ADT29*C&B%KB16E-J01YNA4N
MM=0VH[<%6KV^;4BNY06&0-,<F[2/FX]M<D^@E*P@+2N/1"`2%!(030_'53B_
MW)X/S?<G<L%=)BNOF:#Z2K7N/.58^,XAA]D5*@V\3)"[;(NDYA3MN@F8PB1O
M?;0DJ33ZNXJ`&N@VX_``3RWO\MARZ[Q[4Y69\AV>VX)EJ;A=8*;NNTF+:7H^
MQ,:X,/.+3ZT5:5J_5O$D`'J*:4HM?'A02ON&<,N\9LY_,L$$WN$$QI*VG"AU
M=V0CSH]&M'I2I(^O2A/AJ%FT^Q?*Y[Z9RXD]ZE=(O_>=WE-OE%J9C76QV*'(
M2R(\*VQWB6U!+<V:/M$@HW`GU&F>OP(TUGM+6W:'P4S$T/<DGW//O7-&YOM5
MKN,SF[CC=DNH7N8EVJW.*#*A)6PM,&,VMA004E2T;*GMWU*V'TTJEMCX"YTO
MKM2IBH*A0@`A8JD]B0.WAI^A-K>);)NEQ?W='YBR$^*=@VD$TZUT(7$R^T\K
M:%4[=>_?\8T(7;Z[OZ1^'<]ORZ%%_>F*;MLUH*"$J<24J2I"*(64*!"MKB#O
M20"3TT8+/-D2?]U_+,S@_A1^T0I*_P!XK[8Q!0Z4I=<B1[HV%144<2KJ&T+\
MU*]-0^MWC;.P>\FCZ&BD-*MYK_4HK88Q./O=V!V[L*KR\9G-NLNX39$B6_&$
MR1ZCTAY:G_6=HG>K]9NV@J!Z#IKRMKMU+=WLF9U:E>N^E[6WL[./E,;[K*#"
MF%?3QJFQCVN0BYEE"U/Q0N1->>!-"H)*E]*]`1V'8>&J_"'6[QR_A\ZN[KW/
M:D>Z)!0`4&Q+^WW6?'"'X$MUB"7D-*`4"\!M&YM+RJN);([I!I74Y:ZT^UB<
MV0U<2",!L54U&SMGM)<P<T@T_L3MV;+DQOU4&#:BZI(0X_*"7WBI70N)0\5I
M2Z*UZ`==/8M9GFD#69<A<-PW^1<_GT&6X:]TSG9`TFE*"@!P!"5-YLZ7;>U<
M(:/2GNEEY]Y)-%@D!8#=?334J'0`:>RV%K-)SI&GF=Y'H1I3C!'R(_I4I0X^
MDXI3V:)=79"H,9N*ZA"D>:2^XA55--DI`20"GQK].E7:K<6<S;6(CE$5V`^D
MCL3;4M*M9'&8`A].)'HV)>-V7[3!$I/SUTMD=UM^&EQ:6X%N2"'9"0DI#B4)
M'0FIIJS6[XKF`OE;4T[MO<J8]US#=,CC>.7F&!`/K2ZC7Y6-V0+LCSUOO3);
M7;);2U?JELJ#DC>VHEMU*F$D`*!`/7OJ1LM?@TQP9;5;)Y_75,;+IN34[V2;
M6!GMMU*MIY6T5N'LES/*<HM\^X7.\2IL8,PEL>N05I6\-L@;@`I25$=`>B?#
M75^G-5NM3T]MS.ZKS(X;`,!2FQ4K7;:/3M1=:VV$(`(%:[>TJ?0?=7=)2BLD
MA`I_!2OQU>[2&%S@915N_'L44Q[I"&/Q:449DZLXKD%37;:9CB104WH:)2:#
MN`?#45J\$0KX<4\I]J<>&BX'SE5'V\W`W.*\S$N*_4E2E>I'CH+"EF2X24#;
M0&O?Z=4$VMPZ^)=7+AV;E*1S-AM!#&:$5[=ZE)&CYC>.,LT81!O-UO3DY"8C
M;L=M2UJ#B"4@[/%-=6:>R8S3G/@J+FHIB3O%<-FQ,K0.DOP)\;<@U&S<:8]Z
M(^&.,;_&M;+N2V7(H5Z?<D..16TJ:CQ0VE:F_F7D%*P5]QU[`Z:VL+R/QZ^I
M/;N)C3^`*>E0U]U(R[[%@9'ZC\T0KY=+)<FMY*6FT-K#037ZNQ%"5=":==5[
MJ^6XTVU%Q8'*XC&N/KJFFCPV]SJ#X;[&APVC'`[E$>U<HW&=(8A27ES4M+;N
MP0L)"THEH$6<X7$I"RDNMD[:T'AJGV/5<EQ:B(.__(9AC0?#^\*;,<,:8*R7
MO1D$D3IIF5LJ'"I'O;6X[<%*/'U,2F(S\9DS&+DR$)2%*'HN+Z>F2#4J%0:]
M]=*L9X;BV#G$&6G'?W+S]J=C-;:D86@B$/V<1WI+9;AN0X^ZZ](LJW84E:G(
M\Q146RI9);@E))!4HG;4]=1TL4Q>YKA5M2K'87)MW@L>8R*"F6HI\U?8F]>E
MRU+BQI]@4@./H:;?E%Z;'BDA5%B(XI;9;0D'<`*A-=,9-/A?0S1FE>*LD;XY
MR7-F#I:;JM)\R<1'&G'^1QVX>,Y=`D9RZS)=9MT;&)=FQRYW2.VE_P"R+;D*
ME+0]/>82O8V^TI+RT[4&ND19:8\Y(F4D[S]Z?MDOXQFE<\P#9F-2!V5/I%$H
M^&<-7D<N3":L\:/<[<'WW7Y]Q;MDI?H;TKCM-QTKDNR44(5`EMM!:@0E:0-;
M:=8VT!>^-I#ZG&O:H6_?=BZ8;9_NFII0FA\N&/$$J9T.]W1/$&)[8I$NW2;C
M;"OH26&+B6D)*#T-$#ZW<_'4?G<ZYGK^XP$=]:+MMC$':/;B45D)-=W[JB![
MJ<EDVOC2YA:E1TKN40K;Z$D!((J356T_#MJ"ZGN)?R(W5?QP#CY.&Q:]*2O=
MU)X)U#;D[*=HW[52_D5\1+?W*))43M\/BKL.VN&22F0^_C5=LM3>25S$9!V!
M);[0;VE)Z@T!Z_3T[]M;6N2";*W`/V^3^U2S67+6%T9ILK@E_P`2\29!S#>K
MW!L*P$V6`JYRD;4JE.L)`3MA-TH]YN]>M>FK+TYH>H]0ZF^VMS^"UI)%,<!7
M@H7JCJFTZ6TUES>`&5[@`=VVF(PQ[D@,DLMQQB?)A3H<Z.(4]ZV/FY,IBR1*
MC@E9#*`!0D=>G35::&M/OM*LEG'%J,)G@(#:5H#7R8\$>XTH27VVVVB^Z^&&
M&6`H@K6MY`'5-#WTM;VS-2N6Q0@Y0:&A.W<FWB[:RMYFW>RB](_LQX^RO"<4
M@WBY1/0;NENBN,MI5U92\W1-3W*DCJ">M=>L.C+%\.F-M9ZY`WW>_=Z5XGZ@
M+9^JIIV5Y!/WJRR2);=GC2G'"XXU'HE;@#BO,`DE154K!!(ZZN[M)C=;$W%3
M-WD>A;^&A&X^<JM'D]AI&69%&2G:RW,JA`)\OJ-I=7UK4U6HGZ-4#4K>2V@D
M9(=IJ.[!2^D1LCG#6;*I!VQ"4(*4@`)%!^`?3WU'Z**Y@=E5):X2(\PV@%*.
M-,4Q4$C:1TZ#OT\:?`:L7)CX*F\^7CZ$?VZXI4H$]R2.AIX?`:4:T-%&[%CQ
M$O'T+LGO+*DFO0A9'0=BDD>'PUE)SS2.A<TG`A(JWS%-5*B/-(6.P\%?R:PH
MJ@3EVN6MRW2E)(HH4[#P--93Z`4C'E7/,?<00E)`!":]`:]`?X]"67#\P[\1
M_H1H0E1B:U)EO.CZZNI/X@.W;6;/\:Z=%)BP#[DO!*_,(_W4C.:H^_[)<;J'
M7&O46K<>I'4T!-!4?#43U#(^",LB-&X*VZ%;Q37;1(*C*=]-RC!?,D?M\!:$
MOJ2KU@@]E#;0U%"#3MKGMUJ=[%\#@/(%T6VT73I/C82?XG?>C*U2+A?,0OT*
MW)7*DS+7<X<:(VVEUR2[,8<*([;9!"UO22D`?$TU<+6\=J73G(BQN3'1W::8
M]RY/K+!IG6C!:C+;ME[]A[5Q\;?=]<L7"P,OYA:;:U*R!#;EN3)S$0EP[24N
M_P`W?MS:77(SZ2\.R0!XGMJ)T;].+>[TQ\][&YQ>^GQ.''@5/=4]?=5PZK':
M:5.QMCR,08HW&ON[RTG8EM;ONU.76)&11;)=L-:3>W;#%:$S(I<IQ#D)4FJ*
MHA%&U,8)'7J3UUL.@K738W6]JQS8'?WG'OQ*49U+K6LM@=J;VF6`D@M:&\*8
M`#$&O9BC7CW[L[G3&\CM]PG2,*#+=ZBS?F(^1^L\EIJ8E\NL1%0D*<<V"H02
M#7IJL:;^ENH6VJG4C*`SF$M[&DU`V8T%-JZ?JGZGP:CHK-&MX'"1L08]WS.#
M0USMN%34X*S2)[8K_(M=[BY9FQF6R5)N<B!8X&U9]&8ZPHM+*4A:4J2V1NK7
M78;;2P`'7CA(\#"F%/-1<.FTNZ?*Y]S4VA-6@8$.XU%#LW52-RCC[.8%J3$Q
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M2YR!^M8<\QW!C>13QKJ$?=3R?&:T[`NC:/90VS79&TS4KB3ZT_T%MAYE:FX[
M02EM2FFFT!M`(22$I2D`#<L?E.J]<2O,X:3AF"ND+&"(FFQI]`557O/Y9S6%
MG!P?"[5(OUTE8_;/EV(ZBTBT2)T9Q4M92@!+K@6D%)54H\*:NEC;Q-Q:,>\K
M@_6^IW)?RX7^X>P+F]G*KOQS9<WN/*L2<G.;XJV0;5&?>=2V_:82S<Y)<EH4
MEQE1?64]/S1K;5^8V:-L9I&68X;ZE(]$W7@+*:0G\9TM03CAE`W]JZ+-R?S+
M[@^6F\>MSLVV8O9,GCM7>X072U:;7;X9]9<0R&PE;[\I#6T)43UZ::BQL)8"
M9VDNRG]XCU*P3:AJM_>1![ZP\QM:`#"HKL"L=O5XRR/"9@62"W(5'C--/7F4
MH!*_11Z:0E)JE*RDUZ#J!IA':Z?'BQI'_$?O70H+_4;6/DPN`C[0#ZP44Q>*
M+;ED&;)R>VV&=>7X85&D-NKAE#A*BDNMQ5--O.!1-2H$G6':K'97`MV81$`T
MV[>TX[DA-T\-9MW:A,VMP#EJ*C`8[!0;U#?+.+,K>R>1@2K'#BW5Q"_LN1`:
M0['GQGR1'F)=6"I$6&@CYA0ZI4#JS1ZCILMF_*/]66G*:GXNZM"N>3=,ZG+J
M4=D#EMI'Y3AN/;2H2(Y%]JM_PVR6-ZYWYB_JN:%0[DW:VF_5CW%/\X4EQ"4@
M(;#'E%`*G32#D3_S8KZ/4D]4Z+_+P29`B*S<2,XV6(D#'+K/EOM-N1TR4*9A
M!UT;E$R$%+BU$CJ":#PT_P"3I;/=8VC?XC]ZB(-)EY?N>\VIQ2R;X:DN"W2)
M4<ABY1'#Z<9%'4RH:BF9L(\Q!<4GIVH-8<=/B;S`,1VE*OTN[8W-%A)NW^M-
M'F7'.28WZDJT@^@MP^HFYI#8"6Z;0R:577<=WPZ:2$S'_`F_(U%A_$]04;.3
M>7$\<RK7:8\.W7W+;HCYQRTMRWDQ[;;$I],RK@XA06T5N)J`*>4C3:2Y+7&,
M'WPF&ISWEM;\R-V5W&@/DV)F)O*G-[C2KB7K=98SE'(OV?9TR&6]IJ`9<YMW
MZW;J23H@?<ND!DIR^P>U00U*]GA.=Y<RN-6M'J^]1SR3-\LR&X29F179RXW)
M,M`:<=;92VTDH4%AIA"$LH!/P&F>H;4WD9',`7`G`U30K9<CY7/E,A:GF$/M
M$;E$N2ULDMCJ?SG%CIVU7(HF"Z<\#WJ\=ZMT4K)=)@MI\(@T>05*M>]LV3XU
MFF`W.P7AN`Q>X,5AJ?!N"4T<<>90V^ZEPC>DCTDC:D@:O6BL\6_D3/#6!A/E
M']JC+:6P@G,<[#);T-`"1C7`UP*;/W`XD+=;DS+Q=HL/'XZVW5IMI]!E$9A:
MBAO<T4J20!7H>ND]48ZV/X5PT>0'UK6ZM;RZ.;282T=OO>NJCAB.3V[DS(XA
MMS3T'C+#Y,=YI:WG7'<HO]L<2XMU;:U'^:*=:JKP*3UU7;)QNI7\UV<9CB,*
M^93MQ#;=-V,+]0!%^^-I>*D4<6@G?V[*8+LRW*T7W*H4Z.4H\DB<]M2E.Z.$
M+8M_0``+8;W)![D:RP!UVZ)WP!M:=M5&'FMC&IPFD<AR[*]OL3K<8WG.[(F#
M=+1>[B`PTF0Q`<?5(BSV?J-1$QWO4::6E**%20%&O4ZDHWNB%&8!)>.N?F'F
M"LDXGSAK-K2;LXU]GW&.A<'(+.?-.A7`IJU\PE71J-(IN2I-.AU*MJ0#V)\+
MB4@5.-.`2/O+K:YDGTZ@B4]7S*/2M!X_1K*SXB7CZ$7177$OD!1`HG^[H1XB
M7CZ`E+ZR_C_D^/X="1JNRW6N`J4F5<B$VBU(1>+G/6A1@1(<)7S'S$B4D%I#
M:5M"IKT\>FMWQNB89)*!@XD?>FT5W#/<R6D69UQ&*N`:[#RTH?(J3/>QSQ;.
M8N2\EN&+NW5G!;*VN!<,B2O<BZ,L!*!;<;2M*5MKG.-$*?(]+T@H;JD5Y1UK
MK,%W&VWT]^8L#@\[!NH!6E=AQ&':NL=%:(Z++J%VVKY7`1,H:BFU[\*`"N#:
MYJT)%%3MD-Z7<)TU:UM-1$OTCVN,E9;B-T`::9%#ZJ0@`DIJ-Q-=>>;JX9!<
MN\6:5.&!/=LJO3EE9O9:L+!3#%Q(Q/L1*VS)=HI2BPV@[UN_6(2CJ4[$`K.[
MMVUHUKW_``IR.6*TH33['R)=<;83,SO*416H[@@H_7*2"$?,E!'G\Y3L-.E#
M0ZE-,T*?59O=82&G94"O;BJ_U5U%I?3FCNN+Z<1OV`Y7.I7=[H.W;53.M6'8
MU!BW"$S9[:Q=K:4*6F7;VW?7>Z!A+TM"E*"770`I2:J2#7PUT"ST"RACDC-!
M<QL<ZE-X!.T8;EQ$]3ZU)(R:+-)ITM*.S?N';0$U&!V41P,0EW"(E<FQ1FU)
M6E>VUW%R5';-"-R(KI"Z@JI4"O73>VTZ\N_H,J>\#UE3]KK6F0NK))1M=X/W
M)\\'X&R=YN'/?@7%+$Q05$7\HLH+9"=H4H`[#NK]:FK1IW0NH7+?$W,0`#J?
M$TX8'CVJK=5=8VL5VV"SE#F&('`';5REK#]M&-MXU(DSVV8F3F,M3LR3(#"'
MF/3*OEG"VHK2#VJ!75UAZ<LK6W+9L'9>_'R+FT^LZK+.)V-K$#7:/551-A<(
MYO?KK=8T;Y:1BD2<62N-)>*XTE+G5*VIH9<(+0--H)/X-<_N>D-1N-5$UM'6
MUKMS-'H)KZ%TJ\ZRTL:`R"TDKJ-/>&5PQ[R*>E6>^U[!;QA[Z6%.J9@,QV]K
MI">JB!NJVDE72GPUV71=-?8V;8`*`$G:-ZY;?7<E]/XB3XBT#S*;K;[?K))7
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M%9Y?L*81+7>++<7UEQB.X\L1%*;HH^D%CTG0ZD@]M4*?I%EG,9K,%TM"`,-A
M4[IW6<;;3PNM.$<8`W$X@8?#7:EUQW=LKP*YA$N$NYEF1Z$B-+1M:::;`2X6
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M#<R8%*#OIQG%DDTZJ`(Z:GV6\EN^0R"@+C3SX)CHMLYX8+MH#1B"<3CCYNQ1
MWQJ1D6&YSDG'E^N$BZ,62XSX]AFRU!R2FSL2%JBQ)+S94PZMI@U202=HH>NJ
MO*YMO<2F;#FMRMWU-:TPV8<5T]MQ`+=K6'\..I.!PJ*)EO=HRZ]QS<5(25CY
MF#-)_P"ITB45K-?$!8Z?6^C4+U3&]G3YA>*2$8#R)OT<QT_4WBX\8`=M0-_`
MXJE>^*<:=0`#O*10#Z4?$=!KB$D;HL7BB]"V4;<1N2)7-?:6X5)(%13Q^/AW
MTS?/"/Q`??:#3`JS16\;X^6,:T4V_8;RW"P/F)#EV4W\G>[<[:U+=W(2RAL^
MI&<W;3U^963\>FKU^D'4<VE]0OEOP&VKVEM=NW`8`D[^"XY^N/2,^L]-LCTL
M9Y8Y0ZE0,:BN)H,`*J9_)'MCD9%8\PO&87*X*RY>1HN%C6"U=8638Q?TN2H=
MS8NC!=2EU#K1WLDAUH]'$IUT75.@L[#X=@)[V_>N/']4I=#NV06\E;0G$T<*
M>0XIE?;Q[:+JKDJ%'R.WK%JBRDN(]5YA&]"5;J!*G0H@T'AIITKT)?V.H\Z>
M&EN'`DYF^H&I4AUM^IVDW^E10Z7<9K^9A+FACQB,*5+0/2KT&;=>,5M-G:Q=
MM:8,,K*(]/63&B!JB24;D^ND*J=H-3VZ:]`3^$M[>-MF:N:03@1L/<N22SMY
M$;[@D73GBHV[QO&'I3.9_P"X[G2VWJV6B.AEJW,%A,61^[[K$:4E<AAA$:2X
MB5*4&WBZ-R2D&@K4`'59UK6M1$]86DP\5-TQHD-E.9/Y7>9-\DQHL65+*42C
M#26X3\E@>B^]$2X*^CZB"FO8D5&HB]O?'61D_>:*'U^U/-/GBCN6L>:./84G
M/GR$DE0%`3T4GX_0G3+1-I[U*:W[\-6XBA]2.H5R4ML!!"C7QH/@/$4U9U2<
MI1Y$?DAY(4@`GL-Z/$'KT[Z$F^1C#E<<4;2P5%/;<I)Z;AW*"?C].LM!<<HV
ME(RS1\LX[D@6)'H!T`C=ZZZCX?#K0_'2GAY>'I"8<Z/BG'Q:4A=MF%:@%'=T
MZGL?P?#6?#S</2$^@ECY8Q7-=+J*&BATV^'X/B-9\/*-H2CIXFMS..'E1?%N
M>\K`4"?+TZ#]+^].L<B7AZ0LQRQRBK#4?;BG.P12ER7W3V;4/4/3RD[:#IWZ
M?#2=BTLOY&NVBGJ"4$K('9I31OG]217-D\.2XC"C0^F32G3RBO@*#45U##).
MYT<0J^E=H&`KQ5XZ<FC?<-E:?<RG'O"A+F/6.L#_``XK\/,O:D5[5)-`.^N5
M7Y#9#$?C\ZZQ;$1Q"5^#*;599[/.$46G%O[2,E84S=I;3*+#"?*0J+%>`K,*
M:D!4E)^J?,/$:[+T#I-M;Z5S[_W><P.;OK4=E:>5<2ZMGBFU>:6V.:5LI[/6
MK$;+;;6MI+C@#TA`W%LI*:)!%5;U`)-#3H#JY\\PVAMH1AS*^3'[UIIS[>Y%
M;MU+@#OP2SB3XL5:%L(0R6Z)V';U(_/KV['\.H.Z\?)7EL!\H^]/GW5E!@'4
M'<?N7:]E5H22N:TVE:*D%-5U4FM5>0*H5'3<6%W*`)7913[;%O'U7B(C;M#&
MX!V&(&%=M<=NQ=C6:XP\QZ)+*'2GR>IN:17KT4XL)0@4^)`TO#I?A7F1CR]Q
M%*<-Z>.UZPF;29^7R$X^0(F9N'V^I<.WS68#_J*2ESUFU)(J-J@L':I)^CII
MP(9."82-@NC^`<P/D]:/H%PC-AQER6A3L;H\2HU)31LK%?K;E=>FH\V5R23E
M](3P3:6T92X9AV'=Y%C=I,9]A!"FW``LUVA5*A/Q2>^EH;.9M<[?2%J^?3:>
MX[WNX_<FHO+5N6M:W(J''#W71"20$@?01M&E_".VY5!W,KBZL.S%%O&MNM<C
M)IDV1"H8<-MFWD$*]1TJVN_5KZ90T2:FE:=-,KW"(J7T=]MG&./<?N4O[6RS
MZ31CQ"VH4)?+@.P]/S2K<HTU7'2,8:..)708G1EH='\-,<$93,MB8G9[S<I<
MM*EPU+<)<2M/KOM,AUMML%%5!:@$U'34>ZRN9I@^)M69AO`]94D[4;2&W>'O
MH[([C\I55N=9%D;=SGY_"A*GW*YSI%R#04V%6IA9*_2!6H%U)_O:TU=[>-\=
M,V"\YZU)SY1(<6<5'6'FO)_+.;VBQ1;I<DS[U>(=LC0(>UL5=>I(+JW"AMI+
M<<$[U$)Z4K73F\EMJ-S'W@.!^Y-K6=T]Y';Z?[P(]X?#C7MIN5VN"X78>-\3
MCXM9"7H,-V,[+?6FC]TOCH0FXW%TT"@H/[E=>_AJI75T,Y9'4DX#`[UW#1M*
M?!"V6\:`<#M!]1*7##R=Q\QIM/3K3N/"E--:7/#TC[U9,UM]@C:"XVJ0TV#5
M;RMB$@&I4>PK2B1])Z:3?;Q2'/<FDNSCA]JJ4M+UL5L88A5I<3YZ+DN]QG+N
M4O[%CV^+>8"465623FE.RHL68*/I@[0?.P00D]M;VXABF8[,<@<*X'9YE'73
M7S-=D%)",#P*2,7CVRRKLW=[Q/N-UN`45/RK@OU%*4>_HALE*6:]@>HT]N[U
MA^@:^<>M17]/Q7V%],6CN)]0*4$C%+$HN/(BU>,V,M":T_4,@I*JGR_B[ZC/
M'3@^]4%/K?IVPLH_#VSN9"#6M*8G;M`V)3(LEN59'GXL$..6BX&?&34)4J.4
M^G*4`JA\K*U*V]S3H#TTC<7TSH7!I-</6GUMHUL^=K7CW<?44@.2,2L]Y9N%
MJ3$2@S+1;+G$=\I(CS?F!ZH%00=S)JD^84ZC4KHUX:CG&A\_J4+KND6[*B(+
MSE^\#"HW$7NCL.0-.FY63)['&6\\4*2A-XLC;7S4$(5Y][<'TUCI1>Z@J:ZV
MOY^1J//>?])+3*>-``<-HQ!VKE.MV;;B&2"$5FB()&S`CMV[O.GZMTG'LLM$
M-$2UG:^@H"Q4)`*:D;5`=]76*$>%!%#(ZA'<J1#$)K5\<&,@(J/+VJ`_(.+(
M9Y#F62/&+$:)+;F.JW)V)9AJ,UUQQ8.U`2&4CJ>M>FH/4K65QI04[Q]Z;_BV
M9+WBCJ$<=HHF0D5G7M$.*0[=L@N,LB.V1^RN#2D0E>I^R2IR7N2$DA0I4@`C
M578U_BG1-IF+CO'##?Q4W$R8V7.-<C&MIVT(S"FW85).]\;Y1:<.C79N5-ME
MU855Q49]<5]#*XK2"2M@E:T^JUU2/PZL[M/NG6OND,-1B"/856H;F>VNS*6%
MS-FRF_M4:N0K=REE]HM5OON39#=;)&4'FX2Y*WH*TI<4")!=VN!PTI3M2FJ9
MJG3>LW)_">XU_O#VKIVA=<6MAA+&`!Q!]F"<GCFRWB-&@X[;0F%&-EN%P>82
M4I;<C!M33H#A(2-RJIZFNI718WV-J6W6V%N5QVXC`[.Y5#6[B;J;5I"[Z3Y2
MY@!W$U&WR+5C;:[_`"<ANL&/*F0H$IN#ZL:)(<4W$M[B8Z'5M(;+J6_4</4B
MGXM+:?-'?7<DMJ<T8;2NS>-QH4XOY':=;1Z7/4$',,*[CO%0IR\96V+(CQ`%
MA2VF&W%;4DA+92-M%4VDBG4#J/'4UX>7AZ0F$(,XK&/9ZTZ"4SL`OC&867=(
MCK5\G<;=T2)EJ=0I4E1*B`%(60:'S=.FI%M0T`[:*2`(`!VI4R+RS/C1;K$`
M1$N252&D?G(4?KI4"DJ20?`@:RLKD$]1%0>GX0#_`,Z#H0C_`.TE_P![^S^(
M_P!+H2?,9Q5*7N;]Q-^]RN6V6W^V')<R@06>,'K[R):;O<5V866ZQ57%RX8\
MPJ.#!R&*B-";(=0!O+VTH`!.N+]2=87G44!=H!=R0VIIP\FU=_Z9Z0T'I7_\
MAU(&\ZZDY;`0#F-!6M2"!39ACWJG.^<BYC=VU6V^3IDXPW7F`JXJ6U)AA*]K
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M+V$?B-8EAI\=6^>H]JD>H"=`T"VGCH]S;?,*<0VM-FW<IF\><)LQ;W#CY+OB
M1DO)HN.L+]1(6DA954#::=OX=7BSZ>\&=F`7'_ZGO]<]UP=$".Y6.66S6]N&
MFSPG7#`890Q&2-NZH"?YP#0FIK2GT=^NKC9LY=H6[LQ]06IMI+:1K9)#(YWO
M5K7R>A,QRW<>1<78R1O"\2M5]MF+VV!.RF7>[G!C/(MTY^,PMZVL+#LB7(2V
M_OV(&ZHIJ*NVEQ#1C4T5A@##`>82!E.P5QI@-HVG"N[:GKX7XAB_8,W)KQ'6
MS(RY$:Z*94V$LE12D^JF(5`1EI'E[FHZZ?6-@`:I@GSCVFWVH+9AQD-;F6VP
MM-`1M'UJ`=:UU,&,0G(%E<C#U9BXVWHT*[Z]5=*=J=.^MX?JCO0C^)W7^`?Q
MG4DLHYA?M?R_Q:CKCZI\GJ6T7U4K;8%LNMRFUT6A*P`4@@[P4'Q^!TTF^`JS
M6?#L/J1Y#4^9B2'$!+A_6)]%)*B.@(7NJGIIDG&EXZ@.]=UWB"7=&(B5-M-7
M&.S!>#R4K;&]P)]=2UD!`2%]3V`%:Z=/_EV]WM3W7/J2?;<JJKWR!@%Q]V.<
MQ;G$*&)TJ;BOVZGY-<%Z="9;CMQV5H6I2BAY@;%`?K*^%-1<!B%Y6;X,I7.H
M[,7]XZ`[HW.\U%%OD:UQ+7G-T8@!097)0AQ3E'-S_P!1YQ-0-M2.HU*%^G[,
M*KFNI73H[YUJ*4::)QK0DQ;;`8:5121'<+H%-Q3M/U*T37\.FQRYCD^"N'<I
M6SVM'<GBQR'*GM/1+.&&+M(CO&$N11<5V9Z:E)1*:5M2ZTZ`4D$^-?#0K4SX
M`E3A%AN:;3)AWDM"]/L/)GP(C3;<>W.%:TF/!(KM10;P0!]?M\1;*3]@Q4HP
M#%K494V/(N#=P<<H\3L,992PZX@4+I2E/B1^'4%>_$>]7G3J<MG\(]2JOY:@
MSF.89K$&,\1\XAY]Y390E*4*V+HX*^IZP%#\._75/O(.?<PCA)[%899N39O=
MQ":_W"6H7#BO+7W&]OR;1<0FFX%*DU#-33:EL=*^.L]96-=-;LK3V)7H"]__
M`"+L=_M5&>0HC1E*]4[W:`I!`!%2/I)Z"NO.]]@T^5>E+(U<"FWN!80E3H15
M!519'4I/Y@`KU*J:A(F-?%(#V>U6B#-4%O8GMX/X?R?.9[5QLC+[3C$I#3!<
M28X2DC?Z@>W"I!':G7XZGNE>F-8OI^;:!V4.[>*YE^HG7>DZ%%X*]<PYQC0C
M;B**V_%<LS-ZR8[A.53W5Q</8G1K4E":/%N6M#SOS$JI4X&U)44`UH%TUZGT
MDSMD#;PFG:O#G6MU!*72V0`&;CLQV=J?'#K,DRDW1J<6?EBEUQ]U25N@4W>D
MVDJ22E7B?#5PF-N0WD4V8^ST*G:=J/AVF>^_=(RUX;]O:IG\8<J8ZXH0+V6'
M8B4)CT<6"5M*);6-I2.JTD]*Z1!`-3L!5SL>H;+4:-%"0?2CJ]8;B^3S!:(Z
M8S$"=>8=TM]ZCQG-L9$)3BU65U29#S@<N$=:DU":)I7PH77*L+O"@JK#^8%0
M&YAPUWB7.[EA[,IQ^S,MLW#'W7/5W_9EPWR/1_7)2I0CR5K1N%=VVO0]-5CJ
M2SALHLD``:YE?+6GL6D-]746$''+[2FR:O*U.-H]4$*4`1XT)U7M#VE6#5;X
MFW/\!]27EHEA53ZE*)KV[FJ?A35E5.\;VI3INI0X%[NP`I6G:O6M#K*8W%_2
M2E1L1Q+N12EMS?6C6[:/I;'2M/ITK%]5O>FLM_6)PPV)M1<%+]5:5$DON5%3
MT_'J23#Q?:G-Q"05VJ4I3A25;_*17LH^)(.A/H+\MC`KZ427:?L2H[QTV]/P
MD`=>NA8N-0/)./#UHMMMT"Y*6MP`6%'=T[I_-I3J>NBB7LKTBF."?#C2\(>-
MP;*4@AQ"2K?\"!4C;TIJ.MA74I?)Z@IBYDYMNR0;_O*(N:+!DEP5!NEHQZ]7
M.WI5+:F7*!`=EP8WHIJ!ZC(6M:W:42-H%>YU$=0-F>\MM_J$#S;U=NFGAD0)
M3-<(\6R>5.2XT2X,/?NGC*A?,J:>9*'%1HS@#,1Y*E)5'?4\D$)-24]::@M`
MT!EU?5O14]O>KCJFO>#L=M*!7%05141H\8MICPF&VQ$C-`-H;2V$B/T%*[4I
M3X:ZN(([4>&B^E'@.X+ELMQXN1US_F&OG2BEW7[*:0L`%M;6XO%6W:>AV[:*
M!!'7OH2EO+R7EW]TA-+DO*=N@-N5N"&$BNZ2\\EN,VOJ-BUBI"@`#VZ:QW)A
M>WQV[TWMOYCM5P+JH5YAW,LE?KI;DJV)4DG>$+"%;DU'0FE1K*CQ>DC:L&>3
M,?F(DOWJ:L6U)].5'A.E]\)W#:IM+='G"5=*)22-&*SXPN\B['.8<.QM3;J[
MK/@I])MR)'D,//2/DUBL=U34+YAY(<2#T4D+Z=1H6#U&;/W:[.U?&N8X]VN*
MKA`O0BQ=B"W%F>I'D3B0/(PVI/6H.ZAH:#KH4H-2S-#N(KY\5)#",T3=V4L/
MJ!#K2-CA<W&OFK1.T:$\L[GGEPX47W(I89<=*7.E:=*=J`5!Z^.A/DK^);).
M4U,F.MFBI!$8[?VL7PD`^&XFE.WTZ@;WZ15DT:R!D'>I(/385CM:YMTN#%OA
ML,J4M^0I*$J>`'I,(%2I3CM*#4`V`3/K38KW/=6NF6^6>@>\5'D_M4,N3\YN
MV;SX<5AA^VV5I*_3:+BB[."5$(=?1M;#961T%5>6FK#:60ILQ7(M=UJZ=.?#
MDEA.[@FGNF7VNT*C6PP)%TE/,*@B!!:,F4[(?HAMI#(2?K4ZFO33JJAN1XKW
M=J=_!N)+Q8;A9,RL>(-V*]/VYY9^><'S<)V0LA"W8Y;`;>0DU'7L=+--L(CS
MZ5JI*PZ:N&.\=`*-::*8&-"Y.6EPW4;)Z):?5:"MP4:CU'0OH2"03VU`7;K&
MONTS;N_<NFZ5XVXB&>N1@]`2H8(]5"3T"SM)^`/6O\&H]3*.;#(9%RENJ5N:
MC-[$DT\KB22I=:D`T(Z:8W7U!W)];?3\J,KNEA%@$M!:2\R](D/O!=7)9=>W
M-[Q3R%H*^)TW3A8M^FELM).];2D!2^Q4%MA8)%32A.A"R^'X/[ITUE^-/(?@
M\J4V/36A<H,1YE/RLB2TR\G?T4VXK:H$%/7=72+_`(2GMM]=OE]12`O[S<'*
M6V9*BZW:;?D-OE"E"Y&M<LOVL[:JHN2U/0E*.M*]"=2&G[?,H/7-_E5%'WF=
MH1)L4&[1(Z573$,O?N\MU%%?+--KM]GG!+@ZKCI47!7LKTOIZ3FM6U-*M+C#
M$G_J<N0S-SZC=LK2M!_R"GIHDS[><@Q]C!K;>;Y<+?$B-I4Y)ES9L6-'92$G
MNX^XC<XL]$IIYE=-3,>H6T7);>/#+?(<=PPP7/-/;=!TS+5I=<AV`\N/F"AK
MRMRUQ@G)<QRV/?[>\B3<$VJWMMW!EQ,F,VM1DH<89]1(2^M(&XGH/`Z8W^K]
M.`$^);3O'WJ7CT+J:_<&"U?4X_"=G'8DWQW=>&[1=<;RW*^1\'5>LJO4"^,6
MR'+<6,3M]JD.K6Q<TI9*8\P/>FA+/925;J^&JS;-TJ:^=<-N&Y7NJ,=WG4J_
M1>H;>)K&VDOAHV@5RG$\<!OIY@K.T2\,Y)M+4JP7>RY#&+)2^[;WFRT%$=M@
M^-?Q:Z"R&S9:AT$H>^HPK7#CMW*$NGOG9X:6+(\&I-*;-VQ-XOCMFWQ[A#<@
M1Y,.7O\`39V)'HE20DJ2Y1=:4[4&M,$Q\$."COG-A7@N&91>6H;S,BWV2Y8M
M%D--$EIR\W)V=`N;A_,9CI6&U^`0-U?#44ZS#K"Z?Q<X^M::3974&NQR2UY!
M-1NPJN+V*9V>-\RE2LFQ899B=]AQK=<KK%<BSA8U-K_G-Q?LR0XNXQY>ZBP%
M)+?UANIJ+Z9MC%&]U-I(]*NNH7NC2ZLZ*YIG$((!IQ&Q31]PV)PL#18^3^&(
MTC(L"OER2UDEIQB+)ND[&)4M14BYN1VF]Z;3+*P"E00IDH-0:C5HV*)N?#/=
M2SH!0]W]O!*>W01?<:CO26]N]IM:JH5UWMI)JE00I)->HI4:RFHK3':FB8=E
M8]<Y^-32MU+TE4NQO.U::5O_`&T%?UDM-L-T4%U)432@[Z$(P7-.X@JVJ3Y5
MI2=R0M/16U1`W"OCH0CWYY/^$'U/@G6:%,OO5`G#,2YX5=^1+M`MTXW'++!<
M+1"=5M6A#<MD^JE1HH5JBH(H:CX:X)TKI#M-EDMK(%L)81EVC9VU*[A^H6I0
M:CIVF,N;AM;>=KG9:`_%B3Y."@?EF-2G+]-CR$?+NLONMRTK&W>^IU14I:U4
M)*B>G4:Y%K5@+?7[D%M2YP\XS5]:](]-ZBU^DQW5J[F1EH((_=%,!P6VP<87
MFYW.(Q`AAV.Z4@J0VMS<%*H2H@*I0_3IY9:+XAS0(JBHX\>].]0ZUTRVA=^8
M7`:YK30&@Q`.&Q6=<:<8#$L?C,/L-&06SU2#NJ1UJD4Z]/AKN6B=.,M7BC,:
MX[5X7_4;KBZU_5.9),71$UIAAY@$L+3BF0W[D'CW',>@)D7')LPLN-Q&U)(,
MIR\7"+`?B.@4/H(B2U.$_0>O35AUNT8VYMY&#\1L9'G<MNG9["^L'6UV`Z#,
M'$8GW@/=.!XT4Y/>"C&+[SZF1@5KA1,,X.P_!^#X\F(I2%QG\6MZ7KBMYIMT
M^K#GW\NK:=HIS>JA5MH-;:7I,$=VV[+/]07BKL=F:M-M%IUIU'>26C;$2DV[
M![C:#`@4&ZNS<2E'CZ5S+=;Y!=*BB.E0"EU4!Y3U\?#71G,:[X@N86M[=2"K
MGFO</8$\V(YFJW2$"8I3B63M3O``V"E!T`KXZP&-:W(![JGH9FAPYF+D]MWM
M+F<PH[<=Q#&/W0047!]O8PFYK^88D+MDQ;01ZK"'D"M55%.ITF;:`D.+17RJ
MQQ3,Y!`WC!2"71A#D=I(:3#6Y"VI2$H].,&T,!"?JI0EOL1W[]=+L`C^#!()
M-*45*)4:FOC0=NPUL\32.YA-0F\SW6YY[S^#P[4FI<]BVO>LI(]1T[0Z&GI`
M4:T`#3"5+=-?!(K_``Z3?,V-IH:2<5K;ZBR[E$-K$72.-!M^].?B&#9YF10K
M'L)R>>T0VIR<S%,6`A#I(;6\N8VVMM!*32E3IN>H+6R_F7!W?^Q6:SZ;UO4,
M(8'"J=^[<`\H8Y8G+](LL1_Y<5<MEMF)N5U%>P=8'IIJH4(IV!U%2]5Z?-=%
MS`.6:4&/"AW\5.?_`*^UJ"(3S$M=O&'W)EKUD\S!G$1LML%^LDA=`B+/LSR0
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M99<>Q2=.<+#LJ-*BSXKKZPZE$MN0LDNI2H=0`GPTN;:QD-6,'G/WKCG4FF.M
M[ETQ%)7'$I"V[*KFA*&E@*;8"$>HJB5[4T&\B@H0!729TZ]!JQY$1V;,`J_^
M<RP9!7WM_>GML&<1;3`%RF),AQD#Y6*5%OYN2LAMIO\`5E#FT;MW0_FZSRI(
MS[[JG@K_`&^J13:>Q^R4N&/90^12<XK0J4ZB9+4I^=,47)8422TIQ*%",*=%
M(:01UT54M:-=<"HQ4IW'):[%ZMKA,2[YBK$I#-IEOJ@P+A;YE75O/3-I,=3`
M-`4@D4[:87ED]S<X/:KY8S0QM:PLQ``.W<%5-S#E=U5?YU\N`L%CD19CK,+'
MK7>&KS=YLH5#OVB!&06+<&NK:@=Q<Z:J\L+;>=LDN-78=A4CJMS%X`B-E#CZ
MDP/(U[3D7'>365BLBZ7:T/+^5<31,>4@&3Y=H!_8#8*]#^'2/49GNK0-J3'3
ML58Z,U9UCJ#GSUR5]J@W;O81R#F6.V_)WY#5N>F*4(]KN2TM2I0H5`-#]70)
M0=W7K0:YZ[],+B[`<;@8X[1OQX+M`_5VWLW$"$EFP&A%:;\2N2U_=Z9O!N/S
M&10WI-M9<:>#,<E3;H05%>XI`)ITI16L0_I3+8RATKN:UYV=W&B0OOUMN)+1
MT>FQ%DE,32I[*5\JEKA_&QPE*(\2,JW0F=A;8]/80XV@()4X$U4HJ!\?'75>
MGNG+C2(O]-[E!NIW[ZKRMUSU?=:S=DWD9>ZN^OL*2]\S&';[S-9*4I=#B235
M.\`FBJ[C4=.FD9>H;*W.6Y#2_B?V44K8=*76KZ&+YH+Y-M?-Y$<6O/7'76FV
MI"V]P"$A*T@%)[B@\IK].EK'6[:>X:R'",[1Q\ZK^J])W,4#77+2YE#AW'L3
MHV<W&45OLIOLS8WZZT6&VBY28Z`:E;S27&RFA[?$]-6^Z9$(@8!0$8T_:JQ:
MVCX[IK+2C),P%:GC3M2ZY8R.Z6JR6B?BN87;%<IQN8U$#,]3UJOS"KC"#D>1
M>\>?9<9>C^50;=0"45HJI.JU-++;'_3N+"/MO73+.">S?34?Q65QX^0BBC_G
M'*>4\A*L$K+GTS;]9;&W8I%X024W1#,J1);E@*"4HZ/[:!('347=7EQ>VKW7
M+R][30'#9@=W:G3W6DU_'+:-R1!M"*XUJ34^2B14>Y+#[*?,2'$!2@D4)!%3
M4>&F^AX9BI+6:^#=EV\L^I.);;HMM)VJ56G<4ZCIJS`U7,WSW##0N*/8U[HL
M)=WJ'T@TH:^(Z>&GD$4;V5<*FJ2,TKL24:W'(`IM*$E0)0$I%!T\HZ=?HTN(
MHVG,T4(2<DDAC(JB**^%;PV-G7<JG6I->O<ZWJF!+QM*<O%YJ6[=+0HU4-U?
M,!W)/8GX:RG,5URV!I*3-VFH*5A220:=/C2E/'XZ$IXD2_AG>DDS=5LO+6T5
M)4B@2H4J`:U[Z$JR5\>+#1.YQGD7HFY>H25A040:57Y0J@'8UTFV*-LAE:*2
M':5+0:C*YK89'DM&Y6B>TW-6;U&OV/T0Z;/>8,Q3"TMNI3&N49/IH6T4J'IA
M\]=PI7IK/)B=)S7-K)0XKHG25[GU&.VE-8"UV':!@IMO<-X&_(NUQCXG"MLJ
M_>BN\3[-';@NS%H3Y#*0P6D.*`/2B>VJ<ZZN+?4"(7%HKNI]R[%>Z%I5_8UD
MA:XTXN]A3`\QX99L-1:G+9>)#\B>Z^3#="`^P@(HP%H":A+9`H:4.K7I%W<W
M5PYL[RX=M/8N::WIMGI4D$<4;60D#`5IZ25&+D'D546T-L5<;^69#;R2D)+J
M]BO/YDA1'3PZ:F7DBXR`^[14K6;]FFWHD/\`*%E*;LV&/'CO4!KIE[>17B=(
M./HOEKM;*E75F5)F-1PTZXM"7D)8?92MUI77IUI3PUD4)H%4K_7(Y!S&"C75
MIVT2(:Y3Q_"OGK>U&L\>V3TOA$>'-4]>'R]NVQI+:D+]&)UIY2E8'YVH";6X
MX971NVAQ'F-$O;Z?J5W$)H2_*178*`'':D#,Y`R2#;WF<&>0)MQE+D*R"3YY
M$2(A"G7+?'#H<::/3ZP3O/:NHZ_U>[E8QM@XM?FJ3ALILV%2>F0-AF>=3+C%
MDH`-M:[?O2DXWNS]RDHG7&\/2;O*<6MV!'>>:EJ[47ZSRJ#U"#0>&IO2KM[V
MCQ3LQ5:UZW(E(A!$?$J5=KN#[PD6V6VJ1M:2J$W)M33*FW!172:E0=WA*355
M37\>I8T)PV*3L[XN#6.=L:!1/_QADC[89;D)#3C*PEHI555"2DBG6M*?3I"9
MSF4RE6BRN6LKEP)IY4^]TN$"5*B?:+ZXL1P)]1:17>0`%`_H]>GAI#FR;*JS
M6LL4C??`JGRLO.O#.(VQ9?OR@];XJ6F,;886N\3@DCTH,1S:I"''7`**7X=S
MJ+?%/(*/<2%<=$ZCTAMDY\C&\\`T./WIC;AR3D'+&1?:MR@M6C%8ZW#9L<;4
MO>RUN"BJZA1_6SP4)Z@E(J:4TZL+.)H?S&@FHXJC:CKMYJMS(9)'.BB-&"@%
M`=M,.S>DCR7F#D!J(NT`/W)P)9;:6D;8[BE>DT2`*^D@T))\-2P&1I#<!152
M[NKGX6/()PW?<G.X"XCN,3)'<YO\A5SNKT5HA\H:^S;<[+"=[<-"T`+6X4>5
M74IIT(U!W<CXV58:%=#Z/T.66(27ASN[?V*9?I/2)T@N.J5^L2E94LT40@"H
M->H`^&H9T\LOU'$T72+:`6L+K=E.6YU2-U:4[T=-H#(`30%*-E:U!%*'J:UK
M\>^FYAC<[,1[Z>6SS;>Y%[K'8$<0=OH6B7*$=DNI4-PKMVE)-:$@T_%I7E2\
M$G=211@EN");'=%!JX]556MQ2NWF40BI%2-:.A:3^(*E,H;R4M)8XTJM<RX+
M<CMQJN>FX4505*VE9()\>IW>&M3!%\H2[+JX+@"XTKV);6]]TN+*EGSQF5J)
MIU<KMKV[[=8Y,7!.^=+Q7=.N0MT,2Y39,7<4AYI)<=*@?,-B:]$_@TSFBC,F
M4#&B=0S2B.I<:57*K)68J!*0-BF4I?:5]525(HM#GF-*H4`>H\.NDSI\KP2!
M[J4.JL@H<WO@C'R_<FYSW-6[;R%DDC8)@];&3%B#:I(FR,<@SE+VM^8DS8C+
MA2:@E(!%"09.QLA#]0*M:EJ<T_4?@P\FURURX4]5?2JT/<SB\2]8YR!%S*68
ML=6$W69=W%4(@E=CN5]9;"NG54Q;3BR3N2XJAH.FK'=FW=H;_%`.@B:<@/[N
M).'E)VKG>K.N6:NP69+9'R#-05S<-O``#!>5:^\B9;>I;,9RYSTV:.#M@MOJ
M$0J2"IM2F$4;7M4`14'7F*^ZAU/57R0RS/=9L=@W``8X;`#Z5V[3.EM%TJUY
MT,$3=0=2KZ5<>.))I7?1(&;(C-AQQ"0F0I2U>CM_5NJ4:J6M)JD*!^@=]0[X
M(9/C!)/:?O5KLN:*'<!2N&`X+@M\N7N6L..LE22"RVZO8!];8&]Q202*TIUU
MB&2ZMI"V%[FQ#8*X`>5/-0>R1@B(!'&E*JTK[N/(I=VYPM''%RRPV&#?K9<G
M6ES&_5@K>9@J<1"4T"V&U/O;2%@U244\==.Z'UY\&J<N\>7Q\EU`>/NT\HQ7
M$.M]$$ML+NR:&2&8!SAMICMK7;AYEZ-8OMCS9F.VI<C'[W&75Q"X%T6S*D-*
M"2VK:XVI#9*>WAKK1UJ"-O->W\,JDS].WDEK_IG4FIM"?/C+VO86U:[D>0L>
MM^02K^V]$:Q^[*6]#BVY*5-RDOOLJ;;6M;1(WJ!^C4=J.K2-AI:NRP2XT%,:
M]ZNG2G1LEQ$V35FB65K!0G"F'915H>\+V/0^();.9\-Q;C$Q.X*^9D?*3RE%
M@O9>+T>UW)$5#2T1I11L96#MZ@*K73K29(1!A0$X[\50OU`Z3GT^Y;>6C,'/
M+#O]TM.RI(!J!0IR_;OD=QEV]%HO,DQ;G+M1:M]RA4CK?FO-A$N-D$0!$"68
MZT4W!HG8`>]3J;#7R#\-5_16Q-`CD%9`D[=;I<,2S:=B]Y9:1#N*/F[<ABAB
M@H<*7U(<ZD?,KJL#=V/33\1,H*C&B4?/&)"/[Q]:Y<XQ.)?(RWZ!MY;"7(10
M%!6]*:K&\$%-4T\>NF=Y&YK6\GW34U2$LP/TU'B+=-KJK=,8#<J,I32JJH2A
M!*4+))ZE2*'3#+<_,?1]R3YLG%*3YQ'T=J=_#3W'T)#Q$?%56X]D=AQJ9;YM
MYA2X>.MW`QKH['B^O-B->FJKJHB5I5Z6^@K7QUS?3-7TFQN72SB7ED'8PG=W
MJV:WT-JVKW<UM:2L+]K,SZ#SXT3)73B2W\S<F7[*84==NQ8R4F!%*2R9D)@J
M#<]Q@A5')/<BIU6+3IQO5'4%S=6;?]/F;\7NG&M,-W:KC'^H4_Z9=(6W3TDA
MEU<U$M*EK2*``._>&W&GK4LL$XELN*L-)@VYE3J6J%:MHJ#4H4#LZG8?RZ[-
MIO06G:;`'WC6!U*X4.*\Z=6]>ZGKLY?+-(&DUH`4Y43&DKELH0TKS+`JH$#Z
M"3UH-2PM+9F+!BJ@[4+J7ZN:OG6[%KQ)XYYJPS*[7#9EW7'+B]<8B92=\1J1
M!8<>4^FO1+Z&5'8OX]-5_5H6FZC;3'*>[:KUTIJ,L-G)+*ZD;7COH<-GL\JY
M8,F)D$J6\R;K&<O-R?N60.SY,20S<''7S(2VRAEI#S;+#RCL]12B-2-E9DMS
M```&OF33J'5!<3#EDG'M%,?6I%V00&HD=N(HD,L;5;A3MMJ!U-=2O:F]E<1G
M`5JC`NO2'*1DU":`[_*-PK6G>HII'G1B<6QKS"*]F_?Y%-G/+*#%L`WX)[\9
MOJ[=9L>QFX76/$;;6[>Y$63+C,UAOR]H4A#CR5+!7X`5IHN9V6K@V6M3PQ5@
MM&W`:,U,H[5+J'?;9>[3#N-MFL3P6#%N"8CB7W&KC'=3'#)0@FIV&HZ]M*PO
M$^$?IP4@BM^)*2N6IQA3"(;2WY+DI;,5MIIKTTJ6IR0ZTD)4MY*1UZJ--2<D
MMO:662?ZH).`K@>U,[\\Z!MJVO,<ZG9BI\^U;VPOF>.1,[MKOHQBAG%;0ZI*
MFE)DMFMS?'9AX^J0D=:@UKKBO5W5<4,,EO8E_BW##"@!KQ[0O07Z=?IU'8VT
M6I7S(S<G%F(-30[3NPJI]*B*CPD1K6RX([B%?+L`**:MHW.-(Z$>JTDC<GI3
M7/(=2U"]/^I.)[25V&-]QIH_`AAJ.T?<F+R&[ICRULK<1O5NV4=;3N4@#U4I
M2I:'=[1Z*JF@/CJQV#8FM`<3F58UC4KVYN7.F:UK"!@#7<.P)I)5[1-4N!<(
M3#D1(5\F]<&T7&2V\`2TL*=;=2C:X`1T.K+G9%`7Q$E]1Z2JFZ&P=+5[<TAW
M$8>=1UR>QXQD,]VU91C5K?E%Y#3%]AM1X<Y;K[FR.7G68[)V-JI4&O35ST43
M-A$\WTZ=ZI'4DEG:3BW,31([90#UT7%CW%UJCN[%M6U]"'2SZZH*25AMU3>Y
M1IUVTI7QI76FH:\]DKHXB<@."9Z7H)N;@N<P`[P-B?&WXW9!;9=E>M%JN=JD
MCY&?'?MB%QI##YVN(*E*2`C:/KUZ:J=]K5R]E75RYALQ]"O]KI.GQ5AH!/E.
MW93O5;?NE]M]LQ5=\G\*\;6VY1;^H"[6.U7U@MP4(C+6)Z;'/F$./[F5!*VE
M5\M-M:5M?3]V)V@O)IVX+B/7O3D]Q(?!\IW"CA]RJ"OEFRG#T2)N3XOD%I2W
M*6P\W-MSQ+4X#U1;Y/IEPM2BT-Q2JE$=334QJ^L,M8`W'A@N6:;T-J>LSFVM
M!'S8C1V9V45&VE1C1;^/+;F_(-^@2(N/WJ5'9E)3#CLP'R@!)HEP*V;4@#Q)
M`ZZJUCJ4\MPZ6XKX;+A3$UJ-W=53UWT_=Q1MT6T83J4;@]VW)D`(-';":N&%
M-BM)XNP>^V]2!?ULV`(?(4IQZLIH;&NBFFD.!/CT*JUT\DUNPB<0\OP_NKH/
M1_2^K75(\C0_M-/8I+1$V"):Y'IW&U3KDA;X<,=Z<ZXZP`M(4=R_2$A8H2DB
M@43JJW?44KWN$6;+4TKPK@NHP])B%U)0S,,#COWJN3D?@.\9W>9M[@XC&MC"
MKB[Z5ZN+CL(32?KML%@E;BT(\]#TIJ#DO+R[F97X6NKM2NHZ%:"%H-*5/J7Q
MKVMXP;:J*_=;S&FNL(]61;G6D->M3SMI$P.2*-GIN)H?`:NT5JZ_M@UE"ZF]
M4#4=,T^U?^!4/[DCE\`\]8,Z9G'5ZC9_;4!3BL<R13,:4EM(.Y%O];U6'70B
MI`+B*TZ=:#41;:-J]D_/=.]RNYU?0FU_RIX\L#&YJ;Z!'F*>X#$FIJ,/Y.M$
MW`\E9)BRX][AR8T7UEG95)*%(2TI2?*IKU`0>M.E;99:A:L!:2\OH/B:?155
MJ.2YTSF&XC9DDV93FV5VX8;0C7-L0L5P@NR;4_#E1DU>0(;[;Z2AP>JE;>RH
M(4#7XCQZZFV232MS1%N6F.-,%3M7OH)B1R?>(/[N^G=Q5,GN88>PS,HTYL)3
M'O*5KW@[B2!4)6GIM4"145UP?]1K=EER;]E6VDQJW"AVC:/*NO?HG,;[09M)
MN!FO;<4<-HV;COWI"XIE:@Y&4^^@!4AA2/,FNT#K7KT5]'PU#:7JL$<T3H7'
M*P>]7`U-"*<<%9.I=/@ETZ2(QNYXK2C<-]<>]6?<$7!F8W+N)0)S#S,*VRXZ
MW'&O7B)<2^MII<)34E*7)"4C=N"DUW5Z:]%:'_\`FK#/:N!RM)Q--@JO,K8F
MZ7?E]X"&AU12NT&HJF[]S/(URRK/X.-IN`E6+#;9)9QMN23+O46VW28))MF0
M7EV5(EW.5;I(6&5OE2PR0FHIJJZH\6\O+DVTW8[5>I'F]T\7SL8GN`''9793
MVJ-UPG.AE25D;Z]-IW`#\/34+)(V*!T+OB>:CN^P3:RMFMF#VUHM-HNZ0ZRV
MI1J5(01MK^<!^EHTJ5D!RR;7'"BF=38Z:T>&;HSZDYD62E2/U1!/CNZ=*#^Z
M-6F+\3X%S.>%S'>_Z$8M3'4GTZIK];OTH?\`T-/HWB%N23XMN"T;:OD9S&?"
MC60\E0;74^5`W=/&B:_AZZ4-S%V^9-96$`LWK!F33>6U4H`55Z=.M/'6OB(]
MU?,FKH7[T=VVYAMB02:EX;4D"O5/0UZ]-.X6.F9S&TRG94\$RN(Y6O`;Y5PW
M*>2A=*@T%*CIX5KUUB5CX6YWTR#@4O90R.D#B:E)-J4M;RT)H5'K4_!().FG
MBHZ[U.&W]T%.!@\EP2?5!2E*ZC=7S)VJ*:TZTI32\3N;\.]15W,VUG`Q5CGL
M_M-TC<B9'D\)U4>UC';3;I[:E%*KM+3/+_S#C=/,&!Y@:]3IU+`^"(SR4Y8X
M;<>Q=#Z-BNKG4&31?`&..)IA174P%*DP(DMM)6F0RE24I%7"$@`DH[BAUSZ0
M&:_)9Q7J#10)],,CO@8,57[[[,I1BD3%KS9DPW[]'#S5\B(D)$]-C:25!U#2
M0I:EH;!)'YM-7+2+.>VE,TM,CAA0U7)_U%>V^$+]/(I$!FK@<-M!O5?'(V=8
MEFF$V^ZVN=_MD[&"$2&9)DLE24*#L-TG:6W`NFZHZ4U-!ADG+V4I3[EP_J[5
M[&XLH[4"47+9&U]T[FD;:IL</ML.5`^7B->E=),-QR4I3F^&\VD$N*;9[2'T
M`55]%-+BVE[%"Z9:VMT`<?*$T.<XQBLOU'D,-R%PRAJ>G&+>B#)>2X*%;T^>
M0E]1/UT(%$D].FJU<:9:OD>YX.<N-:=^*FX;^[MY>2QS1&PT&8D@4P!ICCY$
M@;,B#8&7FFL9^4:=44M3;K<O7=?`.X,^BV5LMJ`&ZH2#TIIKX.VMQ5K2!VXI
MW/=S7(SOE;(\;0&D4]`JM4]]]"X]RBQF(BVU^9^&OU:)%*;:)350KVTGG/\`
MZ28QSP3R&`US\"*)Y,)S]]!1]JN.2UCHT^M!4XT"@I!2*CK0TU/07L4K`,<U
M."C`U\5P0TX54K.-[M$1LF.K(6G]8W5/7]9N^)Z=M.96.D:"U6"SF>\D@[.U
M+3+,QN+\9F#'6E3KBU^GYJ)`42H;E>&D.1)V*QV]\V-M'G'L1?C.,LL3EW"X
MRES)TLCU7UCJFH.T#X@GIISRHOL$G;LY+MIR)UY>20\<A//*D!"XK"D^!)*D
MD@)Z]>VL`QME$3?C<*^;^U.KV]TVRA$@+\?B]W?NWJ'65<R7&7FEKBVRKTMM
M@25,R066'4^L0ADO$J!+QHDCX'3$ZG:BY-E5W/[L/.HR1KIH&WL?T2X4X[>"
MMQXNY59RW%[(F=$1CEPBP8T-RU*3Z;#CZ!128SI.UVA'EH!725S9SRMRLI7M
M*Z1HG4'*9RFU#MV">U5Y;:;_`%B]A;`"D'ZXJ*]4UTPCT2_<TD!E!_>_8K=I
MU[)'&]U^X9G/JVAS84W\#7<N+]ZVU[VT+44I"D_L_`"G3S==)C3[B*4!^7!P
MKCVIX=7L]@+LQ_NKG<NA>944$^)%4T_-K\?IU*Y&\$PN9G2X-)\JTVNX.(6H
M*I7>H]*]/*.O?OTU%WL1,HR[,H]J+*3DQ%DWQ9CVX8(_4\EP6XUZJN":]*"J
ME*_NG33D/)H*)_%=19QMVI?QJ%E-".@'\0TA)^%\2DHB)C1BTW.[,VZ*/5=2
M@`DT'574UK2H_%IK#&^XNN9'C'@/*-J4NKR&SMS#+7F[<!7`]JB_R!R+%8EN
M0?M)#+-(RYCZ2?3;B/DN.;EFB0%1VUA7X=7^RM8!![VVBYAJVNQQ/+BYV0$;
MNU;>+4SN0<IR#E.X1ULVZ1<K@;1"2E7R\M,,"WV-]70%,A-NC-K<33R;AWKJ
M'U1]O;CW:^93&AVMWJFLMU6*AM,E*DT=_A5;GWJ$W-,%X@R"5;4*,7)HJ;9=
MI3?JKFN1)LM;]R?4PELG[-#12P\[7:E*!T.JSU9JD=KT>9`75D:X"@K^\1CY
MDXBTXLZQABN2P9I06^\-PK3^([AO*\Q^.2[M?X\D1;$W\M'25/2H9#I0$BM0
M``K8/SC2@&O-.B,N#!*9&U+W"E,5W#J:*UTP01RRL#W-]T#?WG<47-VEZ;<"
MRIE:D**B'`#Z9":)7YZ4Z$ZFX[*:3$9?*:)HR]@MK<2RNHP;:8GS+KE,1K2\
M(S4=)=;3O"_'R>;<3^E725Q+#"WE%KC,,#1M03V%)YW7KC/&_P#TSME3[-R5
M''&2W"S9UC>2P3($ZTW6%/C-ME]M<IUB4RH0DEA27#\XFK=!WKI/I^X__,QN
MD#Q'0C8<:D8*-URVR:7*T937M&&TYNX4[U[E.`^2#D>%XU=7HJK3]JVJV3';
M<\Y(6]!?=M\<NPEHDK4MHQ%U0$CH*:]-:CIUO)H0DA!SY=^"Y?T[JN6^Y=S4
MLKN&93!LTR-)15#R%!:4[DUH37X#Q.J'<&1UO'"S:Q@!QIL"ZZ+HM8'6U`TC
MNPW8+GS/$+-G&*7_`!2ZK(@WNV2HBJ)^K*])2X#Q%?\`I>8E"Z^%*ZE].FD+
M!%49QZN],-6LVZM8OCE#3(T9O+L]JI5CTQ)R.IU3<2YXSEAMLV,M5/3+I>M[
MRXU0/7;=2E"RH4^N?AKIVB-#F`28G!>8)[.?3M9>)BUL6;YNU,E[E,S?LTF!
M<&7*F.\I#2V_.VV[$#7J+=(/D:V*\JO&NLR31B1PQ^([E$W<=S"]TCLI:7$B
MAJ<35.3QGG$'-;+;"Y)+ZU,>GY>M'=@"@?-T[:RP,GJ!N4?:ZI"9',DS`@#<
MF\Y:XSGJW9%8PZW.M[GJ"*DE+-PKU2E]="$I2.G76'1PMP-?,I>*9DPJRM%'
MG]\;G_N9<_Z3\E_05?TW_!]_V/\`?::\N3AO56\5VGXN!^U5TY[[%\JG<)S<
M\Q*T+ND["[3)GYC;G1($F\6%HI#]PB(%`Y*CM**U#JG:@T%=5#6K&PM(R0!5
M=[Z;=?W5H=4J<WV^]1-X"OV/(GS\'E.H?N<-7RENE,@"-*B2&0_Z+&\>H7;=
MN"%UZ;E:C>C=;L+.[FAPS.<VGDS?>JG^H/25[J4$>JBN4!Y/?AB?2I<P+6EM
MST_2!#=$`D"I"?+UITK375M0%S?PMDMS[F!7%M,M[5TSX+@`O:#M2A9C1FO4
M<3&1N2RX16O0[>_?N-(537PG%-]=K0R6+C?2W1<>S7)(<`%4S9@2Q%2#W`<3
MO^GRZ:W%MSB)*`Y0G$$IM#RA^\:^Q,O"N?R/IMH"$J3M0?K`DCI7\)TR%SR7
MMCKM('G3M]KSVNEWT)]J?'#+GZX&]T_LS5(K3ZR:UU+#8F]@/?Q3PPI]OB1W
MI<V4Q$C,ME9><"UDJ`J06VZN;:?#32Z8(SXO>!3[>=6JU^)&TCB/C;W,QK9,
MF7QR#/LMO3"9N6+2829SL."^'G&IZ/6W1GE*31(4C>!]8%5=(6[1JSPY^XJU
MV<CXAF816G`$>8X*;_%^$8YQIC*+?;-[-CQV'/OEWGW"8VE^2ZR@K1-FR9-6
MD$O)0V:"FU1/?4D]@LQF"V[$@K&_-YMYGX]P=Z&Q>H.7Y;;(-]38;S;K[;F;
M9^HG2X%R@-[9`BL?+A?DHOIU.HCJ*^,.A.O-]7#S)72[<7FN0VQ^9OI(7I7R
M+Y'"\:N$V'$E.L8]:_5B1+>V\Z[MMS2$M(APT&JR4-@!'@/P:\XNNCJEPYYW
M%>VO##2]-M&;`6CU%0G]VG$,+F5KBJ[WOFCF_B["<2N2+A>L#XRR65Q_!Y!F
M7%^+=(_[WWB(!?7(\!*_32U&=:3YEA5:ZG;&P`V[5#WMZ<5SW[CWCK*L[Q'E
M4INCF4\;X[=,6Q=UN]W+[+?LMTCICE.16ER0[&R.?&"=R),G<ZI?4G4K&SES
M9."K%W(907G:B+)'FM^\%#3J"E0;"DMME**%9*U_5\O;KJS64//<(^)55O93
M">8,"'#UI@LZMUZN6187+M3;[D29<D+E?*K0]'6F)*8<_G"T5*":$=Q5-=7*
M8^"L.&"I>OCQ>K0$\1[$^R&H[+[Q6AB*PM:E4W*##._JXI2E'<&D*)*C7H*Z
MI\+_`!4YXDKI%O-::;!5]!(&XJ"'-'N\?B29>,\9/,06T7!6-&X$..3)MP:*
MVY;L1!46%6OR?M*;P*==6ZTT6WIS;@>[3T[EQCJ[]0!'<FULW4G)IAP4=\3P
M#E#DBU9!R7:+Q;57O%E38-HF9C>GF["_D#K<6:'$P5N(;5%AJ2VZZZD^JGTD
MH00%+!:WED^%Q\'@*)#IVPU264:CJ9<;4XXJ5.#8CC.41_W00P]G$E"$2LC$
M5#%RD72XT3)NTFZ7A3<F*EV7/WK+B_3V-G::)KIEJX>+"(2_4RBO?A57'1]+
MBGOY[JQ`#'2.=Y*IJ^8>0,+XQ$JR8ZJ'&9C-N6^>QB3;"''):FG'DVZW/M#?
M,EQ0UND%*O32E"CX#2&DQ"9A:=E/:F6L=2Z3I%PZ.&-K]2I1V&.7?Z:)A.+,
MGS7D:XQ19XUTN-JVEV;>F;LU;,>#7J+"H\94A'S=QN+*0/5?!]-1(2.J3K2^
ML1FJ.*8Z!U;JLUW6TAH.Y2^7+%A:2P+-&;!;2VN3&GPI;RB$@+>>3Z?JN.K[
MJI0DDZKSK,9CAO75&7[WM#Y*B0@$]Y&/I6B7=(<F(C<H;`2H1_56K8NE"YZ*
MB$-E0/<`'23X!$YIIM*3GGYS*<$AY,R('B$!.WIX'OX]M7K1/IKGNL_5/>5T
M-S2A'IE[U4$I)0ZVA2#M4%IJD4KM4*CKTIJ[L?87-&NHJ@;VAH2AE>*X3R5:
M39,]QBRY3;'6EH::N,5`D1'%!($B'/C^C/CO(*01M<I4"HZ:8:IT^VX#'V0P
M%:T[:46OC80X<[><%`W-.!,QX+NK^3<<R[WGW&82'KYAZWUR\QQ.W$!*KI;$
M+2EN]V1EPJ!0*OH`I4TU`OL[ZT]TDT2ALM.NV%V4<P-/E_:JO/>['A73'\7N
MMFDIN+<R]2E6V1%:6AU]3RDI,1QEP>JRJ.""H&A`U1_U8\/J'3E@+6E:C_PX
M*7_0.=ECK>H"XP9D-2=@'O8J$L/!.2V(3,W[#N2&T)$FJ7$G]4A-:I2!N2*=
MZZXL[I?66Q&XC:YL8`.WLP7=9.J.DIKAUAS(WRO<:8&NW%2,X&]Q\OC^Z&'?
M%N(;+S49$9:UDMN%:4(+VTTJE1Z]NFKOTAUO/H0\%<NQ<<OGP7*OU!_2]VIQ
M&]TIN.0N/;05P3AY7EEMROD7);W9BD1KBN,\2A2E)7(4VA,A`W$T0TXDE/X=
M6B\U3Q=YM!;54>VTBYT[IF&*\!#V[CA0%%MR=6R@)5UW(W=?Q_P=-/[Y@K&1
MO9[2DXN5.6&+#*VA[ZU]J2T6>&YS5%>;UT5%#TJL=!0^&F;/<][ABI>6U+K5
M^&&0^HIXK9-3Z*7"X:GH10?AU-6%Z:XE<\O;/'<C1N0IR0%)42`D"OTIK4?P
MZG&R<WWTPY?+ARG#$^Q*F5(++(J`1Z222:U[)T54/RQ+/E/'V(O9F-NI>&[;
MM0#T\>_QKK.">>#Q6+-R::1L+BNBE'P'=1/;3J*X$4895(2V+WOJ!@NJ[2B&
MED^4$)\PZD=4C^'6TUSS&%M465E2X:T[#7U%)J/,1'=4\'"M1!%%]A4$=*"O
MCID``:J?=9Y@&X`!.5@#3]S?9BPJN2Y,],1EH?54EVA*N@*MP4K\&I*S&PJK
MZO9_ZD#;@%>AP/B`Q^)&AM-5+5GB-37UI2EQ<Z@#R5[0!1H]O'4SJ7^W.[PN
ML=!V880:;(G_`/2ILW+(WL:X^OUTB-+ER[58[BN$Q'2MR4J1&BF5N]-/5;``
M\VWS?#7-8?YX]ZZ[9:CX319PW@52B[RDQGF;OY%D-VM,^XR_FD6RWRY#OV@R
MR`?45.M4M*51V1U`2KJ:=:ZZ)!C"W^%><[_5;N>\F<\DPF0TX43=<DPN/K#9
M9;L6+!8>4AU]B)%(:CB;+<"G%I:;(VA9J>FMW2\D9]RK.N""\M6LB_F>8#VT
MHY,GB^8VVWNI9=DNH2PMWY5]FAD1GI3+:'V74FJ/DU-@=?K=^NDQJ.-,%$6I
MDLV@D&A'G25RBZP+O;)$9MQ,E^T7J3';((4'(;K1D-KZ4)$>NU'AM'6ITS<X
M/)=VJ3!>"V4U&<5':"D'(MJX0;?CW"&GU&PI;3Z6]Z`17JDUIUTSNFD-&.].
MH9FR'EN:<<*@HH?DO36S"9N,=R34DH9*=@"NU`GKN^.F5'4]TXI^=-BL"+I[
M:L[\4>6>85RFXHHF3&V^NA)Z`)&TJ^/73JS]*CKZV$#><![IQ'EQ4CL7R8H8
M1'*_34TE%5)4:JK7XGL*:L#?IA1>GWU9)&FM!3UE.%$O/S5S@A;@6GO4J))I
M_)30I;Q@XIXHV0PXT9;TIP-^F`?*1W!Z#K\:ZS0*3\<[L4<>1\WD9%.1:[;+
M4V7'2IP-*-0AI:1VK2A!ZZ;G^>B_A=ZPFFH3F>S<3N(]J8S((<I>52$V]]W[
M19MD>3'4*53\NI+E105IN1753?\`^X'=ZGHG!F@,>=V/F*NHX3G8_P`A<+6%
M_<W%RRTPD%^4I0;F/34))2['2>BT!?>H.KIC56#1;J+5+(SVOQ`>9=%BR^\*
MN"[5>W7!,C.ECUG"L.2T"FU]8KMJ*TZ=-.[?Z3N](6&M7$4KX+@FHDP[D]-M
MBNN`.[U%"QZE3X@@'X?#4-<?6\JO%D_Q`#M]:I7AH(C%0)->GAXH/^ETFIE:
MH/[57X5?\[IA<_4\B$I'FU",CT^JXZQ(;![+6#7:JE#MH?#2#?B"WC^,=Z5]
MLEG8A3=%MK"4J4K\UWH5)2`>P&HV\VE6'3]J8WF"]S[?>_E'%!B%)M\>1%<2
MI86L,MGYTD$[*-K[4U9.G=,Y^EBZI_ZCQYBJ5UEJAM-0?"#_`.FT^<*N/EC,
MYMZY,QO'UW`?NWD$1:YK*0EE+IM#4=Z#!=>11:%RTNJ4Z`:T0*="=2X/+>(M
MRXQ=ZKXFYY1.TA6R<&_+NXS!;<?:4R(L>C$=+:&D*:;*`YZ:!0+4TE*"?$(&
MJMKF"]!="_R3?X5"S[R#@^9RUQO>+K:+G=6Y$:%$M3UK5+^2LCUM@R%SFXZ5
M.)4#ODN*6YLH7"=JJ@#4!/9#6-*9IW?_`-149UG%>6&H,UR&F6-P(J*[!3S\
M.U46\6^U:U7BWW:/"/[NY#.<98M<Q2J0G8K@].Y-/L$;:NU+:2*4K76NG_IW
M%"S%M#3V+G-_^I6IZO=QPEQ>R,&H)IL[1CAM]:C[R[[=>2>+)=U;7BUUD6^W
MJ4V+A;H3DN&\V\"LR&GV4*#;?3KNU0NI^D-1MB19AV7L71>F.L(-4<VVO)`V
M8X$.K04V>?=L[5$P8YD]SE[HECN%T6V"W6.-A(K]=T.,5)230A-.VJ3::;K0
M>+;DE[F85IM\ZZL=:Z=M+9K+F=D+J8@GAW$JP'V7>VB^9-RY@,R_V*._!BS7
M;U<8T]*DV^-!AJCJA//K%%B8J2NJ4$[3M[:Z=TQTAJ$UZV6\A#80PFM-XI3V
MKEW5_6.FZC8NT_19RZ\=*VM#^YCF\FQ>KC"\;LELBQ]RDB0DE3S+&P,(<!`W
M-^(#J0%$>!/374KP%EKX,[`*+'3D$=A"+J['O43^6B9%::2F*TP#L`+SQ<VL
M]!5:@@@T16NJ>;!H*OK+]LC1(SX'"H[BCIN0I_>'+C$6$)W`0P[ZE:@>?UB4
M[*?#K724L8M,KP=II[4M'J(8',=^^VBJ]]W/%MSM&4*S>P6>\WFRY).;>E0;
M/;7ICD*XI0$2#_-R$B.C:E:2H;MRC4]M731+[W1V+@_7_3&IRO==6E<:E0/S
M*W/WCYJ-?[#>6($IN2U)E7.W7%$:WM/M-MN2'2(`V%H-#\ZFX]SIX\U<3Q*K
M+=+NH8F&ZK\(]2C18;_<>%,RCQ(U[9ON)3'D2H=U@2=[;(<6?4A2HVU#T:0P
M#4[@`1].D)+KPKFC$!QHH_4(+9T8=;D<]I]X;R*;>WN\JLOPS+[?FEI=,>6)
M33\=MP&B%$G:-P\?JDTU8[&W\6`3P6;&G+1G^Y%D_P!CH_IOSW[!G]M^A]7Z
MG\.GG@>Q+Y+'@%;YB\6T1,>9MZK9;)T*3'7`F6QQEA42YVUT*3(M$ANGIN1I
MC:B@H/0[M<6U".XF;29SG#M7I+0K:"&R,$3&M@^4##S+R=\_<0XCPY[JN5\<
MPBRR;%%QK.);MC;?03(;ME]:CW8-0'TI`7%0X^I`2BJ4H2D=J:B-(TN#QX(8
MUKJC&BHO6FHWT-J;:)\GAO>]T$T\R=&%D4-:@V^M^,^&V_4-%-I4LH2HDE5*
M[J]==QBBGBM6B*5S6TV`KS>P@7Q?RQF+L33;WKHEWAL,+])U`4:#R+&[:3YA
MT/4'39&LS#Q`;;'(*_NI(Y'=7F>/I,EO>6[IE4>V(=226T-6R$N>^H+ZI#;;
MBRA1K0*-#UTWN'N:*-)#:)U::6ZY#9)L33>F#64.+<<04K5U<W`A5/S@2030
M`#56FD=XD$G`.'K5IM]%<8BT&@((]"7V(Y&8:PR@L.NJ;*?UJD4`*D5(!/>H
MU9[.YC>:.-1VJFZO93:6'/837L3P1&,PF2[?.M%M9G%]8@(C+?0AJ2IVGE$=
M1/K?+AS<2`=H/73ZYY<HR%H,=-FY0.FZC?W;BYLLC0'4VG$C^U3IX:QZ[8CC
MZ;=>H^/6_()LB6Y/^Q+;&3\W%2M7H-S9L=NCLX(I52CN*NNM+5D<$@$(#*G=
M@NBV<EX+8N<]^#:[?.G5SQVQQ>,,ZDY(R)-MCV-$ERUN*F--7M3$I#PLLEV"
ME4H0IZD!+Z4@A;8H>FE-1)+<<<58H'.-IG)JZFU,W]VK'QC-O<_AO(RHF.8E
M=\>R]]BYX3CT#Y%*(5VM;L2WW9#A*'Y%O0\XEMM]8IZGEK7IJD=2LDDT-[`2
M(075&ZO<K!^EMLZ3K876HNYED6M#`\@M!J:T&XUI7?L7J2RR4];(<N,M"TR/
M2.SU@4N>FA:0Y7=0G<V"">QKKSU9V\SM2$,#W,:]QV8!>V+RU>Z#G2O+H6M&
M4'$-[N"K7]T7->.RH(M3#CXEI4X)#273MAB'Z3GK!()#0*UDE70:[3TWTO<N
M:+BY<71=N*\[]?\`5XTISH8'%LG8?N4?L'Y^@38;,:WW)H1$CT;E/7.:G.K<
M;25;(D1#BW/42V1NH*^/;5R?T[922<QC(\>P;L%SO1.OKR;W+ETC\3M).%>Y
M-US7SNQ9[Q@R+A)B2+7?,A=@3XC,ZJ'5!I2F(TQN(M3P:#H25I(Z#OTUL-+B
ML/\`44:&M-//@L:OUH7R<L`AOEW;$YO'/(UMLN2,*CW&WMV^Y1X$!W&X[<B?
M;HMQE"0IF;$+X4W`DMM)(64T))%=/]1A9<6/N@'#@G'36J1ZKJ#3<NJ0<*XT
M2U]P%CY(RC`+@QQ#=(5LO,2/)FS+,^H1I.21'6G$/6ZWWRJ46Q`3N4KJ`NI'
MCJBV=J^&XX-!5TZWM+@Z=S;&1S7EM26FE?,J"8F73(>?,VN^LR8UQQL0K([:
MI+#OS-MR*YSPW(2X^XD+=C%`&Y9Z%KK6FK[%?0MMG1/:'NI0`[B=A':-R\P`
MY+^EZP&5X>`]U":BF(WU!5C]@N4/EK!^._;#PQ<9$.?<%3,@Y+S)AR@MDZ))
M6].G1;DS5"&+>@>FV"H!])#8K2FH`QW.D6DEW>R.>75RAQK3N77++7;GJ6&S
MZ+TMSX[IS@'O;4&F)Q(W>52+YZR7'.*L8LWMJX9>?ME]OS<2VY/D\=8@W9U4
MN.F*ZJ;<(WIR%290<4Y)"U;MI)4-1/3C;B^F?<ZFYTMK(XN8U^(:#B``?0K[
MU?-%TK:#0-*>(M1M!R99(R&O>]GNN<XC:2:U.]5,3K$UR!RG=,)M*W5X+Q);
M+=:IRO64VBZ7S(%B=<9#LM"BZD1W8X]1Q!+FQS:>B^LK#&V/5GLA&6#EG`8#
M:%R@Z>W4(Q=R4-^YWO2?OEO`G:030T[.Q3^QN"Q@MDA//;%P(5M:0J7#2V;9
M'C)W%*+%;6D[P4#XI]12R2>XTE?DYZ!7'0KD:0/='XG%=,RZ,+B?:4!Y;K$E
M`E,J*=C[J'D^JCUFR-[;ZTJJM!&Y*NAZC4+`<SR'8XGUJ[3WC3&)1\3@#YQ4
MI"3YM")"3L=>44N`"B]H&X;A4$"NI.:UBDB;1C20>'8J_<:C(S!LCACQ7,RG
MYE`=]7:22*5">Q[T))ZZ(X[B(4BS-'9@HV2YCE-9/>/:M7S$AL[BITI2>U54
M(["OQ&K/9-:'C`*H7<<;&DL`"4$"Z&B/,?*.OFZ#J>]>W;4[+<30M:(G.:",
M:&E=B@'U<X9L:%.GB=WBO.I8?6P\AMT/I:6II='@G;N"5GN4]*'RGQ&F+WOE
MKS"75&]6&P`RC@H5>\WV+6C/K;_:/PO!3&R.SB5?;]QV2AFU71UX?SF?C324
MT8R(M54^PVDH<`VMU5JFZCH;9H6Q2L#HX\6@C!I[."M,UG!8&232LL#Y!E<6
M``N%=AIM51#4*3;A-@26'HSC;+K-RA24+1(C2D,K2]#GH<`6EYA0(VJ`('AI
ME;6ABAEBF%8RW8<=@HN?7K)K:_BF+OQ\U01@1CNX5VGBJQK\I+>2W0MJ"5"X
MR"G:0""EQ121]((Z:\W7@:>H)V_NMJ1V$5(([MR]I:4Y\W3L'-JXEC:UWU`K
M52:XN6?E`XI1W*!65J/53A[J)/=1UT#IMSIX0^8YG\3B5QO]0HV,)B8`(^`V
M;,,$[%U<"D-E2PH^CW*@?%6K0)9'L<7N)(-!4[!A@N76;<IHP4%=R127V42T
M%3+:MKR"5;*UHH&I/8ZB'W$WB&LS.R%U*5[59LKS:N:#B6$>A.W9KC&=82CY
M=H$"H\H%?#5GL`">RBH>H6TH)%3Y$JH3D0K!<"VU&OE0"!2G0@?3JS0#W<.*
MK<\<X%!BWTHSNEQ0AH@H\@;[.`U6B@ITZ5Z==*3.Y<9?P3>VLWOF&'O520;O
M3*B^&RA(":>4T!ZJZ"AZTU&"]!K[Q\ZG#IT[0VI*)Y5]0T2GH""/-6A-16A\
M::8RWIY],Q([T_ATM\@!HEC+N8=ADK(<WI3L)-=U-I\I-02`-24UVUMHYXP<
M*8[]H"B+/3Y6W[00<M3W;"DU%FI6X\%-@E-%;2*[4"NXT-:`?'MI*TO<WQ&O
M>I.[MGBA;4=RFM[2L6:R'(UW5;*%,6BCJ`X@%"7^JDN)J-H6*"AU<M##)I"Y
MXJW=55B6%[M1#9/>8`*_M5WG&3J#:UJ]1!E*6%O$*3ZRED^93@^M4^-=8UQ\
MH)AC)#:C`+L/3<D$.5C6M:2TC#;LV*0-KF_+-A1/G!5L42FJ0XT6G0*@]'&S
MM(\1JJBU>UV=K?>XT5MYD!C,5!RG;1N/>J9??9"QRQ\\)OK+,.5,_<RSN(MU
MD9CPY%KE2:J9?N"8J4KG&8?S2*@:M]J2+2,OKFRBO%<#Z_C%MJ+;?3\L,3G;
M![HH/5A50`R^\2[Q"??D(D-N)*?3;=#B5(H"0$I6`12FFFK<UUJ1$2#6N'<J
M=94&H@/(+<OW)E8U^=@R5(7)6%S6_1?<4[0BBBG]8HGR]*=_#7/[>_NHKLLE
MD>03O/K5ZN-*CN+8.8QN5F(%/4C%#ST.&\Y&N"G''I"U*,>0'%+338FNQ2MP
M]+RCZ-6*VO\`EQO<YQ=CQ2$K(I7QQ20M%&TQ;2G'TU*9'DO-KG;T)8M\QUR=
M.>AP_(^2ZTUZZ5RE(2E14A89!USOJ3J6Y,[8;29[7Y]SB,%U/HKI[3KIKW7L
M$8A;&7`EH^(;-O$X=R4^/MFW9-$;;GR#"EHC36Y$MXI.Q+86XPXXLA(4XH$;
M?'4IIMU?1EK[F61T9QQ)4-K\5O<V;VQQL)82V@`W[Z#AQ3B6/(O^^.YS_3+<
M=KU4N+VD,FI4E"%+("*U(H*]=3UG=7!D<<[LO>JA?Z07V,<9-2=V].]B=Z5(
M2ZXM:B7%`-I437:DJ/D'>@&KCITDLC27.)IBN;ZWILMD&OMB6BIKEPV4VIPA
MEK=K4AU2T;VQ4$K&Y%>O2I!!T]=?P18/HF]C>RO`88LYXTVI.7KF&ZS&'8K?
MI(]442I#@[A51X]S343<Z]$\?@M`[ET"+IK4M7'B'`VT0V@>Z/8CGCBUR;G-
M=NMR+8=3:YSS:EJ&^J2E:G*J(-4(ZU\!UTEI-U+<WN:0GW1053:XL((LUK$_
MFY6G-OQW>U$]WFMVWDV#N4?1?@VB.\IHU4MB0IX3$)(/F*VNX'4ZJUS-*.I"
M`XAI<,%:=/LFOZ*DEE:"\.I4C9B,%8AA:[QB<&S&T(4FVPD-2F'VPM+[MGGT
M+B72CZTAI`&P'KKIAVJ&TESK-@CM"8V'<W`*:%NQVR9G:8MZMI;;N2VTK8G/
M;$R0!U5&D.FB@Z7.H2>M#K5UP8O=W'%6NVT=NH0NN`!S@ZE=^RJ65C%YMP$.
M\1D[0$QV5MH42?S$J6:'\==-IIHW,<<HS4.*M.A.%@/#W3`YSL`2-E<`G";@
MF5&2VD;#N!)`I4!--O0=:[M0G-D^8JU\J/Y0M*8(@24-NI`]0!22L4W$[AM2
M5`;C0:U)<[%Q)*.5'\H1P$%9],52553VZ@TI^'2;R0TD;:+22)I8>6`'TP*S
MQYY2%+@K)2M+ZEH;5T4LDD':@T)_%IB?>Q=BE;)TD'QDI%<[XPJ^XI(O%OW*
MNV.QW`E&TGU(\D5=CHIU4'#]=(\=2VC7=U%<"UCD>VVVY0?=QVFG$J"ZVT^.
M^TLWD+!XDX%U/>P&&/8J*>:;O?+QC7)7V,V_9\WQS)[;-Q:5"9].8VWZL5AQ
M-O"MI4S+BMN,`)J%U*14]-/>I'3LL7OM7.9<``AS<#\0K3O%0N-=.1:?;ZB&
MZJQCVU()<*G8:>8T3O\`LL]S7N]Y%?B8'Q?8;/R-=1%5*F"5CD5AFS1&]S/S
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M(`X]N*BV6ES;D3QYV$['"H]*9_D3/N/+`Y]CP7,98NRE+95!AP;:Y+]9Q1%"
MIA/J+)4OJ:=-)-MK.-]6LC;)W"JCM6;?WC"]O->0:/=B<?[QXT3Y^W%NWVVZ
M2Q\K%4[-1:U264H1ZC2/,MEIUL>=L*4HE(-*ZEK223,8\QY>4X;EOTW%;6MP
M),C1=93[U/>IA7%6L8ZY$<6TS]FQ6PM+9"G43FR?(D=/ET%!104J>NJMK7N/
M);@5Z!Z?E@NXA'=-$D?!V(3[V>SNI:0INU,*;4VE14U-2GU$$#JE+A#M5#L%
M#=\=462XFYCO>=2O%79ME$&@0L:(AL`&`&ZB-78BF4[DVE]NIH5!1?J*'H4I
M!H/ITB^1\@I(20#O639-J"6"H[$236T);6"SZ'J)VN-K04[Q_?(4`.OX-*1W
M-Q#A$]S>XT6TMJ9VY)AG9P.(2-N5OBOT3(2RMD@)4@L-/@H(%$%E2%!:?"E#
MTU8V7-QD'ONV#?V*O3:;82DLFAC<`=A:%#_FOV1\0<LL72XBQC"<MF)6^Q<\
M9,1NW3).VJ7;A:60F+)<-`3ZE*$DCKK839B.>2[A7<JYJ_1-CJ5O7388H)XZ
MDEC0":B@%=JKSPSAWG?A7DM6`&QF_8S+AKEV[(8DN'%AD`!?R_\`.UI^7DJ4
M:*;K0GZM1JSZ=J$D0HQQ`["N07G3^HZ/<%TSWT#J9<:$<?81Y5)+T.2/_H+O
M?]+^POZ(Q_6/Z7]8_M_X?HU9^=+\SME=JC_"'VJRS%[M,EQX;BRE$R&X7$1F
M3^H=4`:$DT/E'7MX:YC>-C+:@%>G]+F9#$8W5+CP5/?WEW&-YL7)&!\MV>$^
MS:LDM(QB^W(L-++F26I]3MO7-*U)0W(N-ND$-D*.X1C6E!6EWT\]M=PR6^`!
M=F]%***U;3(IHWBXHXOKEINXU\X5>:+\;C)6%3&WIH*`^BB4N!24`#<E!4@>
M0#L3TU<[?7IYH6LJ<*5]JY9<=*V\3WOHW$&FW:NN3(<?94@)#]"A?IATM5"%
MI*CN[@)3U(^`U89-6M6VHNZ/,>V@I4=^/M7&ORZ\?JXLWTYN:E=QQIP]B6W!
MN'3/='"D8;B:K;8&^.$7N\W^?<VY+S,M.17-^%;Q;@VEP/R$*BJ+@6&TA!!"
MB>@K^F=6Z=U!<36]FR9KH'AA+PT`DC,"VCC4<:C;N76=8Z"UO1[*UO.;;&.:
M`OH'/J*.H0?<V\*%%E[]L^?VR;<H]NCNW5$)U]I,IM/RZ9R8XH'&XPW!H/4Z
M)KTKI_=:5<YP\%OO;-N_C@JU#<7C'%M1AVG[DWB^,.2[3);4C#KW(<2M*"F#
M$5,6FO4[VV"IQ(!'4TH#I:WL+N$@N+?)7[DRO(W7X(G+=BE_P!BF=?:J+CD=
MKFV2WVQ$A2T76*_&DR-[+8"&F'VDI0V>WJ`U)K\-6"W@E='C3:H6WT9MJ^L6
M7(34[=JF3:9+:%-J0E20%!24A6X)'2@W$U504Z^.G++=X>'&E`5:FW$,=FZ$
M@YRPC=M2^"H%V@O6V[1C-M\MI3,F&L)+<A"@1L6HFJ`*UJ-%U;OG;[M/*GUK
M,UUL(17-3R*,=U]O^3<8Y3:>4_;G?)UBR"P7B%?DXB^\I*;Z]"EHDR;=#N02
MZMV)-9!9<A.!*5UW)4"-1&J:6^?23;ES&OJXU)-,?)7T)SI_YCI,L=]`0[+)
M4AM<U*@X"@'I5]]C]S^*\H\,P<QR.T7/B'*(K:+=G.$YDE-FN%JO*DM[)^/*
MF25?:UBE.'HXA?E*P"-<._IN_@U1K8W1/)?@X$T'?[OL7INW_4JWO=#:717+
M#$SW\[6BN["CS7:-M%$S"N&G_=7F]]E62\PAQMB<]UK(;_&B?:#=\N"DDFRV
M^0E24;[>MHB750`WI`W:ZC?Z[#TUI#;:Y.:[<V@#*=@QK3U+F-MTY<_J!J[K
MBVHVU::GF5%1CLRARX+A[=N+<4NF26G[+M$5RPW-J;;[@RR\SZ,:Z6]32GTM
M>NE$A#4J.L.!5-H[5UKI&H7L^G1W&TO+C3?\1]B5U'I32^GK^3Q0'*C#<1L)
MR@X5IVJGGWC>X+C]N=*PC!^!L'O?[M7!MQGDJYY&O&[@[?Y"EAF7BL.U-B-<
M%LNL$+1(2SNK3QKK36K^]@LB^1CC%F;C4;W;NWS*B75_TGJ5T;6V,[;@M=LC
MS`!M"2^CQ1IK@1F-1L1IPCSK>L@NV&RW8;EKAVRS1KO="^Q(?BH<BQ4.S9-Q
MEQ$26FWQZB:H*C0=JBNK%I5XR[T]I+7-JW>!4>8GUJCV]]+:ZRZUT\DELA:'
M;&G':*^]3#;17@X)A_)V:X=`G9)><3PUF^+^?-H6$7"^N6:>QNM<Q"H"Y*6Y
M"F5HD)0I24;%)W$&H%=NKZUAG?&QKBYKJ5`%*]]5Z*T+1-9U/3F.NY[?(YFP
MN=4=_N>U54^_;@;)^/,MMWN)MTAB\VN);6+;F[%MAQU3F+I9B8EFOLZW1:QD
MLW([?6<+E0?`Z<:1J-L;]OB&R&$`F@`W;-ZY)UST+=PR.EM'0B1CPZI+@*`U
M=CEVD;*^4A37]E_&D7@?A/(><<V9AIRS+\2GY+'@/!H*M=@<BB7;&0VFB6G)
M<AY2UI)Z-T-3JN=6:Y^8Z[%I]N'MMJ@$$#V$J_\`Z9Z+:=.]+W76FH`/OBTB
M$LQ+7`@`NS9:#`[*J!MM>FYW><UY;G.MW2ZQOM"+:GKC/DL6B1<+V_+BKD27
M@@[41(84M.S<H)`H*ZOK8K:WM&6]NTA[&!IKLJ`N0-U/5=9U";4-2E:Z:60O
M?B3BXU.Y-[PS8;7B%PRW&[CE..LY9F>33<GRC);S;W6H$I,I:8]ML^/NI<=2
M[!@0P@56EM977I3KIC%;NBD=,[%QVT\GW*0_-!<SLLK5PCD8T"KL&T&W$5-2
MXD[*>8*<MLQ>-:;:U->R4WB*P?32F!*:@V;TTI2H$H6'1ZGFZJ)!(ITZ:KFJ
MZI%"^KF2FG`#[UU;1]#8+83WUQ;N%-SG$^EH1!D$BW0XL5+;B4*ERB6D(4E\
M.ATE24I=9W(H4GH3M!TG9Q.D(>*`/Q%=U<<4I=P2-:1$YICKAW;MW!(":$N+
MW!:!55.JJ'MXZMEK;.RT--BJ5[',P`N<-N[^Q<8D>C^KWIZ=>BS3K^#3OPSO
M[OV\BA)+P1&CB5A(N3D-!=V%[9UVI)4DUZ==Q`-*Z6@B=$_,ZE$UN+R*5M&A
MWE_M0MN1MONJ$F&\AI.VI:0W^=4>;<X!^#3Z:1L@:&UP446FM>U*![(,;<6I
MA$J9`=;`W.,H9"Z[0H5H]]/Y-(C#$[E*07L43*$&M-U$96GD_P"0*`FZBX0P
M:.B4IUIQ:>GE"MIVD_&NGDEU97?N1M<#V@>PJ-9K-X_XWBE?MN45_<1P]A7,
MLN3E>,/VO'^0)3+K<B*V_'M=HO?HM*^5*TI)I-2D>F5;?UA551&HBZTB2YG;
M#!E#G,=M)IM'`%-;K4B^\AC>:D[]H`KO.U>9CEK#<GP'D;)<>RRRR;'>85R6
M7($D('ZI[<IM]AY*BP_'*:'<A1K77D_J+2KK2.IIX[G*2ZH&7$8UQQ`7MCI>
MYM[SIZWCMY`\AH!/`@#`[QV;BG>XJDK,-OU"2-E>G4]"GXG5GZ;D;#$(G_%V
M+EWZB0/;/EJ-J>&XN)+;9`-/3(\/[X_'5LY3F,=6F)JN86D+FG&F)2)4^CYG
M9152[MK04KN`^-=04A#;EI.P.]JLC87<DNPH&IS[$H!ILDT\*D@=:ZM%A<1M
M-2#15>]9&:X8I=LJ2EY*RH4I\37Q_%XZM5H\2MRMVJK718Q^(K@B;++L(\9U
MPN`%N.HI&ZI/8"@)ZFFF.LWL5I;OB?7,6[MBFM$TJ6]E;.S+RP=^WU)H[-?O
M5#IWDA3G0>6H)/C0_3JI07/.^&NU7*YTKED"C=F]"]3W&U>J5C:0FE._1/P(
M&FMQ<\FX+75)H.[8E+>P:8V[*U*-W<L1\FPWZI*F`2JA20:B@V^;Z=/)-29+
M:F)I(=AZ#51S='>+C,`*^7>A8;N]<9;K4=1*W0VQN(.VKZ@D-G:2K<O;TZ>&
MF&EZTRXO19,#Q(32II2M:<:^A:Z[I!TR%DMP6G,TNHW;0"N\!77<%V5G!K%;
M;4[%8C2G+;$>GOL_M7G9+29+>XJ2@DAMY(->U-=WT6PGLXVF<M)INKW[P%S1
MDD4\YE8"`XUQ\RG;QI<_EFWGG%^1VI&U55`4\030==+W=E)<7'-:6Y.W^Q6O
M2I3#.'N/NY3L[D\CF5M[4!M:P$@[BK:!7I3\XZ0_+)>+/3]RL?YA'_>^WE57
M?N5N0O').0WP3[=;T`1+++#Z&I,N3%M<9QG>ELA2VFU%=0H?5'76P88QRSM:
MN/\`7\XN;ICXP3D./';N4#\V<AAATQG42DEQ*?48.Y'U%]:JV*I^+2%RYC('
M/>*BBK>G0R7%VV=E&LI2AP-<._@HOW)#8<>WD*67"H;:'RGIUK0UUR&[#I;\
MF'#O7;+,11V;>9MIN13>,J8Q3&"(MK]6Z.2%N&6^\HMH;54I+:`?K@'M2GTZ
M::CJK=-MBQS7$GA3VE26D:3;:WJ`:X_#AC^SUJ,,B]7"X9`J\/M./^FL..-;
M0IIH%8JXGK]8DTURIL=Y<ZH+S,.1782:^JGI7;AIEE8:0;5A`E<*5'M4K[%,
ML666-AFY1]Y2DH8]-WY52%@)!"WD;EI"?H!IKM,9@U+3&V\%!,!M.`V<14^A
M>?-1CO="U=UR2XQG:&@'T'!.%9+*TJWB*PVI17,0Y("3O2N,VV4(2E9\RU@@
M=P*CKJ4TV%[J1`C,,#Y,%6=2EO<SI<<I;[O><<4[%ILRX#34K:E#+"5%2"2'
M5;DT`2FFTGI\1J[P'\NB)F!=G%!EQV=].*I+S/>B2*;;3"NQ)ZY(EW22[\MY
M&RH!(>JE0`&TUVA8[C5;U".YN7ET!`';AZJJU=%NZ?T:7/KT<LK1LY8:[_J<
MU&UKQ&)!<;D2FWWG&ST"PDLU6"FJB344)J.G?4C::;&T_BM<I'5>K;K4`8;%
MCHK<_,`#3R53XXG,>A/K:]&$42;/>6(X05$H+EO4`7`4"@J/"NI6D%O=1&!C
MP"UU<!Q':HBRBM+5SY*N,L@JZO'LQ4?LHRM2>6\;@.,-!$ES'27`!Z:6Y3BH
M^U1-*+JKM3MKEEYJUJWJD1N#PXR`;MY`XKL7373EUJ_Z?W$UJ8PQI+CF)&`H
M=P*N:X@C)FQ5V*Y-(<G6](87OZQW[:>D<QE4W..-)[U2D"O0Z[1-$8JEQ!`7
M,-.L9I*92W[>12EQ''Y>(7'YF)&<E62:"VXPXDE,9:^GKH33:%I1V-?#4#?2
ME\@Y9H*;^]7G2[2_MIVXMY!VC&ODPX)[X]I@/H0DK<?94E/IO"A<V*`HM533
M=UTR+Y*5)%*+H;K*TNF-E8*2-H<>(Q6XV,Q27(+ZU!-24.DCR=#Y=N[S`@:;
M<]G`K;P[^(6*V&K@E0D'T9+0*8Q>!2A+@_/40%$(Z]Q4Z.>SM23P8W97;5FT
MR&?3]<>F^G:-R@`EYP"A6R:$J0X>J2:&AUA\S7-(%:E9A<WF-S#"JU7"`[$:
M%TBA*I#1W`"I60>]!MH3^/39*W4#I`>30=Z-&IS-VM#T93+*D.(!G-2*)?4H
M_6`2D*!!(Z5(UFVO8[&[$LH<6X;`/:0MXHF3:>=,FH;D%QK^[1VSM]"I\]T'
M'W[F<GVNZ6R.W'LV07/'D;'`CUD(@W1V7++[;NU@;FW*-T625=.FK9<9=1L'
MWD8I`P8@[=HI2E1OXKSCU9:SZ+K+9,',#MC=IKAP"FK]U-A7%&)<8<FJX[S.
M!EM]O/+%_D9B_;(3K3V/)AH4TSAP?E,Q79%OAQ)/JOJC!YI+J@`3KD6HP7D=
MV71TY%3O[>ZB]-='6TS-*AO)YA%(^-M`WXJ910FM,2*8UQ5G=LM,-^#'AI0I
M*5N34H>4XMQ'HIEOI;6XZX`YZCC5#3;T)II&>=SB`*X*_LBLSRWW>>2Y'Q.(
M%3MIOX4"BI[GL)NEEN-IYDL]BF7W'W+$C%LMB6E"I-TBQK*:L2Y,!MMQQ:)$
M<;%;=QZT-!UU?>E]7AE<W3#F$K@34TR^Z*[:UW88+D?ZHZ(^<C7K-F>WBHTL
M'U#G-,!LH*U-7#!5GV'/.+;7<;M<;AQ9C>&V6:Y->BN2\:3'R6Z.R$K#<TN*
M0I*2VI5#1Q*A7J*ZNQ9MRD'N7")]4MK7"YBF8>T#_P`R9S%,2XKNGV_=G,(@
MR\G5/E2[+>PU*EM28BEJ=0J2AUA)COJI2C:5`4Z'6_AP&"1SHP2-Y-?4HBP?
M+?W\CXA(;21U6\*'LK3:I&\5^T#DF[WY?(&$*2RFXLQG[W#O4MVWP6PG:J,B
MW`L.%:FT@T"PC3*34[73_P`64Y@?=HVA./?3@KAIW0.O7FH-GMG0MB<#3,7`
MXTX-*G9C]FSC$+I;+=D,&*523M;6U)3)1^K2$D;T#:D$IZ#O]&J[?WD5^:PA
MP';^PE=+M=(U#IV9MM?%KGG9D)(]("DQ8Y(>0A906U!*2M!`&U2=I4D4/AJG
MW,;HI'9N)75+.Z@,+(B#G#0#PV=Z4+LE`0?K]>@Z#^7Z-,V2L>\L%:@*0>8F
M-#B,"B.8XV&E%3#3AW$A2QYJ$@T[=M+427.A'[I^WE2$N$9LK"TI`42HCH``
M5=:=CT&I:&]B?1@#J@`;OO5:GLY0]SR6T))W[\>"('G$@.()H4UK6E"*$=#I
M>9KWY2R@(*BII[F![?#D`$^]7AV)J<U>C(CLR&K?$?GQ5*4S(?%14U4`HI2H
M^4=.VI>RAG+*U'V\BK74!MM0;E+2)=Y33_NG=/\`=9[Z_P"]G[1S^M/]#^S_
M`(=6;\YM_DDV4V#[U4/Z:NOFCX[3L\R=BRW"4VRJ4TH(7'_6;4@@*0D$N(2"
M3YUMU"?I.HR]LAEV*ZV=Z0\8X+;S7QU:O<-P;E>`/E#TVZVMRYXW+=4`Y:<D
M@)+EN>9<H?3E-+JT[TZMND"A-13-2L`YS74&%?8K-%_K&$G'+[5Y>%M/6*\W
M*VW"V)L]WMLIZ!<H>U:'XTR(LL2([OJ+4KU6UM$&OCJ!DN?#')N4)>6+<V&P
MIW>#+GAF6X]SMDUUB294OC7`+M?<>CNN@VMQ]UB3;%2+NR$!Z2B+)<"D>FXU
MM4.M>VG>CZD[4--U:,FHM&.]`?\`^51.L=!Q6FH:5>!N-RYOEQ9_YD_7W8&.
MW@XGRUEI<>B0IZL7QJVR5[1&F2K9MN%Z,.B$J+3+LLBA4H@]SIO^D\#;JWFN
M_P#-N*^:K?8IGKLF,FQW6\0:/*`[VJ=P1;+9*<3+_6NR9"FVG2L_K'%N%+:N
ME!U)'T:[]=V(HRG$+S\WZK^X^I-NPA,2[71+5?UCJUDKW**?/3:CL`GZ-9\"
M>";KK?F2OV?K+],BJD=@KJ:@]*E-!K5T7)]U"Z+;(7O`VH`230`'](?WWT:P
MM7_">Y.1:G2ZI#1;25+0M8=+J6FXZ64^JXXXE=2Z"@$``@UT;J*3LMRL.]IG
M!L#*THY2SR&M>$65:UXO;)R%,LY+DB%`1I1%`X(T%VE"%!*@?'7*/U`ZFEMI
M_P`@M32Z+6N/8'?V>E=\_37I!FJ,&LW0K9YW-\K"*^M%7OEL''F289?+??;3
M:6I-P:?F6>/!<C14,WMIKTT*;^42W+4R@U5Z0<]/>`H@TTGT6*1AM]C,XX5V
MU3K]4KS3-/TR:UTT!K\@&'\0*9C[H_FJP6SBK(O;V"]:5X)R'=I4;(G6'8[.
M6VSD.X29$"1,=D+<6N^)NC"XJ!5(]%"3M\U=5S]1^F-3.J0WP)\+F'=2JV_1
M[K/3&Z;-:&GBR"/0LO<]E35L@W*Z2)"K5-+MWDR6'%^FXJV6!4LMM/5(/I2'
M7%*7\12E-=$Z?A=+I$C+05GAB&'>`54_U,U(SMAM'G*Z65P)["33T+R>X':?
M<WS7R5DMFQFUV*\8Q<I3F<6NZW=]B/8+1:[U<I[=I%IN,Z$]]M/-.TJ8ZJ(H
M21T.N4=.ZCUMKVKS6.H1UT9KR2X@Y13%F.-36B=ZOH/Z==-:)#<9G1=0NC#"
MP$&1[A029FDC("*[>!VT5Z/MDX7N?&]LLF+9=F-C,NXW1J5GS\38];6X:[>(
MOR498B.-U?CL[?,"DU4:=J=YAL_!Z>*<%SNQM]/;>&\:T`5J-YVI]>0N>%8C
MG%BR.-&BQ<7MTLXG;V;9+N"5W.$TR(\2Z2XS0241&&F_3<^J!TI0:A/RMES_
M`*BGQ8I2YZQN=*U)[FO(M<V`[*!=7.6<<?YIPOF"7W(EM5D&)SFI;2+NI*'G
M@E#L0O!QQVK3<EM`I].G-KI+89@\44WKG4\&K=+3.9C.6U\E"E%AV0W_`#SV
M*L3[\Z\JY7'`)ME5)#C1:BQ;2VNU--L>FD*0CTHX*=Y6:'OJ@ZC9-/5D51C4
M>I3&E7U/TB?0X9C_`-14:_:A#Q6]<18WC65%VZP!!NWS\!2T_+NW&#E%Q;^=
M3Z;:9"Y#+#K"$U61L413J*6R]NWPWDL7RO(\Q4!T7H_3NH01RS/I,^,%W82,
M=R>>Z<>87;H_V'98T6ZG]8_`E)M3,F;;BM=4LO/2:(HUNH.@4-(QZL+<YIJ9
M2**W7OZ?:!<R9[5_XC?>W;!AP1*8C%MCNV6]25WB.]&#3T&4VU&BM)45)HEF
M#Z92ZD#JHJJ13X::7-S97>)`Q3>QT&TYGA.<:`T2=FRX<*&W`@18\6+'"4,H
M0%K4$(`2A&]Y;BZ)2`.A!T6H:)0&_"-G<D[V?PV:!IKD):.X8>Q-_+GLH=<<
M6ZKJ.@"DT!J>P[C5KMM_<J7J5X<HJ<:I,3+X4@N-*!3]6JJTZ=#V(ZUT[5+O
M;UQ?0'`(FMV?O/,.AYJ.Y3<-J4.;U`*Z`5=(KK*9>->B&3EM_OTLV^U(A6R*
MREQR?<).Y`8:'5`"/627%K2E5*=B-"SXUZ2\SDG&L9M4F\RY3TR)$=6PTN3^
MKFWB8@J#C#""$EIE+B2`\04A(`[ZP:`5W+`O)'$-;M3?1^2+Y<XT?)[V\U#9
MO+CKF,XY%:++DJU)44O7.Y,%;CC094-C0JGU"-X\O336Q=63L*@=4OW632!\
M3<#O`->(2A1R'!,-UMR$3ZX2E3BFD+<9<!W)<CN+2I32Q3Z0=6:-OX3KD;64
M'G%?8H"UZA?-(8'_`%3\)4`??ACT;D7$XF=IB!^]8>^@O2`A+>_&Y*FVD":6
MTI<>>C2`/345``'J#KBGZC].1&/\WI[^)\B]!?\`QSZYU`:_-HM\XNAF!#:_
M,`?510IXM?6(Z$433TUGL:]%)'QUS/1#[P[EV/\`45HY]>#D\DU]9:1T3T33
ML?$$?'5YD/X=>Q<NMV#-1(PJ)E)5TKZM?HKN!U6Y_K>56,#\!P_NIQ[?(*8K
M6XA/GZ4-/`^)KJ<LC@"54+QA+BT)4)G)33S'L/SM6"WN.7.&@[@H&2U+VYCM
MJ4UO)%V7L4`YM'HGQ/4``?$^&JSU1?&AK6E%TSHC3Q*]D5-KDVF(2B^VXKU%
MD^J*C=TI4T(IUZZK5A>4-"=JM'4=GX;=B$J[Z5?+R%E2JLH04"O0[D@FOX*Z
M<WTF:,SC;15W2SG>QIV$GUIH'LD4%%"7J*40A.XG:5D[4CZP[GIJF.UIS;@1
M5WT70K?0A(X>ZIG^S7#)&:93%R>Y07W,:LT]M%P+E#&?GL^HIE"MR2"VA2#5
M/?KWUU;H'1A>7K;TC`&M.)JN/?K'?-TQD>G-ISI*8_*W"HKQ.'D5P+4Y0FO;
MUE+@6``D[0&T[?10!UZ(:"0/H&O0;H^6<G#[EQ)ET639.%/4I*XO=GV+5&;9
M*3)>3ZB@H**=B:%>T!0(Z#6JLUE?.%.-$JGLJ;1&6TEP%7^K$UJE8%*(H>@_
M#76,5(>.>F:S/`,0Y+'^WMB>NMS*%,PKK;E*BW.&ET%"&]S"?3?0A2J_K$+4
M?$ZC)1^(ZNRJA+BU_,Y7UVAQ5?7,'#MSXUO#UO6Z[)M=R85(LY6RM+C;+8VO
M(EK("%24*(IM">E>FFTL7-C<W=15F7+978A_>!Q-=JB`_C;XFO/+WEL+4"*@
MT-37P[:YZ;(&]/&JZ`+]PL1W)J>4VE>@Q;V4I\P0E/0[BL@`5(('\&JSUA94
MC`I@KKT.X-E-P^NRJ9F?#-F8"5$H]9L)<J1YO]4VU_1KKG\S/"PM>-I=3T+J
MEK>F]D=%N:%KLF=31=+;CT41HJ'W`E3Y0Y0!=*J!]6@73OK>#J%UH,H-&IX[
MHJ+5AS'@EY-!]Y5GG#]E:E6EB;*!=<0:*H4^FH)04[@%)))/?OKLNAOSY'_,
MT'S@%<%UVYLX7/@(%6/<W_"2/8EGD5$;6D)2E"2Y]44J*`=?C370)8C-&T</
MV+D^I7\.<>'IM-4C(B$AU5$)KN'P^G2'@CP48;]^\HY]12*K>E.!M(JHN*'I
MCX;O*GK7MUTZU#4K2UCS``$):VM^I=3>&6T;B3AA_:NJP7V`;PVPU)]58B7-
M-$K!VGY%WIT[5U%:3U!9WER8W`%XV>56BSZ/ZBLX9)]4:Y@RU;7>-_L31HP2
MZ\A\MV:U6[UMK=OM-\FSHQ`5"MEI=WNHWE*PF25]B13J.FN5:IH4U[U7XB#X
M&R-=YB"NT]#]41:3T!=6DWQ.#FX\2`%?7[=;&_=[4F4$#[4L:FX<]+P*I"[8
MLT9>>[5?*1YE=C\-=;O[XBJJ724`NGM:=N"L+M4&,F&@%I#C*V0VE#B04*&W
MS+-`*N`]`:ZJMQ>^^"2NW0Z"UL(D`QHN`POLUQ98`#"E&H>ZH::)Z[*;:!*3
M].D1=AQ`KMP3=[>2>65T1Y,0+/\`.XQ\IZ$U'<?WVET(WC-6^;Y5N02"2"H)
M/J=JT!WD4ZZ$HRV;*,YVHMG,VIDJ;,U3R@HMME<1QSTB*@>BI.T432@/765D
MVC6`OX+0T^RD)"7$R$(^LER,MH;2*5)4HA7XNVL))-#>,DCXYFCS33;[EOFQ
MHBG:D*"5K;)=2U0)"0#\0=3,>EB?3&W5,<SAYBJG/JA@ZB?:C_+8?.%7M]X+
M,R'Y6U.XU;[E?+DU&E3K<Y:T(<$>1%CKEM.J;6T\%"*&=Y!'9.G<CS;:!/EV
M@-_ZFKG75(@FUZ%]S]'-CW4*3WLO>R;@;B+"+J7%0\JV7"_W>8X\F.EI=_?F
MW66W(93Z;3[<A#24N%84YN4D;J4&G%KTRV[T873A5^6I/DJG.H]5W6FZK"^`
MN;IX>*#@VH`]"O1XLY.MO)>#6'(X!0VWD%O1-5Z2TJ<CR4K6U):;6GR`MR6E
M"E#2E-<DU6#PU_)#\I'J"]*:-J;-9TN'4H_@D;ZCE]B<QAQ,8%0)"U`AQ\J)
M6[N\J_50HEA9=3T5Y.HTP$LT!YD!I(/L5(O<UK27,SC@HO<G>US`^09*KA",
M>TO.R_F),1;8D1M[BPX^[#;<0LQTNJ%7$[B"JE`-6W2NJG6E!='#M7/.H.AM
M,ZB),[1'7N"4N(^WK#L70S&9CP'V8R$-MO"/&2'4IH=R$ECHHJKW\=-]4Z@N
M;F=\]N2('FH[DIHG0&EZ5#';1@.9&*`\4_,.%%M#:A"8:::7Z+<BK392(S*2
MDJ0V$I:2OMUVG57;J]VZXRRDY>WBNA0V.GV#&2!HJ'`*(WN`SYG'Y%F$63!^
M;5>4?9,%3C4>;+02E,A90@H]5L(!"2$BBAXZZ3T_&+P`N7-/U"UZUM-4BP`(
MHG+P;(8]Y90XRE3?J-)<]-:@MQLK0DE"U"@4I)Z5`&H;6&".[F9P>X>8J;TR
M87,45PWX7L:[SBJ7SWU1^$?Q'5>@_F'?P_<K)/\`2;WHJF_L3_D^&GR9I)S>
MZ?P_W#K:T^KY4WN?A^W!(:Z$CU:$CZW8T^.I\[E5KG:$U>3K:$/=(4H(KW2:
M'J*=R#\=3]D?PE5KWZB9[^W7$/\`!._TC]U_#]O\>WUOIU(^#=P5;_K.V[-N
M7:G3APIQ84B#)#<@_LRZJK50:D*25$$E(('3O36"YQVDE3PP^'!*+!,C1;KZ
MNRWEM<52SN:\Q986I1)?<935*"I:MI)'7M745J,`D8"T```J7TW6VZ9GBDH[
MFTI7&F7A79M5-/WDG$G]F?-S')MD9C(Q'E>WR9;K8C-I;1EL%AJ)>T-E"`V)
M<B"E,L`T6IPK<ZDDZYAJEM()AM!J/6IUMJ-389FNRC*3AV=RKA?1?,7;Y::Q
M+*%X[9K_`,>X^,BL:(+4A&56R]2H#+UA;=53Y"4JZAUUWT_,&T*.JMJ;+BUU
M1T5J]\<4I]\-):'XXYP*!VT[:[58=!NF76F-?<TD=$WW"[WBS#]VM<NP;*;`
MKRO:WA*.//;MQQC*V%,W06=5_P`@HQ\N!>LE=5=Y#'I!"36#'D-L[E"I2D>`
MUZ`Z*LX+72Z11L9[P/NM`W8[`-I7).JWON[]SS([?6I./?CC38*[L%V2;OB]
M_P`Y?PLWI#%YM;7VDNWH0R'FFT*]1E1%0XEAQ20`?IU="]YVDE<QNK)C*O:Z
MAQ*3#K)8N]P1N*T[U>>I4*A0\23T-=9YC_F/G44%KD?7'^9'\:M8JYV)))3:
M9Q#MNY=UI20Z'"/U:%U6HBJ0G=U*OHUJ8C.#"TT<["O"J0D<>622:4XIPX+(
M=F-0G&Z^I+BQGV0V5/EEYYM$A,5`25J68KBE%2*@)'4C3R]N+*VTPVCBWQ-*
M5_>\^U3VG/NO%VS6QDPEPJ:;>]749GRC:>.>'HID,M1;+:HPMV/6Z.D1E.6F
MVQ(K3$U#+:4)4_((4M;@&Y1-2=>=;CI6?4==?<.<YTIRU))<>P5)KAZ%[(NM
M>L.F^C8V1-9$<I=1H#<2`2<*8GCO5.F0\QHY\YALO$TJ\0,-MF7&<&[^_&A/
M7*UP;3;'9]V=MPEI5\LIZT+47G1M]-M9<J%)!UT:TAM^G;82W`:Z1@J*T)X;
M2O,U]K;NL[A^DQ@_CG+GWC?6HQ%:4VJ+'%G*%]BY*>#?;DIO+,A'*EKR;DSG
M)EI1PS`[/A]Z>@XV]97P5,WV8Q:4%*$NK4)K[FX`A"5::7VLC5Z-RYZ#`'$`
M'T;E*Z-H`Z6K+6G:-YX'?Y5)OF9V9SGDV8XP]>=C$FQ9+:D7F2@Q'EVI;'HR
MI_IC:(\QV6%T*2"#T!U8=%M7Q6(<P&-[ZAV7"HK3&E*^50VO:FR]U-TQ]YC<
MN4'$`@#$5V8XJ-6-X$WPWQ]B.#\4)^U[C>OLW%7LPFM%V5:+"&7$SKNN"V4E
MNWV=#"GF(@(?+S@Z^8UE++2F@^&@&2-PQIA6@KC3:13>H+5KV2^SWD@$E[4N
M#B`XC,?>I7%M03LV*3&%."/<D<;\<P%Y'?Y##<N]7:]2%/16+@D>E(R'()PW
MM-25HW+1&J&$)HE"00NK;4I3IS<I)<W=7$)WH=X+Z1NF:4T2L?A(XBI9QH<2
M*5.PA?<PQG.>&KQ>[Y(L&'\OQKW9I%NLT[(7)>V/%6R7+H@P(BOLRT+,SI&6
MX@N/);I6AIIA`9KF)L\=6L<*@#`>1/=2A_I&\E9R8KRR:ZC'2-$E00#6KP[8
M21M4.'>-<*YMRC#+*RC),=N4L%6:8-'E2QC_`,S*?;:MZH\\+"66)SP56-0!
M%!1(%#I.[9.R$O<YX'>578);_6-1CGC8V"SD>&96@-;[Q'[H`;Z*JSE[$K1A
M''=YX-MKC$"UVG%;I"92U++S'S28RY;J$/D_KGDNJV*)\U135+A)?J',D),@
M.!.)'EVKO\>B0Z7TS=6,N7(Z*H:1[H)IB!LKMQ5:7MKR5>+HL%E?94839OYG
M22-ORT\Y7*D"VN*^LW*<80A01W*=I\!J6BNB8KHR-#GB1V)%3OWG%<?T*U;H
MTUG*79N9$PD>0;E);*7I4.<NX6^Y@0):OF7HZI*M[(4*E6W=Y5`&E?IT:(!J
M%H]LD;7$$D5`)P-,*A6;7.=:ZBS489I&1R-REK7.`QH=@--W!(Z?>H*XI7#=
M`4LE;JRH^HX]3S.;NY!%/'PUFRL0Z[REH(KLH$7E[R[421DM?3:#0^=)-V[*
M*"%N*)4B@"EJ)/PI4]-2\%D!,:`8./K4)<ZLTQ5<:ORC;]O.F\O]^<82I+0+
MJE[D'::J;`!\WQ'75EM[=L8JX"E*;%0.H-3SQ-Y;B#G.P[<$SC^52[7<"'"\
M['EQ)#:RZM:FX[I/ZM02I12A:CV(ZZ=9&<!YESN\U&6I]]V']XI)8)ELF7Q]
M><E0XE,AZ[2X3*GR5>AZ*E,2MFZJD%AHE1I]4]=172DD>K6LL\QH8W.V]A4A
M>>(TB[ET&1SW2\IKVN)))S`&@)Q32<A\W7B-='N,,!M\?YRRVQFZ9UR%<Y:E
M0<;@N-"1Z8?45-.SY;15Z3:S7ITUS'J/KG5;34SI^B0MER$YS0'+C[NXX[>"
MZUT3T197G3$.L:Y,]NHS.(AB+B#)0#-A7$`EN-#B:)&6:Y/YFW"O^6KD-X9;
MZ1L=M:GW/M#,I@45J>WE96U9I$C<XM:24A1*-.+'6]2O0'WC7,[!OQ\B-3T;
M3^E(W75M()M8=M8\YFL''*20*#L]*<PRYTF9)O-W4VB:XVVRRPVD-HBL-CTT
M,,MBB666F_*E"0$@=AKH@:&X@`'L7%KV9MTTLC.;VHL>N[A>0E#KBD[NJ0XJ
MAJ2`2*TJ-,[J:9HRA[@TG$`FGK25K8-:<V4!_&F/G39<QOOR<4ND(AQ<?)+!
M/L;B%54R7DN)<CE2"2A3M?,DTJ"*C50_5!SQH32'.%13:>(75_T;B=#KX<RG
M-9*'`[]F..U5^<=GT75-J<V*9D)AJ;K0A,91;]0I'@\I)J?$C7#-">[F;3N&
MU>G>L6ES:O\`>K4UVXG&GD3S37$T=\XH%"G7H!3P^&KN^1_+VGSKFENP88"M
M4DE/);>W*4.CE0">_7H!^&FH*5Y%PTDFF8>M62.-KK8B@J6GU)9VVY!2-H"5
M42#MZ';V%0*4U9;*X9@,,M56+VT<TU`1JJXI30JHGIX@4/X]2GB6":N&;*/:
MHP69,>`KB?8F)Y'NA<6I'J*\P4/KJ`IWZ?1]&N<=4WKG7(C!]T]JZMT/9N:Y
MC@*$%%&!/I^56K?W<37K\%'6NBC,?>QQ.U2?54#W$DIP;PZU]G3W%.)IZ2*`
MJZ]$#KJP:U+%'I`A:`),<1VU5-T\R&>&W:S8XX@;:E16B-W2\7R';H##SDV5
M);,5HI62XX71\MM0JF]+CH`'3J=<KLM)N=3O&P0U,CG8<:C'V+T/>-L](TIM
MY<EK6MB)<:`8$$''L7HYX;XRC<5\58?CC3?I3_L]%TOJRVEIR5=YZ&GWRZ0`
MIWT"K:-Q)'4:]>]%:<-*T5D#V@2ANW?6F..U>`^M+TZ_K]U>2RN?&'G*"20T
M#`4%:#`#8EZW,=^UHQ4A00X/,?!5!M!43WI35O@+N4"\DNXGO5)LK82T>9'$
MX[3MH>_L3^8]=)$:.A02IQE-$)>W[MN\[0@*W%5%]OITKV[U;+6$0TD#B=U.
M].9:+>,B:1+"H\*V[_0N,QX(;;D13U<9B+-#\^E?90H0GQT*SV5A'=-]]V6J
M<&)<\4Q=IN/CD(25V*6S(>6J-,?N%RE%Q*ENM24.%#T1@^8]2V`#TU7[ASA<
M/H33,5/PQ6D(%O&UF9N!-!4TWD[23VJ/OO5;>NF+XHENW_SFX7V6Y'>:CH+S
MD9F"I]`:<2D++3PE[J5`.WMTTDT2O.5A-54NN;-UKI++NTA89S.T$AHK0M<3
MNX@*L`8G*EM/($.207W`2&%`[J`*&[O44TEX&0G-D&;C3'U+FWYCJS:-RO+*
M;,:53#Y[Q^^JZ(=6TXD1J*2EQ!HI;9'3K4;@1JGZIH-Q*]TDE2VII6M-JZ+T
MUU1X.`PO-)32O$<1Y-B3_P#8N]GETM%C@43-G/L1V2AL+])R72.24`45M2JH
MKV(^.H"'HZ/493'='(QHJ-PKL5FLNNIM*D?<0M,H=NV]OD^Y26'LWX6L_P!G
MX](BY+?LIMB4/7?)X4EB`_;WHW5$&+97$;Y;<E=4J>4#VZ=M6:T_3#0Y&^^Y
MKG<2/VIK<?K+U+`YW(:]C23@TT`\M*IR+;`MF&RX^)VUN0P&H"UOHGI+<A"E
MD%I*MX2/5VT[:MDMG;6C!%"QC0P``@`;,-JH4$UU=W3[N\<7/D<7$$U'O&NS
M8D]F4D0RP'*)4ZIV@(H2`E)[T/>NH675'V#B220[B>"NMCH5AKD#XVLC9(P`
MX-`)KVBAW)!17U3`&D2WV%!1Z,Q$N4JH]?5/F5W_`!=M5^ZZHES$-+QY2MK+
MHUNG3%TT;9&5_>:#ZP5WG#KG*_4IO#,TN4H[*GHMRQ3K3T728YK2GF'X.NF;
M])NI162:5P/%SCZRNE2]1]+6HK;VP8X?*UK?51*:R\29+!W7`V^.L'JW(1<(
M[OD4E27/UD,)("DFA"NX/PU*:-IPL7N)Q<X@UWX*J:]U';:I`?"F4-8""'..
M_AB<,%(#CD6+B?'LES"]6)VX7J]W"V6V/!A-^K)%K;2HR51G@GU&X3BT@+(4
M!7N#35VLX8<_,RMYG&@KYZ57,[6^S9X'./AS7W:X=]-E5,_AWW+\2VJ0VNY0
M<BX^N$YAQ3L^X-2'[(II(3TN#[!>6ML5Z%8(336EXQE3@/,K-TYK&B:,\.<9
MR!3:XGUN4F7??5[>K,AV*[DWVI(;:2AN1BMKNMYB3''"4MJ:6\VQ!BO*6"D-
MD@FE?'59EMN8\EK0:8;`NFN_5#0G-:UHF&44.)_\R9B/]XCP[>)US@77#.2&
M8,-^1'CW:.S$E"X1VU%(ENVZ!,$B&'4^8M'<I/;J=)ML7D@!N_@D7?J/TX_X
MFR8[SN[<3N3@V#WD>W*:EJJ\AAH=.UL7/&[VE:5TW566"MVB4`GKTTY_*Y^W
MTK'_`.P.F_\`-'H^].HCW-\$-6MV\6JYR\B])IQR+;[)%?CR)+K2:N,(B7`M
M2774"E2!M->G6NL_E<_;Z4]M^O\`IW)A*-O$?>EOC?._'^70+=+A91CMFGSQ
M'W6&]7AB-=8K;[:5AIZ)(9;"'V@K:H!5`H$5TG)IEP&$X[.U.&];Z%='PT,H
MYK\!B-I\J6L"4^_),_UH=VM.TE0C2XSL-T=Z.24.J3&33LKI4]-,/R^YXN\Y
M4U9ZC9N^)S25&3EKF?%+-E[.+Q[#(D75"(\I,>;$1&C+;?07$IBW`I'S:$@=
MTJ41J<TZ"Z9$(7.?DJ<,QICV*E];=4LTV5T5E;PO?D:>9D;GQ&S-E)PW8]RB
MA.=YCO5U=EW;/;6SB=Q=NT:-8H^+V5-SCL27$-M-"].+=D04*:44[DT]1&Y!
MZ*.K9:60D:(G@.C.T$5![P<#BN02:_J&LPOAGA:"[]Z@S"A!P-*C93`I#9]/
M0_CU^Q^QY##CYS`LKT2/C5QARHSD^W1`C?+C;8[D`T0KH4@'M0'2EW%<P,Y4
M3G-BX`D-\PP]"B)GO:!XASG,%-IK3SJ??L%N3K'M]P:V/REBZVV#+B72*F^6
MQ]^'<W+E-FOLO!]*)+;ZFY`<*"`0%4ZZYKK&F2&=]PYH)-*[]PWKTA^F6JV\
MVD06K)#D!?05IAS'4]VN"L"9DI-(Z[P/754I;EMLMH(3U)*]W0@#I].JBUK1
M<B,@;UUIUB^.X%RU[C&`12IICV578AE)/K*N452D`I"6)#:00>I"@EP`DG3L
MQ1':UI\@2I:#M`*^N795N2'"QO32J7"T'$"G4+3Y5(4`>O>AU'FPFDN#D)$9
M.`&RG8-@322Y;`36F4)H.0>:;1CDB);(DQZ;=;FRZMK]6AJ&TIL`.*<VT3L;
M*A5-*==3]CHG,>`]@)IO"KG4?4D$.FG&C\X%?.JK>?<@F7#)++=WP]+G1[TV
M?745.(C(+F\B`M9/R\8@]D;4[JZZ5HEFRS:/=:/(O,/4=U=7-\;F61[V;LSB
M[S5)4^^%;XQ)L462EUHN*3&4O:M!6D*2DJ234$4^&J]U?:`YI8V@.<2:@4.*
M[5T1JHFL((RXDB)@VUW!/T]="I`(W$%500?H/3OJDV<!8"YV.Y7822.N'5>X
MMILJ:>:JX5S0Y]=W;TIM4O\`AI6G73[*W@$OF=Q/G2;GR`AP*"ZT)(%3U^@#
ML>FI-D<8:"&MK3@$UNGOY>TI$W*X`(>!'4_5Z=3^"NE>2Z5X#=Q5?J2'DG<H
MV\M98C&\=N%XEN-LM6^!(4@/N)0AQ]9*VTA*C13E.W2NKII1ABC#96M)[0%1
M-9DD#SE<1W$JIS]X[O\`[,3_`$W]^/VCG[;_`&'W^O\`1J&YTOS.^/B?,J3X
MVV_R(MORM\^S:KFK!_28W[?]J._;ZQT_72UW<E?6MO\`1/Z2W_1/ZY^LW_1/
M[W]/\6DIOIG9L4?>?5CV;]OD4:/O*/\`[6C"?Z/_`+Z6&_UY_77]!F?U3_U=
M_LO_`*FVZYYJOUQLV^U7W1_Y9WQ?`=FS8J`.1_VN)_T7^K+)^U_9?UQ+_I_^
MO_['_OM576?]T;L^+VIWTS_M;MOP>Q>AV=^PM/\`2_Z@Q_\`S']16[_(/HUW
MGIK_`&T>3U+D74O\\?CV'9LVJ'EF_P#MK\C_`*J_Q0@]OZ9X_M/]?_NZL"Y_
M=?$/J;1ZTZDS^M)_U_VROP]QH2:X)'UQ^T^J/XU:R$VF^/R)0XS^V3]?]J/K
M?5[J^M_>_'Z-+6_UV?Q!,+W^3EV_`=FWR*QCVB?XN\F?XI_U-,_I/^/_`.V:
M_P`7_P#\5/\`9G][KDO6'^\Q?S/Q[OAV';[.VB[YTI_L4'\KL'Q?4V^M$GO`
M_P![W$OZR_K6]_L_Z/\`LH7[?_J;]#^]IJ9T7_<?^%NW;Y5(?J/_`+$/J_3W
M;-FY>>G+?\<N5/\`''_>NRW^J_Z7_6=K_9?_`!!_NS_U#J&ZU_F!\?D^'RKF
M_P"G/Q?N_&?X]^SMX=E5/[V&?_:L8U_47^,]X_Q2_:?TQK_?!_\`C[_87_Q;
MZ&ENF-C?@W?$KCU%O^HG"L_]591_67^+KO\`2_Z\_;+^I_U+_<UU.+X!\'_#
ML7,+KZY^+9[%Q6/^I+C^S_U'M^W^LG^KO[_X_1I9OLW;5K;_`!G;\#O^DIVO
M93_B9R/_`%3_`%E=/VO^-GUW_P"O_P"]_P!C?WF[5:U;?_XE,_IG\%Y\.UWT
M]NT[5Q\D_M(/]8_TJ-W_`*%^V1^Q_O/[M=+V/\G'\.S=LVE2>O\`^VL^I_Q=
MY47?;!_7V.?MO]].^?UK_C9_C`Y_C!_U1_@/^I-FF^J_R3OXE%:=\5M\?\W#
ML^';]J^53?YE_P`9\K_KO]M<OZJ[_P!(7W^G]+^]USNW_GCWKN/67\F[ZGT1
MLV;`J^&OZXL']2_[ZD7^I/Z;_59_KO\`OO\`#_Z[75JMOY2Y^G\9V^5<*L/Y
MNT^I\#?BV;MG9P3J\@?U@C^E?L1^R_8=_'Z-.>G/Y27X-IV=ZG.H?YR/ZFP?
MP[/6D_=?Z/#_`&7]7M?LNW=WZ_\`?_'2UA_.[MJ1OOY,;4CY/[1O]MW';^Y]
M&I*/ZKMGQ%4Z\^#]]-Q??VKG[7N>WX_X=33_`(!LVJE:I\+?B^(^I,_D'8_6
M[CZW?OI`JEW7U/.D!B'^]\]_2_\`'.^_U=^Q^LW^S_O?T_[VNJ/H7\A-\?Q.
M^GLV[_:KYU-_[CL_@^FSXOB_XNQ06E?XL<U_UG_OPP_VG[;]A_\`/=_^*_\`
M@_\`/:Y5I?\`O.H?']9FS;M=\78O5#OYK1/Y?^0E^'9N^A__`!/F[:*5CO\`
M66-?T3_%RW=_\7?Z.W_BG_K'Z/\`?5UT6R_F&_!\/[W?N[5PKJG_`'.X^K]0
M;/B^']_^[P[4KKI]57U_#^/5PWKD-C\0V)*-?MSW^NGZW]S3&[_=5HM_B&S8
M4FN5_P#%NT?_`"H[_$-5+]4?]AC\GK"Z5^D'^_N[_O5>>%?UI-_]WN?^_I.N
M$:%];RCUE>C^KOH^3_PA.].^J]_FC_%J\.^GY5S6VVM2.G?63W[I[=_SNWTZ
M@+KXE9;?Z2/K+^?^U^I_)J0LO^+:F-YO1V_^P_.^M^=W\-2?_KGXOA^]13/I
M[OB*8CD']NG_`#)_NZYWU#_/LV_$NJ=$?N]_WK5@?]#<[?7_`+IU+Z'\0[RG
MO5._N2QOG]7S>_[-'X/J#3WJ'^7W[/8J;HO\_#L^+?WI'^V[_?QQ;^K_`-JW
M_C+_`%?^R=^K_?\`^"_UW;K3].?_`'7:?!^_\6SZ;_3P[5?OUB_]C3_5^%OT
M_BVC_EX]E5Z-)_\`1&.WU#V_I/U&OV_^L?X'^]KKU*WX?W=F[8OGK:_%<?6W
M[=N])A/]/M_[;OX_4_:?Q:<Q_`-BCM,^DSZN_P#ZBGGB?TB'];^F,?LOZ/\`
M7/U_[W2BOND_7;\7PGXMFQ2+B?U"WW_J*[_U;];^D'Z_T:-RG)/_`.M_P+EX
MQ_Q8LW[#]BQ^W_;?M#^T_P!:_2^BNJY<_P`P_P#B*GM'VM^/9^]M\O:DE[@/
MZFP_M_CB]_2__D(?T7_J3X_BTM8_5/\`#]RDNM/_`&_'_P#W#-FWX7J(ES[-
M_P!"^HO^B_\`K[OU_P"_^/T:E/,N4?XTP.8?T]/]"_:G^D?6^O\`QZQ=_2'T
MU4YOYQ_U-IV=^]&7"7^-]R_Q?_H1_K7^D_TIC^I?^K_T?[VNJ]+\0^#:K[T_
M\#OX-^Q3)R?^M+__`(M_5:_I']:_T5G_`.\?H_374U8_!^XEK[;^ZHI^X+^L
M<4^K]9GM_7?[`?\`WG]'^]TQOMOE68_AW;$C[U_50^I_1D?TS]K]7_4_[[_*
MU2=6W;-IVJQ]-?SCOJ_N_#Y=J:FP_P!(5^W^NOZO^:U2[GZG[FU=F_\`IA\'
MP[]J<AC]HG]IW'[3ZO;^/X?3JZ[M^Q5F]_\`Z:<NP?T&9_6GUF?K_L?JJ_9_
MWNG5K\6]4/7OHNV;/W?M]L4JK/\`U!??ZU^J]_6'^+_[$_MO[[^[JV66Y<WL
M_JG;M*AH_P#M[K_6O[=']7_U9W/[+_6=(7GQ%6&/8WV[?*E5B7]8P?Z3_2+=
M]?\`H_\`2W>^HVV^%^SXO8I!O_"G=LO])NW[+]K+_9?M?S_V7^N?H_3I]#]1
MFSX@FM__`",_P_1?L_A*X#_3XW]=_M'/V_[+]@OM_?ZG=_[JY0/A3Y<=_P!7
M6O\`Q/\`VET_QD_K#ZC?U/\`J;]'^^KH/_"I"U^F>]*MG]C>?][/^KW/ZA_I
MG9/?_JCX_372<GTW?!L4OIG^Y0[?J#9M\G:GVXQ_:Q?]]+]C'_Q2_JW]LG]I
M_K?Q^C4<=O[JZU8?'_\`4)Z_<C_1L"_H?[:)_2OZU^I_TY_?_P"&^G2T/Q[D
MSZ@^F?J[OBVI%P?JVO\`H_[9?]/_`*#^R7]?Z/T/[ZFK-8_$-FQ1.G_RSMGE
M3<\W_P"*=Q_J/NCO_7O?_P"!?^J/A^+6U[\)V*MZW]J)QO8M_P#/%_1.]F_:
M_LOZ0Y^W_P#C+_9&J=JO\N?AV*[_`*9?S$?U_B.S9MW>WM5N]F_H2_\`%OZP
M_I']([CZGT?'Z-<@D_W$=Q7KN#^7;\>S>A.^LW_4'97U.W<=]/5LFORKZSG]
M9=S_`$'^A_5'[#_6_P"[J7L=@^'R[56M6VNV[=RA'R=_C3BW]/\`_A#O^V_:
M-?7_`-;^.KKI?Q_N?"5Q;K#^3'U/K-]J:3G'^J8?[#NCZO[?ZQ^K_KNK#NW+
MG.M?RGD\JDU[:/\`%2!^U_81?Z3^U_9M_6_O_CJN]4_RS=GP^Q7[]/?I1?%\
M#=O<I?#]@G_-#_G=4-OT1WKM#/J?\/M7"]]?\0UA+(DN/UT?A_N'4HWX!W)K
M=?32(N7U7.W;\?\`G=2>G_$_9L'M4!^X_N5?WO"_J"Q?TG]L]V_HGUS_`%C_
F`*W\/HU+-5"UKXRH!?\`L?\`4G^3_.:BO/\`%]O(J5__`"]J_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g53110424txpg38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g53110424txpg38.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@!D@+&`P$1``(1`0,1`?_$`)P``0`"`@(#`0$`````
M```````("08'!`4"`PH!"P$!`````````````````````!````4$`0`%!0H)
M!P<+`P4``P0%!@<``0(("1$2UE@9$Q27&)DA%=46UYBXV#E9(M*35)26%WAY
M,4%1M5=W.".T-75VMPIA<3)",[/3)"8VMH&Q-W2F)X@I$0$`````````````
M````````_]H`#`,!``(1`Q$`/P#[^*!00-VPY$(5U`D2-8F>S$V-D^2)6:+U
M?C49>N,`2)/CC^*$?*K51'4X5A(CM+5CZ.E)RJ]4P"XXP=@KB&L,>M:^6-KA
M'KQD8A[FG*G[-K:'L30/&1B'N:<J?LVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[
MFG*G[-K:'L30/&1B'N:<J?LVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K
M:'L30/&1B'N:<J?LVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:'L30=:
MJ<V6M[9P33[]URY%HP;*@Y&FU1WS*&A.PK!82&JO=T)#,;7QD>#D:I!#0BBD
MYEXF3P%,"X8W&,886Z<LL;7"XF@CWM3LY%VG$"OK8Z9Q7*%'$>7:P2[9G-E4
M>3H,FGH]&Y'[;((;710QE1:4%)TNHD7P!`QRSOY7IZ.BUZ"!GC(1#W-.5/V;
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MVJ<>3T/(B0;7U<NB$1`0A\T]&(VN;43/E!\;8A!_A7Z:"O7#F3AX3#$3#3;E
M1SPSQQSPSQXV]H<L<\,K6OCECE9DWMECE:_3:]OY:#R\9&(>YIRI^S:VA[$T
M#QD8A[FG*G[-K:'L30/&1B'N:<J?LVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[F
MG*G[-K:'L30/&1B'N:<J?LVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:
M'L30/&1B'N:<J?LVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:'L30/&1
MB'N:<J?LVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:'L30/&1B'N:<J?
MLVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:'L30/&1B'N:<J?LVMH>Q-
M`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:'L30;.@'E,@38&>6QK<1BO;J'I3>
MS,>[]9J9LCJS+,")SK;D<BMX%Y&6ZJR(B(Y98'0A'6GV'#`\I</SH/K=7KX]
M8+*:!0*!0*!053/OE_UX9DM2_#:+".\LQ.2"WWG&DDK<!:9S=,[&0GR"WD!U
MCMN[S8C=5D015+H#I(&1`?*8BX!&@\KX]7/&]PZ'QD8A[FG*G[-K:'L30/&1
MB'N:<J?LVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:'L30/&1B'N:<J?
MLVMH>Q-`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:'L30/&1B'N:<J?LVMH>Q-
M`\9&(>YIRI^S:VA[$T#QD8A[FG*G[-K:'L30/&1B'N:<J?LVMH>Q-`\9&(>Y
MIRI^S:VA[$T#QD8A[FG*G[-K:'L3027U!W^A?=)P3(SHW:<[Q\]X$$C[&3&+
ML%"3[@MZ(H,HIK@5V2<#;+_3DM6-$5I.;!L7`7$*V'4QQOTWMGC>X3@H%`H%
M!5!)U[VYL=/^B]_=XY-X;7_Y;?M_TJOT7_I]VU!:_05%/99G/<C>?8K5YH['
M2GJO!FGT:0&INP]`Q./"4P3)+^P9!\.TEF;?4D,61R;5C".64U"6`9),303:
MPKJ1BYDWYN3P+YAHV4Y;Y%-4)AXZH06G>1W#>,F2]N<TQRC>LR(:-SC%#-AD
MZ\X57Y]<"FV0VLQ'E'F&.0[A.M0A@44S)0/(FGBBFO,\0RQ<YJ601:D1)1:'
M4QN[#R.Z=G6DZH@FK8F'818L4G]/I4QA2;#+CGET'3C5<)8Q)!LH2:P2*0/G
MG`"9R-9ER1<J=$+!D;*Y<S<^G8;;&I.JKLG9]R]!$NS?FC*4QQ1'S68MH#G(
M+7B6&0Y)!P/O)OJRVG2;ED11SB'963%JW4,AF`B&61T,-[O;<3]LO$[*V\D`
MYN-AJ+FT<EZ>HONX223=U,9UID..IRH8"L2OFKH!A::;H3<0Q;6R-$1A2][X
MW%!RM?(*B-4-NY"=T@Z#X:Q[_;6;QOJ6'5'I;<B%Y<A5HCQ!',,KD4.!?E23
M\9-:^L,-_LO6(]>Y<@&AV%<9VRX8'P3[%3?E;C`A*:">5:0G'%D+M*%M:IPV
MK?BCHLUMU7*[93EF$HU71(Z5Y#DY@#I#K745N)#549:.GX[$R3B:4BDTD]B+
MT#&2&`.8N8;?7^78-PLQ3DO6?563-BV!'FG\1[J3FI%GRP(V7XZC:=(Z796C
M9C-MM.@V:SDB8S;!;1M54$<L9(DB).Y>V)\<T;+%1`M(A>2R,T0[$\Q)B::1
MDV6(T8DEIZ.='!,G4DB^VLE.@HFFS)>UBY@T1+JN(0F8=K89YX7OC[E[4%=7
M-S]F_+/][VF/TV]=:"V"@J)YU_LQ)O\`[SM.OIKZ[4%NU`H%`H%`H%`H%`H%
M`H%`H(N2?MY%,6JCG0CJ=)+T7F@M)+=7$2,8W=+^4"BVI,92D\ZG"8H)$<N`
M.VXW(!+2CY40/$$LHIX6%Q39\J6%#8L13K&4YIZRJ1FXL'`11!&QD9&L7'*>
M<)CW8[:DAEN`@$:P#&--]V,EW$#Q(U;&V`F(F8675'`'"##;U`H%`H%!44U[
MWOSPS7TWO?HXFM;K6_Y+>MWL]?HM_1;IO06ZT"@4"@4%2_.W]D#R`?N^N'^L
MDB@M92KWNEIM[WO>]R!.][W]V][W+A]-[W_GO>@Y]`H*#8-8FW^WS]Y$'@W.
M179*#7!!V]<SP)!K*;#3UQ=,(-EN,2/8F<C2!=[)>L'KCO>2=DMO0U92"LXR
M8YDIT8`C%Q+6%H,2CGG9)K<,ZUC*$51ZX=@GOJTW-AIV;C@V/B#6QAML,P[G
MI&`B1%BW-2X`+(#L?[XBQQFD!%QN`5*I)8`145B5C17,P%@+^WQA:4-'7W-^
MOTVM)+>S[TP?FPL+HA]?:I:4DTN<@Y>DIHKAF.SAY24\5%"+E\#1@'(J:`PN
M6$ZWE`L;WN$<M3>2J8%5C00T=B]59<39`DW00WMK$RTU73'<EOG8\")&G$]I
M-0!8[:HR)A'<ONQ4E1(/HR*(8,IYH)1R#%.$C!<8J&&E98YB@S<>[7QV^F`X
M8-E2)-80MDT]4UDV3URV'>"2SRTHLZ-G`WE17!1'"RHTF-N+CP3L1DM73%=*
M-DS0PA(\9N!GE@&WI1YO8-C&9Y/9IMK-PW#T&3HC:YS!**AL##C8DA)D0ZKM
MIN.588FLZVL@RE(T9QJY7:6(KZP7N4-V$*GQ$T@I@DA!,@E_JCN<]]J97V$;
M27K4ZF#"T"RY-4!XSNYY"91L"1)9@^3!F`Y4MIQPDW,.LNU314',X"L'<@,+
M&0!R=P;Y!XC"!"(IR+2="LJ[O)CM:3VV*R"Y2X4THUPC)LGV.U#;5QES3^#9
M$1TW)=7,45.P:X;^6%0ZH'%`P.8*`GQ1,<LPP,`*#?\`&')U9P26U(=F#7QR
MPO(`^V;CTODR^4@M1^,J/)D$UV2MG(>%).U)*I0KO9TXQZI^:)1VQ%/-$E_"
MR>;*!B"A99!IMU\UT<`X1\F1]&;<5W5+!_8ERQWA+^QL1:ZL!<@+7N7AH2QF
MP:1I$'R*86F9Z@9793?)DCZDI)N`A\UD2(A"&,0Z=3YR(U<0$"?L+AD225>;
MX36IN3VL^IYA:#E]9#:LHNV&G?#4(FGBNGV?L#L`V9!82J5,H:,KETNP%B1G
MWV\@I$\Q`ZI>Y29VAJ>>0K]J6O[@><,P').A,70DRV2XF&3DTRYMN!8[:B8D
MJ9!6LE`BJZ^X))#5#%SZH&52@2/F6.?6RR,9!F*SRZR0QC\Q%Y1T7?#03-5Y
MHA2(ML'(ESA&CM1(^#V*&C(2*G1%GF9)/5IG##19923[B(Y%6\81@L\PP,E`
M?&P=P]SAYM81;TY.MBCM5M_L<8.S)/49YRD=V$A=)D\G+@TA)$/J2Z@ZO*"Z
M%*KFAYKRRM!(BDN@Y8*&%@#2B62C247S.W#*6_RN+RN\&T94-1)`0(#<N[;^
MX_2\VGI+8!@_^WQJRR^88;ZL6B\EY9=,Q&ZWXS<4_):S.`GR!HY;K)@Q4+,W
M<-R\6.R.P&U&L:O*6QC.1FD\PMA-H&&DW0G$WUP@H-6,]AI,CU")XEV\F)H*
M8*S"C9L@9B#7&'5\TNZI?*V)W$/`+(J!05$;%WOXS_&-;IOT6U-Y(KVM_-TW
M5-/>F_1_3?HH+=Z!0*!0*!05$<7=[_MLYB;=-^BW*:\+VM_-TWU)U'Z;]']-
M^B@MWH%`H%!4,\UJ=-SMY-C]8F=LA*6JT$Z;L.!Q7@=@4G'I.8IGF*?4%TOP
MKYX_)(8TBDVA%\<L9'3<`R:6FA'5E74C-S!S$N3P+B!"9X[Z[T:\ONVH8*FB
M[*23#O)1J3KTLS0X@&+'+DEO6?:&*#<NLI&>:<0;]F0DS"7'3E%NJZRC)R>6
M$*II=1")%QCV5@PVQJUR6SXB&SA*?H2>[VAUX<HVRFD;5V7L]8Z)&D1<4=HI
M.CJ"4$I$"<03UY4BUN!IJ8U#*^(:#4PSX=QLB1HOCF=N&PHBYOH-EJ8HQ:9!
MK-Q.AV=)P6]>8;DT#8&'%^35V0$]6<S?;:V]=8TE9$E2/(RDIP-$T40%8Q<T
M=SR,D!5%.3BYT,;$)>\?>Z3VWMBL2=C6M3J@6(7*`2-PZX7I(;*=*_*!$NKN
M9O.I4$:33R,'&4F)*TW+>89J`UQ58B;",XA`VZP=@GW0*!0*"H?43[6[F)_V
M-XV/]STT4%O%`H%`H*GY.^VQT_\`X<N\/^_[2J@M@H*]9VTHD5RS\;VEU7V9
M5=5YL=L<MV)9@R-Q6V9MBV8V2QU9Q+<=&G='3@6FD;)/Z.3SP5PTE=3E@H-Y
MBI#%#81L#$#`$,,B'C+;T62!K9+"C.TH2;)D*ROLU.LDO5_`(IQ4GB5]I(Z#
MCIX+*D22PTQ`C9M-5)*E`4%#028*<GIY`N5MCE?$0<4-3K'$0FI[@29,C"<2
M#=F9$E_<U^`..3H'8LV1VLQ]NM-V$]/>*71%Z\KH61W%BOA-3AV\O)ZREJ9;
M(J/B/Y<L=,EL@D9KUH*3@F8(IF@_-;UE!VQSJ[(VN"J.Z6TRT/XXF90G-NSP
MX7V(69:6WD-L!IR\A73$I#3R`9!/2,P@,<\[E\<\P["/M#6^P.-X;CG+R.O*
M;:&UF?VM=Y2,(:8`XL4M^-%R-,PZ[-X(QDDW4DT%QY#!EO*^1$S"MCEE:U[W
MH,WB::M<XR9^M>O1&:6^ON1P(JI"4/DC%\P75+*CKNT%Q+?ZNWT(N"(,<2T8
MI&RF*94@K72+C!8A@F1,ARUA@B5I!QYQ5$K2CY^1E/*]*+3-\?K&TP;RP8;"
M8DA*S2;4CRM)!:11@,!['$]S#G)2'(&DH8,.Q3(A;$3JC7$PQ"N#8[238W6E
MC./6_49%VY5!)'XZH2TV5Y-B-F:[/)@[(N2%XL?D-,,S(1V15]"6M-WPVT-9
M+EU=V`^_2*J-M2#\T!P54<'*X?1CKE'*G#NO4$1&MF21Q9BR&HOCE7.)MQ;I
MQM39#(0VR?,I]Q\<![DAS29GD%U[6S\G>W3:UZ"`G-S]F_+/][VF/TV]=:"V
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M34PC``"H46$LZ$9L`4R`,EL0LKU3V8GA];![,:L[*,6)V])D!M.")12W9"+F
M=R\PW='\_P!I0)(J:8(OE!17"C.UG+T1J9<YGTBE5`L8+&`L2^5Q2^`0WB2&
M<N1V8=\'WL%,.R#=1X%VT?FIL`1A!^PTMZ_-^'$")&)'9\24\BL/.MFCO.6Y
M$<KT-+F*@Y+JY0HD"IQ8J6#`Q%\N&H2[SWK8V\4/PU`NP,9[=+38XMW(M/.2
MIR=[E8\1/MT,/:/!H8/P^Q(8#>B*?F9;`*XH"BIE[E@R=RQT<2U[WP3<@Q]Q
M<[RXZDR$LHE8,.,1P/'3*"MOWZD3ZX)J4BAA2GLLZ3#3@&.E*#XB?0F"^`&Q
ME`0\Z5DN7(%0C2?<%-.9BFL"8;1=/*SM.[VWL/)FOVM<5D8ZU>TGU[WED1&V
M%?3_`&3*BTVYBB>2Y96X,3&NWF.J%FE)C:3(O4">2HJ"Y$`3]P0LRF>`@@Q<
M-_J>L\V[`LN4;QU)*!&4.;12NP=I%\L\FRO/?*58XD#7J/V>Y-=GC@RY-BQX
MM5$)N9B%CBL,04K!K:">#1[9V+W/X9A,2`H9=K(ER?)-=A5NH^+[2H-CEK(3
M2(@I#>$:\)L90*9.HB@@*BS9M`N!W/A7+$DT0R8')HJ80Q%%RSO?'`):4"@4
M"@4%1+7^WBFS^$WK=]+K9V@MVH%`H%`H*E^=O[('D`_=]</]9)%!:PD_Z*3/
M]7DO\V#H.PH%!3Y;C7V2:[TVA&A;D7?L'11MA.CZG9],QG:]Q&KR(UG#([::
MC2=`$=S$\#"^8;IGWF:!6Q$Z*BFAB!B]Q@L?*6QOB''=7$*S&LJ1RKZDR<B:
M]"LG6*/=1E)-?L$1[LVA+,71$;<9Z+'2DD)'-)9MN3,S#;V6\_?W,R?(*_OC
M?WU3#UP`+X!*I:T`@!7AI4CL9JME1E(_KJN:[![2N9@1^N[$9)"Y%*C$AIV*
M;_+MM'43K@,("H-D8"`R)DAO*Y@8A!%\_)V#0TT<53*FR.8FC59FF0VTF1;H
M#-^@P:RT2*4E.-8;<UMV"D`](X:CD(/@D.!#Q@POGB0Q#&)'`E(P`/TAVM;(
M(Y+'"&`]4V2`7SLBBIIJ0]1W/J"&A09JW%,!16S6BNRO%<L@/)K1PU552O@\
M\E>-+EU',XIFR9P$V'8L"0P*V#%#=JSQ3Y@3+)KPC7802-8BFR?2NR,F1Z5@
MJ,'/*H+_`#ZJB+DC(T7;%N"PSGCJ/Y=64'$PN)XB4K'0,CZABEGD[$U:P(3C
MU@UM3-9&_+B`ENM2=H<L[+;![(FS*FG%$W-$4]@),7)*46H3#)BC8FDQLFEO
M(H7,"7L,.$';//&V5[VH(M+7&8UEF4'A)V<LN4L;=_(E#/(4.DAMQ(S+$W)#
MD%L^#B49!F<SGE14!=3VB&H#'[XXF@1AKAXAWQQZUP]<P\9#6EIF[R-[]L3T
M9KDW$G.*]BVQ(3;1TH%U:Z2O#$=PHR8^<\>&LC..2D?1U6$R:I<0?(N()Y\8
M*]-@K]:X=')O%BSS)G6MQZZ/MMPH\]9]>O51;^3^A%E[#QT[H'#^*YU,071'
MKM4FT*`[VLXVB64DE=354B9"&,G0C89TL;$!L&"S1Q-N:6(<:D%#[9J3ECRT
M+'H?E%`G_76%9[1G6K*JVZEU1G*-4`V09"%!\X>4>Y\H7/II<ZB@)Y=-!]ZL
M\DT`7(.4M<0Z".Y7M9N;$/U*C%]C\?2ZJL9PM9#>;EL]^/)WQ4IQVZ,I-/J!
M%;/XOQE16`D+A8R5&RR-G!E$(;$3H`N&`;,PWJ6KE]\&R^MH5]H9[G[`04\G
MFIH\;K;I3(;7-0D35I&7`#2RC)"BBD607,--O`.%QK0Y)'05!P7*#F@S`-P[
M!E;`XYVXLRD]Y"@_9W%OP(ZMN'M/;_C0C`4:'I?2YA(2L<<\U14A;#N(IB]F
M5%;RF%*/&%E'$13*OB5/&R:<KE4XR#C@&\2O&TV2L7,B,?VKN/,LRN196Y#@
M5CXN)&!E0<BKLN\-DLXP&*6-W``;H*F[LTG$_CE<W<L!B-U/*97QL&]-.-6U
M'49D2'&0,IGI)8:].4S2]'"<KL]&;BS&Z/-LCN66W&PSZZCFQ;OP).?;T5!2
MBF9+E#6)(8(MGAGY"PF02[H%!4/L7]L_QC?NF\D7]:Z?4%O%`H%`H%`H*A^+
MO_\`-O,5_%,>'T2M1Z"WB@4"@4%?4YZ4OUQ3R?VCU8V35]5YQ=[!;<6R^,8C
M%M33%,SLMCJ*^JQZ.^8T<"PU30#\CHRZU0)'7TM93S6)%0&*',#A:P`8(:25
MN*4J;BTN5);)OXUM(>V^C'>%[[7O-E,QU+C_`)OB],)M-O$%F,26#99Z5%2'
M'!(-NHK<3!"0*,0`!$P&%,V'&,AL(GQLMDI%K1C#]J[D$+-/D7/<AX:Q=N)&
M)D\Y3VS+CV5$C`4K8W<$%NX*CBS2;'\<KF_-@K#=3RE[XT&M8#XI\]>7_'P+
M(V%$(ZY1'*+KE&/(>2X*C!'D['%Q*#C6TR*WWLF'8X\7M#;+7W0,83$ZR8GK
M6810B6.JQP`M?`4)OZ:ZTI>G>L<0:SHKL4WTEQ$VS#<)NU83B:0IK81A:55F
MYHVFD!1R903'-4N';$//*W5PM?\`EO0;T>KS:\=-)QOM[+11NM)I(YY><*V>
M\K<NG)2:!F9-&,@RX8QHP)8/#H#!!#$'&$OB&'AGGECC<-3.'::`6F^'%&KC
MDM$27XSF='L@/%LF0%2Z@SV9*CT'CUAN%U7!("E6\077:6%+=)L0+(L&%F8'
ML$5QR&L$@*!05#ZB?:W<Q/\`L;QL?[G9HH+>*!0*!05/R=]MCI__``Y=X?\`
M?]I506P4"@4%;NB\J2+(<^\HK;>[P67,@Q#O$DQ]&24J#!BE&4R1]1]8GL*V
MD/#`(.X"9FZW<IG[X97SOYP<$RZ?=Z+!"R&N1_:PDZ]CX^>\0,V6):=_*#)F
MG>G[&2Y;+-5O%&\PX6)2V\+R2ZPX=`':C`BF-VL;71U<(BY%Q;4U;).#)X7"
M`&%"5W&/,<\34%OP-L&46FP[F!O_`"A&*$P3KL(/=/C%GHD)Z^JB8UF4[B*(
MWL%UDF51P'5I*,C$"AK,!6M<<N`-UP`PR&$]67>EQ3H(G.<BCM=Y:5NI13W@
M-FG!**G(S?9L(3I`":HMQ7(YW&")OLZ_23L#P,Y=-@Q1`Q@L#?3U`D3I]'KJ
MC6"TM'>J==!<CE?\VRL=:MS!<U=E`37-<@R^F,<08IF*3S-,Y+>X*<8\@((7
M\Y+">2SR"ZEZ"3M`H*G^;G[-^6?[WM,?IMZZT%L%!43SK_9ASA_>=IU]-?7:
M@MVH%`H%`H%!H*.-<(^BZ;-C9\;0[D$?&T2E%JK)(*HJ`&T`N9B&/BL:M2S7
M30R!89("%;I/#(Y80<S<<STYXWPM?J4%3+.XF&T+.KLB)SQZLVT6:&BKKU6:
MBXYI3)J,IR2\)=V41=H5AY-\9FE4=;CT6(G8E=5+4Q\BBCBJAE3!3#J%K#YA
M+DUQBQL[&?(K7F?8/;#8!0D?"#T\Z\)7E!N#+;<;>ODLH4TL)NM%"93`9<=)
M&!]\-TN,O*F:$.O+H=[AFC^6.`%@0ELUM>F&T=A)>V72AW#E(LV1[#\9O$N<
M4P!VR"W8149,4V:(B)6)$(P04QC,KJECPN9@;$QCB!;'`/R>5\PC#+O'"Q9#
MEJ1)GC;87:S5-W3610B<[@:QR>WV8@3&9;2(`UT1TN5&=S$?H#;D0@TR19)L
MYFS="7Q$XF6"$-Y^;%\@@SJ%>/S6O79Z,)XPTVE=C`QIJ]?49H-!.6<AVD0B
MP5_VDTX?-EU`L;6U=^JKON(:/+)L^,8/"F!A3%A1Q<QKAHE*XF8:8S6C!MP?
M.^UFO!V.]<F;J<L/&'I.;20[I7@Z/!EPRPT*23;BCYS)`KK9!AU+&2,YT4DB
MN1*LL&\"IT(,2V&`;D+\>&OI)N;,M,@/(Y9"VLUFC;4V1@!WP<6CZ=%$4QI(
M43M/)KKKC*K+@P>%FI):A<XK*AI4,'3F`(XO6SQS\H$PF.T4J/V4T&&A9',T
M1DM=OM%&S4!\3)_-*;:241D[(\9P"`P,',BA+"XN=L,+9Y]-[8VZ>B@RB@4"
M@4"@4%1+7^WBFS^$WK=]+K9V@MVH%`H%`H*E^=O[('D`_=]</]9)%!:PD_Z*
M3/\`5Y+_`#8.@["@4"@4%#4*<C+OCO9'DFC228DWBV(38\W6%;,8J4'ZYO"9
MV%';`$UIUT<`<>E'(U@<":8H%72NJ:H,G#=8<*RI@-?*^(^-L0P;CZY#=H9%
MU1TBC%A12-MWM0[M*4/:N<WK,,S%(304QFN"07<P62">=A..)(/."3Y)<;-6
M"I`C@D%$XF"C#CG3P%K@X#!Q4OEE.J<RK^P;30I-=\7/_0O3`W$6J"@J-]MK
M.>V\^;RS]JU9DJJH9\]0VZY,)"122`OK%ASB>33D44X#@/@'CB*'"4-P]GTG
M:7:9K;(H<@126:TX\)\;,F-(1GE'<;+33>RVQ$CLETO1JO\`7XA0U1;C=^#X
M$23P0SJ`E*:@51C1(N9*V$`4,@DW%_*G(SU5(`>KOU1)L+6C8G:>5]/&?*6$
M[ISFD%.E"-%^;VZ3=JY%`4<)!`K%3L5H)52P1VSBNKDQ10A!4ZY6]A\@]$><
MJLKO!0U'>RMI<KI.MF]"^_RVN\F(DS)CHD[)KM.$I6GAFJ\C0J&P4S%O.*:6
M1%^9AN)"8X5GR7GN(2B9)FL,2XP;&XZN2L_ONH*`A2.(B;[;M':8_;FXRVC9
M\Q/F+EU05"I`>#]EX>-M"-I.A2:TDN;N,8+8IRRA6%*'"WOG8<`*QH,Y@N4Y
M%</)]R#Q(N/%:5(SC37W05RL!DFQ@LT-I+\CF=KL'XK(X&(.(H)MU8LU*L;O
MEGG;/S$+HMCT7Z0B$J\C6Q4-[3\C;5D&-4*3&/&<U:3:]Z@QHUY%2T1Q.67-
MGVHRB;*:2NI*,:)I1!0GJL/$9P.!=4%%2NV21(4L6*J&(6&0@;VT3G#9R3=W
M.1]A;'(-X]M$J;IF`RHK1)$#E&-FY@\XWD=6<[LC9WBLR/U@\COL\G@9&L%!
M)(G`#Q`0.X74PP%%#IWGIOL+)D(/W6X!3CYN-%0GS8YS*#J>@#N,.$?*59W.
M;"Q#/T=J3)<*:`NN6*`GJ:3##5<9?!)5EM.#$,C6(EO('PF[K%'KJ9IC8QUN
MI,S0,IFV6?$F-]M#"`YFD9K$VFP(K1C9S$MF(5+FGL'&.3FS!PRZP-UOJ"VQ
M'Q%QL$I*!0*!05#[%_;/\8W[IO)%_6NGU!;Q0*!0*!0*"H?B[_\`S;S%?Q3'
MA]$K4>@MXH*T^7Z59(A/CTG.2XC>BY'L@-Y;@<NANYN#`EUE+`<6QD2-=="*
M#&`#(.."JW5HV3&Z<+]()C.UNB][7L&D94Y4I)CMP;-N0CJ6`OZZ:=;11KK/
M.$J#3JG)3Z/')*`A$;!X1;$]HX4`'0390<ZI8RN34E]%S$!#SL0%-C6S"##3
M6VW(%LR\T#!7U[B%296OK1Y.]9]/EO8\G+R83D)<4&KN=&$/3V-:%Q&,:*"0
M>ON7!98F2ABY[+1H7/(W9,#(Y6,6#=NO?(PSD1YJ3%DTC("''[IE'E(,)4U2
MO):,\0T=S:/[(.1(?L8!%$ECM7%!9_[*L#SE:1<04T.G-MOFR`XIL8ED<&#4
M;<Y3U$NL.J3U"$)DQD>4=<>-%:B/6):F1JW9IN1=[)BV%8T+LXK<S'Z5E&#P
M-)[>+*3_`%XX95"Q5,+!@ER%QTO/WP#HHUY!]DHSW+VH:&S$8&R%E?9;C(U@
M8<3MN7BKVC>-AMFFG(Q9?EN/7D;CMI*[B;BTHI0!DZGGDA*/Y'28@/2'CA@,
M*$Q90Y&UAH']K4%J0JVE%1UAV3BK7A7=\I;`L6$(<)D9+U]CZ?#,Q2A([P21
M_P!G;":Q9^AH=RI`@Y5I35O-L"Q6^)O*Y8(3H7*,[]BGWIJZF07^+R6S=[MM
M]=Y]96OLFI$_1U/H,,\=\Q;#-\&*'ZGMMH9R2VG&=-M\ZDAY)Z4:Q7BOFHF-
M_)>4$#,(MW>?7*/`C_1H_BN&+YHJ'!>P:*F19M8R9D<!!>C>;&)*"IJIL5&Z
MBU(ND2$9O6DIF9II@N93%%MW%,&0<E7'(O?$8-BRCQV2<G+NW4D,F77I*M]K
M]=)&@\&/7Z@1N25VV^9WD@X;!?2T]$)G-M<.,N$6RX0@$XJ:-&SY)%1@R@60
M_D"@>(70$R^10F4*YCC&LBQ8`OD:,96R,&<@0L0[CCY6M:V0PU\>ME?H]W*]
MZ#DT%0^HGVMW,3_L;QL?[G9HH+>*!0*!041[Q;0P-I]RSZ;3%LG(A&*HS-Z)
M;F,,J\%A'<RHDBO%<FS41926]?)M(BV."H'TENGS`=A,,,,@RN?X76Z+7#='
MCQ\2'?48/ZIRKV!H/2/SU\0Y0$0R;W=C@F6!QZPQHXVI/*%@<.FUNN,8,,0,
M$'#IO:W3EE:W3>@]UN>3B/O[MMU6#>U_=M>S3E7W?_V#05;&-UN/%KSAL1,$
M!<Z;Q@)+V8E9*F608V0M<HW?[=P>J;&L?Q6(92%J4M9G:["1,^UXW3K"`6.^
M3Q%MGGA;&^5[T'!<.S7#N8>LKR&QN6)9CQWNC:TGNM#2LFQB<6!=?I^5HP/0
M]+1E#NK0P(-(,<37'Z@(G+;<<.9P`N!GEDGC%!^H,&&U=>^0#BVUZ3G%[R\P
M3I=+GDO;M4VXF]W..,0LC\M*+AB]!CEP1&?3B4"ETEH1:.,UDQ1)!H@1%63K
MIX!4([<M87`4+`O'CXD.^HP?U3E7L#0/'CXD.^HP?U3E7L#0/'CXD.^HP?U3
ME7L#0/'CXD.^HP?U3E7L#05_\GO+-QX[0Z<NJ"8!V8;4G2X_9DU'`9[&;[4D
MC%7714+;R"G0KXE,U%F$2.%D]OHALV)D(+ACB$!E?I]SHH/ITH*@.>4V"G<6
M6PJL:L8\P0WMJBOJHI4F<4!2B,@;BP`LK2C<FG@&CHP":E$1C`ODP\\K!!97
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M!X\?$AWU&#^J<J]@:!X\?$AWU&#^J<J]@:!X\?$AWU&#^J<J]@:"/>GNU$`;
MD<S<_P`NZS2,1EF-4;C-U]CQ4>"*BNA,2"3W2]H=@G$?;68CE0T0452*H3D(
M&L\0\<\+!&L/PNGK6Q"_B@4"@4"@J>YTBIH[Q#[^EB14T=-"Z^N/R14D7&-F
MAKX'TH3+$$L7P$'&RMAC>_1CC>_1:@Z$ASO<21<@2`$W48'7!*%@L^AI2O:W
M7#!PPRZ+9,#'*WNV_GM:_P#3:@Y?CQ\2'?48/ZIRKV!H'CQ\2'?48/ZIRKV!
MH'CQ\2'?48/ZIRKV!H/2)SV<0P.8`0^[T;@"FL[A%0AVW)P(IL7'&XF010(5
MB8"&A<0[7ROB';+*V-KWO;HM>]!'"!>4GAH@!Y[0O5O[[H2Z>VGGP;8%UDUM
MH2%B4;+A&BN,8HNA-RZ?&A0?)$Q28N*FK7-9#F/.3(W^4\GU,<0@Q'T_<0\"
M,^`"&L7,&Z(.DB$-=@M4E240(H#?YF584)O-7D!!3WBRWO""DSR3S9#N<"B<
M05E.+E<R5U(X"8!.%C&0-@]]I.X`4UJYLQI<ASA:*6EZX:_0.QE=.(/@Z]&.
MZM:MAGMM-'.PY!T*T0'15:9!)M>PRRIB'01DA0%#R#$)>0''"S#L$O97B+5W
M;(,ES3R^.29Y1D^7M$I?<[G4HL%9R,0/:!2RL2O%[19S/:<+$TMML]TGU?,L
MM!99FC@N68QD(P&.-E?$-GM[<3A';D3:U1(6Y%,#:/K+N`\MQFRHFV:\+GW0
M\'H]IX>Y]FN;`.*,2?Q0`.3XH%\+E0P3EP"1?K"WRN+?,*MX$WKTY/SKI0R5
M_;"8X9UITH><\N`NPI"=[2<<-QNV'C!LOP@PF+JW*$21<B["S6,GY2D$8;*Z
M]"R*;8[83Q">5A%(3#H"S+7#<OB,A?8%%V4DSE<&V/E)B0POZ^QPZWU#V+1=
MH$:.A;9*XNF);>D=0BW7//$A'1XY2,,5I?,9!@7#-#@E`S1\V8%!*.]/&XN[
M/RMM+`_-@Y-9'7-D>P]'<D-MGP"SI';JVG0>+((K&/E\ICUS?"DD'B]Y,5;#
M^:C!!CV%QZ^-_)X=4,1?.RG#C(3QFM\N'EE<N#CF],U>=ZRL),;73%=I[4ZB
M8M'"(MJF,>!@G(-$=00;,+8*3:S!,-,^&,8#R(XA#7#L&;1-O7QGQBY=@Y2,
M\T;K<\Z;+N'6U8D24AH;2TD)-1M=#ALN68;%8I:!3#3;3-?[04#2.J8"!'%$
M+`X.<+'`SPGG&(62>/'Q(=]1@_JG*O8&@>/'Q(=]1@_JG*O8&@>/'Q(=]1@_
MJG*O8&@>/'Q(=]1@_JG*O8&@>/'Q(=]1@_JG*O8&@>/'Q(=]1@_JG*O8&@B@
M@;O:K[O<QV@BMJK+R3,B;%VJV_A203K?07BG%6H8>:EJSFU0E,RY&XB%^NNV
M;2AY#$/(3*_FF?6MC^#U@^B.@4"@4"@4'S6ZP<C>E&E&T'+/'>TL\H,./5W<
MCCED%MM]QMM^&S*PRC^L6L3>(N0D906HKIXR:;6VV?+87L-U_*%,^G&UNK?(
M)O>/'Q(=]1@_JG*O8&@C/N%RC<-&Y&O#[US>>_*&T6X_#S"/'W`U&A(.:\1$
M8$CM&2D_`EBLQHHIM\#ZFSP2X_E`<[^;C9]3JY]7*P1_?NX7"._XNW,BL_R,
M73TO=/8QH;(O14(,]X>^;-<K.)0&1)-]HV,10,4S036&OZ?D+<Z&9,]8^9ZH
MEK6"\F&LWQLCQ!.IW+)9$Y>G@QM>U[;9E;P*>MR%'9DXV!9_;,Q-><U_(%\K
M4)J#_+1<_I);>:XI-O`Y8,-;/#F2Q@$&^)2P<J4YRX%YAUW6=<WAR&'?B\L;
M@3'M[=THR`^D=VE%>?I.DEZ2Y%Q<\4BO$"\<O9CR\XF6>!R#N:,-]2SL(+D/
M:PE!L.<MO^#^<7]-$EF^1/-BO"4&;J2C,]79#1=A(Q"3YTJDZ39<@^48\P4X
MA4R@R^G.Z2QL3Q%3".I)Y.+6)YE_(CCVS#1JOL%Q$KP<TR#)/,RY7+/\IRGJ
MG/!*>#\5DFX3BF4=.AE;*)S[-CHI"0#"P8HI17$+*R,JX'L#X0QC/(SB8,9#
MXAUZ[,7#TY`EAYK'+VIN>>UC;!J[G82Z](027BW\);0-="FL0Z<8AE1@O&-U
M2/LXS!RLE$A0/?!!/8ES1-0Q'`\J(&;L#8'A69[F3WDN<K;Z?3J"VHEW;E6<
MZHW%UL.)0DF;-/#>G3O()2E'T*-+%F-Q%:IOWW;H:.$3,H1\N7"!&R+@XXW#
M.]:=T.(N$-@"^S$E<J]]C9<;D)J6O#)>#UAO%E.7",%IQ,]S+!F4W+&T)-Q<
MFV1E)18*5UEQ=&RP+^3,B%B@`YXX*,%D_CQ\2'?48/ZIRKV!H'CQ\2'?48/Z
MIRKV!H'CQ\2'?48/ZIRKV!H-,<8NP$0;2\B_+9.<!/("1HE<R#Q\(C??*<D.
M!*1U=5:D63,FN,B1^,22CFS`R.>SQ#'OB%?'#+*UNGW:"]N@4"@4"@4%5?.%
M]DCOY^[N[O\`O"-!:,F>ZFI]_P"DB4_[@.@YU`H%`H%`H%`H%`H%`H%`H%`H
M%!40I?;U,S^$1)OTRXEH+=Z!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!04]
M\C][VW1X4?WZ95^A+LI;_P"UZ"X2@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4%6?-Y]D1R+_NFR]_\9-4%D3%]UDLZ_\`2U6]_5!2@RJ@4"@4
M"@4"@4"@4"@4%5?.%]DCOY^[N[O^\(4%HR9_HU/_`/T)3_-PZ#G4"@4"@4"@
M4"@4"@4"@4"@4"@4%1"E]O4S/X1$F?3+B6@MWH%`H%`H%`H%`H%`H%`H%`H%
M`H%`H%`H%`H%!3UR0?XTN%']^F5/H2[*4%PM`H%`H%`H%`H%`H%`H%`H%`H%
M`H%`H%`H%`H%`H%`H%`H*L^;S[(CD7_=-E[_`.-&J"R)B_\`LAG?[*M[^J"=
M!E5`H%`H%`H%`H%`H%`H*J^<+[)'?S]W=W?]X0H+,C&:R&TQQ&X733;AP;HF
M:"5631D@CF5G%-RR2RZL>)%%`X331CUL,1Q00!Q0PKY98AYY6MC</GPRY!]D
M]2I5GYCS]/+%VK<L#\>$Z[@[&,=&B4O!;6A:9(L+LE99L9Z_O`RGIBW,,3OT
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MTPJ^ZXI:+$EO`+MBZB8-%R8:1<T/@H4%FFH;[=CXAM)$E*2X]D&<DI16`YO1
MXY6VDLH\02"LJAQQ&X-'^*9@?``Q#Z>J@-ZPQ_JJ2A@G6.&>D8QG>@E#0*!0
M*!0*!0*!0*!05$*7V]3,_A$29],N):"7>U*-LVX18[3H1FQC:VQ81S>[HV)F
M]806V[)#:[8;;?!--1'CE`D)'5XM)%EM7&,&%]:70C&"4EIW4+E\Q37G!0*I
M8!W'W&V[)ZBP.TIN0HP<$MMO>&9U?;=MPLW!UN9M:-8YQ:$):[RC'<22/@X&
M2S,=GBDFI+I."F"I\OBDD<\DO``%3*C%0L2TYV<E6<=&S$S.U%9JK/3!%V.C
M%Y)B4;^)[`=LOZR2A)L,JZF1-K1TU@SFH_G+&OOA:Q@T,&DEE"^&8PF(%Q,@
MI/USYC9I+QU*LOKDU(VU9-E\7TE;MRPQEN"P]?"T$;%M,^W2K/A.+EDL733\
MR0T[5=56THVK@".C)*Q;Q0_DO"AK!0$4)DO'8'D2UF4I`AA=D9O;;37*'')-
MFV,$73X=;[.4VGL)!*Q&S;?48-AG,6Y?X_QPKWFI(/MD@HYF'%D.DCDS"B=R
M.A9`!R86WEEE976_&#PG@J08J%L`YI#6-L)P8;/@Q1=.CC12&$EL\5SMESMR
M/FHW'I/6T#C68];YP-&1\U1MM!;4R`/G98,R(%[X8@8P88H0F`H0N&(@0H>6
M.88@>>-LL!`\\;WQSPSQO:]KVOT7M0>=`H%`H%`H%`H%`H%`H%`H%`H%!3UR
M0?XTN%']^F5/H2[*4%G\MN"1FM'#L7HBCTA*TED$W&[-C]6>1*/4AQK1@T7*
M``++T/IJR"W$8G@/D:-F,"1TQB6`SL`7''N&%F%6NJLH;E[7<>A"37GM!'.N
M,_MJ?=K$:5)9:,-MM^Q@09T"[%SM%H[9;[5D%30\"342D1GD,@EI0&]],RR=
MY4U:XI@>]@VUQ3/_`&HF?6P6>-EY3+2:A3,[55YZTF1XA;\..S'6H7JE(O>+
M];+<4%%.*.66T@"SH")8B9W2TI4)EA<\C.)BV(04UYWQFN2MOAR\O[0/Z%8F
M=NX,^07!<..C0APMV(I83(O>SX93$CU(W,=!,@@G)0D=&90S@*`%QN@W;*Y(
MID,8PS!L&':W<F4V*BMH3+TI[-1.^\M]MF'KKT]]'$%E,U#=6J)@5*E@TV@$
M=?33G[5S3OAEVQRFMI^_&S$T2/GEL00D&F9!E`1P]\2[[[N'&^[F7(#F-I$L
MRZT8J;2"N2E"Z?%+:U)V66G+.BQMFV2%UINMI*DB&=.=<(](O/-651EH(V<S
M3RYI7,X.`H$"'T3,UR-MX-5ON9GNQ'?C964LH<17D@*Z0O(SF)9!VQ#6$]80
M,\T51`.WPOGY4K?R&5[WZEK6]RP9+0*!0*!0*!0*!0*!0*!0*!0*!04^\CLD
M;C08TMA=C6_M!&6MT(0E$[>4(%98$7(<O.[978%1]_,[1O)I%T$`%PFEO9U>
M\#4:R"QC)=QJAU2,&//K">;%<`UWN+R&;%LDYJC'<+LUOM:2#<Q:"7WO.+80
M+J2H):FT\TQS&8.OS=RN'F25YG?YUT'Q0\\K]9#:R6*I"88#**/D*%K&P31E
MMZQT:286G8IKF\0%(BJ"R6>C5LRJ5)H2?B8%5TP=K.U32$;$(^%?&^1O(:V9
M?$.][6]V_0%`3)W1WP+ZM1=,#WVK892--U=Z6/`.O.U#XU_8\?Y0_JL80Y''
M);%.5H!K)EB"./9MVL0NFL`NN>42B!1RH9H]8P8-B)]@SPEO_/2ZW)KB))V)
MN\$O6#?%GZ_S/O5"$(MZ2G"3UX?6LZC-3??(T6M=K2)'8C^09N-)D9N,^FH)
ME'#ZPAP,@1'$S\S"7^E>XDMSD\HN(SVZF+#RHWX&8,>R%%BKDVFLYI>WH<C,
M94F3:UV:B.`\.ZL"&LK04DTBIIB7F+<NX70HD#V60R#:@R3F\^R(Y%_W39>_
M^-&J"R)B_P#LAG?[*M[^J"=!E5`H%`H%`H%`H%`H%`H*J><7/`/B.W^$$RQP
M#PUU=^>>>>5L<,,,<R.666665[8XXXXVZ;WO[EK4&Z%G?+05Q,A5:^'(#JNU
MS"ZU3R#@XVSM)!Y%R-T942!4_%;;YXP[3A<FN)&8_ER@N8(N`9@/'*^&5K7Q
MN%1"LT-8]C3[33=^.7W12<6=$^M6Q>L3#,Q;(<1Q/(DB)>S\:IT/29+4YN98
MG%^I9Y^FH^3N@),;Y!*0K+A@13S"RN$3*E`SR,'7%B0]V/*4O<P7'`^I'UEU
M;E;6S419;*[&#31$]<E$E'Y94G78!NC[(*XC[=)C&)6Z$.WT$XWD7`+`_D!D
M&(<`N1#II>-PDXWCLBYXHY<>-=LX[UP;&T-[<_M$68M?IA/5V''"_%9V1X!+
ME=C&\01`EYGN<UABUW/BOHY0_A@;L()Y8\`;#6)UNQTS]B6;+T0<P'%6N,F!
M8=C6"]1&)LZ.B3.HZULUE1^D,MV.5J*[4W/BIOJ4N2X.GYB+SL,(_OSDFV!3
M"XP!+$8,P%E<S;,Z238]]<\W/R'Z2!13$#TRF%_,PIL1$@9R3)89I(E>$O*"
M9R(*4(,B/WH;,NS(J-YR8%<",AYXY>3+#^5"+/'HHZ6::K+D5';R0<?KFP*P
M9!^L[-#CF9XH9F;K8T".&7'"B2_,MU*3U?%Q3P_!9<&"6C);H*8>8V$#$$N:
MSQ!"T?Q$./\`[\VG?SFH5[;4#Q$./_OS:=_.:A7MM0/$0X_^_-IW\YJ%>VU`
M\1#C_P"_-IW\YJ%>VU`\1#C_`._-IW\YJ%>VU`\1#C_[\VG?SFH5[;4#Q$./
M_OS:=_.:A7MM0/$0X_\`OS:=_.:A7MM0/$0X_P#OS:=_.:A7MM0/$0X_^_-I
MW\YJ%>VU`\1#C_[\VG?SFH5[;4%5JAN[I=ES=-"0L=O-7LF"#Q62,S1GOC/T
M47:(+O-;;Q:MEFJ*Y+.SWF#<9E&)C&PR-QK&<RP68ML+X8Y96#(>1Z1=?MT$
MR&V7&_*IQRL2'V@[5-X39"DQ/QCRI'>R(Q(L0_9XT9)*,;9B'5D_&C36\!U4
M^WA3@R8XCH9/!0"&*%Q"PX=.Y95CQ35]=Y_2.5OBJ2=O8";,RQ.*I)RLTD?6
MR0(*F4VQSYEB*<7@;5J#];BPS5J,&ZJ)BB2=&85S!$P7R*XESM_(!W+,/:/-
M/5HAI<:Y4--W!!S\A;:=B[.K8TPPND2]+$I[3JJPY';++(=:=,%T*+P0'4_W
M6=ND"):U:^*@2!P-!XD<LC(:$NPM3YN)MII[G\KW'H_6#$^H,]Z9Q2G:_O.)
M867%5H;$,9FQJ]I*D@\NSQ(J99V$6<Q"-DM#0RJ>WR2K?,]?`6X1(`H$C];9
M2UW:D[(FQ.U?*WH#-$A1EKP+J[$6$:21%<7H99E+3I:SOD>3GT37ITD$PJ2O
M*BK'[=Q.!)PI!&2BZ3<,J")<T)E@&GYB`U+D@RJR[XC_`!N.S852V==<SF4Z
M6I?B]UP4KQ?^P^6]8HAAI7;9*22*[DGQ%%LIF'`4,8YY!&'N:5C/D0@E7/,`
M+%]=-LN/K7W7Z#H&`Y"]37D#"L0QQ%`3N6-E84+JKH#CUGH[3P<"B7Q?QO$L
M<6,4GS@0*PHM@\A+XVSRZ.M<-R^(AQ_]^;3OYS4*]MJ!XB''_P!^;3OYS4*]
MMJ!XB''_`-^;3OYS4*]MJ!XB''_WYM._G-0KVVH'B(<?_?FT[^<U"O;:@>(A
MQ_\`?FT[^<U"O;:@>(AQ_P#?FT[^<U"O;:@>(AQ_]^;3OYS4*]MJ!XB''_WY
MM._G-0KVVH'B(<?_`'YM._G-0KVVH'B(<?\`WYM._G-0KVVH'B(<?_?FT[^<
MU"O;:@>(AQ_]^;3OYS4*]MJ!XB''_P!^;3OYS4*]MJ!XB''_`-^;3OYS4*]M
MJ!XB''_WYM._G-0KVVH'B(<?_?FT[^<U"O;:@J@Y`]V]+W/M[P]+C;V\U>7T
M5C;IR:OO5719_B=43&@A&].MAD(JM.@^1=HY5`23*XJ%209DWF$#F<-`@VRN
M(+ACD%K_`(B''_WYM._G-0KVVH*M[WTI*\<NQ6B*)RJZ:HJU/JOMV*)+929X
M>QLVV_MG.THRHO)(38PE_`P<-H;3E`RB6,XJ(/EQ@_.K8!6R\AB$ZW'NYIND
M-^*FM!W(/H-'*`R7:Q2KF2E^8XA=9-5A9ME!D];CYH`ITO-7!H.,^0"*A)ZN
M+[X%T_$#+K$1[9VZ@5[J"[#4B/6)VE/?,WH]+6L4%;1)FUS&('9"A]-V4=SB
M9+R6Y`AN+Y-E4*;Q6(<842.Q4*9AGDIK$%=<((I$H9S!MYX,;#HX^0]0K;%Q
MY+,Y\G'&3(+<AR7W).#?<C$MK;%&QL]/X1!?;1B8_M;+#=E&Z*^@8*:<B'@4
M\-(14G%;4RY)2.6"$+7`%#96UZUI3M4LSNXW)R6Z,$E%7CF+XWUK1U"=XI7&
ME'R,T)18L\R@'(J+E)Q"SJ*;#R)'2$AN@`GF6QS9J$4+!WN,*:\H$@]+]A]'
M=9X?5V8ZN071E;=3TF":YM<Q9C["1"@QTU%V;9,<DDJ3*CE%47^:/D6:UQW#
M<L7S'RQ&.BXBF\PP<S%P0PEIXB''_P!^;3OYS4*]MJ!XB''_`-^;3OYS4*]M
MJ!XB''_WYM._G-0KVVH'B(<?_?FT[^<U"O;:@>(AQ_\`?FT[^<U"O;:@>(AQ
M_P#?FT[^<U"O;:@>(AQ_]^;3OYS4*]MJ!XB''_WYM._G-0KVVH'B(<?_`'YM
M._G-0KVVH'B(<?\`WYM._G-0KVVH'B(<?_?FT[^<U"O;:@>(AQ_]^;3OYS4*
M]MJ!XB''_P!^;3OYS4*]MJ!XB''_`-^;3OYS4*]MJ!XB''_WYM._G-0KVVH'
MB(<?_?FT[^<U"O;:@>(AQ_\`?FT[^<U"O;:@J"V6=#$ES=%!VG8_+CQ2CM&+
M&LC)6NL-;"#-Z6F]!CVS*&,7Y,;=Q9VY$3H2O+CQ$-W)%UP^FF#B$B`XDT[(
MO<P?%-AB^S^K?#7LT7">"EO/JRQIT>D]0#/<^/QE;WNU"9<HN*,'7':I(=DV
M*DO;,BU6>J/MI,2R*DJP&(JFV0O-1RPV8Y,+.@FO..Q^MLNPEM_!"7RI:*,=
MJS7"Q^'M?%E-EN,C[Q@T)R12?8;K<3R<1^>11Y54Q7"?R4TX0+%#')@XX@B"
MF!>DS<.+-TS:0.35J/\`72">1'CY82;&!&,V^FM*4W_KK,<(23&T=(H+:&A:
M6(V6'X1'.QZZ$``,/(9+/$%1-.%2ID`;.P.9<<,/U6DK3'5B*M@S+>Y#>.51
MV/GUPJ<@&5=LR7#$9Z_,5QH<8MN*X7CEC16A2@JJB'#<5M1D))7S>ZB.IJ8O
MGQP08,8YU`@B6Z(<T6R<L*V9_)WH@.W$1GZXH<T/!]31$ZS,QY[0!MFL;G.B
M98D=).4@4]KR+LQ++I5`GF*:"R##!$+&"]Q<BN!;()(<R.\FE#[XK-_&:R-P
MM6GB[W+J]*J.W&JUM@HE<#C<"N=;ID(DE(B&DNXVIJJD<&RM@$``$(*)G>V.
M.-[WZ*"\9B?^R&;_`+*M[^J"=!E5`H%`H%`H%`H%`H%`H.E<3;;KP0U1L.U!
M170VEPF*G+;><2616T-83Q[=4<BJ)*F`9(*!,;'W,PA0\\,K?RVH(\^I#I=W
M0]7_`$`Q1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_T`Q1
MV3H'J0Z7=T/5_P!`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.E
MW=#U?]`,4=DZ!ZD.EW=#U?\`0#%'9.@>I#I=W0]7_0#%'9.@>I#I=W0]7_0#
M%'9.@>I#I=W0]7_0#%'9.@>I#I=W0]7_`$`Q1V3H'J0Z7=T/5_T`Q1V3H'J0
MZ7=T/5_T`Q1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_P!`,4=DZ!ZD.EW=#U?]
M`,4=DZ"J=1U+U5QYPF>R,=9M?,68+Q32.Z16E:%XWLVA7,7V[BQ)+N(1"LVO
M>S-<`2S(I;`W<*X^``F8=LK8996N%K'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_P!`
M,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.
MEW=#U?\`0#%'9.@>I#I=W0]7_0#%'9.@>I#I=W0]7_0#%'9.@>I#I=W0]7_0
M#%'9.@>I#I=W0]7_`$`Q1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_T`Q1V3H'J
M0Z7=T/5_T`Q1V3H'J0Z7=T/5_P!`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?
M]`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?\`0#%'9.@>I#I=W0]7_0#%'9.@
M>I#I=W0]7_0#%'9.@>I#I=W0]7_0#%'9.@>I#I=W0]7_`$`Q1V3H'J0Z7=T/
M5_T`Q1V3H'J0Z7=T/5_T`Q1V3H/+'233'&V>..HVL..(ENKG;&`XJM;/&U[9
M6QSM9J=&5K96M?HO_/0>/J0Z7=T/5_T`Q1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=
MT/5_T`Q1V3H'J0Z7=T/5_P!`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?]`,4
M=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?\`0#%'9.@>I#I=W0]7_0#%'9.@>I#I
M=W0]7_0#%'9.@>I#I=W0]7_0#%'9.@>I#I=W0]7_`$`Q1V3H'J0Z7=T/5_T`
MQ1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_P!`,4=DZ!ZD
M.EW=#U?]`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?\`
M0#%'9.@>I#I=W0]7_0#%'9.@>I#I=W0]7_0#%'9.@>I#I=W0]7_0#%'9.@>I
M#I=W0]7_`$`Q1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_T`Q1V3H'J0Z7=T/5_
MT`Q1V3H'J0Z7=T/5_P!`,4=DZ!ZD.EW=#U?]`,4=DZ!ZD.EW=#U?]`,4=DZ#
MSPTETQ"SQ$#U&UB#$PRME@)A`<589X98WZ<<L<L6I;+'*U_Y+VH)-!AA@AAA
M!!X!!!88AA!!XXX!AAX8VQP##PQM;'###&UK6M:W1:U!YT"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1"E]O4S/X1$F?3+B6@MWH%`H%`H%
M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H%!40I?;U,S^$1)GTRXEH+=Z!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0>.66.&-\L\L<,;?RY97MCC;^;W;WZ+6]V@]7
MG1;\X`_*A_C4#SHM^<`?E0_QJ!YT6_.`/RH?XU`\Z+?G`'Y4/\:@>=%OS@#\
MJ'^-0/.BWYP!^5#_`!J!YT6_.`/RH?XU!42I&`/'H9F?EP>KX1,F8];RN'5Z
MWKE1+?HZ>MT=/106[>=%OS@#\J'^-0/.BWYP!^5#_&H'G1;\X`_*A_C4#SHM
M^<`?E0_QJ!YT6_.`/RH?XU`\Z+?G`'Y4/\:@>=%OS@#\J'^-0/.BWYP!^5#_
M`!J!YT6_.`/RH?XU`\Z+?G`'Y4/\:@>=%OS@#\J'^-0/.BWYP!^5#_&H'G1;
M\X`_*A_C4'G@,$)>]@Q0Q+VMTWMAGCE>UK_R7O;&]^BUZ#V4"@4"@4'YEECA
MC?++*V.-K=-\LKVMC:W]-[WZ+6M0>GSHM^<`?E0_QJ!YT6_.`/RH?XU`\Z+?
MG`'Y4/\`&H'G1;\X`_*A_C4#SHM^<`?E0_QJ!YT6_.`/RH?XU`\Z+?G`'Y4/
M\:@>=%OS@#\J'^-0/.BWYP!^5#_&H'G1;\X`_*A_C4#SHM^<`?E0_P`:@>=%
MOS@#\J'^-0/.BWYP!^5#_&H'G1;\X`_*A_C4#SHM^<`?E0_QJ!YT6_.`/RH?
MXU`\Z+?G`'Y4/\:@>=%OS@#\J'^-0/.BWYP!^5#_`!J!YT6_.`/RH?XU`\Z+
M?G`'Y4/\:@\L!P1,NK@,%GET7OU<!,,LNBW\M^BU[WZ+4'MH%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!3_SS$BZIQ8["I![$
M05.7'OJ>@JQ8(R:)W.HR[N-`"0LIPA@D,6-AEU)+.C%Q?)B899!"96Z;=-!V
M/@/\1/<8B3]+?':V@>`_Q$]QB)/TM\=K:!X#_$3W&(D_2WQVMH'@/\1/<8B3
M]+?':V@>`_Q$]QB)/TM\=K:!X#_$3W&(D_2WQVMH'@/\1/<8B3]+?':V@]?@
M,\07EO.?41AWSGR7F_G7E7GYUYOU_*>;V,_&OR]B]Q/PO)];J=;W>CI]V@]G
M@/\`$3W&(D_2WQVMH'@/\1/<8B3]+?':V@>`_P`1/<8B3]+?':V@>`_Q$]QB
M)/TM\=K:!X#_`!$]QB)/TM\=K:!X#_$3W&(D_2WQVMH'@/\`$3W&(D_2WQVM
MH'@/\1/<8B3]+?':V@>`_P`1/<8B3]+?':V@>`_Q$]QB)/TM\=K:!X#_`!$]
MQB)/TM\=K:!X#_$3W&(D_2WQVMH'@/\`$3W&(D_2WQVMH([:?ZJZ^:<<ST_Q
M-K'&")#T<+7&7KY("LSVR<7!D8\]5/:+81OGW**76554O@J&D-ND2N>8=\+7
M"*X6Z.GIO<+A=C-A6#K!%BQ*\AE7DKIA`R21T5J1RRW#(<A/EVK(F19MLED,
MUKD3RHM.1QG[6`+XY6!*`WO<4T.7+!BC!A"I-Y*!GMKGHE*$40,IO>;>0AM)
M#FA6`E.1D9HD4),QBTY,#\6Y%E8TWE0BA-6.V@2\F:-E$=0-G%0X3*%B8F1G
MK!ATQ#D\47TW86:T/:VN)X[62S(>QT7KFNCKDEML5+B)S:@+(+:V-/2#+Y-'
M>2+DU&NY%5&)HAY+2U`1PW<B6*&`7`&'$*A@[QYA&^E1(P95:&OCO7[Y0YLS
M/$_LISO9`93H@QDZ:2VSX+V5;13(%,=*+),K,N3G7F43D<N:3D]8+)XIBRF7
MQ&)XF`L6B&>09ED6>VRVFP/@PX.>:1%N,E"JH8A-\2>50PUR3VX@HN)+`0),
MBT5734DXH9&1+#K]U$AY((1+%R%"#_.H.8*\0N_PY4P8*CX:^..V!@J.*6,!
M]<^E897"'`S#&"RRPRO;IQRM?HO0=00X)>(PP0)#YZ,1'UQBA87/H./J]NL(
M#AGET7S=^>=[=.7\][W_`*;T'+\!_B)[C$2?I;X[6T#P'^(GN,1)^EOCM;0/
M`?XB>XQ$GZ6^.UM`\!_B)[C$2?I;X[6T#P'^(GN,1)^EOCM;0/`?XB>XQ$GZ
M6^.UM`\!_B)[C$2?I;X[6T#P'^(GN,1)^EOCM;0?-(PI#XIE>'2&WDE_\/D[
M([T)O):A&CFVY19>:LD(C%,)LEBQ(==3MBQ&D%+DU.9R8^`_-3AVQ+.P=O=!
MQ,99@XBA;'#>B7#%,VY.ZNH")QM1V44--&1KH^%&1/C4YE%`D@AL6P%=_H0+
M>32CDL:3/>4DDY`YB##"XF<L[9X6QQM[H06@;'@KF9"XV76M\6K"BAI<B#=W
M:=EG4])0-`-_7]NZ1EE\Z\EJ0E81R$B2DF.4@WA1@1P,RX9`._2-?+HO036T
M"T2XD.01`D>76#Q.H$>ZQ)SM-MJ`IPD1=>"2<V:2$@V;(+$CL>-1%D!P-V-<
MC96V*:HJ0^(JG;*_4`#R"'P#"POP'^(GN,1)^EOCM;0/`?XB>XQ$GZ6^.UM`
M\!_B)[C$2?I;X[6T#P'^(GN,1)^EOCM;0/`?XB>XQ$GZ6^.UM`\!_B)[C$2?
MI;X[6T#P'^(GN,1)^EOCM;0/`?XB>XQ$GZ6^.UM!$Q#T@U1TDYD-`4O5.%6S
M"9"3M5=_C4@%6D=<>9=V#L]2U8P:PBL76%M4`$R0;.,_YO?#'#+'SL3IOE^#
MU0^B*@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4%1/.O\`9ASA_>=IU]-?7:@MVH%`H%`H%`H*NN6+>.7-#X/A1[0;&L?RG)<X
M;:0AJTVF])SE7FFSB:G-8CD34M<55IN)ZJIEBY!92BV(M\0!>H7%$SZN>6&.
M&0:@URY+)W0MKGUI1R3PE#VL\KHNMZSMLPI8B:8C\@:_/R$V>O"MV132@O/1
ML,M=8B_'Y@+(T;#40_)"IX8QB_D`@PLC(?LK<V^HZSISN1L;IG*#+V%?NJ$+
MJ4P&HW7$N0H\$7$3$7,LA.0L4>#6:Z^X8Z738.89=?1@3B6/G;''`S?+/'I#
M=&K_`"ZZ*;+LQUJB%L3'1-WP]`R%/T_HQW%TMI!CMAC-XBJ.I[ICG>C?0$9Z
M1LV5(P(4&7D@PH)P8F&.`@V.>>.-PUNK\SVFTH:Z;12GJ'/D5/Q^ZZ0X-+YY
M%F9#FR(6H7:ID7$L@OM;Q6XQ*OI7BU4,YXX8K;>2U8L)D(%;#*]Q<.D-IO\`
MY;-#X"/PVQ=DMEXQCB5Y4C:.)#&0TPN^W(U&ZDR*6(`(;C=+P3F@82(T8K@7
M3GFZ2INX5!#.8987_!OE>U@V09Y+-'RVU0>D/[>D8WM3FXT]JC0XEM9_K"^G
MJRLP2\G)N:NHI;3.-Q&1CK(-A'`U(T=!3LKYV`\OYQTA6"=%`H%`H%`H%!42
MU_MXIL_A-ZW?2ZV=H+7G$6'.-]=)E<+BFC2.IEBP>.6.-Q!QR0X0.%LL\L<<
M;YB96MTWO:UOZ:"@>)]:-EM<M;^$V6C<%O&07]HC!BO$.QD`,568AV4B"'+N
MOJ$Q'`LL?WZ>"&QG>N1W(C*1['"(2SAD:23)P4IF,*#@",'21)KCM)KG*40;
MZ+.N;[>ZL\YHY)7C-FMD<N&.7!-$4,+=Q\PT\8<,)X*R^6W';S<K()ZYH)!W
M$TU=SL6-.(P,3$.ER&>>8;<:VF#L;6@_OC)^K$?RSN0NS_L-L3%D<.H!`?J%
M!$O;C;-.:2$`DZ'(&-FCJC#A<)YHRB]\2HQE,4K-@80M@;S"(Y7#T:\P/MOK
MUN$PXH;1J?52"60_#P:L[UU>;9C7)\ZP*NJ^"FY78O)=E*ZP<W+D7D.555S+
MA^Q*RF.1436=S'O1D"#8-W<[?V0/(!^[ZX?ZQ2*"UA)_T4F?ZO)?YL'0=A0*
M!0*!0*!0*#X?HHU?Y37#Q,NWAI!XY'['BY,4H242=>VTH3%!A.$X]C>0=EE&
M8%%XXM1O/5>D=S*9!K#8DP4TJ2L8$-B>6QOECAY/()VI7"&P9WY,N0F1=L8.
MD%SP3>#-&V)JC(:;-C]C0-Z*L90&*PI0L,4A^36JM*!I-54%,!$]_2]P<!.M
MD5Z<1!<L@K^AKA!GF;82_P"'ZULW`UT?J5#FN>7(YEN>A)<@MI#.,I-D!\''
MQ"[7<RTU7:.KJ*!*1Y+)%S>*&*8'N2&$#&%*Y9=?$+[^'Z*]PM0$B;>/_8=H
M.AU0-K*[\BNC.TQ]6;:D1D_6=?$R4&I&+H*DUH9RI;\AD$V&F7R-$0"@Q.WF
MY6_D"`68X734"@4"@4"@4"@J'V+^V?XQOW3>2+^M=/J"WB@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1/.O]F'.']YVG7TU]
M=J"W:@4"@4"@4"@J"YG=3-C]MX#UU2-6F^P'9*$#[PZY;1V;,E/4RP&RX$*$
MS;I6CB**Y2:&X3!,PJJ)TH7M?$MEE@$(();IOA;#((*27Q>;W<B4A[/3[NR8
MU_UD>#RX\I9T.UMBV#GP\IA(M4[+:SFYG-+DL/I7:3'N?#-'`PTJR4E%<L1$
MD8:^=\!L+7,!$EF<,>\SP@+:M#DR*F,S9H5N-([H+#+G=N^4Z;-''HH'W"V%
MM5%1"KS;:$PX.U[&,-4$XE-VR:?5TH]ET8&+`=?&X3EE3C:WCML`!,^O*[#T
M=N5M\#8?']'KL7CY98)MC:1/E5$>*;Y=H&VDK))V/`&^GCA`*0Q8V"6-"!Y9
M)PV&%P\@KV3>&GDA?V.ZCPD1L(*.[=FN)A0TU1K2ENT]]GWP9G<C*C6=>2TZ
M'BZ8_;Z,QV"Z210Z,G([9`LA((`((>);$P9,WQ#-]DN%/==8FJ9G#'[5:,S1
MUN=K/IS#4KMU5W4FS6=B1.Z==XC1(@>)*4V#%+<-&MEXC7T9+R.IA4`XGJ!)
M0''ZN&`>>=QPN.T`T1DK5C=KDHFYV%6KG&VR!71UNP<JI[A/+[P';.MVN&,3
MNDL[<54MFJ)ML7$!CF4\N>/#G`\KC#9^5Z;Y!;[0*!0*!0*!0?/E..LB;L[S
MA2&WU*;-F81Q:O%GKZL`J^LLX.F#EY=R4-K=F">:<ZE5JWL97TDK8"PA8N-?
MJ`#99YV]W+W`E;X2[7[_`)RP>T!F'_Q*!X2[7[_G+![0&8?_`!*!X2[7[_G+
M![0&8?\`Q*!X2[7[_G+![0&8?_$H'A+M?O\`G+![0&8?_$H*V^8+C<;L2<9&
MZ$DEMR^1Z0##-A996P69*^Z,G/\`CAQ"EE%+ZB:\66L99);D0QLLO\L5'MU!
M+6Z+]'\M!].B3_HI,_U>2_S8.@["@4"@K+V#W+V6:^Y*1IMK%K3%,RNK/6,/
M9MQNF6MBUZ#4=+0!I44(L!;J45;\$3,:65/)1*8&;B"7*!8A9WM[M\;=8.ZB
M#DCBA8BB:'IM&13].WWK-+X,#["1[([U17`GM62%E$:SK8(;#>B26(!RBVY9
M9[X1U)KCDT\LHJ>)RY:Y`(V",!@$R(;FV)-A&&FR?"4A->36$JFE$@5<K34P
M5(B&J(YL1/6450PQZII(7D10!S+G2!L,`X3'PR#&"PSM?&@@W`?*GK)+$JR-
M`SY?\>1'-S3VNFO5YHQHM/LNH+CZ48L=JBVFVK!C"I*000G')I1+%.I3?'%S
M/F`\;V*Y&[6Z]!OU/WVTT59RPUK3-D8J/S<*Y55D@,,JY2XQPT^D(B94UQ@$
MU7#&[>.R"BD"8XAQ!"-YJY7$`3RI?&X>=L0UPG<C>M3/A.,)<V,FB!(D$E15
MD=.:Y%L2V%*+<708V>B\UU]2:[C3VR@*;@3&V42@17";LE`D6\<&S+&A^@/$
M<4-LN+>#4)J2+%42+FQL2EY*G).9*U#S,*N],55R2$"2#*P38CF:!5)%/>_+
M5=1M!-!$U0*^2>*(';&PW2(';,([;#\C!#7G?_432I>BPVJ-G:1K.M3/3>$Z
ML"9",7,55<6U';<5VC=`,B*Y:27F.71BYS%1+6+*!TOA<,3REJ#WH_(VUE7D
M:FC10PRRR&SH(U;-;`OS8Q=>A)+:J<YT5<CG-W1N.C'$@$B3*,N/Y9;ZZI+0
MRO@$5L?L`(7QZF0M!O*,-]-,IE:$D/\`C79:(G*S(?0L'7*#BP=R>E)K&9XQ
M$ZIDWNXA5S-,N08JHGIAD8DMY6]ZCH187(`P)8+/JA$1-Y;X;D>39>9D"J<0
MR&SHH9FG+G-2HYYCSCEJF5O:C9!UP4;8"N"I,-546P]&ZD-XJK(),R'?-V'5
MI/(A^9AF@SUPF:#N[J.8G@76(#8:+1)Z!4S"#G&F+G)W7/C041+N4XS,!NGW
MK$?1-MXW414+$Q=7"(8W,Y%K`VOG8-1&.3;3=Q(LS@PM/,5S/(T1Q%*TN`QZ
MUWB!@.]T:)D<Z><0C.7[$S24ZT8BI%PB9U11KJA<@(8PN+_+CCD$H=>96O/$
M`0;.-T+XKWF:'HSE:[:]\???XNWD1EHCONA>^WF:=[Z>]/OQYOYQYN!Y?R?7
M\GAUNK8-PT"@4%0^Q?VS_&-^Z;R1?UKI]06\4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@J)YU_LPYP_O.TZ^FOKM06[4%!+$
MW+Y3)'@>>-OH_;ND+VBV%9BVX;)778PT)Q9DQOEA:J39)D:J*<DS3G*;K8B7
M)+O0(X$,D,S#2S2LCYD,$;R`5\A@PF<I<K^H24UV([A%25%Q#=4!Q;LZ\E-@
MPG*,G)$"P=,;;%=;$D'8-=CQKN5$BE&54,D<-]"@8L8P(IQL[D%8B7$,XAI=
M3Y>8JB[93<V+IQ+K1.(=<EG7`XAR]%D2RQ)30:T8SC";.?XLFSU(3/2W.R&4
MT;N]P&2Q`]?,IA9,+9F10\@`1S6(26D[DLU;B21G)'KM4)3$),)]LF+Y3EAN
MPA*[G@>(9'D;)J8LQER;,Z(TSC":RRJW?B'Y?KG,P$OWW*>^`A7RV/2&)D>1
M6*F@7D8"0G?:3'@6VTF?6^+(MUUA*:G9*[A4XE1DQR.)GW8%DY?7GBY(\;A@
M4\Y'.F!EF@"6S"RQ&"OECB('.<?*EIZ@)4%G2C@E-YK>QQN44N*H^CV`II>T
MI*2]!KF0&C-K9<D;(+&-O!AN:(%IP88.(@N%$\RF8E3.0F'^0RM0:GY2.0J2
M]!W#IL<9S$9[TCZ6IG<29L0<<0:YFNL:`(_:`CVE"0&/=(5DXK[_`#):A8VK
M"XG0C9?,F1%M?#&_X=@[*;>0EWQ_R>:I:2--M,8]$DAL62W/L5*3@,J&"JPE
MP*))8E&(&TUSI=9(H*>84$6$EQ27,E`N:L&E#$\P[@7%MGF&X8LY-=1I:4,0
M4IWO1F-]6CUY2]'DARY$\EQ#%\RQ+'A`JL/J2X;D.1&NWFK(3/:R"?+*ADP2
M,Y9Y(QD)2"#$3\[&J"%;YYC6TMR2IMZ'BYACQHG\=FW.[!J4=D=>-B6>`738
M:487`B.3D!JC)C2<TF02ZDE]K9X^&A%Q5PT&G`!E\BH@N&(X3*<_)AJY'SV!
MCAY.AY'%5!&B-"E>1&A#<K+L(0Z\9O)-LQ%[=EF4$]LJ+3C%3?EW<EBE"BL=
MP&(E54D,H7*A&@!1`YR=R5:N*<NH41@'Y4"Q=<PK^O#1ET]!\KI^OCLGIKFW
M$F+D1MR<#C3`CY5=Q1::"JG87#.7(&E-/')%S(IH.X-!P]/]NY!GW0-/VW=$
M<E5J0,T+8%:M%\6@J&&;I-Q!),H-!O-=I@KIY6.^_P`[2#&*A86%&$PNH&K]
M6V(=\<,0A'HOR#;5[0*<+/Q.D?0+8^/9(PP&GZ"-;EASM#9;2(LHL]66RAE]
M)TD2LO*DH",YX$2S8<:8*U6@MXJ!_$T3*9`@C%K!/T;D@TX*Q+"LXGI>+I\8
MSZRY/D5@.,^V7:5N&R(4CES2C+[D>"6*AV5V(G1HV&D<#6+JP!3,FJ^13LL?
M/C```@1<V'YA(MB[6Z69E8$2SXM/V+U:`0C$1RAK].,5.@ZS]@Y0(QXSY-+)
MBZPL%)38QW$!5N6,E<!/**Y`-+,>:&S0.-PD,ZN335-E/<ZRG$JRB2#:Y^/D
M*5W[A!\M&XH@)VRFF-U78K(GZ3BC1&9T1O!4).])S-D5@T7$1,5,KDJ>98&`
M<\PQ-[<MFE<?/=VLAQNB5+9,"9CFNCZ>"-K[-[CCIISW@2)GT&'E)\H##44$
MS(#X#4BH:$GDQ30JF9.E``_\L;*X#!W!?E&U9.LLBY$X.;5)YJ$RNG7PO`!'
M7^6A]DL9A9+'+2B[689A.S6L\B8B!%A\LYC!\4'!*Q1#9<Q8U?RX6.83$A:9
M&#L#&#3E^,%)25&0\BITPDF%IN.%H+A8PDJQ]`7$A>:KM2T5S-Q?0%]*-$3Q
M$\4`,E3980//"U\:"MIK_;Q39_";UN^EUL[06[4"@4"@4%2_.W]D#R`?N^N'
M^LDB@M82?]%)G^KR7^;!T'84"@4%.^P;4VSBGDT2]MX8U(=&T,9J^B)?7-3"
M94PP5&JTVWZ6V`59,ZY\C,;]9>9](%;X@5K#D_+]483JWM?HRZ`@_+7'?NE)
MW6W'=K766]/;MY"T#;)[:UZZ3DSV](K,A%H:AJFFT:M6/9M?:(!%R]/+"13G
MQK4,S6!!$4<SZ@EDSX&6)4[D$M=3]!9?S94D.5RR_NMIJY))V0<LPJ**F;#P
M3,4N2BE9Q[%4<HCAV#63\(R!&K<=*DGQI:_O*SS0Y<H2$"N:4SA[,:X(808T
M2V"O!,KLX".D4)W._G,:^[Y$,JZ6>`94(%2MY8NEPQ(HBM[Y8`@.,O$+3'&#
M3Q1<5?JEL">(7E+X!4$7\M-N19]RUK<+(<9R&$'"7)>D;#OHNVY2U<CG21-A
M8I.4@N).=NO,)QRG),MNY_'6<[RJLXC#\R"7!5418,8C'SID$$0,#CSC<W<@
M8YKE*V3+V+5%)`UPGC7]Y,/3[9""8ME-BN%<W4F;89C+J@O2R>!CUW1I*38D
M--#6;)RJ$J(QY&)9BE#F%A+%`L8X[=$Y.U@GMI.YTQJBLYF-OC0UWUR2Q"LG
M`2P<:4CH&P^R<MR+%R6[U9,;KP7VXVTZ1T/$-3$2D]..W!#"+!VP*88!A[=_
M]')NV4V0<DC1ZF$B9)!X^WRU8C?`KA0R!E!W$8>U$"[):\`9)QHX&KE4V[EB
M(,8TI8A6*`EL1`1!+7%MAD$&9&XK=R)T84@6<B,S6#+6SO'1N4F3:MA/=--M
MQ"V]V@VM@J?R,'*"@F&%=<5X_0H_8>3$R7R90\0#0T4*]K#7S#"%#Q<O'3M5
ML*@3@Z5.()];$@D-?HK9K,+[M;>Q3+)B4W)'^T,0;*N77Y)0X)0%ADH\&.:T
M+61L'2NFPE'(9>SN&C`$KG?+AM6:-8MR]JY?V2G'U/QX)+2.D<1[>:S7>\KP
MBJ/MWYZA\A*AL!-SA>><?O9SME)$;,:JF5DG"ZF<%5"1('`++$R+YB`&XXSA
M'<>)D)>U60=.H8D4,#='9K99O;>3DXH]=4-"MF8I1E^<V:_1&(06<YQPV:05
M"1"C/S#]XPDTJ"6&/8*^92X9;,(&-C0[D4D%=UB6I#BN82RC$>J>X,-R41DR
M9=2T>'FM)TOZDK,7M%`U,@_78HWVHS-?\GR5!32!I1Q+K9-,&3@S!.P(!PT$
M'T?Z>1\ZXEU'U:BI^)X20^(SURA&/GFE`'B:H`F.MF1FV&XXD\%33AC">HA$
ME=-&#Q'`$S!&MCU\,LL;VO<)&T"@4%0^Q?VS_&-^Z;R1?UKI]06\4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@J)YU_LPYP_O
M.TZ^FOKM06[4%`3`U"Y4(Y@*?M.V#?2AE1Q-,Q;?N,ALL?DV:'C*#(86U<W2
M;)!I63()"AAKM-4DAGMR2,RY$$=Y!I7OD5#%&S%!ZP68:NECA<>3-?LDXZ[L
M>(9?C:5]=->(*;Q>=MDMHH6_84JZ\PP2U[1EIR,77ZX;>V6C=P1P@IAHXA'C
M+<4;J81POB?L44+YE`D0\>+^5!X%Y5869#ABE++[FP="L0P/;"[I1$%IX15I
M\R==!+/)/NGN50;R%FOM;,8F`4-+@P29EA803,;K6N$>-ON+3=S957V+0%1T
MQE(":]IA8$DP#)\B[0[*-UMPQ%#&5(O7BNOZ5I\RF@)"&;G"5&2HA8OD\;5#
M)K!4L<,%<C(>(&(=Y*7$3,RS(PDYE@(NEA<;NZN\,UID,J,X3CK\EO.$=Q$J
M'@<2V4V1$BYO%B2TQ5V&D\>Q;WM6$!1(F318;.V>0!@`)'ZH<<DG0=,>I,LK
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MCXPD\6VYFA3.'CN0)/<^+TEG8M.A0@E2XLAJ\2-JS`C`U^RBV5T`"ZRI)%Q,
MO_,J'7P\D$@VEJWO?`KRG=HZ^JNM_P"S+:.:(LG)QR_(*P[U"0H*6",7PC%,
MY-M'B#X@J35FDLYD"&K#M$T;<;<Q2#2KG@=`'`)`V'")7A>[MO":H)?TNNJ-
MI!<D%;Z(>RJYL(\=H=DW>MRC#29*#M7V]'D=:L'&@GP#K<KLF/7&3("8)N:D
M"H&$BX89@*QX4X$%FNGFIDK:_P#'\GZI*TFDF7+)5$V"3$R6XQ!#<&#&6I7D
MV47FSWHV"3T1"I-666:6>Q(SYLH$<B@IXKD'GB*#?K9A",KHSNC-TY:F2!LM
M%FB$</[6"6F;*#UW<U\67N>V-GXDR$E2('6$E-%2A]B9Q@SYKS-8@O%/47>Z
M$\)-%'+%"Y@2X!LN$;=38=:4J3;R..R,I@@]R0)U-D-?>.@A,K:`7X?R=VU8
MZ/.N^)(U':LJMLW*D2DMDLRC:.8I>0!>Y5-5TD,7K`"T'>IG%7MNJZ^;+QLQ
MU**H$C^0X[UR_8OJR4VMV(V@UZ!F>$IZ;DWKDHH#SE=B$G3`3#D=":I)N%&X
MVD]3)%"]['Q@\Q0@P+AR9%XA9N>,D;(&C<9ZWOQN;D2RWYN>+LDC97;@LEP.
MJ.YIQXASQ&IS76-;L2.-HFX$<9YL5H*1]09PXV!T(!7`N7)!6$"6)_CIFHTW
MY*2@G3&^!IY<S<6\B*:+DHN+$(&&6/($).I1;)[+%MWSQD@5.C4Y@7+X6S3[
MC"`6R.8XWSRP#7T[\:<PO=Q;(.,>.=;I_:\N;W`[/)$</V3)CA!_I#0"U%AJ
M!$E;BW9&*4(Z\H#FELOF.CID04@05B*TVCF9,0P5%$Z<`LHT5AR;8$UE8L8;
M"2@=EJ3$-3?9XVXE!W.:13*$V'$_7*XF''&<FO<BF/B4+1<R51/;]G(M%BZH
MMV3O.S`0>8M\,0B(U_MXIL_A-ZW?2ZV=H+=J!0*!0*"I?G;^R!Y`/W?7#_62
M106L)/\`HI,_U>2_S8.@["@KCWHW2?&N,@:T03$[>A8:6-I5232K0>NR\J*4
M.P0U2T4(C>6EE+57(B-9WN!T2.[+.<N$WFVGE@C"@$6/FLAP@2(ELPS>!=L'
M@I9(L=;@1PW];)Z<DQ.F&(X1TAY''U%>Q1]LQB!,(;XU_?9YMM526VRK,'`^
M-<FKIR6J$SR(I%;ACV*V'%#G21R+Z5Q-92L]YY;Q0PCOF1(Y5$Y"0GH]5D@Z
MHB+-\S*P!I$9+:<2N$BQG9UIP:^K7`]Z$<R<"`-F0ALO)T&NT#E`UA7MG92U
MZP>:$3;<7:H1;MT=G@RK&,8B6(VDO%]K.:F2>MT?%D@-EML-ID5T1;$6/,#Q
M9:P#+7S%)G;`AG#9Y*-&77',DRRG;&LI-8,/!,P[)ZV\"KE8`S(19&5BZ&P'
M4OH;Z06XX"C)>JJ9L"E+GFET<_?`6X)G/$$:^`86#RU\=0P^)3/:%G$#H3K2
MV:L$%E`?R$HL]67Q4$!MGY$3UEI$#L:M!TBNA/LDN!P!IJ"J^=A^:'!NGW`V
MZ<WRU$3YW`UI.SBURTR&'<4CL)NBDW%BB7DH^@XN<C%V4@^\O[.`Y2.-\3$V
M$V<E:RZ(#GA?$I?K8](=UL?L(:AM9U_CQHH)%W2OLC-:)%3#;J@>$()Y)"2T
M9:D:8)`61B^(AOWGCF(F:L'\`P\;>>JUR!&^87GEA<`C9''(BFO76+;V>E9O
M,QM./664MWX[26`8D`M<5Y@:E/F0V@@J1XV93BAY$,R$"R`C`H.!4S8E<U?$
M/(Q;''+,.T3.4;5!JQ#KB^MAI59\,/>>-=8LV)46'F(Y'7:/&A(S:1E49R/5
M70&X;#9$;)BXI#)X;F<6",DC"%!>D7'((7$,,\E+DJT6A9[*T=R9LDPVR[6Y
M=FB.LAE@OJQ)DIDAIJ2K,AROU>0D54;[$9;H(+A7,FN+!HDCBW%ZEC/7QSQQ
M#WS7R0:/ZZ/M9C6:MBV0PG>V2#>/NLFI@N$XE,ZSP!R,,U->CH1T11:K.<3S
M+6L*C)2F=**:L%F'F4`&Q$POD';[D;3FM54S7-4`:B8Z"TW[<05K6L#*J^(W
MBS00Y=5E0@J/K$Q@G*(9X5KEDVX]BHMRX(V/3UQPK6Z:#54+;^)4UCS5.Q!%
M:3"X[(A;BM=%W%D9YXMI.FIQ-8\;Q?KTC)OG$X%-QUR9A<@*5!>:@H@!N-1Q
M$NE%AT\+`^8#.&_R3Z-..-9&EXML:R4>/XA/,0C*2R]"SECTY']I064YO1NJ
M.UN/U";;G1&V_%A4!`2%4<E@F*%^OD`8SQ"%RP#EM_D8TG<L92M,"?L"TB;"
M@Y50$.6#SD3W2SEUD*[OP(9L=-5F0[D!$?%SD@W52V#<P!31<G$(.'@F^=9Y
M6QN&I7AR@:]BQP=F:$WFUY=C:(YFB&.]L+!?&9K/&!6C,:J&T$YW+S6<C?3%
MA,5F6Y%])4UQ)4BQ0T6;89\S>V`P(08H68T"@J'V+^V?XQOW3>2+^M=/J"WB
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1/.
MO]F'.']YVG7TU]=J"W:@4"@4"@@SI!LB_=C1]Q@WX1;1+&`MYIUUN97Q;('R
M-SC"C5.8QM`/.#SY34_/7*.(Y#%C0X/FX`EL<.H#AT7ZP:&0>42*VP1;C;=1
MF1I^E>2Y3W:;L6LK7'6V1A7`O(6G\Z_LPD)OY-Q17%\/!8C,LMIQ4ZM&U%/3
M7(,7&.)X(-C!<E0>A(Y>]6Y59BDJQ8O24UR;SULFR?H$F:2]?I*(Q')J1"3/
M`<$D&F85/8M=P/E1B@52`$6$2UTDTHA@&,$\P-8,0<,,`B;EV9X[]V00YI;S
MC1(EUTUKTWF(O/:+%3]((LM.+9A"'$+)+49MS#E<."Q(3G548@Q6P4LI+2H<
M$.E;YC#EK6N$E`^3K7`@Q).=CZ1)QBEVQ.JQ8A.&"I)AEX(<^K2S/"\9:<#I
MT?QL2+*QR1A9E=I$TDH.:(.>"$4R1LL9S+#$C>(`=/I'NZZ-L]@]Y&$?8Z_'
MK,UO<\`-EHM>0F`X8ZEY'4I$ATL^WJG2.CKBB<*FA@%HQ@(EFD["Q`RF#!"@
MC&L,\1KA$K<+DFFF.HOVQF&(7%"<>1K"^YVK^C+4D69VZK+K31W6Y94CAG;3
M34^\";W808K'C;.5\$4B4LI)^()]J*1DP9R!,!8`AJIK<D>X;H`W6CZ`I;TA
MY`W?KKJ:B[0L::=7VLYB$<!/8B]%?%3U2DYMI<YR\G"23*K`:2F::9U,<@`I
M7/#(0\0N'B!<R%B3TW:/OIU\<+6U<R;3G"W@,Y3DKKSC35!4*MC31CQ@2D60
M'P6+)2JG9I[G7U][,QK)0IFXI8LH.3RH@(OF^0=PC3JER&SK*,5\>$O2T1CL
M@V-WU/8&"5<PV4-522C"V+9RW*SA@X^5R45];,&&<_&%#*^E'RHM\QL%[WNS
M!%Q",#!8AJ^(H!E`=0T_EYNQD_"D@LV*M96#+LD/!5@A5B9N&8JE:2%3>%+D
MEH2$VLYO;TF*ZTYW,83EIM&S8:XN'D\SF*2+$361D+2M"TIQ(VIL2$'$44T[
M#$!XFV8EK.`P2JC1(I2$[5*$D-0+&?\`S1(TB0\;0BF9<6V(I>X/DL[8YX7M
M8)>T"@4"@J):_P!O%-G\)O6[Z76SM!;M0*!0*!05+\[?V0/(!^[ZX?ZR2*"U
MA)_T4F?ZO)?YL'0=A05M\@4:SL_[QL&U=9('WIUQS*/!$V`U!F0..D=<<BDI
M>\)F.99BYW2HBJS!NX8_$(*A(VC*HJ:">*K-C`!T$P4PQ$"G:4-<W5IGH)LI
M,#F0F%J$HLW:B'MM.-C2I1FH>6$^*9AA-!;%BL#,I?#,W)G71N.JHKE2A6.S
MLCJ0E$G4."1R%RS-98AOY_<>4]L*'M,BC*BZ3I!E^/8QF8_+<\:P;8E=6]JF
MSL3L0^&Y-DOF@UE[&OV+RW`4E2L*J&EM&<155'(G$]),%")O#`8/$,"EWC9W
M]F5@RC&,BBQJX7EL3Q8ZB0&_9I:CM2V$Q6]L_J3,\N3"H,]38:`WT98*QQ,6
M$B%$?%:;28&`F88'A[)8.&9<O0=$]>-S:><V!L@M*,#R(T9`><5:XQ&T@MIM
M[57:.0'22:NVL73O*B25-AJRS%C5B9OHC'$%1Q#/_J)64#!G$0JG@BW"'"5F
MW6A6Q,ND>:G!C-AJ'#F[4':M,*!!3SJ2DP5Q+<3L-VH;J).8<<*^;9))RLN8
MV+"&;Y8"V%SSPM;\+I#&7+I[N8C[S*<A03'ZU"K6=FWS+F*17ZU]D$9UZ=S!
M#`0[3'D5<D_3R3R#H=#7V]7VJA#(@"VQR:(4S6`""T(L8]0P7N$Q]U$T9F;C
M\9&QJS^!'#(E><-?WJI9XY9%&HM;516`VHI<ZEGT>2)DE.4&*F-3`?.^-L3K
MK+A]/0)>@ABSN&Z)U[6K?$&<-/=7'YM3.$X<A<@1-(KM849O%XF$J:I)E!RZ
M]J!R2%1OG%=`/D$AP)>6..0]A$;+"V-KXW"H.FC;4S>359MR&ELG72/]DC^T
M>@.F^O+FQ5YC:#/3(-F?7:`'#";E09)#=!$<5^P"M#.GWV#--JRDJX&;*@?O
M4)8X"/0=2W>+38N.]1>437),!:3V<$^:":N:K02[QW`03/VENR#-$`==E=3<
MV)^PIEG)IR00,Q"_GP@EL0#&0UK^[E>X0@WZ>KFB*).4O3QG%H!F!?VBV'A)
MS&,%::4Q`G=@R=*#`U.9@,-8:YK37M(DO.+_`-&D#T?+C9S.M\8B<MB:-D1$
M,YCF%]'*)IXL[N1CK=$H+/;[\8;>W<UKE2<&LY5O%#356#6&X%4Y(Y3*_E`1
MUC(RE&\0LDX+/$0\$)F%T]7+*UPA%+_''LRV6%M5IUK:0CQ4TOD]1C;:36)L
M/1SXHB%KY/\`&FPC#FN0M0S[;`(J!OU69Y5FAF<1A4PN,$RS"HID;D!2-R>&
M`='LOIMN9NZ\)7GISP`V8%5E".M&H*:$+.>6V(^W*]D>&>0B,MM)BD1[N9F>
M^##3V\UVBVS1!I)GG9U1.C#J(@X9*YP("X>'()`#VCO82<=U'(N16T&$GS/Q
M(OZ(,9/>^308TLR'K6_MDD9TQ7(;M*H#A)P_9=_;>DXMESKA>Z&5<^"?F;%`
M+A9BX!$!<?CPVABSG$.`LIA(;MWCE?4?3"$42.)(;\P-U<EAV:_,".5`L'*C
M0*@,QYO.)4-QY+KM%1A#I!ME44R7S-C9)9@6@^N(F7N4*%2MQA3%RQ8`O<<;
M+K##W!"Q#N,+E_UA1.KULK_SWO0<F@J'V+^V?XQOW3>2+^M=/J"WB@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1/.O\`9ASA
M_>=IU]-?7:@MVH%`H%`H*;H3USY(M8Y:V<QBD#2%Z0CL-N9)6S6*C(+XGEOR
MJWF]*-V@35FYFBMR,5IHFEE'36SED6SL?L`,,);'/+'&U\J#L=:..F4(0V%A
MZ75Q^,-80(W7^5U44DQ)#<.*PH%M^MM(VV!C,,CYXF@$L1V4V&4.27?*"8XW
M/BA^:7&"ZV=@T46XEYK!UIT;A/.3HNR<&K>H&[FNSP5[!NRZ.XW1L]"F,9,]
M=;5KH_GN*`W%6WG"E8T&$8N6]P##//\`!H,(D+AOG!]M:6(W-2%")IF21K%Q
MPHQ-06`I&%/).S/'&NE%=K)*ZVT8%%P<^O$OE_.2RP:+K*0YDL,2V10$03JB
M!AW;=XE9;+HKQD-":6GNO,XMJ5]4I>@1JQFI3A+#*.+^KSR=;T-(T]S-))=O
M2&YFE*.3Y4TTJ01F\0#9@8EE`O94.B#XYA8#IKKQL='4Z;E;$;)*4+AN;:=>
M@Y30V1"BB\UU"CU&B&,LX]]XU)T/5M-)0=JB=$QL;NHXIY'$6XV0=BP.`0=L
M@KS=^G<SR3'V[6F3&P8*7)32Y,8PY%(B4)H)NPM$,HQ)($^LG:S)(5EAN(:^
MI&L0I29SR9RB`6+&!B=B!843#$$V7RS"6VN>G.R@>Y*5N%L<4U+BPZR(!?D#
MMJ--/DE]B%I!+R.]&`\%!T30^WRA,DRX2['O'@8#:1P4;(,@,K*)FYN]QO)4
M'(T&XZ'#J',DUOQVOAMO1G$4H[">F391B:L7.P7JDIRN_9X/1PNC*..)8VO9
MOZ0@DFPI3K@7;3/0`KY>4`SPP",$<:;R!%#(XEM`EQ237@YM;]@Y!W,F*066
M46<&4B,",S\VGV2G@GEDFGF`UQ[R?.K=3BY02V(QDHFK`X>&8)3/*@O]H%`H
M%`H%!42U_MXIL_A-ZW?2ZV=H+=J!0*!0*"I?G;^R!Y`/W?7#_62106L)/^BD
MS_5Y+_-@Z#L*!0=(LMIN./)'S<*`B+V;>62CC0,UE*(JF2&X4_`<(@O(^1X`
M>Z8LD@S0N()H'J#AXB96QRM;*_2'=T$-EC9MP)O($P-.`VLC"M9X:A2ILD:>
MN9\[BODEZ/IBB6,R38+I>(-TX5(44^1AS0H^0EAL!BP>&.-\<LKV#JICW8BK
M7679.1YUE6(8YB2+]?8HF%T**N9?N4B-H649K=<-HS@<I,JTC+)+1DLKZ633
MR!H!3&5,%2QNYLJ7)8`F1`UOCRZ\?=CRBEG9Q5D13;[H;K2>Z:YH4GQK*$6G
MGF90BC'5YD).*+TLU#;+?8[F(60W`Z,4A#5[&.DH;%Q"&N&&OG7RBM2-I_C6
M"72GH3Z.R]O5)^HB2KP\C3.Z+183CW7M/F/'*5P?V5&"><F#KRD1(FDY,,B)
M)5&50U;S_(LG*OFH2,:.^&ETW2;A`+=DU(>3H6'&\&PW@59@OH&,I#><2FC1
MU]-:-)3<C.*1!*CMCPTWS!@^0;ZRIG"%TXP+EACYF8R!"/A'E>@Z3-M-1-;]
M=UM,E-'V'<FPB:Y'N9;<F-A(";D(Q6YW?B\8:=#A:".Q9I:QE[H&"*=5$%14
MDTO<?&^(U\A`NN$L92V'5&SLMKWK,Q41+7G7)J!)\OR4>5!S%@(^@*)R:(AJ
MCB+ER@X(AET.V5)`;2(D@BWL7N`*HFLNOYCY$0*WLN8U'MQ)D-_,,8*SGPY#
MB+(>>NUI6)W"#<JF[23>':N.%C%WE<0N5-9"VPN3\Y\ICU;X6]V@[60^1N/&
MKL%L^R%+7EDRKMM$&PS4U7TBC9HV;XD[;"N%W:P17L(X,L7&X2.0T81PPPY(
M.F':X\A;(:`WB.9LQ<0R($5,!N:6]EMHV06<6OCY;$?I.Q4M:!S-,4!."'#C
MD46^?V9AY$S*2A%*'BZPK*JM[PCR`TE1L'!"Y4=6+8*=QRP%RN..0053HF5R
MLW'I&4V\X')K,KM%%':TEGVL>^*;+T&SX]RS96%LE/A1U!K2<^R4T@*F0K*&
M`N643:S=<%(#F[`+*:%Y.KYZ1%/6K7M2EW`\'*RA"$5'9*P4P\@53%^FF*A#
MNZRH#GAAD"I>_P!F/YQAT6Z@W6M_-0;C5T=(<"6?0UY+3EM%52@Q!42%<B64
MDM2(F<+AF"9]/.A#%#A0</*^.88F&6&6-^B]KVH.E1&(QVRF-Q%;C-:C?1F>
M(.,TDE$;J0E)C6&,E3Q$R*W"!`F`51!#!%4,@YY%L`KYA&!<+].(F=KAE=`H
M*A]B_MG^,;]TWDB_K73Z@MXH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%!45SK6O?C$F^UK7O>\GZ<VM:WNWO>^[&NUK6M;^>]
M[T%NM`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!44U\<K<\,U7O:]K9<36M]\;W
MM>ULK6V[V>QO?&_\]K98WM_SVH+=:!0*!0*"I?G;^R!Y`/W?7#_62106M)>.
M6"8G89XY89X$2F.6.5KXY8Y8EP[98Y8WZ+XY8WMT7M?^2@YU`H%`H*G-GHMW
M`:O(#$6X>MT$QUL"VV]J#+6N#I:3OGP."E5*7'Y,<324F.(@H&8SD@NL)X!"
M.A2P@/D@,_*&<<NOT87MD$7=K-'MQMO'/*4K*\9Q7&+BEC5G1R*S<<F)AN^B
M+?>FO'(TX-C'\GBNTO'Z`66T0S#PQ8R3-63P/.%,?(ED%AB'YQF&<;6\?>PD
MPIG,@69@#"R,[Q,C51O0;FK.@=/\N;AUA%V\[PGJ)@AFLFX5#4\1/,[X>>>7
MPROE>P=[WM0=0+HIM4S9\29T:S:CYX@(O,),&WF33SDL=IJ9_7:;M'PM3S;B
M)K`S35"19^LE?5S2MDAB86P/DBGDPSH0HV/5".FK/$Q/L9^KCKM([*45*,]8
MG8\%(OLDK;Z[./-GN!$`9LFL^.'?!VEV;E(Q[%$WGBK_``??KWTP,-I&#]]<
M"&"CY\!Y`)!:W:D[Q-R2>*UDRI#\%M6)N,QF27%:W+[3EDPX%N:DP;6)6U^C
MAX,".<V,F'6,D+9<L4/.%-5%'(T64#%@RUS)<IYR.$LY,0#T=\J\"3$L`F,F
M1L%I_+.IR2M^1%R36_,C(D-!G]GMP^:Z/($!I*CXL[1BU\KV\N,UK!>[GF%C
MD%<E^$E%QX;$W6,+6740/?TK"J"VQI=P8S"P5?VF$7H06CSAQF[%@6>V1T1)
M`$Q]\NIYUGG?JW_EO>@WD].((.6IFY*)X6L6G%NQ4X3M!<NZ2[6M7J+DKP@J
MP1KQ%#59:B-B;(A>]3<M+3=7`E]O`B9E70W%`4N=RSQ$!L7#:I`K.\Y;I\;=
MYF9S69DT:JP-L%..UQ&.UL^[8X;3MF)JDM>HT;+8=1E/3AS";+"D6=CC2R1L
M/$X53VQE@8OD('B((%OWO2E^]UTCWM3_`'IN#<O=+\S+^]UP+WZ;@7)>3\V\
MC>]_^CU>K_R4'84"@4"@4%1.QF.5N9[C%SOCEU,M3N2/''+HOU;Y8JFGE\L;
M9?R7RQMG;IM_-TV_IH+=J!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0:<G_7^'MI8A>,#3ZQT^2(D?X*0`[V6J'5=.)+(:`X$E
MUHWE#R`HI*P5$3G$A%#8>8!D+.PH&/N]'3:X5T>`WQ2]ULQZ>MF/EEH'@-\4
MO=;,>GK9CY9:!X#?%+W6S'IZV8^66@>`WQ2]ULQZ>MF/EEH'@-\4O=;,>GK9
MCY9:!X#?%+W6S'IZV8^66@>`WQ2]ULQZ>MF/EEH*VSW$/Q[A<OS7UR#@I7PA
M0_QMOR:SC!M.6P_O8/*23L]'+%3GAD:O+%U:R@5::T:)8AV,6+W#&O>X=\[8
MY6"R3P&^*7NMF/3ULQ\LM`\!OBE[K9CT];,?++0/`;XI>ZV8]/6S'RRT#P&^
M*7NMF/3ULQ\LM`\!OBE[K9CT];,?++0/`;XI>ZV8]/6S'RRT#P&^*7NMF/3U
MLQ\LM`\!OBE[K9CT];,?++0/`;XI>ZV8]/6S'RRT#P&^*7NMF/3ULQ\LM`\!
MOBE[K9CT];,?++0/`;XI>ZV8]/6S'RRT#P&^*7NMF/3ULQ\LM!)S5GCATMTJ
M=;N?.LT)$XV>#\;Z8U'8XLGM)3T55=MHZB85TQ%S,R$\G9F4($U,V*/C@!Y*
MWE!,KWZ>F]!-Z@4"@4"@UC-$,QCL/%;YA*9VB1?D626@&FN^6<IF%$H0<*"<
MR#S,IQDRDG$Y3`#%R"QOU@!PA+7M[F5J"M*W`WQ26M:UM6A[6M;HM:T];+VM
M:UOY+6M:9.BUK4'[X#?%+W6S'IZV8^66@>`WQ2]ULQZ>MF/EEH'@-\4O=;,>
MGK9CY9:!X#?%+W6S'IZV8^66@>`WQ2]ULQZ>MF/EEH'@-\4O=;,>GK9CY9:!
MX#?%+W6S'IZV8^66@>`WQ2]ULQZ>MF/EEH'@-\4O=;,>GK9CY9:!X#?%+W6S
M'IZV8^66@]`_`CQ-FK!6-:H8FK%S`1LO8U.6R1FQ<V!>^0!LO8:8<_(&@+WO
M?`3#HSPZ;]%[4'O\!OBE[K9CT];,?++0/`;XI>ZV8]/6S'RRT'H#X$N)L(8P
M9"U1Q",F_(^=F0IRV2#,F_-\,@R]C9C"8<1C-BX>=\0^OEEY.U[VQZ+7O0>_
MP&^*7NMF/3ULQ\LM`\!OBE[K9CT];,?++0/`;XI>ZV8]/6S'RRT#P&^*7NMF
M/3ULQ\LM`\!OBE[K9CT];,?++0/`;XI>ZV8]/6S'RRT&\=<^*K0;4R5"DVP#
M`!1CRF0;BXTB#Q,R)+CT4"#=<V:>(OI9(N_G\Z4XH"JYI1:XV08.(F7D<?PO
M<H+":!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!05$*7V]3,_A$29],N):"W>@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1"E]O4S/X1$F?3
M+B6@MWH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%!40I?;U,S^$1)GTRXEH+=Z!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05$*7V]3,_A
M$29],N):"W>@4"@4"@4$9=N-GVOJ/#1R5%YL.:05Q4=K&B^+8K9.*==Z2W,<
MJNE,8\8QJU\U@XGHY-0<[I6``QCAP<(FG$<!S@^5@2^=!%YK;K['QU,L)Q9N
M]JPRH(0=FG,=C^%I5A_8`:>66GR]@V%MZHT+2]@M1-#RNSG<ZVPUE3-'4DX!
M91%$\1S)W'`&$+><!+,;;;68%C,"2[SC&PK#E8J[CD8NDLYTXTD2"`PFDZGX
M\KLXR6%%LX<VXS6.L*1O`K83((HFF!+VZH>70$1H@Y?]%I&UF@;9QZ3@PH3;
MD_-HZXVZV9#=2:$X4+!$\RL[2SCLG^7+$2K&%5"H*VIWO9(3AQ\,!35K9899
M!(!0W,B1H.+84W)TC0:QX@@AHP@[S,E934@JJ@(FS21<!A%,/5H8)A.[%)+A
MM++`-47%04\W;D9SL4#PS"Q#%#1T1\J6KLF8;;O12D6.&?`6L$HQ=&!&=C\@
M$##5DA5DJ(8[D8,H1)C)J<;1G4E.A]"-FZ%;(ZICJA#/"P>`V7F^`3CAZ:HE
MV!8J=)L)R&U).8:J94")1SL]7+*Z=BII!H0@L(YVX&5QDQ<1CX68!TB9P!-E
M!\,@Q@\,[7QH*Z],.5IA[119NE)K\CL_!(.E4D2TB/1,4W*"[;.2((YS=8:)
M-:0=!1$"Q=(>1B/7$4P(7"%$*GD0R#<86]K7H.1K1RT0-)6E\(;;[.FFQIPH
MS8X9=:R5#[^?`+G=Q5=AZ3WM'3G2TX-/04A;<QM)#9WGJIYHE>32<3'4,96Q
MQL+F$A3.]$%EW,AK'[7->\M>%O654V6!FZ\[MBPN;3*/YILHDX232P("$SL3
MC_&C'SEV>_&!4DI>0(YE[YC^4##5,M<I6LS?@"8)N@%^Q]LP=A-[0<S7LR&.
M_2))02_VX3(RHF0%PZ;][58<%!%P=1A13CV!08@LX)PH98Q?\,4,-]&=[M."
M<Y%]:S.R42`SD:<H;)!CK-W)_OQ=]C$+*@$?YF+9W209!,)V5APT',QBKB!W
MMEB7O:]ND..U]^=+'K+29!31V>AEQRXLK+G;26Q4=[)!Y8/.QEF5@JZV87\@
M-F3S>[?S;Q[,TB^5]]0@"@HUR_D<+YT&DWORAZTI^R,`:O16_H\F>39:V)<<
M`OE":<@)_OO%`S4A^7Y+<;D,)Y=/4@799MN"+0FZK$RI@+))454/`V*$-A8N
M*&Q-IMN75#\E0WKE!,/!S[L]/"2_G<T6.KOH&+X\9,7Q==M%'[+<N2+\6GLH
MMIH(ZZ]D5+)ED]$55175%(,`N!8/`P8`"-#SY,I*U^8"VN;>ZL"0&XF-LWJ]
M!+U=(LI66-;%>/\`99Z)+6#GN+IY6F"T0W2WXV*F3H[C1%%&1U-),$L03.08
M1HL;%"31/?&"I#;\5NW7R480EMM/K9%M:Z.)0/2ZGL8RVG&MH*XOFT-(2%!"
M4U5R2L$13BQ@@TA@DPVIIYG(V&/B#AC<4,DC'?K2N:))38?B?9^&)"DM:2U=
M80VBU'PCJZBNE&\%YPXP4+,J/F36E5M%;>64B!444\G@6N*8!"#M?*@Y44;V
MZ<3G)JA#4/[)1)(LFIY1>/V:+5=R<J'U8@U3P26Z3S7'!S][WB2;"B/@`HBI
M(QT,B+E;$>X=[]%!+&@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@J(4K?_[T
MLR_\WA$2;;I__N7$M!;O0*!0*!0*"!_(9KE)&PT-L(["@[8RG+7/8.%]JH<0
MWR?.)+&?#UA-S^^X\<.]:3B:B>;Z1(;2/JB-@IA%S&24;.@'+A"X@7#R"+KK
M;VW6^DQ:F$)4U(<FG<':P3ZV=I)'791EB&9`>\FR9&#:=:7&L8Q.B0F])!)8
M,H)X.L-96'&MF$@88FE!DRI#/(T-F7")NJ>J^[#/.\4L&OC68\S&AQ[R_LF>
MEF=#LKQ.JM!](CT@39J,HP=$0-IN.U5D!61W";D],'4PUE,0U%&&'Q`Q+&\<
M#!@N&A6UI%N:T-;=-FZ)JSLI'L_:^:AN?4DS+6K.S&K?QL55AKKY+-#;4N17
M.BVJZ^R[IY*PH`2T5$/X&72BC@&2YI)+8&K"7#;*GH1O*`_?V]NF*HY?KXC!
M>X?)G5(SCEPLAE,B=WIJ/#LYL+8MCQ0DJAU(;["Q8KJE0LX&2`NXI"084$8@
M#@.5#M<P7#&)7T>W,F:0)8VE*:]29"5\^2.(-MV_!D;39`+=V">L8(.A@6J*
MZ\6\[1%)ZPHW9W;;Q4!'#9)5SX90V7"-%`E7$V*7/7"U_C0@)^PPT=A77(S(
ME=@.*>]@5"4K),Y34RIIE]<3",;QU'"6]9--Q>AID6,IZ.4BQL/+(J";6@"Y
M,N5$,J`QX4UB&%7##XRMM$0'7=LW92`CLB:I&V+C3D&3C;Y;PEP=;T/D.E'=
MO7Q<32Z0JBV=JA(+0=2ZQ3Y,OD,9(ID@9W,8!V)B^3#LV_JGR`1.A:[H1.+Y
M,)M-*<G)&=?2IJ>Z=0T39M$<VP>]3JF>&4H_+^P61\HSM;'U%*B`I.`LS#6#
M@"70"-CP.5BF`>`173^*'>N^H@D2J\.)`KVSXRMMM9SR(-++#<!0Y+,G<BZ%
M.C3;63F/JB6&NICBB8B,HY*YDN4`R_[(T&5-B7*XA8WR(:,[#3E.4].Z'XZ3
M%9J/C4K0J*&X:!=#/;>1]V0/R,'9Y?2'<BJ*B>.3`:L1FLCY4<;#`J-EGD5+
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M6&\B:P,%@@Q@C=-$:<@.Z+=1%F5H":D61FC;W<>LDQ7K>XW9'#FE5K0]`LZ(
M,A;`2M-;Q;;I7HS5%5T$`@\TIHHQY4%($T;\(P9-GLBY<,5ES1S95S[SOR9V
M^P"!B-U[DQX]=CB2W\;FD4%-Q9!.GSKB25'8*D#JP2G@>07F=)D,2F85CYX*
MV(@`8@`?6L'2PKH=L]'NK_$6Q`HR:"1)NI^Q4_R;+9!1<35-(+1*R%"&Z;90
MU=3.(BF)DZTQQOJ7V_@KET@0T=&`/C""8W\D+E@&H=1=1]]0]G>-.3YNBV9T
M!'U@2)G;TZEGE(FH#>@..W&]M;W-'R8GZ<P#K.530DR"0W9D"2)&ECR3A+)H
MA$,0F)T'S!</INH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H%`H%!%[9G66VR9!H$;S/,T._%(ZKG?.H==EFJ:7O?8N2+^;KPER
MAKSTN0\SZP&/1CU,A,[_`,]!$GPM\>^YNWZ7\?@B@>%OCWW-V_2_C\$4#PM\
M>^YNWZ7\?@B@>%OCWW-V_2_C\$4#PM\>^YNWZ7\?@B@>%OCWW-V_2_C\$4#P
MM\>^YNWZ7\?@B@>%OCWW-V_2_C\$4#PM\>^YNWZ7\?@B@>%OCWW-V_2_C\$4
M#PM\>^YNWZ7\?@B@>%OCWW-V_2_C\$4#PM\>^YNWZ7\?@B@>%OCWW-V_2_C\
M$4#PM\>^YNWZ7\?@B@>%OCWW-V_2_C\$4#PM\>^YNWZ7\?@B@>%OCWW-V_2_
MC\$4#PM\>^YNWZ7\?@B@>%OCWW-V_2_C\$4#PM\>^YNWZ7\?@B@>%OCWW-V_
M2_C\$4%;ROH<-XM38@8KL]L4`*<XZ'Q+EYA&=P)J:"V*7LS'C.O&Q1YYE\+`
MQ>H>^_OF82_-[^45BP)CRENIU+A83X5BOW]MU_245^#J!X5BOW]MU_245^#J
M!X5BOW]MU_245^#J!X5BOW]MU_245^#J!X5BOW]MU_245^#J!X5BOW]MU_24
M5^#J#4$WZ1,G71DDY#EKD3W>;K3/OZ+XR*J)9Y'5T01Y3)(K8BF/DRY%#0%`
M]@$LOAX)Y3,QD'8N5P&N,/F&#AGGB&W_``K%?O[;K^DHK\'4''-\6JD2*&C@
MV^N[N0)0N,9%Q+R&$:'R#`#R%SQ`+%TL0<P-?'"_5PPQRSSRZ+6M>][6H-4@
M:.-@2"L]C3N_6_K?C$O&!N8%`9UJCD:KN1F2GMH9VJ`Z]'KA:B<^4-<((I?/
M(=*-IX*D"-C<',"PMNI09;'G'0G2I'[&D]D<@N[:JRY'9S9?C15!7]DG"J38
M>"*2<*`?$3U%'*J!$0XE*(0EP1P@Q@KY=7/''*U[6#5^TVID6Z8P0_-E-A>1
MW>)FP_&@"&8>#D(.=7=AM-"<3E1FBDY`M]J-I97U&YE>7RH-[%RPM\+"7SRZ
M,,<LK!B\ZP%K_K?%T5S-+?*!N8A1S-S]BR-(K<*<\U-RX/1X3/EC>.4Y()-U
MMJ9_,NO%;Y&;F<PL"Q<KAF,-F&'C?*@E3X5BOW]MU_245^#J#!8^X[R\F)"L
MMMW>OD`)$T9Y/9C&PG<L+['4!%I@NA4:"X9();O:Z*HJ3=-*J.*(F*I<(1-5
MR.01LD,.6&"%S#'1M'F67GA-UJ%Y$]WL9B5HC6IR(MJSS.Y%A8T;SR0&"JKM
MU_%`N@A#EW0YR1>Q/(S8YGB+<3$.X>&>6(;<\*Q7[^VZ_I**_!U`\*Q7[^VZ
M_I**_!U!J1E:.LR0I.FB'FIR);O*#_U]4&(ERJCB/,Z2!;YV26:4?S/"+JAU
M!+I:W92:QX(QED2&,8@99>3%O@):^-@BW-C>UK@E_O6-W'R$<F3V7XG))ZI.
M9R$6/,DZMC7])54@-PD#\W.R)XR=K?CO,9NBXJ61,X8LHA)F>!P0O@5$#%R#
M?L=ZHP]+<@%8UC3DWW$>[A48(CC9='.-R0\U1JKL)RVN.MNQZ^4%Y%D7-KK)
M%R*3)4?)!%C8AC$$+$7/#$,4/+(-D)/'>76I!><9D]Z^0`-Q,1!9CC6SJ@L+
MZ8T32>^Q7,"B@MM\*#7+-%V*I7-IFO?(DFG31M)Q$+9'`P+&RUQ0SKPK%?O[
M;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK
M%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'
M4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^D
MHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[
M;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK
M%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'
M4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^D
MHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[
M;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK
M%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'
M4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^DHK\'4#PK%?O[;K^D
MHK\'4$DD/3,\BZT/+7/+938%3,NYS%7'A,J@[`!I8;V)9::JQ=&0EZQ6P15)
M'Q;%RV8=P[WN`>,8]/X?38)NT"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1
M"E]O4S/X1$F?3+B6@MWH%`H%`H%!5;S&IR@J:?M,JF$#RD9QW<XXCF19/*&#
MIC$HG[[:ZGCQK($L&*)8N2)%Q!1<^CJAAX9997M:U[T%3CXB]5#:NYNV@1R:
M1=BXBYQXQ9D+N_.0Y>L&RH:7-G=2V:[F0T68"OXM*T2NQG/EQ!+96R:,GGRY
MXQF8OEB`#<N&/PJZPV1R*G2J*YAY_?<A;%;A-ITJA-W;.0]NK!K>4&_-J_@!
MMO`R^J/*`)7U)CGWL2T9BKY#-J`V`S:R@CE1C`A@,P$;R:BP7'J2G@\@[RG,
MLI*/"3JV-H6&,Z)V)K#EF=:A25R^R)QBEFH>#S?.U0\BBM8!3)*N)U:$0LR&
M/D,TX=0ZX89*AV4PA0DN<90:\,DVWQZ:+7T3,/O#;\K(*.9SUF;=GRY=,FGK
MFZVJW'SLFE[!YFBZ@D&P#[E&#*(I08*R./U!`^A'DT1W@X.+AMHTAE3;[>BC
M(/'47DH'%I&$L5SJPFW>LOQ_,'66!=2&0R:AGYZ*;(Y9"X$0,L\,\[X!Y94%
M)T]L*2W7#SDUO=;/>YAK</<M0'"L?JJPB*I@K("C-G(;KZ!K@\VV($7,!K^4
M3Z`(Y(BI&0.OYD;=ANV>6-@[]`<;8V6QU/;9V2,R;C,&=H\Y4H:8QTN\95VD
MD3<0K$J-M3&,=.Q9*1^UTQG0'!&D+XB<T;%2@%,)PH"LVU3`0<SFN'\<@@E-
M!T2G-E]L(-BC8$68G?#XTH?\0,JN1EJ3\E=OM!S?$[D6AY"AM/>F"0O)&"^W
MFNUU<UFV2)L7(D7"#P$)X>3!QZH0Z8\CRDQXE;\E/-(V=DA48_$+N=%HJDS'
MF^FI-MFDW.4]G12U,A9G&;3T>K:NS8F2RQU37PB:FX"S:3#2B5#,&0\,[AA9
ME8=!,INO'\$OI(1HG?4.\:Z^F"Z0O_:Q8B<L_#?),UH_DYP1E,,J*@BNYY.`
MC!?*%'4O-,--)W*YE<#X=SI<SEB$Y=C8\.:WR]NC!\9C36QM&R$A\2TC['MU
MI/.9EL)KP3(K\V/;^V[E:"V76UA\M]O.Q-8#/M(HC>.!FL6X&?.C=2XID;,)
MJ\1*;`Y/9SE(.ZMG%I8UX4Y/U:SC1>-*#T7FFH@D=<$=.<1>,'0^!SJ@X([2
MG$6,`$LRADPEEQ;#`$LK%0P<,0Q37';W7[CE7=YX/W*7E>*I7<F[FSNR3'P4
MF(\U\_M/%T_.K%]Q6NPL*W&\K`2PYTAL'"K',(*8(96$X^W+%12P8-RV8@1^
M6M<V)M/L](;JEC6B0->$M!X28+<S#UU1',Z([)0:]%*9=M%9$0!`8?.,YO8R
M?&Y(N4S(EP+7%;9HZ-8$(,;.XEPC,`XI\F%HQF1D!\;"&!I7C/\`X7`&1%5+
M=TGM5P'C$N2/,Q78\V"MH!U+4FVLO%--^3=ALGF5-^3R#R-YX7P!RP#8VPGO
M%K`O[NZU)J"_4W5/#?'2A$9J`[YZF^+]9HD3I.U!&D>05":Y/;J1(,AINLCJ
MDUL`!JB`DC$TM2>"H3*&S)(H<.6$"P3@Q7UXPT=Y&8,LDE"/6-N+8.%TUL%I
MF*1:C1RZ=<X$=(^,(A3VJ+4A"Q&KR`I+IU-,><Y(YTP.9-)88)$8`/$+U:!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05$*7V]3,_A$29],N):"W>@4"@4"
M@4"@4'YU;=-\NBW6O:V-\NBW3>V-\KXVO?\`EO;&^5^C^CIO0+VM?HO>UKWM
M?IMTV_DOT7MTV_HOT7O;_P"M`O:U[VO>UKWQOTXWO:U[XWZ+X]-OZ+]7*]O^
M:]!^T"@_.BW3?+HMTWM:U[]'NWM;IO:U[_RWM:^5^C_GH/V@4'Y:UK6M:UK6
MM:UK6M:W1:UK>Y:UK6]RUK6H/V@_+6M:UK6M:UK6M:UK6Z+6M;W+6M:WN6M:
MU`O:U^B][6O>U^FW3;^2_1>W3;^B_1>]O_K0?M`H/R]K96OCE:U[7M>U[7MT
MVO:_N7M>U_<O:]J#]H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H*B%+[>
MIF?PB),^F7$M!;O0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*"HA2^WJ9G\(B3/IEQ+06[T"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@J<Y-)DVB9DA:`09JU,S;@-R[9;,.V)G7)CBB1
M#FC%";39U^E:6L+I[,7UMNDC)LXJL$$O?/SP#+#`:^73?J]3(.K]4CES^^$8
M'LTHJ^7B@>J1RY_?",#V:45?+Q0/5(Y<_OA&![-**OEXH'JD<N?WPC`]FE%7
MR\4#U2.7/[X1@>S2BKY>*!ZI'+G]\(P/9I15\O%`]4CES^^$8'LTHJ^7B@>J
M1RY_?",#V:45?+Q0/5(Y<_OA&![-**OEXH'JD<N?WPC`]FE%7R\4#U2.7/[X
M1@>S2BKY>*!ZI'+G]\(P/9I15\O%`]4CES^^$8'LTHJ^7B@>J1RY_?",#V:4
M5?+Q0/5(Y<_OA&![-**OEXH'JD<N?WPC`]FE%7R\4'@+J;RW@AB#"\P\?!A!
M89BBB9\:D4XX!AAXWRSSRRO//1CCCC:][W_FM05_QWM/(4M/MO1A&W_$[:*/
M*0G:JA(379R)J!K<9<#B73`GDBJ(BIU]DL!U-9.C?Y,`J#;,<<2]L`\,LKVM
M0<-_;;/F*WN[8UDC_B=]&F0_V$X59I/1G.7377A)<37<Z"=&3EI!6TLWL6&:
M3U5*/E\P1P1,;9ABX7QRM:]KVH).Q@@[WS4XU5GQ'SU:]2.Z$-C1S)JP@,[C
M\A1>5$V/)>0\7-%SS-E"&P(PH+<?S>SL=2C=[>2.EKV$#OEC>UZ#>7JD<N?W
MPC`]FE%7R\4#U2.7/[X1@>S2BKY>*!ZI'+G]\(P/9I15\O%`]4CES^^$8'LT
MHJ^7B@>J1RY_?",#V:45?+Q0/5(Y<_OA&![-**OEXH'JD<N?WPC`]FE%7R\4
M#U2.7/[X1@>S2BKY>*!ZI'+G]\(P/9I15\O%`]4CES^^$8'LTHJ^7B@>J1RY
M_?",#V:45?+Q0/5(Y<_OA&![-**OEXH'JD<N?WPC`]FE%7R\4#U2.7/[X1@>
MS2BKY>*!ZI'+G]\(P/9I15\O%`]4CES^^$8'LTHJ^7B@>J1RY_?",#V:45?+
MQ0>?'O*>W6>V/(!JIM5L"UMDLM9T_4E<8$AMV#F_!!D0O.[&DETN5-56PW7,
M["AOS$RVB@8`V1N^75QROU<>M>U!;I0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!05$*7V]3,_A$29],N):"W>@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4%/7)!_C2X4?WZ94^A+LI07"T"@4"@4"@4"@4"@4"@4"@4"@ZE?_T$M?ZI
M4?\`,QJ#^6]%<D(B/P_ZS9N39/CKDQLQSL&S'V9T.9#71&SR?/@-&W#5%#%F
M($NIRJ\W@GN1P^>>^9<R7;1,6[6&P+6->3OU1@^NKD-C>*53FFX%\C\5,`OE
M):ER*+#U25AC-/(\Z3^.M+<5`[O(`1.'LX5-)/#Y"VR-7,9%S5\A,,K9WOE<
M,)B7:#5#47GNY7@M@9[@?6YOKNN''TA,("59%8\5)"M@VHU7O/$AJ!.951"1
ML-`('BEA"Y6U[%@A@NG'''+&@^EID/AF26SVS(4=.MNOIAO1$3G*T'FT5E/<
M37=#=5RP9U*7&^NI)@VF*Z0I$Q<10#``H@0H>5LL<KVOTT&4T"@4"@4"@4"@
M4"@4"@4"@4"@J'U$^UNYB?\`8WC8_P!SLT4%O%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%!40I?;U,S^$1)GTRXEH+=Z!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!04]<D'^-+A1_?IE3Z$NRE!<+0*!0*!0*!0*"OB1>5CCSB.4';#
MDF[3QXR)`8#A)-5^)KA`<Y!&9*^H$$Q5+)SN>8C?^)+;SNFK10?/,XH@A!!&
M,,L\L;96H+`2Y@N<+@&R@X)HJ:!",%C)<7`<N8+CX8B@C@#!99!C`C!Y6RQR
MQO?'+&]KVOT4&B5K:&`VZ^%&-EJ2T5/?"3(,914HMT8LKY'"LA3*AGG)&38$
M$"31"ESSO0TT<P7RQ$N#A@'>PN8>71:X9_&,H,&964ER+&+E).]E+1M>(I;@
M3PS@)0X;;#A56FO`AAGRQ0U;)-<2&;*Y]8.UKB`Y7QO?&]LKAGM!K^594CV#
MXW>TORRZTMBQI'+=4G:^'@M9#8)+;;B.!D94E90R+@F![%2@&-\LNIAGET?R
M6O01E@/D=T?V>?>$7P?L:Q'G)`Z.=<*>PQ\5UI.]<0TRP>2JKMMO/9';BJYT
M])P&PR-BIX1G`KAGCD+?#&]KW":A@P"4+CFC(F()<L"*8'%S]S`($'#(043+
MHZ;]7##&][_\EJ#"(RDN/YLCAERQ%[F2GS&DE-A)=[)=B1<09'<[5<!(,^DJ
MY"Y@$$40BHD1\1,.OAC>^.7NVM0:34->]+H'3UR<!=?-=(T!BY$6Y!6)&1H5
MC]&5VBCM1--+RTY`%=!:N"V5S24T@*8RS+7N-T!_@VOET6H-UED2-)'%CV5L
M&ZTG8H)*4*OQ@^C[>33ZX@);V1RUCA]HK*D1R6&]@Y4,0+`SYOF!F8`Z,!;7
MM;JV#"'UJ[K/*+B,N^3-=H*D1V'02I<XZ'U$;`=SB-ER)?`H2`,K:^WU!2'!
M)E0L0PL<Q;XAAXVQQM:UK6H(F/OD^XUM6'9GKP\9V8D0N./S)=CDXQ(1^^TT
M@BCIJ2$?+-=K)S:8HJ"9#3T3JBX%DRXN`);"][8XX89=4)X1K)#*E]A-23XY
M7`W*Q7PC%'"UE\(DI)P:LCGL;YE3N!%8)IZH5Q%QMT]0<`(2W\^-J#.*#7T9
MRM'4QMX\[(P=J4]&XF.]\L$^KHP@HA0J\HS=ZTP7XWQ<A@@<['VP\6Z=3S-K
M6OC8P6SMC?*W1>X;!H.M65A,;J.K.!;.@IJ,AIIY85U$Q>^)<@F)A44Z?.CW
MQMEE8$J5`SSRO:U[]7&]!T,>O]FRLPF3*,=.%/=L?R0T6X_&,ZDK,01+<K/=
MR.37VTOIN8H80N9!81E`$P#?+''*X8ENFUK^Y09A0*!0*!0*!0*!0*"H?43[
M6[F)_P!C>-C_`'.S106\4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1"
ME]O4S/X1$F?3+B6@MWH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!3UR0?X
MTN%']^F5/H2[*4%PM`H%`H%`H%`H/CAEI^F0W3SK1.9Y3=1=*VR^MFY/2G!!
MTYQ]'SJD5_I+HTNUT;Z^N-Q779D:SQ)H[V2`\T,KBFM5<'+G"@PI7$R9OYOB
M'0/O9F=UW(PG.AWE-$8]B[C)TOE/6*-),Y!9?TW4(@$=\.+BN^Y`)M1M0-*!
M_=1V1@^DDJU5!%<88^!0-*+DAD.YI=$S%"3>.TFU9G91'07=.3MLHF=VN$QI
M/)!:*F[6NQ,2LUZDNIW3FUVZS7&00%]NL227N6\_.)*BGD30F08=C9<,8/+#
M$.KT>6Y;W7DW62)IGVFVEQ9*UI'O#*SH)QKL%(,8N!W/QB<DJY$$?N1;>3(6
M4AVBBL)D'[D2(0)P(#,,N6",XC@`8@7#7D0;5*DR0W"SGWGWNF#7A-(\24/S
M5K^_&I-:A!6<W[%&W'-:#.DG&SC:,(1&>)<C@DRV*$`RCF"N1&Q<0IC-',W4
M[7P";6Q;U=TB_P##`NB0Y#<RT\7T]N)MHNYZ/!SFQCKA<SG<$#-U67G"O'36
M61@RKJZF:%,&1!+WSR%$RO?W:#)-M=E-:]LI)XQ(LU/FJ(=B-CF?NY",RV$@
MU^M>3U>)81CQKNP?8IY/MQ,516P&"RG)'1LPUQ\5(P5Q65!;*E`@QQ;VM@%>
MVCNR6T,BOS49\R'L0R"4Z33,LRM?:.&%_>.9I0>Z^DIS:F`W)$)B<>(&NY:/
M]53^OQU!)BI:X$MI)1.#20@5!64[+N&1H/+3-=<6G&L?"S+"!/NT"JWIXTBV
M*4YP9=WRNRTWCK6BK2!Q[`,(K#D!N(V:CE`=<6*[,`*-L!$($!5,MEF64LSN
M9D06@TJ@[BRLVQ,%*+]CGV$6E[B2Y#ID7;K/(LN;D2@JOJ-X/8DA0W-;Y:B8
MV$F&M4Y=2SAY2'*);!4<R5\;'`,2P15-+YT&6R]M-M(JN39I;<FS[<AI\0A$
MVI)[5A8DC>V88(&34EWZQQ*^T^7"&HL=:[RPE[UA3)/+C7TA7"/B+1U3&("-
MTD53S0&)D<+L]%4-\RGN?R&3!)<W3FNG(/V?38-CR&<);>&&OS&;:UJ!JQ(K
MI!(Q7YR41%=2-/=\GS18TJ%Q3"?:^-R^!804SY4,KY`Q;A[D<,^-A+X>4W?E
MVW5MG?'KW]0[:W&]NCIMUK^3SRM_S7O_`$T%5?(?L'L$4W%WR;2[L(V=<V]K
M["$-.?5!3>>^$HZ>E4,JXHW5W*Y)Y;,'1_`TLIV[QW*90C;</(:G=3!M@C`(
M@*5@.J6'-ALL_.!-R2?M&[-S=Z)IUBV`@]_Z>(NNL5PB^G@W4U89STA?7YW8
MN./-3SB<!GL\%L;/[N>#9/%G"VET^2*$/>P,),-)XF6`:@@9%=4+L:"-C6'.
M,ZHSGDCGSV'@-RQ[:7'0)!`T/2?O7LFP'E&^$)W/Y1N/B<&+^_.*N*0%<82[
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MEO<S<.:]+]SXETGUT>^I\-,67W'`X!]QOK3QG/\`=SM:D,I1Y*(S>X'SM4L.
MIHKOGI%;&:!9#"+E\DL8O8YF$[GC+FT2?MF6X]B,F2IB+N=+.L6W462F`YG$
M(OQ?J2VF87<6[L:MI[8999MHF3D:"BB*G%<1<<RI>90,0/P`K=4/HWH%`H%`
MH%`H%!4/J)]K=S$_[&\;'^YV:*"WB@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@J(4OMZF9_"(DSZ9<2T%N]`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H*>N2#_`!I<*/[],J?0EV4H+A:!0*!0*!0*!0:1E`CKM&J([)WF!(B)GH;%
M2S3R>4KOE&:::"VDM!+><&7`L.U6*8"D@TXN!:]ALQK98]7&V-^GHM01IBG=
M#0_<F26]'3?42#IE-`23<HQFV9O@.2(P="NVD\PGECTF0J#/4;,TT\$,@,;*
M6,*K:N;Q+8B@Y#9AX"!99!M.>=2&CL#).OK[<[M=""C0'+Z//'Q#:I!FD$B4
M)/9B,>1XQ69$<1ML'WP83HYLKG!R9%/4R!<T,-C8W8<((,.P263VTW$D8`PE
M-]$3#!8H:(%AT]*($QBY`\>]]#Q(`4L`'F$4.*=_.10\;VP$'_RF5KY^[00G
MV0T4*SZMD5!O;%3K`2#FP<HQ<3#BBT4J#&4&QD87Q<5QH-V4HRD0C$4K%BCG
M/$PG>U,4A;\R%#"%%%\U)9%@E8P8DCV,XF9$&M)LD"D61VP&Q%[5:)_"ZPG$
MV.ST`BV$!"-65;F\U,N41$T$'+(Q<7,6V/3G?+*][W#O&PPV,R,3>+,9C4:.
M)_(/(]BV&ZD(&)W(*V5@LC=DHF4L8R"ME?JWSZ>KTWZ*#P)1^PTUTK+Y3F2T
M2#V<1,%.<#P)-M&*NE=3R_D_-R"RX`"0:LIDP/(X=0(<;/#'JVZ+6Z+4&`K,
MCP>R97AN"%4\W$24GVUY(<\+,T-NF+#F&O%A5J)\C'6X=))(B,WBS?)/Q*!&
M"S,%,QPCML`L!<<1+8!P4PGKXUI#!A!$8K/07DX&B[Y<^+R+%MT]"/H`ZJCL
MAYKYUQI[8"9EEQ7..,J4-%!SN*JH%A,\_(BEPQ<\`V0IQU'RTLMAQ+#$9JLX
M&5TV9JZIMA$/K+2M?''"]FPIFB(IU!Z<,,;?^5S"]RUK?S4&LP]@(`0W>OM$
M9VHC6=HLT-V%5`FL(2NTQ';-;KC=/D5OM5O**NC)A*1%T_&X>!SSA*&4`0BY
M(8$0;`0F8"!#>!I,33QA/-G4\B<-))D0XE&310N8,)AL4J.2%-)XPP>8A(R(
M3,B`Y9AWQRN$)EC>_5RO:X:4F!R:]MQX0.3F@DRAGK($GYQ]``[H9P;E5AI1
M^)KJD(1-:BI=$5<FLJW9\?*AZYO(4D%?`A?#ROE;A89!RY37(,9;KB1R2<EM
M/)_.A^IT50RK'F@$XWL,\W2155/-#:!PJDJ2ZE!6;Z$H*2D.%D"5)I9`R:-"
M!@`B9V"#R5RR<92D?(H0,LX):'A*)QJ$GLX==YY:D*$Y3+OP^SC=\IK<D0),
M,IBM^T?$P0NI"+806:K?/"P]Q<O=#*7MR5:!1B\7]%ZZY':(LZ^/(VCR`&Q]
M4-E9$9T6O@-`*.M3"47K&\).AA(:T4;CP"/&Q0U#',`LH7$%RQQ%RO<,Y?&V
MNAD(LEE;$'7=&^:9M<531XV<43,)0D^1=EBQMO\`QC(Y,MJQ$U79)4M@%FV+
M8T/F6(G0B!7.V9C('"_30<=E[8:%3NV(H>;?76`ZD<A-Y.`6%9T1BK(J_$,_
M9)(AM(C1Q-5[M!)=<#OPX43`"Y`LL$D48R.8(%P+YB'26`P5)[^PK)VV!#:1
MTL+:%^1\UGUL>U]($?6-P,QI2<Q9I<H*4QHY<24FN9Q")\GZX,V1EE84@']D
MQEI,Q4&0@CG[`^^)@<80+*=78M$4-TML93E607'),P0N$T-?(T)9(S;:T5Q+
M!4B1]%4TJ")%K70TP-6)J;V>08.*^:6U1;4!L6\GX`C@EL;`W"SB@4"@4"@4
M"@4%0^HGVMW,3_L;QL?[G9HH+>*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*"HA2^WJ9G\(B3/IEQ+06[T"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
MIZY(/\:7"C^_3*GT)=E*"X6@4"@4"@4"@4%6?,&U%]P:C(#D)-)?D1BPWM+J
M'/L[1NV$,ZZ5Q\Z_0IL3'TA2VG$FDG`&CSNQ;[70Q%X5*!"&%4`4C,`,(43/
M$/(-,3GR(:W;"&TQ"T&363N[MLV8`V?E.%9*B),:$HI.J+C+00ZP&DN/YU&;
MC?$!8F)Z"I;0*-T,3!<613N>`Y3S(L;%""II?F1L-N'6LO:'[43U+L@O/BZW
MND3?P55G>5I6<+(>#3U0-.&.Y8EE$=CG6[:T;*I.S%@TE+34XNV%"X!E4*8$
M;EDP*Q,-M'=>`!Y+76$>F7;T^UECA+3MO7*5&VQV,!,.7;9+75)%39W/*I20
MBZFGOLD2'SRQ3T\8F@9#6!$S3,\RA2X`:#'G]@/PC/CJVTW-GAASJE\3G';-
M.KK8;NP4HQF?5=F7]KM(J\N2#$D:,MS(:-*D]..40$4#XO73E.YZQC$'-.'!
M-C6H,)Y`=HI5R:^T+Q=;V68CW1UTAO6PYD0?&Z4SQS)35F?'7F+9,=ZAI+HY
M!+2*MI^Q0;>*\HX.%T/%14TX\HEE8`[<)$3,00PF%LP`];LWEMVR39?V%+2]
MJSR%:_(6M!A&G*7"#!C5HG6'H:L.9#;L6);J`CAP-B0;R6M@KA513%`F>*&\
ML+8AWM?.X21*+^P`?(48XR\WW,&35QVMSY,@Y(R=#EN9OHH*C_&H.!L'9<_Y
M][P!;\7^+?O+8UY'XA8^8^1\S_R5!N7?>=H9UPY1>,F4)\D]DP]')>`.1!O#
MO>0U\BUVN$O+6>I6:0CBK2H*`0"45,,@/D`%EGCD+8'/JVOU;T$'^4';]2D<
M>89"U$V;<RM%*KQ);!.QDOF!)-5QF@'*#6W6UG8=WNV3S54LD3*06F5/J::$
M>PQR.%@A3)?K>2$%PR#$-O8/RB=2YE$^/YBVU2$_4;0J%MM-="6&U>Q2D&RM
MG'(V=G%%Q2V7,'Y!.'G*OJQV%$#,=,/BG$+K9'+V3\;J!B^8=3LZKI3ZV/"=
M^Q\@OD",8=YR-/DPLMK<KR4RF-%3*D7BI9:P?`)&T)U(:.R6XNS*LD[!BX9%
MP,%=8'!PSPR4SF!D,"UREO8QP[*Q<OOS8>.V5N8K\B+YCZ6(F/[%;</.>S\3
M)LQODHJ0>M:-H[&4X+9&O0>O90B?0'MB$"A)H(1!QYK69PP8L.'8P4Y(M>\N
M\0CJ?$\R<\>1E5WKEDSNM#3NEV0G$<8[U3("VV2W21><#JZ^>94)(<7K8Y%#
M88I%)10#K>-=)+(^`8%,4%YTR"#GN6K1E*=%\<6@E:B[R.Z-PQ\N@L8FH!Z:
MI-93-`X7MU!%U*B!T+09:_\`VF!%0/\`5_`S%H*I-%-*=H=R>.'"$'IM<PV#
MI?+$Q[<(;SB)JZRCC3PHQV'NW-YAW,D.>7-,I]MI63W,DC5O?4!C6-D"!S'`
MMT&`\#=!V#:CWD>4'1S,2!HILBA,13:&_+U/)>O*Q!#&<RQ*RTDZL:LFUT-E
MS.\E`\`RGJZF]@&GH.1]`5T(HL%`<S8>8!@QD$'`U;DC3G5B7N.?91,<ZXQ.
M/Y>XSG?JK!\PSL/D`%"&QB;.K;?,J1YL$ZAR91M1-+LF%DD8DHF#OO8FF%MF
M'4X#/#H+`"!O'<O8O7C9707E9F'66/+`$VD7C4TRMN&R@(R6VMJMEHJ*L=<A
MY=BUVIV(3CDT.')-26TV2:_E@*GC*05R:69,!E1>H%V#:@"/$IR.%Z'&^3/*
MSKD=%FT5(4RR:I([/F,E'A>,U-\LJPA&QM%6EEIE\2QH7$;*V>>0XN%L,S1B
MX@9:P8O;L>J<D+J4*HJ"]*[]-R$\UE6&`'/'E;)"06DC)X.1<L5#+HK79S53
M4L@!;&]\"Y2V8F0@X@PH@;'H%`H%`H%`H%!4/J)]K=S$_P"QO&Q_N=FB@MXH
M%`H%`H%`H%`H%`H%`H%`H%`H%!^7O:UKWO>UK6M>][WOT6M:WNWO>]_<M:UJ
M#5T:3E"DTAN(6'9ABV6`F>I61G:)&D@--]AM=8OY?H2G%FUE=5Q1%*_FHO0`
M9\D+?R>7X/X-^@$93E"DU6<>4-S#%LM8L]3Q1';E&<@--^6:RSG8;+!)<5VL
MK*MD13SQ+B7L`9\D+>V&7X/N7Z`_73.,*L9\M&,'M,$7,^2Y`ZOQ#CQTR`TV
M^^7MUS`A3#XHM)65BB^Y.N;"R"MYF7&Z1,;X_P#2M>U!AKEVVU49CI4F.\-F
MM?&H]48YBGK#/<LSQPA.E*/Y!!#XD5)OJCD*JQ$YD`-AG8(4'#.^&>-^CHO:
M@SY/E^)U:2%R'$J3H^4I<;"*4<;DBX@\6\;D)`;Y^Q2Y-;66:741'$F))G%0
M+WP,#%\`LL3(-^MT"A]8,D:KM:SY0B3H93D0G<V5+(Y@FN%M*Q%<1%"Z>>,I
M9[S%53!S)$W8HHDA@!+AB96Q%"RQO[MKVH*J5+[>IF?PB),^F7$M!;O0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"M3D+U+V'V+<FGLI:P21#<=RSJ1.[A
MF1$O.S*>;ZC]R!N2'9"B(XCJ2,PW8RG!Y0$B_P`4R%F&H`VL*#A>][VM?'(-
M:?%+G?\`[=^*'YL>VGUIJ!\4N=_^W?BA^;'MI]::@?%+G?\`[=^*'YL>VGUI
MJ!\4N=_^W?BA^;'MI]::@?%+G?\`[=^*'YL>VGUIJ!\4N=_^W?BA^;'MI]::
M@?%+G?\`[=^*'YL>VGUIJ!\4N=_^W?BA^;'MI]::@?%+G?\`[=^*'YL>VGUI
MJ#@$8]YS$SSGWMF7B23_`#TSF<.>8ZK[6%/.S8G1Y0T9\WVB#\N9$Z/PL\^G
M*_\`/>@`1[SF%<C^9:9>)(OFJBW'5,P-5]K`LE(?(.P.0Q_(/:+&YP7(*UL;
MY"=:]\?<_DH.3\2N=CIZW[<.)OK>1\WZWJO;8]/F_3T^0Z?6EZ?(]/\`U?\`
MH_\`)0:*:>G_`#(,Z<IAV%2YJXM3,@S<BPXA.[!5UNVH/-U-*P6GOE+8AII)
M-]E`AD!2Q)2&HX'!K&!KF+7"MC8*V%[9ANP6/><P<Y91'F7B2&4+$Q4^QX75
M?:P0Y9/'RZXQ&QG/:*XUB8V?NY!=;J97]V]J#W_$?G5Z@@?[;N)GR8V6.8N'
MJN[8=07+#'#'#(3'UI.KGEAB%C:U[]-[6QM_1:@CQ&FFG-7&\W3-L.)M#QRR
M%*<T%6^W3:W(VO\`LZL%8ZC1IJ3B76U$$4IJ/L*WR[5CQ,<3N4U',(;SU2/&
MS5LSAPQ8N6L$'12-,W-@T-L]<]2EF0>*M<<6PL8[!R>A.[+6O:7)':Q*`#,3
ME5A*4$LULP,:.FW1E*Q>Y84$8/$"Q$7RF.5\PZ#>+XOS)12T%9ZR3L]PSQNP
MF^6QR7'8]]?-E6>T44H;-@A8755U=VO3D=.+FCXH>-O*BX8YC98VMTY7M0=B
MTL.:B1FREO9B;-<.[\9KL3@CJ*[FEKWLZZ&RY4G.XN`)M+7T;:\\E+*=EEU[
M8B!"B!7OUK6O_+0841?7+(XI*7X-3=S>$-=F!%)AK#HB`C#FP2G)"4G@8$A@
MU-=8(&W0[F)%``ARV=AC!3'##$0*_3:V6%[A^,YY<L3_`)#>C0C_`''X0GK*
M[`"LE2(UV?#&P+CD-E`!';@63GFBHNW)QR-P$-2QOAY$\$#C8>U\>CKVZ*#K
M6_)7*:Y&Z_Y.:NZ_!LO-5@*1M+E!_M^'Y]5$-FJ[7+WQ.)SZ<R=MT.205%"*
M&OP@CXP0I<(6WN6QSMTASY0UAYJI;<,./-=GKBX2WA!,C@R;&[I;FMFU1%83
M5(RW%UF.AOG!S6S![`\SWXR70?2U<C?'&PX(V`P>81HN6'"#<`;-YVP<+!@S
MGQ/!!VOE>V`>L&V6&%KYY7SSO;'':6V-KYYY7O?^F]^F@8,WG;#N)<.<^)X.
MXN=Q1;X:P;98W$$OCCC<02^.TMNOG?'"UNF_3?HM:@X@\?<YIHH93S4S<29D
M@=N+<X2'U8VM&*&[CYW$'N9+";19`CW&$O?+/K8WZV7NW]V@U1+.KO---"='
M:`])VXM;M*.9+9$J%6<DZU[5)[;<[AC0WFMQ^G.\CZS(V:FV6H]"Z<OER(69
M?#)61B.0E\P0\P!0W+\4N=_^W?BA^;'MI]::@?%+G?\`[=^*'YL>VGUIJ!\4
MN=_^W?BA^;'MI]::@?%+G?\`[=^*'YL>VGUIJ!\4N=_^W?BA^;'MI]::@?%+
MG?\`[=^*'YL>VGUIJ!\4N=_^W?BA^;'MI]::@?%+G?\`[=^*'YL>VGUIJ!\4
MN=_^W?BA^;'MI]::@?%+G?\`[=^*'YL>VGUIJ#.-$M3=IX=GW<?9?;B3X$D"
M2MJBNNB6&F:\,"0(_9372X`:S\:Q6XA"1GP_ULT?6RSN"$SRL>\GCF!GT8XV
MRMC8+/J!0*!0*!0*!0*!0*!0*!0*!0*!01/WQ9>4CZ1[>,'&44Z$K/'6B;VX
M+,"R<,IR)&1=6C=QDS+Y7E`CE@>((+:+BY&SPY?+$<$H$)F'ECG;&]@^4;<A
MS3TU6X\1(]UBA[5@PR^"G;-'>#5URF%JR$`^8>3'EK(FM)^E%Z*D)/)(</E4
M@=T?LW4CF5E_,H9<)C$J3L`+Y4+BM/"Q6`=[R\=/TEILX!'5QSHLK,V;-7HX
M4(,0XB@YDRPVF^B0>[DPQ);Z;#WB$T:=WOI'KJ-73U+,%,7`L@O)97OB&J^7
MEIP0NP'R$R3"@^NQN2(P(0\\>1,Z[SR^#L('&L2M=H2K%+,@)Z+1E0;<02HX
M6""+=C*6":;2,G&H>6`!NK9F#(8;=V8A2`-T=]-7-=C<#Q@$V",:`<A^V2RN
MQ.S0)#?B4W72B,[5V''BX#"(.O>8.F6BR@X5\J,-?(X48&*8-EF4.&`LPTGN
M'JXZX`G0X_VI.!1.59TE/:N2XQQ;+%/839%A.:(.9*)MU+#E?`;I$`<L?:\P
M=%Q]199`!,+#&GNK-5,,BW#*%O.0L;XW-GFC,\=?LA;,%#Z]$H.B/6M?9#!`
M>B5(*-A`LW1A\:(+.AN-*3TO`HZ`FXWS1-;2A`S%R!XIU@SI\N.";%#5ZE]O
M4S/X1$F?3+B6@MWH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H*A]B_MG^,;]TWDB_K73Z@EOMRD:Z.:T#-B<+1F:D!3F:
MYW4='E_)P#,)6VG0HQD=68>*BC))TBF.502V\`L'2A$]EEED*6\J1MBI`E!`
MPA+P^K&+-CS;^(WJ;8Q258^Y$-C&T_#\>*`*=`#KE"0D]J3@82M<V^:OY\TV
MLAM]]ER*HVQAU%437,GK`AHR8%$$%N%2/'H:?3*B_B@GB9&_J_)8LV;A3>R%
M-E($:.1)VWB?9)TH>SXTQ[`J\\`R&86)$?A8\W5\M(S8/MPHFIB,>P!!RN(C
MELS`2R3&3`K8W*XJ%O7/&%!='IMBK:.%]2#6M1Y<3IM%/R?!`\H/V2)H=+D-
MKRU*D4X%X\5/+9XY$E)&>RFF'UD0X<ZM@0U&JPDO:AR`W827E=J["I;!1N-.
M.)"94<-JT.-%^8Q5)"G`'&S$LIJ2NN/XN1?$OS1(9V09)5<0!B)!L1XFD`$T
MP"I%PC0?1=JW/Q;9B&$650VF>8BIFZ9-CYW,P^J$U[)LR!#<G.^()"1R+B3@
MBY!RHA1[,8_9/4@@@+'R/DA[@@9YY`AA(6@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@XYLH44"AH@?*ESI$Z7&*'"9L$,R4-E#(>0)@J
M:+C8Y@F"Y@'.^&>&=KXYXWO:]KVO0:#AC4O6#71/=R5`^OT/Q"FO[(+XZDH^
MCYLM@!T@%@#18DGKF"6G%[*".FE3PX10D)UB90,<7`$/#$3.V08TR]&=-(Y8
M\H1FP]6H%:,>361%29<92#%K/3FS(Z((5-$<6^\$8NDX$5UMEB1\P"73A\,R
M)8(P+B$%AB)G;(.W?VG&I\J2"S97DK7"%7W)4>ET@FS'NZXX:JXY&^4;QRZB
MVRI)34$P<QD6;*EE<TF!B7SP33660Q:P0N5\[AN4LP603?*O)Q1HMPM(K@;"
M$REQ\@(Y`)V*[/:ZFO+3<;"BO8`64SB"A*[I4C)0J()D"`.?'SPQMD+G>X<8
MW&[$4'V6DX^U48Z_B3+5XZ).DX5Q,JA-C.!72EY?:Y40:^89=(7%A"(F#@>&
M./G69(#RO6L"';$,,A+7*"=;D5;;D#Q2R8I1'&LV7UQ-9:*62"ZDJ!D2J43$
M,^1MU[E4E'(@$B!:U[%D\B`&6+!A`!X!V"M/:N.-X(]Y'8_W-U:UC8.S[3!T
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MJ<&2=L7,?$Q&J;&$0M8V\7J=0>1]G+RR71"0H`)@1-1@M9RPBB:MF8QZH5A,
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M4Y_JPBW@7#731MS%4X-3R/N`(H%BH&;"6'/XA88F,Q+88VL'HC;4+5B')(=<
MP11KO#4=2F][*.+JD!FQVUV^ZU<-94+*ZX$,LIJ:7.``+ZQC8XH!@Y!X'SF-
MAS%A!K6SL&0.37&"GBWY9:SJBMFN!!G5=(.B74]620CN#]<B0CMA!0UY<&'O
MF9$6&\E,I(#33(>88R;DFEA"V00@6&=@SB.XZ8D2,EMQO&3206*PV@G8)+::
MC:3BZ6C)!'`00;(,J4+88X>5,F1A!QQ<NL*8,"YBBY9B9YY7#,Z!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!05+\[?V0/(!^[ZX?ZR2*"UA)_T4F?ZO)?YL'0=A0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05Y[/<C3!UFG5I:WA:_;7[#
MRZ[XE59O`;&LL3I$DBHL;HSQ),,\O.$14>[2][P\'.I%B]L<;"]-Q\+]-NGW
M`U+XK"G]V#RS?-6:'RTT#Q6%/[L'EF^:LT/EIH'BL*?W8/+-\U9H?+30/%84
M_NP>6;YJS0^6F@>*PI_=@\LWS5FA\M-`\5A3^[!Y9OFK-#Y::!XK"G]V#RS?
M-6:'RTT#Q6%/[L'EF^:LT/EIH'BL*?W8/+-\U9H?+30/%84_NP>6;YJS0^6F
M@>*PI_=@\LWS5FA\M-`\5A3^[!Y9OFK-#Y::!XK"G]V#RS?-6:'RTT#Q6%/[
ML'EF^:LT/EIH'BL*?W8/+-\U9H?+30/%84_NP>6;YJS0^6F@>*PI_=@\LWS5
MFA\M-`\5A3^[!Y9OFK-#Y::!XK"G]V#RS?-6:'RTT$%N33<B5-O]!]I]9HIX
MR>4,K(LSQ4JLIH&'=K4UT5LA+!XX0&`S6E4M+2F.0(XX%LNN)@7&RM_-C>_N
M4$X"7*BJEB90MEQA\LN61<L`!E>VJS0Z+Y!!887O;_\`FF_\M\:#D^*PI_=@
M\LWS5FA\M-`\5A3^[!Y9OFK-#Y::!XK"G]V#RS?-6:'RTT'8L?EA8KCFZ#H(
M?NG^^VO3BV(>*VP(O=$_P.W6,PE=W(#&=$BGD4=?(2:XC)<W=K,\\.'CB5$O
MG<+H]RW6RQ"U6@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@J(4OMZF9_"(DS
MZ9<2T%N]`H%`H%`H%`H%`H/ENYOMGIJBS?O06$&KL'O'#,-2O#&R;FD9'T'C
M8A+,UN1QL8=GBM`X29)AC/TR=2TT0Z+B>'#)96+$\\\[WQ_Z=@KZ,\B&Z*QQ
M6[7*2#N--8+ZB[D^@_7.*I$DEJ,J,]YV)`<AO5C(V1/8:.R;:+)39<:]=44\
MTD0\FX&CI0++(7''##$$,+%';)>YG''O&V]0W5NO+^W\-[<:1;A2A'"_.J!'
M&,QP--NM+!//BR^EO9@-!I%%MHN!%SP!P)'B.6()[''/"]NIE88+3.&>7Y,G
MWBYTHF29'DL2%*$A0PF.!Z/5?S+B++B61E=8`$/J&94N5`S'R!`PPZ<0\>FV
M-NGIOTWN%FU`H%`H%`H%`H%`H*>N2#_&EPH_OTRI]"792@N%H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H*B%+[>IF?PB),^F7$M!;O0*!0*!0*!0*!0*"JW
M>'C,5MN=BM>]IH\VYF?4R9-<V/)S!:#GB1LQDYA#R'+&:-9SX*)22FRYTWKB
M%$>P&/5`OT8B7O:]LK6O017<?`/&#PU^V,C)X;9;'/*<]K)X@_8*:-LW6''2
MA*"V[==AP,XF2$AM$6FE,!$;#3+`Y!%BV!`3+'$7+&^=PL000@WG$G$*BMV3
MW]L!L7MOL;N-L*Z(`?6M+)DR9K1PCIL+QC(P!G!VAQE'L=,UJ-)-<JZ*8MYX
MI&0C)@<'#R-KX!YBVS#'M)^)V;M);0<S&CR@;2O?7J#`@$M$UT=$=Z]%6,M-
M8L$?L"U51P)4<@/L--P-'O+6$"4K&>MA:WE.K[E!=10*!0*!0*!0*!0*"GKD
M@_QI<*/[],J?0EV4H+A:!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"HA2^WJ
M9G\(B3/IEQ+06[T"@4'R'[*R_,"AL-RWF4U;YDG8^(*EA/0M<,])7,[537J,
MLP=/H*?B`A.=DYK@K&.&@I'<AQ6629U#4PQTP[;+($:^?D[A,5V<W84;ID8L
M%-<>H\L2&V-,=>=CYGDE_;%&H!8TX.27&4H+95G:GIH45/@RZEMVXM8ZIA&%
M@-"2$D)42RI@2PI@?S,.Q4.0=MR),Y5?:J7LD1;$BS=PO&VV3RGY68R420]R
MTQZN)%*F8MP9BD"U4A.(E\`WTV_/1L'@+B&$,8)>;6OF&7Z\\@D]/@*%H(UM
M@HE),@RLW-_I=N[-H]IG+[WLY#UFWG7("/IBX[T2%7:ZW$1<RDXR@;>(%$W#
M%`3KER0F8I<C<P(&>Q=RG31M$WXH,:H:I-ITO%4U*;>WTVM:6YSSCXBQT-U/
MN1XR;$-L!R-V,WV&^I+>+PAIV6(J!\JAH18@E`#FA@[GL`@0R38G;Y\R[P53
M1O#'F"]!<B/WCL?6P+0#;;F',.6+'2LPPHNY(Q1W:5(HY@18:R@+AY(Z&7+Y
M>5"MGCAC[EJ#2\AQ]).AQ?2'8B+]L]LY+2I9V;U7U[F^&ME)P<,_,B0&1M&Y
M$F-#2RU@GV`H.)B2%'3H<Y)P$#B*=*`&2B>:)FRXX(]KA!P8$YU&).\R1$WD
MA!A86)MA)L7X,C4@TIY-.W:QI&`E!X(S#E698"`C8B@M"-Y%56H%CT$G0I*3
M?+K2:,>"O84UB3#%N,G?_;&\#\9;>V7BL@^&[N)&TAMN/YL#G,Z]YY=$AQ#%
M;\F&R_+#-<##;C734V66='JGDF"E72H&$XQ8J&H^3N8$\V#P\9E6=RF\HC?+
M/@4)0?FINV4NHJ=J5ND5E^7H.7H#BW%[*T9S,[&K%I>/&)(ZDC*(X1)::RVY
MBR0NI8P=@S(6`)H4,<<7.TV(F1\FT@-F+%<KKSKOKD^Y=0)XVH&0-DI5690@
M)G3:;8VOB`'%:^5FF0VQ'[H3A#:HO'VP"Y7*?LG%L`A?+&`@LKU\W2F39';&
M>8J9$$LM-UIUY7F,UW-.[@EE6+/]WKDIZX1/L,R@6;#(,:B`@E4U/E$N26<U
M1?)9@=<+,O@/GB8!"""X.R\X1USIRFUW5+#F/:E.=LP)K6%%ZTN#Y,.-YKE.
M#Y$GN.I%1DT7.Y1(/O*\%N%N&Q<;8XF#:J2QSO?.X?0$3X2Y7)+A)R<A6R<Z
M.U5?K.FF5-$S&EL22/(.4?Q7%C'VKRFM)B(1;=*BG.`C%K)58?8"<_'>I%TT
MX/E:X]PBADW<,,0)NQ]S+J,EI)V-8_C&'I9V@4MC(HUQC;&))W57-JH_CLNQ
MI(4P%9*QF\[%B6[T9M1LPH@=@CG2+-4XLEE!'!+%L!PU(J9L&G8JW#G-O3Q(
MI7:W%]-A4*<PIR&2K08.P*VIQ?&<?MCB>)SH=R+&!V*EG90@]RCMY1<I9KFT
M]"'`6U@$X/>QLAF".$T(NWVVZ><.)6S2YHX@80#*FMKNV1A4ZV=FV,5?2(F$
MFRDO2+F7L87E%OQHP(Q4YC:*R&=#5$E><24V!2XY=4$M;#`P(%;^Q'+O(LIP
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M18Q%`,XY#`7#SZ+V#TY\4\=,0)OD]4Y]V"TW3B^N<::HO@I":LP%020H;A\F
MOIT:CGU"5&%(*BV)<9B<[%4`@]$<0DN8AJ`EQA!\PRN9<-*;&\=RV0FR!G'K
M^W9)?.;SV@X^W]-ST?LD-91:L41-QVAK.3>-G#KK4\)=?;^DU*<HQ6XV/Q@'
M.J@=S)T<D'UA!PE]KMQVQ!K7(D=R4S';(ZPM1K'FTL;(I-S*+<,IAQ%VTV@3
MMKG\<4PDQM)9D530GXF8$4C((4((%)OD&8P,#]!BP5L3!QYRMK05BYE::L/:
MEUI+<U1=&NAF8(-V/UNCB37H1.R8]Y"0HNV`0)Y8H#52(]155_GCR"_6';%[
M-P4^JEPRN6!D$3(+!XNT))>%.PN-J9'.<\T%TM;VJLH.Z.C80)O`0Q%15@/)
M89!]QI)X.WDC(AC-.'/D1;Y8V#S&!O>^6%!U;`XUB*?($-/Z?-M=I=M@M=U\
MN\X3CZ:#\*($8,A_I[>4FJAR(::$(PQ$^#U>K50U@V$CFEX=2"2A3.9@N%@:
MZ@^`<N'>-U%A!UL8FR]F]EBFN$42&ZY2BC4LNY6:C12SW([AG.<%;:@Z6\R4
MF87W$;74W@>-H;/77$?1"!CS>V81@$D2!+AX)'%Q`2="^GL#FW/*"NQ=,FS*
M#08_G2^CD5IYH4MP#)^N;J+OE616^F#V,8L>6%$<J.D>]0P"B$`+;*^.&0>8
M:9;?#9'9%%B=NO+9_9&0F_`L#37K##+;4"\$M%M,J%9PA_\`8PX$T5$CR&&H
M6<K[3VX4(#A.10N.H"FD\.PML@1C01@,W,<5+90\5=,AK:O:?7YIR3&$/15L
M`W8J<D?)YF9DZ$HV08@:;T"=ZS':P\X>E-5C%LD$)77V2?031Q/)%KAXES98
M`V&$T87UK94&R#L=(K45G.H*FS,E-"3WD17SY,^GH:PRX5C*"TI/;0@9`NIV
M31FK%9`R8R/F#QH4^,.)<;J9XAX!%S8WBY@K9H/;R[T><LMY0W"`UNR="\QW
M`@H3AC-9U='41X\<T2+`K9/&VXOF_?08-0'-7/6%!$R#"Q!QSSMD'K?O%?KR
M]5"5UA-7Y)CM<?XFHRJPUF/U=NI![7QWZ1DEXC`SQARQYL*A0HHI)5PC%U`H
MLA+"8I$;YE!2URPPP0@?JOQO%GBT3XDD[7[./^?`YF8<_L38Y476"FN.'))C
M%M*;+9]HCBI&89*!VBR1F>X%9-7D6[:,`N<NN*&2F(9&&"%+AUC#XLXP;*\0
M>3VF><)E?&>X1[=IW.>13D=Y9/:55;5A1U(56TJ(K8CYNH*7%F<;*>>95%3R
MY6Y(<(((,?S7"X&0:Q5N&.)GC$0VNTE[*;4R%KVU8?<T'P)$JH\6.CHL$,AP
MYMW%/R(*;;CY)69>7&`EM,@E-H=_#.<%-1PA"P@!G(P8&%#LW9Q!,25#,D+\
MX;.[&2N]I5@MCZ]N=P'`829:.DL"-9N;4[,LNPV)'T0-EGLTV1=+>$!-YA%1
MO?`!0'N-UA,"N18+>Z!0*"GKD@_QI<*/[],J?0EV4H+A:!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*"HA2^WJ9G\(B3/IEQ+06B2*PT24&,ZH\<AMS$4%XHI
MQ!5CC,>#HC]UEB1X.X0PJ`]62K(+M;"GAC?_`"1Q/.%C0-_=P$QO[M!\^.I\
M21/!\S\JTZ2'*>XCK9/'?L!FJQVWW-N7M1(*&A1>UM((/G)UH1]D.Z85!KR)
MD8<#N7#@0:^"?Z13(8?6Q#!"M@'(A[G953Z.IR%,D8,16CM1U:FG:0N0U]SF
MY?=L(APW&G[7LH?G%<DZ)V''JNY7JT,3)).7D-0#3/C&GBD;%Q0!BQ[,.XWB
MV'Y,4/3-?=T@PY%<=*3A=VA[YBMV:][!NA.&2GF\]W]=FZKZN2FI+S>17+_Z
MG:;ES*'G:BDS""=3\U`L.0"M<#`X&QWWR:[:PZYI5@E^0)`+MV+8NQ.A41M<
M=D2B_4*''6U]_'(\6@S%A44W$Q5)XME;C-PL11Q5L<29X)1)8@CE\`A!;E@P
M[ZW)'M$CNUX:J+D*0>M;IDMPH^U19)UN/][IVN"RGR)JF<W)SEYPG%EKCR,B
MD&#$B"K%5!!`!-FE);*EPBIO``W<<J&G9.WME[+8'6EBSD"7B%^ZG[VR2RMH
M$V%'FZ5F*)?BT7B\V*VF8SJ1"JD505M20%-"P*&16ZLA&!4MQHM^J,8PP*F\
MPV#?E<GB&HV@[9O;6`XR:>M.U$-2C,,2EHAD-QO"8(P$8NMCWVV:[`F`BXVP
MWFFY5M_PU'BMADH(`P1-'<1?`EG@:+#XJ&(>]=Y`N12/5%K-U^:I:ZKCNF/2
M;97;^%FQ&LOR"KJ&;I@1*A]?PUJ=UU5@D\3KM5TZ4PBV#E3;633:A?'`,B$&
M'D(*$VM:MXTK;*;E=MPVA)JU`S=U:UYG-7E893-8*V;^V=**SYCN,22'@3N0
MN(CPVDEUY9&R,^6+77TP.P?0)GE8(?Q[$=^1/9'?M6V!EG8)"9.L.R175B!X
M;AB?I;U\1X_)M:#H@DY7FI<$A=WL=9>\ER`YY9',)YM<&/D4U%)$@2A;"^1G
M,<,J;4[;7,QTQ?H7KK(40;AS7&NO:Q,DN[7[(+ZBS6VMM`E,+NAZ.&4=2812
MGD9<$SJRNS51.<2M:Y,H0%;Q@Z8*"FSV">&$>\N8+8V64(\OZYZXQ(F@,30%
MP[NRV4G"4'07--]PQ?,\[0G*FOS:NPFBI@+ZGF[(+4@DET9Y%R&((5S`Q+.P
MP0%@]SPY>-F(MCV27Y(6ML0'#JSQZHG(=KNS65*CJ/'[MA2D!@L4:$YB7E=E
MIZ?\>+92>CC!K2&!DEW&L:!\A?`$(R8#>KTY"]F8!5)UB_8Z*M7D*86EKJTM
MH(I7DS85186OV;"<$O)L+/=#F63)4:*0;:"I"CA7DY1-G4\F=L[$TYB$E$@E
M+H(Y!&UJ\S\PJS5G1*1(YUZG"2HOF_0.,&.ZHR>$PQ]"DF)>^4O+$.H9C([)
MT;".]`/QLX&V<%.GB0*XDJ);,'(N+B-B8+!!OH#DKV#C)\2%&NPL.Q'FI:_[
M>ZEP3/\`(<3/%WYL!(AS=5H`AQ1,*`0>*&`ND%)FS`XD1!<B>?$R*X)I@53!
M-VMC8OB%@>I6Q:YLZAS,_KM)/;D:MG8N78<AA>*J@ZD:DYEPLN!QHYI*.89E
MBY5/)K,O-MS%$P(OD.$.D$"IKRE[F;XX!"3C3E)Y.'A.@N7)$<KPD=YB:FO5
MV.1R.)ZN+)ZN@^EDGF:S&./W(T9<Y16,`D\0PU'`7(V6O;$0._6PQH(9)/+!
MLJS=<G;(,5:]1:NQ+IQH%H7M?*?[5IZDYP2H^FGL%"ZD]%B,F@ZC[073BU(;
M;2F::RL[',:'LK&LP;FP+BF#`Y<-QS7O9/2"+,4);*Q*Q4UZ1K(7%I);8-ZZ
MSQ++53S;`W&W1PAE.;SH=H*"V'.9<D8N&/#8ZL6+X_%]Z)1C$F8`+%C!H"X1
MY9/*;LIKXPW^D3BKPZ[91F7D_P!W=>84=3L5Y<-1K$D>P`[)"5GD:>Y%FL%?
M>ZLU64CME/0FBCHI*QI2&40!%$X3QQ-F<0E#%7*E/.PX$-0Y"T,1>%LQ),H;
M$,]4=S]59:0M9OV;:SM:,W6YIO8(JLP&S+3S0)!M-#72D=+S3B69!7,J01DX
M*&DY"'`DMQ&OB7Y`UDDI;G<T?$D\INQO<W'&D&WHK2"19]VSM?*R&18K7=BT
M6(GU-DLPB2#3D6]RQ3$-,+@8XEP+6\EB&ON2#_&EPH_OTRI]"792@N%H%`H%
M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H*B%+[>IF?PB),^F7$M!;O01G9NI</,U
M7VO5,4U3<Q3<][?'B<6X[CA58;:J;$AQD06>0TI-P($\B395&$P289DJ,(9R
M$'%'S\I;$3$/`(W1QQ>0PRDX-HO26]F9]B5%A9]Z[,*$)QED-Q1:P(:D=%*M
M9TL\DEMAMLY>?A@5FDPT0FKO)1<RVFI5KA%38.8@XHH8P7XDX14D<!(DV;=J
M)NR04>&&E'*K*LI(*JIQ:P8,FZ-]@&LRVE=`8C;3U()>?L2-_%?6UXNLNI83
MDT,L,J]7IRN&Z9&X]H&E&9W).[E.2"&]G3).G4J*8*6YB11"Q<VCSJ>[PA@,
MJG"(9@8%*-*S_/67`;C99*`-@L0\R]\+Y9!TLI<;L$2F\)9DHRY9=9<IRA-<
M/;$IDF,%Z$41VQ),,(1`5@EG.R*\SC>548@&?B_`VE+*<LDUM+6"JH=",ELP
M1_)XAUS1XR]?FZJLYV.)PRQ*4B(,_O#9AYR1);J1EQTS1*+TU]=.KI_*4P$]
MK(S8-,U(A%TY(B4@(R<BI*:6)EK`@8VL-88-;HO$]#C);R2F$WC*<[H,-P_+
M45:HP1LZ_@W?K]!J+)T=JD9&VT2(MAI(4@.5NWCY2%:89MR*KF5DEIFS1)/%
M!\L)?,(:ZAZ1;=1;L&S=FGO&LG`!:LZ;S%!T30K*>Y[?GTR^G>_5**%5`CZ'
MW2&R6NDQ]$#8)1-F0!<KSS-/5=S5"-U;J@I>-[A8+Q;:9CZ5:T'V@X&T@,^1
M9;EV4I]D5GM=PFG<W(]4I*<HYEFQ`VW2=)D#"XVX2BP@@M$D/B"$6%#1;B%P
MPP<\,;!W$S<=C&DR8'I.T=3]M%JE(\K(#=;<U*>L<CMMH)LR$F@GYHC45GN@
M/9A2(BEWPVF[G[V$G*C`)3A"3L`B]SN01<MB"&*8\5.O+028<*Z[/.;]2G!"
MD5N.$4)]P`^$8J\79%CQ=.3]=;:DDW*+2E!*?2FM2(9-.2Z\<)Y.,NOJ!TZ`
M?#%.F_+!DK/XPM6(]1G`VV*EO9L-UQZ6XZ(&T<D[A3H(,,YN.1W:H+89Y:)*
MBR=E%<<DJ+!U073IDT(=,CV%%"R$Z^6812Y&N.5@J^E4W&8U5E,@_6!QQK>F
M;./OU\@(C*(PFWG!'S_5%MVJA9#\Z+.D@5BT$7)5!N';#'$2V(%LL\<L`T$\
M(LT9<RO-L?S=(^]\F3.:C^*7)G-\DG&J<EZ&R.II1C[K,:,XMS;S4241-=43
M6>"6\%7)4;BJ`Z5*^11045H\6Q(`A.YM\7D`+ZJYI7<4T[#S8[9B=VFLO.F2
M7M)#651G<M:82:JS-`*DD$FRQ&^SVTV<E1PYESZ<A)Z<F'TZ]LL`0C8HYP8.
MOW:TK47+$V]HD`1C>69FY#FLQHED$D_913V-'\:!MB,EF+F5,B:/[PFUH`&+
M;&BJT9()V1A74#I;#(EF`+CC?$)X:XP>UM:(#AS7YEYC&&S#L<-*/DU0-8XX
MJ"W\6D8HFG'&KY8Y9W'7'*H`BJ!X;+++,<X9$$RROEE>]P@A!'$ZR->FFW8N
M96X&\RG!C7:CJ8J7`3LE2,%:*[,]V(2^A&F^.2*PFFNH4@EAN$4P2Z%;$0(T
M"#EED)AA?#(,L)<4^L)"&)T@D!0E6[)V%U?U]U'?HPCQ3LET&*]:H]7XSCLR
MWE&S;L"F.X=N.0QDI'<P1PS9FV`F((5L;X7#8\O<?$#S8_WQ)#Q.R"$X9`2M
M/T==P1'*2()V!32.>W!L=#5T\J*AFQ"PQJ07(8P6\LA!+'TZV``=B^6-Q;AK
M!3XKX1&4WBXFS*VQ;`=ROL^[]P(V=S.?K9++FODV281<Z=+YZ'1%=AK!3%ES
M(5>:I@YFXY@G(BG\3F6.!<''`&P8=J;XSHR%;,?>8SKM(F3?&LG2)+C>VM_:
M@C+\_9NV74@LW)-('QG>RG'$^<?O!M)J>0$:H#4`;1$%)("$")0R4`'P"1NJ
M>K<?:?1.)$$;+;_<J$:?\F2:IN"3W3D]'LM/&7'RN2*]U9;<HI(@85!U)TN(
MT/;,7#(7H$Z,L\[VZ:"!G)!_C2X4?WZ94^A+LI07"T"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4%1"E]O4S/X1$F?3+B6@MWH%`H%`H%`H%`H/EKW9D]X27I
M[R';%JBS+8V!_DXUNT[:S*B9W.U`=Q?7[6S=2%(2=;"CS%KN)JJQ!XS2]E1\
M&S8Q0^0-J>"Z3)"&,0"A>X88%*K,E!@Q=O'+.J$,[]Z8:QL[BPWUPF$+;B:Y
M#51'G/V<=$E77=T06S7O/LTO]E/*,@4=QFU5SD1$<H*5-E2V/G(^.&0(=;">
M(7K'\=$6:^:[[QZ4[#NQ=CJ;'W)^U&UB^KPYL+K1'J*G*&S4>,IDF]I]@F]-
M3Z=Z$L`YET'%'35EN8FP%X3,H6)"=<)J:SZNM?D7@Z8MN]C9EV!;,_.N>MNV
MC&SO86PDK1<7TF;L$SU*$)1NW8O93->C<CI,6&6CQP56UPTM)A\5P*ILSDIY
M#E,\"^`9O,+97G;,C`UW2)Z#EIH<EW&W+[5,RF2-D#3,<T^:QHT79LK8I#3&
MH</M-+2)=8\U'+K@"'?%//ED5,P#ZV(>.68;R6]"'H+(+ZV?15=L_ME>*-(#
MS),=3;",(ZBTERAK^1A4Y%#TV*Q51%5X:OLHZ'98(->R,%8%4)%36`XOF98O
M06/P['12'XBBR)2"B95R,71PQXZ)*QS'JG%0HR6REMHLHF\>N)U3)T%,Q%$M
MULNC+*_NW_EH-CT"@4"@4"@4"@IZY(/\:7"C^_3*GT)=E*"X6@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@HFVPEI:U8Y=(UV1<>O.U\N1&K<<3]A"[EUJUQ
MDZ?\4B1E39IBOPDAN$".T16S1+CMEM&3&.8]\;7_``+?]?'I#<'C(Q-W*^5O
MV:^S_8R@>,C$W<KY6_9K[/\`8R@>,C$W<KY6_9K[/]C*!XR,3=ROE;]FOL_V
M,H'C(Q-W*^5OV:^S_8R@>,C$W<KY6_9K[/\`8R@>,C$W<KY6_9K[/]C*!XR,
M3=ROE;]FOL_V,H'C(Q-W*^5OV:^S_8R@K,);&0.M*>U<52)I3RQ*NMDV;2Q#
MO%'P;>X^=I$5UM*<6\[F+(L@L]2PP98@N;4,3%#:4[@!\,>H>^-"D0$L'8K@
M(,$X9QY,-<]AH6ER!)&TFY;1X^FR-'S$[X!1N.C:-(5Q6C(;94VDXPDM5!9(
M@J:HYI"L-8$?'&^0(E[96M>]J#5,O[EZ?S8PH08CMTAY@"'JX/V,)-A)Z-?C
MYVH0I`CYZQ.%@GM]71W,"QQ1<PUANYFD=9*CABE%=(4#14P%G@-?H".,I/31
MV3G?*ZX6UMY^(I9&P:XH.;8J"84U6W0C6#IT<"^1+I3R6GJRT9FW.(JG(B25
M#+.4=M'D`1PAVRR4+F!1!1,PVLV-ZHH(;;LF8/4/Y-&?#>LVL8VN6K<>MGC6
MV3!*)'[1UMH+$M.2Z.08P!1L)*.VHF9[:0"6-KY8%RRF)>V(0Q>U@G!XR,3=
MROE;]FOL_P!C*!XR,3=ROE;]FOL_V,H'C(Q-W*^5OV:^S_8R@>,C$W<KY6_9
MK[/]C*!XR,3=ROE;]FOL_P!C*!XR,3=ROE;]FOL_V,H'C(Q-W*^5OV:^S_8R
M@>,C$W<KY6_9K[/]C*!XR,3=ROE;]FOL_P!C*!XR,3=ROE;]FOL_V,H(E2QM
M*9W@W?XK"\5ZG[[,M*@W:N1I,DQYSMIG-T+,!LM!1U3G9BDSQ]YOAMIZ(".9
M=#F(E0@LA,;B9CVM:_3T6R#Z+J!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
?0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g53110424txpg8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g53110424txpg8.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@!C0+&`P$1``(1`0,1`?_$`)8``0`"`@(#`0``````
M```````("08'!`4"`PH!`0$`````````````````````$```!00!``0("P,'
M"@0&`P$#!`4&!P`!`@@)$1+7&1,4%5>7&%F9(1:6UA=8F+C8.7G55J<Q(B,V
MM]D*05%Q,K0U=;4X>&'4MC<S)#1V)W>!0B9I$0$`````````````````````
M_]H`#`,!``(1`Q$`/P#[^*!05=;;;1;AM?;N#=1-/H_UI<;IDS7^:)_<;FV4
M>4HM-OI*+$C]B%AW142\7M%XJ)M453DL`C?TY?`+$(MG_/M?HQR#I?+'.7YN
M^*#TS;?=@U!C;LDKF;82,,XWRB\/C,;Q<4$$PNNS8/:INHP`QC*^``0RHL0@
M3(A"CY6Z,,<L[7RO_)TT'.">_-<.&BB@-7B*&"<F%A&Z(%/&V0@:\'D1$4[9
MHN>$&7Q5,+IH61BUP/"6\!C<3_4M>]!VWECG+\W?%!Z9MONP:@>6.<OS=\4'
MIFV^[!J#TF'!SAE"XYHTP>)HL5+`BF#)DQ->W8)<N7!PR$&''&$@C$,($(/&
M^6665[8XXVO>]^B@Q%N3!S#O$X.G-$#AL=*@6!N8,D6YL?M$N'"Y?'/$/(<<
MJF0J:'"!L)E;&^66-L>M>UNGIH,G3G7S<K!(!22&5Q)JB<:MGD6/ITX[;GB1
MC$,3,+/(`T6@H4`:V`H>6-[XY7Z,L;V_EM0<WRQSE^;OB@],VWW8-0/+'.7Y
MN^*#TS;?=@U!'O:W:[F0TZUYE'9N38?XS7(P(>02[I=:$Q)AVE'>"DCW6$U+
M,@-X)P0RC(N:E;RC;/"QDR"%?J]%\J"^.@AIR&[.K^F&DVR>T[6:R.]G%!\9
MJSY1VHOGCJ:BKIX@.3`!(*1Y.P$/%BHES73ED%:^?P?!01E+KW.09+@&,(ZX
MHL<#`(0^..4S;>]:V(N&(EK9=6",L>FULO\`)>]J#W>6.<OS=\4'IFV^[!J!
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M4VIM"V'=K2]I6=:4;2W++KFBBS<7@Y19K,-EE`N;:ADU?(N"('X/,*W7OE?/
M'`+6Z!0*!0*"MOD)VMV#UW7=/8SUF8L-O24]M=AE*#TH>=7(]FPP&P"DPW)D
MMFEM0/,!"<;B$%S+1UF5#P#)BVOF/CTVM;IRQ#!/+'.7YN^*#TS;?=@U`\L<
MY?F[XH/3-M]V#4#RQSE^;OB@],VWW8-080B3)S!N55R06X'PTKZYAB-GFC(F
MR.T"JJX8%_\`ZC/).(PJ.<QQ`_\`[WOAT8_Y>B@S?RQSE^;OB@],VWW8-0<,
M^Z>;I*+7.*C)XE$TI88J6N:/SAMN3+6,'C0)(D!<<Q!085ACATP&"%CT]807
M/'#&U\LK6N',\L<Y?F[XH/3-M]V#4'"..KFY3LB6"@RN),CDI'0TU.Q.3CMN
M5R/J(P0PP*>2L/!6%S1T4$N)GB$'UA,L0\KVMT8WZ`YOECG+\W?%!Z9MONP:
M@>6.<OS=\4'IFV^[!J#@ISKYN5@F$H)#+XDE0@-D-@">3IQVW/$Q<RPXI4QB
M$9+04*")D7,@YAYVME>^`F&6-^B]KVH.=Y8YR_-WQ0>F;;[L&H'ECG+\W?%!
MZ9MONP:@>6.<OS=\4'IFV^[!J!Y9YRK]/1'?%!\%^B__`.9]OO@OT6OT7_\`
MP-\%^B]`\L<Y?F[XH/3-M]V#4#RQSE^;OB@],VWW8-0/+'.7YN^*#TS;?=@U
M!^66><J]K7M'?$_>U[=-KVF?;Z]KVO\`R7M?Z!OAM>@_?+'.7YN^*#TS;?=@
MU`\L<Y?F[XH/3-M]V#4'+U/VLW(<6Z$P::;A1YK,W7*P=;(MV.;CJUK>DI.Q
M#4T>29)DB.<$%;M*#09R@54T\W'!@>_@"^85PQP^C.][Y8X!:I0*!0*!0*"B
M76O;;EWW"B\2=X3B'C@0(O6)+F]C-).E.6]FR#^\2AJ:']#9D\XR;2B)QMXN
M:5E%A#&@\2QP7&P`V'3U<NMAB&^_+'.7YN^*#TS;?=@U`\L<Y?F[XH/3-M]V
M#4#RQSE^;OB@],VWW8-0/+'.7YN^*#TS;?=@U!A[IEKF,8PR*6>Q/AP9YAQG
M?)C>`=.QFTC?&7E+^9;R>BA*T)E,U0[TB8_T0%A!/YUO@^&U!EHBYSCA89""
MQ]Q.AX8VRRRS$FG;S##''#'+//+++*![6M;'#&][W_R6M>]!Z"+FYO5,D544
MUC\2R@GGBX)LB?(S=MP;)'"IC#$4`R5-%X)$`,%QPLK989X97QRQO:]KWM0<
MKRQSE^;OB@],VWW8-0/+'.7YN^*#TS;?=@U`\L<Y?F[XH/3-M]V#4#RQSE^;
MOB@],VWW8-0/+'.7YN^*#TS;?=@U`\L<Y7F[XH/3-M]V#4&W>.7:>7-K8EEM
M<G1EQRQY2A3:;8'6)W)T3+CF<3`4U:"'C=G'7$W%-WIB,X14Y:.`B"A6,E0!
M+!=6^6&&5[XV"P*@4"@4%3\B_G;:H_IK[I?>+TQH+8*"E5PQ=%.RW,),<=;8
MLQG2LW(4TG@!]:EQ#*J,E/&/>K)<F3B@[(3$@L%SEE!M++]3U1I-)OFU6Y48
MXCIHA<$/,#!1S\.$.)0B2$&UL+H3`G'5-&$9@,;E$V_;CG,%4/"36?J_)2KH
M!+[QER(819CR(EV&WDQ.1%VXQ%'*646\V%Y<,]8MED`*FX!U!KD6WK4G'%VI
M2.LR`])++['<C4;/^?-?8+@QQ3,^8^TB?\5-%EY-^+IA?+-@IMNMW@381,.@
MZ$$?#+ET;.Z>E@V/Y#$`W7$&SG(9LI*FL.N:O+25JZZ'3!V]CJEMYID1PP^I
M`<:KJULW#T+1BY4]L8/R8XOBQU/!MR#<R[VX*>7\415"/)H>)<;`$<N$E(YV
M#D#:GA$?4[2U=!QDE[:7[+EGR>:R8.D("FXF>UI18JHXDI$&.'Q4@NX!VS<_
MXE8<7$KD8N%AGECAC>@K/TCT@D^68^XKGVP>.O5S1HO">&K4\O'<=@R)'1B;
MYBCYM1(4LY&"3:\1Q8VE]2QV,*JP9=QAN=>S)%4\V9$S".'L`+XADFDFPNXV
MP2/KU!$.3-%VI+.%X[W_`+/*>43ZT1@?`!DE,V[E>+$9+;#06@KLEM,A024X
M(PLE0B61HV8"OD6'*#&!C%@V!&N^.[6WL/J\EL:=(RU65H,XK]7-V76GF8F;
MKY;,S2]L)'LOOA<'<`KX5LU1H:\,?.'<T_JHI@LLW/'S5QE/J$@P1PO$TVDM
MU31J%JK,3[,%#;WEG6Z#9+>1H@3"3B)EU/N,6NZ7"8))X%K`$"@RNJC9!@X?
MS`L+VQM\%J"%W.A^4GO+_P#I_'_U>V*"V*@J8YVOR@>0'_M\<7_,$F@M72?]
MU)G_``\E_LP=!V%`H%`H,==[M;+!:CE?+T6TYLL]FH*NZ'4XU<Q@424!NH)`
M=46EI4-B=`91.2TXJ(..+ET8AA8997^"UZ#"EZ=H7;$;MN8E^5&$EQ4\LF&&
MSY#,NA(LT':)*2BC)$:A-A=P-9I[@&?RHX2!='P*9C9*(IP'$"V=Q,>D.(SM
MA(,D-=1&PQ9;CYW.)RI4CKC?1&\Z4A54UE'B!_`17*:FFDRAD4<V1CV2C(:$
MKB86OB05<\2PM\1;VQH-Q4"@B]L!NSJ)JFI-Y%V0V1AR%5IUE1%!OHLAOM!;
MJRII`!BY,RO!))TW@H!MLF;QN$.I"!X$`!+7Q$%QO\%!ME'F**'$Y6LSF_)#
M(7G0^([-2XS$1%<R0JGW9%I)0;Z2:D1N!$#9CRTS`5)V)@-U(O<0I<10+VMG
M?PN'2&R*!05]3-MG(3:PV)48]38>0V5KD]&:P7W)4T.ARIC?2EM0B@I+CFS*
MH#/255PNTV,$_64W$9+(6P43JRMF<L,1KE0"9T-KZY[#.J75UV,R1HT-Q,_V
MY&VO\MF&6?.YGU)$;,\,I2.AMYPBY@%/!NQDR2Q74@GL0PL`A,$P`QC;"X^0
M082NH%`H%`H*B4O\^E]?I$Q1]\J9Z"W:@4"@4"@I^Y*?^KCA9_4#>GW*]H*"
MX&@4"@^.!BZO:BL[_#C)&W`,/Q+%^U$>:[OJ7X;V89#':C*V!*;-MU^N\S!Q
ME%E)`2R#Z6G([)*"24?Q`0V8Q6P3MR`H0X0]PL@E+)O(GR)GY#VL>$6LB0\&
M]I[,;2AK&,D^+]:@]>'VI-B-8B?4MY;`3_+D[,*48U7'D>DHT"WS"`1*)*"F
MAI9T?%<R-&"^`2`Y7]B5^9-09]B5K0C/\/NMA;#Z1%VQ*\[PUFE0HY'*2Y"M
M:T!#5F>J%75F+("6`JB!*>)8.Y&YY-"RRQ%#ZUKV#%Y-W)VJUV>6W.LK[VI3
MW:\6<]=#D^"9?PU<3WC-[C'VTM,N;QAJ.X/BC%*9$@2>5*00I&FF=4RI5*32
MQT8PNY&RZ=F(,&EF1NSL<[9'9<1SJAB/Y5A;EUUGBMMK>QL#0DA3RG,*5]'9
M%G0,90:44KCGC-BR\AK`HQ9%7D/-/5;(2A8$T5+&!C&.0=AJ%R+<@\PD=9=@
MG:V)$RBC:]/?RJO-AWQ5K0PX+B9NJL0R9*$8'M=Y*29V4YZEAVLD^RR"<NI:
M^AJ)I>3QE-2#)HED^Y:@M>XKG;LS+6F\);%;0S>CR\\MDXBB&:T]#;46-J,F
MU%1-]1XAKQIF(GD0P<5'0#<RH6'&.J0N0US.0E@<0B]PP0PIIXXI!V;6HIXY
M]28(G%-U^9<K13RG3!(+R)Q8SI'?`:I#V^R<WVB59>#Y#/M1'S,B2L<\?S/)
MRD"*5MEC@%@8N$8!#:+*Y:=DXV@"(Y_G\1DNY,G33K8]"BM':[1NW,7GR$:L
MS>Z8U;C(3<0SITR7];9M*)`VF(EQQ\4T\W#^);.X8M[8AC\L;Q\G"%(>RT:L
MX5ZN)YZ$1#`Z>\56/(-UN48-F^>%S71J3O)SJV'>,Q3;%;IA>$W"I."Z0EYM
M(,G=$3BAQ4'4#N0?B`(;J=>\>W35VN*+LI.UU0QJ^I3KKS'344&;"<1[):N%
MD"5V]$B&O15L=,<</TSL!`.T9J7I('2$I0.D2[$+9C(0@@1TJ>%&R"-NH+^W
M,:Y'6+7-E;7'DW/:KD7YCFX_I0=,.1LZ'HU6[`,NSXO@789`V4Q;/EQQO)JB
M&NNJ%U%/2@5$4F`5S*$R9?$-G0=O9O*W6SIK/\R3,V9E:4X2YOAKT^8/:L(M
MAB@'0-.HYVX7FE*+8="<>5W<5E*0UW54(17(>%&;E@W$*7(IY;(H$,*&'0'R
M(<BZVQ8JFU]);V/,G8W4R;IN.BR+$VLD8Q+%;I2=:7-L/%2IJVLL^>7?,DV,
M<D<2`$-0)N5(4U-03S8*V*(D!@FB5PZ69MB=Z!=66^GRCM$F.\KOAPN[A[3G
MPVK"[)CTQ`,E1%"T$OO-.BI:3!3:PKM-WMZ;%%)-^7A3RF4,E05`B:*9?_+8
M!]`&CB6XD;3;5M/=;O//Q>#@2+!SSJ4DE'0SREB=9J0>)!&$Q!+%$L#),(&0
MBEL@P[9#8@6$$OD)GGE<)3T"@J(8_P">SL9^EIJK]Z+:>@MWH%`H%`H%!41P
M8_ER,/\`[@]Z_OT['4%N]`H%`H*']0=<M:]OYDY-7MN/#\4[`3RU]U97@4^C
M3FSVY(1Z(M9FHVFB)KLS6.WWD24P(_8;ZC14#=WC28`4LMJRT<-"C#C`VN"%
M:>NQN4'1+>@R4UY\?2AKE':]SD1MK]8_=,?):5-6X)D=N-6*#1YZ.8-377*D
M9L0T$V$=;\8&,8(J(7,%!K9G#`@H9KJKM7M?H1I)QL/%P2<@3Y$DF\6$Z2NF
M0'>+6XQ0(Y.:G:>MB=8K1V.^FY8P]5P1<04L1#<.:V(IV.FA_'B09''"Q2X;
M!2N0?DCCV$Y,E-]%GTMD7#QQ[4[/H+LF2'=7XI:L?3A#L/)LJ,`UK\BQ=/+_
M`'U,L"KF:P(14`%].4%--QLE&S*K;`\,!07\Z@)$Z)T%M-4V)FHC.DDO0J0?
MAURI$<-Z+D)NDW6@HJG@PVZWF\.;N:;S8/B&,"1U0',*A@N)C8T*()AU[A)V
M@4"@4%1'#Y_4C?S]6WD4_MS/T%N]`H%`H*GY%_.VU1_37W2^\7IC06P4$9-C
M]-=8]MP&GAL+$3?D(^PS2D;8SFS.+S7?#,$6@`2JX$U'^RU=N/=O$EXN6"P/
MEBB@"7/8@AV'P$L'AU0Y#%T\U?C%'A%OQY!T?,Q&UO77.Z(03FXBAI9>/7.]
MFRY&>\G*DV*YX9&7"[&Z\54!2/&[F#1[)0'%&SS&$R$H-;NG2;1J9$]V,57B
M>.W`.B3BZ)K=&+6<"JAOIE3Y)J2`JN]Z8.QE.))?D?O1\MU;"$/6*G2&2@FG
M,;9X9EQ;6R#:$7:IZSPXH1X<B2'F"PU"%X]=L0Q[FU$T-.$9C!D-QME^OALE
M02PO4Z'HZVPFK"F.8Q$.'SX5C0PN8HHF>8<Y@PWKLB0XX-9XY:K%"AA"(.R,
M73%;=.`G4)$*O8J:7'>S%PB7/&3:697"#US-F"H^88]P%'$2UK8"87N$78QV
MS:[;;&CS&B[7MS)$+[!.)8B&'W(FJR&284:Q9'\<2:O1`?5`CYC!QFS\@LB(
M@1DM&(DS5B">;MF=.AY@8AF`S+3J(-7Q6,U9/B:!&M$3D;;,D/5]304[(0X=
M8J0PYJ>OTF1(`I6&Q"4&Z0F@DL'`A_!!9&_"V,6Q#Q$L'B$+=P>(H&;@&6PX
M:(:E-"%VEKR4UM8[8EC7M>>[JU\:Q:R\4%6XC<S0DABYOY&'354B(&S'UBL-
MLHL(1-1`ZF8AP$P%NT-1>@0A$$50NU1U`TUXAC9C1>VS*L,&85#*`P&PEM1'
M'4AP@P0AU`9.20\AL\<,,<A+WO:UK7Z*"N;G0_*3WE__`$_C_P"KVQ06Q4%3
M'.U^4#R`_P#;XXO^8)-!:ND_[J3/^'DO]F#H.PH%`H%!ZAP`3((Q8R"$8+F`
MA`!P!P\!01P1<+AB@C!"6RP%"%PROCECE:]LK7Z+T'SLZ?:BIR3R+3/JVLO@
MPYM1.,E2C79;3+7T\G==,C60]U4V4#Q(NN*(QXQ@Y&MJ_BR',5B\F*6Q^+Y-
MX"8VS$%2DT4`(:J&_.X["@]RRBQ9`57J_&IHES3R:B$5%!;BN0P><'<I3/AV
M.7\H)11!Q\IVA"(U0\(&5OCD5,E".7C@1C+K97#IY'V@W+A>(-K2++VI/IY/
MU2XBEUIK"_N'%.ZTS-1_N7::%XX;\V,I;9\/-%J-:+929#O6P320?$&1C1Y/
M`R1"(!:ZA075ZH"R/$?(5M?JDJ3S,DWQ:B:O:J;#M>T[.=+>[P:+^E&1MFV`
M_P`%"<I)!03A9GN,A$J0;P2<\,R*<=Q'\1P+@#7`Q#4FK4BP3$&\7+44VD?$
M8Q[/#HFJ/GHBK$P.-M-,=T:-8:W10D14(S5)XG"!=5B5HOM*>Q16")9YD2#C
MR/YG+!C&K7$"&T1QKKOLYN/I(B:;.V>M3-6C7&UNZXHS)PZH&X?>CC9(6[L#
MD2!QM*;A+N9RMN'G>Z%&[K;MB&10-02,DS'#`)+%N1$",#'W:W4V+1M1VJ\)
MG=R4CX\;3;V#57VTMJ8@TF7)0E8*:)>C"0Y9<;R>,7O1`?Y2)6M&B`<4V\4+
ME$$F<<N1M6)F2IHB$`&^4N5]M=DVGL2\GONG)K%<,%<.6I^VC=RU8=2$VXL<
MFQ#U;6VRT?F8N.J,$HK.9CNX*)4@YBWS1<L@'`!\\1B8F.`%PPMKAK5N-ML(
M:A_8":Q7(MK$XL[5_:]71V:]G[%1=N[*$M?TIEJ$K-=<BQW-!;+&%5EG$\D&
M1%%&*$A4H(V!;$QEU\0FG&$&H49/.1WR665Q?6W^GQNUPS2^HJ:P>0V!$[9'
M0V4TLEI;4E==<0Q556UM7-J:B9'4#R@MF,QA,K6PZ`W=0*!0*!05$I?Y]+Z_
M2)BC[Y4ST%NU`H%`H%!3]R4_]7'"S^H&]/N5[04%P-`H%!73''$EQO1*]&S(
M##U%BI*=#*7L74S#)\NN.9+:#H"-BJ!5RM=M.E:6FRWW`GJ`V1@J=*$P3)0>
M_A`<\,_AH-I29Q_::S'+>$Y2;K\QW=)F9MFJ"NM*&*N$EO%2CHR&;CY4D5G$
M50HRI,5&*8!"R1S+A3E,=,\"%8MF'8(.V(;2DU,U[FR(#X\HG(X?4'%E5O/I
M26EAQ)(\?%E.(7TE/9!<9QQ@*0207LQ7^RBIVXN9C$,L=3^@7_4RQH,*E72S
M5.>1GZK2A#+0>:G*UHF-O!RB"*A!Q*AN#CCE4X;7$ETH2FG+K:7H\-/15$25
M-),DCQ:R@/;$;JB7M<,'B_1O1%FJ1O**X6BPJN,B8F;)JZ90SQE974J>H_8Z
MJWVH^'D<%6E!4,RFGL*0C&`IY5S%5#I-3P%,YC=<+.P8TP-,^.1E3*:D"/8R
MA%/EUP+4PHZ:53'-BH61W4X2^=Y[`CF.QW(<;$?N]7*+(GQM$;J6G*(H1X2Q
M_*^)C/KA-&.([9,11^R8KC5MIK.CR-VH@,9C-)'#$"26RTFLEE45O(*:&*(*
M(&024HD$`%;+++*V&%NF]_Y:#5,;:EZWP^H1XJQE$#19BC$[;E-GQP;1BQH(
M5H-F;7RER7*Z,D7%-"V#)OE^(I54/6RMG?,T!C?&^-NFUPZ[U,]6+L2(HQ$@
MQ@#L&!):(SO#;6-)-S:7',PICB<CM3Y#;(9D840BY2;D=ZF<#'ZV75&.B7Z.
MB]K6#7LK:2:+;;/LU*$FQ!&,P/)!N#&[N5P58X8)KH3%6A5,O&\OHC872C>D
M9.9ZZ:%$P07454RZ>,.):Q<.XN=L@[99T*TT=TVVV+58+9*G+8+J;3O/.$$R
MM!(RI($?E"24SGPYV(0608^<LAL@HE%`4Q:4DLTKIEB1:P`X=RP/@PZYL:V:
M.Q>LN[9)EQ[&:.K,>2YSG%SOYMJ!E3+-.6'0W51J[!NT,H25CR0@.M<22ITN
MX@"Q<',4WX?,<+QK(3.X0Y0GO&#.7-$&HF:2L=H(,@.-^3%JI<])X11;9LZS
M-$<X2Z_%8FVP&N?*))0TBO=02G2I'E(`[@L.X;!+2E,L`(9L&[-6=,./9U,5
M!V+A[69D-@O.D4.,IBF&L%8V6930FHKXU*\=M!KG5@\U8G+.!1&&)N$FUBJ2
M6.C@98BV$QQQH)7F-4]<SA.-TX[#S*/)T0PZ\-?HW3SR;<Z0:D*R`A-!L/6-
M2!(T**6&:KF;S!1R9LN/B+84`@%C>_1UNL&;0W#D:Z_1BSX:AYKEV5&;`3,T
M9G-0H>5E(F@I.1PT?LG$S:X?4U.Y,$P<$\$&(/GB"'>P8?5#QPQQ#9E`H*B&
M/^>SL9^EIJK]Z+:>@MWH%`H%`H%!41P8_ER,/_N#WK^_3L=06[T'2K#D;K>S
M1@G`O(J&*XUHLVV\&L*A%,S77$=+FSA-!1L#HX&2HM&RB>.*$5`ZXX@8`F6.
M-\<,KV#NJ#I51RMQ#.(Z>M+Z(CJ#B,G2;?(JBJ13SBX;34LZN*)5'+&QP1E,
MRGHB:8.#X`8YY!%0!!<K6#PRRL$,YCT-T/W/64.:90AB.9<5UQI)B:3DIOK:
MNFWD&/1<<E!&0G(XX[<2*6E*/LPSN8I5/5A%-*Z@^=PPNJ)EU@SY8UFU$EC.
M*2`L9Q8O7U#<0R-$R<T+DTC""%O%J):8=9J0099U,#:I,=F'"`9I`&PP)C$,
MBMQ2N0=@+V#G,W7?57)/AM.8T?1JHI>I2.ZX=ATDBBEEHC#B4;:9.-WG'B>`
M$>.@)^=VB1!2CY$Y808,#"P8F-K_`,H:K8_&/H7'"=(R0SM9F`EI,JQ@ZX2=
MZ88S<*RGXPR^<1L7A$;1)+BVI%HXC%Q^&Z3:"W,4I*%R#"O<#I!"O@$QTP\S
MT(XDQREJ2"GJJ<V`CR.S`E(G@L@,]&%)H6"D41<C%U+)!3S(P!2YFP=P<!<\
M`[Y]?*UKA@4N3`1BP[%")Y*R7'#,$HID;-I/\?!2RQ;$)MN>0'HY5,^,$8L7
M3&=&S%65/+&V%[F1RP16V05Q["X!$Z/.0]JR*NN85/CAP)L:(FT<:ZVH\BJ"
MN3ZKM3YEBUH/.*)D2&\"2S,@,%_O9[)J"F8#CXFC)10**W1B6'L#B%BM`H*B
M.'S^I&_GZMO(I_;F?H+=Z!0*!05/R+^=MJC^FONE]XO3&@M@H%`H*FM!QBX.
MZ_,_X04$+++=2#?@S$#PRO:W'WJ3?IZ,LK7Z.F]__#IZ:"M.,GML!&$R[31D
MP]FGHTLMO.=QPZX+<JN%IPZMCPFV4K25K3F>,1P64F"&A6DV5@&8E,)&R7P%
ME*)`A%C!=.$4LAA3@3^XFTU69KRY2F^]Y9(R\YBG)PZ$0[)8Z8TVRJ.T^!J1
MJ0"GDG`DLXHD-/!]HR66"3E:R:3)`CJ!$87$H6ZURX03AC+5!K,>.('CI94C
M;B(ZNR&MO*#S@`QE($2$L-OR6P6$A.,$$84-<^*482881Q,[]4,X*6"-^##$
M_F8ALN`8DM"D:DV886,7&OGW/($A/5QX$K)P*_($KOUR2:_%4FG>&,Y)Z68=
MCL-V)%\A1<RY+$(+(3/+"^=PW/0*"IWG0_*3WE__`$_C_P"KVQ06Q4%3'.U^
M4#R`_P#;XXO^8)-!:ND_[J3/^'DO]F#H.PH%`H%`H.C)-AM)RZMNE/;R&0<S
MF+(Y-R.,DDD"JZX";>P/!H!5;5P"^"@K%D/!3,XD\!Q!,2UC`M@[8^$RZ0B>
MW=-6RA;<"[2_&B^*>AP@\H-C*%4%E-!J,%B(\KOYHRC,KF-F$8@&KN]T2*^6
M01."BF\PP2M\S70&(*9$%H-O-/6;6]A-YTM%BZ^PBRVH^5$FKO5L-.*&&W&\
M\%9.,X'$]4=**CH)--<"B0-AXB@CFPAA0A,;98Y6RMTT&U`6TW"[A/NXN@(H
M#K54E,0%1S@I1$)PJ2$BFE,\CHI]:P`Q4CB2DG5HX,6+""Y`@"FQL\,<<A<[
MY!KF4]>H"G,5!'FR#H?F$=JCB&FN-*<:,N016V:%S"$%,H(CM15?-''$S`PR
MRS+W#RO?#&][_!:@V`$TVJ"MI[E!;+?"<:2@&&FEN`)&3@UM-:QPVGGS;:3U
M7$M8^30#1Y(*#"$PQ,2V8I4+/+"^0>%\0UD[-:-<'ZV6HRWUK_"3T9S#-B'V
M.TW9%+$<;99AX;*^8QUJ(*P@G$MNFQ<[WOD(3"!SRO?IO>@V"(PF*,87S8S+
M:8IIUMPBSW29$;B.(8<K23`U0%-:R^-D3N(L-Q/"7#N(!$Q<0L%B<'MAA:PH
MG6#ODQ,341-3T9&3R*0CI!$HF)24F%"Y!-3$T@7#*D4]/(E0PBI(B2*A8AA!
M!XXAAAXVQQM:UK6H.=0*!0*!0*"HE+_/I?7Z1,4??*F>@MVH%`H%`H*?N2G_
M`*N.%G]0-Z?<KV@H+@:!0*!0*#XG">6_@?\`AVMC2K:1=,KZHV@S>VPAM<7I
MN`GRS*RF>=\W(*$CI;7%CGXW8GKF_$,+G+$<^@&XV>/2):P6=31LYM,"R^3>
M=&%M4F00A\7B`UR4<P`<CV+UYER]@U=3HKV14E[8%8=J"J26*B3NHOP=J-NS
M55VUDFA)]C(61T[<3"P:HBV89C-[5S!!\8/Q8UESW6Y5GUC)$J$&VR'$_F0F
MQWQ0ZHS4'%+**R,WG.Q2DDOE7*V)W.**2HY%TE&4KERUS'@Q0`B;'\X3!K2/
M*`K:?C#D%^HFRO\`B'WT=F4_%$8'G"K2'!T'M1W--V(!F[?/%V"HC.,IA9QD
M$+(FFJI@`0L8`S*X!E\`E[)6[>\.HL?I$E..?O615)CXBIKW4LW7S%$;-1GQ
M#.L6+6K2857V:#&#=:CD'A=-1MA3R@MHZV?6#]BC?Q&#4@\Q![Y!E<U3OO=K
MW-<O:]QWOPPY[63?'DV=@HY<$\(&LD4F6_,+OVIBR'P311YMYHM*-"A23FTX
MU`E&I!PES"5BYC0`"@.HE;8W#"??&CL!($FGMD8DF%Z[#J$K0B[8],K,8;71
M'"S"G2*&Q)3,S4&Z56I"UL5C4"3DT'8LME8.H:XADDTT6+89DSP0@H.`V8=!
MQ.7+!M[D,`P'!)C#\L>_%[9!W+XC8C#242M8>P8F.6&8U\[VO;K8Y6ROT=-K
MVH*Q-'W1L6BMW6O5%H;8R&RR&TF]?,$X7K-IIGP>L24D%=9MCI*S`BF,@UV+
MSS!)N:95U:-.M6,*J.L&"A!'5"Z4"2*>!L2"PSB.:B<OZ<[#QC)+R0)3%>6\
MO)4RWB[4LJD-TA*V2GM!+J6\'"F(B(+DF)WQC+CF#`Y<A?,N5R$SL%?P>.-!
M*9O:+HR8FQ>KK\@O-W/Z(6TR,&V15G0Z+0LN2?$3,4F'%4Q.:*?+`Q<%V)*&
M9!%/@)IPFG'#P6!G,#,R7*C@A)Z"(C1(%AN-8;;QLRI)<=-%';."N=#P"/+I
MPB6Q\JN$^$'EF$$H.!6S'.CXX7OAB,/E;'^;:U!MF@4"@4%1#'_/9V,_2TU5
M^]%M/06[T"@4"@4"@J(X,?RY&'_W![U_?IV.H+=Z"I?E0##$=_%'?/##.X?+
M1``@?7QMEU!+09LY:V>'3:_5SM;*]NFWP_#00@A/:C=BS3T;VE>^S"O(R)LI
MR#3QJ,\==+Q1#Z!'I>+&TZ]O6RQ%-MKJ"STZ2PY82#<")0V:B*MY)9_`T*6$
M3\?@'N&G68^9XF]X\'VX$Q;/)DFG=E')M),5H"LPXM1V?#[B6N/[9E:*M>*#
MK?;Y"0%!"B---9M5T!.A1<(Z@IY!CBYDA+YEA`\XQY!MIXEU1UO:9)29EY!W
MLXV]+#_'N018PCUCLIF;@.TPR8.FEJI#-:#>2&T:9;*RE]GR4$CYEK$D]"3U
MH`(/`@5Q###<S>V&V&6MEW;J2SI638.!E[E,GJ&W1L2R(FA@A(QAIP3QY:]S
M8"W"(:NQ#\?N":Y@=*@9S%<"\D+)X!NI1HJ5"MB5)7*!@''),,P15LRQM?KR
MTD/MLS;R1\SI>:72`U&>F"2VYX>`CU?:"YABE$<2C672BB=/#J1-$R+%1309
MC'P=@`L0PPR)J;U['S\U(39#5GB<EF3GS)?).O'6CIO"NLR]+3LA?7K=EX:^
MPX]#4J;%G4[7"*X?8J46():D9,$CCA=*B.5$`'#""/YCA$2+MO-J)GSB#:M!
M?\/H^VS@X?M@VRB21(*E&C"82R[D+DYB:&4T_954#)J&TE\O],1@\$3',05H
MCNY0*8]3--$MA<+3M0E)[;5KC[C*:'_/=YLT]G&+9-&BK<6#X,0)88\=S-$;
M_C5SLMW/?6U9%@*>XYEYF*SSQ0%I&))QI,&QP!4@#/BN'A0F:D\<^NS`7_&X
M38S5AQLNF>8=GF5VRRD$FCI[N5]>FP3(0ZW$0BFX$DUJH#>=Z`DK0X0(.>`P
MQ4QCCCCD=%$Q"?M`H*B.'S^I&_GZMO(I_;F?H+=Z!0*!05$;A,+<1G;[:[[>
MZRZS-_9Y`9.JVPL`/%I*4]M""5)%6)3E&!'VA+Q52=K?<8*R2!)12;`%!"!Q
MRMF8PROG:V/5S#L?6UY6/9"MOWBD+]E=!J&?N2CD2UDA.4=A)>XETQ'B^&V4
MNR"_%1)W^B!=5"#8;9,0^K&4]%)Q9B:5#8)4+++``._A!;VZN/3E>UKAM4EN
M#RHJ!(FH%>(=N9E3Q4N<+9WY$X7M?(`T#@.#E>UHLRM:]P\[=/1>]O\`QO00
MBE:`)5G.1W++\O\`^'$U@D247D.F&G8_73NGKZI.AQF45&3F\D&%E6%B3QI0
M'34)(*E`<Q;Y9!ERX>%KVQQM:P9^ZVKLX^3$QFW;_A^(!7C>P=F)G-1H_O)`
MF9F23L7!8`QNLN<QA$V`QUQL7`(/R2IVOBH$,@0L@1L,@@[XA[62VMGHW;S<
M:C#_`,/QKZTVZT9:1Y[;B2B;OZ_$BJ5-R"V`F8E2X!8*(K9YR,6:X5B5UD2^
M9\4+I\(+EEEE>X2B];7E8]D*V_>*0OV5T#UM>5CV0K;]XI"_970/6UY6/9"M
MOWBD+]E=`];7E8]D*V_>*0OV5T$3-ZE+E@W5U)G#5<MQ?,V,QIK:@#0Q?REO
MO$;G(M7#-=2%(96,M]/CA..JP8`*?E_0!#A9YWO:ULK4'T,T$`^4W7Z2]JN/
M+;;7:'$]+5I0EN(5IHLE-6E@J@)1U=-FB`Y8N>6CMKE$T`3$OE:XHG\W&_1T
MT&CBNUW*P5+%BUN(9MY6+@`@6R[Q2%_YU@@\0^G_`-J[?R]6@]_K:\K'LA6W
M[Q2%^RN@>MKRL>R%;?O%(7[*Z!ZVO*Q[(5M^\4A?LKH'K:\K'LA6W[Q2%^RN
M@>MKRL>R%;?O%(7[*Z!ZVO*Q[(5M^\4A?LKH-+*7)MR$I.PK1U;/<32:',;X
MB%\3DW4;#?V(,T<Q'<=.YD,=U'S"]:+;%"JF5<,B)6`)2^-Q!PA1!,?YH(G0
M&Z?6UY6/9"MOWBD+]E=`];7E8]D*V_>*0OV5T#UM>5CV0K;]XI"_970/6UY6
M/9"MOWBD+]E=`];7E8]D*V_>*0OV5T#UM>5CV0K;]XI"_970/6UY6/9"MOWB
MD+]E=`];7E8]D*V_>*0OV5T#UM>5CV0K;]XI"_970/6UY6/9"MOWBD+]E=`]
M;7E8]D*V_>*0OV5T#UM>5CV0K;]XI"_970/6UY6/9"MOWBD+]E=!BFK,?;IR
M+R12'N7LMJXW-7F8/I"R=9&TW4_81FSLK+[G;D\/.5#:T*8:3=;F".G9I3OL
M!C@*%G?PI>]^O?KVMB%R-`H%`H%!5+R9PYLR^'KH)-.L4.(<\./5':A;F-V1
MLLRJWH>S7&NL:_3%%.-DUWN5,64X`X569!+#7#N6%RS#"RM:UNGKXAP_6UY6
M/9"MOWBD+]E=`];7E8]D*V_>*0OV5T#UM>5CV0K;]XI"_970/6UY6/9"MOWB
MD+]E=!I2$.3CD*V((24IQ=Q,)ZF4B6:Y1U]>V2KOY#Z-F3DV'7!FV'RGD<!X
MO$\HI)-7#OB6.87L&:#MU\;6M>U`!<N[I:$U?6XOP30T#`2^CNIO+4/A[W0)
MA'RHAOA355EX)1UL8Q)9,,$'*JKIPP<#R#OB.,9$RRM>^5Z#!)$:NS<MR,V)
M<DS_``^VOSWDEGEF^20W<XMX8!4%0,FT3OE)H%%.XL27+N`JSU.]S20&H!FL
M$LS>XI6P0E[Y4';2`3VVE1MR`T9#X#(.=;>E.0TR7)`(JF]D#YYN6545#0FP
MCR4</`Q."H@OQ*;C83R!97`%"/@E"@86`ML+=6X="ALG8YLMQ/:#=_P\^MR&
MUDHM*A--;Z5NEKJ12"1:<FV49\R!%B!:'@RX6,GM@@"17.C'I4BX=L1^O\-!
MWTE*_(H]&@,E,_ATCJ*Y`0X-?,`Q)+*'NMK"ZG!#;%?*>W"I]%:[=>D)K#45
M&I<XRT0<V@GBPJ6I8)0`)@.^&-N@($:P:;[]1(])9?,P\+FG#U+RI!Q77)0A
MN#IQ@&$=?S4:9N\5\NA3>3$7V_*2B]WN]%X!-QSS'/`I2*02"Q1-*!8^$$R"
MQ:"%[=W6-O*S6@+@NBJ+$5P*]EYQ`M;D!A4N=<:UB4`3P51QK!B+C*ROGBJ<
M5"+`"'#`V0!8+`$.^(>&.-@T.L:^2BX)449Q6?\`#@ZO*$O*[ZO)RK(H^Z6O
MOQK49#R5@EW)Z'%7"),3!AR9K(.!G(WE>XN0V-LKWO>U!E[GCS8EY($@M=R?
MX>W7U20I4E7*='\0OO-!!3%P30("*6,2MF.1BDL:3Y!.ES`P9A6*"`'C.!D?
M$43.PXULPR]C`[;1CC&6$<\`T!,8*&'$_7=$H#4W=UZ02T<.:4DU11Y'76:6
M38?+@("D]DI7-%U(4OB'D:","8Y]-LKT$B_6UY6/9"MOWBD+]E=`];7E8]D*
MV_>*0OV5T#UM>5CV0K;]XI"_970/6UY6/9"MOWBD+]E=`];7E8]D*V_>*0OV
M5T#UM>5CV0K;]XI"_9708YJ-'6Y3WY#YRW(V8UD;VL#7=.GT+:YM-JIT_,^=
ME1:7X[F"7Y%55TP?:3?;@2.0&3I(``P"%!SR\(6RRZ][9]7`+B:!0*!0*!0?
M/=I?WIVC\$A:X)_&FT)E36K+>QSN29*);T1.Q2[H19@V)E*8T0Q9I*L?+*BB
M#$4E^@E10A3(N5Q0,L_YMLK88A*OUM>5CV0K;]XI"_9708,]IGY%I(,,<T_N
M%*.'@9C1\I<FQ^.X=_X-4Q6;(:(FK*,D/-NYFHG$NEN--2G$>+@F@NJ*&";%
MQM?HSOTAAR>YMW4ENL!I)G!-#1!L15)"E,$;()7>V!`4ICRFL*+O5U20&R3P
MB2P*0[%!4D!;,"G0;8CYBJIK*^72-GTAK%L1[L.RI4.3>T_\//KFWY:.+CG<
MMW\F;MZ_%G"177ND+Z$]U1%-81'U6^:>R8Z5'!9N1Q+V5LSHHANPPN=\Z#9:
M<X=V$DA!B4F\$$)DT[6,/`+7@F#O/K_B!"P8;0-L$,.-L/HAO9I88,L\*F6L
M3\%:Q//P?\EK=`8V_26VLHM5^LF0.`R#G2V)/DDI,C\3%+>R"+_&*7"".AMX
MC)YDZ!$X*@7D`D@MH@2!6`!0CX14K@%B+;"U\;A%S8-TN6#(<B6,Y=_P]T`(
MT/.W:"-V;%K.;6X<#8I25L7/B\6CEM.$@"@Q0F#M<VZ3JG8DL*H0H=A"0PMC
M?A0<Q;7#=CDB>='8VH_9J[_AV-:3+3BE5>"Q'#=*[JZ]I2.S3,A+@KE?Q1"(
M),1$2Y-#?"^+<XKIEL?)RD/;',P`)?''H#)BS8V8)MTPSRO^'KUK`:)N/7O$
MH[5#W+UNQ;647R2^;R:^X]P0?H9\E`LYT2#>RR:3L`<2N:ACB-;"V>.-[!ET
M#K>[6L*`L-F`>"R*8K2'&K8+KD#:W(!"I<\Y%@(H"GEE)Q+!B+C*RO&R2:7#
M+%\S9@:Y<L'B"%U`\;8V#>GK:\K'LA6W[Q2%^RN@>MKRL>R%;?O%(7[*Z!ZV
MO*Q[(5M^\4A?LKH,QXKX0GJ%8=GXWL='B-%,B3KNQM-LP''B(_DB32[2;,Y2
M!F\D!#-/-"))J8L**:7,Y`C"!``VRRPZW4QZW5L%FM`H%`H%`H*M>;K\HGD7
M_P"TN8/_`$N;H+)&5_4UI?\`VR@_\J*T&34"@4"@4"@4"@4"@4"@4"@4"@4%
M1,@_GIZO?I@[?_>7U(H+=J!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05%<
M/_\`4O?W]6OD._MK,T%NM`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H%`H*B>8K_VQTA_5<XX_O&MJ@MVH%`H%`H%`H%`H%`H%`H*M>;K\HGD7_[2
MY@_]+FZ"R1E?U-:7_P!LH/\`RHK09+:]KWO:U[7OC?HRM:]KWQOT6RZ+_P":
M_5RM?_1>@6RM>^5K7M>^-^KE:U[7OC?HMET9?YK]7*U_]%Z!?*UKXVO>UKY7
MZN-KWM:^5^B^71C_`)[]7&]_]%J!?+&U\;7O:U\KWMC:][6OE>UKY7MC;_+>
MV-KW_P!%!X>%"\+X#P@?AO!^%\#U\?"^"ZW4\)X/IZ_@^O\`!T]'1T_!0?N`
M@8MLKAB8"6PSS#SOAECG;$0._5S#RZM[]7/#*W1>U_AM>@\Z!0*!0*!0*!0*
M!0*"HF0?ST]7OTP=O_O+ZD4%NN65L;7RRO;''&U\LLLKVM;&UK=-[WO?X+6M
M:@7O:UKWO>UK6M>][WOT6M:WPWO>]_@M:UJ#]H/RV5KWRM:]KWQOU<K6O:]\
M;]%LNC+_`#7ZN5K_`.B]`M>U^FUKVO>U^B_1?^2_1:_1?_-?HO:__P#-!Z;&
M2UP;&+&`+E[WMC8>PH=P;Y7$\%:UA;9=2][B_P`W^7_6^#^6@]]`H%`H%`H%
M`H%`H%`H%`H%`H%`H*BN'_\`J7O[^K7R'?VUF:"W6][6_EOT?#:WP_Y[WZ+6
M_P!-[WH%`H/R][8VOEE>V..-KWRRO>UK6M:W3>][W^"UK6H/$00,+&V0HF`>
M-\PP[9"98X8W$&$Q!!#M?*]K7S%%SQQQM_+EE>UK?#>@>$#L)8+KX>%OAD)8
M/K8^$N'CECCEG;#IZU\,<L[6O?HZ+7O:@\Z!0*!0*!0*!0*!0*!0*!0*!0*!
M0?G6QZUL>FW6O:^5L>FW6OCC?&V5[6_EO;&^5NG_`#=-J#]H%!^7O;&W3E>U
MK?!\-[VM;X;]%OAO_GO>@\!!0@O!V%$##N*)8(+PF>.'A!<K7OB&'UKVZXF5
ML;WM:WPWZ*#]\('<2X5L\+BXX8B9!];'PF(>>66..=\.GK6PRRPO:U^CHO>U
M_P#-05&<Q7_MCI#^JYQQ_>-;5!;M0*!0*!0*!0*!0*!0*!05:\W7Y1/(O_VE
MS!_Z7-T%@Y,0B%$Y054<&;33`X\`$472&?(I8C:(X-O'(VX,%-4"'34[-&+V
MR,V',89@`W#ZXF-\+7M0?+5/9`7C/DUXN37)KJ48,M7XK=Z5*")Z;\M"3DZM
M_9_BJ'F?/B?+NR5C09(D3DN-4%M+B^@+XH*R(Z;K"F%<^GE;%T\<)-<;K%*Z
MY;0:PH3SUZ1X6<FUFE+\=\?/R+-E'S,)J;,(\/0:Z7R<W=0'2SFZD.W9(AA(
MA162WTF&E0"_EA;2[FQ`<BF8X:,Y4&A),Z;/;[YQ/"P.R@NN>B\3I&+V<<J*
MT4+W'Y+JV/+$I8RWJ\B$C>.$JS*O1X<370;L`8:IL,PU$=*\NY`*`Q<J&T-R
MXOU\V10DD2#U&1=LN0W=[7^#7;J2]U=:6D/+2&+068VRK>W')J;>!2<]7(Y2
MW*:'>A^UQ+KC\>`V2$4P.A6\5(ALG:F#-AX"VLOM<VRT:O9\NZ;V27@B0E)W
M+1"5GPY'II\-JFTM+55AE6U@E$H#QG<8:;',H@+7B"8DIBF=\G^/E;'+!.+C
M.G>"G=%")!L3_2N.H,6-69,=WQ+[9*-Q;V09\ZN:03P.V2#<FX'"(<0IWDEJ
MN96R"/\`DY6*#"?TZ>5`%*>$"S:@4"@4"@4"@4"@4"@J)D'\]/5[],';_P"\
MOJ10;FY&FGJJ=C5A21N:Y729A")7WY:^@A)Q.KS=V4DASH2FS8UC%>BA"2U%
MTSHX++ZSXVV6F2L)@<7PRY@8N/8KA<(*BH9UK=9^0N/74;;)C*3>UWF5T<EF
MVC<TM?#HS>39C)K-]6A^^K^M$@BXJJDFO3&&F3,"ZO9(%QSR&BK=\"Y+PI=%
M)#8A8CQ[R+@P-"9^%>3X<92,M59VY!HM8\BJQM1>S@0]?=;Y]F-M,4V&?4Q5
M-3=7T:,5L!I).X^9@<<!&"#$R$SME>X4"1`KS[I[%<<S>/%`FM#_`))XBMY'
M2Q)?:\H*4IN_D"V$9T-(^PC(E_:!J*`YP"*IF;K&:2F^"01DV[!_'EY510U@
MN6)AE3@6)!ZK),:R!K_KGIH[5**U??/B2W&0I4?I!T.11LXY5:+?UK`AK;!^
MF@E(XIK<I%'7."Y@<=.-_+*B"L9X9F!,@2G@0Q5H!G]?)?(P6^XCNCQLC[31
MK.UM-M2U4.344I/!O7YM@:\:U,I5=>,.-,7KC:]OK8]Z!&+)!!,&";G7\9,J
MHUS@?1]#<M,:>HGCB:XS5!%J/I693<?[-5!R9E--'&ZZ4HLL)8AQ-.AA'4T]
MB5-8XCEQL,10!L<@\[6RQO:@V30*!0*!0*!0*!0*!0*!0*!0*!05%</_`/4O
M?W]6OD._MK,T&'<B4?/DKN;Q:RV:G*1A6.8WL9<;H6OR9Y#0XK)G%'6;:]Q.
M:075XBG?&A_/,X,W4XLE^/GK)J&5#,^+%?#G!AZ#2&W>BFJFPW)3`T)-B(B"
M*^E8JL;V;DRXCNA^ICL.QJQG:EM"*(O2QR3H"3$<Q/TPW&\J"EP`A+M9HJY4
M&X8AS$8()D<K\)2ELI%6O\$Q<#$RS\<MIXZ79'9$P2VOQ(W)#C"-FT^I"66B
M&;9B<K/MVXF'*W4@R?1T<"YDRDEC5Q!`0,!1<`J'+M9/6&_&$(K&DI@Q!ND^
M^$PQYOIIKJ\]7#,[8FI[.#65FOZ!IS8K9?BLT'E.,3-W"1$147F29P&4D91%
MP-#IYT-)\,('3QEKM/>X>L$J-=OM)OID3ZM[L\B4+QK`&T$HJ**EQ+%;[BI,
M2(8>BF]&Z!*)0-U:8O%[JGDY+L:-"-LGB9()ZD7.I)2]!-W1W<&-RDT@N*75
M"6GQ(DZI^N,#QS+JFUBV3'8L3*+/>:CJN@R`>,*P#A;LG[E#-Q?E(T&73CI<
MD&\4%+539<<$C@('T`4"@4"@4"@4"@4"@4"@4"@4"@4"@^=?;S6^*7KM./%^
MMOT@2MR/OK8F%=BGML\I.0\=$X\(`;;O9JL,A''@D@IB.S&.\XW9*H@-*+<?
M"G'H97CB@I@C)]SRCB$3G=R20UL#RTZ(2$J;%YLYA1KMAL5KA&&OPI9Z(8AQ
M+,:YS1'BC/<L(8R`!XVYI>G#R:B,HF/?,)(:P)=0RL$.MG<2H7.<M+4UK#U'
M?4V["P8E[`*4))!H2$X]4EET(MW3-$G*C?CF,F,6,-=;135LI#DA80TG,3*X
MMP,#%Q,<?YM^D*RW1Q]$M26KQX1))L+R;NSK2Q6IL>Y]H(;BNYE_&'%M[)]H
MJ.-.=CT%+[N('GY!\>YY.AM(2<%8Z79&*TD&A@LL\,CX(:)9,$3]M5H0UG\X
M1&TA,G7@SRDZ[(1S8N8%P5:U%;:!L]@G05M<B/M!3Y"!D23M)8VAA3;)<R$I
M@G#`6-\B:QCAF<%'"SC2/;9D*T[O@]*#2EQ'F_;:4D)L%W0X&L5`CB+PD6`Q
M9\URTV4EC-?\MI$NI.J:A>0G$6LCXHX#K=*R2LH9'+!$[!G/,5_[8Z0_JN<<
M?WC6U06[4"@4"@4"@4"@4"@4"@4%?/*_$TBSOQK;O0U$;6//>3I+UPDQGL5H
M)@I(!0<;E6F^9*):23&431(@&8.&,[8XW%&#PM>_PY6H-!I_(A+5VB1:J[P_
M<F"L2NW"S?64\XRM0SZ6I%;IF"<HDC14WMKX$Z0.!=?#,,4/J"AY7MECT7O:
M@AK#!F(8(<9=RLCA`Y55,9$C]Q1(P4.2EN$I=9L11([[DOC5%D,LF3]Z'8U(
MJ8#B`32Q8XFH90F`.0+`DLK>)@A%\`],6BQ3#@3M"9'"MR[@V=$/KNO:8,O2
M!&3K/1=!#DMA=5B."E-R[]*JG!3'%'``&P+-,9)S!%)$[X9XV($K%P\92SBJ
M83Y51>/"UR^`CC1<UH1>^#2D2-&*!-$0,H`\6;,=S\$S]^T6TYMY,+JAL.WQ
MH\J&1`3IH$0;,$T8#%#$WBSH1>4IOR9K\,O-.QW])A-C)CU/0[L"FP>C+*3&
M34)LB/4;XHQ!R.LEID$9F-8C@43BA8D"7*X9BY886S&%RS"8RYN&Y'*_8CD=
M>X?.5)6<4&ISQ)QM@?3]7C:2B'GR@D6FN.<PE&-QA"JP[\6D7-)993.6'-E2
M"LHA!YXV/&+YAK'7&9$O50VYCT/\-W+&2,N-$:[,+YNDYKL^;,Z,6(>="HP8
MAC_%V;IJV+*BMBJ3W6!TI%(^"+%LU$7_`%L;!6#"5/>83)[(KD_^26I'XNZ!
MWF$R>R*Y/_DEJ1^+N@=YA,GLBN3_`.26I'XNZ!WF$R>R*Y/_`)):D?B[H'>8
M3)[(KD_^26I'XNZ!WF$R>R*Y/_DEJ1^+N@=YA,GLBN3_`.26I'XNZ!WF$R>R
M*Y/_`)):D?B[H'>83)[(KD_^26I'XNZ!WF$R>R*Y/_DEJ1^+N@=YA,GLBN3_
M`.26I'XNZ"LYZ[Z2H;Y@->I)RXS.0<HJHW'OM`T0(M,MK6JTC+:>MS_K(J&G
MTD%0-EQVIDS6V91P2!_,PK%SV)Q3*6!*C!Y"B!!OW:*4V]N,9BH_.O#=R\J2
MI"+B77=%JRP7Q%4,KC0=#C1,FTJKR>MP]OLQE415$;XHQ,(8883,N7-&,`KX
M8F!K9AA9Y99*A&+.BTSQ!<U`Q2.7\JR=&\AFYL:*I.L>/1>0S3875%ESZL\A
M2C,2`06FRH&4XVF@K5DPP2,BA9E\L<[T&S6A-;98*+"[89O"7RAMYI0"V9!:
M,<LXAZOOQ/LB2J1"(R`&^FL/N\,ARNHN?J"&#!YT@+)ZY\R9.6&L:-&!A0UC
M#)^*()<J>YV3PD\KZH,VV.XXOCI!DIR0S+K*AZ,'A@1"=<<PPQI/WK=C3BQF
M.(HEEBAHBBDR@8B>7"(_`2"#+XAE&N4A,S51PGG5#O"WRQDEX5E)L7("@]%^
M$I0$CV(D52R64:'8LQDC>=TAQG%26JWQ'"0D2Q(C?,$"V>&>)4KB"'B[9)1W
M@U5QN&^(#E\159;GQ<V<^DEHKNOC4EE'FU>35!L&7HWI$1-TBCA1Q2<>*0C3
M*%`A;$BS5QP3,`K%@\,;!(R--Z7;#L>,>*(TX:>3-IQ[&[4060R6RGM75`0F
MA-=LIA9'1$L`8YN$9.F<2:>4#PN*.**.+E:^8F>>>665PS?O,)D]D5R?_)+4
MC\7=`[S"9/9%<G_R2U(_%W0.\PF3V17)_P#)+4C\7=`[S"9/9%<G_P`DM2/Q
M=T#O,)D]D5R?_)+4C\7=`[S"9/9%<G_R2U(_%W0.\PF3V17)_P#)+4C\7=`[
MS"9/9%<G_P`DM2/Q=T#O,)D]D5R?_)+4C\7=`[S"9/9%<G_R2U(_%W0.\PF3
MV17)_P#)+4C\7=`[S"9/9%<G_P`DM2/Q=T#O,)D]D5R?_)+4C\7=`[S"9/9%
M<G_R2U(_%W0.\PF3V17)_P#)+4C\7=`[S"9/9%<G_P`DM2/Q=T#O,)D]D5R?
M_)+4C\7=!!?1#979_5]`V?27YQ/<BZH8FG>/:C9=K9M5!U94`23%G&0A7<U$
MM<S4MI$;(LZ$].%L&?`!Q'+A#VO8,<7'HRH)*R3N.M2ZK1,N2#PS\GR^J0=*
M!*98O,W1=7T[XLR.GM!XL0FX;!)6Y9$%5N$U7^K%?%CN)@IEXUX2X5Q`PL\`
M\4C<580IF>^P29PS<GH$NR*P6#%[N=V:+K`9%4F)&"R^7`R6^`EF=RQD1++I
M"S)"R8RS*%@!C(AS^GS$L&%;`-*R3(C1EE*<J<]N&/EN/FW!-I78Y/=))VQ`
MD/B.YM(M0@R"+^AMZIF]Y5S0T<*-<AXG8FV3*6F"`F3>(A;.QXY8<,-''BC*
M,&K%R=PH\MC<"94IN&=&W)C7>$0MZ?B4UO%,54-[RP8V"3-[R\Q*[Z?"`N&T
MU9.G5DQ=23!O$Q\<RH8((8;2(S6B(NLRQJ&V>%SE.:D$N)$<;><3<;^&MY9<
M<2<^%@\NR&(XGR9W1-O9P+,DJ*N?$<*F=/CJ:QFHFLS)C,0?/.X=&OR4U''/
M+8V*/<+?*D7?36'9"D51DK'6Q'C95<T7HSC;D6/-Q1DG;FEF4NO",V^[E$FA
MGS!/(4D`.'T=;(H1R+!+OO,)D]D5R?\`R2U(_%W0.\PF3V17)_\`)+4C\7=`
M[S"9/9%<G_R2U(_%W0.\PF3V17)_\DM2/Q=T#O,)D]D5R?\`R2U(_%W0.\PF
M3V17)_\`)+4C\7=`[S"9/9%<G_R2U(_%W0.\PF3V17)_\DM2/Q=T#O,)D]D5
MR?\`R2U(_%W0.\PF3V17)_\`)+4C\7=`[S"9/9%<G_R2U(_%W0.\PF3V17)_
M\DM2/Q=T#O,)D]D5R?\`R2U(_%W0.\PF3V17)_\`)+4C\7=`[S"9/9%<G_R2
MU(_%W0.\PF3V17)_\DM2/Q=T#O,)D]D5R?\`R2U(_%W0.\PF3V17)_\`)+4C
M\7=!7-DVH@#E=_S4E<._-VUG]*<IF)ID,PR-D\&.VW?))K-/\*X5QBM'DE1F
M0=QL32"A+`IDG^)!IQ4(GB%8L'B%8)D/7<I>D-]P[);NX:N4%5>D!N5T.^*5
MBR/K"1^*[A>;!<L8.0_<@G;EE4U8\HL=WJ)'P1X$R$'8Q<0/'$7'`3$-;K$X
MH[B:QIE.3A@Y6W(V3>QJ1M<(F.-6@U>Q"F]OR:E3"@N`F85]YCAM/;J'(2(5
M/$VX`(&W"N`&)<,CB6_H:#SV&GL+9T=AJLF<//+B0=T7FW$9CN1HO<$&PU)K
M-!>2:71GJD(<A19O$TG86;ST2"@)=53KFLB1VQ<`00*XQ8N($'Z8G1!RUU0-
M3$OA,Y-6UKTW"C222<9MI"U;2$8ZW6@YDQUAMA=,@[CY*C@070II?5<()P<;
M)P%S1L-0S,8FS'A`ZOZ8TKUB_6@OPV\L5Y)\NV>WDVYO7:\;_2C:,_H4M,7T
M8^NG\2OI7M#/_P#E?+?B?C/D7^B_U_Z2@ZW;>;=D]VS.HD6M+C/WLB<-F[_:
M:3B\9!F1'UQ1V$UX]A^9T%VO555#;-V-?#AS$)HA400,(!.&R$OC>WP?Y0^A
MJ@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1,@_GIZO?I@
M[?\`WE]2*"W:@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4%1,@_GIZO?I@[?_>7U(H+=J!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05$R
M#^>GJ]^F#M_]Y?4B@MVH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H%`H%`H%`H%`H%`H%!IG8>?8QU9A*2]AIG6C;=BR(VN=>#X6R",JN$ZG(1#
M(+`P8+(B(5/*RF-;,;&V(1<$03*]_@M00#QYD=9,\<<\(2Y$<\,\<<\,L>-3
M>#+'+'*ULL<L<K0?>U\<K7Z;7M0?O?'ZS>9#D3]VGO!V'4#OC]9O,AR)^[3W
M@[#J!WQ^LWF0Y$_=I[P=AU`[X_6;S(<B?NT]X.PZ@=\?K-YD.1/W:>\'8=0.
M^/UF\R'(G[M/>#L.H*]7=R&1JK\IL&;1DM=^0H2'&/HUL5"+B<-^.K<D,X4D
M:0INUY>;41PT$2'<%TT6/MU@*PV9L(OF6`S`P#$SQS%PM<+"N^/UF\R'(G[M
M/>#L.H'?'ZS>9#D3]VGO!V'4#OC]9O,AR)^[3W@[#J!WQ^LWF0Y$_=I[P=AU
M`[X_6;S(<B?NT]X.PZ@=\?K-YD.1/W:>\'8=0.^/UF\R'(G[M/>#L.H'?'ZS
M>9#D3]VGO!V'4#OC]9O,AR)^[3W@[#J!WQ^LWF0Y$_=I[P=AU`[X_6;S(<B?
MNT]X.PZ@=\?K-YD.1/W:>\'8=0.^/UF\R'(G[M/>#L.H-WZR<C>N>V$JNN$8
MZ3YV:,ILV/DR5%AESKKE-FORT+'ZNXS+13W0D$Y@9+/&6THPXB0Y2PI6PN/A
M0!,>GI#SZ`GE0*!0*!01'VVW:@O2I(C-5FK.1S1B87Z)&4;-J*(DD>:7J['F
M$UU]YC)"4RXN;;I<IC(!M-@\:S$Q+7#P#+Y7O>U!%;OC]9O,AR)^[3W@[#J!
MWQ^LWF0Y$_=I[P=AU`[X_6;S(<B?NT]X.PZ@=\?K-YD.1/W:>\'8=0.^/UF\
MR'(G[M/>#L.H'?'ZS>9#D3]VGO!V'4#OC]9O,AR)^[3W@[#J!WQ^LWF0Y$_=
MI[P=AU`[X_6;S(<B?NT]X.PZ@=\?K-YD.1/W:>\'8=0.^/UF\R'(G[M/>#L.
MH'?'ZS>9#D3]VGO!V'4#OC]9O,AR)^[3W@[#J!WQ^LWF0Y$_=I[P=AU`[X_6
M;S(<B?NT]X.PZ@=\?K-YD.1/W:>\'8=0.^/UF\R'(G[M/>#L.H'?'ZS>9#D3
M]VGO!V'4#OC]9O,AR)^[3W@[#J!WQ^LWF0Y$_=I[P=AU`[X_6;S(<B?NT]X.
MPZ@WOJ_R)Z[[;R4^8>C4C.#5DV.V2VY&<S*G/7B9X`<`;(=JVLMQON1-39@9
M;/-K*4H+;>.EL1BN`N'A2PF/3TXY=`3JH%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%!4QSM?E`\@/_`&^.+_F"306L)5[Y):;E
ME>][W($[WO>_3>][EP[WO>]_AO>]Z#GT"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@J)2_P`^A]?I$Q1]\J9J#<7*=+&U\*:4SU)FHA:,DU^L.(9>?Z](\GJ"@,3B
M]JQ[&#K>AMRM%CD$)6!D603AM$"(HZ>H#D4<N;,XG#V9@N7S(F@T6[I5V%V`
MGO5G4Z.]@7=KN&O:(*^X,N2VP6?%[GD5UN:[BBV-X[:"8#)[*>K(1&QFX'.L
MK2]X%(N;/>)$R8`Q0`4Q?,(N:W[6[C\AQV((L;L_#:N.UE:1*TWRX_HFCZ.G
M(-).Q6&RDTZLMG"Z)+35?J0CPJ1<>M3C7U!%(AEE-0Q6"A7%3+A%LKCACY#>
M_<B6V;ICLVG&WW'3#?NM^GTMJZ:RHT)KFMJ\[U6<55*Y$[[!22KM%RFXL8$.
M:VH]W&U!C*XWLKYB""`#JIP+Q.P6F:,;'`3J1D)0>4N-11EEXN0>7$_6T)>:
M5I#UM@1TDD8I"+4?3+2S&;J0'4OL0!.<;BP5L<C!%Q.,R2MEB7`*X6"/W)1>
M]MN.%J]KWM?O`GK;X+]'P7TKV@M>W^B]K]%Z"X"@4"@4"@4"@4$(^2N8)!U\
MX]]UITB=<P;,G1#K#-,BL!PB)J6LX(CN:+"7%M`5,TE;)J".I8DE(F&)<$T`
M,`)U>KGAEC>]KA12P=I.2[4!+XCME-A]UT?<F`.2F2]9(/DR)73K=%,0.R%W
MEMA&N#N8SLCE]Q2$ECN%+::_?,NH%U0IGXP4#MU,+"#>%+!%]P_XA1P1QI;R
MHM60Y^>9;>N(-J-RH[U94DK6!U+[1:S&8;T(M^(DE4>;:A]2@VXB/8J>#$&<
M1W(UU;X9G<LNL%ED';[/_P"()FG1F>7VWY$6,Y:'<_&/I_*D`Q%FR4M-;`FR
M<L%,STDRU([U:K<!7&]&+91\<U-8`$-XEO`AX%B08`@WA@@^G_1=J3\U]:(Z
M'V<V32-K)F>"6"^W5+#0;+*:D:CV=I8NKIB!%"<R$!`)'8X0DT<()-4CF(R@
MJX7R."YAV&P+`!+R@4"@4"@4"@4%1+(O>_.SL7:][WMCQ9ZK6QM>_3T6]:/:
MC+HM_FMTWO?_`$WH+=J!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!05,<[7Y0/(#_V^.+_F"306KI/^ZDS_`(>2_P!F#H.PH%`H
M%`H%!1S_`(@N2I8C+1!JG8;EZ3X/=+PVXU8C-0?\//!18K](M.0I.(MISDD=
MR)=_&"61U,.Y6^'$0.^6./7PSQM?&X0W79GD[AIY`T**I`V]VIV]TTEC1/:K
M:!W(6T3S2)EF*'W9J0@9/U66V+((:"UE0=O/9K%ADT%(-V\7R4AK9^%Z<`^H
M&CU?G\>FU&JNZC(36I'\%2HN<8NQVW^NDBZV[0A32Y(U%93%.'_H]F,RALIC
MJ4.;$--.5"BR&`5$.E;V!'#Q'",%^IF$Q]#N539H8>"=;MG=929-W//BM;.[
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MLP%0\JOPOD9$`Q(>5,"W@B0N0XX.8@>%@NUH%`H%`H%`H*"9QVMUIU+YR%IV
M;.3M%L"MEV<448-YL+LK/)%924OKA/;V9U(VDI1U<-%"YU0+$/Z;,+#*^>(=
M^MT=%!M39GDVXD-D-<9]UY-\G>H31*SM"\H0Z9=92:(Y6#39`DMDK;,%<!9)
M'<I`%4'1PUFYC`OF.#B-D';"^>%K]:P1:E'<'C8-NB`9;UTYFM+(0GB#X'7]
M93CV=*[&,O,V0X==/Q$4CY!PQ\)*+%,$G.VGG'2<MH)\LL6#*#9FRID`X6-Y
MXX!I=,E+BWA5)AL;3CFTU1@M_1[K*J:H/Q]OQUQ3-0LJL17>2A)OTAGD2\B1
M\20)L0)2<[A7TU4PS-(]C#B/`&DHR!D!B`$D%?;?AI`U/@321C<GNHS=UZBK
M"'F<_416FV/U]Q2U"T2%BAHS&:RLA.9(`)6E5<0$X%U'+EQ\%%$'5"6(&%SU
MA0`P*#=G^*J(=IE6>3_+?I.XF<C.#<!UQ>RD]]L)O/!/6MX9:8$R3`#)<@_2
M0J%7^B-9RQ^"5:I<NCI.1-.,6#-YFQ"A83$,FVEWUTIVQW=X=&;K-M1!,\.U
MM[SO1S+S;BN2&T]%E(;MM.ME4O-<4"*&>.#%$O!24"X%QL[8X^%'PQ_EO0?1
MM0*!0*!0*!0*".&X6O1?;3538K6`VZAF,6V!AF1(@,/(ND8+X[7!?[74FT(O
M`H8JBD!JPB7@HW&L7R-%["WPZOA,.GK6"I^"^&29$AVZ:"[A\A+MVUAS0!19
M3GU@@5)USC"`&>@OV,6;@Q8R>K_7FHMNEU2(IL!#PMFG8F#!?JG,?"B9B8B#
MAC!M!%X?TY&T-Y`](,9^4S!7?"<=EYH.R1E'A8(U&8FQJPD*QIN%6QB\<PW6
M"UO)7@[&<SY#([X6][A@]%K7#*(WXBXM;.Q$E37([N(2^UY4X]XIX^'5%[AC
MT@0)G&&P$VR.YW!DY\'"H'@P9#3;6"-)@1<+$#HQR\9%OAA?$-_<;NF+QT!U
MH1]65O8%;V'8L<.)?+0BN.QH`-EWL*(3QJQQKQ2NJ19R+X+S#8^0@P!)2\&G
M]!+,(K@6"!+@XV"?-`H%`H%`H%`H*B&/^>SL9^EIJK]Z+:>@MWH%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!4QSM?E`\@/_;X
MXO\`F"306KI/^ZDS_AY+_9@Z#L*!0*!0*!00HW[T7C;D.@*VODI/>48Z0"\A
M,&3DMX0XMH#>?J([(W6L7`V#J2JN5L.Y++>+*@>`E[W)9"=;#&^.6-[=-!&F
M%N&[7*/7-+4@37*VSF\$G3+!3JUC<DB[CRP7DIP(D`/K$UB]8M8Q1KMAAM]H
MH#KN;RR/"E25CPN5\KXCX>$&L(&$1UPF1*RHHF&$7-MKO!+T8R5JLZ]+V8SY
M,E]L'VY!D`NH@,EY(\<ME!CQOM96>:&F"8$T]PN8BO*A4B`&6PSL#U\1`V4]
M.'K5N0Q6)@[W!+RFEL7CL=?&6`CA.I!3RJW`#Q241'5EU8-$6F`J8R9B500<
M@CY0<L0QSOEUB6>-[8V#0;2X$(`1R#K">NSFWTM*KMT*?W&X*JOIV1`&"VM7
MWGDDW2V\RD)JPNW$-OK[)LC!YDE"X!C,X8%&&4<3F8ENH&:R'PCP<YUYJ.2,
M]D=P-:E@#76'-5I?4=?I/:S,4MAH=@I,)H\>E9*4SL?K9Y)>J6DD[D_+[:S0
ME'$F,(!AGAAEC;$)JP;HY$NOVS&S&TK)7)!//K:9I:[LM]HKI<19>;2,D:SL
M52CYABMD0RE8NK)34T14S$5C*HIJ8QPUC86V0=[Y6R"9E`H%`H%`H%!3O9&1
MUOGC>P"RDIBN`%Q&Q2*$"ID"A\,(2^Y,SXW$"P-A"XAYY8_!>^/1>]OY?Y*"
MUOX@L3]RFE\G$?\`\G0/B"Q/W*:7R<1__)T#X@L3]RFE\G$?_P`G0/B"Q/W*
M:7R<1_\`R=`^(+$_<II?)Q'_`/)T%2/(JVVZB;><+PR,@(B2,-R`/,(49,22
M!`80+U+=G\_!9BE2X0F05\\;7OC>_5O>UK]'3:U!NSETDN4(HT==SFAV1W-$
MK[5)HU*CLI(+,#0!'4W4*6-L85C!Y#H/QH1'(@A*9MGNX\7"$,D3.`60O7MA
M>^-J"/SR<DR<<6R^K)9];AS-LAJ]LNHSC'DF)&RQ&*EM[0^YXKU]DC9%#E>/
MGI$T61>I#MKXM0ZL)2ZC*192#O8X6-E<P1`1,!@X^KO-U"&P,DQ8T78D1C%#
M6G^/WQ)<..8MM5!LHN5(;[#:0TDJ:9LM';-5<5/6]TFHP+&%K``X;6$\IXB;
M(GSI-0!P+"AW,^;KR]GO7J$T=+\&QME'<J:T;D+;@9#-F>.FU%!MYQ:_=6RR
M,]7?+("*_3*<(S$UXJ26`22RQTP,=7@K#EK`XY&2X>Q1Y<#JM`<"3O'FN*<2
M0I@83W=SE5=D]F(?U?C*-W1'CS/QTXH<O*3HLZR+WE4P\$-2Q(EDY/LE"IA&
MYTR?*8#`8"!J@SS*PND)AG:HX2FS".G7QZ:>["L^)EMSQ$@L?-W;0[&R="\?
MM;QU8+I5VQ)!]\DRZ:X7(ING)GDT`J"<P!!L6-&1P[LKS=-H9H2&53X0;4GS
MLPY/U2CLG%NN>T<.SNQGP!N1(ZG$T2+37FY!#1T(D<3W\A'B"^EK28D&TKP(
M1BWAR1HJ:%#>?)7+^SS7XN7])#*.#:F[1.$QKHU29E`<+;E#*'G9*NR$0QHK
MADW*9;X+<=Y8BENXP'F8\GA8#`B97PQ#SZN6(5Y;D\C^S)O1[256AEV&HPV+
M<;Q:BYMTJ$$Q$-FVDB:\;$1GJ?LVQ,$]43CQ5+,/#9J12*$5%L#AGX@$<R"^
M'"]\0E>\><2$&A.KYC\PW&+E%$8;+INIS\?2CLK#R#-@$G#O=%B]?<S1U/4C
M>,EO"(F3):\&EJBP&:+J>010Z?))9P@5\8$#$]AN1?8)[JT$J<!PV[V/K@L\
MJ$%:B'=EL'VQCIZ0B#3V9#AF<DX]$)M#/JZ%#SQ=;<6FLFKP:EFJFS0(8]B1
M,J8!-7#+X*Y(GV\&E',8:\P=*NU\Y.0EMO+3G3I@F*+8S-,R)H>V^E.`DL1;
MD)'8)-LJ2L[WFVATACHI5$P$\BI.62PH@B%ACID.VVDY>EK6)F92:Z]3E9GL
M-O06TIQ?!+8?86&=<I:-XK;?-NAV13"D3N0ZYE*:I=C)+)9EE=/#.HZ>.LYA
M)Z<>/#9Y7P"2&FTWOF6]GN1Y!77<I.".XUF77$E#*(?)D"@+.9LAZ5:_RLI)
MA*Q8B6/YXJSJ>9U1&L<%,"ACFL\,<L0\<,,0J0V'GS9&*9?V+7MF-M-S-'Y#
M0YI>`>IT@FX)1Y$XDC<*@+A6\*$YC=['BAZG"F3Q;-L`GR==[F:JPDJQLQ=.
M,%"Q<KEF%I[HY+6NTLY\:)^,E0],D.[/ZXZR,^,T]V(OA)N.;6EXX/0K)C+7
M\BPA)-8:\E/)7-G!#&`HB:"SUGKWS\6Z;AIV,^5QQSV]IR8L.:_MM8%C+/99
MKD\3&S$5%9>93Z@(5V)*.+LCKFHD"DDP4Q):7&GGBW5?`-R7S`/)XQTJ3#.X
MWP",<0\UCR;VNFD*1,;&A]=VOFW2B.-M)+SDG:Z$]9(X-,9X%L$EJN1`=CZ1
M4M#.2-,RZF*1M.9J>0L40`2@P:DJE@L`!S(;P<7-017&H<D3735IZ3E'+:T)
M97(J_'6H2>QXULUX0<*W,2(XV>43SA1T7<4SMHS"BQB`E`"X)"B(6&QNK%L<
M`<S(=JY.8W.-6O+SDF35!\1[DT]8HJV^BI,"DQEN@5]PG+TKD8>1U.3%!.)%
MTJ#5=C.!;3U)WV&&7DI!;PID_B?-6)&`K!/'3+:):VLCYQ/=6CUIL\LBNO)`
M0W/%\[1ULC#$G(^:*E*X+MBZ6X]NGX+:65'4A$X^74DA'/DU(F-A8$4O<$R,
M$26/^>SL9^EIJK]Z+:>@MWH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H%`H%`H%`H%`H%`H%!4QSM?E`\@/_;XXO\`F"306KI/^ZDS_AY+_9@Z#YU=
M;]1&_M8B\C4NO#8/;:.9H:'(+O*PXSEI@[<;"M5.B)!CE[B@Q_9"BT"2<84,
MMYF8]%[IB@WS*<;+8Y`F0A`LKVL&K6-SASHXHEUQ34QM0Z',6>A6LVT<WJLG
M-'8I52Y3D&=VZY#Z!'$5I>O<8/L".?C,189M8&7EVXQ,A@N)Y<HF'[!G,RX=
M]EO-N<7E[D(VN@QD-(2)8XX_]&-QG=!>TSLE)MNIG$CT*3[*CJAQA,]`33*9
M',GKJ.AF2ZVKJ!?P`2LGD@1B)G&X@Q4-H[E\S3_UU47L[&<F:QJ;)C..8@E0
MU":R[)3?NSDEM"0&>V'XY3A@I#[4<#*UAQ14=QB%$<1\V'#6AB`AT6Y!,&+F
MLP]4H<GYS7&1Y]C1H-%#2)(D?D=DF#4!Y2LZ]A9=C1M-R+--=>9L?,GJ3!8R
M0]WRC@B%G@GH*4RV@63$455-74S!HGX50'$#OVORF[?3/GJ]%D(P+"Z?-LY2
M_M7$*\\YE'GEB0;FGZT1ZRY0(S/&:2LQ\WI<<K"DQM.\`J6)&B!8PGK.8I7,
MV.$1&,C!W_.4<V,Q:^AB=K8_WLQY@PVO<\@(J6P7,N-\G)ZY`FH>RNPB/$+K
M*)ALK9TL:2')%A9).)AW$4L9P,XWSPOECCT!H2>-S%Z=>0KC5F>(Y3?"#I_'
MAM/,/I$;2TK)3?EEV[,:([&[6>27VBIIP(F[;P_"T5--5*$C.`F)4^\;9VQL
M+CC>P=[`7.FYWV$RI6D6*VT:@N4H>EJ;`T*)V7L@:E#71J1[##OGYLVFIZOR
M+F[";Y!>S(9PB4.?;ZD1)ICK.DB9:ZJ3,74`PUS/>T&[AIYP#,>PS7CUH1B_
M>+SDXV*;\3P%-<R-X0Z*0A6!GRAQG+KB*XMXR*_6,B*6."8]F[XL(3.J"AFG
MER>8()@T$W(GW*W.F&[@3]3X!AIW1UK`W=7F=)C;E:77L3EB67M)\#Q!.CT;
ML6/E6+&T%!PC2,9:2?`K+NS4!70MXF`1;D<,?'A`UP]>7"2&7MJTXF$+:MNI
MAN'=%FZAJD:1P[94DJ<&2FO]_@Q<VY7?TJM!JG]=60X+.(Z543S`43(2P03C
M-B@A_P`JXY$Z"3G&F]7RY^/!>=;BDT<)XEI?Y!R9.39,6#+C*M8%J;B[)H;4
M5'"H.(_E<5K,1'2"@>``P^!8LF$<`,;A@AXVQ"K+6M*=FMLF:=C;1HF^VM>P
MR])D>,B2-R[['.#<[1;?1W/Q*.M3%FO#'.6UY"AE)GAZK!0ZRQ#K!:(C=4LB
M*>2,XXY6!,!/5J<HTQN]LQ,TFOK@FOG:@(QOEALG`[/=)T09DYZ&E%YJ+:0Q
ME(^1P&-J4YS*XH^3&B*I!AEQ4AW7.9>%N6OAD$`IEY4MJYFT.W#6HXD;65C3
M7%33U_<POT>FY\BZ<X:'?TOH30D".)'@6;6DV98;:JA8&@"A%Y`!XHRSX<Z$
M$7)#E@\A`D!-',_+,9RS.C+;\:QJ]2^HSE9<:2S'R&S-H'/*^PDCX1ZQ7_,`
M6N2DPXO=D<,E/:P+YP(MLBZCQH^XE(D*&:ND%A"YX4-@2AR:[CMYRSDYH[@O
M7-P0U"O()&6@!1/=LB2*WI,D1U3<4@Q,9<@`'D]IJ[:8J"S7;/B3Y7*&"JF:
M42!4Y<OXH,$#8R'&D+D_VNBIES$WGS$\0@R-K[N.E:W3;/#+:&PLI:Z1?&SI
MUG:>R#.FUU1C':&X)U+IRJ=>Z:R30.(MTM,63&)\TI!$LL0Z"U;32>3NS.ML
M:S2I*D,KBD[BBWB>6=?9($E:(%<9"<JRWL5=FN\VCH"OXFKETK`T,EJ)(NJH
M1H81-.XW-%!<L@A0E_GTOK](F*/OE3/06[4"@4"@4%/W)3_U<<+/Z@;T^Y7M
M!03-W?U7!W/UR<\!9R*M1,;67=$;Z19";Z"B.A3;3EAJ76/,;7-AMYR8YHBN
M6&<+$+`F`#%KAB%Q,[?R]%!'9K\<BT\)+2I6W6VAD#<Q=9C`E*.(P:2Y'T90
MQ%D?),W-85B2LY"K-BQ%3S[CD!U,,R80L5534S-DY(/'`28`.1L83(.FUNXR
MC4'*S$1'KL8M33!40QHOQ%&\*+4,0^SR;C9"N@E6:E@;).QM(=C^Q"JTF,4L
MFD1395(*CYC#'5`L=/YV,XA)%,TIB5J;(PUL''":B1>3AJ'YXB5*BF/F8UFH
MQ%;">G9"[K<#K-E$,BGV*+B:8A<H#AX$.V)G`V)<6][AA]`0$;O"VD1\M0HY
MHSV36D5S13%DE0P<7'Q!T12T9S9DCS^_=@AW#%A1[D#:7#<LI:](AQ.R7BI=
M3+J:<5(XGD\QD3`OB'(0^$.(TR)4J*#\XR>I`-74W6S6-C.W!$9`#E:BSJ7L
M4^=EH4FP,,\D*Z`LO1(?+L*AJ">=)#(RH53L@QB_@S8X=!MU/XSG"OII4:9=
MH7'(#H);$:FSPG8LZ(8WAZ,F\!J3)I>4FZT6M%[7#/@IQR25VPMG0NFU-043
M@?BV!?Q4`F7`Q"8VW6MB-MQ`SC@A?=*NS$MQ.R(G8,X4(F1/J94Q$<Q,&84\
MF"54K9$\P%E1801(?+*W6#`,9YX?S\<:"$#UX@HC=JUNFM`2@_D;/<60X.?]
MB&!)$4DV$\HHEUK3V\T&-"IP+H"39RF!!,KSCN/>^69X_?,/HN"'>@[+#B],
MH,QO5U1QLN[8YA.3=BAMHG[$2+%L8GGV-(ZV["3_`)!;;-V'4TT=_LJ)Y5?)
M+(^OHP1<R>SP4%`H142)0W<'`.L4N*]5$=S526]MC(K9UB8^Z+?WJ:NMI2/F
M`;!3I8*3-G/3F9@LGF`+.<Q#2])RFJ*Y1%Q+AG$L\H6ZA\4H6+D\`]#3XK%N
M%PH_<FLVUSSAJ8&@A;%,!PR.HQ<P9*37Y%FPVR+VV@S;*PPW#F32"+DBF0GN
M:^*ZR7'MX$$8S@?*GPC686`:@D7@]0WAG.*6C[:2J40-E=?6;`<T.R1X_C*<
M-CE8@S(C%AZZTS=C)&2C[I8Y5](E_'7(F!$3)8TIF#II.R2QCF>>(62ZV:GI
M&N3WV!?9%[+#N5-A%N%U]?+**4FI9%!.PWKM%VO)3!&P(Y""B%W`F1@"J#8C
M9YW`-'!`L+W#PPH(</OB_E%=2IPAAA;YS%'>G>QS@E!8D_7H>-8N?[E14B=%
M!85)L8T-3D\4\ZZHW9+_`#KD5!,"IHBN#(5U(:R4,3QQ`Q!#'26F83XY5HNF
MA,AF0(O@_2W6]*C=.<#E4VU9@;`2N035A`U]56.W4]R+SB6R>MD5RW(A`9<7
M"Z>9P5',$7*X#6+"#XAFJ5Q9>4-D(^G66]CG/,2=##MEUW1"7<46QNF3BE82
MZT'^PS#"D39Y-)_2-)\4,=J26HE41"'!(X7\53,U$91R3@;W#5[.X>7'%[8@
MBT8[=J*7*4'ZZ)6GV$COG7&&I,2WKK:PUU268405Z.EX,NW2,GPSBKFPDYTD
MQ`;*7CQJZHGG<!,`@0W\8XQF>.ASJB&9LE)<%G;CM:G'HX',[<&\ON_!OMK*
M>1C$RJ2P&GIA5<D1PG9Z/#FP+E2R980D%8$$(/++"P<YY<<@:XYB#Z96QTKQ
M*^T#3*-M06L[F,FM+RFC%HNE9!EI&?ADNN)BJEKP;A4V_@E+S?.%Q$E70C1H
MF);&P]\\0S72/1-%T]5Y^?(ST27K)6RKP:;ODDZR8K:$$Q@7,L=K8-%`LT(B
M9`QY'150Z0N(.LJIDZ?4UDV)CD./X(`N""&@6/\`GL[&?I::J_>BVGH+=Z!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05,<[7Y
M0/(#_P!OCB_Y@DT%JZ3_`+J3/^'DO]F#H*KE[B`@QP+DVW&V"W71HOV+E"2)
M9F37UH;&JK)AAZK\O*0JG)*4;3&B@HKU(M9X"#Y@G2)5=`Q'*YY@Y97PSRM<
M-MRIQNPJ_7&2=,>/Z=]6%2\+M?71T8ZK2(5BE.?L',2ZMC'T>N9+%;CB($0X
M[+.)4+M]:1`TARHA53,@DU($/.V.(9-CQ[ZZEV_LPU4\D]4UO;6:X1WJK)2<
M"\E(YD0B.+8V?L4-`DTE%8Q4U=-<!5H2,H8#J1HP>,FC&((PM\L\,KYA'J1^
M'+6B2TB:V6>DS9UK1-L8E-4&;888LP!MF.Y"=3+C-FQ*@2(KXEVN,\"SKP9\
M=H(9PL45RR`JC)(.9]-,VR&Q%#;CSXU8%=BDZW8FNF98]E1P[*'=L4.9H[?A
M9!DJ.9B68:9T`N@VQ3YMOJK>":+SBME%TQ90%5-54=2Q&&S&+Y9>!N"&01GQ
M[PE&3N@Z1`7-,KYD:"W3/3Z2G])DEJ3S<SX>NR*&F-R3G'()@\5"(GA!TA&*
M@)9!,+I20C`@!@DR@(&&(5@WW*FO[!F%\Z_2$\/+GQAUIE%6EV-?)*I8@1^-
MRU%DA0^=^,)7Q8?RNE79\FJ?4`ZP75->"%ZU_!]7((M13Q<ZFPLAQ*VV`@.Q
M-0X9V6DW:II)IIT9J)4S)$IQT_HC6$E?"-D1,%9A(492",AI"1>V`1!.3R`-
ML\\2W\\.)$O&!`T2*;5*`2!L._XCC1L/ME0WK9)TN'75`$0L^1&XHLE=:[99
MH:4FJ[J04Y@+!MOHI5W*;E!;Z*9S*IF)7#J]4,`1>'S7)/#*$5Z5-I9";[;U
MUFW4Z,FM(4SW<:#$&O\`/371F:\6#'X63:*G[9D&\W4\NGK"P85U[`(B7#,'
M3(1<$/`,K=?%-KJYU4[F6>NP#/9+R:L-M"<8D9,IYH4:['I<$-Y"9T?#3&FW
M0S;@'4\66V$Y$5S#>4V\(X$8B`14_&RP6`5@Z<KQ(:[DUUOC%I*V4`CEC;0$
MMQ(S@8M*Y8G"L:SP!,(TZ*+B;C:)M8NN*R*N2(HJ)H5&7E-92BEE0SX@7)B>
M`$`"8<.ZO1%"<(*VO#<1C3@BMP+DU+:^WWR9!=&"Y]/TC/F3I(1U;QDJ"`>0
M%)?D12`#*B!WP#(9X`97SMC?+((@1KQ-05'*S$X`\S[:R3#L!.MMO6"]997G
M8\](%BUPL03`:,1TA$&0B;X=*?$XX``K8(.5?7"",,4+"@`XBEB^885Y:V'(
M3>>Y.XCTEN'Q24@\HK:1F.VF#',NL7,BC:ML0HZ]?<I8$>KC?T-N:[DV=<3(
M6%^X+!3%53!;Z`CG!LO'<+B7"8<:\;NJ6R,*/5U.Z5-II[QGR!B.N@3_`)PD
MTD+,D11FR7_@YC$:ME5;#6;0*&\&9,33!,JR@J!+:R9740.QP\;#!ZN8;@<O
M%M#KF7'(IYS;MBWT>4BT<Y;'LIG37FTFIM$Y(V;#;995^3&&A-HDO$7P]&DS
MTQ-=)YGGVI\9B)((!0P'"QMA0;36./Z`5M)DE%/?'GQ*5=RHWWK=/@73X,7Z
M<XL58?6&MY,$\GY>(LNQR#T/QE,Z,_#X>,6\+CX;^:'0OSCKB%X/&0Y,;LC3
M[$$JR'.R/L28DN))(+MYQMV0$J"VQKD9*(J<L-UQLU39B_%K3+%CZ,N)2P0%
M.7N<PP#,X`B!!('6W7*.M68O`BN-<G$=3!G6^I!<[F>2T(XWJ_)'E!WK#^D:
M0'DN9@%`U%S/)XKYL\:R``+%0\QO!%P``,`PL`@&E_GTOK](F*/OE3/06[4"
M@4"@4%/W)3_U<<+/Z@;T^Y7M!07`T"@CQMS/1/5G5G8K9(\FX+0,$PI)<KX(
M8@N8&"X;8K05G$GH>8X?\\#%9/D`BUQ+?ZEA>M_DH*<C>R<_Z?;?:21E)8FV
MNU^#HXV9J?DRLJ$&GG*RFX=@3,ZZ\'5:5U9I9*Z$"@M%LCNU;142X0MP$=.4
M2J:"%X*^.6`=1"W)?,(TT;JA)L2S<Z7O*N^>NFK^H^LFQYP*#CD9J;AT69<U
M/HV]\\B;]-1Q&A%%9;H>9D8D263RE@*%8L5R'.X88!(A4Y19K27NWM;A-3VJ
M8W`,[9DM3G.P\)_S+PXE#N;5IX;8L2<$.51(F$<:[&"[';0,XFR0C:)KY`^6
M-%<2I@0(#(T'M9_*#,<EG67!;"UB9XVY*W/VT\%.YBN.<%!,@)FD].R[(.2K
M+`<P)T3J[U7V>N!2JT2Z$0#9X*J(><%@C6!<,D8'N$N]2MJG9M7KI)$G.B*3
M$#/MB2AL="3DC_X[DY`%0';`3_=D9JQTN[D]";A%1!/JS9S-%\PBUL+!9X7M
MGG_+04;<8F[4Z\AJ5H=K^]YBG""FTR]5(SV'?DFN@BMLN:.2J0F4H`-F3&_$
MD@*!;'Q37^(WR&6^/2@3S`<CMS4289#$NA"#GSH64I7)U(JD$W9VOK4D!:+.
MS;$/4%$FL.8\!ID^,1V?#.K:--2C".4?`H!.%5B?0,4;"UG:(X@4L8-7$3[`
MWR+X!C,8<J<KNL?7N29`U:;$>:Q;$[.S#J0VY`*3UF[9/0)"BA3GE-!?SAC3
M&*4%#!BUT'=?E8MCD$X!%DCF*".(4S`RO>P<B,.1J;YI7]+B3QU.+Q[KCR76
M?Q*")9;6Q1DS*[%9)>`Y#FUEKLHL@A&R%@SWG*##:."@D@M]QJMD2YC/`T<P
M-E@\#`2EX\YE?$K:QJB5)Z^*Z9=UXEF?=5)+>8F.(9E[.K6Z373&!*0SE@[6
M"Q5Y#:J"F+Q['#'`+`\HC8X8XX8XVH-&\>\UO]Z\+D`S[*[P>L@2*IZ6&9#>
M;U'<GB,@.5<*,A:53JL$[!B"CY.<IG(KT@'\BP_BX_5$N$)U>K<(F)_+S*C(
M@!P/5AZN&Y.C?4_0O2G;N>'Q*FS>&,JK<>;!1*K/$PW6Y<O#(Q239N0TEE*)
MLX?4!6ZDK1D/K7S)BF\`@PV?,O(5*B65ER)Y\A%9AF0(V>_&A(2")KULKY2-
M+T7;C;DI4)H"<X7L?A]+\CKS0<30/EWB@%R!Y-<2&/F4)*H6)JYH`-",SETF
MF$&U+I;94E!II_R%R<;5ZM:[J#[GD*,8?8S%A'-PK#D,RO(0\+DQ&TR(R;;=
M*$DL4FF+K@=BLJ@A9@%<Q,Q<`DI%G+JX-B"<61MKQ"<=2#LT_P"6I^C-72\I
M[$RUD0F_K2VH^=T@S$WI^;<8N-??T?.-*F!H%V^&3:0*B,IKHA8Z$3NFG,K!
M(?B?E:8IEUF?[QG@1P`20!N1O&U%)MN1REWB=CY*9FUDKMANQD3<Y,J2)+:%
M':$F%TA.,@@A!"DB@66&&.-[8V"S*@4%1#'_`#V=C/TM-5?O1;3T%N]`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H*F.=K\H'D
M!_[?'%_S!)H+5TG_`'4F?\/)?[,'0=A0*!0*"K+CI65I5GCEM+*JPK*A9#Y&
MS"2AEU)2.GRZ*E6T\U)4/)2.";'&"3$VQ\^./XN!8,*PPXF?5ZV>5[A"B-]R
MMC#<\$M9]:V;`,<JT[;[<J3)=$@R8#,\H)[<+ZN*+&6"4@$V>+*Z,;5W&^33
MF$!.(A-51$$GD)@*2"*@@9E3`<*(.2;<:1V1JP^IN9>LV48[HM?=F.K1_'!"
M6DUUL=\:J1=,KF%>@L@JKXS"6V=*IJ%U</)$`2TU3;Q92(V#5CPP!@80(LQI
MR`;%:[-^5-F+8M-R0ZT>(#B">T0ZK)P,S+24TY/VL<+^C)BD4URJS]D%S'R1
M-^*&-G,I72U=S.%`*)9</+-0(YC'@F,5Y2-LFLC20SEV+4.17ZL+NJC"UTFM
M<U8VUTZA%1EG:.?D^`#C$DYE;!V4'H=+Q`>6RCER.M]8%^,2()<G;!-/AY"9
MA(;0T?8HMR'<F;;V/=S'=[E0HYT"$;ZI%R>\&I'RD@J37V*ODN)\;/!YO\S'
M[B4%$F,64BX"L>"-V(@&;"VL)8$$*Z=]GHYICU<Y6)P,8NU?4D+?K4;1B/X]
M0'B>9)D6'X0V3U;)NICHJ^754+!LJDY2A)[JNIJ=S)6PR::3@C`WBY(+J!T;
M$UK6%39>8M,#L*SQQEQYN+Q^S6VHEC99V<49^1)3V#8;U9*P'/C%<3(EB1D>
M&)"UJ2ET@-F5Q-DC;K*+=L\@Q`TJ_6"7L9;&OOD'<'%Q$*F85VF[6,FN/;[?
MM#1%%00C+?DC4!S*&O2;#2QDGB@=9)=>[)=25,2(W]&H)4?&<,\,@1,K9!H7
M4I_.N-]5N++9/!RN58<*WR&[3Z@22$JKZLIW>\/[/;D;.L9/2EC(Z:,#'C,?
MRBU68KI0V=\LTXFF&2P-PRYD;#(+,&?Q^N;X@P;'[VDT(-GP66B1L9M)%9;,
M/*+Y0M5Y?.2/KXXT:33R85?$=+C@+IZ3B["F`R@6$N"*$G7(""F#QH)E:PQ6
MO0[#B.TG8;3C;Q5G7*4G/2Z-D*(B$GG-4IO.878C(0HX8(QA#0'`^C!$F-D&
M%F.6+X"9!X99WPL$@*!0*!05$I?Y]+Z_2)BC[Y4ST%NU`H%`H%!3]R4_]7'"
MS^H&]/N5[04%P-`H-+['0FW-E-?IOUY=Q@<FV)PB>08G7#Y4/`8XFIS_`&JJ
M-<PJ$@Q;XAYGDO!3\8`ZU[6\*'CTT$8=<=;'<J.[6W;#8+!=;.TL4ZCNO4M^
MM)-5VZK1XNCK3[CA?>,BII@@5-*0P3J<,.E5-$Z38.0"0K7".%L3>.6(08_(
M_&9&#\>TT2JERG+<?2Y)^R<1;9LV1FB<9^2K"DT0U`Z1KH@*#)2E]IK+>7FL
MY(R(G$]>2'`55BJF563H7]%;(&X`>$?\9\?M20X^FQWR_+4J3JV-F53:Q\RF
M[+L=//RI(9K6EWZHH#?6F\UV@B-IK1NQ(F=MP$5(1"Q#Q<R5Q'&&,"C&\QPC
M+L=H>Z8A=#<F'6=K;$/>0E;:W9#8QPR7!\E:^MV=(>-['L9I-YXM%DQ[L0W"
ML#S!"SR,,--`6$A?.@*Z8:*IZJ2&,#$[AV"3W&3J[)>N>G1J,IO,+0<C21+>
MRTPNTHNO))D1XH.,_3*_)#3$9YR`BIR<W'E(:6W7,5Q75%.+8)0ZUXS<G;(I
M8'+(/3?C!AXIK3IGK\W7])K6<NA!Z-%76S81&-M@.8VDH1XE!M=2`4#@S;%:
MZVVI28HIM`=:,,G>2U=+.YX9`X"A%Q00Z5-XMV.FNM*2\)[F\;5YO[)WV[;^
MGH@D>X14DSMC)QJ;RIH-V@L<.7#$7IDVG,W@5:`J[DDA+ML+]&1$/`C8,Y;_
M`!QQ.W(EUMB$L\7\HH6L6U3UVV:)Q4';8QYSOA\.2>7.JM=XV#;N!(TR\3>P
M2J#B$6!+F[ERI:V0^65A;BA4'$^L6Q<'R[IG)$I,+9**M<..\Q,ZJB12_9RU
MZF.*29^28N=.OT+P%IYG&*(BSG,5U]P2:3)MI3E/!+46^B@ET0/"YDT.)B%@
MF@,LQ;#D'KC,D55<!:3WQ-LFRE.[U*L1Z!Q"+..S6QZ^0>[>8<I&T0)G/1JQ
M5+KR+,*ZJ2,YEL[)X)S_`.C$N8L'=:\\73NUWBYJ:^(^_FTCQUK9\8N>(4N#
M78SM5\4')C.!G+S0(IIEXM_7]$DP09M66\3I0>RS880R4"Q,9#`W%"$#MB?$
MI!I*#MB8&#D.5\VSLEIUKAI:[E;,ZTO+J)'NL\:/*+V>YVX)BU<2`3R7$9ZF
M!U(0R`8)9F@@[@EP<+989!LR;N.6)IUD-_2.Y7I(B4K2$WM*6VJ$D,TW`TXF
M4T;V56=GXX'3\#[>/&<3+J>2T(06[B""8B)F..);$L-TC7#5JIQ3,O!SO1]L
M78><([?1C:Q\;CPLYT8I%2J;@&6I@;3A:T\([:+N".U$L_(NFI,<YK!80'3B
MKA%[>"N0&)B`A"8!E!_C?$&1XT=!#;;9(#:&+)$E.2&_M2M'([=SO%,3@E)*
M!*D>#1BY&,>A5,A1<16ZE!D&JF()`BC&D4@=*Y8G0QS!D)):AZLMO3Z(C41M
ME^2')H*E)LN2RMOB5%%$57RX7A-,C..4'B?6E!NH+:23&8SE=!FX=PR0-L0[
MXX]'P4$H*!05$,?\]G8S]+357[T6T]!;O0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"ICG:_*!Y`?^WQQ?\P2:"U=)_W4F?\`
M#R7^S!T'84"@4"@KC<?&#!"S+<IS.WI3W"BAT32_"<F26CPGM_/<2,1T/@FV
M&PS,7">8C'>B0V;GS+89J:3'SL7Z1@2N&.73:U!MAFZ(:WL*5V_-3::JT4D!
ML2ELI,B.I#.YQG"8#\VT\@?3:I")1E0$3S!1P?%DIXJ5S#N`G=3+Q;$/KY=(
M=.A<>>KS<:$$L9*:*\"W-;U.=%>*"HCU<XXR,>V-;DD-651%`V*I9&5S%81I
M86PR^)K(7$CD8PS`MAD"'?$,(,<5^FATD01#[&=9YI!:D,#2-=8YB3'[9G/:
M!(F\9SB8@]$(!>!+K;ZBTTH&S#>=/2&X4DT;%&+F\!>IG@'O3N,36#-GRZU9
M`%FB<%&;&^QFF\9&G"=Y1D652#9BMRCO>*4ABO\`4W&&NQU>-'X9S<"0<1,R
M*B&O]"B,8'.8X#8AM36G2J'M675+,@L55E5X27.Q>.P)>DJ8Y5>4K/5]9Q60
M<:0QAU%4=JD=!3[H:*YQR881`$H5\7#"Q\%TX=-PCXZN.QK20X=THODC(THZ
MK[>/^&-E+I3->KGC^2H^V5CO)C$G4H("\V+D%).0U\W"C+<I(Z44`30"Z&J8
MB!>"'"RH-O01Q_0+`DH?3<GK$Z2W,99H*T?H$E[(["S'L,Z&6R'`I)2PXVRP
MQI6>+E(,I/<JFA$A5'--+EC)[Q,'`<7,,/#"P;'AK42`X!E?8::XK9?Q<D/:
M-UH;SF)7NKJR@76EM`**()3)(2U`X83VP1-**VHJ9LN0#+@FU93-G!<<AQ\\
M[A'+#0-KMM<TZBR.B!%N:K:M3!+FU)INJS@7'&\'7L`[EB0%EBIV(ZIB8SP9
MJ`\)O=+J,"BG+B!*A!'+%P/%\!;AA9'0*!0*!0*"HE+_`#Z7U^D3%'WRIGH+
M=J!0*!0*"G[DI_ZN.%G]0-Z?<KV@H+@:!0*!0*!0*!0?/)OU/<O+<><XDCL:
M2GW'A;1C4FT%PYBQG6KMH5-EUWP6C[,27+N-TPP5$N\BR<]F:B(AV]["I`:2
M?N6RP\HF+Y![I]WNG%ZOSB^8Y#6G>;5@F\]^(-;[^D"6`(G:C%DAIF(7FXTK
M1FM&XSGB07&OANI4*%5&Q$\F8$1[IGA!A,!0PL<PAMI1M_/6VP.K&E,JRAL1
M`47/*5MSC;EVL6E5PHLA[L/V#]I)&7B&G>O\RX*8BTP6JUHN,DQEU=#%++"Z
MDM]00&[F!@G*9L,+-WTG2BK[8;,:HHRTKO<NTU31ODM@AL.%RF1LRZ:ESHK-
M^:H2)+B^<'"34%0<6OUUM`"'$P)D%AT"6Z0BH(>(8=0-Q7.!@-64V?'#E:9I
M!DU+<L4)?D!FW9CLQ9$R;+(DWO&3)X=IQZ*0,KO^"T$%02V.8*$"(X(9H;"^
M&-CN=BP7?4"@4"@4"@4"@J(8_P">SL9^EIJK]Z+:>@MWH%`H%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!5SS7-!VOWBDWJ9S$:SD
M>SO<$#.$@@--H(:HY7,O'\CJ8)@014!%*G555/"8!Y7Q!`"$$RZ/@M>@QPAS
M+:=%R)(#-H;RVS`*%@<[7XU]_NFV08.&&5K]77'/'IM?'_)>]O\`QO0<OOF]
M./W1WD]VOR`?AOH'?-Z<?NCO)[M?D`_#?0.^;TX_='>3W:_(!^&^@=\WIQ^Z
M.\GNU^0#\-]`[YO3C]T=Y/=K\@'X;Z!WS>G'[H[R>[7Y`/PWT&.#<YFA)9V$
M&$8PV_`?:J@J3J2V2/QZ;V!.Y3:Z,>3DM8<J>VQ-><5DZWTE36"A8T<"!R+%
MQS8(8F>.8H=L@R/OF]./W1WD]VOR`?AOH'?-Z<?NCO)[M?D`_#?0.^;TX_='
M>3W:_(!^&^@=\WIQ^Z.\GNU^0#\-]`[YO3C]T=Y/=K\@'X;Z!WS>G'[H[R>[
M7Y`/PWT#OF]./W1WD]VOR`?AOH'?-Z<?NCO)[M?D`_#?0.^;TX_='>3W:_(!
M^&^@=\WIQ^Z.\GNU^0#\-]`[YO3C]T=Y/=K\@'X;Z!WS>G'[H[R>[7Y`/PWT
M#OF]./W1WD]VOR`?AOH-":L3:@[5\PTGS]%K#GU)B1(XU(WA\P\9CUPG>`")
MJ14S:*27H?;20#-L?,(XMFRS9<I,UED4#&"Z@E[=;K89VQ"]F@4"@4"@I8Y;
MG,)&<N<5LX*C*EAW1["N[SE>,FG(AB"3)K7VJV%+5+8-FDELZSHH:SO=@B:*
MYG*1*7%#)9XX"&,>GX.F@V3WS>G'[H[R>[7Y`/PWT#OF]./W1WD]VOR`?AOH
M'?-Z<?NCO)[M?D`_#?0.^;TX_='>3W:_(!^&^@=\WIQ^Z.\GNU^0#\-]`[YO
M3C]T=Y/=K\@'X;Z!WS>G'[H[R>[7Y`/PWT#OF]./W1WD]VOR`?AOH*NY-VHT
MWE*5M]&$[6EOYGJYR.0(TDB651I\?.]*(]X^F)CM*T(KHZ&`J:P*6(H$GPOD
M@7*',"AL-./M$QXSAT'2]J"6LR;]<><XXZY8O!O\AQ6VK\Y,?8&._(/'5OD1
M\>>[`9ST8Z(4=7C6K1_RFW14=]G<C!<#Q480?`++$;#''+',(]J,Q<5JCIZA
M:8YHO)D39+*D]9FV,I,3=`-[D^;HGF)1FETSRD27'+Y+:G!DV\ZFB^7@=#3A
M?)XH624)D1-AF@!C.(P9U!G)#K<E[3[-[02BTMY,%I[MJ(==HB(C<<.]!Y0"
M@N#078Y[O-;$0-<<$H@X95ER5W(H"$0P@KE4DDF6SP"&N,`$$V>^;TX_='>3
MW:_(!^&^@=\WIQ^Z.\GNU^0#\-]`[YO3C]T=Y/=K\@'X;Z!WS>G'[H[R>[7Y
M`/PWT#OF]./W1WD]VOR`?AOH'?-Z<?NCO)[M?D`_#?0.^;TX_='>3W:_(!^&
M^@=\WIQ^Z.\GNU^0#\-]`[YO3C]T=Y/=K\@'X;Z#16GLRHFT7+CL?L'&;$GE
M&B/'CZUSB4%W3)KK.,`%E&06SL%L$ZUQNHI.;&$PU);&3F^\$XR((5!%"M8Q
MT=;IQRM8+TZ!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!05%R!GG;G1U?PMEE;&_&#N!:^-LKVQOT[,:BY7Z;=/
M1?IR#QO_`*<;?YJ"W2@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1,@_GIZO?I@[?_`'E]2*"W:@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4%1,@_GIZO?I@[?\`WE]2*"W:@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%1,@_GIZO?I@[?_>7U(H+
M=J!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!05$R#^>GJ]^F#M_]Y?4B@MVH%`H%`H%!7]R43O*,%Z]MHO"*
MRF-&7I]V&URU5C^1%M%*N1'BM9V+EUKQJ=E`XWE"^*8NG&.WU@Z>321R]R1M
M7#*`F,<P<\P\PB+*K(E_CGD?4.2VAMSLWL(P)SVLB#5.>XIVA?J)*!)P%Y_-
M*+2:\L1@H%VFWE",'NP7[X@=-IB/X!MGT#,\'DG@BA%QPPW2QN3$21(>T<DQ
MNP<*&L[PSG,$#M=JJLC@%23&7XO8^S#N(+"ZY"S,/9J:4YC>NMRF=@"&`I'!
M8L-T&/%;A#A7/`_,K/C(U"T87]A6-!RC-&S442G)N,JSALJC:T0<^A&*\$A)
M1XV;\EFH1.,1(V#?]G'G=,:IL).2BB8F9&1%;/K9!X!+EW\C9N,9MFI,)15+
M+LEQV-3C19D3P&YID8F,=#2_N&8V$\D-A,5&TVG(C1Q9H)\?*1]]N8NJNLBJ
M)R.`(E%L\R^&!X(UA\ILRZRRUO*)M:UVRWGH>VYU,UH@.'73L,W4?7I@K;[U
M((2HYW@)L(XF.@7:T.J:*UEATGSAENBK%CV5DT-.S.BAAY!:EH5O0UMW6K+)
MA-(LA/><%R?>*Y!M%<J(\Y1&N'S;1;3Z;SNBN74-';I5Z,]P-MU%[9>,)J:H
MIJH7.$#97`4MUQ`IXT>Y#)^C"/>2`YL._5^9W`FO#8J?=,"+GM@.IJS?2ML)
MGTP1=<D(8D6`R-)S7G&,6L5*87\(.%B_BN%[WQOA:@SW4'>C9O7[06!`YW<\
M8SK,1N;-X(ME/:#;;9YAZN1`FJNO>T4GQPE)*FZCK8>3I<+K>!=(P*-I%0FV
M<"#34T<4V:+8@!8F0[7'F<:JFRV[N.FQ?+1U&`XV=F-ECT+I4S-,S&2@I09M
MA&L$NE'(6`8@]W0\C#D%-?%MW!G2A`5`$$Q$3+"'<1"H=QNQR%;,MF)]FH:=
ML7>JGL(PV'IML!'3NC"92<MDE.))DW+:$*N1#65@6/F1\5I`2,T@^FJQ(`NJ
MIADFI6$)J`UK9WQ#>$L\M1V&MFVS"KWBB&T9KNG:B.M6$I&-[>1V:VV/BRB\
MT:/VG.Q755NMAPC%87/N5<!&P\H.<@X;H5_*6:<';H+9!R&1RH26Y''%CF<.
MIQ1JZW2KO#)6@B+)P,ZIZ_(P,KLB3I5B='?HD3!1RG)WT4N1XQ48)"#9.,-:
M(BF;"^(#%`[&!0TL)R![,;"RKQ;R(QXB4(:U!VCV^>J>T)!)2ZGKKNEZ(4?6
M?:!:9J=,D3V8R8&PDJ5%!K)SN00B"\NYEP4L()1N3-"8`7"5NVSGEB:=U]>M
M"F-,3_UZCIV:^SAM)-\B1&<2T"7GH@QH^8DB]EQ)'SX54I:R8!%1<LHB*[A4
MTXO99N33BQ0J8*6-#"W"+FUZ=N-H;$2"`P-G)0V807%O_P`?S>@IFR&X4,I/
MN#2D69VXTI:@"2YX.I^!!YQS))\3$)-5E9,NK)"><.`FS9_`$O?`,_7.0=Z+
MTE,*$IBBQW0M-D8\D.NVMKY1(-GA.<\;NA-FW79XSBPW&HO!P1&WUM\1DI-W
M_P"76VT(CH"E@KDPLPSW@`\;CAW&N7*O)DTG=.G<]-1@XQ@O>%TRI&\./(C.
MJ8_)&3Y"BYD2I(&&#UC0".VVF)C-D!#AU:P1CY1?/'0A\2MCY(I8U?P`>>O7
M+09EC:Z'-8']%L,,QP3VA2RI-EO1CMW'^P,QPRMQ(W\'8HLO:6-V,U2C>BYR
MK3<#,Y!V2'(Y2Q-3*YD1!<[WQ,7"YV@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4$>=@-K(!U;)-E1GB0`F$3>)I3)-L85N
M.]P^4C*."3'4@L0VDWUX4KXL$?!OTCXAXY=?^;>][7Z`C+WN7'C]8DKZ,YE[
M.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]
M8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.
MZ!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8
MDKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z
M!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8D
MKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z!WN7'C]8DKZ,YE[.Z"
MN-U;^ZEKW+E`$_I$HGC\.M+039F)W$_0(QE[)%2I&><[ZV.MK-$S>[!L:\J+
MC<9RJ<!Z`[A>!("];/'+J8YA9IWJ6A?GW_AA,O9Y0.]2T+\^_P##"9>SR@=Z
MEH7Y]_X83+V>4#O4M"_/O_#"9>SR@=ZEH7Y]_P"&$R]GE`[U+0OS[_PPF7L\
MH-&[(;E<7^U<,O&"Y<FA5-LUX!I!BY]N,F<FT[FJYFNNIKL9#[9#G38^P4&R
M^&&\40BL(Z@#>^950)!9WQSQMEAD$2F#)NF@LJQ5*.TG)S.6X?J]KQEV0"QY
M'@?"/F.R7V,WE1I%)4=J-#NO#(O*<KH397#Q1,5%?.Y-,N?,&2I$(X)B8P#7
MD4%>/&+'WK^I`\BDV.*'M3IXE">-<($4X752C48ZO+Z#,**ZF\Y74F006?<A
M)2-C-:M9`%/G\#*45O8#/,U>]Q;!CS?3-)V#"C*@:-N5*=42/F*AR+&J8T7I
MKBF2Q':I"+Z<9-S)#(<T5OO7=1C]?>\:FP3`*&\QB'EO,D?,%5'R@6RP"##N
M";%XCFXUC+;8&WTO,@XWHVT49$)N\FPG\LNN$G'QZ6D7Z"Y'03:]"Q]-="\J
MAR4>*N4DL%324KIH@I.Q8`$?.U@XV:/Q\JV<BOUX\DDWNK9-[S[$FT"%L(-!
MYM-4XVF.'X@4()1;M&.2<"7CLS&BW%BR?1%-MJ9(^$;3SX_6,>-Y8G,`G5K-
MNII3`C9=Q5Y;RR1/S[D%Z&GR[GQ($6R(BD2IX1%16Z0;,=QZS(G1&7&C!1$A
M``L72T\O?,4V(9.&QS)LR,-D$/TU(XE22IJ^KF]KI,436KNQVP^Q2#CE'\E$
M2S\.;"S@I[(*4=O\NGQ(7P5F(R)M!;S@1P,/!C8'VL0$%S$R\+?,,7LA<<;9
M<<//Z)M_9&CN2H@<6W9M+>"GKCC*09IJ[G;%&=EI-14]L27`+A;C5=+>>V0!
M5"<B<`"I@)8.14[X^",('<,.`A;B9+PZ;A>^\<XJ*(9U?V6U5^,BW';R5'@8
M9VS.SZ3M(YG8KJN4)`%59]H;L2,2`!K(N&7,DQ!!!P,Q[V$L$EMH7GQ?[3OZ
M09`=>VS];2E(<'0A!2B1;D6R%D1((,&;+A;/("T1LJQ&?&R65EU!63CMA<LP
M/)W_`,/#`;^DH-"#LSCANZ%[)-Y#Y=0HJ4=S4#>].BQ&U]#)F1IR2Y\(;$GB
M#_E6VO6<H2?&HSZ`'L12%-1\.G%1"X5C8V!`EB"&_4YZ<7Z;&<21@#ML_LTF
M(-[73ONBJ.<7R'Y15)`=4XRG.IMD*O5B/$M\22R_*QLD'<'`,_XD6!ZP]Q>O
MGD&KXWQX]HV?>MQA.Y&)Q4H%T[EITROK-K4?AU9Q9<?C.YE2<QAV>MO$M!(,
MB/MILM&E0^6:@9]1\80T_'`KF*;QQP$P"36U&Q_'UL8X(GE-H;H2%KML5`QA
MV_1).T810^%9:24"02260D*/7@SG_#;I8\AQJ]\$!-'/)2B2OD&?2R1PH.6,
ME\!*".Z+GQM&,3KNE;?69IGGQV;):L;)25.KLBIU(ZPZSNG[S`>4-Q,@L9I0
MBB,"/8>0S5SN/DU*(X'1!E8\;&.#&Q[C8AG+Q=_%\\]@U[8D[ML_RCD7]KM<
M]M3""4BZ0O(0#PUM@5:@!L-<&XT1B*'Q8<#=7!#RAUAKF_'L,?`BAA=(=PZA
MKJG%@VH7TW@[UMY)4&OIFZI-<[34<H[DM-7GI>5(HG.(EY/<RBDQ.3$3<":!
M/*B8*&$OQ(T"<)EL[9]%L[9AK?6Q)X[]>GEJ,Y1>0V4GX@Z/)CY:.O\`'@VN
M15@,XHQGU%9J)CP$@@QQKRVU:0I"!0K$A+N8T:",BC%,\K@6R.GLS`6[]ZEH
M7Y]_X83+V>4#O4M"_/O_``PF7L\H'>I:%^??^&$R]GE`[U+0OS[_`,,)E[/*
M!WJ6A?GW_AA,O9Y0.]2T+\^_\,)E[/*!WJ6A?GW_`(83+V>4#O4M"_/O_#"9
M>SR@=ZEH7Y]_X83+V>4#O4M"_/O_``PF7L\H'>I:%^??^&$R]GE`[U+0OS[_
M`,,)E[/*!WJ6A?GW_AA,O9Y0.]2T+\^_\,)E[/*!WJ6A?GW_`(83+V>4#O4M
M"_/O_#"9>SR@=ZEH7Y]_X83+V>4#O4M"_/O_``PF7L\H'>I:%^??^&$R]GE`
M[U+0OS[_`,,)E[/*!WJ6A?GW_AA,O9Y0.]2T+\^_\,)E[/*!WJ6A?GW_`(83
M+V>4#O4M"_/O_#"9>SR@=ZEH7Y]_X83+V>4#O4M"_/O_``PF7L\H'>I:%^??
M^&$R]GE`[U+0OS[_`,,)E[/*!WJ6A?GW_AA,O9Y0.]2T+\^_\,)E[/*!WJ6A
M?GW_`(83+V>4#O4M"_/O_#"9>SR@=ZEH7Y]_X83+V>4#O4M"_/O_``PF7L\H
M'>I:%^??^&$R]GE`[U+0OS[_`,,)E[/*!WJ6A?GW_AA,O9Y0.]2T+\^_\,)E
M[/*!WJ6A?GW_`(83+V>4$I?I_B3Z%_6%^-G_`.'_`(O?&OXW^07-_N#P_BWC
M_D#R-\:/_C?!X+Q+PW^7J='PT&;NIA,9]!DP7LS&F\04[,85/"=3=1W"&0$,
MXAXF!">"N3-XE<Q\0<+9WPMC?*V-NGIZ+4&&^K[`GF0B'T:LS]BT#U?8$\R$
M0^C5F?L6@>K[`GF0B'T:LS]BT#U?8$\R$0^C5F?L6@>K[`GF0B'T:LS]BT#U
M?8$\R$0^C5F?L6@>K[`GF0B'T:LS]BT#U?8$\R$0^C5F?L6@>K[`GF0B'T:L
MS]BT#U?8$\R$0^C5F?L6@>K[`GF0B'T:LS]BT#U?8$\R$0^C5F?L6@>K[`GF
M0B'T:LS]BT#U?8$\R$0^C5F?L6@>K[`GF0B'T:LS]BT#U?8$\R$0^C5F?L6@
M>K[`GF0B'T:LS]BT#U?8$\R$0^C5F?L6@>K[`GF0B'T:LS]BT#U?8$\R$0^C
M5F?L6@>K[`GF0B'T:LS]BT#U?8$\R$0^C5F?L6@J6D6#H3&YM]:&R-#<4#-P
M]QG[;*AQ"&CEG"I!I3);):F`$U(=.$1LB@I\F`.(&$-?"X@88HF.-[8B9VR"
MU'U6]9?JZ03Z(H_^;U`]5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?J
MZ03Z(H_^;U`]5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4$+.08E">HFK3GG9
MC:JZS.=R(<E:Y,HLCNR(VEY#&3YEV1B6&%\V/Y'2R!_QQ*;\@&C9/JBVP\<`
M"\);,/KX9!A;FV>XH6C)KFBU9B9C8*;!F9M:^2<\">FKE/Q-%,OO@9JDV$S9
M*ETG$HT<M`V^%![I)9-',J6)408^#804*PF&6098A3%QHNB9Q8+0H/9`SD&D
M1\PPBOHUIZM%H.<4V1J2<1Y^Q"@3<+%P<9+$@-$)HJV!Q/!5.MXRE'"H60AL
ML,!@$6SVX_'XS-7F')#CB;7N4I<=^I)_:8;*!=+Y*<\7H[##2UL)&E=\)OT9
M*SXAJ%W`ZT48D5..O,@:$L5-Y6O?`F;%`#+F;MMQUI,*:_O";]?HP)R4_-3(
M-VGG)%AC4)PRXS->V9+;&+.,1ZRHOL.-GF6BV./*I16Q(&ETV&.*GI9DU?KE
MRIDP&&V^1(2)-8=&91V9UXU8U,E*0D@O$X44HSKB]GFH^>*G+$K1['2!F<46
MR23CIA(/`/G$<`<L:PPROX//K7#Z;7"$NU^Z<"1/I-IGLG"VF.L+ND?:ES1-
MBLL!W10V?)T:,DRL-I`V&5E:R4FI:C=4B9W.4FV;!YC8XXKJ@7P$P$MTA9A-
MYS[!\7#2E8Y%*M"S-SS1Y=;6OSIE%+TW7EB`F7.SR/MY(:\1O&=TR*S47-]Z
MJJT[DI/N",IV`***D7*&A0#(N(5!KE-V/X^&CE9M2;$T'R!)SPG#<:-XECW6
M[2F1WZ[G80U)EDNP'\V,6D6B]>75%^1F47$X-QGP;`H)TSB9-I@F9'&V5@Q<
MIM?Q_*TPLE72XHU2QTQ<>@,U;H+$Y*L))Z4XT,Q$4YQ=$B@@'&\?:I543L4Z
MSQ4RZBDCI/EX);(X$\0[#6S`R#9&6V'$\D-66W;(L,MN$RT'MZ-'K(J%.>D3
MQB=Z)L>S"_?HQC>14EE/&($USNEDN5]X")ECJ65-V)FP!`S>)?/"^-!VY#97
MBK&9LS/%=AUFL(:!%B-4*1(_DG3-QL*8`%2;3^23!Q1LQ"YHG3Y%>YB:E?#(
MDUPD=..BJQX,4L'CX<$8,,.ITND;6C;Z=MU&"E:E0NV6-K0Z8-:K:P=VM-XT
ME:RO(D1DWX]$:3F/(K11U=!5V\NF?`D\0R)<$<AF&-AF/@)@-D&G2Q>8-GW?
ML8L:0ZH<;K9AO7"8)!U^2#6RD+*R^[]CY<AP3!'E4%O'HY%;"+"L<HK]R,MD
MBL'"SL/'#Z6:-YIX16P(8X8ZK;?ZV1+L$7BG9S05CQ07]0:'-NG6P6%J\)L7
M*\5NARR)+;1FE'?1Z"V2^&I]&42)S$3Q,UT,$`,R*<ROAEGEG@7##>*UL5QN
M,1U24XWT@ZE&X.2F1I:XF`;8FL#G=C[,F]R5"3$^+%)5,H,>+J"\D&6S#2*!
M-@!O%ACY44(S91QP\9(VR#*R6R/%D:C]UODU";51%1E2^W(`<$/.#2]R(^PH
M,UO1`).UC1J0@8Y%&$H++B>[/405A+N331RIE)RS-^&Q``,9@AOS7,'0S:5K
MNIS17`,9A#,!\JD8R.SI`UF(QA(L<R&C):(O'V@]V$_F(WW,@JOD!RIR@!<0
MO<N;('P#!<04$7'.X2#]5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?J
MZ03Z(H_^;U`]5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?JZ03Z(H_^
M;U`]5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?JZ03Z(H_^;U`]5O67
MZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?JZ03Z(H_^;U`]5O67ZND$^B*/
M_F]0/5;UE^KI!/HBC_YO4#U6]9?JZ03Z(H_^;U`]5O67ZND$^B*/_F]0/5;U
ME^KI!/HBC_YO4#U6]9?JZ03Z(H_^;U`]5O67ZND$^B*/_F]0/5;UE^KI!/HB
MC_YO4#U6]9?JZ03Z(H_^;U`]5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6
M]9?JZ03Z(H_^;U`]5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?JZ03Z
M(H_^;U`]5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?JZ03Z(H_^;U`]
M5O67ZND$^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?JZ03Z(H_^;U`]5O67ZND$
M^B*/_F]0/5;UE^KI!/HBC_YO4#U6]9?JZ03Z(H_^;U`]5O67ZND$^B*/_F]0
M/5;UE^KI!/HBC_YO4#U6]9?JZ03Z(H_^;U`]5O67ZND$^B*/_F]0;*^(+%^*
M'T??$MI?$+Q#R5\2/BXC_%#R7U_">3?BUXGY&\0\)_.\#X'P?6^'HZ:#+*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"HF0?ST]7OTP=O_O+ZD4%NU`H%`H%
M`H(0<BNM[ZVSU1=,'1NHMI*=JW)^M3S*'7><42"%@EP]LS$$QN<$<RE)BP=Q
M.G&NPC@)+&P&6`AT0+`3(,/+(3`(>25QX38\-?>0^*TUP1R$X-L.0..-J(Z,
MFU=?!2DN/6BX-/5142W<8!;0YH@[1RD`K&(()4$X6RR'*6R'QMF)<(,&0N/[
M:5!W@QFMC)\40&UU'9EZ2],4HP?L#.R*V]G80<!9U>)11+.BBT@JT%8S@L#J
MZ9@OR&560C)@RFBJX`>)LW<D$&M82XZ=Z-48@36;$)?622W3+?'9!VE4T7D2
M0Y!:S>BR1H$*30FM*5V482HM=!Z4(X6$:;SX:HW!P&Z>N=3BXH!NV)LS8$-3
MG.&_8)BA!"M=IPY.JI)NE&H^N[TP>VV6V6O#2B"8-;X+"@U4=IEJP(`2*;'0
MBZ44,$WFB*7D!:P'+F`0S08"D)D4"V;:;3AUR;Q[HVG<2'&,@KS53M44%NF3
MF"^W&*21M?9;AMX*0":6N,^'"E$LVQ'!@%,+CF%$;`7(`(<SG_/,4%?,K<1L
M^/(3=9)2Y"C0XQ7J_P!FJ^DK74SCB3+1.S91W!B[=G<Y+>^1-N'RY0X\I<9%
MPFZ&FXF0L$TB4"&N!;/.P88[L1QH[SSO(TE#NM<8$B%<]UXVV,B:6'QMGL:D
M-]GP#'L^1_*[<@!K:<-5F@02VWZWFPTQ$89V*`RWDJ9WS/B8X'#=\R82OUSX
M_)GB7:Z.IQ<B]'AMIM*5N8!\*1)(55TPO"I&_.T$/31#@!,L;;A,GF>0FM'Y
MP%P8Y&,,"IT0'`MD;#RR%P")K?XJ=Y(_87@HCFR+(REQ(U%W?A)KOQ'6G1F8
M3'SL=R)H.V#5$3U$1CCFF^G'XB33B&>702QA1;ZV<P-$BASQ?`3(,.6N(S:=
M].*=WGBCQ9%P<R0[J2P4]JN[;;9';%[$7'KQNXR-C7<X'W,DSLVZNL6>+,33
MX*<42BQ4@0-EP`LPK^,CF0@FAM-QZSM*VR<U[*1LX(P#7RZKQO2G`K:>JLY2
MB,XY'TADG8UVO%E2B,D-M3&;+1?[7FO$BEJY#!5-)BG:QW,D)8KB"8"0^EL$
M[),N?MV=C=CT2(&:J;4.2!EAHQ]$KV<LAX,A#B6)@XZ'2G>[W$PH[Q<#B,FB
M]C%S90@$6N&+8''&U@;9B!I9(@;D&U(>&R;8TY;.J\N0UL7-LC[#L-2GF4)*
MB]TZWRC-AD!PRLFKS:944R&GS3%YF1Q3SD3`":BVE<(14,)PHEPL`#F(=]'&
MC.PC5E20G](\TI$VK[RXR8FU`695<A0)M/5^3FSWYL&[WA("ZUFVW@6TV&6L
M92T2L1!)#&#!<,#,(0,3(*PXX0^8/$UL<UR,,EC[JB(42/&SP-(ZS<JNN@3`
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M4"@4"@4"@4"@4"@4"@4"@4"@4%1,@_GIZO?I@[?_`'E]2*"W:@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M%1,@_GIZO?I@[?\`WE]2*"W:@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&
MO3\MQ2E'3:8J2;'J:I$#`I0\GGWHVR9TD:`SN&,6-E#"D&.7,`B8WQRPSQME
MC>W1>U!Q/IKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-
M<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K
M^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSM
MQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/
MIKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEX
MU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->
M=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:
M!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\
MO&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKA
MKSMQE\O&K^U:!]-<->=N,OEXU?VK0/IKAKSMQE\O&K^U:!]-<->=N,OEXU?V
MK0/IKAKSMQE\O&K^U:#-4-PH#G(8JK:7$=PI>8H@."DAJ9)6(9#`WM88+$X0
M',%\A0KWM;+&V73C_EH.XH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H*B
M9!_/3U>_3!V_^\OJ106[4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@^<;C
MNX\]$-EQ>0&3=AM.M:IND4;E5W\0AGS*<,L)\NL5%1YH/!I*4(NN-#4%')/3
M0QLL0`?">##ME?JVMTWH+%NYSXGO9NZ2?9IB3YJT#N<^)[V;NDGV:8D^:M`[
MG/B>]F[I)]FF)/FK0.YSXGO9NZ2?9IB3YJT#N<^)[V;NDGV:8D^:M`[G/B>]
MF[I)]FF)/FK0.YSXGO9NZ2?9IB3YJT#N<^)[V;NDGV:8D^:M`[G/B>]F[I)]
MFF)/FK0.YSXGO9NZ2?9IB3YJT#N<^)[V;NDGV:8D^:M`[G/B>]F[I)]FF)/F
MK0.YSXGO9NZ2?9IB3YJT#N<^)[V;NDGV:8D^:M`[G/B>]F[I)]FF)/FK0.YS
MXGO9NZ2?9IB3YJT%=O)_K%Q9<=FLA:?D+AZTBG=>59=BF'T".\XJAB+@5%<E
MAS!-9(-&7D?B]V$DPL3/F`[YW%*7#ZN5[Y"!XVOE01%B5D:I.N>)0T]E?_#@
M:.Q;MZD:M.'::#HW;[LU5EB.I@;Z`[R+$R:CGEQN1`G%886U%RJ(>!8942S9
M84'$3/IM>P6(P8?J0W(!V4V"F^&7/_AGM`XK;>JCZO'^TTA!29K,^A8M6C#!
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M3*93$-O-]&(!`D4I&2$XN&`6+@X8!`A88XXVM:UK4%SM`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%!43(/YZ>KWZ8.W_WE]2*"W:@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4%17#__`%+W]_5KY#O[:S-!;K0*!0*!0*!0*!0*!0*!
M0*!0*"ESGJU&FS=C0NT+0+$A&='B#L!`S_5XL47PUHZ*O!BL1Z!+;S1<W8\%
M=$1DSRDC!YE^M<?PMK#=8/'++'HH*_N,GCFV$A+D80=C8ZX\FOQ,:OIT`O6/
MIOB%(VS;VRQS:)ZJ:H";C8]FA-$\LH3*"C8R*,<Q/YC`&1?YP%L<\!\^J%AF
ME>HT^0_L5S,/^0&<41FKMU/B$^8#40G0V%3-XMHE"@3.,GC9)+53AUL9X.##
MP/@5,,H->W\^V-P_YUPB+PX!\I^EVM6HFATT\6AM*8\8"J;/?FRY+=76Q72D
M-`=$ANIX'7D'%"&<5W:JAH15RV#R(%30IDQD#>^&7\ZUK!]*5`H%`H%`H%`H
M%`H%`H%`H%`H%!41P^?U(W\_5MY%/[<S]!;O0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!05$R#^>GJ]^F#M_]Y?4B@MVH%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H%!45P__`-2]_?U:^0[^VLS06ZT"@4"@4"@4&HY_DPQ"L#S9,91(
M"7S42Q')$F%D$<UF1`6S##9JRZ04@8Z$"9$)A*0B58'(7$,3(.V?6MCE>W1<
M*HM?.23:)P.G1BVP4*ZP!L'?LLF@1T8UKV%>LE2K%RRMP8X9[2S4I1@\X?9%
MAF05;K9,)JPLI:F."BJ@Y3$7`0,SAG03R9&_^H$FRLH0?'LYM1QR>6//I%3$
MO`BZ"3;=;CC+$U](;;8D@G6^784BN%A9$3%UM/;ZDJ'DK`J8R,`AV+C=0(PI
M7(P;48W1GQ\==,!,U37;3>;/&B<S3`*U1!-G=AUJ%1E0BJC0(`ICQ@O!I7BK
M%5,R8:DNN?$4DI)Z03PQ/YA(8IR1:1'I?`@@IL$UAY-'EA8@;)(P27?Y#(S>
MB*:FCFX?6'W=N68*')QE12!PR*$=4P%-2M;#,H"/@*%EF'Y;DDT@RF,M`6.P
MC5RE(_*&4)I")BE._)&<$P%S-R:G&#9?.+<NPG.^VZ<QR"5TM/4S)Q'%#SP/
M!E\L,[8A@VZ.U.PT03IJ!KEK3&<,OR1-J3$]B8*\YR$]X_9;238,8R"]SN>1
MI@Q_(JXHGEP!8S`"PL3P##S#M?+/HO>]@Q^*^0DPU%W92,M^6K&^JDF:LL..
MYD>+I0)0-O\`@I_P;*RHZ6RRY.CMX.%FQ^[L!\GVR5-NGT!010E,%8"+AE;G
M<3Q:^08[.G+5KE'T1LN:8W=C=>[-];2"-;)LL[07K&;EA-,E]6!#.NIVL%W-
M%,D%*4R#=,A**41.I17%;!%PN6$SQSQRN&_2?)!I.>B59FT*>$,!AM^3RD)*
MX2BVGXDOXI,B@4)J29%'T0*K5)RX8D=72%``^21`D/-2.)PF)L$$0M_2T'!;
MN^,+RLLZ\#0;)\4.IH2]-,I0NY<7BIOYAR,E.V+8@?4F.-E-J/E9@65`)-;E
MFJ";6$9T7;5R;=N8/8""BXEBQD.5'_)-H[*(KVP8NPS26P6!'[SEA84<TQVI
M**LQ='>>8;ZD>.UY;;J:BRTQ6F)ACB>5FJ862!>XH-LA;7&!ZX;`B':J,=L8
M=?$FZ;O9I2]@D7<#<:"\M%GRTXW7'\4;9);00!G*::.2BJ,90NM$,Q5M#)JQ
M7,H-EF5N8$PN'00-UTVYY(Y<VSG/7%Y05I"VT;5AWP.F3B[&S/L[KBFIMJ;&
M.6D@,]%*0JZ](I587$)KB9@Y%U<PE%Q3]K8V&L#>XM@FA%/(!IS-\AGHMBZ>
M6DZGB6)O!13@0RKB26\\4V/5&R2_5*,WNNHJ6QY7362H7\&KF&RHJP*=_*8R
M#Q^&@B+/O,QJ8S->9MF"`9+8LTNJ&VRRY!%:*J:=D?HSIBUP3(R8F<,KLYU.
M%JE2+^B]KF';X49QMWRLB8CV`"$-86,!99!)%+Y-=$E5B2?)5]C&BALN%UJ.
MT*4U9YI+P80[(,RXK%T.+%!;1GNVV^NA-B1E4SB"B+.!;-(4[XYW+F1,0Q,L
M0[!'Y'M)EJ,9*E\"?&ZFLF'W0WF3)5W0A/5FN]J/!Y!)8S';!Z-7<V4221UZ
M0`UHI=NE2Z2,,O\`C&'D_$S?*@UVY>2&)UN^JRAKZH(4OM^>]SR&H+[&-B.5
MDN:(%X2&Y:E=3Q<[&<S<3G>@O-/#CPEC9&6228,(15<#=K^#R!N*&VXMY`]-
MYJDX:'HQGII.I^7L]+HQ,N5<2>WWM:.#ER$@_1B^EA%3F)*UV,:QRLKV;2DJ
MW3L0\\C'@\<,\L0UBE<L_':M"+F"=M`SA@T%CR-*`QP1"?A1+6HPB-).KLCR
M:RE<XTRZ7(4<--)3AQS"\@C*23E@%EX,QG?X*"8A6:HJ/R0WXB(/E"4)(=,9
M'IF0&H0'$/'E&+$];0FV.^0QBH0Q$)`%7'(3+%Q1!</&A!<O`V$L$+?`-H4"
M@4"@4"@4"@J(X?/ZD;^?JV\BG]N9^@MWH%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H*B9!_/3U>_3!V_^\OJ106[4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@J*X?_`.I>_OZM?(=_;69H+=:!0*!0*!0*#16T3!<DK:S;$Q<S<2N;
MODF"I<8+4Q/&[$"63D>+`<#=0\3AZ^.5B16ZHHA6$%O:]@\.G+H^"@^>K5[C
M6GEM+&@I1L\=>L_'\_\`5]?A]4G7<:*IC8"Q*<SLQB,$1L2Q&)5KQ-&;?4'B
M1V&4K8XJUW4JY$2)<3,YX(RH!%[X!W^F?&%LK";@U*AR1H[>3A9>GDCN%YE)
MV<^]4GNB%'*6;[5DIMQR[82U,(*)>S/E9V!/S`-=).$`%N(Q8RKX%A%6Y@M>
MP1ABO3^8G.`X])&T*P'#/>OG&?PHQM+R8AOM*5FJS'[!7(=,DTR$T%=U$,#!
M4BXBL;MH=1*$C`0)HV$*7RL'C@.'G<+0;Z'[`A0F[687;[-^,ZQS=I.^!8'%
MT$@BYJ!B&]K3GG-;,J%B71@\+1DB9Y63LK7&\8PP+>$_DO8*R&<^ULJM<>.@
MK!-P!+Z#!O+NX7>5D9H3#95GQ9;++DS9V27FHO?5M19:1)L/O".<5LZ2?2\N
M#!H@XN(8Z:9/!KY7P075;YQ7M":VDT&V>UMA!!G_``UI'VB)/U@JDO-V'%$8
MG-D9MAEMY11UYS(RTG'/$#R8.(8!\'CEU+6Z+_#00CV'X\=TMSRNP>S,JH$?
M0[/2^9T?3(%UQ8DZN83!/BC2W8->V16&H^]DVTS$(5M2C-CW=Q_R<K(B09(M
M`=-2!["G,\3.>(=>V>.W9%V.9+E=4A]?8*V8W8XZ9&5"4_;C.S:*:U6&M0WZ
M_P!\.E>=[H5U5R1PC71%&1C5FHB(!@P>&PL.,>-8B"ERQ0-D;%Z>[QAS1M/*
M4))PQAG3+NOK]+:NE1A)L=1QL"[H,8VBR#`;D!B639(:S@;\-OTC+Z8!XZ8Q
M$3%14:()TH35261SJB!H",N*[;=5S%2Y")@L),>>]6XDX+#E4-@%N>Y%9\1;
M)\4*OIXT5Q7?[N*$'(_Y1;$IJ0>"H!?(,J%@'?(@/F0"`O08U&G%_MF9C1`C
M-ZPXX$IR0+HYLCK^SI!DG?J39LCAR2I(>MZEKRTO5IB$4T618OB]V$3>9M3^
M-R>5'02>),D2)#B`>/!!]&&M#!5XIUQU_BYP$T].7XVA**F"MIZ2*".E$5=G
ML1!;RD33!RX8(`R>5.IV>`.>&&.&0>-KVM:W1:@B3%.J\EI&UO*/(SJ&)MZ/
M=OB.N21%;D05D$ZY2X#!UR%BUYJAU*Q#!S0SZ0Y![Y$K9B9>,8X6$M?&WP4%
M0\`<2NRN3)A+6J6V:]FFAZ[P!-,,`;%+V]4J2U&>:TZM99`U<9K\U9UD+J2>
M78HC@;[_`!U!53G45(DFZG9#IJ?@?&N7/@!NZ7=7.0?8W3)-U.<6J>MT5XQ)
MKK%$,@NP:3$%Z*\JO!D3!KBHF[PHJ)J00RBJ`#;"B!5455/<97!85S@B.1L2
M!Q(BFA0W3NIH?/\`.>P^P$B,A#:"DT)';W$6EH%UIS$B`YP73S?Z1-A9N#44
MXP4'\`$F1HYBXR;U^M91.99%\.IE:^5!C^R>B&SKCW!F+;2,6G'SQP:L]\>V
MP<51RY7F7;MIHMK;%6S<5RRR%!6$2U`FQ',GIL[`*K64%`(8B*MII:PV1<&V
M1@(,<.:)[7S/L.6VN?##:\,J$F[XP#+SGB)/DE&<SFBV#H(TAV'UJ#>ZZ[T$
MEBUG-,SM>4L%A[D4C,T6((A1/"\>,"%1>J&"H&B^WCT@'2;36:HT8T&1-Q\L
M]ZISBVIC60"SV69C3V]J)-.J;'/0=%K?0PG^UE%Y),LW<KH++F)00L.GY)I+
MRID9P-8!&;6J7T_86>^+2+GRGZEN2!=5]#]LT&4I)AZ>$>4F@L0V/`D.0X)(
M3];@S3:*AK-$KY(@A!X(3SS)KME#$V2%+88HA@P*$^^#6)74%&TFS^^WDFRD
M3L<2]*=5Y.31;GD]ZZ-:0N)\1S",@IJF+TY'AI=<*POKYPZ!?(JK!YDS00@P
M-P1+A>_0*!0*!0*!0*"HCA\_J1OY^K;R*?VYGZ"W>@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@J)D'\]/5[],';_`.\OJ106[4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@J*X?_ZE[^_JU\AW]M9F@MUH%`H%`H%`H%!7ALUM'.:;
ML3'>F.HC*B]QS\\(F<VP+Z?4YJKI(Q%"\+MYUI3"2EA61&0#9W2`])"?"F(0
M148F;2P<0$P^;-'0L"X80X<5H;E2'"<;R$K\C3%:L%N-ARRVHI9+SB`=V2='
MNTYI_)2<J,,WKTP4]+6)O./-2.G#"2>:(J4?4BB@FF!"Q@\2_P#F<`Y);D8T
M*;+,(RF1?N*+])\T+,*"MY,A:5"TR+VQ;::1ER*42NR(DZ._I:)R\"T$CPY=
M,5DD$^;)W+Y%["A#EKB!SXIY0]))J>D>L*/)96%->E!RKS`:1A5B>86JV198
M:J2NKSFA%<>;J82*T6K.C?16PHFCC-4SI1QEPB0E\R=K]6V0='`W(7QXSS)*
M6:AA_-\Z\Y6078(UY-48=D*.D.6R$5EQSL@MYIS(^(^:K7D)8C$BEBF%A(**
MQHZE`%!Q!0,,"AFX`=RQ.4;22131L)O2JOE4^\4/V=&NYG7#LU,=F2C#T7)Y
M-6D&186>+QCU#;4S-EK)2B6-CC-@RJ9"DS`1D'$4N*&+D'4H?++H2X$1Y.8I
M-*J1;#)A<?8XVY'##TW-A$<L`$%)#1UN:(W/.&.$P.4HU;2DY"(:HK-WRF43
M<#00QC(,`3`7()D$YJC!1EXU`Z<ZRI^5B,8(\S'VL2)*IKQ&-'&Y55H-UT'%
ML`CFW2H#@<*"?`(E\S>)LW8B8$""R"`$SQ#0NI.S+EV(=^Z3<<#90VZ6UAW`
M=6M[9,HQL^9'<[=;\1PS(H#D7<#O]&46C"C)IDMF$7_H+`E0LK?SLLZ#4)3D
MO@%CXJ"3,LF-I4>Z_/>U\4Q0R(#C/8.47<[RFKC[*ME\-S!G)$9J+J5Y+CM.
M6"63GP3"IA'L+XP83S!D@`(8P#VM[E5TQE=&4\81G!#7EE8A64)ABMUNN/9F
M0(>D!)BEM8+KY&;4A#L`LBOH2,O'2V3K2&\84'`C87'"%)XF2XX00:SAGEJA
MAUON;67*QY)8[6UXU$U@VA?>P)-`EDC"#F(3NTW`YUXRT%UY1T@8$6PG!$TO
MXN!G36:VYLE(8N5)W-IIX$()&I'(_IZI1W+,FJ<FK+%0H-!9QF5$*4XKEV*I
M*:I:2#MTR,#&422$Q6W)ZV#*:K;Q)L734@YY?4;9$B/ASF`@&`8?I[OJE;?;
M$[C1<T$(=/8>M(&NI9'5'&TI$CN23#CEYE.UT.YNR)'<F-]K.-HJ;7&0BMBH
M0I$&Y@H;Q'Z<P\P\\@T)M)R.RO'4?;CR%!#%C%S(>N6PFK&GS)5I$47.`CN_
M8&8Y5B1FS`?71&T+B>*1]$:3.J$3#L5"R.FU]/5@LL[!`!6S#6<O\C.Y6H*U
M*3`V=CK5%_O4'13<C<6(%/6]Y2AD1(*&H31;SC4VA-;)?B7DOM]IOX9W$P$I
MPD%#,/,V5,E,B]A;A"4'BD<A^X4;J>G#EG*VALF1[MM,4*0L`R=<'Y)I.=V@
MK3J7"ND.U);CR&<B0_$&.1#%CCH+A^3AB2(`:/XB]4MD'D&U"FWG(!L6'-<L
M:10OK*N0#"TGRS$C/29U>LC)$K[6NJ!7,KL>3C4<JS.3!F/#36.R(VU1O-Q0
M6PW!DIF"%SIHN0)BAWN'?3AMM.J@A31#!>,EV)Y6ECCH>&S^L27D)AE)R0]F
MLWP6[.,/.?R,KKB$8EJ'W0_6H931D<<4H?\`+&6&'6\1R''#3;UTWU14'=/N
MPA+7V,F+!31T/$(LZ4V>PVFC+4YKDP1R\$EXO5?<R*6!<4@JD=P\VD!&;]U7
MQ@0,RY5&X=LQLP<\`MRU_!>9:!H2+R.FE4>0P(CC<%^)!$D53226]`V:C8.E
M.*)Q$(`B0+$ERPX08(.&`06.-L<,;8VM:@V[0*!0*!0*!0*"HCA\_J1OY^K;
MR*?VYGZ"W>@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@J)D'\]/5[],';
M_P"\OJ106[4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@J+X?[7^)>_M^B_
M1?EKY#[V_P#&WTV&K=-O\_PVO:@MTH%`H%`H%`H%!6CLU`VQ[5VQCK>G4QM1
MM*KU2X*<>LLU0/*#\58J+2'%QU\ITFL1T1Y):<T7V1;4A1R\PU+"Y142Q4U7
M2EPSAD8*&"Y?/,(\O?7#D@E4[&>T\BFH./S/!FWB'L'"VEQ1[',XC9L.@Z]2
M;KR\(Q'V&QB]-<2]-#P*RPH.G%P'4`9#3E<F53BP`1/,<YD'2,C0_:%S[3QU
MN+*25%+(<KFW]$VBDJ)FR]U1UDHQBIH\=SWTNCI#374*T48K(4IK*XH$E5>,
MA%4X@7+F?%RPH^!`,0P'=-?C\GI(:NOB.<,1_<]&?,WL1OJZ<@7$HYA"P?*+
MVVV<#:"3Q;M_#(Z_L2$UHOC1#.P8`0F)C'$UG8+"X@0:X^((W1V:T@XTD:S.
MA:"HYU=3Y'G:-IF^-*P\'6_9".Q1L1"T*(:I"AEC(`313T8],>:R]_&UA0!5
M_)=BI3',-1&S*!^)/%WOZ_%"+'/*91(Q>S(U(W2U]D=X27NY,&P)R294V$US
MPCMO/^-V$K1^W8F@>(,GRF]:Z,@I2>H`$U+&V9>P*<&$8"P9:TT';9[3MY;#
M*,6)VN6L_%SL=JGM.8<#HNFH0`4CM75U,<!D$PH)A),SCH-MPVX?**@;')>+
M%_`97"OCGG<(.BX.H<?#>UQ<>P$KN<R_WM-:@UX[CB05!-54@^Z=0M5$4>"]
M57&*FK6`:B!]*3515*0Q!<\</'#+X%,=7&PEK4'9Q%'G(;JQ.FZ8\<ZPP!-4
M4[,;B+>Q;<?"[MJM12Z$)N.:*H9CDVBJC"QURD`N,II0T:&#6.6"OC@8Q,8A
M_P!'?&^5PX&NO'].L6[>1M.#H'C\5F-*>.8&2%'%-<"@<7+(&\LX0O(,*>)$
M1V^6`S4P&XPE#%<#\/AB0'R##"S,XYY98AHIN\76S"5K1Q[1*8-1?9TZQ05O
M_'DEY`NI5R21G)LQ"D@L".16R;^+&`JJ0P7W07R4QA@BN98#PF>&`V5NKD&!
M.[B:VP=462E!_C$5%D65-$.+IC%GR'*+X0\FQLMQKO$=XVCE:2VNUB#H'BF8
MCA[P&+O1E0HLH(8.0X2<*8\#?$,L#XT]DGF`_9F+Q4QH>F9H//31_P`*,Z6-
MU]G=PW#)"MJ9/RA/RJR):F>4#"NDL**G@H'Q"+;+(#=-'T=4''63N8OA;)H8
M6#:70ULPB[.[M;.[%1]&$4X[,D=8B+#CV/Y&.2>L-Y.A-DOEK+=G^Z!66RDL
M\X5`^X`QP<B`(I;`GF&!X3/(OD**%?[XT[>\[PGR2<?=D=L&W:N<DT5[=@D)
M!$4$MH21J]->R$.;+KBE@?#3%&ZL!T,=^LSQ?`++#)2;OBXF808N`M@GE+/&
M;KJT=0-U(<TLUS@2"Y4V4U<F^%DUQM=G(K'S5UQ]QJZ6TTB#N=Z,C&W#@U23
MB60AA,.@P&6MUQ<`,L[=%PCUAQ4I&N;GTTV;T7AS72(-F8.3F3&.QK7;S4;D
M?L39&!G2CHS>FE$4EIO,[,=/E-JJ1;%R-1RV+!&S!DD*FGL\B*D-B&';L^%^
M2'3A,G#7W4R-=:Y;A^2)>FJ6]>)BE*9W3&RKK<:V&?#BE)WM65(I2XG>X\LM
MV/)->:J>0QD1:(&51*$`(&PR@@61O,,[;\>2`Y>0#3)NNA_JLNN31#2>6<MA
M)O.(2*VOI!E[9HS#++9Y0XA-DN2;J&KNM-A)U.@XE%`[!IA:Z;>^-L#);,0+
M9/)Y#Q0-/\2*>(!8`X!$O%@?%`\"^6&8&`9;J>!PP!S#QOA:V/1C?&U[='10
M<N@4"@4"@4"@4"@J)X?;7LR=_+7M>U[<MO(K:]KVZ+VO].9_X+VO_)>@MVH%
M`H%`H%`H%`H%`H%`H%`H%`H%!A\AOQK16P'S)[Y4\45DQPSW,_'@LYA##X)+
M69Z*=<+@4\P"^`@XV)!)3AA;X88Y9Y6PZ+6O?HM05FQSRHHP@#8<&SFOK_U+
M8,KZ[2CM9!CQ?+N8SX^.L-0TU$:1)$!>R`PU!15HME%!C-R$7#=O&+'\!4^Y
MH/`[<X1,E<`W7JYN+*L^/`B@2)IK,FOK<>49!RY&3Z<J\S7R@G&\(<0,+,:7
M?B2=.7@^<1$AV)RF"UE',YXR1R-W!.B#$#8(08KMKOZZ=75B4U,KJ=+TFPKK
MC%:5-6R4Y$UEIL-J,YAJ'QC/J)6*";X-)PT]OIGM9I'5A;24D8J&0*YE"]C0
MB@<`)9!@NWO(S,VJ8F;C+:$RE,41+3JBIBQ=(S,F_7Q&6)@>LPF&XD,YHL.)
M'4]4R43KE.NAPW(^)B)V`M@R9@[E;`F%F-B&<#<BJ*E[)&X8<\5*38C1)E)3
MU\<,ZJKY;(:<W9^0-3?75<C75F5<'%0`CI#@X(?(9U^.W`LL%\R_BEBO5/9!
M+G7:7C4^0RQ9F%9"S'J=)*:9=;4;;C,AC.')@J:F>%CUQ+A4,L6NAJCS9/B"
MP*EB6R,).1_Q,?/(8$2]!7G(/YZ>KWZ8.W_WE]2*"W:@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4%6+_X4.+^3Y`?DI/75-"4WW)SQ<,@/Q=)2+,K>NY'F
MZU$=7<;B.IK;D9(1PU%84C&8PV0)</'+/+^2UNBU!B?<,\3GU24_TP;!=K%`
M[AGB<^J2G^F#8+M8H'<,\3GU24_TP;!=K%`[AGB<^J2G^F#8+M8H'<,\3GU2
M4_TP;!=K%`[AGB<^J2G^F#8+M8H'<,\3GU24_P!,&P7:Q0.X9XG/JDI_I@V"
M[6*!W#/$Y]4E/],&P7:Q0.X9XG/JDI_I@V"[6*!W#/$Y]4E/],&P7:Q0.X9X
MG/JDI_I@V"[6*#\MP+\36-K8X:CIN&-O@MCA+VP&&-K?YL<<97MC:W^B@_>X
M9XG/JDI_I@V"[6*#UB\"?$L8"%`,:AI)@N.'F".7,2W/PX`X(F-\!`1P!96S
M"&"$PRO;+'*U\<K7Z+VZ*#V6X&.)NUK8XZD)V.....&..,O[`XXX886MCAAA
MCC*]L<<,,;6M:UK6M:UNBU!6XU.(7CL4>7";->#FN]AH9:W'WKW+J"Q,I:G2
MR6G22\-@=A&DYG8"/:3K*62@KMMH)A,3'(?(#$,EA?##'/(3+,-Y;)\3O';$
M:[&K#A7BL>6RDB24$\U4,NC3Y-$=1DQVRPB:..M*DC2ZZ90-MYM*RX=<),DW
MTG$`R?6360^6&`14F<-`![H/XW.#Z;]16[NF3U1%8\/JD:..3W"(]97GHJK,
M5&8X:W9_EG'@DS$JIPXK..-I0!''(F#9,SB5N,5&&`S#$S".$1:3<;;Y2%9\
MR!PR[!1M%JEK\Z]E(M=*)+DN3$Y7<S&NDH3D*1X^([C>95)P1)L&_&HZ""BV
MF>>S.#+.&1DL&:P/$C)7`,-MK3Q/,!'GW#9WBG?6OL@PKJJ!N6F1OGLI(LDJ
MCXA@\L*S4+$,UAJS,"CLJ3DYZIF"6IHZEG8D5%-8#%U`X7"-"EPV='6CG%$]
M%EM18L<;V3=V,-[2.365ZQ&G[.S2Z$AH8L*-VC-DC2\2D(J_T\!Q1JU(CD!!
M,^&S34\R.X%HDBY!@&3&(M!8UW"?$MX7QCU0TGQBP7@/&/I;G[QCP'7N)8#P
M_P!*WA?`6$ROEU.GJ]:][]'3>@]G<,\3GU24_P!,&P7:Q0.X9XG/JDI_I@V"
M[6*!W#/$Y]4E/],&P7:Q0>O#@3XE@\A<P]0TD,0?.PA@0.6Y^#$,"8AX`XB&
M!,)6MF.)@"%CA;+.][VPQMC;X+6M0>SN&>)SZI*?Z8-@NUB@=PSQ.?5)3_3!
ML%VL4#N&>)SZI*?Z8-@NUB@=PSQ.?5)3_3!L%VL4#N&>)SZI*?Z8-@NUB@=P
MSQ.?5)3_`$P;!=K%`[AGB<^J2G^F#8+M8H'<,\3GU24_TP;!=K%`[AGB<^J2
MG^F#8+M8H'<,\3GU24_TP;!=K%!/G6C5B`-/(SQA[6R-TN+(WQ<2Z[<FRE**
M^KA#.5S#A&5]:-*+F5EM8-GU4P#CF-F*8SOEE;I_ST$@:!0*!0*!0*!0*!0*
M!0*!0*!0*!087)#;*O*.WZT#S91'J2=3+=+;.,URFA"+<=I5<0SR88;+@.@D
MU`4FB+P)JY4V+B7'R#`%RRL'G>W5N'RF%N,F?MJ4I%8!=G;GP>A0KH/N9KXU
M0=W)ECF0FS%LJ;'0>0@UA0?KTJ15:RS)L11\'<Z=5)!<1<TL*B4FHQ4,P+EF
M:`+!+K3."GY#LX,R<(BT`F75A'A+1B465MJR#BW&H[DW6V2#-1FNQDVV88(R
M>KHLTO%JJ;.=HQ:37&<3!#_QK`*B&^H9.X$@VOR4I$T;.1M(4#.WC\F>4DYZ
MQ8SW[IH_8KDUK()N--H%!L+0=B.R]SDEM)%C4S"C^%2%8LIW#=S94B6)CH#'
M-%;$S(2#^@K8:1=S]$%.?"`;PCW474UZ24YY(2O)I5COK?5^$V;#%UHFVLQP
ME``=H1@,^CR9GD1#!*X.JW4SQ%PMC@'GN+IDP9PG.,B[<@1$R7YF,J..T.P/
MDO,N&!`$=(R0`M149/AG`0,GQL;X5(8)LX`7R5\XV$<!;QG````#,,<XP<]T
M<CTBX[/X3B&FXQ9!=W4%.Y1J$_%]Q,CLIVVB*:]AM<,,*^L!=/Q:-FSU.LE6
MZ1;)^5[^.=`>$@_GIZO?I@[?_>7U'H+=J!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"HAC_GL[&?I::K?>CVGH-\;U+SO
MQ1D..G)J._\`:[565FR\VQ.B;"+E#)S.TW"5--95CC$FT!'E'!MQQZZ_%E0F
MK&TU;"/)AO`E<4`0B.;%`"'D):][+Y\8Q?CNE".WHUG3-^KNZ$8-9\F%YCNM
MJ:JQ\XS#H;&KL*3"Z45PA*SP?K4B)_HR2(?0DY6(FAVP?\.<RO<`P<"+6I&L
MFP,3R%$<BZSZ'+^KLKP#HO,<;[082\^6BBL/=S:`RBQM:&FJ=?K*>+_69=3D
M^1&JX%O*3E8B$=3DU7Q+X].9\X2*A)#6B!G'+.\,T3B-IW*>MNO&P&K;DCS=
M6-]GE1I.T'8K8)<>J*<:15ILXF_)-+79<7,13>26IJH`R:W5P%QE@"1(?$OF
M."&CGYJ_,<8#*DP09$,\PM%@TVR#"2>Q-9RA(?9ILZU-=CRHK$I.1?C,*J+A
MM<VDW>(ME>=!X44RIFF"B-<$]?!/*J.&`7SZ\Y2[E`4(9;`XI^,\91%&^4U8
MI-D^R7C+%V>CWD/%/LDWNDV)V=OC?@_%;^+=7H\%_1]6@W#0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"OS:_CHC';*6HZ
MG-4FC::")5C)@.^+D%Z:P3:HPRMG6(^5]MNAQMQ>/):2H&51..KC13C'@KYX
M8>$*AWO:]\<;V#17=#I7M(^7C[>#R^;=`[H=*]I'R\?;P>7S;H'=#I7M(^7C
M[>#R^;=`[H=*]I'R\?;P>7S;H'=#I7M(^7C[>#R^;=`[H=*]I'R\?;P>7S;H
M'=#I7M(^7C[>#R^;=`[H=*]I'R\?;P>7S;H'=#I7M(^7C[>#R^;=`[H=*]I'
MR\?;P>7S;H'=#I7M(^7C[>#R^;=`[H=*]I'R\?;P>7S;H'=#I7M(^7C[>#R^
M;=`[H=*]I'R\?;P>7S;H'=#I7M(^7C[>#R^;=`[H=*]I'R\?;P>7S;H'=#I7
MM(^7C[>#R^;=`[H=*]I'R\?;P>7S;H'=#I7M(^7C[>#R^;=!`/<+1]XP5/''
M5&S)Y(.5G)N[3;5N*&9.NL;N/!0/X,Y+UQFR4RMVV:N@A>1E?XUL!.ZYCJB]
M8IX8+JVN+83`)^=T.E>TCY>/MX/+YMT#NATKVD?+Q]O!Y?-N@=T.E>TCY>/M
MX/+YMT#NATKVD?+Q]O!Y?-N@=T.E>TCY>/MX/+YMT#NATKVD?+Q]O!Y?-N@=
MT.E>TCY>/MX/+YMT#NATKVD?+Q]O!Y?-N@=T.E>TCY>/MX/+YMT#NATKVD?+
MQ]O!Y?-N@=T.E>TCY>/MX/+YMT#NATKVD?+Q]O!Y?-N@=T.E>TCY>/MX/+YM
MT#NATKVD?+Q]O!Y?-N@=T.E>TCY>/MX/+YMT#NATKVD?+Q]O!Y?-N@=T.E>T
MCY>/MX/+YMT#NATKVD?+Q]O!Y?-N@=T.E>TCY>/MX/+YMT#NATKVD?+Q]O!Y
M?-N@=T.E>TCY>/MX/+YMT&\]4N.:,=4)=D"=TV:MJ)XE:1X[:T4K3RV?FY2F
M98(,)FN)?=:`W$$XJ)*>92T\HON@^8\';//#PAH2]K6OEE>X6"T"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@I^Y*?\`JXX6?U`WI]RO:"@N!H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!3GN+(NZ+SY!]?M-]7=FVKJ\W7
MEJ5.VP[Q=RWKXUI]4%A9C.5X6C]'02B4YG2T<$@J8)2<..(,&9ROUBUL;AY=
M?K8!W'JD<MWM@V+[M>)NW*@>J1RW>V#8ONUXF[<J!ZI'+=[8-B^[7B;MRH'J
MD<MWM@V+[M>)NW*@>J1RW>V#8ONUXF[<J!ZI'+=[8-B^[7B;MRH'JD<MWM@V
M+[M>)NW*@>J1RW>V#8ONUXF[<J!ZI'+=[8-B^[7B;MRH'JD<MWM@V+[M>)NW
M*@@/-NRLL:VR:N0Q/?\`B4-18DE5LXH^;A8;ZT8@]`<:*&X$DBNHHBF0.3MA
MF3#4D93+F@LL^BV0`V.?^K?IH,JFB7=@]=FM%KYFW_$:ZGQNRYO1S[AAYV.+
M1F"`6Y)B"F%T4V?662M%Y\,ISA2RQ9Q$!,ARP@@74-A7ME>V=J#N"S_V;.Z]
MG=L4[_$3:JJFM28K)[?5)M2-&H$5HZ2E]574ILD$%5<:;/YHDF+8[@7"93Q0
M>X9C`8T%CEA;KX](2VMJ3RVW^&W,&Q>B_P#_`,UXF[<J!ZI'+=[8-B^[7B;M
MRH'JD<MWM@V+[M>)NW*@>J1RW>V#8ONUXF[<J!ZI'+=[8-B^[7B;MRH'JD<M
MWM@V+[M>)NW*@TE*G&%R.S.]8%D!_<MS84'/K5)A^7(F-$..Z+4TLDO=3C]X
MQB;.JQ,&;LPUPAFT'XI!8EA;V#Q'$#&M_/"PO8-V^J1RW>V#8ONUXF[<J!ZI
M'+=[8-B^[7B;MRH'JD<MWM@V+[M>)NW*@>J1RW>V#8ONUXF[<:#/>*V;I^FF
M')\);)R(A2Q),$[J[1:T?2(WH_2HP).YN0@^_BBAK@S*1E!53T4\I`@9#"A8
M&1^I?.V/A,^KUKA9O0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05$R#^>GJ]
M^F#M_P#>7U(H+=J!0*!0*!0*!0*!0?"WM*_[M'FDYE4G#>?C_P!+L73&FDR8
M8OO/$;0E>TE]76PZ%XI&(;K=K>#1LVP$I]*P&&36+'+*1'PA02P6..8:<U;F
MG71@-_\`PK#_`)V*,S7V`V&T>4YH.!9GQU$#,?K%DEH%FP3E&SBD)+02P35E
MM\G\%-"#-%2^!,11`*EKYAA@#"!@6[JO%3SUP_Q(,XZGW;OJ"ON=N*8G&+J8
M9$)+A5XSNSY2BW#8QSQ?8F7*H!DN$J'2_EL\1QL7/FA01L<A<+X9T'W'Z_;Y
MZ4;5N969&M&UVO\`/3P;S?S=*XV(EE1G/M<26T"H$$@5>4$QNJQ\V420U14+
M%\A\\,0[#&`\+WZV>-KA+6@4"@4"@4"@4"@4%17#_P#U+W]_5KY#O[:S-!;K
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05$R#^>GJ]^F#M_]Y?4B@MVH%`H
M*X6!RX<><G/1JL)H[$%!5I]/02.64J."-9D9+$=S]P6#K>"9S:E![1XWHT6W
M&?<"<,0)E"RL(,=.AW`+XB"]&%PL>H(QG=Q]=$\NJ&S;[/A`(J;L:KJ6=H_D
MH6X"?J8LDF_/@^(8+/$$,Y,I6400@`PK9B+MLNNDXG@\<L[!(E$64YQ(R0X$
M<?(TDKJ8064LUF7,E,C*<IE0CI(?(J=!+G"V0Q8?'*X8H>`N%[]&6..5KVL'
M9T$?MD=I8(U&8J3)&P;YNPV@OO-`CM!.@-=Y/-27'PZ<#XC>;",VF$WG0YE5
M75L$P?P(0!,2^7@[V^"_1TABFN.[VK6V:B[T*!993W>ZF"`E''HQ5=N/..Y%
M;*8NW,8HBVL1S)C;9SY)MY9%*#!E%')/\1,"@B8!BY9X98V#RV,;VG,<M%[[
M&[,1W"8#;9Z<15GS)[[BQNNQ13TXN,GHB<:43_Q97'$<P+"#%BX5L,1<@\.K
M:UK8X_`&X'=#$/2`10DQ^1/&CV36N6S)ME/=S$:[D(MTF($4`$*(1192CH"0
M6$`(`89!E\0\;X`AVO;HPQZ`Q.3`=?HZC5#:$D-%E$HG77@PHW160)'.#C9@
M[I?+R2D%C(WQ-16XKIA,L;>*D5Z#(I0,B1$O8P.*"'AD+B&3L>$88C%1-K$;
M1%&$>JQ\E=-/*C'8+4::B=3LAP35R!LZ@I*>9,DKF2X8EPL\KA^$PQRZ.G&U
M[!L^@C]`^U.OFS9.4S\$RB@2&5A&5GA!\KYI@2J0S9$IL&Y7XVM)8`7$]*'Q
M,)%CH=[F`L1"0V.5\@1A+8Y7L'8ZZ;)0?MK$K?G;7.0TB5(C=9YRIS<?*"75
M2R2L&V@Y59H.+`G@M)Z6>$"3W$AFBWA?`V"&N%UPLLP\L<\@WA01XAO:Z`-@
MLFI:')!!?(+XBE/FUJ'D]NNXFE+48JCG5&:0<I985T!.2L,AW&C&2_B(@V"C
MA8/PN1>P.6`F02'H-;.Z8(V8;XBB-G<ZB2(^)Q6W0VXI;Y@LHBFGDMLQF+4A
MN=/(#%"9@D5%2&8WCI_/(T*!AD&!?'#+(2^.%PV30*!05%</_P#4O?W]6OD.
M_MK,T%NM`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!43(/YZ>KWZ8.W_`-Y?
M4B@MVH%`H/@EBJ8`LN/&#F"3Y!HRFUPLC:9"=Z-Q!(\<1\++TJN9C[WJ;V:T
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M=A,CE+U(<;Q>3G4BR*VFNWR`$D7/K2^LGA`2*4E%,,[>%''SP"PM?^=E:U!`
M?>/9\QL;.CWV/XK',4FV0M1N+O?1.?$YPFG?'UI9/:6S\'']?H@1':CDE1NR
M-)C?5H^<CQ(-TMDHBD,T_&XH%LE$,(<*_P"8WFM.+4[=YJ1QM#&4I10X^.L)
MXOUJ1!MWM3O,:QD]1G"'4V.)N=LASU&2.VH(EM913;A`4VD&I$E%<N&$;R1`
ML$@02P6#;9.7+1.4MV8F:\J[;C0FO:=Z*2,>#OM0],G6UI>F#<^5(%>LF![#
M36+)YS75A.YJ(Z;C(;C30L<$-%+F%1/`+*`8(V(1CB'8&2421=B(ZCB;PP(R
M;VZ'!>.UT6"=O]@MI8P0B$[;9/%C[!MQG["3`6174\VR_4!J)I%VIZ9<9KAF
M/#EKV\8$/AT'9:ES9L@Z-BH!<3^V,CUI[<NK?*1V#/T.G]I-JY"FT]&J7(,G
M%';!KAT"(Q@H0A$43-*)"!$^V7G@(122&))-6<UP?-4'L;"W[A$8R@+I0P-A
MWM)TXRK+VP15PJ<AN.89BDB12H8+/E*3$-H)31:CN<2FUF&GH;<$!(Y>2"1,
M90"*@B'1#(V%A*"E"%!GU"R?([+BTNM)IOF`G+>O44)>1DD^8LQMA(SY(9^:
MH\GFS)3#'%),`Z7RLZUJQS*]O"7C`J%TWRN%0=$TE5R18P-1-?TISQ[#&D]I
M\YEDL<&6-GYHTIA9>E6,-^'@WX2C)ZS[!;>4'.D&T")1%Y6;C>-G4A+7S1$<
M?(4P83"Q;,)*1++UW>9U&1^03=-Z-W5LWJILL]H(G5JSI/<`MJ9)C:VT:ZWF
M6.L3*O)D'21,LCQ-K270!FCFM$K`OP,R><A8@J>$L/@$1X-FF>(ZTVAAOQQ+
MDULQ@I7$-J`Y7DH,L\Y"JS'T;NGDG46%LK/S<:Y(L<!;LK-G64=9-C+1<EBJ
M))<I<</+&Y0/&P38GJ=-1XZ3_HEUFV@V'E^%)"V8A9J+2JN;Y/"/=&F`[18(
MF%^*T?.[D752DL2JWF6_D]KIZJX6JVW&:-FG8(CD`\R`2NH%3(:ST*DQWR+L
M3I2E.!]7D!MQ/RS\AT;Q8>(R5)\TM=O19CQJ'7JWVVQ9<F0F3DV0XY)++U4<
MT)85L;^.IXP=R>>9"Q6]!]>%`H%!45P__P!2]_?U:^0[^VLS06ZT"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4%1,@_GIZO?I@[?_`'E]2*"PJ>I^8NN#**OZ
M0DR3E9"-KY!M!%8GAR5IQ<UE%1*J!PN*,SH>9[W=1=)Q!3!+"GA">),$2X>`
M@F.8H>.0:)U.Y$-9MV3.6&O)R87&D7;RDYB;R=FM^P46QXLIJ.O@M=3";\AR
M=&C19:^K$UP7(#,B3/#G+7`'OX+JEQKX!.*@TFYY.AB,Y5A^+ET=*0)-GTX_
M$Z+4XHVC>9ET&H\:8[Z>P.:RFI8I%*LFMDMF9O<Z.7Q,7QZ@=\Q+VQH-LB(B
M,,K%UX5)3!5PH4%(%%H0@5S5BI$;.^8Q,NHY!7.`E!<[WOD'CG;#*]^F]J".
MRAJJQUK:5M;7+[E>ZXZV)$S\B&/6`<.-P"+60D2LNLU>E)R):&FMDBOJCO?H
M\>HP)PRJ*A\N$7)]4L`!<8;+,,Z#EV)3$W+&M>"H4SEXO$R--*PS[H2CX(2,
M%EU+,>I"\85\DZS?-8C.)MFB=BGC.1L/`&V5PK!9897"+,K<<T;S-(#A<3XF
MG9-0BMZ2,QY7?&L><C(QV!W2]8^.,Q50;YE%EG*LFMAEG5^/TE356LA.9*;"
MLI%+CF2`ES!RQD)^G4\@I`>+*)(HH%NOB)XN=+`F@.OAT]7/P0^`@?7QZ;]%
M^CIMTT'D3)$T\O@4(%"Q$J'UO!EB8`18N'U\KYY=0$'#`/'K97O>_1;X;WH*
MU%_D]X^XZ>#O91UY*"<V4.1QH]E&9D*!I8/ZOL^6QEHHW3S2DS9-#CLS!2"Z
MB[B,`D%$0^N8A)Q^]BQX8`?'(/$+)QB*<>P'\8)DC@9\E<B:\,7`,8'4X6PG
M6)C]?#/$P2$Q'SZ0\NG"]L[_``?#>@XY1!0R!<L4(HR23*$@"I8F5*)Q,N7*
M%B(MQR1<L""#@&``3'ROF%AA:V(>=^G&UKT'D&BHP2L.O!)*8&NFB@:>96@R
M!7!6,$`<["A$1U'$*QP8H$):V6(66=\,<K=-K=-!S@``"P6`!8$(N`'TV#!`
M#P""PM?*^5[8!AVQPQZ<KWO?HM_+>@]>!(F'X*P90KAX`<8T!U``L?`F3%AK
M#F`NC"W@QQ[&!+9YVZ,LO"9=-[]:_2'!4&^@JR<,CJJ(D*:29%\.82U!-)G4
MX<:YCQNXPQ(R"(6%%N:_I>MEC>_A/YW\OPT&J=A)<AG7Z(W#,D\'T]"BV.C#
M<4EE:.MP^Y@D,VH.-);+<.E$9(2U=3R-X+ZV5""$+E\LP+B=?IQQQRRL&4OU
M\,V*DE*<#C(JP9)7=3*CPCDUF4XW>?Q5Y`=J8TVZ":3F<BK*DG-ZR^N!9GU$
M<(-,2BUQ#AT8`L$*-@&1V:34LAYMBS9;UFT)?*XC>LBIMD/.^1GQW*^:3XMX
MAE?(Y_37Z0_A%_G?ZWPT&O)!EZ*8D6D@@^S(K:\HL^2Y&NYQ&@X##-;S4B!"
M1#CZ7'>_4Y$,M-D^3&\L@7+8*ITF.HEPA\2>(]BIBP0;$:3J;SZ:K9>[25"Z
MXU'BWT9U-A;*6%L46&\X4XLKHJH5L.&$-8NH)IP(;#KX8Y=7.W3:U_@H.EE"
M26;#49R)+\C*UT"/HI8KMDE]KMB1]2NBLUC("@Z'.K63DHL=5%"Z:B)8XW@"
MP(Q@7J=4/#+.]L;AW[:<20[VXWW8WS7CR"Z$1*<2(=N".6\<2%L@`I)IKQ<T
M&"9`\8)&<,^H)A@)CT]&5K7M>U!5+P__`-2]_?U:^0[^VLS06ZT"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4%1,@_GIZO?I@[?\`WE]2*"W:@^5MGJ4^LW_#
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M;@;&"7E(4T=`$5#I#$PH!Y#AAJ@LZ=M;LT9^O)0V7(OLSQ@:O)T@R&61WB2V
M:+Z9B<MDEI[S>ADPDI>+U)SB'H6-=85A@0L',5,B&#EL,%''&]@WK(KE:Y%P
MSL@Z&R3,CIXL0!>/PYMJ[XEDF;Y';['!6M@'\#M*6@J2@%IR2`2`/:_EFR9E
M@)H*(F:.AC"',_%5`8[G<."T7.V4I8Y(YOT>E::G=!V@4YZ#[4QHTOI+EQS,
MM>B9FQ*[,]N(OC0-_+B@?<44O2''`ZC":4"N92!W2``*2ME@4)Y!!>GQMA/U
M_:TN'9!\+KM#=>Z\C2#L^VDMSJ!\Z)&<2R/D62];62BI)\<0!N%VY`#>:Y@\
M0`#`#\O&3XV>'AAA<\@JXU*W7U>U+XUF-HIL`P#C[W"AA@+FN\A<?!F/E%SR
MQLA,&2VNI)S)K,I8;JBC2/'.QBV>NXK.^^)ULY):V(=4#6'@C6(8:)VI=Y(J
MI\BJA)#[FEB<HC-F!M$.+Z(F8_I/2U8-CCQ?#P^MR!KM%C64BL7RE';KE4TO
MD)',XIJF3%RP5@ES,`B5+^!#E21%"\\U2=9@6GML@1E##GSB'6A#<#4F^=&Q
M@SM9I2=>N+#EF.6`D(;J3T)!CMW-Y_."QTT`3MEB*9\8P'"%*%<RX8M*]XUA
M:3`=?Y<E6:HGTI9/.$>C?!/"F"9DQ(3(;=?$Z6F([&RX^\'0(\,-?EB=5XT?
M6`!5#)'3L#)KPF98J&)D"'1.R5V^79#+C$\MN9=TI>F[>V]].9.V9V=FZ&=1
M#D"Q]$<."I3<E&2FN@N:79I;9F:W2^@890C:P02%=,0Q3&!PV63TL/(,ET=:
M:]M(X./B%IU=DSNZ'4TSS5(BZS2<A[(L5KNEI1;M+!:;KLVWO9V.A.E]:9K.
M83EQ%:9%XGQU@--Q*^,9"9!B8W#\09KVGU4U-U*VA92],<HN>34+=+B]2FJ]
MW,\'D9#F8]M/,#=XTY!<1!Q'#`QP5KN-FW9ZLXCEA#QU(<!7,R.-8$/*@LJY
M2XH^@;@XE.'\7"ZG[E$40:^-=6>CC.+CK=[N$9,K1&&Y'PXSYP967%976A$X
MRIGA<\Q<^N()E_);HL'YMCO]KULO%<9I6G&QZ=(SK:V]?&WF_`(B6W*76$V/
MG9O#"K9<`*Z*F@)Q@1IN!),&B2D#GEF5,$A!0S&-P,L[7"NR.H$^/1?1F0'>
MZ]E#KQV.Y9.077^>5'Z=YZ2\'/K$V'3R!J[5A92223Q*I2##V)Z'&MF`6+`%
M<<\<,L0A[8G1+"!KMR(DGN5FJNM`)Z;7-&"$VO\`$JPTS8]'=TJ+>2DRXI?$
M:%=;V8>4#"R.X'A@SP!;D6IFH&CAK$EED6+"9`YB89!I19=R.8;^O"8L3-&$
M=ZB(G&7KPK:GK4M3-N<Q6T<FPJ?D\EM8LPNN0.KA*SRVJCY_)R(1#054<VXT
MTKXF`@D/!#*&-!M3:E42W!"&X:)R0S%,XD\=UA!_J+"6,S9#!N578XM5W4#-
MZ^P87;I]-*KTWO?84<0B_P!MK)%04TI!N0*'P"R2(+?,/K1UUP%"U]@H,<*X
M`P<.1C@,#?#(.X(N#)1,1`KX96MEA</.U[=%_AMT4%=O#_\`U+W]_5KY#O[:
MS-!;K0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!05$R#^>GJ]^F#M_P#>7U(H
M+=J!0>`8886%@P@\`\,>GJX!XXX86ZU[Y9=&.-K6MTY7O>__`(WH/W##$/''
M##''###&V&&&%K8XX8XVM;'''&UK6QQQM;HM:WP6M0>5!XY88YVM;/''.ULL
M,[6RM;*UL@\K9X96M>U[=;#/&U[7_EM>W30>5!I>=X):&P<<&XU=:L^6H3R7
M&VZD1UQ<\UN.GZT'<SU\DZ&RYVNZ6\8+FB2@F+:>&)F"-B8(G@;B%SA<P6&&
M!S"*`W&1!I^(Y;B5:D78U=OL2]4EW[)R>HS$IA2_L"GI35+,#Z.)&>J6G)MP
M8I/1X3#014%#+(I,-,MEB!8$44840.(\N3#5>)$F+DE#;TT/DM(\A3-"L+-6
M!8#?\JJ#W4=9<<DN4S+#;<>HJL;.L-E#IIHH&IAA8$!_)P^1?(0##`3,.K.\
ML^H)"/%Z0#>,XEG&TIFC;7=SP@H:ZS`C[*-Z6YF+8*,6M`]!JVTDV0LL9"(=
M0PDG0"@R<H!VO<$?/(,2V`;4A;D!@&:9+/P^*CS3"LLI[`6933V-LQ!$G:_K
MCCC1OJ:8C.MZLPU);;0T9TH;55%<D"K7(FQAD[QH#,P&&&)AG<-7LWEJU!>[
MI8":1'FI$C:7GDDQW#6RSQ@"66AJW+S[<1TPF-9MQ_.C@:Y%FJV;T4BN99`/
M"BETEPF+X!IAHWF,#B('1S[(<2[".;3YVL\5;Q?\-\BC@BA/'4[&40Y%4E-"
M'IY19C)O!IF"QH)=NYX)P72B!@+TEC'QG25DOD,%X#$4(M:Z;^;*.=-Q=4GF
M4,VD*C@TEDQMMX)LL^X;IA+;Z=7Q`.)]EF62M+9UNM9`.GVRN(">Z?%7X&:3
M%$LJ@W"'"L`%^=!'*4M7X^F67X2EY_K#^5A(!6CCO8<:ANTR3B(:1,B"BEH4
ME.ECER^(#G>S)(K)S%$,&A\BZ>,9N8Q`N9!+#`A(V@4"@4'AF&&)U?"!X9]3
M.PF'7QQRZ@F/3U1,>M:_5SQZ?@O;X;4'[?#'*^.66..66%[Y87O:U[X97QRP
MOEC>]NG&]\,KVZ;?Y+WM0>5!45P__P!2]_?U:^0[^VLS06ZT"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4%1,@_GIZO?I@[?_`'E]2*"W:@4"@4"@4"@4&OY8
MQ=^<627A'N5\']G'[RQ8^>-^B^+OR;JE9M96O_DOBM7`O0?,FT(VD24(_P#\
M-01UCDE>A%23=99@S5)F0HM0Y6`8RUZFS*+O9/=:"\"AEIE5ITO`NI)YD52R
M#,V4KC>#Z3%LN@-O;OZ!OV.&?$KO#V&FV7-IMF>4'CJ.RALX7CV-2[@8#=B9
MRJ[:CTVQ(K;K".Q0T6;%">LGCV/E9+5`!CJ@9,*0QC$2V.`89,FJ.R8NQ&SV
MO6Q$TS#M!+&S7'9MG$'&?M4[T1D,9A1@IR*R""?.NOS]:,,QVR(_9TNK2FB-
MQ=)/(UAADOM<H,2+6*F4P?`V$LXKY(H*7X/UIUE8^M,ER/M&!ZOT5NG2-RPT
M]F8=U]5F6H,].>[ME9R.Z.ST<L6/X``0S"RGKV(Q@DLC)A(-%%&%-%A<0VE"
M$9H4G<@7*$G*),\(P&W*''^_TA131Q"7D39YC0D$NNM61SH>.8(*UC&9>/BZ
MIAC:]C2<8N6,8YA#9X9!8,+K/!6!I-,H\9,YI8E)/29D52;);B(T"3RD=OAJ
M@C><[[!;Z>0R=Z@A+*GY4*YG<A<@U4L7,WO<0'&@WM0*!0*!0*!0*!05%</_
M`/4O?W]6OD._MK,T%NM`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!05R`MZ9
MUOD_UBSU,E]W1CL^!H]LAB$`'KC#4ZQ^JPEG-^O=WH,H&Y5VGUU';[P+O2S?
MQ)AD@%/PQ+(UEF(%;&^.0>SX@<YOUL@O=Z:B_P!YW0/B!SF_6R"]WIJ+_>=T
M#X@<YOUL@O=Z:B_WG=`^('.;];(+W>FHO]YW0/B!SF_6R"]WIJ+_`'G=`^('
M.;];(+W>FHO]YW0/B!SF_6R"]WIJ+_>=T#X@<YOUL@O=Z:B_WG=`^('.;];(
M+W>FHO\`>=T$8]46#RL?$%Z>KCMB:M%WTY3?X+HX]M3LF?=^_20O?3!>,_#\
MG&(.+%O+OESJ6*])#REXYXI?Q;P5!)SX@<YOUL@O=Z:B_P!YW0/B!SF_6R"]
MWIJ+_>=T#X@<YOUL@O=Z:B_WG=!&K6%@\KEVW*'T)[8B8C^L#-/TSV7./;4?
M-[?3O\<CGQ^N]\A>3C`QXY<+Q*Z+TV\5LTO)%B'2F^)WH)*_$#G-^MD%[O34
M7^\[H'Q`YS?K9!>[TU%_O.Z!\0.<WZV07N]-1?[SN@?$#G-^MD%[O347^\[H
M'Q`YS?K9!>[TU%_O.Z!\0.<WZV07N]-1?[SN@?$#G-^MD%[O347^\[H'Q`YS
M?K9!>[TU%_O.Z!\0.<WZV07N]-1?[SN@?$#G-^MD%[O347^\[H-V<*Z9@DZ_
M[*DU-[/.0)'QY!=QLYP<;SBYC0^(-.><D6^E$LV67'<OSBV"[*+.6PMDP<-?
M%$&`OTYA!=%K7"X6@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
.."@4"@4"@4"@4"@4'_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
